Citrus Sinensis ID: 002255
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 947 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | no | no | 0.965 | 0.970 | 0.641 | 0.0 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.831 | 0.652 | 0.292 | 8e-85 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.831 | 0.652 | 0.292 | 2e-84 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.803 | 0.734 | 0.304 | 3e-80 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.794 | 0.630 | 0.320 | 7e-78 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.802 | 0.652 | 0.300 | 3e-76 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.787 | 0.639 | 0.303 | 3e-75 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.817 | 0.647 | 0.292 | 6e-73 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.789 | 0.732 | 0.290 | 8e-72 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.412 | 0.550 | 0.384 | 2e-69 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1164 bits (3012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/930 (64%), Positives = 724/930 (77%), Gaps = 16/930 (1%)
Query: 24 SQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPK 83
+ S D +AM +LK SL P+S GW+DPDPCKW HI C+ + RVTRIQIG ++GTL
Sbjct: 23 ADSDGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSP 82
Query: 84 ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+L +LS L LE+ N ++G +PSLSGL+SLQ ++ +NNF S+PSD F+GLTSLQ++ +
Sbjct: 83 DLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEI 142
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
D N F SW IPESL++A+ LQ FSAN AN++G++P FLG D PGL LHLAFN L+G +
Sbjct: 143 DNNPFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGEL 202
Query: 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ 263
P+S S +Q+LWLNGQK L G + V+QNMT L ++WLH N F+GPLPD SGL L+
Sbjct: 203 PMSLAGSQVQSLWLNGQK----LTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELE 258
Query: 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323
S+RDN TG VP+SL++L SL VVNLTNN QG P F S V D+ K SNSFCL
Sbjct: 259 SLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSP 318
Query: 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383
G CD RV LL I S YP LAESWKGN+PC ++W G++C + GNITV++L+ + L+
Sbjct: 319 G-ECDPRVKSLLLIASSFDYPPRLAESWKGNDPC-TNWIGIAC-SNGNITVISLEKMELT 375
Query: 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIV 443
GTIS F + SL++++L N LTG IP+ELTTLP+L+ LDVS+N LFGKVP FR NV+V
Sbjct: 376 GTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVV 435
Query: 444 KTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCG 503
T+GNPDIGKD SS + S G G+ G ++ G IVGSV+G +
Sbjct: 436 NTNGNPDIGKDKSSLSSPGSSSPSGGS-GSGINGDKDRRGMKSSTFIGIIVGSVLGGLLS 494
Query: 504 AFIVGL-GFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKITVTESSVTGGG-SESQ 560
F++GL FC Y +++KR +S NAVV+HP + G D +VKITV SSV+ GG S++
Sbjct: 495 IFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVGGISDTY 554
Query: 561 SL--TSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIA 618
+L TS ++ +VEAG+M+ISIQVLR+VTNNFS +N+LG GGFG VYKGELHDGTKIA
Sbjct: 555 TLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIA 614
Query: 619 VKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRH 678
VKRME+ V++ KGFAEFKSEIAVLTKVRHRHLV LLGYCLDGNE+LLVYEYMPQGTLSRH
Sbjct: 615 VKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRH 674
Query: 679 LFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738
LF EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA
Sbjct: 675 LFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 734
Query: 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL 798
DFGLVRLAP+ GK SIETR+AGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITGRK+L
Sbjct: 735 DFGLVRLAPE-GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSL 793
Query: 799 DETQSEDSVHLVTWFRRMHINKD-TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPY 857
DE+Q E+S+HLV+WF+RM+INK+ +F+KAID TIDLDEETLAS+ TVA+LAGHCCAREPY
Sbjct: 794 DESQPEESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPY 853
Query: 858 QRPDMGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDSSSS 917
QRPDMGH VN+LSSL ELWKP++ + +DIYGIDLDM+LPQALKKWQAYEG S++ S+SS
Sbjct: 854 QRPDMGHAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSS 913
Query: 918 SFLASTDNTQTSIPTRPSGFADSFTSADGR 947
L S DNTQ SIPTRP GFA+SFTS DGR
Sbjct: 914 L-LPSLDNTQMSIPTRPYGFAESFTSVDGR 942
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 8e-85, Method: Compositional matrix adjust.
Identities = 269/919 (29%), Positives = 429/919 (46%), Gaps = 132/919 (14%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTV-LEVMKNKLTGQIP-SLSGLSSLQEVLFD 120
PS + + + G + +G P +L L V L++ N +G +P SL SSL+ V
Sbjct: 301 PSESLQYLYLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDIS 360
Query: 121 DNNFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
+NNF+ +P D L++++T+ L +N F +P+S + L+ + N+TG IP
Sbjct: 361 NNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGG-LPDSFSNLPKLETLDMSSNNLTGIIPS 419
Query: 180 -------------FLGGDTIPG-----------LMHLHLAFNFLQGPIPLSFG---KSSI 212
+L + G L+ L L+FN+L G IP S G K
Sbjct: 420 GICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKD 479
Query: 213 QTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDN 270
LWLN +L+G + + + +L L L N TGP+P LS + L S+ +N
Sbjct: 480 LILWLN------QLSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNN 533
Query: 271 QLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK-----------------FNSPVRFDMAK 313
QL+G +P+SL L +LA++ L NN G P N + + K
Sbjct: 534 QLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFK 593
Query: 314 GSNSFCL------------DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD- 360
S + + +D C G N+L + G + +PCN
Sbjct: 594 QSGNIAVALLTGKRYVYIKNDGSKECHGAGNLL----EFGGIRQEQLDRISTRHPCNFTR 649
Query: 361 -WKGVS---CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
++G++ + G++ ++L L G+I + L L L N+L+G IP++L
Sbjct: 650 VYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGG 709
Query: 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDS-SSFTPKSPPGSS-------- 467
L ++ +LD+S N G +PN ++ + G D+ ++ S P+S P +
Sbjct: 710 LKNVAILDLSYNRFNGTIPNSLTSLTLL--GEIDLSNNNLSGMIPESAPFDTFPDYRFAN 767
Query: 468 ------PTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLY------- 514
P P S G AN++ + + S+ G V + L FC++
Sbjct: 768 NSLCGYPLPLPCSS---GPKSDANQHQKSHRRQASLAGSVAMGLLFSL-FCIFGLIIVAI 823
Query: 515 -TRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVV 573
T+KR+R + H + +A K T +++ +L
Sbjct: 824 ETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALS--------------INLAAF 869
Query: 574 EAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFA 633
E ++ L TN F ++++G GGFG VYK +L DG+ +A+K++ VS +G
Sbjct: 870 EKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKL--IHVSGQGDR 927
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L +RK+ G+K L W
Sbjct: 928 EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK-LNWP 986
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
R IA+ ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL H
Sbjct: 987 ARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813
+ LAGT GY+ PEY + R +TK DV+S+GV+L+EL+TG++ D D+ +LV W
Sbjct: 1047 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDN-NLVGWV 1105
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADL--AGHCCAREPYQRPDMGHVVNVLSS 871
++H K DR + L E+ I + L A C ++RP M + V++
Sbjct: 1106 -KLHA-KGKITDVFDREL-LKEDASIEIELLQHLKVACACLDDRHWKRPTM---IQVMAM 1159
Query: 872 LAELWKPAEPDSDDIYGID 890
E+ + DS G D
Sbjct: 1160 FKEIQAGSGMDSTSTIGAD 1178
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 269/919 (29%), Positives = 428/919 (46%), Gaps = 132/919 (14%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTV-LEVMKNKLTGQIP-SLSGLSSLQEVLFD 120
PS + + + G + +G P +L L V L++ N +G +P SL SSL+ V
Sbjct: 301 PSESLQYLYLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDIS 360
Query: 121 DNNFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
NNF+ +P D L++++T+ L +N F +P+S + L+ + N+TG IP
Sbjct: 361 YNNFSGKLPVDTLSKLSNIKTMVLSFNKFVGG-LPDSFSNLLKLETLDMSSNNLTGVIPS 419
Query: 180 -------------FLGGDTIPG-----------LMHLHLAFNFLQGPIPLSFG---KSSI 212
+L + G L+ L L+FN+L G IP S G K
Sbjct: 420 GICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKD 479
Query: 213 QTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDN 270
LWLN +L+G + + + +L L L N TGP+P LS + L S+ +N
Sbjct: 480 LILWLN------QLSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNN 533
Query: 271 QLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK-----------------FNSPVRFDMAK 313
QL+G +P+SL L +LA++ L NN G P N + + K
Sbjct: 534 QLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFK 593
Query: 314 GSNSFCL------------DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD- 360
S + + +D C G N+L + G + +PCN
Sbjct: 594 QSGNIAVALLTGKRYVYIKNDGSKECHGAGNLL----EFGGIRQEQLDRISTRHPCNFTR 649
Query: 361 -WKGVS---CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
++G++ + G++ ++L L G+I + L L L N+L+G IP++L
Sbjct: 650 VYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGG 709
Query: 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDS-SSFTPKSPPGSS-------- 467
L ++ +LD+S N G +PN ++ + G D+ ++ S P+S P +
Sbjct: 710 LKNVAILDLSYNRFNGTIPNSLTSLTLL--GEIDLSNNNLSGMIPESAPFDTFPDYRFAN 767
Query: 468 ------PTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLY------- 514
P P S G AN++ + + S+ G V + L FC++
Sbjct: 768 NSLCGYPLPIPCSS---GPKSDANQHQKSHRRQASLAGSVAMGLLFSL-FCIFGLIIVAI 823
Query: 515 -TRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVV 573
T+KR+R + H + +A K T +++ +L
Sbjct: 824 ETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALS--------------INLAAF 869
Query: 574 EAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFA 633
E ++ L TN F ++++G GGFG VYK +L DG+ +A+K++ VS +G
Sbjct: 870 EKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKL--IHVSGQGDR 927
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L +RK+ G+K L W
Sbjct: 928 EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIK-LNWP 986
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
R IA+ ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL H
Sbjct: 987 ARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813
+ LAGT GY+ PEY + R +TK DV+S+GV+L+EL+TG++ D D+ +LV W
Sbjct: 1047 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDN-NLVGWV 1105
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADL--AGHCCAREPYQRPDMGHVVNVLSS 871
++H K DR + L E+ I + L A C ++RP M + V++
Sbjct: 1106 -KLHA-KGKITDVFDREL-LKEDASIEIELLQHLKVACACLDDRHWKRPTM---IQVMAM 1159
Query: 872 LAELWKPAEPDSDDIYGID 890
E+ + DS G D
Sbjct: 1160 FKEIQAGSGMDSTSTIGAD 1178
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (768), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 266/874 (30%), Positives = 414/874 (47%), Gaps = 113/874 (12%)
Query: 61 CSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-PSLSGLSSLQEVLF 119
CS S + ++ I + G LP L S+ L L + N L+G++ +LS LS L+ +L
Sbjct: 206 CSKS--IQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLLI 263
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
+N F+ V D F LT L+ + + N F S P SL + L+ +++G+I
Sbjct: 264 SENRFSDVIPDVFGNLTQLEHLDVSSNKF-SGRFPPSLSQCSKLRVLDLRNNSLSGSINL 322
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGD------------- 223
G T L L LA N GP+P S G K I +L N +G
Sbjct: 323 NFTGFT--DLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLF 380
Query: 224 --------SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTG 274
+ ++ V+Q+ +L+ L L N +P+ ++G +L ++ + L G
Sbjct: 381 LSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRG 440
Query: 275 IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVL 334
+PS L+N L V++L+ N F G P + + K + F +D + G + V
Sbjct: 441 QIPSWLLNCKKLEVLDLSWNHFYGTIPHW-------IGKMESLFYIDFSNNTLTGAIPVA 493
Query: 335 LSIVKSV--------------GYPAVLAESWKGNN-PCNSDWKGVSCDAGGNITVVNLKN 379
++ +K++ G P + + N P N + + L N
Sbjct: 494 ITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSRFPPS--------IYLNN 545
Query: 380 LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ 439
L+GTI RL L L LS N TGTIP ++ L +LE+LD+S NHL+G +P Q
Sbjct: 546 NRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQ 605
Query: 440 NVIV---------KTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGN-------GSSGG 483
++ + G G SF S G+ DS + G
Sbjct: 606 SLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLMSNMLNPKGS 665
Query: 484 ANKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAV 543
+ +N+N GK S + V+ + +G+ L +V++ + D +
Sbjct: 666 SRRNNNGGKFGRSSIVVLTISLAIGITLLL---------------SVILLRISRKDVDDR 710
Query: 544 KITVTESSVTGGGSESQSLTSSGPSDLHVVEA-GSMVISIQVLRNVTNNFSEENVLGRGG 602
V E +++G S++L GPS + + + G +S++ L TNNFS+ N++G GG
Sbjct: 711 INDVDEETISG---VSKAL---GPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGG 764
Query: 603 FGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662
FG VYK DG+K AVKR+ + EF++E+ L++ H++LV L GYC GN+
Sbjct: 765 FGLVYKANFPDGSKAAVKRLSGDCGQME--REFQAEVEALSRAEHKNLVSLQGYCKHGND 822
Query: 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722
RLL+Y +M G+L L R + G L W RL IA ARG+ YLH + + IHRD+
Sbjct: 823 RLLIYSFMENGSLDYWLHERVD-GNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDV 881
Query: 723 KPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVF 782
K SNILL + A +ADFGL RL H + T L GT GY+ PEY+ + T + DV+
Sbjct: 882 KSSNILLDEKFEAHLADFGLARLLRPYDTH-VTTDLVGTLGYIPPEYSQSLIATCRGDVY 940
Query: 783 SFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA--IDRTI--DLDEETL 838
SFGV+L+EL+TGR+ ++ + + LV+ +M K R+A ID TI +++E T+
Sbjct: 941 SFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAEK---REAELIDTTIRENVNERTV 997
Query: 839 ASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
+ ++A C EP +RP + VV L L
Sbjct: 998 LEM---LEIACKCIDHEPRRRPLIEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 281/877 (32%), Positives = 416/877 (47%), Gaps = 125/877 (14%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
S + I + G + GT+ + + SSL L + N++ G IP L + D NN
Sbjct: 376 SGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDLDSNN 435
Query: 124 FT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
FT +P +K T+L + YN + + +P + +A L+R + +TG IP +G
Sbjct: 436 FTGEIPKSLWKS-TNLMEFTASYNRLEGY-LPAEIGNAASLKRLVLSDNQLTGEIPREIG 493
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLT 240
T L L+L N QG IP+ G +S+ TL L G + L G + I + L
Sbjct: 494 KLT--SLSVLNLNANMFQGKIPVELGDCTSLTTLDL----GSNNLQGQIPDKITALAQLQ 547
Query: 241 QLWLHGNSFTG-------------PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287
L L N+ +G +PDLS L F + N+L+G +P L L
Sbjct: 548 CLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLV 607
Query: 288 VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347
++L+NN G+ P +++ +N LD +G A G SI K +G L
Sbjct: 608 EISLSNNHLSGEIPA-------SLSRLTNLTILDLSGNALTG------SIPKEMGNSLKL 654
Query: 348 AESWKGNNPCNSDWKGVSCDAGG--------NIT-----------VVNLKNL-------- 380
+G N N+ G ++ G N+T + NLK L
Sbjct: 655 ----QGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFN 710
Query: 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN 440
LSG +SS S + L L + N+ TG IP EL L LE LDVS N L G++P
Sbjct: 711 NLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIP----- 765
Query: 441 VIVKTDGNPDIGKDSSSFTPKSPPGSSPT------PPGGDSGGNGSSGGANKNSNTGKIV 494
K G P++ + + + G P+ P GN G S+ KI
Sbjct: 766 --TKICGLPNL--EFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDC-KIE 820
Query: 495 GS-------VVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITV 547
G+ + G++ G I+ F R+ + RV+ + P + + +K V
Sbjct: 821 GTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRD----DPERMEE-SRLKGFV 875
Query: 548 TESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVY 607
++ GS S+ S ++ + E + + + + T++FS++N++G GGFGTVY
Sbjct: 876 DQNLYFLSGSRSREPLSI---NIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVY 932
Query: 608 KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667
K L +AVK++ A +G EF +E+ L KV+H +LV LLGYC E+LLVY
Sbjct: 933 KACLPGEKTVAVKKLSEA--KTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVY 990
Query: 668 EYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726
EYM G+L L R + G L+ L+W++RL IA+ ARG+ +LH IHRD+K SN
Sbjct: 991 EYMVNGSLDHWL--RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASN 1048
Query: 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGV 786
ILL D KVADFGL RL H + T +AGTFGY+ PEY + R TTK DV+SFGV
Sbjct: 1049 ILLDGDFEPKVADFGLARLISACESH-VSTVIAGTFGYIPPEYGQSARATTKGDVYSFGV 1107
Query: 787 ILMELITGRKAL--DETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASIST- 843
IL+EL+TG++ D +SE +LV W I K KA+D ID L S++
Sbjct: 1108 ILLELVTGKEPTGPDFKESEGG-NLVGW----AIQKINQGKAVD-VID---PLLVSVALK 1158
Query: 844 -----VADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875
+ +A C A P +RP+M ++VL +L E+
Sbjct: 1159 NSQLRLLQIAMLCLAETPAKRPNM---LDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 258/859 (30%), Positives = 406/859 (47%), Gaps = 99/859 (11%)
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQ-----EVLFD 120
R+T + + NI G++P L + S+L VL++ N+ TG++PS G SLQ E L
Sbjct: 352 RITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPS--GFCSLQSSSVLEKLLI 409
Query: 121 DNNFTS--VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
NN+ S VP + K SL+TI L +N+ + +IP+ + L N+TG IP
Sbjct: 410 ANNYLSGTVPVELGK-CKSLKTIDLSFNAL-TGLIPKEIWTLPKLSDLVMWANNLTGGIP 467
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
+ + D L L L N L G +P S K + LW++
Sbjct: 468 ESICVDG-GNLETLILNNNLLTGSLPESISKCT-NMLWIS-------------------- 505
Query: 239 LTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L N TG +P + L L + +N LTG +PS L N +L ++L +N
Sbjct: 506 -----LSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLT 560
Query: 298 GQTPKFNSPVRFDMAKGSNS-----FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
G P + + GS S F ++ G C G +V+ G A E +
Sbjct: 561 GNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAG----GLVEFEGIRAERLEHFP 616
Query: 353 GNNPCNSD--WKGVSC---DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT 407
+ C + G++ + G++ ++L +SG+I + + L+ L L N LT
Sbjct: 617 MVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLT 676
Query: 408 GTIPKELTTLPSLEMLDVSNNHLFGKVP------NFRQNVIVKTD---GNPDIGKDSSSF 458
GTIP L ++ +LD+S+N L G +P +F ++ V + G G ++F
Sbjct: 677 GTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTF 736
Query: 459 TPKSPPGSS-----PTPPGGDSGGNGSSGGANKNSN---TGKIVGSVVGVVCGAFIVGLG 510
+S P PP SG + A+ TG G V +C IV L
Sbjct: 737 PLTRYANNSGLCGVPLPP-CSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMC---IVMLI 792
Query: 511 FCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSES--QSLTSSGPS 568
LY ++ + Q + P++G + S+ E + LT +
Sbjct: 793 MALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFA--- 849
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS 628
H++EA TN FS ++++G GGFG VYK +L DG+ +A+K++ V+
Sbjct: 850 --HLLEA-------------TNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKL--IQVT 892
Query: 629 EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK 688
+G EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L + ++G
Sbjct: 893 GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGI 952
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L+W+ R IA+ ARG+ +LH IHRD+K SN+LL D A+V+DFG+ RL
Sbjct: 953 FLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSA 1012
Query: 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808
H + LAGT GY+ PEY + R T K DV+S+GVIL+EL++G+K +D + + +
Sbjct: 1013 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNN 1072
Query: 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868
LV W ++++ K + +D + D+ + +A C P++RP M V+ +
Sbjct: 1073 LVGWAKQLYREKRG-AEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTM 1131
Query: 869 LSSLAELWKPAEPDSDDIY 887
L ++ E DS D +
Sbjct: 1132 FKELVQV--DTENDSLDEF 1148
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (725), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 262/862 (30%), Positives = 389/862 (45%), Gaps = 116/862 (13%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQ-----EVLFDD 121
+T + + NI G++P L + S+L VL++ N TG +PS G SLQ E +
Sbjct: 353 ITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPS--GFCSLQSSPVLEKILIA 410
Query: 122 NNFTS--VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
NN+ S VP + K SL+TI L +N IP+ + L N+TGTIP+
Sbjct: 411 NNYLSGTVPMELGK-CKSLKTIDLSFNELTG-PIPKEIWMLPNLSDLVMWANNLTGTIPE 468
Query: 180 FLGGDTIPG--LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
G + G L L L N L G IP S I T
Sbjct: 469 ---GVCVKGGNLETLILNNNLLTGSIPES--------------------------ISRCT 499
Query: 238 SLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
++ + L N TG +P + LS L + +N L+G VP L N SL ++L +N
Sbjct: 500 NMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNL 559
Query: 297 QGQTPKFNSPVRFDMAKGSNS-----FCLDDAGVACDG----------------RVNVLL 335
G P + + GS S F ++ G C G R+ ++
Sbjct: 560 TGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVH 619
Query: 336 SIVKSVGYPAVLAESWKGNNPC---NSDWKGVSC---DAGGNITVVNLKNLG---LSGTI 386
S + Y + ++ N + + VS GN+ + + NLG ++GTI
Sbjct: 620 SCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTI 679
Query: 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTD 446
+F L ++ L LS N L G +P L +L L LDVSNN+L G +P Q
Sbjct: 680 PDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVS 739
Query: 447 GNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNS-NTGKIVGSVVGVVCGAF 505
+ P P GS+P P S A K + T I G +C
Sbjct: 740 RYAN--NSGLCGVPLRPCGSAPRRP------ITSRIHAKKQTVATAVIAGIAFSFMCFVM 791
Query: 506 IVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSS 565
+V LY R RK + Q + S+ GS S L SS
Sbjct: 792 LV---MALY-RVRKVQKKEQKREKYI------------------ESLPTSGSCSWKL-SS 828
Query: 566 GPSDLHV----VEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKR 621
P L + E ++ L TN FS E ++G GGFG VYK +L DG+ +A+K+
Sbjct: 829 VPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKK 888
Query: 622 MESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFN 681
+ ++ +G EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L
Sbjct: 889 L--IRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHE 946
Query: 682 RK-EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740
+ ++G L W R IA+ ARG+ +LH IHRD+K SN+LL +D A+V+DF
Sbjct: 947 KSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDF 1006
Query: 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 800
G+ RL H + LAGT GY+ PEY + R T K DV+S+GVIL+EL++G+K +D
Sbjct: 1007 GMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP 1066
Query: 801 TQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
+ + +LV W ++++ K + +D + D+ + +A C P++RP
Sbjct: 1067 GEFGEDNNLVGWAKQLYREKRG-AEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRP 1125
Query: 861 DMGHVVNVLSSLAELWKPAEPD 882
M + +++ E+ E D
Sbjct: 1126 TM---IQLMAMFKEMKADTEED 1144
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 6e-73, Method: Compositional matrix adjust.
Identities = 255/873 (29%), Positives = 409/873 (46%), Gaps = 99/873 (11%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNF 124
+T + + G + G +P S S L L + N +G++P +L + L+ + N F
Sbjct: 318 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 377
Query: 125 T-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATG-LQRFSANGANITGTIPDFLG 182
+ +P SL T+ L N+F ++P ++ LQ TG IP L
Sbjct: 378 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL- 436
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
L+ LHL+FN+L G IP S G K LWLN +G+ + + +L
Sbjct: 437 -SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP-----QELMYVKTL 490
Query: 240 TQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N TG +P LS ++L S+ +N+LTG +P + L +LA++ L+NN F G
Sbjct: 491 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 550
Query: 299 QTPK-----------------FNSPVRFDMAKGSNSFCL-------------DDAGVACD 328
P FN + M K S D C
Sbjct: 551 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 610
Query: 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWK------GVSCDAGGNITVVNLKNLGL 382
G N+L + G + NPCN + + D G++ +++ L
Sbjct: 611 GAGNLL----EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 666
Query: 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVI 442
SG I + L L L N+++G+IP E+ L L +LD+S+N L G++P +
Sbjct: 667 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 726
Query: 443 VKTDGN----------PDIGKDSSSFTPK---SPPGSSPTP-PGGDSGGNGSSGGANKNS 488
+ T+ + P++G+ +F P + PG P P D + + G A+
Sbjct: 727 MLTEIDLSNNNLSGPIPEMGQ-FETFPPAKFLNNPGLCGYPLPRCDP--SNADGYAHHQR 783
Query: 489 NTGK----IVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVK 544
+ G+ + GSV + +F+ G L R+ ++ R + + +G G+
Sbjct: 784 SHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTA 843
Query: 545 ITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFG 604
T +TG E+ S+ +L E ++ L TN F ++++G GGFG
Sbjct: 844 -NNTNWKLTGV-KEALSI------NLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFG 895
Query: 605 TVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664
VYK L DG+ +A+K++ VS +G EF +E+ + K++HR+LV LLGYC G+ERL
Sbjct: 896 DVYKAILKDGSAVAIKKL--IHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERL 953
Query: 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 724
LVYE+M G+L L + K+ G+K L W+ R IA+ ARG+ +LH IHRD+K
Sbjct: 954 LVYEFMKYGSLEDVLHDPKKAGVK-LNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKS 1012
Query: 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSF 784
SN+LL +++ A+V+DFG+ RL H + LAGT GY+ PEY + R +TK DV+S+
Sbjct: 1013 SNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSY 1072
Query: 785 GVILMELITGRKALDETQSEDSVHLVTWFR---RMHINKDTFRKAIDRTIDLDEETLASI 841
GV+L+EL+TG++ D D+ +LV W + ++ I+ D F + + E+ I
Sbjct: 1073 GVVLLELLTGKRPTDSPDFGDN-NLVGWVKQHAKLRIS-DVFDPEL-----MKEDPALEI 1125
Query: 842 STVADL--AGHCCAREPYQRPDMGHVVNVLSSL 872
+ L A C ++RP M V+ + +
Sbjct: 1126 ELLQHLKVAVACLDDRAWRRPTMVQVMAMFKEI 1158
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 252/868 (29%), Positives = 387/868 (44%), Gaps = 120/868 (13%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFT 125
V + + N+ G++P+EL LS+L+VL + N+L+G + S L LS+L + N F+
Sbjct: 208 VEYLGLASNNLSGSIPQELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISSNKFS 267
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
D F L L S N F+ +P SL ++ + S ++G I +L
Sbjct: 268 GKIPDVFLELNKLWYFSAQSNLFNG-EMPRSLSNSRSISLLSLRNNTLSGQI--YLNCSA 324
Query: 186 IPGLMHLHLAFNFLQGPIP-----------LSFGK----SSIQTLWLNGQKGDS------ 224
+ L L LA N G IP ++F K + I + N Q S
Sbjct: 325 MTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSFSNS 384
Query: 225 ---KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLS--------------------- 260
++ ++ ++Q+ +L L L N LP + L
Sbjct: 385 SIQNISSALEILQHCQNLKTLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTVPQW 444
Query: 261 -----SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
SLQ + NQL+G +P L +L+SL ++L+NN F G+ P + ++ ++K
Sbjct: 445 LSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVSK-E 503
Query: 316 NSFCLDDAGVACDGRVNVL---LSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG-- 370
N+ + N L + +P ++ S+ N S W + G
Sbjct: 504 NAVEEPSPDFPFFKKKNTNAGGLQYNQPSSFPPMIDLSYNSLN--GSIWP----EFGDLR 557
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ V+NLKN LSG I +N S +TSL L LS N L+G IP L L L V+ N L
Sbjct: 558 QLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPSLVKLSFLSTFSVAYNKL 617
Query: 431 FGKVP---NFRQNVIVKTDGNPDIGKDSSS---FTPKSPPGSSPTPPGGDSGGNGSSGGA 484
G +P F+ +GN + + +S T +SP GS+
Sbjct: 618 SGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSPHGSA----------------V 661
Query: 485 NKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVK 544
N KIV VG G + L + G V P D + ++
Sbjct: 662 KSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVD--------PEKKADADEIE 713
Query: 545 ITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFG 604
+ GS S L + S+ +S+ + T++F++ N++G GGFG
Sbjct: 714 L----------GSRSVVLFHNKDSNNE--------LSLDDILKSTSSFNQANIIGCGGFG 755
Query: 605 TVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664
VYK L DGTK+A+KR+ + + EF++E+ L++ +H +LV LLGYC N++L
Sbjct: 756 LVYKATLPDGTKVAIKRLSGD--TGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKL 813
Query: 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 724
L+Y YM G+L + + K +G L+W RL IA A G+ YLH +HRD+K
Sbjct: 814 LIYSYMDNGSLD-YWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKS 872
Query: 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSF 784
SNILL D A +ADFGL RL H + T L GT GY+ PEY T K DV+SF
Sbjct: 873 SNILLSDTFVAHLADFGLARLILPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSF 931
Query: 785 GVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTV 844
GV+L+EL+TGR+ +D + S L++W +M K I D++ + V
Sbjct: 932 GVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEKR--ESEIFDPFIYDKDHAEEMLLV 989
Query: 845 ADLAGHCCAREPYQRPDMGHVVNVLSSL 872
++A C P RP +V+ L ++
Sbjct: 990 LEIACRCLGENPKTRPTTQQLVSWLENI 1017
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 169/440 (38%), Positives = 242/440 (55%), Gaps = 49/440 (11%)
Query: 463 PPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVG-SVVGVVCGAFIVGLGFCLYTRKRKRS 521
P + PP +SGG G K I G +V+ ++ F+V RK+KR+
Sbjct: 215 PSSGNSVPPPANSGG----GYQGKTMAGFAIAGFAVIALMAVVFLV-------RRKKKRN 263
Query: 522 GRVQSPNAVVIHPSN---GGDGNAVKITVTESSVTGGGSESQSLTSSGPS---------- 568
S ++ + PSN DG T+ GG SQ ++SG S
Sbjct: 264 IDAYS-DSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGY 322
Query: 569 -------DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKR 621
D V+ +G + + L ++T FS+ N+LG GGFG VYKG+L+DG +AVK+
Sbjct: 323 TRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQ 382
Query: 622 MESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFN 681
++ V S +G EFK+E+ ++++V HRHLV L+GYC+ +ERLL+YEY+P TL HL
Sbjct: 383 LK--VGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG 440
Query: 682 RKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
+ G LEW RR+ IA+ A+G+ YLH H IHRD+K +NILL D+ A+VADFG
Sbjct: 441 K---GRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFG 497
Query: 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDET 801
L +L D+ + + TR+ GTFGYLAPEYA +G++T + DVFSFGV+L+ELITGRK +D+
Sbjct: 498 LAKLN-DSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQY 556
Query: 802 QSEDSVHLVTWFRRM---HINKDTFRKAIDRTID---LDEETLASISTVADLAGHCCARE 855
Q LV W R + I F + +DR ++ ++ E I T A H +
Sbjct: 557 QPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK- 615
Query: 856 PYQRPDMGHVVNVLSSLAEL 875
RP M VV L S ++
Sbjct: 616 ---RPRMVQVVRALDSEGDM 632
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 947 | ||||||
| 255573218 | 935 | receptor protein kinase, putative [Ricin | 0.980 | 0.993 | 0.701 | 0.0 | |
| 224108223 | 930 | predicted protein [Populus trichocarpa] | 0.957 | 0.975 | 0.690 | 0.0 | |
| 224101923 | 931 | predicted protein [Populus trichocarpa] | 0.978 | 0.995 | 0.686 | 0.0 | |
| 359472575 | 937 | PREDICTED: probable receptor protein kin | 0.977 | 0.988 | 0.697 | 0.0 | |
| 359476563 | 889 | PREDICTED: probable receptor protein kin | 0.935 | 0.996 | 0.676 | 0.0 | |
| 449450141 | 950 | PREDICTED: probable receptor protein kin | 0.963 | 0.96 | 0.662 | 0.0 | |
| 7672732 | 945 | LRR receptor-like protein kinase [Nicoti | 0.960 | 0.962 | 0.691 | 0.0 | |
| 224069210 | 945 | predicted protein [Populus trichocarpa] | 0.987 | 0.989 | 0.662 | 0.0 | |
| 449445063 | 953 | PREDICTED: probable receptor protein kin | 0.990 | 0.984 | 0.670 | 0.0 | |
| 351727489 | 941 | NAK-type protein kinase precursor [Glyci | 0.983 | 0.989 | 0.663 | 0.0 |
| >gi|255573218|ref|XP_002527538.1| receptor protein kinase, putative [Ricinus communis] gi|223533088|gb|EEF34847.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1325 bits (3430), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/953 (70%), Positives = 771/953 (80%), Gaps = 24/953 (2%)
Query: 1 MKKRHLGVSLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPC--KWKH 58
MKKRH GVSL + NSQ + DA+ M LK SLGNP+ W+ DPC KW H
Sbjct: 1 MKKRHPGVSLIPFFFMGFLSLANSQQNGDASVMLKLKESLGNPSF--WSGSDPCNDKWDH 58
Query: 59 IQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVL 118
+ C SNRVT IQIG QN+ GTLP EL+ L++L LEVM N L+G +PSLSGLSSLQ VL
Sbjct: 59 VTCDSSNRVTDIQIGRQNLVGTLPPELSKLTALKRLEVMFNNLSGPVPSLSGLSSLQVVL 118
Query: 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
+N F+S PSDFF GL S+ T+SLDYN F W IP SL +A+ L+ FSAN A+ITG IP
Sbjct: 119 LHNNEFSSFPSDFFNGLNSITTVSLDYNPFTPWEIPVSLTNASTLKEFSANKASITGKIP 178
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS-SIQTLWLNGQKGDSKLNGSVAVIQNMT 237
DF D PGL LHLA N L+G +P SF +S +I +LWLNGQ+ LNG+++V+QNMT
Sbjct: 179 DFFNNDVFPGLESLHLAMNSLEGELPGSFSRSPTITSLWLNGQR----LNGTISVLQNMT 234
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LT++WLH N FTGPLP+ + + LQ S+RDN+ TGIVP SLV L +L+VVNLTNNL Q
Sbjct: 235 GLTEIWLHMNQFTGPLPEFNDFNGLQKLSLRDNRFTGIVPESLVKLPTLSVVNLTNNLLQ 294
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
G TP+F VR DM SN FC + GVACD RV VLLSIVK GYPA LA++W+GN+PC
Sbjct: 295 GPTPEFPDSVRVDMTSESNRFCTPNPGVACDHRVEVLLSIVKDFGYPANLADNWEGNDPC 354
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
+ WKG++C GGNITV+N + +GL+GTIS NFS + SL++L+L+ N L GTIP ELTT+
Sbjct: 355 -AQWKGITCSPGGNITVINFQGMGLTGTISPNFSLIPSLQKLILANNSLNGTIPSELTTM 413
Query: 418 PSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSP--TPPGGDS 475
PSL +L+V+NN L+GK+P+F+Q V V TDGNPDIGKD+SS PPGS+P TP G
Sbjct: 414 PSLSLLNVANNQLYGKLPSFKQ-VQVITDGNPDIGKDTSS---SIPPGSTPGSTPSGKPG 469
Query: 476 GGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPS 535
GG+ S NKNS+TGKI+GSVVG VCG +VGLG Y+RK+KR +VQSPN +VIHP
Sbjct: 470 GGSNSDATGNKNSSTGKIIGSVVGAVCGLCVVGLGVFFYSRKQKRYSKVQSPNMMVIHPR 529
Query: 536 NGGDGNAVKITVTESSVTGGGSESQSLT-SSGPSDLHVVEAGSMVISIQVLRNVTNNFSE 594
+ G+ +AVKITV ESS G ++S T SSGPSD+HVVEAG+MVISIQVLRNVTN+FSE
Sbjct: 530 HSGNQDAVKITVAESSTVG---RAESCTDSSGPSDIHVVEAGNMVISIQVLRNVTNDFSE 586
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+N+LGRGGFGTVYKGELHDGTKIAVKRMES V+SEKG AEF SEIAVL KVRHRHLV LL
Sbjct: 587 DNILGRGGFGTVYKGELHDGTKIAVKRMESGVLSEKGLAEFTSEIAVLNKVRHRHLVALL 646
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
GYCLDGNERLLVYEYMPQGTLS+ LFN KEEG+KPL+WTRRLTIALDVARGVEYLHGLAH
Sbjct: 647 GYCLDGNERLLVYEYMPQGTLSKFLFNWKEEGVKPLDWTRRLTIALDVARGVEYLHGLAH 706
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
QSFIHRDLKPSNILLGDD+RAKVADFGLVRLAP+ GK SIETRLAGTFGYLAPEYAVTGR
Sbjct: 707 QSFIHRDLKPSNILLGDDLRAKVADFGLVRLAPE-GKASIETRLAGTFGYLAPEYAVTGR 765
Query: 775 VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834
VTTKVDVFSFGVILME+ITGR+ALD++Q EDS+HLVTWFRRMHINKDTFRK+ID TIDLD
Sbjct: 766 VTTKVDVFSFGVILMEMITGRRALDDSQPEDSMHLVTWFRRMHINKDTFRKSIDPTIDLD 825
Query: 835 EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMT 894
EETLASISTVA+LAGHC AREPYQRPDMGHVVNVLSSL ELW+PAEPDSDDIYGIDL+MT
Sbjct: 826 EETLASISTVAELAGHCTAREPYQRPDMGHVVNVLSSLVELWRPAEPDSDDIYGIDLEMT 885
Query: 895 LPQALKKWQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADSFTSADGR 947
LPQALKKWQA+EG + G SSSF STDNTQTSIPTRPSGFADSFTSADGR
Sbjct: 886 LPQALKKWQAFEGGNVDG---SSSFATSTDNTQTSIPTRPSGFADSFTSADGR 935
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108223|ref|XP_002314766.1| predicted protein [Populus trichocarpa] gi|222863806|gb|EEF00937.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1269 bits (3283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 641/928 (69%), Positives = 748/928 (80%), Gaps = 21/928 (2%)
Query: 23 NSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLP 82
NSQ + DAAAM L+ SLGNP++LGW+ DPC W H+ C NRVTRIQIG QN++GTLP
Sbjct: 21 NSQQNDDAAAMMKLRGSLGNPSTLGWSGSDPCNWLHVGCL-DNRVTRIQIGNQNLQGTLP 79
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
EL L+ LT EVM N+L G +PSLSGLS LQ + +N F+S+P DFF G+TSL ++
Sbjct: 80 PELKDLTQLTRFEVMNNQLMGALPSLSGLSFLQVLFLHNNTFSSIPPDFFAGMTSLTSVY 139
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
LDYN F+SW IPESLKDA+ L+ FSANGAN+ G IP+F D PG+ LHLAFN+ +G
Sbjct: 140 LDYNPFESWEIPESLKDASALKEFSANGANVAGKIPEFFNSDVFPGMETLHLAFNYFEGG 199
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
+PL+F S+IQ+LWLNGQK +S+LNG+++++QNMTSL ++WL GN FTGPLPDLSG+ SL
Sbjct: 200 LPLNFSGSTIQSLWLNGQKSNSRLNGTISILQNMTSLKEIWLQGNHFTGPLPDLSGMISL 259
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDD 322
+D ++RDN LTG+VP SL+N+ +L VVN TNN QG TP F V DM G+N+FCLD+
Sbjct: 260 EDLNLRDNSLTGVVPPSLLNISTLRVVNFTNNKLQGPTPSFARTVDADMIPGTNNFCLDN 319
Query: 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD--WKGVSCDAGGNITVVNLKNL 380
GVACD VNVLLS+ K+ GYPA LA+ WKGN+PC S WKG++C GG+I V+NLK
Sbjct: 320 PGVACDSTVNVLLSVAKNFGYPASLADLWKGNDPCTSTQAWKGITC-GGGDILVINLKKA 378
Query: 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN 440
GLSGTISS+FS ++ L++L+LS N LTGTIP EL +L +L +LDVSNN L G++P FR N
Sbjct: 379 GLSGTISSDFSLISRLQKLILSDNMLTGTIPDELISLSNLALLDVSNNKLSGQIPKFRSN 438
Query: 441 VIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGV 500
V V+ GNPDIGK ++S+ +PPG+ + G GS G NKNS +GKIVGSV+G
Sbjct: 439 VQVEYGGNPDIGKINTSY---APPGAPGS--TPSGTGGGSDGSGNKNSASGKIVGSVIGA 493
Query: 501 VCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQ 560
V +VGLG Y++K+KRS +VQSPN ++IHP D + VKITV SS G +
Sbjct: 494 VGVVCVVGLGVFFYSKKQKRSSKVQSPNMMIIHPRRSWDQDEVKITVAGSSANSG---VE 550
Query: 561 SLTSS-GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAV 619
S T S GPSD+ VV +MVISIQVLRNVTNNFSEEN+LGRGGFGTVYKGELHDGTKIAV
Sbjct: 551 SFTDSVGPSDIQVVRTENMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAV 610
Query: 620 KRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL 679
KRMES V+SEKG AEF SEIAVLTKVRHRHLV LLGYCLDGNERLLVYEYMP+GTLS HL
Sbjct: 611 KRMESGVISEKGLAEFMSEIAVLTKVRHRHLVALLGYCLDGNERLLVYEYMPRGTLSSHL 670
Query: 680 FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739
F+ KEEG+KPL+WTRRLTI LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD
Sbjct: 671 FSWKEEGVKPLDWTRRLTIGLDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 730
Query: 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALD 799
FGLVRLAP+ GK SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILME+ITGRKALD
Sbjct: 731 FGLVRLAPE-GKASIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEMITGRKALD 789
Query: 800 ETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQR 859
ETQ EDS+HLVTWFRRMHINKDTFRK ID TI+LDEETL SISTVADLAGHC AREPYQR
Sbjct: 790 ETQPEDSLHLVTWFRRMHINKDTFRKTIDPTINLDEETLGSISTVADLAGHCTAREPYQR 849
Query: 860 PDMGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDSSSSSF 919
PDMGHVVNVLSSL E+WKPAEPDSD++YGID +M LP+ L KWQA++G SSSSF
Sbjct: 850 PDMGHVVNVLSSLVEIWKPAEPDSDEMYGIDFEMPLPEVLLKWQAFDG-------SSSSF 902
Query: 920 LASTDNTQTSIPTRPSGFADSFTSADGR 947
LAS DNTQTSIPTRPSGFA+SFTSADGR
Sbjct: 903 LASGDNTQTSIPTRPSGFAESFTSADGR 930
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101923|ref|XP_002312477.1| predicted protein [Populus trichocarpa] gi|222852297|gb|EEE89844.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1263 bits (3268), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 649/946 (68%), Positives = 757/946 (80%), Gaps = 19/946 (2%)
Query: 6 LGVSLFLLS--LLSATLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSP 63
+GV LF+ + LLS +SQ + DAA M L+ SL ++LGW+ DPC+W H+ C+
Sbjct: 1 MGVWLFIHTSLLLSLLCIAHSQQNDDAAVMLKLRDSLVKSSTLGWSASDPCQWAHVGCT- 59
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
+NRV RIQIG QN++GTLP EL +L+ LT EVM N LTG +PSLSGLSSLQ +L NN
Sbjct: 60 NNRVDRIQIGYQNLQGTLPPELRNLTQLTRFEVMSNNLTGSLPSLSGLSSLQVLLLHTNN 119
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
F+S+P DFF G+TSL ++SLD N F+SW IPESLKDAT L+ FSAN AN+ G IP+F
Sbjct: 120 FSSIPPDFFTGMTSLTSVSLDTNPFESWEIPESLKDATSLKEFSANDANVAGKIPEFFNN 179
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243
D PGL LHLAFN+L+G +PL+F S+I++LWLNGQK +S+LNG+++++QNMTSLT++W
Sbjct: 180 DVFPGLESLHLAFNYLEGELPLNFSGSTIRSLWLNGQKSNSRLNGTLSILQNMTSLTEIW 239
Query: 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303
LHGNS TGPLPDLSG+ SL+D S+RDN LTG+VP SLVN+ +L VN TNN QG TPKF
Sbjct: 240 LHGNSLTGPLPDLSGMISLEDLSLRDNSLTGVVPPSLVNISTLRAVNFTNNKLQGPTPKF 299
Query: 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD-WK 362
V DM G+N+FCLD GVACD V+VLLS+ K+ GYPA LA+ WKGN+PC+S+ WK
Sbjct: 300 ADRVSVDMNPGTNNFCLDKPGVACDATVDVLLSVAKNFGYPASLADFWKGNDPCSSNTWK 359
Query: 363 GVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
G++C G +I V+NLK GL+GTISS+F +++L++L LS N LTGTIP ELT L L +
Sbjct: 360 GIAC-VGKDILVINLKKAGLTGTISSDFFLISTLQELFLSDNMLTGTIPDELTNLSDLTI 418
Query: 423 LDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSG 482
LDVSNN L+G +P FR NV V+ GNPDIGK+ S + P + PG++P P G G S G
Sbjct: 419 LDVSNNRLYGNIPKFRNNVQVEYAGNPDIGKNGSVYPPPATPGTAPGSPSGTVG--DSDG 476
Query: 483 GANKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNA 542
NKN TGKIVGSV+G VCG +VGLG Y RK+KRS +VQSPN ++IHP + GD +A
Sbjct: 477 SGNKNLATGKIVGSVIGFVCGLCMVGLGVFFYNRKQKRSSKVQSPNMMIIHPRHSGDQDA 536
Query: 543 VKITVTESSVTGGGSESQSLTSS-GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRG 601
VKITV SS G ++S T S GPSD+++ +MVISIQVL NVTNNFSEEN+LGRG
Sbjct: 537 VKITVAGSSANIG---AESFTDSVGPSDINLARTENMVISIQVLSNVTNNFSEENILGRG 593
Query: 602 GFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661
GFGTVYKGELHDGTKIAVKRMES VVSEKG AEF SEIAVLTKVRHRHLV L+GYCLDGN
Sbjct: 594 GFGTVYKGELHDGTKIAVKRMESGVVSEKGLAEFMSEIAVLTKVRHRHLVALIGYCLDGN 653
Query: 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721
ERLLVYEYMPQGTLSRHLF KEEG+K LEWTRRLTI LDVARGVEYLHGLAHQ FIHRD
Sbjct: 654 ERLLVYEYMPQGTLSRHLFCWKEEGVKSLEWTRRLTIGLDVARGVEYLHGLAHQCFIHRD 713
Query: 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDV 781
LKPSNILLGDDMRAKVADFGLVR AP+ GK SIETRLAGTFGYLAPEYAVTGRVTTKVDV
Sbjct: 714 LKPSNILLGDDMRAKVADFGLVRPAPE-GKTSIETRLAGTFGYLAPEYAVTGRVTTKVDV 772
Query: 782 FSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASI 841
FSFGVILME+ITGRKALDETQ EDS+HLVTWFRRMHINKDTF KAID TI+LDEETL SI
Sbjct: 773 FSFGVILMEMITGRKALDETQPEDSLHLVTWFRRMHINKDTFHKAIDPTINLDEETLGSI 832
Query: 842 STVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALKK 901
STVA+LAGHC AREPYQRPDMGHVVNVLSSL E+WK AEPDSDD+YGID + LP+ L K
Sbjct: 833 STVAELAGHCTAREPYQRPDMGHVVNVLSSLTEIWKAAEPDSDDMYGIDFETPLPEVLLK 892
Query: 902 WQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADSFTSADGR 947
WQA++G SSSSFL S DNTQTSIPTRPSGFA+SFTSADGR
Sbjct: 893 WQAFDG-------SSSSFLPSGDNTQTSIPTRPSGFAESFTSADGR 931
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472575|ref|XP_002281552.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1259 bits (3257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 661/947 (69%), Positives = 763/947 (80%), Gaps = 21/947 (2%)
Query: 8 VSLFLLSLLSATLSVNSQSSS-DAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNR 66
+ + L+ LL+ TL+V SQSSS DA MQ LK +L P+ LGW+D DPCKW + C R
Sbjct: 5 LCVVLVCLLALTLNVQSQSSSGDADVMQVLKKNLNQPSDLGWSDSDPCKWDGVSCDGDRR 64
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
VTRIQIGG+N++G+LP L L++L +LEV N+L+G +PSLS LS LQ +L +NNFTS
Sbjct: 65 VTRIQIGGKNLKGSLPSNLTDLTALEILEVQYNQLSGPLPSLSRLSLLQRLLLSNNNFTS 124
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
VPS FF G+TSLQT++LD N F WV P SL+ A L+ FSAN A I+G P+ +
Sbjct: 125 VPSGFFDGMTSLQTVALDNNPFSPWVFPVSLQAAGSLKSFSANSAGISGKFPEIF--EAF 182
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
P L LHLAFN L+G +P SF SSIQTLWLNGQ+ SKLNG++ V+QNMTSLTQ+WL+
Sbjct: 183 PSLTDLHLAFNSLEGGLPSSFSGSSIQTLWLNGQESASKLNGTIEVLQNMTSLTQVWLNM 242
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
NSFTGPLPD S L++LQD ++RDN TG VPS+L+NL SL VNLTNNL QG P+F S
Sbjct: 243 NSFTGPLPDFSSLTNLQDLNLRDNGFTGPVPSTLLNLKSLKTVNLTNNLLQGPMPEFASS 302
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
V DM G N FCL + G C VN LL + KS+GYP+ LA++WKGN+PC+ W G++C
Sbjct: 303 VAADMV-GVNMFCLPEPG-PCSQTVNTLLEVAKSMGYPSSLAKNWKGNDPCDQ-WFGLTC 359
Query: 367 DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426
D GG I VVNL+ +GLSGTISSNFS L SL++L+L+ N LTGTIP ELT L +L LDVS
Sbjct: 360 DDGG-IAVVNLQKMGLSGTISSNFSTLGSLQKLILADNNLTGTIPAELTNLQNLRELDVS 418
Query: 427 NNHLFGKVPNFRQNVIVKTDGNPDIGK----DSSSFTPKSPPGSSPTPPGGDSGGNGSSG 482
NN L+G++PNFR NVIVKT+GNPDIGK D + TP P SPT P DS GNG
Sbjct: 419 NNQLYGQIPNFRSNVIVKTEGNPDIGKEGGDDPNPGTPSGGPPDSPTSPDADSPGNGG-- 476
Query: 483 GANKNSNTGKIVGSVVGVVCGAFIVGL-GFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DG 540
K SNT IVGSVVG V F++GL GFC Y ++K GRVQSPN +VIHP + G D
Sbjct: 477 ---KKSNTVVIVGSVVGSVGAVFLIGLVGFCFYRTRQKHFGRVQSPNTMVIHPRHSGSDN 533
Query: 541 NAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGR 600
+AVKIT+ SSV GGGSE+ S SSGPSD+ ++EAGSMVISIQVLRNVTNNFSEENVLGR
Sbjct: 534 DAVKITIANSSVNGGGSETYSHASSGPSDIQMIEAGSMVISIQVLRNVTNNFSEENVLGR 593
Query: 601 GGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660
GGFGTVYKGELHDGTKIAVKRMES VVSEKG EFKSEIAVLTKVRHRHLV LLGYCLDG
Sbjct: 594 GGFGTVYKGELHDGTKIAVKRMESGVVSEKGLTEFKSEIAVLTKVRHRHLVALLGYCLDG 653
Query: 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
NERLLVYEYMPQGTLSRHLFN KEEG+KPLEW +RL+IALDVARGVEYLHGLAHQSFIHR
Sbjct: 654 NERLLVYEYMPQGTLSRHLFNWKEEGMKPLEWMKRLSIALDVARGVEYLHGLAHQSFIHR 713
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVD 780
DLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETRLAGTFGYLAPEYAVTGRVTTKVD
Sbjct: 714 DLKPSNILLGDDMRAKVADFGLVRLAPE-GKASIETRLAGTFGYLAPEYAVTGRVTTKVD 772
Query: 781 VFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLAS 840
VFSFGVILME+I+GR+ALDETQ E+S+HLVTWFRRM INK++F+K+ID+TIDLDEETLAS
Sbjct: 773 VFSFGVILMEIISGRRALDETQPEESMHLVTWFRRMQINKESFQKSIDQTIDLDEETLAS 832
Query: 841 ISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALK 900
ISTVA+LAGHCCAREPYQRPDM H VNVLSSL ELWKPA+ DS+D+YGIDLDMTLPQALK
Sbjct: 833 ISTVAELAGHCCAREPYQRPDMSHAVNVLSSLVELWKPADLDSEDMYGIDLDMTLPQALK 892
Query: 901 KWQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADSFTSADGR 947
KWQA+EG+S + SSSS++AS DNTQTSIPTRP GFA+SFTSADGR
Sbjct: 893 KWQAFEGSSQL--DSSSSYIASADNTQTSIPTRPYGFAESFTSADGR 937
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476563|ref|XP_002265087.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1245 bits (3221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/918 (67%), Positives = 733/918 (79%), Gaps = 32/918 (3%)
Query: 33 MQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLT 92
M ALK SL N SLGW+ PDPC+WKH+ CS RVTRIQ+G Q ++GTLP L +L+ L
Sbjct: 1 MLALKDSLSNSESLGWSGPDPCEWKHVVCSEDKRVTRIQVGRQGLQGTLPSSLGNLTELE 60
Query: 93 VLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWV 152
LE+ N ++G +PSL GLSSLQ ++ +N FT +P DFF GL+SLQ++ +D N F +W
Sbjct: 61 RLELQWNNISGPLPSLKGLSSLQVLMLSNNQFTYIPVDFFSGLSSLQSVEIDNNPFSAWE 120
Query: 153 IPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212
IP+SLK+A+ LQ FSAN ANITG IPDFLG PGL++LHLAFN L G +P + S I
Sbjct: 121 IPQSLKNASALQNFSANSANITGNIPDFLGPVAFPGLVNLHLAFNALVGGLPSALSGSLI 180
Query: 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQL 272
++LW+NGQ + KL+G++ VIQNMTSL ++WLH N+F+GPLPD SGL LQ S+RDN
Sbjct: 181 ESLWVNGQMSEEKLSGTIDVIQNMTSLKEVWLHSNAFSGPLPDFSGLKDLQSLSLRDNLF 240
Query: 273 TGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVN 332
TG+VP SLVNL SL VNLTNN QG P+F + V DM NSFCL G CD RVN
Sbjct: 241 TGVVPVSLVNLGSLEAVNLTNNFLQGPVPEFKNSVAVDMTPDGNSFCLPKPG-ECDPRVN 299
Query: 333 VLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR 392
+LLSIVKS GYP A++WKGN+PC ++W G++C+ GNITVVN + +GL+GTISSNFS
Sbjct: 300 ILLSIVKSFGYPTKFAKNWKGNDPC-TEWFGITCN-NGNITVVNFQKMGLTGTISSNFSS 357
Query: 393 LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIG 452
L SL++L+L+ N +TG+IPKELTTLP+L LDVSNN L+GK+P+F+ NV+V +G+ D
Sbjct: 358 LISLQKLVLADNNITGSIPKELTTLPALTQLDVSNNQLYGKIPSFKGNVLVNANGSQD-- 415
Query: 453 KDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGL-GF 511
G+ +GG +S G IV SV+G V F++GL F
Sbjct: 416 -----------------------SGSSMNGGKKSSSLIGIIVFSVIGGVFVIFLIGLLVF 452
Query: 512 CLYTRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKITVTESSVTGGG-SESQSLTSSGPSD 569
CLY RK+KR RVQSPNA+VIHP + G D ++VKITV SSV+ G SE+ + SS P+D
Sbjct: 453 CLYKRKQKRFTRVQSPNAMVIHPRHSGSDNDSVKITVAGSSVSVGAISETHTHPSSEPND 512
Query: 570 LHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE 629
+ +VEAG+MVISIQVLRNVTNNFSEEN+LG+GGFGTVY+GELHDGTKIAVKRMES V++
Sbjct: 513 IQMVEAGNMVISIQVLRNVTNNFSEENILGQGGFGTVYRGELHDGTKIAVKRMESGVITG 572
Query: 630 KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
KG AEFKSEIAVLTKVRHRHLV LLGYCLDGNE+LLVYEYMPQGTLSRHLF+ EEG+KP
Sbjct: 573 KGLAEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRHLFSWPEEGIKP 632
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
LEWTRRL IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+
Sbjct: 633 LEWTRRLAIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE- 691
Query: 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809
GK SIETR+AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE+Q E+S+HL
Sbjct: 692 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 751
Query: 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
VTWF+RMHINKDTFRKAID TID+DEETLASISTVA+LAGHCCAREPYQRPDMGH VNVL
Sbjct: 752 VTWFKRMHINKDTFRKAIDPTIDVDEETLASISTVAELAGHCCAREPYQRPDMGHAVNVL 811
Query: 870 SSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDSSSSSFLASTDNTQTS 929
SSL ELWKP + +++DIYGIDLDM+LPQALKKWQA+EG S++ SSSSSFLAS DNTQTS
Sbjct: 812 SSLVELWKPVDQNTEDIYGIDLDMSLPQALKKWQAFEGRSHMDSSSSSSFLASLDNTQTS 871
Query: 930 IPTRPSGFADSFTSADGR 947
IPTRP GFA+SFTSADGR
Sbjct: 872 IPTRPYGFAESFTSADGR 889
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450141|ref|XP_004142822.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449526311|ref|XP_004170157.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1240 bits (3208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 613/925 (66%), Positives = 734/925 (79%), Gaps = 13/925 (1%)
Query: 27 SSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELN 86
+ D + M LK S+G P+SLGWT D C+W H++C +RV +IQIG QN++G+LPKEL
Sbjct: 35 AGDGSVMNLLKNSVGAPSSLGWTGSDYCQWNHVKCDSQSRVVKIQIGNQNLKGSLPKELF 94
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
SLS+L LEV N+L G P+L+ SLQ +L DN FTS+P+DFF ++LQTI +D N
Sbjct: 95 SLSALVQLEVQSNQLGGPFPNLA--DSLQILLAHDNLFTSMPADFFAKKSALQTIDIDNN 152
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS 206
F +W IP++++DA+ LQ+ SAN NITG IP G T P L +LHLA NFL+G +P S
Sbjct: 153 PFSAWQIPDNIRDASALQQLSANRVNITGIIPGIFDGATFPTLTNLHLAGNFLEGELPAS 212
Query: 207 FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFS 266
SSIQ+LWLNGQ+ SKLNGS+A++QNMT+L ++WLH N F+GPLPD S L L S
Sbjct: 213 LAGSSIQSLWLNGQQSSSKLNGSIAILQNMTNLQEVWLHMNQFSGPLPDFSNLQGLAKLS 272
Query: 267 VRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326
+RDNQLTGIVPSSLVNL SL VVNLTNNL QG TP F+ V+ DM +N FCLD G
Sbjct: 273 LRDNQLTGIVPSSLVNLKSLMVVNLTNNLLQGPTPAFDPNVQLDMKPQTNKFCLDSPGEP 332
Query: 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAG-GNITVVNLKNLGLSGT 385
CD RVN LLS+ +S+G+P A+ W GN+PC +KG+SC NI+V+NLKN+GL+G+
Sbjct: 333 CDPRVNALLSVAESMGFPTAFAQGWAGNDPCQG-FKGISCIGNPTNISVINLKNMGLAGS 391
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKT 445
IS +FS LTS+++L LS N L+GTIP EL T+PSL LDVSNN L GKVP FR+NVIV T
Sbjct: 392 ISPSFSLLTSVQKLFLSNNFLSGTIPNELATMPSLTELDVSNNRLHGKVPVFRKNVIVNT 451
Query: 446 DGNPDIGKDSSSF-TPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGA 504
GNPDIGKD++S P SP G SP+ GDS GN K SN G +VG+++GV+ G
Sbjct: 452 QGNPDIGKDNASPPVPGSPTGRSPSDGSGDSAGNDE-----KKSNAGVVVGAIIGVIVGL 506
Query: 505 FIVG-LGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLT 563
+VG + F L RK++R RVQSPN VV+HPS+ GD N+VKIT+TE+ G E+ +
Sbjct: 507 LVVGTVIFFLCKRKKRRGNRVQSPNTVVVHPSHSGDQNSVKITITEARSDGSAPETSRVP 566
Query: 564 SSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRME 623
+GPSD+HVVEAG++VISIQVLR+VTNNFS EN+LG+GGFGTVYKGELHDGT IAVKRME
Sbjct: 567 IAGPSDVHVVEAGNLVISIQVLRSVTNNFSPENILGKGGFGTVYKGELHDGTMIAVKRME 626
Query: 624 SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK 683
S V+ EKG EFK+EIAVLTKVRHR+LV LLGYCLDGNERLLVYEYMPQGT SR LFN K
Sbjct: 627 SGVIGEKGLNEFKAEIAVLTKVRHRNLVALLGYCLDGNERLLVYEYMPQGTFSRFLFNWK 686
Query: 684 EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
EEG++PLEW RRL + LDVARGVEYLH LAHQSFIHRDLKPSNILLGDD+RAKVADFGLV
Sbjct: 687 EEGIRPLEWKRRLIVVLDVARGVEYLHSLAHQSFIHRDLKPSNILLGDDLRAKVADFGLV 746
Query: 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS 803
RLAP+ GK SIETRLAGTFGYLAPEYAVTGRVTTKVDV+SFGVILME+I+GRKA+DE+Q
Sbjct: 747 RLAPE-GKASIETRLAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMEMISGRKAIDESQP 805
Query: 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863
E+S+HLV+WFRRMHINKDTF KAID +ID+DEETL SI+TVADLAGHCCAREPYQRPDMG
Sbjct: 806 EESLHLVSWFRRMHINKDTFSKAIDPSIDIDEETLVSINTVADLAGHCCAREPYQRPDMG 865
Query: 864 HVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIG-DSSSSSFLAS 922
H VNVLSSL ++WKP EPDS++ GIDL+++LPQAL+KWQA+EGNSN+ SSSSSFLAS
Sbjct: 866 HAVNVLSSLVDVWKPTEPDSEENLGIDLELSLPQALRKWQAFEGNSNVDMSSSSSSFLAS 925
Query: 923 TDNTQTSIPTRPSGFADSFTSADGR 947
DNTQTSIP RPSGFA+SFTS D R
Sbjct: 926 GDNTQTSIPNRPSGFANSFTSVDAR 950
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7672732|gb|AAF66615.1| LRR receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 1239 bits (3206), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 640/926 (69%), Positives = 734/926 (79%), Gaps = 16/926 (1%)
Query: 26 SSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKEL 85
+++DAA MQ LK + P+SLGW DPDPCKW +QC+ RVTRIQIG Q ++G+LP L
Sbjct: 32 AANDAAVMQELKKRINPPSSLGWNDPDPCKWGKVQCTKDGRVTRIQIGNQGLKGSLPPNL 91
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
N+L+ L V EV N LTG +PS SGL SLQ +L ++N FTS+P+DFF GLTSLQ++ LD
Sbjct: 92 NNLTELLVFEVQNNGLTGSLPSFSGLDSLQSLLLNNNGFTSIPTDFFDGLTSLQSVYLDK 151
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N F W IPESLK AT +Q FSA ANITGTIPDF D L +LHL+FN L G +P
Sbjct: 152 NQFSPWSIPESLKSATSIQTFSAVSANITGTIPDFF--DAFASLTNLHLSFNNLGGSLPS 209
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL-WLHGNSFTGPLPDLSGLSSLQD 264
SF S IQ+LWLNG KG +LNGS+AVIQNMT LT+ N+F+ PLPD SGLS LQ+
Sbjct: 210 SFSGSQIQSLWLNGLKG--RLNGSIAVIQNMTQLTRTSGCKANAFSSPLPDFSGLSQLQN 267
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324
S+RDN LTG VP+SLVNL SL VV LTNN QG TPKF S V+ DM +NSFCL G
Sbjct: 268 CSLRDNSLTGPVPNSLVNLPSLKVVVLTNNFLQGPTPKFPSSVQVDMLADTNSFCLSQPG 327
Query: 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384
V CD RVN LL++ K VGYP AE+WKGN+PC S W G++CD GGNITV+N + +GL+G
Sbjct: 328 VPCDSRVNTLLAVAKDVGYPREFAENWKGNDPC-SPWMGITCD-GGNITVLNFQKMGLTG 385
Query: 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVK 444
TIS N+S +TSL++L+L+ N L GTIP EL LP+L LDVSNN L+GK+P F+ NV++K
Sbjct: 386 TISPNYSSITSLQKLILANNNLIGTIPNELALLPNLRELDVSNNQLYGKIPPFKSNVLLK 445
Query: 445 TDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGA 504
T GN +IGKD+ P S SGG + + K S+TG +VGSV+G VC A
Sbjct: 446 TQGNVNIGKDNPPPPAPGTPSGSTPGSSDGSGGGQTHANSGKKSSTGVVVGSVIGGVCAA 505
Query: 505 FIVG--LGFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKITVTESSVTGGGSESQS 561
++ FCLY KRKRSGRVQSP+ VVIHP + G D +AVKIT+ SSV GG S
Sbjct: 506 VVLAGLFVFCLYRTKRKRSGRVQSPHTVVIHPHHSGSDQDAVKITIAGSSVNGGDSCG-- 563
Query: 562 LTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKR 621
+SS P DLH+VEAG+MVISIQVLR+VTNNFSE N+LGRGGFGTVYKGELHDGTK+AVKR
Sbjct: 564 -SSSAPGDLHIVEAGNMVISIQVLRDVTNNFSEVNILGRGGFGTVYKGELHDGTKMAVKR 622
Query: 622 MESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFN 681
MES V+SEKG EFKSEIAVLTKVRHRHLV LLGYCLDGNERLLVYEYMPQGTLSR+LFN
Sbjct: 623 MESGVMSEKGLDEFKSEIAVLTKVRHRHLVTLLGYCLDGNERLLVYEYMPQGTLSRYLFN 682
Query: 682 RKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
KEEGLKPLEWTRRLTIALDVARGVEYLHGLA QSFIHRDLKPSNILLGDDMRAKVADFG
Sbjct: 683 WKEEGLKPLEWTRRLTIALDVARGVEYLHGLAQQSFIHRDLKPSNILLGDDMRAKVADFG 742
Query: 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDET 801
LVRLAPD K S+ TRLAGTFGYLAPEYAVTGRVTTK+DVFSFGVILMELITGRKALDE+
Sbjct: 743 LVRLAPD-PKASVVTRLAGTFGYLAPEYAVTGRVTTKIDVFSFGVILMELITGRKALDES 801
Query: 802 QSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD 861
Q E+S+HLV WFRRMHINK+TFRKAID T+DLDEETL+S+STVA+LAGH CAREP+QRPD
Sbjct: 802 QPEESMHLVPWFRRMHINKETFRKAIDPTVDLDEETLSSVSTVAELAGHSCAREPHQRPD 861
Query: 862 MGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDSSSSSFLA 921
MGH VNVLSSLAELWKPAE D D+IYGID DM+LPQA+KKWQA EG S I SSS+LA
Sbjct: 862 MGHAVNVLSSLAELWKPAEVDEDEIYGIDYDMSLPQAVKKWQALEGMSGI--DGSSSYLA 919
Query: 922 STDNTQTSIPTRPSGFADSFTSADGR 947
S+DNTQTSIPTRPSGFADSFTSADGR
Sbjct: 920 SSDNTQTSIPTRPSGFADSFTSADGR 945
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069210|ref|XP_002302927.1| predicted protein [Populus trichocarpa] gi|222844653|gb|EEE82200.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1234 bits (3193), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/957 (66%), Positives = 743/957 (77%), Gaps = 22/957 (2%)
Query: 1 MKKRHLGVSLFLLSLLSATLSV----NSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKW 56
MK+R + LL L S+ NSQ+S DA M +LK SL P SLGW+DPDPC W
Sbjct: 1 MKRRSHRRTKLLLVFLVGFSSIFHFANSQTSPDAEVMFSLKKSLNVPDSLGWSDPDPCNW 60
Query: 57 KHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQE 116
H+ CS RVTRIQIG QN++GTLP L +L+ L LE+ N ++G +PSL+GLSSLQ
Sbjct: 61 NHVVCSDEKRVTRIQIGRQNLQGTLPSNLRNLAQLERLELQYNNISGPLPSLNGLSSLQV 120
Query: 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT 176
+L DN F SVPSDFF GL+SLQ++ +D N F +WVIPES+K+A+ LQ FSAN ANI+G+
Sbjct: 121 ILLSDNKFISVPSDFFTGLSSLQSVEIDNNPFSNWVIPESIKNASALQNFSANSANISGS 180
Query: 177 IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM 236
IP F G D+ PGL L LAFN L+G +P SF S +Q+LWLNGQK L+G + VIQNM
Sbjct: 181 IPGFFGPDSFPGLTILRLAFNDLEGELPASFSGSQVQSLWLNGQK----LSGGIDVIQNM 236
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
T L ++WLH N F+GPLPD SGL L+ S+RDN TG+VP SLVNL SL VNL+NNL
Sbjct: 237 TLLREVWLHSNGFSGPLPDFSGLKDLESLSLRDNSFTGLVPESLVNLESLKFVNLSNNLL 296
Query: 297 QGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
QG P F S V DM K SN FCL + CD RVN LLSIVKS+ YP LA+SWKGN+P
Sbjct: 297 QGPMPVFKSSVSVDMVKDSNRFCLPTPDL-CDSRVNTLLSIVKSMDYPQRLADSWKGNDP 355
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
C +DW G++C+ GNITVVN + +GL+G+IS +F+ + SL +L+L+ N LTG+IP+E+TT
Sbjct: 356 C-ADWIGITCN-NGNITVVNFEKMGLTGSISPDFASVKSLERLVLANNNLTGSIPQEITT 413
Query: 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSG 476
LP L++LDVSNNHL+G+VP F NVIV T+GNP+IGKD + S S +P
Sbjct: 414 LPGLKVLDVSNNHLYGRVPAFTSNVIVNTNGNPNIGKDVN--ISTSSESPSASPSANTGS 471
Query: 477 GNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGL----GFCLYTRKRKRSGRVQSPNAVVI 532
G+G S + ++ IV + V+ G F++ L FCLY +K+KR RVQSPN +VI
Sbjct: 472 GSGGSSRKSGKKSSTLIVVIIFSVIGGVFLLSLIGLLVFCLYKKKQKRFSRVQSPNEMVI 531
Query: 533 HPSNGG-DGNAVKITVTESSVTGGG-SESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTN 590
HP + G D +VKITV SS++ G SE+ ++ +S D+ +VEAG+MVISIQVLRNVTN
Sbjct: 532 HPRHSGSDNESVKITVAGSSISVGAISETHTIPASEQGDIQMVEAGNMVISIQVLRNVTN 591
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
NFSEEN+LG GGFG VYKGELHDGTKIAVKRMES V+S KG EFKSEIAVLTKVRHRHL
Sbjct: 592 NFSEENILGWGGFGVVYKGELHDGTKIAVKRMESGVISGKGLTEFKSEIAVLTKVRHRHL 651
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V LLGYCLDGNE+LLVYEYMPQGTLSRH+FN EEGLKPLEWTRRLTIALDVARGVEYLH
Sbjct: 652 VALLGYCLDGNEKLLVYEYMPQGTLSRHIFNWAEEGLKPLEWTRRLTIALDVARGVEYLH 711
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETR+AGTFGYLAPEYA
Sbjct: 712 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEYA 770
Query: 771 VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830
VTGRVTTKVDVFSFGVILMELITGRKALDE Q E+S+HLVTWFRRMH+NKDTFRKAID T
Sbjct: 771 VTGRVTTKVDVFSFGVILMELITGRKALDERQPEESLHLVTWFRRMHLNKDTFRKAIDPT 830
Query: 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGID 890
IDL+EETLASISTVA+LAGHCCAREPYQRPDMGH VNVLSSL ELWKP + S+DIYGID
Sbjct: 831 IDLNEETLASISTVAELAGHCCAREPYQRPDMGHTVNVLSSLVELWKPTDQSSEDIYGID 890
Query: 891 LDMTLPQALKKWQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADSFTSADGR 947
L+M+LPQALKKWQAYEG SN+ SSS S DNTQTSIP RP GFA+SFTSADGR
Sbjct: 891 LEMSLPQALKKWQAYEGRSNMDSSSSLL--PSLDNTQTSIPARPYGFAESFTSADGR 945
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445063|ref|XP_004140293.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449479894|ref|XP_004155738.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1233 bits (3191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 642/958 (67%), Positives = 744/958 (77%), Gaps = 20/958 (2%)
Query: 2 KKRHLGVSLFL-LSLLSATLSVNSQS-SSDAAAMQALKTSLGNPASLGWTDPDPCKWKHI 59
KK H FL L++ S SV Q S DA AM ALK SL SLGW+DP+PCKW H+
Sbjct: 4 KKTHFVNKHFLILAIFSIFHSVEPQELSPDAPAMTALKKSLNPTESLGWSDPNPCKWNHV 63
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLF 119
CS NRVTRIQIG QN++G LP L +L++L LE+ NK++G +PSLSGL+SLQ +L
Sbjct: 64 LCSDDNRVTRIQIGRQNLQGMLPLNLQNLTALERLELQWNKISGPLPSLSGLTSLQVLLL 123
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
N FTS+PSDFF G+TSLQ + +D N F +W IP SL++A+ LQ FSAN AN+TG IP+
Sbjct: 124 SGNQFTSIPSDFFAGMTSLQAVEIDENPFSAWEIPASLRNASTLQNFSANSANVTGRIPE 183
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
FLGG+ IPGL +LHLAFN L+G +P SF S +++LW+NGQ KL+GS+ V+QNMTSL
Sbjct: 184 FLGGEDIPGLTNLHLAFNNLEGGLPSSFSGSQLESLWVNGQNSADKLSGSIDVLQNMTSL 243
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299
++WLH NSF+GPLPD S L LQ S+RDN+ TG VPSSLVN SL VVNLTNNL QG
Sbjct: 244 IEVWLHSNSFSGPLPDFSRLKDLQALSLRDNKFTGPVPSSLVNSPSLKVVNLTNNLLQGP 303
Query: 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359
P F + V DM SNSFCL D G CD RVN LLSIVK +GYP AE+WKGN+PC +
Sbjct: 304 IPLFKTGVVVDMTNDSNSFCLQDPG-ECDSRVNTLLSIVKFMGYPQRFAENWKGNDPC-A 361
Query: 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPS 419
+W G+SC +IT+VN + +GLSG IS F+ L L +L+L+ N LTG+IP+ELTTLP
Sbjct: 362 EWIGISC-RNQSITIVNFQKMGLSGMISPEFASLKGLERLVLADNHLTGSIPEELTTLPF 420
Query: 420 LEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDS---- 475
L LDVSNN L GK+P FR NV++ GNPDIGK+ T S G+SP+ D+
Sbjct: 421 LTELDVSNNQLSGKIPKFRSNVMMTITGNPDIGKEK---TDSSSNGASPSASSNDTKEAG 477
Query: 476 ---GGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGL-GFCLYTRKRKRSGRVQSPNAVV 531
GGN G +S G IV SVVG V F++GL C+Y K+KR +VQSPNA+V
Sbjct: 478 SNGGGNSGDGEKKPSSMVGVIVLSVVGGVFVLFLIGLVVLCVYKMKQKRFSQVQSPNAMV 537
Query: 532 IHPSN-GGDGNAVKITVTESSV-TGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVT 589
IHP + G D +VKITV SSV G SE+Q+ SS D+ +VEAG+MVISIQVL+NVT
Sbjct: 538 IHPRHSGSDNESVKITVAGSSVRVGAISETQNGASSETGDIQMVEAGNMVISIQVLKNVT 597
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
NNFSEEN+LG+GGFGTVYKGELHDGTKIAVKRMES V+ KG EFKSEIAVLTKVRHRH
Sbjct: 598 NNFSEENILGQGGFGTVYKGELHDGTKIAVKRMESGVIKGKGLTEFKSEIAVLTKVRHRH 657
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV LLGYCLDGNE+LLVYEYMPQGTLSRHLFN EEGLKPLEWT+RLTIALDVARGVEYL
Sbjct: 658 LVALLGYCLDGNEKLLVYEYMPQGTLSRHLFNWPEEGLKPLEWTKRLTIALDVARGVEYL 717
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETR+AGTFGYLAPEY
Sbjct: 718 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEY 776
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829
AVTGRVTTKVDVFSFGVILMELITGRKALDE+Q E+S+HLVTWFRRM INKD+F KAID
Sbjct: 777 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRMQINKDSFHKAIDP 836
Query: 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGI 889
TIDL EET ASI+TVA+LAGHCCAREPYQRPDMGH VNVLSSL E WKP + +S+DIYGI
Sbjct: 837 TIDLTEETFASINTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEFWKPTDQNSEDIYGI 896
Query: 890 DLDMTLPQALKKWQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADSFTSADGR 947
DL+M+LPQALKKWQAYEG S + +SSSSS L S DNTQTSIPTRP GFA+SFTSADGR
Sbjct: 897 DLEMSLPQALKKWQAYEGRSQM-ESSSSSLLPSFDNTQTSIPTRPYGFAESFTSADGR 953
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727489|ref|NP_001238698.1| NAK-type protein kinase precursor [Glycine max] gi|223452361|gb|ACM89508.1| NAK-type protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1229 bits (3179), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/947 (66%), Positives = 747/947 (78%), Gaps = 16/947 (1%)
Query: 9 SLFLLSLLSATLSVNSQSSSD---AAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSN 65
+L LL+++ TL V SQ D A+ M ALK SL P GW+DPDPCKW + CS
Sbjct: 3 ALALLAIIVFTLLVRSQEEEDYDDASVMLALKNSLNPP---GWSDPDPCKWARVLCSDDK 59
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT 125
RVTRIQIG N++GTLP L L+ L LE+ N ++G +PSL+GL+SL+ L +N F+
Sbjct: 60 RVTRIQIGRLNLQGTLPTTLQKLTHLEHLELQYNNISGPLPSLNGLTSLRVFLASNNRFS 119
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
+VP+DFF G++ LQ + +D N F+ W IP+SL++A+GLQ FSAN AN+ G+IP+F G D
Sbjct: 120 AVPADFFAGMSQLQAVEIDSNPFEPWEIPQSLRNASGLQNFSANSANVGGSIPEFFGSDV 179
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
PGL LHLA N L+G +PLSF S IQ+LWLNGQK +KL GSV V+QNMT LT +WL
Sbjct: 180 FPGLTLLHLAMNNLEGTLPLSFSGSQIQSLWLNGQKSVNKLGGSVEVLQNMTFLTDVWLQ 239
Query: 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPKFN 304
N+FTGPLPDLSGL SL+D S+RDN+ TG VP +S V L +L VVNLTNNLFQG P F
Sbjct: 240 SNAFTGPLPDLSGLKSLRDLSLRDNRFTGPVPVASFVGLKTLKVVNLTNNLFQGPMPVFG 299
Query: 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364
V D K SNSFCL G CD RV+VLLS+V +GYP AESWKGN+PC + W G+
Sbjct: 300 DGVVVDNVKDSNSFCLPSPG-DCDPRVDVLLSVVGVMGYPPRFAESWKGNDPC-AYWIGI 357
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+C + G ITVVN + + LSG IS F++L SL++++L+ N LTG+IP+EL TLP+L L+
Sbjct: 358 TC-SNGYITVVNFQKMELSGVISPEFAKLKSLQRIVLADNNLTGSIPEELATLPALTQLN 416
Query: 425 VSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKS-PPGSSPTPPGGDSGGNGSSGG 483
V+NN L+GKVP+FR+NV+V T+GN DIGKD SS +P+ P +P G DSGG GG
Sbjct: 417 VANNQLYGKVPSFRKNVVVSTNGNTDIGKDKSSLSPQGLVPPMAPNAKG-DSGGVSGIGG 475
Query: 484 ANKNSNTGKIVGSVVGVVCGAFIVG-LGFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DGN 541
+S+ G IV SV+G V ++G L FCL+ K+K+ RVQSPNA+VIHP + G D
Sbjct: 476 KKSSSHVGVIVFSVIGAVFVVSMIGFLVFCLFRMKQKKLSRVQSPNALVIHPRHSGSDNE 535
Query: 542 AVKITVTESSVT-GGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGR 600
+VKITV SSV+ G SE++++ S SD+ +VEAG+MVISIQVL+NVT+NFSE+NVLG+
Sbjct: 536 SVKITVAGSSVSVGAASETRTVPGSEASDIQMVEAGNMVISIQVLKNVTDNFSEKNVLGQ 595
Query: 601 GGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660
GGFGTVY+GELHDGT+IAVKRME ++ KG AEFKSEIAVLTKVRHRHLV LLGYCLDG
Sbjct: 596 GGFGTVYRGELHDGTRIAVKRMECGAIAGKGAAEFKSEIAVLTKVRHRHLVSLLGYCLDG 655
Query: 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
NE+LLVYEYMPQGTLSRHLF+ EEGL+PLEW RRLTIALDVARGVEYLHGLAHQSFIHR
Sbjct: 656 NEKLLVYEYMPQGTLSRHLFDWPEEGLEPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 715
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVD 780
DLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETR+AGTFGYLAPEYAVTGRVTTKVD
Sbjct: 716 DLKPSNILLGDDMRAKVADFGLVRLAPE-GKASIETRIAGTFGYLAPEYAVTGRVTTKVD 774
Query: 781 VFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLAS 840
VFSFGVILMELITGRKALDETQ EDS+HLVTWFRRM INKD+FRKAID TI+L+EETLAS
Sbjct: 775 VFSFGVILMELITGRKALDETQPEDSMHLVTWFRRMSINKDSFRKAIDSTIELNEETLAS 834
Query: 841 ISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALK 900
I TVA+LAGHC AREPYQRPDMGH VNVLSSL ELWKP++ +S+DIYGIDLDM+LPQALK
Sbjct: 835 IHTVAELAGHCGAREPYQRPDMGHAVNVLSSLVELWKPSDQNSEDIYGIDLDMSLPQALK 894
Query: 901 KWQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADSFTSADGR 947
KWQAYEG S + S+SSS L S DNTQTSIPTRP GFADSFTSADGR
Sbjct: 895 KWQAYEGRSQMESSASSSLLPSLDNTQTSIPTRPYGFADSFTSADGR 941
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 947 | ||||||
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.951 | 0.956 | 0.615 | 3.4e-299 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.952 | 0.956 | 0.605 | 1.1e-291 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.935 | 0.954 | 0.490 | 1.4e-222 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.817 | 0.873 | 0.435 | 3.7e-142 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.307 | 0.290 | 0.405 | 7e-75 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.313 | 0.229 | 0.398 | 7.1e-75 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.315 | 0.316 | 0.411 | 8.6e-75 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.315 | 0.313 | 0.411 | 2.7e-74 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.297 | 0.281 | 0.406 | 1.4e-71 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.307 | 0.460 | 0.394 | 1.6e-71 |
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2872 (1016.1 bits), Expect = 3.4e-299, P = 3.4e-299
Identities = 566/919 (61%), Positives = 683/919 (74%)
Query: 36 LKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLE 95
LK SL P+S GW+DPDPCKW HI C+ + RVTRIQIG ++GTL +L +LS L LE
Sbjct: 35 LKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLRNLSELERLE 94
Query: 96 VMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155
+ N ++G +PSLSGL+SLQ ++ +NNF S+PSD F+GLTSLQ++ +D N F SW IPE
Sbjct: 95 LQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNNPFKSWEIPE 154
Query: 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215
SL++A+ LQ FSAN AN++G++P FLG D PGL LHLAFN L+G +P+S S +Q+L
Sbjct: 155 SLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMSLAGSQVQSL 214
Query: 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLTGI 275
WLNGQK L G + V+QNMT L ++WLH N F+ + S+RDN TG
Sbjct: 215 WLNGQK----LTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLSLRDNSFTGP 270
Query: 276 VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLL 335
VP+SL++L SL VVNLTNN QG P F S V D+ K SNSFCL G CD RV LL
Sbjct: 271 VPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPG-ECDPRVKSLL 329
Query: 336 SIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS 395
I S YP LAESWKGN+PC ++W G++C + GNITV++L+ + L+GTIS F + S
Sbjct: 330 LIASSFDYPPRLAESWKGNDPC-TNWIGIAC-SNGNITVISLEKMELTGTISPEFGAIKS 387
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDX 455
L++++L N LTG IP+ELTTLP+L+ LDVS+N LFGKVP FR NV+V T+GNPDIGKD
Sbjct: 388 LQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNPDIGKDK 447
Query: 456 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGL-GFCLY 514
IVGSV+G + F++GL FC Y
Sbjct: 448 SSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGI-IVGSVLGGLLSIFLIGLLVFCWY 506
Query: 515 TRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKIXXXXXXXXXXXXXXQSLTSSGPSD---- 569
+++KR +S NAVV+HP + G D +VKI + T G S+
Sbjct: 507 KKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVGGIS-DTYTLPGTSEVGDN 565
Query: 570 LHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE 629
+ +VEAG+M+ISIQVLR+VTNNFS +N+LG GGFG VYKGELHDGTKIAVKRME+ V++
Sbjct: 566 IQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMENGVIAG 625
Query: 630 KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
KGFAEFKSEIAVLTKVRHRHLV LLGYCLDGNE+LLVYEYMPQGTLSRHLF EEGLKP
Sbjct: 626 KGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKP 685
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+
Sbjct: 686 LLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE- 744
Query: 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809
GK SIETR+AGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITGRK+LDE+Q E+S+HL
Sbjct: 745 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEESIHL 804
Query: 810 VTWFRRMHINKD-TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868
V+WF+RM+INK+ +F+KAID TIDLDEETLAS+ TVA+LAGHCCAREPYQRPDMGH VN+
Sbjct: 805 VSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMGHAVNI 864
Query: 869 LSSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDXXXXXFLASTDNTQT 928
LSSL ELWKP++ + +DIYGIDLDM+LPQALKKWQAYEG S++ + L S DNTQ
Sbjct: 865 LSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDL-ESSTSSLLPSLDNTQM 923
Query: 929 SIPTRPSGFADSFTSADGR 947
SIPTRP GFA+SFTS DGR
Sbjct: 924 SIPTRPYGFAESFTSVDGR 942
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2801 (991.1 bits), Expect = 1.1e-291, P = 1.1e-291
Identities = 556/918 (60%), Positives = 668/918 (72%)
Query: 36 LKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLE 95
LK+SL + + W++P+PCKW+ +QC SNRVT+IQ+ + I GTLP L SLS L +LE
Sbjct: 36 LKSSLNLTSDVDWSNPNPCKWQSVQCDGSNRVTKIQLKQKGIRGTLPTNLQSLSELVILE 95
Query: 96 VMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155
+ N+++G IP LSGLS LQ + DN FTSVP + F G++SLQ + L+ N FD WVIP+
Sbjct: 96 LFLNRISGPIPDLSGLSRLQTLNLHDNLFTSVPKNLFSGMSSLQEMYLENNPFDPWVIPD 155
Query: 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215
++K+AT LQ + + +I G IPDF G ++P L +L L+ N L+G +P+SF +SIQ+L
Sbjct: 156 TVKEATSLQNLTLSNCSIIGKIPDFFGSQSLPSLTNLKLSQNGLEGELPMSFAGTSIQSL 215
Query: 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLTGI 275
+LNGQK LNGS++V+ NMTSL ++ L GN F+ + F+VR+NQLTG+
Sbjct: 216 FLNGQK----LNGSISVLGNMTSLVEVSLQGNQFSGPIPDLSGLVSLRVFNVRENQLTGV 271
Query: 276 VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLL 335
VP SLV+L SL VNLTNN QG TP F V D+ NSFC + AG ACD RV+ L+
Sbjct: 272 VPQSLVSLSSLTTVNLTNNYLQGPTPLFGKSVGVDIVNNMNSFCTNVAGEACDPRVDTLV 331
Query: 336 SIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS 395
S+ +S GYP LAESWKGNNPC +W G++C +GGNITVVN++ LSGTIS + ++LTS
Sbjct: 332 SVAESFGYPVKLAESWKGNNPC-VNWVGITC-SGGNITVVNMRKQDLSGTISPSLAKLTS 389
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDX 455
L + L+ N+L+G IP ELTTL L +LDVSNN +G P FR V + T+GN ++GK+
Sbjct: 390 LETINLADNKLSGHIPDELTTLSKLRLLDVSNNDFYGIPPKFRDTVTLVTEGNANMGKNG 449
Query: 456 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGLGFCLYT 515
+VG VVG +C +VGLG CLY
Sbjct: 450 PNKTSDAPGASPGSKPSGGSDGSETSKKSSNVKIIVPVVGGVVGALC---LVGLGVCLYA 506
Query: 516 RKRKRSGRVQSPNA-VVIHPSNGGDGNAVKIXXXXXXXXXXXXXXQ-SLTSSGPSDLHVV 573
+KRKR RVQSP++ +VIHP + GD + +K+ S + S SD+HVV
Sbjct: 507 KKRKRPARVQSPSSNMVIHPHHSGDNDDIKLTVAASSLNSGGGSDSYSHSGSAASDIHVV 566
Query: 574 EAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFA 633
EAG++VISIQVLRNVTNNFSEEN+LGRGGFGTVYKGELHDGTKIAVKRMES+VVS+KG
Sbjct: 567 EAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESSVVSDKGLT 626
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
EFKSEI VLTK+RHRHLV LLGYCLDGNERLLVYEYMPQGTLS+HLF+ KEEG KPL+WT
Sbjct: 627 EFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEEGRKPLDWT 686
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDMRAKV+DFGLVRLAPD GK+S
Sbjct: 687 RRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRLAPD-GKYS 745
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813
IETR+AGTFGYLAPEYAVTGRVTTKVD+FS GVILMELITGRKALDETQ EDSVHLVTWF
Sbjct: 746 IETRVAGTFGYLAPEYAVTGRVTTKVDIFSLGVILMELITGRKALDETQPEDSVHLVTWF 805
Query: 814 RRMHINKD--TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
RR+ +KD F+ AID I LD++T+ASI V +LAGHCCAREPYQRPDM H+VNVLSS
Sbjct: 806 RRVAASKDENAFKNAIDPNISLDDDTVASIEKVWELAGHCCAREPYQRPDMAHIVNVLSS 865
Query: 872 LAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDXXXXXFLA--STDNTQTS 929
L WKP E D DD+YGID DM LPQ LKKWQA+EG S D A S DNTQTS
Sbjct: 866 LTVQWKPTETDPDDVYGIDYDMPLPQVLKKWQAFEGLSQTADDSGSSSSAYGSKDNTQTS 925
Query: 930 IPTRPSGFADSFTSADGR 947
IPTRPSGFADSFTS DGR
Sbjct: 926 IPTRPSGFADSFTSVDGR 943
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2149 (761.5 bits), Expect = 1.4e-222, P = 1.4e-222
Identities = 447/911 (49%), Positives = 588/911 (64%)
Query: 42 NPASLGWTDP-DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK 100
NP W+ D CKW ++C+ RVT I + +++ G + E+++LS L + + +NK
Sbjct: 38 NPPPSDWSSTTDFCKWSGVRCT-GGRVTTISLADKSLTGFIAPEISTLSELKSVSIQRNK 96
Query: 101 LTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL-DYNSFDSWVIPESLKD 159
L+G IPS + LSSLQE+ D+NNF V + F GLTSLQ +SL D N+ +W P L D
Sbjct: 97 LSGTIPSFAKLSSLQEIYMDENNFVGVETGAFAGLTSLQILSLSDNNNITTWSFPSELVD 156
Query: 160 ATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNG 219
+T L + NI G +PD D++ L +L L++N + G +P S GKSSIQ LW+N
Sbjct: 157 STSLTTIYLDNTNIAGVLPDIF--DSLASLQNLRLSYNNITGVLPPSLGKSSIQNLWINN 214
Query: 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLTGIVPSS 279
Q D ++G++ V+ +MTSL+Q WLH N F D +RDN LTGIVP +
Sbjct: 215 Q--DLGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSKSENLFDLQLRDNDLTGIVPPT 272
Query: 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVK 339
L+ L SL ++L NN FQG P F+ V+ + N FC AG +C +V LL++
Sbjct: 273 LLTLASLKNISLDNNKFQGPLPLFSPEVKVTI--DHNVFCTTKAGQSCSPQVMTLLAVAG 330
Query: 340 SVGYPAVLAESWKGNNPCNSDWKGVSCD-AGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398
+GYP++LAESW+G++ C S W VSCD AG N+ +NL G +G IS + LTSL+
Sbjct: 331 GLGYPSMLAESWQGDDAC-SGWAYVSCDSAGKNVVTLNLGKHGFTGFISPAIANLTSLKS 389
Query: 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVK-TDGNPDIGKDXXX 457
L L+GN+LTG IPKELT + SL+++DVSNN+L G++P F V GN +G +
Sbjct: 390 LYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPATVKFSYKPGNALLGTNGGD 449
Query: 458 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGLGFCLYTRK 517
+ +++G V F++ + + R
Sbjct: 450 GSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAILGFVVYKFVMKRKYGRFNRT 509
Query: 518 R-KRSGRVQSPNAVVIHPSNGGDGNAVKIXXXXXXXXXXXXXXQSLTSSGPSDLHVVEAG 576
++ G++ +AV SNGG GN S +S SD ++E G
Sbjct: 510 DPEKVGKILVSDAV----SNGGSGNG---GYANGHGANNFNALNSPSSGDNSDRFLLEGG 562
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFK 636
S+ I ++VLR VTNNFSE+N+LGRGGFG VY GELHDGTK AVKRME A + KG +EF+
Sbjct: 563 SVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQ 622
Query: 637 SEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+EIAVLTKVRHRHLV LLGYC++GNERLLVYEYMPQG L +HLF E G PL W +R+
Sbjct: 623 AEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRV 682
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756
+IALDVARGVEYLH LA QSFIHRDLKPSNILLGDDMRAKVADFGLV+ APD GK+S+ET
Sbjct: 683 SIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPD-GKYSVET 741
Query: 757 RLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816
RLAGTFGYLAPEYA TGRVTTKVDV++FGV+LME++TGRKALD++ ++ HLVTWFRR+
Sbjct: 742 RLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKALDDSLPDERSHLVTWFRRI 801
Query: 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876
INK+ KA+D+T++ DEET+ SI VA+LAGHC AREP QRPDMGH VNVL L E W
Sbjct: 802 LINKENIPKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEKW 861
Query: 877 KPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDXXXXXFLASTDNTQTSIPTRPSG 936
KP+ + ++ +GID++M+LPQAL++WQ EG S+ F S TQ+SIP + SG
Sbjct: 862 KPSCQEEEESFGIDVNMSLPQALQRWQN-EGTSS-STMFHGDF--SYSQTQSSIPPKASG 917
Query: 937 FADSFTSADGR 947
F ++F SADGR
Sbjct: 918 FPNTFDSADGR 928
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1390 (494.4 bits), Expect = 3.7e-142, P = 3.7e-142
Identities = 374/858 (43%), Positives = 462/858 (53%)
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+P D K LTSL + N IP SL L AN + T DF G +
Sbjct: 76 LPPDLGK-LTSLTKFEVMRNRLTG-PIP-SLAGLKSLVTVYANDNDFTSVPEDFFSG--L 130
Query: 187 PGLMHLHLAFN-FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVI----QNMTSLTQ 241
L H+ L N F IP S + T ++ + L+G + ++ +SLT
Sbjct: 131 SSLQHVSLDNNPFDSWVIPPSLENA---TSLVDFSAVNCNLSGKIPDYLFEGKDFSSLTT 187
Query: 242 LWLHGNSFTXXXXXXXXXXXXQDFSVRDNQ----LTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L L NS Q + + L G + S L + SL V L N F
Sbjct: 188 LKLSYNSLVCEFPMNFSDSRVQVLMLNGQKGREKLHGSI-SFLQKMTSLTNVTLQGNSFS 246
Query: 298 GQTPKFNS-------PVRFDMAKG---SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347
G P F+ VR + G S+ F L G N+L + P +
Sbjct: 247 GPLPDFSGLVSLKSFNVRENQLSGLVPSSLFELQSLSDVALGN-NLLQGPTPNFTAPDIK 305
Query: 348 AESWKGNNPCNSDWKGVSCDAGGNITV---------VNLK-----NLGLSGTISSNFSRL 393
+ G N D G SCD N + VN N SG + +
Sbjct: 306 PDL-NGLNSFCLDTPGTSCDPRVNTLLSIVEAFGYPVNFAEKWKGNDPCSGWVGITCTG- 363
Query: 394 TSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVI-VKTDGNPDIG 452
T + + L GTI SL ++++S N+L G +P + +KT D+
Sbjct: 364 TDITVINFKNLGLNGTISPRFADFASLRVINLSQNNLNGTIPQELAKLSNLKT---LDVS 420
Query: 453 KDXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGLGFC 512
K+ IVGSV+G++ ++G+
Sbjct: 421 KNRLCGEVPRFNTTIVNTTGNFEDCPNGNAGKKASSNAGKIVGSVIGILLALLLIGVAIF 480
Query: 513 LYTRKRKRSGRVQSPNAVVIHPSN-GGDGNAVKIXXXXXXXXXXXXXXQSLTSSGPSDLH 571
+K+ + ++ HP D +A KI SG +D H
Sbjct: 481 FLVKKKMQYHKM--------HPQQQSSDQDAFKITIENLCTGVSESGF-----SG-NDAH 526
Query: 572 VVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKG 631
+ EAG++VISIQVLR+ T NF E+N+LGRGGFG VYKGELHDGTKIAVKRMES+++S KG
Sbjct: 527 LGEAGNIVISIQVLRDATYNFDEKNILGRGGFGIVYKGELHDGTKIAVKRMESSIISGKG 586
Query: 632 FAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE 691
EFKSEIAVLT+VRHR+LV L GYCL+GNERLLVY+YMPQGTLSRH+F KEEGL+PLE
Sbjct: 587 LDEFKSEIAVLTRVRHRNLVVLHGYCLEGNERLLVYQYMPQGTLSRHIFYWKEEGLRPLE 646
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
WTRRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDM AKVADFGLVRLAP+ G
Sbjct: 647 WTRRLIIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMHAKVADFGLVRLAPE-GT 705
Query: 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVT 811
SIET++AGTFGYLAPEYAVTGRVTTKVDV+SFGVILMEL+TGRKALD +SE+ VHL T
Sbjct: 706 QSIETKIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELLTGRKALDVARSEEEVHLAT 765
Query: 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
WFRRM INK +F KAID ++++EETL SI+ VA+LA C +REP RPDM HVVNVL S
Sbjct: 766 WFRRMFINKGSFPKAIDEAMEVNEETLRSINIVAELANQCSSREPRDRPDMNHVVNVLVS 825
Query: 872 LAELWKPAE--PDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDXXXXXFLASTDNTQTS 929
L WKP E DS+DIYGID D LPQ + + G DNT TS
Sbjct: 826 LVVQWKPTERSSDSEDIYGIDYDTPLPQLILD-SCFFG----------------DNTLTS 868
Query: 930 IPTRPSGFADSFTSADGR 947
IP+RPS +F S GR
Sbjct: 869 IPSRPSELESTFKSGQGR 886
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 7.0e-75, Sum P(2) = 7.0e-75
Identities = 122/301 (40%), Positives = 174/301 (57%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
+V ++ E+N++G+GG G VYKG + G +AVKR+ + F +EI L ++R
Sbjct: 685 DVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIR 744
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
HRH+V LLG+C + LLVYEYMP G+L L +K G L W R IAL+ A+G+
Sbjct: 745 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-G--HLHWNTRYKIALEAAKGL 801
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
YLH +HRD+K +NILL + A VADFGL + D+G + +AG++GY+A
Sbjct: 802 CYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 861
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM-HINKDTFRK 825
PEYA T +V K DV+SFGV+L+ELITG+K + E D V +V W R M NKD K
Sbjct: 862 PEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFG--DGVDIVQWVRSMTDSNKDCVLK 919
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE--LWKPAEPDS 883
ID + L + ++ V +A C + +RP M VV +L+ + + L K +S
Sbjct: 920 VID--LRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAES 977
Query: 884 D 884
D
Sbjct: 978 D 978
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 7.1e-75, Sum P(2) = 7.1e-75
Identities = 120/301 (39%), Positives = 177/301 (58%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS 628
+L E + ++ + T NFS+ +++G GGFGTVYK L +G ++A+KR+
Sbjct: 979 NLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQF 1038
Query: 629 EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK 688
+ G EF +E+ + KV+H +LV LLGYC+ G+ER L+YEYM G+L L NR + L+
Sbjct: 1039 Q-GDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRAD-ALE 1096
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L W RL I L ARG+ +LH IHRD+K SNILL ++ +V+DFGL R+
Sbjct: 1097 ALGWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISA 1156
Query: 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808
H + T +AGTFGY+ PEY +T + TTK DV+SFGV+++EL+TGR + + + +
Sbjct: 1157 CETH-VSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGN 1215
Query: 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868
LV W R M I + + D + + ++ V +A C A EP++RP M VV
Sbjct: 1216 LVGWVRWM-IARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKG 1274
Query: 869 L 869
L
Sbjct: 1275 L 1275
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 8.6e-75, Sum P(3) = 8.6e-75
Identities = 128/311 (41%), Positives = 188/311 (60%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEF 635
G+ + + L TNNFS+ N +G GG+G VYKG L +G IA+KR + S +G EF
Sbjct: 618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG--SMQGAFEF 675
Query: 636 KSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR 695
K+EI +L++V H+++V LLG+C D E++LVYEY+P G+L L + G+K L+WTRR
Sbjct: 676 KTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKN--GVK-LDWTRR 732
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L IAL +G+ YLH LA IHRD+K +NILL + + AKVADFGL +L D K +
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVT 792
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815
T++ GT GYL PEY +T ++T K DV+ FGV+++EL+TG+ +D + V V ++
Sbjct: 793 TQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPID--RGSYVVKEVK--KK 848
Query: 816 MHINKDTF--RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873
M +++ + ++ +D TI + L D+A C E RP M VV L S+
Sbjct: 849 MDKSRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESIL 908
Query: 874 ELWKPAEPDSD 884
L P++D
Sbjct: 909 RL-VGLNPNAD 918
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 2.7e-74, Sum P(3) = 2.7e-74
Identities = 128/311 (41%), Positives = 191/311 (61%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEF 635
G+ + + L+ T+NFSE N +G GG+G VY+G L +G IA+KR + S +G EF
Sbjct: 615 GAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQG--SLQGGLEF 672
Query: 636 KSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR 695
K+EI +L++V H+++V LLG+C D NE++LVYEY+ G+L L + G++ L+WTRR
Sbjct: 673 KTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKS--GIR-LDWTRR 729
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L IAL +G+ YLH LA IHRD+K +NILL +++ AKVADFGL +L D K +
Sbjct: 730 LKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVT 789
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815
T++ GT GYL PEY +T ++T K DV+ FGV+L+EL+TGR ++ + + V V +
Sbjct: 790 TQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIE--RGKYVVREVK--TK 845
Query: 816 MHINKDTF--RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873
M+ ++ + ++ +D TI L DLA C E RP MG VV + ++
Sbjct: 846 MNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIENIM 905
Query: 874 ELWKPAEPDSD 884
+L P+SD
Sbjct: 906 QL-AGLNPNSD 915
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 1.4e-71, Sum P(2) = 1.4e-71
Identities = 118/290 (40%), Positives = 172/290 (59%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
+V ++ E+N++G+GG G VYKG + +G +AVKR+ + F +EI L ++R
Sbjct: 689 DVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIR 748
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
HRH+V LLG+C + LLVYEYMP G+L L +K G L W R IAL+ A+G+
Sbjct: 749 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-G--HLHWDTRYKIALEAAKGL 805
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
YLH +HRD+K +NILL + A VADFGL + D+G + +AG++GY+A
Sbjct: 806 CYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 865
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM-HINKDTFRK 825
PEYA T +V K DV+SFGV+L+EL+TGRK + E D V +V W R+M NKD+ K
Sbjct: 866 PEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFG--DGVDIVQWVRKMTDSNKDSVLK 923
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875
+D L + ++ V +A C + +RP M VV +L+ + +L
Sbjct: 924 VLDPR--LSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKL 971
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.6e-71, Sum P(2) = 1.6e-71
Identities = 118/299 (39%), Positives = 182/299 (60%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
LR+ TN+F+ +N+LGRGG+G VYKG L+DGT +AVKR++ ++ G +F++E+ ++
Sbjct: 294 LRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAG-GEVQFQTEVETISL 352
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
HR+L+ L G+C ER+LVY YMP G+++ L + G L+W+RR IA+ AR
Sbjct: 353 ALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIR-GEPALDWSRRKKIAVGTAR 411
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH IHRD+K +NILL +D A V DFGL +L H + T + GT G+
Sbjct: 412 GLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGH 470
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH-LVTWFRRMHINKDTF 823
+APEY TG+ + K DVF FG++L+ELITG+KALD +S ++ W +++H +
Sbjct: 471 IAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLH-QEGKL 529
Query: 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS--LAELWKPAE 880
++ ID+ ++ D+ + + +A C P RP M V+ +L LAE W+ +
Sbjct: 530 KQLIDKDLN-DKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQ 587
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 947 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-32 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-32 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-32 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-29 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-29 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-29 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-26 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-23 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PRK15387 | 788 | PRK15387, PRK15387, E3 ubiquitin-protein ligase Ss | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 4e-55
Identities = 90/274 (32%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG G FGTVYK + G +AVK ++ K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D + LV EY G L +L PL IAL + RG+EYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHS---N 117
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR- 774
IHRDLKP NILL ++ K+ADFGL + + T GT Y+APE + G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNG 175
Query: 775 VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834
KVDV+S GVIL EL+TG+ D + L R+ + ++ D
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL-------------IRRILGPPLEFD 222
Query: 835 EETLASIS-TVADLAGHCCAREPYQRPDMGHVVN 867
E +S S DL C ++P +RP ++
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 78/271 (28%), Positives = 112/271 (41%), Gaps = 30/271 (11%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ LG G FG VY + G +A+K ++ + + EI +L K++H ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L D ++ LV EY G L L +K L + R + +EYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRL-SEDEARF--YLRQILSALEYLH 114
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
+ +HRDLKP NILL +D K+ADFGL R K T GT Y+APE
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVL 168
Query: 771 VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830
+ VD++S GVIL EL+TG+ F + F+K
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGK---------------PPFPGDDQLLELFKKIGKPK 213
Query: 831 IDLDEETLASIS-TVADLAGHCCAREPYQRP 860
IS DL ++P +R
Sbjct: 214 PPFPPP-EWDISPEAKDLIRKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 77/197 (39%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG GGFGTVY G K+A+K + S E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
D N LV EY G+L L + L L I L + G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 717 FIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE-YAVTGR 774
IHRDLKP NILL D+ + K+ADFGL +L + S+ + GT Y+APE G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGTPAYMAPEVLLGKGY 170
Query: 775 VTTKVDVFSFGVILMEL 791
+ K D++S GVIL EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 5e-49
Identities = 86/283 (30%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 595 ENVLGRGGFGTVYKGEL-----HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG G FG VYKG L ++AVK + E A + EF E ++ K+ H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V LLG C + ++V EYMP G L +L + + L + L+ AL +ARG+EY
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD---LLSFALQIARGMEY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAP 767
L ++FIHRDL N L+G+++ K++DFGL R D+ +L ++AP
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAP 173
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826
E G+ T+K DV+SFGV+L E+ T G + + + + + R+ +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC---- 229
Query: 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
E + L C A +P RP +V +L
Sbjct: 230 -------PPE-------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 87/284 (30%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 596 NVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG VYKG+L T++AVK + E A SE+ +F E V+ K+ H ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNV 58
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHL----FNRKEEGLKPLEWTRRLTIALDVARGV 706
V LLG C + LV EYM G L +L L L+ A+ +A+G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
EYL + F+HRDL N L+G+D+ K++DFGL R D+ + +T ++A
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825
PE G T+K DV+SFGV+L E+ T G +E+ + + R+
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--------- 226
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+ +E + +L C +P RP +V L
Sbjct: 227 --PKPEYCPDE-------LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-48
Identities = 76/206 (36%), Positives = 113/206 (54%), Gaps = 18/206 (8%)
Query: 595 ENVLGRGGFGTVYKGEL-----HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG G FG VYKG+L ++AVK + E A SE+ EF E ++ K+ H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHP 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V LLG C + +V EYM G L +L + + L + L+ AL +ARG+EY
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEY 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE-TRLAGTFGYLAP 767
L ++FIHRDL N L+G+++ K++DFGL R D+ + +L ++AP
Sbjct: 118 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAP 172
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT 793
E G+ T+K DV+SFGV+L E+ T
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 9e-48
Identities = 91/285 (31%), Positives = 134/285 (47%), Gaps = 44/285 (15%)
Query: 597 VLGRGGFGTVYKGELHD-----GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG VYKG L TK+AVK + E A SE+ EF E +++ K+ H ++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMKKLSHPNI 63
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V LLG C G +V EYMP G L L E L L +AL +A+G+EYL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL----- 765
++F+HRDL N L+ +++ K++DFGL R + + G L
Sbjct: 120 S---KNFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIKWM 171
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFR 824
APE G+ T+K DV+SFGV+L E+ T G + +E+ + L+ R+ ++
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENC-- 229
Query: 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+E + +L C A +P RP +V L
Sbjct: 230 ---------PDE-------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 74/268 (27%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 596 NVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+LGRG FG+VY D G +AVK +E + SE+ + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 655 GYCLD--GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
G D N + EY+ G+LS L +K L R+ T + G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPV-IRKYTR--QILEGLAYLHS- 119
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
+HRD+K +NIL+ D K+ADFG + D + GT ++APE
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 773 GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832
D++S G ++E+ TG+ E + + + I I
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSEL--GNPMAAL-----YKIGSSGEPPEIP--EH 228
Query: 833 LDEETLASISTVADLAGHCCAREPYQRP 860
L EE + C R+P +RP
Sbjct: 229 LSEEAKDFLR-------KCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 76/201 (37%), Positives = 112/201 (55%), Gaps = 15/201 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G + TK+AVK ++ +S + F + E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVC 70
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+ +V EYM +G+L L + EG K L + + +A +A G+ YL +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL--KSGEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVTGRV 775
IHRDL NIL+G+++ K+ADFGL RL D+ R F + APE A GR
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRF 181
Query: 776 TTKVDVFSFGVILMELIT-GR 795
T K DV+SFG++L E++T GR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 75/202 (37%), Positives = 114/202 (56%), Gaps = 22/202 (10%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G+G FG V G+ G K+AVK ++ F +E +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
L GN +V EYM +G+L +L +R G + ++L ALDV G+EYL ++F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 718 IHRDLKPSNILLGDDMRAKVADFGL---VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
+HRDL N+L+ +D+ AKV+DFGL D+GK ++ + APE +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKK 175
Query: 775 VTTKVDVFSFGVILMELIT-GR 795
+TK DV+SFG++L E+ + GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 592 FSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
F +G+GGFG VYK G ++A+K ++ + S++ + +EI +L K +H ++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V G L +E +V E+ G+L L + + L ++ + ++ +G+EYLH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH 115
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEY 769
IHRD+K +NILL D K+ DFGL +L+ ++++ GT ++APE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYWMAPEV 168
Query: 770 AVTGRVTTKVDVFSFGVILMELITGR 795
K D++S G+ +EL G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 20/231 (8%)
Query: 597 VLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG V+ GE +D +AVK ++ S +F+ E +LT +H ++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENI 70
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHL------FNR-KEEGLKPLEWTRR--LTIALD 701
V G C +G+ ++V+EYM G L++ L K E T L IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+ R + +
Sbjct: 131 IASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811
++ PE + + TT+ DV+SFGV+L E+ T G++ +E+ + +T
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 9e-34
Identities = 69/201 (34%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG+G FG V + G A+K ++ ++ K +E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
Y E+L LV EY P G L HL +EG E R A ++ +EYLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS--- 111
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
I+RDLKP NILL D K+ DFGL + G + GT YLAPE +
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVLLGKG 169
Query: 775 VTTKVDVFSFGVILMELITGR 795
VD +S GV+L E++TG+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (334), Expect = 2e-33
Identities = 98/363 (26%), Positives = 149/363 (41%), Gaps = 26/363 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH-R 648
++ LG G FG VY D +A+K + + S+ E F EI +L + H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V L + D LV EY+ G+L L +G PL + L I + +EY
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSALEY 116
Query: 709 LHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLA----GTFG 763
LH + IHRD+KP NILL D K+ DFGL +L PD G S L GT G
Sbjct: 117 LH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 764 YLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820
Y+APE ++ D++S G+ L EL+TG + E + + ++ +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF---EGEKNSSATSQTLKIILEL 230
Query: 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAE 880
T A + E + S DL A++P R ++ L K E
Sbjct: 231 PTPSLASPLSPSNPELISKAAS---DLLKKLLAKDPKNRLSS--SSDLSHDLLAHLKLKE 285
Query: 881 PDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDSSSSSFLASTDNTQTSIPTRPSGFADS 940
D D+ D L +L S++ + S D++ S P+G + S
Sbjct: 286 SDLSDLLKPDDSAPLRLSLPPSLEAL-ISSLNSLAISGSDLKLDDSNFSKELAPNGVSSS 344
Query: 941 FTS 943
+
Sbjct: 345 PHN 347
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 73/202 (36%), Positives = 113/202 (55%), Gaps = 10/202 (4%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
F+ E LG G FG V++G + ++A+K ++S +F+ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLI 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L C G ++ E M +G+L F R EG + L + +A VA G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE- 121
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
Q+ IHRDL NIL+G+D+ KVADFGL RL ++ S + ++ + + APE A
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAAS 177
Query: 772 TGRVTTKVDVFSFGVILMELIT 793
G +TK DV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 74/218 (33%), Positives = 116/218 (53%), Gaps = 25/218 (11%)
Query: 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIA 640
SIQ+LR LG G FG V++G ++ T +AVK ++ + K +F +E
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
++ K+RH L+ L C +V E M G+L +L + + L+ + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAA 110
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
VA G+ YL Q++IHRDL N+L+G++ KVADFGL R+ ++ E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED---IYEAREGA 164
Query: 761 TF--GYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GR 795
F + APE A+ R + K DV+SFG++L E++T GR
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 598 LGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G FG V+ E H D +AVK ++ A SE +F+ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIV 70
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNR----------KEEGLKPLEWTRRLTIALD 701
G C +G L+V+EYM G L+R L + ++ L + L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+A G+ YL L F+HRDL N L+G + K+ DFG+ R + + R
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINK 820
++ PE + + TT+ D++SFGV+L E+ T G++ + + +++ +T R +
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL---- 243
Query: 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQR 859
E V + C REP QR
Sbjct: 244 --------------ERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 83/266 (31%), Positives = 116/266 (43%), Gaps = 34/266 (12%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G+ +A+K + +SE F E E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+V EYM G L +L R+ +G EW L + DV +EYL F
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWL--LDMCSDVCEAMEYLE---SNGF 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYLAPEYAVTGR 774
IHRDL N L+G+D KV+DFGL R D+ S + GT + PE R
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSR 177
Query: 775 VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834
++K DV+SFGV++ E+ + K E S V +++ L
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----------------VESVSAGYRLY 221
Query: 835 EETLASISTVADLAGHCCAREPYQRP 860
LA V + C +P RP
Sbjct: 222 RPKLAPTE-VYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 89/267 (33%), Positives = 135/267 (50%), Gaps = 36/267 (13%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G + TK+AVK ++ +S + F E E ++ K+RH LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + +V EYM +G+L F + EG + L+ + +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLL--DFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVTGR 774
+IHRDL+ +NIL+GD + K+ADFGL RL DN R F + APE A+ GR
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 179
Query: 775 VTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833
T K DV+SFG++L EL+T GR + + + V RM +D
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD------------ 227
Query: 834 DEETLASISTVADLAGHCCAREPYQRP 860
++ +L C ++P +RP
Sbjct: 228 ------CPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 69/218 (31%), Positives = 112/218 (51%), Gaps = 25/218 (11%)
Query: 592 FSEENVLGRGGFGTVYKGEL------HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTK 644
F EE LG G FG VYKGEL T +A+K + E+A + EF+ E +++
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSD 64
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-----------KEEGLKPLEWT 693
++H ++V LLG C +++EY+ G L L E L+ +
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
L IA+ +A G+EY L+ F+HRDL N L+G+ + K++DFGL R +
Sbjct: 125 DFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 791
++++ ++ PE + G+ TT+ D++SFGV+L E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
N+ +++GRG FG VYKG L G +A+K++ + E+ EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVA---R 704
+V +G + ++ EY G+L + + F E L +A+ V +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----------VAVYVYQVLQ 110
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFG 763
G+ YLH Q IHRD+K +NIL D K+ADFG+ +L N + + GT
Sbjct: 111 GLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPY 164
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
++APE +T D++S G ++EL+TG
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 77/202 (38%), Positives = 116/202 (57%), Gaps = 18/202 (8%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG+G FG V+ G + T++A+K ++ +S + F + E V+ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + +V EYM +G+L L K E K L + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVTGR 774
++HRDL+ +NIL+G+++ KVADFGL RL DN R F + APE A+ GR
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 179
Query: 775 VTTKVDVFSFGVILMELIT-GR 795
T K DV+SFG++L EL T GR
Sbjct: 180 FTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 32/275 (11%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G G FG V+ G + K+A+K + +SE+ +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+ + LV+E+M G LS +L R + G L + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGK--FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTT 777
IHRDL N L+G++ KV+DFG+ R D+ +++ T + +PE + ++
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 778 KVDVFSFGVILMELITGRKALDETQSEDSV--HLVTWFRRMHINKDTFRKAIDRTIDLDE 835
K DV+SFGV++ E+ + K E +S V + FR L +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------------LYK 222
Query: 836 ETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870
LAS S V +L HC P RP +++ L+
Sbjct: 223 PRLASQS-VYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ +G+G FG VY DG +K ++ + +SEK + +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP-----LEWTRRLTIALDVAR 704
++ + + +V EY G LS+ + +K+EG L+W +L +AL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK--- 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
YLH + +HRD+KP NI L + K+ DFG+ ++ + + GT Y
Sbjct: 118 ---YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYY 169
Query: 765 LAPE------YAVTGRVTTKVDVFSFGVILMELITGRKA 797
L+PE Y K D++S G +L EL T +
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G+G FG VYKG L T++AVK S + + +F E +L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+ +V E +P G+L L RK++ ++ + L ++LD A G+EYL ++
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVK--KLLQMSLDAAAGMEYLES---KNC 114
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT-FGYLAPEYAVTGRVT 776
IHRDL N L+G++ K++DFG+ R + G +++ L + APE GR T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 777 TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEE 836
++ DV+S+G++L E + T + M N+ T R+ I+ +
Sbjct: 174 SESDVWSYGILLWETFSLG--------------DTPYPGMS-NQQT-RERIESGYRMPAP 217
Query: 837 TLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
L + L C A +P RP + N L
Sbjct: 218 QLCPEE-IYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 76/202 (37%), Positives = 117/202 (57%), Gaps = 18/202 (8%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG+G FG V+ G + TK+A+K ++ + + F + E ++ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKLRHDKLVPL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + +V E+M +G+L L KE K L+ + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVTGR 774
+IHRDL+ +NIL+GD++ K+ADFGL RL DN R F + APE A+ GR
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 179
Query: 775 VTTKVDVFSFGVILMELIT-GR 795
T K DV+SFG++L EL+T GR
Sbjct: 180 FTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-29
Identities = 109/366 (29%), Positives = 174/366 (47%), Gaps = 51/366 (13%)
Query: 77 IEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-SVPSDFFKG 134
+ G +P ++ S SSL VL++ N L G+IP SL+ L+SL+ + N +P + +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ- 210
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+ SL+ I L YN N++G IP +GG T L HL L
Sbjct: 211 MKSLKWIYLGYN-------------------------NLSGEIPYEIGGLT--SLNHLDL 243
Query: 195 AFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLTQLWLHGNSFTGP 252
+N L GPIP S G ++Q L+L +KL+G + I ++ L L L NS +G
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLY----QNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 253 LPDL-SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDM 311
+P+L L +L+ + N TG +P +L +L L V+ L +N F G+ PK ++
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK-------NL 352
Query: 312 AKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGN 371
K +N LD + G + L ++ + + S +G P S A +
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP-------KSLGACRS 405
Query: 372 ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
+ V L++ SG + S F++L + L +S N L G I +PSL+ML ++ N F
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465
Query: 432 GKVPNF 437
G +P+
Sbjct: 466 GGLPDS 471
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 38/292 (13%)
Query: 598 LGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G FG V+ E + D +AVK ++ A S+ +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIV 70
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNR------KEEGLKPLEWTRR--LTIALDVA 703
G C++G+ ++V+EYM G L++ L EG +P E T+ L IA +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ R + +
Sbjct: 131 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822
++ PE + + TT+ DV+S GV+L E+ T G++ + + + + +T R
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-------- 239
Query: 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+ R +E V DL C REP+ R ++ + ++L +LA+
Sbjct: 240 ---VLQRPRTCPKE-------VYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 16/209 (7%)
Query: 597 VLGRGGFGTVYKGELH--DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+LG G FG+V +G+L DG+ K+AVK M+ + + EF SE A + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 653 LLGYCLDGNER------LLVYEYMPQGTLSRHLF-NRKEEGLKPLEWTRRLTIALDVARG 705
L+G C + + +++ +M G L L +R + L L +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT-FGY 764
+EYL ++++FIHRDL N +L +DM VADFGL + +G + + R+A +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY-SGDYYRQGRIAKMPVKW 181
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+A E T+K DV++FGV + E+ T
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 596 NVLGRGGFGTVYKGE---LHDGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG V L D T ++AVK + + E+ ++F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTLDHENI 68
Query: 651 VGLLGYCLD--GNERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGVE 707
V G C G L+ EY+P G+L +L +R + LK L L + + +G++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMD 123
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH--SIETRLAGTFGYL 765
YL Q +IHRDL NIL+ + K++DFGL ++ P++ + E + F Y
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
APE T + ++ DV+SFGV L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 73/206 (35%), Positives = 115/206 (55%), Gaps = 24/206 (11%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FG V G+ + G K+AVK +++ ++ F +E +V+T++RH +LV LL
Sbjct: 11 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLL 65
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G ++ L +V EYM +G+L +L +R G L L +LDV +EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA-- 120
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP---DNGKHSIETRLAGTFGYLAPEYA 770
+F+HRDL N+L+ +D AKV+DFGL + A D GK ++ + APE
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL 171
Query: 771 VTGRVTTKVDVFSFGVILMELIT-GR 795
+ +TK DV+SFG++L E+ + GR
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 76/203 (37%), Positives = 112/203 (55%), Gaps = 24/203 (11%)
Query: 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
++G G FG V +GE + G K+AVK ++ V ++ F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
L N +V E M +G L L R G + + L +LDVA G+EYL +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAP---DNGKHSIETRLAGTFGYLAPEYAVTG 773
+HRDL NIL+ +D AKV+DFGL R+ DN K ++ + APE
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--------WTAPEALKHK 172
Query: 774 RVTTKVDVFSFGVILMELIT-GR 795
+ ++K DV+S+GV+L E+ + GR
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 81/280 (28%), Positives = 122/280 (43%), Gaps = 31/280 (11%)
Query: 598 LGRGGFGTVYKGELHDGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG G FG V +GE +AVK ++S +S+ +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G L + ++V E P G+L L +++ L + A+ +A G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFGYLAPEYAVT 772
+ FIHRDL NILL D + K+ DFGL+R P N H + E L F + APE T
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 773 GRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831
+ DV+ FGV L E+ T G + W ++ K ID+
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP--------------W---AGLSGSQILKKIDKEG 217
Query: 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
+ E A + ++ C A P RP + L
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-28
Identities = 117/378 (30%), Positives = 164/378 (43%), Gaps = 66/378 (17%)
Query: 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-SV 127
I +G N+ G +P E+ L+SL L+++ N LTG IP SL L +LQ + N + +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 128 PSDFFKGLTSLQTISLDY-NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
P F L L ISLD ++ S IPE + L+ N TG IP L ++
Sbjct: 277 PPSIF-SLQKL--ISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT--SL 331
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
P L L L N G IP + GK N +LT L L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGK------------------------HN--NLTVLDLST 365
Query: 247 NSFTGPLPDL---SG-LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
N+ TG +P+ SG L L FS N L G +P SL SL V L +N F G+ P
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWK 362
+ K + LD + GR+N + S+ ++ + G P + K
Sbjct: 423 -------EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475
Query: 363 GVSCDAGGNITVVNLKNLGL-----SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
L+NL L SG + L+ L QL LS N+L+G IP EL++
Sbjct: 476 -------------RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522
Query: 418 PSLEMLDVSNNHLFGKVP 435
L LD+S+N L G++P
Sbjct: 523 KKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 80/295 (27%), Positives = 138/295 (46%), Gaps = 41/295 (13%)
Query: 598 LGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G FG V+ E + D +AVK ++ ++ + +F+ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----KPLE------WTRRLTIAL 700
G C DG+ ++V+EYM G L++ L + + +P + ++ L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R + +
Sbjct: 131 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 761 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHIN 819
++ PE + + TT+ DV+SFGVIL E+ T G++ + + + + +T R +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL--- 244
Query: 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
E V D+ C REP QR ++ + +L +L +
Sbjct: 245 ---------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 72/212 (33%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 596 NVLGRGGFGTVYKG----ELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
N LG G FG VY+G L G+ ++AVK + ++ EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP--LEWTRRLTIALDVARGV 706
++V LLG CL + ++ E M G L +L + + E P L L I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 707 EYLHGLAHQSFIHRDLKPSNILL----GDDMR-AKVADFGLVRLAPDNGKHSIETRLAGT 761
YL + FIHRDL N L+ D R K+ DFGL R + + E
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
++APE + G+ TT+ DV+SFGV++ E++T
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 34/286 (11%)
Query: 598 LGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG+G FG VY+G T++A+K + E+A + E+ EF +E +V+ + H+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHV 71
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARG 705
V LLG G L+V E M +G L +L +R+ E GL P + + +A ++A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ YL F+HRDL N ++ +D+ K+ DFG+ R + + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825
APE G TTK DV+SFGV+L E+ T + + S + V + D
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--------LKFVID--GG 238
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
+D + ++ + +L C P RP +V+ L
Sbjct: 239 HLDLPENCPDK-------LLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 74/208 (35%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 596 NVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
V+G+G FG VY G L D AVK + + + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 652 GLLGYCLDGN-ERLLVYEYMPQGTLSRHLFNRKEE---GLKPLEWTRRLTIALDVARGVE 707
LLG CL L+V YM G L R+ F R E +K L + L VA+G+E
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDL-RN-FIRSETHNPTVKDL-----IGFGLQVAKGME 112
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYL 765
YL A + F+HRDL N +L + KVADFGL R D +S+ ++
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
A E T + TTK DV+SFGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 42/221 (19%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVLTK 644
+ + LG G +G VYK + G +A+K R+++ E+G S EI++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGI---PSTALREISLLKE 54
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++H ++V LL + LV+EY L + +++ L + I + R
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DL-KKYLDKRPGPL-SPNLIKS--IMYQLLR 109
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLAGT 761
G+ Y H +HRDLKP NIL+ D K+ADFGL R + H + T
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----T 161
Query: 762 FGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y APE Y +T VD++S G I E+ITG+
Sbjct: 162 LWYRAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 82/291 (28%), Positives = 137/291 (47%), Gaps = 38/291 (13%)
Query: 598 LGRGGFGTVYK---GELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
LG+G FG+V L D T +AVK+++ + + + +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69
Query: 653 LLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
G C R LV EY+P G+L +L +E L+ + L A + +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYL- 124
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG---TFGYLAP 767
+ ++HRDL NIL+ + R K+ DFGL ++ P + K + R G F Y AP
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWY-AP 180
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827
E + + DV+SFGV+L EL T D++ S + + R M +K + +
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFM----RMMGNDKQG-QMIV 232
Query: 828 DRTIDLDEET------LASISTVADLAGHCCAREPYQRP---DMGHVVNVL 869
I+L + + + + C +P QRP ++ V +
Sbjct: 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-27
Identities = 113/441 (25%), Positives = 187/441 (42%), Gaps = 77/441 (17%)
Query: 2 KKRHLGVSLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGNPASL--GW-TDPDPCKWKH 58
KK + L L+ + + + + + K+S+ +P W + D C W+
Sbjct: 3 KKGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQG 62
Query: 59 IQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQE 116
I C+ S+RV I + G+NI G + + L + + + N+L+G IP + SSL+
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 117 VLFDDNNFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG 175
+ +NNFT S+P + +L+T+ L N S IP + + L+ G + G
Sbjct: 123 LNLSNNNFTGSIPRGS---IPNLETLDLSNNML-SGEIPNDIGSFSSLKVLDLGGNVLVG 178
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN 235
IP+ L + L L LA N L G IP G+
Sbjct: 179 KIPNSLT--NLTSLEFLTLASNQLVGQIPRELGQ-------------------------- 210
Query: 236 MTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
M SL ++L N+ +G +P ++ GL+SL + N LTG +PSSL NL +L + L N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
Query: 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
G P P F + LD + + G + L+ ++
Sbjct: 271 KLSGPIP----PSIFSL---QKLISLDLSDNSLSGEIPELVIQLQ--------------- 308
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414
N+ +++L + +G I + L L+ L L N+ +G IPK L
Sbjct: 309 ----------------NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
Query: 415 TTLPSLEMLDVSNNHLFGKVP 435
+L +LD+S N+L G++P
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/210 (33%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 597 VLGRGGFGTVYKG---ELHDGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG G FGTVYKG + KI A+K + S K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYL 709
LLG CL ++ L+ + MP G L ++ N K+ L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 710 --HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
L +HRDL N+L+ K+ DFGL +L + K ++A
Sbjct: 126 EEKRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
E + T K DV+S+GV + EL+T G K
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 595 ENVLGRGGFGTVYKG--ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
++ LG G +G VY+G + + T +AVK ++ + + EF E AV+ +++H +LV
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQ 66
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
LLG C ++ E+M G L +L + + + L +A ++ +EYL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE-- 121
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYLAPEY 769
++FIHRDL N L+G++ KVADFGL RL + T AG + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPES 176
Query: 770 AVTGRVTTKVDVFSFGVILMELIT 793
+ + K DV++FGV+L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 77/220 (35%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 598 LGRGGFGTVYKGEL-----HDGT-KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHL 650
LG G FG V K E + T +AVK M +EK ++ SE+ ++ + +H+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK-----PLEWTRRLT------IA 699
+ LLG C +V EY G L L R+ G P LT A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
VARG+E+L A + IHRDL N+L+ +D K+ADFGL R H I+
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRK 190
Query: 760 GTFGYL-----APEYAVTGRV-TTKVDVFSFGVILMELIT 793
T G L APE A+ RV T + DV+SFGV+L E+ T
Sbjct: 191 TTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 95/307 (30%), Positives = 144/307 (46%), Gaps = 53/307 (17%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH-DGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKV- 645
N+ ++V+G G FG V K + DG ++ A+KRM+ S+ +F E+ VL K+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 65
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTL------SRHL-----FNRKEEGLKPLEWTR 694
H +++ LLG C L EY P G L SR L F L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
L A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R G+
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQ--- 174
Query: 755 ETRLAGTFG-----YLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQSEDSV 807
E + T G ++A E TT DV+S+GV+L E+++ G T +E
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234
Query: 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
L +R +++ ++ D+E V DL C +PY+RP ++
Sbjct: 235 KLPQGYR------------LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILV 275
Query: 868 VLSSLAE 874
L+ + E
Sbjct: 276 SLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+ +G G G VYK + G ++A+K+M + ++ +EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++V L G+E +V EYM G+L+ F R E + + +V +
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-------QIAYVCREVLQ 127
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGK-HSIETRLAGTF 762
G+EYLH Q+ IHRD+K NILL D K+ADFG +L + K +S+ GT
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV----VGTP 180
Query: 763 GYLAPEYAVTGRV-TTKVDVFSFGVILMELITG 794
++APE + + KVD++S G++ +E+ G
Sbjct: 181 YWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 31/228 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKV-R 646
++F ++G G F TV E + A+K ++ ++ EK K E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 647 HRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H ++ L Y E L V EY P G L +++ ++ G + TR A ++
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTR--FYAAEILLA 114
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA------ 759
+EYLH IHRDLKP NILL DM K+ DFG ++ N A
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 760 ------------GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
GT Y++PE D+++ G I+ +++TG+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 93/304 (30%), Positives = 141/304 (46%), Gaps = 51/304 (16%)
Query: 595 ENVLGRGGFGTVYKGELH-DGTKI-AVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLV 651
E+V+G G FG V + + DG K+ A +M SE +F E+ VL K+ H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 652 GLLGYCLDGNERLLVYEYMPQGTL------SRHL-----FNRKEEGLKPLEWTRRLTIAL 700
LLG C + + EY P G L SR L F ++ L + L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
DVA G++YL + + FIHRDL N+L+G+++ +K+ADFGL R G+ E +
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GE---EVYVKK 175
Query: 761 TFG-----YLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQSEDSVHLVTWF 813
T G ++A E TTK DV+SFGV+L E+++ G T +E L +
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873
R +++ + D+E V +L C PY+RP + LS +
Sbjct: 236 R------------MEKPRNCDDE-------VYELMRQCWRDRPYERPPFAQISVQLSRML 276
Query: 874 ELWK 877
E K
Sbjct: 277 EARK 280
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+LG+G FG V+KG L D T +AVK + + E +F SE +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
C +V E +P G L +K+E L+ + + ALD A G+ YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVT 776
IHRDL N L+G++ K++DFG+ R D+G +S + APE GR +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 777 TKVDVFSFGVILME 790
++ DV+S+G++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 75/233 (32%), Positives = 112/233 (48%), Gaps = 39/233 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
NN +G+G FG V++ T +AVK M S A+F+ E A++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMA 63
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLK------------ 688
+ H ++V LLG C G L++EYM G L+ RH R + L
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 689 --PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-- 744
PL T +L IA VA G+ YL + + F+HRDL N L+G++M K+ADFGL R
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 745 LAPD----NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ D + +I R ++ PE R TT+ DV+++GV+L E+ +
Sbjct: 181 YSADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
VLG+G G VYK H T A+K++ E + E+ L ++V
Sbjct: 8 VLGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCY 65
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP--LEWTRRLTIALDVARGVEYLHGL 712
G E +V EYM G+L+ L +K + L IA + +G++YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLA-----YIARQILKGLDYLHTK 118
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA------GTFGYLA 766
H IHRD+KPSN+L+ K+ADFG+ + +E L GT Y++
Sbjct: 119 RHI--IHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQCNTFVGTVTYMS 168
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGR 795
PE + D++S G+ L+E G+
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 69/202 (34%), Positives = 111/202 (54%), Gaps = 18/202 (8%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G + TK+A+K ++ +S + F E ++ +++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQLQHPRLVRL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + ++ EYM G+L L + EG+K L + + +A +A G+ ++ ++
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFL--KTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVTGR 774
+IHRDL+ +NIL+ + + K+ADFGL RL DN R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGT 179
Query: 775 VTTKVDVFSFGVILMELIT-GR 795
T K DV+SFG++L E++T GR
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 596 NVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
N +G G FG VY L G +AVK + K E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G + + + EY GTL L + + R T+ L G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQL--LEGLAYLH---S 117
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFG---YLAPEYA 770
+HRD+KP+NI L + K+ DFG V+L N ++ + G Y+APE
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK--NNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 771 VTGRVTTK---VDVFSFGVILMELITGRK 796
G+ D++S G +++E+ TG++
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/227 (30%), Positives = 111/227 (48%), Gaps = 24/227 (10%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G+ K+A+K + +SE+ F E E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+V E+M G L +L R+ + K + L++ DV G+EYL SF
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLE---RNSF 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG------YLAPEYAV 771
IHRDL N L+ KV+DFG+ R D+ S + G + PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-------SSGAKFPVKWSPPEVFN 174
Query: 772 TGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMH 817
+ ++K DV+SFGV++ E+ T G+ ++ + + V +++ R++
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 14/198 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G ++ TK+AVK ++ +S + F E E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 70
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
++ EYM +G+L F + +EG K + + + + +A G+ Y+ +++
Sbjct: 71 TKEEPIYIITEYMAKGSLLD--FLKSDEGGK-VLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVTGRV 775
IHRDL+ +N+L+ + + K+ADFGL R+ DN R F + APE G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSF 181
Query: 776 TTKVDVFSFGVILMELIT 793
T K DV+SFG++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 37/214 (17%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEK-GFA-EFKSEIAVLTKVRHRHLVGLL 654
+G G +G VYK G +A+K++ + +EK GF EI +L K+RH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 655 GYCLD--GNERLLVYEYMP---QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V+EYM G L E +K + G++YL
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--------CYMKQLLEGLQYL 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE-TRLAGTFGYLAPE 768
H +HRD+K SNIL+ +D K+ADFGL R P ++S + T T Y PE
Sbjct: 117 H---SNGILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPE 171
Query: 769 -------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y +VD++S G IL EL G+
Sbjct: 172 LLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 23/205 (11%)
Query: 598 LGRGGFGTVYKG--ELHDGTKI--AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
LG G FG+V KG + G ++ AVK + + + + K EF E +V+ ++ H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTIALDVARGVEYLHG 711
L+G C G +LV E P G L ++L R+E E A VA G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTF--GYLAPE 768
+ F+HRDL N+LL + +AK++DFG+ R L + + T AG + + APE
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPE 168
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT 793
G+ ++K DV+S+GV L E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+F LG+G +G+VYK + L D A+K ++ +S+K + +EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ LDGN+ +V EY P G LS+ + RK++ K + I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN-GKHSIETRLAGTFGYLAPE 768
H Q +HRDLK +NILL + K+ D G+ ++ N K I GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPE 171
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
+ K D++S G +L E+ T
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 596 NVLGRGGFGTVYKGEL----HDGTKIAVK---RMESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG G FG VY+G D ++ V ES SE+ ++F E +++K H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQ 69
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARGV 706
++V L+G + R ++ E M G L L + +P T + L A DVA+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 707 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
+YL FIHRD+ N LL G AK+ADFG+ R + R
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMEL 791
++ PE + G T+K DV+SFGV+L E+
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 45/225 (20%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE---FKS--EIAVLTK 644
+ + LG G + VYK G +A+K+++ + K + F + EI +L +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQE 58
Query: 645 VRHRHLVGLLG-YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIAL 700
++H +++GLL + N L V+E+M T + K L P + +
Sbjct: 59 LKHPNIIGLLDVFGHKSNINL-VFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTL--- 112
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETR 757
RG+EYLH +HRDLKP+N+L+ D K+ADFGL R + H + TR
Sbjct: 113 ---RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 758 LAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y APE Y V VD++S G I EL+
Sbjct: 167 W-----YRAPELLFGARHYGVG------VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G G V+K + G +A+K++ + + EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
G+ +LV EYMP LS L R EE P + L +GV Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRML--LKGVAYMHAN---G 119
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR-V 775
+HRDLKP+N+L+ D K+ADFGL RL + + + T Y APE R
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 776 TTKVDVFSFGVILMELITGR 795
VD+++ G I EL+ G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKG-FAEFKSEIAVLTKVRHR 648
+F V+G+G FG V + D K+ A+K M EKG +E +L ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
LV L D LV + + G L HL + +K E + I ++ +EY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWIC-EIVLALEY 115
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + IHRD+KP NILL + + DF + + T +GT GY+APE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPE 169
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRK 796
+ VD +S GV E + G++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 82/233 (35%), Positives = 116/233 (49%), Gaps = 42/233 (18%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVR--- 646
+ E +G G +GTVYK +L+ G +A+K++ +SE+G EIA+L ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 647 HRHLVGLLGYCLDGNER------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
H ++V LL C G LV+E++ Q L+ +L + GL P E + L L
Sbjct: 60 HPNIVRLLDVC-HGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP-ETIKDLMRQL 116
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
RGV++LH +H +HRDLKP NIL+ D + K+ADFGL R +S E L
Sbjct: 117 --LRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTS 165
Query: 761 ---TFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804
T Y APE YA T VD++S G I EL R+ L SE
Sbjct: 166 VVVTLWYRAPEVLLQSSYA------TPVDMWSVGCIFAELFR-RRPLFRGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 23/219 (10%)
Query: 592 FSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
F EE LG FG +YKG L+ +A+K ++ + + + + EF+ E +++ ++
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD-INNPQQWGEFQQEASLMAELH 65
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK----------EEGL--KPLEWTR 694
H ++V LLG +++EY+ QG L L R E+G L+
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
L IA+ +A G+EYL + F+H+DL NIL+G+ + K++D GL R + +
Sbjct: 126 FLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ + ++ PE + G+ ++ D++SFGV+L E+ +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/201 (32%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG+GGFG V ++ K+ A K+++ + KG +E +L KV R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
Y + + L LV M G L H++N E G R + A + G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE---ARAIFYAAQIICGLEHLH---Q 113
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
+ ++RDLKP N+LL D +++D GL K AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEV 170
Query: 775 VTTKVDVFSFGVILMELITGR 795
VD F+ G L E+I GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 598 LGRGGFGTVYKGELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG+V +G+L+ K+AVK M+ A+ + +F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 655 GYCLDGNER------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL--DVARGV 706
G CL E +++ +M G L L + G P ++ + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL-GDCPQYLPTQMLVKFMTDIASGM 125
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT-FGYL 765
EYL + +SFIHRDL N +L ++M VADFGL + NG + + R+A ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVKWI 181
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
A E TTK DV+SFGV + E+ T
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 87/294 (29%), Positives = 129/294 (43%), Gaps = 37/294 (12%)
Query: 597 VLGRGGFGTV--YKGE-LHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG G FG V Y + +DGT +AVK ++ ++ + +K EI +L + H ++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIV 69
Query: 652 GLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
G C + + L+ EY+P G+L +L + + L L L A + G+ YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQL-----LLFAQQICEGMAYL 123
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG---TFGYLA 766
H Q +IHRDL N+LL +D K+ DFGL + P+ G R G F Y A
Sbjct: 124 HS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWY-A 178
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826
E + + DV+SFGV L EL+T D QS F M I +
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT---HCDSKQSPP-----KKFEEM-IGPKQGQMT 229
Query: 827 IDRTIDLDEETL------ASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+ R I+L E + V L +C E RP ++ +L +
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 81/273 (29%), Positives = 129/273 (47%), Gaps = 32/273 (11%)
Query: 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F + VLG+GGFG V ++ G A K++E + + KG + +E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H+++ E G E R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF---EEGRAVFYAAEICCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + ++RDLKP NILL D +++D GL P+ +I+ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPE 171
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
R T D ++ G +L E+I G+ + R+ I R+ ++
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ-------------RKKKIK----REEVE 214
Query: 829 RTI-DLDEETLASISTVA-DLAGHCCAREPYQR 859
R + ++ EE S A L ++P +R
Sbjct: 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 14/222 (6%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V G+ +A+K ++ +SE EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+V EYM G L +L E K + ++ L + DV G+ YL + Q F
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQ-F 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAPEYAVTGRVT 776
IHRDL N L+ D KV+DFGL R D+ S+ ++ + PE + + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFS 179
Query: 777 TKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMH 817
+K DV++FGV++ E+ + G+ + + ++V V+ R++
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY 221
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 596 NVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFK---SEIAVLTKVRHRHL 650
LG G G V K LH G +AVK + + A K E+ +L K ++
Sbjct: 7 GELGAGNSGVVSKV-LHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYI 61
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
VG G + + + EYM G+L + ++ +G P ++ +A V +G+ YLH
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVA--VLKGLTYLH 117
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 118 EKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMAPERI 171
Query: 771 VTGRVTTKVDVFSFGVILMELITGR 795
+ K D++S G+ L+EL TGR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E V+G G FG V +G L K +A+K +++ S+K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNI 67
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G +++ EYM G+L + L R+ +G + + + +A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDG--KFTVGQLVGMLRGIASGMKYL- 122
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD--------NGKHSIETRLAGTF 762
+ +++HRDL NIL+ ++ KV+DFGL R D GK I
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------- 173
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ APE + T+ DV+SFG+++ E+++
Sbjct: 174 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+G G +G VYK + G +A+K++ ES + + EI +L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNIIK 62
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
LL + LV+E+M L ++ GL P + L +G+ + H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLY--KLIKDRQRGL-PESLIKSYLYQL--LQGLAFCH-- 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNG--KHSIETRLAGTFGYLAPEY 769
+H +HRDLKP N+L+ + K+ADFGL R H + TR Y APE
Sbjct: 116 SH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPEL 169
Query: 770 AVTGRV-TTKVDVFSFGVILMELITGR 795
+ + +T VD++S G I EL++ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 90/300 (30%), Positives = 135/300 (45%), Gaps = 51/300 (17%)
Query: 596 NVLGRGGFGTVYKGELH-DGTKI-AVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652
+V+G G FG V K + DG ++ A + S+ +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 653 LLGYCLDGNERLLVYEYMPQGTL------SRHL-----FNRKEEGLKPLEWTRRLTIALD 701
LLG C L EY P G L SR L F L + L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
VARG++YL + + FIHRDL NIL+G++ AK+ADFGL R E + T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKT 169
Query: 762 FG-----YLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQSEDSVHLVTWFR 814
G ++A E TT DV+S+GV+L E+++ G T +E L +R
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
Query: 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+++ ++ D+E V DL C +PY+RP ++ L+ + E
Sbjct: 230 ------------LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 71/207 (34%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F + VLG+GGFG V ++ G A KR+E + + KG + +E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H++N G E R L A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---EEERALFYAAEILCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH ++ ++RDLKP NILL D +++D GL P+ SI R+ GT GY+APE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-GTVGYMAPE 171
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
R T D + G ++ E+I G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 29/214 (13%)
Query: 598 LGRGGFGTVY----KGELHDG--TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG+G FG VY KG + D T++A+K + E+A + E+ EF +E +V+ + H+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEFNCHHV 71
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARG 705
V LLG G L++ E M +G L +L + + E P + + +A ++A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN------GKHSIETRLA 759
+ YL+ F+HRDL N ++ +D K+ DFG+ R + GK + R
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+++PE G TT DV+SFGV+L E+ T
Sbjct: 187 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRME----SAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG+G +GTVY G + G IAVK++E + + +EK + + + E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
LG CLD N + E++P G++S L G P + T + GV YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYT--KQILDGVAYLH- 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHS-IETRLAGTFGYLAP 767
+ +HRD+K +N++L + K+ DFG R +G HS + + GT ++AP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKAL 798
E K D++S G + E+ TG+ L
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 598 LGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+ +G +G V+ + T A+K ++ A + K + +E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y G + L LV EY+P G L+ L N G + R + IA ++ +EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVAR-IYIA-EIVLALEYLHSN- 112
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGL-----VRLAPDNGKHSIET-RLAGTFGYLAP 767
IHRDLKP NIL+ + K+ DFGL VR + E R+ GT Y+AP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 768 EYAVTGRVTTK-VDVFSFGVILMELITG 794
E + G+ +K VD +S G IL E + G
Sbjct: 171 E-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 6e-22
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 52/220 (23%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS--------EIAVLTKV-RH 647
LG G FG+VY G +A+K+M+ +F S E+ L K+ H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V L + +E V+EYM +G L L K+ KP + +I + +G+
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNL-YQLM--KDRKGKPFSESVIRSIIYQILQGLA 113
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL-----AGTF 762
++H F HRDLKP N+L+ K+ADFGL R I +R T
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTR 162
Query: 763 GYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y APE Y ++ VD+++ G I+ EL T R
Sbjct: 163 WYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 65/212 (30%), Positives = 112/212 (52%), Gaps = 34/212 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA-----EFKSEIAVLTKVRHRHLV 651
LG G FG+VY+G L DG AVK E ++ + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVK--EVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 652 GLLGYCLDGNERLLVY-EYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVARGVEY 708
LG + + L ++ E +P G+L++ L + E + L +TR++ + G+EY
Sbjct: 66 QYLGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQILL------GLEY 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA----GTFGY 764
LH ++ +HRD+K +NIL+ + K+ADFG+ K +E A G+ +
Sbjct: 118 LHD---RNTVHRDIKGANILVDTNGVVKLADFGM-------AKQVVEFSFAKSFKGSPYW 167
Query: 765 LAPEYAV-TGRVTTKVDVFSFGVILMELITGR 795
+APE G D++S G ++E+ TG+
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKI----AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
+LG G FGTV+KG + +G I A+K ++ + F E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
LLG C G LV + P G+L H+ ++ L P R L + +A+G+ YL
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRD-SLDP---QRLLNWCVQIAKGMYYLE- 126
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+HR+L NILL D ++ADFG+ L + K + ++A E +
Sbjct: 127 --EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 772 TGRVTTKVDVFSFGVILMELIT 793
GR T + DV+S+GV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTK 644
N + V+G G +G V K G +A+K+ + V + E+ VL +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+RH ++V L LV+EY+ + L L GL P + R L +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPP-DAVRSYIWQL--LQ 111
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
+ Y H + IHRD+KP NIL+ + K+ DFG R + +A T Y
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWY 167
Query: 765 LAPEYAVTGRVTTK-VDVFSFGVILMELITGR 795
APE V K VDV++ G I+ EL+ G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 596 NVLGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FGTV K DG + K ++ ++EK + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 655 GYCLD-GNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLE----W--TRRLTIALDVARGV 706
+D N+ L +V EY G L++ + K+E K +E W +L +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALY----- 119
Query: 707 EYLHGLAH--QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
H + + +HRDLKP+NI L + K+ DFGL ++ + S GT Y
Sbjct: 120 -ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYY 176
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
++PE K D++S G ++ EL
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 597 VLGRGGFGTVYKGE------LHDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V K T +AVK + E+A SE + SE +L +V H H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPH 64
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHL-FNRKEE------------------GLKPL 690
++ L G C LL+ EY G+L L +RK + L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
++ A ++RG++YL A +HRDL N+L+ + + K++DFGL R +
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 751 KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ ++ ++A E TT+ DV+SFGV+L E++T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 74/290 (25%), Positives = 139/290 (47%), Gaps = 34/290 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH-DGTK---IAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ +++ V+G G FG V++G L G K +A+K ++ +EK +F SE +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQF 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIALDVAR 704
H +++ L G +++ EYM G L ++L R +G + L +A
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLR---GIAA 118
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT-FG 763
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ D+ + + T
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822
+ APE + T+ DV+SFG+++ E+++ G + + + + +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM--------------- 220
Query: 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
KAI+ L + S V L C ++ +RP +VN+L L
Sbjct: 221 --KAINDGFRL-PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLTKVRHRHLV 651
V+G G VY L + K+A+KR++ EK E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRK--EEGLKPLEWTRRLTIALDVARGV 706
+ G+E LV Y+ G+L + + R +E + T+ +V +G+
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-------TVLKEVLKGL 115
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGY 764
EYLH IHRD+K NILLG+D K+ADFG+ D G + + R GT +
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 765 LAPE--YAVTGRVTTKVDVFSFGVILMELITGR 795
+APE V G K D++SFG+ +EL TG
Sbjct: 173 MAPEVMEQVHG-YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 34/278 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG G FG V+ + TK+AVK M+ +S + F E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTLQHDKLV-KL 66
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ ++ E+M +G+L F + +EG K + + + +A G+ ++
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLD--FLKSDEGSK-QPLPKLIDFSAQIAEGMAFIE---Q 120
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYAVT 772
+++IHRDL+ +NIL+ + K+ADFGL R+ DN R F + APE
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINF 177
Query: 773 GRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831
G T K DV+SFG++LME++T GR + + + + RM R
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-----------RPE 226
Query: 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+ EE + ++ C P +RP ++ +VL
Sbjct: 227 NCPEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F VLG+GGFG V ++ K+ A K++E + + KG A +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H++N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF---DEERAVFYAAEITCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + ++RDLKP NILL D +++D GL P+ +I R+ GT GY+APE
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRV-GTVGYMAPE 171
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
R T D + G ++ E+I G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 591 NFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
N E LGRG FG V+ + T + VK ++ E +EF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF--NRKEEGLK--PLEWTRRLTIAL 700
+ H+++V LLG C + ++ EY G L + L K+E LK PL +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+A G+++L ++ F+HRDL N L+ KV+ L + ++ + + L
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 761 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807
+LAPE +TK DV+SFGV++ E+ T + S++ V
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 598 LGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG+G FG VY+G D T++AVK + ESA + E+ EF +E +V+ H+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASVMKGFTCHHV 71
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARG 705
V LLG G L+V E M G L +L + + E G P + +A ++A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR------LAPDNGKHSIETRLA 759
+ YL+ + F+HRDL N ++ D K+ DFG+ R GK + R
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
++APE G TT D++SFGV+L E+ +
Sbjct: 187 ----WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-21
Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 28/218 (12%)
Query: 598 LGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V E + TK+AVK ++S +EK ++ SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHK 84
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLT 697
+++ LLG C ++ EY +G L +L R+ G+ + L + ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP--DNGKHSIE 755
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R D K +
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
RL ++APE T + DV+SFGV+L E+ T
Sbjct: 202 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 74/222 (33%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS--E 638
R+VT F + N +G G +G VY+ + G +A+K RM++ E+ S E
Sbjct: 2 RCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN----ERDGIPISSLRE 56
Query: 639 IAVLTKVRHRHLVGLL----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
I +L +RH ++V L G LD LV EY Q L+ L N P ++
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQ-DLASLLDNMP----TPFSESQ 109
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
+ L + RG++YLH IHRDLK SN+LL D K+ADFGL R K
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 755 ETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 795
+ T Y APE + TT +D+++ G IL EL+ +
Sbjct: 167 PKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 27/284 (9%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVR 646
NF E +G+G F VYK L DG +A+K+++ ++ K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H +++ L ++ NE +V E G LSR + + K++ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSAL 119
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFGY 764
E++H + +HRD+KP+N+ + K+ D GL R + HS L GT Y
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYY 172
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824
++PE K D++S G +L E+ AL D ++L + ++ I K +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKK--IEKCDY- 225
Query: 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868
+ +E + DL C +P +RPD+ +V+ V
Sbjct: 226 PPLPADHYSEE--------LRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 598 LGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V E + +AVK ++ +EK ++ SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHK 81
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK-----------PLEWTRRLT 697
+++ LLG C ++ EY +G L +L R+ G++ + + ++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP--DNGKHSIE 755
VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL R D K +
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 756 TRLAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELIT 793
RL ++APE A+ RV T + DV+SFGV++ E+ T
Sbjct: 199 GRLP--VKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-20
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 28/200 (14%)
Query: 614 GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL--GYCLDGNERLL-VYEY 669
G ++A+K + A E A F+ E A+ ++ H ++V LL G G L V+EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEY 60
Query: 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH---QSFIHRDLKPSN 726
+P TL L +G P T RL + + L LA Q +HRDLKP N
Sbjct: 61 VPGRTLREVLAA---DGALPAGETGRLML--------QVLDALACAHNQGIVHRDLKPQN 109
Query: 727 ILL---GDDMRAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTK 778
I++ G AKV DFG+ L P + T + GT Y APE VT
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 779 VDVFSFGVILMELITGRKAL 798
D++++G+I +E +TG++ +
Sbjct: 170 SDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 38/295 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVL 642
NN S LG G FG V + + K+AVK + +A SE+ SE+ ++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIM 92
Query: 643 TKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
+ + H ++V LLG C G L++ EY G L L RK E L L+ +
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESF--LTLEDLLSFSYQ 149
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE--TRLA 759
VA+G+ +L A ++ IHRDL N+LL K+ DFGL R ++ + ++ RL
Sbjct: 150 VAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHI 818
++APE T + DV+S+G++L E+ + G + M +
Sbjct: 207 --VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG---------------SNPYPGMPV 249
Query: 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873
+ F K I + + A + + D+ C +P +RP +V ++
Sbjct: 250 D-SKFYKLIKEGYRMAQPEHAP-AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 77/285 (27%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 598 LGRGGFGTVYKGEL---------------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVL 642
LG G FG V+ E +AVK + + V +F EI ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-TARNDFLKEIKIM 71
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-------KEEGLKPLEWTRR 695
+++++ +++ LLG C+ + ++ EYM G L++ L R + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L +A+ +A G++YL L +F+HRDL N L+G+ K+ADFG+ R + I+
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815
R ++A E + G+ TT DV++FGV L E+ T K E L++ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK-------EQPYSLLSDEQV 241
Query: 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
+ + FR R I L + L S V L C +R+ RP
Sbjct: 242 IENTGEFFRNQ-GRQIYLSQTPLCP-SPVFKLMMRCWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 65/226 (28%), Positives = 114/226 (50%), Gaps = 35/226 (15%)
Query: 598 LGRGGFGTVYKGELHDGTK-----------------IAVKRMESAVVSEKGFAEFKSEIA 640
LG G FG V+ E+ + +AVK + ++ +F E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PDANKNARNDFLKEVK 71
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEG--------- 686
+L++++ +++ LLG C+D + ++ EYM G L S HL +++E G
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
L + ++ L +AL +A G++YL L +F+HRDL N L+G+++ K+ADFG+ R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELI 792
+ I+ R ++A E + G+ TT DV++FGV L E++
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 70/207 (33%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 598 LGRGGFGTVY------KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG+GGFG V G+L+ K+ KR++ KG+ E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK----RKGYEGAMVEKRILAKVHSRFIV 56
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
L Y L LV M G L H++N EE R + G+E+LH
Sbjct: 57 SL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH 114
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETR-LAGTFGYLAPE 768
+ I+RDLKP N+LL +D +++D GL V L K T+ AGT G++APE
Sbjct: 115 ---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK----TKGYAGTPGFMAPE 167
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
VD F+ GV L E+I R
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 70/208 (33%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESA-VVSEKGFAEFKSEIAVLTKVRH 647
++F LG G FG V K A+K + A +V K +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
LV L G D + LV EY+P G L HL RK G P R A V +E
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKS-GRFPEPVAR--FYAAQVVLALE 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH ++RDLKP N+LL D K+ DFG + T L GT YLAP
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYT-LCGTPEYLAP 167
Query: 768 EYAVTGRVTTK-VDVFSFGVILMELITG 794
E + + K VD ++ G+++ E++ G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-20
Identities = 69/222 (31%), Positives = 111/222 (50%), Gaps = 36/222 (16%)
Query: 598 LGRGGFGTVYKGELHDGTK--------IAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V + E + K +AVK ++ ++K A+ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHK 78
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLT 697
+++ LLG C ++ EY +G L L R+ G + L + ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
A VARG+EYL + IHRDL N+L+ +D K+ADFGL R G H I+
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYY 190
Query: 758 LAGTFG-----YLAPEYAVTGRVTT-KVDVFSFGVILMELIT 793
+ G ++APE A+ RV T + DV+SFG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ +G G +G VYK ++ G +A+K + + F + EI++L + RH ++
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DVARGVE 707
V G L ++ +V EY G+L ++ L L+ IA + +G+
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQ------IAYVCRETLKGLA 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETR--LAGTFGY 764
YLH IHRD+K +NILL +D K+ADFG+ +L +I R GT +
Sbjct: 116 YLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFIGTPYW 167
Query: 765 LAPEYA---VTGRVTTKVDVFSFGVILMEL 791
+APE A G K D+++ G+ +EL
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVK----------------RMESAVVSEKGFAE 634
NF E+ LG G FG V+ E + K ++ S+ +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------GLK 688
F E+ +L+++ ++ LLG C ++ EYM G L++ L E K
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L ++ L +A +A G+ YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ + ++ R ++A E + G+ TTK DV++FGV L E++T
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-20
Identities = 88/285 (30%), Positives = 139/285 (48%), Gaps = 35/285 (12%)
Query: 594 EENVLGRGGFGTVYKGE-LHDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
EENV+ RG G YKG+ + +G + VK + + + SEIA + K++H ++V
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-------SEIADMGKLQHPNIV 746
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L+G C L++EY+ LS E L+ L W RR IA+ +A+ + +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLS--------EVLRNLSWERRRKIAIGIAKALRFLHC 798
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+ + +L P I++ D +RL+ G +T+ + Y+APE
Sbjct: 799 RCSPAVVVGNLSPEKIII------DGKDEPHLRLSLP-GLLCTDTKCFISSAYVAPETRE 851
Query: 772 TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH--LVTWFRRMHIN--KDTFRKAI 827
T +T K D++ FG+IL+EL+TG+ D +E VH +V W R + + D + I
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMW---I 905
Query: 828 DRTIDLDEETLAS-ISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
D +I D + I V +LA HC A +P RP V+ L S
Sbjct: 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 74/231 (32%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVRHR 648
NF + LG G + TVYKG G +A+K E + +E+G EI+++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALK--EIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V L N+ +LV+EYM + L +++ G + T L +G+ +
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAF 115
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFGYLA 766
H +HRDLKP N+L+ K+ADFGL R P N S E T Y A
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV---TLWYRA 168
Query: 767 PEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816
P+ + R +T +D++S G I+ E+ITGR T +ED L+ FR M
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIM 217
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 598 LGRGGFGTV----YKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
LG G FG V Y E + G ++AVK ++ A+ K EI +L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 70
Query: 653 LLGYCLD--GNERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
G C + GN L+ E++P G+L +L N+ + LK L A+ + +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDYL 125
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPE 768
+ ++HRDL N+L+ + + K+ DFGL + + D ++++ L + APE
Sbjct: 126 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT 793
+ + DV+SFGV L EL+T
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-20
Identities = 66/250 (26%), Positives = 100/250 (40%), Gaps = 42/250 (16%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGF-AEFKSEIAVLTKVRHRHLVGLL 654
V+GRG FG V+ + G A+K + + + ++ A ++E +L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
D LV EYMP G L L + + P E R L +A ++ +H L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGL-----------------VRLAPDNGKHSIETR 757
FIHRD+KP NIL+ D K+ADFGL L +
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 758 L----------AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807
GT Y+APE + D +S GVIL E++ G D++
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF----YSDTL 235
Query: 808 HLVTWFRRMH 817
T+ + ++
Sbjct: 236 QE-TYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 598 LGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG GGFG V ++ A+K ++ + E G E SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D ++ EY G L L ++ GL E+T R IA V EYLH ++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIAC-VVLAFEYLH---NR 112
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
I+RDLKP N+LL + K+ DFG + L + GT Y+APE +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF----CGTPEYVAPEIILNKG 168
Query: 775 VTTKVDVFSFGVILMELITGR 795
VD +S G++L EL+TGR
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-20
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 30/219 (13%)
Query: 598 LGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V E + +AVK ++ ++K ++ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHK 78
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLT 697
+++ LLG C ++ EY +G L +L R+ G+ + L + ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP--DNGKHSIE 755
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL R D K +
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 756 TRLAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELIT 793
RL ++APE A+ RV T + DV+SFGV+L E+ T
Sbjct: 196 GRLP--VKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKIA---VKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+G G FG V GE H G A VK + SA E+ F E+ ++ H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT--IALDVARGVEYLHG 711
LG C++ LLV E+ P G L +L R G+ + + +A +VA G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA- 770
FIH DL N L D+ K+ D+GL + + A +LAPE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 771 ------VTGRVTTKVDVFSFGVILMELIT 793
+ T K +++S GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 592 FSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
F LG G +G+VYK +H G +A+K + E+ E EI++L + +
Sbjct: 5 FDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPY 59
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V G + +V EY G++S + + L E I +G+EYL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIA---AILYQTLKGLEYL 115
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFGYLAPE 768
H IHRD+K NILL ++ +AK+ADFG+ +L K T + GT ++APE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNT-VIGTPFWMAPE 169
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
K D++S G+ +E+ G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM---ESAVVSEKGFAEFKSEIAVL 642
+V + + +G G +G V G K+A+K++ E ++ E K +L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 643 TKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+ +H +++G+L + N+ +V E M E L L T+ L
Sbjct: 58 RRFKHENIIGILDIIRPPSFE-SFNDVYIVQELM-------------ETDLYKLIKTQHL 103
Query: 697 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ + RG++Y+H + +HRDLKPSN+LL + K+ DFGL R+A
Sbjct: 104 SNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 751 KHSIE-TRLAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 795
H+ T T Y APE + + TK +D++S G IL E+++ R
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 73/249 (29%), Positives = 115/249 (46%), Gaps = 30/249 (12%)
Query: 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F VLG+GGFG V ++ G A K++E + + KG A +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H++N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---DEQRAIFYAAELCCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L + ++RDLKP NILL D +++D GL P+ ++ R+ GT GY+APE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRV-GTVGYMAPE 171
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
+ T D + G ++ E+I G+ FR+ + R+ +D
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP---------------FRKR--KERVKREEVD 214
Query: 829 RTIDLDEET 837
R + D+E
Sbjct: 215 RRVKEDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKG---FAEFKSEIAVLTKVRHRHLVGL 653
LG+GGFG V ++ + G A K+++ + +K A + EI L KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y + L LV M G L H++N E GL E R + + + G+ +LH +
Sbjct: 59 -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---EMERVIHYSAQITCGILHLHSM 114
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
++RD+KP N+LL D +++D GL D GK T+ AGT GY+APE
Sbjct: 115 ---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-GKTI--TQRAGTNGYMAPEILKE 168
Query: 773 GRVTTKVDVFSFGVILMELITGR 795
+ VD F+ G + E++ GR
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 592 FSEENVLGRGGFGTVYKGEL--HDGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
F+ +LG+G FG+V + +L DG+ K+AVK +++ + S EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 648 RHLVGLLGYCLDGNER------LLVYEYMPQGTLSRHLF-NRKEEGLKPLEWTRRLTIAL 700
+++ L+G L + +++ +M G L L +R E L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPDNGKHSIETRL 758
D+A G+EYL + ++FIHRDL N +L ++M VADFGL + + D + ++L
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 759 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+LA E TT DV++FGV + E++T
Sbjct: 178 P--VKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKR--MESAVVSEKGFAEFKSEIAVLTKVRHR 648
F+ +G+G FG VYK + +A+K +E +E + + EI L++ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP--LEWTRRLTIALDVARGV 706
++ G L G++ ++ EY G+ L LKP L+ T I +V G+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSC-LDL-------LKPGKLDETYIAFILREVLLGL 111
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG--KHSIETR--LAGTF 762
EYLH + IHRD+K +NILL ++ K+ADFG+ +G ++ R GT
Sbjct: 112 EYLHE---EGKIHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTP 162
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
++APE K D++S G+ +EL G
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 35/224 (15%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKI----AVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
F + VLG G FGTVYKG + +G K+ A+K + A S K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVAR 704
+ H+ LLG CL +L + + MP G L ++ K+ L W + +A+
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--------APDNGKHSIET 756
G+ YL + +HRDL N+L+ K+ DFGL +L + GK I+
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK- 176
Query: 757 RLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALD 799
++A E + T + DV+S+GV + EL+T G K D
Sbjct: 177 -------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-19
Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN 123
N +T + + N+ G +P+ L S +L L + N L G+IP SL SL+ V DN+
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 124 FT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
F+ +PS+F K L + + + N+ I D LQ S G +PD G
Sbjct: 416 FSGELPSEFTK-LPLVYFLDISNNNL-QGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
L +L L+ N G +P G S + L L+ K ++ ++ + + SL
Sbjct: 474 SKR---LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD- 529
Query: 242 LWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300
L N +G +P S + L + NQL+G +P +L N+ SL VN+++N G
Sbjct: 530 --LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
Query: 301 P 301
P
Sbjct: 588 P 588
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKG-------FAEFKSEIAVLTKVRH 647
++G+G +G VY + G +AVK++E A ++ + +SEI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 648 RHLVGLLGYCLDGNERLLVY-EYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVAR 704
++V LG E L ++ EY+P G++ L + R EE L R T V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-----VRFFT--EQVLE 119
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH + +HRDLK N+L+ D K++DFG+ + + D + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 765 LAPEYAVTGR--VTTKVDVFSFGVILMELITGRK 796
+APE + + KVD++S G +++E+ GR+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 597 VLGRGGFGTVYKGELHD--GTKIAV-----KRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G G FG VY+G KIAV K S V EK F E ++ + H H
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK----FLQEAYIMRQFDHPH 68
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G + N +V E P G L +L K L+ + + ++ + YL
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYL 123
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAPE 768
+ F+HRD+ N+L+ K+ DFGL R D + + +L ++APE
Sbjct: 124 ES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPE 178
Query: 769 YAVTGRVTTKVDVFSFGVILMELI 792
R T+ DV+ FGV + E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 67/283 (23%), Positives = 126/283 (44%), Gaps = 39/283 (13%)
Query: 591 NFSEENVLGRGGFGTVY--KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + V+GRG FG V+ + D + +K++ +++ ++E VL + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP---LEWTRRLTIALDVARG 705
+++ L+ ++V EY P GTL+ ++ R L L + ++ +A
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------ 113
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
LH + + +HRDLK NILL M K+ DFG+ ++ S + GT Y
Sbjct: 114 ---LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCY 167
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824
++PE K D+++ G +L EL + ++A + + + LV + I TF
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE---AANLPALV-----LKIMSGTFA 219
Query: 825 KAIDR-TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVV 866
DR + DL + L+ ++ +P +RP + ++
Sbjct: 220 PISDRYSPDLRQLILSMLNL-----------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 76/287 (26%), Positives = 139/287 (48%), Gaps = 38/287 (13%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E V+G G FG V G L K +A+K +++ +EK +F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT--RRLTIALDVARGVEY 708
+ L G ++V EYM G+L F RK +G ++T + + + +A G++Y
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDG----QFTVIQLVGMLRGIASGMKY 121
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG--YLA 766
L + ++HRDL NIL+ ++ KV+DFGL R+ D+ + + TR G + A
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTA 177
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825
PE + T+ DV+S+G+++ E+++ G + E ++D + K
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-----------------K 220
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
AI+ L + + + L C ++ +RP +V++L L
Sbjct: 221 AIEEGYRL-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 34/284 (11%)
Query: 598 LGRGGFGTVYKGELHDG--TKIAVKRM--------ESAVVSEKGFAEFKSEIAVLTK-VR 646
LG G FG VYK + +A+K + + +K + SE+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H ++V L+ + +V + + L H + KE+ + R I + + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMVLAL 126
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
YLH + +HRDL P+NI+LG+D + + DFGL + K T + GT Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826
PE K DV++FG IL ++ T + S + + L T K
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---YSTNMLSLAT-------------KI 225
Query: 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870
++ + E + S V D+ C + RPD+ V ++S
Sbjct: 226 VEAVYEPLPEGMYS-EDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 595 ENVLGRGGFGTVYKGEL-HDGTK---IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E V+G G FG V +G L G + +A+K ++S +EK +F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G +++ E+M G L F R+ +G + + + + +A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 122
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG---TFGYLAP 767
+ +++HRDL NIL+ ++ KV+DFGL R D+ T G + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT 793
E + T+ DV+S+G+++ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVK---RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
VLG G FGTVYKG + +G + + ++ + K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHG 711
LLG CL +L V + MP G L ++ K+ G + L L + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--------PDNGKHSIETRLAGTFG 763
+ +HRDL N+L+ K+ DFGL RL D GK I+
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK-------- 176
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALD 799
++A E + T + DV+S+GV + EL+T G K D
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------EIAVLTKVRHR 648
++G G FG+VY G G +AVK++E VS +S EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V LG LD + + EY+P G+++ L N E T + +G+ Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNY 121
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR------LAPDNGKHSIETRLAGTF 762
LH ++ IHRD+K +NIL+ + K++DFG+ + L+ L G+
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA--RPSLQGSV 176
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
++APE T K D++S G +++E++TG+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 36/233 (15%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKR--MESAVVSEKGFAEFKS--EIA 640
R+V + + + N + G +G VY+ + G +A+K+ ME ++GF S EI
Sbjct: 2 RSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFP-ITSLREIN 56
Query: 641 VLTKVRHRHLVGL----LGYCLDGNERLLVYEYMPQGTLSRH----LFNRKEEGLKPLEW 692
+L K++H ++V + +G LD + +V EY+ H L ++ E
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV------EHDLKSLMETMKQPFLQSE- 107
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
+ L + GV +LH +HRDLK SN+LL + K+ DFGL R K
Sbjct: 108 --VKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162
Query: 753 SIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSE 804
T+L T Y APE + +T +D++S G I EL+T +K L +SE
Sbjct: 163 Y--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
NF + +G G +G VYK G +A+K++ +E + EI++L ++ H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V LL N+ LV+E++ Q L + + G+ PL + L +G+ +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGI-PLPLIKSYLFQL--LQGLAFC 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHSIETRLAGTFGYLA 766
H +H+ +HRDLKP N+L+ + K+ADFGL R + H + T Y A
Sbjct: 117 H--SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 168
Query: 767 PEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSE 804
PE + + +T VD++S G I E++T R+AL SE
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 597 VLGRGGFGTVYKGELHDGT---KI-AVKRMESA--VVSEKGFAEFKSEIAVLTKVRHRHL 650
VLG+GG+G V++ G KI A+K ++ A V ++K A K+E +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L+ G + L+ EY+ G L HL + EG+ +E T ++ +++ +E+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIF-MEDTACFYLS-EISLALEHLH 117
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
Q I+RDLKP NILL K+ DFGL + + G ++ GT Y+APE
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEIL 172
Query: 771 VTGRVTTKVDVFSFGVILMELITG 794
+ VD +S G ++ +++TG
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 592 FSEENVLGRGGFGTVYKG---ELHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLTKV 645
+ E +GRG +G VYK DG + A+K+ + G ++ S EIA+L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--SACREIALLREL 59
Query: 646 RHRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNRKEEG-------LKPLEWTRRL 696
+H ++V L+ L+ ++ L+++Y F+R+ + +K L W
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW---- 115
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDM---RAKVADFGLVRL--APDNG 750
+ GV YLH +HRDLKP+NIL+ G+ K+ D GL RL AP
Sbjct: 116 ----QILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 751 KHSIETRLAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELIT 793
+ T Y APE + R TK +D+++ G I EL+T
Sbjct: 169 LAD-LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 597 VLGRGGFG--TVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
VLG+G FG T+Y+ D + + K + +SEK + +EI +L+ ++H +++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +D N L+ EY GTL + R++ L E L + V Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMV--LWYLFQIVSAVSYIH---K 119
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
+HRD+K NI L K+ DFG+ ++ ++S+ + GT Y++PE +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 775 VTTKVDVFSFGVILMELITGRKALDET 801
K D+++ G +L EL+T ++ D T
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G+G GTVY ++ G ++A+K+M +K +EI V+ + +H ++V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDS 84
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
L G+E +V EY+ G+L+ + +EG + + + + +E+LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHS---N 134
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
IHRD+K NILLG D K+ DFG ++ P+ K S + GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKA 191
Query: 775 VTTKVDVFSFGVILMELITG 794
KVD++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+ E VLG+G +G VY +L +IA+K + + EIA+ + ++H
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKH 64
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DVAR 704
R++V LG + + E +P G+LS L R + G PL+ TI +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWG--PLK-DNEQTIIFYTKQILE 119
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV-RLAPDNGKHSIETRLAGTF 762
G++YLH +HRD+K N+L+ K++DFG RLA G + GT
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA---GINPCTETFTGTL 173
Query: 763 GYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQS 803
Y+APE G D++S G ++E+ TG+ E
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 600 RGGFGTVYKGELH-DGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G FG+VY + G A+K + +S ++++ K+E A++ V L Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ L LV EY+ G + + K G P +W + +V GVE LH +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQ---RG 117
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVT 776
IHRD+KP N+L+ K+ DFGL R + GT YLAPE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDD 171
Query: 777 TKVDVFSFGVILMELITG 794
D +S G ++ E + G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 72/224 (32%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKI----AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG G FGTVYKG + DG + A+K + S K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLF-NRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
LLG CL +L V + MP G L ++ N+ G + L L + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKGMSYLE 126
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--------PDNGKHSIETRLAGTF 762
+ +HRDL N+L+ K+ DFGL RL D GK I+
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------- 176
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSED 805
++A E + R T + DV+S+GV + EL+T G K D + +
Sbjct: 177 -WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G F + Y+ ++ GT +AVK++ ++ E+ + EI ++ ++ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 652 GLLG-YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+LG C D + L V E+M G++S L + + + RG+ YLH
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLH 120
Query: 711 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFG-LVRLAPD-NGKHSIETRLAGTFGYL 765
IHRD+K +N+L+ G +R +ADFG RLA G + +L GT ++
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITGR 795
APE + DV+S G +++E+ T +
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 588 VTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVL 642
+TN + + +G G FG V + G +A+K++ + V++++ + E K +L
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LL 63
Query: 643 TKVRHRHLVGLLGYCLDGNERL-LVYEYMPQGT-LSRHLFNRKEEGLKPLEWTRRLTIAL 700
+RH +++ L + E + V E + GT L R L +R PLE
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR------PLEKQFIQYFLY 115
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ RG++Y+H +HRDLKPSNIL+ ++ K+ DFGL R+ + TR
Sbjct: 116 QILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 761 TFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
Y APE +T + +VD++S G I E++ G+
Sbjct: 171 ---YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 72/274 (26%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVRHR 648
NF E +GRG F VY+ L DG +A+K+++ ++ K A+ EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFN-RKEEGLKPLEWTRRLTIALDVARGVE 707
+++ ++ NE +V E G LSR + + +K++ L P + + + L A +E
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
++H + +HRD+KP+N+ + K+ D GL R + K + L GT Y++P
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM----------- 816
E K D++S G +L E+ AL D ++L + +++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGH 850
H +++ R+ ++ I+ D E I+ V D+A
Sbjct: 232 HYSEE-LRQLVNMCINPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 49/229 (21%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRM----ESAVVSEKGFAEFKSEIAVL 642
V + + + +G G +G V G K+A+K++ +SA+ +++ + E+ +L
Sbjct: 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY----RELRLL 68
Query: 643 TKVRHRHLVGLLGYCLDGNERL-------LVYEYMPQ--GTLSRHLFNRKEEGLKPLEWT 693
+ H +++GLL L LV M + +
Sbjct: 69 KHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVK---------------C 112
Query: 694 RRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
++L+ + + RG++Y+H A IHRDLKPSNI + +D K+ DFGL R
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 748 DNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
D + TR Y APE + VD++S G I+ EL+TG+
Sbjct: 170 DEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS----EIAVLTKVRHRHLVGL 653
LG G G+V K + H T M VV + + E+ ++ + R ++V
Sbjct: 13 LGAGNGGSVSKVK-HIPTGTV---MAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G L+ N + E+M G+L R K+ G P+E + IA+ V G+ YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGK--IAVAVVEGLTYLYNVH 123
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK--HSIETRLAGTFGYLAPEYAV 771
+HRD+KPSNIL+ + K+ DFG+ +G+ +SI GT Y++PE
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGV------SGELINSIADTFVGTSTYMSPERIQ 175
Query: 772 TGRVTTKVDVFSFGVILMELITGRKALDETQSED 805
G+ T K DV+S G+ ++EL G+ + +D
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 27/272 (9%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+F N +G+G FG V+K D A+K+++ + ++ + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ LD + +V EY G L + L K + +PL + + + G+ +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H + +HRD+K N+ L K+ D G+ +L DN + + GT YL+PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPEL 172
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829
K DV++ GV+L E TG+ D + + L+ + I + F + +
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI-----LKIIRGVF-PPVSQ 223
Query: 830 TIDLDEETLASISTVADLAGHCCAREPYQRPD 861
+A L C ++ QRPD
Sbjct: 224 MYSQQ---------LAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 73/227 (32%), Positives = 108/227 (47%), Gaps = 32/227 (14%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEK-GFA-EFKSEIAVL 642
R V F +G G +G VYK D G +A+K++ + +EK GF EI +L
Sbjct: 4 RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKIL 60
Query: 643 TKVRHRHLVGLLGYCLDGNERL----------LVYEYMPQ---GTLSRHLFNRKEEGLKP 689
++ HR++V L D + L LV+EYM G L L + E+ +K
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++L L+ G+ Y H ++F+HRD+K SNILL + + K+ADFGL RL
Sbjct: 121 F--MKQL---LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 750 GKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGR 795
++ T Y PE + R +DV+S G IL EL T +
Sbjct: 170 ESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 70/247 (28%), Positives = 106/247 (42%), Gaps = 39/247 (15%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEK-GFA-EFKSEIAVLTKV 645
++ LG G FG VYK ++ G +A+K++ + +EK GF EI +L K+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKL 64
Query: 646 RHRHLVGLLGYCLD-----GNERLLVYEYMP------QGTLSRHLFNRKEEGLKPLEWTR 694
+H ++V L+ ++ +R VY P G L E +K
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------ 118
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL----APDNG 750
L + G+ YLH +HRD+K +NIL+ + K+ADFGL R P+
Sbjct: 119 --CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 751 KHSIE-----TRLAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDETQS 803
T L T Y PE + G R TT VD++ G + E+ T R L
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232
Query: 804 EDSVHLV 810
D +HL+
Sbjct: 233 IDQLHLI 239
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 592 FSEENVLGRGGFGTVYKGE---LHDGTK--------------IAVKRMESAVVSEKGFAE 634
F E+ LG G FG V+ E + +AVK M ++ +
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDANKNARND 65
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL----SRHLFNR--KEEGLK 688
F EI ++++++ +++ LL C+ + ++ EYM G L SRH ++ +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
+ ++ + +A +A G++YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ I+ R +++ E + G+ TT DV++FGV L E++T
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLTKV 645
N+ +LG+G FG VY ++ G ++AVK++ S + E + EI +L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 646 RHRHLVGLLGYCLDGNERLLVY-EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+H +V G CL +E L ++ EYMP G++ L K G TR+ T +
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYT--RQILE 115
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFG 763
GVEYLH +HRD+K +NIL K+ DFG RL + + GT
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+++PE K DV+S G ++E++T
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-17
Identities = 90/339 (26%), Positives = 140/339 (41%), Gaps = 50/339 (14%)
Query: 77 IEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-SVPSDFFKG 134
+ G +P+ + L +L +L + N TG+IP +L+ L LQ + N F+ +P + K
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+L + L N+ + IPE L + L + ++ G IP LG L + L
Sbjct: 356 -NNLTVLDLSTNNL-TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG--ACRSLRRVRL 411
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ-NMTSLTQLWLHGNSFTGPL 253
N G +P F K + ++ L G + + +M SL L L N F G L
Sbjct: 412 QDNSFSGELPSEFTKLPLVYFL---DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAK 313
PD G L++ + NQ +G VP L +L L + L+ N G+ P S
Sbjct: 469 PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS-------- 520
Query: 314 GSNSFCLDDAGVACDGRVNVLLSIVKSVGY-PAVLAESWKGNNPCNSDWKGVSCDAGGNI 372
+C V++ LS + G PA +E P S
Sbjct: 521 ------------SCKKLVSLDLSHNQLSGQIPASFSEM-----PVLSQ------------ 551
Query: 373 TVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411
++L LSG I N + SL Q+ +S N L G++P
Sbjct: 552 --LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 72/281 (25%), Positives = 132/281 (46%), Gaps = 26/281 (9%)
Query: 568 SDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV 626
SD ++E ++S+ + F + +G+G GTVY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 627 VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEE 685
+K +EI V+ + ++ ++V L L G+E +V EY+ G+L+ + +E
Sbjct: 58 QPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VR 744
G + + + + +E+LH IHRD+K NILLG D K+ DFG +
Sbjct: 116 G-------QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804
+ P+ K S + GT ++APE KVD++S G++ +E+I G
Sbjct: 166 ITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 805 DSVHLVTWFRRMHINKD-----TFRKAIDRTIDLDEETLAS 840
+++L+ + FR ++R +D+D E S
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRH 649
F++ +G G FG VY ++ +A+K+M S S + + + E+ L ++RH +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ G L + LV EY G+ S L K KPL+ I +G+ YL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYC-LGSASDILEVHK----KPLQEVEIAAICHGALQGLAYL 131
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APDNGKHSIETRLAGTFGYLAPE 768
H IHRD+K NILL + K+ADFG L +P N GT ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-------FVGTPYWMAPE 181
Query: 769 YAVT---GRVTTKVDVFSFGVILMEL 791
+ G+ KVDV+S G+ +EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 3e-17
Identities = 63/228 (27%), Positives = 95/228 (41%), Gaps = 57/228 (25%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS---------EIAVLTKV 645
+G G +G V G K+A+K++ + F EI +L +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV---------FDDLIDAKRILREIKLLRHL 56
Query: 646 RHRHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
RH +++GLL D N+ +V E M + L + + + + PL
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQ-----PLTDDHIQYFLY 110
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE----- 755
+ RG++YLH A+ IHRDLKPSNIL+ + K+ DFGL R +
Sbjct: 111 QILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 756 -TRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
TR Y APE Y T +D++S G I EL+T +
Sbjct: 168 VTRW-----YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+GRG FG V+ G L D T +AVK + + A+F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGV 61
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
C +V E + G L + EG + L+ + + + A G+EYL +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL---RTEGPR-LKVKELIQMVENAAAGMEYLES---KH 114
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVT 776
IHRDL N L+ + K++DFG+ R D S + APE GR +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 777 TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEE 836
++ DV+SFG++L E S+ V + +++ R+AI++ + L
Sbjct: 175 SESDVWSFGILLWEAF-------------SLGAVPY---ANLSNQQTREAIEQGVRLPCP 218
Query: 837 TLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
L V L C +P QRP V L S
Sbjct: 219 ELCP-DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 29/287 (10%)
Query: 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVRHR 648
NF E +GRG F VY+ D +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ L ++ NE +V E G LS+ + + +K++ L P + + L A VE
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFGYL 765
++H + +HRD+KP+N+ + K+ D GL R + HS L GT Y+
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYM 173
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825
+PE K D++S G +L E+ AL D ++L + ++ I + +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQK--IEQCDYPP 227
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
L E + + +L C +P QRPD+G+V + +
Sbjct: 228 -------LPTEHYS--EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHR 648
F++ +G+G FG VYKG + +A+K +E A E + + EI VL++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSP 62
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++ G L G + ++ EY+ G+ L + G PLE T TI ++ +G++Y
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPG--PLEETYIATILREILKGLDY 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + IHRD+K +N+LL + K+ADFG+ D GT ++APE
Sbjct: 117 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPE 171
Query: 769 YAVTGRVTTKVDVFSFGVILMELITG 794
K D++S G+ +EL G
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
F++ +G+G FG V+KG + K+ ++ +E + + EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
G L + ++ EY+ G+ + E G PL+ T+ TI ++ +G++YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+ IHRD+K +N+LL + K+ADFG+ D GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIK 174
Query: 772 TGRVTTKVDVFSFGVILMELITG 794
+K D++S G+ +EL G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 598 LGRGGFGTVYKGELHDGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL- 654
LG G FG VYK + H T + A K ++ + SE+ +F EI +L++ +H ++VGL
Sbjct: 13 LGDGAFGKVYKAQ-HKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
Y + +L+ E+ G L + E + L + + + + +LH
Sbjct: 70 AYFYENKLWILI-EFCDGGALD----SIMLELERGLTEPQIRYVCRQMLEALNFLH---S 121
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYLAPEYAVT 772
IHRDLK NILL D K+ADFG+ K +++ R GT ++APE
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAK----NKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 773 GRVTT-----KVDVFSFGVILMELITGR 795
K D++S G+ L+EL
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 23/243 (9%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG V+ + A+K M V+ K +E VL +V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D ++ EY+P G L +L N + L A ++ +EYLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSK--- 120
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV 775
++RDLKP NILL + K+ DFG + D L GT YLAPE +
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGH 175
Query: 776 TTKVDVFSFGVILMELITGR-----KALDETQSEDSVHLVTWFRRMH-INKDTFRK--AI 827
VD ++ G+++ E++ G + + + R + KD +K +
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235
Query: 828 DRT 830
DRT
Sbjct: 236 DRT 238
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E +LG G FG + +G L +K +A+ A S+K F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIH-TLRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L G GN ++V EYM G L F RK EG L + + + +A G++Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEG--QLVAGQLMGMLPGLASGMKY-- 122
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL--APE 768
L+ ++H+ L +L+ D+ K++ F RL ++ +I T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827
++ DV+SFG+++ E+++ G + + +D + V +D FR
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV---------EDGFRLPA 229
Query: 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
R + + L C +E +RP + ++LS +
Sbjct: 230 PRNCP---------NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 597 VLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAE-FKSEIAVL---TKVRHRHLV 651
VLGRG FG V E G A+K ++ + + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHL----FNRKEEGLKPLEWTRRLTIALDVARGV 706
L C + + V EY G L H+ F+ R + A V G+
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----------RAVFYAACVVLGL 114
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+YLH ++RDLK N+LL + K+ADFGL + G + GT +LA
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLA 169
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITG 794
PE T VD + GV++ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 598 LGRGGFGTVYKGELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+GRG +G VYK + DG + A+K++E +S EIA+L +++H +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIALQ 64
Query: 655 GYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIAL--DVARGVEYL 709
L ++R L+++Y F+R + KP++ R + +L + G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 710 HGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFG 763
H +HRDLKP+NIL+ + R K+AD G RL +P ++ + TF
Sbjct: 125 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 764 YLAPEYAVTGRVTTK-VDVFSFGVILMELIT 793
Y APE + R TK +D+++ G I EL+T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKR------MESAVVSEKGFAEFKSEIAVLTK 644
+F + LG G G V K LH + + + R ++ A+ ++ E+ VL +
Sbjct: 2 DFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQ-----IIRELKVLHE 55
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++VG G E + E+M G+L + L K+ G P +++IA V R
Sbjct: 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIA--VLR 110
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YL +HRD+KPSNIL+ K+ DFG+ D S+ GT Y
Sbjct: 111 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 164
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
++PE T + D++S G+ L+E+ GR
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 62/218 (28%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
E + LG G G+V K L + I + + + + E+ + + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 650 LVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGL----KPLEWTRRLTIALDVA 703
+V G LD + + EY G+L K+ G K L IA V
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESVL 115
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE--TRLAGT 761
+G+ YLH + IHRD+KPSNILL + K+ DFG+ S E LAGT
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----------SGELVNSLAGT 162
Query: 762 FG----YLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
F Y+APE + DV+S G+ L+E+ R
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 588 VTNNFSEENVLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V + + + +G G +GTV + G K+A+K++ SE E+ +L ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 647 HRHLVGLLGY-----CLDG-NERLLVYEYMPQ--GTLSRHLFNRKEEGLKPLEWTRRLTI 698
H +++GLL LD ++ LV +M G L +H + L R +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFL 123
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
+ +G++Y+H IHRDLKP N+ + +D K+ DFGL R + TR
Sbjct: 124 VYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 759 AGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGR 795
Y APE + T VD++S G I+ E++TG+
Sbjct: 181 -----YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 598 LGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G G V E H G ++AVK+M+ + ++ +E+ ++ H ++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
L G+E +V E++ G L+ + + + EE + T+ L V R + YLH +
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLSVLRALSYLH---N 136
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
Q IHRD+K +ILL D R K++DFG A + + L GT ++APE
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 775 VTTKVDVFSFGVILMELITG 794
T+VD++S G++++E+I G
Sbjct: 195 YGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 591 NFSEENVLGRGGFGTVY----KGELHDGTKIAVKRMESA-VVSEKGFAEF-KSEIAVLTK 644
NF VLG G +G V+ G G A+K ++ A +V + AE ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 645 VRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
VR + L Y + +L L+ +Y+ G L HL+ R+ E R+ IA ++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE----HFTESEVRVYIA-EIV 115
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTF 762
+++LH L I+RD+K NILL + + DFGL + + + + GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTI 170
Query: 763 GYLAPEYAVTGRV--TTKVDVFSFGVILMELITG 794
Y+APE G VD +S GV+ EL+TG
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 598 LGRGGFGTVYKGELHDG---TKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+G G FG V GE++ G ++ VK + SA V E+ +F E ++H +L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ--MKFLEEAQPYRSLQHSNLLQC 60
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFN-RKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
LG C + LLV E+ P G L +L + RK E + P + T +A ++A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH-- 117
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA-- 770
+FIH DL N LL D+ K+ D+GL + +L ++APE
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 771 VTGRV-----TTKVDVFSFGVILMEL 791
V G + T + +V+S GV + EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V + DG AVK ++ A++ +K +E VL K V+H LVGL
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y ++L V +Y+ G L HL R+ +P R A ++A + YLH L
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEP----RARFYAAEIASALGYLHSL 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
+ I+RDLKP NILL + DFGL + ++ K + + GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT--STFCGTPEYLAPEVLRK 170
Query: 773 GRVTTKVDVFSFGVILMELITG 794
VD + G +L E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 50/236 (21%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS-------------EIAV 641
LG G +G V K G +A+K+++ +S + + E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT---- 697
+ +++H +++GL+ ++G+ LV + M L + + +RK RLT
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRK----------IRLTESQV 121
Query: 698 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR----------L 745
I L + G+ LH F+HRDL P+NI + K+ADFGL R L
Sbjct: 122 KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 746 APDNGKHSIE--TRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKAL 798
+ D E T T Y APE + + VD++S G I EL+TG K L
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-16
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G+G GTVY ++ G ++A+K+M +K +EI V+ + ++ ++V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 84
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
L G+E +V EY+ G+L+ + +EG + + + + +++LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALDFLHS---N 134
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
IHRD+K NILLG D K+ DFG ++ P+ K S + GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKA 191
Query: 775 VTTKVDVFSFGVILMELITG 794
KVD++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+ +LG G GTVYK L +AVK + + E + SE+ +L K +++G
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ-KQIMSELEILYKCDSPYIIGF 64
Query: 654 LGYCLDGNERLLVYEYMPQGTLS------RHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
G N + E+M G+L H+ R IA+ V +G+
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR---------------IAVAVVKGLT 109
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YL L +HRD+KPSN+L+ + K+ DFG+ + SI GT Y+AP
Sbjct: 110 YLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAP 162
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGR 795
E + DV+S G+ MEL GR
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVK--RMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGL 653
+G G +G VYKG G +A+K R+ES E+G EI++L +++H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+ + L++E++ L ++L + + E + + +G+ + H
Sbjct: 65 QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL--YQILQGILFCH--- 118
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL----AGTFGYLAPEY 769
+ +HRDLKP N+L+ + K+ADFGL R I R+ T Y APE
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVTLWYRAPEV 172
Query: 770 AVTG-RVTTKVDVFSFGVILMELITGRKALDETQSE 804
+ R +T VD++S G I E+ T +K L SE
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 598 LGRGGFGTVYKGELHDGTK---IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+GRG +G VYK + DG A+K++E +S EIA+L +++H +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 64
Query: 655 GYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIAL--DVARGVEYL 709
L +R L+++Y F+R + KP++ R + +L + G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 710 HGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFG 763
H +HRDLKP+NIL+ + R K+AD G RL +P ++ + TF
Sbjct: 125 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 764 YLAPEYAVTGRVTTK-VDVFSFGVILMELIT 793
Y APE + R TK +D+++ G I EL+T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/225 (25%), Positives = 115/225 (51%), Gaps = 16/225 (7%)
Query: 598 LGRGGFGTVYKGELHDGTK---IAVKRMESAVVSEKGFA-EFKSEIAVLTKVRHRHLVGL 653
LG G FG V KG K +A+K +++ +EK E E ++ ++ + ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+G C + +LV E G L++ L +K+E + + + + V+ G++YL G
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEG-- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPEYAVT 772
++F+HRDL N+LL + AK++DFGL + L D+ + + + APE
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 773 GRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816
+ +++ DV+S+G+ + E + G+K + + + + + +R+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 74/314 (23%), Positives = 143/314 (45%), Gaps = 37/314 (11%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVV 627
D ++E ++SI + ++ +G+G GTV+ ++ G ++A+K++
Sbjct: 1 DEEIMEKLRTIVSIG---DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ 57
Query: 628 SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL 687
+K +EI V+ ++++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE------ 109
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 746
++ + + + + +E+LH IHRD+K N+LLG D K+ DFG ++
Sbjct: 110 TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806
P+ K S + GT ++APE KVD++S G++ +E++ G +
Sbjct: 167 PEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
Query: 807 VHLVTWFRRMHINK-----DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD 861
++L+ + FR ++R +++D E S A+E Q P
Sbjct: 224 LYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS------------AKELLQHPF 271
Query: 862 MGHVVNVLSSLAEL 875
+ + LSSL L
Sbjct: 272 L-KLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 597 VLGRGGFGTVY-----KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG+G FG V+ G G A+K ++ A + + K E +L +V H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
L Y +L L+ +++ G L F R + + E + +A ++A +++LH
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALALDHLH 115
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
L I+RDLKP NILL ++ K+ DFGL + + D+ K + GT Y+APE
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVV 170
Query: 771 VTGRVTTKVDVFSFGVILMELITG 794
T D +SFGV++ E++TG
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 36/215 (16%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVS-EKGFAEFKS---------EIAVLTKVR- 646
LG+G +G V+K A+ R VV+ +K F F++ EI L ++
Sbjct: 15 LGKGAYGIVWK---------AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 647 HRHLVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H ++V LL N++ LV+EYM + L H R + LE + I + +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-ETDL--HAVIRA--NI--LEDVHKRYIMYQLLK 118
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PDNGKHSIETRLAGT 761
++Y+H + IHRDLKPSNILL D R K+ADFGL R +N ++ + T T
Sbjct: 119 ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 762 FGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGR 795
Y APE + + R T VD++S G IL E++ G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 25/268 (9%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKS-EIAVLT-KVRHRHLVGL 653
VLG+G FG V EL + A+K ++ VV E E E VL H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 654 LGYC-LDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
+C E L V EY+ G L H+ + + R A ++ G+++LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICGLQFLH- 113
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+ I+RDLK N+LL D K+ADFG+ + NG+ T GT Y+APE
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKAST-FCGTPDYIAPEILK 169
Query: 772 TGRVTTKVDVFSFGVILMELITGRKAL---DETQSEDSV-HLVTWFRRMHINKDTFRKAI 827
+ VD +SFGV+L E++ G+ DE + DS+ + F R I+K+ + +
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR-WISKEA-KDCL 227
Query: 828 DRTIDLDEETLASISTVADLAGHCCARE 855
+ + D + D+ H R
Sbjct: 228 SKLFERDPTK--RLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+ V+G+G +G V + H G K+A+K++ EI +L +RH +V +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 654 LGYCLDGNER-----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
L + R +V+E M H + + L P L L R ++Y
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFGYLAP 767
+H + HRDLKP NIL D + K+ DFGL R+A ++ +I T T Y AP
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 768 EY--AVTGRVTTKVDVFSFGVILMELITGR 795
E + + T +D++S G I E++TG+
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+G G FG V+ + DG ++A+K+M ++ V ++ F E K +L +H +++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 653 LLGYC----LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
L +D E + V + Q L + + + + PL + RG++Y
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APDNGKHSIETRLAGTFGYLAP 767
LH A +HRD+KP N+L+ + K+ DFGL R+ PD KH T+ T Y AP
Sbjct: 119 LHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM--TQEVVTQYYRAP 173
Query: 768 EYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQS 803
E + R T+ VD++S G I EL+ GR+ L + QS
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 597 VLGRGGFGTVYKGELHD-GTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
++G G +G V K + + G +A+K+ + +V + EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLRHENLV 63
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L+ LV+E++ L + GL R+ + RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLD-ESRVRK--YLFQILRGIEFCH- 117
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+ IHRD+KP NIL+ K+ DFG R + T T Y APE V
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPELLV 173
Query: 772 T----GRVTTKVDVFSFGVILMELITG 794
GR VD+++ G ++ E++TG
Sbjct: 174 GDTKYGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 19/219 (8%)
Query: 578 MVISIQVLRNVTNNFSEENVLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFK 636
MV+ R++ N+ + +G G G V E H G ++AVK M+ + ++
Sbjct: 12 MVVDQGDPRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLF 66
Query: 637 SEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+E+ ++ +H+++V + L G E ++ E++ G L+ + + L +
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIA 120
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIE 755
T+ V + + YLH Q IHRD+K +ILL D R K++DFG +++ D K
Sbjct: 121 TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-- 175
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
L GT ++APE T+VD++S G++++E++ G
Sbjct: 176 -SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGL 653
+G G +G VYK + G +A+K R+E+ ++G EI++L ++ H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
L N+ LV+E++ L +++ + GL P + L +G+ Y H
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQL--LQGIAYCHS-- 117
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHSIETRLAGTFGYLAPEYA 770
H+ +HRDLKP N+L+ + K+ADFGL R + H + T Y APE
Sbjct: 118 HR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEIL 171
Query: 771 VTGR-VTTKVDVFSFGVILMELITGR 795
+ R +T VD++S G I E++ R
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 22/228 (9%)
Query: 590 NNFSEENVLGRGGFGTVY-KGELHDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
+F ++++GRG FG V E G A+K M +S +++++ + F+ E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+ L D + LV EY P G L L NR E+ + +A V
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYED---QFDED---MAQFYLAELVL 113
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIETRLAGTFGYLA 766
+H + ++HRD+KP N+L+ K+ADFG RL + K GT Y+A
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--KMVNSKLPVGTPDYIA 171
Query: 767 PEYAVT------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808
PE T G + D +S GVI E+I GR E +
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF----HEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRH---RHLV 651
++GRG +G VY+G H T +A+K + + ++ + E+A+L+++R ++
Sbjct: 8 LIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNIT 65
Query: 652 GLLGYCLDGNERLLVYEYMPQG---TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
G L G ++ EY G TL + P+ I +V ++Y
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK---------AGPIAEKYISVIIREVLVALKY 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAP 767
+H IHRD+K +NIL+ + K+ DFG+ L ++ K S GT ++AP
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAP 170
Query: 768 EYAVTGRV-TTKVDVFSFGVILMELITG 794
E G+ TK D++S G+ + E+ TG
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 598 LGRGGFGTVYKG-ELHDGTK-IAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVG 652
+G G +G V+K +L +G + +A+KR+ E E+AVL + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 653 LLGYCL----DGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L C D +L LV+E++ Q L+ +L E G+ P E + + L RG++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQL--LRGLD 124
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+LH +H+ +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 125 FLH--SHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 178
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGR 795
E + T VD++S G I E+ +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
VLG+G FG V EL ++ AVK ++ V+ + E +E VL +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C +RL V EY+ G L H+ + G R A ++ G+++LH
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRAR--FYAAEIVLGLQFLH-- 113
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
+ I+RDLK N+LL + K+ADFG+ + G + + GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSY 170
Query: 773 GRVTTKVDVFSFGVILMELITGR---KALDETQ-----SEDSVHLVTWF 813
VD ++ GV+L E++ G+ + DE + ED V W
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G G V + G ++AVK+M+ + ++ +E+ ++ +H ++V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD--LRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 657 CLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
L G+E +V E++ G L+ H EE + T+ L V + + +LH
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIA--------TVCLAVLKALSFLHA-- 133
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET----RLAGTFGYLAPEY 769
Q IHRD+K +ILL D R K++DFG + S E L GT ++APE
Sbjct: 134 -QGVIHRDIKSDSILLTSDGRVKLSDFGFC------AQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 770 AVTGRVTTKVDVFSFGVILMELITG 794
T+VD++S G++++E++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 14/224 (6%)
Query: 598 LGRGGFGTVYKG--ELHDGTK-IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FGTV KG ++ K +AVK +++ E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G C + +LV E G L++ L K K + + V+ G++YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE---E 113
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
+F+HRDL N+LL AK++DFGL + L D + +T + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 774 RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816
+ ++K DV+SFGV++ E + G+K + + ++ RM
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM 217
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFK---SEIAVLTKVRHRHLVGL 653
+G G +G V+K + G +A+K+ V SE K EI +L +++H +LV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF---VESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
+ +L LV+EY L + + G+ P +++ + V + H
Sbjct: 66 I-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGV-PEHLIKKII--WQTLQAVNFCH-- 117
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
H IHRD+KP NIL+ + K+ DFG R+ G T T Y APE V
Sbjct: 118 KHNC-IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLV- 173
Query: 773 GRVT--TKVDVFSFGVILMELITGRKALDETQSE-DSVHLVT 811
G VDV++ G + EL+TG + L +S+ D ++L+
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIR 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGL 653
+G G +GTVYK + H G +A+K + + E+A+L ++ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 654 LGYC----LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+ C D ++ LV+E++ Q L +L GL P E + L RG+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL-PAETIKDLMRQF--LRGLDF 123
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH +HRDLKP NIL+ + K+ADFGL R+ T + T Y APE
Sbjct: 124 LHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804
+ T VD++S G I E+ RK L SE
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 71/204 (34%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V + DG+ AVK ++ + +K +E VL K ++H LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y E+L V +Y+ G L HL R+ L+P R A +VA + YLH L
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEP----RARFYAAEVASAIGYLHSL 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET--RLAGTFGYLAPEYA 770
+ I+RDLKP NILL + DFGL + G ET GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVL 168
Query: 771 VTGRVTTKVDVFSFGVILMELITG 794
VD + G +L E++ G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
F++ +G+G FG V+KG + ++ ++ +E + + EI VL++ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
G L G + ++ EY+ G+ L P + + T+ ++ +G++YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+ IHRD+K +N+LL + K+ADFG+ D GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQ 174
Query: 772 TGRVTTKVDVFSFGVILMELITG 794
+K D++S G+ +EL G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRH 649
FS+ +G G FG VY ++ + +A+K+M S S + + + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ G L + LV EY G+ S L K KPL+ + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYL 131
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APDNGKHSIETRLAGTFGYLAPE 768
H + IHRD+K NILL + K+ DFG + AP N GT ++APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPE 181
Query: 769 YAVT---GRVTTKVDVFSFGVILMEL 791
+ G+ KVDV+S G+ +EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 597 VLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGLL 654
VLG+G FG V L G AVK ++ V+ + E +E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 655 GYCLDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C +RL V E++ G L H+ + + + R A ++ + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLH--- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
+ I+RDLK N+LL + K+ADFG+ + NGK + + GT Y+APE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEM 171
Query: 774 RVTTKVDVFSFGVILMELITGRKALDETQSED 805
VD ++ GV+L E++ G E ++ED
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPF-EAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G+GG+G V+ + D +I A+KRM +S + +E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D L EY+P G R L N G+ + R + A V+ LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNL--GVLSEDHARFYMAEMFEA--VDALHELG-- 121
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL----VRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+IHRDLKP N L+ K+ DFGL V A +S+ G+ Y+APE
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA-----NSV----VGSPDYMAPEVLR 171
Query: 772 TGRVTTKVDVFSFGVILMELITG 794
VD +S G +L E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 592 FSEENVLGRGGFGTVY-KGELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRH 649
F++ +G G FG VY ++ +A+K+M S S + + + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ G L + LV EY G+ S L K KPL+ I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYL 141
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H + IHRD+K NILL + + K+ADFG +A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEV 192
Query: 770 AVT---GRVTTKVDVFSFGVILMEL 791
+ G+ KVDV+S G+ +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+G G +G+V + G ++AVK++ +S + +++ + E + +L ++H +++G
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLKHMKHENVIG 80
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT------IALDVARGV 706
LL D E L HL L + ++LT + + RG+
Sbjct: 81 LL----DVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+Y+H IHRDLKPSN+ + +D K+ DFGL R D + TR Y A
Sbjct: 134 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRA 185
Query: 767 PEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810
PE + VD++S G I+ EL+TGR T D + L+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G FG VYK + + G A K +E+ SE+ ++ EI +L H ++V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT---IALDVARGVEYLHGLA 713
+ ++ E+ P G + + LE R LT I + + +E L L
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIM----------LELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYLAPEYAV 771
IHRDLK N+LL D K+ADFG ++ N K +++ R GT ++APE +
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVK-TLQRRDSFIGTPYWMAPEVVM 183
Query: 772 TGRVTT-----KVDVFSFGVILMEL 791
+ K D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 38/288 (13%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVV----SEKGFAEFKSEIAVLTKVRHRHLV 651
++L G FG ++ G L D + + V SE E +L + H++++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 652 GLLGYCLDGNERLLV-YEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTI--ALDVARGVE 707
+L C++ E V Y YM G L L + E P + + + A+ +A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSI---ETRLAGTFG 763
YLH IH+D+ N ++ ++++ K+ D L R L P + H + E R
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD-YHCLGDNENR---PVK 184
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823
++A E V ++ DV+SFGV+L EL+T L +T + + F KD +
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT----LGQTPYVE----IDPFEMAAYLKDGY 236
Query: 824 RKAIDRTIDLDEETLASISTVADLAGHCC-AREPYQRPDMGHVVNVLS 870
R + + I+ +E A ++ CC A +P +RP +V L+
Sbjct: 237 R--LAQPINCPDELFAVMA--------CCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 76/267 (28%), Positives = 106/267 (39%), Gaps = 76/267 (28%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK------IAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
LGRG FG V + K +AVK + E A SE + +E+ +L +
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE--YKALMTELKILIHIGH 69
Query: 647 HRHLVGLLGYCLDGNERLLV-YEYMPQGTLS------RHLFN-------RKEEGLKPLEW 692
H ++V LLG C L+V EY G LS R F+ RK E +
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 693 TRRLT-------------------------------------------IALDVARGVEYL 709
+RL + VARG+E+L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHSIETRLAGTFGYLA 766
A + IHRDL NILL ++ K+ DFGL R PD + + RL ++A
Sbjct: 190 ---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-DARLP--LKWMA 243
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELIT 793
PE TT+ DV+SFGV+L E+ +
Sbjct: 244 PESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 70/201 (34%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G+G FG V + D +I A+K + A +VS +E VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ E+L LV ++ G L HL + EG L R T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLAPEYAVTG 773
+ I+RDLKP NILL + DFGL +L N K +T GT YLAPE +
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 774 RVTTKVDVFSFGVILMELITG 794
T VD ++ GV+L E++TG
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-14
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH---LVG 652
+G+G FG VY+ D +I A+K + + +V++K A E +L + +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
L ++ LV +YM G L HL ++EG E + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFS-EDRAKFYIA-ELVLALEHLH-- 113
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
++RDLKP NILL + DFGL + + + GT YLAPE +
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 773 GRVTTK-VDVFSFGVILMELITG 794
+ TK VD +S GV++ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 598 LGRGGFGTVY-KGELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG VY H +AVK+M S + + + + E+ L +++H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
L + LV EY G+ S L K KPL+ I +G+ YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---H 140
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT--- 772
+ IHRD+K NILL + + K+ADFG + S GT ++APE +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPEVILAMDE 194
Query: 773 GRVTTKVDVFSFGVILMELITGRKAL 798
G+ KVDV+S G+ +EL + L
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGELHD--GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + +GRG FGTV K LH GT +AVKR+ S V EK ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRS 59
Query: 646 RH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR----KEEGLKPLEWTRRLTIAL 700
++V G + + E M +S F + + + P E ++ +A
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILGKIAVA- 115
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK--HSI-ETR 757
+ + YL IHRD+KPSNILL + K+ DFG+ +G+ SI +TR
Sbjct: 116 -TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI------SGQLVDSIAKTR 166
Query: 758 LAGTFGYLAPEYAVTGRVTT--------KVDVFSFGVILMELITGR 795
AG Y+APE R+ + DV+S G+ L E+ TG+
Sbjct: 167 DAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMES-AVVSEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V K AVK ++ A++ +K SE VL K V+H LVGL
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
+ ++L V +Y+ G L HL R+ L+P R A ++A + YLH L
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP----RARFYAAEIASALGYLHSL 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH-SIETRLAGTFGYLAPEYAV 771
+ ++RDLKP NILL + DFGL + +N +H + GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 772 TGRVTTKVDVFSFGVILMELITG 794
VD + G +L E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 33/227 (14%)
Query: 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAE------FKSEIAVL 642
T F EE LG FG VYKG L GT + A+ + K AE FK E +
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLF-GTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK--------------EEGLK 688
++++H ++V LLG +++ Y L L R + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LA 746
P ++ + I +A G+E+L + +H+DL N+L+ D + K++D GL R A
Sbjct: 123 PADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
D K + L +++PE + G+ + D++S+GV+L E+ +
Sbjct: 177 ADYYKLMGNSLLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 78/256 (30%), Positives = 114/256 (44%), Gaps = 47/256 (18%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVV----------SEKGFAEFKSEIAVLTKV 645
VLG+G FG V EL G AVK ++ VV EK E LT
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT-- 59
Query: 646 RHRHLVGLLGYC-LDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
HL YC E L V E++ G L H+ +++G + R A ++
Sbjct: 60 ---HL-----YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKG--RFDLYRATFYAAEIV 106
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN--GKHSIETRLAGT 761
G+++LH + I+RDLK N++L D K+ADFG+ + +N G + T GT
Sbjct: 107 CGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST-FCGT 159
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA--------LDETQSEDSVHLVTWF 813
Y+APE + T VD +SFGV+L E++ G+ L E+ D+ H W
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
Query: 814 RRMHINKDTFRKAIDR 829
+ +KD K +R
Sbjct: 220 TKE--SKDILEKLFER 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 591 NFSEENVLGRGGFGTVY--KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ +G G FG +Y K + D +K ++ + K K E+ +L K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V + +V EY G L + + NR+ L + L+ + ++ G+++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVL--FSEDQILSWFVQISLGLKH 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+H + +HRD+K NI L + M AK+ DFG+ R N + GT YL+P
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSP 171
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT 793
E K D++S G +L EL T
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 588 VTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS------EIA 640
V + + +G G +G V + G K+A+K++ A F E+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA------FDVPTLAKRTLRELK 56
Query: 641 VLTKVRHRHLVGLLGYCL----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+L +H +++ + D + +V + M + L + + + PL
Sbjct: 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQ-----PLTEEHIR 110
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE- 755
+ RG++Y+H + IHRDLKPSN+L+ +D ++ DFG+ R + E
Sbjct: 111 YFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS---PTEH 164
Query: 756 ----TRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKAL 798
T T Y APE ++ TT +D++S G I E++ GR+ L
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKS-EIAVLTKV-RHRHLVGL 653
+LG+G FG V+ EL A+K ++ VV E E VL+ H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 654 LGYC-LDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
YC E L V EY+ G L H+ + + R A ++ G+++LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET-RLAGTFGYLAPEYA 770
+ ++RDLK NILL D K+ADFG+ + +N +T GT Y+APE
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 771 VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808
+ + T VD +SFGV+L E++ G+ E+
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLG 655
+G G F V K G A+K M+ S + EI L ++ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 656 YCLD-GNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
D RL LV+E M L + RK +PL R + + + ++++H
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAV 771
+ F HRD+KP NIL+ DD K+ADFG R ++ I TR Y APE +
Sbjct: 119 NGIF-HRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRW-----YRAPECLL 171
Query: 772 T-GRVTTKVDVFSFGVILMELIT 793
T G K+D+++ G + E+++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 43/106 (40%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R + K T T
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 764 YLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808
Y APE + TT +DV+S G I EL+ GRK L +D VH
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL--FPGKDYVH 216
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-13
Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 46/246 (18%)
Query: 598 LGRGGFGTVYKGELHD---GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+G+GG G VY +D ++A+K++ E + F E + + H +V +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 654 LGYCLDGNERLLVYEYMP--QGTLSRHLFN--RKEEGL-KPLEWTRR----LTIALDVAR 704
C DG+ VY MP +G + L ++E L K L L+I +
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-------------VRLAPDNGK 751
+EY+H + +HRDLKP NILLG + D+G + + N
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 752 HS---IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT---------GRKALD 799
+S I ++ GT Y+APE + + D+++ GVIL +++T GRK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
Query: 800 ETQSED 805
Sbjct: 242 RDVILS 247
|
Length = 932 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 15/220 (6%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME---SAVVSEKGFAEFKSEIAVLTKVR 646
N+ +LG+G FG VY ++ G ++A K+++ + + K + + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 647 HRHLVGLLGYCLDGNERLLV--YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +V G D E+ L EYMP G++ L K G TR+ T +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYT--RQILE 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFG 763
G+ YLH +HRD+K +NIL K+ DFG RL + + GT
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS 803
+++PE K DV+S G ++E++T + E ++
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE---FKSEIAVLTKVR 646
N+ +LGRG FG VY + G ++AVK++ S++ E + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 647 HRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +V G D E+ L EYMP G++ L K G TRR T + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYT--RQILQ 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPDNGKHSIETRLA 759
GV YLH +HRD+K +NIL K+ DFG + G S+
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV----T 170
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS 803
GT +++PE K DV+S ++E++T + E ++
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 66/233 (28%), Positives = 96/233 (41%), Gaps = 62/233 (26%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGT------KIAVKRMESAVVSEKGFAEFKSEIAV 641
+ SE N +G G GTVYK +H T K+ E V + EI +
Sbjct: 72 SLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQ-----ICREIEI 125
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
L V H ++V E ++ E+M G+L E+ L D
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA-DEQFLA------------D 172
Query: 702 VAR----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPDNGKH 752
VAR G+ YLH + +HRD+KPSN+L+ K+ADFG+ R + P N
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 753 SIETRLAGTFGYLAPEYAVTGRVTTKV----------DVFSFGVILMELITGR 795
GT Y++PE R+ T + D++S GV ++E GR
Sbjct: 229 ------VGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 26/233 (11%)
Query: 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSE 638
I + LR+ F V+G G +G VYKG + G A+K M+ V+E E K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 639 IAVLTKV-RHRHLVGLLGYCL------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE 691
I +L K HR++ G + ++ LV E+ G+++ + N K LK +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNG 750
W I ++ RG+ +LH AH+ IHRD+K N+LL ++ K+ DFG+ +L G
Sbjct: 122 WIA--YICREILRGLAHLH--AHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 751 KHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKAL 798
+ + GT ++APE + D++S G+ +E+ G L
Sbjct: 177 RRNT---FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 591 NFSEENVLGRGGFGTVY---KGELHDGTKI-AVKRMESAVVSEKG--FAEFKSEIAVLTK 644
NF VLG G +G V+ K HD K+ A+K ++ A + +K ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 645 VRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLE-WTRRLTIALDV 702
+R + L Y + +L L+ +Y+ G L HL R+ + ++ ++ + +AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL-- 118
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA--- 759
E+LH L I+RD+K NILL + + DFGL + H E A
Sbjct: 119 ----EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF-----HEDEVERAYSF 166
Query: 760 -GTFGYLAPEYAVTGRV--TTKVDVFSFGVILMELITG 794
GT Y+AP+ G VD +S GV++ EL+TG
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K ++ V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL + R ++ ++YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLH--S 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
++ ++RDLK N++L D K+ DFGL + +G +++T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT-FCGTPEYLAPEVLEDN 171
Query: 774 RVTTKVDVFSFGVILMELITGR 795
VD + GV++ E++ GR
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
++F + LG G G V K + I +++ + + E+ VL + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+VG G E + E+M G+L + L KE P E +++IA V RG+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIA--VLRGLAYL 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
HQ +HRD+KPSNIL+ K+ DFG+ D S+ GT Y++PE
Sbjct: 120 RE-KHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPER 173
Query: 770 AVTGRVTTKVDVFSFGVILMELITGR 795
+ + D++S G+ L+EL GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME---SAVVSEKGFAEFKSEIAVLTKVR 646
N+ +LG+G FG VY + G ++AVK+++ + + K + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 647 HRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +V G D ER L E+MP G++ L K G TR+ T +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYT--RQILE 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPDNGKHSIETRLA 759
GV YLH +HRD+K +NIL K+ DFG + G S+
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----T 170
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS 803
GT +++PE K D++S G ++E++T + E ++
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH----LVG 652
+G G G VYK G +AVK+M E E K + L V H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKRILMDLDVVLKSHDCPYIVK 78
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL--- 709
GY + ++ + E M T L R + + P + ++T+A + + + YL
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKLLKRIQGPI-PEDILGKMTVA--IVKALHYLKEK 133
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFGYLAPE 768
HG+ IHRD+KPSNILL K+ DFG+ RL K TR AG Y+APE
Sbjct: 134 HGV-----IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK----TRSAGCAAYMAPE 184
Query: 769 Y----AVTGRVTTKVDVFSFGVILMELITGR 795
+ + DV+S G+ L+EL TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 75/268 (27%), Positives = 111/268 (41%), Gaps = 58/268 (21%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG V D + A+K + A V+ A K+E +L + + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y + L V +Y+P G + L EE L R IA ++ +E +H +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIA-ELTCAIESVHKM 120
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGL---VRLAPDN-----GKH------------ 752
FIHRD+KP NIL+ D K+ DFGL R D+ G H
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 753 ---------SIETR------------LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 791
+E R L GT Y+APE + T D +S GVIL E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 792 ITGRKA-LDETQSEDSVHLVTWFRRMHI 818
+ G+ L +T +E + ++ W +HI
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHI 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G +G VYK + IA+K++ E + EI++L +++H ++V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 657 CLDGNERLLVYEYMPQGTLSRHL-----FNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
LV+EY+ L +H+ F + +K + + RG+ Y H
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY--------QILRGIAYCH- 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRA---KVADFGLVRLAPDNGKHSIETRL----AGTFGY 764
+H+ +HRDLKP N+L+ D R K+ADFGL R I R T Y
Sbjct: 120 -SHR-VLHRDLKPQNLLI--DRRTNALKLADFGLAR------AFGIPVRTFTHEVVTLWY 169
Query: 765 LAPEYAVTGR-VTTKVDVFSFGVILMELITGR 795
APE + R +T VD++S G I E++ +
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 75/260 (28%), Positives = 125/260 (48%), Gaps = 42/260 (16%)
Query: 598 LGRGGFGTVYKG---ELHDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVR-HRHLVG 652
LG+G +G V E + +A+K++ + V S+K A+ E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 653 LLGYCLD-----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L Y +D L +YE + + L H R + PL + + G++
Sbjct: 67 L--YDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQ---PLTDAHFQSFIYQILCGLK 119
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHS-IETRLAGTFGYL 765
Y+H + +HRDLKP N+L+ D K+ DFGL R + + G+++ T T Y
Sbjct: 120 YIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 766 APEYAVTGRVTTK-VDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824
APE ++ + TK +DV+S G IL EL+ GRK + + +D V +N+
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK--GKDYVD--------QLNQ---- 221
Query: 825 KAIDRTIDL-DEETLASIST 843
I + + DEETL+ I +
Sbjct: 222 --ILQVLGTPDEETLSRIGS 239
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K ++ V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL E + + R ++ + YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRAR--FYGAEIVSALGYLH--- 112
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
++RDLK N++L D K+ DFGL + +G GT YLAPE
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDN 170
Query: 774 RVTTKVDVFSFGVILMELITGR 795
VD + GV++ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 67/240 (27%), Positives = 109/240 (45%), Gaps = 26/240 (10%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
LR+ F ++G G +G VYKG + G A+K M+ E+ E K EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLK 57
Query: 644 KV-RHRHLVGLLGYCLDGN------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
K HR++ G + N + LV E+ G+++ + N K LK EW
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIA-- 114
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIE 755
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ +L G+ +
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 170
Query: 756 TRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810
GT ++APE K D++S G+ +E+ G L + ++ L+
Sbjct: 171 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 76/266 (28%), Positives = 106/266 (39%), Gaps = 77/266 (28%)
Query: 597 VLGRGGFGTVYKGE---LHDGTK---IAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-RHR 648
VLG G FG V + + + +AVK + E A SE SE+ +L + H
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKILIHIGNHL 71
Query: 649 HLVGLLGYCLDGNERLLV-YEYMPQGTLS------------------------------- 676
++V LLG C N L+V E+ G LS
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 677 -----------RHLFNR----KEEGLKPLE-----WTRRLTI------ALDVARGVEYLH 710
LF+R P + W LT+ + VARG+E+L
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHSIETRLAGTFGYLAP 767
A + IHRDL NILL ++ K+ DFGL R PD + RL ++AP
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-SARLP--LKWMAP 245
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT 793
E TT+ DV+SFGV+L E+ +
Sbjct: 246 ESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 66/235 (28%), Positives = 99/235 (42%), Gaps = 46/235 (19%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
L + T F V+G G +G VYK G +A+K M+ E+ E K E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE---EIKEEYNILR 57
Query: 644 KV-RHRHLVGLLGYCL------DGNERLLVYEYMPQGTLS------RHLFNRKEEGLKPL 690
K H ++ G + + ++ LV E G+++ R R +E
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE----- 112
Query: 691 EWTRRLTIAL---DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LA 746
EW IA + RG+ YLH ++ IHRD+K NILL + K+ DFG+ L
Sbjct: 113 EW-----IAYILRETLRGLAYLH--ENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
Query: 747 PDNGKH--SIETRLAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELITG 794
G+ I GT ++APE + DV+S G+ +EL G
Sbjct: 165 STLGRRNTFI-----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K + V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL +R+ + R ++ +EYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL-SRE----RVFTEERARFYGAEIVSALEYLHS-- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
+ ++RD+K N++L D K+ DFGL + +G +++T GT YLAPE
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT-FCGTPEYLAPEVLEDN 170
Query: 774 RVTTKVDVFSFGVILMELITGR 795
VD + GV++ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGLL 654
VLG+G FG V EL ++ A+K ++ V+ + + +E +L + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 655 GYCLDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C +RL V EY+ G L +F + + + R A +V + +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRS--RKFDEPRSRFYAAEVTLALMFLH--- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
I+RDLK NILL + K+ADFG+ + NG T GT Y+APE
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL 171
Query: 774 RVTTKVDVFSFGVILMELITGRKALDETQSED 805
VD ++ GV++ E++ G+ + +D
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 28/232 (12%)
Query: 591 NFSEENVLGRGGFGTVY---KGELHDGTKI-AVKRMESA--VVSEKGFAEFKSEIAVLTK 644
NF VLG G +G V+ K HD K+ A+K ++ A V K ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 645 VRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNR---KEEGLKPLEWTRRLTIAL 700
VR + L Y +L L+ +Y+ G + HL+ R E+ ++ ++ + +AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEIILAL 118
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
E+LH L ++RD+K NILL + + DFGL + K + G
Sbjct: 119 ------EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCG 168
Query: 761 TFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALD-----ETQSEDS 806
T Y+APE K VD +S G+++ EL+TG TQSE S
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 591 NFSEENVLGRGGFGTV----YKGELHDGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKV 645
+F LG G FG V +KG G A+K ++ ++ K E ++L ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H +V ++ D N + E++ G L HL ++ G P + + L +A
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA-- 130
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
EYLH I+RDLKP N+LL + KV DFG + PD L GT YL
Sbjct: 131 FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYL 182
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITG 794
APE + VD ++ GV+L E I G
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR-HLVGLLG 655
+G G +G VYK + + G +A+K+ + E EI++L + ++V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 656 YCLDGNER-------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++ E LV+EY+ N + G +PL + + +GV +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG-RPLPAKTIKSFMYQLLKGVAH 125
Query: 709 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLA 766
H +HRDLKP N+L+ K+AD GL R + ++ E T Y A
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---TLWYRA 179
Query: 767 PEYAVTGR-VTTKVDVFSFGVILMELITG 794
PE + +T VD++S G I E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G G V+ D ++AVK++ + + EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 657 CLDGNERL--------------LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
L +V EYM L N E+G E R L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQL-- 123
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHS--IETRLA 759
RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+ + H + L
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 760 GTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 795
+ Y +P ++ TK +D+++ G I E++TG+
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V + DG AVK ++ +V + K +E VL K V+H LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y E+L V +++ G L HL ++E E R A ++A + YLH +
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFP--EPRARFYAA-EIASALGYLHSI 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
+ ++RDLKP NILL + DFGL + + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT--TTFCGTPEYLAPEVIRK 170
Query: 773 GRVTTKVDVFSFGVILMELITG 794
VD + G +L E++ G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 13/221 (5%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL-- 653
VLG G GTV + DG AVK ++ +SE ++E+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 654 -LGYCLDGNERL-----LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
N LV +Y G L + + +R + + + + V V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVH 157
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
++H + IHRD+K +NILL + K+ DFG ++ + GT Y+AP
Sbjct: 158 HVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808
E + K D+FS GV+L EL+T ++ D E+ +H
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
|
Length = 496 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 39/233 (16%)
Query: 598 LGRGGFGTVYKGELH-DGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL- 653
LG G + TV+KG +A+K R+E E E+++L ++H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 654 ----LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL-DVARGVEY 708
CL LV+EY+ L ++L N L + I + + RG+ Y
Sbjct: 70 DIIHTERCLT-----LVFEYL-DSDLKQYLDN-----CGNLMSMHNVKIFMFQLLRGLSY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG----TFGY 764
H + +HRDLKP N+L+ + K+ADFGL R S+ T+ T Y
Sbjct: 119 CH---KRKILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNEVVTLWY 169
Query: 765 LAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816
P+ + + +T +D++ G IL E+ TGR + ++ +HL+ FR +
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI--FRLL 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 575 AGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFA 633
A MV+ R +NF + +G G G V + G +AVK+M+ + ++
Sbjct: 8 ALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRE 62
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLE 691
+E+ ++ +H ++V + L G+E +V E++ G L+ + + + EE +
Sbjct: 63 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--- 119
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
+ L V + + LH Q IHRD+K +ILL D R K++DFG A + +
Sbjct: 120 -----AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKE 169
Query: 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
L GT ++APE +VD++S G++++E++ G
Sbjct: 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 31/183 (16%)
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-- 745
+PL + L I + G+ YLH Q IHRD+K NI + D + + D G +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 746 -APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE---T 801
AP LAGT APE + +K D++S G++L E++ + E +
Sbjct: 209 VAPA------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262
Query: 802 QSEDSV-----HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREP 856
E+ V HL+ + ++ + F + + AS R+P
Sbjct: 263 TPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYAS-----------LERQP 311
Query: 857 YQR 859
Y R
Sbjct: 312 YTR 314
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 46/233 (19%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS--EIAVLTKVRHRHLV 651
LG G + TVYKG G +A+K R+E E+G A F + E ++L ++H ++V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEH----EEG-APFTAIREASLLKDLKHANIV 66
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL-DVARGVEYL 709
L + + L LV+EY+ L +++ + GL + + L + RG+ Y
Sbjct: 67 -TLHDIIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSM----HNVRLFLFQLLRGLAYC 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG----TFGYL 765
H + +HRDLKP N+L+ + K+ADFGL R S+ ++ T Y
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVPSKTYSNEVVTLWYR 170
Query: 766 AP-------EYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQSEDSVHLV 810
P EY +T +D++ G I E+ TGR T ED +H +
Sbjct: 171 PPDVLLGSTEY------STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 50/245 (20%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKG-FAEFKSEIAVLTKVRH 647
++F V+GRG FG V + D I A+K++ + + EK A ++E +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 648 RHLVGLLGYC--LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+V L Y D N L+ EY+P G + L K++ E R IA +
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFT--EEETRFYIA-ETILA 113
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL----------------VRLAPDN 749
++ +H L +IHRD+KP N+LL K++DFGL P N
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 750 GKHSIET-----RLA---------------GTFGYLAPEYAVTGRVTTKVDVFSFGVILM 789
I R A GT Y+APE + + D +S GVI+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 790 ELITG 794
E++ G
Sbjct: 231 EMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 598 LGRGGFGTVYKG--ELHDGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG G + TVYKG +L D +A+K R+E E E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LV+EY L + L ++ + + RG+ Y H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG----TFGYLAPEY 769
+ +HRDLKP N+L+ + K+ADFGL R SI T+ T Y P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPPDI 175
Query: 770 AV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810
+ + +T++D++ G I E+ TGR + E+ +H +
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+++ + LG G + TVYKG+ +G +A+K + F + E ++L ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 649 HLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V LL + E L LV+EY+ L +++ ++ GL P L + RG+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFL---FQLLRGLS 117
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y+H + +HRDLKP N+L+ D K+ADFGL R A H+ + T Y P
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPP 172
Query: 768 EYAV-TGRVTTKVDVFSFGVILMELITGRKAL 798
+ + + +T +D++ G I +E+I G A
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G +G+V + G K+A+K++ SE E+ +L ++H +++GLL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 657 ---CLDGNERLLVYEYMP------QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+ G+E Y MP Q + L K + L + G++
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL-----------VYQMLCGLK 131
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y+H IHRDLKP N+ + +D K+ DFGL R A + TR Y AP
Sbjct: 132 YIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAP 183
Query: 768 EYAVTG-RVTTKVDVFSFGVILMELITGR 795
E + VD++S G I+ E++TG+
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 597 VLGRGGFGTVY------KGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++GRGGFG VY G+++ D +I +K+ E+ ++E+ + L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-------IMLSLVST 53
Query: 646 RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ + Y ++L + + M G L HL K + + A ++
Sbjct: 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIIL 108
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+E++H ++ ++RDLKP+NILL + +++D G LA D K + GT GY
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASV-GTHGY 161
Query: 765 LAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSED 805
+APE G + D FS G +L +L+ G + +++D
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 69/225 (30%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRM---ESAVVSEKGFA 633
I LR +F V+GRG FG V + H +K A+K + E S+ F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF- 89
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
F E ++ +V L D +V EYMP G L + N P +W
Sbjct: 90 -FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----IPEKWA 144
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
R T A V L + FIHRD+KP N+LL K+ADFG NG
Sbjct: 145 RFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199
Query: 754 IETRLAGTFGYLAPEY----AVTGRVTTKVDVFSFGVILMELITG 794
+T + GT Y++PE G + D +S GV L E++ G
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
++F + + LG G G V+K I +++ + + E+ VL + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+VG G E + E+M G+L + L K+ G P + +++IA V +G+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+HRD+KPSNIL+ K+ DFG+ D S+ GT Y++PE
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPER 173
Query: 770 AVTGRVTTKVDVFSFGVILMELITGR 795
+ + D++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 598 LGRGGFGTVYKG--ELHDGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG G + TV+KG +L + +A+K R+E E E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LV+EY L + L ++ + + RG+ Y H
Sbjct: 70 HDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--- 121
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG----TFGYLAPEY 769
+ +HRDLKP N+L+ + K+ADFGL R S+ T+ T Y P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPPDV 175
Query: 770 AV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810
+ + +T++D++ G I E+ +GR + ED +HL+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 16/219 (7%)
Query: 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESA--VVSEKGFAEFKSEI 639
I+ LR ++ V+GRG FG V K+ ++ S ++ A F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
++ +V L D +V EYMP G L + N P +W R T
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAE 150
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ +A L + FIHRD+KP N+LL K+ADFG G +T +
Sbjct: 151 VVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 760 GTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITG 794
GT Y++PE + G + D +S GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 598 LGRGGFGTVYKGELHDGTKI--AVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG+G +G+VYK LH T + A+K R+E + E F + E+ +L K ++V
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G + EYM G+L + P + RR+T A V +G+++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK--E 120
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY---- 769
+ IHRD+KP+N+L+ + + K+ DFG+ N S+ G Y+APE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 770 AVTGRVTTKV--DVFSFGVILMELITGR 795
T V DV+S G+ ++E+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G +GTV+K + + +A+KR+ E + EI +L +++H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY--LHGLAH 714
+ LV+EY Q LK + I ++ + + L GLA
Sbjct: 68 LHSDKKLTLVFEYCDQ-------------DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 715 ---QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG----TFGYLAP 767
+ +HRDLKP N+L+ + K+ADFGL R I R T Y P
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLAR------AFGIPVRCYSAEVVTLWYRPP 168
Query: 768 EYAVTGRV-TTKVDVFSFGVILMELITGRKAL 798
+ ++ +T +D++S G I EL + L
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS--------EIAVLTKVRHRH 649
LG+G FGTVY L K AV V+ E E E +L+K+ H
Sbjct: 8 LGKGSFGTVY---LVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK-----PLEWTRRLTIALDVAR 704
+V L+ + ++ EY L L K G EW +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
GV Y+H + +HRDLK NI L +++ K+ DFG+ RL G + T GT Y
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYY 171
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMEL 791
++PE +K D++S G IL E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 591 NFSEENVLGRGGFGTV----YKGELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKV 645
+F+ LG G FG V YK E D +A+KR E S ++ +K SE +L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H V L G D + LV E++ G F R+ K A +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRN---KRFPNDVGCFYAAQIVLI 143
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR---LAGTF 762
EYL L + ++RDLKP N+LL D K+ DFG ++ ++TR L GT
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTP 192
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
Y+APE + D ++ G+ + E++ G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 32/177 (18%)
Query: 32 AMQALKTSLGNPASLGWTDPDPC-----KWKHIQCSPSNRVTRIQIGGQNIEGTLPKELN 86
A+Q LK+SLG P GW + DPC W C + + I G ++
Sbjct: 376 ALQTLKSSLGLPLRFGW-NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLD-------- 426
Query: 87 SLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
L G IP+ +S L LQ + N+ +TSL+ + L Y
Sbjct: 427 -----------NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
NSF+ IPESL T L+ + NG +++G +P LGG + +FNF
Sbjct: 476 NSFNG-SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR-----ASFNFTDNA 526
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 40/113 (35%), Positives = 57/113 (50%), Gaps = 11/113 (9%)
Query: 331 VNVLLSIVKSVGYPAVLAESWKGNNPC---NSDWKGVSC---DAGGN--ITVVNLKNLGL 382
V+ L ++ S+G P W G+ PC W G C G I + L N GL
Sbjct: 374 VSALQTLKSSLGLPLRFG--WNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGL 430
Query: 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
G I ++ S+L L+ + LSGN + G IP L ++ SLE+LD+S N G +P
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKS-EIAVLTKVRHR 648
+F+ VLG+G FG V E ++ A+K ++ VV + E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 649 HLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+ L C +RL V EY+ G L H+ + + + + + A +++ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLA 766
+LH + I+RDLK N++L + K+ADFG+ + ++ + TR GT Y+A
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIA 169
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807
PE VD +++GV+L E++ G+ D + ED +
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFK-SEIAVLTKVRH 647
+F+ VLG+G FG V E GT A+K ++ V+ + E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
+ L C +RL V EY+ G L H+ ++ G + + A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVG--KFKEPHAVFYAAEIAIGL 114
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYL 765
+LH + I+RDLK N++L + K+ADFG+ + +N TR GT Y+
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYI 168
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITGRKALD 799
APE VD ++FGV+L E++ G+ D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 42/228 (18%)
Query: 597 VLGRGGFGTVY------KGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++GRGGFG VY G+++ D +I +K+ E+ ++E+ + L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-------IMLSLVST 53
Query: 646 RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHL-----FNRKEEGLKPLEWTRRLTIA 699
+ + Y ++L + + M G L HL F+ E A
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF----------YA 103
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
++ G+E++H ++ ++RDLKP+NILL + +++D G LA D K +
Sbjct: 104 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASV- 156
Query: 760 GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDS 806
GT GY+APE G + D FS G +L +L+ G + +++D
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 62/228 (27%)
Query: 598 LGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LGRG +G V K H GT +AVKR+ + V S++ + R L+
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQE---------------QKRLLMD--- 49
Query: 656 YCLDGNERLLVYEYMPQ--GTLSRH--------LFNRKEEGLKPLEWTRRLTI------- 698
LD + R + Y G L R + + + + + LTI
Sbjct: 50 --LDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 699 -ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
A+ + + +EYLH + S IHRD+KPSN+L+ + + K+ DFG+ D+ +I+
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-- 163
Query: 758 LAGTFGYLAPE----------YAVTGRVTTKVDVFSFGVILMELITGR 795
AG Y+APE Y V K DV+S G+ ++EL TGR
Sbjct: 164 -AGCKPYMAPERINPELNQKGYDV------KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 47/218 (21%)
Query: 598 LGRGGFGTV---YKGELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+G G +G+V Y L K+AVK++ +S + + + + E + +L ++H ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELR----LLKHMKHENV 76
Query: 651 VGLLGYCL------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT------I 698
+GLL + NE LV M L + ++L+ +
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGAD-------------LNNIVKCQKLSDEHVQFL 123
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
+ RG++Y+H IHRDLKPSN+ + +D ++ DFGL R A D + TR
Sbjct: 124 IYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW 180
Query: 759 AGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGR 795
Y APE + VD++S G I+ EL+ G+
Sbjct: 181 -----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
V+GRG + V L +I A+K ++ +V++ ++ ++E V + H LVGL
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 654 LGYCLDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V EY+ G L +F+ + + P E R + + +A + YLH
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLH-- 113
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
+ I+RDLK N+LL + K+ D+G+ + G + + GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRG 170
Query: 773 GRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806
VD ++ GV++ E++ GR D S D+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 49/235 (20%)
Query: 597 VLGRGGFGTVYKGELHD-GTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G G V+ L G A+K ++ ++ +E +L + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL- 66
Query: 655 GYC-LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVEY 708
Y L LV +Y P G L R L R+ E R + +AL EY
Sbjct: 67 -YASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLAL------EY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL---------------VRLAPDNGKHS 753
LH L ++RDLKP NILL + ++DF L + + + +S
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 754 IETRLA------------GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 795
I + GT Y+APE ++G + VD ++ G++L E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K ++ V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y +RL V EY+ G L HL + R ++ ++YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS-- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 114 -GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT-FCGTPEYLAPEVLEDN 170
Query: 774 RVTTKVDVFSFGVILMELITGR 795
VD + GV++ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYK------GELHDGTKIAVKRMESAVVSEKGFAEFKSEI 639
RN +F +G G +G VYK GEL I V ++E + FA + EI
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL---AAIKVIKLEPG----EDFAVVQQEI 57
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLT 697
++ +H ++V G L ++ + E+ G+L H+ PL ++
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-------PLSESQIAY 110
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
++ + +G+ YLH + +HRD+K +NILL D+ K+ADFG+ A +
Sbjct: 111 VSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKS 165
Query: 758 LAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMEL 791
GT ++APE A R D+++ G+ +EL
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 43/218 (19%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTK------VRHRHL 650
+G G FG V E++ T +A VV E K A K + L + ++H ++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVA-----RVVVKELKANASSKEQNEFLQQGDPYRILQHPNI 57
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT-------IALDVA 703
+ LG C++ LLV+EY G L +L +W RR + +A ++A
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE--------QWHRRNSQLLLLQRMACEIA 109
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS-IET--RLAG 760
GV ++H +F+H DL N L D+ KV D+G + P K IET
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCV 163
Query: 761 TFGYLAPEYA-------VTGRVTTKVDVFSFGVILMEL 791
+LAPE +T T +V++ GV L EL
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG VYK + + +A ++ SE+ ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
N ++ E+ G + + E +PL + + + YLH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLH---ENKI 124
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYLAPEYAV--TG 773
IHRDLK NIL D K+ADFG ++ N + +I+ R GT ++APE + T
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFG---VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 774 R---VTTKVDVFSFGVILMEL 791
+ K DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 35/232 (15%)
Query: 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGT-KIAVKRMESAVVSEKGFAEFKS 637
+I + R+ ++ N++G G FG VY+ D + K+A+K+ V+ + +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYK--NR 108
Query: 638 EIAVLTKVRHRHLVGLLGY----CLDGNERLL----VYEYMPQGTLSRHL--FNRKEEGL 687
E+ ++ + H +++ L Y C NE+ + V E++PQ T+ +++ + R L
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRA-KVADFGLVR- 744
PL + + L R + Y+H FI HRDLKP N+L+ + K+ DFG +
Sbjct: 168 -PLFLVKLYSYQL--CRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 745 -LAPDNGKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITG 794
LA I +R Y APE + TT +D++S G I+ E+I G
Sbjct: 221 LLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 598 LGRGGFG-TVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G FG + DG + +K + + +S K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRK-----EEGLKPLEWTRRLTIALDVARGVEYLHG 711
+ +V +Y G L + + ++ E+ + L+W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICLAL------KHVH- 118
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+ +HRD+K NI L D K+ DFG+ R+ N + GT YL+PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEICE 174
Query: 772 TGRVTTKVDVFSFGVILMELITGRKALD 799
K D+++ G +L E+ T + A +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVL-TKVRHRHLVGL 653
V+GRG + V EL +I A+K ++ +V++ ++ ++E V T H LVGL
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V E++ G L H+ +++ L P E R + + +A L+ L
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHM--QRQRKL-PEEHARFYSAEISLA-----LNFL 112
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
+ I+RDLK N+LL + K+ D+G+ + G + + GT Y+APE
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIAPEILRG 170
Query: 773 GRVTTKVDVFSFGVILMELITGRKALD 799
VD ++ GV++ E++ GR D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 36/91 (39%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 183
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
APE + VD++S G I+ E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-11
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 4/165 (2%)
Query: 629 EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK 688
E+ A +SE+ L H +V ++ LL+ EY G L++ + R +E L
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP 165
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
E+ L + + ++ +H + +HRDLK +NI L K+ DFG + D
Sbjct: 166 FQEYEVGL-LFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ + + GT YLAPE R + K D++S GVIL EL+T
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 16/215 (7%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKS-EIAVLTKVRHRHLVGLL 654
VLG+G FG V E ++ A+K ++ VV + E E VL + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C +RL V EY+ G L + + + + + A ++A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFLHS-- 119
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLAPEYAVT 772
+ I+RDLK N++L + K+ADFG+ + +N + T+ GT Y+APE
Sbjct: 120 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 773 GRVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807
VD ++FGV+L E++ G+ E + ED +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKG--FAEFKSEIAVL 642
RN +++ +G G +G VYK LH G AVK + E G F+ + EI ++
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVK----IIKLEPGDDFSLIQQEIFMV 60
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLTIAL 700
+ +H ++V G L + + EY G+L H+ PL + +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-------PLSELQIAYVCR 113
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ +G+ YLH +HRD+K +NILL D+ K+ADFG+ A + G
Sbjct: 114 ETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIG 168
Query: 761 TFGYLAPEYAV---TGRVTTKVDVFSFGVILMEL 791
T ++APE A G D+++ G+ +EL
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKR--MESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGL 653
+G+G FG V+K +A+K+ ME+ ++GF EI +L ++H ++V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 654 LGYC----LDGNER----LLVYEYMPQ---GTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+ C N LV+E+ G LS +K + +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--------KVMKML 128
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPDNGKHSIETRLAG 760
G+ Y+H +HRD+K +NIL+ D K+ADFGL R N K + T
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 761 TFGYLAPEYAVTGR-VTTKVDVFSFGVILMELIT 793
T Y PE + R +D++ G I+ E+ T
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 52/210 (24%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 598 LGRGGFGTVYKG---ELHDG-----TKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR 648
LG+G F ++KG E+ D T++ +K ++ S + ++E F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
HLV G C+ G+E ++V EY+ G+L +L +K + L + W L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWK------LEVAKQLAW 111
Query: 709 -LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYL 765
LH L + H ++ N+LL + K + ++L+ ++ + L ++
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 766 APEYAVTGR-VTTKVDVFSFGVILMELITG 794
PE + ++ D +SFG L E+ +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKG--FAEFKSEIAVLTKVRHRHLVGLL 654
LG G + TVYKG +G +A+K + ++ +E+G F + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIR-EASLLKGLKHANIV-LL 68
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+ E L V+EYM L++++ + GL P + RL + + RG+ Y+H
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHP--YNVRLFM-FQLLRGLAYIH--- 120
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG----TFGYLAPEY 769
Q +HRDLKP N+L+ K+ADFGL R SI ++ T Y P+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWYRPPD- 173
Query: 770 AVTGRV--TTKVDVFSFGVILMELITGRKALDETQS 803
+ G ++ +D++ G I +E++ G+ A
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 16/223 (7%)
Query: 578 MVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESA--VVSEKGFAEF 635
+V I+ L+ ++ V+GRG FG V K+ ++ S ++ A F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 636 KSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR 695
E ++ +V L D +V EYMP G L + N P +W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF 146
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
T +V ++ +H + IHRD+KP N+LL K+ADFG + G +
Sbjct: 147 YTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 756 TRLAGTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITG 794
T + GT Y++PE + G + D +S GV L E++ G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 75/275 (27%), Positives = 108/275 (39%), Gaps = 56/275 (20%)
Query: 592 FSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRH 649
F + LG G FG V D A+K + V+ A K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L D + V +Y+P G + L G+ P + R L A VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VESV 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---RLAPD-----NGKH--------- 752
H + FIHRD+KP NIL+ D K+ DFGL R D +G H
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 753 ----------------SIETR------------LAGTFGYLAPEYAVTGRVTTKVDVFSF 784
+E R L GT Y+APE + T D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 785 GVILMELITGRKA-LDETQSEDSVHLVTWFRRMHI 818
GVIL E++ G+ L +T E + ++ W +HI
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 56/275 (20%)
Query: 592 FSEENVLGRGGFGTV-YKGELHDGTKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRH 649
F + LG G FG V ++ A+K + V++ A K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L D + V +Y+P G + L + P E R IA ++ +E +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFP-EVLARFYIA-ELTLAIESV 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---RLAPDN-----GKH--------- 752
H + FIHRD+KP NIL+ D K+ DFGL R ++ G H
Sbjct: 118 HKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 753 ----------------SIETR------------LAGTFGYLAPEYAVTGRVTTKVDVFSF 784
++E R L GT Y+APE + T D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 785 GVILMELITGRKA-LDETQSEDSVHLVTWFRRMHI 818
GVIL E++ G+ L T +E + ++ W +HI
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 32/193 (16%)
Query: 614 GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673
G +AVK++ ++ E+ +L V H++++ LL + PQ
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93
Query: 674 TLS--RHLFNRKEEGLKPLEWTRRLTIALDVAR----------GVEYLHGLAHQSFIHRD 721
+L + ++ E L + + + LD R G+++LH IHRD
Sbjct: 94 SLEEFQDVYLVME--LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRD 148
Query: 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDV 781
LKPSNI++ D K+ DFGL R A N + T T Y APE + VD+
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 782 FSFGVILMELITG 794
+S G I+ EL+ G
Sbjct: 206 WSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKVRHRHLVGLL 654
V+GRG + V L +I A+K ++ +V + ++ ++E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C RL LV EY+ G L H+ +++ P E R A ++ + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHAR--FYAAEICIALNFLH--- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
+ I+RDLK N+LL D K+ D+G+ + G + + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRGE 171
Query: 774 RVTTKVDVFSFGVILMELITGRKALD 799
VD ++ GV++ E++ GR D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
N F V+G G +G V K H TK +A+K+ + + +E+ E+ +L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCR-HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ 59
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V L + LV+EY+ + L L G+ P E R L ++
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPP-EKVRSYIYQL-----IK 111
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+H +HRD+KP N+L+ + K+ DFG R + G ++ T T Y +P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSP 170
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGR 795
E + VD++S G IL EL G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726
Y+ + L + EGL L+ L+ VARG+E+L A ++ +HRDL N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFL---ASKNCVHRDLAARN 267
Query: 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGV 786
+LL K+ DFGL R + + + ++APE TT DV+S+G+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 787 ILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVAD 846
+L E+ + DS T++ ++ K +R A + + V D
Sbjct: 328 LLWEIFSLGGTPYPGMIVDS----TFYNKI---KSGYRMA---------KPDHATQEVYD 371
Query: 847 LAGHCCAREPYQRPDMGHVVNVLSSL 872
+ C EP +RP H+ +++ SL
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 71/258 (27%), Positives = 107/258 (41%), Gaps = 44/258 (17%)
Query: 591 NFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKVRHR 648
+F V+GRG FG V + D G A+K + A + EK ++E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V + D L+ E++P G + L K++ L E + IA + ++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLT--EEETQFYIA-ETVLAIDS 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-----------------RLAPD--- 748
+H L FIHRD+KP N+LL K++DFGL L D
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 749 ---NGKHSIET------RLA----GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
N K ET +LA GT Y+APE + D +S GVI+ E++ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 796 KAL-DETQSEDSVHLVTW 812
ET E ++ W
Sbjct: 234 PPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKI----------AVKRMESAVVSEKGFAEFKSEIA 640
+F V+GRG FG V +L + K+ +KR E+A F+ E
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC--------FREERD 53
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RL 696
VL ++ + L D N LV +Y G L L ++ E+ L P + R +
Sbjct: 54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRL-PEDMARFYLAEM 111
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIE 755
IA+D V LH ++HRD+KP NIL+ + ++ADFG ++L D +++
Sbjct: 112 VIAID---SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQ 159
Query: 756 TRLA-GTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITG 794
+ +A GT Y++PE G+ + D +S GV + E++ G
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 44/259 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEK-GFAEFKSEIAVLTKVRH 647
++F V+GRG FG V + D I A+K + A + EK A ++E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V + D L+ E++P G + L K++ L E + IA + ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLS--EEATQFYIA-ETVLAID 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-----------------------R 744
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 116 AIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 745 LAPDNGKHSIET------RLA----GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
N K ET +LA GT Y+APE + D +S GVI+ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 795 RKAL-DETQSEDSVHLVTW 812
ET E ++ W
Sbjct: 233 YPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 9/109 (8%)
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--- 744
K L + + VA+G+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
PD + + RL ++APE T + DV+SFGV+L E+ +
Sbjct: 231 KDPDYVRKG-DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 617 IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
+A+K++ ++ E+ ++ V H++++GLL + PQ +L
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 677 --RHLFNRKEEGLKPLEWTRRLTIALDVAR----------GVEYLHGLAHQSFIHRDLKP 724
+ ++ E L + + + LD R G+++LH IHRDLKP
Sbjct: 100 EFQDVYIVME--LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKP 154
Query: 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSF 784
SNI++ D K+ DFGL R A G + T T Y APE + VD++S
Sbjct: 155 SNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 785 GVILMELITGR 795
G I+ E+I G
Sbjct: 212 GCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 244 LHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQT 300
L N +GP+PD + SSL+ ++ +N TG +P S+ NL +L +L+NN+ G+
Sbjct: 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETL---DLSNNMLSGEI 156
Query: 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD 360
P D+ S+ LD G G++ L+ + S+ + + + G P
Sbjct: 157 PN-------DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP---- 205
Query: 361 WKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
++ + L LSG I LTSL L L N LTG IP L L +L
Sbjct: 206 ---RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262
Query: 421 EMLDVSNNHLFGKVPN 436
+ L + N L G +P
Sbjct: 263 QYLFLYQNKLSGPIPP 278
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 333 VLLSIVKSVGYPAVLAESWKGNNP-CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFS 391
+LLS S+ P +W + C W+G++C+ + ++L +SG ISS
Sbjct: 33 LLLSFKSSINDPLKYLSNWNSSADVCL--WQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 392 RLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNHLFGKVPN 436
RL ++ + LS N+L+G IP ++ TT SL L++SNN+ G +P
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
|
Length = 968 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/276 (22%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
V+G+G +G V DG + +K++ S + + E +L++++H ++V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYR 65
Query: 656 YCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGL---KPLEWTRRLTIALDVARGVEYLH 710
+G + LL V + G L L +K + L + +EW ++ +AL +YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLH 119
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
+ +HRDLK N+ L KV D G+ R+ + + + + L GT Y++PE
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELF 174
Query: 771 VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830
K DV++ G + E+ T + A + V+ + + + KD +
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPE----- 229
Query: 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVV 866
+ +L ++ P +RP + ++
Sbjct: 230 -------------LGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
F +++++V H HL + G C+ G+E ++V E++ G L L RKE+G P+ W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAW-- 118
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-------GDDMRAKVADFGLVRLAP 747
++T+A +A + YL ++ +H ++ NILL G K++D G+ A
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA- 174
Query: 748 DNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMEL-ITGRKALDE-TQSE 804
S E R+ ++APE G ++T D +SFG L+E+ G L E T SE
Sbjct: 175 ----LSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
K+ F ++ L E S +A L C EP QRP
Sbjct: 230 ---------------KERF---YEKKHRLPE---PSCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 597 VLGRGGFGTVYKGELHDGTKI----------AVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V+GRG FG V ++ + ++ +KR E+A F+ E VL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC--------FREERDVLVNGD 59
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
R + L D N LV +Y G L L ++ E+ L P + R +A V
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRL-PEDMAR-----FYLAEMV 112
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIETRLA-GTFGY 764
+ + ++HRD+KP N+LL + ++ADFG +RL D ++++ +A GT Y
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDY 169
Query: 765 LAPEY--AV---TGRVTTKVDVFSFGVILMELITG 794
++PE A+ GR + D +S GV + E++ G
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI----------AVKRMESAVVSEKGFAEFKSEI 639
++F V+GRG FG V ++ +I +KR E+A F+ E
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC--------FREER 52
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
VL + + L D N LV +Y G L L ++ E+ L P + R
Sbjct: 53 NVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLT-LLSKFEDRL-PEDMAR----- 105
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+A V +H + ++HRD+KP N+LL + ++ADFG +G ++++ +A
Sbjct: 106 FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVA 163
Query: 760 -GTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITG 794
GT Y++PE G+ + D +S GV + E++ G
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 34/200 (17%)
Query: 617 IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
+A+K++ ++ E+ ++ V H++++ LL + PQ +L
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLE 92
Query: 677 RHLFNRKEEGLKPLEWTRRLTIALDVAR----------GVEYLHGLAHQSFIHRDLKPSN 726
L + + + LD R G+++LH IHRDLKPSN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN 149
Query: 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGV 786
I++ D K+ DFGL R A G + T T Y APE + VD++S G
Sbjct: 150 IVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 787 ILMELI------TGRKALDE 800
I+ E++ GR +D+
Sbjct: 207 IMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 38/130 (29%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 668 EYMPQGTLSRHLFNRKE----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723
E P + S + K+ E PL+ L + VA+G+++L A ++ IHRD+
Sbjct: 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVA 239
Query: 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFS 783
N+LL D AK+ DFGL R ++ + ++ ++APE T + DV+S
Sbjct: 240 ARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWS 299
Query: 784 FGVILMELIT 793
+G++L E+ +
Sbjct: 300 YGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 45/156 (28%), Positives = 65/156 (41%), Gaps = 22/156 (14%)
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHL---FNRKEEGLKPLEWTRRLTIALDVARG 705
++V L Y + + LV ++ G L H+ N EE +K W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK--RWAAEMVVALD---- 99
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIETRLAGTFGY 764
L + + RDL P+NILL D ++ F + ++E Y
Sbjct: 100 -----ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------Y 148
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 800
APE T D +S G IL EL+TG K L E
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 36/227 (15%)
Query: 597 VLGR----GGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
++G+ + K + T +AVK++ S++ + EI +++H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DVARGVEYL 709
+ + +E +V M G+ L EGL L IA DV ++Y+
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYI 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK-----HSIETRLAGTFGY 764
H + FIHR +K S+ILL D + ++ +GK H +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 765 LAPE--------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQS 803
L+PE Y K D++S G+ EL G + +
Sbjct: 175 LSPEVLQQNLQGY------NEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 26/163 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
+F V+G+G FG V + D KI A+K + +S + + A K+E VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--- 704
+V L D L+ E++P G L L T + DV R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------------TFSEDVTRFYM 107
Query: 705 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
+E +H L FIHRD+KP NIL+ K++DFGL
Sbjct: 108 AECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 21/143 (14%)
Query: 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 724
+V EY+ G + L K G P++ R+ A V +EYLH +HRDLKP
Sbjct: 78 MVMEYVEGGDCATLL---KNIGALPVD-MARMYFAETVL-ALEYLHNYG---IVHRDLKP 129
Query: 725 SNILLGDDMRAKVADFGLVRLAPDN-------GKHSIETR------LAGTFGYLAPEYAV 771
N+L+ K+ DFGL ++ + G +TR + GT Y+APE +
Sbjct: 130 DNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189
Query: 772 TGRVTTKVDVFSFGVILMELITG 794
VD ++ G+IL E + G
Sbjct: 190 RQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 597 VLGRGGFGT--VYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
V+G G FG + + D K A+K + S + + E +L K++H ++V
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF- 63
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKP----LEWTRRLTIALDVARGVEYL 709
+ + L +V EY G L + + ++ + L P L+W ++ + GV+++
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-LFPEDTILQWFVQMCL------GVQHI 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H + +HRD+K NI L + + K+ DFG RL G ++ GT Y+ PE
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPYYVPPEI 171
Query: 770 AVTGRVTTKVDVFSFGVILMELIT 793
K D++S G IL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R ++ + ++
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
++APE T + DV+S+G++L E+ +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-07
Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 44/231 (19%)
Query: 598 LGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG V+ + H T+ K + + E+ ++ E+ V+ +++H+++V +
Sbjct: 21 IGNGRFGEVFLVK-HKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 656 YCLD-GNERL-LVYEYMPQGTLSRH------LFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L+ N++L ++ E+ G LSR+ +F + EE ++ TR+L AL
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH-AIVDITRQLLHAL------A 132
Query: 708 YLHGLAH----QSFIHRDLKPSNILLGDDMR-----------------AKVADFGLVRLA 746
Y H L + +HRDLKP NI L +R AK+ DFGL +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-- 190
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAV--TGRVTTKVDVFSFGVILMELITGR 795
+ G S+ GT Y +PE + T K D+++ G I+ EL +G+
Sbjct: 191 -NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 48/157 (30%), Positives = 67/157 (42%), Gaps = 52/157 (33%)
Query: 148 FDS----WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL---HLAFNFLQ 200
FDS W I D GL + + G IP+ I L HL +L+ N ++
Sbjct: 411 FDSTKGKWFI-----DGLGL-----DNQGLRGFIPN-----DISKLRHLQSINLSGNSIR 455
Query: 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGL 259
G IP S G ++TSL L L NSF G +P+ L L
Sbjct: 456 GNIPPSLG--------------------------SITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 260 SSLQDFSVRDNQLTGIVPSSLVN--LHSLAVVNLTNN 294
+SL+ ++ N L+G VP++L LH A N T+N
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHR-ASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L + + + VA G+E+L A ++ +HRDL N+L+ + K+ DFGL R D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR---DI 289
Query: 750 GKHSIETRLAGTF---GYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ S TF ++APE TT DV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 47/172 (27%), Positives = 68/172 (39%), Gaps = 23/172 (13%)
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L I V R ++YLH IHRD+K NI + + DFG D +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE-------TQSEDSVH 808
AGT APE VD++S G++L E+ T +L E S+ +
Sbjct: 242 G-WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300
Query: 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
L+ RR + + F ID +LDE + +R+P RP
Sbjct: 301 LI--IRRSGTHPNEF--PIDAQANLDEIYIGLAKKS--------SRKPGSRP 340
|
Length = 391 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-07
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 600 RGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLGYC 657
RG FG VY G + +K+ AVK ++ A + K ++E L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 658 LDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
N LV EY+ G + H++ +E + +++ + +ALD YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-VKYISEVALALD------YLH---RH 123
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
IHRDLKP N+L+ ++ K+ DFGL ++
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 50/280 (17%)
Query: 598 LGRGGFGTVYKGELHD--GTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVRHRH 649
LG+G F +YKG L I E +VV + F ++++++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L G C+ +E ++V EY+ G L L +E+ L W +L +A +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFL--HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 710 HGLAHQSFIHRDLKPSNILL---GDDMR----AKVADFGLVRLAPDNGKHSIETRLAGTF 762
+ +H ++ NIL+ G + K++D G+ + R+
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERIP--- 169
Query: 763 GYLAPEYAVTGRV--TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820
++APE G+ T D +SFG L+E+ + + + S +++ H
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE--PLSTLSSSEKERFYQDQHRLP 226
Query: 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
+ + +A+L C +P +RP
Sbjct: 227 -----------------MPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-06
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 42/207 (20%)
Query: 232 VIQNMTSLTQLWLHGNSFTGPL-PDLSGLSSLQDFSVRDNQLTGIVPSSLVNL-HSLAVV 289
N + + + L G + +G + + L +Q ++ +NQL+G +P + SL +
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
NL+NN F G P+ + P N LD + G + + S+
Sbjct: 124 NLSNNNFTGSIPRGSIP---------NLETLDLSNNMLSGEIPNDIGSFSSLKV------ 168
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
D GGN+ L G I ++ + LTSL L L+ N+L G
Sbjct: 169 ----------------LDLGGNV---------LVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 410 IPKELTTLPSLEMLDVSNNHLFGKVPN 436
IP+EL + SL+ + + N+L G++P
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPY 230
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 19/60 (31%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 90 SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148
+L L++ N+LT + GL +L+ + NN TS+ + F GL SL+++ L N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 3e-06
Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ ++L N L+ F L +L+ L LSGN LT P+ + LPSL LD+S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 43/247 (17%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEF 635
S ++ ++ L + T+ + +G+G +G VYK DG+ AVK ++ ++ E
Sbjct: 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE---EI 65
Query: 636 KSEIAVLTKV-RHRHLVGLLG--YCLD---GNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
++E +L + H ++V G Y D G + LV E G+++ + +GL
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGL-- 118
Query: 690 LEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
L +RL I G+++LH + IHRD+K +NILL + K+ DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGV- 174
Query: 744 RLAPDNGKHSIETRL-----AGTFGYLAPEYAVTGR-----VTTKVDVFSFGVILMELIT 793
TRL GT ++APE + + DV+S G+ +EL
Sbjct: 175 ------SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 794 GRKALDE 800
G L +
Sbjct: 229 GDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 43/200 (21%), Positives = 83/200 (41%), Gaps = 35/200 (17%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN 122
+ + + + IE +LP L +L +L L++ N L+ LS LS+L + N
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGN 196
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
+ +P + L++L+ + L NS + SL + L + + +P+ +G
Sbjct: 197 KISDLP-PEIELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLELSNNKLE-DLPESIG 252
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
S+++TL L+ S++ + ++T+L +L
Sbjct: 253 NL-------------------------SNLETLDLSN-----NQISSISSLGSLTNLREL 282
Query: 243 WLHGNSFTGPLPDLSGLSSL 262
L GNS + LP ++ L L
Sbjct: 283 DLSGNSLSNALPLIALLLLL 302
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 39/197 (19%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 606 VYKGELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664
+YKG + ++ ++ + K + ++EI L ++ +++ + G+ +D + L
Sbjct: 36 IYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 665 ----LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
L+ EY +G L L K+ L + +L +A+D +G+ L+ + + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLY--KYTNKPYK 147
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA--VTGRVTTK 778
+L + L+ ++ + K+ GL ++ ++ Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN-----FMVYFSYKMLNDIFSEYTIK 202
Query: 779 VDVFSFGVILMELITGR 795
D++S GV+L E+ TG+
Sbjct: 203 DDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 595 ENVLGRGGFGTVYKGEL---HDGTKIAVKRMES----AVVSE----KGFAEFKSEIAVLT 643
+ ++G GGFG VY+ + H AV ++E+ +V E + +IA+
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYD-IDKIALWK 75
Query: 644 KVRHRHLVGLLGY--CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL--TIA 699
+ + +G+ Y C + Y ++ L + + N KE + ++L I
Sbjct: 76 NIHNIDHLGIPKYYGCGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIM 132
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH---SIET 756
D+ +EY+H H D+KP NI++ + R + D+G+ +GKH S E
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 757 R--LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR----KALDETQSEDSVHLV 810
+ GT Y + VT + D+ S G +++ G K +
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW-AGIKLPWKGFGHNGNLIHAAKC 248
Query: 811 TWFRRMHINKDTFRKAIDRTIDLDEETLASIS 842
+ +R+H K + A ++ I E + +S
Sbjct: 249 DFIKRLHEGKIKIKNA-NKFIYDFIECVTKLS 279
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 2/67 (2%)
Query: 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434
+NL N +G+I + +L L LS N L+G IP ++ + SL++LD+ N L GK+
Sbjct: 123 LNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 435 PNFRQNV 441
PN N+
Sbjct: 181 PNSLTNL 187
|
Length = 968 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 36/176 (20%), Positives = 54/176 (30%), Gaps = 29/176 (16%)
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
+ L + LH A K NILL D K+ G V S
Sbjct: 22 VCLQCLGALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE--QSRPDP 68
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS-EDSVHLVTWFRRM 816
++APE T K D++S G+ L E + L + E S L M
Sbjct: 69 Y-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYE--LPYNEERELSAILEILLNGM 121
Query: 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
D ++ + + C +R P +R H + +L
Sbjct: 122 P-ADDPRDRSNLEG-VSAARSFEDFMRL------CASRLPQRREAANHYLAHCRAL 169
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 67/328 (20%), Positives = 109/328 (33%), Gaps = 40/328 (12%)
Query: 487 NSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKIT 546
++++ K+ S + + A S + + + +
Sbjct: 4 HTDSSKVSDSNINLGYEAI--------------FSLTGGTDTSDSKDTTGDKFDDC-DEL 48
Query: 547 VTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTV 606
VT S P E S V ++ + L G G V
Sbjct: 49 GDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEV 108
Query: 607 YKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663
+ H K+ VK AV K EI +L + HR ++ L+ +
Sbjct: 109 FVCTKHGDEQRKKVIVK----AVTGGK---TPGREIDILKTISHRAIINLIHAYRWKSTV 161
Query: 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723
+V MP+ + + PL + +TI + + YLHG + IHRD+K
Sbjct: 162 CMV---MPK---YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVK 212
Query: 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL---APEYAVTGRVTTKVD 780
NI L + A + DFG A H + G G L +PE K D
Sbjct: 213 TENIFLDEPENAVLGDFG---AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTD 269
Query: 781 VFSFGVILMELITGRKALDETQSEDSVH 808
++S G++L E+ L Q + S
Sbjct: 270 IWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
L+PL + +A + ++Y+HG + IHRD+K N+L+ + DFG A
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILME 790
+ +AGT APE T VD++S G+++ E
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLG 655
+G+G +G V+K +G+K AVK ++ ++ E ++E +L + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPNVVKFYG 82
Query: 656 Y-----CLDGNERLLVYEYMPQGT---LSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+G++ LV E G+ L + R E +P+ IA + +
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALM 135
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
L L IHRD+K +NILL + K+ DFG V + + T + GT ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG-VSAQLTSTRLRRNTSV-GTPFWMAP 193
Query: 768 EY-----AVTGRVTTKVDVFSFGVILMELITGRKALDE 800
E + + DV+S G+ +EL G L +
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 64/282 (22%), Positives = 118/282 (41%), Gaps = 51/282 (18%)
Query: 598 LGRGGFGTVYKGELHDGT-------------KIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
LGRG +Y G L+ K+ +K ++ + + A F++ +++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETA-SMMRQ 60
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
V H+H+V L G C+ E ++V E++ G L LF ++ + W + +A +A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPW--KFKVAKQLAS 116
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETR--LAGT 761
+ YL + +H ++ NILL + + + F ++L+ ++ +R
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVER 171
Query: 762 FGYLAPEYAVTGRV-TTKVDVFSFGVILMEL-ITGRKAL-DETQSEDSVHLVTWFRRMHI 818
++APE + + D +SFG L E+ G L D+T +E
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------------- 217
Query: 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
K+ F + + + LA DL HC +P QRP
Sbjct: 218 -KERFYEGQCMLVTPSCKELA------DLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 6e-05
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 44/218 (20%)
Query: 601 GGFGTVY--KGELHDGT-KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
G FG V K H T K+ V++ ++ K F + + L K + + + L Y
Sbjct: 27 GKFGKVSVLK---HKPTQKLFVQK----IIKAKNFNAIEPMVHQLMK-DNPNFIKLY-YS 77
Query: 658 LDG-NERLLVYEYMPQGTLSRHLFN--RKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +L+ +Y+ G L F+ +KE L E ++ I + + LH H
Sbjct: 78 VTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAE-VKK--IIRQLVEALNDLH--KH 128
Query: 715 QSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE----- 768
IH D+K N+L R + D+GL ++ + GT Y +PE
Sbjct: 129 N-IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPEKIKGH 181
Query: 769 -YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED 805
Y V+ D ++ GV+ EL+TG+ E + E+
Sbjct: 182 NYDVS------FDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 7e-05
Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 238 SLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
+L L L N T +PD GL +L+ + N LT I P + L SL ++L+ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 296 F 296
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 23/169 (13%)
Query: 634 EFKSEIAVLTKVRHRHLVGL--------LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE 685
+ ++EI L ++ H +++ + Y + +Y +M F+ K+
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA-----FDWKD- 262
Query: 686 GLKPLEW-TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+PL TR + L A VEY+H + IHRD+K NI L D + + DFG
Sbjct: 263 --RPLLKQTRAIMKQLLCA--VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA- 314
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
+ + + + + GT +PE D++S G+IL+++++
Sbjct: 315 MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 17/61 (27%), Positives = 31/61 (50%), Gaps = 1/61 (1%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
+L+ + +N T +P FKGL +L+ + L N+ S + PE+ L+ +G N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59
Query: 173 I 173
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|185285 PRK15387, PRK15387, E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 5e-04
Identities = 97/352 (27%), Positives = 140/352 (39%), Gaps = 109/352 (30%)
Query: 25 QSSSDAAAMQALKTSLGNPASL------GWTDPDPCKWKHIQ--CSPSNRVTRIQIGGQN 76
+S AA +Q ++ L N ++ G T C HI P N +T +
Sbjct: 184 ESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLP----- 238
Query: 77 IEGTLPKEL-------NSLSSLTVL-------EVMKNKLTGQIPSL-SGLSSL------- 114
LP EL N L+SL VL + N LT +P+L SGL L
Sbjct: 239 ---ALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQL 294
Query: 115 ----------QEVLFDDNNFTSVPS---------DFFKGLTSLQTISLDYNSFDSWVIPE 155
QE+ DN S+P+ + LTSL T+
Sbjct: 295 TSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLP------------- 341
Query: 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215
+GLQ S + N ++P T+P ++ A+N +P S ++ L
Sbjct: 342 -----SGLQELSVSD-NQLASLP------TLPSELYKLWAYNNRLTSLPAL--PSGLKEL 387
Query: 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDL-SGLSSLQDFSVRDNQLTG 274
++G + S + V+ + L +L + GN T LP L SGL SL SV NQLT
Sbjct: 388 IVSGNRLTS-----LPVLP--SELKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLTR 436
Query: 275 IVPSSLVNLHSLAVVNLTNNLFQGQT----------PKFNSP-VRFDMAKGS 315
+ P SL++L S VNL N +T P ++ P +RFDMA S
Sbjct: 437 L-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 487
|
Length = 788 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 28/146 (19%)
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVL 118
S R+ + + G +P++L SLS L L++ +NKL+G+IP LS L +
Sbjct: 470 DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
Query: 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
N + F + L + L N ++G IP
Sbjct: 530 LSHNQLSGQIPASFSEMPVLSQLDLSQN-------------------------QLSGEIP 564
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIP 204
LG + L+ ++++ N L G +P
Sbjct: 565 KNLGN--VESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 7e-04
Identities = 13/42 (30%), Positives = 18/42 (42%), Gaps = 5/42 (11%)
Query: 26 SSSDAAAMQALKTSLGNP---ASLGW--TDPDPCKWKHIQCS 62
+ D A+ A K+SL A W + DPC W + C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 17/37 (45%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 394 TSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
T+L L LS N++T +P L+ LP+LE LD+S N +
Sbjct: 1 TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 37/125 (29%), Positives = 55/125 (44%), Gaps = 15/125 (12%)
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDM------RAKVADFGLVRLAPDN 749
I ++Y H H +H DLKP NIL+ D + RA D VR+
Sbjct: 236 IIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 750 G----KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED 805
G +HS T + T Y +PE + D++S G I+ EL TG+ D + +
Sbjct: 294 GCCDERHS-RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352
Query: 806 SVHLV 810
+HL+
Sbjct: 353 HLHLM 357
|
Length = 467 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 28/87 (32%), Positives = 36/87 (41%), Gaps = 16/87 (18%)
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
Y +D + L+V EY+ G L LK R + +V R V LH
Sbjct: 67 YDVDPDNGLIVMEYIE-GEL-----------LKDALEEARPDLLREVGRLVGKLH---KA 111
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL 742
+H DL SNI+L R DFGL
Sbjct: 112 GIVHGDLTTSNIILSGG-RIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 590 NNFSEENVLGRGGFGTVYK------GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+N LG G FG V + G+ + ++AVK ++++ +++ A SE+ +L+
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREA-LMSELKILS 96
Query: 644 KV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKE 684
+ +H+++V LLG C G L++ EY G L L + E
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.003
Identities = 14/39 (35%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275
T+L L L N T LP LS L +L+ + N++T +
Sbjct: 1 TNLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKITDL 38
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 27/115 (23%), Positives = 42/115 (36%), Gaps = 14/115 (12%)
Query: 635 FKSEIAVLTKVRHRHLVG--LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
+ E+A+L + + L +L L+ E++ TL KE+
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED------- 90
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
IA +A + LH L H DL P NIL+ D + D+ P
Sbjct: 91 -----IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 947 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.64 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.95 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.91 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.86 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.86 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.39 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-82 Score=802.67 Aligned_cols=785 Identities=28% Similarity=0.424 Sum_probs=453.2
Q ss_pred CChHHHHHHHHHHHHcCCCCC--CCCC-CCCCCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcc
Q 002255 25 QSSSDAAAMQALKTSLGNPAS--LGWT-DPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKL 101 (947)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~--~~w~-~~d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l 101 (947)
..+.|++||++||+++.++.. .+|+ ..|||.|.||+|+..++|+.|+|++++++|.+++.|..+++|+.|+|++|++
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 356899999999999976643 3786 4689999999998888999999999999999999999999999999999999
Q ss_pred cCcCC-C-CCCCCCCcEEecCCCcCCC----------------------CCcccccCCCCCcEEeccCCCCCCCCCcccc
Q 002255 102 TGQIP-S-LSGLSSLQEVLFDDNNFTS----------------------VPSDFFKGLTSLQTISLDYNSFDSWVIPESL 157 (947)
Q Consensus 102 ~~~~p-~-~~~l~~L~~L~L~~n~l~~----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~ 157 (947)
++.+| . +.++++|++|+|++|++++ ..|..++++++|++|+|++|.+.+ .+|..+
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~ 184 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-KIPNSL 184 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc-cCChhh
Confidence 88777 3 4466666666666666554 334445555556666665555543 455555
Q ss_pred cCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCCCCCCc-------
Q 002255 158 KDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGS------- 229 (947)
Q Consensus 158 ~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~------- 229 (947)
+++++|++|+|++|++++.+|..++ .+++|++|+|++|++++.+|..++. .+|+.|++++|.+.......
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 262 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELG--QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHc--CcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence 5555555555555555555555554 4555555555555555555555443 45555555555443222111
Q ss_pred --------------hhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCC
Q 002255 230 --------------VAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294 (947)
Q Consensus 230 --------------~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N 294 (947)
+..+.++++|+.|+|++|.+++.+|. +.++++|++|++++|.+++.+|..+..+++|+.|+|++|
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 342 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCC
Confidence 11223334444444444444443332 333444444444444444444444444444444444444
Q ss_pred cccccCCCCCCCcc-cc-cccCCC---------------CcccCcCCCcCCCcc-----------------ceee-----
Q 002255 295 LFQGQTPKFNSPVR-FD-MAKGSN---------------SFCLDDAGVACDGRV-----------------NVLL----- 335 (947)
Q Consensus 295 ~l~g~~p~~~~~~~-~~-~~~~~~---------------~~~~~~~~~~~~~~~-----------------~~~~----- 335 (947)
.++|.+|..+.... +. +....| ...++...+.+.+.. +.+.
T Consensus 343 ~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~ 422 (968)
T PLN00113 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422 (968)
T ss_pred CCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECCh
Confidence 44444443221110 00 000000 000011111000000 0000
Q ss_pred --ecccccCCh------------------hhhhccCCCC------CCC-------------CCCCCCc---ccCCCCcee
Q 002255 336 --SIVKSVGYP------------------AVLAESWKGN------NPC-------------NSDWKGV---SCDAGGNIT 373 (947)
Q Consensus 336 --~~~~~l~~~------------------~~l~~~~~~~------~~~-------------~~~~~~~---~~~~~~~L~ 373 (947)
..++.+..+ ..+....... .|. ...+.+. .+....+|+
T Consensus 423 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~ 502 (968)
T PLN00113 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELM 502 (968)
T ss_pred hHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccC
Confidence 000000000 0000000000 000 0001111 112234566
Q ss_pred EEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccce----eeecCCCC
Q 002255 374 VVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV----IVKTDGNP 449 (947)
Q Consensus 374 ~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~----~~~~~~n~ 449 (947)
.|+|++|.+.|.+|..++++++|+.|+|++|+++|.+|..+..+++|+.|||++|+++|.+|...... .+.+.+|+
T Consensus 503 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~ 582 (968)
T PLN00113 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582 (968)
T ss_pred EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence 67777777777777777777777777777777777777777777777777777777777777543322 33455555
Q ss_pred CCCCCCCCCCCCC----CCCCCCCCCCCCC-CCCCCCCCCCCCCCcceEEEeehhHHHHHHHHHhheeEEEEeeccCCCC
Q 002255 450 DIGKDSSSFTPKS----PPGSSPTPPGGDS-GGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRV 524 (947)
Q Consensus 450 ~~~~~~~~~~~~~----~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~i~~~v~gvv~~~~i~~l~~~~~~r~r~~~~~~ 524 (947)
..+..|....... .....+.-.+... .....+....+......++++++++++++++++++++ ++|+|++....
T Consensus 583 l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 661 (968)
T PLN00113 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFV-FIRGRNNLELK 661 (968)
T ss_pred ceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHH-HHHhhhccccc
Confidence 5443332110000 0000000000000 0000000011111111222222222222222222222 22222111100
Q ss_pred CCCCceeecCCCCCCCCceeEEeeccccCCCCCCccccCCCCCCCcceec-CCceeecHHHHHHHhcCCCcCceecccCc
Q 002255 525 QSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVE-AGSMVISIQVLRNVTNNFSEENVLGRGGF 603 (947)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~lg~G~~ 603 (947)
+.. ...+ ..+ ..... .....+ ..+.+...|...++||+|+|
T Consensus 662 ~~~---------~~~~---------------~~~-----------~~~~~~~~~~~~---~~~~~~~~~~~~~~ig~G~~ 703 (968)
T PLN00113 662 RVE---------NEDG---------------TWE-----------LQFFDSKVSKSI---TINDILSSLKEENVISRGKK 703 (968)
T ss_pred ccc---------cccc---------------ccc-----------ccccccccchhh---hHHHHHhhCCcccEEccCCC
Confidence 000 0000 000 00000 000112 22334456888899999999
Q ss_pred eEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCchhhhhhcc
Q 002255 604 GTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR 682 (947)
Q Consensus 604 g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~ 682 (947)
|.||+|+. .+|..||||++..... ....|++++++++|||||+++++|.+++..++||||+++|+|.++++
T Consensus 704 g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-- 775 (968)
T PLN00113 704 GASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775 (968)
T ss_pred eeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--
Confidence 99999987 4789999999864321 11346889999999999999999999999999999999999999984
Q ss_pred cccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccc
Q 002255 683 KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762 (947)
Q Consensus 683 ~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 762 (947)
.++|.++.+++.||++||+|||+.+.++|+||||||+||+++.++.+++. ||....... .....||+
T Consensus 776 ------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~ 842 (968)
T PLN00113 776 ------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISS 842 (968)
T ss_pred ------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccc
Confidence 27899999999999999999997656899999999999999999988875 665543322 12236889
Q ss_pred cccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCC-hhcHHHH
Q 002255 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD-EETLASI 841 (947)
Q Consensus 763 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 841 (947)
+|+|||++.+..++.++|||||||++|||+||+.||+.... .....+.|.+.... .......+++.+... .......
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccchhheeCccccCCCCccHHHH
Confidence 99999999999999999999999999999999999954332 23445566554322 223444555544211 2234455
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 842 STVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 842 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.++.+++.+|++.+|++||+|.||++.|+++..
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 678899999999999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=451.51 Aligned_cols=291 Identities=49% Similarity=0.843 Sum_probs=252.2
Q ss_pred CceeecHHHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEE
Q 002255 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655 (947)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 655 (947)
....|++.+++.+|++|...++||+|+||.||+|.+.+|+.||||++....... ..+|.+|+.++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456789999999999999999999999999999999999999999887653221 456999999999999999999999
Q ss_pred EEEeCC-eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 656 YCLDGN-ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 656 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
||.+++ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.++++||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 599999999999999999875432 6899999999999999999999987789999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
+||+|||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+++|++||+.+.+...+.....++.|+.
T Consensus 216 aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 999999999766541 1111111179999999999999999999999999999999999999998776666677999997
Q ss_pred HhhcChhhHHHHhhccCCCChhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETL-ASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
..... ..+.+++|+.+....... .....+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 295 ~~~~~-~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEE-GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHC-cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 66653 388999999876333332 57777999999999999999999999999986544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=399.92 Aligned_cols=260 Identities=34% Similarity=0.553 Sum_probs=214.6
Q ss_pred CcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-eeEEEEEecC
Q 002255 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-ERLLVYEYMP 671 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~ 671 (947)
...+.||+|+||+||+|.++....||||++.....+....++|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 344669999999999999984444999999877656555789999999999999999999999999887 7999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC-eeecCCCCCcEEEcCCC-cEEEeecCcceecCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS-FIHRDLKPSNILLGDDM-RAKVADFGLVRLAPDN 749 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~~ 749 (947)
+|+|.++++.. ....+++..++++|.|||+||+|||+ .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999874 22569999999999999999999997 55 99999999999999998 9999999999876543
Q ss_pred CCcceeecccccccccCccccc--cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAV--TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....... ... .++
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~-------------~v~ 259 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VAS-------------AVV 259 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHH-------------HHH
Confidence 2 1223368999999999999 5689999999999999999999999998765411 111 111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
..... +..+......+..++.+||+.||.+||++.+++..|+.+.....
T Consensus 260 ~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 260 VGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred hcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11111 12122255678899999999999999999999999999876444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.86 Aligned_cols=205 Identities=32% Similarity=0.526 Sum_probs=186.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|...+.||.|+||+||+|+++ ++..||||.+.+.....+..+.+..|+++++.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999875 6899999999888767778888999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC------CcEEEeecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------MRAKVADFG 741 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~------~~~kl~DfG 741 (947)
|||.||+|.++++.++ .+++.+...++.|+|.||++||+ ++||||||||+|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999998764 38899999999999999999996 899999999999999865 569999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCcc
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 804 (947)
+||...+. ......+|++.|||||+++..+|+.|+|+||+|+|+|++++|+.||+.....
T Consensus 161 fAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 161 FARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 99988653 3445689999999999999999999999999999999999999999866543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=376.74 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=209.4
Q ss_pred CcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-eeEEEEEec
Q 002255 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-ERLLVYEYM 670 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~ 670 (947)
+....||+|..|+|||+.++ +++.+|+|.+... .+....+++.+|++++++.+||+||+++|+|.... +..++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 44678999999999999876 6888999999443 46677889999999999999999999999999988 599999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
++|+|++++... +.+++....+|+.+|++||.|||. .++||||||||+|||++..|+|||||||.++...+.
T Consensus 161 DgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999998553 348889999999999999999996 489999999999999999999999999999877553
Q ss_pred CcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCc--cchhhHHHHHHHhhcChhhHHHHhh
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS--EDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ .+. -+.+..+++
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-------------~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-------------FELLCAIVD 296 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH-------------HHHHHHHhc
Confidence 44567999999999999999999999999999999999999999976411 111 122344444
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....-+.. ...+++.+++..||++||.+||+++|+++
T Consensus 297 ~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 322211111 35567999999999999999999999977
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=367.89 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=216.1
Q ss_pred cCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEE-EEEeCCe-eEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG-YCLDGNE-RLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 666 (947)
.+|++.++||+|.||+|||+. ..+|..||.|.++....+.+..+++..|+.++++|+|||||++++ .+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888999999999999995 568999999999988888888999999999999999999999999 4555555 7999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC-CeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||.+|+|.+.+...+... +.+++.++++++.|++.||.++|+..++ -|+||||||.||+++.+|.||++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999997765543 6799999999999999999999974322 388999999999999999999999999998
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+..- ..+ .++
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L-------------~~K 239 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSL-------------CKK 239 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHH-------------HHH
Confidence 86643 234568999999999999999999999999999999999999999987531 111 112
Q ss_pred HhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 826 AIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 826 ~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
+-...+ ++.+ ......+..||..|+..||+.||+...++..+..
T Consensus 240 I~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 IEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 222222 2222 3455678899999999999999997666665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=380.36 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=214.2
Q ss_pred HhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChH-----HHHHHHHHHHHHHcCCCCCcceEEEEEEeCC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEK-----GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 661 (947)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+...... ....+.+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 56788899999999999999995 56899999999987543321 2234679999999999999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC---CcEEEe
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVA 738 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~ 738 (947)
..|+||||++||+|.+++...+ .+.+.....+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999986643 36677778899999999999997 899999999999999765 789999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCc---CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV---TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~ 815 (947)
|||+|+..+.. .....++|||.|.|||++.++.+ ..++|+||+|||||-+++|.+||.+...+
T Consensus 322 DFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----------- 387 (475)
T KOG0615|consen 322 DFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----------- 387 (475)
T ss_pred ccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-----------
Confidence 99999988642 33456899999999999987643 34889999999999999999999765432
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCC
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASI-STVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKP 878 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 878 (947)
......+....+.+.+..+..+ ++..+||.+||..||++||++.|+++ ++|..
T Consensus 388 ----~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~------hpW~~ 441 (475)
T KOG0615|consen 388 ----PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN------HPWFK 441 (475)
T ss_pred ----ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc------Chhhh
Confidence 1123445566666665555544 45679999999999999999999876 56664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=389.82 Aligned_cols=249 Identities=27% Similarity=0.485 Sum_probs=215.5
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+|...++||+|||+.||+++. .+|+.||+|++.+.. ......+.+.+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999987 789999999998754 34455678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|+|++++|.+++.++ +++++.++..+.+||+.||.|||+ .+|+|||||-.|++++++.+|||+|||||....
T Consensus 98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999988643 458999999999999999999997 889999999999999999999999999999886
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
..+.. ....+|||-|.|||++.....+..+||||+|||+|-|+.|++||+...- .+.+.++.
T Consensus 170 ~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------------kety~~Ik 231 (592)
T KOG0575|consen 170 YDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------------KETYNKIK 231 (592)
T ss_pred Ccccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----------------HHHHHHHH
Confidence 54332 3457999999999999999999999999999999999999999986542 23344444
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.++. ....+..+||.++|+.+|.+||++.+|+.
T Consensus 232 ~~~Y~~P~---~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 LNEYSMPS---HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCccccc---ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44443322 34456789999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=384.16 Aligned_cols=254 Identities=33% Similarity=0.535 Sum_probs=212.6
Q ss_pred CcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
...+.||+|.||.||.|.++....||+|.++....+ .++|.+|+++|++|+|+|||+++|+|..++..+||||||+.
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345789999999999999997779999999875333 36788999999999999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.++|.... ...+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+||...++ ..
T Consensus 286 GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y 358 (468)
T KOG0197|consen 286 GSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EY 358 (468)
T ss_pred CcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCC-ce
Confidence 99999997622 2458889999999999999999997 89999999999999999999999999999955443 23
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
.......-+..|.|||.+..+.++.|+|||||||+||||+| |+.|+.+....+ +-+.+++..
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~~~le~Gy 421 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VLELLERGY 421 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HHHHHhccC
Confidence 33333344678999999999999999999999999999999 888887765332 333444444
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.. +.+..++..+.+++..||+.+|++|||+..+...|+.+..
T Consensus 422 Rl-p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 RL-PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred cC-CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 32 2233456678999999999999999999999988887654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=396.88 Aligned_cols=264 Identities=28% Similarity=0.507 Sum_probs=220.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+.+....+.||+|.||+||+|+.. +...||||.++... +.+..++|++|++++..++|||||+++|+|.+++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345556788999999999999754 34579999998663 55578999999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCC---------CcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGL---------KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
.++|+|||..|||.++|..+..... .+++..+.+.||.|||.|++||-+ +.+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence 9999999999999999976543222 238889999999999999999996 8899999999999999999
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~ 812 (947)
.|||+|||++|.....+.+.......-..+|||||.++.++|+.++|||||||+|||+++ |+.||.+...++.+..+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i-- 718 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI-- 718 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH--
Confidence 999999999997766555554444455789999999999999999999999999999999 88999887654433222
Q ss_pred HHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
-++.+ -+.+...+.+++.|+..||+.+|++||+++||...|+...+
T Consensus 719 --------------~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 --------------RAGQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --------------HcCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11111 12334556678999999999999999999999999987654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=359.36 Aligned_cols=244 Identities=27% Similarity=0.448 Sum_probs=204.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.++||+|+||.||.++.+ +++.+|+|++++.... ..+.+...+|..++.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367999999999999999999654 6899999999877543 34678899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
+||+.||.|..+|.+. ..+++..+.-++..|+.||.|||+ ++||||||||+|||+|++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999653 348888888889999999999996 89999999999999999999999999999965
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
...+. ....++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...... ...+.+
T Consensus 176 ~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~~I 237 (357)
T KOG0598|consen 176 LKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYDKI 237 (357)
T ss_pred ccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHHHH
Confidence 44332 234479999999999999999999999999999999999999999875532 223333
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 860 (947)
....+...+. -...+..+++.++++.||++|.
T Consensus 238 ~~~k~~~~p~--~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPPG--YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCCc--cCCHHHHHHHHHHhccCHHHhc
Confidence 3333221111 1234577999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=348.65 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=210.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|+...++|+|+||.|||++.+ +|+.||||++.....++...+-.++|++++++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888899999999999999876 69999999998776556666778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||+..-| +.|.... ..++.....++++|++.|+.|+|+ +++|||||||+|||++.+|.+|+||||+|+....
T Consensus 82 ~~dhTvL-~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVL-HELERYP----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHH-HHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9977544 4443333 237788889999999999999996 8999999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.+ ...+.++.|.+|+|||.+.+ ..|...+||||+||++.||++|.+-|.+..+-++...+...-.-.. .....++
T Consensus 154 pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~--prhq~iF 229 (396)
T KOG0593|consen 154 PG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI--PRHQSIF 229 (396)
T ss_pred Cc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC--HHHHHHh
Confidence 33 34567889999999999987 6899999999999999999999999988776555544332211111 1112222
Q ss_pred hcc-----CCCC----h-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRT-----IDLD----E-----ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~-----~~~~----~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... +.++ . ........+.++++.|++.||++|++.++++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 211 0000 0 01122235679999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=364.82 Aligned_cols=270 Identities=24% Similarity=0.354 Sum_probs=219.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCC-ee
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN-ER 663 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 663 (947)
.+.++|...++||.|.||.||+|+. .+|+.||||+++....+-++ ..-.+|++.+++++ |||||++.+++.+.+ ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4567899999999999999999965 47999999999887555332 23468999999998 999999999999887 99
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||| ..+|++++.++. +.++...+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccc
Confidence 9999999 569999997763 679999999999999999999995 99999999999999999999999999999
Q ss_pred eecCCCCCcceeecccccccccCccccc-cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
|....... .+.++.|.+|+|||++. .+.|+.+.||||+|||++|+.+=++-|.+..+.|++..+..+-.....+.+
T Consensus 158 Rev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 158 REVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 97755332 35678999999999875 567999999999999999999999999988877766655555444333322
Q ss_pred HH-HHhhccCCC----------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 823 FR-KAIDRTIDL----------DEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 823 ~~-~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.. ..+...+.+ .........+.++++.+|+++||++|||++++++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 22 111111111 11112345678899999999999999999999884
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=363.60 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=215.9
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccc-cChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
..+|..++.||+|+|++|++|+. ++++.||||++.+.. ..+...+-+..|-.+|.+| .||.|++++..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46789999999999999999965 479999999987654 3344456678899999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|+||+++|+|.+++.+.+ .+++.....+|.+|+.||+|||+ +|||||||||+|||+|+|+++||+|||.|+.
T Consensus 152 vLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999997653 48888888999999999999997 8999999999999999999999999999997
Q ss_pred cCCCCCc---------ce--eecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 746 APDNGKH---------SI--ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 746 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
+.+.... .. ...++||..|.+||++.....+..+|+|+||||+|+|+.|.+||.+..+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----------- 292 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----------- 292 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----------
Confidence 7543222 11 1458999999999999999999999999999999999999999987542
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
...+.++++-.+.+++.-. +.+.+|+++.|..||.+|++.++|.+.
T Consensus 293 -----yliFqkI~~l~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 293 -----YLIFQKIQALDYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HHHHHHHHHhcccCCCCCC---HHHHHHHHHHHccCccccccHHHHhhC
Confidence 2346667776666554433 456799999999999999999888763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.16 Aligned_cols=270 Identities=25% Similarity=0.331 Sum_probs=213.4
Q ss_pred hcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 665 (947)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++......+....-..+||.+|++|+||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567778899999999999996 46899999999988765666667778999999999999999999998876 68999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|+|||+. ||.-++... ...++..++..++.|+++||+|||+ ++|+|||||.+|||||.+|.+||+|||||++
T Consensus 196 VFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 9999965 777777442 2458999999999999999999997 8999999999999999999999999999998
Q ss_pred cCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
+...... ..+..+-|.+|+|||.+.+. .|+.++|+||.||||.||++|++.|.+..+.++.+.+..+-....+..+-.
T Consensus 268 y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 268 YTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred ccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 8665433 24556789999999998874 699999999999999999999999998887666665543333322221110
Q ss_pred ------HHhhccCC----CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 ------KAIDRTID----LDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ------~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+.+... +.+..........+|+..+|..||++|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00110000 00001122235678999999999999999998876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=349.30 Aligned_cols=262 Identities=23% Similarity=0.411 Sum_probs=212.9
Q ss_pred cCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|+..++||.|..++||+|+ .+.++.||||++.-+.++.. .+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 578899999999999999996 45789999999988765554 7899999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||.+|++.+++......+ +++..+..|.+++++||.|||. +|.||||||+.||||+.+|.|||+|||.+..+.+
T Consensus 105 fMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999998766544 8888999999999999999996 8999999999999999999999999998765544
Q ss_pred CCCcc-ee-ecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 749 NGKHS-IE-TRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 749 ~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.+... .. ..++||+.|||||+++. ..|+.|+||||||++..||.+|+.||....+.....+ ..+... ...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~p---p~~- 252 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDP---PTL- 252 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCC---CCc-
Confidence 44222 12 45789999999999654 4699999999999999999999999998776443211 000000 000
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.-..++ .+........+.+++..||+.||++|||++++++
T Consensus 253 --~t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 --LTSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --ccccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000011 1222333447889999999999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.54 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=214.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+++.+.+.+|+++++.++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999765 68899999999888888889999999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+.| +|..++... ..++++.+..++.+++.||.|||+ .+|+|||+||+|||++..|.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9966 999999653 348999999999999999999997 8999999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
. ..+.+...|||.|||||+..++.|+..+|+||+|||+||+++|++||.... ..+++ +.++.
T Consensus 153 ~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv-------------~~I~~ 214 (808)
T KOG0597|consen 153 N--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLV-------------KSILK 214 (808)
T ss_pred C--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHH-------------HHHhc
Confidence 3 456778899999999999999999999999999999999999999997532 11111 12222
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... .+......+..++...+.+||.+|.+..+++.
T Consensus 215 d~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCC---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2111 12245567889999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.88 Aligned_cols=268 Identities=26% Similarity=0.473 Sum_probs=215.3
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
++-+...+.+.+.+.||+|.||+||+|.|. ..||||++.....+.+..+.|+.|+.++++-+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 334445566778899999999999999997 479999999887788889999999999999999999999999999888
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.+|+.||+|.+|+.+++... ..++..+...||+|||+|+.|||. ++|||||||..||++.+++.|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999998765 348889999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccC---CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
+..-..-..........|...|||||+++.. +|++.+||||||+|+|||+||..||.....+..+..+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-------- 606 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-------- 606 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec--------
Confidence 7533211111112234577899999999754 68999999999999999999999998433322221110
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
++.+. .+..........++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 607 rG~l~------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 RGYLM------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccccC------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11000 00111122344578899999999999999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=328.45 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=212.5
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.+|...+++|+|.||.||+|+. ++|+.||||+++.....+.......+||+.++.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999964 579999999998876555556778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||+ .+|+..++++. ..+.-..+..++.++++|++|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 994 58988886543 568888999999999999999996 8999999999999999999999999999998876
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh-----
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT----- 822 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~----- 822 (947)
.... .+..+-|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+..+-++...+-.+-.....+.+
T Consensus 154 p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 154 PNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 5433 334478999999998876 46999999999999999999999888876654444333222211111111
Q ss_pred HHHHhh----ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 823 FRKAID----RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 823 ~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+.+.++ +.......-.....+..+|+.+++..||.+|++++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 1111111112334566899999999999999999999773
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.62 Aligned_cols=252 Identities=24% Similarity=0.419 Sum_probs=210.5
Q ss_pred HHhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.....|....+||+|..|.||.|. ..+++.||||++.... ....+-+.+|+.+|+..+|+|||++++.|..+++.|.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 345678889999999999999995 4578999999998663 3344678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|||||+||+|.+.+.. ..+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..
T Consensus 348 VMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 9999999999998844 238899999999999999999996 8999999999999999999999999999887
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
+..... .....+|||+|||||+.....|.+|+||||||++++||+.|++||-...+-....++.
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------------- 482 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------- 482 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh--------------
Confidence 755432 3455789999999999999999999999999999999999999997654432211110
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... -.........+.+|+.+||..|+++|++++|+++
T Consensus 483 -~ng~P~-lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 483 -TNGTPK-LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -hcCCCC-cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111111 1222334467889999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.18 Aligned_cols=238 Identities=28% Similarity=0.410 Sum_probs=208.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+.. ...+..+...+|..+++.+.||+++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999876 68899999997653 44566778899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||++||.|..++++.+ .++...+.-+|.||+.||+|||+ .+|++||+||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999997643 47888888999999999999997 899999999999999999999999999999875
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ....+|||.|+|||++....+..++|.|||||++|||+.|.+||....+. ..+.+++
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~KI~ 254 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEKIL 254 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHHHH
Confidence 52 34579999999999999999999999999999999999999999877642 3456677
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCC
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQR 859 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 859 (947)
...+.++..- .+.+.+|+.++++.|-.+|
T Consensus 255 ~~~v~fP~~f---s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKVKFPSYF---SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcccCCccc---CHHHHHHHHHHHhhhhHhh
Confidence 7777655443 3457899999999998888
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=360.53 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=209.5
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccC---hHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 662 (947)
..++|...+.||+|+||.|+.|.. .+|+.||+|++...... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999965 47899999977664221 133556778999999998 9999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEeecC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 741 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG 741 (947)
.++||||+.+|+|.+++..+ ..+.+.++.++++|++.|++|||+ ++|+||||||+|||++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999763 347778999999999999999997 899999999999999999 999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCC-cC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR-VT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
++..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++...
T Consensus 167 ~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---------------- 228 (370)
T KOG0583|consen 167 LSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---------------- 228 (370)
T ss_pred cccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----------------
Confidence 9987741 122345579999999999999877 86 789999999999999999999987332
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...++.+....+.++.... ..++..|+.+|+..+|.+|+++.+|++
T Consensus 229 ~~l~~ki~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 229 PNLYRKIRKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHHHhcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1223334444444433322 566889999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.95 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=200.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC--eeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--ERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 666 (947)
.++...+.||+|+||.||++... +|+..|||.+.... ....+.+.+|+.+|++++|||||+++|.....+ .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 34667789999999999999875 48999999987652 222677899999999999999999999865544 68999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecCccee
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRL 745 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~ 745 (947)
|||+++|+|.+++.+.+. .+++..+..+..||++||+|||+ ++||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999999966432 48999999999999999999997 89999999999999999 79999999999886
Q ss_pred cCC-CCCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 746 APD-NGKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 746 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
... ...........||+.|||||++..+. ...++||||+||++.||+||++||... .+.. .+ .+
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~---~~---------~~ 233 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEA---EA---------LL 233 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchH---HH---------HH
Confidence 653 11112234578999999999998643 345999999999999999999999864 1111 00 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
...... ..+.-+.....+..+++.+|++.+|++|||+.++++.-
T Consensus 234 ~ig~~~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 234 LIGRED--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHhccC--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111111 11122223445678999999999999999999998853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=364.71 Aligned_cols=266 Identities=27% Similarity=0.444 Sum_probs=207.6
Q ss_pred HhcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 660 (947)
..++|++.++||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 346899999999999999999964 235689999987542 344457789999999999 899999999988764
Q ss_pred -CeeEEEEEecCCCchhhhhhccccc------------------------------------------------------
Q 002255 661 -NERLLVYEYMPQGTLSRHLFNRKEE------------------------------------------------------ 685 (947)
Q Consensus 661 -~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 685 (947)
...++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4578999999999999998653210
Q ss_pred ---CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccc
Q 002255 686 ---GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762 (947)
Q Consensus 686 ---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 762 (947)
...++++.++..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++...............+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 01347888999999999999999996 899999999999999999999999999998654322222222345678
Q ss_pred cccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHH
Q 002255 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASI 841 (947)
Q Consensus 763 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (947)
.|+|||++.+..++.++|||||||++|||++ |..||......+. .. ....+.... ..+....
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~-------------~~~~~~~~~--~~~~~~~ 303 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC-------------QRLKDGTRM--RAPENAT 303 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH-------------HHHhcCCCC--CCCCCCC
Confidence 8999999988899999999999999999997 9999976443211 00 011111100 0111223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 842 STVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 842 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+.+++.+|++.||++||++.|+++.|+++.+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=368.97 Aligned_cols=258 Identities=26% Similarity=0.493 Sum_probs=220.9
Q ss_pred cCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
....+.++||.|.||.||+|+++- ...||||.++.. ..++...+|+.|+.+|.+++||||+++-|+.......++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 345678999999999999998762 356999999866 467778999999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|+|||++|+|+.+|+... ..+.+.+...++++||.|+.||-+ .++|||||.++||||+.+-.+||+|||++|.
T Consensus 708 iTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999997644 348999999999999999999996 8999999999999999999999999999998
Q ss_pred cCCCCCcceeecccc--cccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 746 APDNGKHSIETRLAG--TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 746 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
..++... ..+...| ..+|.|||.+..++++.++||||||+|+||.++ |.+||.+.... +
T Consensus 781 ledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----------------d 842 (996)
T KOG0196|consen 781 LEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------------D 842 (996)
T ss_pred cccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----------------H
Confidence 7664422 2222223 469999999999999999999999999999888 99999876533 3
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+.++..+.+ +.+.+++..+.+|+..||++|-.+||.+.+|+..|.++..
T Consensus 843 VIkaIe~gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 843 VIKAIEQGYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHHHHHhccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 44455555553 3445677889999999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.87 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=208.5
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
..|+..+.||+|.||.||+|.. ++++.||+|++.... .+.+.++++.|+.++.+++++||.++++.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4577789999999999999965 578999999997654 44557889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||.||++.+.+.... .+++....-+++++..|+.|||+ .+.+|||||+.|||+..+|.+|++|||.+-....
T Consensus 92 y~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999999985432 23556666788999999999997 8999999999999999999999999999887765
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.... ...++|||.|||||++....|+.|+||||||++.+||.+|.+|+.+..+.....++. +-..
T Consensus 164 ~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~P 228 (467)
T KOG0201|consen 164 TVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSAP 228 (467)
T ss_pred hhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCCC
Confidence 4332 256899999999999998899999999999999999999999999887754433221 0001
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+ .........+.+++..||+.+|+.||+++++++
T Consensus 229 P-----~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 P-----RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred C-----ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1 111233455889999999999999999999988
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=323.46 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=216.1
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
..+.|++.+.||+|.|+.||+... .+|+.+|+|++.....+....+++.+|+++-+.++|||||++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788889999999999999854 5799999999988777777889999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGla 743 (947)
+|+|.|++|..-+..+ ..+++..+-...+||+++|.|+|+ ++|||||+||+|+++.. .--+|++|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998776554 236777788899999999999997 89999999999999954 346999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
..... .......+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.+. ...+
T Consensus 161 i~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----------------~rly 221 (355)
T KOG0033|consen 161 IEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------------HRLY 221 (355)
T ss_pred EEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----------------HHHH
Confidence 98863 2345667999999999999999999999999999999999999999987432 2234
Q ss_pred HHHhhccCCCChhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDEETLA-SISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+....++.+...+. ..++..+|+++||..||++|.|+.|+++
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 5566666666654443 3345679999999999999999998876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.54 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=203.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
-.++|+.+.+||+|+||.||.|+-+ +|+.+|+|++++.. ....+.+.++.|-.+|....+|.||+++..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999754 79999999998875 344567889999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||++||++..+|... ..++...+...+.+++-|++-+|. .|+|||||||+|+|||..|++||+||||+.-
T Consensus 219 iMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999653 357888888888899999999995 8999999999999999999999999999842
Q ss_pred cCCC---------------------CCcc-----ee-------------------ecccccccccCccccccCCcCcccc
Q 002255 746 APDN---------------------GKHS-----IE-------------------TRLAGTFGYLAPEYAVTGRVTTKVD 780 (947)
Q Consensus 746 ~~~~---------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~D 780 (947)
.... .... .. ...+|||-|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 2110 0000 00 1257999999999999999999999
Q ss_pred cccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC
Q 002255 781 VFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ 858 (947)
Q Consensus 781 vwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~ 858 (947)
.||+|||+|||+.|.+||....+.+. +++++... +.++.+ .....+..|||.+|+. ||++
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T----------------~rkI~nwr~~l~fP~~-~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQET----------------YRKIVNWRETLKFPEE-VDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHHHhhhccCCCc-CcccHHHHHHHHHHhc-CHHH
Confidence 99999999999999999998776432 33333322 222222 2222567899999999 9999
Q ss_pred CCC
Q 002255 859 RPD 861 (947)
Q Consensus 859 RPs 861 (947)
|..
T Consensus 433 RLG 435 (550)
T KOG0605|consen 433 RLG 435 (550)
T ss_pred hcC
Confidence 996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=348.61 Aligned_cols=269 Identities=26% Similarity=0.400 Sum_probs=221.7
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
..+.+.+...+.++||+|-||.|..+....+..||||.++... ......+|.+|+++|.+++|||||+++|+|..++..
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3455667788899999999999999999988999999998764 445568999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++|+|||++|+|.+++....-.. +.-....+|+.||+.|++||.+ .++||||+.++|+|++.++++||+|||++
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccc
Confidence 99999999999999997653221 3444567799999999999997 79999999999999999999999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh--CCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
|-........+..+.+-..+|||+|.+.-++++.++|||+||+++||+++ ...||.....++.. +...
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~------- 754 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAG------- 754 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---Hhhh-------
Confidence 97777666777777788899999999999999999999999999999876 67888766543322 1111
Q ss_pred hHHHHhhcc-C-CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 822 TFRKAIDRT-I-DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 822 ~~~~~~~~~-~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
++++.. . .....+...+..+.+++.+||+.|-++||+++++...|++.
T Consensus 755 ---~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 ---EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111 0 01122334556788999999999999999999999988764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.85 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=211.4
Q ss_pred cCCCcCceecccCceEEEEEEEcC--C---cEEEEEEeccc-ccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD--G---TKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~--g---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++....++||+|+||.||+|+++. + ..||||..+.+ ........+|..|+++|++++|||||+++|++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999998753 2 23899998863 35677889999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++|||+|.||+|.++|..... .++..++..++.++|.||+|||+ +++|||||.++|+|++.++.+||+|||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999976442 48999999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcceee-cccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 744 RLAPDNGKHSIET-RLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 744 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+.... ..... .-.-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+
T Consensus 310 ~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---------------- 370 (474)
T KOG0194|consen 310 RAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---------------- 370 (474)
T ss_pred cCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----------------
Confidence 75431 11111 1134578999999999999999999999999999999 888998765321
Q ss_pred hHHHHh-hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 822 TFRKAI-DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 822 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
.+..+ ...+. ...+...+..+..++.+|+..+|++||+|.++.+.++.+.....
T Consensus 371 -v~~kI~~~~~r-~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 371 -VKAKIVKNGYR-MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -HHHHHHhcCcc-CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11112 22222 11122344567789999999999999999999999999876433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=351.44 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=210.8
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEeccc-ccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+-|..++.||+|+.|.|..|++ .+|+.+|||++.+. ..++.....+.+|+-+|+-+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4467889999999999999975 58999999999876 345555678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|.|++++..++ ++...++.+++.||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|....
T Consensus 92 Eyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999997653 48889999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
++ ......+|+|.|.|||++++..|+ .++||||.|||||.|+||+.||++... .. .+.++
T Consensus 164 ~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~-------------LLlKV 224 (786)
T KOG0588|consen 164 PG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RV-------------LLLKV 224 (786)
T ss_pred CC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HH-------------HHHHH
Confidence 53 233456999999999999999986 689999999999999999999985331 11 22223
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
-...+..+ .....+..+|+++|+..||++|.|+.||++.
T Consensus 225 ~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 QRGVFEMP---SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HcCcccCC---CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 33333322 2334567899999999999999999999883
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.60 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=214.0
Q ss_pred HhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
...+|++.+.||+|.||.|-+|. ...|+.||||.+++.. .+++..-.+++||++|..++||||+.++++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45678889999999999999996 4689999999998765 456667889999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||..+|.|++++..++ .+++.+..++++||+.|+.|+| ++++||||||.+|||+|.++++||+|||++-.
T Consensus 131 vMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999997654 4889999999999999999999 49999999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
+... .....++|+|-|.+||++.+.+|. +.+|-||+||+||.|+.|..||++.+... ..+
T Consensus 203 y~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~----------------lvr 263 (668)
T KOG0611|consen 203 YADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR----------------LVR 263 (668)
T ss_pred hccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH----------------HHH
Confidence 7553 234568999999999999998885 78999999999999999999998865321 122
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+-...+.-+ ..++...-||++||..+|++|-|..+|....+
T Consensus 264 QIs~GaYrEP----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 264 QISRGAYREP----ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HhhcccccCC----CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2222333211 22345668999999999999999999987553
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.62 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=209.8
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh------------HHHHHHHHHHHHHHcCCCCCcce
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE------------KGFAEFKSEIAVLTKVRHRHLVG 652 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~ 652 (947)
+...++|++.+.||+|.||.|-+|+.. +++.||||++.+..... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445688999999999999999999754 68999999997643221 12357899999999999999999
Q ss_pred EEEEEEe--CCeeEEEEEecCCCchhhhhhcccccCCCc-ccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 653 LLGYCLD--GNERLLVYEYMPQGTLSRHLFNRKEEGLKP-LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 653 l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
++++..+ .+..|||+|||..|.+...=. .++ +...++.+++++++.||+|||. ++||||||||+|+|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEE
Confidence 9999876 467899999999887743221 123 8899999999999999999997 899999999999999
Q ss_pred cCCCcEEEeecCcceecCCCC---CcceeecccccccccCccccccCC----cCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 730 GDDMRAKVADFGLVRLAPDNG---KHSIETRLAGTFGYLAPEYAVTGR----VTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
+++|+|||+|||.+....... ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999988663321 112223478999999999887632 3568999999999999999999997654
Q ss_pred ccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 803 SEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 803 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
. -+.+++++...+.++... +....+.+||.++|.+||++|.+..+|.....
T Consensus 324 ~----------------~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 E----------------LELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H----------------HHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 2 345667777777765554 44466889999999999999999999977443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=323.40 Aligned_cols=267 Identities=26% Similarity=0.327 Sum_probs=206.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 666 (947)
+.|+..+.|++|+||.||+|+.+ +++.||+|+++.....+.-.-.-.+||.++.+++|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778899999999999999765 78999999998764333333456899999999999999999998764 3578999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
||||+. +|...+...+ +++...++..+..|+++|++|||. ..|+|||||++|+|+.+.|.+||+|||+||.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999965 8888886654 468889999999999999999996 88999999999999999999999999999988
Q ss_pred CCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh--H
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT--F 823 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~ 823 (947)
+..-. ..+..+-|.+|+|||.+.+. .|+.+.||||+|||+.||+++++-|.+....++.+.+-..-....+..+ +
T Consensus 228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 77532 24567889999999998775 5999999999999999999999999888766655443222221111100 0
Q ss_pred --HHHhhccCCCChhc----------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 --RKAIDRTIDLDEET----------LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 --~~~~~~~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+. ...+...+ ......-++|+..++..||.+|.|+.|.++
T Consensus 306 ~~lp~~k-~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVK-KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhh-ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 00101000 002244569999999999999999998876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.35 Aligned_cols=267 Identities=26% Similarity=0.445 Sum_probs=206.1
Q ss_pred hcCCCcCceecccCceEEEEEEEcC-----------------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcc
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD-----------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (947)
.++|.+.++||+|+||.||+|.+++ +..||+|.+.... ......++.+|++++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3678899999999999999997532 3469999987543 344567899999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCchhhhhhcccc--------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCe
Q 002255 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKE--------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717 (947)
Q Consensus 652 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 717 (947)
++++++.+.+..++||||+++|+|.+++..... .....++|.++.+++.||+.||+|||+ .+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 999999999999999999999999998855321 111347888999999999999999996 799
Q ss_pred eecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh--CC
Q 002255 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GR 795 (947)
Q Consensus 718 vHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~ 795 (947)
+||||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986644333333334456889999999988899999999999999999987 55
Q ss_pred CCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 796 KALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 796 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.||......+. ...+.... +.... ... .......+..+.+++.+|++.+|++||++.+|.+.|+
T Consensus 240 ~p~~~~~~~~~---~~~~~~~~------~~~~~-~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQV---IENAGEFF------RDQGR-QVY-LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHH---HHHHHHHh------hhccc-ccc-ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67765432221 11111110 00000 000 0011122356889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.75 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=206.8
Q ss_pred hcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|++.++||+|+||.||+|.+ .++..||||+++... .....+.+.+|+++++.+ +|||||+++++|.+++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 45788999999999999999964 245689999987543 233456789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc--------------------------------------------------------
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE-------------------------------------------------------- 685 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 685 (947)
..++||||+++|+|.+++......
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999998653210
Q ss_pred --------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 686 --------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 686 --------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
....++|..+.+++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 11247889999999999999999996 8999999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
........++..|+|||++.+..++.++|||||||++|||++ |..||........ +.+.+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~----------------~~~~~~~~ 333 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK----------------FYKMIKEG 333 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH----------------HHHHHHhC
Confidence 222223345678999999999999999999999999999998 8888865432211 11111111
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
... ..+.....++.+++.+|++.||++||++.||++.|++
T Consensus 334 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 YRM-LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ccC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 110 0011123568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=334.48 Aligned_cols=273 Identities=25% Similarity=0.410 Sum_probs=207.2
Q ss_pred CCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC--CCCCcceEEEEEEeCC----eeEE
Q 002255 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV--RHRHLVGLLGYCLDGN----ERLL 665 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l 665 (947)
.+..++||+|+||.||||.+. ++.||||++. ..+.+.|.+|-++.+.. +|+||++++++-..+. +++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 345678999999999999998 5999999985 45667889998888875 7999999999987665 8999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhc------cCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL------AHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
|+||.+.|+|.++|... .++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999653 489999999999999999999974 367899999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCC------cCcccccccHHHHHHHHHhCCCCCC-ccCccchhhHHHH
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR------VTTKVDVFSFGVILMELITGRKALD-ETQSEDSVHLVTW 812 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~p~~-~~~~~~~~~l~~~ 812 (947)
||+|..+............+||.+|||||++.+.. .-.+.||||+|.|+|||+++...+. +..++-+.-....
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99999887654443444579999999999986532 1237899999999999999766553 2222111111111
Q ss_pred HHHhhcChhhHHHHhhccCCCChh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
+.... .-+.+.+.+-++...+.. .-..+..+.+.+..||..||+.|.|+.=|.+.+..+...+.
T Consensus 440 vG~hP-t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHP-TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCC-CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11111 112222222222111111 11334567899999999999999999999999888876544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.62 Aligned_cols=272 Identities=25% Similarity=0.388 Sum_probs=214.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-----C
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-----G 660 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 660 (947)
.+...|...+.||+|+||.|+.|..+ +|+.||+|++..........++..+|++++++++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566777899999999999999764 79999999998666667778899999999999999999999999865 3
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...|+|+|+| +.+|.+.++.. +.+......-+++|+++||.|+|+ .+|+|||+||.|++++.+..+||+||
T Consensus 99 ~DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence 5789999999 67898888553 337778888899999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc-
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI- 818 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~- 818 (947)
|+|+...........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++-|.+.+.-++..++-.+-....
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998754322233466788999999998754 5799999999999999999999999988776555544432222211
Q ss_pred ------ChhhHHHHhhccCCCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 ------NKDTFRKAIDRTIDLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ------~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..+..+......+..+ ....+...+|+.+||..||.+|+|++|+++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1112223333222212111 122345679999999999999999999977
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.11 Aligned_cols=249 Identities=18% Similarity=0.338 Sum_probs=200.8
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccCh-HHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCeeEEEEEe
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVYEY 669 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 669 (947)
...||+|++|.||+|.+. |+.||||+++...... ...+.+.+|+.++++++|||||++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 368999999999999884 8999999997653322 224778899999999999999999999877 3467899999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++|+|.+++... ..++|....+++.|++.||+|||+ ..+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 9999999998653 347899999999999999999996 357889999999999999999999999998865432
Q ss_pred CCcceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+. +..++
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~----------------~~~i~ 235 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI----------------YDLII 235 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHH
Confidence 1 23468899999999876 6799999999999999999999999986542211 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
...... ..+......+.+++.+||+.||++||+++|+++.|+.+.
T Consensus 236 ~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 236 NKNNSL-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred hcCCCC-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111110 111123456889999999999999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.04 Aligned_cols=264 Identities=26% Similarity=0.466 Sum_probs=207.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|++.+.||+|+||.||+|... ++..||||+++... .....+.+.+|+++++.+ +|+|||+++++|...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 457889999999999999998742 24579999997653 334456789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcccc---------------------------------------------------------
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKE--------------------------------------------------------- 684 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 684 (947)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998864321
Q ss_pred --------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceee
Q 002255 685 --------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756 (947)
Q Consensus 685 --------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 756 (947)
.....+++.++.+++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011347888999999999999999997 899999999999999999999999999998654432222222
Q ss_pred cccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh
Q 002255 757 RLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE 835 (947)
Q Consensus 757 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (947)
...++..|+|||++.+..++.++|||||||++|||++ |+.||........ +...+...... .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----------------~~~~~~~~~~~-~ 335 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----------------FYKMVKRGYQM-S 335 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----------------HHHHHHcccCc-c
Confidence 2345678999999988899999999999999999997 9999975432211 11111111110 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 836 ETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 836 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.......++.+++.+|++.||++||++.+|++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01112356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.44 Aligned_cols=268 Identities=24% Similarity=0.389 Sum_probs=208.3
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC--CCCCcceEEEEEEeC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV--RHRHLVGLLGYCLDG 660 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~ 660 (947)
-..+.+..+....+.||+|.||.||+|.|+ |+.||||++... +.+.+.+|.++++.+ +|+||+.+++.-..+
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 345778888999999999999999999998 999999998643 346778888888876 999999999987654
Q ss_pred C----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhh-----ccCCCeeecCCCCCcEEEcC
Q 002255 661 N----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG-----LAHQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 661 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivHrDlkp~Nill~~ 731 (947)
. ++|||++|.+.|||+|||.+ ..++-...++++..+|.||+|||. .+++.|.|||||+.||||.+
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 3 67999999999999999965 347888999999999999999995 46889999999999999999
Q ss_pred CCcEEEeecCcceecCCCCCc--ceeecccccccccCccccccCC----c--CcccccccHHHHHHHHHhC---------
Q 002255 732 DMRAKVADFGLVRLAPDNGKH--SIETRLAGTFGYLAPEYAVTGR----V--TTKVDVFSFGVILMELITG--------- 794 (947)
Q Consensus 732 ~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~elltg--------- 794 (947)
++.+.|+|+|+|......... ......+||.+|||||++.+.. + -..+||||||.|+||+...
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 999999999999766543211 1233468999999999986532 2 2369999999999999762
Q ss_pred -CCCCCccCccchhhHHHHHHHhhcChhhHHHHh-hccC----CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 795 -RKALDETQSEDSVHLVTWFRRMHINKDTFRKAI-DRTI----DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 795 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+.||.+..+.+-. .+..++.+ .+.+ ...-...+....+.++++.||..+|.-|.|+-.+.+.
T Consensus 432 y~~Pyyd~Vp~DPs------------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPS------------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred hcCCcccCCCCCCC------------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 3566555443211 11111111 1111 1112223555667899999999999999999999999
Q ss_pred HHhhhh
Q 002255 869 LSSLAE 874 (947)
Q Consensus 869 L~~l~~ 874 (947)
|.++.+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 988764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=373.10 Aligned_cols=264 Identities=31% Similarity=0.517 Sum_probs=216.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC--Cc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD--GT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
...+..+.||+|.||.||+|.+.+ |. .||||.++.. .+.++..+|.+|+.+|++++|||||+++|+|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445667899999999999998653 43 4899988765 3677789999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccccc--CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
++++|||++|+|..+|++.+.. ....+...+.+.++.|||+|+.|||+ +++|||||.++|+|+++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999765222 13458889999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+|+...+...+.......-...|||||.++.+.++.|+|||||||++||++| |..||......+...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------------ 915 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------------ 915 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------------
Confidence 9996655444433333334569999999999999999999999999999999 888998765433221
Q ss_pred hhHHHHhh-ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 002255 821 DTFRKAID-RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876 (947)
Q Consensus 821 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 876 (947)
..+. .++..+. .++..+.+++..||+.+|++||++..+++.+..+....
T Consensus 916 ----~~~~ggRL~~P~---~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 916 ----DVLEGGRLDPPS---YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ----HHHhCCccCCCC---CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1111 2233222 34456789999999999999999999999988887543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.60 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=207.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
.++|...++||+|+||+|+++..+ +++.+|||.+++.. ...++.+..+.|.+++... +||.++.++.+|...++.|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999876 68899999999875 4566778899999999888 49999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+.||++..+.+. ..++...+.-+|..|+.||.|||+ ++|||||||-+|||+|.+|.+||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999996544432 348889999999999999999996 9999999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
....+ .....++|||.|||||++.+..|+.++|.|||||++|||+.|+.||.+.+++ +.+..
T Consensus 518 ~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----------------e~Fds 579 (694)
T KOG0694|consen 518 GMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----------------EVFDS 579 (694)
T ss_pred cCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHH
Confidence 54322 2456689999999999999999999999999999999999999999876532 23344
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
++..... ++.....+...++++++.++|++|..+
T Consensus 580 I~~d~~~---yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVR---YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCC---CCCcccHHHHHHHHHHhccCcccccCC
Confidence 4433332 233444567899999999999999977
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=357.67 Aligned_cols=259 Identities=27% Similarity=0.363 Sum_probs=214.5
Q ss_pred cCCCcCceecccCceEEEEEEEcCC-cEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEE-EEe------C
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDG-TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGY-CLD------G 660 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 660 (947)
.++++.++|.+|||+.||.|....+ ..||+|++... ++.....+.+||++|++|+ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4567889999999999999987655 99999999766 7888899999999999997 9999999993 321 2
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
-+++|.||||++|.|-+++..+... .+.+.++++|+.++++|+++||.+ +.+|||||||-+|||++.++..|||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 4678999999999999999876553 389999999999999999999985 688999999999999999999999999
Q ss_pred CcceecCCCCCcce-------eecccccccccCcccc---ccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH
Q 002255 741 GLVRLAPDNGKHSI-------ETRLAGTFGYLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810 (947)
Q Consensus 741 Gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~ 810 (947)
|.|.-......... .-...-|+.|+|||.+ .+...++|+|||||||+||-|+....||++....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 99863322111100 1123468999999987 4667999999999999999999999999875322
Q ss_pred HHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 811 TWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
.+++..+.+++. ......+.+||+.||+.+|.+||++.+|++.+.+++..
T Consensus 265 --------------aIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 --------------AILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------eEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 345555655544 45667899999999999999999999999999888754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.97 Aligned_cols=240 Identities=29% Similarity=0.488 Sum_probs=199.5
Q ss_pred CcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
..++-||.|+.|.||+|+++ ++.||||+++.- -..+|+.|++|+|+||+.+.|+|...-.+++|||||..
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 45688999999999999998 799999987532 13589999999999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|-|+..|+.. .++.-.....+..+||.|+.|||. +.|||||||.-||||..+..|||+|||.++...+.
T Consensus 197 GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--- 265 (904)
T KOG4721|consen 197 GQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--- 265 (904)
T ss_pred ccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence 9999999653 346667788999999999999996 88999999999999999999999999999876543
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
...-.++||..|||||++...+.++|+||||||||||||+||..||.+.+.... ++.+. .. .+.
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGVG--sN--------sL~ 329 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGVG--SN--------SLH 329 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEecc--CC--------ccc
Confidence 233457999999999999999999999999999999999999999976543211 11110 00 011
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
-+.+..++..+.-|+++||+..|..||++.+++..|.
T Consensus 330 -LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 330 -LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred -ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1222344567889999999999999999999998774
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=308.18 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=210.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++++.||+|-||.||.|+.+ ++-.||+|++.++... .....++.+|+++-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467999999999999999999765 5778999998765432 23356899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
+||..+|+++..|..++. ..++......+..|+|.|+.|+|. ++|+||||||+|+|++.++.+|++|||-+...
T Consensus 101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999975433 447778888999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
+.+ .....+||..|.+||...+..++.++|+|++|++.||++.|.+||..... .+.++++
T Consensus 175 p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----------------~etYkrI 234 (281)
T KOG0580|consen 175 PSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----------------SETYKRI 234 (281)
T ss_pred CCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----------------HHHHHHH
Confidence 432 23457999999999999999999999999999999999999999976542 2334444
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..-.+..+ .......+++|.+|+..+|.+|.+..|+++
T Consensus 235 ~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 235 RKVDLKFP---STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHccccCC---cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 44444322 233456789999999999999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=339.26 Aligned_cols=260 Identities=28% Similarity=0.489 Sum_probs=209.5
Q ss_pred cCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......++.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999997643 2579999987543 344567799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCC-----------CcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
+++|||+++++|.+++........ ..+++.+++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 999999999999999865422111 457889999999999999999996 899999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~ 811 (947)
+.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV----- 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999986644333233344567889999999988899999999999999999998 9999976543211
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.+.+..... ...+...+..+.+|+.+|++.+|++||+++||++.|++
T Consensus 236 ------------~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ------------IEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111111 11122344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=339.19 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=201.3
Q ss_pred CCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.|+..+.||+|+||.||+|.. .+|+.||+|.+...... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999976 47899999998754322 2334567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888754322 348899999999999999999996 8999999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh-
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI- 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~- 827 (947)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||........... ....+
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-------------~~~~~~ 218 (285)
T cd05631 155 GE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-------------VDRRVK 218 (285)
T ss_pred CC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-------------HHHHhh
Confidence 22 12345799999999999999999999999999999999999999986543221110 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
..... ........+.+|+.+||+.||++||+ ++++++
T Consensus 219 ~~~~~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 EDQEE---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccccc---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11111 11122346789999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=342.84 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=220.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe-eEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE-RLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV 666 (947)
.++|...+++|+|+||.++.++++ ++..|++|.+.-...++........|+.++++++|||||.+.+.+.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999999765 57899999998887777777789999999999999999999999999888 8999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|+||+||++.+.+.+++. ..++...++.++.|++.|+.|||+ .+|+|||||+.||+++.++.|||+|||+|+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EeecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 999999999999977652 458899999999999999999995 89999999999999999999999999999988
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.+.. .....++||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. ....++
T Consensus 157 ~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----------------~Li~ki 218 (426)
T KOG0589|consen 157 NPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----------------ELILKI 218 (426)
T ss_pred CCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH----------------HHHHHH
Confidence 7643 2345578999999999999999999999999999999999999999875532 122233
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+... ..+.+.....++..++..|++.+|..||++.+++..
T Consensus 219 ~~~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhcc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3332 234455666789999999999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=340.87 Aligned_cols=268 Identities=20% Similarity=0.268 Sum_probs=203.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999876 58899999997654444456778899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++++.+..+... . ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~-~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-P----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-C----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998877544322 1 347888999999999999999996 8999999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh-
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI- 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~- 827 (947)
... .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+....... .........
T Consensus 153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (287)
T cd07848 153 GSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL-PAEQMKLFYS 230 (287)
T ss_pred ccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC-CHHHHHhhhc
Confidence 221 12234578999999999988889999999999999999999999997654322211111110000 000000000
Q ss_pred --------hccCCCCh-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 --------DRTIDLDE-----ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 --------~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+...... ........+.+++.+||+.||++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.60 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=208.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 661 (947)
.++|.+.++||+|+||.||+|+.. .+..||||++.... .....+.+.+|+++++++. |||||++++++.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 568889999999999999999753 23479999987543 3444578999999999996 999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc--------------------------------------------------------
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE-------------------------------------------------------- 685 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 685 (947)
..++||||+++|+|.++++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988653210
Q ss_pred -----------------------------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc
Q 002255 686 -----------------------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (947)
Q Consensus 686 -----------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 730 (947)
....+++.++..++.||++||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 11247888899999999999999996 8999999999999999
Q ss_pred CCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhH
Q 002255 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHL 809 (947)
Q Consensus 731 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l 809 (947)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--- 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--- 348 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---
Confidence 999999999999986644322222233457788999999988899999999999999999997 8999875432111
Q ss_pred HHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+...+..... ..........+.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 349 -------------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 -------------FYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -------------HHHHHhcCCC-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111111 0111223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.45 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=206.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+++.+ +|..||+|.+.... .......+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 368999999999999999999876 68889999987542 3445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999998553 247888999999999999999997 3579999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC--------
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-------- 819 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-------- 819 (947)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+......
T Consensus 156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccc
Confidence 321 23357999999999999889999999999999999999999999754432111 111000000
Q ss_pred -------------------------hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 820 -------------------------KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 820 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.+....++..... .........++.+|+.+||+.||++||++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP-KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCc-CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000011111000 00011234568899999999999999999999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.81 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=197.3
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
++||+|+||.||+|..+ +|+.||+|+++.... .......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976432 3344567889999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 150 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--
Confidence 999888543 347889999999999999999996 8999999999999999999999999999875432221
Q ss_pred eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCC
Q 002255 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 833 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+......+
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~~~~~ 214 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILMEEIRF 214 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH----------------HHHHHcCCCCC
Confidence 12345799999999999988999999999999999999999999975432111 11111111111
Q ss_pred ChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 834 DEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 834 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
. ......+.+++.+||+.||++|| ++.++++
T Consensus 215 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 P---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred C---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1 12335678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.08 Aligned_cols=256 Identities=22% Similarity=0.401 Sum_probs=204.5
Q ss_pred cCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||.||+|.++ .+..||+|.++... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 56888999999999999999753 35689999987653 34445789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999986532 348899999999999999999996 8999999999999999999999999998765
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
...... .......++..|+|||++.+..++.++|||||||++||+++ |+.||......+. . .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~-------------~ 219 (266)
T cd05064 157 DKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I-------------K 219 (266)
T ss_pred ccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H-------------H
Confidence 422111 11112345678999999988999999999999999999775 9999976542211 1 1
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
. +..... .+........+.+++.+|++.+|++||++.+|.+.|+++
T Consensus 220 ~-~~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 A-VEDGFR-LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H-HHCCCC-CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 111111 011122345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=341.52 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 689999999875432 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999998653 347888899999999999999996 899999999999999999999999999988654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.
T Consensus 153 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----------------~~~~i~ 211 (291)
T cd05612 153 DR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----------------IYEKIL 211 (291)
T ss_pred CC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 32 123469999999999998889999999999999999999999997654221 111222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
........ .....+.+++.+|++.||.+||+ +.|+++
T Consensus 212 ~~~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 212 AGKLEFPR---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred hCCcCCCc---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 22222111 11345789999999999999995 776654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=345.16 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 688999999875432 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999988653 247788888999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+.
T Consensus 170 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~ 228 (329)
T PTZ00263 170 DRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------IYEKIL 228 (329)
T ss_pred CCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------HHHHHh
Confidence 421 23479999999999998899999999999999999999999997543211 111222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
......+. .....+.+++.+||+.||.+||+ +.++++
T Consensus 229 ~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 229 AGRLKFPN---WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred cCCcCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 22222111 12245789999999999999997 466554
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.93 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=221.7
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCee
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNER 663 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 663 (947)
.....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ......+.+|+++|+++. |||||.+.++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 45578889999999999999999876 4999999999876432 234578999999999998 99999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC----CcEEEee
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVAD 739 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~D 739 (947)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .+|+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999765 28889999999999999999997 899999999999999643 5799999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||++...... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+....
T Consensus 183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------------- 244 (382)
T KOG0032|consen 183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------------- 244 (382)
T ss_pred CCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---------------
Confidence 9999988662 2345679999999999999899999999999999999999999999876532
Q ss_pred hhhHHHHhhccCCCChhcHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCC
Q 002255 820 KDTFRKAIDRTIDLDEETLASI-STVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAE 880 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~ 880 (947)
..+.++....+.+....++.. ..+.+++++|+..||.+|+++.++++ ++|....
T Consensus 245 -~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~------HpWi~~~ 299 (382)
T KOG0032|consen 245 -EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ------HPWIKSI 299 (382)
T ss_pred -HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc------CccccCC
Confidence 233355566666666655554 45669999999999999999999988 6787654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=340.78 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=204.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.. +++.||+|+++..... ......+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999876 5899999999765322 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999998543 347888899999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ... ...+
T Consensus 153 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~-------~~~~ 217 (333)
T cd05600 153 T-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---KYW-------KETL 217 (333)
T ss_pred c-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---Hhc-------cccc
Confidence 3 123457999999999999889999999999999999999999999765432211110 000 0000
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..... .........++.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000 00011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.97 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=215.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC-CcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+.|+..+.||+|.-|+||.++.++ +..+|+|++.+... ......+.+.|.+||+.++||.++.+|+.++.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346667889999999999998874 58899999987653 3455678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||+||+|..+++++.. +.++...+.-+|..|+-||+|||. .|||+|||||+||||.++|++.|+||.|+....
T Consensus 157 eyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999998877654 458888888899999999999996 899999999999999999999999999874321
Q ss_pred C---------------------------------CCCc---------------------ceeecccccccccCccccccC
Q 002255 748 D---------------------------------NGKH---------------------SIETRLAGTFGYLAPEYAVTG 773 (947)
Q Consensus 748 ~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~ 773 (947)
. .... .....++||..|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0000 001236799999999999999
Q ss_pred CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcc
Q 002255 774 RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCA 853 (947)
Q Consensus 774 ~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 853 (947)
..+.++|.|+|||++|||+.|.-||.+... +..+..++.+.+.+...+ .....+.|||+++|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhc
Confidence 999999999999999999999999987653 456778888888876665 445678899999999
Q ss_pred cCCCCCCC----HHHHHH
Q 002255 854 REPYQRPD----MGHVVN 867 (947)
Q Consensus 854 ~dP~~RPs----~~evl~ 867 (947)
+||.+|.. +.||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777755
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.77 Aligned_cols=256 Identities=26% Similarity=0.470 Sum_probs=207.2
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3578899999999999999999888889999988653 2235688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||+++....
T Consensus 82 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999865322 347888999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .......++..|+|||++....++.++|||||||++|||++ |+.||......+ .... +
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~--------------~ 217 (261)
T cd05072 156 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA--------------L 217 (261)
T ss_pred Cce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH--------------H
Confidence 221 12223346778999999988889999999999999999998 999997543221 1111 1
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
....... ........+.+++.+|++.+|++||++.++.+.|+++
T Consensus 218 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 QRGYRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1111101 1112234678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=359.29 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=210.2
Q ss_pred HHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 661 (947)
...++|++.+.||+|+||.||+|.. .+|+.||||++.....+......+.+|+.++..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999975 47899999999876656667778899999999999999999988775432
Q ss_pred ----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 662 ----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 662 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
..++||||+++|+|.+++..+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 367999999999999998764332 2468899999999999999999996 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------------ 252 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------------ 252 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------------
Confidence 99999987654332233345679999999999999899999999999999999999999997543211
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.+......... ..+......+.+++.+||+.+|++||++.++++.
T Consensus 253 ----~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 ----VMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----HHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111111 1112233568899999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=328.53 Aligned_cols=257 Identities=25% Similarity=0.468 Sum_probs=207.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||.||+|.++. ...||||.++... ......+|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 578899999999999999998752 4579999887543 44456788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++.... ..+++..+.+++.|++.|++|||+ .+|+||||||+||++++++.++++|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999986532 258899999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~-------------- 218 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VI-------------- 218 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HH--------------
Confidence 753222222223345678999999988899999999999999999998 999986543221 11
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
+.+..... .+........+.+++.+|++.+|++||++.||++.|.++
T Consensus 219 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 219 KAVEDGYR-LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111111 011122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=333.01 Aligned_cols=259 Identities=29% Similarity=0.505 Sum_probs=208.0
Q ss_pred cCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|.+.+.||+|+||.||+|...+ ++.||||.++... ..+..+.+.+|++++++++|+||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 568888999999999999997643 4789999987653 333567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccc---------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKE---------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
++||||+++++|.+++..... .....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999965421 122457899999999999999999996 79999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+. ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~-- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE-- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH--
Confidence 99999999986543322222333456789999999999999999999999999999998 9999875443211 11
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+...... .........+.+++.+||+.+|++||++.||++.|+
T Consensus 236 -----------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 -----------CITQGRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -----------HHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111 111223456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.59 Aligned_cols=262 Identities=29% Similarity=0.508 Sum_probs=209.4
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 57888999999999999999742 3456899988654 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccc--------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcE
Q 002255 664 LLVYEYMPQGTLSRHLFNRKE--------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 735 (947)
++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 999999999999999865331 122348999999999999999999996 899999999999999999999
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~ 814 (947)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------- 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------- 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------
Confidence 9999999886544322222233456788999999988889999999999999999998 8999875542211
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+...... .........+.+++.+|++.+|.+||++.|+.+.|+++.+
T Consensus 232 --------~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 232 --------IECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --------HHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111111110 0011123468899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.82 Aligned_cols=273 Identities=23% Similarity=0.307 Sum_probs=205.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC-cceEEEEEEeCC-----
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH-LVGLLGYCLDGN----- 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 661 (947)
...|...++||+|+||+||+|+.+ +|+.||+|++.-....+.......+|+.+++.++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345667788999999999999754 7899999999866433334456789999999999999 999999998877
Q ss_pred -eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 662 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
..++||||+ .-+|.+++....... ..++...+..++.||+.||+|||+ ++|+||||||+||||+++|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeecc
Confidence 788999999 568999987654321 235667889999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+|+...-... ..+..++|..|+|||++.+. .|+...||||+|||++||+++++-|.+..+.++...+-..-.....
T Consensus 165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 99996653222 23456789999999999876 7999999999999999999999999877654433322222111111
Q ss_pred hhhHHHH--hhccCCCChh------cH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 820 KDTFRKA--IDRTIDLDEE------TL---ASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 820 ~~~~~~~--~~~~~~~~~~------~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+-... .+-...+... .. .......+++.+|++.+|++|.+++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1110000 0000000000 00 111356799999999999999999998874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.82 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=204.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.+|+..+.||+|+||.||+|.+. +++ .||+|.++.. ......+++.+|+.+++.++||||++++++|..+ ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 56899999999999999999864 333 4899998643 2344567899999999999999999999999764 568
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 9999999999999986532 347888999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----------------~ 220 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 220 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence 7654332222222345678999999999999999999999999999998 999997543211 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+....... ........+.+++.+|++.+|++||++.+++..+..+..
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 221 SSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11111111111 111223457899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=341.01 Aligned_cols=265 Identities=27% Similarity=0.473 Sum_probs=207.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe-C
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD-G 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~ 660 (947)
.++|++.++||+|+||.||+|... +++.||+|+++... .....+.+..|+.++.++ +|+||++++++|.. +
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 457999999999999999999642 35789999987543 344556788999999999 89999999998865 4
Q ss_pred CeeEEEEEecCCCchhhhhhccccc-------------------------------------------------------
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEE------------------------------------------------------- 685 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 685 (947)
...++||||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999988543211
Q ss_pred -CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccc
Q 002255 686 -GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764 (947)
Q Consensus 686 -~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 764 (947)
....++|..+.+++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+++...............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 01258999999999999999999996 89999999999999999999999999999866433222222234567789
Q ss_pred cCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHH
Q 002255 765 LAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASIST 843 (947)
Q Consensus 765 ~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (947)
+|||++.+..++.++|||||||++|||++ |..||......+. +...+..... .........+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~-~~~~~~~~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----------------FCRRLKEGTR-MRAPEYATPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----------------HHHHHhccCC-CCCCccCCHH
Confidence 99999999999999999999999999998 9999976432211 1111111111 0011122356
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 844 VADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 844 l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+.+++.+|++.+|++||++.|+++.|+.+.+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=304.94 Aligned_cols=265 Identities=25% Similarity=0.350 Sum_probs=210.5
Q ss_pred hcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----Ce
Q 002255 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 662 (947)
.++|.+.+.+|+|||+.||.++ ..+++.||+|++... ..++.+..++|++..++++|||+++++++...+ .+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3689999999999999999996 567899999999876 356678899999999999999999999887543 35
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.|++++|...|+|.+.+.....++ ..+++.+.+.|+.+|++||++||+. ..+++||||||.|||+++++.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 899999999999999998766544 4689999999999999999999984 24699999999999999999999999999
Q ss_pred ceecCCCCCcc-------eeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 743 VRLAPDNGKHS-------IETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 743 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
++..+-.-... .......|..|+|||.+. +...++++|||||||+||+|+.|..||+......
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------- 248 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------- 248 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-------
Confidence 87543211111 012234688999999874 4467899999999999999999999997543211
Q ss_pred HHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
....-.+....+.++...+ ..+.+.+++++|++.||.+||+..+++..+..+
T Consensus 249 -------gSlaLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -------GSLALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------CeEEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0001122223333333322 567788999999999999999999999988765
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=341.63 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=201.0
Q ss_pred cCCCcCceecccCceEEEEEEEcC--CcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD--GTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
++|++.+.||+|+||.||+|.++. +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568899999999999999997653 36899999865432 334456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999998653 247888999999999999999996 89999999999999999999999999999866
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----------------~~~~i 240 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----------------IYQKI 240 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----------------HHHHH
Confidence 432 123579999999999988889999999999999999999999997643211 11122
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
.......+.. ....+.+++.+|++.||++|+ +++++++
T Consensus 241 ~~~~~~~p~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 241 LEGIIYFPKF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred hcCCCCCCCC---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 2222221111 224567999999999999995 7887765
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.68 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=206.4
Q ss_pred CCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe-----
Q 002255 592 FSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE----- 662 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 662 (947)
|.+.+.||+|+||.||+|.... +..||+|+++...........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999997642 3679999998765556667789999999999999999999999876554
Q ss_pred -eEEEEEecCCCchhhhhhcccc-cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 663 -RLLVYEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 663 -~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
.++||||+++|+|..++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999998855432 122458899999999999999999996 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||.+....+ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~---------- 224 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I---------- 224 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----------
Confidence 99987654332222222345678999999988889999999999999999999 888886543211 1
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
+....+... ..........+.+++.+|++.||++||++.|+++.|+++
T Consensus 225 ---~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 ---YDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111110 111123345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=334.24 Aligned_cols=267 Identities=24% Similarity=0.329 Sum_probs=197.8
Q ss_pred cCCCcCceecccCceEEEEEEEc--CCcEEEEEEecccccChHHHHHHHHHHHHHHcC---CCCCcceEEEEEEe-----
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLD----- 659 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 659 (947)
++|++.+.||+|+||.||+|+.. +|+.||+|+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999763 468899999876543333345566788777766 69999999999852
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
....++||||+. ++|.+++..... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999995 689888865332 347899999999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+....+........
T Consensus 154 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~- 229 (290)
T cd07862 154 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG- 229 (290)
T ss_pred ccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC-
Confidence 9999866443 122345689999999999888899999999999999999999999987554322211110000000
Q ss_pred hhhHHH-------HhhccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFRK-------AIDRTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~~-------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.. .+....... .........+.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 001100 000000000 000112345679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.77 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=197.8
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-----eeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 664 (947)
.|...+++|.|+||.||+|... +++.||||+.-.... --.+|+++|+.+.|||||++..+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4667799999999999999765 579999998764421 2247999999999999999999886532 235
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEeecCcc
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLV 743 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla 743 (947)
+|||||+ .+|.+.++.....+ ..++...+.-+..||++||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP-~tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 8999995 58999887532222 346666777889999999999996 899999999999999976 99999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+....+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....++ ++..+.........
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTRE 248 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHH
Confidence 988665433 334578899999998774 699999999999999999999999988654443 33333333332222
Q ss_pred HHHHhhcc--------CCCCh----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRT--------IDLDE----ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~--------~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
--..+... +.... ......++..+|+.++++.+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11222211 11111 12234467889999999999999999999886
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.01 Aligned_cols=241 Identities=27% Similarity=0.379 Sum_probs=194.9
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||+|+||.||+|... +++.||+|++.... ........+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 58899999987542 2344556788999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 150 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKT 150 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccc
Confidence 9988643 347889999999999999999996 899999999999999999999999999988543322 122
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE 835 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (947)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+.........
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----------------~~~~~~~~~~~~~~ 214 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----------------MYRKILQEPLRFPD 214 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----------------HHHHHHcCCCCCCC
Confidence 34579999999999999899999999999999999999999997543211 11222222222111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 836 ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 836 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....+.+++.+||+.||++||++.++.+
T Consensus 215 ---~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 215 ---GFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 22345789999999999999987544433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=327.32 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=206.5
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++..++..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 46788999999999999999998878899999987543 234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999986533 2358899999999999999999996 8999999999999999999999999999987653
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... .......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~~~~~ 217 (261)
T cd05068 156 DIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----------------VLQQV 217 (261)
T ss_pred Cccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHH
Confidence 2211 1111223458999999988899999999999999999999 999997543211 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
...... .........+.+++.+|++.+|++||++.++.+.|++
T Consensus 218 ~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 DQGYRM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HcCCCC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111110 1112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=355.71 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=204.4
Q ss_pred CCCcCceecccCceEEEEEEEc-C-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-D-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++|||||++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888899999999999999654 3 678899876543 34445678889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..... ...++++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999998865322 22457888999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.....
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----------------~~~~~~~ 285 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----------------IMQQVLY 285 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHh
Confidence 333223445679999999999998899999999999999999999999997543211 1111121
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... .........+.+++.+|++.+|++||++.+++.
T Consensus 286 ~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKYD--PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCC--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111 111123356889999999999999999999875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=332.53 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=207.3
Q ss_pred CCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
+|++.+.||+|+||.||+|... ....+|+|.+.... ......++.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999753 23578898886543 3445678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccc-------------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCC
Q 002255 665 LVYEYMPQGTLSRHLFNRKE-------------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 725 (947)
+||||+.+|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999998864221 112458899999999999999999996 89999999999
Q ss_pred cEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCcc
Q 002255 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSE 804 (947)
Q Consensus 726 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~ 804 (947)
||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+..+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999886543322212223346678999999988889999999999999999999 99999654322
Q ss_pred chhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 805 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+ +.+.+....... ........+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 237 ~-----------------~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 R-----------------LFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-----------------HHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111111111111 111233568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.27 Aligned_cols=251 Identities=33% Similarity=0.586 Sum_probs=196.1
Q ss_pred cCceecccCceEEEEEEEc-----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 594 EENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3578999999999999887 3678999999653 345557899999999999999999999999998888999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++.... ...+++..++.|+.||++||+|||+ .+++|+||+++||++++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999997752 2458999999999999999999997 7899999999999999999999999999987743
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
...........+...|+|||.+....++.++||||||+++|||++ |+.||......+ . ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~-------------~~~~~ 219 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I-------------IEKLK 219 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H-------------HHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c-------------ccccc
Confidence 333333334457789999999998899999999999999999999 678886653211 1 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
+.... .........+.+++.+||+.+|++||++.++++.|
T Consensus 220 ~~~~~--~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRL--PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEET--TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc--eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111 11122345578999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=337.20 Aligned_cols=243 Identities=27% Similarity=0.394 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
+.||+|+||.||++..+ +|+.||+|++..... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976532 3344567788999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 150 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--
Confidence 998888543 347899999999999999999996 8999999999999999999999999999875432211
Q ss_pred eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCC
Q 002255 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 833 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----------------~~~~~~~~~~~ 214 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------------FELILMEEIRF 214 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhcCCCCC
Confidence 12335799999999999988999999999999999999999999975442211 11111112211
Q ss_pred ChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 834 DEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 834 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
.. .....+.+++.+||+.||++|| ++.++++
T Consensus 215 p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CC---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11 2235678999999999999998 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=305.04 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=214.6
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC------hHHHHHHHHHHHHHHcC-CCCCcceEEE
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKV-RHRHLVGLLG 655 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~l~~ 655 (947)
......+.|...+.||.|..+.|.++..+ +|..+|+|++...... ..-.++-..|+.+++++ .||+|+.+.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 34456678889999999999999998654 7889999998643211 12245567899999999 6999999999
Q ss_pred EEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcE
Q 002255 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 656 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 735 (947)
+|+.+...++|+|.|+.|.|.++|... ..+++.+..+|++|+.+|++|||. .+|||||+||+|||++++.++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccce
Confidence 999999999999999999999999543 458888999999999999999996 899999999999999999999
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCcccccc------CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l 809 (947)
||+|||+|+...++.. ....+|||+|+|||.+.- ..|+..+|+||.|||+|.|+.|.+||.....
T Consensus 163 ~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ 233 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ 233 (411)
T ss_pred EEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------
Confidence 9999999998877543 356899999999998853 3578899999999999999999999965321
Q ss_pred HHHHHHhhcChhhHHHHhhccCCCChhcHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASI-STVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
--.++-+....+.+....+... ....+||.+||+.||.+|.|++|+++.
T Consensus 234 ----------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 ----------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1134566677777666655444 457799999999999999999999873
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.13 Aligned_cols=267 Identities=23% Similarity=0.348 Sum_probs=200.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..++||+|+||.||+|..+ +++.||+|+++... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 56899999999999999999765 68899999987542 22234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++ |+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 997 58988885432 347888999999999999999996 8999999999999999999999999999876533
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc--------C
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI--------N 819 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~--------~ 819 (947)
... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+............. .
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 221 1233468999999998865 5689999999999999999999999976654333222111110000 0
Q ss_pred hhhHHHHhhccCCCCh---hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFRKAIDRTIDLDE---ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.....+...... .......+..+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111111111110000 00012245779999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.80 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=201.8
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ..+++..|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45788899999999999999998888999998865432 235788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999886432 247899999999999999999996 89999999999999999999999999998865432
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......++..|+|||++....++.++||||||+++|||++ |+.||......+ ... .+..
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~-------------~i~~ 216 (256)
T cd05114 154 EY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVE-------------MISR 216 (256)
T ss_pred ce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-------------HHHC
Confidence 21 11222345678999999988889999999999999999999 899997543221 111 1111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
...... +......+.+++.+|++.+|++||+++++++.|
T Consensus 217 ~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 GFRLYR--PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 100000 111234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.43 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=202.2
Q ss_pred CCcCceecccCceEEEEEEEcC-Cc--EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------Ce
Q 002255 592 FSEENVLGRGGFGTVYKGELHD-GT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------NE 662 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 662 (947)
|.+.++||+|+||.||+|.+.. +. .||+|.++.........+.+..|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998764 32 689999877655666678899999999999999999999987532 24
Q ss_pred eEEEEEecCCCchhhhhhccc-ccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRK-EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
.++||||+++|+|.+++.... ......+++.....++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 1222458899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~--------- 225 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD--------- 225 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---------
Confidence 9987654322111222346778999999998899999999999999999999 788986543211 111
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.+..... ..........+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ----~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 ----YLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----HHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111110 001112334578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.04 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=197.8
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764 68899999997643 233456778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999998643 247888888999999999999996 8999999999999999999999999999754311
Q ss_pred CCC---------------------------------------------cceeecccccccccCccccccCCcCccccccc
Q 002255 749 NGK---------------------------------------------HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFS 783 (947)
Q Consensus 749 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 783 (947)
... .......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 00012357999999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHH--hcccCCCCC
Q 002255 784 FGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGH--CCAREPYQR 859 (947)
Q Consensus 784 lGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~R 859 (947)
|||++|||++|+.||......+.. ..++. ...... .......++.+++.+ |+..+|..|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQ----------------LKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHH----------------HHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCC
Confidence 999999999999999765432111 11111 111111 111123457788888 555667779
Q ss_pred CCHHHHHH
Q 002255 860 PDMGHVVN 867 (947)
Q Consensus 860 Ps~~evl~ 867 (947)
|++.|+++
T Consensus 297 ~~~~~~l~ 304 (381)
T cd05626 297 NGADDIKA 304 (381)
T ss_pred CCHHHHhc
Confidence 99999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.14 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=213.3
Q ss_pred cCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.+.....+||.|.||.||.|.|+. .-.||||.++.. ....++|..|+.+|+.++|||+|+++|+|..+..+|+|+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 455667899999999999999974 567999999764 4567899999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||..|+|.+||++..+. .++-...+.+|.||+.|++||.. +++|||||.++|+||.++..|||+|||+++++..
T Consensus 344 fM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred cccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999775543 35566678899999999999994 8999999999999999999999999999998865
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
+. +.......-...|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+..+ ...++
T Consensus 418 DT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----------------VY~LL 479 (1157)
T KOG4278|consen 418 DT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYGLL 479 (1157)
T ss_pred Cc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----------------HHHHH
Confidence 32 222222334568999999998999999999999999999999 667887654322 22334
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+. .+.+..+++.+++|++.||+++|.+||++.|+.+.++.+.+
T Consensus 480 EkgyR-M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 480 EKGYR-MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred hcccc-ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 44443 22334556778999999999999999999999999998753
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=331.02 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=205.2
Q ss_pred HhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 661 (947)
..++|+..+.||+|+||.||+|.++ .++.||+|.+.... ......++.+|+.+++.++||||+++++++.++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4578999999999999999999753 25679999886432 3344567899999999999999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc-----CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 736 (947)
..++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653211 12346788899999999999999996 7999999999999999999999
Q ss_pred EeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~ 815 (947)
++|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~--------- 230 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV--------- 230 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence 999999876544322222222345788999999988889999999999999999999 7888865432211
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+........ .........+.+++.+|++.+|++||++.|+++.|+
T Consensus 231 -------~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 -------LRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------HHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111110 011122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=343.11 Aligned_cols=268 Identities=24% Similarity=0.377 Sum_probs=198.9
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----CeeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 664 (947)
+|++.++||+|+||.||+|... +|+.||||++...........++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999865 689999999875433444456788999999999999999999988643 2479
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999994 6898887542 248899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCC-cceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc---
Q 002255 745 LAPDNGK-HSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI--- 818 (947)
Q Consensus 745 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~--- 818 (947)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6533221 112234579999999998865 6789999999999999999999999976543222111110000000
Q ss_pred ----ChhhHHHHhh---ccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 ----NKDTFRKAID---RTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ----~~~~~~~~~~---~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......+.+. ...... .........+.+++.+|++.||++||+++|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000111111 100000 000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=338.49 Aligned_cols=202 Identities=26% Similarity=0.413 Sum_probs=176.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.++||+|+||.||++..+ ++..+|+|++.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 368999999999999999999876 68889999887543 3445677999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.....++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999998542 247888889999999999999996 3579999999999999999999999999987553
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 156 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 32 1223568999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=332.44 Aligned_cols=264 Identities=29% Similarity=0.448 Sum_probs=209.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 660 (947)
..++|+..+.||+|+||.||++.... ...+|+|.+.... ......++.+|+.+++++ +|+||+++++++..+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34678889999999999999997642 3679999987543 344557789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccc-----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
+..++||||+++|+|.+++..+.. .....+++..+++++.|++.||+|||+ .+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 999999999999999999865321 223468999999999999999999996 899999999999999
Q ss_pred cCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhh
Q 002255 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVH 808 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 808 (947)
+.++.+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 9999999999999987654332222222345678999999988889999999999999999998 8999865432211
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.+.+..... ..........+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 244 ---------------~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ---------------FKLLKEGYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---------------HHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111111 0111123356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.17 Aligned_cols=262 Identities=29% Similarity=0.500 Sum_probs=209.4
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
.+|...+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45778899999999999999743 3456899988654 344456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccc-----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
++||||+++++|.+++..... .....+++..++.++.||+.|++|||+ ++|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999865321 112348899999999999999999996 899999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~ 811 (947)
+.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence 9999999999986544332222334557889999999988899999999999999999999 9999876543211 11
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+...... ......+..+.+++.+|++.+|++||++.+|++.|+++.+
T Consensus 237 -------------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -------------CITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -------------HHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111 1111233568899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.71 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=205.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.+|++.+.||+|+||.||+|..+ .++.||+|++... .....++.+|++++++++|+||+++++++..++..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45778899999999999999765 5889999998753 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ..+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999855322 348899999999999999999996 8999999999999999999999999999886644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+. .+.+
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----------------~~~~ 218 (263)
T cd05052 157 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YELL 218 (263)
T ss_pred cee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HHHH
Confidence 221 11122234668999999988899999999999999999998 8999875432111 0111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
..... ..........+.+++.+|++.+|++||++.+++++|+.+
T Consensus 219 ~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGYR-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111 111122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.32 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=205.7
Q ss_pred cCCCcCceecccCceEEEEEEE-----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......++.+|++++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999974 246789999987542 3445578899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccc------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 665 LVYEYMPQGTLSRHLFNRKE------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
+||||+++++|.+++..... .....+++.+...++.|++.||+|||+ ++|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999999854321 012347888999999999999999996 799999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~ 811 (947)
+.+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV----- 235 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999986544332222333456778999999988889999999999999999998 8889875432111
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.+.+..... ..........+.+++.+|++.+|++||++.+|.+.|..
T Consensus 236 ------------~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 ------------IEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111 01111223567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.07 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=209.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ........+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999764 78999999886532 24455567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||+++...
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988854322 12457888899999999999999996 899999999999999999999999999988764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ... . ..+
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~---~-----------~~~ 220 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSL---C-----------QKI 220 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHH---H-----------HHH
Confidence 4221 1223468899999999988889999999999999999999999996543211 111 1 111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
................+.+++.+|++.+|++||++.+|++.++.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111101111233456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.53 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
+.||+|+||.||++..+ +|+.||+|++..... .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 689999999976532 3345577889999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 150 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--A 150 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--c
Confidence 998888543 348899999999999999999996 899999999999999999999999999987543221 1
Q ss_pred eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCC
Q 002255 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 833 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+......+
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----------------~~~~~~~~~~~ 214 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILMEDIKF 214 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----------------HHHhccCCccC
Confidence 12345799999999999988999999999999999999999999975432211 11111111111
Q ss_pred ChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 834 DEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 834 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
+ ......+.+++.+||+.||++|| ++.|+++
T Consensus 215 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 215 P---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred C---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1 12234578999999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=346.73 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=196.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.. +++.||||++..... .......+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999764 689999999865422 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999998653 247788888899999999999996 899999999999999999999999999975321
Q ss_pred CCCC-----------------------------------------cceeecccccccccCccccccCCcCcccccccHHH
Q 002255 748 DNGK-----------------------------------------HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGV 786 (947)
Q Consensus 748 ~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 786 (947)
.... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 0000 00012357999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcccCCCCCC---C
Q 002255 787 ILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCAREPYQRP---D 861 (947)
Q Consensus 787 il~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s 861 (947)
++|||++|+.||......+... .+.. ...... ........+.+++.+|+ .+|.+|+ +
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~----------------~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQL----------------KVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHH----------------HHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 9999999999997654322110 1110 001100 01112345678888876 5999999 7
Q ss_pred HHHHHH
Q 002255 862 MGHVVN 867 (947)
Q Consensus 862 ~~evl~ 867 (947)
+.|+++
T Consensus 295 ~~ell~ 300 (376)
T cd05598 295 ADEIKA 300 (376)
T ss_pred HHHHhC
Confidence 788765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=345.54 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=205.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh-HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|... +|+.||+|+++...... .....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999875 68999999997653222 44567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998654 347888999999999999999996 899999999999999999999999999988654
Q ss_pred CCC---------------------------CcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCc
Q 002255 748 DNG---------------------------KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 800 (947)
Q Consensus 748 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~ 800 (947)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 432 00112335699999999999999999999999999999999999999976
Q ss_pred cCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 002255 801 TQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCAREPYQRPD-MGHVVN 867 (947)
Q Consensus 801 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 867 (947)
...... ..++.. .....+.. ......+.+++.+|+. +|.+||+ +.++++
T Consensus 233 ~~~~~~----------------~~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQET----------------YNKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHH----------------HHHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 542211 111111 11111111 1134567899999997 9999999 999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.51 Aligned_cols=264 Identities=27% Similarity=0.456 Sum_probs=207.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 661 (947)
.++|.+.++||+|+||.||+|+++ .++.||||+++... .....+.+.+|++++.++. |||||++++++...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 356788899999999999999864 34689999997653 2334567899999999997 999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcccc---------------------------------------------------------
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKE--------------------------------------------------------- 684 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 684 (947)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999965321
Q ss_pred ------------------------------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 685 ------------------------------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 685 ------------------------------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
.....+++..+..++.|++.||+|||+ .+|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence 011346788889999999999999996 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
+++++.+|++|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986543222112223457889999999988889999999999999999998 8889865432211
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
..+.+....... .+.....++.+++.+|++.+|.+||+++||++.|+.+.
T Consensus 351 ---------------~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ---------------FYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------------HHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111111100 11122356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.06 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=197.8
Q ss_pred CCCcCceecccCceEEEEEEE----cCCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCee
Q 002255 591 NFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 663 (947)
+|++.+.||+|+||.||+++. .+++.||+|++..... .....+.+..|+.+++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999865 3588999999875422 223346788999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++|+|.+++..+ ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999988653 347889999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... +
T Consensus 153 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~--------- 219 (332)
T cd05614 153 KEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---V--------- 219 (332)
T ss_pred ccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---H---------
Confidence 865432221 22345799999999998765 478899999999999999999999975432221110 0
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
...+........ ......+.+++.+|++.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 220 SRRILKCDPPFP---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHhcCCCCCC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011111111111 12234578999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.70 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCc
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGT 674 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 674 (947)
+.||+|+||.||+|..+ +++.||+|.+.... .......+.+|++++++++||||+++++++..+...++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999875 68999999876442 44456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcce
Q 002255 675 LSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754 (947)
Q Consensus 675 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 754 (947)
|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+|++|||+++..........
T Consensus 80 L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTEG----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999985432 347899999999999999999996 8999999999999999999999999999875433211111
Q ss_pred eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCC
Q 002255 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833 (947)
Q Consensus 755 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 833 (947)
.....++..|+|||.+.++.++.++|||||||++|||++ |..||......+ ....+.....
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~~~~- 214 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQGVR- 214 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCC-
Confidence 111123457999999988889999999999999999998 888886543211 1111111111
Q ss_pred ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 834 DEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 834 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
..........+.+++.+|++.+|++||++.+++++|+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0111122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.21 Aligned_cols=258 Identities=26% Similarity=0.452 Sum_probs=203.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.+.||+|+||.||+|.+. +++ .|++|.+... .......++..|+.++++++||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46788899999999999999864 344 4778877533 23344567888999999999999999999875 45578
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++
T Consensus 85 ~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 9999999999999996533 348999999999999999999996 789999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............++..|+|||++.++.++.++|||||||++||+++ |+.||.+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------- 220 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----------------- 220 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------
Confidence 7654332222334567789999999988899999999999999999998 9999976542211
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+.+....... ........+.+++.+|+..+|++||++.|+++.|..+..
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 221 PDLLEKGERLA-QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHCCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111111000 001122356789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.01 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=193.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..++||+|+||.||+|+.. +|+.||||++.... .......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 34566789999999999999865 68999999986542 34445788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999986432 24566778899999999999996 8999999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+.......
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----------- 287 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----------- 287 (353)
T ss_pred ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-----------
Confidence 221 1233579999999998743 2345689999999999999999999974332221111100
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... . ..........+.+|+.+||+.||++||++.|+++
T Consensus 288 --~~~~~-~-~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 288 --ICMSQ-P-PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --HhccC-C-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0 1111123356889999999999999999999987
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.41 Aligned_cols=257 Identities=30% Similarity=0.508 Sum_probs=209.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
...+|+..++||.|+||.||+|...+++.+|+|.+... ......++.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34678899999999999999999888999999998765 3334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 82 ELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred eecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999965432 457899999999999999999996 889999999999999999999999999987664
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... ......++..|+|||++....++.++||||||+++|+|++ |+.||......+. +...
T Consensus 156 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~----------------~~~~ 217 (261)
T cd05148 156 EDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV----------------YDQI 217 (261)
T ss_pred Cccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH----------------HHHH
Confidence 3221 1223346778999999988889999999999999999998 8999965442111 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
. .... ...+......+.+++.+|++.+|++||+++++++.|+.+
T Consensus 218 ~-~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 T-AGYR-MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred H-hCCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1 1111 111123345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.72 Aligned_cols=243 Identities=29% Similarity=0.459 Sum_probs=195.8
Q ss_pred ceecccCceEEEEEEE----cCCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 596 NVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++||+|+||.||+++. .+++.||+|+++.... .......+..|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578999999875422 223345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++... ..+.+..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999988543 236778888899999999999996 89999999999999999999999999998754332
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+...
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------------~~~~~~~~ 215 (323)
T cd05584 154 GT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------------TIDKILKG 215 (323)
T ss_pred CC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcC
Confidence 21 2234579999999999988889999999999999999999999997643211 11222222
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
....+.. ....+.+++.+|++.+|++|| ++.++++
T Consensus 216 ~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 KLNLPPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2222211 234578999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.05 Aligned_cols=239 Identities=26% Similarity=0.403 Sum_probs=188.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHH-HHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|+.. +|+.||+|++..... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999875432 2233345555654 67889999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|..++... ..+....+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 9998887542 347778888899999999999996 899999999999999999999999999987532221
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~~~~ 214 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----------------MYDNILHKPLQ 214 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHhcCCCC
Confidence 12234579999999999988899999999999999999999999997643211 11122222222
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
... .....+.+++.+|++.+|.+||++.
T Consensus 215 ~~~---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPG---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCC---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 221 1234578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.13 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=197.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|..+ +++.||||++..... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 368999999999999999999876 689999999875432 222346778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+. ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 67877775432 347888899999999999999997 899999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh-cCh-hhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH-INK-DTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~-~~~-~~~~ 824 (947)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... .....+.... ... ..+.
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhcc
Confidence 321 11233568999999998865 458889999999999999999999997643211 1111111000 000 0000
Q ss_pred HH-----hh-ccCC-CChhc-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KA-----ID-RTID-LDEET-L------ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~-----~~-~~~~-~~~~~-~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. .+ .... ..+.. . .....+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 00 0000 00000 0 01235679999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=344.47 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=197.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.++||+|+||.||++..+ +|+.||||++.... ......+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999764 68999999986542 23344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999988543 347888888999999999999996 899999999999999999999999999986432
Q ss_pred CCCCc---------------------------------------------ceeecccccccccCccccccCCcCcccccc
Q 002255 748 DNGKH---------------------------------------------SIETRLAGTFGYLAPEYAVTGRVTTKVDVF 782 (947)
Q Consensus 748 ~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 782 (947)
..... ......+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 000124699999999999988999999999
Q ss_pred cHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcccCCCCC-
Q 002255 783 SFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCAREPYQR- 859 (947)
Q Consensus 783 SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R- 859 (947)
||||++|||++|+.||......+. +..+.. ..+.... ......++.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHET----------------YRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHH----------------HHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999999999976543211 111111 1111111 11123457899999997 67765
Q ss_pred --CCHHHHHH
Q 002255 860 --PDMGHVVN 867 (947)
Q Consensus 860 --Ps~~evl~ 867 (947)
+++.|+++
T Consensus 295 ~r~~~~~~l~ 304 (377)
T cd05629 295 GRGGAHEIKS 304 (377)
T ss_pred CCCCHHHHhc
Confidence 58888776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.95 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=218.0
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.+-|...+.||+|.|+.|-.|++ -+|++||||++.+...+......+..|++.|+-++|||||++|++.......|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 456788889999999999999964 4799999999999888887788899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CCCcEEEeecCccee
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRL 745 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~ 745 (947)
.|.=.+|+|++|+....+ .+.+....+++.||+.|+.|+|. ..+|||||||+||++= +-|-||++|||++-.
T Consensus 96 LELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999999977543 37888889999999999999995 7899999999999875 568999999999987
Q ss_pred cCCCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
+.++.. .+..+|+..|-|||++.+..|+ +++||||+|||||-|++|++||+.... .+.+.
T Consensus 169 f~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLT 229 (864)
T KOG4717|consen 169 FQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLT 229 (864)
T ss_pred CCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhh
Confidence 766433 3456899999999999999987 689999999999999999999987654 34566
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.++|-++..+. ....+..+||..||..||++|-+.+||..
T Consensus 230 mImDCKYtvPs---hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 230 MIMDCKYTVPS---HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhcccccCch---hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 67777665433 34456889999999999999999999876
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.46 Aligned_cols=264 Identities=26% Similarity=0.435 Sum_probs=208.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 467888999999999999999641 24579999887542 344567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
....++||||+++|+|.+++..+... ....++|.++..++.||++||+|||+ ++|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999999764321 11357889999999999999999996 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~- 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence 99999999999999987654332222223346778999999988889999999999999999998 7888865432111
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+.+..... ..........+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 249 ----------------~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 ----------------FKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----------------HHHHHcCCc-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111111 01111234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=332.07 Aligned_cols=264 Identities=29% Similarity=0.443 Sum_probs=208.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|.+.+.||+|+||.||+|... ++..+|+|.+.... ......++.+|+++++++ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 357899999999999999999753 23569999987543 344567788999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
++..++||||+++|+|.+++..+... ....++|.++++++.|++.||+|||+ .+++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheE
Confidence 99999999999999999999764321 11348899999999999999999996 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-- 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence 99999999999999876543221111222234578999999988889999999999999999998 888886543211
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+.+.+..... ..........+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 251 ---------------~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 ---------------LFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ---------------HHHHHHcCCC-CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 11112234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.48 Aligned_cols=252 Identities=24% Similarity=0.432 Sum_probs=200.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.++||+|+||.||+|+.. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999875 689999999975432 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998653 247889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcc------------------------------------eeecccccccccCccccccCCcCcccccccHHHHHHHH
Q 002255 748 DNGKHS------------------------------------IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 791 (947)
Q Consensus 748 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~el 791 (947)
...... .....+||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211100 01124699999999999988999999999999999999
Q ss_pred HhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc--cCCCChhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 002255 792 ITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR--TIDLDEETLASISTVADLAGHCCAREPYQRPD---MGHVV 866 (947)
Q Consensus 792 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 866 (947)
++|+.||......+. ...+... .+.... .......+.+++.+|+. +|.+|++ +.|++
T Consensus 233 ~~G~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 233 LVGYPPFCSDNPQET----------------YRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred hcCCCCCCCCCHHHH----------------HHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 999999976543211 1111111 111111 11223457799999996 9999998 77776
Q ss_pred H
Q 002255 867 N 867 (947)
Q Consensus 867 ~ 867 (947)
+
T Consensus 295 ~ 295 (364)
T cd05599 295 S 295 (364)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.05 Aligned_cols=264 Identities=23% Similarity=0.438 Sum_probs=210.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcC-----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 662 (947)
.++|++.+.||+|+||.||+|.... +..|++|++... ........+.+|+.++++++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678899999999999999998765 688999988643 345556788999999999999999999998876 567
Q ss_pred eEEEEEecCCCchhhhhhccccc---CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEE---GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
.++++||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654321 12458999999999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhc
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||......+ +..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~------ 231 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY------ 231 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH------
Confidence 999986644332222223456778999999988889999999999999999999 999997643221 1111
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+....... ........+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 232 --------~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 --------LKDGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --------HHcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111101 111223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.94 Aligned_cols=244 Identities=26% Similarity=0.394 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
+.||+|+||.||++... +|+.||+|++..... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976532 2334567788999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++... ..+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 998887543 348899999999999999999995 36999999999999999999999999999875433221
Q ss_pred eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCC
Q 002255 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 833 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+......+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----------------~~~i~~~~~~~ 215 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILMEEIRF 215 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----------------HHHHhcCCCCC
Confidence 12335799999999999988999999999999999999999999976432211 11111111111
Q ss_pred ChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 834 DEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 834 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
.. ....++.+++.+|++.||++|+ ++.++++
T Consensus 216 p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PR---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CC---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 11 1234578999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.49 Aligned_cols=267 Identities=28% Similarity=0.444 Sum_probs=208.8
Q ss_pred HhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 661 (947)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......++.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3578999999999999999999653 24579999886543 2334457889999999999999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc-----CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 736 (947)
..++||||+++|+|.+++...... +.....+..+..++.|++.||+|||+ ++|+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999653321 12345777889999999999999996 8999999999999999999999
Q ss_pred EeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~ 815 (947)
++|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---------- 229 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---------- 229 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------
Confidence 999999886544322222222345678999999988899999999999999999999 788886543221
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 876 (947)
......+.... .........+.+++.+|++.+|++||++.++++.|++..+++
T Consensus 230 ------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 230 ------VLKFVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred ------HHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 11111111111 011122356889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=337.28 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=195.6
Q ss_pred ceecccCceEEEEEEE----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 596 NVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
+.||+|+||.||++.. .+|+.||+|++............+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999864 358899999998654344445677889999999999999999999999999999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999988542 347899999999999999999997 8999999999999999999999999999886543221
Q ss_pred cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----------------~~~~i~~~~~ 215 (318)
T cd05582 154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----------------TMTMILKAKL 215 (318)
T ss_pred --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence 2234579999999999988889999999999999999999999997643211 1111222222
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGH 864 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 864 (947)
..+. .....+.+++.+||+.||++||++.+
T Consensus 216 ~~p~---~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQ---FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCC---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2111 12345789999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.57 Aligned_cols=242 Identities=27% Similarity=0.422 Sum_probs=192.6
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHH---HcCCCCCcceEEEEEEeCCeeEEE
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVL---TKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
|++.+.||+|+||.||+|..+ +|+.||||+++.... .....+.+.+|++++ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999765 689999999975432 223345677776665 566899999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|..++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887743 248899999999999999999996 89999999999999999999999999998754
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+
T Consensus 152 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----------------~~~~i 213 (324)
T cd05589 152 MGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----------------VFDSI 213 (324)
T ss_pred CCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----------------HHHHH
Confidence 3221 12234679999999999998899999999999999999999999997654221 11112
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
........ ......+.+++.+||+.||++||++.
T Consensus 214 ~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 214 VNDEVRYP---RFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred HhCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 22211111 11234578999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.23 Aligned_cols=240 Identities=26% Similarity=0.414 Sum_probs=190.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHH-HHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|..+ +|+.||+|++..... ......++..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 689999999875432 2223345555655 56789999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-- 150 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence 9999888542 347888899999999999999996 899999999999999999999999999987543221
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~~~~ 214 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNILNKPLR 214 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence 12234579999999999999899999999999999999999999997643211 11222222222
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMGH 864 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 864 (947)
... .....+.+++.+|++.||++||++.+
T Consensus 215 ~~~---~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 215 LKP---NISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCC---CCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 211 12356789999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.65 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=201.0
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+....++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999876 58899999986532 223344568899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999988542 36778888999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccC----CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------------- 254 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------------- 254 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------------
Confidence 987643222 122345799999999998653 37889999999999999999999997643211
Q ss_pred ChhhHHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002255 819 NKDTFRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 867 (947)
.+.++++.. +..+ ........+.+++.+|+..++.+ |+++.|+++
T Consensus 255 ---~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 255 ---TYSKIMDHKNSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred ---HHHHHHhCCcccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 122222221 1111 11122345678999999855543 889998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.55 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=204.5
Q ss_pred CCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
+|.+.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667789999999999999753 25789999987543 3334567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccc-----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 665 LVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
+++||+++++|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999999853211 112347888999999999999999996 8999999999999999999
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~ 812 (947)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+....+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999886644332222233456789999999988889999999999999999998 888887543211
Q ss_pred HHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
....+.+.... .........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 235 ---------~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 ---------VIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111121111 1112234557899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.33 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=207.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|...+.||+|+||.||+|... .+..||||.++... .....+.+.+|+++++++ +|+||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 357899999999999999999642 35579999887543 334457889999999999 7999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ ++|+|+||||+||+++.++.++++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999865332 237999999999999999999996 799999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------------- 251 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------------- 251 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------
Confidence 9986644322222223456788999999988899999999999999999998 999987543221
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.+.+.+...... .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 252 -~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -KFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111112211111 11112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.85 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=197.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||++... +++.||+|.... ..+.+|++++++++|||||++++++..+...++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 467999999999999999999764 689999996432 34678999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|++ +++|.+++... ..+++.+++.++.||+.||+|||+ ++||||||||+||+++.++.+||+|||+++...
T Consensus 163 e~~-~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRY-KTDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecC-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 998 47888887543 247899999999999999999996 799999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccc-----hhhHHHHHHHhhcC---
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED-----SVHLVTWFRRMHIN--- 819 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~-----~~~l~~~~~~~~~~--- 819 (947)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...+...+......
T Consensus 234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred cccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 2211 12234579999999999998899999999999999999999998875433211 11111111111000
Q ss_pred -----hhhHHHHh----hccCCC---C---hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 -----KDTFRKAI----DRTIDL---D---EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 -----~~~~~~~~----~~~~~~---~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.... ...... . ........++.+|+.+||+.||++|||++|+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00111111 000000 0 011123456889999999999999999999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.91 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=201.2
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
..++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999875 688999999865322 22334567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++... .++...+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999988542 26677788899999999999996 8999999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccC----CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------------- 254 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------------- 254 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----------------
Confidence 6443221 12345799999999988653 47889999999999999999999997644211
Q ss_pred hHHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002255 822 TFRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVN 867 (947)
Q Consensus 822 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 867 (947)
.+..+.... +..+. .......+.+++.+|++.+|++ ||++.|+++
T Consensus 255 ~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 255 TYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 112222211 11111 1123456789999999999988 999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.76 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=204.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|+..++||+|+||.||+|.+. +|+ .||+|.+.... ......++.+|+.+++.++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 56888999999999999999754 444 48999987542 44456788999999999999999999999875 4568
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
++|||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence 9999999999999986532 348899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............+++.|+|||...+..++.++|||||||++|||++ |..||....... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~-------------- 220 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I-------------- 220 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H--------------
Confidence 7654322211222345678999999988899999999999999999998 899986543211 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...+..... ..........+.+++.+|++.||++||++.++++.|+.+...
T Consensus 221 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 221 PDLLEKGER-LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHCCCc-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 111111111 011112334678999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=326.88 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=201.2
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..|...+.||.|+||.||.|+. ++.+.||||++.... .+.+.+.++..|++.+++++|||+|.+.|||..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3456667799999999999965 578899999997654 34556789999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||| -|+-.|++.-.+ +++...++..|..+.+.||+|||+ .+.||||||+.|||+++.|.||++|||.|....
T Consensus 106 EYC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999 567777775433 568888999999999999999998 899999999999999999999999999988765
Q ss_pred CCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
+.. .++|||+|||||++. .+.|+-|+||||+|++..||...++|+........ + ..+..
T Consensus 178 PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--L-YHIAQ--------- 239 (948)
T KOG0577|consen 178 PAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L-YHIAQ--------- 239 (948)
T ss_pred chh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--H-HHHHh---------
Confidence 532 468999999999985 57899999999999999999999999876543211 1 11110
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....+.. ..-...+..++..||+.-|.+|||..++++
T Consensus 240 ---NesPtLqs--~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 240 ---NESPTLQS--NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---cCCCCCCC--chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11111111 222345779999999999999999998876
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.61 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=198.3
Q ss_pred eecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 597 VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.||+|+||.||+|.++ ++..+|+|+++.........+++..|+.+++.++||||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998766545556778999999999999999999999875 45678999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999998542 247889999999999999999996 899999999999999999999999999998664432211
Q ss_pred e-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 754 I-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 754 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
. .....++..|+|||.+....++.++|||||||++|||++ |+.||......+. .. .+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~--------------~i~~~~ 215 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ--------------MIESGE 215 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------HHHCCC
Confidence 1 122234678999999988889999999999999999998 9999976543211 11 111111
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
. ...+......+.+++.+|++.||++||++.+|.+.|++.
T Consensus 216 ~-~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 R-MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C-CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 011112345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=338.47 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=202.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999765 689999999986532 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999986542 348889999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCccccc------cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV------TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--------------- 217 (330)
T cd05601 154 ANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--------------- 217 (330)
T ss_pred CCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---------------
Confidence 43322 233457999999999986 45678999999999999999999999976442211
Q ss_pred hHHHHhhc--cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 TFRKAIDR--TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+... ....+. .......+.+++.+|++ +|++||++.++++
T Consensus 218 -~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 218 -YNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -HHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111111 111111 11233567899999998 9999999998865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.71 Aligned_cols=267 Identities=26% Similarity=0.426 Sum_probs=207.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcC-----------------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcc
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD-----------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (947)
.++|++.+.||+|+||.||+|.... +..||+|.+.... .....+++.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4678999999999999999987542 2458999987553 345567899999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCchhhhhhccccc------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCC
Q 002255 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (947)
Q Consensus 652 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 725 (947)
++++++..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999998764421 12368999999999999999999996 89999999999
Q ss_pred cEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh--CCCCCCccCc
Q 002255 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQS 803 (947)
Q Consensus 726 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~p~~~~~~ 803 (947)
||+++.++.++++|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999886544333333344567789999999988889999999999999999998 6677765432
Q ss_pred cchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 804 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+ ............ ..... .........++.+++.+|++.||++||++.||++.|+
T Consensus 240 ~~---~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ---VIENAGHFFRDD-------GRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHHhccccc-------ccccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 111111100000 00000 0111122356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.65 Aligned_cols=250 Identities=30% Similarity=0.466 Sum_probs=200.8
Q ss_pred CCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
+|++.+.||+|+||.||+|.++++..+|+|++...... ..++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 57788999999999999998887788999998654322 356788999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
++++|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++...+..
T Consensus 82 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 82 ANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999986533 247899999999999999999996 889999999999999999999999999988654322
Q ss_pred CcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . +.+..
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~--------------~~~~~ 216 (256)
T cd05059 155 YT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V--------------ESVSA 216 (256)
T ss_pred cc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H--------------HHHHc
Confidence 11 1112234457999999988899999999999999999999 8899875432211 0 11111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.... .........+.+++.+|++.+|++||++.|+++.|
T Consensus 217 ~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 GYRL-YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCcC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1110 11112345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=332.71 Aligned_cols=264 Identities=28% Similarity=0.436 Sum_probs=207.7
Q ss_pred cCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 660 (947)
.+|++.+.||+|+||.||+|+.. .+..||+|.++.. ......+++.+|+++++++ +||||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999642 1236899988754 2445567899999999999 799999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
+..++||||+++|+|.+++..+... ....++|.++..++.|++.||+|||+ ++|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 9999999999999999998754311 12358899999999999999999996 899999999999999
Q ss_pred cCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhh
Q 002255 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVH 808 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 808 (947)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 9999999999999986644222211222334568999999998899999999999999999998 8888865432111
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...+..... ..........+.+++.+|++.+|++||++.|+++.|+.+...
T Consensus 246 ---------------~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 246 ---------------FKLLKEGHR-MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ---------------HHHHHcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111111 011112234688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.18 Aligned_cols=260 Identities=30% Similarity=0.476 Sum_probs=206.9
Q ss_pred hcCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|++.+.||+|+||.||+|..+. +..||+|.+.... .......+.+|+.+++.++||||+++++++..+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4678899999999999999997642 4689999986543 33445678999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccccc-----CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
.++||||+++|+|.+++...... ....++|..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999998654321 12347889999999999999999996 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||......+. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~----- 232 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK----- 232 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH-----
Confidence 99999886544332222233456789999999988889999999999999999998 8999865442211 11
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
....... ...+......+.+++.+|++.+|++|||+.++++.|+
T Consensus 233 --------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 --------FVIDGGH--LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------HHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111110 0111122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=338.88 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=196.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++.+++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999765 688999999975432 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999998653 347889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCc---------------------------------ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhC
Q 002255 748 DNGKH---------------------------------SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794 (947)
Q Consensus 748 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg 794 (947)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 001235799999999999988999999999999999999999
Q ss_pred CCCCCccCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHH
Q 002255 795 RKALDETQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCA--REPYQRPDMGHVVN 867 (947)
Q Consensus 795 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~ 867 (947)
+.||......+. +..+.. ..+.+++. .....++.+++.+++. .++..||++.||++
T Consensus 233 ~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 233 YPPFCSETPQET----------------YKKVMNWKETLIFPPE-VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCCCHHHH----------------HHHHHcCcCcccCCCc-CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 999976543211 111111 11111111 1123456677877553 23445689998866
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=319.99 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=210.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 79999999887533 23344678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++..... ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999998865322 22457899999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ...
T Consensus 158 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----------~~~ 221 (267)
T cd08224 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK----------KIE 221 (267)
T ss_pred CCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh----------hhh
Confidence 3221 122346889999999998888999999999999999999999999654311 111110 111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
..... ..........+.+++.+|+..+|++||++.+|+++|+.+.
T Consensus 222 ~~~~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 KCDYP-PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCC-CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111 1111133456789999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.11 Aligned_cols=267 Identities=27% Similarity=0.452 Sum_probs=204.7
Q ss_pred hcCCCcCceecccCceEEEEEEEcC---------------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD---------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 653 (947)
.++|++.+.||+|+||.||++.... ...||+|.++... .......+.+|++++++++|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3679999999999999999986532 2358999987542 44556789999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCchhhhhhccccc-------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 002255 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726 (947)
Q Consensus 654 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 726 (947)
++++..+...++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 99999999999999999999999998653211 11247889999999999999999996 899999999999
Q ss_pred EEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh--CCCCCCccCcc
Q 002255 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQSE 804 (947)
Q Consensus 727 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~p~~~~~~~ 804 (947)
|++++++.+||+|||+++...............++..|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876544322222233456778999999988899999999999999999998 56677654432
Q ss_pred chhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 805 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
+.... .... +........ ..........+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ~~~~~---~~~~------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIEN---TGEF------FRNQGRQIY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHH---HHHh------hhhcccccc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 21111 0000 000000000 0011112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.08 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=203.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+++|.+.+.||+|+||.||+|.+. .+..||+|.+.... .......+..|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 467889999999999999999875 35678999876442 34445678999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccccc--CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC---cEEE
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 737 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl 737 (947)
.++||||+++++|.+++...... ....++|..+.+++.||+.||+|||+ .+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998664321 12358999999999999999999997 7899999999999998754 6999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---------- 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---------- 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 99999986633221111122234568999999998899999999999999999997 9999976443211
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+.+..... ..........+.+++.+|++.+|++||++.+|++.|+
T Consensus 231 -------~~~~~~~~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 -------MEFVTGGGR-LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111100 0111122356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=320.62 Aligned_cols=255 Identities=31% Similarity=0.506 Sum_probs=203.4
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.++||+|+||.||+|..++...||+|+++.... ..+++.+|++++++++|+||+++++++. +...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 357899999999999999999887777899999875432 2357889999999999999999999874 456799999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++.... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999996432 1347899999999999999999996 8999999999999999999999999999986644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .......++..|+|||+..+..++.++||||||+++|||++ |+.||......+. ...+
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----------------~~~~- 216 (262)
T cd05071 155 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQV- 216 (262)
T ss_pred ccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----------------HHHH-
Confidence 322 11223346778999999988899999999999999999999 8888865432211 1111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
..... ..........+.+++.+|++.+|++||+++++++.|+..
T Consensus 217 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 217 ERGYR-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred hcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11111 011123345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.69 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=201.9
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45778899999999999999888777899998875432 235789999999999999999999999998899999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+.+|+|.+++.... ..+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999886532 248899999999999999999996 89999999999999999999999999998866443
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......++..|+|||+.....++.++|||||||++|||++ |+.||......+. ...+..
T Consensus 154 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----------------~~~~~~ 216 (256)
T cd05113 154 EY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET----------------VEKVSQ 216 (256)
T ss_pred ce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHHhc
Confidence 21 11222345678999999988889999999999999999999 9999875442211 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.... .........+.+++.+||+.+|.+||++.++++.|
T Consensus 217 ~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 217 GLRL--YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 1111 00111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.34 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=200.9
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+|+..++||+|+||.||++... +++.||+|++...... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999764 6899999998754322 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988754321 358899999999999999999997 7999999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... .....|++.|+|||++.+..++.++||||+||++|||++|+.||.......... .+...+.
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~-------------~~~~~~~ 218 (285)
T cd05605 155 GET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE-------------EVERRVK 218 (285)
T ss_pred CCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH-------------HHHHHhh
Confidence 221 123478999999999988889999999999999999999999997644321110 1111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
... ..........+.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 219 EDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hcc--cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 110 111122335578999999999999999 6777755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.21 Aligned_cols=240 Identities=25% Similarity=0.401 Sum_probs=193.2
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|..+ +++.||||++..... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 588999999875432 234456778898988877 699999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 9999888543 247888999999999999999996 8999999999999999999999999999875432221
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------------~~~i~~~~~~ 214 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----------------FEAILNDEVV 214 (320)
T ss_pred -cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------------HHHHhcCCCC
Confidence 22345799999999999988999999999999999999999999976542211 1111221111
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMGH 864 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 864 (947)
.. ......+.+++.+|++.||++||++.+
T Consensus 215 ~~---~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 YP---TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CC---CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11 112346789999999999999999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=332.11 Aligned_cols=243 Identities=25% Similarity=0.387 Sum_probs=194.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|+.+ +++.||+|++..... .....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 578999999876432 234456678899999876 799999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 9999888543 347888999999999999999996 8999999999999999999999999999876433221
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----------------~~~~i~~~~~~ 214 (321)
T cd05591 152 -TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----------------LFESILHDDVL 214 (321)
T ss_pred -cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence 2234579999999999998899999999999999999999999997654321 11122222111
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRP-------DMGHVVN 867 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 867 (947)
.+. ....++.+++.+|++.||++|| ++.++++
T Consensus 215 ~p~---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPV---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111 1234678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=318.31 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=207.4
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||+|..+ +++.|++|.+..........+++.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999875 689999999876555566778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++++|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999865421 458899999999999999999996 89999999999999999999999999998876543
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||....... . .......
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-------------~~~~~~~ 216 (256)
T cd08529 155 TN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---L-------------ILKIIRG 216 (256)
T ss_pred cc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHHcC
Confidence 22 1233468899999999998889999999999999999999999997554211 1 1111111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .........+.+++.+|++.+|++||++.++++
T Consensus 217 ~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 217 VFP--PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCC--CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111 111133456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.51 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=204.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..++|++.++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+|++++++++. ++..++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3467899999999999999999988899999999875532 2457889999999999999999999874 56789999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++++|||++....
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 80 EYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999885532 2358899999999999999999996 899999999999999999999999999988665
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... .......++..|+|||++....++.++||||||+++||+++ |+.||......+. .. .
T Consensus 154 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~--------------~ 215 (260)
T cd05067 154 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ--------------N 215 (260)
T ss_pred CCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH--------------H
Confidence 3221 12223346778999999988889999999999999999999 9999975442211 11 1
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
+...... +........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 LERGYRM-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111110 1111223468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.66 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=205.1
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
.+|...++||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 56778899999999999999642 3567899987654 455567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccc----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKE----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
++||||+++++|.+++..... .....+++.+++.++.|++.|++|||+ .+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 999999999999999865431 111347899999999999999999996 8999999999999999999
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~ 812 (947)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------ 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------
Confidence 999999999876544322222233346788999999988899999999999999999998 8999865432211
Q ss_pred HHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.......... .........+.+++.+||+.||.+||++.||++.|+
T Consensus 234 ----------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ----------IECITQGREL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------HHHHHcCccC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111100 111123356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=327.17 Aligned_cols=267 Identities=24% Similarity=0.426 Sum_probs=205.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-----------------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcc
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-----------------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (947)
.++|++.++||+|+||.||++... ++..||+|++.... ......++.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 457999999999999999998543 23468999987542 344567899999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCchhhhhhccccc------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCC
Q 002255 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (947)
Q Consensus 652 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 725 (947)
++++++..++..++||||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence 9999999999999999999999999998764321 11347888999999999999999996 79999999999
Q ss_pred cEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh--CCCCCCccCc
Q 002255 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDETQS 803 (947)
Q Consensus 726 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~p~~~~~~ 803 (947)
||+++.++.++++|||+++...............++..|+|||+...+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999886544322222233345678999999888889999999999999999998 6788865443
Q ss_pred cchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 804 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+.... ... .+...... .. .+........+.+++.+|++.||++||++.||++.|+
T Consensus 240 ~~~~~~---~~~------~~~~~~~~-~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIEN---TGE------FFRDQGRQ-VY-LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHH---HHH------HHhhcccc-cc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 221110 000 00000000 00 0111122356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.52 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=196.0
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||+|+||+||++..+ +|+.||+|.+...... ....+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 6889999998754322 23446778899999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+++....... ..
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 888754322 22458899999999999999999997 8999999999999999999999999999986644322 12
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE 835 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (947)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~~~~--- 219 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRILNDSVT--- 219 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH------------HHHHHhhcccCCC---
Confidence 3357899999999999999999999999999999999999999754322110 0011111111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 836 ETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 836 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
........+.+++.+|++.||++|| ++.++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1112345678999999999999999 5565554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.43 Aligned_cols=262 Identities=31% Similarity=0.490 Sum_probs=205.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC-Cc--EEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.++||+|+||.||+|..++ +. .+++|.++.. ......+.+.+|+++++++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578899999999999999998753 33 4788887643 2344567889999999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
||||+++++|.+++...... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999998653211 11348899999999999999999996 89999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||......+.
T Consensus 158 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------- 227 (297)
T cd05089 158 SKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------- 227 (297)
T ss_pred EEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 9999999986432110 1111223567999999988889999999999999999997 9999976543211
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 876 (947)
... +...... .........+.+++.+|++.+|.+||++.++++.|+.+.+.+
T Consensus 228 ---------~~~-~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 ---------YEK-LPQGYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------HHH-HhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 1111110 111123356789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=330.47 Aligned_cols=240 Identities=27% Similarity=0.411 Sum_probs=190.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|..+ +++.||+|+++.... .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578999999976532 223345566777777654 899999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 9999888543 247888899999999999999997 899999999999999999999999999998653322
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. +..+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----------------~~~i~~~~~~ 214 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----------------FDSILNDRPH 214 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHcCCCC
Confidence 223345799999999999988899999999999999999999999976542211 1111111111
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMGH 864 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 864 (947)
.+.....++.+++.+||+.+|++||++.+
T Consensus 215 ---~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 215 ---FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred ---CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 11112345779999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.57 Aligned_cols=254 Identities=31% Similarity=0.523 Sum_probs=203.0
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|..+++..||+|.+...... .+++.+|+.++++++|+|++++++++. +...++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3578899999999999999999888889999998765332 357899999999999999999999875 456899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++++|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999986532 2347899999999999999999997 7999999999999999999999999999987644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ... . +
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~-------------~-~ 216 (260)
T cd05070 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE-------------Q-V 216 (260)
T ss_pred cccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-------------H-H
Confidence 3211 1122345678999999988889999999999999999999 888986543211 111 1 1
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
..... .+........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 217 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ERGYR-MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcCCC-CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111 01112233568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.76 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=195.4
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCC-CcceEEEEEEeCCeeEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHR-HLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 667 (947)
+|++.+.||+|+||.||+|..+ +++.||||++..... .....+.+..|++++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999765 578899999976432 334556788999999999764 6888999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 999999999888543 247888999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..+.
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~ 214 (324)
T cd05587 153 FGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQSIM 214 (324)
T ss_pred CCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 2221 2234579999999999999899999999999999999999999997644221 111122
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
....... ......+.+++.+|++.+|.+|++.
T Consensus 215 ~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 215 EHNVSYP---KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred cCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2211111 1223457899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.21 Aligned_cols=262 Identities=26% Similarity=0.334 Sum_probs=205.4
Q ss_pred CCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-C-----CCcceEEEEEEeCCee
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-H-----RHLVGLLGYCLDGNER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~ 663 (947)
+|.+.++||+|+||.|-+|.. ++++.||||+++.. ..-..+...|+.+|..++ | -|+|+++++|...+|.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999954 57999999999865 444567788999999997 4 4999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC--CcEEEeecC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFG 741 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfG 741 (947)
|||+|.+ ..+|++++.... ...++...+..++.||+.||.+||. .+|||+||||+|||+.+. ..+||+|||
T Consensus 264 ciVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999988 679999996644 3558899999999999999999996 899999999999999754 479999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC--
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-- 819 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-- 819 (947)
.|......-. ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+..+.++...+..+......
T Consensus 337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9987755322 345567899999999999999999999999999999999988887776655443222111000
Q ss_pred ---hhhHHHHhhc-------------------------------cCCCC--------hhcHHHHHHHHHHHHHhcccCCC
Q 002255 820 ---KDTFRKAIDR-------------------------------TIDLD--------EETLASISTVADLAGHCCAREPY 857 (947)
Q Consensus 820 ---~~~~~~~~~~-------------------------------~~~~~--------~~~~~~~~~l~~li~~cl~~dP~ 857 (947)
.......++. ....+ .........+.+++++|+..||+
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0000000000 00000 01113345688999999999999
Q ss_pred CCCCHHHHHH
Q 002255 858 QRPDMGHVVN 867 (947)
Q Consensus 858 ~RPs~~evl~ 867 (947)
+|+|+.++++
T Consensus 492 ~R~tp~qal~ 501 (586)
T KOG0667|consen 492 ERITPAQALN 501 (586)
T ss_pred hcCCHHHHhc
Confidence 9999998876
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=322.10 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=194.2
Q ss_pred ceecccCceEEEEEEEcC---CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|.+.+ +..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999997653 4579999887553 233446788999999999999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++...........++..+..++.|++.|++|||+ .+++||||||+||+++.++.+|++|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999976443333456778888999999999999996 89999999999999999999999999998754433222
Q ss_pred ceeecccccccccCccccccC-------CcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 753 SIETRLAGTFGYLAPEYAVTG-------RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.......|+..|+|||++... .++.++||||||+++|||++ |+.||......+.... .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~--------- 225 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY--TVRE--------- 225 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH--Hhhc---------
Confidence 222335678899999988542 35789999999999999996 9999976543221100 0000
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.......+.........+.+++.+|+ .+|++||++.||++.|+
T Consensus 226 --~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 --QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00001101111122345778999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=320.99 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=209.2
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|.. .+++.||||.+.... ......+++.+|+.+++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 478999999886532 23344578899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998864322 22458899999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......|+..|+|||++.+..++.++||||||+++|||++|..||....... ... .....
T Consensus 158 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-------------~~~~~ 221 (267)
T cd08229 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL-------------CKKIE 221 (267)
T ss_pred cCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHH-------------hhhhh
Confidence 4221 1223468899999999988889999999999999999999999996543211 000 01111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
..... ..........+.+++.+|++.+|++||||.+|++.++++
T Consensus 222 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 222 QCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11110 111112345688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=353.91 Aligned_cols=266 Identities=22% Similarity=0.330 Sum_probs=206.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.++||+|+||.||+|... +|+.||+|++..... .+...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 589999999975432 2344567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccccc------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 668 EYMPQGTLSRHLFNRKEE------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
||+++|+|.+++...... .....++..+++++.||++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642211 11235677889999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCC----------------cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccc
Q 002255 742 LVRLAPDNGK----------------HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED 805 (947)
Q Consensus 742 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~ 805 (947)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001123579999999999999999999999999999999999999997643211
Q ss_pred hhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 002255 806 SVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-DMGHVVNVLSSLAE 874 (947)
Q Consensus 806 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~~ 874 (947)
.. ....+...... ......+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus 239 i~---------------~~~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS---------------YRDVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh---------------hhhhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 00000000000 00112334578999999999999996 66777777777654
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=331.03 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=196.0
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999765 578999999876532 233445677788888887 5899999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999888543 247889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+.
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----------------~~~i~ 214 (323)
T cd05616 153 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------FQSIM 214 (323)
T ss_pred CCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH----------------HHHHH
Confidence 2221 22345799999999999999999999999999999999999999976543211 11222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
......+ .....++.+++.+|++.+|++|++.
T Consensus 215 ~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 EHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred hCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2222211 1233567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=322.71 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=196.2
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||+|+||.||+++.+ +|+.||+|.+...... ......+..|++++++++||||+++++++.++.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999765 6899999998654322 22334566799999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 151 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TI 151 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---ee
Confidence 988854332 347899999999999999999996 899999999999999999999999999988764422 22
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE 835 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (947)
....|+..|+|||++.+..++.++||||+||++|||++|+.||........ ... .....+.......
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~----------~~~~~~~~~~~~~- 218 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEE----------LKRRTLEDEVKFE- 218 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHH----------HHHHhhccccccc-
Confidence 345789999999999888899999999999999999999999975432111 000 1111111111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 836 ETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 836 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
......++.+++.+||+.||++||+++|+++.+
T Consensus 219 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 -HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 012234578999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=336.24 Aligned_cols=267 Identities=23% Similarity=0.347 Sum_probs=201.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-----eeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 664 (947)
+|+..++||+|+||.||+|... +|+.||+|++..........+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999864 7899999998754434445678899999999999999999999998776 789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+. ++|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999995 6787777432 348899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc-----
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI----- 818 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~----- 818 (947)
....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||......+....+........
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 152 VEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 6543221 122334688999999998764 478999999999999999999999987654332222111100000
Q ss_pred -ChhhHHHHhhccCCCChh-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 -NKDTFRKAIDRTIDLDEE-------TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 -~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........+......... ......++.+|+.+|++.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000111111111100000 0112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=340.17 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=195.4
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+|+..++||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999764 688999999875432 23445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999988543 247788888899999999999996 8999999999999999999999999999753211
Q ss_pred CCC---------------------------------------------cceeecccccccccCccccccCCcCccccccc
Q 002255 749 NGK---------------------------------------------HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFS 783 (947)
Q Consensus 749 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 783 (947)
... .......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 00012347999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC
Q 002255 784 FGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCAREPYQRPD 861 (947)
Q Consensus 784 lGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 861 (947)
|||++|||++|+.||....+.+. ...++. ...... .......++.+++.+|+ .+|++|++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLET----------------QMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHH----------------HHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999999976543211 111111 111111 11122345678888876 59999997
Q ss_pred ---HHHHHH
Q 002255 862 ---MGHVVN 867 (947)
Q Consensus 862 ---~~evl~ 867 (947)
+.|+++
T Consensus 296 ~~~~~ei~~ 304 (382)
T cd05625 296 KNGADEIKA 304 (382)
T ss_pred CCCHHHHhc
Confidence 666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=324.96 Aligned_cols=261 Identities=30% Similarity=0.469 Sum_probs=205.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|++.+.||+|+||.||+|..+ ++..||+|.+.... ......++.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467899999999999999999763 46789999987543 34445779999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccc-----------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKE-----------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 725 (947)
.++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999964321 112347889999999999999999996 89999999999
Q ss_pred cEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCcc
Q 002255 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSE 804 (947)
Q Consensus 726 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~ 804 (947)
||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543222111222345678999999988899999999999999999998 88888654322
Q ss_pred chhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 805 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
+. ...+.+.... .........+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~~----------------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV----------------IYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH----------------HHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 1111111111 0111233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.57 Aligned_cols=260 Identities=33% Similarity=0.517 Sum_probs=203.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc--EEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||.||+|.++ ++. .+|+|.++.. ........+.+|++++.++ +|+||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57888999999999999999865 454 4577776543 2445567889999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
||||+++++|.+++...... ....+++.+++.++.|++.|++|||+ .+|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 99999999999998654311 12357899999999999999999996 89999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||......+. .
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~--- 233 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y--- 233 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H---
Confidence 999999998643211 11112234678999999988889999999999999999998 9999965432211 0
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+.+..... ..........+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus 234 -----------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 -----------EKLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -----------HHHhcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111111 00111223457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.22 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=197.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999865 58999999987532 23334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999985422 347888899999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---------------- 216 (331)
T cd05597 154 ADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---------------- 216 (331)
T ss_pred CCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----------------
Confidence 43221 1223469999999999863 4578899999999999999999999975432111
Q ss_pred HHHHhhc--cCCCChhcHHHHHHHHHHHHHhcccCC--CCCCCHHHHHH
Q 002255 823 FRKAIDR--TIDLDEETLASISTVADLAGHCCAREP--YQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~ 867 (947)
+..+... ..............+.+++.+|+..++ ..||++.++++
T Consensus 217 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 217 YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 1111111 111111112234567789999876533 34788888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=322.92 Aligned_cols=271 Identities=26% Similarity=0.420 Sum_probs=204.8
Q ss_pred cCC-CcCceecccCceEEEEEEE-----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--C
Q 002255 590 NNF-SEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--N 661 (947)
Q Consensus 590 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 661 (947)
++| +..+.||+|+||.||++.+ .+++.||+|.++... .....+.+.+|++++++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 8889999999999988653 357889999987552 334457788999999999999999999988653 4
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++++|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecc
Confidence 578999999999999998542 38999999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~-~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG-QMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc-ccch
Confidence 98866543221 11222345677999999988889999999999999999999999986543211 011100000 0001
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
..+.+.++..... .........+.+++.+|++.+|++||+++++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1122222222111 111223456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=332.94 Aligned_cols=265 Identities=26% Similarity=0.437 Sum_probs=204.6
Q ss_pred hcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC-
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG- 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 660 (947)
.++|++.++||+|+||.||+|.+ .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 46799999999999999999963 347889999997543 334456788999999999 689999999988654
Q ss_pred CeeEEEEEecCCCchhhhhhccccc-------------------------------------------------------
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEE------------------------------------------------------- 685 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 685 (947)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998653210
Q ss_pred -------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecc
Q 002255 686 -------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758 (947)
Q Consensus 686 -------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 758 (947)
....+++..+..++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01236888899999999999999996 89999999999999999999999999998865432222122223
Q ss_pred cccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhc
Q 002255 759 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEET 837 (947)
Q Consensus 759 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (947)
.++..|+|||++.+..++.++||||||+++|||++ |..||........ +...+...... ..+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~-~~~ 304 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEGTRM-RAP 304 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----------------HHHHHhccCCC-CCC
Confidence 45678999999988889999999999999999997 8999865432211 01111111100 001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 838 LASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 838 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
......+.+++.+|++.+|++||++.||++.|+.+.+
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.49 Aligned_cols=265 Identities=27% Similarity=0.446 Sum_probs=207.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|.+.++||+|+||.||+|+.. ....||+|.++... ......++..|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 367888999999999999999642 24578999887543 344567789999999999 69999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccc-----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
++..++||||+++|+|.+++..... .....++|.++.+++.|++.||+|||+ ++|+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence 9999999999999999999966431 112458899999999999999999996 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~- 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL- 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986643221111122234567999999988889999999999999999999 8888865432111
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
. +.+..... ..........+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 246 --~--------------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 --F--------------KLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred --H--------------HHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1 11111100 011112234678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=333.84 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=200.4
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 661 (947)
.+.++|++.+.||+|+||.||++... +|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35588999999999999999999764 6899999999765545556678889999999999999999999986543
Q ss_pred --eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 662 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEec
Confidence 47999999965 56555532 26788888999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..........
T Consensus 167 fg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~~ 241 (359)
T cd07876 167 FGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW--NKVIEQLGTP 241 (359)
T ss_pred CCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCC
Confidence 9998754332 1223457899999999999989999999999999999999999999865432211 1111111000
Q ss_pred hh--------hHHHHhhccCCCCh-----------------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KD--------TFRKAIDRTIDLDE-----------------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~--------~~~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. .............. ........+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 01111111000000 00112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=351.97 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=202.8
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCee
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNER 663 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 663 (947)
...++|.+.+.||+|+||.||+|... ++..||+|.+............+..|+.++++++|||||++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999765 57789999988665566667889999999999999999999998864 4568
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc----CCCeeecCCCCCcEEEcC--------
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA----HQSFIHRDLKPSNILLGD-------- 731 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~ivHrDlkp~Nill~~-------- 731 (947)
|+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999998653321 245899999999999999999999732 146999999999999964
Q ss_pred ---------CCcEEEeecCcceecCCCCCcceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCc
Q 002255 732 ---------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDE 800 (947)
Q Consensus 732 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~ 800 (947)
.+.+||+|||+++...... ......||+.|+|||++.. ..++.++||||||||+|||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3459999999998664321 2234579999999998854 4588999999999999999999999975
Q ss_pred cCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 801 TQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 801 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... .+ ...+....... .......+.+||.+||+.+|.+||++.+++.
T Consensus 246 ~~~~~--ql--------------i~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFS--QL--------------ISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHH--HH--------------HHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 43211 11 11111111111 0112356889999999999999999999985
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.88 Aligned_cols=245 Identities=24% Similarity=0.412 Sum_probs=192.4
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|..+ +++.||+|+++.... .......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 678999999986532 234456688899998877 799999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9998887543 348889999999999999999996 8999999999999999999999999999875432221
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccch--hhHHHHHHHhhcChhhHHHHhhcc
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDS--VHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .....++ ...+....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~i~~~~ 221 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVILEKQ 221 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH---------HHHHhcCC
Confidence 12345799999999999999999999999999999999999999964322111 0011111 11122222
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
...+ ......+.+++.+||+.||++||++
T Consensus 222 ~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 IRIP---RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCC---CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2211 1223457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.17 Aligned_cols=248 Identities=28% Similarity=0.470 Sum_probs=198.6
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
++||+|+||.||+|..+++..||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4699999999999998888999999987543 344456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++.... ..+++..+..++.|++.||.|+|+ ++++||||||+||+++.++.+|++|||++....... ....
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~ 151 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSS 151 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc-cccC
Confidence 99885432 347899999999999999999996 899999999999999999999999999987543321 1111
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCC
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (947)
....++..|+|||++.+..++.++||||||+++||+++ |..||........ . ..+..... .
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~--------------~~~~~~~~-~ 213 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R--------------EQVEKGYR-M 213 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H--------------HHHHcCCC-C
Confidence 22244678999999988889999999999999999998 9999975432211 0 11111111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 835 EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 835 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.........+.+++.+|++.+|++||++.|+++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111123356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=335.37 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=201.3
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
...+...++|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999876 68899999986532 2233445678999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...++||||+++|+|.+++... .++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999988542 26777888899999999999996 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccC----CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
|+++........ ......||+.|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 187 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------- 254 (371)
T cd05622 187 GTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------- 254 (371)
T ss_pred CceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----------
Confidence 999876443221 22345799999999998653 37889999999999999999999997644211
Q ss_pred hcChhhHHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 002255 817 HINKDTFRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVNV 868 (947)
Q Consensus 817 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 868 (947)
.+.++.... +.+.. .......+.+++.+|+..++.+ |+++.|+++.
T Consensus 255 -----~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 255 -----TYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -----HHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 112222211 11111 1123455779999999844433 6788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.53 Aligned_cols=253 Identities=30% Similarity=0.501 Sum_probs=201.9
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|.+.+.||+|+||.||+|..+.+..+|+|++.... ...+.+.+|++++++++|+|++++++++. ++..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5688889999999999999998877789999876542 22357889999999999999999999875 4568999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999986532 2347899999999999999999996 89999999999999999999999999999866442
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......++..|+|||+..+..++.++|||||||++|||++ |+.||.+....+. ..+ +.
T Consensus 156 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~--------------~~ 217 (260)
T cd05069 156 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ--------------VE 217 (260)
T ss_pred cc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH--------------HH
Confidence 21 11222346778999999988889999999999999999999 8999976432211 111 11
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.... ..........+.+++.+|++.+|++||++.+|++.|++
T Consensus 218 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYR-MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111 01111234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.66 Aligned_cols=257 Identities=25% Similarity=0.496 Sum_probs=203.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC-C---cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-G---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||.||+|..+. + ..||||.+.... ......+|..|+.++++++||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 357788999999999999998653 3 369999987542 45556789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999886532 347899999999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCCcce-eeccc--ccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 746 APDNGKHSI-ETRLA--GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 746 ~~~~~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
......... ..... .+..|+|||++....++.++|||||||++||+++ |..||......+ ...++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i-------- 224 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI-------- 224 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH--------
Confidence 543222111 11111 2457999999998899999999999999999887 999997544221 11111
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
....... .....+..+.+++.+|++.+|++||++.+|+..|+++
T Consensus 225 ------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ------EQDYRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------HcCCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111101 1112334578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.83 Aligned_cols=257 Identities=26% Similarity=0.498 Sum_probs=204.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CC---cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|+..+.||+|+||.||+|..+ ++ ..+|+|.+.... .....+++..|++++++++|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 56788899999999999999875 33 379999886542 34456788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+|++|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999985432 348899999999999999999996 7999999999999999999999999999886
Q ss_pred cCCCCCcce-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 746 APDNGKHSI-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 746 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
......... ......+..|+|||++....++.++|||||||++|||++ |+.||......+ . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~-------------~ 220 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---V-------------M 220 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H-------------H
Confidence 644222111 111223567999999988889999999999999999998 999996543211 1 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.. +..... .+........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 221 ~~-i~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KA-INDGFR-LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HH-HhcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 111111 111123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.84 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=192.0
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|+.. +++.||||+++.... .+.....+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578999999976532 123345667788888764 899999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 9999988543 247888999999999999999996 8999999999999999999999999999875432211
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+ ......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i-------------~~~~~~ 214 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI-------------RMDNPC 214 (316)
T ss_pred -ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH-------------HhCCCC
Confidence 2234579999999999998899999999999999999999999997644221 11111 001111
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMG-HVV 866 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 866 (947)
.+ ......+.+++.+|++.+|++||++. ++.
T Consensus 215 ~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YP---RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CC---ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11 11234578999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=329.64 Aligned_cols=245 Identities=23% Similarity=0.404 Sum_probs=193.1
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|..+ +++.||+|+++..... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999865332 33456688999999998 799999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9998887543 348899999999999999999996 8999999999999999999999999999875322111
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccc--hhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED--SVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......+. ...+....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~~~ 221 (329)
T cd05588 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL---------FQVILEKQ 221 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH---------HHHHHcCC
Confidence 2234579999999999999899999999999999999999999996433211 10011111 11122222
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
...+. .....+.+++.+|++.||.+||++
T Consensus 222 ~~~p~---~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 222 IRIPR---SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCC---CCCHHHHHHHHHHhccCHHHcCCC
Confidence 22111 123457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=381.49 Aligned_cols=377 Identities=28% Similarity=0.397 Sum_probs=259.3
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|++.+.+|..|+++++|++|+|++|.+++.+| .+.++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 367888999999999999999999999999999999988887 7888999999999999998888888888899999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCC
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKG 222 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~ 222 (947)
++|.+.+ .+|..+.++++|++|++++|.+++.+|..+. .+++|+.|+|++|++++.+|..++. .+|+.|++++|.+
T Consensus 292 s~n~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l 368 (968)
T PLN00113 292 SDNSLSG-EIPELVIQLQNLEILHLFSNNFTGKIPVALT--SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368 (968)
T ss_pred cCCeecc-CCChhHcCCCCCcEEECCCCccCCcCChhHh--cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCee
Confidence 9998865 6788888888888888888888888888877 6888888888888888888877765 5788888888876
Q ss_pred CCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCC
Q 002255 223 DSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (947)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (947)
...... .+..+++|+.|++++|++.+.+|. +..+++|+.|++++|++++.+|..+.++++|+.|+|++|+++|.+|
T Consensus 369 ~~~~p~---~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 445 (968)
T PLN00113 369 TGEIPE---GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445 (968)
T ss_pred EeeCCh---hHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccC
Confidence 644322 233344455555555555544442 4444455555555555554444444444444444444444444444
Q ss_pred CCCCCcc-c---cc------------ccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcc
Q 002255 302 KFNSPVR-F---DM------------AKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365 (947)
Q Consensus 302 ~~~~~~~-~---~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 365 (947)
..+.... + .+ ....+...++...+.+.+..+.....+. .+.......+....... ..
T Consensus 446 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~------~L~~L~Ls~N~l~~~~p-~~ 518 (968)
T PLN00113 446 SRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS------ELMQLKLSENKLSGEIP-DE 518 (968)
T ss_pred hhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh------ccCEEECcCCcceeeCC-hH
Confidence 3211100 0 00 0011222333333333322221111111 12222222211111110 12
Q ss_pred cCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccce---e
Q 002255 366 CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV---I 442 (947)
Q Consensus 366 ~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~---~ 442 (947)
+..+.+|+.|+|++|.++|.+|..++++++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|...+.. .
T Consensus 519 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~ 598 (968)
T PLN00113 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598 (968)
T ss_pred HcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccCh
Confidence 3456789999999999999999999999999999999999999999999999999999999999999999764432 2
Q ss_pred eecCCCCCCCCC
Q 002255 443 VKTDGNPDIGKD 454 (947)
Q Consensus 443 ~~~~~n~~~~~~ 454 (947)
..+.||+.+|+.
T Consensus 599 ~~~~~n~~lc~~ 610 (968)
T PLN00113 599 SAVAGNIDLCGG 610 (968)
T ss_pred hhhcCCccccCC
Confidence 346799999874
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.92 Aligned_cols=242 Identities=27% Similarity=0.400 Sum_probs=191.7
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|+.+ +|+.||+|+++.... .......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 688999999976432 123345667788888765 899999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence 9999888543 247888899999999999999996 899999999999999999999999999987532211
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~-------------~~~~~~~~~ 214 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF-------------ESIRVDTPH 214 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHHhCCCC
Confidence 12234679999999999998899999999999999999999999997543211 11 111111111
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMG-HVV 866 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 866 (947)
.. .....++.+++.+|++.||++||++. ++.
T Consensus 215 ~~---~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YP---RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 11234578999999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.29 Aligned_cols=257 Identities=25% Similarity=0.462 Sum_probs=204.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-C---CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-D---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||.||+|... + +..+|+|.++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999764 2 3479999887543 34456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++.... ..+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++++|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999986532 347899999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcce-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 746 APDNGKHSI-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 746 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~------------ 220 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IK------------ 220 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HH------------
Confidence 654322111 112234568999999988889999999999999999887 9999976543211 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.+.+ ... .+........+.+++.+|++.+|.+||++.++++.|.++
T Consensus 221 -~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 -AIEE-GYR-LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -HHhC-CCc-CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111 111 011112335678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.57 Aligned_cols=254 Identities=32% Similarity=0.554 Sum_probs=202.6
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
|++.+.||+|+||+||++... +++.||+|++..............+|+.++++++||||+++++++.++...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999876 4668999999877544444445567999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
++++|.+++... ..+++.+++.++.|+++||+|||+ .+|+|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccc-----cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 999999999622 348999999999999999999997 89999999999999999999999999998865221
Q ss_pred CcceeecccccccccCccccc-cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 751 KHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
........++..|+|||++. +..++.++||||+|+++|+|++|..||......+.......... .....
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---------~~~~~ 221 (260)
T PF00069_consen 152 -NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---------RPLPS 221 (260)
T ss_dssp -TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---------THHHH
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---------ccccc
Confidence 22334567899999999998 78899999999999999999999999987622222111111100 00000
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ........+.+++.+||+.||++||++.++++
T Consensus 222 ~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00011267889999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.43 Aligned_cols=243 Identities=25% Similarity=0.413 Sum_probs=194.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|..+ +++.||||+++.... .......+..|+++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578999999976532 233456678899999888 699999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 9999888543 248899999999999999999996 8999999999999999999999999999875322211
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+......
T Consensus 152 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~-------------~~~i~~~~~~ 214 (318)
T cd05570 152 -TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---L-------------FQSILEDEVR 214 (318)
T ss_pred -cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---H-------------HHHHHcCCCC
Confidence 1233568999999999999999999999999999999999999997543211 1 1111111111
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDM-----GHVVN 867 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 867 (947)
.. ......+.+++.+||+.||++||++ .++++
T Consensus 215 ~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11 1223467899999999999999999 66544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.92 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=197.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ........+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 67889999987532 22334556888999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999996532 347888899999999999999996 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
..... ......||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+ .
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~ 216 (331)
T cd05624 154 QDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------T 216 (331)
T ss_pred CCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----------------H
Confidence 43221 2233579999999998865 467889999999999999999999997543211 1
Q ss_pred HHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002255 823 FRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 867 (947)
+..+.... ...+.........+.+++.+|+..++++ |+++.++++
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 217 YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 11111111 1111111123456789999999865544 456776654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=329.74 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=190.8
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHH-HHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|+.+ +++.||+|++...... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 5788999998754321 222334445544 56788999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+.......++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 9999988543 236777888899999999999996 8999999999999999999999999999875432211
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~~~~ 214 (325)
T cd05602 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNILNKPLQ 214 (325)
T ss_pred -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----------------HHHHHHhCCcC
Confidence 2234579999999999999899999999999999999999999997544221 11112222222
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
... .....+.+++.+|++.+|.+||++.+.+..
T Consensus 215 ~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 215 LKP---NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCC---CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 111 223457899999999999999998865443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.72 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=205.0
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34688999999999999999998877888999988753 3345678999999999999999999999887 7789999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++...
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 80 EFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999986532 2347889999999999999999996 899999999999999999999999999987664
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... .......++..|+|||++....++.++|||||||++|++++ |+.||......+. . ..
T Consensus 154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~--------------~~ 215 (260)
T cd05073 154 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I--------------RA 215 (260)
T ss_pred CCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---H--------------HH
Confidence 4221 12223346678999999988889999999999999999999 8999975432111 1 11
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
+...... +........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 LERGYRM-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HhCCCCC-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111110 1111233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.15 Aligned_cols=250 Identities=30% Similarity=0.503 Sum_probs=200.2
Q ss_pred ceecccCceEEEEEEEcC--C--cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 596 NVLGRGGFGTVYKGELHD--G--TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
++||+|++|.||+|.+.+ + ..||+|.+...... ...+++.+|+.++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998643 3 36899999876433 556789999999999999999999999988 88999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+++|.+++..... ..++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999866432 358999999999999999999996 8999999999999999999999999999987654322
Q ss_pred c-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 752 H-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 752 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+.. ...
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~-----------~~~ 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK-----------EGE 218 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh-----------cCC
Confidence 2 12223457789999999988899999999999999999999 9999975443221 111100 000
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
... .....+..+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011 11123356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.78 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=195.7
Q ss_pred eecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 597 VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.||+|+||.||+|.+. ++..||+|++.... .....+++.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999764 35579999987542 3444567999999999999999999999875 45789999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++.... ..+++.++++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999886432 348899999999999999999996 799999999999999999999999999988654432211
Q ss_pred e-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 754 I-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 754 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
. .....++..|+|||++....++.++|||||||++||+++ |+.||......+. ...+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----------------MSFIEQGK 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HHHHHCCC
Confidence 1 112234578999999988889999999999999999996 9999976543211 11111111
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
. ...+.....++.+++.+|+..+|++||++.+|.+.|+.+
T Consensus 216 ~-~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 R-LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 011112345688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.70 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=208.0
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 668 (947)
..|++.++||+||.+.||++...+.+.||+|++.....+......|..|+..|.+++ |.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 458889999999999999998888889999988877778888899999999999995 9999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|= ..+|..+|..+... ...| .+..+..||+.|+.++|. +||||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred cc-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 64 67999999765432 2345 677889999999999996 999999999999999 467999999999998877
Q ss_pred CCCcceeecccccccccCccccccC-----------CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTG-----------RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
....-.....+||+-||+||.+... ..++++||||+|||||+|+.|+.||......
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------------- 578 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------------- 578 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------------
Confidence 6666667778999999999988532 2567999999999999999999999754311
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
-..+..+.++.-.++-.......++.++++.||++||++||+..|+++
T Consensus 579 --~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 --IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 123445555533221111122223889999999999999999999987
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.09 Aligned_cols=249 Identities=32% Similarity=0.534 Sum_probs=204.2
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 57888999999999999999876 89999999876532 457889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999999865332 358999999999999999999996 89999999999999999999999999998866332
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. ...++..|+|||++....++.++||||||+++||+++ |+.||......+ +...+.
T Consensus 156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~ 213 (256)
T cd05039 156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPHVE 213 (256)
T ss_pred cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHh
Confidence 11 2235668999999988889999999999999999997 999986543221 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.... .......+..+.+++.+|+..+|++||++.|++++|++
T Consensus 214 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 KGYR-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCC-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111 01111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.69 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=190.6
Q ss_pred eecccCceEEEEEEEcC---CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 597 VLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|+.+++.++|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 3568888776432 3445567889999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++...........++.....++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976543323345678888999999999999996 899999999999999999999999999987543322111
Q ss_pred eeecccccccccCcccccc-------CCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 754 IETRLAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
......++..|+|||+... ..++.++|||||||++|||++ |..||......+. +..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----------------~~~ 221 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----------------LKQ 221 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----------------HHH
Confidence 1223456778999998643 356789999999999999999 7888865432211 111
Q ss_pred Hhhc---cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 826 AIDR---TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 826 ~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.+.. .+............+.+++..|+ .||++||+++||++.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 222 VVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1110 11101111123345667888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=325.13 Aligned_cols=244 Identities=26% Similarity=0.443 Sum_probs=199.2
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCc
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGT 674 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 674 (947)
-+||+|.||+||-|+.. +...+|||.+... +....+-+..||...++++|.|||+++|.+.+++..-++||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 38999999999999865 4667899998765 45556778999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccCCCcc--cHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CCCcEEEeecCcceecCCCCC
Q 002255 675 LSRHLFNRKEEGLKPL--EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 675 L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~~~~~~ 751 (947)
|.++++.+. .++ .+.++--+..||++||.|||+ ..|||||||-+||||+ -.|.+||+|||.++.... -
T Consensus 659 LSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--i 729 (1226)
T KOG4279|consen 659 LSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--I 729 (1226)
T ss_pred HHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc--C
Confidence 999996643 334 667777788999999999996 8899999999999996 579999999999987643 2
Q ss_pred cceeecccccccccCccccccC--CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 752 HSIETRLAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
......+.||..|||||++..+ .|..++|||||||++.||.||++||.+....... .++ -.
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------------MFk---VG 792 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------------MFK---VG 792 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------hhh---hc
Confidence 3345567899999999999765 4889999999999999999999999766532210 000 01
Q ss_pred cCCC-ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDL-DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.++. ++-+.....+...+|.+|+.+||.+||+++++++
T Consensus 793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1121 2333445566779999999999999999999976
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.15 Aligned_cols=249 Identities=31% Similarity=0.491 Sum_probs=199.5
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEE-eCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL-DGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e 668 (947)
.+|++.+.||+|+||.||++..+ |..||+|.++.. ...+.+.+|+.++++++|+|++++++++. .++..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888999999999999999776 788999988643 23467889999999999999999999765 4567899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+|++|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999865332 347899999999999999999996 8999999999999999999999999999875533
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .... +
T Consensus 155 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~--------------~ 212 (256)
T cd05082 155 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR--------------V 212 (256)
T ss_pred cC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------------H
Confidence 21 12345578999999988889999999999999999998 999986543211 1111 1
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
..... ..........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 213 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 213 EKGYK-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111 011112345678999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=329.60 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=192.5
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHH-HHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 689999999875432 2233455666655 46778999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9998887542 347889999999999999999996 8999999999999999999999999999875432211
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~~~~~~~~ 214 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----------------MYDNILHKPLV 214 (325)
T ss_pred -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----------------HHHHHHcCCcc
Confidence 2234579999999999999899999999999999999999999997643211 11222222222
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+ .....+.+++.+|++.+|.+||++.+.++.
T Consensus 215 ~~~---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 215 LRP---GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCC---CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 111 123457799999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.98 Aligned_cols=269 Identities=25% Similarity=0.445 Sum_probs=202.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNE 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 662 (947)
.+|++.+.||+|+||.||++..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46888899999999999999753 5789999998754 44556789999999999999999999998754 346
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 789999999999999985432 347899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcc-eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc---
Q 002255 743 VRLAPDNGKHS-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI--- 818 (947)
Q Consensus 743 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~--- 818 (947)
++......... ......++..|+|||++.+..++.++|||||||++|||++|..++......- .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~ 230 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF----MRMMGNDKQGQM 230 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh----hhhccccccccc
Confidence 98765432211 1112234456999999988889999999999999999999887764332110 000000000
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
....+.+.+...... .........+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111222221111 11112234688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=341.75 Aligned_cols=268 Identities=22% Similarity=0.264 Sum_probs=195.7
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC------CCcceEEEE
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH------RHLVGLLGY 656 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 656 (947)
++....++|++.++||+|+||.||+|... +++.||||+++.. .....++..|+++++.++| .++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 34455789999999999999999999764 5788999998643 1223455667777777755 458889998
Q ss_pred EEeC-CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC--
Q 002255 657 CLDG-NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 733 (947)
Q Consensus 657 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-- 733 (947)
+..+ .+.++|||++ +++|.+++... ..+++..+..++.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcc
Confidence 8764 5788999988 77888888543 348899999999999999999996 35999999999999998765
Q ss_pred --------------cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCC
Q 002255 734 --------------RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 734 --------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~ 799 (947)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764322 1234679999999999999999999999999999999999999998
Q ss_pred ccCccchhhHHHHHHHhhc-------ChhhHHHHhhccCC----CC------------hhcHHHHHHHHHHHHHhcccCC
Q 002255 800 ETQSEDSVHLVTWFRRMHI-------NKDTFRKAIDRTID----LD------------EETLASISTVADLAGHCCAREP 856 (947)
Q Consensus 800 ~~~~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~----~~------------~~~~~~~~~l~~li~~cl~~dP 856 (947)
.....+....+........ .....+++++.... .. .........+.+|+.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 7654333222211100000 00000111110000 00 0001112457799999999999
Q ss_pred CCCCCHHHHHH
Q 002255 857 YQRPDMGHVVN 867 (947)
Q Consensus 857 ~~RPs~~evl~ 867 (947)
++||++.|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.38 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=206.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..++|++.++||+|+||.||+|..+++..||||.+..... ..+++.+|+.++++++|+||+++++++..+...++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3578999999999999999999988888999999875432 3467889999999999999999999999989999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... ...+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.+|++|||+++...
T Consensus 81 e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 81 EYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred eccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999999986532 2358999999999999999999996 799999999999999999999999999988765
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... . +..+
T Consensus 155 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~-------------~~~~ 217 (261)
T cd05034 155 DDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---V-------------LEQV 217 (261)
T ss_pred chhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHH
Confidence 4211 11122335578999999998889999999999999999999 999996543211 1 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
. .... ..........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 218 ~-~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 E-RGYR-MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred H-cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1 1111 00111124568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.91 Aligned_cols=252 Identities=33% Similarity=0.506 Sum_probs=204.1
Q ss_pred ceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 596 NVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
++||+|+||.||+|.... +..||+|.+....... ..+.+.+|+++++.++|+|++++++++..+...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999998753 7889999998664333 56789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccccc----CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 672 QGTLSRHLFNRKEE----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 672 ~gsL~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
+++|.+++...... ....+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.++...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999998664211 02458999999999999999999996 899999999999999999999999999998775
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
............++..|+|||.+....++.++||||+|+++|||++ |..||......+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~~ 220 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----------------LEYL 220 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHH
Confidence 5432222334567889999999988889999999999999999999 6999976532211 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.+.. . ..........+.+++.+|++.+|++||++.++++.|
T Consensus 221 ~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 221 RKGY-R-LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HcCC-C-CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111 1 111122246788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.15 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=201.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG----- 660 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 660 (947)
.+.++|+..+.||+|+||.||++... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999764 688999999976554555567888999999999999999999988643
Q ss_pred -CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 661 -NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 661 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 357999999965 66666532 37788889999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... ..+......
T Consensus 163 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~ 237 (355)
T cd07874 163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTP 237 (355)
T ss_pred CcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCC
Confidence 99998654321 2234578999999999998899999999999999999999999997654322111 001100000
Q ss_pred --------hhhHHHHhhccCC----------------CCh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 820 --------KDTFRKAIDRTID----------------LDE-ETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 820 --------~~~~~~~~~~~~~----------------~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.......++.... .+. ........+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0011111111000 000 001123457899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.26 Aligned_cols=266 Identities=22% Similarity=0.354 Sum_probs=200.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|...+.||+|+||.||+|+.+ +++.||+|.++... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57889999999999999999765 67889999987543 22233467789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9964 8888775432 347888899999999999999996 8999999999999999999999999999876533
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+............. ...+..+.
T Consensus 157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (309)
T cd07872 157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT-EETWPGIS 233 (309)
T ss_pred Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHhhhc
Confidence 221 1223467899999998865 4688999999999999999999999977654433222211111000 00111100
Q ss_pred ------h---ccCCCC---hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 ------D---RTIDLD---EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ------~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+ +..... ........++.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 000000 000112345779999999999999999999977
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.19 Aligned_cols=253 Identities=33% Similarity=0.541 Sum_probs=196.7
Q ss_pred ceecccCceEEEEEEEcC-Cc--EEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 596 NVLGRGGFGTVYKGELHD-GT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
++||+|+||.||+|..++ +. .+|+|.++.. ......+.+..|+++++++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 469999999999998753 43 4688887643 2344556889999999999 79999999999999999999999999
Q ss_pred CCchhhhhhcccc-----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 672 QGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 672 ~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
+|+|.+++..... .....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 9999999865431 112347899999999999999999996 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++..... ........+..|+|||++....++.++|||||||++|||++ |..||......+.
T Consensus 157 gl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------------- 220 (270)
T cd05047 157 GLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------------- 220 (270)
T ss_pred CCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------------
Confidence 998632211 11111234567999999988889999999999999999997 9999965432111
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+.. +...... .........+.+++.+|++.+|.+||++.++++.|+.+.
T Consensus 221 ---~~~-~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 ---YEK-LPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---HHH-HhCCCCC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 1111110 011122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.04 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=202.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC---hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|...+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999764 6899999998754322 2234678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999988543 347788889999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCCcce-eecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSI-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
......... .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------------~ 217 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----------------F 217 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----------------H
Confidence 543211111 12346788999999999888999999999999999999999999754321110 0
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
........ ..........+.+++.+|+..+|.+||++.++++.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111000 11112233467899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.01 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=197.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.++||+|+||.||++..+ +++.||+|++.+.. ........+..|+.++..++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999876 57889999986532 22333456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999996532 347888899999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
.... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+.
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~---------------- 216 (332)
T cd05623 154 EDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---------------- 216 (332)
T ss_pred cCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH----------------
Confidence 3222 1223357999999999886 34678999999999999999999999975432111
Q ss_pred HHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002255 823 FRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 867 (947)
+..+.... ...+.........+.+++.+|+..++++ |+++.|+++
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 217 YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred HHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 11111111 1111111223456789999988654444 678888866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=330.69 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=200.3
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 660 (947)
+.++|++.+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999764 688999999976544555567788999999999999999999987643
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999964 67666632 36788889999999999999996 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .+.......
T Consensus 171 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~ 245 (364)
T cd07875 171 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK--VIEQLGTPC 245 (364)
T ss_pred CCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcCCCC
Confidence 9998654321 22345789999999999998999999999999999999999999976553222111 111110000
Q ss_pred h--------hHHHHhhccCCCC-----------------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 D--------TFRKAIDRTIDLD-----------------EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~--------~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. .....+....... .........+.+++.+|++.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0011111100000 000112245789999999999999999999977
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.73 Aligned_cols=246 Identities=23% Similarity=0.400 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|..+ +++.||+|+++.... .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 578999999986532 234456788999999998 699999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 9998887542 348899999999999999999997 8999999999999999999999999999875332221
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+. ...+......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~ 221 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---------FQVILEKPIR 221 (327)
T ss_pred -ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH---------HHHHHhCCCC
Confidence 223457999999999999999999999999999999999999999654322211111111 1111222222
Q ss_pred CChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 833 LDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 833 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
.+. .....+.+++.+||+.||++|+++.
T Consensus 222 ~p~---~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 IPR---FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCC---CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 111 1234567999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=316.75 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=198.7
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..++||+|+||.||+|.. .+++.||+|.+.... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999975 468899999986542 34455679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999986542 25778888999999999999996 8999999999999999999999999999876543
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............ ........+
T Consensus 148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~~~ 214 (279)
T cd06619 148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCIVD 214 (279)
T ss_pred cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHHhc
Confidence 21 23357899999999999889999999999999999999999999754322211000 001111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... ..........+.+++.+|++.+|++||++.|+++
T Consensus 215 ~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 215 EDPP-VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCC-CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111 0001112345789999999999999999999977
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.72 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=200.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.|+..++||+|+||.||++... +++.||||.+...... ....+.+..|+.++++++|++++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999765 6889999998754322 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999998854332 348889999999999999999996 8999999999999999999999999999876543
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........... ....++
T Consensus 155 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-------------~~~~~~ 218 (285)
T cd05630 155 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-------------VERLVK 218 (285)
T ss_pred Ccc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-------------HHhhhh
Confidence 221 1234789999999999988999999999999999999999999976432211100 001110
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
... ..........+.+++.+|++.||++||+ +.|+++
T Consensus 219 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 219 EVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 0001112345789999999999999999 777766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.93 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=199.7
Q ss_pred cCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEEecC
Q 002255 594 EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
....||.|+-|.||+++++ +|..+|||.+.... ..++.+++...+.++..-+ +|.||+-+|||..+...++.||.|
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 4466999999999999876 58899999998764 5566788899999887775 899999999999999999999988
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
...++.++.+.+ .++++...-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||++-++.+.
T Consensus 174 s~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 174 STCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HHHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 334555554432 458888888999999999999998 799999999999999999999999999999877553
Q ss_pred cceeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 752 HSIETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
...++.+|.+.|||||.+.- ..|+-++||||||+.++||.||+.||.+-..+ -+.+.++++
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe~ltkvln 309 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FEVLTKVLN 309 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HHHHHHHHh
Confidence 23456689999999999853 46889999999999999999999999874432 223334444
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....-+....-...+.+++..||++|+.+||.+.++++
T Consensus 310 ~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 310 EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 322211122224567889999999999999999999987
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.10 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 596 NVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
++||+|+||.||+|.+.. +..||+|.+...... ...+++.+|+++++.+.|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999997532 268999998765433 45578999999999999999999999875 556899999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999996532 47899999999999999999996 7899999999999999999999999999886644332
Q ss_pred cce-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 752 HSI-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 752 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....++...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~------------- 214 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESG------------- 214 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcC-------------
Confidence 211 111224568999999988899999999999999999998 99999764322 111111110
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.. ..........+.+++.+|+..+|++||++.++++.|+++
T Consensus 215 -~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 -ER-LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -Cc-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00 011112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=322.51 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=203.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||++... ++..||+|.+.... ......++.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46889999999999999999765 68889999887542 34445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++... ..+++..+..++.|+++||+|||+ +.+++||||||+||+++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999998653 347888899999999999999996 36899999999999999999999999999875533
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC---------
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN--------- 819 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--------- 819 (947)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+.......
T Consensus 153 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (308)
T cd06615 153 SM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGEAKESHRP 225 (308)
T ss_pred cc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCccccccccCCccc
Confidence 21 23357899999999988888999999999999999999999999654322111 111100000
Q ss_pred --------------hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 820 --------------KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 820 --------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
....+..+..... .........++.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPP-KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCc-cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111111000 00001123458899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=332.65 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=200.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
...+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++|||||++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 4568999999999999999999753 3578999987643 23467999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+|||++. ++|.+++... ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.++|+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999985 6888887322 358999999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH-HHHHHhhcCh---
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV-TWFRRMHINK--- 820 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~-~~~~~~~~~~--- 820 (947)
...............||+.|+|||++....++.++|||||||++|||++|+.||.+.......... ..+.......
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 665433322333467999999999999889999999999999999999999999765543221111 1111110000
Q ss_pred -----hhHHHHhh-------ccCCCChh--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 821 -----DTFRKAID-------RTIDLDEE--TLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 821 -----~~~~~~~~-------~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+.+.+. +....+.. ......++.+++.+|++.||++||++.|++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00000000 00112457789999999999999999999873
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=333.96 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=195.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ........+.+|+.++.+++|+||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999765 68999999997542 22344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998643 347888899999999999999996 899999999999999999999999999987543
Q ss_pred CCCCc---------------------------------ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhC
Q 002255 748 DNGKH---------------------------------SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794 (947)
Q Consensus 748 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg 794 (947)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21100 001235799999999999999999999999999999999999
Q ss_pred CCCCCccCccchhhHHHHHHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 795 RKALDETQSEDSVHLVTWFRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 795 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
+.||........ +..+.. ..+.++.. .....++.+++.+|+. +|.+|++..
T Consensus 233 ~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 233 YPPFCSETPQET----------------YRKVMNWKETLVFPPE-VPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCCHHHH----------------HHHHHcCCCceecCCC-CCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999976543221 111111 11111111 1123457788888774 999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.86 Aligned_cols=249 Identities=30% Similarity=0.498 Sum_probs=199.1
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
++||+|+||.||++...+++.||+|++...... ...+.+..|++++++++|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999998877999999988765322 4567899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99985532 247888999999999999999996 89999999999999999999999999998765432111111
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCC
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (947)
....++..|+|||.+.++.++.++|||||||++|||++ |..||........ ...+......
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-----------------~~~~~~~~~~- 214 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-----------------RERIESGYRM- 214 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-----------------HHHHhcCCCC-
Confidence 12234567999999988889999999999999999999 8888865542211 1111111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 835 EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 835 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.........+.+++.+|++.+|++||++.|+++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 111123356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.31 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=201.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++..+...++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 467889999999999999999764 68899999987653 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998843 237888999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.... ..+ ..
T Consensus 168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~-------------~~ 230 (296)
T cd06654 168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI-------------AT 230 (296)
T ss_pred cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH-------------hc
Confidence 3221 122346889999999998888999999999999999999999999754432111 000 00
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ..........+.+++.+|+..+|++||++.|+++
T Consensus 231 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 231 NGTPE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCC-CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00000 0111223345789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.17 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=195.5
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 667 (947)
+|+..+.||+|+||.||+|..+ +|+.||+|++..... .....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999765 688999999876432 2334566788999998885 577888999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999888543 348899999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~ 214 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----------------LFQSIM 214 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 3221 2234569999999999998889999999999999999999999997654221 111222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
....... ......+.+++.+|++.+|.+|++..
T Consensus 215 ~~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 215 EHNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 2222211 11234578999999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=338.17 Aligned_cols=264 Identities=20% Similarity=0.332 Sum_probs=193.2
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 660 (947)
...+|++.++||+|+||.||+|... +++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999764 68899999885431 2335799999999999999999887432
Q ss_pred --CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEE
Q 002255 661 --NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 737 (947)
Q Consensus 661 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl 737 (947)
...++||||++ ++|.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 24679999996 467776654322 22458899999999999999999997 8999999999999999665 7999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+.. ...+...
T Consensus 213 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~i~~~~ 287 (440)
T PTZ00036 213 CDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL--VRIIQVL 287 (440)
T ss_pred eccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHh
Confidence 99999986644221 2235789999999988654 6899999999999999999999999765433221 1111111
Q ss_pred hcChhhHHHHhhccC---CCCh---------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 817 HINKDTFRKAIDRTI---DLDE---------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~---~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
............+.+ .++. .+.....++.+|+.+||+.||.+||++.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111110000111100 0000 00112356889999999999999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.06 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=213.0
Q ss_pred HhcCCCcCceecccCceEEEEEEEc---CCc--EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH---DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
..+.....++||.|-||.||+|.+. .|+ .||||.-+... +.+..+.|..|+.+|+.++|||||+++|+|.+ ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3445567789999999999999764 233 47888877654 44457899999999999999999999999975 56
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.|+|||.++-|.|..+|...+ ..++..+...+++||..||+|||+ ..+|||||..+||||.....||++|||+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccch
Confidence 899999999999999997654 348888899999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+|.+.+...... +...-...|||||.+.-.+++.++|||-|||.+||++. |..||.+....+.+..++ .+
T Consensus 538 SR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE--------nG 608 (974)
T KOG4257|consen 538 SRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE--------NG 608 (974)
T ss_pred hhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec--------CC
Confidence 998877544332 33345678999999999999999999999999999988 999998876554332111 00
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+ -+.+..+++.+..|+.+||+.+|.+||.+.|+...|..+.+
T Consensus 609 -------eR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 -------ER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -------CC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 22333455678899999999999999999999999998865
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.88 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=194.7
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC---CCCCcceEEEEEEe-----CC
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLD-----GN 661 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 661 (947)
+|++.+.||+|+||.||+|..+ +|+.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888899999999999999765 688999999876433332334556677777665 69999999998864 34
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 5799999996 588888755332 347899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-h
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-K 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~ 820 (947)
+++...... ......||..|+|||++.+..++.++||||+||++|||++|++||......+... ......... .
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~--~~~~~~~~~~~ 228 (288)
T cd07863 154 LARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--KIFDLIGLPPE 228 (288)
T ss_pred ccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH--HHHHHhCCCCh
Confidence 998664322 1233568999999999988899999999999999999999999997654322211 111100000 0
Q ss_pred hhHHHHhh---ccCC------CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DTFRKAID---RTID------LDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~---~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..... .... ...........+.+++.+|++.||++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000 00000122345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.63 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=200.1
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45799999999999999999986 46889999998754 2234457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999999988542 247888999999999999999996 899999999999999999999999999988664
Q ss_pred CCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.+....
T Consensus 158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------------- 220 (267)
T cd06646 158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------------- 220 (267)
T ss_pred cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee---------------
Confidence 3211 122346889999999874 34578899999999999999999999965432211100
Q ss_pred HHhhccCCC--ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 825 KAIDRTIDL--DEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 825 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
........ ..........+.+++.+|++.+|++||+++++++.
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 221 -MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000000 00111223568899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=335.39 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=197.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999875 578899996432 24568999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|++ .++|.+++.... ..++|.+++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999 578888875432 358999999999999999999996 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccc-----hhhHHHHHHHhhcChh-
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED-----SVHLVTWFRRMHINKD- 821 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~-----~~~l~~~~~~~~~~~~- 821 (947)
............||+.|+|||++.+..++.++|||||||++|||++|..|+....... ...+...+........
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 4322222334679999999999999999999999999999999999887654322110 1112222221110000
Q ss_pred -------hHHHHh-h---c--cCCCChhcH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 -------TFRKAI-D---R--TIDLDEETL----ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 -------~~~~~~-~---~--~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.... . . ........+ .....+.+|+.+||+.||.+||++.|+++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000000 0 0 000000001 11235779999999999999999999987
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.06 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=203.0
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|++.+.||+|+||.||++... +++.||+|.++... .....+.+..|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4788899999999999999765 68899999986542 334567888999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++..... ..++......++.|++.||+|||+ .+|+|+||||+||++++++.++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999998854322 347888899999999999999996 89999999999999999999999999998866443
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----------------~~~~~~~ 215 (255)
T cd08219 154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----------------ILKVCQG 215 (255)
T ss_pred cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----------------HHHHhcC
Confidence 22 22345688999999999888899999999999999999999999975432111 1111111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
... ..+......+.+++.+||+.||++||++.|++..
T Consensus 216 ~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYK--PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCC--CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 1111223457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.26 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=207.7
Q ss_pred CCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..++||+|+||.||.++. .+++.+++|.+.....+.....++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999865 4688999999876655666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ...+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999986543 1347899999999999999999996 78999999999999999999999999999876443
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||......+ ...++...
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~~~ 216 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------------LVVKIVQG 216 (256)
T ss_pred cc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHcC
Confidence 31 2234568999999999988888999999999999999999999997543221 11111111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
... ........++.+++.+|++.+|++||++.++++.
T Consensus 217 ~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 217 NYT--PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCC--CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111 1112234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.61 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=207.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+-|.+.++||+|+||.||+|.++ .|..+|+|.+... ...+++..|+.+|++...|++|++||.|......|+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 34567789999999999999765 6999999988643 456889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||..|++.+.++.+. +++.+.++..+++..++||+|||. ..-+|||||+.|||++-+|.+|++|||.|....+
T Consensus 109 YCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 109 YCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999999997654 569999999999999999999997 5679999999999999999999999999876644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.- .....+.|||.|||||++..-.|+.++||||+|+...||..|++||.+..+...+..+. ..
T Consensus 182 TM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~ 244 (502)
T KOG0574|consen 182 TM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TK 244 (502)
T ss_pred hH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CC
Confidence 21 12334689999999999999999999999999999999999999998877654332210 01
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+...+ ..+..-..++.+++++||-..|++|-|+-++++
T Consensus 245 PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 PPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11111 112333457889999999999999999988876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.72 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=206.4
Q ss_pred CcCceecccCceEEEEEEEc--CCc--EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 593 SEENVLGRGGFGTVYKGELH--DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
...++||+|.||.|++|.|+ .|+ .||||.++...... ...+|.+|+.+|.+|+|||++++||+..+ ....+|||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34578999999999999886 344 58999998765433 67899999999999999999999999987 67789999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
.++.|+|.+.|++.. ...+-......++.|||.|+.||.+ +++||||+..+|+++-..-.|||+|||+++.++.
T Consensus 191 LaplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999997722 2457888899999999999999997 8999999999999999999999999999998877
Q ss_pred CCCcce-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 749 NGKHSI-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 749 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
+...++ .....-.+.|+|||.+....++.++|||+|||++|||+| |+.||-+....+..+ .
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-----------------~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-----------------N 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-----------------h
Confidence 655443 233445678999999999999999999999999999999 788998766433222 2
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
+|.. ..-+.+..+.+++++++..||..+|++||++.+|.+.+
T Consensus 328 iD~~-erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAG-ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccc-ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2211 00122234556789999999999999999999998544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=316.23 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=204.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.+|+..+.||+|+||.||+|.++ +|+ .||+|.+.... ......++.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 56888899999999999999864 333 58999876553 34456788999999999999999999999987 7889
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 9999999999999986532 248899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............++..|+|||.+....++.++||||||+++||+++ |+.||......+ +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~ 220 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----------------I 220 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------H
Confidence 7654322211122234568999999988889999999999999999999 999997654221 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+....... .+......+.+++.+|+..+|.+||++.++++.|.++.+
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 221 PDLLEKGERLP-QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHhCCCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111111101 111122457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.32 Aligned_cols=248 Identities=28% Similarity=0.398 Sum_probs=196.4
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
|+..++||+|+||+||+|... +++.||+|.+...... ......+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999764 6889999998755322 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998885432 2358999999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............ . ......
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~----------~~~~~~ 220 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--D----------RRVLET 220 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----------Hhhhcc
Confidence 11 12346899999999998889999999999999999999999999765432111110 0 001111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
... ........+.+|+.+|++.||++||++.
T Consensus 221 ~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 221 EEV---YSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccc---cCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 001 1111234578999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.36 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=198.7
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG---- 660 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 660 (947)
.+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45678899999999999999999765 58899999986542 2345788999999999 699999999998753
Q ss_pred --CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEe
Q 002255 661 --NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (947)
Q Consensus 661 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 738 (947)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||+ ++|+||||||+||++++++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 46799999999999999986532 2358899999999999999999997 799999999999999999999999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
|||+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||........... .
T Consensus 154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---~ 228 (272)
T cd06637 154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---I 228 (272)
T ss_pred cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---H
Confidence 9999886543221 123457899999999885 34578899999999999999999999965432211100 0
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ ........+.+++.+|+..+|.+||++.++++
T Consensus 229 ----------~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 ----------PRNPAPRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----------hcCCCCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000000 11122346789999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.28 Aligned_cols=251 Identities=29% Similarity=0.514 Sum_probs=201.2
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
.+|+..+.||+|+||.||+|.+.+++.+|+|++...... ..++.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 467788999999999999998877889999998755333 35688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999886432 347899999999999999999996 78999999999999999999999999998865432
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......++.+|+|||++.++.++.++||||||+++|||++ |+.||......+ ... . +.
T Consensus 154 ~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~-------------~-~~ 215 (256)
T cd05112 154 QY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE-------------T-IN 215 (256)
T ss_pred cc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH-------------H-Hh
Confidence 11 11222345678999999988889999999999999999998 899987543211 111 0 11
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
..... .........+.+++.+|++.+|++||++.|+++.|
T Consensus 216 ~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 AGFRL-YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00000 00011235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.88 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=203.0
Q ss_pred CCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC------
Q 002255 592 FSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 661 (947)
|.+.+.||+|+||.||+|.+. +++.||||++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3688999999876656666788999999999999999999999886532
Q ss_pred eeEEEEEecCCCchhhhhhccc-ccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRK-EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
..++++||+.+|+|.+++.... ......+++....+++.|++.||+|||+ .+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988875422 1122347888999999999999999996 79999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++...............+++.|++||.+....++.++|||||||++|||++ |+.||......+ ...++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~--- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIKG--- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHcC---
Confidence 99886643322222223346678999999988889999999999999999999 888886543211 11111100
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.... ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 232 ---------~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---------NRLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011 0112235688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=315.96 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=198.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
.|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++|||++++++++..+...++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3677789999999999999876 5778899988654 345567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|..++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 84 CAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 99999988875422 358999999999999999999997 89999999999999999999999999998765332
Q ss_pred CCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 750 GKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
. .......|+..|+|||++. ...++.++|||||||++|||++|+.||......+. ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------------~~ 218 (282)
T cd06643 157 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV----------------LL 218 (282)
T ss_pred c--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH----------------HH
Confidence 1 1123356899999999874 34578899999999999999999999975432111 00
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...................+.+++.+|++.+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 219 KIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110000000011122356889999999999999999998866
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=324.80 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=200.1
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC---
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--- 660 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 660 (947)
...+.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 345678999999999999999999976 4688999999876543444456788999999999999999999987543
Q ss_pred ---CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 661 ---NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 661 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEE
Confidence 4568999988 7899887743 348899999999999999999997 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... .+....
T Consensus 160 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~ 232 (343)
T cd07878 160 LDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK--RIMEVV 232 (343)
T ss_pred cCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHh
Confidence 999999865432 123578999999999876 468899999999999999999999997644322111 111100
Q ss_pred hcC---------hhhHHHHhhccCCCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 817 HIN---------KDTFRKAIDRTIDLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ~~~---------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .......+.......... ....+.+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 001111111100000000 011234679999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.99 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=201.1
Q ss_pred CCCcCceecccCceEEEEEEEcCCcEEEEEEeccccc----ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV----SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+|+..+.||+|+||.||+|...+|+.+|+|.+..... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999888899999998865422 123346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998543 237888899999999999999996 78999999999999999999999999998754
Q ss_pred CCCCC----cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 747 PDNGK----HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 747 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
..... ........|+..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------- 217 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--------------- 217 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH---------------
Confidence 32111 11122356899999999998888999999999999999999999999754321110
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....................+.+++.+|++.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 -FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000001111123355789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=320.95 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=202.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+.... ......++.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 56788899999999999999764 444 57888876542 333445789999999999999999999998754 467
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 9999999999999986532 347889999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~------------- 221 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP------------- 221 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------
Confidence 6644322222223345778999999988889999999999999999998 899987543211 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
+.+....... ........+.+++.+|+..+|++||++.++++.|+.+.+.
T Consensus 222 -~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 222 -DLLEKGERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -HHHHCCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111101 1111234578999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.13 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=203.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 668 (947)
+|++.+.||+|++|.||++..+ +++.||+|++..........+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999765 57899999987655455566788999999999999999999998764 446789999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ...+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999886532 2358899999999999999999996 8999999999999999999999999999886643
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ......
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~ 216 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----------------VYRIIE 216 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHHh
Confidence 221 22345688999999999988999999999999999999999999975432111 011111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+ ..........+.+++.+|++.+|++||++.++++
T Consensus 217 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 217 GKL--PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cCC--CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111 1111233456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.17 Aligned_cols=200 Identities=29% Similarity=0.440 Sum_probs=161.5
Q ss_pred CceecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCeeEEEEEe
Q 002255 595 ENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLVYEY 669 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~ 669 (947)
.++||+|+||.||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 467899999875422 2456789999999999999999999864 4567899999
Q ss_pred cCCCchhhhhhcccc----cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----cCCCcEEEeecC
Q 002255 670 MPQGTLSRHLFNRKE----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG 741 (947)
+. ++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 588777643211 112347888999999999999999996 899999999999999 456899999999
Q ss_pred cceecCCCCCc-ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99876443211 12234578999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=311.62 Aligned_cols=239 Identities=24% Similarity=0.409 Sum_probs=187.6
Q ss_pred ceecccCceEEEEEEEcC-------------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 596 NVLGRGGFGTVYKGELHD-------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+.||+|+||.||+|.+.. ...||+|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 235889987654 23445678899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc-------E
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-------A 735 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-------~ 735 (947)
.++||||+++|+|..++..+. ..+++..++.++.||++||+|||+ ++|+||||||+||+++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 999999999999988875432 347889999999999999999996 89999999999999987664 8
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCccccc-cCCcCcccccccHHHHHHHHH-hCCCCCCccCccchhhHHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELI-TGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~p~~~~~~~~~~~l~~~~ 813 (947)
+++|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|+.||......+.
T Consensus 152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------- 218 (262)
T cd05077 152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------- 218 (262)
T ss_pred EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------
Confidence 99999998755322 1235788999999886 466899999999999999998 58888765332111
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
........... .+....+.+|+.+||+.||.+||++.+|++.+
T Consensus 219 ----------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ----------ERFYEGQCMLV---TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------HHHHhcCccCC---CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01111111101 11234678999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=317.38 Aligned_cols=271 Identities=23% Similarity=0.430 Sum_probs=203.2
Q ss_pred CCCcCceecccCceEEEEEEE-----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--Cee
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 663 (947)
.|++.+.||+|+||.||++.+ .++..||+|.++... .......+.+|++++++++|||++++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468889999999999999974 257889999987542 344557899999999999999999999998775 568
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 89999999999999985432 347999999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+........ .......++..|+|||++.+..++.++|||||||++|||++++.|......... ....... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~~~~~~~-~~~~~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-KMIGPTH-GQMTVTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-hhccccc-ccccHHH
Confidence 866443221 122234577789999999888899999999999999999998776533211000 0000000 0000000
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
..+.+......+ ........+.+|+.+|++.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111111 1112345688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.06 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEEcC-------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 596 NVLGRGGFGTVYKGELHD-------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.||+|+||.||+|...+ ++.+|+|.+.... ......++.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 369999999999997642 2579999876542 23446788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccccc--CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-----cEEEeecC
Q 002255 669 YMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFG 741 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-----~~kl~DfG 741 (947)
|+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999754322 12347899999999999999999996 7899999999999999887 89999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~-------- 225 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH-------- 225 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH--------
Confidence 9876543322222223346788999999999999999999999999999998 999986543211 1111
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
+..... ..........+.+++.+|++.+|++||++.++++.|+
T Consensus 226 ------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 ------VTAGGR-LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------HhcCCc-cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111000 0111123456789999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.34 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=200.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+.|++.++||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++|+|++++++++..+...++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 367889999999999999999875 5889999998754 4556678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|..++.... ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 89 EFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred ecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999988775432 348899999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
.... ......+++.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------------- 223 (292)
T cd06644 162 KTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---------------- 223 (292)
T ss_pred cccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH----------------
Confidence 3211 122346889999999884 34568899999999999999999999965432110
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..................+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111100000111122345789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.03 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=203.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|.+.++||+|+||.||+|.+.+ ...||+|...... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 468888999999999999997643 2468999886542 34456789999999999999999999998875 55789
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999986532 247999999999999999999996 8999999999999999999999999999886
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
...... .......++..|+|||.+....++.++||||||+++||+++ |+.||......+. ..++...
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~~-------- 224 (270)
T cd05056 157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIENG-------- 224 (270)
T ss_pred cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHcC--------
Confidence 644321 12222345568999999988889999999999999999996 9999976543211 1111000
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.... ........+.+++.+|+..+|++||++.++++.|+++..
T Consensus 225 ----~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 ----ERLP---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0011 111223568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.24 Aligned_cols=267 Identities=23% Similarity=0.353 Sum_probs=200.4
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|++.+.||+|+||.||+|..+ +++.||+|++......+.....+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999875 689999999876543444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
++ ++|.+++..... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 688888754332 2458899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc----------
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI---------- 818 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~---------- 818 (947)
. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .........
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 155 V--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred c--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcch
Confidence 1 122234678999999987654 4788999999999999999999999765432111 111110000
Q ss_pred ChhhHHHHhhccCC--CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTID--LDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....++..+..... ..........++.+++.+|++.||++||++.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00011111111000 00001112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=316.89 Aligned_cols=272 Identities=26% Similarity=0.447 Sum_probs=207.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNE 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 662 (947)
..|+..+.||+|+||.||+|.+. +++.||||.+...... ...+.+.+|+++++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45777899999999999999864 3688999998765332 356789999999999999999999999887 567
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 899999999999999996543 248899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 743 VRLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 743 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+......... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~-~~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGI-AQGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-cccc-ccccccHH
Confidence 9876532221 1112234566799999998888999999999999999999999998654321100 0000 00000011
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.+.+.+....... ........+.+++.+|++.+|++||++.||+++|+++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1222222222211 1122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.77 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=193.1
Q ss_pred ceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEE-eCCeeEEEEEec
Q 002255 596 NVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL-DGNERLLVYEYM 670 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~ 670 (947)
+.||+|+||.||+|.+. ++..||+|++... ......+.+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 2457999987543 23445678899999999999999999999876 455678999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
.+|+|.+++.... ....+..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999986532 235677888999999999999996 899999999999999999999999999987554322
Q ss_pred Ccc--eeecccccccccCccccccCCcCcccccccHHHHHHHHHhC-CCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 751 KHS--IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 751 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ......++..|+|||++.+..++.++|||||||++|||++| .+||...... .+.. ...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~-------------~~~ 216 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITV-------------YLL 216 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-------------HHh
Confidence 111 11233567789999999888899999999999999999995 5556433211 1111 111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
... . .......+..+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 217 ~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 217 QGR-R-LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCC-C-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 110 0 0011122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.37 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..++||+|+||.||+|...+ ++.||+|.+.... ..+++.+|++++++++|+||+++++++.++...+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 678899999999999999998764 7899999986542 26789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999985432 458999999999999999999996 7999999999999999999999999999886644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----------------~~~~ 213 (256)
T cd06612 152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----------------MIPN 213 (256)
T ss_pred Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----------------hhcc
Confidence 321 2233458899999999988899999999999999999999999997643321110 0000
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...............+.+++.+|++.+|++||++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000000111122346789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.93 Aligned_cols=238 Identities=26% Similarity=0.431 Sum_probs=186.2
Q ss_pred eecccCceEEEEEEEcC-------------------------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcc
Q 002255 597 VLGRGGFGTVYKGELHD-------------------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (947)
.||+|+||.||+|.+.. ...||+|++... ......++.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 69999999999997421 135889988644 233446788999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC
Q 002255 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 652 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 731 (947)
++++++.++...++||||+++|+|..++.... ..+++..+..++.||++||+|||+ ++|+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 99999999999999999999999998885422 347888899999999999999996 89999999999999976
Q ss_pred CC-------cEEEeecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHH-hCCCCCCccC
Q 002255 732 DM-------RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELI-TGRKALDETQ 802 (947)
Q Consensus 732 ~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~p~~~~~ 802 (947)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 43 4899999987644321 12357788999998865 56899999999999999995 6899987654
Q ss_pred ccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 803 SEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 803 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
..+.. ..+........ .....+.+++.+||+.+|++||++.+|++.|
T Consensus 227 ~~~~~-----------------~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEKE-----------------RFYEKKHRLPE---PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHHH-----------------HHHHhccCCCC---CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 32211 11111111111 1123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=326.24 Aligned_cols=238 Identities=25% Similarity=0.371 Sum_probs=185.4
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC---CCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
||+|+||.||+|+.+ +|+.||||++..... .......+..|..++.+. +||||+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 689999999865422 223344556677777665 699999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 9999888542 347889999999999999999997 8999999999999999999999999999875433221
Q ss_pred ceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 753 SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..+.....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~ 214 (330)
T cd05586 152 -TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----------------MYRNIAFGKV 214 (330)
T ss_pred -CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence 12345799999999998754 48999999999999999999999997643211 1111111111
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
..... .....+.+++.+||+.||++||++.
T Consensus 215 ~~~~~--~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 215 RFPKN--VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred CCCCc--cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 11111 1234577999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.57 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=203.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+|++++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 46888899999999999999865 68899999987543 33445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++... .+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++++|||+++....
T Consensus 80 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999998542 58899999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||....+.... ... .....
T Consensus 151 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~~-------~~~~~ 215 (274)
T cd06609 151 TM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FLI-------PKNNP 215 (274)
T ss_pred cc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HHh-------hhcCC
Confidence 32 1223456889999999998888999999999999999999999999754422110 000 00000
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.+. .......+.+++.+|+..+|++||+++++++
T Consensus 216 ~~~~----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLE----GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCc----ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 0113456789999999999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.07 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=192.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++..+...++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999875 5778999975432 234689999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+ .++|.+++.... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEcc-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999 568888875432 458999999999999999999996 89999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccch--------hhHHHHHHHhhc
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDS--------VHLVTWFRRMHI 818 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--------~~l~~~~~~~~~ 818 (947)
.... ......||+.|+|||++.+..++.++|||||||++|||+++..|+....+... .++...+.....
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~ 284 (357)
T PHA03209 208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284 (357)
T ss_pred ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence 3211 12345799999999999998999999999999999999996655533222111 111111111110
Q ss_pred Chh---------hHHHHhhcc-CCCChh-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKD---------TFRKAIDRT-IDLDEE-------TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~---------~~~~~~~~~-~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .....++.. ....+. .......+.++|.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000 011111100 000000 0011234567999999999999999999976
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.52 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=202.0
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 5689999999999999999975 478999999987542 3335678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999998843 237899999999999999999997 8999999999999999999999999999876543
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......+.... ...
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~----------------~~~ 229 (296)
T cd06655 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----------------IAT 229 (296)
T ss_pred ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------------HHh
Confidence 221 12234688999999999888899999999999999999999999976543221110 000
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...............+.+++.+|+..||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000111123345779999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.42 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=209.5
Q ss_pred HHhcCCCcC-ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe----
Q 002255 587 NVTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD---- 659 (947)
Q Consensus 587 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 659 (947)
.++++|++. ++||-|-.|.|-.+..+ +|+++|+|++... ...++|++..-.. .|||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 356667664 68999999999998655 7999999988643 3456788876666 69999999999864
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAK 736 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~k 736 (947)
.....+|||.|+||.|...+.+++. ..+.+.++..|+.||+.|+.|||+ .+|.||||||+|+|... +..+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceE
Confidence 4567899999999999999977554 568999999999999999999997 89999999999999964 56799
Q ss_pred EeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
++|||+|+.-.... .....+-||+|.|||++...+|+..+|+||+||++|-|++|.+||......
T Consensus 205 LtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~------------ 269 (400)
T KOG0604|consen 205 LTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------------ 269 (400)
T ss_pred ecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc------------
Confidence 99999998654322 223457899999999999889999999999999999999999999765532
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHH-HHHHHhcccCCCCCCCHHHHHH
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+.+.-+++....+.++...|.++++.+ ++|+.+|+.+|.+|.|..+++.
T Consensus 270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 22345556677777888888888877655 9999999999999999999876
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=316.26 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=202.8
Q ss_pred ecHHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEE
Q 002255 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (947)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 657 (947)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|++... .....++.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 344556677899999999999999999999764 5889999987643 22235678899999999 699999999988
Q ss_pred E-----eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 658 L-----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 658 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
. .++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 4 345689999999999999987643222 2457888999999999999999996 899999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchh
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 807 (947)
+.+|++|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 9999999999886643221 1223468999999998753 45788999999999999999999999765322110
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
. . . ......... ........+.+++.+|++.+|++||++.|+++.
T Consensus 239 ~--~----~-------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 F--K----I-------PRNPPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h--h----c-------cccCCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0 0 000000000 001112457899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.68 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=201.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 467889999999999999999875 6889999998654 4555678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999885532 348899999999999999999996 899999999999999999999999999987554
Q ss_pred CCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
.... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---------------- 216 (280)
T cd06611 155 STLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---------------- 216 (280)
T ss_pred cccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH----------------
Confidence 3221 123356899999999874 34577899999999999999999999976432211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....................+.+++.+|++.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 217 LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 011111100000011122346789999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.04 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=203.4
Q ss_pred CCCcCceecccCceEEEEEEEcC--CcEEEEEEecccc--------cChHHHHHHHHHHHHHHc-CCCCCcceEEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELHD--GTKIAVKRMESAV--------VSEKGFAEFKSEIAVLTK-VRHRHLVGLLGYCLD 659 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 659 (947)
.|++.+.||+|+||.||+|..+. ++.+|+|.+.... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998764 6889999885432 223445667889988875 799999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
++..++||||+++++|.+++...... ...+++..+++++.|++.||.|||+ ..+++||||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542221 2458889999999999999999995 36899999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------------- 221 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------------- 221 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------------
Confidence 99998765432 22345688999999999988899999999999999999999999965432111
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.....+.... ..........+.+++.+|++.||++||++.|+.++++
T Consensus 222 ---~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ---ATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111 1111122356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.49 Aligned_cols=266 Identities=18% Similarity=0.276 Sum_probs=196.2
Q ss_pred cCceeccc--CceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 594 EENVLGRG--GFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 594 ~~~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
+.++||+| +|++||++.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999976 47899999999766544555667888999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+......+
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999855322 347899999999999999999996 899999999999999999999999998654332211
Q ss_pred Cc-----ceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc---Ch
Q 002255 751 KH-----SIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI---NK 820 (947)
Q Consensus 751 ~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~ 820 (947)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccc
Confidence 10 01122356788999999875 4588999999999999999999999975432111 0000000000 00
Q ss_pred hh-HHHHh---------hcc----------------CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DT-FRKAI---------DRT----------------IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~-~~~~~---------~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. ..+.. +.. ....+........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00000 000 0000111122346789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.17 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=199.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||+|..+ +++.||+|.+.... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57889999999999999999765 68899999986543 22233567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++ ++|.+++.... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 68888875532 347888999999999999999996 8999999999999999999999999999875433
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+............. ...+...+
T Consensus 157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (301)
T cd07873 157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGIL 233 (301)
T ss_pred CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhh
Confidence 221 1223457899999998765 3578899999999999999999999976543322111110000000 11111111
Q ss_pred hcc----CCCCh--------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRT----IDLDE--------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~----~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ..... ........+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 100 00000 00112345789999999999999999999977
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.50 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=202.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||+|..+ +|+.||+|.+.... .......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46888999999999999999876 78999999887542 44456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ...+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999888855321 2358999999999999999999996 36899999999999999999999999999876533
Q ss_pred CCCcceeecccccccccCccccccC------CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
.. .....|++.|+|||++.+. .++.++|||||||++|||++|+.||......... ..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~ 218 (286)
T cd06622 156 SL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQ 218 (286)
T ss_pred Cc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HH
Confidence 21 2234688899999988543 3578999999999999999999999654321110 01
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+.+.... .........+.+++.+|++.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 219 LSAIVDGDPP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHhhcCCC--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1112221111 111224456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.13 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=205.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||++... +|+.||+|++..........+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999764 688999999876544555667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++..... ..+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998864322 347888999999999999999996 89999999999999999999999999998866443
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......|++.|+|||+..+..++.++|||||||++++|++|+.||......+ ...+++..
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~~~ 216 (256)
T cd08218 155 VE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------------LVLKIIRG 216 (256)
T ss_pred hh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----------------HHHHHhcC
Confidence 21 1223468899999999988889999999999999999999999997543211 11112211
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .........+.+++.+|++.+|++||++.+|++
T Consensus 217 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 217 SYP--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCC--CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 111223456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=312.72 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=199.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 357888899999999999999764 6889999998755 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++.++..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 86 EFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred eccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999999988543 347899999999999999999996 799999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
... .......|+..|+|||++. ...++.++|||||||++|||++|+.||....+.......
T Consensus 158 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-------------- 221 (267)
T cd06645 158 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------------- 221 (267)
T ss_pred Ccc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--------------
Confidence 321 1223457899999999874 456889999999999999999999998654432111000
Q ss_pred HHhhccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ .........+.+++.+|++.+|++||++.++++
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 222 --TKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --hccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000000 000112245789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.59 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=203.0
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
...+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 447899999999999999999986 479999999987543 23346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 95 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 95 MEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred ecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 999999999998843 237888999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...... .
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----------------~ 227 (297)
T cd06656 166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----------------I 227 (297)
T ss_pred cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----------------e
Confidence 44321 12334688999999999888899999999999999999999999976443211100 0
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.................+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 228 ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000111222345779999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.79 Aligned_cols=247 Identities=32% Similarity=0.535 Sum_probs=198.1
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688899999999999999975 57889999986432 346788999999999999999999998654 47999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++..... ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999865332 347889999999999999999996 89999999999999999999999999998764332
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
. .....+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..+.+.
T Consensus 154 ~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~ 211 (254)
T cd05083 154 V-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VKECVE 211 (254)
T ss_pred C-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHh
Confidence 1 12234578999999988899999999999999999998 999997544221 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
...... ........+.+++.+|++.+|++||+++++++.|++
T Consensus 212 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 KGYRME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111111 111233567899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.99 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=204.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||++... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56788899999999999999765 68899999886542 33446788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .++++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999887542 347899999999999999999996 36899999999999999999999999999865432
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............ .... .+.+...+.
T Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~--~~~~~~~~~ 227 (284)
T cd06620 157 SI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---PMGI--LDLLQQIVQ 227 (284)
T ss_pred hc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---hhHH--HHHHHHHhh
Confidence 21 12357899999999998888999999999999999999999999765432110000 0000 001111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.... ..........+.+++.+|++.||++||++.|+++..
T Consensus 228 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 228 EPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 001112335678999999999999999999998853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.71 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=205.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||.|+||.||+|... ++..+|+|++....... ..+.+.+|+++++.++|+|++++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47889999999999999999864 68899999987554333 56789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++++|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999865322 1357899999999999999999996 8999999999999999999999999999876654
Q ss_pred CCCc--ceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 749 NGKH--SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 749 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
.... .......|+..|+|||++... .++.++|||||||++|||++|+.||........ .......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---------- 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---------- 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC----------
Confidence 3322 123345689999999998776 789999999999999999999999976543211 1110000
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
-...+............+.+++.+|++.+|++||++.++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 -DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111111111133456789999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.56 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=206.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCeeEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLVY 667 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 667 (947)
+|++.+.||.|+||.||+|... +|+.||+|++..........+++..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999754 68899999998765566667889999999999999999999998764 45679999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc--CCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||+++++|.+++..... ....+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+|++|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999865432 2246899999999999999999999432 38999999999999999999999999999887
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~------------ 222 (265)
T cd08217 160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI------------ 222 (265)
T ss_pred ccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH------------
Confidence 654322 122346899999999998888999999999999999999999999765421 111111
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ..........+.+++.+|++.+|++||++.+|++
T Consensus 223 -~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 223 -KEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -hcCCC--CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 1112233456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.77 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=201.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..........+.+.+|++++++++|+|++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999876 58999999987543333334568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++++.|..++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998887766332 248899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+..... ............+..
T Consensus 153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 228 (286)
T cd07847 153 PGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI--RKTLGDLIPRHQQIF 228 (286)
T ss_pred Ccc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCChHHhhhc
Confidence 321 1223457889999998865 45789999999999999999999999765433221111 000000000000000
Q ss_pred hc----------cCCC-C---hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DR----------TIDL-D---EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~----------~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+. .... . .........+.+++.+|++.+|++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000 0 000112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.48 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=200.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh-------HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+|.+...||+|+||.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999764 68899999886543221 223678899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999998543 347888899999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 743 VRLAPDNGKH----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 743 a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
++........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------------ 220 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------------ 220 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------------
Confidence 8866432111 111234688999999999888899999999999999999999999976432111
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ ...........+.+++.+|++.||.+||++.|+++
T Consensus 221 ----~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 ----IFKIGENA--SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HHHHhccC--CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111100 01111223456789999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.16 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=187.8
Q ss_pred eecccCceEEEEEEEcCCc---EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 597 VLGRGGFGTVYKGELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.||+|+||.||+|...++. .+++|.+.... .....+.+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999755433 45666655432 2345678999999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++...... ....++.....++.||++||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999998754322 2346677788999999999999996 899999999999999999999999999976432221112
Q ss_pred eeecccccccccCcccccc-------CCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 754 IETRLAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
......|+..|+|||++.. ..++.++|||||||++|||++ |..||......+. ...+. . +....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~---~--~~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LNHVI---K--DQQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---h--hcccc
Confidence 2234568899999998743 245789999999999999997 4667754432111 11000 0 00001
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
..++.+. ......+.+++..|+ .+|++||++++|++.|.
T Consensus 229 ~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111111 112345678999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.14 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=202.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||++... +++.||+|.+..... .......+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999875 578999999875532 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+|++|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998543 347889999999999999999996 899999999999999999999999999986421
Q ss_pred CCCC-------------cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 748 DNGK-------------HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 748 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
.... ........|+..|+|||++.+..++.++|||||||++|||++|..||.+....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--------- 223 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------- 223 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------
Confidence 1100 001122457889999999988889999999999999999999999997543211
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.+....................+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 -------LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -------HHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111111111111234557899999999999999998767666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=309.10 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=203.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
..|+..+.||+|+||.||+|..+ +++.||+|.+.... .......+.+|+.++++++|+||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45778889999999999999865 58899999987542 34456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.. ..+++.....++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999998853 237788889999999999999996 8999999999999999999999999999976644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......++..|+|||++.+..++.++|||||||++|||++|..||....+.... ..+.
T Consensus 154 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~~ 214 (277)
T cd06640 154 TQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLIP 214 (277)
T ss_pred Ccc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhhh
Confidence 321 123346888999999998888999999999999999999999999764432111 0011
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
... ...........+.+++.+|++.+|++||++.++++.
T Consensus 215 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCC-CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000 111222345668899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=310.92 Aligned_cols=239 Identities=24% Similarity=0.425 Sum_probs=188.0
Q ss_pred ceecccCceEEEEEEEcC--------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 596 NVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+.||+|+||.||+|..+. ...||+|.+... .....+++.+|+.+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997642 234888887543 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc--------EEEee
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVAD 739 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--------~kl~D 739 (947)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 9999999999986543 247899999999999999999996 89999999999999987765 69999
Q ss_pred cCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCC-CCCCccCccchhhHHHHHHHhh
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR-KALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
||++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+........
T Consensus 152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~----------- 214 (258)
T cd05078 152 PGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK----------- 214 (258)
T ss_pred cccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----------
Confidence 9988654331 22467889999999876 45789999999999999999985 55544322111
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
..........+. ....++.+++.+|++.+|++||+++++++.|
T Consensus 215 ------~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 215 ------LQFYEDRHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------HHHHHccccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 011111111111 1224678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.93 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=202.7
Q ss_pred ecHHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEE
Q 002255 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (947)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 657 (947)
++++.+..+.++|++.+.||+|+||.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 344556667889999999999999999999764 68899999986532 2245678899999999 799999999998
Q ss_pred EeC-----CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 658 LDG-----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 658 ~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
... +..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.+
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~ 164 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTE 164 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCC
Confidence 753 3589999999999999988643221 2458899999999999999999996 899999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCccccccC-----CcCcccccccHHHHHHHHHhCCCCCCccCccchh
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-----RVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 807 (947)
+.+||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||........
T Consensus 165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~- 241 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT- 241 (291)
T ss_pred CCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence 9999999999876543221 11234688999999987543 368899999999999999999999975432111
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+ .+........-.........+.+++.+|++.+|++||++.|+++
T Consensus 242 -~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 -L--------------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -H--------------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 01100000000011122345789999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.08 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=203.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 367889999999999999999764 57889999987652 335678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++....
T Consensus 80 e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 80 EYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred eCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999885532 347889999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccC---CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.... ......++..|+|||.+... .++.++||||||+++|||++|+.||........... ...
T Consensus 153 ~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~~~--------- 218 (262)
T cd06613 153 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---ISK--------- 218 (262)
T ss_pred hhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---------
Confidence 3221 12335688899999998776 789999999999999999999999976543221110 000
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+.. ............+.+++.+|+..+|.+||++++|+.
T Consensus 219 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 219 SNFPP--PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccCCC--ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 001112233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.11 Aligned_cols=256 Identities=22% Similarity=0.366 Sum_probs=198.3
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
..++.+.....||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34566666789999999999999754 6788999988754 34456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecCcce
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVR 744 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~ 744 (947)
||||+++++|.+++...... ...++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999998653211 112778888999999999999996 89999999999999986 6799999999987
Q ss_pred ecCCCCCcceeecccccccccCccccccCC--cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
....... ......|++.|+|||++.... ++.++||||||+++|||++|+.||......... .+
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~---------- 222 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MF---------- 222 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hh----------
Confidence 6543221 122346889999999986543 788999999999999999999999654321110 00
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ ...+.....++.+++.+|++.+|++||++.|+++
T Consensus 223 -~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 -KVGMFKIH--PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hhhhhccC--CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000000 0111122345789999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.20 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=195.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHH-HHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAV-LTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||+|+++....... ..++..|+.. ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 46888999999999999999875 699999999876543333 3455556664 66678999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||++ |+|.+++....... ..+++..++.++.||+.||+|||+ +.+++||||||+||+++.++.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9995 68888775533222 468999999999999999999996 2489999999999999999999999999988654
Q ss_pred CCCCcceeecccccccccCcccccc----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~ 217 (283)
T cd06617 156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---------------QQL 217 (283)
T ss_pred ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---------------HHH
Confidence 321 1223468899999998754 456889999999999999999999996432110 011
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+..... .........++.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 KQVVEEPSP-QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHhcCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111100 0001112356889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.03 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=195.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc---ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 663 (947)
.+|+..+.||+|+||.||+|... ++..||+|++..... .......+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999764 689999998865422 22345678899999999999999999998875 3567
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999988543 237888899999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+........ .......++..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---------------- 217 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---------------- 217 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH----------------
Confidence 765332111 112234688999999999888899999999999999999999999975432111
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......... ...+......+.+++ +|+..+|++||+++||++
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPTN-PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCCC-CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111110000 111122234456777 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.77 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=202.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|.++.-||.|+||.||+|..++ +-..|.|+|... ++.+.+++.-||+++..+.||+||++++.|..++.+|+..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 445667789999999999997664 444577877644 67788999999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||.||-++..+..-. .++...++.-+++|++.||.|||+ .+|||||||+.|||++-+|.++++|||.+.....
T Consensus 110 FC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh
Confidence 999999988875533 458899999999999999999997 8999999999999999999999999998654322
Q ss_pred CCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
. ......+.|||+|||||+.+ ..+|+.++||||||++|.||..+.+|.....+....
T Consensus 183 t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl---------------- 244 (1187)
T KOG0579|consen 183 T--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---------------- 244 (1187)
T ss_pred H--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH----------------
Confidence 1 12234578999999999875 467999999999999999999999998776554221
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.++-......-..+..-...+.|++.+||..+|..||+++++++
T Consensus 245 lKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 245 LKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111111111112233346889999999999999999999986
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.32 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=201.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34666788999999999999764 57889999887543 23455789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.. ..+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++++|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999988743 347889999999999999999996 8999999999999999999999999999876544
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+..... .+.
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~~ 214 (277)
T cd06642 154 TQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----------------LIP 214 (277)
T ss_pred cch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----------------hhh
Confidence 221 1223468899999999988889999999999999999999999987543221100 011
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.... ..........+.+++.+|++.+|++||++.++++.
T Consensus 215 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 215 KNSP-PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCCC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 11111233567899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=305.64 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=200.9
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc---cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV---VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+|+..+.||+|+||.||+|..+ +++.|++|.+.... ..++..+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 78999999886542 1234567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++..+..++.|++.|++|||+ .+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998542 247888999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
.... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||......... . .
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~--------------~ 213 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--F--------------K 213 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--H--------------H
Confidence 4432 123456889999999987766 899999999999999999999999765421110 0 0
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ..............+.+++.+|++.+|++||++.++++
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGR-SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHh-cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000 00001111122355789999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.69 Aligned_cols=200 Identities=29% Similarity=0.433 Sum_probs=160.8
Q ss_pred CceecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCeeEEEEEe
Q 002255 595 ENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLVYEY 669 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~ 669 (947)
..+||+|+||.||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 368999999999999865 35789999886542 22457789999999999999999999854 5677999999
Q ss_pred cCCCchhhhhhcccc----cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----cCCCcEEEeecC
Q 002255 670 MPQGTLSRHLFNRKE----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG 741 (947)
+. ++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 577777643211 112357889999999999999999996 899999999999999 566899999999
Q ss_pred cceecCCCCCc-ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99876443221 11234578999999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.57 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=202.8
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+.... .....+++.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888999999999999999864 24679999876532 233457899999999999999999999999998999
Q ss_pred EEEEEecCCCchhhhhhcccccC----CCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEG----LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986543211 1258999999999999999999996 7999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhc
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~------ 230 (275)
T cd05046 161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR------ 230 (275)
T ss_pred cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH------
Confidence 999875433211 12223356778999999988888999999999999999999 788886543211 1111
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
......... ........+.+++.+|++.+|++||++.|+++.|.
T Consensus 231 -------~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 -------LQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------HHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111100 01122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.74 Aligned_cols=277 Identities=17% Similarity=0.250 Sum_probs=193.3
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEcC--CcEEEEEE--------------eccc-ccChHHHHHHHHHHHHHHcCCCC
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELHD--GTKIAVKR--------------MESA-VVSEKGFAEFKSEIAVLTKVRHR 648 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~ 648 (947)
..+.++|++.+.||+|+||.||++.++. +..++.|. +.+. .........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456899999999999999999986542 22222221 1111 11223446788999999999999
Q ss_pred CcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 649 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
|||++++++...+..|+|+|++ +++|.+++..................++.||+.||+|||+ ++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 9999999999999999999998 5677777654322111223355677899999999999997 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCC-CCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p-~~~~~~~~~~ 807 (947)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987654322 222345799999999999998999999999999999999998754 4433322222
Q ss_pred hHHHHHHHhhcChh-------hHHHHhhc-cCCCCh-h------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 808 HLVTWFRRMHINKD-------TFRKAIDR-TIDLDE-E------TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 808 ~l~~~~~~~~~~~~-------~~~~~~~~-~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+...+........ .+...++. .+.... . .......+.+++.+||+.||++||++.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 22222221111000 11111111 000000 0 0011235678899999999999999999976
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=315.58 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=202.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh-HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||+|... +++.||+|.+....... ...+.+..|++++++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999775 58999999997654332 35567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+.+++|.+++..... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998864321 358889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcc---------------------------eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCc
Q 002255 748 DNGKHS---------------------------IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 800 (947)
Q Consensus 748 ~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~ 800 (947)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 221100 01134688999999999988899999999999999999999999975
Q ss_pred cCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 801 TQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 801 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... .+.++.......... ......+.+++.+|++.+|++||+++..++
T Consensus 235 ~~~~~----------------~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 235 SNRDE----------------TFSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CchHH----------------HHHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 54221 122222222221111 113466889999999999999999444333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.71 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=203.6
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||++... +++.+|+|.+............+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999764 688999999977655556678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~~~~~ 748 (947)
+++++|.+++.... ...+++..+.+++.|++.|++|||+ ++++||||||+||+++.+ +.+|++|||.++....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999996533 2347899999999999999999996 899999999999999865 4689999999987654
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ......
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----------------~~~~~~ 215 (256)
T cd08220 155 KSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----------------VLKIMS 215 (256)
T ss_pred Ccc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----------------HHHHHh
Confidence 321 1234688999999999888899999999999999999999999976442211 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... .........+.+++.+|++.+|++||++.|+++
T Consensus 216 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 216 GTFA--PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cCCC--CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1110 111123346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=304.84 Aligned_cols=252 Identities=33% Similarity=0.559 Sum_probs=201.1
Q ss_pred CCcCceecccCceEEEEEEEcC-----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 592 FSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
|++.+.||.|+||.||++.... +..||+|.+.... .....+.+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4567899999999999998763 3889999986553 233567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++++|||+++..
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999865332 127899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
....... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+ ... .
T Consensus 154 ~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~-------------~ 216 (258)
T smart00219 154 YDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLE-------------Y 216 (258)
T ss_pred ccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-------------H
Confidence 5532221 112347789999999988889999999999999999998 788886532211 111 1
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
..... . ..........+.+++.+|+..+|++||++.++++.|
T Consensus 217 ~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGY-R-LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCC-C-CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111 1 111122445688999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.04 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=198.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|.....||+|+||.||++... ++..||||.+... .....+.+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34455577999999999999764 6889999998654 33445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 100 ~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 100 FLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999999988743 237888999999999999999997 7999999999999999999999999999875533
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|+..|+|||+..+..++.++||||||+++|||++|+.||.......... .....+.
T Consensus 171 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~~~ 235 (292)
T cd06658 171 EVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------------RIRDNLP 235 (292)
T ss_pred ccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhcCC
Confidence 221 1223468999999999988889999999999999999999999997543221110 0111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... ........+.+++.+|+..||.+||++.++++
T Consensus 236 ~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 236 PRVK---DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred Cccc---cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 11122345779999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.61 Aligned_cols=237 Identities=25% Similarity=0.469 Sum_probs=188.1
Q ss_pred ceecccCceEEEEEEEcCCc-----------EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 596 NVLGRGGFGTVYKGELHDGT-----------KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
+.||+|+||.||+|.+.+.. .|++|.+.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46999999999999876432 57888765442 125788999999999999999999999988 7789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-------cEEE
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-------RAKV 737 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-------~~kl 737 (947)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++ .+|+
T Consensus 77 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999986543 247889999999999999999996 8999999999999999888 7999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccC--CcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~ 814 (947)
+|||+++.... .....++..|+|||++... .++.++|||||||++|||++ |..||.......... +..
T Consensus 150 ~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~ 220 (259)
T cd05037 150 SDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ 220 (259)
T ss_pred CCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh
Confidence 99999886543 1223567789999998776 78999999999999999999 577776543221110 000
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
..... .. .....+.+++.+|+..+|.+||++.++++.|
T Consensus 221 -------------~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -------------DQHRL-PM---PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------------cCCCC-CC---CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01000 00 1115678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.10 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=201.0
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
...+....+.|++.+.||+|+||.||+|... +++.||+|++... .....++..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3445556789999999999999999999864 6889999988643 33446788999999999 69999999999853
Q ss_pred ------CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 660 ------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 660 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
....++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCC
Confidence 4678999999999999998865332 347788889999999999999996 8999999999999999999
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhh
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 808 (947)
.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.....
T Consensus 159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 999999999875532211 122356899999999875 3467889999999999999999999997543221111
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ... ..............+.+++.+||+.||.+||++.|+++
T Consensus 237 ~----------------~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 L----------------IPR-NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h----------------Hhh-CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 00001111123356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=308.74 Aligned_cols=265 Identities=26% Similarity=0.364 Sum_probs=203.0
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|++.+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788899999999999999875 689999999987654455567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+ +++|.+++.... ..+++.++..++.||++||+|||+ .+++|+||||+||+++.++.++++|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886533 458999999999999999999996 89999999999999999999999999998866543
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc-Chh-hHH--
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI-NKD-TFR-- 824 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~~-~~~-- 824 (947)
.. .......|+..|+|||++.+. .++.++||||+|+++|||++|++||........ ..++..... ... ...
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 153 EP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhc
Confidence 22 112334689999999988654 468999999999999999999888865433211 111111000 000 000
Q ss_pred -------HHhhcc-CC--CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 -------KAIDRT-ID--LDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 -------~~~~~~-~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.... .. ...........+.+++.+|++.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 00 00000112356789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.38 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..++||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999876 58999999987654344445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.++.... ..+++.++..++.||+.||+|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999888766432 237899999999999999999997 7999999999999999999999999999886544
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ......++..|+|||++.+ ..++.++||||||+++|||++|++||......+............ ........
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 228 (286)
T cd07846 153 PGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL--IPRHQEIF 228 (286)
T ss_pred Ccc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC--chhhHHHh
Confidence 321 2233568899999998865 457889999999999999999999997544322111111000000 00011111
Q ss_pred hcc-----CCCCh---------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRT-----IDLDE---------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~-----~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.. ..... ........+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000 00122356889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=315.29 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=197.0
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 689999999876543333446678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
++ ++|.+++.... ..+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 57877775422 348899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh-hcCh-hhHHHH
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM-HINK-DTFRKA 826 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~-~~~~-~~~~~~ 826 (947)
.. ......+++.|+|||++.+. .++.++|||||||++|||++|+.|+....... .....+... .... ..+...
T Consensus 153 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 153 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHh
Confidence 21 12234678899999988764 46899999999999999999998865432211 111111110 0000 000000
Q ss_pred ---hhc-cCC-C------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 ---IDR-TID-L------DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ---~~~-~~~-~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+. ... . .........++.+++.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000 0 0000112356789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.15 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=198.3
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC--------hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS--------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 661 (947)
+|...+.||+|+||.||+|... +|+.||+|.++..... ....+.+..|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999754 6899999988642111 112356888999999999999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998553 347888899999999999999996 799999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCC--cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
+++...............|+..|+|||++.... ++.++||||||+++||+++|..||........ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~---------- 221 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--M---------- 221 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--H----------
Confidence 987654322222233456889999999987654 78999999999999999999999964322110 0
Q ss_pred hhhHHHHhhc--cCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFRKAIDR--TIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~~~~~~--~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.... ..... .........+.+++.+|++.+|++||++.+|++
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 222 ----FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ----HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000000 00000 111123456889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.10 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..+.||+|+||.||+|..+ +++.||+|+++.........+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999876 58899999987654444556788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++++.+..+.... ..+++.++..++.||+.||+|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99887776554321 337889999999999999999996 8999999999999999999999999999887654
Q ss_pred CCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+........... .........
T Consensus 153 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (288)
T cd07833 153 RPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP--LPPSHQELF 229 (288)
T ss_pred Ccc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC--CCHHHhhhc
Confidence 332 122345688999999999887 7899999999999999999999999765432211111000000 000000000
Q ss_pred h--ccC------CC-Ch------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 D--RTI------DL-DE------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~--~~~------~~-~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. +.. .. .. .......++.+++++|+..+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000 00 00 00112456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=303.76 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=203.0
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||+|... +++.||+|.++.........+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888899999999999999765 688999999987654445678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999988542 236788899999999999999996 89999999999999999999999999998876543
Q ss_pred CCcce--eecccccccccCccccccCC---cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 750 GKHSI--ETRLAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 750 ~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
..... .....++..|+|||++.... ++.++||||||+++||+++|+.||........ ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~------------ 218 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFH------------ 218 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHH------------
Confidence 22211 11346788999999988766 88999999999999999999999975432110 0000
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.........+. .......+.+++.+|++.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VGAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HhcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00011111111 1112345779999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=309.31 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=201.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||++... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999765 689999999875432 2344577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998553 347888999999999999999996 899999999999999999999999999988764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||....... ....+.
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~ 211 (290)
T cd05580 153 GR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----------------IYEKIL 211 (290)
T ss_pred CC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHh
Confidence 43 233468999999999988888999999999999999999999997544211 111122
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
........ .....+.+++.+|+..+|.+|+ +++|+++
T Consensus 212 ~~~~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 212 EGKVRFPS---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCccCCc---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 22222111 1235678999999999999999 5566543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.93 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=196.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc---ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--Cee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 663 (947)
.+|++.++||+|+||.||+|... +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999764 589999998864321 233456888999999999999999999988763 467
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++++|.+++... ..+++....+++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999988543 236788889999999999999996 88999999999999999999999999998
Q ss_pred eecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------------- 217 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---------------- 217 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----------------
Confidence 755321111 112234688999999999888899999999999999999999999975422110
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+...... ....+......+.+++.+|+. +|++||+++|+++
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 IFKIATQPT-NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhcCCC-CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111100 111122333457789999995 9999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.98 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=198.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
..|.....||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34445568999999999999764 68999999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 99 FLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred cCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9999999887743 237899999999999999999996 8999999999999999999999999999875543
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+..
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~------------- 231 (297)
T cd06659 170 DVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRD------------- 231 (297)
T ss_pred ccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhc-------------
Confidence 221 123356899999999998888999999999999999999999999754322111 11100
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
...............+.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 232 SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000111223457899999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.68 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=209.8
Q ss_pred CcCceecccCceEEEEEEE-cCCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 593 SEENVLGRGGFGTVYKGEL-HDGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
...++||+|+||+||+|.| .+|+ +||+|++.... ..+..+++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3458999999999999976 3443 68999886543 4455689999999999999999999999998776 78999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
+||+.|+|.++++..+ ..+.-...+.|..|||+|+.|||. +++|||||.++||||.....+||.|||+++...
T Consensus 777 q~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999997754 347788899999999999999995 899999999999999999999999999999887
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.++.........-.+.|||-|.+....|+.++|||||||.+||++| |..|+++...++. .+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-----------------~dl 912 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-----------------PDL 912 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-----------------hHH
Confidence 7666555444455678999999999999999999999999999999 8999987664432 222
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+...-.+ ..+.....++.-++.+||..|++.||+++++...+.++.
T Consensus 913 le~geRL-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 913 LEKGERL-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HhccccC-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 3222111 112233446778999999999999999999999998875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=336.86 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=193.7
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG----- 660 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 660 (947)
....+|++.++||+||||.||+++.+ ||+.||||+|.... +......+.+|+.++.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45567888999999999999999876 89999999998776 677788899999999999999999998422100
Q ss_pred --------------------------------------------------------------------------------
Q 002255 661 -------------------------------------------------------------------------------- 660 (947)
Q Consensus 661 -------------------------------------------------------------------------------- 660 (947)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHH
Q 002255 661 ----------------------------------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706 (947)
Q Consensus 661 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L 706 (947)
...|+-||||+...+.+++++..... .-...++++++|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHH
Confidence 02478899999888877775533211 3456789999999999
Q ss_pred HHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC------C----------CCCcceeecccccccccCcccc
Q 002255 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP------D----------NGKHSIETRLAGTFGYLAPEYA 770 (947)
Q Consensus 707 ~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~ 770 (947)
+|+|+ .+||||||||.||+++++..|||+|||+|+... . .......+..+||.-|+|||++
T Consensus 711 aYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99997 889999999999999999999999999998621 0 0011124567899999999998
Q ss_pred ccC---CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCC-hhcHHHHHHHHH
Q 002255 771 VTG---RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD-EETLASISTVAD 846 (947)
Q Consensus 771 ~~~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 846 (947)
.+. .|+.|+||||+|||++||+. ||.... +... .+..+-+..+..+ ....+..+.-+.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~-------------iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERAS-------------ILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHH-------------HHHhcccCCCCCCcccccccchHHHH
Confidence 764 49999999999999999997 565332 1111 1111112222222 112333445578
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 002255 847 LAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 847 li~~cl~~dP~~RPs~~evl~ 867 (947)
+|+++++.||.+|||+.|++.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999987
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.94 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=200.0
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC----
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN---- 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 661 (947)
.+++|++.+.||+|+||.||+|..+ +++.+++|++.... ...+++.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5689999999999999999999875 57899999987542 2346789999999999 6999999999997644
Q ss_pred --eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 662 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
..++||||+++++|.+++...... ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 489999999999999988653311 2458899999999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
||++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||.........
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------- 227 (275)
T cd06608 157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL------- 227 (275)
T ss_pred Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-------
Confidence 999876543221 1233568899999998753 34678999999999999999999999754321110
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+.......-.........+.+++.+|+..||++||++.++++
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 ---------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111000111123456889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=313.18 Aligned_cols=273 Identities=23% Similarity=0.349 Sum_probs=199.5
Q ss_pred CCCcCceecccCceEEEEEEEc---CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH---DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 664 (947)
+|++.++||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999875 47899999998642 1223346678899999999999999999999988 8899
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC----CCcEEEeec
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD----DMRAKVADF 740 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~----~~~~kl~Df 740 (947)
+||||+++ ++.+++..........++...+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 67676654333333468889999999999999999996 89999999999999999 999999999
Q ss_pred CcceecCCCCC-cceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccch-------hhHHH
Q 002255 741 GLVRLAPDNGK-HSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDS-------VHLVT 811 (947)
Q Consensus 741 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-------~~l~~ 811 (947)
|+++....... ........+++.|+|||++.+. .++.++|||||||++|||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886644322 1122335678999999987664 578999999999999999999999976544320 11111
Q ss_pred HHHHhhcChhh----------HHHHhh--ccCCCC-hh--cH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 812 WFRRMHINKDT----------FRKAID--RTIDLD-EE--TL-----ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 812 ~~~~~~~~~~~----------~~~~~~--~~~~~~-~~--~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+..+...... +....+ ...... .. .. .....+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111110000 000000 000000 00 00 12245789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.98 Aligned_cols=255 Identities=24% Similarity=0.425 Sum_probs=201.5
Q ss_pred CCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccC----hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS----EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 57899999998754311 2245788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCcce
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 744 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~ 744 (947)
||||+++++|.+++... .++++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999988543 347889999999999999999996 8999999999999998776 59999999987
Q ss_pred ecCCCCCc--ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKH--SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
........ .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------ 220 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------------ 220 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH------------
Confidence 66543211 1122346889999999998888999999999999999999999999654322111110
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+..... .....+......+.+++.+|++.+|++||++.++++
T Consensus 221 -~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 -FKIASAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HHHhccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000000 111122233456889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.48 Aligned_cols=211 Identities=28% Similarity=0.407 Sum_probs=175.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEcC-----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GN 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 661 (947)
....|+....||+|.||.||+|.-++ ...+|+|.++.+..........-+|+..++.++|||++.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 44678999999999999999995432 2368999998663333334567789999999999999999999987 88
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC----CcEEE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKV 737 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl 737 (947)
..++++||.+. +|.+.++.......+.++-..+..|+.||+.|+.|||+ +=|+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEe
Confidence 89999999965 78888876555555678888999999999999999997 679999999999999877 99999
Q ss_pred eecCcceecCCCCCcc-eeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 738 ADFGLVRLAPDNGKHS-IETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
+|||++|.+.+.-..- ....++-|..|+|||.+.+. .|+.+.||||.|||+.||+|-++-|.+..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999999876643332 34557789999999998875 69999999999999999999888776543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=302.83 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=204.6
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
...+.|..-++||+||||.||-++.+ +|+.+|.|.+.+.... ..+......|-.++.+++.+.||.+--.|+..+..+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34467888999999999999999654 7999999988765432 334556788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+|+..|.||+|.-+|..... ..+++.++.-+|.+|+.||++||. .+||+||+||+|||+|+.|+++|+|.|+|.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred EEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEE
Confidence 99999999999988876543 458999999999999999999996 899999999999999999999999999999
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.+..... .+..+||.+|||||++.+..|+...|.||+||++|||+.|+.||........ +
T Consensus 336 ei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----------------~ 395 (591)
T KOG0986|consen 336 EIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----------------R 395 (591)
T ss_pred ecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----------------H
Confidence 8876433 2334899999999999999999999999999999999999999976543211 1
Q ss_pred HHhhccCCC--ChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 825 KAIDRTIDL--DEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 825 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
+-+|+.... .+.+..-.++..++.+..|+.||.+|...
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 112221111 11223334567789999999999999843
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.56 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=200.2
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC---hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+|+..+.||+|+||.||+|..+ +|+.||+|++...... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999865 6899999999765433 23345678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+ ++|+||||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 999999985532 258999999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-hhhHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-KDTFR 824 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~ 824 (947)
...... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+.. .......... ...+.
T Consensus 153 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 153 GSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWP 228 (298)
T ss_pred cCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhh
Confidence 543221 223356788999998854 46789999999999999999998888654432211 1111110000 00000
Q ss_pred H------Hhhcc----CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 K------AIDRT----IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~------~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ..... .............+.+++.+|++.+|++||+++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 00000 0000001122356789999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.65 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=197.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
...|+..+.||+|+||.||+|... +|+.||+|.+.... ......+++.+|+++++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999865 68999999986442 2344557789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+. |++.+++.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99996 57767664322 348899999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
... ....|++.|+|||++. ...++.++||||||+++|||++|+.||......... .
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---~------------ 224 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y------------ 224 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---H------------
Confidence 432 2246788999999874 456889999999999999999999999754321110 0
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
........ ..........+.+++.+||+.+|++||++.+++..
T Consensus 225 -~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 -HIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -HHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 01111233468899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.32 Aligned_cols=248 Identities=23% Similarity=0.455 Sum_probs=199.2
Q ss_pred CCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC---CCCcceEEEEEEeCCeeEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 666 (947)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+++.+|+.++++++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999986 468999999987542 3344567889999999997 99999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... .+++..++.++.|++.||+|||+ .+|+||||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999987432 47899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
..... ......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||.......... .. ..
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~~----------~~ 216 (277)
T cd06917 152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---LI----------PK 216 (277)
T ss_pred CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---cc----------cc
Confidence 55332 12334689999999988654 46899999999999999999999997543221100 00 00
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.+. . ......+.+++.+|++.||++||++.|+++
T Consensus 217 ~~~~~~~--~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 217 SKPPRLE--D--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCC--c--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0001111 0 013356889999999999999999999977
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=307.64 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=199.4
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||+|..+ +|+.||||++............+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999765 689999999876543444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+. ++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+|++|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 688888754322 358899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH-----
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF----- 823 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----- 823 (947)
.. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||......+. ....+..........
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 154 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhh
Confidence 21 122335788999999886644 68899999999999999999999976443221 111111111111000
Q ss_pred -----HHHhhccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 -----RKAIDRTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 -----~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+....... .........+.+++.+|++.||++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=289.57 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=206.7
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
..++|...++||+|.||.|-.++-+ +|+.+|+|++++.+ ....+.+.-..|-++++..+||.+..+--.|...+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4577888999999999999999755 79999999999876 345566778899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||..||.|.-+|.+. +.++.....-+-..|+.||.|||+ .+||.||+|.+|.|+|++|++||+|||+++.
T Consensus 246 VMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999998888553 347777777788899999999997 8999999999999999999999999999985
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
-...+. ....++|||.|+|||++....|..++|.|.+|||+|||++|+.||...+.+. .+.-
T Consensus 318 ~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeL 379 (516)
T KOG0690|consen 318 EIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFEL 379 (516)
T ss_pred cccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHH
Confidence 444332 3456899999999999999999999999999999999999999998765322 2222
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
++-..+.++ ....++...|+..+|..||++|. +++||.+
T Consensus 380 Il~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 380 ILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 333333322 22334567889999999999998 4556554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.89 Aligned_cols=266 Identities=24% Similarity=0.380 Sum_probs=211.6
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEe
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD 659 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 659 (947)
++++-..++ +.||+|+|+.|--+. ..+|..||||++.+. ......++.+|++++.+.+ |+||+.++++|++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 445444443 689999999999884 678999999999876 4556788999999999995 9999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC---cEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAK 736 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~k 736 (947)
++..|||||-|.||.|..++..++ .+.+.++-++..+|+.||.+||. ++|.|||+||+|||-.+.. -+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence 999999999999999999997754 48899999999999999999996 9999999999999997553 589
Q ss_pred EeecCcceecCCCCC-----cceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccch
Q 002255 737 VADFGLVRLAPDNGK-----HSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806 (947)
Q Consensus 737 l~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 806 (947)
|+||.+..-...... .......+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.-..+-
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 999988542221111 11123467999999999763 34688999999999999999999999976543220
Q ss_pred ----hhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHH-HHHHHhcccCCCCCCCHHHHHH
Q 002255 807 ----VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 807 ----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~li~~cl~~dP~~RPs~~evl~ 867 (947)
....... ....+..+-+..+.+++..|..++..+ +++..++..|+.+|.++.+++.
T Consensus 300 GWdrGe~Cr~C-----Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVC-----QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHH-----HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000000 033466777788888888887777655 9999999999999999988876
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=304.61 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=203.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..+.||+|+||.||++..+ +++.||+|++.... .....+++.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 35778889999999999999876 68899999987653 23556788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ..++...+..++.|++.|++|||+ ..+++||||||+||++++++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 999999999986532 457888899999999999999995 37999999999999999999999999999875533
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||........ .... .......
T Consensus 154 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~----------~~~~~~~ 218 (265)
T cd06605 154 SLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFE----------LLQYIVN 218 (265)
T ss_pred HHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHH----------HHHHHhc
Confidence 211 115788999999999888999999999999999999999999975432111 0111 1111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... ..........+.+++.+|+..+|++||++.++++
T Consensus 219 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 219 EPPP-RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCC-CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 0011113456889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.00 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=198.5
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
.|...++||+|++|.||++... +++.||+|++... .....+.+.+|+.+++.++|||++++++++..++..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 4555689999999999999764 6889999988643 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||+|+||+++.++.++++|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999998854 237888999999999999999996 89999999999999999999999999987755432
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.... .. .......
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~-------~~~~~~~ 233 (285)
T cd06648 169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KR-------IRDNLPP 233 (285)
T ss_pred Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HH-------HHhcCCC
Confidence 21 122346899999999998888999999999999999999999999754321111 00 0000000
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 234 KLK---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCc---ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111 11113356889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.87 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+-|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 45778899999999999999764 68899999876543 23445788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 83 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999988843 247899999999999999999996 8999999999999999999999999999876544
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......... . .+..
T Consensus 154 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~----------~~~~ 215 (277)
T cd06641 154 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------F----------LIPK 215 (277)
T ss_pred chh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------H----------HHhc
Confidence 221 122346888999999998888999999999999999999999999654321110 0 0000
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
... ..........+.+++.+|++.+|.+||++.++++.
T Consensus 216 ~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NNP--PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCC--CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 11111233557899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.95 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=196.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 67889999999999999999875 6899999998754322 223456789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+. ++|.+++.... ..+++.....++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 58988886532 247889999999999999999996 8999999999999999999999999999875432
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHHhhcC-hhhHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSE-DSVHLVTWFRRMHIN-KDTFRK 825 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~-~~~~l~~~~~~~~~~-~~~~~~ 825 (947)
... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... +..... ....... ...+..
T Consensus 156 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI--FRVLGTPTEETWPG 231 (291)
T ss_pred CCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH--HHhcCCCChhhhhh
Confidence 211 1122356889999998865 45889999999999999999999999655421 111110 0000000 000000
Q ss_pred Hhh------cc---CCCCh-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AID------RT---IDLDE-----ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~------~~---~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .. ..... ........+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00 00000 00111245679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.64 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=206.8
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|++.++||+|+||.||++..+ +++.+|+|.+...........++.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 688999999987655556667888999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++...... ...+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998664322 2458899999999999999999996 89999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
......|++.|+|||...+..++.++|+||||+++|||++|+.||......+ +...+..
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----------------~~~~~~~ 215 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----------------LRYKVQR 215 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHhc
Confidence 1223468899999999998889999999999999999999999997654211 1111111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ...........++.+++.+|++.+|++||++.++++
T Consensus 216 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 G-KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred C-CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1 111122234466889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.99 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=210.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
...|.+...||+|.|+.|..|++. +|..||+|.+.+...+......+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 367889999999999999999764 7999999999988777776677999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+.+|.+++++..... ....++..++.|+.+|++|||+ +.|||||||++|||++.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999976543 3447778899999999999996 899999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.. ......+|++.|.|||++.+..|+ +++|+||+|+++|-|+.|..||++..-.+- -.+.
T Consensus 207 ~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L----------------r~rv 267 (596)
T KOG0586|consen 207 YG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL----------------RPRV 267 (596)
T ss_pred cc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc----------------cchh
Confidence 43 344567999999999999988774 799999999999999999999987543211 1122
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
+...+.++... ..+..+++++++-.+|.+|++++++.+.-
T Consensus 268 l~gk~rIp~~m---s~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRGKYRIPFYM---SCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeeeeccccee---echhHHHHHHhhccCccccCCHHHhhhhc
Confidence 33333322221 13456899999999999999999998743
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.09 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=198.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCe-----
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNE----- 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 662 (947)
++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 6899999988765433334467888999999995 6999999999987665
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFG 741 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG 741 (947)
.++||||+++ +|.+++..........+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 88888865443323468999999999999999999996 89999999999999998 8999999999
Q ss_pred cceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ +...+.......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 9886533211 1122356889999998765 4578999999999999999999999976433211 111111000000
Q ss_pred h-hHHHH------hh-ccCC---CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 D-TFRKA------ID-RTID---LDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~-~~~~~------~~-~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. .+... .. +... ...........+.++|.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 00 0000 00000123356789999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.86 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=201.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 666 (947)
++|...+.||.|++|.||+|..+ +++.+|+|.+.... ......++.+|++++++++||||+++++++.+. ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46788899999999999999874 68899999987543 234567889999999999999999999998653 468999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999988754322 22457888899999999999999996 89999999999999999999999999998754
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCc--cchhhHHHHHHHhhcChhhHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS--EDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ........+..... ..
T Consensus 156 ~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~--- 226 (287)
T cd06621 156 VNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NP--- 226 (287)
T ss_pred cccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--ch---
Confidence 3321 1234678899999999888999999999999999999999999976532 11111222211100 00
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+... ..........+.+++.+|++.+|.+||++.|+++
T Consensus 227 -~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 -ELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -hhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000 0000122356789999999999999999999977
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=309.24 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=194.8
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 668 (947)
+|+..+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556788999999999999765 6899999998754322 44567899999999996 9999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+. +++.++...........+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 455443321111112458899999999999999999996 35899999999999999999999999999876543
Q ss_pred CCCcceeecccccccccCccccccC---CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .... ..+
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~----------~~~ 222 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ----------LTQ 222 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH----------Hhh
Confidence 221 1234688999999998765 689999999999999999999999975431 1010 111
Q ss_pred Hhh---ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 826 AID---RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 826 ~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
... +.+. ..........+.+|+.+|++.+|++||++.+|++.
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 VVKGDPPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hcCCCCCcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 0111 11112234568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.88 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=205.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
..++.|+..+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|++++++++|+|++++++++..+...++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 35567888899999999999999876 688999999875432 45778899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.++|+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 999999999999996643 358999999999999999999996 8999999999999999999999999998765
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||......... ..
T Consensus 166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~----------------~~ 227 (286)
T cd06614 166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----------------FL 227 (286)
T ss_pred hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence 543221 122345788999999998888999999999999999999999999754332110 01
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..................+.+++.+|++.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111101111113356889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.78 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=201.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|||++++++++..++..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 68889999999999999999754 6889999998644 23345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++... .+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999999988542 36788999999999999999996 8999999999999999999999999999876544
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|++.|+|||.+....++.++|||||||++||+++|+.||......+..... . ..
T Consensus 168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~------------~~ 230 (293)
T cd06647 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A------------TN 230 (293)
T ss_pred ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---h------------cC
Confidence 322 122346889999999998888999999999999999999999999765432211100 0 00
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+.... .........+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00010 1111223457899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.07 Aligned_cols=272 Identities=27% Similarity=0.358 Sum_probs=202.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC--Ce
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG--NE 662 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~ 662 (947)
.+.++|++.+.||+|+||.||+|... +|+.||+|++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678999999999999999999875 688999998865433444456778899999999 999999999998653 46
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||++ ++|..++... .++|..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 899999996 5898887442 47888999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc---ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 743 VRLAPDNGKH---SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 743 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
++........ .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 8865443221 12234568999999998754 4578899999999999999999999976543322111111100000
Q ss_pred C-------hhhHHHHhhccCC-----CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 819 N-------KDTFRKAIDRTID-----LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 819 ~-------~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
. .......++.... ...........+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0000011110000 000011124568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.76 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=195.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+++|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+++++.++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467999999999999999999764 689999999865432 223346778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+. +++.+++.... ..+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 67777664322 236778888999999999999996 799999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh-HH-
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT-FR- 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~- 824 (947)
..... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||........ .+............. +.
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 155 IPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhh
Confidence 32211 1234578999999988654 578899999999999999999999976543211 111100000000000 00
Q ss_pred --------HHhhccCCCC-----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 --------KAIDRTIDLD-----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 --------~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......... .........+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 000111346779999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.69 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=206.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|++|.||+|... +++.||||++...... .....+.+|++++.+++|+|++++++++..+...++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888899999999999999876 5999999998765322 456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++... ..+++..+..++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999998653 347899999999999999999994 27999999999999999999999999999886644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.............++ ..
T Consensus 153 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------~~ 217 (264)
T cd06623 153 TLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-------------CD 217 (264)
T ss_pred CCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-------------hc
Confidence 3221 12346889999999998888999999999999999999999999765432211111111 11
Q ss_pred ccCCCChhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLA-SISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... ..... ....+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 218 GPPP--SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCC--CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1110 11111 3456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.27 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=194.7
Q ss_pred CceecccCceEEEEEEEc-CCcEEEEEEeccc--ccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe--eEEEEEe
Q 002255 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESA--VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE--RLLVYEY 669 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~ 669 (947)
..+||+|+|-+||||.+. +|..||--.++.. ..+....++|..|+.+|+.|+|||||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999654 5777774333222 2245566899999999999999999999999987655 6799999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~ 748 (947)
+..|+|..|+.+.++ ++......|++||++||.|||+. .++|||||||-+||+|+. .|.|||+|.|+|.....
T Consensus 125 ~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999976543 66778899999999999999995 689999999999999975 59999999999987755
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .....|||.|||||... ..|++.+||||||+.++||+|+..||..-.... ..++++..
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A---------------QIYKKV~S 258 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA---------------QIYKKVTS 258 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH---------------HHHHHHHc
Confidence 32 23368999999999775 789999999999999999999999997544321 12222222
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. +.........+++.++|.+|+.. ..+||++.|+++
T Consensus 259 Gi-KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 259 GI-KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CC-CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 21 11222222345688999999999 999999999987
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=302.58 Aligned_cols=251 Identities=22% Similarity=0.385 Sum_probs=201.8
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|+||.||+|..+ +|..||+|.+..........+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999875 588999999876544444566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~ 748 (947)
+++++|.+++..... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++ .+|++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999998865322 347899999999999999999996 8999999999999999886 469999999876644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... ......|++.|+|||+..+..++.++||||||+++|||++|+.||......+ + ......
T Consensus 155 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~----------~~~~~~ 216 (257)
T cd08225 155 SME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------L----------VLKICQ 216 (257)
T ss_pred Ccc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------H----------HHHHhc
Confidence 321 1223468899999999988889999999999999999999999996543211 1 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... .........+.+++.+|++.+|++||++.|+++
T Consensus 217 ~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 217 GYFA--PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ccCC--CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111 111122346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=344.04 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=206.0
Q ss_pred HHHHhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++.++-+++...+||.|.||.||-|. .++|+-.|||.++.........+.+.+|..++..++|||+|+++|+-..++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 45666788889999999999999996 56799999999887665566778899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
+|.||||++|+|.+.+...+- .++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|.+|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccce
Confidence 999999999999999855321 3344444567799999999996 99999999999999999999999999999
Q ss_pred eecCCCCCc--ceeecccccccccCccccccC---CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 744 RLAPDNGKH--SIETRLAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 744 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
..+...... ......+||+.|||||++.+. .-..+.||||+|||+.||+||++||...+.. |.-.++.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V 1454 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHV 1454 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHH
Confidence 877554211 112357899999999999754 3456899999999999999999999876532 2221111
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. - ..+..+....++-.+++.+|+..||++|.++.|+++
T Consensus 1455 ~~-------g---h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 AA-------G---HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hc-------c---CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 00 0 112222234556679999999999999999887766
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.62 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=199.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 666 (947)
++|+..+.||+|+||.||+|..+ +++.+|+|.++.....+.....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999876 588999999976544443445678899999999999999999999877 889999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+. ++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 58988875533 248999999999999999999996 79999999999999999999999999998876
Q ss_pred CCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh-hHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD-TFR 824 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~ 824 (947)
...... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+ ......... .+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (293)
T cd07843 157 GSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI--FKLLGTPTEKIWP 232 (293)
T ss_pred cCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCchHHHH
Confidence 543211 1234578899999988654 4689999999999999999999999765433221111 010000000 000
Q ss_pred HHh--------------hccCCCChhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAI--------------DRTIDLDEETLA-SISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~--------------~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ...+. ...... ....+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred Hhhccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 00000 000000 2345779999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=303.40 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=202.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999875 689999999976532 23456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999988543 357889999999999999999996 7999999999999999999999999999876644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... +.....
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~~~ 215 (258)
T cd05578 153 DT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ--------------IRAKQE 215 (258)
T ss_pred Cc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH--------------HHHHhc
Confidence 32 1233568889999999988889999999999999999999999997654321111 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDM--GHVV 866 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 866 (947)
. .....+......+.+++.+|++.+|++||++ +|++
T Consensus 216 ~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 T--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 0011111233568899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.58 Aligned_cols=265 Identities=25% Similarity=0.352 Sum_probs=200.5
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG----- 660 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 660 (947)
.+.++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35688999999999999999999764 789999999876544455556788999999999999999999988643
Q ss_pred -CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 661 -NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 661 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEcc
Confidence 35799999995 588777632 16788889999999999999996 7999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||+++....... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.. ..........
T Consensus 162 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~ 236 (353)
T cd07850 162 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW--NKIIEQLGTP 236 (353)
T ss_pred CccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHhcCCC
Confidence 999987644221 22346889999999999989999999999999999999999999765432111 0000000000
Q ss_pred hhhH--------HHHhhccCCC--------------C----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTF--------RKAIDRTIDL--------------D----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~--------~~~~~~~~~~--------------~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+ ....+..... . .........+.+++.+||+.||++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0011100000 0 001123445789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=306.45 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=198.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..|...+.||+|+||.||+|... ++..||+|++.... ........+..|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44778899999999999999864 68899999986542 23344567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+. |++.+.+.... ..++|.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9996 57777764422 348899999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.. ....|++.|+|||++. .+.++.++|||||||++|||++|+.||........ ..
T Consensus 177 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------------~~ 234 (317)
T cd06635 177 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LY 234 (317)
T ss_pred Cc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----------------HH
Confidence 32 2346889999999873 45688999999999999999999999875432111 11
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.+...... ..........+.+++.+|++.+|.+||++.++++....
T Consensus 235 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 235 HIAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHhccCC-CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11111111 11111233457899999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.26 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=199.5
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
|++.+.||.|++|.||+|..+ +|+.||+|++............+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999765 7999999998765434444567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
+++|.+++..... ..+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 -DLDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred -CcCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 4689988865432 348999999999999999999996 799999999999999999999999999987653321
Q ss_pred CcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh--------
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD-------- 821 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-------- 821 (947)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +...........+
T Consensus 154 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 154 R--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhh
Confidence 1 11223568899999987654 578899999999999999999999976543221 1111111110000
Q ss_pred --hHHHHhhccC--CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 --TFRKAIDRTI--DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 --~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+...+.... ............+.+++.+|++.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000010000 000011112246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=295.51 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=203.2
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999875 688999999876532 4567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999886542 358999999999999999999996 89999999999999999999999999998876553
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. .....|+..|+|||++....++.++||||||+++|+|++|+.||........... ....
T Consensus 152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~~~ 212 (253)
T cd05122 152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK----------------IATN 212 (253)
T ss_pred cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH----------------HHhc
Confidence 21 2345688999999999888899999999999999999999999976532211100 0000
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..............+.+++.+|++.||++||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000111111356889999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=296.23 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=206.5
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLVY 667 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 667 (947)
+|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 689999999876654456678899999999999999999999999988 8899999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999986532 58999999999999999999996 899999999999999999999999999988776
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
............++..|+|||...+..++.++||||||+++|+|++|+.||...... ... .....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-------------~~~~~ 217 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAA-------------LYKIG 217 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHH-------------HHhcc
Confidence 543211123456889999999998888999999999999999999999999765411 000 00111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ............+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSG-EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccC-CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000 001111222456889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.69 Aligned_cols=267 Identities=23% Similarity=0.376 Sum_probs=197.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 661 (947)
+.++|++.++||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3578999999999999999999764 68999999986432 233456788899999999999999999987654 3
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 5799999996 578777643 348899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCc-ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc-
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI- 818 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~- 818 (947)
+++........ .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~ 228 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGT 228 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCC
Confidence 98865432211 11233568999999998654 4688999999999999999999999975432211 111111100
Q ss_pred -ChhhHHHHhhcc-------CCCC-h-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 819 -NKDTFRKAIDRT-------IDLD-E-----ETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 819 -~~~~~~~~~~~~-------~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+.+..+.+.. .... . ........+.+++.+|++.+|++||++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111111100 0000 0 001123467899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.93 Aligned_cols=253 Identities=24% Similarity=0.414 Sum_probs=208.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||.|+||.||++... +++.||+|++...........++.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999765 689999999987655556677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++..... ....+++.++..++.+++.||+|||+ .+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999876432 12568999999999999999999996 79999999999999999999999999998876543
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
. .......|++.|+|||......++.++||||+|+++++|++|+.||......+ ........
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~~ 218 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----------------LALKILKG 218 (258)
T ss_pred c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----------------HHHHHhcC
Confidence 2 12233568899999999988889999999999999999999999996543211 11111111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. ...+......+.+++.+|+..+|++||++.|+++
T Consensus 219 ~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 219 QY--PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 1111123356789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.92 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=197.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|++|.||+|..+ +|+.||+|++..........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999875 68899999987654334445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecCcceecC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 747 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~ 747 (947)
|++ ++|.+++..... ..+++.....++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 578777744322 235778888999999999999996 79999999999999985 5679999999997654
Q ss_pred CCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh----
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT---- 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---- 822 (947)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||......+.... .+.........
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 155 IPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPG 230 (294)
T ss_pred CCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCChhhccc
Confidence 3211 1223467889999998865 4578999999999999999999999976543221111 00000000000
Q ss_pred ------HHHHhhccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 ------FRKAIDRTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+........... .........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000 001112345789999999999999999999987
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.44 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=197.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 661 (947)
.++|+..+.||+|+||.||+|... +++.||||.+............+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999865 6899999998654333333445678999999999999999999987654
Q ss_pred --eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 662 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
..++||||+. ++|.+.+.... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence 4599999995 57877775432 248899999999999999999996 7999999999999999999999999
Q ss_pred cCcceecCCCCCc--ceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 740 FGLVRLAPDNGKH--SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 740 fGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
||++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||..............+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9998765432211 112234578899999987654 4788999999999999999999999765543332222222110
Q ss_pred hcChhhHH-----HHhhccCCCChhc----------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 817 HINKDTFR-----KAIDRTIDLDEET----------LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ~~~~~~~~-----~~~~~~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. .+.+. ...+ ........ ......+.+++.+|++.||++||+++|+++
T Consensus 243 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 IT-PEVWPGVDKLELFK-KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CC-hhhcccccchhhhh-hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00000 0000 00000000 001234679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.67 Aligned_cols=267 Identities=26% Similarity=0.359 Sum_probs=198.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 665 (947)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++...........+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367899999999999999999875 689999999875533333334567899999999999999999998764 56899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+. ++|.+++.... ..+++.++..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 57888875432 458999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+. ...........
T Consensus 158 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII--QLLGTPNESIW 233 (309)
T ss_pred cCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcCCCChhhc
Confidence 6543211 122346788999998865 457899999999999999999999997654432221111 10000000000
Q ss_pred HHhh-----ccCCCCh--------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAID-----RTIDLDE--------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~-----~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..++ ....... ........+.+++.+|++.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000000 00112345679999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.23 Aligned_cols=270 Identities=22% Similarity=0.344 Sum_probs=201.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCee
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNER 663 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 663 (947)
.++|++.+.||+|+||.||+|..+ +|+.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999765 69999999987654333445678889999999999999999998763 3568
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 6888887542 338899999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCc--ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh---
Q 002255 744 RLAPDNGKH--SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH--- 817 (947)
Q Consensus 744 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~--- 817 (947)
+........ .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 765432211 11223578899999998765 468899999999999999999999997654332211111100000
Q ss_pred ----cChhhHHHHhhccCCCChh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 ----INKDTFRKAIDRTIDLDEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+...+.++........ .......+.+++.+|++.+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011111111111110111 1123466889999999999999999999877
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.50 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=199.3
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|++|.||+|+.. +|+.||||.++.... ....+.+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788999999999999999875 688999999876532 23345677899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++ +|.+++..... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.++++|||+++.....
T Consensus 80 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 974 88888755332 2458999999999999999999997 79999999999999999999999999998755332
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-hhhHHHHh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-KDTFRKAI 827 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~ 827 (947)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.||......+..... ....... ...+....
T Consensus 154 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 154 VN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI--FRIMGTPTESTWPGIS 229 (284)
T ss_pred cc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--HHHhCCCChhhHHHHh
Confidence 11 11234578899999987653 5788999999999999999999999765433221111 1110000 00111000
Q ss_pred h-----ccCCC-Chh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 D-----RTIDL-DEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~-----~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ..... ... .......+.+++.+|++.||.+||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000 000 0112345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=309.04 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=199.7
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC--
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-- 661 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 661 (947)
+..+.++|++.+.||+|+||.||+|... +|+.||||++............+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4456789999999999999999999754 7899999998655434445567889999999999999999999987543
Q ss_pred ----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 662 ----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 662 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence 458999998 7789887743 247899999999999999999996 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|++++|+.||........ +.......
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~ 232 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVT 232 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhc
Confidence 999998765332 123467889999998865 4588999999999999999999999975542211 11111100
Q ss_pred hcChhhHH---------HHhhccCCCChh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 817 HINKDTFR---------KAIDRTIDLDEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ~~~~~~~~---------~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......+. ............ .......+.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000111 111100000000 0112235779999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=303.51 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=194.9
Q ss_pred cCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|..+. ++.||||+++.... .....++..|+.++.+.. |+||+++++++.++...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 668889999999999999998874 89999999876532 233456677887777775 999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+. +++.+++.... ..+++..+..++.|++.|++|||+ .++|+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9984 56766654322 358899999999999999999996 3689999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCC----cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGR----VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
.... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... +.+
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~ 228 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---------------EVL 228 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---------------HHH
Confidence 3221 12335788999999986543 7889999999999999999999996532110 011
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
...+...............++.+++.+|++.||++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111211111001111233568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=302.06 Aligned_cols=261 Identities=16% Similarity=0.215 Sum_probs=184.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChH-H--------HHHHHHHHHHHHcCCCCCcceEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEK-G--------FAEFKSEIAVLTKVRHRHLVGLLG 655 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-~--------~~~~~~E~~~l~~l~h~niv~l~~ 655 (947)
.++|.+.++||+|+||.||+|...+ +..+|+|.......... + ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998754 34566665432211100 0 011223445566778999999999
Q ss_pred EEEeCC----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC
Q 002255 656 YCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 656 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 731 (947)
++.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 876543 3467888763 3555555321 224677788999999999999996 89999999999999999
Q ss_pred CCcEEEeecCcceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccch
Q 002255 732 DMRAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806 (947)
Q Consensus 732 ~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 806 (947)
++.++|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999876432211 111234699999999999999999999999999999999999999986632221
Q ss_pred hhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 807 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.... .. .+....+........ .....+.+++..|++.+|++||++.++++.|
T Consensus 242 ~~~~--~~-----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHA--AK-----CDFIKRLHEGKIKIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHH--hH-----HHHHHHhhhhhhccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1000 00 011111111211111 1235688999999999999999999999865
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=301.06 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=195.8
Q ss_pred CceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
..+||+|+||.||++..+ +|+.||+|++... .......+.+|+.++++++|+|++++++++..++..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 367999999999999774 6899999988543 3345567899999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+++.. ..+++.....++.|++.|++|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-- 171 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 171 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence 99987743 237888999999999999999997 7999999999999999999999999999876543221
Q ss_pred eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCC
Q 002255 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDL 833 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 833 (947)
......|++.|+|||++.+..++.++||||+|+++|||++|..||......+... . ....+.....
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~----------~~~~~~~~~~- 237 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---M----------IRDNLPPKLK- 237 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H----------HHhhCCcccC-
Confidence 1233568899999999988889999999999999999999999997543221111 0 0111111111
Q ss_pred ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 834 DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 834 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........+.+++.+|++.+|.+||++.++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01112345779999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=299.59 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=186.0
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEecccccCh-HHHHHHHHHHHHHH---cCCCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLT---KVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
+||+|+||.||++... +++.||+|.+....... .....+.+|..+++ ..+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 68999999887653222 22233444544443 3479999999999999999999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 99999888543 348999999999999999999997 889999999999999999999999999987554321
Q ss_pred cceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 752 HSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........... . .... .
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~----------~~~~-~ 213 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----D----------RMTL-T 213 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----H----------HHhh-c
Confidence 123468999999998864 5588999999999999999999999976543221111 0 0000 0
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
.. ...+.....++.+++.+|++.||++|| +++|+++
T Consensus 214 ~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 214 VN-VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CC-cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 00 011112335678999999999999999 5888866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.54 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=195.9
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||.|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 489999999876533 234457899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||+++...... ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~ 149 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT 149 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence 9998653 237888999999999999999996 899999999999999999999999999988765432 12
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE 835 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (947)
....|++.|+|||.+....++.++|+||||+++|||++|..||.....+. .....+..+.... ..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~-~~ 214 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGNGK-LE 214 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccCCC-CC
Confidence 23468899999999988889999999999999999999999997654211 1111222211111 11
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 836 ETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 836 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
.+......+.+++.+|++.+|++||+ ++|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11112456889999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=299.54 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=194.7
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeC--CeeEEEE
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDG--NERLLVY 667 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 667 (947)
|++.+.||+|+||.||+|..+ +++.||+|+++....+.. .....+|+.++.++. |+|++++++++.++ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 567789999999999999764 688999999876532322 234457899999995 99999999999987 8899999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||++ +++.+++..+. ..++|.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 58878775432 358999999999999999999996 89999999999999999 999999999988664
Q ss_pred CCCCcceeecccccccccCccccc-cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc-ChhhHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI-NKDTFRK 825 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~ 825 (947)
..... ....++..|+|||++. +..++.++|||||||++|||++|..||......+. +.+...... ....+..
T Consensus 151 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 151 SKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLK 224 (282)
T ss_pred cCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence 32221 2346789999999764 45678899999999999999999999976543222 122211111 1111111
Q ss_pred Hhhcc----CCCCh--------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRT----IDLDE--------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~----~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+... ..... ........+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11110 00000 01123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.50 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=204.5
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|+..+.||+|++|.||+|... +++.||+|.+......+...+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999765 678999999987755556678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++... ..+++..+..++.|++.|+.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999988543 358999999999999999999996 89999999999999999999999999999876553
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
... .....++..|+|||...+..++.++||||+|+++|+|++|+.||........ . ......
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~--------------~~~~~~ 214 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L--------------FRIVQD 214 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H--------------HHHhcc
Confidence 321 2335688999999998887889999999999999999999999975432110 0 000000
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. ..........+.+++.+|++.+|++||++.+++.
T Consensus 215 ~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DH--PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC--CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 1111122356789999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.35 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=198.2
Q ss_pred cCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 594 EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
.+..||.|+||+|+|..++ .|+..|||+++... .+.+.++++.|.++..+- +.||||+++|.+..++..|+.||.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 3467999999999999775 69999999998775 356678888898866655 7899999999999999999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
..+++.+-..-..-....+++...-+|....+.||.||-. ...|||||+||+|||++..|.+|+||||++-...+.
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 4566544322111122457888888888899999999987 578999999999999999999999999998765432
Q ss_pred cceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 752 HSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
...+.-+|...|||||.+.. ..|+-++||||+|++|||+.||..|+.+... .. +.+..++..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vf----------eql~~Vv~g 285 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VF----------EQLCQVVIG 285 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HH----------HHHHHHHcC
Confidence 22344579999999999853 3589999999999999999999999987643 11 112222222
Q ss_pred ---cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 830 ---TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 830 ---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.+..+.........+..+|.-|+.+|-.+||.+.++.+.
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 223344445566678899999999999999999998763
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=300.43 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=199.1
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEEEEE
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLVYE 668 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 668 (947)
|++.+.||+|+||.||+|... +|+.||+|++............+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999876 588999999986643344456788999999999999999999999988 88999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++ ++|.+++.... ..+++..++.++.||++||+|||+ .+++|+||||+||++++++.+|++|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 996 48888875432 358899999999999999999996 7999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH----
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF---- 823 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---- 823 (947)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.................... ...+
T Consensus 153 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (287)
T cd07840 153 RNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT-DENWPGVS 230 (287)
T ss_pred CCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-hhhccccc
Confidence 321 11233457889999997764 4578999999999999999999999976553322111110000000 0000
Q ss_pred ----HHHhhccCCCC-----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 ----RKAIDRTIDLD-----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ----~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........... .........+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000 000001456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.00 Aligned_cols=270 Identities=24% Similarity=0.365 Sum_probs=200.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 661 (947)
+.++|.+.+.||+|+||.||+|... +++.||||.+............+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999764 689999999876533444456778899999999999999999988644 3
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 5799999995 6888877532 348899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh----
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM---- 816 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~---- 816 (947)
+++....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..................
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 154 LARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred cccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9986644321 1233467889999998765 46889999999999999999999999764322111111000000
Q ss_pred ---hcChhhHHHHhhccCCCC-----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 817 ---HINKDTFRKAIDRTIDLD-----EETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 817 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
........+.++...... .........+.+++.+|++.+|++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000111111111100000 0011233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.42 Aligned_cols=270 Identities=28% Similarity=0.371 Sum_probs=199.5
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 661 (947)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++...........+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999875 5889999998765433344467788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcE
Q 002255 662 ------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 662 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 735 (947)
..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999975 676766443 2358999999999999999999996 899999999999999999999
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+. .
T Consensus 156 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~--~ 232 (302)
T cd07864 156 KLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS--R 232 (302)
T ss_pred EeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--H
Confidence 9999999886644322 11122356788999998764 357889999999999999999999997544322111111 1
Q ss_pred HhhcC-hhhHHHHhhc--------cC----CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 815 RMHIN-KDTFRKAIDR--------TI----DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 815 ~~~~~-~~~~~~~~~~--------~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ...+..+... .. ............+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10000 0000000000 00 000000112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=299.03 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=190.7
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||+|+||+||++... +|+.||+|.+...... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 6899999998754322 23345677899999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++..... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.++++|||+++...... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 151 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KI 151 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cc
Confidence 999865432 358899999999999999999996 899999999999999999999999999987654321 12
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH-HhhccCCCC
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK-AIDRTIDLD 834 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~ 834 (947)
....++..|+|||++.+..++.++|||||||++|+|++|+.||.......... .+.+ .......
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~~~-- 216 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTLEMAVE-- 216 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhcccccccc--
Confidence 23467889999999988889999999999999999999999997654321100 0000 0100111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002255 835 EETLASISTVADLAGHCCAREPYQRPDMGH 864 (947)
Q Consensus 835 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 864 (947)
........+.+++.+||+.+|++||+..+
T Consensus 217 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 217 -YPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred -CCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 11122456789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.35 Aligned_cols=263 Identities=19% Similarity=0.322 Sum_probs=194.6
Q ss_pred ceeccc--CceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRG--GFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
..||+| +||+||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999864 799999999876654556668899999999999999999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
+++.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998865432 347888899999999999999996 89999999999999999999999999865432221111
Q ss_pred c-----eeecccccccccCccccccC--CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC------
Q 002255 753 S-----IETRLAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN------ 819 (947)
Q Consensus 753 ~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------ 819 (947)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 0 01112356679999998763 478999999999999999999999976542211 11111000000
Q ss_pred -----------hhhHH--------------HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 -----------KDTFR--------------KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 -----------~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ......+. ..........+.+|+++|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 00000011 1112234457889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.85 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=197.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc---cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--Cee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV---VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 663 (947)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999764 68999999875431 1234557889999999999999999999998764 467
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999988542 237788889999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCC-cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGK-HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+....... ........|+..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------- 217 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA---------------- 217 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----------------
Confidence 76532111 1112235689999999999888899999999999999999999999975432111
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+....... ...+......+.+++.+|++ +|..||++.+++.
T Consensus 218 ~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111100 11122233567899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.87 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=195.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..|+..+.||+|+||.||+|... +++.||+|.+.... .......++.+|+++++.++|+|++++++++..+...++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777789999999999999865 57889999886432 23444567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+. |++.+.+.... ..+++.++..++.|++.|+.|||+ .+++||||||+||+++.++.++++|||++....
T Consensus 95 e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 68877764432 347889999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.. ....|++.|+|||++. ...++.++|||||||++|||++|+.||......+.. .
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------------~ 224 (308)
T cd06634 167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------Y 224 (308)
T ss_pred Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH----------------H
Confidence 32 2346889999999874 356788999999999999999999998654321110 0
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
........ ..........+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 225 HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHhhcCCC-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00111100 11111233457899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=299.98 Aligned_cols=264 Identities=24% Similarity=0.367 Sum_probs=202.2
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
|+..+.||+|++|.||+|... +|+.+|+|++............+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999765 6889999998766544445678889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
++ ++.+++..+. ..+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 64 8888775532 358899999999999999999996 899999999999999999999999999988775543
Q ss_pred CcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-hhhHHHHhh
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-KDTFRKAID 828 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~ 828 (947)
. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+...... ...... ...+....+
T Consensus 153 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 R--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTS 228 (283)
T ss_pred c--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchh
Confidence 1 12234688899999998776 78999999999999999999999997654322211110 000000 000000000
Q ss_pred ----------c--cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 ----------R--TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ----------~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ..............+.+++.+|++.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000111223456889999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=284.34 Aligned_cols=271 Identities=22% Similarity=0.329 Sum_probs=222.0
Q ss_pred cHHHHHHHhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEE
Q 002255 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654 (947)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 654 (947)
..+++..-..+++...++-+|.||.||+|.|. +.+.|-||.++... ++-....+..|.-++..+.|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 45666677788999999999999999999664 34557788776553 566678899999999999999999999
Q ss_pred EEEEeC-CeeEEEEEecCCCchhhhhhcccc---cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc
Q 002255 655 GYCLDG-NERLLVYEYMPQGTLSRHLFNRKE---EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (947)
Q Consensus 655 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 730 (947)
+++.++ +..+.+|.++.-|+|..++...+. ...+.+.-.+...++.|++.|++|||. ++|||.||.++|+++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence 998764 567899999999999999974332 123456777788999999999999995 9999999999999999
Q ss_pred CCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhH
Q 002255 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHL 809 (947)
Q Consensus 731 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l 809 (947)
+.-++|++|=.++|...+.+..........+..||+||.+....|+.++|||||||++|||+| |+.|+.+.++.+..++
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 999999999999998877666666555667789999999999999999999999999999999 9999988877654433
Q ss_pred HHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.. ..+. -..+..++.++..++..||+..|++||+++++..-|.+.-
T Consensus 511 lk-----------------dGyR-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 511 LK-----------------DGYR-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred Hh-----------------ccce-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 21 1111 1122345567899999999999999999999999998764
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=296.80 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=197.4
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||+|+||.||++... +|+.||+|++..... .....+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999875532 234567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC----
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---- 751 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~---- 751 (947)
.+++.... .+++..+..++.||++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99986532 47899999999999999999996 8999999999999999999999999999875433211
Q ss_pred --cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 752 --HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 752 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
........++..|+|||......++.++||||||+++||+++|+.||......+ .+......
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~~ 216 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----------------IFQNILNG 216 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcC
Confidence 112234568889999999988889999999999999999999999997554221 11111111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
....... ......+.+++.+|++.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 KIEWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CcCCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111111 112456789999999999999999966666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=298.33 Aligned_cols=245 Identities=25% Similarity=0.407 Sum_probs=202.1
Q ss_pred CceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 595 ENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.++||+|.||+||-|.+ ++|+.||||++.+..+..+...++++|+.++++++||.||.+-..|+..+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 47999999999999975 579999999999988888888999999999999999999999999999999999999995 5
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC---CcEEEeecCcceecCCCC
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfGla~~~~~~~ 750 (947)
+..+.+..... ..++.....-++.||+.||.|||. ++|||+|+||+|||+... .++||||||+||..++.
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 55555533222 347777777788999999999995 899999999999999654 57999999999998763
Q ss_pred CcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
.....++|||.|+|||++..+.|+..-||||.|||+|-=++|..||.+..+- -+.+-...
T Consensus 721 --sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI------------------ndQIQNAa 780 (888)
T KOG4236|consen 721 --SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI------------------NDQIQNAA 780 (888)
T ss_pred --hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch------------------hHHhhccc
Confidence 3345679999999999999999999999999999999999999999754321 11222233
Q ss_pred CCCChhcHHHHHH-HHHHHHHhcccCCCCCCCHHHHHH
Q 002255 831 IDLDEETLASIST-VADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 831 ~~~~~~~~~~~~~-l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+-+++.+|.+++. ..|||..+|+..-.+|-+....+.
T Consensus 781 FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 781 FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 3445566655554 559999999999999998876543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.61 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=189.1
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHH-HcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVL-TKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|... +|+.||+|.+...... ......+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999764 5899999998754321 22233445555544 445899999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999988543 247888899999999999999997 7999999999999999999999999999875433
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||........ +.........
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~ 211 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV----------------FDNILSRRIN 211 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhcccC
Confidence 1234688999999999888889999999999999999999999975432211 1111111111
Q ss_pred CCh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 833 LDE-ETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 833 ~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
... ........+.+++.+|++.+|++||++.++.+.|
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 111 1112345688999999999999999887665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.01 Aligned_cols=264 Identities=28% Similarity=0.372 Sum_probs=197.3
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC---CCCCcceEEEEEEeCCe-----
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLDGNE----- 662 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 662 (947)
|++.+.||+|+||.||+|..+ +++.||+|+++...........+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999886 489999999976543333345667788877766 59999999999988776
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 588888755332 248899999999999999999996 7999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+........ .....++..|+|||++.+..++.++|||||||++|||++|++||......+. ..............
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 228 (287)
T cd07838 154 ARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEE 228 (287)
T ss_pred ceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChH
Confidence 887644321 1233578899999999988899999999999999999999999976543221 11111111100000
Q ss_pred -H-------HHHhhccCCC--ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 -F-------RKAIDRTIDL--DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 -~-------~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+ .......... ..........+.+++.+|++.||++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 0011123356779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=298.18 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=194.3
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|+++++.++|||++++++++.++...++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3677788999999999999764 688999999865432 33445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+. |++.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 102 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 995 67777765432 348899999999999999999996 7999999999999999999999999999764322
Q ss_pred CCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
. ....|+..|+|||++. ...++.++|||||||++|||++|..||......... . .
T Consensus 174 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~-------------~ 231 (313)
T cd06633 174 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y-------------H 231 (313)
T ss_pred C------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H-------------H
Confidence 1 2346889999999874 456888999999999999999999999765422111 0 0
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....... ..........+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 232 IAQNDSP-TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHhcCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0011112235789999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.22 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=202.6
Q ss_pred CCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|...++||+|.||+||+|+. ++++.||+|+++....++.......+|+.+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566778999999999999974 5688999999987765665667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
| ..+|..+..... ..++...+..++.|+++||.++|+ +++.|||+||+|.+++.+|++|++|||+++.++-.
T Consensus 83 c-dqdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-hHHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9 457777764432 347888889999999999999997 89999999999999999999999999999977543
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
- ......+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++-|.+.+.+++...+-|.-....++.+ ..+.
T Consensus 155 v--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w-ps~t 231 (292)
T KOG0662|consen 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW-PSMT 231 (292)
T ss_pred e--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC-Cccc
Confidence 2 223344678999999999875 48899999999999999987 66666666555554444443333322211 1110
Q ss_pred h-ccCC---CCh--hcH-HHH----HHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 D-RTID---LDE--ETL-ASI----STVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~-~~~~---~~~--~~~-~~~----~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. +.+. ..+ ..+ +.+ +.=.+++.+.+.-+|.+|.++.++++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 0010 000 011 111 12358899999999999999998765
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.91 Aligned_cols=270 Identities=25% Similarity=0.385 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
...+..+.++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 355667889999999999999999999975 4789999999876543444456788999999999999999999988643
Q ss_pred ------CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 661 ------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 661 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888887 7899887743 237899999999999999999996 89999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||............ .
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~ 231 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--L 231 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H
Confidence 999999998754332 123468899999998766 46888999999999999999999999654432211111 1
Q ss_pred HHhhcChhh---------HHHHhh---ccCC--CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 814 RRMHINKDT---------FRKAID---RTID--LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 814 ~~~~~~~~~---------~~~~~~---~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
......... .+..+. .... ...........+.+++.+|++.||.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100000000 011110 0000 000001123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=291.65 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=192.3
Q ss_pred HHHHHHhcCCCcCcee--cccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEE
Q 002255 583 QVLRNVTNNFSEENVL--GRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCL 658 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 658 (947)
.+.....++|.+.+.+ |+|+||.||++..+ +++.+|+|.+........ |+.....+ +|||++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEe
Confidence 4445556778887777 99999999999764 688899999865432211 22222222 7999999999999
Q ss_pred eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEE
Q 002255 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 737 (947)
Q Consensus 659 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl 737 (947)
.++..++||||+++++|.+++.... .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence 9999999999999999999985432 58999999999999999999996 7899999999999999998 9999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
+|||+++..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ......+...
T Consensus 152 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-- 222 (267)
T PHA03390 152 CDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKR-- 222 (267)
T ss_pred ecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHh--
Confidence 999998765432 1236889999999998888999999999999999999999999744322 1111111111
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD-MGHVVN 867 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 867 (947)
...... ........+.+++.+|++.+|.+||+ ++|+++
T Consensus 223 ---------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 ---------QQKKLP---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------hcccCC---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111111 11123456889999999999999996 588865
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.92 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=194.3
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
+.+.+|.|+++.||++.. +++.||||++..........+.+.+|++++++++|+||+++++++.+++..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455566666666544 5899999999876445666788999999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC--
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK-- 751 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~-- 751 (947)
+|.+++..... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999865432 247788889999999999999996 8999999999999999999999999998875533221
Q ss_pred ---cceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc---ChhhH
Q 002255 752 ---HSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI---NKDTF 823 (947)
Q Consensus 752 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~ 823 (947)
........++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+....... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 111223457789999999865 358899999999999999999999997643221 11111110000 00000
Q ss_pred HHH-----------hhccC---CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKA-----------IDRTI---DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~-----------~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .+... ............+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 00000 000111223356789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=305.63 Aligned_cols=270 Identities=26% Similarity=0.348 Sum_probs=196.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 661 (947)
.++|++.++||+|+||.||+|..+ +++.||+|++............+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 6899999998755433333456788999999999999999999875433
Q ss_pred --eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 662 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
..++||||+.+ ++...+.... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 46999999864 6766664422 358999999999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcc---------eeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhH
Q 002255 740 FGLVRLAPDNGKHS---------IETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809 (947)
Q Consensus 740 fGla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l 809 (947)
||+++......... ..+...|++.|+|||++.+. .++.++|||||||++|||++|++||.+.........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99987654322111 11234578889999987653 578999999999999999999999976554332221
Q ss_pred HHHHHHhhcChhhHH------HHh----hccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 810 VTWFRRMHINKDTFR------KAI----DRTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 810 ~~~~~~~~~~~~~~~------~~~----~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......... ..... ... ....... .........+.+++.+|++.+|++||++.|++.
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPT-EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCC-hhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111100000 00000 000 0000000 000111246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=292.81 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEecccccCh-HHHHHHHHHH---HHHHcCCCCCcceEEEEEEeCCeeEEEEEecC
Q 002255 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEI---AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
+||+|+||.||+|... +++.||+|.+....... .....+..|. +.++...||+|+++++++..++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 68899999987643221 1122233443 34445579999999999999999999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+|+|.+++... ..+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||+++......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999887532 358999999999999999999996 899999999999999999999999999987553321
Q ss_pred cceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 752 HSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||............ .......
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~ 215 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------RMTLTMA 215 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-------------HHhhccC
Confidence 1234689999999998754 6899999999999999999999999765332211100 0000001
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
.... ......+.+++.+|+..+|.+|| ++.++++
T Consensus 216 ~~~~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCC---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111 11235688999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.73 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 666 (947)
++|...+.||+|+||.||+|... +|+.||+|++.... ......+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999875 68999999987642 23444578899999999998 99999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999998653 258999999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCc------------------ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhh
Q 002255 747 PDNGKH------------------SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808 (947)
Q Consensus 747 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 808 (947)
...... .......|+..|+|||+.....++.++||||||++++++++|+.||.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--- 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---
Confidence 432211 11223467899999999988889999999999999999999999997654211
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM----GHVVN 867 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 867 (947)
.+........... ......+.+++.+|++.+|.+||++ .++++
T Consensus 230 -------------~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -------------TFQKILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------------HHHHHHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111112111111 1123557899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.66 Aligned_cols=267 Identities=23% Similarity=0.372 Sum_probs=197.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 660 (947)
+.++|...+.||+|+||.||+|... +|+.||||++......+.....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999864 689999999876543344456788999999999999999999998754
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeC
Confidence 34689999985 46665541 247889999999999999999996 79999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. .....
T Consensus 162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~--~~~~~ 234 (342)
T cd07879 162 GLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK--VTGVP 234 (342)
T ss_pred CCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hcCCC
Confidence 998754332 123467889999999876 4688999999999999999999999986543222111111 00000
Q ss_pred hhhHHHHh---------hccCCCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 002255 820 KDTFRKAI---------DRTIDLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVNV--LSSL 872 (947)
Q Consensus 820 ~~~~~~~~---------~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l 872 (947)
...+.+.+ .......... ......+.+++.+|++.||++||++++++.. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 11111111 0000000000 0123457799999999999999999999853 4444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=321.50 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=209.7
Q ss_pred cCCCcCceecccCceEEEEEEEc----C----CcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH----D----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 660 (947)
++..+.+.+|+|.||.||+|..+ . ...||||.++..... .+.+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 34455669999999999999743 1 456999998876544 6788999999999999 699999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccc---------ccCC--CcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRK---------EEGL--KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
+..++|+||++.|+|.++++..+ .... ..+...+.+.++.|||.|++||++ .++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999998766 1111 138888999999999999999997 789999999999999
Q ss_pred cCCCcEEEeecCcceecCCCCCcceeecccc--cccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccch
Q 002255 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAG--TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDS 806 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 806 (947)
.++..+||+|||+|+...+....... .-.| ...|||||.+....|+.|+|||||||+|||++| |..||.+......
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 99999999999999976654433222 1222 446999999999999999999999999999999 8888876321111
Q ss_pred hhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 807 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+-+.+..... .+.+.....++.++++.||+.+|++||++.++.+.+....
T Consensus 531 ----------------l~~~l~~G~r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 ----------------LLEFLKEGNR-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ----------------HHHHHhcCCC-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1112222222 1222333567889999999999999999999999998853
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=296.84 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=199.3
Q ss_pred CCCcCceecccCceEEEEEEE----cCCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCee
Q 002255 591 NFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 663 (947)
+|++.+.||+|+||.||++.. .+++.||||.++.... .....+.+..|++++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999864 3578899999875422 123346788999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++++|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999988542 247888899999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcceeecccccccccCccccccCC--cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+....... .......|+..|+|||...+.. .+.++||||||+++|||++|..||........ ....
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~--------- 220 (288)
T cd05583 153 KEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEI--------- 220 (288)
T ss_pred cccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHH---------
Confidence 76544321 1122346889999999987654 78899999999999999999999964322111 0000
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
.......... ........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 221 -~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 -SRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -HHHHHccCCC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111111111 111223457899999999999999999988776553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=295.88 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=194.3
Q ss_pred CCCcCceecccCceEEEEEEE----cCCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCee
Q 002255 591 NFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 663 (947)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 3689999999875422 122346788999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998643 247788889999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcceeecccccccccCccccccC--CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+....... .......|+..|+|||.+... .++.++||||||+++|+|++|+.||........ .....
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~-------- 221 (290)
T cd05613 153 KEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEIS-------- 221 (290)
T ss_pred eecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHH--------
Confidence 86543221 112235688999999998653 467899999999999999999999964322111 11111
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
......... ........+.+++.+|++.+|++|| ++.+++.
T Consensus 222 --~~~~~~~~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 222 --RRILKSEPP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --HHhhccCCC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111111111 1112334578999999999999998 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=325.94 Aligned_cols=147 Identities=29% Similarity=0.440 Sum_probs=131.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|.+.++||+|+||.||+|... +++.||||+++... ........+..|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999876 68999999997543 23444578899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
||+.+++|.+++... ..+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998543 247888899999999999999996 799999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=299.62 Aligned_cols=266 Identities=23% Similarity=0.371 Sum_probs=199.3
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CCee
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNER 663 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 663 (947)
..++++|++.+.||+|+||.||+|..+ +++.||+|++..........+.+..|++++++++||||+++++++.. +...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999755 78999999987544344455778899999999999999999999875 5678
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+ +++|.+++.. ..+++.....++.|+++||+|||+ .+|+||||||+||++++++.++|+|||++
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 9999998 6688887743 236778888899999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .........+.
T Consensus 156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~--~~~~~~~~~~~ 228 (328)
T cd07856 156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI--ITDLLGTPPDD 228 (328)
T ss_pred cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCCHH
Confidence 754321 123467889999998765 5689999999999999999999999976543211110 00000000000
Q ss_pred ---------HHHHhhccCCCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 823 ---------FRKAIDRTIDLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 823 ---------~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+.+.......... ......+.+++.+|++.+|++||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111000000000 1123568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.27 Aligned_cols=272 Identities=26% Similarity=0.377 Sum_probs=200.5
Q ss_pred CCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------CeeE
Q 002255 592 FSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------NERL 664 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 664 (947)
+...+.||+|+||.||+|+. .+|+.||||.+.... .....+...+|++++++++|+|||+++++-.+. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34457899999999999984 579999999987653 445567889999999999999999999986654 3678
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc--CCC--cEEEeec
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDM--RAKVADF 740 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~--~~kl~Df 740 (947)
+|||||.+|||+..+.+- +....++..+.+.++..++.||.|||. ++||||||||.||++- ++| ..||+||
T Consensus 94 lvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 999999999999999653 233559999999999999999999996 8999999999999983 444 4799999
Q ss_pred CcceecCCCCCcceeecccccccccCccccc-cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|.|+...++. ....++||..|++||... .+.|+..+|.|||||++||..||..||..........-+.|.......
T Consensus 169 G~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 169 GAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9999887653 456789999999999987 488999999999999999999999999655433211111111111110
Q ss_pred hhhHHHHhh----------ccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhh
Q 002255 820 KDTFRKAID----------RTIDLD-EETLASISTVADLAGHCCAREPYQRP--DMGHVVNVLSSLA 873 (947)
Q Consensus 820 ~~~~~~~~~----------~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~l~ 873 (947)
. ....... ..+.++ .........+...+..+|..+|++|- ...+....+..+.
T Consensus 246 ~-~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 246 S-GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred C-ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 0 0000000 001110 11122233445677778888999998 5555555555443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=302.25 Aligned_cols=269 Identities=25% Similarity=0.368 Sum_probs=203.3
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-----eeE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERL 664 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 664 (947)
+|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999875 5899999998765433455678999999999999999999999988775 789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 5888887542 258899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-ceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh-----
Q 002255 745 LAPDNGKH-SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH----- 817 (947)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~----- 817 (947)
........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 76543210 112334678999999999887 78999999999999999999999997665332211110000000
Q ss_pred --cChhhHHHHhhccCCCCh-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 818 --INKDTFRKAIDRTIDLDE-----ETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 818 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.......+.+........ ........+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000011111111000000 011134567899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=301.05 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=193.9
Q ss_pred CCCcCceecccCceEEEEEEEc-C--CcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC----Ce
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-D--GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG----NE 662 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 662 (947)
+|++.+.||+|+||.||++... + +..||+|++..........+.+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999865 3 77899999875433334456788999999999 599999999875432 45
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++++||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999885 6898887432 348899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc--ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 743 VRLAPDNGKH--SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 743 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
++........ .......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||............ +......
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~ 229 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI--LQVLGTP 229 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH--HHHhCCC
Confidence 9865432211 11233578999999998765 46899999999999999999999999765422111100 0000000
Q ss_pred -hhhHHHH--------hh---cc--CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 -KDTFRKA--------ID---RT--IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 -~~~~~~~--------~~---~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.+.++ .. .. ..+..........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000100 00 00 0000000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=293.29 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=196.9
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEEe
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
|++.+.||+|+||.||+|... +++.||+|++...... .......+|+..+++++ |+|++++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567889999999999999875 5788999998755322 22334567999999999 99999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||+++.....
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889988886543 1357999999999999999999996 89999999999999999999999999998866442
Q ss_pred CCcceeecccccccccCccccc-cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH----
Q 002255 750 GKHSIETRLAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR---- 824 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---- 824 (947)
.. .....|+..|+|||++. ...++.++||||||++++||++|+.||......+............. ...+.
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (283)
T cd07830 153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPT-KQDWPEGYK 228 (283)
T ss_pred CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCC-hhhhhhHhh
Confidence 22 12346888999999874 44578999999999999999999999976543322111100000000 00000
Q ss_pred --HHhhccCC----C--ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 --KAIDRTID----L--DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 --~~~~~~~~----~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..++..+. . ..........+.+++++|++.+|++||+++|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0 0000111356889999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=304.38 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=200.5
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe---
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE--- 662 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 662 (947)
.+.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++|+|++++++++..++.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999875 58899999987654344455678889999999999999999998876554
Q ss_pred ---eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 663 ---RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 663 ---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 6799888753 348999999999999999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... .......
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~--i~~~~~~ 234 (343)
T cd07851 162 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR--IMNLVGT 234 (343)
T ss_pred cccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHhcCC
Confidence 9998865432 123467889999998765 3678999999999999999999999976543221111 0000000
Q ss_pred C---------hhhHHHHhhccCCCC-----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 N---------KDTFRKAIDRTIDLD-----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~---------~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. .......+....... .........+.+++.+|++.+|++|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 011111111110000 000112456889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=318.39 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=207.8
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 659 (947)
..+++.-.++|.+.++||+|+||.|..++.+ +++.||+|++.+-.. ......-|..|-.+|..-+.+-||.+.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4556666789999999999999999999876 688899999976432 23445778999999999999999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
+.+.|+|||||+||+|..++.... .++...+.-++..|+.||.-+|+ .|+|||||||+|||+|..|++|++|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 999999999999999999996543 36666666778899999999996 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
||.+-.+..++... ....+|||-|.+||++.. +.|.+.+|.||+||++|||+.|.-||....-
T Consensus 219 FGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----------- 286 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----------- 286 (1317)
T ss_pred chhHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----------
Confidence 99988776655433 345689999999999852 5789999999999999999999999975432
Q ss_pred HhhcChhhHHHHhhc--cCCCChhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 002255 815 RMHINKDTFRKAIDR--TIDLDEETLASISTVADLAGHCCAREPYQRPD---MGHVVN 867 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 867 (947)
-+.+.++++- .+.++ ..........+||.+.+. +|+.|.. +.++..
T Consensus 287 -----veTY~KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 287 -----VETYGKIMNHKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -----HHHHHHHhchhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1233444443 34444 223355667789988764 5778877 666644
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=288.57 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=195.9
Q ss_pred CCCcCceecccCceEEEEEEEcC-CcEEEEEEeccc---ccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESA---VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+|.+.+.||+|+||.||++.... +..+++|.++.. ........++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999997653 445666655432 22233445677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++...... ...+++..++.++.|+++||.|||+ .+++|+||||+||+++. +.++++|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999888653222 2458999999999999999999996 89999999999999975 56999999998876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......|++.|+|||...+..++.++||||||+++|+|++|+.||....... . ....
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~-------------~~~~ 217 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---V-------------VLRI 217 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---H-------------HHHH
Confidence 44322 2233568899999999888888999999999999999999999996432110 0 0111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ..........+.+++.+|++.+|++||++.|+++
T Consensus 218 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 VEGPT--PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HcCCC--CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11111 1112233456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=299.56 Aligned_cols=268 Identities=24% Similarity=0.339 Sum_probs=195.5
Q ss_pred HhcCCCc-CceecccCceEEEEEEEc-CCcEEEEEEecccccChH------------HHHHHHHHHHHHHcCCCCCcceE
Q 002255 588 VTNNFSE-ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK------------GFAEFKSEIAVLTKVRHRHLVGL 653 (947)
Q Consensus 588 ~~~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l 653 (947)
+.++|.. .+.||+|+||.||+|..+ +++.||||.+........ ....+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456654 577999999999999865 689999999865432210 01257789999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 654 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
++++..++..++||||+. |+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKG 156 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCC
Confidence 999999999999999996 6898888542 347888999999999999999996 8999999999999999999
Q ss_pred cEEEeecCcceecCCCCC------------cceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCc
Q 002255 734 RAKVADFGLVRLAPDNGK------------HSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDE 800 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~ 800 (947)
.++++|||+++....... ........+++.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876541110 0111223468899999998764 468999999999999999999999976
Q ss_pred cCccchhhHHHHHHHhhc-C-hhhHHHHhh--------ccCC--CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 801 TQSEDSVHLVTWFRRMHI-N-KDTFRKAID--------RTID--LDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 801 ~~~~~~~~l~~~~~~~~~-~-~~~~~~~~~--------~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+.. ..+..... . ...+..... .... ...........+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 5532221 11111000 0 000000000 0000 00000112345789999999999999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=283.11 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=202.2
Q ss_pred HHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC--C----CcceEEEEEEe
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--R----HLVGLLGYCLD 659 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~ 659 (947)
..+++|.+...+|+|.||.|-++.. +.+..||||+++.- ....+..+-|+++++++.+ | -+|.+.+||..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 4478999999999999999999854 35789999998753 3345667889999999943 2 37788899999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc---------
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--------- 730 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--------- 730 (947)
.++.++|+|.+ |-|+.+++.. .+..+++...+..|+.|++++++|||+ .+++|-||||+|||+.
T Consensus 163 rghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEec
Confidence 99999999987 7799999954 445778999999999999999999997 8999999999999993
Q ss_pred -----------CCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCC
Q 002255 731 -----------DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 731 -----------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~ 799 (947)
++..++|+|||.|+...... ...+.|.-|.|||++.+-.++.++||||+||||+|++||..-|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 13469999999998764432 34578899999999999999999999999999999999999997
Q ss_pred ccCccchhhHHHHHHHhhcChhhHH-----HHhhcc-C-------------------CCC---hhcHHHHHHHHHHHHHh
Q 002255 800 ETQSEDSVHLVTWFRRMHINKDTFR-----KAIDRT-I-------------------DLD---EETLASISTVADLAGHC 851 (947)
Q Consensus 800 ~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~~~~-~-------------------~~~---~~~~~~~~~l~~li~~c 851 (947)
.-...+...+.+.+-. ..+..... +.+... + ... .....+...+.||+++|
T Consensus 311 tHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 6653332222222211 00111111 111110 0 000 01123345689999999
Q ss_pred cccCCCCCCCHHHHHH
Q 002255 852 CAREPYQRPDMGHVVN 867 (947)
Q Consensus 852 l~~dP~~RPs~~evl~ 867 (947)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999976
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.08 Aligned_cols=264 Identities=27% Similarity=0.369 Sum_probs=199.9
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
|+..+.||+|+||.||+|... +++.||+|.+......+...+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999876 5899999999866433444567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 58999986542 348899999999999999999997 799999999999999999999999999988664432
Q ss_pred CcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh-hhHHHHhh
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK-DTFRKAID 828 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~ 828 (947)
. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+.... ......... ..+....+
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 153 R--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK--IFQILGTPTEESWPGVTK 228 (282)
T ss_pred c--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH--HHHHhCCCcHHHHHhhcc
Confidence 1 11223467789999998776 789999999999999999999999976543221110 001000000 01100000
Q ss_pred -----ccCC---CC---hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 -----RTID---LD---EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 -----~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... .. .........+.+++.+|+..+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 00 000112356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=285.60 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=198.9
Q ss_pred HhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccc-cCh----HHHHHHHHHHHHHHcCCCCCcceEEEEEEe-C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAV-VSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-G 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 660 (947)
..++|-...+||+|||+.||+|. +...+.||||+-.... +.+ ...+...+|.++.+.|.||.||++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34678888999999999999994 5568899999764332 111 123557789999999999999999999964 5
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl 737 (947)
+.++-|.|||+|.+|+-+|... +.+++.++..|+.||+.||.||... +.+|||-||||.|||+-. -|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6678999999999999888654 3488899999999999999999975 689999999999999954 488999
Q ss_pred eecCcceecCCCCCcc-----eeecccccccccCccccccC----CcCcccccccHHHHHHHHHhCCCCCCccCccchhh
Q 002255 738 ADFGLVRLAPDNGKHS-----IETRLAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 808 (947)
+|||+++.+.++.... .....+||.+|++||.+.-+ ..+.|+||||+|||+|..+.|+.||+.......+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI- 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI- 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-
Confidence 9999999886644332 24557899999999987533 4788999999999999999999999875432211
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVV 866 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 866 (947)
.. ...+.+ ...+.++..+ ...++..++|++||+.--++|.+..++.
T Consensus 694 -Lq--------eNTIlk--AtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 -LQ--------ENTILK--ATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -Hh--------hhchhc--ceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 10 001000 1122222222 2335677999999999999998776653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=295.87 Aligned_cols=240 Identities=27% Similarity=0.375 Sum_probs=193.1
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
.++.|.....+|.|+|+.|-++.. .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 467888888999999999999865 468889999997652 2334577666666 79999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE-cCCCcEEEeecCcce
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVR 744 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill-~~~~~~kl~DfGla~ 744 (947)
|||.+.++-+.+.+...+. +. .++..|+.+|+.|+.|||+ +||||||+||+|||+ +..++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999988877755332 22 6677899999999999997 899999999999999 689999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
..... ....+-|..|.|||+.....|++++|+||||++||+|++|+.||...... ..+.
T Consensus 465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~-------------- 523 (612)
T KOG0603|consen 465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH-------------- 523 (612)
T ss_pred hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH--------------
Confidence 77554 11224578899999999999999999999999999999999999765433 1111
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+....+........++|+.+||+.||.+||+|.++..
T Consensus 524 ----~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 524 ----TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111112222334456779999999999999999999866
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=299.66 Aligned_cols=265 Identities=20% Similarity=0.334 Sum_probs=193.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------- 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 660 (947)
..+|...+.||.|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 468999999999999999999764 68999999986553 34456788999999999999999999876543
Q ss_pred -------CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-C
Q 002255 661 -------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-D 732 (947)
Q Consensus 661 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~ 732 (947)
...++||||++ ++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999996 588877743 237889999999999999999996 89999999999999974 5
Q ss_pred CcEEEeecCcceecCCCCCcc-eeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH
Q 002255 733 MRAKVADFGLVRLAPDNGKHS-IETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~ 810 (947)
+.+|++|||+++......... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+....
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~- 230 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL- 230 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 678999999987653321111 1123457889999997654 5678899999999999999999999976543222111
Q ss_pred HHHHHhhcChh-h-------HHHHhhccCCCChh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 811 TWFRRMHINKD-T-------FRKAIDRTIDLDEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 811 ~~~~~~~~~~~-~-------~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......... . .............. ......++.+++.+|++.||++||++.|+++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 -ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 1110000000 0 00000000000000 0112345779999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=282.00 Aligned_cols=238 Identities=30% Similarity=0.447 Sum_probs=193.9
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCch
Q 002255 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 675 (947)
||+|+||.||++... +++.||+|++...... ....+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 5899999998765432 23567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCccee
Q 002255 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
.+++... ..+++.....++.|++.|+.|||+ .+++|+||||+||+++.++.++++|||++....... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~ 150 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRT 150 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Ccc
Confidence 9998543 247899999999999999999996 899999999999999999999999999988664422 122
Q ss_pred ecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh
Q 002255 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE 835 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (947)
....++..|+|||...+...+.++|+||||+++||+++|+.||....... ....+.......+.
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~ 214 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----------------IYEKILKDPLRFPE 214 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHhcCCCCCCC
Confidence 34568889999999988888999999999999999999999996543211 11111111122111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002255 836 ETLASISTVADLAGHCCAREPYQRPDMGH 864 (947)
Q Consensus 836 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 864 (947)
.....+.+++.+|+..||++||++++
T Consensus 215 ---~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 ---FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11356789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-33 Score=290.98 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=203.5
Q ss_pred cCCCcCceecccCceEEEEEEEcCCc-EEEEEEeccc-ccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGT-KIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+++....||-||||.|=.+..+... .+|+|++++. .++....+.+..|-++|...+.|.||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566778999999999999877433 3899998765 356666788899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|-|-||.|...+++++. ++..+..-++..+++|++|||+ ++||+|||||+|.+++.+|-+|+.|||+|+...
T Consensus 500 EaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999977643 6677777788899999999997 899999999999999999999999999999987
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.+.+ +..++|||.|.|||++.++..+.++|.||+|+++|||++|.+||.+.++.....++ +
T Consensus 572 ~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I----------------L 632 (732)
T KOG0614|consen 572 SGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI----------------L 632 (732)
T ss_pred cCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH----------------H
Confidence 7543 34689999999999999999999999999999999999999999988765433221 1
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPD 861 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 861 (947)
+.++.-..+........++++++++.+|.+|..
T Consensus 633 -kGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 633 -KGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 111111222333445679999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=272.32 Aligned_cols=271 Identities=23% Similarity=0.362 Sum_probs=200.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--------C
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--------G 660 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 660 (947)
+.|....+||+|.||.||+|+.+ +|+.||+|++-.+...+.--....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999765 57889998764432222233566889999999999999999988853 3
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...|+||++|+. +|.-++.... ..++..++.+++.++..||.|+|. ..|+|||+||+|+|++.+|.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 457999999965 7777775543 348889999999999999999996 78999999999999999999999999
Q ss_pred CcceecCCCCC--cceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 741 GLVRLAPDNGK--HSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 741 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
|+++.+..... ....+..+-|..|++||.+.+ ..|+++.|||..|||+.||.||.+-+.+.......+++...-...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99986543222 122345567999999998876 468999999999999999999999998877666666554333222
Q ss_pred cChh-------hHHHHhhcc-CCCChh--------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 818 INKD-------TFRKAIDRT-IDLDEE--------TLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 818 ~~~~-------~~~~~~~~~-~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+- .+.+.+... +..... +.....+..+|+.+++..||++|+++.+++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2110 011111000 000000 00112356799999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=298.08 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=209.5
Q ss_pred eecHHHHHHHhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEE
Q 002255 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGY 656 (947)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 656 (947)
.+.++.+...++.|++.++||+|.+|.||+++ .++|+.+|+|++... ....+++..|.++++.. .|||++.++|+
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 34456666777889999999999999999996 457899999988754 34446778899999998 69999999999
Q ss_pred EEe-----CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC
Q 002255 657 CLD-----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 657 ~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 731 (947)
+.. +++.|||||||.+|+..|++..-. ...+.|..+..|++.++.|+.+||. ..++|||||-.|||++.
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTE 158 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEec
Confidence 863 678999999999999999997655 2558999999999999999999995 88999999999999999
Q ss_pred CCcEEEeecCcceecCCCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccch
Q 002255 732 DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806 (947)
Q Consensus 732 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 806 (947)
++.||++|||.+....... .......|||.|||||++.. ..|+.++|+||+|++..||--|.+|+.+..+...
T Consensus 159 e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra 236 (953)
T KOG0587|consen 159 NAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA 236 (953)
T ss_pred cCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence 9999999999987664422 12234689999999999854 3477899999999999999999999988765432
Q ss_pred hhHHHHHHHhhcChhhHHHHhhccCCCCh---hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDE---ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 807 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. +....+.++ .+..-..++.++|..|+..|.++||++.++++
T Consensus 237 L-------------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 L-------------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred h-------------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 111111011 11233356889999999999999999998876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=276.73 Aligned_cols=243 Identities=25% Similarity=0.384 Sum_probs=197.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 666 (947)
.+|....+||+|+||.|..|..+ +.+.+|||++++.+.- ....+--+.|-+++... +-|.++++..+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888899999999999999766 4677999999987643 33344455677777766 578999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+.||+|--++...+ .+.+..+.-+|..||-||-+||+ ++||+||||..||+++.+|++||+|||+++..
T Consensus 429 MEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999987775543 35666777889999999999996 89999999999999999999999999999854
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
...+. ....++|||.|+|||++...+|...+|.|||||+||||+.|++||++.++ .+.+..+
T Consensus 501 i~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----------------~elF~aI 562 (683)
T KOG0696|consen 501 IFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------DELFQAI 562 (683)
T ss_pred ccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHH
Confidence 44332 24568999999999999999999999999999999999999999998653 2345555
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPD 861 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 861 (947)
.+.....+. ....+...+.+..+...|.+|..
T Consensus 563 ~ehnvsyPK---slSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHNVSYPK---SLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHccCcCcc---cccHHHHHHHHHHhhcCCccccC
Confidence 555554332 23345668888899999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=294.35 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=189.0
Q ss_pred CCcCceecccCceE-EEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEEe
Q 002255 592 FSEENVLGRGGFGT-VYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 592 ~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
|...+++|.|+.|+ ||+|.+. |+.||||++-. +...-..+||..++.- +|||||++++.-.++...|++.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44557899999985 8999987 89999999853 3345678999999988 699999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---C--CcEEEeecCcce
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---D--MRAKVADFGLVR 744 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~--~~~kl~DfGla~ 744 (947)
| ..+|.+++.... .......-...+.+..|++.||++||+ .+||||||||+||||+. + .+++|+|||+++
T Consensus 585 C-~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 C-ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9 569999996631 111111113456788999999999997 79999999999999975 2 579999999999
Q ss_pred ecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhC-CCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
....+... .......||-+|+|||++....-+.++||||+|||+|+.++| .+||++.-..+.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------------- 723 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------------- 723 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------------
Confidence 87654322 224457899999999999988888999999999999999996 899986532211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.++........-......+..+||.+|++.+|..||++.+|+.
T Consensus 724 --NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 724 --NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1122111111100000015679999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=249.00 Aligned_cols=205 Identities=27% Similarity=0.384 Sum_probs=169.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+.......||+|++|.|-+.++. +|...|||++.... ..+..++..+|+.+..+- .+|.+|.++|.+......|+.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 44455677999999999988764 79999999998765 455667888888876665 7999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|.| ..+|+.+-..--. ....+++...-+||..|++||.|||+ +..++|||+||+|||++.+|++|+||||++-...
T Consensus 125 E~M-~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHh-hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 998 4577665543222 22568888899999999999999998 6899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCcccccc----CCcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
+.- ..+...|...|||||.+.. ..|+-|+||||+|+.+.||.+++.||+...
T Consensus 201 dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 DSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 532 2233468899999998843 468999999999999999999999998765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=272.52 Aligned_cols=222 Identities=22% Similarity=0.231 Sum_probs=175.7
Q ss_pred cCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCchhhhh
Q 002255 601 GGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL 679 (947)
Q Consensus 601 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 679 (947)
|.||.||++... +++.||+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999764 68999999987542 2334555556667999999999999999999999999999999988
Q ss_pred hcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeeccc
Q 002255 680 FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759 (947)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 759 (947)
... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++++|||.+....... ....
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~ 143 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA 143 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence 553 237899999999999999999996 899999999999999999999999999876554321 2234
Q ss_pred ccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHH
Q 002255 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLA 839 (947)
Q Consensus 760 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (947)
++..|+|||.+....++.++||||+|+++|||++|+.|+........ . ......+ ..
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~-------~~~~~~~---~~ 200 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------T-------HTTLNIP---EW 200 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------c-------ccccCCc---cc
Confidence 67789999999888899999999999999999999988753221000 0 0000111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHH
Q 002255 840 SISTVADLAGHCCAREPYQRPDMGHV 865 (947)
Q Consensus 840 ~~~~l~~li~~cl~~dP~~RPs~~ev 865 (947)
....+.+++.+|++.||++||++.+.
T Consensus 201 ~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 201 VSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred CCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 23457899999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=289.16 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=183.4
Q ss_pred HhcCCCcCceecccCceEEEEEEE-----------------cCCcEEEEEEecccccChHHH--------------HHHH
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-----------------HDGTKIAVKRMESAVVSEKGF--------------AEFK 636 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~ 636 (947)
..++|.+.++||+|+||.||+|.+ ..++.||||++.... .... +...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccchhH
Confidence 357899999999999999999964 235689999986432 1111 2234
Q ss_pred HHHHHHHcCCCCCc-----ceEEEEEEe--------CCeeEEEEEecCCCchhhhhhccccc------------------
Q 002255 637 SEIAVLTKVRHRHL-----VGLLGYCLD--------GNERLLVYEYMPQGTLSRHLFNRKEE------------------ 685 (947)
Q Consensus 637 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~------------------ 685 (947)
.|+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888876654 677787753 35689999999999999998653210
Q ss_pred -CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccc
Q 002255 686 -GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764 (947)
Q Consensus 686 -~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 764 (947)
....++|..+..++.|++++|+|||+ .+|+||||||+||+++.++.+||+|||+++....... .......+|+.|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y 376 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRY 376 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcce
Confidence 01235678889999999999999996 7899999999999999999999999999976543221 111223458899
Q ss_pred cCccccccCC--------------------c--CcccccccHHHHHHHHHhCCC-CCCccCccchhhHHHHHHHhhcChh
Q 002255 765 LAPEYAVTGR--------------------V--TTKVDVFSFGVILMELITGRK-ALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 765 ~aPE~~~~~~--------------------~--~~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+|||.+.... + ..+.||||+||++|||++|.. |+........ ..........
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-----~~~~~~~~~~ 451 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-----ELRQYDNDLN 451 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-----HHhhccchHH
Confidence 9999875422 1 235799999999999999875 6643321110 0000000011
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREP---YQRPDMGHVVN 867 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 867 (947)
.++......+.+.. .........+|+.+++..+| .+|+|++|+++
T Consensus 452 ~~r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 452 RWRMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 12222222222221 11223456799999999766 68999999976
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.26 Aligned_cols=268 Identities=22% Similarity=0.349 Sum_probs=200.7
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----CeeEE
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NERLL 665 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 665 (947)
.+..+.||.|+||.||.++.. +|+.||+|++..-..+-...+.+.+|++++..++|.|++..+++..-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 455689999999999999764 799999999876543444567899999999999999999998876543 35678
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|+|.| ..+|...+.. .+.++-..+.-+.+||++||.|||+ .+|.||||||.|.|++.+..+||||||+++.
T Consensus 135 ~TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 88887 5677776633 2457777777889999999999997 8999999999999999999999999999997
Q ss_pred cCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-----
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN----- 819 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 819 (947)
........+ +..+-|.+|.|||++++. .|+.+.||||.|||+.|++..+.-|....+-+..+++...-.....
T Consensus 206 ee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 765443333 445678999999999875 6999999999999999999999888877766655544322211110
Q ss_pred --hhhHHHHhhccCCCChhc--------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 820 --KDTFRKAIDRTIDLDEET--------LASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 820 --~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
++.-..++....+.+... .....+..++..+++..||++|.+..+++..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111112222222211111 11123455788899999999999999887754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=298.63 Aligned_cols=266 Identities=19% Similarity=0.223 Sum_probs=170.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-C----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEE------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-D----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY------ 656 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------ 656 (947)
..++|+..++||+|+||.||+|.+. + +..||||++.... . .+.+..| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--A--VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--h--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999875 4 6899999876432 1 1111111 1122222222222211
Q ss_pred EEeCCeeEEEEEecCCCchhhhhhccccc---------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecC
Q 002255 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEE---------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (947)
Q Consensus 657 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 721 (947)
...+.+.++||||+.+++|.+++...... .........+..++.||+.||+|||+ ++|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 24567889999999999999988653210 00011223456799999999999996 8999999
Q ss_pred CCCCcEEEcC-CCcEEEeecCcceecCCCCCcceeecccccccccCccccccC----------------------CcCcc
Q 002255 722 LKPSNILLGD-DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG----------------------RVTTK 778 (947)
Q Consensus 722 lkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 778 (947)
|||+|||++. ++.+||+|||+|+...... ........|++.|+|||.+... .++.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999986 5899999999998654322 2233456789999999965322 23456
Q ss_pred cccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChh-----cHHHHHHHHHHHHHhcc
Q 002255 779 VDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEE-----TLASISTVADLAGHCCA 853 (947)
Q Consensus 779 ~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~ 853 (947)
+|||||||++|||+++..+++.. .......+.....+...+...+......+.. .........+|+.+||+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 79999999999999977664321 1111111111111111122222221100000 00011234589999999
Q ss_pred cCCCCCCCHHHHHH
Q 002255 854 REPYQRPDMGHVVN 867 (947)
Q Consensus 854 ~dP~~RPs~~evl~ 867 (947)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=266.13 Aligned_cols=239 Identities=32% Similarity=0.457 Sum_probs=192.3
Q ss_pred CceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCchhhhhh
Q 002255 602 GFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF 680 (947)
Q Consensus 602 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~ 680 (947)
+||.||+|... +|+.+|+|++........ .+.+.+|++.+++++|+|++++++++..+...++||||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999886 489999999876532221 5789999999999999999999999999999999999999999999885
Q ss_pred cccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccc
Q 002255 681 NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760 (947)
Q Consensus 681 ~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 760 (947)
... .+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++++|||.+....... ......+
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 532 27889999999999999999996 799999999999999999999999999998765532 2234568
Q ss_pred cccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHH
Q 002255 761 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLAS 840 (947)
Q Consensus 761 t~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (947)
+..|++||......++.++||||||++++++++|..||......+ .. ..................
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--EL-------------FKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH-------------HHHHhccCCCCccccccC
Confidence 889999999988889999999999999999999999996532111 11 111111111111111113
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 841 ISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 841 ~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.+++.+|+..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 456889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=275.74 Aligned_cols=208 Identities=28% Similarity=0.407 Sum_probs=173.9
Q ss_pred cCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.-|..++.||-|+||.|.+++ .++...||+|.+++.. ........++.|..||..-..+-||+++-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778999999999999995 4556779999987653 34455677889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||++||++-.+|.+.+ .+++..+.-++..+..|+++.| +.|+|||||||+|||||.+|++||+||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999886643 3666666667778999999999 5899999999999999999999999999975221
Q ss_pred C--------CCCcce--------------------------------eecccccccccCccccccCCcCcccccccHHHH
Q 002255 748 D--------NGKHSI--------------------------------ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVI 787 (947)
Q Consensus 748 ~--------~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 787 (947)
. .+.+.. ....+||+-|+|||++....|+.-+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1 111000 012579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCccCccc
Q 002255 788 LMELITGRKALDETQSED 805 (947)
Q Consensus 788 l~elltg~~p~~~~~~~~ 805 (947)
||||+.|+.||....+.+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999998776644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=242.41 Aligned_cols=259 Identities=18% Similarity=0.359 Sum_probs=195.5
Q ss_pred cCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeC--CeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDG--NERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 665 (947)
++|++.+++|+|-++.||.|. ..+.++++||+++.- ..+.+.+|+.+++.++ ||||++++++..+. ....|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 678899999999999999995 567899999998743 3467899999999997 99999999998765 45679
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEeecCcce
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVR 744 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~ 744 (947)
|+||+.+.+...+- ..+...++...+.+++.||.|+|| .||+|||+||.|+++|.. -.++++|+|+|.
T Consensus 113 iFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred HhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHh
Confidence 99999988876554 236666778889999999999998 899999999999999965 579999999999
Q ss_pred ecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCcc-chh----------hHHHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSE-DSV----------HLVTW 812 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~-~~~----------~l~~~ 812 (947)
++.+.....+ .+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||...... ++. ++..+
T Consensus 182 FYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 9877544433 356778999998866 45889999999999999999999999654322 211 12222
Q ss_pred HHHhhcC-hhhHHHHhhccCCC-------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHIN-KDTFRKAIDRTIDL-------DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~-~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+...... ...+..++.+.... .+...-..++..+++.+.|..|..+|||++|++.
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 2222221 11222222221110 0111112256789999999999999999999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=250.78 Aligned_cols=251 Identities=22% Similarity=0.384 Sum_probs=198.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChH-HHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
.++|...++||+|+|+.|-.++++ +.+.+|+|+++++.+.+. ..+-.+.|-.+..+. +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367899999999999999999865 578899999998765543 345567788888877 69999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|.||++||+|--++.++ +.++++.+.-+...|.-||.|||+ .|||.||+|..|+|+|.+|.+|++|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999997666543 347888887888899999999997 8999999999999999999999999999886
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccc-hhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED-SVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~ 824 (947)
--..+. ....++|||-|.|||++.+..|...+|.|++||+++||+.|+.||+-...+. +.... .-.+.
T Consensus 401 ~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte---------dylfq 469 (593)
T KOG0695|consen 401 GLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE---------DYLFQ 469 (593)
T ss_pred CCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh---------HHHHH
Confidence 544333 3456899999999999999999999999999999999999999997443211 11111 11223
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD 861 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 861 (947)
-++.+.+..+.. ..-....+++.-+++||++|..
T Consensus 470 vilekqiriprs---lsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 470 VILEKQIRIPRS---LSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHhhhcccccce---eehhhHHHHHHhhcCCcHHhcC
Confidence 344444432221 1123457888899999999873
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=277.09 Aligned_cols=324 Identities=23% Similarity=0.291 Sum_probs=219.4
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcC-CCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEe
Q 002255 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-PSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 64 ~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (947)
.+|++.|+|.+|.|+..-.+++..++.|+.||||.|.|+... |+|..-.++++|+|++|.|+.+-...|..|.+|.+|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 356777777777666555566777777777777777776544 3666666777777777777777766777777777777
Q ss_pred ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccc-cCCCCceeeeccCC
Q 002255 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQK 221 (947)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~l~~n~ 221 (947)
|++|+++. ..+..|.+|++|+.|+|..|.|.-.---.|. .+++|+.|.|..|++...-...| +..+++.|+|..|+
T Consensus 204 LsrNritt-Lp~r~Fk~L~~L~~LdLnrN~irive~ltFq--gL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~ 280 (873)
T KOG4194|consen 204 LSRNRITT-LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQ--GLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNR 280 (873)
T ss_pred cccCcccc-cCHHHhhhcchhhhhhccccceeeehhhhhc--CchhhhhhhhhhcCcccccCcceeeecccceeecccch
Confidence 77777754 3345566677777777777776533233333 46667777777777764444443 33567777777776
Q ss_pred CCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccC
Q 002255 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (947)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (947)
+.....++ +.+++.|+.|+||+|.|..+-+ .+...++|++|+|++|+|+...+.+|..+..|+.|+|++|.++-.-
T Consensus 281 l~~vn~g~---lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~ 357 (873)
T KOG4194|consen 281 LQAVNEGW---LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLA 357 (873)
T ss_pred hhhhhccc---ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHH
Confidence 66655544 4566777777777777765444 3555667777777777777666666777777777777777665210
Q ss_pred CCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCC
Q 002255 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL 380 (947)
Q Consensus 301 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 380 (947)
...+....+|+.|||++|
T Consensus 358 --------------------------------------------------------------e~af~~lssL~~LdLr~N 375 (873)
T KOG4194|consen 358 --------------------------------------------------------------EGAFVGLSSLHKLDLRSN 375 (873)
T ss_pred --------------------------------------------------------------hhHHHHhhhhhhhcCcCC
Confidence 012233458999999999
Q ss_pred Cceeeccc---cccCCccCCeEeccCCcccccCC-CcCCCCCCCCccccccccccccCCCCccce---eeecCCCCCCCC
Q 002255 381 GLSGTISS---NFSRLTSLRQLMLSGNELTGTIP-KELTTLPSLEMLDVSNNHLFGKVPNFRQNV---IVKTDGNPDIGK 453 (947)
Q Consensus 381 ~l~g~ip~---~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~---~~~~~~n~~~~~ 453 (947)
.|++.|-+ .|..|++|+.|+|.||+|. .|| .+|.++.+|+.|||.+|.+-..-|+.+... .+.+..-.++|.
T Consensus 376 ~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 376 ELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred eEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEe
Confidence 99998764 5778999999999999999 666 679999999999999999987777654333 234555667777
Q ss_pred CCC
Q 002255 454 DSS 456 (947)
Q Consensus 454 ~~~ 456 (947)
+..
T Consensus 455 Cql 457 (873)
T KOG4194|consen 455 CQL 457 (873)
T ss_pred ccH
Confidence 654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=272.58 Aligned_cols=302 Identities=21% Similarity=0.255 Sum_probs=252.2
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCC-CCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLS-SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+..|++++|.|+.+-+..|.++++|+.++|.+|.|+ .||.|++.+ +|+.|+|.+|.|+.+-.+.+..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4678999999999888889999999999999999998 567777755 49999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCcccc-CCCCceeeeccCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG-KSSIQTLWLNGQKGD 223 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~l~~n~~~ 223 (947)
.|.|+. ..-.+|..-.++++|+|++|.|+..-...|. .+.+|..|.|+.|+++...+..|. ...|+.|+|..|++.
T Consensus 158 rN~is~-i~~~sfp~~~ni~~L~La~N~It~l~~~~F~--~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 158 RNLISE-IPKPSFPAKVNIKKLNLASNRITTLETGHFD--SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred hchhhc-ccCCCCCCCCCceEEeecccccccccccccc--ccchheeeecccCcccccCHHHhhhcchhhhhhcccccee
Confidence 999976 3336777788999999999999988888887 688999999999999966667777 478999999999887
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
....- .|.++++|+.|.|..|.+...-.. |.++.+++.|+|+.|+++..-..++.++++|+.|+||+|.+...-++
T Consensus 235 ive~l---tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d 311 (873)
T KOG4194|consen 235 IVEGL---TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID 311 (873)
T ss_pred eehhh---hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecc
Confidence 55332 367799999999999999976653 88899999999999999988888899999999999999999855443
Q ss_pred CCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCc
Q 002255 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (947)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (947)
.++ ...+|+.|+|++|+|
T Consensus 312 ~Ws--------------------------------------------------------------ftqkL~~LdLs~N~i 329 (873)
T KOG4194|consen 312 SWS--------------------------------------------------------------FTQKLKELDLSSNRI 329 (873)
T ss_pred hhh--------------------------------------------------------------hcccceeEecccccc
Confidence 221 234677888888888
Q ss_pred eeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCC
Q 002255 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 383 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
+.--+.+|..|..|++|+|++|+++-.--..|..+.+|+.|||++|.|++.|-+
T Consensus 330 ~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 330 TRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred ccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 876777788888888888888888744455677778888888888888777764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=251.06 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=120.5
Q ss_pred CCCCCCcceecCCceeecHHHHHHHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHH
Q 002255 564 SSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVL 642 (947)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l 642 (947)
.+..+..|++..|... ...+|.+.++||.|.|++||++-. .+.+.||+|+.+.. +...+....||+++
T Consensus 60 dY~kGGYHpV~IGD~F--------~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL 128 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVF--------NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLL 128 (590)
T ss_pred hhhcCCCceeeccccc--------cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHH
Confidence 3444556666555432 137899999999999999999954 46789999998764 33346678899999
Q ss_pred HcCC-----C---CCcceEEEEEEe----CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHh
Q 002255 643 TKVR-----H---RHLVGLLGYCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710 (947)
Q Consensus 643 ~~l~-----h---~niv~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH 710 (947)
++++ | .+||++++.|.. +.|.++|+|++ |-+|..++..... +-++...+.+|++||+.||.|||
T Consensus 129 ~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH 204 (590)
T KOG1290|consen 129 QQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLH 204 (590)
T ss_pred HHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHH
Confidence 9994 2 479999999964 67899999998 7788888865443 44888899999999999999999
Q ss_pred hccCCCeeecCCCCCcEEE
Q 002255 711 GLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 711 ~~~~~~ivHrDlkp~Nill 729 (947)
. +.+|||-||||+|||+
T Consensus 205 ~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 205 R--ECGIIHTDLKPENVLL 221 (590)
T ss_pred H--hcCccccCCCcceeee
Confidence 8 6899999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=244.18 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=195.6
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------C
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------N 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 661 (947)
..+|...+.+|.|.- .|..|.. -.++.||+|++..........++..+|..++..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999887 5555532 2589999999877665666678889999999999999999999998754 3
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
+.|+|||+| ..+|.+.+.. .++-.+...|..|++.|+.|||+ .+|+||||||+||++..++.+||.|||
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccch
Confidence 579999999 5688887752 15567788899999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+|+..... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.+.-++-.. .+........
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k--i~~~lgtpd~ 238 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK--IIEQLGTPDP 238 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHH--HHHHhcCCCH
Confidence 99865442 345667899999999999998899999999999999999999998875543221110 0011100111
Q ss_pred hHH-----------------------HHhhcc-CCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 TFR-----------------------KAIDRT-IDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 ~~~-----------------------~~~~~~-~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+. +.+... +... +...-....+.+++.+||..+|++|.++.++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111 111000 0000 011112234569999999999999999999977
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=258.74 Aligned_cols=276 Identities=21% Similarity=0.270 Sum_probs=212.8
Q ss_pred eecHHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC------CCcc
Q 002255 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH------RHLV 651 (947)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv 651 (947)
.|.++..+....+|.+....|+|-|++|.+|... .|..||||+|... +.-.+.=+.|+++|++|+. -|.+
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4556666777899999999999999999999754 5889999999865 3333455789999999953 4899
Q ss_pred eEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC
Q 002255 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 652 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 731 (947)
+++-.|....|+|||+|-+ ..+|.+.|...+.. ..+....+..++.|+.-||..|-. .+|+|.||||.||||++
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 9999999999999999987 56899999776544 346777888899999999999994 89999999999999997
Q ss_pred C-CcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH
Q 002255 732 D-MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810 (947)
Q Consensus 732 ~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~ 810 (947)
. ..+||||||.|.....+.. +.+.-+..|.|||++.+..|+...|+||+||+||||.||+.-|.+....+...+.
T Consensus 572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred CcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 6 5689999999987766432 2233456799999999999999999999999999999999999887665544332
Q ss_pred HHHHHh--------------hc---------------------------ChhhHHHHhhccCCCChhcHHHHHHHHHHHH
Q 002255 811 TWFRRM--------------HI---------------------------NKDTFRKAIDRTIDLDEETLASISTVADLAG 849 (947)
Q Consensus 811 ~~~~~~--------------~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 849 (947)
..+... +. +...+...+...-..+.........+.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 211100 00 0011111111111223344556677889999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 002255 850 HCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 850 ~cl~~dP~~RPs~~evl~ 867 (947)
+|+..||++|.+..++++
T Consensus 728 kml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccChhhcCCHHHHhc
Confidence 999999999999998865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=269.11 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=203.8
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
...++|+....+|.|.||.|||++.+ +++..|||+++.. ....++-++.|+-+++..+|||||.++|.+...+..|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 45678999999999999999999754 6899999999866 34456778899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
+||||.+|+|.+.-+. ..++++.++..+.+...+|++|||+ .+-+|||||-.||++++.|.+|++|||.+..
T Consensus 90 cMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhh
Confidence 9999999999876533 2468888889999999999999997 7889999999999999999999999999766
Q ss_pred cCCCCCcceeecccccccccCcccc---ccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+...- .....+.||++|||||+. ..+.|..++|||+.|+...|+-.-++|..+..+.....+...
T Consensus 162 itati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk---------- 229 (829)
T KOG0576|consen 162 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK---------- 229 (829)
T ss_pred hhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc----------
Confidence 54421 223457899999999986 456799999999999999999888888766655433222110
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+++.-..++. .-.+.+.+|++.|+..+|++||++..++.
T Consensus 230 --S~~qpp~lkDk~--kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 --SGFQPPTLKDKT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --cCCCCCcccCCc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 001111000111 22345779999999999999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=258.13 Aligned_cols=198 Identities=21% Similarity=0.355 Sum_probs=167.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHH------HHHHHHHHHHHHcCC---CCCcceEEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKG------FAEFKSEIAVLTKVR---HRHLVGLLGYCLD 659 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 659 (947)
..|...+.+|+|+||.|+.|.++. ...|+||.+.++..-... .-.+..||++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468899999999999999998874 556889988765432221 223567999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEe
Q 002255 660 GNERLLVYEYM-PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (947)
Q Consensus 660 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 738 (947)
++.+||+||-. ++.+|.+++..+. .+++.++.-|+.||+.|+++||+ .+|||||||-+||.++.+|.+|++
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 99999999975 4568999986543 38889999999999999999997 899999999999999999999999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCC
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~ 799 (947)
|||.|..... +.. ..++||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus 713 dfgsaa~~ks-gpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKS-GPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcC-CCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999876544 222 346899999999999888774 56899999999999999888875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=236.31 Aligned_cols=211 Identities=37% Similarity=0.598 Sum_probs=182.1
Q ss_pred ecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCchh
Q 002255 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 676 (947)
||+|++|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++||||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998764 8999999987653221 3568899999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecCcceecCCCCCccee
Q 002255 677 RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPDNGKHSIE 755 (947)
Q Consensus 677 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~ 755 (947)
+++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++++|||.+........ ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 9986532 347889999999999999999996 79999999999999999 89999999999887654321 12
Q ss_pred ecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCC
Q 002255 756 TRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834 (947)
Q Consensus 756 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (947)
....+...|++||..... .++.+.|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 234578899999998777 888999999999999999
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 835 EETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 835 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-29 Score=270.07 Aligned_cols=341 Identities=27% Similarity=0.369 Sum_probs=252.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCC--CCCcccccCCCCCcEEe
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT--SVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~ 142 (947)
.+++-|.|...+|. .+|++++.|.+|+.|.+++|+|...--.++.|+.|+.+++..|++. |||++.| .|..|+.||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhc-ccccceeee
Confidence 47889999999988 9999999999999999999999887778999999999999999987 8888866 699999999
Q ss_pred ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccc-cCCCCceeeeccCC
Q 002255 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQK 221 (947)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~l~~n~ 221 (947)
||+|++.. .|..+..-+++-.|+|++|+|. .||..+. .++..|-+||||+|++. .+|..+ ....|++|.|++|.
T Consensus 110 LShNqL~E--vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lf-inLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 110 LSHNQLRE--VPTNLEYAKNSIVLNLSYNNIE-TIPNSLF-INLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred cchhhhhh--cchhhhhhcCcEEEEcccCccc-cCCchHH-HhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 99999975 8999999999999999999998 6776655 27889999999999999 555554 34789999999997
Q ss_pred CCCCCCCchhhhcCCCCCcEEEccCCcCc--CCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccccc
Q 002255 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFT--GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
+...- ...+-.+++|..|.+++.+-+ ..++.+..+.+|..+||+.|++. .+|..+.++.+|+.|+||+|+++..
T Consensus 185 L~hfQ---LrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL 260 (1255)
T KOG0444|consen 185 LNHFQ---LRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL 260 (1255)
T ss_pred hhHHH---HhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee
Confidence 65321 123345778888888887644 35557888999999999999998 8899999999999999999998742
Q ss_pred CCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCc--ccCCCCceeEEEe
Q 002255 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV--SCDAGGNITVVNL 377 (947)
Q Consensus 300 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~L~~L~L 377 (947)
-... ..-.+. -.++.+.|.+..++.++-.+..+..++..++..+ +.|+ .++.+.+|+++.+
T Consensus 261 ~~~~--------~~W~~l-------EtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~--FeGiPSGIGKL~~Levf~a 323 (1255)
T KOG0444|consen 261 NMTE--------GEWENL-------ETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLT--FEGIPSGIGKLIQLEVFHA 323 (1255)
T ss_pred eccH--------HHHhhh-------hhhccccchhccchHHHhhhHHHHHHHhccCccc--ccCCccchhhhhhhHHHHh
Confidence 2110 000000 1122334445555555555555544444443322 2222 2233456666777
Q ss_pred cCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCC
Q 002255 378 KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 378 s~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP 435 (947)
++|.+. ..|..++.|..|+.|.|+.|+|- ++|..|.-|+.|++|||.+|.=--.+|
T Consensus 324 anN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 324 ANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 777766 66777777777777777777777 777777777777777777775444444
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=231.51 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=186.0
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEE-EEeCCee
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGY-CLDGNER 663 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~ 663 (947)
...+.|.+.+.+|+|.||.+-.++++ +.+.+++|.++.. ....++|.+|...--.| .|.||+.-+++ |...+.+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 34578999999999999999999876 5778999998765 34457899998877777 58999988765 5667788
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc--CCCcEEEeecC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFG 741 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~DfG 741 (947)
++++||++.|+|..-+.. ..+.+....+++.|++.|+.|||+ +++||||||.+||||- +..++|+||||
T Consensus 98 vF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecc
Confidence 899999999999887743 226677788999999999999997 8999999999999993 34589999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccC-----CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-----RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+.+..+..- ....-+..|.|||..... ...+.+|||.||+++|.++||..||.....++ ..+..|.+-.
T Consensus 169 ~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~ 242 (378)
T KOG1345|consen 169 LTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWL 242 (378)
T ss_pred cccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHh
Confidence 987654321 122345679999976432 35678999999999999999999998544332 2333333211
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....- ..+..-....+.+..+.++-+..+|++|=-..++.+
T Consensus 243 ~rk~~----------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 243 KRKNP----------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cccCc----------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11000 111111223345678888999999999944444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=242.84 Aligned_cols=205 Identities=26% Similarity=0.407 Sum_probs=169.4
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEE
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYC 657 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 657 (947)
+....+.+.|...++||+|.|++||++.+. ..+.||+|.+... ....++..|+++|..+. +.||+++.+++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh
Confidence 445667788999999999999999999643 4678999998754 23357889999999994 89999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEE
Q 002255 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAK 736 (947)
Q Consensus 658 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~k 736 (947)
...+...+|+||++.....++... ++..++...++.+..||+++|. .|||||||||.|+|.+. .+.-.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCce
Confidence 999999999999999888888733 6677888899999999999995 89999999999999985 57899
Q ss_pred EeecCcceecC-----------------C-CCC------------------------cceeecccccccccCccccccC-
Q 002255 737 VADFGLVRLAP-----------------D-NGK------------------------HSIETRLAGTFGYLAPEYAVTG- 773 (947)
Q Consensus 737 l~DfGla~~~~-----------------~-~~~------------------------~~~~~~~~gt~~y~aPE~~~~~- 773 (947)
|.|||+|.... . .+. .......+||+||.|||++...
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999986210 0 000 0001235799999999998754
Q ss_pred CcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 774 RVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 774 ~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
..+.++||||.|||++.+++++.||....
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCc
Confidence 57899999999999999999999996554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-29 Score=268.12 Aligned_cols=228 Identities=22% Similarity=0.346 Sum_probs=197.2
Q ss_pred cEEEEEecCCccc-ccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 66 RVTRIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 66 ~v~~l~L~~~~l~-g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
-|..+|+++|.++ +..|.....+++++.|.|...+|...+..++.|.+|++|.+++|++..+..+ ++.|+.|+.+++.
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGE-Ls~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGE-LSDLPRLRSVIVR 86 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhh-hccchhhHHHhhh
Confidence 4788999999999 5789999999999999999999986555899999999999999999988766 7889999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC--CCCceeeeccCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK--SSIQTLWLNGQKG 222 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~l~~n~~ 222 (947)
.|++....||..+..|..|+.|+|++|++. ..|..+. ..+++-.|+||+|+|. .||..+.- +.|-.|+|++|++
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE--~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLE--YAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhh--hhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchh
Confidence 999998889999999999999999999998 6788876 6789999999999999 78877533 7788999999987
Q ss_pred CCCCCCchhhhcCCCCCcEEEccCCcCcC-CCCCCCCCCCCCEEEccCCccc-cCCCccccCCCCCCeEeccCCcccccC
Q 002255 223 DSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLT-GIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (947)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~l~~N~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (947)
.... ..+..+..|++|+|++|.+.. .+-.+..|++|++|.+++.+=+ .-+|.++..+.+|..+|||.|.+. .+
T Consensus 163 e~LP----PQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 163 EMLP----PQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred hhcC----HHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 6543 445678899999999999865 3335777889999999987654 368999999999999999999997 44
Q ss_pred CCC
Q 002255 301 PKF 303 (947)
Q Consensus 301 p~~ 303 (947)
|++
T Consensus 238 Pec 240 (1255)
T KOG0444|consen 238 PEC 240 (1255)
T ss_pred hHH
Confidence 553
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-29 Score=258.22 Aligned_cols=369 Identities=22% Similarity=0.290 Sum_probs=239.8
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
-.+.+++.+|+++ ++|++++.+..+..|+.++|+++..++.+..+.+|+.|+.++|.+..++++ ++.+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 3678888888888 888899999999999999999987777888899999999999999988887 56788888999999
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS 224 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~ 224 (947)
|++.+ .|+.+.++.+|..|++.+|++....|..+. ++.|++||..+|.++ .+|..++. .+|+.|+|..|++..
T Consensus 147 N~i~s--lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~---m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~ 220 (565)
T KOG0472|consen 147 NQISS--LPEDMVNLSKLSKLDLEGNKLKALPENHIA---MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF 220 (565)
T ss_pred ccccc--CchHHHHHHHHHHhhccccchhhCCHHHHH---HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc
Confidence 98875 788888888888888888888866665553 778888888888887 66666655 678888888887765
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (947)
.. .|.++..|++|+++.|++...+.+ ...+++|.+|||++|++. ..|..+..+.+|++||+|+|.+++.++..
T Consensus 221 lP-----ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 221 LP-----EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSL 294 (565)
T ss_pred CC-----CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccc
Confidence 43 234455556666666655544433 334556666666666665 55666666666666666666665554432
Q ss_pred CCCcccc-----------------------cccC----------CCCcccCcCCCc-CC---------------------
Q 002255 304 NSPVRFD-----------------------MAKG----------SNSFCLDDAGVA-CD--------------------- 328 (947)
Q Consensus 304 ~~~~~~~-----------------------~~~~----------~~~~~~~~~~~~-~~--------------------- 328 (947)
... -+. +.++ ++.-........ ..
T Consensus 295 gnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~q 373 (565)
T KOG0472|consen 295 GNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQ 373 (565)
T ss_pred ccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccc
Confidence 111 100 0000 000000000000 00
Q ss_pred ---------------------CccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeecc
Q 002255 329 ---------------------GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTIS 387 (947)
Q Consensus 329 ---------------------~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip 387 (947)
..-+.+...++.+.....+....... .-.-.|.+......++|+.|+|++|-+. .+|
T Consensus 374 lt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~ls-nn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP 451 (565)
T KOG0472|consen 374 LTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLS-NNKISFVPLELSQLQKLTFLDLSNNLLN-DLP 451 (565)
T ss_pred cccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhh-cCccccchHHHHhhhcceeeecccchhh-hcc
Confidence 00011111111111111110000000 0011355556667789999999999988 799
Q ss_pred ccccCCccCCeEeccCCccc----------------------ccCCCc-CCCCCCCCccccccccccccCCCCcc---ce
Q 002255 388 SNFSRLTSLRQLMLSGNELT----------------------GTIPKE-LTTLPSLEMLDVSNNHLFGKVPNFRQ---NV 441 (947)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~----------------------g~iP~~-l~~l~~L~~L~ls~N~l~g~iP~~~~---~~ 441 (947)
..++.+..|+.||||.|+|. |.+|++ +..+.+|.+|||.+|.+.-.+|..++ ..
T Consensus 452 ~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~ 531 (565)
T KOG0472|consen 452 EEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLR 531 (565)
T ss_pred hhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhcccccee
Confidence 99999999999999988876 466655 77888999999999999766664322 22
Q ss_pred eeecCCCCCC
Q 002255 442 IVKTDGNPDI 451 (947)
Q Consensus 442 ~~~~~~n~~~ 451 (947)
.+.+.|||+-
T Consensus 532 hLeL~gNpfr 541 (565)
T KOG0472|consen 532 HLELDGNPFR 541 (565)
T ss_pred EEEecCCccC
Confidence 4567888764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=222.75 Aligned_cols=276 Identities=16% Similarity=0.277 Sum_probs=224.5
Q ss_pred cCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 667 (947)
-.|.++++||+|.||.++.|+ +-+++.||||.-... .+..++..|.+..+.|. .++|...+-+..++.+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 368899999999999999995 557999999965432 23457788999999985 699999998888888999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-----CcEEEeecCc
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVADFGL 742 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-----~~~kl~DfGl 742 (947)
|.+ |-+|.|+..-+. +.++..+++.+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+
T Consensus 104 dLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 988 889988875443 459999999999999999999997 899999999999999754 4599999999
Q ss_pred ceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
|+.+.+.... .......||.+||+-..+.+.+.+.+.|+-|+|-++++.+-|..||.+...+.....
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-------- 247 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-------- 247 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH--------
Confidence 9988765432 223457899999999999999999999999999999999999999998876554332
Q ss_pred cChhhHHHHhhccCC--CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCccccc
Q 002255 818 INKDTFRKAIDRTID--LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGID 890 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~ 890 (947)
+.++-+.+.. +...+...+.+++.-++.....+..+-|++.-+...+.++.+.........+||+..+
T Consensus 248 -----YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 248 -----YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred -----HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 3333332222 1223344556788888888889999999999999999999888888888888887665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=231.86 Aligned_cols=200 Identities=36% Similarity=0.495 Sum_probs=171.7
Q ss_pred CCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 592 FSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
|...+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999998764 899999998765322 25678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCC
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 750 (947)
++++|.+++..... .+++.....++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999865331 17888999999999999999996 799999999999999999999999999988775532
Q ss_pred CcceeecccccccccCcccc-ccCCcCcccccccHHHHHHHHHhCCCCCCc
Q 002255 751 KHSIETRLAGTFGYLAPEYA-VTGRVTTKVDVFSFGVILMELITGRKALDE 800 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~p~~~ 800 (947)
.. ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11 12334678899999988 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=213.39 Aligned_cols=268 Identities=20% Similarity=0.267 Sum_probs=214.3
Q ss_pred HhcCCCcCceecccCceEEEEEE-EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC-CCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 665 (947)
..++|.+.++||.|+||.+|.|. ..+|+.||+|.-.... ...++..|.++.+.++| ..|..+..+..+++.-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 35789999999999999999995 5689999999865442 23467889999999975 788888888899999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGl 742 (947)
|||.+ |.+|.++..-.. +.++..+++-+|.|++.-++|+|. +++|||||||+|+|..- -..+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99988 889988874433 458889999999999999999996 89999999999999964 35799999999
Q ss_pred ceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
|+.+.+.... .......||.+|.+-..+.+.+.+.+.|+-|+|.+|.++.-|..||.+.......+.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-------- 232 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-------- 232 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH--------
Confidence 9977654322 223457899999999988888899999999999999999999999998876544333
Q ss_pred cChhhHHHHhhccCCCCh--hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCC
Q 002255 818 INKDTFRKAIDRTIDLDE--ETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAE 880 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~ 880 (947)
+.++.+.+..... .+...+.++.-.+..|-..-.++-|++.-+.+.++-+.....-..
T Consensus 233 -----yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 233 -----YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred -----HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 3334444333222 233455678888999999999999999999888887765444333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-25 Score=271.08 Aligned_cols=196 Identities=19% Similarity=0.260 Sum_probs=138.9
Q ss_pred cCCC-CCcceEEEEE-------EeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC
Q 002255 644 KVRH-RHLVGLLGYC-------LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715 (947)
Q Consensus 644 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 715 (947)
.++| +||++++++| ...+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 3445 5788888877 2334567888987 679999995421 458999999999999999999996 8
Q ss_pred CeeecCCCCCcEEEcC-------------------CCcEEEeecCcceecCCCCC--------------cceeecccccc
Q 002255 716 SFIHRDLKPSNILLGD-------------------DMRAKVADFGLVRLAPDNGK--------------HSIETRLAGTF 762 (947)
Q Consensus 716 ~ivHrDlkp~Nill~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~ 762 (947)
+||||||||+||||+. ++.+|++|||+++....... .......+||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 44566667776653211000 00011246899
Q ss_pred cccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHH
Q 002255 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASIS 842 (947)
Q Consensus 763 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (947)
.|||||++.+..++.++|||||||++|||++|..|+..... ...... ...+ +........
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~---------~~~~------~~~~~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR---------HRVL------PPQILLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH---------Hhhc------ChhhhhcCH
Confidence 99999999999999999999999999999999887643210 000000 0000 111111223
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 843 TVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 843 ~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+++.+||+.+|.+||+|.|+++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 4568889999999999999999976
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-23 Score=226.52 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=197.7
Q ss_pred CCCcCceecccCceEEEEEEEcCC--cEEEEEEecccccChHHHHHHHHHHHHHHcCCC----CCcceEEEEE-EeCCee
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDG--TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH----RHLVGLLGYC-LDGNER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~ 663 (947)
+|.+.++||+|+||.||.+..... ..+|+|......... ...+..|+.++..+.. +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999986543 478888776542111 1267789999999873 6889999988 477788
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-----CcEEEe
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVA 738 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-----~~~kl~ 738 (947)
++||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++|+ .|++||||||.|+++... ..+.+.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999987 889999775544 3568999999999999999999996 899999999999999865 469999
Q ss_pred ecCcce--ecCCCCCc----ce--eecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH
Q 002255 739 DFGLVR--LAPDNGKH----SI--ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810 (947)
Q Consensus 739 DfGla~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~ 810 (947)
|||+++ .+...... .. .....||..|++++.+.+.+.+++.|+||++.++.|+..|..||............
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 33222211 11 12356999999999999999999999999999999999999999665433221111
Q ss_pred HHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 002255 811 TWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876 (947)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 876 (947)
.+....... ..........+.++...+-..+..++|.+..+...++......
T Consensus 250 -------------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 250 -------------EKDPRKLLT-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -------------HHHhhhhcc-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111000000 0011112244667777777799999999999999988876554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-27 Score=241.05 Aligned_cols=313 Identities=23% Similarity=0.324 Sum_probs=194.5
Q ss_pred EEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 67 v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
+.+||+..|-++ ++|++++.|.+|+.|+|..|++.. .|.|.+++.|++|+++.|+|+.++.+...+|++|.+|||..|
T Consensus 185 L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdN 262 (565)
T KOG0472|consen 185 LKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDN 262 (565)
T ss_pred HHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc-CCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccc
Confidence 444555444443 778888888888888888888763 457888888888888888888888777778888888888888
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccc-cC----------------
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF-GK---------------- 209 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~---------------- 209 (947)
++++ .|..+..+.+|.+||+++|.|+ .+|..++ .+ +|+.|-+-+|.+... -..+ ..
T Consensus 263 klke--~Pde~clLrsL~rLDlSNN~is-~Lp~sLg--nl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~d 335 (565)
T KOG0472|consen 263 KLKE--VPDEICLLRSLERLDLSNNDIS-SLPYSLG--NL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDD 335 (565)
T ss_pred cccc--CchHHHHhhhhhhhcccCCccc-cCCcccc--cc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccC
Confidence 8865 7888888888888888888887 4666776 45 777777777766421 1110 00
Q ss_pred --------------------------CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCC
Q 002255 210 --------------------------SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ 263 (947)
Q Consensus 210 --------------------------~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~ 263 (947)
...+.|++++-+++......+.+- .-.-.+..+++.|++...+..+..+..+.
T Consensus 336 glS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~-~~~~Vt~VnfskNqL~elPk~L~~lkelv 414 (565)
T KOG0472|consen 336 GLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAA-KSEIVTSVNFSKNQLCELPKRLVELKELV 414 (565)
T ss_pred CCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHh-hhcceEEEecccchHhhhhhhhHHHHHHH
Confidence 123334444444333332222111 01124456666666654443343333333
Q ss_pred E-EEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccC
Q 002255 264 D-FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVG 342 (947)
Q Consensus 264 ~-L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 342 (947)
+ +.+++|.++ .+|..++.+++|..|+|++|.+...+-+.++..++.... ..++.+-.+++
T Consensus 415 T~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~Ln---------------lS~NrFr~lP~--- 475 (565)
T KOG0472|consen 415 TDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLN---------------LSFNRFRMLPE--- 475 (565)
T ss_pred HHHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheec---------------ccccccccchH---
Confidence 2 344444443 566666666666666666666654333322221111000 00011111111
Q ss_pred ChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCc
Q 002255 343 YPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422 (947)
Q Consensus 343 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 422 (947)
.|....-++.+-.++|++...-|..+.+|.+|..|||.+|.|. .||+.++++.+|+.
T Consensus 476 ----------------------~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~h 532 (565)
T KOG0472|consen 476 ----------------------CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRH 532 (565)
T ss_pred ----------------------HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeE
Confidence 1112223556667778888666677999999999999999999 99999999999999
Q ss_pred ccccccccc
Q 002255 423 LDVSNNHLF 431 (947)
Q Consensus 423 L~ls~N~l~ 431 (947)
|+|++|+|.
T Consensus 533 LeL~gNpfr 541 (565)
T KOG0472|consen 533 LELDGNPFR 541 (565)
T ss_pred EEecCCccC
Confidence 999999998
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=247.52 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=211.5
Q ss_pred EEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 67 v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
-..|+|++++|+ .+|+.+. ++|+.|+|++|+|+.. |.+ +++|++|+|++|+|+.+|. ..++|++|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~l--p~~Lk~LdLs~N~LtsLP~----lp~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PAL--PPELRTLEVSGNQLTSLPV----LPPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CCC--CCCCcEEEecCCccCcccC----cccccceeeccCC
Confidence 356899999998 7898886 4899999999999964 432 5889999999999999874 2578999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
.+.. +|..+ .+|+.|++++|+++ .+|.. +++|+.|+|++|+|++ +|... .+|+.|++++|.+....
T Consensus 273 ~L~~--Lp~lp---~~L~~L~Ls~N~Lt-~LP~~-----p~~L~~LdLS~N~L~~-Lp~lp--~~L~~L~Ls~N~L~~LP 338 (788)
T PRK15387 273 PLTH--LPALP---SGLCKLWIFGNQLT-SLPVL-----PPGLQELSVSDNQLAS-LPALP--SELCKLWAYNNQLTSLP 338 (788)
T ss_pred chhh--hhhch---hhcCEEECcCCccc-ccccc-----ccccceeECCCCcccc-CCCCc--ccccccccccCcccccc
Confidence 9974 56533 57889999999998 45642 4689999999999995 55422 35888999999887533
Q ss_pred CCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCC
Q 002255 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306 (947)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 306 (947)
. . ..+|+.|+|++|+|++.++ + ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|..
T Consensus 339 ~-l------p~~Lq~LdLS~N~Ls~LP~-l--p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l--- 400 (788)
T PRK15387 339 T-L------PSGLQELSVSDNQLASLPT-L--PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVL--- 400 (788)
T ss_pred c-c------ccccceEecCCCccCCCCC-C--Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCc---
Confidence 2 1 2579999999999997543 2 357888999999999 47764 3578999999999985 3321
Q ss_pred cccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeec
Q 002255 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTI 386 (947)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~i 386 (947)
..+|+.|++++|+|++ +
T Consensus 401 --------------------------------------------------------------~s~L~~LdLS~N~Lss-I 417 (788)
T PRK15387 401 --------------------------------------------------------------PSELKELMVSGNRLTS-L 417 (788)
T ss_pred --------------------------------------------------------------ccCCCEEEccCCcCCC-C
Confidence 1258899999999995 7
Q ss_pred cccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCc
Q 002255 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR 438 (947)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~ 438 (947)
|..+ .+|+.|+|++|+|+ .+|.+++.+++|+.|+|++|+|+|.+|..+
T Consensus 418 P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 418 PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 7643 46889999999999 899999999999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=210.12 Aligned_cols=164 Identities=23% Similarity=0.259 Sum_probs=125.2
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++..+. ..++|.+++.++.||+.||+|||+ .+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 68888886532 358999999999999999999997 33 999999999999999 99988764421
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 832 (947)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+...+.....
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---------------~~~~~~~~~~~ 123 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---------------ILEILLNGMPA 123 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---------------HHHHHHHHhcc
Confidence 2588999999999999999999999999999999999999965432111 01111111110
Q ss_pred C----ChhcHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 833 L----DEETLASI--STVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 833 ~----~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
. ........ ..+.+++.+|++.+|++||++.|+++.+..+.
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 124 DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 00111111 25889999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=225.94 Aligned_cols=179 Identities=26% Similarity=0.236 Sum_probs=136.6
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc--CCcEEEEEEeccccc---ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
+.+.++|...+.||+|+||+||+|.++ +++.||||++..... .....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 456688999999999999999999765 577889998753311 23345679999999999999999953322 2
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCC-CCCcEEEcCCCcEEEee
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVAD 739 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~D 739 (947)
+..++||||+++++|.... . . . ...++.|++++|+|||+ ++|+|||| ||+|||++.++.+||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~~---~-~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR---P-H--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHHhC---c-c--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999996321 1 0 0 13578899999999997 89999999 99999999999999999
Q ss_pred cCcceecCCCCCcce------eecccccccccCccccccCC------cCcccccc
Q 002255 740 FGLVRLAPDNGKHSI------ETRLAGTFGYLAPEYAVTGR------VTTKVDVF 782 (947)
Q Consensus 740 fGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 782 (947)
||+|+.+...+.... .+...+++.|+|||++...+ .+...|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999997755432211 13567899999999886543 22346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=211.95 Aligned_cols=248 Identities=22% Similarity=0.397 Sum_probs=193.4
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
...+|.+...|..|+|+|. |..+++|++.....+.....+|..|.-.++-+.||||++++|.|....+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456888999999999998 778888988877667777789999999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCee-ecCCCCCcEEEcCCCcEEEe--ecCcceecCCCC
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRAKVA--DFGLVRLAPDNG 750 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv-HrDlkp~Nill~~~~~~kl~--DfGla~~~~~~~ 750 (947)
+|+..++.... ...+-.++.++|.+||+|++|||+. .+++ ---+.+..+++|++.+++|+ |--++..
T Consensus 273 slynvlhe~t~---vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 273 SLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred HHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 99999987543 4577888999999999999999996 3444 44689999999999887774 3222111
Q ss_pred CcceeecccccccccCccccccCCcC---cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 751 KHSIETRLAGTFGYLAPEYAVTGRVT---TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 751 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.....-.|.||+||.++..+-+ .++|+|||++++||+.|...||.+..+.+.... ..-+.++.-+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk--------ialeglrv~i 410 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK--------IALEGLRVHI 410 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh--------hhhccccccC
Confidence 1112345889999999876544 479999999999999999999998876543211 1011111111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
. + ....-+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus 411 p------p---gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 P------P---GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred C------C---CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 1 12234678999999999999999999999998764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=226.69 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=199.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|++.+|+|+ .+|.. +++|++|+|++|+|+.. |.+ .++|+.|+|++|.++.++. .+.+|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsL-P~l--p~sL~~L~Ls~N~L~~Lp~----lp~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSL-PVL--PPGLLELSIFSNPLTHLPA----LPSGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcc-cCc--ccccceeeccCCchhhhhh----chhhcCEEECc
Confidence 37899999999999 57753 58999999999999965 432 4689999999999998775 24679999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|++.. +|.. +++|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|... .+|+.|+|++|++..
T Consensus 291 ~N~Lt~--LP~~---p~~L~~LdLS~N~L~~-Lp~l-----p~~L~~L~Ls~N~L~~-LP~lp--~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 291 GNQLTS--LPVL---PPGLQELSVSDNQLAS-LPAL-----PSELCKLWAYNNQLTS-LPTLP--SGLQELSVSDNQLAS 356 (788)
T ss_pred CCcccc--cccc---ccccceeECCCCcccc-CCCC-----cccccccccccCcccc-ccccc--cccceEecCCCccCC
Confidence 999975 6653 4789999999999985 5543 3468899999999984 66422 479999999999886
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
.... ..+|+.|++++|+|+. +|.+ ..+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|++ +|..
T Consensus 357 LP~l-------p~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l- 420 (788)
T PRK15387 357 LPTL-------PSELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML- 420 (788)
T ss_pred CCCC-------Ccccceehhhcccccc-Cccc--ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc-
Confidence 4321 3578899999999996 4543 367999999999999 46754 3679999999999985 4431
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
..+|+.|+|++|+|+
T Consensus 421 ----------------------------------------------------------------~~~L~~L~Ls~NqLt- 435 (788)
T PRK15387 421 ----------------------------------------------------------------PSGLLSLSVYRNQLT- 435 (788)
T ss_pred ----------------------------------------------------------------hhhhhhhhhccCccc-
Confidence 124778999999998
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCC
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l 417 (947)
.+|..++++++|+.|+|++|+|+|.+|..+..+
T Consensus 436 ~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 436 RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 799999999999999999999999988777443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-20 Score=206.45 Aligned_cols=263 Identities=28% Similarity=0.467 Sum_probs=198.7
Q ss_pred CCcCceecccCceEEEEEEEcCCcEEEEEEecccccChH-HHHHHHHHHHHHHcCCCC-CcceEEEEEEeCCeeEEEEEe
Q 002255 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKVRHR-HLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 669 (947)
|...+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999877 7899999987654443 577899999999999988 799999999777778999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~ 748 (947)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666443211 247788889999999999999996 7899999999999999998 799999999986554
Q ss_pred CCCcc----eeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHHhhcCh
Q 002255 749 NGKHS----IETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSE-DSVHLVTWFRRMHINK 820 (947)
Q Consensus 749 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~-~~~~l~~~~~~~~~~~ 820 (947)
..... ......|+..|+|||.+.. ..+....|+||+|++++++++|..||...... ........+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 33221 2355689999999999987 57889999999999999999999997655431 011111111111100
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
....... ..........+.+++.+|+..+|..|.++.+....
T Consensus 234 -----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccC-ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001122456799999999999999999988774
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-22 Score=233.87 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=187.4
Q ss_pred CcCceecccCceEEEEEEEc-CCcEEEEEEec----ccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRME----SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
...+++|.|.+|.|+.+... ..+..+.|.+. ...........+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877533 34444555433 22111222233778888889999999988888777776666679
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||++ +|..++... ..+...++..++.|++.|+.|+|+ .||.|||+|++|+++..+|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999988553 236677788899999999999997 899999999999999999999999999987654
Q ss_pred CCCCc--ceeecccccccccCccccccCCcCc-ccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKH--SIETRLAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
-.... ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+..... ... ... .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----~~~-~~~-~ 544 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----NNY-SDQ-R 544 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----hcc-ccc-c
Confidence 44333 4566788999999999999999986 689999999999999999999766544332100 000 000 0
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .....-....+.....++.++++.+|.+|-++++|++
T Consensus 545 ~~~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIF---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 0000111223345668999999999999999999987
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-23 Score=234.41 Aligned_cols=361 Identities=23% Similarity=0.280 Sum_probs=211.5
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
++..|||++|.+. ..|..+..+.+|+.|+++.|.+...+-+..++.+|++|.|.+|.+...|.+ +..+++|++||+|+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 3788999988877 889999999999999999999987666888999999999999999988876 78899999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEe-------------------ccCceeeeccCcccCCCCCCCccEEEccCCcccCc----
Q 002255 146 NSFDSWVIPESLKDATGLQRFS-------------------ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP---- 202 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~-------------------l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~---- 202 (947)
|++. .+|..+..++.+..+. +..|.+.+.++..+. .+.. .|||.+|.+.-.
T Consensus 124 N~f~--~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~--~l~~--~ldLr~N~~~~~dls~ 197 (1081)
T KOG0618|consen 124 NHFG--PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY--NLTH--QLDLRYNEMEVLDLSN 197 (1081)
T ss_pred hccC--CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh--hhhe--eeecccchhhhhhhhh
Confidence 9995 4665544444444444 444444444444333 1212 255555555411
Q ss_pred ------------------------------------CCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC
Q 002255 203 ------------------------------------IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (947)
Q Consensus 203 ------------------------------------~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (947)
+-..+-..+|++++++.|++.+. +.+++.+.+|+.|...+
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~l----p~wi~~~~nle~l~~n~ 273 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNL----PEWIGACANLEALNANH 273 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcc----hHHHHhcccceEecccc
Confidence 11111113444444444444332 24455555666666666
Q ss_pred CcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCc
Q 002255 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (947)
Q Consensus 247 N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (947)
|+|+..+..+..+.+|+.|++.+|.+. -+|..+..+++|++|+|..|+|...++.++...... ....|..+.......
T Consensus 274 N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~-l~~ln~s~n~l~~lp 351 (1081)
T KOG0618|consen 274 NRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNAS-LNTLNVSSNKLSTLP 351 (1081)
T ss_pred hhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHH-HHHHhhhhccccccc
Confidence 666544444555566666666666666 567777777777777777777764433221111100 000000000000000
Q ss_pred CCCccceeeecccccCChhhhhccCCCCCCCC-CCCCCcccCCCCceeEEEecCCCceeecc-ccccCCccCCeEeccCC
Q 002255 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCN-SDWKGVSCDAGGNITVVNLKNLGLSGTIS-SNFSRLTSLRQLMLSGN 404 (947)
Q Consensus 327 ~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip-~~~~~l~~L~~L~Ls~N 404 (947)
.. .-.....+.+++..++... ..|. ......+|++|+|++|.|. .+| ..+.+|..|+.|+||||
T Consensus 352 ~~-----------~e~~~~~Lq~LylanN~Ltd~c~p--~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGN 417 (1081)
T KOG0618|consen 352 SY-----------EENNHAALQELYLANNHLTDSCFP--VLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGN 417 (1081)
T ss_pred cc-----------cchhhHHHHHHHHhcCcccccchh--hhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccc
Confidence 00 0001122233332222111 1111 1233567888888888777 444 35667777777777777
Q ss_pred ccc----------------------ccCCCcCCCCCCCCccccccccccc-cCCCC---ccceeeecCCCCCCCCCC
Q 002255 405 ELT----------------------GTIPKELTTLPSLEMLDVSNNHLFG-KVPNF---RQNVIVKTDGNPDIGKDS 455 (947)
Q Consensus 405 ~l~----------------------g~iP~~l~~l~~L~~L~ls~N~l~g-~iP~~---~~~~~~~~~~n~~~~~~~ 455 (947)
+|+ -..| ++..++.|+.+|||.|+|+- .+|.. .+...+++.||.+.-.+.
T Consensus 418 kL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~ 493 (1081)
T KOG0618|consen 418 KLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDH 493 (1081)
T ss_pred hhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccch
Confidence 776 1445 66677888999999999863 34432 234467888998754433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=229.83 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=163.0
Q ss_pred CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEec
Q 002255 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (947)
.+.+.|+|+++.++..+..+. +.|+.|+|++|+|+.+|...+ ++|++|+|++|+|+. +|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lts--LP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTS--IPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCChhhc---cCCCEEECCCCcccc--CChhhh--ccccEEEC
Confidence 345667777777665433342 457777777777776665433 467777777777653 555443 35777777
Q ss_pred cCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCc
Q 002255 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (947)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (947)
++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++....... .++|+.|+|++|+
T Consensus 249 s~N~L~-~LP~~l~----s~L~~L~Ls~N~L~-~LP~~l~-~sL~~L~Ls~N~Lt~LP~~l------p~sL~~L~Ls~N~ 315 (754)
T PRK15370 249 SINRIT-ELPERLP----SALQSLDLFHNKIS-CLPENLP-EELRYLSVYDNSIRTLPAHL------PSGITHLNVQSNS 315 (754)
T ss_pred cCCccC-cCChhHh----CCCCEEECcCCccC-ccccccC-CCCcEEECCCCccccCcccc------hhhHHHHHhcCCc
Confidence 777766 5565542 36777777777776 4565554 36777777777666432221 2467888888888
Q ss_pred CcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCC
Q 002255 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (947)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (947)
++..++.+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+. +|..
T Consensus 316 Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~------------------------- 364 (754)
T PRK15370 316 LTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPET------------------------- 364 (754)
T ss_pred cccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChh-------------------------
Confidence 886544332 678888888888884 676664 688888888888863 3321
Q ss_pred CccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccc
Q 002255 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (947)
Q Consensus 329 ~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 408 (947)
...+|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+
T Consensus 365 ---------------------------------------lp~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~- 401 (754)
T PRK15370 365 ---------------------------------------LPPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV- 401 (754)
T ss_pred ---------------------------------------hcCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-
Confidence 0125778888888888 4666654 36888888888888
Q ss_pred cCCCcCC----CCCCCCccccccccccc
Q 002255 409 TIPKELT----TLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 409 ~iP~~l~----~l~~L~~L~ls~N~l~g 432 (947)
.+|..+. .++++..|+|.+|+|+.
T Consensus 402 ~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 402 RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 6665543 35778888888888863
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=223.83 Aligned_cols=329 Identities=20% Similarity=0.276 Sum_probs=221.5
Q ss_pred ccCCChHHHHHHHHHHHHcCCCCC-----CCCCC-CCCCCCc----------------eeEeCCCCcEEEEEecCCcccc
Q 002255 22 VNSQSSSDAAAMQALKTSLGNPAS-----LGWTD-PDPCKWK----------------HIQCSPSNRVTRIQIGGQNIEG 79 (947)
Q Consensus 22 ~~~~~~~~~~~l~~~k~~~~~~~~-----~~w~~-~d~C~w~----------------gv~C~~~~~v~~l~L~~~~l~g 79 (947)
.....+.+.+.+..+.+.+..|.- .+|.+ .|+|.-. -|.|. .+.|+.+...+.-...
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~-~~~vt~l~~~g~~~~~ 135 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG-GKSVTYTRVTESEQAS 135 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC-CCcccccccccccccc
Confidence 345667899999999988877652 24864 5788432 25664 3456666554422111
Q ss_pred cCcccccCCCCCCEEEcc----cCcccCcCC----CC-----CCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 80 TLPKELNSLSSLTVLEVM----KNKLTGQIP----SL-----SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~----~N~l~~~~p----~~-----~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
... +.-+.-.+.... ++.-.+..+ .+ .-..+...|+++++.++.+|... .++|+.|+|++|
T Consensus 136 ~~~---~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~I---p~~L~~L~Ls~N 209 (754)
T PRK15370 136 SAS---GSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACI---PEQITTLILDNN 209 (754)
T ss_pred cCC---CCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCccc---ccCCcEEEecCC
Confidence 110 000000000000 111111111 01 11245789999999999887653 357999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
+|.. +|..+. .+|+.|++++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|++|++....
T Consensus 210 ~Lts--LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~----~~L~~L~Ls~N~L~-~LP~~l~-s~L~~L~Ls~N~L~~LP 278 (754)
T PRK15370 210 ELKS--LPENLQ--GNIKTLYANSNQLT-SIPATLP----DTIQEMELSINRIT-ELPERLP-SALQSLDLFHNKISCLP 278 (754)
T ss_pred CCCc--CChhhc--cCCCEEECCCCccc-cCChhhh----ccccEEECcCCccC-cCChhHh-CCCCEEECcCCccCccc
Confidence 9975 676654 58999999999988 5676553 47999999999998 6777665 47999999999887543
Q ss_pred CCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCC
Q 002255 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306 (947)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 306 (947)
... .++|+.|+|++|+|++.++.+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.+++ +|..
T Consensus 279 ~~l------~~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~--- 343 (754)
T PRK15370 279 ENL------PEELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPAS--- 343 (754)
T ss_pred ccc------CCCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChh---
Confidence 321 2579999999999997654443 57899999999998 4666553 689999999999885 3321
Q ss_pred cccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeec
Q 002255 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTI 386 (947)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~i 386 (947)
..++|+.|+|++|+|+ .+
T Consensus 344 -------------------------------------------------------------l~~sL~~L~Ls~N~L~-~L 361 (754)
T PRK15370 344 -------------------------------------------------------------LPPELQVLDVSKNQIT-VL 361 (754)
T ss_pred -------------------------------------------------------------hcCcccEEECCCCCCC-cC
Confidence 0136889999999998 57
Q ss_pred cccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCc--------cceeeecCCCCCC
Q 002255 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR--------QNVIVKTDGNPDI 451 (947)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~--------~~~~~~~~~n~~~ 451 (947)
|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|... ....+.+.+|+..
T Consensus 362 P~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 362 PETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred Chhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 77663 68999999999999 7887765 36999999999998 455321 1234566777754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-22 Score=207.39 Aligned_cols=240 Identities=22% Similarity=0.321 Sum_probs=185.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCC-CcCCCCCcccccCCCCCcEEe
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDD-NNFTSVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 142 (947)
...++|+|..|+|+..-|.+|..+.+|++||||+|+|+.+-| .|.+|.+|..|.+.+ |+|+.++...|++|.+|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 368999999999996656789999999999999999998888 899999998888776 999999999999999999999
Q ss_pred ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCccc------------CcCCccccC-
Q 002255 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ------------GPIPLSFGK- 209 (947)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~------------~~~p~~~~~- 209 (947)
+.-|++.. .....|..|++|..|.+.+|.+...--..+. .+..++++.+..|.+- -..|.+++.
T Consensus 147 lNan~i~C-ir~~al~dL~~l~lLslyDn~~q~i~~~tf~--~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsga 223 (498)
T KOG4237|consen 147 LNANHINC-IRQDALRDLPSLSLLSLYDNKIQSICKGTFQ--GLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGA 223 (498)
T ss_pred cChhhhcc-hhHHHHHHhhhcchhcccchhhhhhcccccc--chhccchHhhhcCccccccccchhhhHHhhchhhcccc
Confidence 99999987 6778999999999999999999833333555 5778888888888721 111222111
Q ss_pred ----------------------CCCcee--eeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCE
Q 002255 210 ----------------------SSIQTL--WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQD 264 (947)
Q Consensus 210 ----------------------~~L~~L--~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~ 264 (947)
..++.+ .++.+..-.. ......|..+++|+.|+|++|+++++-+ .|.+...++.
T Consensus 224 rc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~-~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e 302 (498)
T KOG4237|consen 224 RCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS-ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE 302 (498)
T ss_pred eecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC-cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence 111111 1111111111 1112347789999999999999998766 4888999999
Q ss_pred EEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcc
Q 002255 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR 308 (947)
Q Consensus 265 L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 308 (947)
|.|..|+|...--..|.++..|+.|+|.+|+|+...|..+....
T Consensus 303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~ 346 (498)
T KOG4237|consen 303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF 346 (498)
T ss_pred hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccc
Confidence 99999999877777788899999999999999988887665444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-20 Score=232.50 Aligned_cols=306 Identities=20% Similarity=0.216 Sum_probs=224.4
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCc-CCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 143 (947)
..++.|.+.++.+. .+|..+ ...+|+.|+|.+|++......+..+++|+.|+|++|. +..++ . +..+++|++|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~-ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIP-D-LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCC-c-cccCCcccEEEe
Confidence 35788888888776 788777 5799999999999998665578899999999999875 45554 3 788999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCC
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~ 223 (947)
++|.... .+|..++++++|+.|++++|...+.+|..+ .+++|++|+|++|...+.+|... .+|+.|+|++|.+.
T Consensus 665 ~~c~~L~-~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i---~l~sL~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 665 SDCSSLV-ELPSSIQYLNKLEDLDMSRCENLEILPTGI---NLKSLYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIE 738 (1153)
T ss_pred cCCCCcc-ccchhhhccCCCCEEeCCCCCCcCccCCcC---CCCCCCEEeCCCCCCcccccccc--CCcCeeecCCCccc
Confidence 9987544 689999999999999999988777888876 48999999999998777777543 57999999999876
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCcCcCC-------CCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCc
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGP-------LPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-------~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 295 (947)
..... ..+++|+.|++.++..... .+. ....++|+.|+|++|...+.+|.+++++++|+.|+|++|.
T Consensus 739 ~lP~~-----~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 739 EFPSN-----LRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred ccccc-----ccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 54322 1477888888877443221 111 2235789999999998888999999999999999999986
Q ss_pred ccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEE
Q 002255 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375 (947)
Q Consensus 296 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L 375 (947)
.-+.+|..... .++..++.... ..... ......+|+.|
T Consensus 814 ~L~~LP~~~~L--------~sL~~L~Ls~c------------------------------~~L~~----~p~~~~nL~~L 851 (1153)
T PLN03210 814 NLETLPTGINL--------ESLESLDLSGC------------------------------SRLRT----FPDISTNISDL 851 (1153)
T ss_pred CcCeeCCCCCc--------cccCEEECCCC------------------------------Ccccc----ccccccccCEe
Confidence 55566653210 00000000000 00000 01122467788
Q ss_pred EecCCCceeeccccccCCccCCeEeccC-CcccccCCCcCCCCCCCCcccccccc
Q 002255 376 NLKNLGLSGTISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSNNH 429 (947)
Q Consensus 376 ~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~ls~N~ 429 (947)
+|++|.++ .+|.+++++++|+.|+|++ |+|. .+|..+..+++|+.|+++++.
T Consensus 852 ~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 852 NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 88888887 5777888888888888887 4444 677778888888888887764
|
syringae 6; Provisional |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=190.09 Aligned_cols=175 Identities=15% Similarity=0.171 Sum_probs=135.9
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChH-HHHH------HHHHHHHHHcCCCCCcceEEEEEE
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK-GFAE------FKSEIAVLTKVRHRHLVGLLGYCL 658 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~l~~~~~ 658 (947)
..+.++|...+++|.|+||.||.+.. ++..+|+|.+........ ..+. +.+|++.+.+++|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999766 577899999976543322 2223 679999999999999999998866
Q ss_pred eC--------CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc
Q 002255 659 DG--------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (947)
Q Consensus 659 ~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 730 (947)
.. ...++||||++|.+|.++.. ++. ....+++.++..+|. .+++|||+||+||+++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 43 35789999999999977631 121 245699999999996 8999999999999999
Q ss_pred CCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHH
Q 002255 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELI 792 (947)
Q Consensus 731 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 792 (947)
.++ ++++|||..+........ ..+.....++.++|+|+|||.+.-+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987654221110 11445566778999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=187.17 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=108.7
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccChHH------------------------HHHHHHHHHHHHcCCCCCc
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKG------------------------FAEFKSEIAVLTKVRHRHL 650 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 650 (947)
...||+|+||.||+|...+|+.||||+++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998888999999999765321111 1122459999999988877
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHH-hhccCCCeeecCCCCCcEEE
Q 002255 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 651 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDlkp~Nill 729 (947)
.....+.. ...++||||++++++....... ..++..+..+++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 54433322 2238999999887765443211 3478888999999999999999 55 799999999999999
Q ss_pred cCCCcEEEeecCcceec
Q 002255 730 GDDMRAKVADFGLVRLA 746 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~ 746 (947)
+ ++.++++|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 578999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.9e-19 Score=222.88 Aligned_cols=315 Identities=17% Similarity=0.143 Sum_probs=230.8
Q ss_pred CcEEEEEecCC------cccccCcccccCCC-CCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCC
Q 002255 65 NRVTRIQIGGQ------NIEGTLPKELNSLS-SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137 (947)
Q Consensus 65 ~~v~~l~L~~~------~l~g~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 137 (947)
.++..|.+..+ ++...+|..|..++ +|+.|.+.+|.+...+..| .+.+|++|+|.+|++..++.. +..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCC
Confidence 35666666543 34557788887775 6999999999987665555 579999999999999987665 678999
Q ss_pred CcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeee
Q 002255 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWL 217 (947)
Q Consensus 138 L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l 217 (947)
|++|+|++|.... .+| .+..+++|+.|+|++|.....+|..+. .+++|+.|+|++|...+.+|..+...+|+.|+|
T Consensus 636 Lk~L~Ls~~~~l~-~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~--~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~L 711 (1153)
T PLN03210 636 LRNIDLRGSKNLK-EIP-DLSMATNLETLKLSDCSSLVELPSSIQ--YLNKLEDLDMSRCENLEILPTGINLKSLYRLNL 711 (1153)
T ss_pred CCEEECCCCCCcC-cCC-ccccCCcccEEEecCCCCccccchhhh--ccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeC
Confidence 9999999876433 455 488999999999999988889999988 799999999999876678888877789999999
Q ss_pred ccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCcc-------ccCCCccccCCCCCCeEe
Q 002255 218 NGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQL-------TGIVPSSLVNLHSLAVVN 290 (947)
Q Consensus 218 ~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l-------~g~~p~~l~~l~~L~~L~ 290 (947)
++|.....++. ..++|+.|+|++|.++.. |....+++|++|++.++.. ....|......++|+.|+
T Consensus 712 sgc~~L~~~p~------~~~nL~~L~L~~n~i~~l-P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 712 SGCSRLKSFPD------ISTNISWLDLDETAIEEF-PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784 (1153)
T ss_pred CCCCCcccccc------ccCCcCeeecCCCccccc-cccccccccccccccccchhhccccccccchhhhhccccchhee
Confidence 99864333322 246899999999999754 4444688899999887432 212222333457899999
Q ss_pred ccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCC
Q 002255 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370 (947)
Q Consensus 291 Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 370 (947)
|++|...+.+|..+..+. ++..++..... ....+. ....+.
T Consensus 785 Ls~n~~l~~lP~si~~L~-------~L~~L~Ls~C~------------------------------~L~~LP--~~~~L~ 825 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLH-------KLEHLEIENCI------------------------------NLETLP--TGINLE 825 (1153)
T ss_pred CCCCCCccccChhhhCCC-------CCCEEECCCCC------------------------------CcCeeC--CCCCcc
Confidence 999998888886533221 11111111000 000000 001345
Q ss_pred ceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccc-ccccccCCC
Q 002255 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN-NHLFGKVPN 436 (947)
Q Consensus 371 ~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~-N~l~g~iP~ 436 (947)
+|+.|+|++|..-..+|.. .++|+.|+|++|.++ .+|.++..+++|++|+|++ |+|.+ +|.
T Consensus 826 sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~ 887 (1153)
T PLN03210 826 SLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSL 887 (1153)
T ss_pred ccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc-cCc
Confidence 7899999998766666653 367999999999998 8999999999999999998 55554 554
|
syringae 6; Provisional |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=179.33 Aligned_cols=144 Identities=21% Similarity=0.222 Sum_probs=111.5
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccCh------------------------HHHHHHHHHHHHHHcCCCCCc
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE------------------------KGFAEFKSEIAVLTKVRHRHL 650 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~ni 650 (947)
...||+|+||.||+|...+|+.||||+++...... .....+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999988789999999987652110 001234689999999999988
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc
Q 002255 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (947)
Q Consensus 651 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 730 (947)
.....+... ..++||||++++++....... ..++..+...++.|++.++.|+|+ ..+|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 655444333 248999999888654332111 235677888999999999999995 37999999999999999
Q ss_pred CCCcEEEeecCcceecCC
Q 002255 731 DDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 731 ~~~~~kl~DfGla~~~~~ 748 (947)
++.++|+|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999986644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=174.77 Aligned_cols=190 Identities=18% Similarity=0.153 Sum_probs=141.1
Q ss_pred CcCceecccCceEEEEEEEcCCcEEEEEEecccccC--hHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEEe
Q 002255 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
.+...|++|+||+||.+.. .+.+++.+.+.....- ......+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998766 5788888877654321 112235889999999995 5889999886 346999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCC-CCCcEEEcCCCcEEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
++|.+|.+.+.. ....++.|++++|+++|+ .||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998654311 113467899999999996 89999999 79999999999999999999986554
Q ss_pred CCCc----ce-------eecccccccccCccccccC-CcC-cccccccHHHHHHHHHhCCCCCCccC
Q 002255 749 NGKH----SI-------ETRLAGTFGYLAPEYAVTG-RVT-TKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 749 ~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
.... .. ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.+.....
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 3321 00 0112367788888743221 222 46788999999999999998876544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.7e-19 Score=183.70 Aligned_cols=235 Identities=24% Similarity=0.341 Sum_probs=152.7
Q ss_pred CCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCC----------CCcceEEEEEE-
Q 002255 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRH----------RHLVGLLGYCL- 658 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~- 658 (947)
+...+.||.|+++.||.+++. +|+++|||++.... ......+++.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345689999999999999876 58999999886543 223456788888766666433 12222222221
Q ss_pred --------eC---C-----eeEEEEEecCCCchhhhhhc---ccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeee
Q 002255 659 --------DG---N-----ERLLVYEYMPQGTLSRHLFN---RKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIH 719 (947)
Q Consensus 659 --------~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 719 (947)
.. . ..+++|+-+ .++|.+++.. .... ...+....++.+..|+++.+++||+ .|+||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 1 236788876 6788777532 2111 1234555667788999999999997 89999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCcccccc--------CCcCcccccccHHHHHHHH
Q 002255 720 RDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT--------GRVTTKVDVFSFGVILMEL 791 (947)
Q Consensus 720 rDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~el 791 (947)
+||||+|++++.+|.++|+||+.....+.. ... ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999987765432 111 244578999997643 2478899999999999999
Q ss_pred HhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCC
Q 002255 792 ITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQR 859 (947)
Q Consensus 792 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 859 (947)
.+|+.||+...+..... . .+.... ..++.+..||..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~-------------~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE-------------W---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG-------------G---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc-------------c---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999998664332110 0 111122 556678899999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-20 Score=201.98 Aligned_cols=227 Identities=25% Similarity=0.334 Sum_probs=178.7
Q ss_pred eecccCceEEEEEE----EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEEecC
Q 002255 597 VLGRGGFGTVYKGE----LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
++|+|+||.|+.++ .+.|..+|+|..++.............|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999763 345778899988765332222225567888899997 9999999999999999999999999
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCC
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+|+|...+.... .+...........++-+++++|+ .+|+|||+|++||+++.+|.+++.|||+++..-+...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988775432 35556666667788999999995 8999999999999999999999999999986644322
Q ss_pred cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
.+||..|||||++. ....++|.||||++.+||+||..||.. +..+.+...++
T Consensus 153 ------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~~~ 204 (612)
T KOG0603|consen 153 ------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKAEL 204 (612)
T ss_pred ------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhhcc
Confidence 18999999999987 677899999999999999999999975 11222333232
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
. .+........+++.++...+|..|...
T Consensus 205 ~---~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 E---MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred C---CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2 233444556789999999999999866
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=207.96 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=179.0
Q ss_pred CCCcCceecccCceEEEEEEEcCCcEEEEEEecccc--cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAV--VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+|...+.||++.|=+|.+|++++|. |+||++-+.. .+-....+...|++ ...++|||.+++.-+...+..-|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677789999999999999998877 8999886543 22233445555666 666699999999888777777789989
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee--c
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--A 746 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~--~ 746 (947)
|+.. +|+|.+..+. .+...+..=|+.|++.||..+|. .+|+|||||.+||||+.-.=+.|+||..-+. .
T Consensus 102 yvkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 9854 8988886543 36667777799999999999995 8999999999999999999999999976442 2
Q ss_pred CCCCCcce---eecccccccccCccccccC-----------CcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002255 747 PDNGKHSI---ETRLAGTFGYLAPEYAVTG-----------RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811 (947)
Q Consensus 747 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~ 811 (947)
+.+..... ......-..|.|||.+... ..+++-||||+||+++||++ |+++|.-.+ +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 22211111 0111122469999987541 15678999999999999998 677775321 111
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
+-..-.. ..+.+-+.+. + ..+..++..|++.||++|.++.+.++.-+.
T Consensus 247 Yr~~~~~----~~e~~Le~Ie-d-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSGNAD----DPEQLLEKIE-D-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhccCcc----CHHHHHHhCc-C-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1111011 1111111111 0 136789999999999999999999997443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=191.84 Aligned_cols=218 Identities=24% Similarity=0.414 Sum_probs=161.0
Q ss_pred HHcCCCCCcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecC
Q 002255 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (947)
Q Consensus 642 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 721 (947)
|+.+.|.|+.+++|.+.++.+.+.|.+||..|+|.+.+... ...++|.....+.++|+.||+|+|+ ..-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence 35789999999999999999999999999999999999663 2458999999999999999999997 23339999
Q ss_pred CCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccC-------CcCcccccccHHHHHHHHHhC
Q 002255 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-------RVTTKVDVFSFGVILMELITG 794 (947)
Q Consensus 722 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~elltg 794 (947)
+++.|++++..+.+|++|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999997765431111111112234569999988653 146789999999999999999
Q ss_pred CCCCCccCccch-hhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 795 RKALDETQSEDS-VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 795 ~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+.||+....... ..++.++.. .....++.. +. ... ....++..++..||..+|.+||++..|...++.+.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~----i~--~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK--GGSNPFRPS----IE--LLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHh--cCCCCcCcc----hh--hhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999986543222 122222221 001111111 11 000 22336789999999999999999999999887765
Q ss_pred h
Q 002255 874 E 874 (947)
Q Consensus 874 ~ 874 (947)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 3
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.5e-21 Score=195.81 Aligned_cols=310 Identities=20% Similarity=0.230 Sum_probs=210.8
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC-
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY- 145 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~- 145 (947)
..++.++.+|+ .+|..+- ..-+.+.|..|+|+.++| .|+.+++|+.|||++|+|+.|-|.+|..|.+|..|-+.+
T Consensus 49 ~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 49 GIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred ceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 34666777777 7776554 467889999999998887 899999999999999999999999999999988877765
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCc-cccCCCCceeeeccCCCCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~L~l~~n~~~~ 224 (947)
|+|+. .....|++|..|+.|.++-|++.....+.|. .+++|..|.|..|.+. .++. .|
T Consensus 126 NkI~~-l~k~~F~gL~slqrLllNan~i~Cir~~al~--dL~~l~lLslyDn~~q-~i~~~tf----------------- 184 (498)
T KOG4237|consen 126 NKITD-LPKGAFGGLSSLQRLLLNANHINCIRQDALR--DLPSLSLLSLYDNKIQ-SICKGTF----------------- 184 (498)
T ss_pred Cchhh-hhhhHhhhHHHHHHHhcChhhhcchhHHHHH--Hhhhcchhcccchhhh-hhccccc-----------------
Confidence 88976 3346788899999999999999887777777 6888888888888887 4443 33
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
..+.+++.+.+..|.+-- .++++.+... + ...|..++...-.....|.++++...-+.-+
T Consensus 185 ---------~~l~~i~tlhlA~np~ic----dCnL~wla~~-~------a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf 244 (498)
T KOG4237|consen 185 ---------QGLAAIKTLHLAQNPFIC----DCNLPWLADD-L------AMNPIETSGARCVSPYRLYYKRINQEDARKF 244 (498)
T ss_pred ---------cchhccchHhhhcCcccc----ccccchhhhH-H------hhchhhcccceecchHHHHHHHhcccchhhh
Confidence 346777777777776431 2222222211 1 1222233333333444444444432221100
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
. .+...+.....+.......-...-+..+++|+.|+|++|+|++
T Consensus 245 ~------------------------------------c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~ 288 (498)
T KOG4237|consen 245 L------------------------------------CSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR 288 (498)
T ss_pred h------------------------------------hhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence 0 0000000000011000000011123456789999999999999
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccce----eeecCCCCCCCCCCCC
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV----IVKTDGNPDIGKDSSS 457 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~----~~~~~~n~~~~~~~~~ 457 (947)
+-+.+|..+.+|++|+|..|+|.-.--..|.++..|+.|+|.+|+++..-|-.++.. .+.+-+|||.|.....
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 999999999999999999999984445668889999999999999998888665543 3457799999987643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=179.26 Aligned_cols=198 Identities=26% Similarity=0.342 Sum_probs=138.3
Q ss_pred CCCCcceEEEEEEe---------------------------CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHH
Q 002255 646 RHRHLVGLLGYCLD---------------------------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTI 698 (947)
Q Consensus 646 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i 698 (947)
+|||||++.++|.+ ....|+||... ..+|.+++..+. .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC------CchHHHHHH
Confidence 59999999987753 12568999866 568999986543 344556667
Q ss_pred HHHHHHHHHHHhhccCCCeeecCCCCCcEEEc--CC--CcEEEeecCcceecCCCC----CcceeecccccccccCcccc
Q 002255 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DD--MRAKVADFGLVRLAPDNG----KHSIETRLAGTFGYLAPEYA 770 (947)
Q Consensus 699 ~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~--~~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~ 770 (947)
+.|+++|+.|||. ++|.|||+|++|||+. +| ..+.|+|||.+--....+ .........|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 8899999999994 9999999999999993 34 358899999864222111 01112234678889999987
Q ss_pred ccCC-----c-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHH
Q 002255 771 VTGR-----V-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTV 844 (947)
Q Consensus 771 ~~~~-----~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 844 (947)
...+ . -.|+|.|+.|.+.||+++...||....+.- .+...+++. ..+..+...+..+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~------------L~~r~Yqe~-----qLPalp~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML------------LDTRTYQES-----QLPALPSRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe------------echhhhhhh-----hCCCCcccCChHH
Confidence 6432 1 248999999999999999999998643211 111111111 1122223344567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 845 ADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 845 ~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
.+++...++.||.+|++..-+...|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 79999999999999999877766654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-20 Score=211.39 Aligned_cols=264 Identities=27% Similarity=0.353 Sum_probs=191.0
Q ss_pred CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEec
Q 002255 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (947)
++|+.|+.+.|.++...+.+ .-.+|+++++++|+++.+| ++++.+.+|+.|+..+|++. .+|..+..+++|++|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~~p-~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~--~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVHP-VPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV--ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecccc-ccccceeeecchhhhhcch-HHHHhcccceEecccchhHH--hhHHHHhhhhhHHHHHh
Confidence 34555555555555222222 2356888888888888888 88888888888888888885 48888888888888888
Q ss_pred cCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC---CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEcc
Q 002255 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK---SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (947)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (947)
..|.+. .+|.... .++.|++|+|..|+|. ..|..+-. ..+..|+.+.|.+.......- ..++.|+.|+|.
T Consensus 295 ~~nel~-yip~~le--~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e---~~~~~Lq~Lyla 367 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLE--GLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE---NNHAALQELYLA 367 (1081)
T ss_pred hhhhhh-hCCCccc--ccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccc---hhhHHHHHHHHh
Confidence 888887 5666665 5788999999999987 55554322 335566666565544432111 135678999999
Q ss_pred CCcCcC-CCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCC
Q 002255 246 GNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324 (947)
Q Consensus 246 ~N~l~~-~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 324 (947)
+|.|+. .+|.+.++.+|+.|+|++|+|.......+.++..|+.|+||+|+|+.. |..
T Consensus 368 nN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-p~t--------------------- 425 (1081)
T KOG0618|consen 368 NNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-PDT--------------------- 425 (1081)
T ss_pred cCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh-hHH---------------------
Confidence 999998 456789999999999999999844445578899999999999999842 221
Q ss_pred CcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCC
Q 002255 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN 404 (947)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N 404 (947)
...++.|++|..-+|+|. ..| .+.+++.|+.+|||.|
T Consensus 426 -----------------------------------------va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 426 -----------------------------------------VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCN 462 (1081)
T ss_pred -----------------------------------------HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccc
Confidence 112345777888888887 677 7888888888888888
Q ss_pred ccc-ccCCCcCCCCCCCCcccccccc
Q 002255 405 ELT-GTIPKELTTLPSLEMLDVSNNH 429 (947)
Q Consensus 405 ~l~-g~iP~~l~~l~~L~~L~ls~N~ 429 (947)
+|+ +.+|...-. ++|++|||++|.
T Consensus 463 ~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 463 NLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred hhhhhhhhhhCCC-cccceeeccCCc
Confidence 887 334433332 788888888887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=167.87 Aligned_cols=136 Identities=19% Similarity=0.235 Sum_probs=104.2
Q ss_pred CCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-----CCCCcceEEEEEEeCC---e-
Q 002255 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-----RHRHLVGLLGYCLDGN---E- 662 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~- 662 (947)
+...++||+|+||.||. .-.++.. +||++.... ....+.+.+|+++++++ .||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34568899999999996 2234444 799886542 23456799999999999 5799999999998864 3
Q ss_pred eEEEEEe--cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHH-HHHhhccCCCeeecCCCCCcEEEcC----CCcE
Q 002255 663 RLLVYEY--MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV-EYLHGLAHQSFIHRDLKPSNILLGD----DMRA 735 (947)
Q Consensus 663 ~~lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivHrDlkp~Nill~~----~~~~ 735 (947)
..+|+|| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+ ++||||||||+|||++. ++.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcE
Confidence 3378999 5579999999542 14443 35677888777 99996 89999999999999974 3489
Q ss_pred EEeecCc
Q 002255 736 KVADFGL 742 (947)
Q Consensus 736 kl~DfGl 742 (947)
+|+||+.
T Consensus 149 ~LiDg~G 155 (210)
T PRK10345 149 VVCDNIG 155 (210)
T ss_pred EEEECCC
Confidence 9999543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.2e-18 Score=199.01 Aligned_cols=196 Identities=22% Similarity=0.250 Sum_probs=155.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC---CCCcceEEEEEEeCCeeE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 664 (947)
-.+.|.+.+.||+|+||.||+|...+|+.||+|+-+....- +|.-=.+++.+|+ -+.|..+..++.-.+.-+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34678889999999999999999888999999987655321 2222223444444 244555666666677889
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-------CCcEEE
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------DMRAKV 737 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-------~~~~kl 737 (947)
||+||.+.|+|.+++. ..+.++|...+.++.|+++.+++||. .+|||+||||+|+|+.. ...++|
T Consensus 771 lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999985 33568999999999999999999996 89999999999999953 356999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCC
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 796 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 796 (947)
+|||.+-.+.--..........+|-.+-.+|...++.++...|.|.++.+++-|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998754322111223445678899999999999999999999999999999999874
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-19 Score=165.86 Aligned_cols=137 Identities=22% Similarity=0.390 Sum_probs=97.3
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.++|.|.|++|.++ .+|+.+++|.+|+.|++++|++...+++++.+++|+.|+++-|++..+|.. |+.++.|+.|||.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg-fgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc-cCCCchhhhhhcc
Confidence 36777778887777 777777888888888888888877777777788888888877777766655 7777788888888
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccc
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (947)
+|++..-.+|..|..++.|+.|+|++|.+. .+|..++ .+++|+.|.+..|.+. .+|..+
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg--~lt~lqil~lrdndll-~lpkei 169 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG--KLTNLQILSLRDNDLL-SLPKEI 169 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh--hhcceeEEeeccCchh-hCcHHH
Confidence 877776666777767777777777666665 5555555 5666666666666655 445443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-18 Score=194.98 Aligned_cols=215 Identities=27% Similarity=0.410 Sum_probs=153.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|..++.|..|+||.||.++++ +.+.+|+|+ .+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-------hhhhc--cccccCCccee-----------------
Confidence 57888899999999999999876 467788854 3221 00110 22222333333
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+....+... .+++. +++.+++|+|+ .+|||||+||+|.+|+.-|++|++|||+++....
T Consensus 136 ----gDc~tllk~~-----g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-----GPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhcccC-----CCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 5555555321 22222 23789999996 8999999999999999999999999999864321
Q ss_pred CCCc-------------ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002255 749 NGKH-------------SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 749 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~ 815 (947)
.... -....++||+.|.|||++....|...+|.|++|+|+||.+.|..||.+..+++
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---------- 265 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---------- 265 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH----------
Confidence 1110 01234689999999999999999999999999999999999999999876532
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+..++...+..++..+....+.++++.++|+.+|.+|.-....++
T Consensus 266 ------lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 266 ------LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred ------HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 2333343344444555666678899999999999999985554444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-17 Score=168.50 Aligned_cols=144 Identities=17% Similarity=0.149 Sum_probs=110.5
Q ss_pred CCCcCceecccCceEEEEEE--EcCCcEEEEEEecccccCh----------------------HHHHHHHHHHHHHHcCC
Q 002255 591 NFSEENVLGRGGFGTVYKGE--LHDGTKIAVKRMESAVVSE----------------------KGFAEFKSEIAVLTKVR 646 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 646 (947)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++...... .....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 4689999999987542110 01134678999999997
Q ss_pred CCC--cceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC-eeecCCC
Q 002255 647 HRH--LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS-FIHRDLK 723 (947)
Q Consensus 647 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlk 723 (947)
+.. +.+++++ ...++||||+++++|....... ......+...++.|++.+++|||+ .+ |+|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCC
Confidence 633 3444443 2358999999998886654221 224455667899999999999996 78 9999999
Q ss_pred CCcEEEcCCCcEEEeecCcceecC
Q 002255 724 PSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 724 p~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|+||+++ ++.++++|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999887543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-19 Score=164.00 Aligned_cols=163 Identities=28% Similarity=0.477 Sum_probs=124.2
Q ss_pred CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCC
Q 002255 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186 (947)
Q Consensus 107 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 186 (947)
.+..++..+.|.||+|+++.+||. +..|.+|+.|++++|+|+. +|.+++.+++|+.|++.-|.+. .+|..|+ .+
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppn-ia~l~nlevln~~nnqie~--lp~~issl~klr~lnvgmnrl~-~lprgfg--s~ 101 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPN-IAELKNLEVLNLSNNQIEE--LPTSISSLPKLRILNVGMNRLN-ILPRGFG--SF 101 (264)
T ss_pred cccchhhhhhhhcccCceeecCCc-HHHhhhhhhhhcccchhhh--cChhhhhchhhhheecchhhhh-cCccccC--CC
Confidence 344455555555666666666555 5566666666666666653 6666666666666666666665 6788887 78
Q ss_pred CCccEEEccCCcccC-cCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEE
Q 002255 187 PGLMHLHLAFNFLQG-PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDF 265 (947)
Q Consensus 187 ~~L~~L~Ls~N~l~~-~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 265 (947)
|.|+.|||.+|++.. .+|..| ..++.|+.|+|++|.|.-.+|+++.+++|+.|
T Consensus 102 p~levldltynnl~e~~lpgnf--------------------------f~m~tlralyl~dndfe~lp~dvg~lt~lqil 155 (264)
T KOG0617|consen 102 PALEVLDLTYNNLNENSLPGNF--------------------------FYMTTLRALYLGDNDFEILPPDVGKLTNLQIL 155 (264)
T ss_pred chhhhhhccccccccccCCcch--------------------------hHHHHHHHHHhcCCCcccCChhhhhhcceeEE
Confidence 888888888888863 445443 23788999999999999888899999999999
Q ss_pred EccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 266 SVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 266 ~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
.+++|.+- .+|..++.++.|+.|++.+|+++-.+|+
T Consensus 156 ~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 156 SLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred eeccCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 99999998 8999999999999999999999977775
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=161.91 Aligned_cols=147 Identities=21% Similarity=0.173 Sum_probs=112.6
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccCh--------------------HHHHHHHHHHHHHH
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE--------------------KGFAEFKSEIAVLT 643 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~ 643 (947)
++......|...+.||+|+||.||++..++|+.||||++....... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333334488889999999999999988889999999876432110 01123678999999
Q ss_pred cCCCCC--cceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecC
Q 002255 644 KVRHRH--LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (947)
Q Consensus 644 ~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 721 (947)
++.|++ ++..++. ...++||||+++++|.+.... .....++.+++.++.++|+ .+|+|||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 998874 4444432 345899999999998765320 2345688999999999996 8999999
Q ss_pred CCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 722 LKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 722 lkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|||+||++++++.++|+|||.+.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.2e-19 Score=195.30 Aligned_cols=280 Identities=21% Similarity=0.232 Sum_probs=179.9
Q ss_pred EEEecCCccc-ccCcccccCCCCCCEEEcccCcccCc----CC-CCCCCCCCcEEecCCCcCCC------CCcccccCCC
Q 002255 69 RIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQ----IP-SLSGLSSLQEVLFDDNNFTS------VPSDFFKGLT 136 (947)
Q Consensus 69 ~l~L~~~~l~-g~~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~ 136 (947)
.|+|..+.++ +.....+..+..|+.|+++++.++.. ++ .+...+.|++|+++++.+.+ ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3667777776 34455566677788888888877542 23 45566778888888877763 2223456677
Q ss_pred CCcEEeccCCCCCCCCCcccccCCCC---CCeEeccCceeee----ccCcccCCCCC-CCccEEEccCCcccCcCCcccc
Q 002255 137 SLQTISLDYNSFDSWVIPESLKDATG---LQRFSANGANITG----TIPDFLGGDTI-PGLMHLHLAFNFLQGPIPLSFG 208 (947)
Q Consensus 137 ~L~~L~Ls~N~l~~~~~p~~~~~l~~---L~~L~l~~n~l~~----~~p~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~ 208 (947)
+|++|+|++|.+.. ..+..+..+.+ |++|++++|++++ .+...+. .+ ++|+.|+|++|.+++.....+
T Consensus 82 ~L~~L~l~~~~~~~-~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~--~~~~~L~~L~L~~n~l~~~~~~~~- 157 (319)
T cd00116 82 GLQELDLSDNALGP-DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK--DLPPALEKLVLGRNRLEGASCEAL- 157 (319)
T ss_pred ceeEEEccCCCCCh-hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH--hCCCCceEEEcCCCcCCchHHHHH-
Confidence 88888888877753 34444444444 7777777777763 2222232 34 677777777777774322221
Q ss_pred CCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCC-----CCCCCCCCCCEEEccCCccccC----CCcc
Q 002255 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL-----PDLSGLSSLQDFSVRDNQLTGI----VPSS 279 (947)
Q Consensus 209 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~g~----~p~~ 279 (947)
...+..+..|+.|+|++|.+++.. ..+..+++|+.|+|++|.+++. ++..
T Consensus 158 ---------------------~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 158 ---------------------AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred ---------------------HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 123445678888888888887521 1244567888888888888643 3455
Q ss_pred ccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCC
Q 002255 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (947)
Q Consensus 280 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~ 359 (947)
+.++++|++|++++|++++.....+ ...
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~l---------------------------------~~~------------------- 244 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAAL---------------------------------ASA------------------- 244 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHHH---------------------------------HHH-------------------
Confidence 6678889999999988774211100 000
Q ss_pred CCCCcccCCCCceeEEEecCCCce----eeccccccCCccCCeEeccCCccccc----CCCcCCCC-CCCCccccccccc
Q 002255 360 DWKGVSCDAGGNITVVNLKNLGLS----GTISSNFSRLTSLRQLMLSGNELTGT----IPKELTTL-PSLEMLDVSNNHL 430 (947)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~----g~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l-~~L~~L~ls~N~l 430 (947)
.......|+.|++++|.++ +.+...+..+++|++|++++|.++.. +...+-.. +.|+.|++.+|.+
T Consensus 245 -----~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 245 -----LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred -----HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 0001236888888888887 24556677778899999999999844 45555555 6888888888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=162.79 Aligned_cols=136 Identities=23% Similarity=0.362 Sum_probs=114.1
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccCh------HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+.||+|++|.||+|.. .|..|++|+........ .....+.+|++++..++|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57889999866432211 1234678899999999999998888887778888999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
++|++|.+++... .+ ++..++.+++.+|.++|+ .+++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887431 12 778899999999999996 8999999999999999 88999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-17 Score=180.63 Aligned_cols=174 Identities=29% Similarity=0.408 Sum_probs=131.7
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...|+.|++|+..+|.+++.++... ...+|.....++.|++.|++| ++.+|||+||.||++..+..+||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence 3578999999999999999754433 346788899999999999999 47999999999999999999999999
Q ss_pred CcceecCCCC----CcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002255 741 GLVRLAPDNG----KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 741 Gla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~ 815 (947)
|+........ .....+..+||..||+||.+.+..|+.|+||||||++|+|++. -.-+++.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------- 465 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------- 465 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------------
Confidence 9987665543 1223456789999999999999999999999999999999998 2222211
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
...+.++-+..+ ++......++-+.|+.+++...|.+||++.
T Consensus 466 ----~~t~~d~r~g~i--p~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 466 ----IATLTDIRDGII--PPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred ----HHhhhhhhcCCC--ChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 111222222222 222222333446899999999999999433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=159.11 Aligned_cols=132 Identities=23% Similarity=0.364 Sum_probs=107.5
Q ss_pred eecccCceEEEEEEEcCCcEEEEEEecccccC------hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEec
Q 002255 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
.||+|+||.||+|.+. |..|++|........ .....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999864 788999986543211 112356788999999999987766666666677789999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
+|++|.+.+.... . .++.+++.+|+++|+ .+++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988774311 0 689999999999996 8999999999999999 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.2e-16 Score=182.18 Aligned_cols=141 Identities=23% Similarity=0.318 Sum_probs=113.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccC------hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 661 (947)
....|...+.||+|+||.||+|.+.. ..+++|+....... ....+++.+|++++++++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34455678999999999999998764 34444433221111 122356889999999999999998888888777
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++++|.+++. ....++.|++++|.|||+ .+++||||||+||++ .++.++|+|||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 8899999999999988773 346789999999999996 899999999999999 67899999999
Q ss_pred cceec
Q 002255 742 LVRLA 746 (947)
Q Consensus 742 la~~~ 746 (947)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.2e-16 Score=182.16 Aligned_cols=132 Identities=30% Similarity=0.584 Sum_probs=100.9
Q ss_pred CCChHHHHHHHHHHHHcCCCCCCCCCCCCCC-----CCceeEeCCC-----CcEEEEEecCCcccccCcccccCCCCCCE
Q 002255 24 SQSSSDAAAMQALKTSLGNPASLGWTDPDPC-----KWKHIQCSPS-----NRVTRIQIGGQNIEGTLPKELNSLSSLTV 93 (947)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~~~w~~~d~C-----~w~gv~C~~~-----~~v~~l~L~~~~l~g~~p~~l~~l~~L~~ 93 (947)
.+.+.|.+||+++|+++.++...+|.+ |+| .|.||.|+.. .+|+.|+|+++++.|.+|+.++.|++|+.
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 455679999999999998776568976 455 6999999531 25889999999999999999999999999
Q ss_pred EEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccc
Q 002255 94 LEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESL 157 (947)
Q Consensus 94 L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~ 157 (947)
|+|++|.|.|.+| .+..+++|+.|+|++|++++.+|..+++|++|++|+|++|++.+ .+|..+
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g-~iP~~l 510 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG-RVPAAL 510 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc-cCChHH
Confidence 9999999988887 67777777777777777776666666666666666666666543 344433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-17 Score=181.89 Aligned_cols=259 Identities=20% Similarity=0.214 Sum_probs=178.1
Q ss_pred EEEcccCcccCc-CC-CCCCCCCCcEEecCCCcCCCC----CcccccCCCCCcEEeccCCCCCC-----CCCcccccCCC
Q 002255 93 VLEVMKNKLTGQ-IP-SLSGLSSLQEVLFDDNNFTSV----PSDFFKGLTSLQTISLDYNSFDS-----WVIPESLKDAT 161 (947)
Q Consensus 93 ~L~L~~N~l~~~-~p-~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~-----~~~p~~~~~l~ 161 (947)
.|+|..+.+++. .. .+..+.+|++|++++|.++.. ++..+...++|++|++++|.+.. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 477888888743 23 466677799999999888532 34446677788888888887752 11334566677
Q ss_pred CCCeEeccCceeeeccCcccCCCCCCC---ccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCC-C
Q 002255 162 GLQRFSANGANITGTIPDFLGGDTIPG---LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM-T 237 (947)
Q Consensus 162 ~L~~L~l~~n~l~~~~p~~~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l-~ 237 (947)
+|+.|++++|.+.+..+..+. .+.. |++|++++|++++.....+ ...+..+ +
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~--~l~~~~~L~~L~ls~~~~~~~~~~~l----------------------~~~l~~~~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLE--SLLRSSSLQELKLNNNGLGDRGLRLL----------------------AKGLKDLPP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHHHH--HHhccCcccEEEeeCCccchHHHHHH----------------------HHHHHhCCC
Confidence 788888877777655555443 2333 7777777777663111111 1224456 8
Q ss_pred CCcEEEccCCcCcCCCC-----CCCCCCCCCEEEccCCccccC----CCccccCCCCCCeEeccCCcccccCCCCCCCcc
Q 002255 238 SLTQLWLHGNSFTGPLP-----DLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR 308 (947)
Q Consensus 238 ~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 308 (947)
+|+.|+|++|.+++... .+..+.+|++|++++|.+++. ++..+..+++|+.|+|++|.+++.....+
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l---- 213 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASAL---- 213 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHH----
Confidence 99999999999995322 256678999999999999853 45556677899999999999874321100
Q ss_pred cccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccc
Q 002255 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISS 388 (947)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~ 388 (947)
. ..+...++|++|++++|.+++....
T Consensus 214 ---------------------------------------~---------------~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 214 ---------------------------------------A---------------ETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred ---------------------------------------H---------------HHhcccCCCCEEecCCCcCchHHHH
Confidence 0 0112335799999999999874333
Q ss_pred ccc-----CCccCCeEeccCCccc----ccCCCcCCCCCCCCcccccccccccc
Q 002255 389 NFS-----RLTSLRQLMLSGNELT----GTIPKELTTLPSLEMLDVSNNHLFGK 433 (947)
Q Consensus 389 ~~~-----~l~~L~~L~Ls~N~l~----g~iP~~l~~l~~L~~L~ls~N~l~g~ 433 (947)
.+. ..++|+.|++++|.++ ..+...+..+++|++||+++|+++..
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 332 2479999999999997 34556677779999999999999855
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.8e-15 Score=148.14 Aligned_cols=140 Identities=20% Similarity=0.202 Sum_probs=100.5
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHH----------------------HHHHHHHHHcCCCCC--c
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAE----------------------FKSEIAVLTKVRHRH--L 650 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n--i 650 (947)
.+.||+|+||.||+|...+|+.||||++............ ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998888999999998754322211111 135666666665443 4
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCchhhh-hhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 651 VGLLGYCLDGNERLLVYEYMPQGTLSRH-LFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 651 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
.+.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++|+ ..+|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 444443 246899999998554321 11100 01 4567899999999999995 3799999999999999
Q ss_pred cCCCcEEEeecCcceecCC
Q 002255 730 GDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~ 748 (947)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 99999999999875533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=140.42 Aligned_cols=136 Identities=23% Similarity=0.213 Sum_probs=114.2
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC--CCcceEEEEEEeCCeeEEEEEecC
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLVYEYMP 671 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~ 671 (947)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++++..++..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 45789999999999998864 7899998865432 4578899999999976 589999998888888999999998
Q ss_pred CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8777543 34556778999999999999754458999999999999999999999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-16 Score=182.23 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=192.8
Q ss_pred cCCCcCceecccCceEEEEEEEc--CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 666 (947)
..|...+.||+|+|+.|-..... ....+|+|.+...............|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35667778999999999887543 3456777777655433444556667888888886 99999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCccee
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRL 745 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~ 745 (947)
.+|..++++.+.+.. ......+....-..+.|+..++.|+|. ..++.||||||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999887731 111124445566789999999999994 38999999999999999999 999999999988
Q ss_pred cCC-CCCcceeecccc-cccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 746 APD-NGKHSIETRLAG-TFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 746 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+.. .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......+. ....|.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~--------- 244 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWK--------- 244 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeec---------
Confidence 777 555556666788 9999999998874 446789999999999999999999986654331 111111
Q ss_pred HHHHhhccCCCChhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETL-ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....+....+ .......++..+++..+|..|.+.+++..
T Consensus 245 -----~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 245 -----SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----ccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11100011111 11123568888999999999999887754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.2e-14 Score=147.21 Aligned_cols=138 Identities=19% Similarity=0.194 Sum_probs=106.2
Q ss_pred Cceec-ccCceEEEEEEEcCCcEEEEEEeccccc-----------ChHHHHHHHHHHHHHHcCCCCCc--ceEEEEEEeC
Q 002255 595 ENVLG-RGGFGTVYKGELHDGTKIAVKRMESAVV-----------SEKGFAEFKSEIAVLTKVRHRHL--VGLLGYCLDG 660 (947)
Q Consensus 595 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 660 (947)
...|| .||.|+||++... +..++||++..... +......+.+|++++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999876 78899998854211 11233568899999999998875 6777765433
Q ss_pred Ce----eEEEEEecCC-CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcE
Q 002255 661 NE----RLLVYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 661 ~~----~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 735 (947)
.. .++||||+++ .+|.+++... .++.. .+.+++.++.+||+ .||+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 22 2599999997 6898887431 23332 36789999999996 899999999999999999999
Q ss_pred EEeecCcceec
Q 002255 736 KVADFGLVRLA 746 (947)
Q Consensus 736 kl~DfGla~~~ 746 (947)
+|+|||.++..
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999987653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-14 Score=169.98 Aligned_cols=86 Identities=29% Similarity=0.436 Sum_probs=73.9
Q ss_pred CceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccc-----eeee
Q 002255 370 GNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN-----VIVK 444 (947)
Q Consensus 370 ~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~-----~~~~ 444 (947)
.+|+.|+|++|.++|.+|..++++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..... ..+.
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 46888888888888899999999999999999999999999999999999999999999999999975433 2456
Q ss_pred cCCCCCCCCCC
Q 002255 445 TDGNPDIGKDS 455 (947)
Q Consensus 445 ~~~n~~~~~~~ 455 (947)
+.+|+.+|+.+
T Consensus 522 ~~~N~~lc~~p 532 (623)
T PLN03150 522 FTDNAGLCGIP 532 (623)
T ss_pred ecCCccccCCC
Confidence 78999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.7e-13 Score=150.34 Aligned_cols=148 Identities=25% Similarity=0.333 Sum_probs=104.2
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChH--------------------------------------H
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK--------------------------------------G 631 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--------------------------------------~ 631 (947)
..|. .+.||.|++|.||+|++++|+.||||+.+......- .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 368999999999999999999999999865421100 0
Q ss_pred HHHHHHHHHHHHcCC----CCCcceEEEEEE-eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHH-H
Q 002255 632 FAEFKSEIAVLTKVR----HRHLVGLLGYCL-DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR-G 705 (947)
Q Consensus 632 ~~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~-~ 705 (947)
.-+|.+|++.+.+++ |.+-+.+-.++. ..+..+|||||++|++|.+....... + . .+.+++.+++. .
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~---~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G---L---DRKALAENLARSF 269 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C---C---CHHHHHHHHHHHH
Confidence 013556676666662 333333333332 24567999999999999887643211 1 1 23456666666 4
Q ss_pred HHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 706 L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
+..+|. .|++|+|+||.||+++++++++++|||++....+
T Consensus 270 l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 677885 8999999999999999999999999999877644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-13 Score=147.41 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=184.5
Q ss_pred cCCCcCceecc--cCceEEEEEEE---cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGR--GGFGTVYKGEL---HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 663 (947)
..|.....+|. |.+|.||.+.. .++..+|+|+-+...........=.+|+...+.+ .|+|.|+....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999965 4688999998554433333334445677777777 499999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHH----HHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEe
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVA 738 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~ 738 (947)
++-+|++ +.+|..+.+... ..++....+....+..+ |+.++|+ .+++|-|+||.||+...+ ...+++
T Consensus 194 fiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 9999998 578877765533 23555566677777777 9999997 899999999999999999 889999
Q ss_pred ecCcceecCCCCCcce---eecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002255 739 DFGLVRLAPDNGKHSI---ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 739 DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~ 815 (947)
|||+...+.+...... ..+..|...|++||.. .+.++.+.|+|++|.++.+..++........... |.+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~- 337 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ- 337 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc-
Confidence 9999988876543222 2334678899999966 5688999999999999999999876654321110 110
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+++.+...++.......+...+..+++.+|..|++.+++..
T Consensus 338 -----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111223333334445566888999999999999887755
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.5e-14 Score=154.64 Aligned_cols=123 Identities=20% Similarity=0.301 Sum_probs=72.4
Q ss_pred CcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCc
Q 002255 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSF 318 (947)
Q Consensus 239 L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~ 318 (947)
|+.|-+++|+++-.+++++.+..|..||.+.|++. .+|..++.+.+|+.|.+..|++...+++..
T Consensus 145 Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-------------- 209 (722)
T KOG0532|consen 145 LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-------------- 209 (722)
T ss_pred ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh--------------
Confidence 55555555555555555555566666666666665 556666666666666666666553332210
Q ss_pred ccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCe
Q 002255 319 CLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398 (947)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~ 398 (947)
.-.|..||+|.|+++ .||..|.+|+.|++
T Consensus 210 --------------------------------------------------~LpLi~lDfScNkis-~iPv~fr~m~~Lq~ 238 (722)
T KOG0532|consen 210 --------------------------------------------------SLPLIRLDFSCNKIS-YLPVDFRKMRHLQV 238 (722)
T ss_pred --------------------------------------------------CCceeeeecccCcee-ecchhhhhhhhhee
Confidence 002455555555555 67777777888888
Q ss_pred EeccCCcccccCCCcCCCCCCC---Cccccccc
Q 002255 399 LMLSGNELTGTIPKELTTLPSL---EMLDVSNN 428 (947)
Q Consensus 399 L~Ls~N~l~g~iP~~l~~l~~L---~~L~ls~N 428 (947)
|-|.+|.|+ .-|..++....+ ++|+..-.
T Consensus 239 l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 239 LQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred eeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 888888887 666666654432 34444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=148.55 Aligned_cols=48 Identities=33% Similarity=0.511 Sum_probs=30.4
Q ss_pred cccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCC
Q 002255 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
+..++++++|+.|++++|+++ .++. ++.+.+|+.|++++|.++..+|.
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 444555666666666666666 5554 66666666666666666666654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-12 Score=148.05 Aligned_cols=153 Identities=22% Similarity=0.258 Sum_probs=100.7
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccCh--------------------------------HHH
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSE--------------------------------KGF 632 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~--------------------------------~~~ 632 (947)
......|+. +.||+|++|.||+|++++ |+.||||+++...... +..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344556776 899999999999999987 9999999997542100 001
Q ss_pred ------HHHHHHHHHHHcCC----CCCcceEEEEEEe-CCeeEEEEEecCCCchhhhhhccccc-CCCcccHHHHHHHHH
Q 002255 633 ------AEFKSEIAVLTKVR----HRHLVGLLGYCLD-GNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIAL 700 (947)
Q Consensus 633 ------~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~ 700 (947)
-++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-.... ....+.......++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 12455666555553 4444554455543 46678999999999997742111110 001122222222333
Q ss_pred HHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC----cEEEeecCcceecCCC
Q 002255 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVADFGLVRLAPDN 749 (947)
Q Consensus 701 ~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfGla~~~~~~ 749 (947)
|+ + ..|++|+|+||.||+++.++ +++++|||++....+.
T Consensus 275 Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 33 2 37899999999999999988 9999999999877543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-14 Score=151.80 Aligned_cols=132 Identities=24% Similarity=0.344 Sum_probs=110.2
Q ss_pred CCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccC
Q 002255 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKG 314 (947)
Q Consensus 235 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~ 314 (947)
++..|+.|+|+.|+++..+..++.++ |+.|-+++|+++ .+|..++.+..|..||.+.|.+...++..
T Consensus 119 ~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql----------- 185 (722)
T KOG0532|consen 119 NLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQL----------- 185 (722)
T ss_pred hhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHh-----------
Confidence 46777888888888887766777665 999999999999 89999999999999999999998554431
Q ss_pred CCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCc
Q 002255 315 SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLT 394 (947)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~ 394 (947)
..+..|+.|++..|++. .+|+.++.|
T Consensus 186 ----------------------------------------------------~~l~slr~l~vrRn~l~-~lp~El~~L- 211 (722)
T KOG0532|consen 186 ----------------------------------------------------GYLTSLRDLNVRRNHLE-DLPEELCSL- 211 (722)
T ss_pred ----------------------------------------------------hhHHHHHHHHHhhhhhh-hCCHHHhCC-
Confidence 11225778888999988 688888854
Q ss_pred cCCeEeccCCcccccCCCcCCCCCCCCccccccccccccC
Q 002255 395 SLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434 (947)
Q Consensus 395 ~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~i 434 (947)
.|..||+|.|+++ .||..|..|..|++|-|.+|.|+.+.
T Consensus 212 pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 212 PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 5999999999999 99999999999999999999997653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.3e-12 Score=145.15 Aligned_cols=182 Identities=25% Similarity=0.435 Sum_probs=108.6
Q ss_pred cCCCCCCEEEcccCcccCcCCCCCCCC-CCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCC
Q 002255 86 NSLSSLTVLEVMKNKLTGQIPSLSGLS-SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (947)
..++.++.|++.+|.++...+....++ +|+.|++++|++..++. .+..+++|+.|++++|++.. +|...+.++.|+
T Consensus 113 ~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~-~~~~l~~L~~L~l~~N~l~~--l~~~~~~~~~L~ 189 (394)
T COG4886 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPS-PLRNLPNLKNLDLSFNDLSD--LPKLLSNLSNLN 189 (394)
T ss_pred hcccceeEEecCCcccccCccccccchhhcccccccccchhhhhh-hhhccccccccccCCchhhh--hhhhhhhhhhhh
Confidence 333455555555555554444334342 55555555555554431 13445555555555555542 444444444444
Q ss_pred eEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEc
Q 002255 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (947)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (947)
.|++++|+++ .+|..+. .+..|++|.+++|++. . .+..+.++.++..|.+
T Consensus 190 ~L~ls~N~i~-~l~~~~~--~~~~L~~l~~~~N~~~-----------------------~----~~~~~~~~~~l~~l~l 239 (394)
T COG4886 190 NLDLSGNKIS-DLPPEIE--LLSALEELDLSNNSII-----------------------E----LLSSLSNLKNLSGLEL 239 (394)
T ss_pred heeccCCccc-cCchhhh--hhhhhhhhhhcCCcce-----------------------e----cchhhhhccccccccc
Confidence 4444444444 3333322 1223444444444322 1 1122456788888889
Q ss_pred cCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 245 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
.+|++...+..+..+++|++|++++|+++ .++. ++.+.+|+.|++++|.++..+|.
T Consensus 240 ~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 240 SNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred CCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 99999877666888899999999999999 5555 99999999999999999987775
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-12 Score=129.45 Aligned_cols=206 Identities=21% Similarity=0.306 Sum_probs=140.0
Q ss_pred HHHHHcCCCCCcceEEEEEEeC-----CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc
Q 002255 639 IAVLTKVRHRHLVGLLGYCLDG-----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713 (947)
Q Consensus 639 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 713 (947)
..-+-++.|.|||+++.|+.+. ....+++|||.-|++.++|++.+... ..+....-.+++.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 3445566799999999988653 34689999999999999997755433 3455555678999999999999995
Q ss_pred CCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC--CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHH
Q 002255 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD--NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 791 (947)
Q Consensus 714 ~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~el 791 (947)
.++|+|+++..+-|++..+|-+|+.----...... ...........+-++|.|||+-.....+.++|||+||+...||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 68999999999999999999888852211110000 0001111223467899999987777778899999999999999
Q ss_pred HhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 792 ITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 792 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..--......-. .+......+-. + ... .-++++.+|++.+|..||+|.+++.
T Consensus 276 ailEiq~tnseS~~~------------~ee~ia~~i~~-l---en~-----lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVE------------VEENIANVIIG-L---ENG-----LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceee------------hhhhhhhheee-c---cCc-----cccCcCcccccCCCCCCcchhhhhc
Confidence 887653222111000 00011110000 0 000 0136889999999999999998875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-11 Score=120.66 Aligned_cols=130 Identities=18% Similarity=0.152 Sum_probs=95.9
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcc-eEEEEEEeCCeeEEEEEecCCC
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV-GLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.+.++.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 357899999999999876 78899998754421 123567899999998765655 444433 33458999999998
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc--CCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
++.+.- . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 875420 0 01235678999999999732 22369999999999999 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-10 Score=126.78 Aligned_cols=167 Identities=16% Similarity=0.191 Sum_probs=125.3
Q ss_pred EEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCc
Q 002255 610 ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689 (947)
Q Consensus 610 ~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~ 689 (947)
+..++.+|.|+..+... ........+-++.++.++||||+++++.+..++..|+|+|-+. -|..++...
T Consensus 33 ~k~~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------- 101 (690)
T ss_pred eeccCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------
Confidence 34468889998887652 3445667788999999999999999999999999999999875 455566432
Q ss_pred ccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccc
Q 002255 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769 (947)
Q Consensus 690 ~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 769 (947)
......--+.||+.||.+||+ +++++|++|.-..|+|++.|+.||++|.++........ ......--..|..|+.
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 233445567899999999997 68999999999999999999999999988765433221 0111112234666765
Q ss_pred cccCCcCcccccccHHHHHHHHHhC
Q 002255 770 AVTGRVTTKVDVFSFGVILMELITG 794 (947)
Q Consensus 770 ~~~~~~~~~~DvwSlGvil~elltg 794 (947)
+.... -..|.|-||++++|++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 43222 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.3e-10 Score=111.55 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=97.8
Q ss_pred ceecccCceEEEEEEEcC-------CcEEEEEEeccccc-----------C---------hHHHHHHH----HHHHHHHc
Q 002255 596 NVLGRGGFGTVYKGELHD-------GTKIAVKRMESAVV-----------S---------EKGFAEFK----SEIAVLTK 644 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~-----------~---------~~~~~~~~----~E~~~l~~ 644 (947)
..||.|--+.||.|...+ +..+|||+.+.... + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997543 47999998753211 0 01122333 89999999
Q ss_pred CCC--CCcceEEEEEEeCCeeEEEEEecCCCchhh-hhhcccccCCCcccHHHHHHHHHHHHHHHHHH-hhccCCCeeec
Q 002255 645 VRH--RHLVGLLGYCLDGNERLLVYEYMPQGTLSR-HLFNRKEEGLKPLEWTRRLTIALDVARGVEYL-HGLAHQSFIHR 720 (947)
Q Consensus 645 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHr 720 (947)
+.. -++.+++++ ...++||||+.+..+.. .+.+ ..++..+...+..+++.++.+| |. .+|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 954 456666654 45689999997654422 2211 1133445567789999999999 64 899999
Q ss_pred CCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 721 DLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 721 Dlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|+++.||+++ ++.+.++|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 5789999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.7e-12 Score=131.07 Aligned_cols=91 Identities=19% Similarity=0.259 Sum_probs=50.7
Q ss_pred CCCCCCcEEecCCCcCCCCCc-ccccCCCCCcEEeccCCCCCCCCCc-ccccCCCCCCeEeccCceeeeccCcccCCCCC
Q 002255 109 SGLSSLQEVLFDDNNFTSVPS-DFFKGLTSLQTISLDYNSFDSWVIP-ESLKDATGLQRFSANGANITGTIPDFLGGDTI 186 (947)
Q Consensus 109 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 186 (947)
.++++|+++.|.+..+..... .....+++++.||||.|-|..+..- .-+..|++|+.|+|+.|.+....-..... .+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~-~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL-LL 196 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh-hh
Confidence 445666666666666554332 3344566666666666665543211 23345666666666666665433333332 45
Q ss_pred CCccEEEccCCccc
Q 002255 187 PGLMHLHLAFNFLQ 200 (947)
Q Consensus 187 ~~L~~L~Ls~N~l~ 200 (947)
++|+.|.|+.|.|+
T Consensus 197 ~~lK~L~l~~CGls 210 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLS 210 (505)
T ss_pred hhhheEEeccCCCC
Confidence 66777777777665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.2e-11 Score=119.85 Aligned_cols=134 Identities=28% Similarity=0.390 Sum_probs=108.6
Q ss_pred hcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccc
Q 002255 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMA 312 (947)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~ 312 (947)
+..+..|++|||++|.|+..-....-.+.++.|++++|.|. .+- .+..+++|+.||||+|.++....
T Consensus 280 ~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~G----------- 346 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVG----------- 346 (490)
T ss_pred cchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhh-----------
Confidence 44567899999999999987777777899999999999998 443 49999999999999999973210
Q ss_pred cCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccC
Q 002255 313 KGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR 392 (947)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~ 392 (947)
| -..++|++.|+|+.|.|.. -..++.
T Consensus 347 --------------------------------------w--------------h~KLGNIKtL~La~N~iE~--LSGL~K 372 (490)
T KOG1259|consen 347 --------------------------------------W--------------HLKLGNIKTLKLAQNKIET--LSGLRK 372 (490)
T ss_pred --------------------------------------h--------------HhhhcCEeeeehhhhhHhh--hhhhHh
Confidence 0 0124689999999998752 134788
Q ss_pred CccCCeEeccCCcccccCC--CcCCCCCCCCccccccccccccC
Q 002255 393 LTSLRQLMLSGNELTGTIP--KELTTLPSLEMLDVSNNHLFGKV 434 (947)
Q Consensus 393 l~~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L~ls~N~l~g~i 434 (947)
|-+|..||+++|+|. .+- ..+++||-|+.|.|.+|+|.+.+
T Consensus 373 LYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 373 LYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccc
Confidence 889999999999998 443 57999999999999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=113.83 Aligned_cols=143 Identities=20% Similarity=0.282 Sum_probs=109.7
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCC--CcceEEEEEEeCC---eeEEEEEec
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR--HLVGLLGYCLDGN---ERLLVYEYM 670 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~ 670 (947)
+.|+.|.++.||+++..+|+.+++|........ .....+..|+++++.+++. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998877789999987654221 1345788999999999764 4567777766542 568999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-------------------------------------
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA------------------------------------- 713 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 713 (947)
+|.++.+.+.. ..++...+..++.+++++|++||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765521 13566677788888888888888521
Q ss_pred ----------------CCCeeecCCCCCcEEEcC--CCcEEEeecCccee
Q 002255 714 ----------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRL 745 (947)
Q Consensus 714 ----------------~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~ 745 (947)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 255799999999999998 67789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-09 Score=102.35 Aligned_cols=133 Identities=26% Similarity=0.335 Sum_probs=101.9
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccC-h-----HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS-E-----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
..+++|+-+.+|.+.+. |..+++|.-..+... + -...+-.+|++++.+++--.|.-.+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999876 555677743332221 1 1234567899999999876776666667778888999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
++|-.|.+.+... ...++..+-+-+.-||. .+|||+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888442 24567777778888995 9999999999999998776 99999999763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.2e-11 Score=139.25 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=172.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.+.+.+.+.+-+|.++.++.+.-. .|...+.|...... ......+....+-.+.-..+||-+++....+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 355667778889999999877533 24333444332211 1111223333444444444567777666555667788999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
++|..+++|...++...- .+..-.......+..+++|||+ ..++|||++|.|++...++..+++|||.....
T Consensus 883 ~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998876441 2222222344467788999996 55899999999999999999999999843221
Q ss_pred CCC---CC--------------------------cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCC
Q 002255 747 PDN---GK--------------------------HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 797 (947)
Q Consensus 747 ~~~---~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p 797 (947)
.-. .. ........||+.|.+||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0012235799999999999999999999999999999999999999
Q ss_pred CCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 002255 798 LDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHV 865 (947)
Q Consensus 798 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 865 (947)
|....+.. .++.+...................+++.+.+..+|.+|-.|...
T Consensus 1035 ~na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1035 FNAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence 98766432 23444444444344444555567799999999999999988733
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-10 Score=129.67 Aligned_cols=249 Identities=18% Similarity=0.162 Sum_probs=175.3
Q ss_pred HHHhcCCCcCceecccCceEEEEEEE--cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCe
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGEL--HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 662 (947)
.....+|.....||.|.|+.|++... .++..|++|..............-..|+.+...+ .|.++++....+..-++
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34567889999999999999999854 3678899998876654444434445677766666 58999998888877788
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEeecC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 741 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG 741 (947)
.|+--|||+++++...+... ..++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccc
Confidence 88999999999887665221 336667788899999999999996 899999999999999886 888999999
Q ss_pred cceecCCCCCcceeeccccccccc--CccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYL--APEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
....+.-.. ......-+++ +++......+-.+.|+||||.-+.|.+++..--.....
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------------- 471 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------------- 471 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------------
Confidence 876421111 1112223344 44444556678899999999999999998753322111
Q ss_pred hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
+..+....+.... .....+..+.+.+...++..||.+.++....
T Consensus 472 ---~~~i~~~~~p~~~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 472 ---SLTIRSGDTPNLP---GLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ---ceeeecccccCCC---chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 0001111111011 1113456778889999999999988776543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.8e-11 Score=127.72 Aligned_cols=213 Identities=22% Similarity=0.228 Sum_probs=129.2
Q ss_pred cCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCC
Q 002255 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212 (947)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L 212 (947)
.++.+|+...|.+..+....+......+++++.|+|++|-+...-|-.--...||+|+.|+|+.|++.-..-.....
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~--- 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL--- 194 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh---
Confidence 36778899999988885422224677899999999999988754332111126889999999999987332221110
Q ss_pred ceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCC-CC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEe
Q 002255 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP-LP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290 (947)
Q Consensus 213 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~ 290 (947)
.++.|+.|.|+.|.|+-. +. -+..+++|+.|+|..|...+.--.....+..|+.||
T Consensus 195 ----------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld 252 (505)
T KOG3207|consen 195 ----------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD 252 (505)
T ss_pred ----------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence 256677777777777621 11 144567777777777743333334445566677777
Q ss_pred ccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCC
Q 002255 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370 (947)
Q Consensus 291 Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 370 (947)
|++|++-... . +...+.++
T Consensus 253 Ls~N~li~~~-~------------------------------------------------------------~~~~~~l~ 271 (505)
T KOG3207|consen 253 LSNNNLIDFD-Q------------------------------------------------------------GYKVGTLP 271 (505)
T ss_pred ccCCcccccc-c------------------------------------------------------------cccccccc
Confidence 7777764211 0 00112233
Q ss_pred ceeEEEecCCCcee-ecccc-----ccCCccCCeEeccCCcccccCC--CcCCCCCCCCccccccccccc
Q 002255 371 NITVVNLKNLGLSG-TISSN-----FSRLTSLRQLMLSGNELTGTIP--KELTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 371 ~L~~L~Ls~n~l~g-~ip~~-----~~~l~~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L~ls~N~l~g 432 (947)
.|..|+++.+++.. .+|+. ...+++|++|+++.|++. ..+ ..+..+++|+.|.+..|.|+-
T Consensus 272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccccc
Confidence 45666666666654 23443 356778888888888886 333 345556677777776776643
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.1e-11 Score=113.93 Aligned_cols=106 Identities=25% Similarity=0.429 Sum_probs=33.1
Q ss_pred cEEEEEecCCcccccCccccc-CCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 66 RVTRIQIGGQNIEGTLPKELN-SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
+.++|+|.+|.|+. | +.++ .+++|+.|||++|.|+. ++.+..+++|++|++++|+|+.+.......+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence 45666677666662 3 2344 45667777777776664 3456666667777777777766654323356667777777
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceee
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANIT 174 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (947)
+|+|.....-..+..+++|+.|+|.+|.++
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 776655333455556666666666666654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.1e-09 Score=97.47 Aligned_cols=144 Identities=23% Similarity=0.261 Sum_probs=107.0
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEeccccc------ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
...++-+|+-+.|+++.+. |+...||.-..... ..-...+..+|++.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999887 78877774322211 1223456788999999997666666566666777778999
Q ss_pred EecCC-CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC---cEEEeecCcc
Q 002255 668 EYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLV 743 (947)
Q Consensus 668 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla 743 (947)
||+++ -++.+++....... ........++..|-+.+.-||. ..|+|+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99976 47778876543322 2222236788899999999996 8999999999999997654 4689999986
Q ss_pred e
Q 002255 744 R 744 (947)
Q Consensus 744 ~ 744 (947)
.
T Consensus 164 ~ 164 (229)
T KOG3087|consen 164 S 164 (229)
T ss_pred h
Confidence 5
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.6e-11 Score=122.90 Aligned_cols=65 Identities=23% Similarity=0.270 Sum_probs=35.1
Q ss_pred hcCCCCCcEEEccCCcCcCCCC-----CCCCCCCCCEEEccCCccccC----CCccccCCCCCCeEeccCCccc
Q 002255 233 IQNMTSLTQLWLHGNSFTGPLP-----DLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
+...+.|+.+.++.|.|.-.-- .+..+++|+.|||++|-|+-. +...+..+++|+.|+++++.+.
T Consensus 181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 4445666666666666642211 245566666666666666522 2333445555666666665554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.8e-10 Score=109.62 Aligned_cols=41 Identities=17% Similarity=0.335 Sum_probs=5.3
Q ss_pred CCCCCCCCcEEecCCCcCCCCCccccc-CCCCCcEEeccCCCCC
Q 002255 107 SLSGLSSLQEVLFDDNNFTSVPSDFFK-GLTSLQTISLDYNSFD 149 (947)
Q Consensus 107 ~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~ 149 (947)
.+.+..++++|+|.+|.|+.+-. ++ .+.+|+.|||++|.|.
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~ 55 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQIT 55 (175)
T ss_dssp ----------------------S----TT-TT--EEE-TTS--S
T ss_pred ccccccccccccccccccccccc--hhhhhcCCCEEECCCCCCc
Confidence 34444445555555555554421 22 3455555555555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.7e-10 Score=131.23 Aligned_cols=197 Identities=25% Similarity=0.303 Sum_probs=119.2
Q ss_pred cCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCe
Q 002255 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (947)
..+..++.+++..|.+......+..+++|+.|++.+|+|..+... +..+++|++|+|++|.|.. -..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~---i~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITK---LEGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheecccccccc---ccchhhccchhh
Confidence 345666677777777776444577777888888888888776653 5567788888888888754 345666666888
Q ss_pred EeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCc-cccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEc
Q 002255 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (947)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (947)
|++.+|.|+.. . .+. .++.|+.+++++|++...-+. .-...+++.+++.+|.+..... +..+..+..+++
T Consensus 145 L~l~~N~i~~~-~-~~~--~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~~-----~~~~~~l~~~~l 215 (414)
T KOG0531|consen 145 LNLSGNLISDI-S-GLE--SLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIEG-----LDLLKKLVLLSL 215 (414)
T ss_pred heeccCcchhc-c-CCc--cchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcccc-----hHHHHHHHHhhc
Confidence 88888887632 2 222 367788888888888744331 1222445555555554443321 112334444466
Q ss_pred cCCcCcCCCCCCCCCC--CCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 245 HGNSFTGPLPDLSGLS--SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 245 ~~N~l~~~~~~~~~l~--~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
..|.++..-+ +..+. .|+.+++++|++. .++..+..+..+..|++.+|++.
T Consensus 216 ~~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 216 LDNKISKLEG-LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ccccceeccC-cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 6666653222 22222 2666677777666 44455566666666666666654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.5e-10 Score=129.89 Aligned_cols=108 Identities=25% Similarity=0.328 Sum_probs=61.3
Q ss_pred ccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCC
Q 002255 157 LKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM 236 (947)
Q Consensus 157 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l 236 (947)
+..+++|..|++.+|.|..... .+. .+++|++|+|++|+|+...+ +..+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~~-~l~--~~~~L~~L~ls~N~I~~i~~----------------------------l~~l 139 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIEN-LLS--SLVNLQVLDLSFNKITKLEG----------------------------LSTL 139 (414)
T ss_pred cccccceeeeeccccchhhccc-chh--hhhcchheeccccccccccc----------------------------hhhc
Confidence 4444444444444444442222 122 46667777777777764333 2235
Q ss_pred CCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCcc-ccCCCCCCeEeccCCccc
Q 002255 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSS-LVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 237 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~ 297 (947)
+.|+.|++++|.|+ .+..+..+..|+.+++++|++...-+ . +..+.+|+.+++.+|.+.
T Consensus 140 ~~L~~L~l~~N~i~-~~~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 140 TLLKELNLSGNLIS-DISGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR 199 (414)
T ss_pred cchhhheeccCcch-hccCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh
Confidence 55666777777766 33445556777777777777763322 2 466677777777777765
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.3e-10 Score=112.06 Aligned_cols=133 Identities=26% Similarity=0.301 Sum_probs=98.0
Q ss_pred CCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCc
Q 002255 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQ 213 (947)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 213 (947)
..+.|++||||+|.|+. +.++..-++.++.|++++|.|+..- .+. .+++|+.||||+|.++...-
T Consensus 282 TWq~LtelDLS~N~I~~--iDESvKL~Pkir~L~lS~N~i~~v~--nLa--~L~~L~~LDLS~N~Ls~~~G--------- 346 (490)
T KOG1259|consen 282 TWQELTELDLSGNLITQ--IDESVKLAPKLRRLILSQNRIRTVQ--NLA--ELPQLQLLDLSGNLLAECVG--------- 346 (490)
T ss_pred hHhhhhhccccccchhh--hhhhhhhccceeEEeccccceeeeh--hhh--hcccceEeecccchhHhhhh---------
Confidence 34578888888888864 7778888888888888888887332 244 57888888888888873221
Q ss_pred eeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccC-CCccccCCCCCCeEecc
Q 002255 214 TLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI-VPSSLVNLHSLAVVNLT 292 (947)
Q Consensus 214 ~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~-~p~~l~~l~~L~~L~Ls 292 (947)
+-..+-+++.|.|++|.+. .+..+..+-+|.+||+++|+|... --..++++|.|+.+.|.
T Consensus 347 ------------------wh~KLGNIKtL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~ 407 (490)
T KOG1259|consen 347 ------------------WHLKLGNIKTLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLT 407 (490)
T ss_pred ------------------hHhhhcCEeeeehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhc
Confidence 1224677888888888876 334566678899999999998732 23568899999999999
Q ss_pred CCcccccC
Q 002255 293 NNLFQGQT 300 (947)
Q Consensus 293 ~N~l~g~~ 300 (947)
+|++.+.+
T Consensus 408 ~NPl~~~v 415 (490)
T KOG1259|consen 408 GNPLAGSV 415 (490)
T ss_pred CCCccccc
Confidence 99998653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-10 Score=118.09 Aligned_cols=141 Identities=20% Similarity=0.219 Sum_probs=102.2
Q ss_pred hcCCCCCcEEEccCCcCcCCCCC-----CCCCCCCCEEEccCCccccC----CCccccCCCCCCeEeccCCcccccCCCC
Q 002255 233 IQNMTSLTQLWLHGNSFTGPLPD-----LSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (947)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~~~-----~~~l~~L~~L~l~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (947)
..+-+.|+.+..++|++...... +...+.|+.+.+..|.|... +-..+..+++|+.|||.+|-|+-....
T Consensus 153 ~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~- 231 (382)
T KOG1909|consen 153 AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV- 231 (382)
T ss_pred cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH-
Confidence 34568899999999999765542 66678999999999998632 345678999999999999999832211
Q ss_pred CCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCce
Q 002255 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (947)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (947)
.+.... ..+++|+.|++++|.++
T Consensus 232 ---------------------------------------~LakaL------------------~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 232 ---------------------------------------ALAKAL------------------SSWPHLRELNLGDCLLE 254 (382)
T ss_pred ---------------------------------------HHHHHh------------------cccchheeecccccccc
Confidence 000111 12246899999999887
Q ss_pred eecc----ccc-cCCccCCeEeccCCccc----ccCCCcCCCCCCCCcccccccccc
Q 002255 384 GTIS----SNF-SRLTSLRQLMLSGNELT----GTIPKELTTLPSLEMLDVSNNHLF 431 (947)
Q Consensus 384 g~ip----~~~-~~l~~L~~L~Ls~N~l~----g~iP~~l~~l~~L~~L~ls~N~l~ 431 (947)
..-. ..+ ...++|++|.|.+|.++ ..+-..+...+.|..|+|++|.|.
T Consensus 255 ~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 255 NEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 5322 222 34689999999999998 234455667889999999999993
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.9e-08 Score=96.66 Aligned_cols=129 Identities=21% Similarity=0.236 Sum_probs=83.2
Q ss_pred EEEEEEEcCCcEEEEEEeccccc------------------------ChHHHHHHHHHHHHHHcCCCC--CcceEEEEEE
Q 002255 605 TVYKGELHDGTKIAVKRMESAVV------------------------SEKGFAEFKSEIAVLTKVRHR--HLVGLLGYCL 658 (947)
Q Consensus 605 ~Vy~~~~~~g~~vavK~~~~~~~------------------------~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 658 (947)
.||.|...+|+.+|||+.+.... .........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999998753211 011224567899999999866 455666442
Q ss_pred eCCeeEEEEEecC--CCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEE
Q 002255 659 DGNERLLVYEYMP--QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 659 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 736 (947)
..++||||++ |..+..+. ... +.......++.+++..+..++. ..+|||+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~------~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD------LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG------GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc------ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEE
Confidence 3479999998 55554433 211 1123345677788886666432 4899999999999999988 999
Q ss_pred EeecCcceecC
Q 002255 737 VADFGLVRLAP 747 (947)
Q Consensus 737 l~DfGla~~~~ 747 (947)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.7e-08 Score=106.16 Aligned_cols=170 Identities=20% Similarity=0.274 Sum_probs=126.5
Q ss_pred eEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCeeEEEEEecCC-Cchhh
Q 002255 604 GTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVYEYMPQ-GTLSR 677 (947)
Q Consensus 604 g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~ 677 (947)
.+.||+.. .+|..|++|+++.... ...-....-+++++++.|.|+|++.+++.. +...++||+|.++ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 57899964 4799999999953321 111123456789999999999999998873 4567999999986 67877
Q ss_pred hhhccccc----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 678 HLFNRKEE----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 678 ~l~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
.-...... .....++...|.++.|+..||.++|+ .|+.-+-+.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65432211 12346778899999999999999997 789999999999999999999999888876554
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCC
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 797 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p 797 (947)
.+.. |-+ .--.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4220 101 112356888999999999999653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.4e-07 Score=97.98 Aligned_cols=277 Identities=17% Similarity=0.183 Sum_probs=168.6
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEE------EeCC-eeEE
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC------LDGN-ERLL 665 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~-~~~l 665 (947)
..+.||+|+-+.+|-.-- -...+-|+++... .....+ .+..|... .||-+-.-+.|= -++. ...+
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pp--pa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPP--PAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCC--chHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 457899999999996421 1223557766542 211111 23334444 566443312221 1222 2567
Q ss_pred EEEecCCCc-hhhhhh-cccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 666 VYEYMPQGT-LSRHLF-NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 666 V~e~~~~gs-L~~~l~-~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
.|..+.+.. +..+.. ..++.......|...+++++.+|.+.+-||. .|.+-+|+.++|+||++++.+.+.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence 788776642 222221 1123345668999999999999999999996 88999999999999999999999985433
Q ss_pred eecCCCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhC-CCCCCccCccch--hhHHHHHHH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITG-RKALDETQSEDS--VHLVTWFRR 815 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~--~~l~~~~~~ 815 (947)
... .++ ......+|...|.+||... +..-+...|.|.+||++++++.| ++||.+...... .-+...+..
T Consensus 165 qi~-~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN-ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec-cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 332 212 2233457899999999654 33456789999999999999997 999976532110 000000000
Q ss_pred hhcChhhHHHHhhcc--CCCC---hhcHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhhhhhCCCCCCCCCccc
Q 002255 816 MHINKDTFRKAIDRT--IDLD---EETLASISTVADLAGHCCARE--PYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYG 888 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~ 888 (947)
- .+...-+.. +... ..-....+.+.-+..+|+... +.-||+++..+..|..+.+.+.+........+.
T Consensus 242 g-----~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~ 316 (637)
T COG4248 242 G-----RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYP 316 (637)
T ss_pred c-----eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccccccc
Confidence 0 000001111 1111 111233345667788888753 678999999999999988776665554444333
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.8e-08 Score=101.67 Aligned_cols=142 Identities=16% Similarity=0.137 Sum_probs=100.5
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHH----------HHHHHHHHHHHcCCCCC--cceEEEEEEe----
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGF----------AEFKSEIAVLTKVRHRH--LVGLLGYCLD---- 659 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~---- 659 (947)
+.+-.-....|++..+. |+.|.||+.......+ .. ..+.+|...+.++...+ .++++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44554444557777664 7899999875432111 11 14778999999885433 3345555543
Q ss_pred -CCeeEEEEEecCCC-chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC------
Q 002255 660 -GNERLLVYEYMPQG-TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------ 731 (947)
Q Consensus 660 -~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~------ 731 (947)
...-++|||++++. +|.+++..... ...+...+..++.+++..++-||. .||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCC
Confidence 23568999999875 78888743211 224455677899999999999996 89999999999999975
Q ss_pred -CCcEEEeecCccee
Q 002255 732 -DMRAKVADFGLVRL 745 (947)
Q Consensus 732 -~~~~kl~DfGla~~ 745 (947)
++.+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 47899999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4e-09 Score=84.20 Aligned_cols=60 Identities=37% Similarity=0.584 Sum_probs=40.9
Q ss_pred CCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002255 89 SSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (947)
++|++|++++|+|+...+ .|.++++|++|++++|+++.+++..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 356677777777766555 566677777777777777777776677777777777776654
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.4e-09 Score=124.72 Aligned_cols=295 Identities=22% Similarity=0.255 Sum_probs=150.3
Q ss_pred CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCc--CCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeE
Q 002255 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN--FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (947)
...+.+.+.+|.+.-. +.-...++|++|-+..|. +..++..+|..++.|++|||++|.=. +.+|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~~-~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l-~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHI-AGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSL-SKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhhc-cCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCcc-CcCChHHhhhhhhhcc
Confidence 4555555555555422 222223356666666664 55566666666666666666665432 2466666666666666
Q ss_pred eccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCcccc-CCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEcc
Q 002255 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG-KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (947)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (947)
+|++..+. .+|..+. .|..|.+|++.++.-...+|.... ..+|++|.+-... ..........+.++.+|+.|...
T Consensus 601 ~L~~t~I~-~LP~~l~--~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~-~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLG--NLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA-LSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred cccCCCcc-ccchHHH--HHHhhheeccccccccccccchhhhcccccEEEeeccc-cccchhhHHhhhcccchhhheee
Confidence 66666665 5666665 566666666666655444444443 3556666554332 11111222334556666666665
Q ss_pred CCcCcCCCCCCCCCCCCC----EEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccC
Q 002255 246 GNSFTGPLPDLSGLSSLQ----DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLD 321 (947)
Q Consensus 246 ~N~l~~~~~~~~~l~~L~----~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~ 321 (947)
.... -.+.++..+..|. .+.+..+... ..+.++..+.+|+.|.+.++........+........
T Consensus 677 ~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~---------- 744 (889)
T KOG4658|consen 677 ISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLL---------- 744 (889)
T ss_pred cchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhh----------
Confidence 4444 2222333333322 3443344444 5567788888888888888877633322211111000
Q ss_pred cCCCcCCCccceeeecccccCChhhhhccCCCC--CCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeE
Q 002255 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN--NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQL 399 (947)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L 399 (947)
.+..+...-..+ .+....| ....++|+.|.+..+.....+.+....+..+..+
T Consensus 745 ---------------------~f~~l~~~~~~~~~~~r~l~~----~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~ 799 (889)
T KOG4658|consen 745 ---------------------CFPNLSKVSILNCHMLRDLTW----LLFAPHLTSLSLVSCRLLEDIIPKLKALLELKEL 799 (889)
T ss_pred ---------------------hHHHHHHHHhhccccccccch----hhccCcccEEEEecccccccCCCHHHHhhhcccE
Confidence 000000000000 0000001 0124577777777777666666666666666666
Q ss_pred eccCCccccc-CCCcCCCCCCCCccccc
Q 002255 400 MLSGNELTGT-IPKELTTLPSLEMLDVS 426 (947)
Q Consensus 400 ~Ls~N~l~g~-iP~~l~~l~~L~~L~ls 426 (947)
-+..+.+.|. .-.+.+.++++..+.++
T Consensus 800 i~~f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 800 ILPFNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred EecccccccceeeecCCCCceeEecccC
Confidence 6777777655 34455555555544443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-08 Score=81.03 Aligned_cols=61 Identities=39% Similarity=0.570 Sum_probs=56.3
Q ss_pred CceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccc
Q 002255 370 GNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430 (947)
Q Consensus 370 ~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l 430 (947)
++|+.|++++|+++..-+..|.++++|++|+|++|+|+...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3689999999999977778999999999999999999977778999999999999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-07 Score=95.68 Aligned_cols=136 Identities=21% Similarity=0.188 Sum_probs=94.9
Q ss_pred CCCcCceecccCceEEEEEEEcCCcEEEEEEecccccC--------------------hHHHHHHHHHHHHHHcCCCC--
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS--------------------EKGFAEFKSEIAVLTKVRHR-- 648 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~-- 648 (947)
-+.+...||-|--+.||.|....|.++|||.=+....+ .-......+|.++|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34567899999999999999999999999954221110 11234567899999999755
Q ss_pred CcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 649 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
.+.+.+++ +...+||||++|-.|...--. .-... .++..|++-+..+-. .||||+|+.+-||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~-------~en~~---~il~~il~~~~~~~~---~GiVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLD-------VENPD---EILDKILEEVRKAYR---RGIVHGDLSEFNIL 234 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCc-------ccCHH---HHHHHHHHHHHHHHH---cCccccCCchheEE
Confidence 67777765 345799999998766543210 11122 233333333333322 78999999999999
Q ss_pred EcCCCcEEEeecCcc
Q 002255 729 LGDDMRAKVADFGLV 743 (947)
Q Consensus 729 l~~~~~~kl~DfGla 743 (947)
++++|.+.++||--+
T Consensus 235 V~~dg~~~vIDwPQ~ 249 (304)
T COG0478 235 VTEDGDIVVIDWPQA 249 (304)
T ss_pred EecCCCEEEEeCccc
Confidence 999999999999543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.1e-07 Score=108.34 Aligned_cols=143 Identities=22% Similarity=0.310 Sum_probs=95.5
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccCh----------------------------H----------HHHHHHH
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE----------------------------K----------GFAEFKS 637 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------~----------~~~~~~~ 637 (947)
+.|+.++-|.||+|++++|+.||||+.+...... . ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999886532110 0 0113455
Q ss_pred HHHHHHcCC----CCCcceEEEEEE-eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHH-HHHHhh
Q 002255 638 EIAVLTKVR----HRHLVGLLGYCL-DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG-VEYLHG 711 (947)
Q Consensus 638 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~-L~~LH~ 711 (947)
|+..+.+++ +..-+++=.+|. ..+...|+|||++|..+.+....+. .+ .+ +..++..++++ +..+=
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g---~d---~k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AG---ID---RKELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cC---CC---HHHHHHHHHHHHHHHHH-
Confidence 666666663 222333333443 3567799999999999988753322 11 23 22233333332 11111
Q ss_pred ccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 712 ~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
..|+.|.|.+|.||+++.+|++.+.|||++....+
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 26899999999999999999999999999876654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.3e-09 Score=105.77 Aligned_cols=55 Identities=27% Similarity=0.423 Sum_probs=31.9
Q ss_pred CCCCcEEEccCCcCcC--CCCCCCCCCCCCEEEccCCccccCC----Cc--cccCCCCCCeEe
Q 002255 236 MTSLTQLWLHGNSFTG--PLPDLSGLSSLQDFSVRDNQLTGIV----PS--SLVNLHSLAVVN 290 (947)
Q Consensus 236 l~~L~~L~L~~N~l~~--~~~~~~~l~~L~~L~l~~N~l~g~~----p~--~l~~l~~L~~L~ 290 (947)
++.+..|.|+.|+|.. .+.++.+++.|..|.+++|.+...+ +. -++++++++.|+
T Consensus 223 ~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLN 285 (418)
T KOG2982|consen 223 FPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLN 285 (418)
T ss_pred CCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEec
Confidence 4555566677776654 2234666777777777777665322 21 145666666665
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.2e-06 Score=84.01 Aligned_cols=140 Identities=21% Similarity=0.170 Sum_probs=102.1
Q ss_pred ecccCceEEEEEEEcCCcEEEEEEecccccC----hHHHHHHHHHHHHHHcCCCC--CcceEEEEEEe--C--CeeEEEE
Q 002255 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVS----EKGFAEFKSEIAVLTKVRHR--HLVGLLGYCLD--G--NERLLVY 667 (947)
Q Consensus 598 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~--~--~~~~lV~ 667 (947)
-|+||-+-|++..+. |..+-+|+-...... .-....|.+|+..+.++..- .+.+.+.+... + -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998776 557889987532111 23567899999999999532 34444422211 1 2357999
Q ss_pred EecCC-CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc--EEEeecCcce
Q 002255 668 EYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVR 744 (947)
Q Consensus 668 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfGla~ 744 (947)
|-+.+ .+|.+++.... ..+.+...+..+..+++..++-||+ .++.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98754 58888874422 2335667778899999999999996 89999999999999986666 9999997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-06 Score=88.75 Aligned_cols=107 Identities=26% Similarity=0.329 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHHcCCCC--CcceEEEEEEeCC----eeEEEEEecCCC-chhhhhhcccccCCCcccHHHHHHHHHHHHH
Q 002255 632 FAEFKSEIAVLTKVRHR--HLVGLLGYCLDGN----ERLLVYEYMPQG-TLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704 (947)
Q Consensus 632 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~ 704 (947)
.....+|...+..+... ...+.+++..... ..++|+|++++. +|.+++..... .+......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 34678888888888543 3456666665532 358999999884 78888854221 344556789999999
Q ss_pred HHHHHhhccCCCeeecCCCCCcEEEcCCC---cEEEeecCcceec
Q 002255 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLA 746 (947)
Q Consensus 705 ~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~~ 746 (947)
.++-||. .||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999996 8999999999999999887 8999999977654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-07 Score=111.99 Aligned_cols=127 Identities=19% Similarity=0.206 Sum_probs=85.3
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcc-cCcCC--CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEe
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKL-TGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l-~~~~p--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (947)
.+..+.+-++.+. .++....+ +.|++|-+..|.. -..++ .|..++.|++|||++|.=.+-.|..++.|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4455555555554 33333322 3678888887752 22333 377788888888887766566666678888888888
Q ss_pred ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCc
Q 002255 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198 (947)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~ 198 (947)
|++..+.. +|..+++|..|.+|++..+.....+|..+. .+++|++|.|..-.
T Consensus 602 L~~t~I~~--LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~--~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 602 LSDTGISH--LPSGLGNLKKLIYLNLEVTGRLESIPGILL--ELQSLRVLRLPRSA 653 (889)
T ss_pred ccCCCccc--cchHHHHHHhhheeccccccccccccchhh--hcccccEEEeeccc
Confidence 88888864 788888888888888887776656655554 57788888776554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1e-07 Score=107.72 Aligned_cols=152 Identities=20% Similarity=0.298 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc-------eeecccccccccCccccc
Q 002255 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS-------IETRLAGTFGYLAPEYAV 771 (947)
Q Consensus 699 ~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 771 (947)
+.+++.|+.|+|. ..++||+.|.|++|.++..+..|++.|+.+.......... ...-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999997 6899999999999999999999999999865443311110 111112345799999999
Q ss_pred cCCcCcccccccHHHHHHHHHhC-CCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHH
Q 002255 772 TGRVTTKVDVFSFGVILMELITG-RKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGH 850 (947)
Q Consensus 772 ~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 850 (947)
....+.++|+||+||++|-+..| +.-+.........+. ....+. ..........++++.+=+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~-~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLN-AGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccc-cccccccccCcHHHHHHHHH
Confidence 88889999999999999999954 444433221111100 000000 00011123445677888889
Q ss_pred hcccCCCCCCCHHHHHH
Q 002255 851 CCAREPYQRPDMGHVVN 867 (947)
Q Consensus 851 cl~~dP~~RPs~~evl~ 867 (947)
++..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999997776654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.4e-09 Score=117.36 Aligned_cols=131 Identities=26% Similarity=0.314 Sum_probs=101.1
Q ss_pred CCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCC
Q 002255 236 MTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315 (947)
Q Consensus 236 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~ 315 (947)
...|...+.++|.|+-.-..+.-++.|+.|+|++|+++.. ..+..+++|++|||++|.|.- +|..
T Consensus 163 Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l------------ 227 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQL------------ 227 (1096)
T ss_pred hhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-cccc------------
Confidence 3467888899999987666677789999999999999854 389999999999999999973 2221
Q ss_pred CCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCcc
Q 002255 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS 395 (947)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~ 395 (947)
..+.| +|+.|+|++|-++. + -.+.+|++
T Consensus 228 ----------------------------------------------~~~gc----~L~~L~lrnN~l~t-L-~gie~Lks 255 (1096)
T KOG1859|consen 228 ----------------------------------------------SMVGC----KLQLLNLRNNALTT-L-RGIENLKS 255 (1096)
T ss_pred ----------------------------------------------chhhh----hheeeeecccHHHh-h-hhHHhhhh
Confidence 00112 48899999998772 2 24789999
Q ss_pred CCeEeccCCcccccCC-CcCCCCCCCCcccccccccccc
Q 002255 396 LRQLMLSGNELTGTIP-KELTTLPSLEMLDVSNNHLFGK 433 (947)
Q Consensus 396 L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~ls~N~l~g~ 433 (947)
|+.|||++|-|.+.-- .-+..|..|+.|+|.+|+|...
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999999999985432 2245577899999999999754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=7e-06 Score=84.78 Aligned_cols=138 Identities=19% Similarity=0.229 Sum_probs=85.1
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC--cceEEEEEEeCCeeEEEEEecCCC
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 67999999999984 25567888876432 2245688999999986443 467788877777888999999886
Q ss_pred c-hhhhh---------------------hcccccCCCcccHHHHHH-HHH----------HHHH-HHHHHhhc-cCCCee
Q 002255 674 T-LSRHL---------------------FNRKEEGLKPLEWTRRLT-IAL----------DVAR-GVEYLHGL-AHQSFI 718 (947)
Q Consensus 674 s-L~~~l---------------------~~~~~~~~~~~~~~~~~~-i~~----------~i~~-~L~~LH~~-~~~~iv 718 (947)
+ +...+ |..... ......... +.. .+.+ ...+|... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 3 21111 110000 001111000 000 0001 12222211 134578
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 719 HRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 719 HrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
|+|+.|.||++++++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999988 9999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.4e-08 Score=89.16 Aligned_cols=117 Identities=19% Similarity=0.194 Sum_probs=89.7
Q ss_pred cCCCCCcEEEccCCcCcCCCCCCCC-CCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccc
Q 002255 234 QNMTSLTQLWLHGNSFTGPLPDLSG-LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMA 312 (947)
Q Consensus 234 ~~l~~L~~L~L~~N~l~~~~~~~~~-l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~ 312 (947)
.....|+..+|++|.|...++.|.. ++.++.|+|++|.|+ .+|..+..++.|+.|+++.|+|.
T Consensus 50 ~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~--------------- 113 (177)
T KOG4579|consen 50 SKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN--------------- 113 (177)
T ss_pred hCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc---------------
Confidence 3456777888899988887777654 567888888899888 78888888888888888888876
Q ss_pred cCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccC
Q 002255 313 KGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR 392 (947)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~ 392 (947)
..|..+..
T Consensus 114 ------------------------------------------------------------------------~~p~vi~~ 121 (177)
T KOG4579|consen 114 ------------------------------------------------------------------------AEPRVIAP 121 (177)
T ss_pred ------------------------------------------------------------------------cchHHHHH
Confidence 23444555
Q ss_pred CccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCcc
Q 002255 393 LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ 439 (947)
Q Consensus 393 l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~ 439 (947)
|.+|-.||..+|.+. +||..+-.-..+...++.+|.|.|.-|.-++
T Consensus 122 L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 122 LIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred HHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 778888999999988 8887755555566778888888888776544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 947 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-53 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-27 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-27 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-26 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-24 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-24 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-23 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-133
Identities = 111/313 (35%), Positives = 167/313 (53%), Gaps = 19/313 (6%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEE------NVLGRGGFGTVYKGELHDGTKIAVKRM 622
L V + S L+NVTNNF E N +G GGFG VYKG + + T +AVK++
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 623 ESAVV--SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF 680
+ V +E+ +F EI V+ K +H +LV LLG+ DG++ LVY YMP G+L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 681 NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740
G PL W R IA A G+ +LH IHRD+K +NILL + AK++DF
Sbjct: 123 CLD--GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 800
GL R + + + +R+ GT Y+APE + G +T K D++SFGV+L+E+ITG A+DE
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 801 TQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
+ L+ + + T ID+ +++ S+ + +A C + +RP
Sbjct: 237 HREPQ--LLLDIKEEIEDEEKTIEDYIDK--KMNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 861 DMGHVVNVLSSLA 873
D+ V +L +
Sbjct: 293 DIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-128
Identities = 114/319 (35%), Positives = 173/319 (54%), Gaps = 8/319 (2%)
Query: 557 SESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK 616
S++ + + S ++V S + + L TNNF + ++G G FG VYKG L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 617 IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
+A+KR S +G EF++EI L+ RH HLV L+G+C + NE +L+Y+YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 677 RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736
RHL+ + + W +RL I + ARG+ YLH ++ IHRD+K NILL ++ K
Sbjct: 124 RHLY-GSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 796
+ DFG+ + + + + T + GT GY+ PEY + GR+T K DV+SFGV+L E++ R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 797 ALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREP 856
A+ ++ + V+L W H N + +D + D+ S+ D A C A
Sbjct: 240 AIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSS 297
Query: 857 YQRPDMGHVVNVLSSLAEL 875
RP MG V+ L L
Sbjct: 298 EDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-122
Identities = 121/299 (40%), Positives = 177/299 (59%), Gaps = 13/299 (4%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
L+ ++NFS +N+LGRGGFG VYKG L DGT +AVKR+ ++ G +F++E+ +++
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQTEVEMISM 83
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
HR+L+ L G+C+ ERLLVY YM G+++ L R E PL+W +R IAL AR
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSAR 142
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH IHRD+K +NILL ++ A V DFGL +L H + T + GT G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGH 201
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS--EDSVHLVTWFRRMHINKDT 822
+APEY TG+ + K DVF +GV+L+ELITG++A D + +D V L+ W + + K
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK- 260
Query: 823 FRKAIDRTI--DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS--LAELWK 877
+D + + +E + + VA L C P +RP M VV +L LAE W+
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALL---CTQSSPMERPKMSEVVRMLEGDGLAERWE 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 5e-79
Identities = 66/341 (19%), Positives = 125/341 (36%), Gaps = 44/341 (12%)
Query: 556 GSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGT 615
G +S + L + V RG FG V+K +
Sbjct: 2 GHHHHHHSSGVDLGT------------ENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNE 48
Query: 616 KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERLLVYEYMP 671
+AVK ++ + + + E+ L ++H +++ +G G + L+ +
Sbjct: 49 YVAVKIFPIQ--DKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105
Query: 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH-------GLAHQSFIHRDLKP 724
+G+LS L + W IA +ARG+ YLH + HRD+K
Sbjct: 106 KGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA-----VTGRVTTKV 779
N+LL +++ A +ADFGL GT Y+APE ++
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 780 DVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR-----TIDLD 834
D+++ G++L EL + A D E + + H + + ++ + +
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ-HPSLEDMQEVVVHKKKRPVLRDY 278
Query: 835 EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875
+ A ++ + + C + R G V ++ + L
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 5e-73
Identities = 89/298 (29%), Positives = 142/298 (47%), Gaps = 28/298 (9%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+ + + +G G FGTV++ E H G+ +AVK + + EF E+A++ ++RH
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V +G +V EY+ +G+L R L K + L+ RRL++A DVA+G+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH + +HR+LK N+L+ KV DFGL RL S AGT ++AP
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAP 208
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW-FRRMHINKDTFRKA 826
E K DV+SFGVIL EL T ++ V V + +R+ I ++
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL---- 264
Query: 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSD 884
+ + VA + C EP++RP ++++L L + P SD
Sbjct: 265 -------NPQ-------VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-69
Identities = 87/318 (27%), Positives = 137/318 (43%), Gaps = 31/318 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
E V+GRG FG V K + +A+K++ES E F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPN 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L G CL N LV EY G+L L E L ++ L ++GV YL
Sbjct: 63 IVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H + ++ IHRDLKP N+LL K+ DFG + T G+ ++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
+ K DVFS+G+IL E+IT RK DE + + ++ T R +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDE------IGGPAFRIMWAVHNGT-RPPLI 226
Query: 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYG 888
+ + + L C +++P QRP M +V +++ L + A+
Sbjct: 227 KNLP---------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277
Query: 889 IDLDMTLPQALKKWQAYE 906
L ++ + +
Sbjct: 278 HSLPPGEDGRVEPYVDFA 295
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 5e-67
Identities = 68/315 (21%), Positives = 124/315 (39%), Gaps = 52/315 (16%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
F + ++G+G FG VY G H ++A++ ++ +E FK E+ + RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V +G C+ ++ TL + + K L+ + IA ++ +G+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMG 144
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL---AGTFGY 764
YLH + +H+DLK N+ D+ + + DFGL ++ E +L G +
Sbjct: 145 YLHA---KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 765 LAPE---------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815
LAPE + DVF+ G I EL +E + + +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE- 874
++++ K I +D+ C A E +RP ++++L L +
Sbjct: 261 PNLSQIGMGKEI-----------------SDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
Query: 875 ---------LWKPAE 880
WK AE
Sbjct: 304 NRRLSHPGHFWKSAE 318
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-67
Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 28/283 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G G FGTVYKG+ H +AVK + + + FK+E+ VL K RH +++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
GY +V ++ +L HL + E + + IA ARG++YLH
Sbjct: 87 GYSTAPQ-LAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE---YAV 771
+S IHRDLK +NI L +D K+ DFGL +L+G+ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 772 TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT- 830
+ + + DV++FG++L EL+TG+ + D + + + + + + +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-------VGRGSLSPDLSKVR 251
Query: 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873
+ + + L C ++ +RP ++ + LA
Sbjct: 252 SNCPKR-------MKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-66
Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 43/296 (14%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE--KGFAEFKSEIAVLTKV 645
+F+E E ++G GGFG VY+ G ++AVK + + + E + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+H +++ L G CL LV E+ G L+R L ++ + + A+ +ARG
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARG 117
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVADFGLVRLAPDNGKHSIETR 757
+ YLH A IHRDLK SNIL+ + K+ DFGL R K
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MS 173
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF-RRM 816
AG + ++APE + DV+S+GV+L EL+TG + V +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
I E A L C +P+ RP ++++ L+++
Sbjct: 234 PIPSTC-----------PEP-------FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-66
Identities = 79/299 (26%), Positives = 134/299 (44%), Gaps = 46/299 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRM-----ESAVVSEKGFAEFKSEIAVLT 643
N E +G+GGFG V+KG + D + +A+K + E + F EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+ H ++V L G + +V E++P G L L ++ P++W+ +L + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIA 132
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILL-----GDDMRAKVADFGLVRLAPDNGKHSIETRL 758
G+EY+ + +HRDL+ NI L + AKVADFGL + + L
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGL 186
Query: 759 AGTFGYLAPE--YAVTGRVTTKVDVFSFGVILMELITGR---KALDETQSEDSVHLVTWF 813
G F ++APE A T K D +SF +IL ++TG + + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
R I +D + ++ C + +P +RP ++V LS L
Sbjct: 247 LRPTIPEDC------------------PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 3e-65
Identities = 74/311 (23%), Positives = 118/311 (37%), Gaps = 42/311 (13%)
Query: 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
VLG+G FG K + G + +K + E+ F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+G + EY+ GTL + + W++R++ A D+A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR------------LAGT 761
+ IHRDL N L+ ++ VADFGL RL D R + G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQSEDSVHLVTW-FRRMHIN 819
++APE KVDVFSFG++L E+I A D L F +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPA 879
+ + + CC +P +RP + + L +L
Sbjct: 246 PNC------------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 880 EPDSDDIYGID 890
P + +D
Sbjct: 288 LPLGPQLEQLD 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-64
Identities = 59/292 (20%), Positives = 109/292 (37%), Gaps = 37/292 (12%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+F + L G ++KG G I VK ++ S + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 648 RHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+++ +LG C + +MP G+L L ++ ++ + ALD+ARG
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARG 123
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ +LH L L ++++ +DM A+++ + G+ ++
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWV 175
Query: 766 APE---YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822
APE D++SF V+L EL+T + + + V +
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL--------EG 227
Query: 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
R I I V+ L C +P +RP +V +L + +
Sbjct: 228 LRPTIPPGIS---------PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-64
Identities = 70/323 (21%), Positives = 119/323 (36%), Gaps = 47/323 (14%)
Query: 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+N ++GRG +G VYKG L +AVK A + + F K I + + H
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA--NRQNFINEK-NIYRVPLMEHD 67
Query: 649 HLVGLLGYCLDGN-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
++ + E LLV EY P G+L ++L +W +A V
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVT 121
Query: 704 RGVEYLH------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR------LAPDNGK 751
RG+ YLH + HRDL N+L+ +D ++DFGL L +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 752 HSIETRLAGTFGYLAPEYA-------VTGRVTTKVDVFSFGVILMELITGRKALDETQS- 803
+ GT Y+APE +VD+++ G+I E+ L +S
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 804 -------EDSVHLVTWFRRMH--INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAR 854
+ V F M ++++ R + + S+ + C +
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL---KETIEDCWDQ 298
Query: 855 EPYQRPDMGHVVNVLSSLAELWK 877
+ R ++ L +W+
Sbjct: 299 DAEARLTAQXAEERMAELMMIWE 321
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 3e-59
Identities = 77/431 (17%), Positives = 154/431 (35%), Gaps = 81/431 (18%)
Query: 17 SATLSVNSQSSSDAAAMQALKTSLGNPASL-GWT-DPDPCKWKHIQCSPSNRVTRIQIGG 74
S S + + + + K L + L W+ + +PC + + C ++VT I +
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSS 59
Query: 75 QNIE---GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT-SVPSD 130
+ + + L SL+ L L + + + G + +SL + N+ + V +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 131 F-FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPG 188
+ L+ +++ N+ D L+ + +I+G ++ D
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
L HL ++ N + G + +S +L L + N+
Sbjct: 180 LKHLAISGNKISGDVDVS----------------------------RCVNLEFLDVSSNN 211
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP-- 306
F+ +P L S+LQ + N+L+G ++ L ++N+++N F G P
Sbjct: 212 FSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 271
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
+ N F G + P L+ +
Sbjct: 272 QYLSL--AENKF---------TGEI------------PDFLSGACD-------------- 294
Query: 367 DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDV 425
+T ++L G + F + L L LS N +G +P + L + L++LD+
Sbjct: 295 ----TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 426 SNNHLFGKVPN 436
S N G++P
Sbjct: 351 SFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-53
Identities = 92/389 (23%), Positives = 151/389 (38%), Gaps = 42/389 (10%)
Query: 76 NIEGTLPKELNSLS-SLTVLEVMKNKLTGQIPSLSG---LSSLQEVLFDDNNFT-SVPSD 130
G LP+ L +LS SL L++ N +G I ++LQE+ +N FT +P
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
+ L ++ L +N S IP SL + L+ + G IP L + L
Sbjct: 414 LSN-CSELVSLHLSFNYL-SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM--YVKTLE 469
Query: 191 HLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNS 248
L L FN L G IP +++ + L +++L G + I + +L L L NS
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISL----SNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 249 FTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV 307
F+G +P L SL + N G +P+++ N
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 308 RFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP-CNSDWKGVSC 366
A F G + L+ + + + + + G+ + +
Sbjct: 586 ECHGAGNLLEF---------QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 367 -DAGGN---------------ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTI 410
D N + ++NL + +SG+I L L L LS N+L G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 411 PKELTTLPSLEMLDVSNNHLFGKVPNFRQ 439
P+ ++ L L +D+SNN+L G +P Q
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-50
Identities = 90/387 (23%), Positives = 148/387 (38%), Gaps = 67/387 (17%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFT 125
T + + G + G +P S S L L + N +G++P +L + L+ + N F+
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 126 -SVPSDFFKGLTSLQTISLDYNSFDSWVIPESL--KDATGLQRFSANGANITGTIPDFLG 182
+P SL T+ L N+F I +L LQ TG IP L
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSG-PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLT 240
L+ LHL+FN+L G IP S G S ++ L L + L G + + + +L
Sbjct: 416 N--CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL----WLNMLEGEIPQELMYVKTLE 469
Query: 241 QLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299
L L N TG +P LS ++L S+ +N+LTG +P + L +LA++ L+NN F G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 300 TP----KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
P S + D+ +N F G +I PA + +
Sbjct: 530 IPAELGDCRSLIWLDLN--TNLF----NG-----------TI------PAAMFKQSG--- 563
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN--ELTGTIPKE 413
+ ++G ++ +GN E G ++
Sbjct: 564 --------------------KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
Query: 414 LTTLPSLEMLDVSNNHLFGKVPNFRQN 440
L L + ++++ G N
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDN 630
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-48
Identities = 86/373 (23%), Positives = 139/373 (37%), Gaps = 84/373 (22%)
Query: 76 NIEGTLPKEL---NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT-SVPSDF 131
+I G + L L + NK++G + +S +L+ + NNF+ +P
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPF-- 218
Query: 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191
++LQ + + N S ++ T L+ + + G IP + L +
Sbjct: 219 LGDCSALQHLDISGNKL-SGDFSRAISTCTELKLLNISSNQFVGPIPPLP----LKSLQY 273
Query: 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
L LA N G IP +LT L L GN F G
Sbjct: 274 LSLAENKFTGEIPDFLS-------------------------GACDTLTGLDLSGNHFYG 308
Query: 252 PLPD-LSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPK--FNSP- 306
+P S L+ ++ N +G +P +L+ + L V++L+ N F G+ P+ N
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 307 --VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364
+ D++ SN+F G + L NP N
Sbjct: 369 SLLTLDLS--SNNF---------SGPI------------LPNL-----CQNPKN------ 394
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+ + L+N G +G I S + L L LS N L+GTIP L +L L L
Sbjct: 395 ------TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 425 VSNNHLFGKVPNF 437
+ N L G++P
Sbjct: 449 LWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-33
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 27/245 (11%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT- 125
I + + G +PK + L +L +L++ N +G IP L SL + + N F
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF--SANGANITGTIPDFLGG 183
++P+ FK Q+ + N + +K+ + + N G + L
Sbjct: 553 TIPAAMFK-----QSGKIAANFI-AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN- 605
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWL--NGQKGDSKLNGSV-AVIQNMTSL 239
+ ++ G +F S+ L + N L+G + I +M L
Sbjct: 606 -RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN------MLSGYIPKEIGSMPYL 658
Query: 240 TQLWLHGNSFTGPLPD-LSGLSSLQ--DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
L L N +G +PD + L L D S N+L G +P ++ L L ++L+NN
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILDLS--SNKLDGRIPQAMSALTMLTEIDLSNNNL 716
Query: 297 QGQTP 301
G P
Sbjct: 717 SGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-31
Identities = 47/241 (19%), Positives = 101/241 (41%), Gaps = 15/241 (6%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT- 125
+ + ++ G +P L++ ++L + + N+LTG+IP + L +L + +N+F+
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
++P++ SL + L+ N F + IP ++ Q I G ++ D
Sbjct: 529 NIPAELGD-CRSLIWLDLNTNLF-NGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDG 582
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLW 243
+ H QG + S+ + G N S+ L
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI----TSRVYGGHTSPTFDNNGSMMFLD 638
Query: 244 LHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
+ N +G +P + + L ++ N ++G +P + +L L +++L++N G+ P+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 303 F 303
Sbjct: 699 A 699
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-18
Identities = 32/128 (25%), Positives = 50/128 (39%), Gaps = 14/128 (10%)
Query: 315 SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITV 374
S S L L+S + +L W N + + GV+C +T
Sbjct: 5 SPSQSLYREIHQ-------LISFKDVLPDKNLLP-DWSSNKNPCT-FDGVTCR-DDKVTS 54
Query: 375 VNLKNLGLS---GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
++L + L+ +SS+ LT L L LS + + G++ SL LD+S N L
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 432 GKVPNFRQ 439
G V
Sbjct: 114 GPVTTLTS 121
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-13
Identities = 20/77 (25%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 370 GNITVVNLKNL--------GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLE 421
G++ V NL S I ++L+ L +SGN+L+G + ++T L+
Sbjct: 192 GDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELK 250
Query: 422 MLDVSNNHLFGKVPNFR 438
+L++S+N G +P
Sbjct: 251 LLNISSNQFVGPIPPLP 267
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-13
Identities = 32/123 (26%), Positives = 42/123 (34%), Gaps = 13/123 (10%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ ++L N L+G I RL +L L LS N +G IP EL SL LD++ N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 431 FGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNT 490
G +P + K S G D G N
Sbjct: 551 NGTIP-------------AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 491 GKI 493
G
Sbjct: 598 GIR 600
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-11
Identities = 34/198 (17%), Positives = 61/198 (30%), Gaps = 35/198 (17%)
Query: 9 SLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVT 68
++F S A + + K G L + + +
Sbjct: 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS-----TRN 611
Query: 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-S 126
I + G ++ S+ L++ N L+G IP + + L + N+ + S
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+P + L L + L N + G IP + +
Sbjct: 672 IPDE-VGDLRGLNILDLSSN-------------------------KLDGRIPQAMSA--L 703
Query: 187 PGLMHLHLAFNFLQGPIP 204
L + L+ N L GPIP
Sbjct: 704 TMLTEIDLSNNNLSGPIP 721
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-56
Identities = 67/315 (21%), Positives = 121/315 (38%), Gaps = 42/315 (13%)
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSE--IAV 641
+ R V + + +G+G +G V++G G +AVK + S + + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYN 55
Query: 642 LTKVRHRHLVGLLGYCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT 697
+RH +++G + + + L+ Y G+L +L L+ L
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLR 109
Query: 698 IALDVARGVEYLHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 753 --SIETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQS- 803
GT Y+APE +VD+++FG++L E+ + +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 804 ----EDSVHLVTWFRRMH--INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPY 857
D V F M + D R I D +++++A L C + P
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP----TLTSLAKLMKECWYQNPS 285
Query: 858 QRPDMGHVVNVLSSL 872
R + L+ +
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-55
Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 38/304 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G +G V+ G+ G K+AVK + +E+ ++EI +RH +++G +
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 655 GYCLDGNER----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ G L+ +Y G+L +L + L+ L +A G+ +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 711 GLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFG 763
+ HRDLK NIL+ + +AD GL + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 764 YLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQS-----EDSVHLVTW 812
Y+ PE + D++SFG+IL E+ + + D V
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 813 FRRMH--INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870
+ M + R + DE + + L C A P R V L+
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDE----CLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 871 SLAE 874
++E
Sbjct: 328 KMSE 331
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-54
Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 22/291 (7%)
Query: 26 SSSDAAAMQALKTSLGNPASL-GW---TDPDPCKWKHIQCSP---SNRVTRIQIGGQNIE 78
+ D A+ +K LGNP +L W TD W + C + RV + + G N+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 79 GT--LPKELNSLSSLTVLEVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFT-SVPSDFFK 133
+P L +L L L + N L G IP +++ L+ L + N + ++P +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM-HL 192
+ +L T+ YN+ S +P S+ L + +G I+G IPD G L +
Sbjct: 124 -IKTLVTLDFSYNAL-SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS--FSKLFTSM 179
Query: 193 HLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNSFTG 251
++ N L G IP +F ++ + L + L G + + + ++ L NS
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDL----SRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
L + +L +R+N++ G +P L L L +N++ N G+ P+
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 8/113 (7%)
Query: 332 NVLLSIVKSVGYPAVLAESWKGNNP-CNSDWKGVSCDAGGN---ITVVNLKNLGLSGT-- 385
LL I K +G P L+ SW CN W GV CD + ++L L L
Sbjct: 9 QALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67
Query: 386 ISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
I S+ + L L L + G N L G IP + L L L +++ ++ G +P+F
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 1/66 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N ++L L+ + +L L L N + GT+P+ LT L L L+VS N+L
Sbjct: 222 NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 431 FGKVPN 436
G++P
Sbjct: 281 CGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-12
Identities = 17/67 (25%), Positives = 32/67 (47%), Gaps = 1/67 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ V+L L G S F + +++ L+ N L + ++ +L LD+ NN +
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256
Query: 431 FGKVPNF 437
+G +P
Sbjct: 257 YGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 21/69 (30%), Positives = 32/69 (46%), Gaps = 9/69 (13%)
Query: 376 NLKNLG--------LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL-EMLDVS 426
+K L LSGT+ + S L +L + GN ++G IP + L + +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 427 NNHLFGKVP 435
N L GK+P
Sbjct: 183 RNRLTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 4e-09
Identities = 17/75 (22%), Positives = 27/75 (36%), Gaps = 4/75 (5%)
Query: 233 IQNMTSLTQLWLHGNSFTGPL---PDLSGLSSLQDFSVRD-NQLTGIVPSSLVNLHSLAV 288
+ L L G + P L+ L L + N L G +P ++ L L
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 289 VNLTNNLFQGQTPKF 303
+ +T+ G P F
Sbjct: 106 LYITHTNVSGAIPDF 120
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 7e-09
Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 1/56 (1%)
Query: 382 LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
L+G I F+ L +L + LS N L G + + + + ++ N L +
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 17/48 (35%), Positives = 21/48 (43%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
I GTLP+ L L L L V N L G+IP L + +N
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 10/68 (14%)
Query: 370 GNI-TVVNLKNL--------GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
++ V KNL + GT+ ++L L L +S N L G IP+ L
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRF 293
Query: 421 EMLDVSNN 428
++ +NN
Sbjct: 294 DVSAYANN 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-53
Identities = 63/304 (20%), Positives = 110/304 (36%), Gaps = 38/304 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+ +G+G FG V++G+ G ++AVK S E+ ++EI +RH +++G +
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 655 GYCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
N + LV +Y G+L +L + + +AL A G+ +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH 156
Query: 711 GLAHQS-----FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFG 763
+ HRDLK NIL+ + +AD GL GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 764 YLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQS-----EDSVHLVTW 812
Y+APE + D+++ G++ E+ + D V
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 813 FRRMH--INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870
M + + R I E ++ +A + C R + LS
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCE----ALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 871 SLAE 874
L++
Sbjct: 333 QLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-46
Identities = 77/284 (27%), Positives = 114/284 (40%), Gaps = 32/284 (11%)
Query: 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+GRG FG V+ G L D T +AVK + A+F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+G C +V E + G L R E L L + D A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL--RTEGA--RLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAPEYAV 771
+ IHRDL N L+ + K++DFG+ R D + APE
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG--LRQVPVKWTAPEALN 288
Query: 772 TGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830
GR +++ DV+SFG++L E + G + + N+ T +++
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP---------------YPNLS-NQQTREF-VEKG 331
Query: 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
L L V L C A EP QRP + L S+ +
Sbjct: 332 GRLPCPELCP-DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 79/315 (25%), Positives = 135/315 (42%), Gaps = 44/315 (13%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+LG+G FG+V + +L K+AVK +++ +++ EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 651 VGLLGYCLDGNER------LLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVA 703
L+G L + +++ +M G L L +R E L + +D+A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+EYL + ++FIHRDL N +L +DM VADFGL R +S + G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-----YSGDYYRQGCAS 199
Query: 764 YL-----APEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMH 817
L A E T DV++FGV + E++T G+ ++ + + + R+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL- 258
Query: 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877
+ + EE V DL C + +P QRP + L ++
Sbjct: 259 ----------KQPPECMEE-------VYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 878 PAEPDSDDIYGIDLD 892
D +Y I+++
Sbjct: 302 VLSTSQDPLY-INIE 315
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G G FG V+ G + K+A+K + +SE+ +F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G CL+ LV E+M G LS +L R + GL L + LDV G+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYL--RTQRGL--FAAETLLGMCLDVCEGMAYL---EE 122
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYLAPEYAV 771
IHRDL N L+G++ KV+DFG+ R D+ T GT + +PE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVFS 178
Query: 772 TGRVTTKVDVFSFGVILMELIT-GRK 796
R ++K DV+SFGV++ E+ + G+
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-44
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 23/214 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+LG G FG+V +G L K+AVK M+ S++ EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 651 VGLLGYCLDGN-----ERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVAR 704
+ LLG C++ + + +++ +M G L +L ++R E G K + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+EYL ++++F+HRDL N +L DDM VADFGL + +S + G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-----YSGDYYRQGRIAK 210
Query: 765 L-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
+ A E T+K DV++FGV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 36/225 (16%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV 645
LG G FG V E +AVK + + A +EK ++ SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMI 97
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--------- 695
+H++++ LLG C ++ EY +G L +L R+ G++ R
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 696 --LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R ++
Sbjct: 158 DLVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-----NN 209
Query: 754 IETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
I+ T G L APE T + DV+SFGV++ E+ T
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG+G FG+V G +AVK+++ + +E+ +F+ EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V G C R L+ EY+P G+L +L KE ++ + L + +G+E
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 159
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYL 765
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P + ++ + + G +
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFWY 215
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
APE + + DV+SFGV+L EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG V G+ +AVK ++ +SE EF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFY 69
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G C +V EY+ G L +L + + LE ++ L + DV G+ +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFL---ES 122
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYLAPEYAV 771
FIHRDL N L+ D+ KV+DFG+ R D+ GT + APE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPEVFH 178
Query: 772 TGRVTTKVDVFSFGVILMELIT-GRK 796
+ ++K DV++FG+++ E+ + G+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG+G FG+V G +AVK+++ + +F+ EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDN 72
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V G C R L+ EY+P G+L +L KE ++ + L + +G+E
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 128
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYL 765
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P + + + + G +
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-FKVKEPGESPIFWY 184
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
APE + + DV+SFGV+L EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG V G+ +A+K ++ +SE EF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G C ++ EYM G L +L R+ + + L + DV +EYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYL--REMRH--RFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAPEYAVT 772
+ F+HRDL N L+ D KV+DFGL R D+ + + F PE +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMY 195
Query: 773 GRVTTKVDVFSFGVILMELIT-GRK 796
+ ++K D+++FGV++ E+ + G+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-43
Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 36/225 (16%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV 645
LG G FG V E TK+AVK + A + ++ SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMI 131
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----------FNRKEEGLKPLEWT 693
+H++++ LLG C ++ EY +G L +L +N + L
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
++ A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R H
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HH 243
Query: 754 IETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
I+ T G L APE T + DV+SFGV+L E+ T
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVL 642
N S LG G FG V + + +AVK + SA ++E+ SE+ VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVL 80
Query: 643 TKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR------ 695
+ + H ++V LLG C G L++ EY G L L +++ +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 696 -------LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-- 195
Query: 749 NGKHSIETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
+ + L APE T + DV+S+G+ L EL +
Sbjct: 196 ---KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 594 EENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ V+G+G FG VY GE D + A+K + + + F E ++ + H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV--EAFLREGLLMRGLNHP 82
Query: 649 HLVGLLGYCLDGNERLL-VYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGV 706
+++ L+G L + YM G L + + ++ +K L ++ L VARG+
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGM 137
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GY 764
EYL A Q F+HRDL N +L + KVADFGL R D +S++ +
Sbjct: 138 EYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELIT 793
A E T R TTK DV+SFGV+L EL+T
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-43
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 36/225 (16%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV 645
LG G FG V E +AVK + + A +EK ++ SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMI 143
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWT 693
+H++++ LLG C ++ EY +G L +L R+ G+ + + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R ++
Sbjct: 204 DLVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-----NN 255
Query: 754 IETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
I+ T G L APE T + DV+SFGV++ E+ T
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 83/348 (23%), Positives = 144/348 (41%), Gaps = 55/348 (15%)
Query: 555 GGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHD 613
G S SSG +L+ ++ I ++ LG GGF V E LHD
Sbjct: 2 GSSHHHHHHSSGRENLYFQ---GHMVIID-----NKHYLFIQKLGEGGFSYVDLVEGLHD 53
Query: 614 GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVYEY 669
G A+KR+ ++ E + E + H +++ L+ YCL +E L+ +
Sbjct: 54 GHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729
+GTL + K++G L + L + L + RG+E +H + + HRDLKP+NILL
Sbjct: 112 FKRGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILL 167
Query: 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLA-------GTFGYLAPE------YAVTGRVT 776
GD+ + + D G + A + + S + T Y APE + V +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV---ID 224
Query: 777 TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEE 836
+ DV+S G +L ++ G + + D+ A+ + + +
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGP---------------YDMVFQKGDSVALAVQNQLSIPQS 269
Query: 837 TLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSD 884
S S + L +P+QRP + +++ L +L +P P
Sbjct: 270 PRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQLEAL----QPPAPGQH 312
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-43
Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 24/292 (8%)
Query: 516 RKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEA 575
R S A ++ P + + S+ + S++L G + +H+ +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 576 GSMVISIQVLRNVTNNFSEENV-----LGRGGFGTVYKGELHDG----TKIAVKRM-ESA 625
+Q +++V S V +GRG FG VY G L D AVK +
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 626 VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKE 684
++F +E ++ H +++ LLG CL L+V YM G L + N
Sbjct: 130 --DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 685 E-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
+K L + L VA+G+++L A + F+HRDL N +L + KVADFGL
Sbjct: 188 NPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
Query: 744 RLAPDNGKHSIETRLAGTF--GYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
R D S+ + ++A E T + TTK DV+SFGV+L EL+T
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 32/221 (14%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ LG G FG V+ E ++ +AVK ++ ++ + +F+ E +LT ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHE 77
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----------FNRKEEGLKPLEWTRRLT 697
H+V G C DG+ ++V+EYM G L++ L + + L ++ L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
IA +A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R + +
Sbjct: 138 IASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 758 LAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
L PE + + TT+ DV+SFGVIL E+ T
Sbjct: 195 -----TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V G ++AVK ++ A+ K EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHEN 84
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V G C + L+ E++P G+L +L K + + ++L A+ + +G++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMD 140
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYL 765
YL + ++HRDL N+L+ + + K+ DFGL + + K + +
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-KEYYTVKDDRDSPVFWY 196
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
APE + + DV+SFGV L EL+T
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 596 NVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG+G FG VY+G T++A+K + E+A + E+ EF +E +V+ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEFNCH 88
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-----EEGLKPLEWTRRLTIALDVA 703
H+V LLG G L++ E M +G L +L + + L P ++ + +A ++A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+ YL F+HRDL N ++ +D K+ DFG+ R + + G G
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKGGKG 200
Query: 764 YL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
L +PE G TT DV+SFGV+L E+ T
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG G FG V K T +AVK + E+A SE + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDLLSEFNVLKQVNH 85
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-------------------K 688
H++ L G C LL+ EY G+L L ++ G +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L ++ A +++G++Y LA +HRDL NIL+ + + K++DFGL R
Sbjct: 146 ALTMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-- 200
Query: 749 NGKHSIETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
+ ++ + + G + A E TT+ DV+SFGV+L E++T
Sbjct: 201 ---YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 74/220 (33%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 595 ENVLGRGGFGTVYKGELHDG---TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-RHRH 649
++V+G G FG V K + A+KRM E A S+ +F E+ VL K+ H +
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPN 87
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR-----------LTI 698
++ LLG C L EY P G L L + P L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R E +
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYV 196
Query: 759 AGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
T G L A E TT DV+S+GV+L E+++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 595 ENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
LG G FG V + K+AVK + +A EK SE+ +++ + +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQ 108
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK---------EEGLKPLEWTRRLT 697
H ++V LLG C G L++ EY G L L + L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
+ VA+G+ +L A ++ IHRD+ N+LL + AK+ DFGL R +
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-----MNDSNY 220
Query: 758 LAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
+ L APE T + DV+S+G++L E+ +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
VLG G FG V + ++AVK + E A SE+ SE+ ++T++
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMTQLGS 107
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR----------- 695
H ++V LLG C L++EY G L +L +++E+ +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 696 -------LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 749 NGKHSIETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
S + L APE G T K DV+S+G++L E+ +
Sbjct: 223 ---MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 596 NVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-RH 647
LGRG FG V + + +AVK + E A SE SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHH 90
Query: 648 RHLVGLLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRR 695
++V LLG C +++ E+ G LS +L +++ E + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
+ + VA+G+E+L A + IHRDL NILL + K+ DFGL R +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-----YKDP 202
Query: 756 TRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
+ L APE T + DV+SFGV+L E+ +
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 71/207 (34%), Positives = 111/207 (53%), Gaps = 24/207 (11%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FG V G+ G K+AVK +++ ++ F +E +V+T++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 80
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G ++ L +V EYM +G+L +L R L L +LDV +EYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGR-SVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHSIETRLAGTFGYLAPEYA 770
+F+HRDL N+L+ +D AKV+DFGL + D GK ++ + APE
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL 186
Query: 771 VTGRVTTKVDVFSFGVILMELIT-GRK 796
+ +TK DV+SFG++L E+ + GR
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG G FG VY+G++ ++AVK + E ++ +F E +++K H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNH 92
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARG 705
+++V +G L R ++ E M G L L + +P L +A D+A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+Y L FIHRD+ N LL G AK+ DFG+ R + G
Sbjct: 153 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGC 204
Query: 763 GYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
L PE + G T+K D +SFGV+L E+ +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG-TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 74
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LG C ++ E+M G L +L R+ + + L +A ++ +EYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL--RECNR-QEVSAVVLLYMATQISSAMEYL---E 128
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL-----APE 768
++FIHRDL N L+G++ KVADFGL RL + T A APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPE 182
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT-GRK 796
+ + K DV++FGV+L E+ T G
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-42
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 281
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LG C ++ E+M G L +L R+ + + L +A ++ +EYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL--RECNR-QEVSAVVLLYMATQISSAMEYL---E 335
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAPEYAVT 772
++FIHR+L N L+G++ KVADFGL RL + + + APE
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAY 393
Query: 773 GRVTTKVDVFSFGVILMELIT 793
+ + K DV++FGV+L E+ T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-42
Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 595 ENVLGRGGFGTVYKGELHDGT-----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ V+G G FG VYKG L + +A+K +++ +EK +F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHN 107
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ L G +++ EYM G L + L R+++G + + + +A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL--REKDG--EFSVLQLVGMLRGIAAGMKYL 163
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAP 767
A+ +++HRDL NIL+ ++ KV+DFGL R+ D+ + T G AP
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWTAP 219
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
E + T+ DV+SFG+++ E++T G +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG V+ G + TK+AVK ++ +S F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
++ EYM G+L L + G L + L +A +A G+ ++
Sbjct: 75 AVVT-QEPIYIITEYMENGSLVDFL--KTPSG-IKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAPEYAVT 772
+++IHRDL+ +NIL+ D + K+ADFGL RL DN R F APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINY 184
Query: 773 GRVTTKVDVFSFGVILMELIT 793
G T K DV+SFG++L E++T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-41
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG G FG VY+G++ ++AVK + E ++ +F E +++K H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNH 133
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARG 705
+++V +G L R ++ E M G L L + +P L +A D+A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+Y L FIHRD+ N LL G AK+ DFG+ R + G
Sbjct: 194 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGC 245
Query: 763 GYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
L PE + G T+K D +SFGV+L E+ +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-41
Identities = 73/385 (18%), Positives = 132/385 (34%), Gaps = 29/385 (7%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
T + +G I P+ L L VL + N+L+ + + ++L E+ N+
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ ++ F +L T+ L +N S + LQ + I + L
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 187 PGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
L L L+ N ++ P F + L+LN + L + + TS+ L L
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 246 GNSFTGPLPD-LSGL--SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
+ + GL ++L + N L + S L L L N Q
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV-GYPAVLAE-SWKGNNPCNSD 360
L + + L I + L + + N+
Sbjct: 291 S-----LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI---- 341
Query: 361 WKGVSCDAGGNITVVNLKNLGLSG------TISSN-FSRL--TSLRQLMLSGNELTGTIP 411
G+ + + NLK L LS T+++ F L + L L L+ N+++
Sbjct: 342 -PGIKSNMFTGLI--NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 412 KELTTLPSLEMLDVSNNHLFGKVPN 436
+ L LE+LD+ N + ++
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-37
Identities = 62/375 (16%), Positives = 117/375 (31%), Gaps = 60/375 (16%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFK- 133
+I+ +L L++ N L+ + L +LQE+L +N ++ S+
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 134 -GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMH 191
+SL+ + L N P L N + ++ + + +
Sbjct: 168 FANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226
Query: 192 LHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLTQLWLHGN 247
L L+ + L +F +++ L L + LN + L +L N
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDL----SYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 248 SFTGPLPD-LSGLSSLQ---------DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L GL +++ S+ L I S L L +N+ +N
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN--- 339
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW-KGNNP 356
N L L+ S+
Sbjct: 340 ----DIPGIKSNMFTGLINLKYLS-------------------------LSNSFTSLRTL 370
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP-KELT 415
N + ++ + ++NL +S S FS L L L L NE+ + +E
Sbjct: 371 TNETFVSLA---HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 416 TLPSLEMLDVSNNHL 430
L ++ + +S N
Sbjct: 428 GLENIFEIYLSYNKY 442
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-35
Identities = 58/387 (14%), Positives = 113/387 (29%), Gaps = 83/387 (21%)
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVL 118
+C+ S+ V + +P +L +++TVL + N+L + + S L +
Sbjct: 1 KCTVSHEV--ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLD 55
Query: 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
N + + + + L L+ ++L +N + ++ T L +I
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
+ L+ L L+ N L + + +
Sbjct: 115 NPFVK--QKNLITLDLSHNGLSSTKLGTQV--------------------------QLEN 146
Query: 239 LTQLWLHGNSFTGPLPD---LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L +L L N + + SSL+ + NQ+ P + L + L N
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVL-LSIVKSVGYPAVLAESWKGN 354
+ CL+ A + L LS +
Sbjct: 207 LGPSLTE--------------KLCLELANT----SIRNLSLS----------------NS 232
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLS-----GTISSNFSRLTSLRQLMLSGNELTGT 409
S + NL L LS + +F+ L L L N +
Sbjct: 233 Q-----LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 410 IPKELTTLPSLEMLDVSNNHLFGKVPN 436
L L ++ L++ + +
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSISL 314
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-33
Identities = 70/414 (16%), Positives = 132/414 (31%), Gaps = 66/414 (15%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP----------SLSGLSSLQEVLFDDNNFT 125
NI+ L+ L ++ L + ++ I S L L+ + +DN+
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESL---KDATGLQRFSANGANITGTIPDFLG 182
+ S+ F GL +L+ +SL + + + L + I+ D
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLS-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
+ L L L N + + + +I ++L+ K S + SL
Sbjct: 403 W--LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS---FALVPSLQ 457
Query: 241 QLWLHGNSFTGPLPDLSGLS---SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+L L + S +L + +N + I L L L +++L +N
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 298 GQTPKFNSPVRFDMAKGSNSFC-LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
N KG + L+ L N
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILN-------------LE----------------SNG- 547
Query: 357 CNSDWKGVSCDAGGNITVVNLKNL-----GLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411
+ + + ++ LK + L+ +S F+ SL+ L L N +T
Sbjct: 548 ----FDEIPVEVFKDLF--ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 412 KEL-TTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPP 464
K +L LD+ N + V + + +I + SS + +PP
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-24
Identities = 49/257 (19%), Positives = 93/257 (36%), Gaps = 24/257 (9%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122
T+ I ++ L L L + N + G +GL +L+ + ++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 123 --NFTSVPSDFFKGL--TSLQTISLDYNSFDSWVIPESLKDATGLQ--RFSANGANITGT 176
+ ++ ++ F L + L ++L N + ++ L+ N I
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHLEVLDLGLN--EIGQE 420
Query: 177 IP-DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQ 234
+ G + + ++L++N SF S+Q L L ++ S + Q
Sbjct: 421 LTGQEWRG--LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL-KNVDSSPSPFQ 477
Query: 235 NMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLT--------GIVPSSLVNLHS 285
+ +LT L L N+ D L GL L+ ++ N L G L L
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 286 LAVVNLTNNLFQGQTPK 302
L ++NL +N F +
Sbjct: 538 LHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 47/268 (17%), Positives = 76/268 (28%), Gaps = 52/268 (19%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTG--QIPS-LSGLSSLQEVLFDDNNFTSVPSDFF 132
+ SL L + + L PS L +L + +NN ++ D
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 133 KGLTSLQTISLDYNSFDS-------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
+GL L+ + L +N+ LK + L + +
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD-- 558
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
+ L + L N L F N SL L L
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFN--------------------------NQVSLKSLNLQ 592
Query: 246 GNSFTGPLPDL--SGLSSLQDFSVRDNQLTGIVPS-----SLVNLHSLAVVNLTNNLFQG 298
N T + +L + +R N S + +N + L+++
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN 652
Query: 299 QTPKF-NSPVR-FDMAKGSNSFCLDDAG 324
P + PVR FD S C D A
Sbjct: 653 TPPHYHGFPVRLFD-----TSSCKDSAH 675
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-10
Identities = 24/117 (20%), Positives = 38/117 (32%), Gaps = 5/117 (4%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122
N + R+ G L LS L +L + N L L+ + N
Sbjct: 513 HNNLARLWKHA--NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIP 178
N ++P+ F SL++++L N S V + A L T
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 19/72 (26%), Positives = 33/72 (45%), Gaps = 5/72 (6%)
Query: 371 NITVVNLKNLGLSGTISSNFS---RLTSLRQLMLSGNELTGTIPKELTTL--PSLEMLDV 425
+ + L N+ L +++ TS+R L LS ++L+ T L +L MLD+
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 426 SNNHLFGKVPNF 437
S N+L +
Sbjct: 256 SYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 14/79 (17%), Positives = 25/79 (31%), Gaps = 9/79 (11%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN---------ELTGTIPKELTTLPSLE 421
+ L+ + S + L ++R L L + L L LE
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 422 MLDVSNNHLFGKVPNFRQN 440
L++ +N + G N
Sbjct: 333 HLNMEDNDIPGIKSNMFTG 351
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-41
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 21/202 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FG V G+ G K+AVK +++ ++ F +E +V+T++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 252
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G ++ L +V EYM +G+L +L +R L L +LDV +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC---LLKFSLDVCEAMEYL---E 306
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAPEYAV 771
+F+HRDL N+L+ +D AKV+DFGL + + T+ G APE
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALR 359
Query: 772 TGRVTTKVDVFSFGVILMELIT 793
+ +TK DV+SFG++L E+ +
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 594 EENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E+ LG G FGTV KG +AVK +++ E +E V+ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V ++G C +LV E G L+++L + K + + + V+ G++YL
Sbjct: 81 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYL- 133
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPE 768
+F+HRDL N+LL AK++DFGL + + + + + G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPE 190
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT-GRK 796
+ ++K DV+SFGV++ E + G+K
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
VLG G FGTVYKG +A+K + A S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEY 708
+ LLG CL + L+ + MP G L ++ K+ G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYL 765
L + +HRDL N+L+ K+ DFGL +L E G ++
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM 186
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
A E + T + DV+S+GV + EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E ++G G G V G L +A+K +++ +E+ +F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNI 112
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G G ++V EYM G+L L R +G + + + V G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDG--QFTIMQLVGMLRGVGAGMRYL- 167
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL--APE 768
+ ++HRDL N+L+ ++ KV+DFGL R+ D+ + T G APE
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWTAPE 224
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT-GRK 796
++ DV+SFGV++ E++ G +
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 71/208 (34%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
V+GRG FG VY G L D AVK + ++F +E ++ H +
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPN 87
Query: 650 LVGLLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVE 707
++ LLG CL L+V YM G L + N +K L + L VA+G++
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMK 142
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYL 765
YL A + F+HRDL N +L + KVADFGL R D +S+ + ++
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT 793
A E T + TTK DV+SFGV+L EL+T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 595 ENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V G +AVK +++ + + +K EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++ G C D LV EY+P G+L +L + + L A + G+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMA 148
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL-- 765
YLH Q +IHRDL N+LL +D K+ DFGL + P+ E G
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG----HEYYRVREDGDSPV 201
Query: 766 ---APEYAVTGRVTTKVDVFSFGVILMELIT 793
APE + DV+SFGV L EL+T
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 4e-41
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 33/222 (14%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG FG VYKG L +A+K + + A EF+ E + +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQH 71
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRL 696
++V LLG +++ Y G L L R LE +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756
+ +A G+EYL + +H+DL N+L+ D + K++D GL R ++ +
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-----YAADY 183
Query: 757 RLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
L APE + G+ + D++S+GV+L E+ +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 72/220 (32%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ LG G FG V+ E H+ +AVK ++ A SE +F+ E +LT ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR----------KEEGLKPLEWTRRLTI 698
H+V G C +G L+V+EYM G L+R L + ++ PL + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
A VA G+ Y LA F+HRDL N L+G + K+ DFG+ R +S +
Sbjct: 164 ASQVAAGMVY---LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-----YSTDYYR 215
Query: 759 AGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
G L PE + + TT+ DV+SFGV+L E+ T
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ LG+G FG+V G +AVK++ S ++ +F+ EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSD 84
Query: 649 HLVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
+V G + LV EY+P G L L + L+ +R L + + +G+
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGM 140
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GY 764
EYL + +HRDL NIL+ + K+ADFGL +L P + + R G +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY-YVVREPGQSPIFW 196
Query: 765 LAPEYAVTGRVTTKVDVFSFGVILMELIT 793
APE + + DV+SFGV+L EL T
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 6e-41
Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 32/294 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG+G FG V+ G + T++A+K ++ +S + F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLY 245
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +V EYM +G+L L + E G K L + + +A +A G+ Y+
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFL--KGETG-KYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAPEYAVTG 773
+++HRDL+ +NIL+G+++ KVADFGL RL DN + + APE A+ G
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYG 356
Query: 774 RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832
R T K DV+SFG++L EL T GR + + + V RM +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES------- 409
Query: 833 LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDI 886
+ DL C +EP +RP ++ L +P +++
Sbjct: 410 -----------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 595 ENVLGRGGFGTVYKGELH----DGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V +GE +AVK + + + +F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
L+ L G L +V E P G+L L RK +G L A+ VA G+ YL
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLG--TLSRYAVQVAEGMGYL 137
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAP 767
+ FIHRDL N+LL K+ DFGL+R P N H + + AP
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAP 193
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
E T + D + FGV L E+ T G++
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-40
Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG G FG V+ + TK+AVK M+ +S + F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKLH 249
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
++ E+M +G+L L + +EG + + + +A G+ ++
Sbjct: 250 AVVT-KEPIYIITEFMAKGSLLDFL--KSDEG-SKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAPEYAVT 772
+++IHRDL+ +NIL+ + K+ADFGL R+ DN R F APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINF 359
Query: 773 GRVTTKVDVFSFGVILMELIT-GRK 796
G T K DV+SFG++LME++T GR
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
VLG G FGTV+KG + +K +E + F + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAH 76
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEY 708
+V LLG C G+ LV +Y+P G+L H+ + G + L L + +A+G+ Y
Sbjct: 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYL 765
L +HR+L N+LL + +VADFG+ L P + + + ++
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWM 184
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
A E G+ T + DV+S+GV + EL+T G +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ V+G G FG V G L +K +A+K ++ +EK +F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNI 108
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G ++V EYM G+L L RK + + + + +A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDA--QFTVIQLVGMLRGIASGMKYL- 163
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL--APE 768
+ ++HRDL NIL+ ++ KV+DFGL R+ D+ + T G +PE
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRWTSPE 220
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT-GRK 796
+ T+ DV+S+G++L E+++ G +
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
+G G FG V++ T +AVK + E A S A+F+ E A++ + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDN 109
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-------------------EEGLK 688
++V LLG C G L++EYM G L+ L + G
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
PL +L IA VA G+ Y L+ + F+HRDL N L+G++M K+ADFGL R
Sbjct: 170 PLSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI-- 224
Query: 749 NGKHSIETRLAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
+S + A + PE R TT+ DV+++GV+L E+ +
Sbjct: 225 ---YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 594 EENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ LG G FG+V +G +A+K ++ + E E ++ ++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYI 72
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L+G C +LV E G L + L ++EE + + + V+ G++YL
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL- 126
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPE 768
++F+HRDL N+LL + AK++DFGL + + + R AG + + APE
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPE 183
Query: 769 YAVTGRVTTKVDVFSFGVILMELIT-GRK 796
+ +++ DV+S+GV + E ++ G+K
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 46/219 (21%), Positives = 84/219 (38%), Gaps = 23/219 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-- 647
+S +G GG V++ A+K + + +++EIA L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++ L Y + +V E L+ L K++ + ++ V
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVH 141
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+H +H DLKP+N L+ D K+ DFG+ + ++ GT Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 768 E-----------YAVTGRVTTKVDVFSFGVILMELITGR 795
E +++ K DV+S G IL + G+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
VLG G FGTVYKG +A+K + A S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEY 708
+ LLG CL + L+ + MP G L ++ K+ G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYL 765
L + +HRDL N+L+ K+ DFGL +L E G ++
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM 186
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
A E + T + DV+S+GV + EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 62/209 (29%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
+F + LG G +G V+K DG AVKR S K A +E+ KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
V L +G L E +L +H + G L + D + +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAP 767
LH Q +H D+KP+NI LG R K+ DFGL+ L E G Y+AP
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAP 225
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRK 796
E + G T DVFS G+ ++E+ +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-39
Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 32/294 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG+G FG V+ G + T++A+K ++ +S + F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLY 328
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +V EYM +G+L L + E G K L + + +A +A G+ Y+
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFL--KGETG-KYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAPEYAVTG 773
+++HRDL+ +NIL+G+++ KVADFGL RL DN + + APE A+ G
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYG 439
Query: 774 RVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832
R T K DV+SFG++L EL T GR + + + V RM +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES------- 492
Query: 833 LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDI 886
+ DL C +EP +RP ++ L +P +++
Sbjct: 493 -----------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+F LGRGGFG V++ + D A+KR+ E + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 649 HLVGLLGYCLDGNE---------RLLVY---EYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+V L+ N ++ +Y + + L + R ++ E + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCL 121
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL----------A 746
I L +A VE+LH + +HRDLKPSNI D KV DFGLV
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793
++ T GT Y++PE + KVD+FS G+IL EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 57/298 (19%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
LG+G F ++KG + T++ +K ++ A + F ++++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLS 70
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H+HLV G C+ G+E +LV E++ G+L +L +K + + W +L +A +A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILW--KLEVAKQLAAAM 126
Query: 707 EYLHGLAHQSFIHRDLKPSNILL--------GDDMRAKVADFGLVRLAPDN--GKHSIET 756
+ L + IH ++ NILL G+ K++D G+ + I
Sbjct: 127 HF---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 757 RLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFR 814
++ PE + D +SFG L E+ + G K L S+ +
Sbjct: 183 -------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
++ K +A+L +C EP RP ++ L+SL
Sbjct: 236 QLPAPKAA--------------------ELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+LG G FG VY+G + +AVK + + K +F SE ++ + H H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPH 74
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G ++ E P G L +L + + L+ + +L + + + YL
Sbjct: 75 IVKLIGIIE-EEPTWIIMELYPYGELGHYL--ERNKN--SLKVLTLVLYSLQICKAMAYL 129
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT---FGYLA 766
+ +HRD+ NIL+ K+ DFGL R D + + T +++
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWMS 182
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
PE R TT DV+ F V + E+++ G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-39
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRH 649
+F ++VLG G GT+ + D +AVKR+ + F+ E+ +L + H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPN 79
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ D + + E TL +K+ LE +T+ G+ +L
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 710 HGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGL-VRLAPDNGKHSIETRLAGTFG 763
H + +HRDLKP NIL+ ++A ++DFGL +LA S + + GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 764 YLAPEY---AVTGRVTTKVDVFSFGVILMELITG 794
++APE T VD+FS G + +I+
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 61/270 (22%), Positives = 111/270 (41%), Gaps = 33/270 (12%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+GRG F TVYKG + ++A ++ +++ FK E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 656 YCLD---GNERLLVY-EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
G + +++ E M GTL +L K + ++ R + +G+++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRS--WCRQILKGLQFLHT 147
Query: 712 LAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
IHRDLK NI + G K+ D GL L + ++ GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFMAPEM- 201
Query: 771 VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830
+ VDV++FG+ ++E+ T E Q+ +R+
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQN---------------AAQIYRRVTSGV 246
Query: 831 IDLDEETLASISTVADLAGHCCAREPYQRP 860
+ +A V ++ C + +R
Sbjct: 247 KPASFDKVAI-PEVKEIIEGCIRQNKDERY 275
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-39
Identities = 70/386 (18%), Positives = 134/386 (34%), Gaps = 45/386 (11%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
+ + I+ SLS L+ L + N + + SGLSSLQ+++ + N S
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT- 185
+ + L +L+ +++ +N S+ +PE + T L+ + I L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 186 -IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQL 242
+ L L+ N + P +F + + L L ++ + +V IQ + L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR----NNFDSLNVMKTCIQGLAGLEVH 230
Query: 243 WLHGNSFTG----PLPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLT 292
L F D S L L + ++ + +L + + L +++ +L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
+ F G L + P + +S K
Sbjct: 291 SV-------TIERVKDFSYNFGWQHLELVN---------CKFGQF------PTLKLKSLK 328
Query: 353 GNNPCNSDWKGVSCDAG-GNITVVNLKN--LGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
++ + ++ ++L L G S + TSL+ L LS N + T
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 387
Query: 410 IPKELTTLPSLEMLDVSNNHLFGKVP 435
+ L LE LD +++L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 61/400 (15%), Positives = 133/400 (33%), Gaps = 61/400 (15%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTG-QIP-SLSGLSSLQEVLFDDNNFTSVPSDFFK 133
N+ + L +L L V N + ++P S L++L+ + N S+ +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 134 GLTSLQ----TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL 189
L + ++ L N +++ P + K+ L + + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPM-NFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQG-LAGL 227
Query: 190 MHLHLAFNFLQGPIPLS-FGKSSIQTLW------LNGQKGDSKLNGSVAVIQNMTSLTQL 242
L + L F KS+++ L D L+ + + +T+++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 243 WLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS-------------------SLVNL 283
L + + D S Q + + + S V+L
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
Query: 284 HSLAVVNLTNN--LFQGQTPKFNSP----VRFDMAKGSNSFCLDDAGVACDGRVNVLLSI 337
SL ++L+ N F+G + + D++ N ++++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF------------------NGVITM 388
Query: 338 VKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLR 397
+ L ++ + + N+ +++ + + F+ L+SL
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 398 QLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHLFGKVPN 436
L ++GN + T L +L LD+S L P
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 55/363 (15%), Positives = 100/363 (27%), Gaps = 81/363 (22%)
Query: 81 LPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+P L S L++ N L S LQ + ++ ++ L+ L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
T+ L N S + + + LQ+ A N+ +G + L L++A N +
Sbjct: 80 TLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELNVAHNLI 136
Query: 200 QG-PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLS 257
Q +P F N+T+L L L N DL
Sbjct: 137 QSFKLPEYFS--------------------------NLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 258 GLSSLQDFSVR----DNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAK 313
L + ++ N + I P + + L + L NN
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVM----KTCIQGLA 225
Query: 314 GSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNIT 373
G L G + + A +
Sbjct: 226 GLEVHRLVL------------------------------GEFRNEGNLEKFDKSALEGLC 255
Query: 374 VVNLKNLGLS------GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
+ ++ L+ I F+ LT++ L + + + L++ N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 428 NHL 430
Sbjct: 314 CKF 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 43/253 (16%), Positives = 87/253 (34%), Gaps = 33/253 (13%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFK-- 133
+ N L++++ ++ + ++ S Q + + F P+ K
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 134 -----------------GLTSLQTISLDYNSF-DSWVIPESLKDATGLQRFSANGANITG 175
L SL+ + L N +S T L+ + +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK--SSIQTLWLNGQKGDSKLNGSVA-V 232
+FLG + L HL + L+ S ++ L ++ + + +
Sbjct: 388 MSSNFLG---LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS----HTHTRVAFNGI 440
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
++SL L + GNSF + L +L + QL + P++ +L SL V+N
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 291 LTNNLFQGQTPKF 303
+++N F
Sbjct: 501 MSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-28
Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 16/225 (7%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN--NFTSVPSDFFKGLTSLQTISL 143
L SL L NK S L SL+ + N +F S G TSL+ + L
Sbjct: 322 LKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGP 202
+N + + + L+ +N+ + L++L ++ +
Sbjct: 381 SFNGVIT--MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS--LRNLIYLDISHTHTRVA 436
Query: 203 IPLSFGK-SSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQLWLHGNSFTGPLPD-LSG 258
F SS++ L + G + + + + +LT L L P +
Sbjct: 437 FNGIFNGLSSLEVLKMAG----NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 259 LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303
LSSLQ ++ N + L+SL V++ + N +
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-25
Identities = 36/221 (16%), Positives = 71/221 (32%), Gaps = 15/221 (6%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
T+ L L L+ + L L +L + + + F GL+S
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
L+ + + NSF +P+ + L + + P + L L+++ N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS--LSSLQVLNMSHN 504
Query: 198 FLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQLWLHGNSFTG--P 252
+ +S+Q L + + S + +SL L L N F
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLN----HIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
Query: 253 LPDLSG-LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ + V ++ PS + + +N+T
Sbjct: 561 HQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 20/71 (28%), Positives = 32/71 (45%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+T ++L L + F+ L+SL+ L +S N L SL++LD S NH+
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 431 FGKVPNFRQNV 441
Q+
Sbjct: 531 MTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 13/67 (19%), Positives = 25/67 (37%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ V++L + + L+ L L+L+GN + + L SL+ L +L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 431 FGKVPNF 437
Sbjct: 113 ASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 1/71 (1%)
Query: 371 NITVVNLKNLGLSGTISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
++ V+ + + F+ L +L L LS +L P +L SL++L++S+N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 430 LFGKVPNFRQN 440
F +
Sbjct: 506 FFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 1/63 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP-SLEMLDVSNNH 429
++ V+N+ + + + L SL+ L S N + + +EL P SL L+++ N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 430 LFG 432
Sbjct: 555 FAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 15/71 (21%), Positives = 21/71 (29%), Gaps = 3/71 (4%)
Query: 366 CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425
C L I N S + L LS N L + P L++LD+
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 426 SNNHLFGKVPN 436
S +
Sbjct: 60 SRCEIQTIEDG 70
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G G FG V++G +A+K S+ +F E + + H H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPH 77
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G N ++ E G L L + + L+ + A ++ + YL
Sbjct: 78 IVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKY--SLDLASLILYAYQLSTALAYL 132
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAP 767
+ F+HRD+ N+L+ + K+ DFGL R D+ + G ++AP
Sbjct: 133 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAP 186
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
E R T+ DV+ FGV + E++ G K
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 9e-39
Identities = 71/425 (16%), Positives = 138/425 (32%), Gaps = 59/425 (13%)
Query: 524 VQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQ 583
+ +V S + A K G++ SS ++ V+
Sbjct: 4 HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR------- 56
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+S +G GG V++ A+K + + +++EIA L
Sbjct: 57 -------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 644 KVRH--RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
K++ ++ L Y + +V E L+ L K++ + +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS--YWKN 163
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ V +H +H DLKP+N L+ D K+ DFG+ + ++ G
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 762 FGYLAPE-----------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810
Y+ PE +++ K DV+S G IL + G+ + ++
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ 273
Query: 811 TWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD----MGH-- 864
+ I + D + D+ C R+P QR + H
Sbjct: 274 -ISKLHAIIDPNHEIEFPDIPEKD---------LQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 865 VVNVLSSLAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAYEGNSNIGDSSSSSFLASTD 924
V + ++ K + + G + + P ++ K G S +S + T
Sbjct: 324 VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 383
Query: 925 NTQTS 929
+
Sbjct: 384 EKKRG 388
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+F E ++G GGFG V+K + DG +KR++ + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHV 64
Query: 649 HLVGLLGYCLDGNERL----------------LVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
++V G + + E+ +GTL + + R+ E L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL- 123
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
L + + +GV+Y+H + I+RDLKPSNI L D + K+ DFGLV ++GK
Sbjct: 124 --ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQS 803
TR GT Y++PE + +VD+++ G+IL EL+ ET
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 67/348 (19%), Positives = 128/348 (36%), Gaps = 50/348 (14%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGL 653
+G GG V++ A+K + + +++EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y + +V E L+ L K++ + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVHTIH--- 125
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE----- 768
+H DLKP+N L+ D K+ DFG+ + ++ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 769 ------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822
+++ K DV+S G IL + G+ T F+++
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---------------TPFQQIINQISK 229
Query: 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD----MGH--VVNVLSSLAELW 876
ID +++ + + D+ C R+P QR + H V + ++
Sbjct: 230 LHAIIDPNHEIEFPDIPE-KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 288
Query: 877 KPAEPDSDDIYGIDLDMTLPQALKK-----WQAYEGNSNIGDSSSSSF 919
K + + G + + P ++ K ++ Y G + SSS +F
Sbjct: 289 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
+F LG+G FG VY E +A+K + A + + G + E+ + + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ L GY D L+ EY P GT+ R L +K E T ++A +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD--EQRTA-TYITELANALS 123
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H + IHRD+KP N+LLG K+ADFG AP + + L GT YL P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 176
Query: 768 EYAVTGRV-TTKVDVFSFGVILMELITGR 795
E + GR+ KVD++S GV+ E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 66/305 (21%), Positives = 127/305 (41%), Gaps = 36/305 (11%)
Query: 598 LGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGL 653
LG GG TVY D K+A+K + ++ + F+ E+ +++ H+++V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+ + + LV EY+ TLS ++ + G PL + + G+++ A
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKH----A 127
Query: 714 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT 772
H +HRD+KP NIL+ + K+ DFG+ + + L GT Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKG 186
Query: 773 GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID 832
D++S G++L E++ G + E +V + HI D D
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN---GETAVSIAI----KHIQDSVPNVTTDVRKD 239
Query: 833 LDEETLASISTVADLAGHCCAREPYQRP-DMGHVVNVLSSLAELWKPAEPDSDDIYGIDL 891
+ + ++++ ++ R + + + LSS+ + E + +D
Sbjct: 240 IPQS-------LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYE----LDK 288
Query: 892 DMTLP 896
T+
Sbjct: 289 MKTIA 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 65/300 (21%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
++F E VLG+G FG V K D A+K++ +E+ + SE+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNH 61
Query: 648 RHLVGLLGYCLDGNERL-------------LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
+++V L+ + + EY GTL + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDE 117
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
+ + + Y+H Q IHRDLKP NI + + K+ DFGL + +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 755 E------------TRLAGTFGYLAPE-YAVTGRVTTKVDVFSFGVILMELITGRKALDET 801
T GT Y+A E TG K+D++S G+I E+I T
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----ST 230
Query: 802 QSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
E + +K +I+ + + V + +P +RP
Sbjct: 231 GMER--------------VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 6e-38
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
+ LG G FG+V +G +A+K ++ + E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 399
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L+G C +LV E G L + L ++EE + + + V+ G++YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL-- 452
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY--LAPEY 769
++F+HR+L N+LL + AK++DFGL + + + R AG + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPEC 510
Query: 770 AVTGRVTTKVDVFSFGVILMELIT-GRK 796
+ +++ DV+S+GV + E ++ G+K
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG+G F VY+ +H G ++A+K ++ + + G + ++E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL-EWTRRLTIALDVARGVEYLHGLAH 714
Y D N LV E G ++R+L NR KP E R + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRV----KPFSENEAR-HFMHQIITGMLYLH---S 130
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEYAVTG 773
+HRDL SN+LL +M K+ADFGL +L + KH T L GT Y++PE T
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YT-LCGTPNYISPE-IATR 186
Query: 774 RV-TTKVDVFSFGVILMELITGR 795
+ DV+S G + L+ GR
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGR 209
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRME-SAVVSEKGFAE-------------- 634
N++ L +G F + E D A+K+ E S + ++ F +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----FNRKEEGLKP 689
FK+E+ ++T +++ + + G + +E ++YEYM ++ + ++ P
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++ + I V Y+H ++ HRD+KPSNIL+ + R K++DFG D
Sbjct: 150 IQVIKC--IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 750 GKHSIETRLAGTFGYLAPEYAVTGRVTT---KVDVFSFGVILMELITGR 795
GT+ ++ PE + + KVD++S G+ L +
Sbjct: 206 KIKG----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
++F LG+G FG VY E + +A+K + + + ++G + EI + + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ + Y D L+ E+ P+G L + L +K E + ++A +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD--EQRSATFME-ELADALH 128
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H + IHRD+KP N+L+G K+ADFG AP + + + GT YL P
Sbjct: 129 YCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLDYLPP 181
Query: 768 EYAVTGRV-TTKVDVFSFGVILMELITGR 795
E + G+ KVD++ GV+ E + G
Sbjct: 182 E-MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-37
Identities = 55/388 (14%), Positives = 109/388 (28%), Gaps = 70/388 (18%)
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT 125
+ + I + ++ K T + + N +T ++ L+ L++ ++ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
+ + + + +Y + L +P FL
Sbjct: 220 AEN-----ICEAWENENSEYAQQ-YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-- 271
Query: 186 IPGLMHLHLAFNFL--------QGPIPLSFGK-SSIQTLWLNGQKGDSKL-NGSV-AVIQ 234
+P + +++A N IQ +++ + L V +Q
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG----YNNLKTFPVETSLQ 327
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
M L L N G LP L ++ NQ+T I + + ++ +N
Sbjct: 328 KMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 295 LFQG-----QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
+ + D N V + + K +
Sbjct: 388 KLKYIPNIFDAKSVSVMSAIDF--SYNEI----GSVDGKNFDPLDPTPFKGI-------- 433
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG- 408
N++ +NL N +S FS + L + L GN LT
Sbjct: 434 ---------------------NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 409 ------TIPKELTTLPSLEMLDVSNNHL 430
+ L +D+ N L
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-34
Identities = 56/372 (15%), Positives = 112/372 (30%), Gaps = 64/372 (17%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+ K + L+ L + + + + + E + + + L L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA---QQYKTEDLKWDN-LKDLT 252
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG------LMHLH 193
+ + +P LK +Q + + + ++
Sbjct: 253 DVEVYNCPN-LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 194 LAFNFLQ-GPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
+ +N L+ P+ S K + L ++L G + + L L L N T
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLEC----LYNQLEGKLPAFGSEIKLASLNLAYNQITE 367
Query: 252 PLPDLSG-LSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRF 309
+ G +++ S N+L I ++ ++ ++ + N K P+
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 310 DMAKGSN--SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367
KG N S L + N + K +
Sbjct: 428 TPFKGINVSSINLSN---------NQISKFPKELF----------STGS----------- 457
Query: 368 AGGNITVVNLKNLGLSG-------TISSNFSRLTSLRQLMLSGNELTGTIPKEL--TTLP 418
++ +NL L+ + NF L + L N+LT + + TTLP
Sbjct: 458 ---PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513
Query: 419 SLEMLDVSNNHL 430
L +D+S N
Sbjct: 514 YLVGIDLSYNSF 525
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-34
Identities = 39/233 (16%), Positives = 78/233 (33%), Gaps = 19/233 (8%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
+ L + L +LE + N+L G++P+ L + N T +P++F
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG-------LM 190
++ +S +N K + + + I + +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP--LDPTPFKGINVS 436
Query: 191 HLHLAFNFLQGPIPLSFGK-SSIQTLWLNG----QKGDSKLNGSVAVIQNMTSLTQLWLH 245
++L+ N + F S + ++ L G + + L +N LT + L
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 246 GNSFTGPLPD---LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
N T L D + L L + N + P+ +N +L + N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQR 547
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 57/441 (12%), Positives = 111/441 (25%), Gaps = 95/441 (21%)
Query: 16 LSATLSVNSQSSSDAAAMQALKTSLGNP--ASLGWTDPDPCKWKH------------IQC 61
+ LS ++ D A++ + +L + G+ W +
Sbjct: 18 VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77
Query: 62 SPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-----PSLSGLSSLQE 116
+ + RVT + + G G +P + L+ L VL + + +S S ++
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNS-FDSWVIPESLKDATGLQRFSANGANITG 175
++ D+ I NS I +S + + NIT
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN 235
+ + + L ++ + ++
Sbjct: 198 -VSKAVMR--LTKLRQFYMGNSPFVAENICEAWENEN----------------------- 231
Query: 236 MTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-N 293
L L D V + +P+ L L + ++N+ N
Sbjct: 232 --------SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 294 NLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKG 353
G+ K + D G + N L + L
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGY-------NNLKTF----PVETSL------ 326
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGT 409
+ L L F L L L+ N++T
Sbjct: 327 ----------------QKMK--KLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEI 368
Query: 410 IPKELTTLPSLEMLDVSNNHL 430
+E L ++N L
Sbjct: 369 PANFCGFTEQVENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 62/386 (16%), Positives = 117/386 (30%), Gaps = 86/386 (22%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
T + ++L LT +EV ++P L L +Q + N S
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 135 --------LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+Q I + YN+ ++ + SL+ L + G +P F
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS---E 352
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
L L+LA+N + IP +F + L
Sbjct: 353 IKLASLNLAYNQITE-IPANF-------------------------CGFTEQVENLSFAH 386
Query: 247 NSFTG--PLPDLSGLSSLQDFSVRDNQLTGIV-------PSSLVNLHSLAVVNLTNNLFQ 297
N + D +S + N++ + + +++ +NL+NN
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN--- 443
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
+ + + + GS ++ G N+L I K S K N
Sbjct: 444 ----QISKFPKELFSTGSPLSSINLMG-------NMLTEIPK---------NSLKDENEN 483
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISS-NFSRLTSLRQLMLSGNELTGTIPKELTT 416
+ +T ++L+ L+ + L L + LS N + P +
Sbjct: 484 FKNTY--------LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 417 LPSLEMLDVSN------NHLFGKVPN 436
+L+ + N N + P
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-29
Identities = 42/247 (17%), Positives = 83/247 (33%), Gaps = 31/247 (12%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSG-LSSLQEVLFDDNNFTSVPSDFFKG 134
+EG LP S L L + N++T + G ++ + F N +P+ F
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 135 -LTSLQTISLDYNSFDS------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIP 187
++ + I YN S + + + + + I+ + T
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS--TGS 457
Query: 188 GLMHLHLAFNFLQG-------PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQ--NMT 237
L ++L N L +F + ++ L +KL + +
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL----RFNKLTKLSDDFRATTLP 513
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD------NQLTGIVPSSLVNLHSLAVVNL 291
L + L NSF+ S+L+ F +R+ N+ P + SL + +
Sbjct: 514 YLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573
Query: 292 TNNLFQG 298
+N +
Sbjct: 574 GSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 38/255 (14%), Positives = 76/255 (29%), Gaps = 28/255 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG---------QIPSLSGLSSLQEVL 118
T +++ LP L +L + ++ V N+ + +Q +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 119 FDDNNFTSVP-SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTI 177
NN + P + + L + YN + + L + IT
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG--KLPAFGSEIKLASLNLAYNQITEIP 369
Query: 178 PDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNG----QKGDSKLNGSVA 231
+F G + +L A N L+ P S + + + +
Sbjct: 370 ANFCGF--TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGI-------VPSSLVNL 283
+++ + L N + + S S L ++ N LT I + N
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 284 HSLAVVNLTNNLFQG 298
+ L ++L N
Sbjct: 488 YLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 38/238 (15%), Positives = 82/238 (34%), Gaps = 24/238 (10%)
Query: 80 TLPK--ELNSLSSLTVLEVMKNKLTGQI--------PSLSGLSSLQEVLFDDNNFTSVPS 129
+P + S+S ++ ++ N++ P+ ++ + +N + P
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 130 DFFKGLTSLQTISLDYNSFDS------WVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
+ F + L +I+L N E+ K+ L +T + D
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRA 509
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS--KLNGSV-AVIQNMTSL 239
T+P L+ + L++N P S+++ + Q+ + I SL
Sbjct: 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
TQL + N + + ++ ++DN I S + + L + Q
Sbjct: 569 TQLQIGSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-21
Identities = 50/376 (13%), Positives = 118/376 (31%), Gaps = 60/376 (15%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
N+L+ ++ + ++ I L + + L + N++ +G + + ++
Sbjct: 10 NALTDDAIVPIKLSRTAEYIKDYLALKEIWDAL-NGKNWS------QQGFGTQPGANWNF 62
Query: 146 N-SFDSWVIPE--SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
N D W SL + S G +G +PD +G + L L L + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ--LTELEVLALGSHGEKVN 120
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVI-----QNMTSLTQLWLHGNSFTGPLPDLS 257
L I + QK +++ + ++ + L + ++ + + S
Sbjct: 121 ERLFGP-KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 258 GLS-SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSN 316
++ N +T + +++ L L + N+ F + +
Sbjct: 180 RITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENE-NSEYAQQ 237
Query: 317 SFCLDDAGVACDGRVNVLLSIVKSVGY-PAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375
D +V + ++ P L +
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL----------------------KALP-- 273
Query: 376 NLKNLGLS-------------GTISSNFSRLTSLRQLMLSGNEL-TGTIPKELTTLPSLE 421
++ + ++ ++ ++ + + N L T + L + L
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333
Query: 422 MLDVSNNHLFGKVPNF 437
ML+ N L GK+P F
Sbjct: 334 MLECLYNQLEGKLPAF 349
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 9/62 (14%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
+ + + SL QL + N++ + +++ P++ +LD+ +N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 436 NF 437
++
Sbjct: 605 SY 606
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-36
Identities = 73/310 (23%), Positives = 122/310 (39%), Gaps = 53/310 (17%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS-EIAVLTK 644
+++ N E +LG G GTV G +AVKRM F + EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTE 64
Query: 645 V-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALD 701
H +++ + E L + ++ +E LK + +++
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILL-------------GDDMRAKVADFGLVRLAPD 748
+A GV +LH IHRDLKP NIL+ +++R ++DFGL + D
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-D 179
Query: 749 NGKHSIETRL---AGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGRKAL 798
+G+ S T L +GT G+ APE R+T +D+FS G + +++ K
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-- 237
Query: 799 DETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPY 857
F + + + I ++ S+ A DL +P
Sbjct: 238 ------------HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL 285
Query: 858 QRPDMGHVVN 867
+RP V+
Sbjct: 286 KRPTAMKVLR 295
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 70/300 (23%), Positives = 114/300 (38%), Gaps = 47/300 (15%)
Query: 598 LGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGL 653
LG GG V+ D +AVK + + + + F F+ E + H +V +
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 654 LGYCLD-GNERLLVY---EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
L Y EY+ TL + EG P+ R + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNF- 131
Query: 710 HGLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA-GTFGYLAP 767
+HQ+ IHRD+KP+NI++ KV DFG+ R D+G +T GT YL+P
Sbjct: 132 ---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD-----T 822
E A V + DV+S G +L E++TG + V + H+ +D
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAY----QHVREDPIPPSA 241
Query: 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-DMGHVVNVLSSLAELWKPAEP 881
+ + +D + A+ P R + L + P P
Sbjct: 242 RHEGLSADLD-------------AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 595 ENVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHL 650
++GRGG G VY+ D +A+K M + S+ F + E +++ H+
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V + + + + + L+ L + +G PL R + I + ++
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDA-- 149
Query: 711 GLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
AH + HRD+KP NIL+ D A + DFG+ D + + GT Y+APE
Sbjct: 150 --AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPER 206
Query: 770 AVTGRVTTKVDVFSFGVILMELITGR 795
T + D+++ +L E +TG
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGS 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-36
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G G FG V++G +A+K S+ +F E + + H H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPH 452
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G + N ++ E G L L + + L+ + A ++ + YL
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKF--SLDLASLILYAYQLSTALAYL 507
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAP 767
+ F+HRD+ N+L+ + K+ DFGL R D+ + G ++AP
Sbjct: 508 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAP 561
Query: 768 EYAVTGRVTTKVDVFSFGVILMELIT-GRK 796
E R T+ DV+ FGV + E++ G K
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
++ +G G +G K DG + K ++ ++E SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 649 HLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
++V +D L V EY G L+ + +E + L+ L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 707 EYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
+ H + +HRDLKP+N+ L K+ DFGL R+ N S GT Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYY 182
Query: 765 LAPE------YAVTGRVTTKVDVFSFGVILMELITGRKA 797
++PE Y K D++S G +L EL
Sbjct: 183 MSPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ +G G FG + DG + +K + + +S K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V + +V +Y G L + + + + + L + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+H + +HRD+K NI L D ++ DFG+ R+ N + GT YL+PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPE 195
Query: 769 ------YAVTGRVTTKVDVFSFGVILMELITGRKA 797
Y K D+++ G +L EL T + A
Sbjct: 196 ICENKPY------NNKSDIWALGCVLYELCTLKHA 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-35
Identities = 44/228 (19%), Positives = 77/228 (33%), Gaps = 30/228 (13%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE------LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVL 642
+ ++LG G F VY+ + K +K + A E F + L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERL 121
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+ L N +LV E GTL + K K + ++ A+ +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-----------KVADFGL---VRLAPD 748
+E +H IH D+KP N +LG+ + D G ++L P
Sbjct: 182 LYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 749 NGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 795
T T G+ E ++ + ++D F + ++ G
Sbjct: 239 GTIF---TAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 37/349 (10%), Positives = 72/349 (20%), Gaps = 55/349 (15%)
Query: 555 GGSESQSLTSSGPSDLHVVEA----GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG- 609
G ++L V + +L L G V+
Sbjct: 23 GYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVR 82
Query: 610 ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLGYC----------- 657
++ A+K + + E ++
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 658 ---------------LDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLTIAL 700
LL+ L + +
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ R L + +H P N+ + D R + D + G +
Sbjct: 202 QLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSV 253
Query: 761 TFGYLAPEY--AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818
Y E+ A T T ++ + G+ + + +W R
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL---VTPGIKGSWKRPSLR 310
Query: 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
T A L + V L G + +R +
Sbjct: 311 VPGTDSLAFGSCTPLPDF-------VKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG+GGF ++ + A K + +++ + E EI++ + H+H+VG G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
+ D + +V E + +L RK L E R + G +YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPE-ARYYLRQI--VLGCQYLH---RN 134
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
IHRDLK N+ L +D+ K+ DFGL ++ D + + L GT Y+APE ++ +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-LCGTPNYIAPE-VLSKK 190
Query: 775 V-TTKVDVFSFGVILMELITGR 795
+ +VDV+S G I+ L+ G+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG+GGF ++ + A K + +++ + E EI++ + H+H+VG G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
+ D + +V E + +L RK L E R + G +YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPE-ARYYLRQI--VLGCQYLH---RN 160
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
IHRDLK N+ L +D+ K+ DFGL ++ D + + L GT Y+APE ++ +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-LCGTPNYIAPE-VLSKK 216
Query: 775 V-TTKVDVFSFGVILMELITGR 795
+ +VDV+S G I+ L+ G+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 8/210 (3%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
NF E +GRG F VY+ L DG +A+K+++ ++ K A+ EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ ++ NE +V E G LSR + + K++ + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
++H + +HRD+KP+N+ + K+ D GL R + K + L GT Y++P
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 205
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKA 797
E K D++S G +L E+ +
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 54/223 (24%), Positives = 84/223 (37%), Gaps = 27/223 (12%)
Query: 595 ENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVG 652
VL GGF VY+ + + G + A+KR+ E+ E+ + K+ H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 653 LLGYCLDGNER-------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
G E L+ + +G L L + G PL L I R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRA 148
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA------ 759
V+++H IHRDLK N+LL + K+ DFG +S +
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 760 ----GTFGYLAPE-YAVTGR--VTTKVDVFSFGVILMELITGR 795
T Y PE + + K D+++ G IL L +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 24/224 (10%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + ++LG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 646 RHRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
H+++V L + R L+ E+ P G+L L P + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL--RDVV 122
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPDNGKHSIETRLA 759
G+ +L +HR++KP NI+ K+ DFG R D+ + + L
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVS-LY 176
Query: 760 GTFGYLAPE--------YAVTGRVTTKVDVFSFGVILMELITGR 795
GT YL P+ + VD++S GV TG
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-34
Identities = 80/363 (22%), Positives = 125/363 (34%), Gaps = 59/363 (16%)
Query: 560 QSLTSSGPSDLHVVEAGSMVISIQVLR---NVTNNFSEENVLGRGGFGTVYKG-ELHDGT 615
SSG +L+ + + +++ + LG G +G V +
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 616 KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675
+ A+K + VS ++ E+AVL + H +++ L + D LV E G
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE- 122
Query: 676 SRHLFNR-KEEGLKPLEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728
LF+ + I V GV YLH + +HRDLKP N+L
Sbjct: 123 ---LFDEIIHRM--------KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLL 168
Query: 729 L---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFG 785
L D K+ DFGL + + K GT Y+APE + + K DV+S G
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIG 224
Query: 786 VILMELITGRKAL-DETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTV 844
VIL L+ G +T E RK D ++S
Sbjct: 225 VILFILLAGYPPFGGQTDQE-----------------ILRKVEKGKYTFDSPEWKNVSEG 267
Query: 845 A-DLAGHCCAREPYQRPDMGHVVNVLSSLAELW-KPAEPDSDDIYGIDLDMTLPQALKKW 902
A DL + +R L W K + + + ++K+
Sbjct: 268 AKDLIKQMLQFDSQRRISAQQA------LEHPWIKEMCSKKESGIELPSLANAIENMRKF 321
Query: 903 QAY 905
Q
Sbjct: 322 QNS 324
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 588 VTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
+ + LG GGFG V + G ++A+K+ + S K + EI ++ K+
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLN 70
Query: 647 HRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
H ++V + LL EY G L ++L N+ E E R T+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR-TLLS 128
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETR 757
D++ + YLH IHRDLKP NI+L + K+ D G +
Sbjct: 129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEF 183
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
+ GT YLAPE + T VD +SFG + E ITG
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 66/392 (16%), Positives = 127/392 (32%), Gaps = 43/392 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
+ + IE K + L L+ L + N + P S SGL+SL+ ++ + S
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG--D 184
+ S L +L+ +++ +N S +P + T L + I + L +
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+ L ++ N + +F + L L G S + + +QN+ L L
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT--CLQNLAGLHVHRL 236
Query: 245 HGNSFTG-------PLPDLSGLSSLQ--DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
F + GL + +F + L +++ ++L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 296 FQGQTPKFNSPVRFDMAKGSNSF------------CLDDAGVACDGRVNVLLSIVKSVGY 343
+ ++ L N K V
Sbjct: 297 IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTM-------NKGSISFKKVAL 349
Query: 344 PAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQL 399
P+ L+ N + C + ++ +L++L LS +S+NF L L+ L
Sbjct: 350 PS-LSYLDLSRNALSF----SGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHL 404
Query: 400 MLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ L +L L LD+S +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-26
Identities = 65/362 (17%), Positives = 116/362 (32%), Gaps = 35/362 (9%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
+P ++ SS +++ N L S S S LQ + ++ + GL L
Sbjct: 25 KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198
+ L N S P S T L+ A + +G + L L++A NF
Sbjct: 83 SNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQ--LITLKKLNVAHNF 139
Query: 199 LQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQ----LWLHGNSFTG 251
+ +P F +++ + L+ + + +V +Q + Q L + N
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSY----NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195
Query: 252 PLPDLSGLSSLQDFSVRDNQLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTP-KFNSPVRF 309
L + ++R N + I+ + L NL L V L F+ + + P
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 310 DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV-GYPAVLAESWKGNNPCNSDWKGVSCDA 368
+ S A ++
Sbjct: 256 EGLCDVTIDEFRLTY-------TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHF- 307
Query: 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
+++ L L L+ L L+ N+ +I + LPSL LD+S N
Sbjct: 308 --KWQSLSIIRCQLK---QFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRN 360
Query: 429 HL 430
L
Sbjct: 361 AL 362
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 41/222 (18%), Positives = 77/222 (34%), Gaps = 10/222 (4%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFK--GLTSLQTISL 143
L L L + NK + L SL + N + + G SL+ + L
Sbjct: 325 LDLPFLKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
+N + + LQ + + + +F ++ L++L +++ +
Sbjct: 384 SFNGAII--MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSS 261
F +S+ TL + G +V N T+LT L L L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNV--FANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303
LQ ++ N L + S L+SL+ ++ + N +
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-24
Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 14/225 (6%)
Query: 79 GTLPKELNSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
G++ + +L SL+ L++ +N L+ S G +SL+ + N + + F GL
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA-NFMGL 398
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
LQ + +++ + L + N G + L L +A
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG--LTSLNTLKMA 456
Query: 196 FNFLQGPIPLSFGK--SSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGP 252
N + + +++ L L+ +L S V + L L + N+
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSK----CQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 253 LPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
+ L SL N++ SLA NLTNN
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-23
Identities = 49/367 (13%), Positives = 102/367 (27%), Gaps = 64/367 (17%)
Query: 79 GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL-SSLQEVLFDDNNFTSVPSDFFKGLTS 137
G+L + + ++T M KL+ ++P + SS + + N + S F +
Sbjct: 2 GSLNPCIEVVPNITYQ-CMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
LQ + L + ++ L G I P G + L +L
Sbjct: 58 LQWLDLSRCEI-ETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG--LTSLENLVAVET 114
Query: 198 FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPD- 255
L G + +L +L + N LP
Sbjct: 115 KLASLESFPIG--------------------------QLITLKKLNVAHNFIHSCKLPAY 148
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV----NLTNNLFQGQTPKFNSPVRF-- 309
S L++L + N + I + L L V +++ N + ++
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
Query: 310 -DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368
+ N + + + G + +
Sbjct: 209 LTL--RGNFNSSNIMKTCLQNLAGLHVH------------RLILGEFKDERNLEIFEPSI 254
Query: 369 GGNITVVNLKNLGLSGT-----ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEML 423
+ V + L+ T F L ++ + L+G + +++ + L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312
Query: 424 DVSNNHL 430
+ L
Sbjct: 313 SIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-19
Identities = 35/224 (15%), Positives = 72/224 (32%), Gaps = 12/224 (5%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFK 133
N + L L L+ + L + L L + N F
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLH 193
GLTSL T+ + NSF + + T L + + + L L+
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT--LHRLQLLN 503
Query: 194 LAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTG 251
++ N L + S+ TL + +++ + SL L NS
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSF----NRIETSKGILQHFPKSLAFFNLTNNSVAC 559
Query: 252 PLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + +++ + + ++ V +++ V++ N+
Sbjct: 560 -ICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 2/97 (2%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFK 133
+ TL + ++LT L++ K +L L LQ + NN + S +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
L SL T+ +N L F+
Sbjct: 519 QLYSLSTLDCSFNRI-ETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 18/70 (25%), Positives = 25/70 (35%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+T ++L L F L L+ L +S N L L SL LD S N +
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 431 FGKVPNFRQN 440
+
Sbjct: 534 ETSKGILQHF 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 14/60 (23%), Positives = 29/60 (48%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ ++N+ + L SS++++L SL L S N + + SL +++NN +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 371 NITVVNL-KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
++ + + N T+S+ F+ T+L L LS +L TL L++L++S+N+
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 430 L 430
L
Sbjct: 509 L 509
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-33
Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 28/207 (13%)
Query: 597 VLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGL 653
+ GG G +Y +G + +K + + + +E L +V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 654 LGYCLDGNERL-----LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+ + +V EY+ +L R + L + L++ + Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSY 197
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH ++ DLKP NI+L ++ + K+ D G V G L GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAPE 247
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
T D+++ G L L
Sbjct: 248 IV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 77/334 (23%), Positives = 121/334 (36%), Gaps = 56/334 (16%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
++ +LG+G FG V K + + AVK + A K + E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------ 697
+ H +++ L D + +V E G LF+ + R +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRK--------RFSEHDAAR 125
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSI 754
I V G+ Y+H + +HRDLKP NILL D K+ DFGL N K
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQSEDSVHLVTWF 813
GT Y+APE + G K DV+S GVIL L++G + + +
Sbjct: 181 -KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------- 229
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMGHVVNVLSSL 872
++ D +IS A DL P R L
Sbjct: 230 --------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC------L 275
Query: 873 AELW-KPAEPDSDDIYGIDLDMTLPQALKKWQAY 905
W + ++ I + + ++++QA
Sbjct: 276 EHPWIQKYSSETPTISDLPSLESAMTNIRQFQAE 309
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 28/226 (12%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + ++LG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 646 RHRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNR--KEEGLKPLEWTRRLTIALD 701
H+++V L + R L+ E+ P G L+ + L + L + D
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPDNGKHSIETR 757
V G+ +L +HR++KP NI+ K+ DFG R D+ + +
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVS- 174
Query: 758 LAGTFGYLAPE--------YAVTGRVTTKVDVFSFGVILMELITGR 795
L GT YL P+ + VD++S GV TG
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 71/334 (21%), Positives = 112/334 (33%), Gaps = 56/334 (16%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLT 643
++ + + VLG+G FG V + G + AVK + V + E+ +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT----- 697
++ H +++ L + D LV E G LF+ R +
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRK--------RFSEVDAA 129
Query: 698 -IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHS 753
I V G+ Y+H +HRDLKP N+LL D ++ DFGL + K
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQSEDSVHLVTW 812
GT Y+APE + G K DV+S GVIL L++G + +
Sbjct: 186 --KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------- 234
Query: 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMGHVVNVLSS 871
+K + +S A DL P R
Sbjct: 235 ---------ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA------ 279
Query: 872 LAELWKPAEPDSDDIYGIDLDMTLPQALKKWQAY 905
L W + ++++Q
Sbjct: 280 LDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT 313
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-32
Identities = 55/376 (14%), Positives = 110/376 (29%), Gaps = 66/376 (17%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
N + K + L+ L ++ + T ++ + + + L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD----YAKQYENEELSWSNL 490
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG------- 188
L + L +P+ L D LQ + +
Sbjct: 491 KDLTDVELYNCPN-MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 189 LMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
+ ++ +N L+ P S K + L +K+ + LT L L
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCV----HNKVR-HLEAFGTNVKLTDLKLDY 604
Query: 247 NSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQTPKF 303
N +P+ + ++ N+L I + +++ + V+ + N +
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGR-- 661
Query: 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKG 363
N D KG N+ + + N + +
Sbjct: 662 NISCSMDDYKGINASTVTLSY-------NEIQKFPTELF----------ATGS------- 697
Query: 364 VSCDAGGNITVVNLKNLGLS-------GTISSNFSRLTSLRQLMLSGNELTGTIPKEL-- 414
I+ + L N ++ N+ L + L N+LT ++ +
Sbjct: 698 -------PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA 749
Query: 415 TTLPSLEMLDVSNNHL 430
TTLP L +DVS N
Sbjct: 750 TTLPYLSNMDVSYNCF 765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-31
Identities = 58/381 (15%), Positives = 107/381 (28%), Gaps = 68/381 (17%)
Query: 71 QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSD 130
I + K+ T + + N++T ++ L+ LQ + F ++ FT
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI- 465
Query: 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
+ + DY S + L +PDFL +P L
Sbjct: 466 ----AVDWEDANSDYAKQYE-NEELSWSNLKDLTDVELYNCPNMTQLPDFLYD--LPELQ 518
Query: 191 HLHLAFNFLQGP---------IPLSFGK-SSIQTLWLNGQKGDSKLNG--SVAVIQNMTS 238
L++A N + IQ ++ + L + A +Q M
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG----YNNLEEFPASASLQKMVK 574
Query: 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N L L D + NQ+ I + + ++N +
Sbjct: 575 LGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 299 QTPKFNSPVRFDMAKGSN--SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
P F+ S N + S +++ +
Sbjct: 634 ------IPNIFNAKSVYVMGSVDFSY---------NKIGSEGRNISCSMDDYK------- 671
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT-------GT 409
G N + V L + + F+ + + ++LS N +T
Sbjct: 672 ------------GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 410 IPKELTTLPSLEMLDVSNNHL 430
L +D+ N L
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-30
Identities = 40/230 (17%), Positives = 75/230 (32%), Gaps = 16/230 (6%)
Query: 80 TLPKE--LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
P L + L +L+ + NK+ + + L ++ D N +P DF
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQ 620
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG---TIPDFLGGDTIPGLMHLHL 194
++ + +N + K + + I I + + L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 195 AFNFLQGPIPLSFGK-SSIQTLWLNG----QKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249
++N +Q F S I T+ L+ ++ L +N LT + L N
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 250 TGPLPD---LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
T L D + L L + V N + P+ +N L + +
Sbjct: 741 TS-LSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRD 788
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 36/254 (14%), Positives = 73/254 (28%), Gaps = 28/254 (11%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG---------QIP-SLSGLSSLQEV 117
T +++ LP L L L L + N+ ++ +Q
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 118 LFDDNNFTSVP-SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT 176
NN P S + + L + +N E+ L + I
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKV---RHLEAFGTNVKLTDLKLDYNQIE-E 609
Query: 177 IPDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWL--NGQKGDSKLNGSVAV 232
IP+ T + L + N L+ P + + ++ N + +
Sbjct: 610 IPEDFCAFT-DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGI-------VPSSLVNLH 284
+ + + L N + + S + + +N +T I + N +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 285 SLAVVNLTNNLFQG 298
L ++L N
Sbjct: 729 LLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-26
Identities = 51/426 (11%), Positives = 112/426 (26%), Gaps = 68/426 (15%)
Query: 19 TLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIE 78
L ++ D A++A+ +L ++ + + + +
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWG------- 312
Query: 79 GTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
+L++ +T L + G++P ++ L+ L+ + F ++ T F +
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
+ L L I P+ I + L
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKP---IKKDSRISLKDT 428
Query: 198 FLQG------PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
+ I + + + +Q ++ S
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFAN----SPFTY----DNIAVDWEDANSDYAKQY 480
Query: 251 GPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRF 309
S L L D + + +P L +L L +N+ N R
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 310 DMAKGSNS----FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365
+ + F + N L A +
Sbjct: 541 ADDEDTGPKIQIFYMGY---------NNLEEFP---------ASASLQKMV--------- 573
Query: 366 CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLD 424
+ +++ + + + + F L L L N++ IP++ +E L
Sbjct: 574 -----KLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 425 VSNNHL 430
S+N L
Sbjct: 626 FSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-24
Identities = 37/233 (15%), Positives = 76/233 (32%), Gaps = 22/233 (9%)
Query: 80 TLPK--ELNSLSSLTVLEVMKNKLTGQIPSLSG------LSSLQEVLFDDNNFTSVPSDF 131
+P S+ + ++ NK+ + ++S + V N P++
Sbjct: 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 132 FKGLTSLQTISLDYNSFDS------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
F + + TI L N S + K+ L +T ++ D T
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS--KLNGSV-AVIQNMTSLTQ 241
+P L ++ +++N P S ++ + Q+ ++ I SL Q
Sbjct: 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810
Query: 242 LWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L + N + + L + DN I +S+ + L +
Sbjct: 811 LQIGSNDIRK-VDE-KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-22
Identities = 35/239 (14%), Positives = 70/239 (29%), Gaps = 34/239 (14%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+P++ + L NKL IP + + + V F N S + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 136 -----TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT----- 185
+ T++L YN E + + + +T +IP+
Sbjct: 668 DDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYK 725
Query: 186 -IPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
L + L FN L + + ++ + + N + L
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSY----NCFSSFPTQPLNSSQLKAF 781
Query: 243 ------WLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
GN P ++ SL + N + + L+ L ++ +N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYIL---DIADN 837
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 6e-20
Identities = 46/363 (12%), Positives = 94/363 (25%), Gaps = 69/363 (19%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISLD 144
N L+ + + + I L ++ E L N + S + +
Sbjct: 249 NKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFN--- 305
Query: 145 YNSFDSW--VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
D W L + + S G G +PD +G + L L +
Sbjct: 306 -KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQ--LTELKVLSFGTHSETVS 362
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT-----GPLPDLS 257
L + + +K +++ + L L ++ P+ S
Sbjct: 363 GRLFGDEELTPDMSEE-RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
Query: 258 GLS-SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSN 316
+S N++T I ++ L L ++ N+ F
Sbjct: 422 RISLKDTQIGNLTNRITFI-SKAIQRLTKLQIIYFANSPF-------------------T 461
Query: 317 SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVN 376
+ + N ++T V
Sbjct: 462 YDNIAVDWEDANSDYAKQYENE-----ELSW-----SNLK--------------DLTDVE 497
Query: 377 LKNLGLSGTISSNFSRLTSLRQLMLSGNELTG---------TIPKELTTLPSLEMLDVSN 427
L N + L L+ L ++ N + + T P +++ +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 428 NHL 430
N+L
Sbjct: 558 NNL 560
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-12
Identities = 30/253 (11%), Positives = 63/253 (24%), Gaps = 65/253 (25%)
Query: 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSV 267
+ W ++ D + + N +T L L G G +PD + L+ L+ S
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVAC 327
+ T + + + + K D
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK-------------MFLDYDQRLNLS 401
Query: 328 DGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG--- 384
D + + + + ++LK+ +
Sbjct: 402 DLLQDAINRNPEMKPIK--------------------------KDSRISLKDTQIGNLTN 435
Query: 385 ---TISSNFSRLTSLRQLMLSGNELTG-------------------TIPKELTTLPSLEM 422
IS RLT L+ + + + T + L L
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495
Query: 423 LDVSNNHLFGKVP 435
+++ N ++P
Sbjct: 496 VELYNCPNMTQLP 508
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 344 PAVLAESWKGNNPCNS--DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML 401
+ + +W N + D GV D G +T ++L G G + +LT L+ L
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 402 SGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436
+ T + + +M + + +
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 11/55 (20%), Positives = 26/55 (47%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + + + SL QL + N++ + ++L P L +LD+++N
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 10/65 (15%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQL------MLSGNELTGTIPKELTTLPSLEMLDV 425
L N+ +S + + + L+ GN + P +TT PSL L +
Sbjct: 754 YLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 426 SNNHL 430
+N +
Sbjct: 814 GSNDI 818
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-32
Identities = 36/235 (15%), Positives = 67/235 (28%), Gaps = 41/235 (17%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVK--------------RMESAVVSEKGFAEFKSEIAV 641
VLG+ + G V +M+ V+ + K++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 642 LTKVR---------HRHLVGLLGYCLDGNERLLVYEY--MPQ-----GTLSRHLFNRKEE 685
+R ++ LD + ++ + P+ T L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
K L RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 205 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 746 APDNGKHSIETRLAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGR 795
S R A +T D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 22/262 (8%)
Query: 540 GNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLG 599
G A + + + G ++ Q L + V+ + R + + + +G
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 600 RGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658
RG FG V++ + G + AVK++ V + E+ + +V L G
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVR 120
Query: 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFI 718
+G + E + G+L + + K+ G L R L G+EYLH + +
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI---KQMG--CLPEDRALYYLGQALEGLEYLHT---RRIL 172
Query: 719 HRDLKPSNILLGDD-MRAKVADFGL-VRLAPDNGKHSIETR--LAGTFGYLAPEYAVTGR 774
H D+K N+LL D RA + DFG + L PD S+ T + GT ++APE V G+
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGK 231
Query: 775 -VTTKVDVFSFGVILMELITGR 795
KVD++S +++ ++ G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGC 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-32
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 10/209 (4%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+ F + VLGRGGFG V+ ++ K+ A K++ + KG+ E +L KV
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
R +V L Y + L LV M G + H++N E+ E A + G+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGL 302
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
E+LH ++ I+RDLKP N+LL DD +++D GL + AGT G++A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGY-AGTPGFMA 357
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGR 795
PE + VD F+ GV L E+I R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 37/241 (15%), Positives = 72/241 (29%), Gaps = 52/241 (21%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVK--------------RMESAVVSEKGFAEFKSEIAV 641
VLG+ + + G V +M+ V+ + K++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 642 LTKVR------------HRHLVGLLGYCLDGN--ERLLVYEYMPQ--GTLSRHLFNRKEE 685
+R + ++ + D R +Y M T L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
K L RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 200 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 746 APDNGKHSIETRLAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITG 794
+ + + G+ PE +T D ++ G+++ +
Sbjct: 255 -----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 795 R 795
Sbjct: 310 D 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 49/237 (20%), Positives = 83/237 (35%), Gaps = 44/237 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
T F E +G G FG+V+K + DG A+KR + + E+ +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+H H+V + + L+ EY G+L+ + + + L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDD-------------------MRAKVADFGLVRL 745
G+ Y+H S +H D+KPSNI + + K+ D G V
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 746 APDNGKHSIETRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ E G +LA E + K D+F+ + ++
Sbjct: 184 I--SSPQVEE----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 45/288 (15%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK----RMESAVVSEKGFAEFKSEIA 640
+ V + + LG G F V K E G + A K R A E + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIA 699
+L +V H +++ L + + +L+ E + G LF+ ++ + +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKE----SLSEEEATS 119
Query: 700 L--DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHS 753
+ GV YLH + H DLKP NI+L K+ DFGL D +
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTW 812
+ GT ++APE + + D++S GVI L++G L +T+ E
Sbjct: 177 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------- 225
Query: 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
T + D DEE + S +A D +E +R
Sbjct: 226 ---------TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 45/287 (15%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA----EFKSEIAV 641
V +++ LG G F V K + G + A K ++ +S E + E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL 700
L ++RH +++ L + + +L+ E + G LF+ E+ T
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKE----SLTEDEATQF 113
Query: 701 --DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHSI 754
+ GV YLH + H DLKP NI+L + R K+ DFG+ +
Sbjct: 114 LKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWF 813
+ GT ++APE + + D++S GVI L++G L ET+ E
Sbjct: 171 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------- 218
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
T D DEE ++ S +A D ++P +R
Sbjct: 219 --------TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
N F + VLG+GGFG V ++ K+ A K++E + KG A +E +L KV
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
R +V L Y + + L LV M G L H+++ + G E A ++ G+
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAA-EICCGL 299
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
E LH + ++RDLKP NILL D +++D GL P+ I+ R GT GY+A
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMA 353
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGR 795
PE R T D ++ G +L E+I G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+F +LG G F TV ++ A+K +E ++ E E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDV 702
V L D +E+L Y G L +++ ++ G TR + AL
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSAL-- 143
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
EYLHG IHRDLKP NILL +DM ++ DFG ++ K + GT
Sbjct: 144 ----EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 763 GYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 795
Y++PE +T + K D+++ G I+ +L+ G
Sbjct: 197 QYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-31
Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 40/283 (14%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+V + + LG G FG V++ E G K + + +K K+EI+++ ++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQL 105
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL--DV 702
H L+ L D E +L+ E++ G LF+R E K + I
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYK---MSEAEVINYMRQA 158
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
G++++H S +H D+KP NI+ K+ DFGL + +
Sbjct: 159 CEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTA 212
Query: 761 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWFRRMHIN 819
T + APE V D+++ GV+ L++G E E
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------------- 257
Query: 820 KDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPD 861
T + + DE+ +S+S A D + +EP +R
Sbjct: 258 --TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 59/290 (20%), Positives = 102/290 (35%), Gaps = 55/290 (18%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ + + LGRG FG V++ E K ++ V K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVA 703
RHR+++ L E ++++E++ +F R + E ++
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNE--------REIV 105
Query: 704 R-------GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSI 754
+++LH + H D++P NI+ K+ +FG R +
Sbjct: 106 SYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 755 ETRLAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVT 811
L Y APE V V+T D++S G ++ L++G L ET +
Sbjct: 163 ---LFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------- 210
Query: 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
++ DEE IS A D +E R
Sbjct: 211 ----------IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-31
Identities = 61/395 (15%), Positives = 117/395 (29%), Gaps = 63/395 (15%)
Query: 49 TDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-S 107
+ C N+ + +P L +S LE N L +
Sbjct: 3 SSDQKC-----IEKEVNKT--YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTT 52
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167
S L +L + + D F+ L T+ L N + +L L+
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLF 111
Query: 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKL 226
I+ L L L+L N + ++ L
Sbjct: 112 FIQTGISSIDFIPLHN--QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVN--LH 284
++ +Q T+L+ L L+GN G P + Q + Q ++ L N +
Sbjct: 170 KEDMSSLQQATNLS-LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 285 SLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYP 344
SL + + + +P F+ + ++ L
Sbjct: 229 SLWLGTFEDMDDEDISPAV-----FEGLCEMSVESIN-------------LQ-------- 262
Query: 345 AVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLM 400
+ + +S + + L+ L L+ + S L++L++L+
Sbjct: 263 --------KHY-----FFNISSNTFHCFS--GLQELDLTATHLSELPSGLVGLSTLKKLV 307
Query: 401 LSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
LS N+ + PSL L + N ++
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-26
Identities = 44/250 (17%), Positives = 87/250 (34%), Gaps = 15/250 (6%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN 122
V I + + S L L++ L+ L GLS+L++++ N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR--FSANGANITGTIPDF 180
F ++ SL +S+ N+ + L++ L+ S + +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG--SVAVIQNMT 237
L + L L+L++N +F + ++ L L ++L + + QN+
Sbjct: 372 LRN--LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF----TRLKVKDAQSPFQNLH 425
Query: 238 SLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIV---PSSLVNLHSLAVVNLTN 293
L L L + GL +LQ +++ N +SL L L ++ L+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 294 NLFQGQTPKF 303
Sbjct: 486 CDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 41/236 (17%), Positives = 79/236 (33%), Gaps = 23/236 (9%)
Query: 76 NIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDF 131
L L +L +L L++ + + L LS LQ + N S+ ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191
FK L+ + L + ++ L+ + + + + + G +P L H
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG--LPALQH 453
Query: 192 LHLAFNFLQGPIPLSFGK----SSIQTLWLNGQKGDSKLNG----SVAVIQNMTSLTQLW 243
L+L N ++ L L+ ++ + +
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF-------CDLSSIDQHAFTSLKMMNHVD 506
Query: 244 LHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L N T + LS L + ++ N ++ I+PS L L +NL N
Sbjct: 507 LSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-23
Identities = 38/232 (16%), Positives = 78/232 (33%), Gaps = 9/232 (3%)
Query: 71 QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSD 130
Q +G + SL T ++ ++ + S++ + + F ++ S+
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
F + LQ + L +P L + L++ + P L
Sbjct: 273 TFHCFSGLQELDLTATHLSE--LPSGLVGLSTLKKLVLSANKFENLCQISASN--FPSLT 328
Query: 191 HLHLAFNFLQGPIPLSF--GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
HL + N + + +++ L L+ + ++N++ L L L N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDD-IETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 249 FTG-PLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQG 298
L+ + +L S NLH L V+NL+++L
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-19
Identities = 40/319 (12%), Positives = 75/319 (23%), Gaps = 70/319 (21%)
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+ +P S + + +N + + + L I D
Sbjct: 21 NLGLNEIPGTLP---NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
L L L N L + +L
Sbjct: 77 FQS--QHRLDTLVLTANPLIFMAETAL--------------------------SGPKALK 108
Query: 241 QLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299
L+ + L +L+ + N ++ I L V++ NN
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359
+ + + + + L+ G N + I AV G
Sbjct: 169 SKED-----MSSLQQATNLSLNLNG-------NDIAGIEPGAFDSAVFQSLNFGGT---- 212
Query: 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP- 418
+V K L S + SL + P L
Sbjct: 213 -----------QNLLVIFKGLK--------NSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 419 -SLEMLDVSNNHLFGKVPN 436
S+E +++ ++ F N
Sbjct: 254 MSVESINLQKHYFFNISSN 272
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
L+ L L+ S F L L+ L LS + L + + LP+L+ L++ NH
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460
Query: 430 L 430
Sbjct: 461 F 461
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/62 (25%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 371 NITVVNLKN--LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
N+ ++L + + S + L+ L+ L LS NE + P LE+LD++
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 429 HL 430
L
Sbjct: 411 RL 412
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-06
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 8/63 (12%)
Query: 376 NLKNLGLSG--------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
L++L L G +++ L L L+LS +L+ T+L + +D+S+
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 428 NHL 430
N L
Sbjct: 510 NRL 512
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE---LTTLPSLEMLDVSN 427
+ V+NL + L + F L +L+ L L GN ++ L TL LE+L +S
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 428 NHL 430
L
Sbjct: 486 CDL 488
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 14/61 (22%), Positives = 28/61 (45%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
+L++L LS ++ + F L L L+ L + L L++L++S++
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 430 L 430
L
Sbjct: 437 L 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 1/70 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ ++ L LS F+ L + + LS N LT + + L+ L + L++++NH+
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 431 FGKVPNFRQN 440
+P+
Sbjct: 536 SIILPSLLPI 545
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 14/63 (22%), Positives = 30/63 (47%), Gaps = 3/63 (4%)
Query: 371 NITVVNLKNLGLSGTISSN-FSRLTSLRQLMLSGNELT--GTIPKELTTLPSLEMLDVSN 427
++T +++K + + L +LR+L LS +++ +L L L+ L++S
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 428 NHL 430
N
Sbjct: 386 NEP 388
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 13/60 (21%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ V+L + L+ + S L + L L+ N ++ +P L L +++ N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 66/287 (22%), Positives = 110/287 (38%), Gaps = 45/287 (15%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA----EFKSEIAV 641
V + + LG G F V K E G + A K ++ E + E+++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL 700
L +V H +++ L + + +L+ E + G LF+ ++ + +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKE----SLSEEEATSF 120
Query: 701 --DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHSI 754
+ GV YLH + H DLKP NI+L K+ DFGL D +
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWF 813
+ GT ++APE + + D++S GVI L++G L +T+ E
Sbjct: 178 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 225
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
T + D DEE + S +A D +E +R
Sbjct: 226 --------TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 45/287 (15%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK----RMESAVVSEKGFAEFKSEIAV 641
NV + + LG G F V K E G + A K R + + + E+++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL 700
L +++H +++ L + + +L+ E + G LF+ E+ T
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKE----SLTEEEATEF 119
Query: 701 --DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHSI 754
+ GV YLH L H DLKP NI+L R K+ DFGL +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174
Query: 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWF 813
+ GT ++APE + + D++S GVI L++G L +T+ E
Sbjct: 175 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 224
Query: 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
T + ++E ++ S +A D ++P +R
Sbjct: 225 --------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 78/277 (28%), Positives = 121/277 (43%), Gaps = 40/277 (14%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
S+ +LG G FG V+K E G K+A K +++ + +K E K+EI+V+ ++ H +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHAN 147
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVARGVEY 708
L+ L N+ +LV EY+ G LF+R +E E L + + G+ +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYNLTELDTILFM-KQICEGIRH 202
Query: 709 LHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+H +H DLKP NIL D + K+ DFGL R K + GT +LA
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLA 256
Query: 767 PEYAVTGR--VTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWFRRMHINKDTF 823
PE V V+ D++S GVI L++G L + +E T
Sbjct: 257 PE--VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-----------------TL 297
Query: 824 RKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
+ DL++E IS A + +E R
Sbjct: 298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR 334
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
VLG+G +G VY G +L + +IA+K + + EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT--IALDVARGVEYLHGLA 713
+ + E +P G+LS L R + G PL+ + + G++YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALL--RSKWG--PLKDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 714 HQSFIHRDLKPSNILLGDDM-RAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE--- 768
+HRD+K N+L+ K++DFG RLA G + GT Y+APE
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPEIID 196
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
G D++S G ++E+ TG+
Sbjct: 197 KGPRGY-GKAADIWSLGCTIIEMATGK 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 72/287 (25%), Positives = 107/287 (37%), Gaps = 49/287 (17%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ +LG+G FG V K + + AVK + A K + E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------I 698
H +++ L D + +V E G LF+ + R + I
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRK--------RFSEHDAARI 126
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIE 755
V G+ Y+H + +HRDLKP NILL D K+ DFGL N K
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--- 180
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQSEDSVHLVTWFR 814
GT Y+APE + G K DV+S GVIL L++G + + +
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---------- 229
Query: 815 RMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
++ D +IS A DL P R
Sbjct: 230 -------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 19/248 (7%)
Query: 549 ESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYK 608
SS G+E+ S + A MV+ + +G G G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG---DPRLLLDSYVKIGEGSTGIVCL 63
Query: 609 G-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667
E H G ++AVK M+ + ++ +E+ ++ +H ++V + L G E ++
Sbjct: 64 AREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727
E++ G L+ + L + T+ V + + YLH Q IHRD+K +I
Sbjct: 122 EFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172
Query: 728 LLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGV 786
LL D R K++DFG +++ D K L GT ++APE T+VD++S G+
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 787 ILMELITG 794
+++E++ G
Sbjct: 230 MVIEMVDG 237
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++N+ + LG+G F V + G + A K + + +S + F + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIAL 700
+H ++V L + + LV++ + G L +R ++ +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD--------ASHCI--Q 112
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETR 757
+ + Y H +HR+LKP N+LL K+ADFGL D+
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HG 166
Query: 758 LAGTFGYLAPE------YAVTGRVTTKVDVFSFGVIL 788
AGT GYL+PE Y + VD+++ GVIL
Sbjct: 167 FAGTPGYLSPEVLKKDPY------SKPVDIWACGVIL 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 63/330 (19%), Positives = 112/330 (33%), Gaps = 67/330 (20%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK---RMESAVVSEKGF 632
++ L + + + +G+G +G V E A+K + + ++ K
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 633 AEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
K+E+ ++ K+ H ++ L D LV E G L L ++
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 693 TRRLT-----------------------------------IALDVARGVEYLHGLAHQSF 717
T I + + YLH +Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGI 189
Query: 718 IHRDLKPSNILLGDDMRA--KVADFGLVRL--APDNGKHSIETRLAGTFGYLAPE--YAV 771
HRD+KP N L + K+ DFGL + +NG++ T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 772 TGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830
K D +S GV+L L+ G ++ T + +++
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-----------------TISQVLNKK 292
Query: 831 IDLDEETLASISTVA-DLAGHCCAREPYQR 859
+ + +S +A DL + R +R
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDER 322
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-30
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 60/298 (20%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK-----------RMESAVVSEKGFAE 634
+ ++ + LG G +G V E + ++ A+K + EK E
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWT 693
+EI++L + H +++ L D LV E+ G L F +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRH------- 141
Query: 694 RRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 744
+ I + G+ YLH + +HRD+KP NILL + K+ DFGL
Sbjct: 142 -KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQS 803
+ K GT Y+APE + + K DV+S GVI+ L+ G +
Sbjct: 198 FFSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253
Query: 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
+ +K D +IS A +L + +R
Sbjct: 254 D-----------------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 77/301 (25%), Positives = 120/301 (39%), Gaps = 44/301 (14%)
Query: 573 VEAGSMVISIQVLRNVTNNFS-EENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEK 630
V+ G+ + Q + N N + LGRG F V + G + A K ++ +
Sbjct: 11 VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD 70
Query: 631 GFAEFKSEIAVLTKVRHR-HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR---KEEG 686
AE EIAVL + ++ L + +E +L+ EY G + F+ +
Sbjct: 71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAE 126
Query: 687 LKPLEWTRRLTIAL--DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 741
+ + I L + GV YLH + +H DLKP NILL K+ DFG
Sbjct: 127 M----VSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDE 800
+ R + + GT YLAPE +TT D+++ G+I L+T + E
Sbjct: 180 MSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236
Query: 801 TQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
E T+ +D EET +S+S +A D + P +R
Sbjct: 237 DNQE-----------------TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR 279
Query: 860 P 860
P
Sbjct: 280 P 280
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 74/327 (22%), Positives = 119/327 (36%), Gaps = 53/327 (16%)
Query: 550 SSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEE----NVLGRGGFGT 605
S V G + S + S+V + + + S+ + LGRG
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 606 VYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664
VY+ + A+K ++ V + ++EI VL ++ H +++ L E
Sbjct: 69 VYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 665 LVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------IALDVARGVEYLHGLAHQSF 717
LV E + G LF+R E+G + + V YLH
Sbjct: 125 LVLELVTGG----ELFDRIVEKG--------YYSERDAADAVKQILEAVAYLH---ENGI 169
Query: 718 IHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
+HRDLKP N+L D K+ADFGL ++ + GT GY APE
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCA 226
Query: 775 VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD 834
+VD++S G+I L+ G F ++ FR+ ++
Sbjct: 227 YGPEVDMWSVGIITYILLCG---------------FEPFYDERGDQFMFRRILNCEYYFI 271
Query: 835 EETLASISTVA-DLAGHCCAREPYQRP 860
+S A DL +P +R
Sbjct: 272 SPWWDEVSLNAKDLVRKLIVLDPKKRL 298
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 70/298 (23%), Positives = 115/298 (38%), Gaps = 44/298 (14%)
Query: 517 KRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAG 576
++R + + + S +E++ L + P +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 577 SMVISIQVLR-NVTNNFSEE----NVLGRGGFGTVYKG-ELHDGTKIAVKRME------S 624
SM ++ F ++ +V+GRG V + G + AVK ME S
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 625 AVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR- 682
E+ + E +L +V H H++ L+ + LV++ M +G L F+
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYL 191
Query: 683 KEEGLKPLEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736
E+ L+ I + V +LH + +HRDLKP NILL D+M+ +
Sbjct: 192 TEKV--------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR 240
Query: 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGVIL 788
++DFG K L GT GYLAPE +VD+++ GVIL
Sbjct: 241 LSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-30
Identities = 74/357 (20%), Positives = 121/357 (33%), Gaps = 44/357 (12%)
Query: 516 RKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEA 575
R + QS P + + G + SS +
Sbjct: 81 RIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140
Query: 576 GSMVISIQVLR--NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGF 632
++ +V +++ LG G FG V++ E G A K + E
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDK 198
Query: 633 AEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR--KEEGLKPL 690
+ EI ++ +RH LV L D NE +++YE+M G LF + E
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHN---- 250
Query: 691 EWTRRLTIAL--DVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLA 746
+ + + V +G+ ++H +++H DLKP NI+ K+ DFGL
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSED 805
+ GT + APE A V D++S GV+ L++G E E
Sbjct: 308 DPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE- 363
Query: 806 SVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPD 861
T R ++D+ + IS D +P R
Sbjct: 364 ----------------TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 68/297 (22%), Positives = 100/297 (33%), Gaps = 59/297 (19%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK-------RMESAVVSEKGFAEFKSE 638
N+ + +LGRG V + + AVK SA ++ E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 639 IAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRL 696
+ +L KV H +++ L LV++ M +G LF+ E+ L
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKV--------TL 121
Query: 697 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ I + + LH + +HRDLKP NILL DDM K+ DFG
Sbjct: 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 751 KHSIETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQS 803
K + GT YLAPE +VD++S GVI+ L+ G Q
Sbjct: 179 KL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235
Query: 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
R + S DL +P +R
Sbjct: 236 L-----------------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 67/287 (23%), Positives = 102/287 (35%), Gaps = 51/287 (17%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ ++ EN +GRG +G V + + A K++ V + FK EI ++ +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSL 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------I 698
H +++ L D + LV E G LF R + I
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKR--------VFRESDAARI 111
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIE 755
DV V Y H + HRDLKP N L D K+ DFGL
Sbjct: 112 MKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--- 165
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWFR 814
GT Y++P+ + G + D +S GV++ L+ G T SE
Sbjct: 166 RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---------- 214
Query: 815 RMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
K + T E+ ++S A L + P QR
Sbjct: 215 -------VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI 254
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-30
Identities = 58/242 (23%), Positives = 98/242 (40%), Gaps = 41/242 (16%)
Query: 566 GPSDLHVVEAGSMVISIQVLRNVTNNFSEE----NVLGRGGFGTVYKG-ELHDGTKIAVK 620
GP + M + + N + FS+ LG+G F V + G + A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 621 RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL----- 675
+ + +S + F + + E + K++H ++V L + + LV++ + G L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDD 732
+R ++ + + + Y H +HR+LKP N+LL
Sbjct: 121 AREFYSEAD--------ASHCI--QQILESIAYCH---SNGIVHRNLKPENLLLASKAKG 167
Query: 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGV 786
K+ADFGL D+ AGT GYL+PE Y + VD+++ GV
Sbjct: 168 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPY------SKPVDIWACGV 218
Query: 787 IL 788
IL
Sbjct: 219 IL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 60/223 (26%), Positives = 90/223 (40%), Gaps = 39/223 (17%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE------FKSE 638
+ + + + LG G G V E K+A+K + + E ++E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 639 IAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT 697
I +L K+ H ++ + + D + +V E M G LF++ RL
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVVGNK--------RLK 112
Query: 698 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPD 748
+ V+YLH IHRDLKP N+LL +D K+ DFG ++ +
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 749 NGKHSIETRLAGTFGYLAPE---YAVTGRVTTKVDVFSFGVIL 788
S+ L GT YLAPE T VD +S GVIL
Sbjct: 170 T---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/229 (25%), Positives = 114/229 (49%), Gaps = 19/229 (8%)
Query: 568 SDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV 626
SD ++E ++S+ + ++ +G+G GTVY ++ G ++A+++M +
Sbjct: 1 SDEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--L 55
Query: 627 VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG 686
+ +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRL 745
++ + + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
P+ K + + GT ++APE KVD++S G++ +E+I G
Sbjct: 167 TPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
N+ F VLG G F V+ + G A+K ++ + + ++EIAVL K+
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKI 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------I 698
+H ++V L LV + + G LF+R E G T +
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERG--------VYTEKDASLV 111
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIE 755
V V+YLH +HRDLKP N+L ++ + + DFGL ++ + I
Sbjct: 112 IQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 788
+ GT GY+APE + VD +S GVI
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKV-- 645
N+FS ++GRGGFG VY D K+ A+K ++ + ++G +E +L+ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 646 -RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+V + Y ++L + + M G L HL + E R A ++
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFS--EADMRFYAA-EII 302
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+E++H ++RDLKP+NILL + +++D GL H+ GT G
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 355
Query: 764 YLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 795
Y+APE G D FS G +L +L+ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 23/226 (10%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFA 633
+ +V ++F + + LG G G V+K H + +A K + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEI-KPAIRN 76
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
+ E+ VL + ++VG G E + E+M G+L + L K+ G P +
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQIL 133
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDN 749
+ +++ V +G+ YL +HRD+KPSNIL+ K+ DFG L+
Sbjct: 134 GK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 184
Query: 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
S+ GT Y++PE + + D++S G+ L+E+ GR
Sbjct: 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 32/252 (12%)
Query: 557 SESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK 616
+ + P D + + ++ V+G G FG V++ +L + +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 617 IAVKRMESAVVSEKGFAEFKS-EIAVLTKVRHRHLVGLLGYCLDGNERL------LVYEY 669
+A+K++ FK+ E+ ++ V+H ++V L + ++ LV EY
Sbjct: 67 VAIKKVLQ-------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 670 MPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727
+P+ T+ R + + ++ + P+ + L R + Y+H + HRD+KP N+
Sbjct: 120 VPE-TVYRASRHYAKLKQTM-PMLLIKLYMYQL--LRSLAYIHSI---GICHRDIKPQNL 172
Query: 728 LL-GDDMRAKVADFGLVR-LAPDNGK-HSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFS 783
LL K+ DFG + L I +R Y APE TT +D++S
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWS 227
Query: 784 FGVILMELITGR 795
G ++ EL+ G+
Sbjct: 228 TGCVMAELMQGQ 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-29
Identities = 69/291 (23%), Positives = 108/291 (37%), Gaps = 45/291 (15%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE------FKSE 638
+ + + + LG G G V E K+A++ + + E ++E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 639 IAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR--KEEGLKPLEWTRRL 696
I +L K+ H ++ + + D + +V E M G L F++ + LK +
Sbjct: 191 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEAT-CKLY 244
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHS 753
+ V+YLH IHRDLKP N+LL +D K+ DFG ++ + S
Sbjct: 245 F--YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---S 296
Query: 754 IETRLAGTFGYLAPE---YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810
+ L GT YLAPE T VD +S GVIL ++G
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---------------Y 341
Query: 811 TWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
F + + E A +S A DL +P R
Sbjct: 342 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 67/283 (23%), Positives = 107/283 (37%), Gaps = 39/283 (13%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + F + LG G FG V+ E G + +K + + ++EI VL +
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSL 77
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL--DV 702
H +++ + D + +V E G L R + + L +
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ Y H Q +H+DLKP NIL K+ DFGL L + T A
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA 187
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWFRRMHI 818
GT Y+APE VT K D++S GV++ L+TG + E
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------------- 232
Query: 819 NKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRP 860
+KA + + E ++ A DL ++P +RP
Sbjct: 233 ---VQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRP 271
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 52/352 (14%), Positives = 122/352 (34%), Gaps = 16/352 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
S + V + T IPS ++++ + N T + + +LQ + L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPS-GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPL 205
+ + ++ L+ + +++ + G + L +L+L N Q +
Sbjct: 61 RI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP--LSSLKYLNLMGNPYQTLGVTS 117
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQ 263
F +++QTL + + S++ +TSL +L + S L + +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRID--FAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175
Query: 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323
++ ++ ++ L S+ + L + +F
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383
+ LL + + + G N V + G + V ++ L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE-LGKVETVTIRRLHIP 294
Query: 384 G-----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+S+ +S L ++++ + +++ L SLE LD+S N +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 72/379 (18%), Positives = 128/379 (33%), Gaps = 40/379 (10%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFK 133
I +L + ++L VL + +++ I + L SL+ + DN+ +S+ S +F
Sbjct: 37 KITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP--DFLGGDTIPGLMH 191
L+SL+ ++L N + + + + T LQ I DF G + L
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG---LTSLNE 152
Query: 192 LHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVI-QNMTSLTQLWLHGNSF 249
L + L+ S I L L+ S+ + + ++S+ L L +
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLH----LSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 250 TG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR 308
L + + + S L L L + + N
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK------GNNPCNSDWK 362
F+ ++ L R + V + K N+
Sbjct: 269 FNPSESDVVSELGKVETV-TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL--- 324
Query: 363 GVSCDAGGNITVVNLKNLGLSG--------TISSNFSRLTSLRQLMLSGNELTGTIPKE- 413
V C ++ +L+ L LS S+ SL+ L+LS N L ++ K
Sbjct: 325 -VPCSFSQHLK--SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTG 380
Query: 414 --LTTLPSLEMLDVSNNHL 430
L TL +L LD+S N
Sbjct: 381 EILLTLKNLTSLDISRNTF 399
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 53/372 (14%), Positives = 119/372 (31%), Gaps = 63/372 (16%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
+ +L++L L + + +I +GL+SL E+ + + S K +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG---------TIPDFLGGDTIPG 188
+ ++L + ++++ + ++ N+ + + G
Sbjct: 174 IHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN-----MTSLTQLW 243
+ +FN L + S ++ V+ ++ +L
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 244 LHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
+ L S L ++ +V ++++ + S +L SL ++L+ NL +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY-- 350
Query: 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWK 362
+ + L N L S+
Sbjct: 351 LKNSACKGAWPSLQTLVLSQ---------NHLRSM------------------------- 376
Query: 363 GVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP 418
+T+ NL +L +S + + +R L LS + + +
Sbjct: 377 --QKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQ 431
Query: 419 SLEMLDVSNNHL 430
+LE+LDVSNN+L
Sbjct: 432 TLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-22
Identities = 46/239 (19%), Positives = 79/239 (33%), Gaps = 24/239 (10%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNF 124
+ R+ I + L + L + + V +K+ +P L SL+ + +N
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346
Query: 125 TSVP---SDFFKGLTSLQTISLDYNSFDS-WVIPESLKDATGLQR--FSANGANITGTIP 178
S SLQT+ L N S E L L S N +P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN--TFH-PMP 403
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
D + L+L+ ++ +++ L ++ N + +
Sbjct: 404 DSCQW--PEKMRFLNLSSTGIRVVKTCIP--QTLEVLDVSN-------NNLDSFSLFLPR 452
Query: 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L +L++ N LPD S L + NQL + L SL + L N +
Sbjct: 453 LQELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 58/383 (15%), Positives = 123/383 (32%), Gaps = 80/383 (20%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEV-LFDDNNFTSVPSDFFKGL 135
+L LSSL L +M N G L++LQ + + + F+ + F GL
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
TSL + + S + +SLK + + + + + + D + + +L L
Sbjct: 148 TSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSESA-FLLEIFA-DILSSVRYLELR 204
Query: 196 FNFLQ----GPIPLSFGKSSIQTLWLNGQK-GDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L P+P+ S ++ L G D N + +++ + L+++ +
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264
Query: 251 G----------PLPDLSGLS--SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQ 297
G + +L + +++ + L + + L + + + + +F
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 298 GQTPKFNSPVRF---DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
D+++ N+++
Sbjct: 325 VPCSFSQHLKSLEFLDLSE------------------NLMVEEY---------------- 350
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSG-------TISSNFSRLTSLRQLMLSGNELT 407
NS KG +L+ L LS L +L L +S N
Sbjct: 351 -LKNSACKG---------AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
Query: 408 GTIPKELTTLPSLEMLDVSNNHL 430
+P + L++S+ +
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 36/263 (13%), Positives = 79/263 (30%), Gaps = 28/263 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
++I ++ + L S+ + L + ++ + LSS++ + D N
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWV------IPESLKDATGLQRFSANGANITG----- 175
+ + + L+ L + + G
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 176 ----TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG-S 229
+ LG + LH+ +L + + ++ + + +SK+
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE----NSKVFLVP 326
Query: 230 VAVIQNMTSLTQLWLHGNSFT----GPLPDLSGLSSLQDFSVRDNQLTGI--VPSSLVNL 283
+ Q++ SL L L N SLQ + N L + L+ L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 284 HSLAVVNLTNNLFQGQTPKFNSP 306
+L ++++ N F P
Sbjct: 387 KNLTSLDISRNTFHPMPDSCQWP 409
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 19/67 (28%), Positives = 33/67 (49%), Gaps = 6/67 (8%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTG-TIPKELTTLPSLEMLDVSNNH 429
+L++L LS ++SS+ F L+SL+ L L GN + L +L+ L + N
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 430 LFGKVPN 436
F ++
Sbjct: 135 TFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 17/56 (30%), Positives = 30/56 (53%), Gaps = 3/56 (5%)
Query: 376 NLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S + S L L++L +S N+L T+P + + P L ++ +S N L
Sbjct: 432 TLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQL 485
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 36/217 (16%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
T + LG+G F V + ++ G + A + + +S + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIAL 700
+H ++V L + L+++ + G L +R ++ + A
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD--------------AS 113
Query: 701 DVAR----GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHS 753
+ V + H +HR+LKP N+LL K+ADFGL +
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-- 168
Query: 754 IETRLAGTFGYLAPEYAVTGRV--TTKVDVFSFGVIL 788
AGT GYL+PE V + VD+++ GVIL
Sbjct: 169 AWFGFAGTPGYLSPE--VLRKDPYGKPVDLWACGVIL 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 63/239 (26%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKS------------------ 637
+G+G +G V +D T A+K + ++ + GF
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 638 -----EIAVLTKVRHRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPL 690
EIA+L K+ H ++V L+ D NE L V+E + QG +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132
Query: 691 EWTRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
L+ D AR G+EYLH +Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 ----PLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 743 VRLAPDNGKHSIETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ + GT ++APE +G+ +DV++ GV L + G+
Sbjct: 184 SNEFKGSDAL-LSNT-VGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQ 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 19/220 (8%)
Query: 582 IQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIA 640
++ + + LG G FG VYK G A K +E SE+ ++ EI
Sbjct: 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIE 68
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
+L H ++V LLG + ++ E+ P G + + E + L + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCR 124
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLA 759
+ + +LH + IHRDLK N+L+ + ++ADFG+ + K
Sbjct: 125 QMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFI 178
Query: 760 GTFGYLAPEYAVTGRVT-----TKVDVFSFGVILMELITG 794
GT ++APE + + K D++S G+ L+E+
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK-VR 646
+ + +GRG +G+V K +H G +AVKR+ + V EK + ++ V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKM-VHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSD 79
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
++V G + + E M + + + I L + +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDNGKHSI-ETRLAGT 761
+L + IHRD+KPSNILL K+ DFG LV SI +TR AG
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--------SIAKTRDAGC 188
Query: 762 FGYLAPE----YAVTGRVTTKVDVFSFGVILMELITGR 795
Y+APE A + DV+S G+ L EL TGR
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 22/222 (9%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVLT 643
+++ + V+G G V K+A+KR+ E + E EI ++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMS 68
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLKPLEWTRRLTIAL 700
+ H ++V + +E LV + + G++ +H+ + E L+ + TI
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDNGKHSIET 756
+V G+EYLH IHRD+K NILLG+D ++ADFG L +T
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 757 RLAGTFGYLAPEYAVTGRVT---TKVDVFSFGVILMELITGR 795
GT ++APE V +V K D++SFG+ +EL TG
Sbjct: 186 -FVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEI 639
+ + F LG G +G+VYK G +A+K++ E E EI
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEI 75
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
+++ + H+V G + +V EY G++S + R K L TI
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATIL 131
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRL 758
+G+EYLH IHRD+K NILL + AK+ADFG+ +L K +
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTV 185
Query: 759 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
GT ++APE D++S G+ +E+ G
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 62/243 (25%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 566 GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRME 623
G S + G + I Q + N+ +G G G V+K T IAVK+M
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKTGHVIAVKQMR 59
Query: 624 SAVVSEKGFAEFKSEIAVLTK-VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR 682
+ +++ ++ V+ K ++V G + + + E M GT + +
Sbjct: 60 RSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCA-EKLKK 115
Query: 683 KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG- 741
+ +G P + + + + + + YL IHRD+KPSNILL + + K+ DFG
Sbjct: 116 RMQGPIPERILGK--MTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 742 ---LVRLAPDNGKHSI-ETRLAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELI 792
LV + R AG Y+APE + DV+S G+ L+EL
Sbjct: 172 SGRLVD--------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 793 TGR 795
TG+
Sbjct: 224 TGQ 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 48/208 (23%), Positives = 81/208 (38%), Gaps = 31/208 (14%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE---FKSEIAVLTKVRHRHLVG 652
V+G+G F V + G + AVK ++ A + K E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL--DVARGVEYL 709
LL +V+E+M L + ++ + + + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 710 HGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
H + IHRD+KP +LL + K+ FG+ ++G + GT ++A
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMA 201
Query: 767 PE------YAVTGRVTTKVDVFSFGVIL 788
PE Y VDV+ GVIL
Sbjct: 202 PEVVKREPY------GKPVDVWGCGVIL 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-28
Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 45/230 (19%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKS-EIAVLT 643
R ++++ V+G G FG VY+ +L D G +A+K++ FK+ E+ ++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMR 102
Query: 644 KVRHRHLVGLLGYCLDGNERL------LVYEYMPQGTLSRHL--FNRKEEGLKPLEWTRR 695
K+ H ++V L + E+ LV +Y+P+ T+ R ++R ++ L P+ + +
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTL-PVIYVKL 160
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVR-LAPDNGKHS 753
L R + Y+H HRD+KP N+LL D K+ DFG + L S
Sbjct: 161 YMYQL--FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 754 -IETRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
I +R Y APE Y T+ +DV+S G +L EL+ G+
Sbjct: 216 YICSRY-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK-VR 646
++ LGRG +G V K H G +AVKR+ A V+ + ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKM-RHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVD 64
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
V G + + E M + + P + + IA+ + + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDNGKHSI-ETRLAGT 761
E+LH IHRD+KPSN+L+ + K+ DFG LV + + AG
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--------DVAKDIDAGC 172
Query: 762 FGYLAPE----YAVTGRVTTKVDVFSFGVILMELITGR 795
Y+APE + K D++S G+ ++EL R
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ F++ +G+G FG V+KG + +A+K ++ ++ + + EI VL++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQ 76
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++ G L + ++ EY+ G+ L PL+ T+ TI ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG-----PLDETQIATILREILK 130
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFG 763
G++YLH + IHRD+K +N+LL + K+ADFG+ +L K GT
Sbjct: 131 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR---NTFVGTPF 184
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITG 794
++APE +K D++S G+ +EL G
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
++F +G+G FG V + +D K+ A+K M V E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
LV L Y E + +V + + G L HL ++ K E T +L I ++ +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFK--EETVKLFIC-ELVMAL 128
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+YL Q IHRD+KP NILL + + DF + + P + T +AGT Y+A
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMA 182
Query: 767 PE--YAVTGRVTTK-VDVFSFGVILMELITGR 795
PE + G + VD +S GV EL+ GR
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 56/376 (14%), Positives = 104/376 (27%), Gaps = 49/376 (13%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+ +L + L +L + N L + L LS+L+ + ++N +
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELL-----VG 98
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
S++T+ N+ + S G + IT G + +L L
Sbjct: 99 PSIETLHAANNNISR--VSCSR--GQGKKNIYLANNKITMLRDLDEGC--RSRVQYLDLK 152
Query: 196 FNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWLHGNSFTG 251
N + +++ L L N V L L L N
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQY-------NFIYDVKGQVVFAKLKTLDLSSNKLAF 205
Query: 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF---NSPVR 308
P+ + + S+R+N+L I +L +L +L N F T + +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368
+AK + C PA A+
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI---------------- 308
Query: 369 GGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+ L G + R++ + I + + L+
Sbjct: 309 --ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366
Query: 425 VSNNHLFGKVPNFRQN 440
L +V N R+
Sbjct: 367 QKKKALDEQVSNGRRA 382
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 40/339 (11%), Positives = 84/339 (24%), Gaps = 44/339 (12%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+EL S+ L N ++ ++ S + + +N T + + +Q +
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L N D+ E + L+ + I + + L L L+ N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV---VFAKLKTLDLSSNKLAF- 205
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
+ F + +T + L N L +L
Sbjct: 206 MGPEFQ--------------------------SAAGVTWISLRNNKLVLIEKALRFSQNL 239
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDD 322
+ F +R N + V + + T + ++C +D
Sbjct: 240 EHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382
R+ L + ++ + ++
Sbjct: 299 LPAPFADRLIALKR----------KEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLE 421
I R + L L + L+
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 6e-19
Identities = 50/374 (13%), Positives = 113/374 (30%), Gaps = 63/374 (16%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
+ + + +V + L + S +++E+ N + + + T L+ ++L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N L+ + L+ N + + P + LH A N + +
Sbjct: 68 NVLYE---TLDLESLSTLRTLDLNNNYVQ-ELLVG------PSIETLHAANNNISR-VSC 116
Query: 206 SFGKSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTG-PLPDLSG-LSSL 262
S G + ++L ++K+ + + L L N +L+ +L
Sbjct: 117 SRG-QGKKNIYLA----NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDD 322
+ +++ N + + V L ++L++N P+F S L +
Sbjct: 172 EHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGV------TWISLRN 223
Query: 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP----CNSDWK---------------- 362
N L+ I K++ + L N D+
Sbjct: 224 ---------NKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 363 --GVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG----TIPKELTT 416
G + + T+ + + RL +L++ + G + E
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 417 LPSLEMLDVSNNHL 430
+D
Sbjct: 335 QARQREIDALKEQY 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 25/166 (15%), Positives = 58/166 (34%), Gaps = 14/166 (8%)
Query: 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188
+ + + + +S + + A ++ +G ++ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAP--FTK 59
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
L L+L+ N L + L S+++TL LN N V + S+ L N+
Sbjct: 60 LELLNLSSNVLYETLDLE-SLSTLRTLDLNN-------N-YVQELLVGPSIETLHAANNN 110
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + S ++ + +N++T + + ++L N
Sbjct: 111 ISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 24/219 (10%), Positives = 61/219 (27%), Gaps = 7/219 (3%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSV-PSDFFKGLTS 137
+ E S + +T + + NKL I +L +L+ N F DFF
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
+QT++ + E T + ++ D L L +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 198 FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-L 256
+ ++ + + ++ + ++ V + L + + +
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQ---VTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 257 SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
+ L + + ++ + +
Sbjct: 381 RAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRY 419
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 15/69 (21%), Positives = 32/69 (46%), Gaps = 1/69 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + L ++S ++++L LSGN L+ +L LE+L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 431 FGKVPNFRQ 439
+ +
Sbjct: 71 YE-TLDLES 78
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 22/219 (10%), Positives = 56/219 (25%), Gaps = 8/219 (3%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+ K L +L ++ N + + + + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 140 TISLDYNSFDSWVIPES-LKDATGLQRFSANGANITGTIPDFLGGDTI--PGLMHLHLAF 196
+ +P L+R + G+ + L + +
Sbjct: 288 LGHYGAYCCED--LPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 197 NFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
+ I K + TL + D +++ + Q + +
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
S L L+ R ++ V V +++ ++ +
Sbjct: 406 QSPLQLLRAIVKRYEEM--YVEQQSVQNNAIRDWDMYQH 442
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 7/45 (15%), Positives = 17/45 (37%)
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
I + ++ + L + + +++ LD+S N L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 43/232 (18%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA--EFKSEIAVL 642
R + F E + G+G FGTV G E G +A+K+ V+ + F E + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDPRFRNREL-QIMQDL 73
Query: 643 TKVRHRHLVGLLGYCLDGNER-------LLVYEYMPQGTLSRHLFNRKEEGLK-PLEWTR 694
+ H ++V L Y ER +V EY+P TL R N + P +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHS 753
L R + LH + HRD+KP N+L+ D K+ DFG + + +
Sbjct: 133 VFLFQL--IRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN 188
Query: 754 IE---TRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ +R Y APE Y TT VD++S G I E++ G
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L +L+ + L + N + LS ++ L + ++ V LT L ++S
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L+YN + L T L F+A IT P + + L L + N +
Sbjct: 184 LNYNQIEDI---SPLASLTSLHYFTAYVNQITDITP--VAN--MTRLNSLKIGNNKITDL 236
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLS 260
PL+ S + L + N + ++++T L L + N + + L+ LS
Sbjct: 237 SPLA-NLSQLTWLEIGT-------NQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLS 287
Query: 261 SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L + +NQL + L +L + L+ N
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 39/220 (17%), Positives = 84/220 (38%), Gaps = 19/220 (8%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
N + L++++ L L V ++K+ + ++ L+ L + + N + L
Sbjct: 142 NHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISP--LASL 198
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
TSL + N + + T L IT P L + L L +
Sbjct: 199 TSLHYFTAYVNQITD---ITPVANMTRLNSLKIGNNKITDLSP--LAN--LSQLTWLEIG 251
Query: 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
N + + + ++ L + +++ ++V+ N++ L L+L+ N +
Sbjct: 252 TNQISDINAVK-DLTKLKMLNVGSN----QIS-DISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 256 -LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ GL++L + N +T I L +L + + N
Sbjct: 306 VIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 40/230 (17%), Positives = 100/230 (43%), Gaps = 20/230 (8%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNF 124
+T++ + G+ + + + L++L L + N++T I LS L L + N
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD 184
T + + + LT+L+ + L+ ++ L + T + + + +
Sbjct: 101 TDISA--LQNLTNLRELYLNEDNISD---ISPLANLTKMYSLNLGANHNLSDLSPL---S 152
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+ GL +L + + ++ P++ + + +L L +++ ++ + ++TSL
Sbjct: 153 NMTGLNYLTVTESKVKDVTPIA-NLTDLYSLSL----NYNQIE-DISPLASLTSLHYFTA 206
Query: 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N T + ++ ++ L + +N++T + S L NL L + + N
Sbjct: 207 YVNQITD-ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L++L LT L + NK+T I +L L++L+E+ +++N + + LT + +++
Sbjct: 82 SPLSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L N S L + TGL + + + + + L L L +N ++
Sbjct: 139 LGANHNLS--DLSPLSNMTGLNYLTVTESKVKD-VTPI---ANLTDLYSLSLNYNQIEDI 192
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
PL+ +S+ +++ + + NMT L L + N T L L+ LS L
Sbjct: 193 SPLA-SLTSLHYFTA----YVNQIT-DITPVANMTRLNSLKIGNNKITD-LSPLANLSQL 245
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ NQ++ I +++ +L L ++N+ +N
Sbjct: 246 TWLEIGTNQISDI--NAVKDLTKLKMLNVGSN 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-22
Identities = 40/210 (19%), Positives = 78/210 (37%), Gaps = 18/210 (8%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L+ + K +T + + L S+ +++ S+ + LT+L+ ++L+
Sbjct: 18 DADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLN 74
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N L + L IT I + L L+L + + P
Sbjct: 75 GNQITD---ISPLSNLVKLTNLYIGTNKIT-DISAL---QNLTNLRELYLNEDNISDISP 127
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L+ + + +L L + ++ + NMT L L + + + ++ L+ L
Sbjct: 128 LA-NLTKMYSLNLGA----NHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYS 181
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
S+ NQ+ I S L +L SL N
Sbjct: 182 LSLNYNQIEDI--SPLASLTSLHYFTAYVN 209
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 6e-21
Identities = 38/190 (20%), Positives = 74/190 (38%), Gaps = 15/190 (7%)
Query: 84 ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ +L+ L L + N++ I L+ L+SL N T + +T L ++ +
Sbjct: 172 PIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
N L + + L I+ I + L L++ N +
Sbjct: 229 GNNKITD---LSPLANLSQLTWLEIGTNQIS-DINAV---KDLTKLKMLNVGSNQISDIS 281
Query: 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ 263
L+ S + +L+LN + ++ + VI +T+LT L+L N T + L+ LS +
Sbjct: 282 VLN-NLSQLNSLFLNNNQLGNE---DMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMD 336
Query: 264 DFSVRDNQLT 273
+ +
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-12
Identities = 33/204 (16%), Positives = 65/204 (31%), Gaps = 63/204 (30%)
Query: 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150
L + + QI + L+ + + T V + + L S+ + +
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK--- 55
Query: 151 WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210
+ G++ L +L+L N + PLS
Sbjct: 56 ------VASIQGIEYL--------------------TNLEYLNLNGNQITDISPLS---- 85
Query: 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDN 270
N+ LT L++ N T + L L++L++ + ++
Sbjct: 86 ------------------------NLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNED 120
Query: 271 QLTGIVPSSLVNLHSLAVVNLTNN 294
++ I S L NL + +NL N
Sbjct: 121 NISDI--SPLANLTKMYSLNLGAN 142
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 3/58 (5%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L + IS S + L+ L L L+ N+L + + L +L L +S NH+
Sbjct: 266 KLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-06
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 4/58 (6%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L+ + S + LT + L L N + L+ + L L V+ + +
Sbjct: 111 NLRELYLNEDNISDISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 5/67 (7%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L NL + T S LT+LR+L L+ + ++ P L L + L++ NH
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146
Query: 433 KVPNFRQ 439
+
Sbjct: 147 DLSPLSN 153
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 13/58 (22%), Positives = 23/58 (39%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L T + + +T L L + N++T P L L L L++ N +
Sbjct: 200 SLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 15/58 (25%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L +L L+ S + LTSL N++T P + + L L + NN +
Sbjct: 178 DLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L+G T S S L L L + N++ T L L +L L ++ +++
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNI 122
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 14/58 (24%), Positives = 23/58 (39%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L ++ + + LT L L L+ N++ P L +L SL N +
Sbjct: 156 GLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + L N L LT+L L LS N +T P L +L ++ D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 17/58 (29%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++ L ++G ++S LT+L L L+GN++T P L+ L L L + N +
Sbjct: 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 7e-05
Identities = 16/64 (25%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L L + IS + LT L+ L + N+++ L L L L ++NN L
Sbjct: 244 QLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN 301
Query: 433 KVPN 436
+
Sbjct: 302 EDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 5e-04
Identities = 11/58 (18%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L T L S+ +L+++G ++ + + L +LE L+++ N +
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQI 78
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFK--SEIAVLTKVRHRHLVGL 653
+LG G +G V + + AVK ++ + E EI +L ++RH++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 654 LGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR------- 704
+ + ++ +V EY G + + E R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK--------RFPV--CQAHGYFCQLI 119
Query: 705 -GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+EYLH Q +H+D+KP N+LL K++ G+ G+
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 764 YLAPEYAVTGRVT---TKVDVFSFGVILMELITGR 795
+ PE G T KVD++S GV L + TG
Sbjct: 177 FQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+F V+GRG FG V +L + K+ A+K + ++ A F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDV 702
+ + L Y + L LV +Y G L L K E P E R + IA+
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIAI-- 188
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+ +H L ++HRD+KP NIL+ + ++ADFG ++G GT
Sbjct: 189 ----DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTP 240
Query: 763 GYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGR 795
Y++PE GR + D +S GV + E++ G
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 68/379 (17%), Positives = 130/379 (34%), Gaps = 41/379 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFT 125
+ + I+ SLS L+ L + N + + SGLSSLQ+++ + N
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG-- 183
S+ + L +L+ +++ +N S+ +PE + T L+ + I L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243
+ L L+ N + P +F + + L L LN IQ + L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF--DSLNVMKTCIQGLAGLEVHR 231
Query: 244 LHGNSFTG----PLPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTN 293
L F D S L L + ++ + +L + + L +++ +L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 294 NLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKG 353
+ + + + F +
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT------------------ 333
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKN--LGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411
+N + + V ++ ++L L G S + TSL+ L LS N + T+
Sbjct: 334 SNKGGNAFSEVDL---PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389
Query: 412 KELTTLPSLEMLDVSNNHL 430
L LE LD +++L
Sbjct: 390 SNFLGLEQLEHLDFQHSNL 408
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 68/374 (18%), Positives = 120/374 (32%), Gaps = 53/374 (14%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP-SDFFKGLT 136
+L + LSSL L ++ L + L +L+E+ N S ++F LT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196
+L+ + L N S + L+ + + L L+
Sbjct: 150 NLEHLDLSSNKIQS-IYCTDLRVLHQMPLL----------------------NLSLDLSL 186
Query: 197 NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG----P 252
N + P +F + + L L LN IQ + L L F
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNF--DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 253 LPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
D S L L + ++ + +L + + L +++ +L + + +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRV-----NVLLSIVKSVGYPAVLAESWKGNNPCNSDW 361
+ + F + N + V P+ L N +
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS-LEFLDLSRNGLSF-- 361
Query: 362 KGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTT 416
C + + +LK L LS T+SSNF L L L + L +
Sbjct: 362 --KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 417 LPSLEMLDVSNNHL 430
L +L LD+S+ H
Sbjct: 420 LRNLIYLDISHTHT 433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-24
Identities = 46/219 (21%), Positives = 81/219 (36%), Gaps = 16/219 (7%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT--SVPSDFFKGLTSLQTISL 143
L SL L NK S L SL+ + N + S G TSL+ + L
Sbjct: 322 LKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
+N + + + L+ +N+ + +F ++ L++L ++ +
Sbjct: 381 SFNGVIT--MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQLWLHGNSFTGPLPD--LSG 258
F SS++ L + G + + + + +LT L L L +
Sbjct: 438 NGIFNGLSSLEVLKMAG----NSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNS 492
Query: 259 LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LSSLQ ++ NQL + L SL + L N +
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 62/349 (17%), Positives = 115/349 (32%), Gaps = 24/349 (6%)
Query: 89 SSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
S L++ N L + S LQ + ++ ++ L+ L T+ L N
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ-GPIPL 205
S + + + LQ+ A N+ +G + L L++A N +Q +P
Sbjct: 87 PIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELNVAHNLIQSFKLPE 143
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMT-SLTQLWLHGNSFTGPLPDLSGLSSLQ 263
F ++++ L L+ K S + V+ M L L N P L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 264 DFSVRDNQLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTP-KFNSPVRFDMAKGSNSFCLD 321
++R+N + ++ + + L L V L F+ + + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG 381
A + + + L + + + + L N
Sbjct: 264 LAYLD--------YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 382 LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L SL++L + N+ LPSLE LD+S N L
Sbjct: 316 FG---QFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGL 359
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 53/394 (13%), Positives = 113/394 (28%), Gaps = 74/394 (18%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFK 133
N+ + L +L L V N + S L++L+ + N S+ +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 134 GLTSLQ----TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL 189
L + ++ L N + I L + + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLHKLTLRNNFDSLNVMKTCI-QGLAGL 227
Query: 190 MHLHLAFNFLQGPIPLSF-------GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
L + L G ++ D L+ + + +T+++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 243 WLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSL-------------------VNL 283
L + + D S Q + + + L V+L
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
Query: 284 HSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGY 343
SL ++L+ N + S ++ LD N ++++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQS-----DFGTTSLKYLD-----LSF--NGVITM------ 388
Query: 344 PAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSN-FSRLTSLRQLMLS 402
+S++ G+ + ++ ++ L + F L +L L +S
Sbjct: 389 --------------SSNFLGLE-----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 403 GNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436
L SLE+L ++ N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-16
Identities = 54/325 (16%), Positives = 107/325 (32%), Gaps = 39/325 (12%)
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+ NF +P + S + + L +N + S LQ + I
Sbjct: 16 ELNFYKIPDNLP---FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG-SVAVIQNMTS 238
+ L L L N +Q +F SS+Q L ++ L I ++ +
Sbjct: 72 YQS--LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV----ETNLASLENFPIGHLKT 125
Query: 239 LTQLWLHGNSFT-GPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT---- 292
L +L + N LP+ S L++L+ + N++ I + L LH + ++NL+
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 293 -NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW 351
N + Q F + +N L+ G L +
Sbjct: 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG--LEVH----------RLV 233
Query: 352 KGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG------TISSNFSRLTSLRQLMLSGNE 405
G + + A + + ++ L+ I F+ LT++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + + + L++ N
Sbjct: 294 IE-RVK-DFSYNFGWQHLELVNCKF 316
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 28/74 (37%), Positives = 38/74 (51%), Gaps = 3/74 (4%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
E LP L +LT L++ + +L Q+ + + LSSLQ + N SVP F L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517
Query: 136 TSLQTISLDYNSFD 149
TSLQ I L N +D
Sbjct: 518 TSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
N+ +++ + + F+ L+SL L ++GN + T L +L LD+S
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 430 L 430
L
Sbjct: 482 L 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+L+ L ++G + F+ L +L L LS +L P +L SL++L++++N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 430 L 430
L
Sbjct: 506 L 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 12/87 (13%)
Query: 356 PCNSDWKGVSCDAGG-NITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSG 403
PC ++ N + + KNL LS + S F L+ L LS
Sbjct: 2 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 404 NELTGTIPKELTTLPSLEMLDVSNNHL 430
E+ +L L L ++ N +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPI 88
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL L LS +S F+ L+SL+ L ++ N+L ++P L SL+ + + N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNP 529
Query: 430 L 430
Sbjct: 530 W 530
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 7e-27
Identities = 62/346 (17%), Positives = 109/346 (31%), Gaps = 59/346 (17%)
Query: 589 TNNFSEENVLGRG--GFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ V+G+G TV G + V+R+ S + + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DV 702
H ++V + NE +V +M G+ + +G+ E L IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--E----LAIAYILQGV 137
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK-----HSIETR 757
+ ++Y+H H ++HR +K S+IL+ D + ++ +G+ H
Sbjct: 138 LKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 758 LAGTFGYLAPEYAVTGRV--TTKVDVFSFGVILMELITGR---------KALDETQSEDS 806
+L+PE K D++S G+ EL G + L E +
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA------------------DLA 848
L+ L + S +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 849 GHCCAREPYQRPD----MGHV------VNVLSSLAELWKPAEPDSD 884
C R P RP + H +L EL +P P ++
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITN 360
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G+G F V + G ++A+K ++ ++ + E+ ++ + H ++V L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 657 -CLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
++ + L L+ EY G + +L +K E R + V+Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKE-ARS--KFRQIVSAVQYCH---Q 132
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
+ +HRDLK N+LL DM K+ADFG GK ++ G Y APE G+
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDA-FCGAPPYAAPE-LFQGK 188
Query: 775 VTT--KVDVFSFGVILMELITGR 795
+VDV+S GVIL L++G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 66/287 (22%), Positives = 106/287 (36%), Gaps = 46/287 (16%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVG 652
+ LG G F K AVK ++S++ A + EI L H ++V
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 653 LLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L D LV E + G L + F+ E I + V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVS 120
Query: 708 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
++H +HRDLKP N+L D++ K+ DFG RL P + + ++T T Y
Sbjct: 121 HMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTP-CFTLHY 175
Query: 765 LAPEYAVTGRVT--TKVDVFSFGVILMELITGRKA-LDETQSEDSVHLVTWFRRMHINKD 821
APE + + D++S GVIL +++G+ +S +
Sbjct: 176 AAPE--LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----------TSAVE 223
Query: 822 TFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMGHVVN 867
+K + E ++S A DL +P +R M +
Sbjct: 224 IMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/257 (22%), Positives = 97/257 (37%), Gaps = 24/257 (9%)
Query: 550 SSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG 609
SS S + + + + + + + +LG GGFG+VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 610 E-LHDGTKIAVKRMESAVVSEKGFAEF----KSEIAVLTKVRHR--HLVGLLGYCLDGNE 662
+ D +A+K +E +S+ G E+ +L KV ++ LL + +
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 663 RLLVYEY-MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721
+L+ E P L + R L+ R V V + H + +HRD
Sbjct: 123 FVLILERPEPVQDLFDFITERGA--LQEEL-ARS--FFWQVLEAVRHCH---NCGVLHRD 174
Query: 722 LKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR--VTTK 778
+K NIL+ + K+ DFG L D GT Y PE+ +
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEW-IRYHRYHGRS 229
Query: 779 VDVFSFGVILMELITGR 795
V+S G++L +++ G
Sbjct: 230 AAVWSLGILLYDMVCGD 246
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 62/361 (17%), Positives = 130/361 (36%), Gaps = 66/361 (18%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+ P L +L++L L++ NK++ I L+ L++L+ ++ +N + + L
Sbjct: 166 QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
T+L +SL+ N +L T L I+ + + L L L
Sbjct: 221 TNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISN-LAPL---SGLTKLTELKLG 273
Query: 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
N + PL+ G +++ L LN ++L ++ I N+ +LT L L+ N+ + +
Sbjct: 274 ANQISNISPLA-GLTALTNLELNE----NQLE-DISPISNLKNLTYLTLYFNNISD-ISP 326
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
+S L+ LQ +N+++ + SSL NL ++ ++ +N TP
Sbjct: 327 VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-------------- 370
Query: 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375
+ + + + + + N+++
Sbjct: 371 -------------------------LANLTRITQLGLNDQAWTNA----PVNYKANVSIP 401
Query: 376 NLKNLGLSGTIS-SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434
N I+ + S S + ++ N + + T + G V
Sbjct: 402 NTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 435 P 435
Sbjct: 461 T 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 22/228 (9%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+ +G N+ T+ L +T L+ + + I + L++L ++ F +N T
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT L I ++ N L + T L + IT P L +
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIAD---ITPLANLTNLTGLTLFNNQITDIDP--LKN--L 133
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
L L L+ N + LS G +S+Q L Q D K + N+T+L +L +
Sbjct: 134 TNLNRLELSSNTISDISALS-GLTSLQQLSFGNQVTDLK------PLANLTTLERLDISS 186
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
N + + L+ L++L+ +NQ++ I + L L +L ++L N
Sbjct: 187 NKVSD-ISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 20/217 (9%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+L+ + K +T S + L + + D S+ + L +L I+
Sbjct: 20 DTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 76
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N I LK+ T L N I P L + L L L N + P
Sbjct: 77 NNQLTD--ITP-LKNLTKLVDILMNNNQIADITP--LAN--LTNLTGLTLFNNQITDIDP 129
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L +++ L L+ + ++ ++ + +TSL QL GN T P L+ L++L+
Sbjct: 130 LK-NLTNLNRLELSS----NTIS-DISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLER 181
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301
+ N+++ I S L L +L + TNN TP
Sbjct: 182 LDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-16
Identities = 37/206 (17%), Positives = 76/206 (36%), Gaps = 40/206 (19%)
Query: 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD 149
L + ++ QI + + L+ + + N T S L + T+ D
Sbjct: 2 PLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG-- 57
Query: 150 SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+K G++ + L ++ + N L PL
Sbjct: 58 -------IKSIDGVEYLNN--------------------LTQINFSNNQLTDITPLK-NL 89
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
+ + + +N ++++ + + N+T+LT L L N T + L L++L +
Sbjct: 90 TKLVDILMN----NNQIA-DITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSS 143
Query: 270 NQLTGIVPSSLVNLHSLAVVNLTNNL 295
N ++ I S+L L SL ++ N +
Sbjct: 144 NTISDI--SALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 50/250 (20%), Positives = 94/250 (37%), Gaps = 50/250 (20%)
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
M L + + + + TL + ++G ++ + +LTQ+ N
Sbjct: 26 KMKTVLGKTNVTDTVSQT-DLDQVTTLQADRLGI-KSIDG----VEYLNNLTQINFSNNQ 79
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP-- 306
T + L L+ L D + +NQ+ I + L NL +L + L NN P N
Sbjct: 80 LTD-ITPLKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDIDPLKNLTNL 136
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
R ++ SN+ +S + ++ L + GN +
Sbjct: 137 NRLEL--SSNT-----------------ISDISALSGLTSLQQLSFGNQVTDL------- 170
Query: 367 DAGGNITVVNLKNL---GLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
+ NL L +S + S ++LT+L L+ + N+++ P L L +L
Sbjct: 171 -----KPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 421 EMLDVSNNHL 430
+ L ++ N L
Sbjct: 224 DELSLNGNQL 233
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 5/69 (7%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L+ L + S+ + LT++ L N+++ P L L + L +++
Sbjct: 332 KLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 433 KVPNFRQNV 441
N++ NV
Sbjct: 390 APVNYKANV 398
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/183 (27%), Positives = 73/183 (39%), Gaps = 15/183 (8%)
Query: 628 SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL 687
S +I + ++ VG L + + + L + R L
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SL 158
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--- 744
+ E L I + +A VE+LH + +HRDLKPSNI D KV DFGLV
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 745 -------LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 797
+ ++ T GT Y++PE + KVD+FS G+IL EL+
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 798 LDE 800
E
Sbjct: 276 QME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+F +GRGGFG V++ + D A+KR+ E + E+ L K+ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHP 64
Query: 649 HLV 651
+V
Sbjct: 65 GIV 67
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 32/223 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + +G G +GTVYK + H G +A+K R+ + G E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALL 65
Query: 643 ---TKVRHRHLVGLL----GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
H ++V L+ D ++ LV+E++ Q L +L GL E +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA-ETIK 123
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK--H 752
L RG+++LH +HRDLKP NIL+ K+ADFGL R+
Sbjct: 124 DLMRQF--LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
+ T Y APE + T VD++S G I E+ +
Sbjct: 179 VVVTLW-----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + +G G +G V+K G +A+K + K EI +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVI---KKIALREIRML 56
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+++H +LV LL LV+EY T+ H +R + G+ + +T
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV-LHELDRYQRGVPEHL-VKSITWQT-- 111
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLA 759
+ V + H + IHRD+KP NIL+ K+ DFG RL + TR
Sbjct: 112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW- 167
Query: 760 GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 795
Y +PE V VDV++ G + EL++G
Sbjct: 168 ----YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 50/229 (21%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ F + LG G + TVYKG G +A+K +++S E+G S EI+++
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTP---STAIREISLM 57
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQ---GTLSRHLFNRKEEGLKPLE---WTRRL 696
+++H ++V L N+ LV+E+M + GL+ + +L
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HS 753
+G+ + H +HRDLKP N+L+ + K+ DFGL R
Sbjct: 118 L------QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 754 IETRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ T Y AP+ Y +T +D++S G IL E+ITG+
Sbjct: 169 VVTLW-----YRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 46/236 (19%)
Query: 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFK 636
+++ V + + + LG G F TVYK + + +A+K ++ ++ G
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI---N 56
Query: 637 S----EIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE- 691
EI +L ++ H +++GLL + LV+++M L + + L P
Sbjct: 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSL-VLTPSHI 114
Query: 692 --WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ +G+EYLH +HRDLKP+N+LL ++ K+ADFGL +
Sbjct: 115 KAYMLMTL------QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 750 GK---HSIETRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ H + TR Y APE Y VD+++ G IL EL+
Sbjct: 166 NRAYTHQVVTRW-----YRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAE 634
+V+ ++ +R ++F V+GRG F V ++ ++ A+K M ++ +
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
F+ E VL R + L + L LV EY G L L K P E
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMA 164
Query: 694 R----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
R + +A+ + +H L ++HRD+KP NILL ++ADFG
Sbjct: 165 RFYLAEIVMAI------DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC--LKLR 213
Query: 750 GKHSIETRLA-GTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
++ + +A GT YL+PE TG + D ++ GV E+ G+
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + +G G +GTV+K +A+K R++ ++G S EI +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVP---SSALREICLL 55
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIA 699
+++H+++V L + LV+E+ Q L ++ + L P + +L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLL-- 111
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIET 756
+G+ + H ++ +HRDLKP N+L+ + K+A+FGL R + + T
Sbjct: 112 ----KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164
Query: 757 RLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGRKAL 798
Y P+ Y +T +D++S G I EL + L
Sbjct: 165 LW-----YRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLT 643
+ FS+ +G G FG VY ++ + +A+K+M S S + + + E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
K+RH + + G L + LV EY G+ S L K KPL+ +
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGAL 164
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
+G+ YLH + IHRD+K NILL + K+ DFG + GT
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPY 215
Query: 764 YLAPEYAVTGRVTT---KVDVFSFGVILMELITG 794
++APE + KVDV+S G+ +EL
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 69/304 (22%), Positives = 112/304 (36%), Gaps = 68/304 (22%)
Query: 582 IQVLRNVTNNFSEE----NVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFK 636
+Q L + F++ +G G + + + AVK ++ K +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPT 63
Query: 637 SEIAVLTK-VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTR 694
EI +L + +H +++ L DG +V E M G L ++ +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQK-------- 111
Query: 695 RLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGL-V 743
+ + + + VEYLH Q +HRDLKPSNIL G+ ++ DFG
Sbjct: 112 FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV--TTKVDVFSFGVILMELITG----RKA 797
+L +NG T ++APE V R D++S GV+L ++TG
Sbjct: 169 QLRAENGLL---MTPCYTANFVAPE--VLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223
Query: 798 LDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREP 856
D+T E + L S+S A DL +P
Sbjct: 224 PDDTPEE-----------------ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDP 266
Query: 857 YQRP 860
+QR
Sbjct: 267 HQRL 270
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 43/223 (19%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVK--RMESAVVSEKGFAEFKS--EIAVLTKV 645
+ + +G G +G VYK + G +A+K R+++ ++G + EI++L ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIP-STAIREISLLKEL 76
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIALDV 702
H ++V L+ LV+E+M + L + L + + GL+ + + +L
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLL----- 129
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLA 759
RGV + H +HRDLKP N+L+ D K+ADFGL R + H + T
Sbjct: 130 -RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW- 184
Query: 760 GTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y AP+ Y +T VD++S G I E+ITG+
Sbjct: 185 ----YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 47/291 (16%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVG 652
E+VLG G V L + AVK +E + + E+ +L + + HR+++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLE 75
Query: 653 LLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L+ + + + LV+E M G++ R FN E + DVA ++
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVASALD 125
Query: 708 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL-VRLAPDNGKHSIETRL----A 759
+LH ++ HRDLKP NIL K+ DF L + + I T
Sbjct: 126 FLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 760 GTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGR-----KALDETQSEDSVHL 809
G+ Y+APE + D++S GVIL L++G + + +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQR 859
+ F + + ++ A IS A DL R+ QR
Sbjct: 243 PACQNML------FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 597 VLGRGGFGTVY---KGELHDGTKI-AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
VLG+G FG V+ K D ++ A+K ++ A + + K E +L +V H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 653 LLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVE 707
L Y +L L+ +++ G L L +E + E + L +AL +
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL------D 140
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+LH L I+RDLKP NILL ++ K+ DFGL + + D+ K + GT Y+AP
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAP 195
Query: 768 EYAVTGRVTTK-VDVFSFGVILMELITGR 795
E V R T+ D +SFGV++ E++TG
Sbjct: 196 E-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSE 638
I + LR+ F ++G G +G VYKG + G A+K M+ V+ E K E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 639 IAVLTKV-RHRHLVGLLG-----YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLE 691
I +L K HR++ G +++L LV E+ G+++ + K L+
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLK 127
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNG 750
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ L G
Sbjct: 128 EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 751 KHSIETRLAGTFGYLAPEYAVTGRVT-----TKVDVFSFGVILMELITG 794
+ GT ++APE K D++S G+ +E+ G
Sbjct: 185 RR---NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 30/217 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ ++G G +G V K G +A+K +K K EI +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMV---KKIAMREIKLL 78
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
++RH +LV LL C LV+E++ T+ L GL ++ +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQV-VQKYLFQI-- 133
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLA 759
G+ + H + IHRD+KP NIL+ K+ DFG R G+ + TR
Sbjct: 134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW- 189
Query: 760 GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 795
Y APE V VDV++ G ++ E+ G
Sbjct: 190 ----YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G +G V +AVK ++ K EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVEY 708
+GN + L EY G L F+R +E + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDR-------IEPDIGMPE--PDAQRFFHQLMAGVVY 120
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH HRD+KP N+LL + K++DFGL + N + + ++ GT Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 769 ------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ VDV+S G++L ++ G
Sbjct: 178 LLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 31/274 (11%), Positives = 66/274 (24%), Gaps = 69/274 (25%)
Query: 597 VLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVG 652
G ++ D ++A+ ++ V + S L+++ +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
+L L+V E++ G+L + P+ + +A +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV---GAIRAMQSLAAAADA---- 144
Query: 713 AHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
AH++ PS + + D +A +
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAY----------------------PATMPD---- 178
Query: 772 TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD-----TFRKA 826
+ D+ G L L+ R L E + +
Sbjct: 179 ---ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ERDTAGQPIEPADIDRD 231
Query: 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
I I +A + R
Sbjct: 232 IPFQIS-------------AVAARSVQGDGGIRS 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG G FG V GE G K+AVK + + K EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
+ +V EY+ G L ++ R+ AR V+
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----------RVEE--MEARRLFQQILSAVD 125
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H +HRDLKP N+LL M AK+ADFGL + D + T G+ Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTS-CGSPNYAAP 179
Query: 768 EYAVTGR--VTTKVDVFSFGVILMELITGR 795
E ++GR +VD++S GVIL L+ G
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE----FKSEIAVLTKVR----H 647
+LG+GGFGTV+ G L D ++A+K + V E+A+L KV H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARG 705
++ LL + +LV E + LF+ E L +R V
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGP-SRC--FFGQVVAA 151
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
+++ H + +HRD+K NIL+ AK+ DFG L D GT Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVY 204
Query: 765 LAPEYAVTGR--VTTKVDVFSFGVILMELITGR 795
PE+ ++ V+S G++L +++ G
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 26/230 (11%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAE 634
+ I+ LR ++ V+GRG FG V K+ A+K + ++ A
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
F E ++ +V L Y + L +V EYMP G L + + P +W
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDV-PEKWA 170
Query: 694 R----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
R + +AL + +H + FIHRD+KP N+LL K+ADFG
Sbjct: 171 RFYTAEVVLAL------DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 750 GKHSIETRLAGTFGYLAPE----YAVTGRVTTKVDVFSFGVILMELITGR 795
G +T GT Y++PE G + D +S GV L E++ G
Sbjct: 222 GMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-25
Identities = 75/375 (20%), Positives = 129/375 (34%), Gaps = 53/375 (14%)
Query: 82 PKELNSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLT--S 137
+L +LT L++ KN++ PS L+SL+ + F N V + L +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 138 LQTISLDYNSF-----DSWVIPESLKDATGLQRFSANGANITGTIPD----------FLG 182
L SL NS W + L+ +G T I
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
+M F+ ++ P +F +SS++ L L+ LN V + + L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS-HGFVFSLNSRV--FETLKDL 292
Query: 240 TQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L L N + D GL +LQ ++ N L + S+ L +A ++L N
Sbjct: 293 KVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
+ F + + L D N L +I + + + + N
Sbjct: 352 IIQDQT-----FKFLEKLQTLDLRD---------NALTTI----HFIPSIPDIFLSGNKL 393
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGTIPKEL-T 415
+ K +++L L I R+ L+ L+L+ N + + +
Sbjct: 394 VTLPKINL-----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 416 TLPSLEMLDVSNNHL 430
PSLE L + N L
Sbjct: 449 ENPSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-24
Identities = 68/342 (19%), Positives = 121/342 (35%), Gaps = 39/342 (11%)
Query: 99 NKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLK 158
LT Q+P L++ + +L N +V + F L LQ + L + E+ +
Sbjct: 14 CNLT-QVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR 70
Query: 159 DATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN 218
+ L+ + I PD G + L L L F L
Sbjct: 71 NLPNLRILDLGSSKIYFLHPDAFQG--LFHLFELRLYFCGL------------------- 109
Query: 219 GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT--GPLPDLSGLSSLQDFSVRDNQLTGIV 276
S +N+ +LT+L L N P L+SL+ NQ+ +
Sbjct: 110 -----SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164
Query: 277 PSSLVNLH--SLAVVNLTNNLFQGQTPK-FNSPVRFDMAKGSNSFCLDDAGVACDGRVNV 333
L L +L+ +L N + + + + G D N
Sbjct: 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224
Query: 334 LLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN 389
+I KS + +LA G + K + + ++++L LS +++S
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
Query: 390 -FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
F L L+ L L+ N++ + L +L++L++S N L
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 55/375 (14%), Positives = 110/375 (29%), Gaps = 59/375 (15%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNF 124
R+ + I L L +LE+ I + L +L+ + +
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPES-LKDATGLQRFSANGANITG-TIPDFLG 182
+ D F+GL L + L + V+ + ++ L R + I + G
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSF---GKSSIQTLWLNGQKGDSKLNGSVAVIQNM--- 236
+ L + + N + ++ L S+++ N
Sbjct: 146 K--LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
L L + GN +T + N ++ SL+ H + +
Sbjct: 204 MVLEILDVSGNGWTVDITGNF-----------SNAISKSQAFSLILAHHIMGAGFGFHNI 252
Query: 297 QGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
+ F S+ LD + + S+ + ++
Sbjct: 253 KDPDQNT-----FAGLARSSVRHLDLSH-------GFVFSL---------NSRVFETLK- 290
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
++ V+NL ++ F L +L+ L LS N L
Sbjct: 291 --------------DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 417 LPSLEMLDVSNNHLF 431
LP + +D+ NH+
Sbjct: 337 LPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-23
Identities = 61/383 (15%), Positives = 116/383 (30%), Gaps = 39/383 (10%)
Query: 81 LPKELNSLSSLTVLEVMKNKLTG-QIPSLSGLS--SLQEVLFDDNNFTSVPSDFFKGL-- 135
L L+SL ++ N++ L L +L N+ S S +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 136 ----TSLQTISLDYNSFD-----------SWVIPESLKDATGLQRFSANGANITGTIPDF 180
L+ + + N + S SL A + NI +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
G + HL L+ F+ F ++ L L K +K+ + +L
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI-NKIADEA--FYGLDNL 316
Query: 240 TQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N + GL + ++ N + I + L L ++L +N
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT- 375
Query: 299 QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA------ESWK 352
S + N +++ + ++++ L
Sbjct: 376 TIHFIPSIPDIFL--SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSN-----FSRLTSLRQLMLSGNELT 407
N +S + ++ + L L + F L+ L+ L L+ N L
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 408 GTIPKELTTLPSLEMLDVSNNHL 430
P + L +L L +++N L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 71/380 (18%), Positives = 125/380 (32%), Gaps = 57/380 (15%)
Query: 77 IEGTLPKELNSLS--SLTVLEVMKNKLT-------------GQIPSLSGLSSLQEVLFDD 121
+ K +N L +L+V N T Q SL + F
Sbjct: 190 VSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249
Query: 122 NNFTSVPSDFFKGL--TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
+N + F GL +S++ + L + S + + L+ + I +
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNG-SVAVIQNMT 237
G + L L+L++N L +F G + + L + + + +
Sbjct: 309 AFYG--LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK----NHIAIIQDQTFKFLE 362
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSL-VNLHSLAVVNLTNNLF 296
L L L N+ T + + S+ D + N+L + +L NL L+ L N
Sbjct: 363 KLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDI 418
Query: 297 QGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVN-VLLSIVKSVGYPAVLAESWKGNN 355
+ + N F + L + G N
Sbjct: 419 LYFLLRVPHLQILILN--QNRFSSCSGDQTPSENPSLEQLFL---------------GEN 461
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTI 410
W+ + +L+ L L+ ++ FS LT+LR L L+ N LT +
Sbjct: 462 MLQLAWET-ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VL 519
Query: 411 PKELTTLPSLEMLDVSNNHL 430
+LE+LD+S N L
Sbjct: 520 SHN-DLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-19
Identities = 50/242 (20%), Positives = 84/242 (34%), Gaps = 25/242 (10%)
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNN 123
+ + + I + L +L VL + N L ++ + GL + + N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNH 349
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
+ FK L LQT+ L N+ ++ + +G + T+P
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNAL------TTIHFIPSIPDIFLSGNKLV-TLPKIN-- 400
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGK--SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
+HL+ N L+ L F +Q L LN + S SL Q
Sbjct: 401 ---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD--QTPSENPSLEQ 455
Query: 242 LWLHGNSFTG------PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L+L N GLS LQ + N L + P +L +L ++L +N
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 296 FQ 297
Sbjct: 516 LT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 43/213 (20%), Positives = 71/213 (33%), Gaps = 37/213 (17%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS------LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+ SL L + +N L + GLS LQ + + N S+P F LT+L+
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+SL+ N + + AN L L ++ N L
Sbjct: 508 GLSLNSNRLTV--LSHND--------LPAN-------------------LEILDISRNQL 538
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
P P F S+ + N + +L+ + + + P SG+
Sbjct: 539 LAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYP-DSFSGV 597
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
SL S ++ S +L + V LT
Sbjct: 598 -SLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
SC G I + L+ + L + +L+LS N + L L++L+
Sbjct: 1 SCSFDGRI--AFYRFCNLT-QV---PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 425 VSNNHLFGKVPN 436
+ + + +
Sbjct: 55 LGSQYTPLTIDK 66
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 51/300 (17%), Positives = 96/300 (32%), Gaps = 39/300 (13%)
Query: 28 SDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNS 87
+ A++ L D + Q + SN G+ ++ L
Sbjct: 20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-SNNPQIETRTGRALK-ATADLLED 77
Query: 88 LSS--LTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+ LE+ L Q P LS LQ + D +P + L+T++L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQ-FAGLETLTLA 135
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG-------LMHLHLAFN 197
N + +P S+ L+ S +P+ L G L L L +
Sbjct: 136 RNPLRA--LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 198 FLQGPIPLSFGK-SSIQTLWLNGQK--------------------GDSKLNGSVAVIQNM 236
++ +P S ++++L + G + L +
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 237 TSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L +L L S LP + L+ L+ +R +PS + L + ++ + +L
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 24/208 (11%), Positives = 52/208 (25%), Gaps = 51/208 (24%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ + L+ G++ P D LS Q D N ++ + T
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHD--VLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRT 64
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
+ + + A L+ L
Sbjct: 65 GRALK------ATADLLEDATQPGRVALELRS-------VPLPQFPDQAF---------- 101
Query: 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTG 408
++ +L+++ + + + L L L+ N L
Sbjct: 102 ------------------RLS--HLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR- 140
Query: 409 TIPKELTTLPSLEMLDVSNNHLFGKVPN 436
+P + +L L L + ++P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPE 168
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 375 VNLKNLGLSGT----ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
VNL++L L T + ++ + L +L+ L + + L+ + + LP LE LD+
Sbjct: 183 VNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241
Query: 431 FGKVPN 436
P
Sbjct: 242 LRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 7/67 (10%)
Query: 376 NLKNLGLSG-----TISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSNNH 429
L+ L L G F L++L+L + L T+P ++ L LE LD+
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 430 LFGKVPN 436
++P+
Sbjct: 289 NLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 375 VNLKNLGLSG-----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
LK L L T+ + RLT L +L L G +P + LP+ ++ V +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 430 L 430
Sbjct: 313 Q 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 13/65 (20%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
NLK+L + + L L +L L G P L+ L + +
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 432 GKVPN 436
+P
Sbjct: 267 LTLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 9e-06
Identities = 13/69 (18%), Positives = 25/69 (36%), Gaps = 15/69 (21%)
Query: 376 NLKNLGLSG--------------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLE 421
L+ L + S L +L+ L L + ++P + L +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 422 MLDVSNNHL 430
L + N+ L
Sbjct: 210 SLKIRNSPL 218
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 12/69 (17%), Positives = 26/69 (37%), Gaps = 13/69 (18%)
Query: 375 VNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKEL---------TTLPSLE 421
L+ L L+ + ++ + L LR+L + +P+ L L +L+
Sbjct: 127 AGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 422 MLDVSNNHL 430
L + +
Sbjct: 187 SLRLEWTGI 195
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 68/255 (26%), Positives = 104/255 (40%), Gaps = 13/255 (5%)
Query: 544 KITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGF 603
I + + S PSD E + ++ R N F +LG+G F
Sbjct: 102 AIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTF 161
Query: 604 GTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKVRHRHLVGLLGYCLDGN 661
G V + + A+K ++ V+ K +E VL RH L L Y +
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTH 220
Query: 662 ERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
+RL V EY G L HL E + + R ++ ++YLH ++ ++R
Sbjct: 221 DRLCFVMEYANGGELFFHL---SRERVFSEDRARFY--GAEIVSALDYLHS--EKNVVYR 273
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVD 780
DLK N++L D K+ DFGL + +G GT YLAPE VD
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 781 VFSFGVILMELITGR 795
+ GV++ E++ GR
Sbjct: 332 WWGLGVVMYEMMCGR 346
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 598 LGRGGFGTVYKG---ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+GRG +G VYK + D A+K++E +S EIA+L +++H +++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 655 GYCLDGNERL--LVYEYMPQ---GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
L +R L+++Y + H ++ + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRA----KVADFGLVRL--APDNGKHSIETRLAGTFG 763
H +HRDLKP+NIL+ + K+AD G RL +P ++ + TF
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 764 YLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y APE Y T +D+++ G I EL+T
Sbjct: 201 YRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 76/417 (18%), Positives = 131/417 (31%), Gaps = 107/417 (25%)
Query: 51 PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SL 108
P C +CS +R + + +P+ + + +L++ KN++ +
Sbjct: 4 PPRC-----ECSAQDRA--VLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIK-TLNQDEF 52
Query: 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168
+ L+E+ ++N ++V F L +L+T+ L N + + L +
Sbjct: 53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDI 111
Query: 169 NGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226
+ I + D F + L L + N L I
Sbjct: 112 SENKIV-ILLDYMFQD---LYNLKSLEVGDNDL----------VYI-------------- 143
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHS 285
S + SL QL L + T P LS L L +R + I S L+
Sbjct: 144 --SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 286 LAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345
L V+ +++ + G LSI
Sbjct: 202 LKVLEISH----------------------WPYLDTMTPNCLYGLNLTSLSI-------- 231
Query: 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN-FSRLTSLRQLM 400
+ + V A ++ L+ L LS TI + L L+++
Sbjct: 232 -------THCNLTA----VPYLAVRHLV--YLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278
Query: 401 LSGNELTGTIPKE-LTTLPSLEMLDVSNNHL-------FGKVPNFRQNVIVKTDGNP 449
L G +L + L L +L+VS N L F V N + D NP
Sbjct: 279 LVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET---LILDSNP 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 48/222 (21%), Positives = 87/222 (39%), Gaps = 15/222 (6%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
L +L LEV N L I SGL+SL+++ + N TS+P++ L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLI 179
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTI-PDFLGGDTIPGLMHLHLAFNF 198
+ L + + ++ + S K L+ + T+ P+ L G L L +
Sbjct: 180 VLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG---LNLTSLSITHCN 235
Query: 199 LQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-- 255
L L+ ++ L L+ + + + L ++ L G +
Sbjct: 236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSM---LHELLRLQEIQLVGGQLAV-VEPYA 291
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
GL+ L+ +V NQLT + S ++ +L + L +N
Sbjct: 292 FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 33/189 (17%), Positives = 61/189 (32%), Gaps = 44/189 (23%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-PSLSGLSSLQEVLFDDN 122
+ I+ L L VLE+ + P+ +L +
Sbjct: 185 HLNINAIR----------DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--F 180
N T+VP + L L+ ++L YN S + L + LQ G + + F
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAF 292
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
G + L L+++ N L ++++ +V ++ +L
Sbjct: 293 RG---LNYLRVLNVSGNQL----------TTLEE----------------SVFHSVGNLE 323
Query: 241 QLWLHGNSF 249
L L N
Sbjct: 324 TLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
L+ + L G + F L LR L +SGN+LT T+ + + ++ +LE L + +N
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNP 331
Query: 430 L 430
L
Sbjct: 332 L 332
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 65/355 (18%), Positives = 122/355 (34%), Gaps = 53/355 (14%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
++ T L++LT L+ + +T + + L+ L +++ NN T++
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITTLD---LSQN 84
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
T+L ++ D N + + + T L + + +T L P L +L+ A
Sbjct: 85 TNLTYLACDSNKLTN--LD--VTPLTKLTYLNCDTNKLTK-----LDVSQNPLLTYLNCA 135
Query: 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
N L I +S + + L + K +KL+ + T LT L N T D
Sbjct: 136 RNTLT-EIDVS-HNTQLTELDCHLNKKITKLD-----VTPQTQLTTLDCSFNKITEL--D 186
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
+S L + N +T + + + L L + ++N D+ +
Sbjct: 187 VSQNKLLNRLNCDTNNITKLDLNQNIQLTFL---DCSSNKLT----------EIDVTPLT 233
Query: 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375
D C N L + V + L + D N ++
Sbjct: 234 QLTYFD-----CSV--NPLTEL--DVSTLSKLTTLHCIQT------DLLEIDLTHNTQLI 278
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ G + + T L L +T + L+ P L L ++N L
Sbjct: 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 67/368 (18%), Positives = 118/368 (32%), Gaps = 60/368 (16%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNF 124
+T + +I + + L+ LT L N +T + LS ++L + D N
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD-LSQNTNLTYLACDSNKL 97
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD 184
T++ LT L ++ D N + S L + +T +
Sbjct: 98 TNLD---VTPLTKLTYLNCDTNKLTK--LDVS--QNPLLTYLNCARNTLT-----EIDVS 145
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
L L N + ++ ++ + TL + K ++L+ + L +L
Sbjct: 146 HNTQLTELDCHLNKKITKLDVT-PQTQLTTLDCSFNK-ITELD-----VSQNKLLNRLNC 198
Query: 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304
N+ T DL+ L N+LT I + L L + + N
Sbjct: 199 DTNNITKL--DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYF---DCSVNPLT------- 246
Query: 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364
D++ S L C LL I + + L +
Sbjct: 247 ---ELDVSTLSKLTTLH-----CIQ--TDLLEI--DLTHNTQLIYFQAEGCRKIKEL--- 291
Query: 365 SCDAGGNITVVNLKNLGLSGT-ISS-NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
D N L L I+ + S+ L L L+ ELT + ++ L+
Sbjct: 292 --DVTHNT---QLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS 343
Query: 423 LDVSNNHL 430
L N H+
Sbjct: 344 LSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 47/238 (19%), Positives = 80/238 (33%), Gaps = 28/238 (11%)
Query: 57 KHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQE 116
I S + ++T + ++ + LT L+ NK+T ++ +S L
Sbjct: 140 TEIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELD-VSQNKLLNR 195
Query: 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT 176
+ D NN T + L + N I + T L F + +T
Sbjct: 196 LNCDTNNITKLD---LNQNIQLTFLDCSSNKLTE--ID--VTPLTQLTYFDCSVNPLT-E 247
Query: 177 IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM 236
+ T+ L LH L I L+ + + G + +L+ + +
Sbjct: 248 LDV----STLSKLTTLHCIQTDLLE-IDLTHN-TQLIYFQAEGCRKIKELD-----VTHN 296
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
T L L T L DLS L + + +LT + S L SL + N
Sbjct: 297 TQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTELDVSHNTKLKSL---SCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 10/60 (16%), Positives = 23/60 (38%), Gaps = 2/60 (3%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N + T + + +L +L L + +T + + L L L ++N++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI 76
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 63/274 (22%), Positives = 94/274 (34%), Gaps = 85/274 (31%)
Query: 595 ENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
LGRG FG V + + +AVK + E A SE SE+ +L +
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGH 84
Query: 647 HRHLVGLLG--------------YCLDGN------------------------------- 661
H ++V LLG +C GN
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR-----------------LTIALDVAR 704
+ + + T S+ + K L + + VA+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+E+L A + IHRDL NILL + K+ DFGL R + + +
Sbjct: 205 GMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----VRKGDAR 256
Query: 765 L-----APEYAVTGRVTTKVDVFSFGVILMELIT 793
L APE T + DV+SFGV+L E+ +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G +G V +AVK ++ + K EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGH 73
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVEY 708
+GN + L EY G L F+R +E + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDR-------IEPDIGMPE--PDAQRFFHQLMAGVVY 120
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH HRD+KP N+LL + K++DFGL + N + + ++ GT Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 769 ------YAVTGRVTTKVDVFSFGVILMELITGR 795
+ VDV+S G++L ++ G
Sbjct: 178 LLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 41/222 (18%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVLT 643
+ +G G +G VYK + + G A+K R+E ++G S EI++L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIP---STTIREISILK 55
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+++H ++V L +LV+E++ Q L + L + GL+ + + + L
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEG-GLESVT-AKSFLLQL--L 110
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLAG 760
G+ Y H + +HRDLKP N+L+ + K+ADFGL R + H I T
Sbjct: 111 NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-- 165
Query: 761 TFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y AP+ Y +T +D++S G I E++ G
Sbjct: 166 ---YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + + LG G + TVYKG+ +A+K R+E E+G E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAP---CTAIREVSLL 54
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
++H ++V L LV+EY+ + L ++L + + + L
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHN-VKLFLFQL-- 109
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLA 759
RG+ Y H Q +HRDLKP N+L+ + K+ADFGL R K + + T
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW- 165
Query: 760 GTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
Y P+ Y +T++D++ G I E+ TGR
Sbjct: 166 ----YRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 42/233 (18%), Positives = 88/233 (37%), Gaps = 21/233 (9%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDN 122
NR ++ +++ L S ++ L++ N L+ QI L+ + L+ + N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN 68
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
+ L++L+T+ L+ N + L ++ A NI+ +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYV------QELLVGPSIETLHAANNNIS-RVSC--- 116
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
G +++LA N + L G S +Q L L + +N + + + +L
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-DTVNFA-ELAASSDTLEH 173
Query: 242 LWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L N + + L+ + N+L + + + ++L NN
Sbjct: 174 LNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNN 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 33/241 (13%), Positives = 68/241 (28%), Gaps = 36/241 (14%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+EL S+ L N ++ ++ S + + +N T + + +Q +
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L N D+ E + L+ + I + + L L L+ N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV---FAKLKTLDLSSNKLAF- 205
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSS 261
+ F + +T + L N + L +
Sbjct: 206 MGPEFQ--------------------------SAAGVTWISLRNNKLVL-IEKALRFSQN 238
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLD 321
L+ F +R N + V + + T + ++C +
Sbjct: 239 LEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 322 D 322
D
Sbjct: 298 D 298
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 25/166 (15%), Positives = 58/166 (34%), Gaps = 14/166 (8%)
Query: 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188
+ + + + +S + + A ++ +G ++ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAP--FTK 59
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
L L+L+ N L + L S+++TL LN N V + S+ L N+
Sbjct: 60 LELLNLSSNVLYETLDLE-SLSTLRTLDLNN-------N-YVQELLVGPSIETLHAANNN 110
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + S ++ + +N++T + + ++L N
Sbjct: 111 ISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 16/59 (27%), Positives = 22/59 (37%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L LS + F + + L N+L I K L +LE D+ N
Sbjct: 192 KLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 15/69 (21%), Positives = 32/69 (46%), Gaps = 1/69 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + L ++S ++++L LSGN L+ +L LE+L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 431 FGKVPNFRQ 439
+ +
Sbjct: 71 -YETLDLES 78
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 20/117 (17%), Positives = 36/117 (30%), Gaps = 6/117 (5%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVP-SDFFKGLTSL 138
+ E S + +T + + NKL +L +L+ N F DFF +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
QT++ + ++ + G D + L H H
Sbjct: 265 QTVAKQTVKK----LTGQNEEECTVPTLGHYG-AYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 18/58 (31%), Positives = 29/58 (50%), Gaps = 8/58 (13%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L LS + + L++LR L L+ N + EL PS+E L +NN++
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 6/59 (10%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L++L L + L+ L LS N+L + E + + + + NN L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTG-TIPKELTTLPSLEMLDVSNNH 429
KN+ L+ + + ++ L L NE+ + + +LE L++ N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 430 L 430
+
Sbjct: 181 I 181
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 17/67 (25%), Positives = 32/67 (47%), Gaps = 3/67 (4%)
Query: 232 VIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ Q+ ++ +L L GN + DL+ + L+ ++ N L L +L +L ++
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLD 86
Query: 291 LTNNLFQ 297
L NN Q
Sbjct: 87 LNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 12/61 (19%), Positives = 22/61 (36%), Gaps = 8/61 (13%)
Query: 376 NLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
++ L L + + +L L L N + + L+ LD+S+N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNK 202
Query: 430 L 430
L
Sbjct: 203 L 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 11/57 (19%), Positives = 26/57 (45%), Gaps = 2/57 (3%)
Query: 376 NLKNLGLSGT-ISS-NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+++ L + IS + SR + + L+ N++T + ++ LD+ N +
Sbjct: 100 SIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 7/45 (15%), Positives = 17/45 (37%)
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
I + ++ + L + + +++ LD+S N L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 8/55 (14%), Positives = 20/55 (36%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L L+ S+ L + N ++ + + + ++NN +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKI 132
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 60/251 (23%), Positives = 95/251 (37%), Gaps = 45/251 (17%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEF------KSEIAVLT 643
+S + LG G FG V+ ++ VK ++ V E + E EIA+L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR--KEEGLKPLEWTRRLTIALD 701
+V H +++ +L + LV E G LF + L I
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPL-ASY--IFRQ 138
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ V YL + IHRD+K NI++ +D K+ DFG T GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYT-FCGT 192
Query: 762 FGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDETQ------------- 802
Y APE Y G +++++S GV L L+ E +
Sbjct: 193 IEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 803 SEDSVHLVTWF 813
S++ + LV+
Sbjct: 248 SKELMSLVSGL 258
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 62/309 (20%), Positives = 107/309 (34%), Gaps = 47/309 (15%)
Query: 567 PSDLHVVEAGSMVISIQVLRNVTNNFSE-----ENVLGRGGFGTVYKG-ELHDGTKIAVK 620
H +G V+ Q ++ + VLG G G V + G K A+K
Sbjct: 2 AHHHHHHSSGLEVL-FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 621 RMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER----LLVYEYMPQGTL 675
++ + + + E+ + H+V +L + + L++ E M G L
Sbjct: 61 -----LLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDD 732
+ R ++ E I D+ +++LH + HRD+KP N+L D
Sbjct: 114 FSRIQERGDQAFTEREAAE---IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKD 167
Query: 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELI 792
K+ DFG + N + T Y+APE + D++S GVI+ L+
Sbjct: 168 AVLKLTDFGFAKETTQNALQTP----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223
Query: 793 TGRKA-LDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGH 850
G T S + R+ + +S A L
Sbjct: 224 CGFPPFYSNTGQAISPGM-------------KRRIRLGQYGFPNPEWSEVSEDAKQLIRL 270
Query: 851 CCAREPYQR 859
+P +R
Sbjct: 271 LLKTDPTER 279
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 52/234 (22%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEK-GFAEFKS----EIAV 641
+ + + +G+G FG V+K G K+A+K ME+ EK GF EI +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGF---PITALREIKI 69
Query: 642 LTKVRHRHLVGLLGYCLDGNERL--------LVYEYMPQ---GTLSRHLFNRKEEGLKPL 690
L ++H ++V L+ C LV+++ G LS L +K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-- 127
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APD 748
+ + G+ Y+H +HRD+K +N+L+ D K+ADFGL R
Sbjct: 128 ------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 749 NGKHSIETRLAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 795
N + + T T Y PE Y +D++ G I+ E+ T
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKG--ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAV 641
+ +G G +G V+K + G +A+K R+++ E+G E+AV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMP---LSTIREVAV 64
Query: 642 L---TKVRHRHLVGLL----GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
L H ++V L D +L LV+E++ Q L+ +L E G+ E
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT-ETI 122
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK-- 751
+ + L RG+++LH +HRDLKP NIL+ + K+ADFGL R+
Sbjct: 123 KDMMFQL--LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
+ T Y APE + T VD++S G I E+ +
Sbjct: 178 SVVVTLW-----YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 60/214 (28%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+ F LG G FG V + + A+K ++ VV K +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDV 702
LV L D N L +V EY+ G + HL R+ G R ++ +
Sbjct: 101 PFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHL--RRI-GRFSEPHARFYAAQIVLTF-- 154
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGT 761
EYLH I+RDLKP N+L+ +V DFG + T L GT
Sbjct: 155 ----EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGT 201
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
LAPE ++ VD ++ GV++ E+ G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 68/214 (31%), Positives = 94/214 (43%), Gaps = 40/214 (18%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG G FG V G+ G K+AVK + + S + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
++ +V EY+ G L ++ RL +R GV+
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----------RLDE--KESRRLFQQILSGVD 130
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H +HRDLKP N+LL M AK+ADFGL + D + T G+ Y AP
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTS-CGSPNYAAP 184
Query: 768 E------YAVTGRVTTKVDVFSFGVILMELITGR 795
E YA G +VD++S GVIL L+ G
Sbjct: 185 EVISGRLYA--GP---EVDIWSSGVILYALLCGT 213
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 62/378 (16%), Positives = 118/378 (31%), Gaps = 100/378 (26%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSG--------------LSSLQEVLFDDNNFT 125
+P E ++ S T ++ P +G E+ ++ +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
S+P L+++ NS +PE + L + N ++ D
Sbjct: 85 SLPEL----PPHLESLVASCNSLTE--LPELPQSLKSLLVDNNNLKALS---------DL 129
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
P L +L ++ N L+ +P S ++ + ++ N + SL +
Sbjct: 130 PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDN-------NSLKKLPDLPPSLEFIAAG 181
Query: 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305
N LP+L L L +N L + P ++L S+ NN
Sbjct: 182 NNQLEE-LPELQNLPFLTAIYADNNSLKKL-PDLPLSLESI---VAGNN----------- 225
Query: 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365
+L + + L + NN + +
Sbjct: 226 ----------------------------ILEELPELQNLPFLTTIYADNNLLKT----LP 253
Query: 366 CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPK---------ELTT 416
++ +N+++ L+ + LT L + L+ P E+ +
Sbjct: 254 DLPP-SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS 311
Query: 417 LP----SLEMLDVSNNHL 430
L SLE L+VSNN L
Sbjct: 312 LCDLPPSLEELNVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 40/216 (18%), Positives = 78/216 (36%), Gaps = 35/216 (16%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
LP+ SL+ L V E + + L+ P+L L+ N S+ SL+
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLN------ASSNEIRSLCDL----PPSLE 320
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+++ N +P L+R A+ ++ +P+ L LH+ +N L
Sbjct: 321 ELNVSNNKLIE--LPALP---PRLERLIASFNHLA-EVPELPQ-----NLKQLHVEYNPL 369
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+ P S++ L +N + V + +L QL + N PD+
Sbjct: 370 RE-FPDIPE--SVEDLRMN--------SHLAEVPELPQNLKQLHVETNPLRE-FPDI--P 415
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
S++D + ++ + L ++
Sbjct: 416 ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 36/218 (16%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
EL +L LT + N L +P L SL+ + DN T +P + + LT L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDL--PPSLEALNVRDNYLTDLP-ELPQSLTFLD 283
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
++ + E L +A+ I ++ D P L L+++ N L
Sbjct: 284 VSENIFSG-----LSELPP---NLYYLNASSNEIR-SLCDLP-----PSLEELNVSNNKL 329
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+P + ++ L + N V + +L QL + N PD+
Sbjct: 330 IE-LPALPPR--LERLIASF-------NHLAEVPELPQNLKQLHVEYNPLRE-FPDI--P 376
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
S++D + ++ L + P NL L ++ N +
Sbjct: 377 ESVEDLRM-NSHLAEV-PELPQNLKQL---HVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 8/67 (11%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L+ LG+S + L+ + + N L +P PSLE + NN L
Sbjct: 132 LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQL-E 186
Query: 433 KVPNFRQ 439
++P +
Sbjct: 187 ELPELQN 193
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 40/183 (21%), Positives = 65/183 (35%), Gaps = 28/183 (15%)
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAK 313
P + LQ+ + LT + P N+ S + ++ P N R +MA
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQR-EMAV 62
Query: 314 GSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNIT 373
CLD + L S+ + + L N ++T
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPH---LESLVASCN---------------SLT 104
Query: 374 VV-----NLKNLGLSGTISSNFSRL-TSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
+ +LK+L + S L L L +S N+L +P EL L+++DV N
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDN 162
Query: 428 NHL 430
N L
Sbjct: 163 NSL 165
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 21/56 (37%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L S I S SL +L +S N+L +P P LE L S NHL
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 10/55 (18%), Positives = 26/55 (47%), Gaps = 4/55 (7%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++++L ++ ++ +L+QL + N L P S+E L +++ +
Sbjct: 378 SVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERV 428
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS--------- 637
+ + ++ + + G +G V G +G +A+KR+ + V +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 638 EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
EI +L H +++GL ++ LV E M + L++ + +++ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRI----VISP 133
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
+ G+ LH A +HRDL P NILL D+ + DF L R +
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 753 S--IETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
+ + R Y APE + T VD++S G ++ E+ +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+F LG G FG V+ + A+K ++ VV K E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR-- 704
++ + G D +++ ++ +Y+ G L L RK +R VA+
Sbjct: 66 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLL--RKS---------QRFPN--PVAKFY 111
Query: 705 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR- 757
+EYLH + I+RDLKP NILL + K+ DFG + PD T
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYT 162
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
L GT Y+APE T +D +SFG+++ E++ G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 48/254 (18%)
Query: 564 SSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK-- 620
G + GSM +S + + LG G +G VYK + +A+K
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI 67
Query: 621 RMESAVVSEKGFAEFKS----EIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
R+E E+G E+++L +++HR+++ L + L++EY L
Sbjct: 68 RLEHE---EEGVP---GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120
Query: 677 RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-----GD 731
+++ + + + + GV + H + +HRDLKP N+LL +
Sbjct: 121 KYM-----DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASE 172
Query: 732 DMRAKVADFGLVRLAPDNGK---HSIETRLAGTFGYLAPE-------YAVTGRVTTKVDV 781
K+ DFGL R + H I T Y PE Y +T VD+
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLW-----YRPPEILLGSRHY------STSVDI 221
Query: 782 FSFGVILMELITGR 795
+S I E++
Sbjct: 222 WSIACIWAEMLMKT 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 28/211 (13%)
Query: 597 VLGRGGFGTVY---KGELHDGTKI-AVKRMESAVVSEKG--FAEFKSEIAVLTKVRHRHL 650
VLG+GG+G V+ K + KI A+K ++ A++ A K+E +L +V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 651 VGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARG 705
V L+ Y +L L+ EY+ G L L + EG+ + +++AL
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMAL----- 134
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+LH I+RDLKP NI+L K+ DFGL + + +G + GT Y+
Sbjct: 135 -GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTIEYM 188
Query: 766 APEYAVTGRVTTK-VDVFSFGVILMELITGR 795
APE + + VD +S G ++ +++TG
Sbjct: 189 APE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 52/222 (23%), Positives = 83/222 (37%), Gaps = 20/222 (9%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTI 141
P L L L + KN+L ++P +LQE+ +N T V F GL + +
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHENEITKVRKSVFNGLNQMIVV 150
Query: 142 SLDYNSFDSWVIPE-SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200
L N S I + + L NIT TIP P L LHL N +
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ----GLPPSLTELHLDGNKIT 205
Query: 201 GPIPLSF-GKSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGPLPDLSG 258
S G +++ L L+ + ++ + N L +L L+ N L+
Sbjct: 206 KVDAASLKGLNNLAKLGLSF----NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 261
Query: 259 LSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTNN 294
+Q + +N ++ I P S + V+L +N
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 47/254 (18%)
Query: 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGL 111
C + +QCS + ++ PK+L +L++ NK+T +I L
Sbjct: 31 CHLRVVQCS-DLGLEKV-----------PKDL--PPDTALLDLQNNKIT-EIKDGDFKNL 75
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
+L ++ +N + + F L L+ + L N +PE + LQ +
Sbjct: 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE--LPEKM--PKTLQELRVHEN 131
Query: 172 NITGTIPD--FLGGDTIPGLMHLHLAFNFLQ-GPIP-LSF-GKSSIQTLWLNGQKGDSKL 226
IT + F G + ++ + L N L+ I +F G + + +
Sbjct: 132 EIT-KVRKSVFNG---LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN----- 182
Query: 227 NGSVAVIQNM-----TSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSL 280
I + SLT+L L GN T L GL++L + N ++ + SL
Sbjct: 183 ------ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 281 VNLHSLAVVNLTNN 294
N L ++L NN
Sbjct: 237 ANTPHLRELHLNNN 250
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 49/245 (20%), Positives = 82/245 (33%), Gaps = 59/245 (24%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT-GQIPS--LSGLSSLQEVLFD 120
N +T+++ N L+ + V+E+ N L I + G+ L +
Sbjct: 130 ENEITKVR----------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD- 179
D N T++P LT L LD N V SLK L + + +I+ + +
Sbjct: 180 DTNITTIPQGLPPSLTEL---HLDGNKITK-VDAASLKGLNNLAKLGLSFNSIS-AVDNG 234
Query: 180 -FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
P L LHL N L +P +
Sbjct: 235 SLAN---TPHLRELHLNNNKLVK-VPGGL--------------------------ADHKY 264
Query: 239 LTQLWLHGNSFT-------GPLPDLSGLSSLQDFSVRDNQL--TGIVPSSLVNLHSLAVV 289
+ ++LH N+ + P + +S S+ N + I PS+ ++ A V
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 290 NLTNN 294
L N
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 16/60 (26%), Positives = 30/60 (50%), Gaps = 6/60 (10%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL LGLS + + + LR+L L+ N+L +P L ++++ + NN++
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 12/86 (13%)
Query: 356 PCNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C + V C + V + L L I F L +L L+L N
Sbjct: 28 RCQCHLRVVQCS-DLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 405 ELTGTIPKELTTLPSLEMLDVSNNHL 430
+++ P L LE L +S N L
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQL 112
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 17/60 (28%), Positives = 26/60 (43%), Gaps = 5/60 (8%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L L L G + + L +L +L LS N ++ L P L L ++NN L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 8/60 (13%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L IS F+ L L +L LS N+L +P+++ +L+ L V N +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI 133
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 12/66 (18%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-------LTTLPSLEMLD 424
+L+ L L+ + + ++ + L N ++ I T S +
Sbjct: 241 HLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVS 299
Query: 425 VSNNHL 430
+ +N +
Sbjct: 300 LFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 9/62 (14%), Positives = 23/62 (37%), Gaps = 7/62 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELT-GTIPKE-LTTLPSLEMLDVSNN 428
L+ L + + + F+ L + + L N L I + L + +++
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 429 HL 430
++
Sbjct: 182 NI 183
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 10/62 (16%)
Query: 376 NLKNLGLSG------TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
+ + L I + F + L + ++ +T TIP+ L PSL L + N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 429 HL 430
+
Sbjct: 203 KI 204
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG G FG V K+A+K + ++ + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
+ ++V EY G L ++ +K R+T D R +E
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKK-----------RMTE--DEGRRFFQQIICAIE 122
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H +HRDLKP N+LL D++ K+ADFGL + D ++T G+ Y AP
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--LKT-SCGSPNYAAP 176
Query: 768 E------YAVTGRVTTKVDVFSFGVILMELITGR 795
E YA G +VDV+S G++L ++ GR
Sbjct: 177 EVINGKLYA--GP---EVDVWSCGIVLYVMLVGR 205
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 56/262 (21%), Positives = 97/262 (37%), Gaps = 79/262 (30%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-EIAVLTK 644
+ +S LG G FG V + ++ G + A+K++ +K+ E+ ++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-------DPRYKNRELDIMKV 56
Query: 645 VRHRHLVGLLGYCLDGNERL--------------------------------------LV 666
+ H +++ L+ Y + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 667 YEYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 724
EY+P TL + L F R + P+ L R V ++H L HRD+KP
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSI-PMNLISIYIYQL--FRAVGFIHSL---GICHRDIKP 169
Query: 725 SNILL-GDDMRAKVADFGLVRLAPDNGKHSIE---TRLAGTFGYLAPE-------YAVTG 773
N+L+ D K+ DFG + + S+ +R Y APE Y
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAYICSRF-----YRAPELMLGATEY---- 219
Query: 774 RVTTKVDVFSFGVILMELITGR 795
T +D++S G + ELI G+
Sbjct: 220 --TPSIDLWSIGCVFGELILGK 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 24/283 (8%)
Query: 518 RKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGS 577
K + + V P G +GN E + G G+++ ++
Sbjct: 276 FKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNR 335
Query: 578 MVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF- 635
+ + +F+ VLG+G FG V E ++ AVK ++ VV + E
Sbjct: 336 DRMKLT-------DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 636 KSEIAVLTKV-RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
E VL + L L C +RL V EY+ G L H+ ++ G
Sbjct: 389 MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHA 444
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
A ++A G+ +L + I+RDLK N++L + K+ADFG+ + +G +
Sbjct: 445 V--FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 795
GT Y+APE + + K VD ++FGV+L E++ G+
Sbjct: 500 --KTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKVRHRHLVGLL 654
+LG+G FG V + A+K + V+ K +E VL RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL E + E R ++ +EYLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFY--GAEIVSALEYLHSR- 124
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPEY 769
++RD+K N++L D K+ DFGL + +G TF G YLAPE
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLAPE- 175
Query: 770 AVTGRVTTK-VDVFSFGVILMELITGR 795
+ + VD + GV++ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 57/216 (26%), Positives = 82/216 (37%), Gaps = 46/216 (21%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG +AVK +E A + E + EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
L ++ EY G L + N R + D AR GV
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAG-----------RFSE--DEARFFFQQLLSGVS 130
Query: 708 YLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
Y H HRDLK N LL R K+ DFG + + + + ++ + GT Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV-GTPAYI 184
Query: 766 APE------YAVTGRVTTKVDVFSFGVILMELITGR 795
APE Y G+ DV+S GV L ++ G
Sbjct: 185 APEVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 55/266 (20%), Positives = 101/266 (37%), Gaps = 28/266 (10%)
Query: 51 PDPC----KWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEV 96
P C ++ + C P + + I+ L L +L++
Sbjct: 36 PSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 97 MKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIP 154
+N + I + +GL++L + DN T++P+ F L+ L+ + L N +S +
Sbjct: 96 SRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPS 153
Query: 155 ESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212
+ L+R I + F G + L +L+LA L+ IP +
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEG---LSNLRYLNLAMCNLRE-IPNLTPLIKL 209
Query: 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQ 271
L L+G + GS Q + L +LW+ + L SL + ++ N
Sbjct: 210 DELDLSGNHLSAIRPGS---FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 272 LTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LT + LH L ++L +N +
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 17/88 (19%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
+ L L LSG I F L L++L + +++ I + L SL +++++N
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHN 265
Query: 429 HL-------FGKVPNFRQNVIVKTDGNP 449
+L F + + + + NP
Sbjct: 266 NLTLLPHDLFTPLHHLER---IHLHHNP 290
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 22/61 (36%), Positives = 29/61 (47%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
+L+ L LS TI F+ L +L L L N LT TIP L L+ L + NN
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP 147
Query: 430 L 430
+
Sbjct: 148 I 148
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
NL+ L L+ + N + L L +L LSGN L+ I L L+ L + + +
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 22/85 (25%), Positives = 32/85 (37%), Gaps = 12/85 (14%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNE 405
C++ + V C N+ V N + L L I N F L L L LS N
Sbjct: 41 CSNQFSKVICV-RKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
+ L +L L++ +N L
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRL 124
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 8/61 (13%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+L+ L L IS F L++LR L L+ L IP LT L L+ LD+S NH
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNH 218
Query: 430 L 430
L
Sbjct: 219 L 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVS-NN 428
NL L L TI + F L+ L++L L N + +IP +PSL LD+
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
Query: 429 HL 430
L
Sbjct: 172 RL 173
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 39/225 (17%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + +G G G V + +A+K++ F++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---------FQNQTHAKRAY 72
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ ++ V H++++GLL + + +V E M L + + L
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-------QMEL 124
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A +
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 751 KHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
+ T T Y APE + VD++S G I+ E+I G
Sbjct: 182 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 36/270 (13%)
Query: 51 PDPC----KWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEV 96
P C ++ + C+ P + + NI+ L L VL++
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQL 106
Query: 97 MKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIP 154
+N + QI + +GL+SL + DN T +PS F+ L+ L+ + L N +
Sbjct: 107 GRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPS 164
Query: 155 ESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212
+ L R I + F G + L +L+L ++ +P +
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEG---LFNLKYLNLGMCNIKD-MPNLTPLVGL 220
Query: 213 QTLWLNGQKGDSKLNG----SVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSV 267
+ L ++G N ++SL +LW+ + + GL+SL + ++
Sbjct: 221 EELEMSG-------NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N L+ + L L ++L +N +
Sbjct: 274 AHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 21/88 (23%), Positives = 40/88 (45%), Gaps = 17/88 (19%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
V L+ L +SG I F L+SL++L + ++++ I + L SL L++++N
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHN 276
Query: 429 HL-------FGKVPNFRQNVIVKTDGNP 449
+L F + + + NP
Sbjct: 277 NLSSLPHDLFTPLRYLVE---LHLHHNP 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 20/61 (32%), Positives = 25/61 (40%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
+L+ L L I F+ L SL L L N LT IP L L L + NN
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNP 158
Query: 430 L 430
+
Sbjct: 159 I 159
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/59 (33%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
NLK L L I N + L L +L +SGN I L SL+ L V N+ +
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 12/85 (14%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNE 405
C++ + V C ++ V N + L L I ++ F L L L L N
Sbjct: 52 CSNQFSKVVCT-RRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
+ L SL L++ +N L
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWL 135
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 20/61 (32%), Positives = 27/61 (44%), Gaps = 8/61 (13%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+L L L IS F L +L+ L L + +P LT L LE L++S NH
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229
Query: 430 L 430
Sbjct: 230 F 230
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 20/62 (32%), Positives = 27/62 (43%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVS-NN 428
+L L L I S F L+ LR+L L N + +IP +PSL LD+
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182
Query: 429 HL 430
L
Sbjct: 183 KL 184
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 71/262 (27%), Positives = 107/262 (40%), Gaps = 35/262 (13%)
Query: 548 TESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVY 607
+S GG Q LT + + + I NF VLG G +G V+
Sbjct: 19 AGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGI-------ENFELLKVLGTGAYGKVF 71
Query: 608 ---KGELHDGTKI-AVKRMESAVVSEKG--FAEFKSEIAVLTKVRHRH-LVGLLGYCLDG 660
K HD K+ A+K ++ A + +K ++E VL +R LV L Y
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQT 130
Query: 661 NERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVEYLHGLAHQ 715
+L L+ +Y+ G L HL + + + +AL E+LH L
Sbjct: 131 ETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLAL------EHLHKL--- 178
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV 775
I+RD+K NILL + + DFGL + + GT Y+AP+ G
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDS 237
Query: 776 --TTKVDVFSFGVILMELITGR 795
VD +S GV++ EL+TG
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGA 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 5e-22
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + +G G G V + +A+K++ F++
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------FQNQTHAKRAY 109
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ ++ V H++++ LL + + LV E M L + + L
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-------QMEL 161
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 751 K--HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
+ TR Y APE + VD++S G I+ E++ +
Sbjct: 219 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
V+GRG + V L +I A+K ++ +V++ ++ ++E V + H LVGL
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V EY+ G L H+ + + P E R A +++ + YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 128
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPDNGKHSIETRLAGTFGYLAPEYA 770
+ I+RDLK N+LL + K+ D+G+ + L P + + GT Y+APE
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----FCGTPNYIAPE-I 181
Query: 771 VTGRVTTK-VDVFSFGVILMELITGR 795
+ G VD ++ GV++ E++ GR
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 42/224 (18%), Positives = 81/224 (36%), Gaps = 16/224 (7%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSV-PSDFFKGLTSLQTI 141
+SL SL L++ N L+ + S LSSL + N + ++ + F LT LQ +
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154
Query: 142 SLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFL 199
+ + + + T L+ + +++ + +I + HL L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSL---KSIQNVSHLILHMKQH 210
Query: 200 QGPIPLSFGK-SSIQTLWLNGQKGDSK-----LNGSVAVIQNMTSLTQLWLHGNSFTGPL 253
+ + SS++ L L D+ G + + + + S +
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L+ +S L + NQL + L SL + L N +
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 52/351 (14%), Positives = 110/351 (31%), Gaps = 98/351 (27%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
++ L++ N++T I + L +LQ ++ N ++ D F L SL+ + L YN
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS 206
+ + S F + L L+L N
Sbjct: 111 YLSN--LSSSW----------------------F---KPLSSLTFLNLLGN--------- 134
Query: 207 FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQD 264
+TL G ++ ++T L L + + +GL+ L++
Sbjct: 135 ----PYKTL------------GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324
+ + L P SL ++ +++ + L
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI--------------LLLEIFV------ 218
Query: 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384
D +V L ++ + G + I +N+ ++
Sbjct: 219 ---DVTSSVECLE---------LRDTDLDTFHFSELSTGET---NSLIKKFTFRNVKITD 263
Query: 385 ----TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ ++++ L +L S N+L ++P L SL+ + + N
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 45/229 (19%), Positives = 82/229 (35%), Gaps = 26/229 (11%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+L +L L + N + I S L SL+ + N +++ S +FK L+SL
Sbjct: 69 NSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLT 127
Query: 140 TISLDYNSFDSWVIPES--LKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLA 195
++L N + + + E+ T LQ + I F G + L L +
Sbjct: 128 FLNLLGNPYKT--LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG---LTFLEELEID 182
Query: 196 FNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF----- 249
+ LQ P S ++ L L+ ++ L + +S+ L L
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI---FVDVTSSVECLELRDTDLDTFHF 239
Query: 250 ----TGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
TG L + ++ + D L + L + L + + N
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQV-MKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 49/334 (14%), Positives = 103/334 (30%), Gaps = 49/334 (14%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL-SSLQEVLFDDNNFTSVPSDFFKGLT 136
E + + S + + L IPS GL +++ + +N T + + +
Sbjct: 20 EESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCV 76
Query: 137 SLQTISLDYNSFDSWVIPE-SLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLH 193
+LQ + L N ++ I E S L+ + ++ + F + L L+
Sbjct: 77 NLQALVLTSNGINT--IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWF---KPLSSLTFLN 130
Query: 194 LAFNFLQ--GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
L N + G L + +Q L + +K+ +T L +L + +
Sbjct: 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI--QRKDFAGLTFLEELEIDASDLQS 188
Query: 252 -PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFD 310
L + ++ + Q ++ + S+ + L + S +
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 311 MAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370
+F NV ++ +L +
Sbjct: 249 SLIKKFTF------------RNVKITDESLFQVMKLL-------------------NQIS 277
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN 404
+ + L F RLTSL+++ L N
Sbjct: 278 GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 2/86 (2%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
+ + L + +++ L + L+ +S L E+ F N
Sbjct: 231 DTDLDTFHF--SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQ 288
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFD 149
SVP F LTSLQ I L N +D
Sbjct: 289 LKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 39/241 (16%), Positives = 82/241 (34%), Gaps = 30/241 (12%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV 267
++++L L+ + + + S + +Q +L L L N + + S L SL+ +
Sbjct: 52 EAVKSLDLSNNR-ITYI--SNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDL 107
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ--GQTPKFNSPVRFDMAKGSNSFCLDDAGV 325
N L+ + S L SL +NL N ++ G+T F+ + + + N
Sbjct: 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI-- 165
Query: 326 ACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385
+ + L E + S + N++ + L
Sbjct: 166 ----QRKDFAGLTF-------LEELEIDASDLQSYEPKS-LKSIQNVSHLILHMKQHILL 213
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTT--------LPSLEMLDVSNNHLFGKVPNF 437
+ +S+ L L +L EL+T + + +++ LF +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL 273
Query: 438 R 438
Sbjct: 274 N 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 25/220 (11%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
+ ++ L + N + +P + L ++ + N+ +S+P F
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 141
Query: 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196
L T+S+ N+ + + ++ + T LQ + +T + IP L H ++++
Sbjct: 142 KLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL----SLIPSLFHANVSY 195
Query: 197 NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM--TSLTQLWLHGNSFTGPLP 254
N L + + +++ L + N S+ V++ LT L L N+ T
Sbjct: 196 NLLST-LAIP---IAVEELDASH-------N-SINVVRGPVNVELTILKLQHNNLT-DTA 242
Query: 255 DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L + + N+L I+ V + L + ++NN
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-20
Identities = 41/218 (18%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
LP L+S + +L + ++ +I + + ++Q++ N +P F+ +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196
L + L+ N S + + L S + N+ I D T L +L L+
Sbjct: 118 LLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT-TSLQNLQLSS 174
Query: 197 NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDL 256
N L + LS S+ ++ + + ++ +L NS +
Sbjct: 175 NRLTH-VDLS-LIPSLFHANVSYNLLST--------LAIPIAVEELDASHNSINV-VRGP 223
Query: 257 SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L ++ N LT + L+N L V+L+ N
Sbjct: 224 V-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYN 258
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 38/245 (15%), Positives = 91/245 (37%), Gaps = 27/245 (11%)
Query: 59 IQCSPSNRVTRI-----QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGL 111
+C SN I Q + E +L++ ++ + + ++P+ L
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 68
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
++ + +D + + F ++Q + + +N+ + P ++ L
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERN 127
Query: 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV 230
+++ ++P + + P L L ++ N L+ +F +S+Q L L+ N
Sbjct: 128 DLS-SLPRGIFHN-TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS-------NRLT 178
Query: 231 AV-IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
V + + SL + N + L+ ++++ N + + V L L
Sbjct: 179 HVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSINVVRGPVNVELTIL--- 231
Query: 290 NLTNN 294
L +N
Sbjct: 232 KLQHN 236
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 43/235 (18%), Positives = 86/235 (36%), Gaps = 36/235 (15%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGL- 135
+LP+ + ++ LT L + N L +I +SLQ + N T V L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 189
Query: 136 ---------------TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+++ + +NS + + + L N+T
Sbjct: 190 HANVSYNLLSTLAIPIAVEELDASHNSINV--VRGPVN--VELTILKLQHNNLT-DTAWL 244
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
L PGL+ + L++N L+ + F K ++ L+++ ++L Q + +L
Sbjct: 245 LN---YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN----NRLVALNLYGQPIPTL 297
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L N + L++ + N + + S+ L +L L++N
Sbjct: 298 KVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 34/221 (15%), Positives = 74/221 (33%), Gaps = 36/221 (16%)
Query: 80 TLPKELNSLSSLTVLEV-MKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
+ L + + M+ + L++ + V F ++ +P+ +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198
+ ++L+ + + + A +Q+ I +P + + P L L L N
Sbjct: 72 ELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV-PLLTVLVLERN- 127
Query: 199 LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--L 256
+ +L + N LT L + N+ + D
Sbjct: 128 ------------DLSSL-------------PRGIFHNTPKLTTLSMSNNNLER-IEDDTF 161
Query: 257 SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+SLQ+ + N+LT + S + +L N++ NL
Sbjct: 162 QATTSLQNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 25/187 (13%), Positives = 54/187 (28%), Gaps = 36/187 (19%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
LT+L++ N LT L L EV N + F + L+ + +
Sbjct: 223 PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N + + + L+ + ++ + L +L+L N +
Sbjct: 282 NRLVA--LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ--FDRLENLYLDHNSI------ 330
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDF 265
+++ + +L L L N + + ++
Sbjct: 331 ----VTLK-------------------LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARP 366
Query: 266 SVRDNQL 272
+V D
Sbjct: 367 AVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S ++ + +L+ L LS N L + + LE L + +N +
Sbjct: 273 RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 6/60 (10%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L + LS I + F ++ L +L +S N L + +P+L++LD+S+NHL
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 7/66 (10%)
Query: 371 NITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLD 424
+IT+ N K + + + + L L+ ++ I +++ L
Sbjct: 41 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLY 99
Query: 425 VSNNHL 430
+ N +
Sbjct: 100 MGFNAI 105
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 14/71 (19%), Positives = 29/71 (40%), Gaps = 5/71 (7%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
L + +L VL++ N L + + L+ + D N+ ++ L +L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL 344
Query: 139 QTISLDYNSFD 149
+L +N +D
Sbjct: 345 ---TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 5/60 (8%)
Query: 375 VNLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V L L L T ++ L ++ LS NEL I + LE L +SNN L
Sbjct: 226 VELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 7/59 (11%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L LS + N + L L L N + T+ L+T +L+ L +S+N
Sbjct: 296 TLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 15/61 (24%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
++ L + + + F + L L+L N+L+ ++P+ + P L L +SNN+
Sbjct: 94 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 152
Query: 430 L 430
L
Sbjct: 153 L 153
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
++ L L+ I + F+ ++++L + N + +P +P L +L + N
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
Query: 430 L 430
L
Sbjct: 129 L 129
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
L L L ++ F L L +S N L I + SL+ L +S+N
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 430 L 430
L
Sbjct: 177 L 177
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 10/55 (18%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L + +S + S + ++ +L S N + + + L +L + +N+L
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 6/57 (10%), Positives = 22/57 (38%), Gaps = 2/57 (3%)
Query: 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V++ L + + + + + +P L + +E+L++++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 81
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 8/60 (13%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L +S I + F TSL+ L LS N LT + L+ +PSL +VS N L
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 7/57 (12%)
Query: 376 NLKNLGLSGT-ISS-NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L+NL LS ++ + S + SL +S N L+ L ++E LD S+N +
Sbjct: 166 SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
V+GRG + V L +I A++ ++ +V++ ++ ++E V + H LVGL
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V EY+ G L H+ + + P E R A +++ + YLH
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 171
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
+ I+RDLK N+LL + K+ D+G+ + G TF G Y+APE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD------TTSTFCGTPNYIAPE 223
Query: 769 YAVTGRVTTK-VDVFSFGVILMELITGR 795
+ G VD ++ GV++ E++ GR
Sbjct: 224 -ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
VLG+G FG V E ++ AVK ++ VV + E E VL + L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C +RL V EY+ G L H+ ++ G A ++A G+ +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV--FYAAEIAIGLFFLQS- 139
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
+ I+RDLK N++L + K+ADFG+ + +G TF G Y+APE
Sbjct: 140 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------TTKTFCGTPDYIAPE 191
Query: 769 YAVTGRVTTK-VDVFSFGVILMELITGR 795
+ + K VD ++FGV+L E++ G+
Sbjct: 192 -IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
VLG+G FG V + + + AVK ++ V+ + E +E +L+ H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C +RL V E++ G L H+ ++ R A ++ + +LH
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARAR--FYAAEIISALMFLHD- 142
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
+ I+RDLK N+LL + K+ADFG+ + NG TF G Y+APE
Sbjct: 143 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV------TTATFCGTPDYIAPE 194
Query: 769 YAVTGRVTTK-VDVFSFGVILMELITGR 795
+ + VD ++ GV+L E++ G
Sbjct: 195 -ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTK-VRHRHLVGL 653
V+G+G FG V AVK ++ + +K + SE VL K V+H LVGL
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVEY 708
+ ++L V +Y+ G L HL + E R + AL Y
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASAL------GY 154
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLAP 767
LH L + ++RDLKP NILL + DFG L +N +H+ T GT YLAP
Sbjct: 155 LHSL---NIVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHNSTTSTFCGTPEYLAP 208
Query: 768 EYAVTGRVTTK-VDVFSFGVILMELITGR 795
E + + + VD + G +L E++ G
Sbjct: 209 E-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 37/215 (17%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTI 141
K + L L L + KN L +IP + SSL E+ DN VP F GL ++ I
Sbjct: 95 EKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 142 SLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201
+ N ++ D L + A +T IP D L LHL N
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK----DLPETLNELHLDHN---- 203
Query: 202 PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGL 259
IQ + + + + L +L L N + + LS L
Sbjct: 204 ---------KIQAI-------------ELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFL 240
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+L++ + +N+L+ + P+ L +L L VV L N
Sbjct: 241 PTLRELHLDNNKLSRV-PAGLPDLKLLQVVYLHTN 274
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 52/260 (20%), Positives = 97/260 (37%), Gaps = 36/260 (13%)
Query: 43 PASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT 102
P + P C C +Q ++ +PKE++ T+L++ N ++
Sbjct: 20 PPTYSAMCPFGC-----HCHL----RVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDIS 67
Query: 103 GQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
++ GL L ++ +N + + F L LQ + + N IP +L
Sbjct: 68 -ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE--IPPNL--P 122
Query: 161 TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQ-GPI-PLSFGKSSIQTLW 216
+ L + I +P F G + + + + N L+ P +F + L
Sbjct: 123 SSLVELRIHDNRIR-KVPKGVFSG---LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178
Query: 217 LNGQKGDSKLNGSVAVIQNM-TSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTG 274
++ + +++ +L +L L N L DL S L + NQ+
Sbjct: 179 ISE-------AKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 275 IVPSSLVNLHSLAVVNLTNN 294
I SL L +L ++L NN
Sbjct: 232 IENGSLSFLPTLRELHLDNN 251
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 59/332 (17%), Positives = 96/332 (28%), Gaps = 103/332 (31%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
L+ V D +VP + T L L N + +
Sbjct: 34 HLRVVQCSDLGLKAVPKEISPDTTLL---DLQNNDISE--LRKD---------------- 72
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
DF G + L L L N + S I
Sbjct: 73 ------DFKG---LQHLYALVLVNNKI----------SKI----------------HEKA 97
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ L +L++ N P+L SSL + + DN++ + L ++ + +
Sbjct: 98 FSPLRKLQKLYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
N + NS G L + L I P L E
Sbjct: 156 GNPLE------NSGFEPGAFDGLKLNYLRISE-------AKLTGI--PKDLPETLNELHL 200
Query: 353 GNNPCNSDWKGVSCDAGGNITVV---------NLKNLGLSG----TISSN-FSRLTSLRQ 398
+N I + L LGL I + S L +LR+
Sbjct: 201 DHN---------------KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L N+L+ +P L L L+++ + N++
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 40/245 (16%), Positives = 75/245 (30%), Gaps = 60/245 (24%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT-GQIPS--LSGLSSLQEVLFD 120
NR+ ++ + L ++ +E+ N L GL L +
Sbjct: 132 DNRIRKVP----------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRIS 180
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD- 179
+ T +P D +L + LD+N + + E L + L R I I +
Sbjct: 181 EAKLTGIPKDLP---ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENG 235
Query: 180 -FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
+P L LHL N L +P ++
Sbjct: 236 SLSF---LPTLRELHLDNNKLSR-VPAGL--------------------------PDLKL 265
Query: 239 LTQLWLHGNSFT-------GPLPDLSGLSSLQDFSVRDNQLT--GIVPSSLVNLHSLAVV 289
L ++LH N+ T P+ + S+ +N + + P++ + +
Sbjct: 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 290 NLTNN 294
N
Sbjct: 326 QFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 12/86 (13%)
Query: 356 PCNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C+ + V C + V + L L + + F L L L+L N
Sbjct: 30 GCHCHLRVVQCS-DLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88
Query: 405 ELTGTIPKELTTLPSLEMLDVSNNHL 430
+++ K + L L+ L +S NHL
Sbjct: 89 KISKIHEKAFSPLRKLQKLYISKNHL 114
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 10/66 (15%), Positives = 20/66 (30%), Gaps = 12/66 (18%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-------LTTLPSLEMLD 424
L+ L L + + L L+ + L N +T + +
Sbjct: 242 TLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300
Query: 425 VSNNHL 430
+ NN +
Sbjct: 301 LFNNPV 306
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 71/396 (17%), Positives = 119/396 (30%), Gaps = 93/396 (23%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFD 120
P++ V + + +I + L L L+V + I + GLSSL + D
Sbjct: 29 PAH-VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
N F + + F GL +L+ ++L + D V+ + F
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF----------------------F 125
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
+ L L L N +I+ + NM
Sbjct: 126 ---KPLTSLEMLVLRDN-------------NIKKIQPAS------------FFLNMRRFH 157
Query: 241 QLWLHGNSFT----GPLPDLSG-------LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
L L N L + G LSS+ + + L + S+ +
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217
Query: 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
+L+ N F+ ++ K + + +
Sbjct: 218 DLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK------ 270
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVV---------NLKNLGLSG----TISSN-FSRLTS 395
S K I + +L+ L L+ I N F LT
Sbjct: 271 -----GLEASGVKTCDLS-KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 396 LRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNHL 430
L +L LS N L +I + L LE+LD+S NH+
Sbjct: 325 LLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI 359
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 57/349 (16%), Positives = 105/349 (30%), Gaps = 52/349 (14%)
Query: 100 KLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKD 159
L Q+P L + + V N+ + F L LQ + ++ + + + +
Sbjct: 21 GLH-QVPELP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 160 ATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPI--PLSFGK-SSIQT 214
+ L + + F + + L L L L G + F +S++
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAF---NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
Query: 215 LWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT----GPLPDLSG-------LSSLQ 263
L L + NM L L N L + G LSS+
Sbjct: 134 LVLRDNNIKKIQPA--SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191
Query: 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323
+ + L + S+ ++L+ N F + +
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGN-------GFKESMAKRFFDAIAGTKIQSL 244
Query: 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383
++ + +P N +KG+ + +L +
Sbjct: 245 ILSNSYNMGSSFG-------------HTNFKDPDNFTFKGLEA---SGVKTCDLSKSKIF 288
Query: 384 GTISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ + FS T L QL L+ NE+ I L L L++S N L
Sbjct: 289 -ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 46/230 (20%), Positives = 78/230 (33%), Gaps = 52/230 (22%)
Query: 88 LSSLTVLEVMKNKLT----GQIPSLSGLSSLQE----------VLFDDNNFTSVPSDFFK 133
+S+T L++ N + + +Q F NF + FK
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 134 GL--TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGL 189
GL + ++T L + + ++ T L++ + I I D F G + L
Sbjct: 271 GLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWG---LTHL 325
Query: 190 MHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249
+ L+L+ NFL F +N+ L L L N
Sbjct: 326 LKLNLSQNFLGSIDSRMF--------------------------ENLDKLEVLDLSYNHI 359
Query: 250 TGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L D GL +L++ ++ NQL + L SL + L N +
Sbjct: 360 RA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 24/117 (20%), Positives = 49/117 (41%), Gaps = 12/117 (10%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ + L L + +N++ +I GL+ L ++ N S+ S F+ L L+ + L
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354
Query: 144 DYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFN 197
YN + + + L+ + + + ++PD F D + L + L N
Sbjct: 355 SYNHIRA--LGDQSFLGLPNLKELALDTNQLK-SVPDGIF---DRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 3/66 (4%)
Query: 86 NSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+L L VL++ N + + S GL +L+E+ D N SVP F LTSLQ I L
Sbjct: 344 ENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402
Query: 144 DYNSFD 149
N +D
Sbjct: 403 HTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 12/86 (13%)
Query: 356 PCNSDWKGVSCDAGGNITVV-----NLKNLGLSGT-ISS----NFSRLTSLRQLMLSGNE 405
C+ C + V ++ + LS I+ +FSRL L+ L +
Sbjct: 7 ECSVIGYNAICI-NRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQT 65
Query: 406 LTGTIPKEL-TTLPSLEMLDVSNNHL 430
I L SL +L + N
Sbjct: 66 PGLVIRNNTFRGLSSLIILKLDYNQF 91
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 7/60 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
L+ L LS + F L +L++L L N+L ++P L SL+ + + N
Sbjct: 347 DKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 42/226 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
+ + +G G +G+V + G K+A+K++ F+S
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------FQSEIFAKRAY 71
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ +L ++H +++GLL + + LV +M Q L + +
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-------GLKF 123
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ + + +G++Y+H +HRDLKP N+ + +D K+ DFGL R A
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 751 KHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
+ TR Y APE ++ VD++S G I+ E++TG+
Sbjct: 181 TGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + + +G G +G V + G K+A+K++ F+S
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------FQSELFAKRAY 72
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ +L +RH +++GLL D + LV +M L + + + + L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKL 125
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
R + + +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 751 KHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
+ TR Y APE + R T VD++S G I+ E+ITG+
Sbjct: 183 TGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAE-FKSEIAVLTKV-RHRHLVGL 653
+LG+G FG V+ E + A+K ++ VV E E VL+ H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
E L V EY+ G L H+ + L A ++ G+++LH
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRAT--FYAAEIILGLQFLHSK 137
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
++RDLK NILL D K+ADFG+ + TF G Y+APE
Sbjct: 138 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA------KTNTFCGTPDYIAPE 188
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGR 795
+ + VD +SFGV+L E++ G+
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 46/206 (22%), Positives = 80/206 (38%), Gaps = 31/206 (15%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652
VLG G G V + K A+K ++ + + E+ + + + H+V
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVR 119
Query: 653 LLGYCLDGNER----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARGV 706
++ + L+V E + G L + +R ++ T R I + +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-----TEREASEIMKSIGEAI 174
Query: 707 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTF 762
+YLH + HRD+KP N+L + K+ DFG N + T
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP----CYTP 227
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVIL 788
Y+APE + D++S GVI+
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 54/270 (20%), Positives = 86/270 (31%), Gaps = 57/270 (21%)
Query: 51 PDPCK-----WKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLE 95
P C C P RI + G I + +LT+L
Sbjct: 3 PGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 96 VMKNKLTGQIPS--LSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISLDYNSFDSWV 152
+ N L +I + +GL+ L+++ DN SV F GL L T+ LD
Sbjct: 63 LHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-- 119
Query: 153 IPE-SLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+ + LQ + +PD F + L HL L N + +F
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD---LGNLTHLFLHGNRISSVPERAF-- 173
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV 267
+ + SL +L LH N + L L +
Sbjct: 174 ------------------------RGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYL 208
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N L+ + +L L +L + L +N +
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL +L L G ++ F L SL +L+L N + + L L L + N+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANN 212
Query: 430 L 430
L
Sbjct: 213 L 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/61 (24%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
L L L + F L +L+ L L N L +P + L +L L + N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164
Query: 430 L 430
+
Sbjct: 165 I 165
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
L+ L L + + F L +L L L GN ++ + L SL+ L + N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 430 L 430
+
Sbjct: 189 V 189
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 15/62 (24%), Positives = 23/62 (37%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
L+ L LS ++ F L L L L L + L +L+ L + +N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 429 HL 430
L
Sbjct: 140 AL 141
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 23/93 (24%), Positives = 33/93 (35%), Gaps = 15/93 (16%)
Query: 357 CNSDWKG-VSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C ++ K SC + V + + L G + + F +L L L N
Sbjct: 8 CYNEPKVTTSCP-QQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 405 ELTGTIPKE-LTTLPSLEMLDVSNNHLFGKVPN 436
L I T L LE LD+S+N V
Sbjct: 67 VLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-20
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 58/244 (23%)
Query: 583 QVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---- 637
+++ N++++F +++LG G +G V G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 638 -----EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGT-LSRHLFNRKEEG 686
EI +L +H +++ + + NE ++ E M T L R +
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST----- 106
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
+ L R V+ LHG ++ IHRDLKPSN+L+ + KV DFGL R+
Sbjct: 107 -QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 747 PDNGKHSIETRLAGTFG--------YLAPE-------YAVTGRVTTKVDVFSFGVILMEL 791
++ + E + Y APE Y + +DV+S G IL EL
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAEL 216
Query: 792 ITGR 795
R
Sbjct: 217 FLRR 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
+V ++ + +G G +G V + + ++A+K++ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTL 73
Query: 638 -EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE 691
EI +L + RH +++G+ + +V + M + L + L + L
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT------QHLS 126
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
+ RG++Y+H + +HRDLKPSN+LL K+ DFGL R+A +
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 752 HSIE-TRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
H+ T T Y APE + T +D++S G IL E+++ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 37/268 (13%)
Query: 54 CKWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG 103
C I+C+ P+ TR+++ ++ + L+ LT L + N L+
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 104 Q---IPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
+ S G +SL+ + N ++ S+ F GL L+ + +++
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 161 TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFN-FLQGPIPLSFGK-SSIQTLW 216
L + + + F G + L L +A N F + +P F + ++ L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNG---LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 217 LNGQKGDSKLNG----SVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDN 270
L+ S +++SL L + N+F L L+SLQ N
Sbjct: 182 LSQ-------CQLEQLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLN 233
Query: 271 QLTGIVPSSLVNL-HSLAVVNLTNNLFQ 297
+ L + SLA +NLT N F
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 7/73 (9%)
Query: 364 VSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE--LTTL 417
C + + +LK L LS T+SSNF L L L + L + + +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 125
Query: 418 PSLEMLDVSNNHL 430
+L LD+S+ H
Sbjct: 126 RNLIYLDISHTHT 138
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL L LS +S F+ L+SL+ L +S N ++ L SL++LD S NH
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234
Query: 430 L 430
+
Sbjct: 235 I 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 18/61 (29%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL L +S + F+ L+SL L ++GN + T L +L LD+S
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 430 L 430
L
Sbjct: 187 L 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
+L+ L ++G + F+ L +L L LS +L + +L SL++L++S+N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 429 HL 430
+
Sbjct: 210 NF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 14/88 (15%)
Query: 356 PCNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C+ + C+ +T V + L L ++ F +LT L +L LS N
Sbjct: 4 RCSCSGTEIRCN-SKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 405 ELT--GTIPKELTTLPSLEMLDVSNNHL 430
L+ G + SL+ LD+S N +
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGV 90
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 14/62 (22%), Positives = 22/62 (35%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG----TISSN--FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
L++L +S F L +L L +S L SLE+L ++ N
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGN 160
Query: 429 HL 430
Sbjct: 161 SF 162
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + + +G G +G+V + G ++AVK++ F+S
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------FQSIIHAKRTY 76
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ +L ++H +++GLL + N+ LV M L+ + + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKL 129
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ + RG++Y+H IHRDLKPSN+ + +D K+ DFGL R D
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 751 KHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
+ TR Y APE + VD++S G I+ EL+TGR
Sbjct: 187 TGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 45/227 (19%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+++ LGRG + V++ + + K+ VK ++ V +K + K EI +L +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKK---KIKREIKILENL 87
Query: 646 R-HRHLVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
R +++ L D R LV+E++ + + LT D+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------------QTLTDY-DI 132
Query: 703 A-------RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPDNGKHSI 754
+ ++Y H +HRD+KP N+++ + R ++ D+GL ++++
Sbjct: 133 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 755 E--TRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKAL 798
+R + PE V ++ +D++S G +L +I ++
Sbjct: 190 RVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 42/212 (19%), Positives = 85/212 (40%), Gaps = 23/212 (10%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+L++ + K+ +T + + L + + T++ + L +L + L
Sbjct: 15 DPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELK 71
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N LK+ T + +G + + + + L L + P
Sbjct: 72 DNQITD---LAPLKNLTKITELELSGNPLK-NVSAI---AGLQSIKTLDLTSTQITDVTP 124
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
L+ G S++Q L+L+ N +++ + +T+L L + + L L+ LS L
Sbjct: 125 LA-GLSNLQVLYLDL-------NQITNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKL 175
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
DN+++ I S L +L +L V+L NN
Sbjct: 176 TTLKADDNKISDI--SPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 50/239 (20%), Positives = 100/239 (41%), Gaps = 21/239 (8%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+I G N+ T+ L +T L +T I + L++L + DN T
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITD 77
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT + + L N + ++ ++ IT + +
Sbjct: 78 LAP--LKNLTKITELELSGNPLKN---VSAIAGLQSIKTLDLTSTQIT-DVTPL---AGL 128
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
L L+L N + PL+ G +++Q L + +++++ + + N++ LT L
Sbjct: 129 SNLQVLYLDLNQITNISPLA-GLTNLQYLSIG----NAQVS-DLTPLANLSKLTTLKADD 182
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305
N + + L+ L +L + +++NQ++ + S L N +L +V LTN Q +N+
Sbjct: 183 NKISD-ISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNN 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L I+ + LT + +L LSGN L + + L S++ LD+++ +
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQI 119
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 16/58 (27%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++K L L+ T + + L++L+ L L N++T P L L +L+ L + N +
Sbjct: 108 SIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 16/58 (27%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L I+ S + LT+L+ L + +++ P L L L L +N +
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 8/90 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L L IS S + L +L ++ L N+++ P L +L ++ ++N +
Sbjct: 174 KLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231
Query: 433 KVPNFRQNVIVKTDGNPDIGKDSSSFTPKS 462
+ + N++V N G + P +
Sbjct: 232 QPVFYNNNLVVP---NVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 15/58 (25%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L + +S + + L+ L L N+++ I L +LP+L + + NN +
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ L LSG + S + L S++ L L+ ++T P L L +L++L + N +
Sbjct: 86 KITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI 141
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 55/256 (21%), Positives = 96/256 (37%), Gaps = 60/256 (23%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
+V +N+ ++++GRG +G VY + + +A+K++ F+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---------FEDLIDCKRIL 73
Query: 638 -EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGT-LSRHLFNRKEEGLKPL 690
EI +L +++ +++ L L +E +V E + L + L
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPI-----FL 126
Query: 691 EWTRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
TI ++ G ++H G+ IHRDLKP+N LL D KV DFGL R
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGI-----IHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 749 NGKHSIETRLAGTFGYLAP---------EYAVT------------GRVTTKVDVFSFGVI 787
+I L + VT T +D++S G I
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241
Query: 788 LMELITGRKALDETQS 803
EL+ ++ +
Sbjct: 242 FAELLNMLQSHINDPT 257
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 3e-19
Identities = 39/221 (17%), Positives = 74/221 (33%), Gaps = 29/221 (13%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
+ + +N+ + ++ E+ + N +S+P +
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE-CLINQFSELQLNRLNLSSLPDNLPPQ 81
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+T L + N+ S +PE L+ A ++ T+P + L HL +
Sbjct: 82 ITVL---EITQNALIS--LPELP---ASLEYLDACDNRLS-TLP-----ELPASLKHLDV 127
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP 254
N L +P ++ + + N + + TSL L + N T LP
Sbjct: 128 DNNQLTM-LPELPA--LLEYINADN-------NQLTMLPELPTSLEVLSVRNNQLTF-LP 176
Query: 255 DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
+L SL+ V N L + P+ V H +
Sbjct: 177 EL--PESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRC 214
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 2e-16
Identities = 43/233 (18%), Positives = 79/233 (33%), Gaps = 46/233 (19%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+LP+ +SL L+ N+L+ +P L +SL+ + D+N T +P L+
Sbjct: 94 SLPELP---ASLEYLDACDNRLS-TLPEL--PASLKHLDVDNNQLTMLPEL----PALLE 143
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
I+ D N +PE T L+ S +T +P+ L L ++ N L
Sbjct: 144 YINADNNQLTM--LPELP---TSLEVLSVRNNQLT-FLPELPES-----LEALDVSTNLL 192
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSG 258
+ +P + + + N T +P+ +
Sbjct: 193 ES-LPAVPVR----------------------NHHSEETEIFFRCRENRITH-IPENILS 228
Query: 259 LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDM 311
L + DN L+ + SL + + F + N+ R
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 18/56 (32%), Positives = 26/56 (46%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ + ++ TSL L + N+LT +P+ SLE LDVS N L
Sbjct: 141 LLEYINADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLL 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 7/60 (11%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + L L LS ++ N + L ++ N L ++P+ SLE LD +N L
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 9/61 (14%)
Query: 376 NLKNLGLSGTISSNFSR------LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+ L G + + +L L+ L+ ++P L P + +L+++ N
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNA 91
Query: 430 L 430
L
Sbjct: 92 L 92
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 18/59 (30%), Positives = 28/59 (47%), Gaps = 11/59 (18%)
Query: 376 NLKNLGLSGTISSNFSRL----TSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+LK+L + + + L L + N+LT +P+ T SLE+L V NN L
Sbjct: 121 SLKHLDVDN---NQLTMLPELPALLEYINADNNQLT-MLPELPT---SLEVLSVRNNQL 172
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 19/73 (26%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKE-------------LTTLP--- 418
+ L ++ + S SL L N L+ T+P+ LT LP
Sbjct: 81 QITVLEITQNALISLPELPASLEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPELP 139
Query: 419 -SLEMLDVSNNHL 430
LE ++ NN L
Sbjct: 140 ALLEYINADNNQL 152
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 50/235 (21%), Positives = 98/235 (41%), Gaps = 46/235 (19%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVLT 643
++ + + + LG GG G V+ + ++A+K++ + E K ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIR 63
Query: 644 KVRHRHLVGLL--------------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
++ H ++V + G + N +V EYM E L
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-------------ETDLAN 110
Query: 690 LEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGL 742
+ L + RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 743 VRLAPDNGKHSIE-TRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 795
R+ + H + T Y +P ++ T +D+++ G I E++TG+
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 71/410 (17%), Positives = 130/410 (31%), Gaps = 90/410 (21%)
Query: 538 GDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENV 597
G + +S T H + + + + + + ++
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---------EIAVLTKVRH 647
+G G +G V + + + +A+K++ F+ EIA+L ++ H
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRV---------FEDLIDCKRILREIAILNRLNH 111
Query: 648 RHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
H+V +L +E +V E + R L L T+ ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTEL---HIKTLLYNL 165
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
GV+Y+H +HRDLKP+N L+ D KV DFGL R + + ++
Sbjct: 166 LVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 763 GYLAP--------------EYAVT------------GRVTTKVDVFSFGVILMELITGRK 796
+ + VT T +DV+S G I EL+ K
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 797 ALDETQSE--------DSVHLVTWFRRMHINKDTFRKAID---RTIDL----DEETLASI 841
++ L + + K R D ++ EE + ++
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342
Query: 842 STVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIYGIDL 891
+ A P + + LAE + + D I L
Sbjct: 343 EK--EDAKRYIRIFPKREG---------TDLAERFPASSAD-----AIHL 376
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-18
Identities = 41/253 (16%), Positives = 86/253 (33%), Gaps = 38/253 (15%)
Query: 65 NRVTRIQIGGQNIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDD 121
N + + LP L+S + +L + ++ +I + + ++Q++
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFL 181
N +P F+ + L + L+ N S + + L S + N+ I D
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 182 GGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
T L +L L+ N L + LS S+ ++ ++ + ++ +
Sbjct: 167 FQAT-TSLQNLQLSSNRLTH-VDLS-LIPSLFHANVSYNL--------LSTLAIPIAVEE 215
Query: 242 LWLHGNSFT----GPLPDL----------------SGLSSLQDFSVRDNQLTGIVPSSLV 281
L NS +L L + + N+L I+ V
Sbjct: 216 LDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFV 275
Query: 282 NLHSLAVVNLTNN 294
+ L + ++NN
Sbjct: 276 KMQRLERLYISNN 288
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 7e-18
Identities = 43/235 (18%), Positives = 86/235 (36%), Gaps = 36/235 (15%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
+LP+ + ++ LT L + N L +I +SLQ + N T V L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 195
Query: 137 ----------------SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+++ + +NS + + + L N+T
Sbjct: 196 HANVSYNLLSTLAIPIAVEELDASHNSINV--VRGPV--NVELTILKLQHNNLT-DTAWL 250
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
L PGL+ + L++N L+ + F K ++ L+++ ++L Q + +L
Sbjct: 251 LN---YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN----NRLVALNLYGQPIPTL 303
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L N + L++ + N + + S+ L +L L++N
Sbjct: 304 KVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-14
Identities = 40/238 (16%), Positives = 83/238 (34%), Gaps = 45/238 (18%)
Query: 72 IGGQ---NIEGTLPK----ELNSLSSLTVLEVMKNKLTGQIPSLS---GLSSLQEVLFDD 121
+GGQ N++ P+ + N +V + T + L++ + V F +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFL 181
+ +P+ ++ ++L+ + + + A +Q+ I +P +
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
Query: 182 GGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
+ P L L L N + +L + N LT
Sbjct: 119 FQNV-PLLTVLVLERN-------------DLSSL-------------PRGIFHNTPKLTT 151
Query: 242 LWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L + N+ + D +SLQ+ + N+LT + S + +L N++ NL
Sbjct: 152 LSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 26/197 (13%), Positives = 57/197 (28%), Gaps = 36/197 (18%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
LT+L++ N LT L L EV N + F + L+ + +
Sbjct: 229 PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N + + + L+ + ++ + L +L+L N +
Sbjct: 288 NRLVA--LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ--FDRLENLYLDHNSI------ 336
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDF 265
+++ + +L L L N + + ++
Sbjct: 337 ----VTLK-------------------LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARP 372
Query: 266 SVRDNQLTGIVPSSLVN 282
+V D + L +
Sbjct: 373 AVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S ++ + +L+ L LS N L + + LE L + +N +
Sbjct: 279 RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 6/60 (10%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L + LS I + F ++ L +L +S N L + +P+L++LD+S+NHL
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
L + +L VL++ N L + L+ + D N+ ++ L +L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 351
Query: 140 TISLDYNSFD 149
L +N +D
Sbjct: 352 ---LSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 5/60 (8%)
Query: 375 VNLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V L L L T ++ L ++ LS NEL I + LE L +SNN L
Sbjct: 232 VELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 7/66 (10%)
Query: 371 NITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLD 424
+IT+ N K + + + + L L+ ++ I +++ L
Sbjct: 47 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLY 105
Query: 425 VSNNHL 430
+ N +
Sbjct: 106 MGFNAI 111
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 7/59 (11%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L LS + N + L L L N + T+ L+T +L+ L +S+N
Sbjct: 302 TLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 15/61 (24%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
++ L + + + F + L L+L N+L+ ++P+ + P L L +SNN+
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158
Query: 430 L 430
L
Sbjct: 159 L 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
++ L L+ I + F+ ++++L + N + +P +P L +L + N
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 430 L 430
L
Sbjct: 135 L 135
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
L L L ++ F L L +S N L I + SL+ L +S+N
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 430 L 430
L
Sbjct: 183 L 183
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 6/57 (10%), Positives = 22/57 (38%), Gaps = 2/57 (3%)
Query: 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V++ L + + + + + +P L + +E+L++++ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 87
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 10/55 (18%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L + +S + S + ++ +L S N + + + L +L + +N+L
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 8/60 (13%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L +S I + F TSL+ L LS N LT + L+ +PSL +VS N L
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 64/252 (25%)
Query: 583 QVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---- 637
+V R+V + LG+G +G V+K + G +AVK++ A F++
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDA 52
Query: 638 -----EIAVLTKVR-HRHLVGLLGYCL--DGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
EI +LT++ H ++V LL + + LV++YM E L
Sbjct: 53 QRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-------------ETDLHA 99
Query: 690 LEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
+ L + + + ++YLH +HRD+KPSNILL + KVADFGL
Sbjct: 100 VIRANILEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLS 156
Query: 744 RLAPDNGKHSIETRLAGTFGYLAP--------EYAVT------------GRVTTKVDVFS 783
R + + + L+ +Y T + T +D++S
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216
Query: 784 FGVILMELITGR 795
G IL E++ G+
Sbjct: 217 LGCILGEILCGK 228
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-18
Identities = 49/215 (22%), Positives = 76/215 (35%), Gaps = 38/215 (17%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+LP L L++ L L L N TS+P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW------IFGNQLTSLPVL----PPGLQ 144
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+S+ N S +P + L + A +T ++P GL L ++ N L
Sbjct: 145 ELSVSDNQLAS--LPALP---SELCKLWAYNNQLT-SLP-----MLPSGLQELSVSDNQL 193
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+P + LW N ++ + L +L + GN T LP L
Sbjct: 194 AS-LPTLPS--ELYKLWAYN-------NRLTSLPALPSGLKELIVSGNRLTS-LPVL--P 240
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
S L++ V N+LT + P L SL ++ N
Sbjct: 241 SELKELMVSGNRLTSL-PMLPSGLLSL---SVYRN 271
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 5e-17
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 39/235 (16%)
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLF 119
C + + +G + TLP L + +T L + N LT +P+L L+ +
Sbjct: 36 ACLNNG-NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPAL--PPELRTLEV 88
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
N TS+P GL L S +P +GL + G +T ++P
Sbjct: 89 SGNQLTSLP-VLPPGLLELSIFSNPLTH-----LPALP---SGLCKLWIFGNQLT-SLP- 137
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
PGL L ++ N L +P + LW +++L ++ + L
Sbjct: 138 ----VLPPGLQELSVSDNQLAS-LPALPS--ELCKLWAY----NNQLT---SLPMLPSGL 183
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+L + N LP L S L +N+LT + P+ L L ++ N
Sbjct: 184 QELSVSDNQLAS-LPTL--PSELYKLWAYNNRLTSL-PALPSGLKEL---IVSGN 231
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 36/187 (19%), Positives = 65/187 (34%), Gaps = 31/187 (16%)
Query: 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
+ + ++ T++P +T+L + N+ S +P L+ +G
Sbjct: 39 NNGNAVLNVGESGLTTLPDCLPAHITTL---VIPDNNLTS--LPALP---PELRTLEVSG 90
Query: 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230
+T ++P G L L +P S + LW+ G N
Sbjct: 91 NQLT-SLPVLPPGLL--ELSIFSNPLTHLP-ALP-----SGLCKLWIFG-------NQLT 134
Query: 231 AVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
++ L +L + N LP L S L +NQLT + P L L +
Sbjct: 135 SLPVLPPGLQELSVSDNQLAS-LPAL--PSELCKLWAYNNQLTSL-PMLPSGLQEL---S 187
Query: 291 LTNNLFQ 297
+++N
Sbjct: 188 VSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 33/243 (13%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+LP + L L N+LT +P L S LQE+ DN S+P+ + L
Sbjct: 155 SLPALPSELCKLWAYN---NQLT-SLPML--PSGLQELSVSDNQLASLPTL----PSELY 204
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+ N S +P +GL+ +G +T ++P L L ++ N L
Sbjct: 205 KLWAYNNRLTS--LPALP---SGLKELIVSGNRLT-SLPVLPSE-----LKELMVSGNRL 253
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSG 258
+P+ + +L + ++L + +++S T + L GN + L L
Sbjct: 254 TS-LPMLPS--GLLSLSVY----RNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 259 LSSLQDFS---VRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
++S +S +R + P LH A L +G+ + F +
Sbjct: 307 ITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR-EGEPAPADRWHMFGQEDNA 365
Query: 316 NSF 318
++F
Sbjct: 366 DAF 368
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 2/56 (3%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L +SG ++S + L L + N+LT +P+ L L S +++ N L
Sbjct: 242 ELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 5/62 (8%)
Query: 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
+IT + + + L+ ++ + L +L +SGN+LT ++P L L +
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 429 HL 430
HL
Sbjct: 115 HL 116
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 17/73 (23%), Positives = 24/73 (32%), Gaps = 19/73 (26%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTL-------------- 417
L+ L +SG ++ L L L +P L L
Sbjct: 82 ELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLP 140
Query: 418 PSLEMLDVSNNHL 430
P L+ L VS+N L
Sbjct: 141 PGLQELSVSDNQL 153
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 16/56 (28%), Positives = 29/56 (51%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S ++S + + L +L N+LT ++P + L+ L VS+N L
Sbjct: 142 GLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L +SG ++S + L++LM+SGN LT ++P + L L V N L
Sbjct: 222 GLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQL 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 5e-18
Identities = 62/377 (16%), Positives = 120/377 (31%), Gaps = 72/377 (19%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
T+L + +N ++ ++ + + LS L+ ++ N + FK L+ + L +N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPL 205
I L HL L+FN PI
Sbjct: 80 KLVK--------------------------ISC----HPTVNLKHLDLSFNAFDALPICK 109
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLS----GLS 260
FG S ++ L L+ + SV I ++ L + G ++
Sbjct: 110 EFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 261 SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCL 320
SL + + I+ S+ + +L + N+ L + F S + +N
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ---TNPKLS 223
Query: 321 DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL 380
+ + N + I++ V + V S +G ++ +++ +
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 381 G--------------------LSGTISSN-------FSRLTSLRQLMLSGNELTGTIPKE 413
+ T+S S+++ L S N LT T+ +
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 414 LTTLPSLEMLDVSNNHL 430
L LE L + N L
Sbjct: 344 CGHLTELETLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 35/215 (16%), Positives = 67/215 (31%), Gaps = 33/215 (15%)
Query: 86 NSLSSLTVLEVMKNKLTG-QIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
S++ + + + S +S + F +N T + LT L+T+ L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ-GPI 203
N + L + + L L ++ N +
Sbjct: 357 MNQL------KELSKIAEM--T-----------------TQMKSLQQLDISQNSVSYDEK 391
Query: 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
S+ +L ++ + L ++ + L LH N + L +L
Sbjct: 392 KGDCSWTKSLLSLNMSS----NILTDTIF-RCLPPRIKVLDLHSNKIKSIPKQVVKLEAL 446
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
Q+ +V NQL + L SL + L N +
Sbjct: 447 QELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-16
Identities = 56/426 (13%), Positives = 126/426 (29%), Gaps = 95/426 (22%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG------- 103
+ P + + T + I I ++ SLS L +L + N++
Sbjct: 7 RSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 104 -------------QIPSLS--GLSSLQEVLFDDNNFTSVPSD-FFKGLTSLQTISLDYNS 147
++ +S +L+ + N F ++P F ++ L+ + L
Sbjct: 67 FNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126
Query: 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207
+ + + G + + + L F
Sbjct: 127 LEK-SSVLPIAHLNISKVLLVLGETYG----EKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 208 GKSSIQTL--------------WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL 253
S++T+ + +L + NSF L
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLV-----NLHSLAVVNLTNNLFQGQTPKFNSPVR 308
+ +++ FS+ + +L G + +L +L++ + +++F F
Sbjct: 242 QLVW-HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-----FPQSYI 295
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVL-LSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367
+++ +N+ ++ + +
Sbjct: 296 YEIFS----------------NMNIKNFTVSGTRMVHML------------------CPS 321
Query: 368 AGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE---LTTLPSLEMLD 424
++ N L+ T+ N LT L L+L N+L + K T + SL+ LD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380
Query: 425 VSNNHL 430
+S N +
Sbjct: 381 ISQNSV 386
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 5e-12
Identities = 55/386 (14%), Positives = 119/386 (30%), Gaps = 50/386 (12%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLS----GLSSLQEVLFDDNN 123
+ + ++E + + L+ VL V+ + SL V +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWV-----IPESLKDATGLQRFSANGANITG--- 175
F + K + +L+ ++ D+ I L+ L + N T
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 176 -TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ 234
I + T+ ++ + +S++ L ++ D + +
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 235 NMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
+++ + + S +S +N LT V + +L L + L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 294 NLFQ------GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347
N + T + S + D+ NS D+ C + L
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDI--SQNSVSYDEKKGDCSWTKS--------------L 401
Query: 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSG 403
+N + + +K L L +I +L +L++L ++
Sbjct: 402 LSLNMSSNILTD---TIF----RCLPP-RIKVLDLHSNKIKSIPKQVVKLEALQELNVAS 453
Query: 404 NELTGTIPKE-LTTLPSLEMLDVSNN 428
N+L ++P L SL+ + + N
Sbjct: 454 NQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 57/373 (15%), Positives = 124/373 (33%), Gaps = 44/373 (11%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLT-GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
+ KE ++S L L + L + ++ L+ + +L + +GL
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDF 163
Query: 139 QTISLD----YNSFDSWVIPESLKDATGLQ----RFSANGANITGTIPDFLGGDTIPGLM 190
T SL N +++ S+K L+ + + + T P L
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 191 HLHLAFNFLQGPIPLSFGK----SSIQTLWL--NGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+L L + + +++ + +G ++ +L+ +
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 245 HGNSFTGPLPDL-SGLSSLQDFSVRDNQLTGI---VPSSLVNLHSLAVVNLTNNLFQGQT 300
+ F P + S++ + + + PS + L + +NNL
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL---DFSNNLLTDTV 340
Query: 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK---GNNPC 357
+ + L N L + K + + N
Sbjct: 341 FEN-----CGHLTELETLILQM---------NQLKELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
+ D K C ++ +N+ + L+ TI ++ L L N++ +IPK++ L
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKL 443
Query: 418 PSLEMLDVSNNHL 430
+L+ L+V++N L
Sbjct: 444 EALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 50/370 (13%), Positives = 99/370 (26%), Gaps = 48/370 (12%)
Query: 86 NSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ +L L++ N +S L+ + + L + + +
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
++ PE L+D N + T+ L ++
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 204 PLSFGKSS-------IQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-- 254
+ + L LN + + + T++ + G L
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 255 ----DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQGQTPKFNSPVRF 309
+ L +L V + ++ + N T + + F
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 310 ---DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
D +N C L N +S
Sbjct: 327 LHLDF--SNNLLTDTVFEN-CGHLTE--------------LETLILQMNQLKE----LSK 365
Query: 367 DAGGNITVVNLKNLGLSGT------ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
A + +L+ L +S + S SL L +S N LT TI + L P +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRI 423
Query: 421 EMLDVSNNHL 430
++LD+ +N +
Sbjct: 424 KVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 29/175 (16%), Positives = 59/175 (33%), Gaps = 38/175 (21%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSG----LSSLQEVLFDDNNFTSV-PSDFFKG 134
T+ + L+ L L + N+L ++ ++ + SLQ++ N+ +
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
SL ++++ N + F I L L
Sbjct: 398 TKSLLSLNMSSNILTDTI-------------FRCLPPRIK----------------VLDL 428
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249
N ++ ++Q L + + S +G +TSL ++WLH N +
Sbjct: 429 HSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGI---FDRLTSLQKIWLHTNPW 480
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 37/210 (17%), Positives = 84/210 (40%), Gaps = 19/210 (9%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
++ + + K +T + + L+S+ +++ ++++ SV + L ++ + L+
Sbjct: 20 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N + L + L + + D + L L L N +
Sbjct: 77 GNKLTDI---KPLANLKNLGWLFLDENKVK----DLSSLKDLKKLKSLSLEHNGISDING 129
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L +++L+L K + V+ +T L L L N + + L+GL+ LQ+
Sbjct: 130 LV-HLPQLESLYLGNNKITD-----ITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQN 182
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N ++ + +L L +L V+ L +
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 19/214 (8%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+ + L ++T L + NKLT I L+ L +L + D+N + K L L+++S
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLS 118
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L++N L L+ IT I + L L L N +
Sbjct: 119 LEHNGISDI---NGLVHLPQLESLYLGNNKIT-DITVL---SRLTKLDTLSLEDNQISDI 171
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSS 261
+PL+ G + +Q L+L+ + + + +L L L P+ S L
Sbjct: 172 VPLA-GLTKLQNLYLSKNHISD-----LRALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
D L + P + + N+ +L
Sbjct: 226 PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
L L L IS + LT L+ L LS N ++ + + L L +L++L++ +
Sbjct: 156 TKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 213
Query: 432 GKVPNFRQNVIV 443
K N + N++V
Sbjct: 214 NKPINHQSNLVV 225
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L++L L I+ + SRLT L L L N+++ I L L L+ L +S NH+
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK+L L IS + L L L L N++T L+ L L+ L + +N +
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 14/59 (23%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ L L+G ++ + L +L L L N++ L L L+ L + +N +
Sbjct: 68 PNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI 124
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 19/59 (32%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L + S+ L L+ L L N ++ I L LP LE L + NN +
Sbjct: 90 KNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI 146
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 54/205 (26%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLL 654
VLG G G V + K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 77
Query: 655 GYCLDGNER----LLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRR--LTIALDVARGVE 707
+ L+V E + G LF+R ++ G + T R I + ++
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGG----ELFSRIQDRGDQAF--TEREASEIMKSIGEAIQ 131
Query: 708 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
YLH + HRD+KP N+L + K+ DFG
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165
Query: 765 LAPEYAVTGRV-TTKVDVFSFGVIL 788
A E TG D++S GVI+
Sbjct: 166 FAKE--TTGEKYDKSCDMWSLGVIM 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 37/210 (17%), Positives = 84/210 (40%), Gaps = 19/210 (9%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
++ + + K +T + + L+S+ +++ ++++ SV + L ++ + L+
Sbjct: 17 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 73
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N + L + L + I + + L L L N +
Sbjct: 74 GNKLTDI---KPLTNLKNLGWLFLDENKIK-DLSSL---KDLKKLKSLSLEHNGISDING 126
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L +++L+L K + V+ +T L L L N + + L+GL+ LQ+
Sbjct: 127 LV-HLPQLESLYLGNNKITD-----ITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQN 179
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N ++ + +L L +L V+ L +
Sbjct: 180 LYLSKNHISDL--RALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
L L L IS + LT L+ L LS N ++ + + L L +L++L++ +
Sbjct: 153 TKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 210
Query: 432 GKVPNFRQNVIV 443
K N + N++V
Sbjct: 211 NKPINHQSNLVV 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L++L L I+ + SRLT L L L N+++ I L L L+ L +S NH+
Sbjct: 132 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 187
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK+L L IS + L L L L N++T L+ L L+ L + +N +
Sbjct: 109 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ L L+G ++ + L +L L L N++ L L L+ L + +N +
Sbjct: 66 NVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 20/59 (33%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L I S+ L L+ L L N ++ I L LP LE L + NN +
Sbjct: 87 KNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI 143
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++ + + + I S L ++ +L L+GN+LT P LT L +L L + N +
Sbjct: 44 SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 50/281 (17%), Positives = 88/281 (31%), Gaps = 33/281 (11%)
Query: 45 SLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMK------ 98
S ++DP P C + V + GG+++E L + +++K
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADV-ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKR 72
Query: 99 ---------NKLTGQIPSLSGLSSLQEVLFDDNNFTSV--PSDFFKGLTSLQTISLDYNS 147
+++ + G+S LQE+ ++ T P L ++L S
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 148 ---FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
D+W+ GL+ S A+ + + P L L L+ N G
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR--VFPALSTLDLSDNPELGERG 190
Query: 205 LS-----FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDL--S 257
L ++Q L L ++ A+ L L L NS
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
S L ++ L + L L +L+ N
Sbjct: 251 WPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 52/321 (16%), Positives = 92/321 (28%), Gaps = 75/321 (23%)
Query: 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDF 180
N + + + G SL+ + ++ + + L+R + A I +
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
L I GL L L + G P +++ L
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEAT------------------------GPDLN 124
Query: 241 QLWLHGNSFTGPLPDLSGLS-----SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L L S+ L+ L L+ S+ + +L+ ++L++N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
G+ ++ C + L + N
Sbjct: 185 ELGERGLISA--------------------LCPLKFPTLQVLALR-------------NA 211
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGT 409
+ S A V L+ L LS + + + L L LS L
Sbjct: 212 GMETPSGVCSALAAAR---VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267
Query: 410 IPKELTTLPSLEMLDVSNNHL 430
+PK L L +LD+S N L
Sbjct: 268 VPKGL--PAKLSVLDLSYNRL 286
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 32/211 (15%), Positives = 60/211 (28%), Gaps = 24/211 (11%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLS-----SLQEVLFDDNNFTSVPSDFF 132
P + L +L + + L+ L L+ + + + +
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169
Query: 133 KGLTSLQTISLDYNSFDSW------VIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ +L T+ L N + P L +A +G
Sbjct: 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA--R 227
Query: 187 PGLMHLHLAFNFLQGPIPLSF--GKSSIQTLWLNGQKGDSKLNGSVAVIQNM-TSLTQLW 243
L L L+ N L+ S + +L L+ G V + + L+ L
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF-------TGLKQVPKGLPAKLSVLD 280
Query: 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTG 274
L N P L + + S++ N
Sbjct: 281 LSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 28/203 (13%), Positives = 55/203 (27%), Gaps = 41/203 (20%)
Query: 58 HIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLS 112
+Q + + I + +++ +L+ L++ N G+
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 113 SLQEVLFDDNNFTSVP---SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169
+LQ + + + S LQ + L +NS S + L + +
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGS 229
+ +P L L L L++N L
Sbjct: 262 FTGLK-QVPKGLP----AKLSVLDLSYNRLD----------------------------R 288
Query: 230 VAVIQNMTSLTQLWLHGNSFTGP 252
+ + L L GN F
Sbjct: 289 NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 12/69 (17%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 371 NITVVNLKNLGLSGTISSNFS----RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426
++ ++NL+N+ + + L+ L ++ +++ P+L LD+S
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 427 NNHLFGKVP 435
+N G+
Sbjct: 182 DNPELGERG 190
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVR-------- 646
LG G F TV+ + + + T +A+K V +K + E + EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 647 ---HRHLVGLLGY----CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
H++ LL + +G ++V+E + + L + + G+ PL + ++ I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGI-PLIYVKQ--IS 137
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA------KVADFGLVRLAPDNGKHS 753
+ G++Y+H IH D+KP N+L+ K+AD G ++ +S
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
I+TR Y +PE + D++S ++ ELITG
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 11/215 (5%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
S L++ N L + S LQ + ++ ++ L+ L T+ L N
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 147 SFDSWVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIP 204
S + + LQ+ A N+ ++ +F G + L L++A N +Q +P
Sbjct: 87 PIQS--LALGAFSGLSSLQKLVAVETNLA-SLENFPIGH-LKTLKELNVAHNLIQSFKLP 142
Query: 205 LSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT-QLWLHGNSFTGPLPDLSGLSSL 262
F ++++ L L+ K S + V+ M L L L N P L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
++ ++ NQL + L SL + L N +
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 8/71 (11%)
Query: 85 LNSLSSLTV----LEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
L L + + L++ N + I + + L+E+ D N SVP F LTSL
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSL 226
Query: 139 QTISLDYNSFD 149
Q I L N +D
Sbjct: 227 QKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 20/86 (23%), Positives = 29/86 (33%), Gaps = 14/86 (16%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNE 405
C N + + KNL LS + S F L+ L LS E
Sbjct: 5 EVVPNITYQCM-ELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 406 LTGTIPKEL-TTLPSLEMLDVSNNHL 430
+ TI +L L L ++ N +
Sbjct: 64 IQ-TIEDGAYQSLSHLSTLILTGNPI 88
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
L+ L LS TI + L+ L L+L+GN + ++ + L SL+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
Query: 429 HL 430
+L
Sbjct: 111 NL 112
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 48/257 (18%), Positives = 90/257 (35%), Gaps = 35/257 (13%)
Query: 50 DPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS-- 107
PC +C + ++I+ +P + S L++++ L IPS
Sbjct: 4 SSPPC-----ECHQEEDFR---VTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHA 50
Query: 108 LSGLSSLQEV-LFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
S L ++ + + D + S F L+ + I + +++ P++LK+ L+
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110
Query: 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGK--SSIQTLWLNGQKGD 223
+ PD + L + N IP+ +F + TL L
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN---- 165
Query: 224 SKLNGSVAVIQ----NMTSLTQLWLHGNSFTGPLPD--LSGL-SSLQDFSVRDNQLTGIV 276
NG +Q N T L ++L+ N + + G+ S V +T +
Sbjct: 166 ---NG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP 221
Query: 277 PSSLVNLHSLAVVNLTN 293
L +L L N
Sbjct: 222 SKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 13/85 (15%)
Query: 356 PCN-SDWKGVSCDAGGNITVV-----NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
PC + +I + + + L L TI S+ FS L ++ ++ +S +
Sbjct: 7 PCECHQEEDFRVT-CKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 405 ELTGTIPKEL-TTLPSLEMLDVSNN 428
+ L + +++ N
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNT 90
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 37/219 (16%), Positives = 70/219 (31%), Gaps = 56/219 (25%)
Query: 234 QNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQ-LTGIVPSSLVNLHSLAVVN 290
N+ +++++++ + L LS + +R+ + LT I P +L L L +
Sbjct: 52 SNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111
Query: 291 LTNN---LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV--GYPA 345
+ N +F T +++ + F + N + SI + G
Sbjct: 112 IFNTGLKMFPDLTKVYSTDIFFILEITDN---------------PYMTSIPVNAFQGLCN 156
Query: 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVV--------NLKNLGLSG-----TISSN-FS 391
NN T V L + L+ I + F
Sbjct: 157 ETLTLKLYNN---------------GFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
Query: 392 RLTS-LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+ S L +S +T +P + L L+ L N
Sbjct: 202 GVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 7/62 (11%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
N+ + +S + S+ F L+ + + + I + L LP L+ L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 429 HL 430
L
Sbjct: 116 GL 117
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 52/222 (23%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR------ 648
V+G+G FG V K +A+K V +EK F EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 649 HLVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRLT 697
+++ +L C+ +E LS +L+ K +G L R+
Sbjct: 160 NVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGF-SLPLVRK-- 204
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFGLVRLAPDNGKHS-- 753
A + + ++ LH IH DLKP NILL R+ KV DFG ++ +
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTY 259
Query: 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
I++R F Y APE + R +D++S G IL EL+TG
Sbjct: 260 IQSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 48/353 (13%), Positives = 103/353 (29%), Gaps = 36/353 (10%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+++ LS L VL + N++ + L+ + N ++ + SL+
Sbjct: 69 MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNIS---CCPMASLR 124
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+ L +N FD +P +F + L L L+
Sbjct: 125 HLDLSFNDFDV--LPVC---------------------KEF---GNLTKLTFLGLSAAKF 158
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+ L + + L+ K + ++ T++ L H NS ++S +
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-V 217
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFC 319
++L + + +L L+ S T Q + + +
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 320 LDDAGV-ACD-GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNL 377
++ + S L N + + + + L
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY-SVFAEMNIKML 336
Query: 378 KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+S L + N T ++ + +TL L+ L + N L
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 39/240 (16%), Positives = 72/240 (30%), Gaps = 15/240 (6%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSL-SGLSSLQEVLFDDN 122
+ + I + +L SL + V +L S + + + +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
+ + +S ++ N F + + LQ +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGCSTLKRLQTLILQRNGLK-NFFK--V 395
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSF-----GKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
+ L L ++ SI L L+ + L GSV
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS----SNMLTGSVF-RCLPP 450
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L LH N D++ L +LQ+ +V NQL + L SL + L +N +
Sbjct: 451 KVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 57/374 (15%), Positives = 118/374 (31%), Gaps = 39/374 (10%)
Query: 88 LSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL------TSLQ 139
++SL L++ N L+ L + F + L L
Sbjct: 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLV 179
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF- 198
+ + +S IP + L + + + + L ++ L
Sbjct: 180 SYHIKGGETESLQIPNTTV----LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 199 --LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-- 254
L + ++ + L + K + + + L ++ + T +
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 255 ----DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQGQTPKFNSPVRF 309
+ L SL V++ + + + L+ ++ SP F
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
Query: 310 DMAKGSNSFCLDDAGVACDGRV---------NVLLSIVKSVGYPAVLAESWKGNNPCNSD 360
+ + D C N L + K ++ + NS
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
Query: 361 WKGVS---CDAGGNITVVNLKNLGLSGTISSNFSRLT-SLRQLMLSGNELTGTIPKELTT 416
C +I V+NL + L+G++ F L ++ L L N + +IPK++T
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTH 471
Query: 417 LPSLEMLDVSNNHL 430
L +L+ L+V++N L
Sbjct: 472 LQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 52/375 (13%), Positives = 112/375 (29%), Gaps = 69/375 (18%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVL-FDDNNFTSVPSDFFKGLTSLQTISLDY 145
S ++++ LT +P L + L N+ + + L+ L+ + L +
Sbjct: 29 SNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSH 85
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N S + + F F L +L ++ N LQ +
Sbjct: 86 NRIRS--LDFHV--------F------------LFN-----QDLEYLDVSHNRLQN---I 115
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT-GPLPDLSGL---- 259
S +S++ L L+ D N+T LT L L F L ++ L
Sbjct: 116 SCCPMASLRHLDLSFNDFDVL--PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 260 --SSLQDFSVRDNQLTGIVPSSLVNLH------------------SLAVVNLTNNLFQGQ 299
L + ++ + + + LH +L + L+N +
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359
+ ++ +G L+ + + + + +P + N
Sbjct: 234 NCQRLMTFLSELTRGPTL--LNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITE 290
Query: 360 DWKGVSCDAGGN----ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELT 415
+ + ++KN + + +S + MLS ++
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350
Query: 416 TLPSLEMLDVSNNHL 430
+ S L+ + N
Sbjct: 351 SPSSFTFLNFTQNVF 365
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 47/253 (18%), Positives = 81/253 (32%), Gaps = 37/253 (14%)
Query: 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGL 111
C + C ++VT I P +L + L + KL I SG
Sbjct: 9 CSNRVFLCQ-ESKVTEI-----------PSDL--PRNAIELRFVLTKLR-VIQKGAFSGF 53
Query: 112 SSLQEVLFDDNNFTS-VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
L+++ N+ + +D F L L I ++ + ++ PE+ ++ LQ +
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 171 ANITGTIPDFLGGDTIPGLMHLHLAFNF-LQGPIPLSFGK--SSIQTLWLNGQKGDSKLN 227
I +PD + + L + N + SF LWLN N
Sbjct: 114 TGIK-HLPDVHKIHS-LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK-------N 164
Query: 228 G----SVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLV 281
G + N+ LP+ G S + ++ + L
Sbjct: 165 GIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIHSLPSYGLE 223
Query: 282 NLHSLAVVNLTNN 294
NL L + N
Sbjct: 224 NLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 32/213 (15%), Positives = 59/213 (27%), Gaps = 28/213 (13%)
Query: 234 QNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV-RDNQLTGIVPSSLVNLHSLAVVN 290
L ++ + N + S L L + + + N L I P + NL +L +
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110
Query: 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKS---VGYPAVL 347
++N LD N+ + ++ VG
Sbjct: 111 ISNT-------GIKHLPDVHKIHSLQKVLLDIQD-------NINIHTIERNSFVGLSFES 156
Query: 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSN-FSRLTSLRQLMLSGNEL 406
W N + + N L + ++ F + L +S +
Sbjct: 157 VILWLNKNGIQEIHNSA-FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214
Query: 407 TGTIPKE-LTTLPSLEMLDVSNNHLFGKVPNFR 438
++P L L L N K+P
Sbjct: 215 H-SLPSYGLENLKKLRARSTYNLK---KLPTLE 243
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 43/333 (12%), Positives = 88/333 (26%), Gaps = 103/333 (30%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
S + L ++ T +PSD + L I +
Sbjct: 10 SNRVFLCQESKVTEIPSDLPRNAIEL---RFVLTKLRV--IQKG---------------- 48
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
F G L + ++ N + I V
Sbjct: 49 ------AFSG---FGDLEKIEISQNDVLEVIEAD-------------------------V 74
Query: 233 IQNMTSLTQLWL-HGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
N+ L ++ + N+ P+ L +LQ + + + + ++ +++
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 291 LTNNL---------FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341
+ +N+ F G + + S L+ N + I S
Sbjct: 135 IQDNINIHTIERNSFVGLSFE------------SVILWLNK---------NGIQEIHNSA 173
Query: 342 -GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT----ISSN-FSRLTS 395
+ + NN + + D + L +S T + S L
Sbjct: 174 FNGTQLDELNLSDNNN----LEELPNDVFHGAS--GPVILDISRTRIHSLPSYGLENLKK 227
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
LR + +P L L +L ++
Sbjct: 228 LRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 7/65 (10%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+ S +L++ + ++ +PS L L L+ N +P+ + L +L S
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLR--ARSTYNLKKLPT--LEKLVALMEAS 252
Query: 143 LDYNS 147
L Y S
Sbjct: 253 LTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 12/65 (18%), Positives = 19/65 (29%), Gaps = 3/65 (4%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
N + N L ++P G S + S+PS + L L+ S
Sbjct: 174 FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 232
Query: 143 LDYNS 147
Sbjct: 233 TYNLK 237
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 38/210 (18%), Positives = 73/210 (34%), Gaps = 42/210 (20%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L++ + K +T + S LS +Q D++N S+ + T+L+ + L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLS 71
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
+N LKD T L+ S N + + G+ L
Sbjct: 72 HNQISDL---SPLKDLTKLEELSVNRNRLK----------NLNGIPSACL---------- 108
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L+L+ + + + ++ +L L + N + L LS L+
Sbjct: 109 --------SRLFLDNNEL-RDTDS----LIHLKNLEILSIRNNKLKS-IVMLGFLSKLEV 154
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N++T L L + ++LT
Sbjct: 155 LDLHGNEITNT--GGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 38/196 (19%), Positives = 71/196 (36%), Gaps = 42/196 (21%)
Query: 99 NKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLK 158
+ Q+ GL++ + + T + S K L+ +Q + D ++ S ++
Sbjct: 7 TPIN-QVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS---LAGMQ 60
Query: 159 DATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN 218
T L+ + I+ + L L + ++ L +N
Sbjct: 61 FFTNLKELHLSHNQIS----------DLSPLKDL-----------------TKLEELSVN 93
Query: 219 GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS 278
+ LNG L++L+L N L L +L+ S+R+N+L I
Sbjct: 94 RNR-LKNLNGI-----PSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--V 144
Query: 279 SLVNLHSLAVVNLTNN 294
L L L V++L N
Sbjct: 145 MLGFLSKLEVLDLHGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/257 (14%), Positives = 81/257 (31%), Gaps = 29/257 (11%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+ +G Q++ + LS + + + + + ++L+E+ N +
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQISD 77
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT L+ +S++ N + S L R + + +
Sbjct: 78 L--SPLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNELR-DTDSL---IHL 127
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWL 244
L L + N L+ + L S ++ L L+G N + + + + + L
Sbjct: 128 KNLEILSIRNNKLKSIVMLG-FLSKLEVLDLHG-------NEITNTGGLTRLKKVNWIDL 179
Query: 245 HGNSFT-GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK- 302
G P+ L +V+D I P + N S + L
Sbjct: 180 TGQKCVNEPVKYQPELYITN--TVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVS 237
Query: 303 --FNSPVRFDMAKGSNS 317
F+ + +
Sbjct: 238 YKFSEYINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 5/63 (7%)
Query: 371 NITVVNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
I L L L + + L +L L + N+L +I L L LE+LD+
Sbjct: 102 GIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHG 159
Query: 428 NHL 430
N +
Sbjct: 160 NEI 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 15/72 (20%), Positives = 29/72 (40%), Gaps = 5/72 (6%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
NL+ L + + L+ L L L GNE+T LT L + +D++
Sbjct: 128 KNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCV 185
Query: 432 GKVPNFRQNVIV 443
+ ++ + +
Sbjct: 186 NEPVKYQPELYI 197
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 32/218 (14%), Positives = 76/218 (34%), Gaps = 46/218 (21%)
Query: 583 QVLRNVT-NNFSEENVLGRGGFGTVYKGE---------LHDGTKIAVKRMESAVVSEKGF 632
VL + + + ++ R G +Y+ K ++K +++ + F
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAK--DGRLF 90
Query: 633 AEFKS--------EIAVLTKVRHRHLVG---LLGYCLDGNE-RLLVYEYMPQGTLSRHLF 680
E ++ K+ L+ +G+ + ++ R LV + G +
Sbjct: 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL 148
Query: 681 NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--A 738
+ + + L +A + +E+LH ++H ++ NI + + +++V A
Sbjct: 149 DVSPKHVLSERSV--LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLA 203
Query: 739 DFGLVRLAPDNGKHSIETR------LAGTFGYLAPEYA 770
+G +GKH + G E+
Sbjct: 204 GYGFAFRYCPSGKH-VAYVEGSRSPHEGD-----LEFI 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR----- 648
+++G+G FG V K + +A+K + ++K F + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 649 -HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRLTIALDVA 703
++V L + + N LV+E LS +L+ N G+ L TR+ A +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGV-SLNLTRK--FAQQMC 167
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFGLVRLAPDNGKHS--IETRLA 759
+ +L S IH DLKP NILL + R+ K+ DFG + I++R
Sbjct: 168 TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSR-- 222
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
F Y +PE + +D++S G IL+E+ TG
Sbjct: 223 --F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 47/217 (21%), Positives = 81/217 (37%), Gaps = 59/217 (27%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
K + L+ L +L + NKL +P+ L +L+ + DN ++P F L +L
Sbjct: 54 SKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLA 112
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+ LD N S +P + F D++ L +L L +N L
Sbjct: 113 ELRLDRNQLKS--LPPRV--------F-----------------DSLTKLTYLSLGYNEL 145
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LS 257
Q S+ V +TSL +L L+ N +P+
Sbjct: 146 Q----------SL----------------PKGVFDKLTSLKELRLYNNQLKR-VPEGAFD 178
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L+ L+ + +NQL + + +L L ++ L N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 21/181 (11%)
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD 179
T++PS+ + + L N S +P T L+ N + T+P
Sbjct: 25 SKKLTAIPSNIP---ADTKKLDLQSNKLSS--LPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 180 --FLGGDTIPGLMHLHLAFNFLQGPIPLS-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQN 235
F + L L + N LQ +P+ F + ++ L L+ + S V +
Sbjct: 79 GIF---KELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPR---VFDS 131
Query: 236 MTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
+T LT L L N LP L+SL++ + +NQL + + L L + L N
Sbjct: 132 LTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 294 N 294
N
Sbjct: 191 N 191
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ L+SL L + N+L ++P L+ L+ + D+N VP F L L+ + L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 144 DYNSFD 149
N +D
Sbjct: 213 QENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV 267
+ + L L K S L +T L L+L+ N LP L +L+ V
Sbjct: 37 ADTKKLDLQSNK-LSSL--PSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWV 92
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
DN+L + L +LA + L N +
Sbjct: 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLK 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 43/249 (17%), Positives = 79/249 (31%), Gaps = 62/249 (24%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSG 110
C +++ P + T + + + L + LT L + + +LT ++
Sbjct: 17 CDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT 75
Query: 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
L L + N S+P + L +L + + +N S +P
Sbjct: 76 LPVLGTLDLSHNQLQSLPL-LGQTLPALTVLDVSFNRLTS--LPLGA------------- 119
Query: 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230
+ L L+L N L+ ++
Sbjct: 120 ---------L---RGLGELQELYLKGNELK----------TLPP---------------- 141
Query: 231 AVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288
++ L +L L N+ T LP L+GL +L +++N L I P H L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPF 199
Query: 289 VNLTNNLFQ 297
L N +
Sbjct: 200 AFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 18/192 (9%)
Query: 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
+S ++S EV D N T++P D + L N + +L T L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQL 60
Query: 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSK 225
+ + A +T + T+P L L L+ N LQ +PL ++ L ++ ++
Sbjct: 61 NLDRAELT-KLQVD---GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS----FNR 111
Query: 226 LNG-SVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVN 282
L + ++ + L +L+L GN LP L+ L+ S+ +N LT + L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 283 LHSLAVVNLTNN 294
L +L + L N
Sbjct: 171 LENLDTLLLQEN 182
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 39/208 (18%), Positives = 64/208 (30%), Gaps = 57/208 (27%)
Query: 230 VAVIQNMTSLTQLWLHGNSFTGPLPDLSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288
+ + + S ++ + T LP L + +N L ++L+ L
Sbjct: 3 ICEVSKVASHLEVNCDKRNLTA-LP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 289 VNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348
+NL V + L N L S+ P +
Sbjct: 60 LNLDRAELT------KLQV-DGTLPVLGTLDLSH---------NQLQSL------PLLGQ 97
Query: 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSG 403
+ L L +S ++ L L++L L G
Sbjct: 98 ----------------------TLP--ALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133
Query: 404 NELTGTIPKEL-TTLPSLEMLDVSNNHL 430
NEL T+P L T P LE L ++NN+L
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 18/62 (29%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
L+ L L G T+ + L +L L+ N LT +P L L +L+ L + N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 429 HL 430
L
Sbjct: 183 SL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 6/59 (10%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
L+ L L+ + + + L +L L+L N L TIPK L + N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 35/215 (16%), Positives = 69/215 (32%), Gaps = 63/215 (29%)
Query: 89 SSLTVLEVMKNKLTGQIPS---LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
S +L++ N L+ ++ + + L++L +L N+ + S+ F + +L+ + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N L F + L L L N +
Sbjct: 98 NH---------------LHTLDEF---------LFSD---LQALEVLLLYNNHIVVVDRN 130
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT----GPLPDLSGLSS 261
+F ++M L +L+L N + + D + L
Sbjct: 131 AF--------------------------EDMAQLQKLYLSQNQISRFPVELIKDGNKLPK 164
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAV--VNLTNN 294
L + N+L + + L L + + L NN
Sbjct: 165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 35/178 (19%), Positives = 65/178 (36%), Gaps = 16/178 (8%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKE--LNSLSSLTVLEVMKNKLTGQIPS- 107
C + + P + + + N+ L E L++L L + N L I S
Sbjct: 25 CSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82
Query: 108 -LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
+ +L+ + N+ ++ F L +L+ + L N V + +D LQ+
Sbjct: 83 AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKL 141
Query: 167 SANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNG 219
+ I+ P G+ +P LM L L+ N L+ L+L+
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
NL+ L LS T+ FS L +L L+L N + + + + L+ L +S N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 429 HL 430
+
Sbjct: 147 QI 148
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 24/62 (38%), Positives = 34/62 (54%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
NL +L LS ISS F + +LR L LS N L T+ + + L +LE+L + NN
Sbjct: 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN 122
Query: 429 HL 430
H+
Sbjct: 123 HI 124
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 18/91 (19%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE----LTTLPSLEMLDV 425
L+ L L + N F + L++L LS N+++ P E LP L +LD+
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170
Query: 426 SNNHL-------FGKVPNFRQNVIVKTDGNP 449
S+N L K+P + +N + NP
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGL-YLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 24/184 (13%), Positives = 50/184 (27%), Gaps = 58/184 (31%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
+ + +VP + + L +N+ L R A
Sbjct: 19 ASNILSCSKQQLPNVPQSLP---SYTALLDLSHNN---------------LSRLRAEWT- 59
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
+ L L L+ N + + S
Sbjct: 60 -------PTR---LTNLHSLLLSHN-------------HLNFI-------------SSEA 83
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ +L L L N L + S L +L+ + +N + + ++ ++ L +
Sbjct: 84 FVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142
Query: 291 LTNN 294
L+ N
Sbjct: 143 LSQN 146
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 17/87 (19%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN--FSRLTSLRQLMLSGN 404
C S+ +SC + + V L LS + + +RLT+L L+LS N
Sbjct: 18 CASNI--LSC-SKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN 74
Query: 405 ELTGTIPKE-LTTLPSLEMLDVSNNHL 430
L I E +P+L LD+S+NHL
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHL 100
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 19/188 (10%), Positives = 61/188 (32%), Gaps = 35/188 (18%)
Query: 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
+ + ++SL + + N T + + +++ ++++ ++ + + L+R
Sbjct: 39 TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNY---NPISGLSNLERL 93
Query: 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226
G ++T L G + L L ++ +
Sbjct: 94 RIMGKDVTSDKIPNLSG--LTSLTLLDISHSAHD-------------------------- 125
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSL 286
+ + I + + + L N + L L L+ +++ + + + + L
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKL 183
Query: 287 AVVNLTNN 294
+ +
Sbjct: 184 NQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 22/193 (11%), Positives = 50/193 (25%), Gaps = 56/193 (29%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+ ++ L + T +SGLS+L+ + + TS GLTSL +
Sbjct: 60 TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
+ ++ +I + +P + + L++N
Sbjct: 119 ISHS-------------------------AHDDSILTKINT--LPKVNSIDLSYN----- 146
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
+ ++ + L L + + + L
Sbjct: 147 ----------------------GAITDIMPLKTLPELKSLNIQFDGVHD-YRGIEDFPKL 183
Query: 263 QDFSVRDNQLTGI 275
+ G
Sbjct: 184 NQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 16/59 (27%), Positives = 33/59 (55%), Gaps = 3/59 (5%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+K+L ++ + + S L++L +L + G ++T L+ L SL +LD+S++
Sbjct: 66 HNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 2/79 (2%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV 127
T + I + ++ ++N+L + +++ N I L L L+ + +
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY 174
Query: 128 PSDFFKGLTSLQTISLDYN 146
+ L +
Sbjct: 175 --RGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 5/60 (8%)
Query: 376 NLKNLGLSGT-IS----SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L + G ++ N S LTSL L +S + +I ++ TLP + +D+S N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 13/60 (21%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++T++++ + +I + + L + + LS N I L TLP L+ L++ + +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 9/58 (15%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L + L+ ++ + +++ L ++ T P ++ L +LE L + +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 9/59 (15%), Positives = 19/59 (32%), Gaps = 6/59 (10%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ ++ LS T L L+ L + + + + P L L + +
Sbjct: 137 KVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 41/235 (17%)
Query: 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEI 639
S+ VL V NF +G G FG + G+ L+ +A+K +E + + E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPM---KSRAPQLHLEY 55
Query: 640 AVLTKVRH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT- 697
++ + + + G +V E + G LF+ + R +
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD---------RTFSL 104
Query: 698 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR--L 745
IA+ + +EY+H ++ I+RD+KP N L+G + DF L + +
Sbjct: 105 KTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 746 APDNGKHSIETR----LAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGR 795
P+ KH I R L GT Y G+ + + D+ + G + M + G
Sbjct: 162 DPETKKH-IPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 50/241 (20%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE 634
GSM + + N + +G G FG +Y G + G ++A+K E +
Sbjct: 1 GSMELRVG------NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTK 47
Query: 635 FKS---EIAVLTKVRH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E + ++ + + +G+ ++V E + G LFN
Sbjct: 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCS------ 99
Query: 691 EWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFG 741
R+ + +A + +EY+H ++FIHRD+KP N L+G + + DFG
Sbjct: 100 ---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153
Query: 742 LVR--LAPDNGKHSIETR----LAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITG 794
L + +H I R L GT Y A G + + D+ S G +LM G
Sbjct: 154 LAKKYRDARTHQH-IPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
Query: 795 R 795
Sbjct: 212 S 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/231 (20%), Positives = 90/231 (38%), Gaps = 46/231 (19%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE---FKSEIAVLT 643
V ++ +G G FG +++G L + ++A+K E ++ + E
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSDAPQLRDEYRTYK 60
Query: 644 KVRH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT----- 697
+ + + + +G +LV + + +L L + R+ +
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCG---------RKFSVKTVA 109
Query: 698 -IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR--LAPDN 749
A + V+ +H +S ++RD+KP N L+G V DFG+V+ P
Sbjct: 110 MAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 750 GKHSIETR----LAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGR 795
+H I R L+GT Y GR + + D+ + G + M + G
Sbjct: 167 KQH-IPYREKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 53/206 (25%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKG-----FAEFK--------SEIAVLTK 644
+G+GGFG +Y +++ + V E F E K +I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSD-APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 645 VRHRHLVG---LLGYCLDGNE----RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT 697
R +G G L R ++ + G+ + ++ +R +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA---------KRFS 150
Query: 698 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVRLAPDN 749
++L + +EY+H ++H D+K SN+LL +V D+GL
Sbjct: 151 RKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 750 GKHS-IETR----LAGTFGYLAPEYA 770
G H GT E+
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFT 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 38/181 (20%), Positives = 64/181 (35%), Gaps = 42/181 (23%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKG--FAEFK--------SEIAVLTKVR 646
+G GGFG +Y + K A + E G F+E K I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 647 HRHLVGL-------LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT-- 697
+G+ L + R +V E + G + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG----------QNGTFKKS 151
Query: 698 ----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVRLAPDNGK 751
+ + + +EY+H ++H D+K +N+LLG +V AD+GL NG
Sbjct: 152 TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 752 H 752
H
Sbjct: 209 H 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 61/279 (21%), Positives = 97/279 (34%), Gaps = 82/279 (29%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEF-KSEIAVLTKVR--------H 647
LG G F TV+ + +A+K V S + + E EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK----VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 648 RHLVGLLGY----CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+V LL ++G +V+E + L + + +GL PL ++ I V
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGL-PLPCVKK--IIQQVL 156
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLG--------------------------------- 730
+G++YLH IH D+KP NILL
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 731 ----------------DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR 774
+ ++ K+AD G + I+TR Y + E +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR-----QYRSLEVLIGSG 269
Query: 775 VTTKVDVFSFGVILMELITGRKALD----ETQSEDSVHL 809
T D++S + EL TG + E + D H+
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 3e-11
Identities = 33/201 (16%), Positives = 55/201 (27%), Gaps = 54/201 (26%)
Query: 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVK--RMESAVVSE----KGFAEFKSEIAVL 642
T +G G FG V++ D T +A+K +E + K F E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 643 TKV---------RHRHLVGLLGYCL------------------------------DGNER 663
++ R +GL ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723
+V E+ G + K +I + + F HRDL
Sbjct: 138 FIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 724 PSNILLGDDMRAKVADFGLVR 744
N+LL K+ +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 59/259 (22%), Positives = 88/259 (33%), Gaps = 87/259 (33%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR-----H 649
+G G FG V + + + AVK V + K + K E +L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 650 LVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRLTI 698
+V G CL ++E L L+ G +E +
Sbjct: 98 IVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGF-HIEDIKL--Y 142
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA----------------------- 735
+++ + + YL + S H DLKP NILL D
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 736 --KVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFG 785
K+ DFG + H I TR Y APE + D++SFG
Sbjct: 200 GIKLIDFG--CATFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFG 246
Query: 786 VILMELITGRKALDETQSE 804
+L EL TG L T
Sbjct: 247 CVLAELYTG-SLLFRTHEH 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 57/255 (22%), Positives = 86/255 (33%), Gaps = 83/255 (32%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR----- 648
LG G FG V + H K +A+K + + + E + EI VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 649 -HLVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRL 696
V + + C+ +E L ++ F + PL R
Sbjct: 82 FLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPY-PLPHVRH- 127
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-------------------KV 737
+A + + +LH H DLKP NIL + +V
Sbjct: 128 -MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 738 ADFGLVRLAPDNGKHS--IETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILM 789
ADFG D+ H+ + TR Y PE + DV+S G IL
Sbjct: 184 ADFG--SATFDHEHHTTIVATR----H-YRPPEVILELGW------AQPCDVWSIGCILF 230
Query: 790 ELITGRKALDETQSE 804
E G L +T
Sbjct: 231 EYYRG-FTLFQTHEN 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLT 643
V N F +G G FG +Y G + ++A+K E + E +
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYR 57
Query: 644 KVR-HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT----- 697
++ + + + ++G+ +LV + + +L LFN R+L+
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCS---------RKLSLKTVL 106
Query: 698 -IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVRL--APDNGK 751
+A + VE++H +SF+HRD+KP N L+G RA + DFGL + +
Sbjct: 107 MLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 752 HSIETR----LAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGR 795
H I R L GT Y A G + + D+ S G +LM + G
Sbjct: 164 H-IPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 16/162 (9%)
Query: 92 TVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150
L++ L + GL+ L + D N ++ + F LT L T+ L N S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 151 WVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLS- 206
+P + D T L + G + ++P F D + L L L N LQ IP
Sbjct: 98 --LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF---DRLTKLKELRLNTNQLQS-IPAGA 150
Query: 207 FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
F K +++QTL L+ + S +G+ + L + L GN
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFD---RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 3/65 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L+ L L + N+L IP+ L++LQ + N SVP F L LQTI+L
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 145 YNSFD 149
N FD
Sbjct: 188 GNQFD 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
L ++ L + NKL I +L L++L ++ N S+P+ F LT+L+ + L
Sbjct: 60 QYLPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 146 NSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGP 202
N S +P+ + D T L + + ++P F D + L L L++N LQ
Sbjct: 119 NQLQS--LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVF---DKLTNLTELDLSYNQLQS- 171
Query: 203 IPLS-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
+P F K + ++ L L + S +G V +TSL +WLH N
Sbjct: 172 LPEGVFDKLTQLKDLRLYQNQLKSVPDG---VFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 19/210 (9%)
Query: 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD 149
+ K +T + + L+S+ +++ ++++ SV + L +++ ++L N
Sbjct: 20 ETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH 76
Query: 150 SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+ L + T L ++ + D L L L L N LQ F K
Sbjct: 77 DISALKELTNLTYLILTGNQLQSLPNGVFDKLTN-----LKELVLVENQLQSLPDGVFDK 131
Query: 210 -SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSG----LSSLQD 264
+++ L L + S G V +T+LT+L L N LP+ G L+ L+D
Sbjct: 132 LTNLTYLNLAHNQLQSLPKG---VFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKD 185
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ NQL + L SL + L +N
Sbjct: 186 LRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 34/176 (19%), Positives = 58/176 (32%), Gaps = 47/176 (26%)
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
P D F +L S V L + + + ++
Sbjct: 10 KQIFPDDAF---AETIKANLKKKSVTDAVTQNELNSIDQIIANN----SDIKSVQGI--- 59
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243
+P + +L L N L ++ ++ +T+LT L
Sbjct: 60 QYLPNVRYLALGGNKLH----------------------------DISALKELTNLTYLI 91
Query: 244 LHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGI---VPSSLVNLHSLAVVNLTNN 294
L GN LP+ L++L++ + +NQL + V L NL L NL +N
Sbjct: 92 LTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---NLAHN 143
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 7/106 (6%)
Query: 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
+L + +SI + N S V IQ + ++ L L GN
Sbjct: 24 ANLKKKSVTD-AVTQNELNSIDQIIANNSDIKS-----VQGIQYLPNVRYLALGGNKLH- 76
Query: 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L L++L + NQL + L +L + L N Q
Sbjct: 77 DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 61/255 (23%), Positives = 85/255 (33%), Gaps = 83/255 (32%)
Query: 597 VLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR----- 648
LG G FG V + H G +AVK V + + E +SEI VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK----IVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 649 -HLVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRL 696
V +L + C+ V+E L + L+ R+
Sbjct: 77 FRCVQMLEWFEHHGHICI-------VFE-----LLGLSTYDFIKENGFLPF-RLDHIRK- 122
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-------------------KV 737
+A + + V +LH H DLKP NIL KV
Sbjct: 123 -MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 738 ADFGLVRLAPDNGKHS--IETRLAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILM 789
DFG D+ HS + TR Y APE + + DV+S G IL+
Sbjct: 179 VDFG--SATYDDEHHSTLVSTR----H-YRAPEVILALGW------SQPCDVWSIGCILI 225
Query: 790 ELITGRKALDETQSE 804
E G + T
Sbjct: 226 EYYLG-FTVFPTHDS 239
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 9/135 (6%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
++T + + +N + IP S L+ + +N + + D F+GL SL ++ L N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 147 SFDSWVIPESL-KDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
+P+SL + LQ N I + + L L L N LQ
Sbjct: 91 KITE--LPKSLFEGLFSLQLLLLNANKIN-CLRVDA-FQDLHNLNLLSLYDNKLQTIAKG 146
Query: 206 SFGK-SSIQTLWLNG 219
+F +IQT+ L
Sbjct: 147 TFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 33/187 (17%), Positives = 55/187 (29%), Gaps = 56/187 (29%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
++ E+ + N +P F L+ I L N + A
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--LAP--------------DA 75
Query: 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVA 231
F + L L L N + +P S
Sbjct: 76 --------F---QGLRSLNSLVLYGNKITE-LPKS------------------------- 98
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
+ + + SL L L+ N L L +L S+ DN+L I + L ++ +
Sbjct: 99 LFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157
Query: 290 NLTNNLF 296
+L N F
Sbjct: 158 HLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 27/121 (22%), Positives = 48/121 (39%), Gaps = 12/121 (9%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
P + L +++ N+++ ++ GL SL ++ N T +P F+GL SLQ
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQ 107
Query: 140 TISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAF 196
+ L+ N + + L S + TI F + + +HLA
Sbjct: 108 LLLLNANKINC--LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF---SPLRAIQTMHLAQ 161
Query: 197 N 197
N
Sbjct: 162 N 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 4/73 (5%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
LPK L L SL +L + NK+ + + L +L + DN ++ F L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 137 SLQTISLDYNSFD 149
++QT+ L N F
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
+L +L L G + + F L SL+ L+L+ N++ + + L +L +L + +N
Sbjct: 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 429 HL 430
L
Sbjct: 139 KL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 27/109 (24%), Positives = 49/109 (44%), Gaps = 7/109 (6%)
Query: 192 LHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
+ L N ++ P +F ++ + L+ + Q + SL L L+GN T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD---AFQGLRSLNSLVLYGNKIT 93
Query: 251 GPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LP GL SLQ + N++ + + +LH+L +++L +N Q
Sbjct: 94 E-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 36/216 (16%), Positives = 68/216 (31%), Gaps = 13/216 (6%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
++ + L E+ K T L LQE+ ++ + L L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
F +LK ++ + + + + + LHLA L
Sbjct: 400 YEKETLQYF------STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
L + L L+ + L + + L L N+ + ++ L
Sbjct: 454 TVLCHLE-QLLLVTHLDLSHNR----LRALPPALAALRCLEVLQASDNALEN-VDGVANL 507
Query: 260 SSLQDFSVRDNQLTGI-VPSSLVNLHSLAVVNLTNN 294
LQ+ + +N+L LV+ L ++NL N
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 47/297 (15%), Positives = 86/297 (28%), Gaps = 23/297 (7%)
Query: 3 KRHLGVSLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGN--PASLGWTDPDPC-KWKHI 59
+ H + +S A LSV + + + P S+ W PD + H+
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLF 119
+ Q+ + +S +L+ + L + +
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVI--PESLKDATGLQRFSANGANITGTI 177
S + LQ + + +I +L + + +
Sbjct: 360 KSTVLQS----ELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415
Query: 178 PDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
P L FL L + ++ L L K + L ++ +
Sbjct: 416 PMRAA-------YLDDLRSKFLLENSVLKMEYADVRVLHLAH-KDLTVLCH----LEQLL 463
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+T L L N P L+ L L+ DN L + + NL L + L NN
Sbjct: 464 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 7/72 (9%)
Query: 376 NLKNLGLSG-TISS--NFSRLTSLRQLMLSGNELTGTIP--KELTTLPSLEMLDVSNNHL 430
L+ L S + + + L L++L+L N L + L + P L +L++ N L
Sbjct: 487 CLEVLQASDNALENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
Query: 431 FGKVPNFRQNVI 442
+ ++ +
Sbjct: 546 -CQEEGIQERLA 556
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 6/60 (10%)
Query: 375 VNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + +L LS + + L L L S N L + + LP L+ L + NN L
Sbjct: 463 LLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++ V++L + L+ + + +L + L LS N L +P L L LE+L S+N L
Sbjct: 442 DVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 38/177 (21%), Positives = 64/177 (36%), Gaps = 38/177 (21%)
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--FLG 182
+P + L+ N F K L++ + + IT I + F
Sbjct: 24 NKIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAF-- 77
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
+ G+ + L N L+ + + + + SL L
Sbjct: 78 -EGASGVNEILLTSNRLEN-VQHK-------------------------MFKGLESLKTL 110
Query: 243 WLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L N T + + GLSS++ S+ DNQ+T + P + LHSL+ +NL N F
Sbjct: 111 MLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 36/160 (22%), Positives = 56/160 (35%), Gaps = 23/160 (14%)
Query: 54 CKWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPK-ELNSLSSLTVLEVMKNKLT 102
C+ + CS P + +++ L L + NK+T
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 103 GQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
I G S + E+L N +V FKGL SL+T+ L N +
Sbjct: 71 -DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC--VGNDSFIG 127
Query: 161 -TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFN 197
+ ++ S IT T+ F DT+ L L+L N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAF---DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/65 (35%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L SL L + N++T + S GLSS++ + DN T+V F L SL T++L
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 145 YNSFD 149
N F+
Sbjct: 162 ANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
+ + L+ + F L SL+ LML N +T + + L S+ +L + +N
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 429 HL 430
+
Sbjct: 140 QI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
L+ + S I F + + +++L+ N L + ++ L SL+ L + +N
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR 116
Query: 430 L 430
+
Sbjct: 117 I 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 23/122 (18%), Positives = 41/122 (33%), Gaps = 13/122 (10%)
Query: 51 PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SL 108
PD C S+ + + G + L +LT L + + + L
Sbjct: 2 PDACC-----PHGSSGLRCTRDGALDS----LHHLPGAENLTELYIENQQHLQHLELRDL 52
Query: 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168
GL L+ + + V D F L ++L +N+ +S + LQ
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES--LSWKTVQGLSLQELVL 110
Query: 169 NG 170
+G
Sbjct: 111 SG 112
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 8e-07
Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 16/90 (17%)
Query: 356 PCNSDWK-GVSCDAGGNITV-------VNLKNLGLSG-----TISSN-FSRLTSLRQLML 401
C G+ C G + NL L + + L LR L +
Sbjct: 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 402 SGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ L + + P L L++S N L
Sbjct: 64 VKSGLR-FVAPDAFHFTPRLSRLNLSFNAL 92
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 17/111 (15%), Positives = 36/111 (32%), Gaps = 7/111 (6%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
+ + G +L + ++ + L+ L+ + +
Sbjct: 8 HGSSGLRCTRDGALDSLHHL-PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 172 NITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQ 220
+ + F P L L+L+FN L+ + S+Q L L+G
Sbjct: 67 GLR-FVAPDAFHF---TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 17/101 (16%), Positives = 36/101 (35%), Gaps = 8/101 (7%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ +LT+L++ L L GL L++ ++ + L + P + L+ +N
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRV 331
L+ N + + K L + C +
Sbjct: 87 LSFNALESLSWKT-----VQGLSLQE-LVLSGNPLHCSCAL 121
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
L+NL + ++ + F L +L LS N L ++ + SL+ L +S N
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
Query: 430 L 430
L
Sbjct: 115 L 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 1e-08
Identities = 62/389 (15%), Positives = 110/389 (28%), Gaps = 123/389 (31%)
Query: 557 SESQSLTSSGP--SDLHVVEAGSMVISIQ-VLRNVTNNFSEENVL--GRGGFGTVYKGEL 611
+ L + + +V + ++ L + +NVL G G G K
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRL-QPYLKLRQALLELR---PAKNVLIDGVLGSG---K--- 163
Query: 612 HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL-----LV 666
T +A+ +S K + +I L L C L L+
Sbjct: 164 ---TWVAL----DVCLSYKVQCKMDFKIFWLN----------LKNCNSPETVLEMLQKLL 206
Query: 667 YEYMPQGT-LSRHLFNRK------EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIH 719
Y+ P T S H N K + L+ L ++ L V V+ +F
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF-- 262
Query: 720 RDLKPSNILL--GDDMRAKVADFGLVRLAPDNGKH-SIETRLAG-----TFGYLA----- 766
+L ILL +V DF L+ H S++ L
Sbjct: 263 -NLS-CKILLTTRF---KQVTDF----LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 767 -----PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821
P +T + +I D L TW H+N D
Sbjct: 314 RPQDLPREVLTT-----------NPRRLSII-AESIRD--------GLATWDNWKHVNCD 353
Query: 822 TFRKAIDRTID-LDEETLASISTVADLAGHCCAREPYQ-----RPDMGHVVNV-LSSLAE 874
I+ +++ L+ R+ + P ++ L+
Sbjct: 354 KLTTIIESSLNVLEPAEY---------------RKMFDRLSVFPPS----AHIPTILLSL 394
Query: 875 LWKPAEPDSDDIYGIDLDMTLPQALKKWQ 903
+W + D+ + + ++K
Sbjct: 395 IW--FDVIKSDVMVVVNKLHKYSLVEKQP 421
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 7e-06
Identities = 59/338 (17%), Positives = 102/338 (30%), Gaps = 113/338 (33%)
Query: 13 LSLLSATLSVNSQSSSDAAAMQALKTSLGNP-------ASLGWTDPDPCKW---KHIQCS 62
SLL L Q + L NP S+ W KH+ C
Sbjct: 304 KSLLLKYLDCRPQDLPR----EVLT---TNPRRLSIIAESI---RDGLATWDNWKHVNC- 352
Query: 63 PSNRVTRIQIGGQNIEGTL----PKELNSL-SSLTVLEVMKNKLTGQIPS--LSGL---- 111
+++T I IE +L P E + L+V + IP+ LS +
Sbjct: 353 --DKLTTI------IESSLNVLEPAEYRKMFDRLSVFP--PSA---HIPTILLSLIWFDV 399
Query: 112 --SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD------------------YN---SF 148
S + V+ + ++ V + S+ +I L+ YN +F
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLG--------GDTIPGLMHLHLAFNFLQ 200
DS + D +G + + + L F FL+
Sbjct: 460 DSDDLIPPYLD---------------QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504
Query: 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL- 259
I + DS + I N L QL + P L
Sbjct: 505 QKI-----------------RHDSTAWNASGSILNT--LQQLKFYKPYICDNDPKYERLV 545
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+++ DF + ++ S +L +A++ +F+
Sbjct: 546 NAILDFLPKIE--ENLICSKYTDLLRIALMAEDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 5e-05
Identities = 42/297 (14%), Positives = 81/297 (27%), Gaps = 102/297 (34%)
Query: 37 KTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEV 96
KT + C +QC ++ + + N T+ + L L ++
Sbjct: 163 KTWVALDV---------CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQI 209
Query: 97 MKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL---TSLQTISLDYNSFDSWVI 153
N S + ++ + K L + L N ++
Sbjct: 210 DPN-------WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLL-NVQNAKAW 259
Query: 154 PESLKDATGLQ-------RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS 206
+A L RF +T DFL T + ++
Sbjct: 260 -----NAFNLSCKILLTTRF----KQVT----DFLSAAT---------TTHISLDHHSMT 297
Query: 207 FGKS---SIQTLWLNGQKGD---SKLNGS---VAVI----QNMTSLTQLWLHGNSFTGPL 253
S+ +L+ + D L + +++I ++ + W H
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH-------- 349
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNL---------HSLAV----VNLTNNLFQ 297
V ++LT I+ SSL L L+V ++ L
Sbjct: 350 -------------VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 6e-04
Identities = 69/431 (16%), Positives = 129/431 (29%), Gaps = 120/431 (27%)
Query: 67 VTRIQIGGQNI-EGTLPKELNSLSSLTVLEVMKNKLT--------GQIPSLSGLSSLQEV 117
Q ++I +++ V ++ K+ L+ ++SG L
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 118 LFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWV---IPESLKDATGLQRFSANGANIT 174
L + F + + L+ +Y ++ I + + + R +
Sbjct: 71 LLSKQE--EMVQKFVEEV--LRI---NYK----FLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 175 GTIPDFLGGDTIP----------GLMHLHLAFN-FLQGPIPLSFGKSSIQTLWLNGQKGD 223
+ L+ L A N + G L GK+ + K
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV--LGSGKTWVALDVCLSYKVQ 177
Query: 224 SKLNGSVAVIQNMTSLTQLWLH-GNSFTG-----PLPDL-----SGLSSLQDFSVRDNQL 272
K++ + WL+ N + L L +S D S
Sbjct: 178 CKMDFKI-----------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 273 TGIVPSSLVNL-------HSLAVV-NLTN----NLFQGQ-----TPKFNSPVRFDMAKGS 315
+ + L L + L V+ N+ N N F T +F F A +
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 316 NSFCLDD--AGVACDGRVNVLLSIVK----------SVGYP---AVLAESWKGNNPCNSD 360
LD + D ++LL + P +++AES + + D
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-DGLATWD 345
Query: 361 -WKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS--LRQL--MLSGNELTGTI-PKEL 414
WK V+CD L+ I S+ + L R++ LS + P
Sbjct: 346 NWKHVNCDK-------------LTTIIESSLNVLEPAEYRKMFDRLS-------VFPPS- 384
Query: 415 TTLPS--LEML 423
+P+ L ++
Sbjct: 385 AHIPTILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 8e-04
Identities = 50/376 (13%), Positives = 117/376 (31%), Gaps = 97/376 (25%)
Query: 504 AFIVGLGFC---LYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQ 560
AF + C L TR ++ + + A H S + +T+T E +
Sbjct: 261 AFNLS---CKILLTTRFKQVTDFLS--AATTTHIS----LDHHSMTLTPD-------EVK 304
Query: 561 SL----TSSGPSDL-HVVEAGS-MVISI--QVLRNVTNNFSEENVLGRGGFGTVYKGELH 612
SL P DL V + +SI + +R+ + +N +K
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW--DN----------WK---- 348
Query: 613 DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE---Y 669
+ ++ + + +S + VL +R + + +RL V+ +
Sbjct: 349 ---HVNCDKLTTII---------ESSLNVLEPAEYRKM-----F-----DRLSVFPPSAH 386
Query: 670 MPQGTLSRHLFNRKEEGLKPL--EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS-- 725
+P LS F+ + + + + + + + + + + + + +
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 726 -NILLGDDMRAKVADFGLVRLAPDN------GKHSIETRLAGTFGYLAPEYAVTGRVTTK 778
+I+ ++ L+ D G H +
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF--------- 497
Query: 779 VDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI--NKDTFRKAIDRTIDLDEE 836
+D F F + ++ A + + S + F + +I N + +R ++ +
Sbjct: 498 LD-FRF--LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY----ERLVNAILD 550
Query: 837 TLASISTVADLAGHCC 852
L I + +
Sbjct: 551 FLPKIEENLICSKYTD 566
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 369 GGNITVVNLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425
G L+ L ++S N +L L++L LS N ++G + P+L L++
Sbjct: 36 GLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 426 SNNHL 430
S N +
Sbjct: 96 SGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 17/88 (19%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
S ++ L L+ + S + L L T + +L L+ L+ + D
Sbjct: 17 SDVKELVLDNSR--SNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 270 NQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N+++G + +L +NL+ N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 1/90 (1%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
++ EG L + L L + LT I +L L+ L+++ DN + +
Sbjct: 28 RSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEK 86
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQ 164
+L ++L N E LK L+
Sbjct: 87 CPNLTHLNLSGNKIKDLSTIEPLKKLENLK 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 20/119 (16%), Positives = 47/119 (39%), Gaps = 7/119 (5%)
Query: 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL 192
+ + ++ + LD + + + + L+ S +T +I + + L L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANL---PKLNKLKKL 69
Query: 193 HLAFNFLQGPIP-LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L+ N + G + L+ ++ L L+G K ++ ++ + +L L L T
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLENLKSLDLFNCEVT 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 27/107 (25%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--L 108
C K ++ P VT + + G +PKEL++ LT++++ N+++ + +
Sbjct: 17 CSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSF 74
Query: 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155
S ++ L ++ N +P F GL SL+ +SL N +PE
Sbjct: 75 SNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV--VPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 8/106 (7%)
Query: 192 LHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L+L N +P + + L+ + + N NMT L L L N
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQ---SFSNMTQLLTLILSYNRLR 91
Query: 251 GPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+P GL SL+ S+ N ++ + + +L +L+ + + N
Sbjct: 92 C-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 29/129 (22%), Positives = 46/129 (35%), Gaps = 28/129 (21%)
Query: 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW 151
T L + N+ T LS L + +N +++ + F +T L T+ L YN
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 152 VIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210
IP D L+ S +G N +P+ AFN L S
Sbjct: 93 -IPPRTFDGLKSLRLLSLHG-NDISVVPEG--------------AFNDL----------S 126
Query: 211 SIQTLWLNG 219
++ L +
Sbjct: 127 ALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 6/61 (9%)
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP---SSLVNLHSLAVVNLTN 293
+T+L+L GN FT +LS L + +N+++ + S++ L +L L+
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL---ILSY 87
Query: 294 N 294
N
Sbjct: 88 N 88
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 92 TVLEVMKNKLTGQIPSL-SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150
+L + N++T P + L +L+E+ N ++P F LT L + L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 151 WVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+P ++ D L+ N +P G + + L HL L N L+ +F +
Sbjct: 103 --LPSAVFDRLVHLKELFMCC-NKLTELPR--GIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 210 -SSIQTLWLNG 219
SS+ +L G
Sbjct: 158 LSSLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 34/181 (18%), Positives = 55/181 (30%), Gaps = 55/181 (30%)
Query: 115 QEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT 174
Q + DN T + F L +L+ + L N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSN---------------QLG---------- 77
Query: 175 GTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ 234
+P G+ F+ L + + L L + + V
Sbjct: 78 -ALP--------VGV------FDSL----------TQLTVLDLGTNQLTVLPSA---VFD 109
Query: 235 NMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
+ L +L++ N T LP + L+ L ++ NQL I + L SL L
Sbjct: 110 RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 294 N 294
N
Sbjct: 169 N 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 21/64 (32%), Positives = 29/64 (45%), Gaps = 2/64 (3%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
L L L + NKLT +P + L+ L + D N S+P F L+SL L
Sbjct: 110 RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 146 NSFD 149
N +D
Sbjct: 169 NPWD 172
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 17/88 (19%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
++++ L L+ K S + +L L L + +L L L+ + +
Sbjct: 24 AAVRELVLDNCK--SNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 270 NQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N++ G + L +L +NL+ N +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 21/59 (35%), Positives = 31/59 (52%), Gaps = 3/59 (5%)
Query: 375 VNLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
VNL+ L L + S N +L L++L LS N + G + LP+L L++S N L
Sbjct: 49 VNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 16/90 (17%), Positives = 34/90 (37%), Gaps = 1/90 (1%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
++ +G + +L L ++ L + +L L L+++ +N +
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQ 164
L +L ++L N E LK L+
Sbjct: 94 LPNLTHLNLSGNKLKDISTLEPLKKLECLK 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 20/117 (17%), Positives = 44/117 (37%), Gaps = 7/117 (5%)
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+++ + LD + I + L+ S + ++ + +P L L L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNL---PKLPKLKKLEL 78
Query: 195 AFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
+ N + G + + K ++ L L+G K ++ ++ + L L L T
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLKSLDLFNCEVT 133
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 15/61 (24%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 373 TVVNLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
T+ + S I F L L+ L+++ N + LP L L ++NN
Sbjct: 40 TLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 430 L 430
L
Sbjct: 100 L 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 13/60 (21%), Positives = 20/60 (33%), Gaps = 1/60 (1%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + N L L L+ V +N++ I L L + LTNN
Sbjct: 40 TLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 16/113 (14%), Positives = 39/113 (34%), Gaps = 13/113 (11%)
Query: 52 DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL 111
+ + + + ++ I+ N+ TL + ++ N++ ++ L
Sbjct: 17 NAVRDRELDLR-GYKIPVIE----NLGATLDQ-------FDAIDFSDNEIR-KLDGFPLL 63
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164
L+ +L ++N + + L L + L NS + L L
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 23/75 (30%), Positives = 35/75 (46%), Gaps = 11/75 (14%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
L L LE+ +N+LTG I G S +QE+ +N + + F GL L+T++L
Sbjct: 51 GRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 144 DYN--------SFDS 150
N SF+
Sbjct: 110 YDNQISCVMPGSFEH 124
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 17/65 (26%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
+ + + +L L N + + GL L+ ++ DNQ++ ++P S +L+SL +
Sbjct: 73 AFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 290 NLTNN 294
NL +N
Sbjct: 132 NLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 3/65 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
S + L++ +NK+ +I + GL L+ + DN + V F+ L SL +++L
Sbjct: 76 GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 145 YNSFD 149
N F+
Sbjct: 135 SNPFN 139
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 65/386 (16%), Positives = 111/386 (28%), Gaps = 79/386 (20%)
Query: 89 SSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVP----SDFFKGLTSLQTIS 142
+ L++ +L+ L L Q V DD T S + +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 143 LDYNSFDSW---VIPESLKDA-TGLQRFSANGANITGT----IPDFLGGDTIPGLMHLHL 194
L N + + L+ +Q+ S +TG + L T+P L LHL
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR--TLPTLQELHL 120
Query: 195 AFNFLQ--GPIPLSFG----KSSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLTQLWLHGN 247
+ N L G L G + ++ L L + +A V++ +L + N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 248 SFTGP-LPDLS-GLS----SLQDFSVRDNQLT----GIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L GL L+ + +T + + + SL + L +N
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN--- 237
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVA--CDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
L D G+A C G ++ +
Sbjct: 238 ---------------------KLGDVGMAELCPGLLHPSSRLRTL---------WIWECG 267
Query: 356 PCNSDWKGVSCDAGGNITVVNLK----NLGLSGTIS---SNFSRLTSLRQLMLSGNELTG 408
+ ++ L LG G + L L + T
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 409 T----IPKELTTLPSLEMLDVSNNHL 430
L L L +SNN L
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 73/423 (17%), Positives = 129/423 (30%), Gaps = 119/423 (28%)
Query: 62 SPSNRVTRIQIGGQNI--EG--TLPKELNSLSSLTVLEVMKNKLTGQ-IPSLSGL----- 111
+PS ++ ++ + + G L L +L +L L + N L + L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 112 SSLQEVLFDDNNFTSVP----SDFFKGLTSLQTISLDYNSF-DSWV--IPESLKDAT-GL 163
L+++ + + ++ + + + +++ N ++ V + + LKD+ L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 164 QRFSANGANITGTIPDFLGG--DTIPGLMHLHLAFNFL--QGPIPLSFG----KSSIQTL 215
+ +T L G + L L L N L G L G S ++TL
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 216 WLN----GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP-LPDLSGL-----SSLQDF 265
W+ KG L V++ SL +L L GN L L+
Sbjct: 262 WIWECGITAKGCGDL---CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 266 SVRDNQLTG----IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLD 321
V+ T S L L + ++NN L+
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNN------------------------RLE 354
Query: 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG 381
DAGV L + L+ L
Sbjct: 355 DAGVRE-------------------LCQGLGQPGS-------------------VLRVLW 376
Query: 382 LSG---------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTL-----PSLEMLDVSN 427
L+ ++++ SLR+L LS N L +L LE L + +
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 436
Query: 428 NHL 430
+
Sbjct: 437 IYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 63/396 (15%), Positives = 115/396 (29%), Gaps = 115/396 (29%)
Query: 85 LNSLSSLTVLEVMKNKLTGQ-IPSLS-GLSS----LQEVLFDDNNFTSVP----SDFFKG 134
L +L L + N+L + + GL + +Q++ + T S +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 135 LTSLQTISLDYNSFDS---WVIPESLKDA-TGLQRFSANGANITGTIPDFLGG--DTIPG 188
L +LQ + L N ++ E L D L++ +++ + L P
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 189 LMHLHLAFNFL--QGPIPLSFG----KSSIQTLWLN----GQKGDSKLNGSVAVIQNMTS 238
L ++ N + G L G ++ L L L ++ + S
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL---CGIVASKAS 228
Query: 239 LTQLWLHGNSFTGP----LPD--LSGLSSLQDFSVRDNQLT----GIVPSSLVNLHSLAV 288
L +L L N L L S L+ + + +T G + L SL
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288
Query: 289 VNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348
++L N L D G +L
Sbjct: 289 LSLAGN------------------------ELGDEGAR-------------------LLC 305
Query: 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT---------ISSNFSRLTSLRQL 399
E+ L++L + SS ++ L +L
Sbjct: 306 ETLLEPGC-------------------QLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 400 MLSGNELTGTIPKEL-----TTLPSLEMLDVSNNHL 430
+S N L +EL L +L +++ +
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 42/163 (25%), Positives = 63/163 (38%), Gaps = 36/163 (22%)
Query: 89 SSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147
+ T L++ N L L+SL ++ N S+P+ F LTSL ++L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 148 FDSWVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL- 205
S +P + D T L+ L L N LQ +P
Sbjct: 88 LQS--LPNGVFDKLTQLK--------------------------ELALNTNQLQS-LPDG 118
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
F K + ++ L L + S +G V +TSL +WLH N
Sbjct: 119 VFDKLTQLKDLRLYQNQLKSVPDG---VFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 7/67 (10%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSG----LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L+ L L + N+L +P G L+ L+++ N SVP F LTSLQ I
Sbjct: 98 KLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 143 LDYNSFD 149
L N +D
Sbjct: 155 LHDNPWD 161
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/168 (16%), Positives = 57/168 (33%), Gaps = 37/168 (22%)
Query: 84 ELNSLSSLTVLEV----MKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
E S+ + +V M + +LS L + + + NN + G+ +L+
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLR 73
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+SL N +K L + L L +++N +
Sbjct: 74 ILSLGRNL---------IKKIENLDAVADT-------------------LEELWISYNQI 105
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
+ +++ L+++ K + G + + + L L L GN
Sbjct: 106 ASLSGIE-KLVNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 234 QNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLT 292
+L +LW+ N L + L +L+ + +N++T L L L + L
Sbjct: 90 AVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148
Query: 293 NN 294
N
Sbjct: 149 GN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 15/60 (25%), Positives = 30/60 (50%), Gaps = 6/60 (10%)
Query: 375 VNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L I + + +L +L +S N++ ++ + L +L +L +SNN +
Sbjct: 70 ENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKI 127
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 27/67 (40%), Positives = 37/67 (55%), Gaps = 7/67 (10%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSG----LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L+ LT+L + +NKL +P+ G L+ L+E+ D N SVP F LTSLQ I
Sbjct: 74 KLTKLTILYLHENKLQ-SLPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130
Query: 143 LDYNSFD 149
L N +D
Sbjct: 131 LHTNPWD 137
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 947 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.98 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.93 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.51 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.4 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.39 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.2 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.13 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.73 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.7 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.24 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.17 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.14 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.01 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.92 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.86 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.59 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.53 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.27 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.86 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.55 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.15 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.19 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.14 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.02 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.02 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=457.48 Aligned_cols=261 Identities=32% Similarity=0.537 Sum_probs=209.0
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|.+.++||+|+||.||+|+++ +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46777889999999999999875 4788999999754 566678899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccccc----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEE----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
++|||||++|+|.++++..... ...+++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 9999999999999999764321 12469999999999999999999997 8999999999999999999
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~ 812 (947)
.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+. ..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~- 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID- 271 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH-
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence 999999999997655444444456789999999999999999999999999999999999 8999986543221 11
Q ss_pred HHHhhcChhhHHHHhhc-cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 813 FRRMHINKDTFRKAIDR-TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+... .+..+ ...+.++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 272 ------------~i~~g~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 ------------CITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ------------HHHHTCCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------------HHHcCCCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 11111 2234568899999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=454.95 Aligned_cols=262 Identities=29% Similarity=0.507 Sum_probs=215.9
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|.+.+.||+|+||.||+|++. +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56788899999999999999864 4788999999754 566678899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccc--------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcE
Q 002255 664 LLVYEYMPQGTLSRHLFNRKE--------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 735 (947)
++|||||++|+|.++++.... .....++|.+++.++.|||+||+|||+ ++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 999999999999999976431 223469999999999999999999997 899999999999999999999
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~ 814 (947)
||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+. .
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~---- 240 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I---- 240 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H----
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----
Confidence 9999999987655433333344579999999999999999999999999999999999 8999987543221 1
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+..... .+.+...+.++.+|+.+||+.||++|||++||++.|+++.+
T Consensus 241 ---------~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ---------ECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ---------HHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------HHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111 11112234568899999999999999999999999998865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=449.61 Aligned_cols=261 Identities=26% Similarity=0.481 Sum_probs=209.1
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.++||+|+||+||+|+++ ..||||+++....+....++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56788899999999999999875 369999998766667778899999999999999999999998864 568999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
|++|+|.++++... ..++|.++..|+.|||+||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999996543 358999999999999999999997 79999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.........+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+...... +...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~----------------~~~~ 249 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ----------------IIFM 249 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----------------HHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH----------------HHHH
Confidence 33333455789999999999864 4689999999999999999999999976543221 1111
Q ss_pred hhccCC---CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 002255 827 IDRTID---LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876 (947)
Q Consensus 827 ~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 876 (947)
+..... ........+..+.+|+.+||+.||++||||.||++.|+.+++.+
T Consensus 250 ~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 250 VGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111111 11112233456889999999999999999999999999887643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=452.23 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=212.7
Q ss_pred cCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++++..+.||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34566789999999999999863 46889999997543 344567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
++|||||++|+|.++|..+... ....++|.++++|+.|||+||+|||+ ++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 9999999999999999754321 12358999999999999999999997 899999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~ 811 (947)
+.+||+|||+|+...............||++|||||++.++.|+.++|||||||++|||+| |+.||.+....+ +..
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~ 258 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE 258 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999987654333334455689999999999999999999999999999999999 899998654322 111
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
. +..... .+.+...+..+.+|+.+||+.||++||+|+||++.|+.+
T Consensus 259 ~-------------i~~~~~--~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 M-------------IRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H-------------HHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H-------------HHcCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 111111 111223345688999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=455.75 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=207.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||+|+.+ +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 69999999998776677778899999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||+||+|.+++..++. ..+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999965432 347888999999999999999997 8999999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
. .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+ .+..++.
T Consensus 178 ~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~~ 239 (350)
T 4b9d_A 178 T--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----------------LVLKIIS 239 (350)
T ss_dssp H--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHH
T ss_pred C--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHHHHc
Confidence 2 112344689999999999999999999999999999999999999997654321 1222222
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... +.......++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 240 GSFP--PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2221 111223456889999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=439.65 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=218.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.++||+|+||+||+|+.+ +|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999875 699999999976432 2334578999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||+||+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999653 348899999999999999999997 899999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
...........+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... ..+..+.
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~~i~ 247 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----------------LIFAKII 247 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Confidence 544444445678999999999999999999999999999999999999999765422 1223333
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCC
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKP 878 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 878 (947)
...+.++.. ...++.+|+.+||+.||++|||+.|++..-.=..++|..
T Consensus 248 ~~~~~~p~~---~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~ 295 (311)
T 4aw0_A 248 KLEYDFPEK---FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295 (311)
T ss_dssp HTCCCCCTT---CCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred cCCCCCCcc---cCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence 333433322 235678999999999999999999986543333466653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=442.04 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=207.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+.|+..+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999875 699999999975532 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 99999999998854 238899999999999999999997 899999999999999999999999999999775
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+. +..+.
T Consensus 222 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----------------~~~i~ 283 (346)
T 4fih_A 222 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----------------MKMIR 283 (346)
T ss_dssp SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHH
T ss_pred CCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHH
Confidence 4322 23457899999999999999999999999999999999999999976543221 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..............++.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 284 DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111101111223456889999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=440.00 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=206.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|+..++||+|+||.||+|+.+ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45778889999999999999875 699999999976532 2469999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCcceecC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAP 747 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~ 747 (947)
||+||+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.+| ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999653 348999999999999999999996 8999999999999999998 69999999999775
Q ss_pred CCCCcc---eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHS---IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
...... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+.. .
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~ 266 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC----------------L 266 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH----------------H
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH----------------H
Confidence 433211 123467999999999999999999999999999999999999999865543321 1
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+.................+.+++.+||+.||++|||+.|+++.|....+
T Consensus 267 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 267 KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp HHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11111111111112234567899999999999999999999999877654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=428.52 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=200.1
Q ss_pred CcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCeeEEEE
Q 002255 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVY 667 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 667 (947)
+..++||+|+||.||+|.+. +++.||+|++..........+.|.+|++++++++|||||++++++.+ +...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999875 68999999998776677777899999999999999999999999865 34579999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC--eeecCCCCCcEEEc-CCCcEEEeecCcce
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLVR 744 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~-~~~~~kl~DfGla~ 744 (947)
|||++|+|.+++... ..+++..+..++.||+.||+|||+ ++ ||||||||+|||++ +++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999653 348999999999999999999997 45 99999999999997 47999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...... +.
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----------------~~ 239 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IY 239 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----------------HH
T ss_pred eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----------------HH
Confidence 64332 2345689999999998864 699999999999999999999999975432211 11
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..............+++.+|+.+||+.||++|||++|+++
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111111222346889999999999999999999866
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=440.07 Aligned_cols=271 Identities=25% Similarity=0.404 Sum_probs=219.9
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCC-CCcceEEEE
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGY 656 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~ 656 (947)
..+...++|++.+.||+|+||.||+|.+.. ++.||||+++... .....++|.+|+++|.+++| ||||+++|+
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 334456889999999999999999998652 3679999997653 44556789999999999965 899999999
Q ss_pred EEeC-CeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCC
Q 002255 657 CLDG-NERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 724 (947)
Q Consensus 657 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp 724 (947)
|.+. +..++|||||++|+|.++|+..... ....++|.++..++.|||+||+|||+ ++||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence 9764 5689999999999999999764321 12458999999999999999999997 8999999999
Q ss_pred CcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCc
Q 002255 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQS 803 (947)
Q Consensus 725 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~ 803 (947)
+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997765544444556789999999999999999999999999999999998 8999976543
Q ss_pred cchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 804 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
.+. +.+.+..... ...+.....++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 294 ~~~----------------~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 DEE----------------FCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SHH----------------HHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----------------HHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 221 1111211111 011112345688999999999999999999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=443.44 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=207.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+.|+..+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 467999999999999999999875 69999999997653 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||+||+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 228 Ey~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999998854 238899999999999999999997 899999999999999999999999999999775
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+. +..+.
T Consensus 299 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----------------~~~i~ 360 (423)
T 4fie_A 299 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----------------MKMIR 360 (423)
T ss_dssp SSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHH
T ss_pred CCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHH
Confidence 4322 23456899999999999999999999999999999999999999976543221 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..............++.+|+.+||+.||++|||+.|+++
T Consensus 361 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 361 DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111001111123356889999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=417.18 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=192.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||+||+|..+ +|+.||||++.+.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 6999999999765433 334567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+ +|+|.+++..+ ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 78999998653 348999999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.+..... .+..+
T Consensus 164 ~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----------------~~~~i 224 (275)
T 3hyh_A 164 DGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----------------LFKNI 224 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHH
T ss_pred CCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHH
Confidence 432 2334689999999999988776 579999999999999999999997643211 12222
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......++. ....++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 225 SNGVYTLPK---FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHTCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCC---CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 233333222 12356789999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=427.75 Aligned_cols=273 Identities=21% Similarity=0.309 Sum_probs=202.7
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----eeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 665 (947)
.+|.+.++||+|+||+||+|+++ |+.||||++... ......+..|+..+.+++|||||+++++|.+++ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 45778899999999999999985 899999998654 222223345666677889999999999998654 5799
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----CCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
|||||++|+|.++++.. .++|..+.+++.|+++||+|||+.+ +++||||||||+|||++.++++||+||
T Consensus 79 V~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 99999999999999652 4899999999999999999999731 348999999999999999999999999
Q ss_pred CcceecCCCCCcc--eeecccccccccCccccccC------CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 741 GLVRLAPDNGKHS--IETRLAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 741 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
|+|+......... .....+||+.|||||++.+. .++.++|||||||++|||+||+.||........... .+
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~ 231 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DL 231 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hc
Confidence 9998765433221 22346799999999998654 478899999999999999999888754432211000 00
Q ss_pred HHHhhcChhhHH-HHhhccCC--CC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 813 FRRMHINKDTFR-KAIDRTID--LD--EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 813 ~~~~~~~~~~~~-~~~~~~~~--~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.. ......... .+....+. .+ ....+....+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 232 VP-SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SC-SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00 000001111 12222221 11 1122445678899999999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=427.10 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=198.0
Q ss_pred cCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||+||+|+.. +++.||||+++...........+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999763 47899999997664444444578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|||||+||+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999653 348999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+..
T Consensus 176 ~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~ 237 (304)
T 3ubd_A 176 SIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----------------TMTM 237 (304)
T ss_dssp -----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHH
T ss_pred ccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----------------HHHH
Confidence 544322 2334689999999999999999999999999999999999999998654321 1222
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
+....+..+. ....++.+|+.+||+.||++|||+.
T Consensus 238 i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 238 ILKAKLGMPQ---FLSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp HHHCCCCCCT---TSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred HHcCCCCCCC---cCCHHHHHHHHHHcccCHHHCCCCC
Confidence 3333333222 2335678999999999999999853
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=413.72 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=191.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-------
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------- 661 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 661 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .+...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46899999999999999999875 68999999997543 4455678999999999999999999999987544
Q ss_pred -----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEE
Q 002255 662 -----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 662 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 736 (947)
..|+|||||++|+|.+++..+... ...++..++.++.||++||+|||+ ++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 368999999999999999764322 335677788999999999999997 8999999999999999999999
Q ss_pred EeecCcceecCCCCCcc----------eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccch
Q 002255 737 VADFGLVRLAPDNGKHS----------IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 806 (947)
|+|||+|+......... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... +.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH
Confidence 99999998765432211 1234579999999999999999999999999999999996 665321 11
Q ss_pred hhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 807 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... +..+.. ...++......+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~-------------~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT-------------LTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-------------HHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-------------HHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 111111 1223333334456778999999999999999999876
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=457.22 Aligned_cols=91 Identities=31% Similarity=0.426 Sum_probs=75.5
Q ss_pred CCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccce---ee
Q 002255 367 DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV---IV 443 (947)
Q Consensus 367 ~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~---~~ 443 (947)
..+.+|+.|+|++|+++|.||..|+++++|+.|||++|+|+|.||..++.+++|++||||+|+|+|.||...+.. ..
T Consensus 653 ~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~ 732 (768)
T 3rgz_A 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 732 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGG
T ss_pred hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHH
Confidence 345678888888888888999999999999999999999999999999999999999999999999999764432 24
Q ss_pred ecCCCCCCCCCCCC
Q 002255 444 KTDGNPDIGKDSSS 457 (947)
Q Consensus 444 ~~~~n~~~~~~~~~ 457 (947)
.+.||+.+|+.+..
T Consensus 733 ~~~gN~~Lcg~~l~ 746 (768)
T 3rgz_A 733 KFLNNPGLCGYPLP 746 (768)
T ss_dssp GGCSCTEEESTTSC
T ss_pred HhcCCchhcCCCCc
Confidence 57899999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=412.57 Aligned_cols=270 Identities=21% Similarity=0.332 Sum_probs=207.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe------CC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------GN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 661 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999875 79999999998766566667889999999999999999999999764 36
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..|+|||||+ |+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999995 7899988543 358999999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCC--cceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 742 LVRLAPDNGK--HSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 742 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
+|+.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....+........
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987643221 1223457899999999998775 569999999999999999999999987654433322211111000
Q ss_pred C-------hhhHHHHhhccCCCChhcH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 N-------KDTFRKAIDRTIDLDEETL-----ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~-------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. .......+..........+ ....++.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0011111111111111111 12346789999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=407.05 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=173.9
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEE
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 657 (947)
+.+..+.++|++.++||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++.+ +|||||++++++
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 334456789999999999999999999764 46789999986542 235678999999998 699999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEE
Q 002255 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAK 736 (947)
Q Consensus 658 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~k 736 (947)
.+.++.|+||||+++|+|.+++. .+++.++..++.||+.||+|||+ ++||||||||+|||++.+ +.+|
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEE
T ss_pred EECCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEE
Confidence 99999999999999999999882 37889999999999999999997 899999999999999877 8999
Q ss_pred EeecCcceecCCCCCc--------------------------ceeecccccccccCccccccC-CcCcccccccHHHHHH
Q 002255 737 VADFGLVRLAPDNGKH--------------------------SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILM 789 (947)
Q Consensus 737 l~DfGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ 789 (947)
|+|||+|+...+.... ...+..+||+.|+|||++.+. .|+.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 9999999866442211 112335799999999998775 5899999999999999
Q ss_pred HHHhCCCCCCccC
Q 002255 790 ELITGRKALDETQ 802 (947)
Q Consensus 790 elltg~~p~~~~~ 802 (947)
||++|+.||....
T Consensus 239 ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 239 SLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHTCSSSSCCS
T ss_pred HHHHCCCCCCCCC
Confidence 9999999996543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=432.34 Aligned_cols=417 Identities=18% Similarity=0.245 Sum_probs=286.6
Q ss_pred CChHHHHHHHHHHHHcCCCC----------CCCCC-CCCCCCC---ceeEeCCCCcEEEEEecCCcccccCcccccCCCC
Q 002255 25 QSSSDAAAMQALKTSLGNPA----------SLGWT-DPDPCKW---KHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSS 90 (947)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~----------~~~w~-~~d~C~w---~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~ 90 (947)
....|++||.++++++..+. ..+|. +.|||.| .||+|+..+||+.|+|+++++.|.+|++|++|++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 33579999999999986542 12585 5699999 9999988899999999999999999999999999
Q ss_pred CCEEEcccCc----------------------------------------------------------------------
Q 002255 91 LTVLEVMKNK---------------------------------------------------------------------- 100 (947)
Q Consensus 91 L~~L~L~~N~---------------------------------------------------------------------- 100 (947)
|++|+|++|.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 9999999984
Q ss_pred --------ccCcCC-CCCCCCCCcEEecCCCcCCCC-----------------Cccccc--CCCCCcEEeccCCCCCCCC
Q 002255 101 --------LTGQIP-SLSGLSSLQEVLFDDNNFTSV-----------------PSDFFK--GLTSLQTISLDYNSFDSWV 152 (947)
Q Consensus 101 --------l~~~~p-~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~ 152 (947)
++| +| .|+++++|++|+|++|++++. .|..++ ++++|++|+|++|++.+ .
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~-~ 264 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT-K 264 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS-S
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc-c
Confidence 445 56 689999999999999999993 555577 99999999999999876 7
Q ss_pred CcccccCCCCCCeEeccCce-eee-ccCcccCCCCC------CCccEEEccCCcccCcCCc--cccC-CCCceeeeccCC
Q 002255 153 IPESLKDATGLQRFSANGAN-ITG-TIPDFLGGDTI------PGLMHLHLAFNFLQGPIPL--SFGK-SSIQTLWLNGQK 221 (947)
Q Consensus 153 ~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~-~~L~~L~l~~n~ 221 (947)
+|..++++++|++|++++|+ ++| .+|..++ .+ ++|++|+|++|+++ .+|. .++. .+|+.|++++|.
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~--~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~ 341 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQ--ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQ 341 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH--HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCC
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHH--hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCc
Confidence 89999999999999999998 998 8998876 44 89999999999999 8887 6765 689999999998
Q ss_pred CCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCC-CCEEEccCCccccCCCccccCCC--CCCeEeccCCcccc
Q 002255 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLH--SLAVVNLTNNLFQG 298 (947)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~l~~N~l~g~~p~~l~~l~--~L~~L~Ls~N~l~g 298 (947)
+...+. .+.++++|+.|+|++|+++..+..+..+++ |++|++++|+++ .+|..+..++ +|+.|+|++|+++|
T Consensus 342 l~g~ip----~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ 416 (636)
T 4eco_A 342 LEGKLP----AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS 416 (636)
T ss_dssp CEEECC----CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred Cccchh----hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCC
Confidence 874443 466778888899999988855556888888 888999988888 7888877755 88888888888888
Q ss_pred cCCCCCCCcccccccCCCCcccCcCCCcCCC-----------------ccceeeecccccC--------ChhhhhccCCC
Q 002255 299 QTPKFNSPVRFDMAKGSNSFCLDDAGVACDG-----------------RVNVLLSIVKSVG--------YPAVLAESWKG 353 (947)
Q Consensus 299 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~--------~~~~l~~~~~~ 353 (947)
.+|..+...........+...++...+.+.. ..+.+...+.... ....+......
T Consensus 417 ~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp TTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECC
T ss_pred cchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECc
Confidence 8887655222111122222222222222221 0000000000000 00011111111
Q ss_pred CCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEec------cCCcccccCCCcCCCCCCCCcccccc
Q 002255 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML------SGNELTGTIPKELTTLPSLEMLDVSN 427 (947)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~L------s~N~l~g~iP~~l~~l~~L~~L~ls~ 427 (947)
.+........+....+++|+.|+|++|++++ +|..++++++|+.|+| ++|++.+.+|..++.+++|+.|+|++
T Consensus 497 ~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 575 (636)
T 4eco_A 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575 (636)
T ss_dssp SSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCS
T ss_pred CCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCC
Confidence 1111100000000244556666666666665 5666666666666666 34555666666666666666666666
Q ss_pred ccccccCCCCcc--ceeeecCCCCCCCC
Q 002255 428 NHLFGKVPNFRQ--NVIVKTDGNPDIGK 453 (947)
Q Consensus 428 N~l~g~iP~~~~--~~~~~~~~n~~~~~ 453 (947)
|+| +.||.... ...+.+.+|+..|-
T Consensus 576 N~l-~~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 576 NDI-RKVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SCC-CBCCSCCCTTCCEEECCSCTTCEE
T ss_pred CcC-CccCHhHhCcCCEEECcCCCCccc
Confidence 666 55554321 11344555555543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=393.63 Aligned_cols=283 Identities=38% Similarity=0.706 Sum_probs=233.4
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++..++++|+..+.||+|+||.||+|.+++|+.||||++... .....+.+.+|++++++++||||+++++++.+++..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 345577899999999999999999999888999999998765 334567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++|+|.+++..... ....++|.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999865432 22458999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
+...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......|...... ...+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 265 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQL 265 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccH
Confidence 876543333333445699999999999888999999999999999999999999987776665555555433222 1112
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+++.+. ..........+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 266 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 266 EQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 222232222 22345666788999999999999999999999999998865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=411.75 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=202.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC----hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS----EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.++||+|+||.||+|+.+ +|+.||||++.+.... .........++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999876 6999999999754321 112223334567777889999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+|||||+||+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999653 348899999999999999999996 899999999999999999999999999999
Q ss_pred ecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+...+ .
T Consensus 341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i-------------~ 403 (689)
T 3v5w_A 341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------D 403 (689)
T ss_dssp ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH-------------H
T ss_pred ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------H
Confidence 775432 234689999999999965 5799999999999999999999999976543332111 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
..+....+..+. ....++.+|+.+||+.||.+|++ +.||++
T Consensus 404 ~~i~~~~~~~p~---~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 404 RMTLTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHCCCCCCT---TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HhhcCCCCCCCc---cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 222233333222 22356789999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=415.82 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=214.7
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||.||+|..+ +|+.||+|++... .....+.+.+|+++|+.++|||||++++++.+++..|+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3478999999999999999999875 6999999999765 344567889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC--CcEEEeecCcce
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVR 744 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfGla~ 744 (947)
||||+||+|.+++..+. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+
T Consensus 233 ~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 99999999999985432 358999999999999999999997 899999999999999854 899999999999
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.+.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ .+.
T Consensus 306 ~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----------------~~~ 366 (573)
T 3uto_A 306 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------------TLR 366 (573)
T ss_dssp ECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHH
T ss_pred EccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHH
Confidence 875532 2344689999999999999999999999999999999999999998654322 122
Q ss_pred HHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002255 825 KAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPA 879 (947)
Q Consensus 825 ~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 879 (947)
.+......+.... .....++.+|+.+||+.||.+||++.|+++ ++|...
T Consensus 367 ~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~------Hpw~~~ 416 (573)
T 3uto_A 367 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTP 416 (573)
T ss_dssp HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTSC
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcCcCC
Confidence 2222222222221 223456789999999999999999999866 677643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=428.37 Aligned_cols=393 Identities=19% Similarity=0.254 Sum_probs=280.0
Q ss_pred CChHHHHHHHHHHHHcCCCCCCCCCC------CCC--CCC------------ceeEeCCCCcEEEEEecCCcccccCccc
Q 002255 25 QSSSDAAAMQALKTSLGNPASLGWTD------PDP--CKW------------KHIQCSPSNRVTRIQIGGQNIEGTLPKE 84 (947)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~~w~~------~d~--C~w------------~gv~C~~~~~v~~l~L~~~~l~g~~p~~ 84 (947)
+...|++||++||+++.++ +|.. .+| |.| .||+|+..+||+.|+|+++++.|.+|++
T Consensus 266 ~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred cchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 3457999999999999876 5632 356 999 9999998899999999999999999999
Q ss_pred ccCCCCCCEEEc-ccCcccCc-----------------------------------------------------------
Q 002255 85 LNSLSSLTVLEV-MKNKLTGQ----------------------------------------------------------- 104 (947)
Q Consensus 85 l~~l~~L~~L~L-~~N~l~~~----------------------------------------------------------- 104 (947)
|++|++|++|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77765544
Q ss_pred -----------------CC-CCCCCCCCcEEecCCCcCCC-----------------CCccccc--CCCCCcEEeccCCC
Q 002255 105 -----------------IP-SLSGLSSLQEVLFDDNNFTS-----------------VPSDFFK--GLTSLQTISLDYNS 147 (947)
Q Consensus 105 -----------------~p-~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~ 147 (947)
+| .|.++++|++|+|++|+|++ .+|..++ ++++|++|+|++|+
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 56 68889999999999999998 1344455 99999999999999
Q ss_pred CCCCCCcccccCCCCCCeEeccCce-eee-ccCcccCC-----CCCCCccEEEccCCcccCcCCc--cccC-CCCceeee
Q 002255 148 FDSWVIPESLKDATGLQRFSANGAN-ITG-TIPDFLGG-----DTIPGLMHLHLAFNFLQGPIPL--SFGK-SSIQTLWL 217 (947)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~-----~~l~~L~~L~Ls~N~l~~~~p~--~~~~-~~L~~L~l 217 (947)
+.+ .+|..++++++|++|+|++|+ ++| .+|..++. ..+++|++|+|++|+++ .+|. .++. .+|+.|+|
T Consensus 503 l~~-~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~L 580 (876)
T 4ecn_A 503 NMT-QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDC 580 (876)
T ss_dssp TCC-SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEEC
T ss_pred CCc-cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEEC
Confidence 876 789999999999999999998 888 88876651 13459999999999999 8888 6765 78999999
Q ss_pred ccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCC-CCEEEccCCccccCCCccccCCCC--CCeEeccCC
Q 002255 218 NGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLHS--LAVVNLTNN 294 (947)
Q Consensus 218 ~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~l~~N~l~g~~p~~l~~l~~--L~~L~Ls~N 294 (947)
++|.+. .++ .+.++++|+.|+|++|+++..++.+..+++ |+.|+|++|+|+ .+|..+..++. |+.|+|++|
T Consensus 581 s~N~l~-~lp----~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N 654 (876)
T 4ecn_A 581 VHNKVR-HLE----AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYN 654 (876)
T ss_dssp TTSCCC-BCC----CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSS
T ss_pred CCCCcc-cch----hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCC
Confidence 999888 332 577899999999999999954446888888 999999999999 78988887765 999999999
Q ss_pred cccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCc------ccCC
Q 002255 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV------SCDA 368 (947)
Q Consensus 295 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~------~~~~ 368 (947)
+++|.+|....... .....++..++...+.+..--......+..+ .......+......... .|..
T Consensus 655 ~l~g~ip~l~~~l~--~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L------~~L~Ls~N~L~~ip~~~~~~~~~~l~n 726 (876)
T 4ecn_A 655 KIGSEGRNISCSMD--DYKGINASTVTLSYNEIQKFPTELFATGSPI------STIILSNNLMTSIPENSLKPKDGNYKN 726 (876)
T ss_dssp CTTTTSSSCSSCTT--TCCCCCEEEEECCSSCCCSCCHHHHHTTCCC------SEEECCSCCCSCCCTTSSSCTTSCCTT
T ss_pred cCCCccccchhhhc--cccCCCcCEEEccCCcCCccCHHHHccCCCC------CEEECCCCcCCccChHHhccccccccc
Confidence 99998875431110 0111122223333332221000000001111 11111111111000000 0112
Q ss_pred CCceeEEEecCCCceeecccccc--CCccCCeEeccCCcccccCCCcCCCCCCCCcccccc------ccccccCCCCc
Q 002255 369 GGNITVVNLKNLGLSGTISSNFS--RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN------NHLFGKVPNFR 438 (947)
Q Consensus 369 ~~~L~~L~Ls~n~l~g~ip~~~~--~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~------N~l~g~iP~~~ 438 (947)
+++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|.++..+++|+.|+|++ |++.|.+|..+
T Consensus 727 l~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l 802 (876)
T 4ecn_A 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802 (876)
T ss_dssp GGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTG
T ss_pred cCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHH
Confidence 236666777777666 5666665 66667777777776664 666666666666666654 66666666543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=379.64 Aligned_cols=265 Identities=31% Similarity=0.488 Sum_probs=208.3
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..++|++.+.||+|+||.||+|+.. |+.||||++..........+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3568899999999999999999874 899999999877666777788999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC--eeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||+++|+|.+++...... ..+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999653321 238899999999999999999996 67 99999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~---~~~----------- 252 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AVG----------- 252 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HHH-----------
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH-----------
Confidence 54322 12334579999999999999999999999999999999999999997654322110 000
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
....... .+......+.+++.+||+.||++||++.++++.|+.+.+...
T Consensus 253 ~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 253 FKCKRLE---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred hcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 0001111 112233568899999999999999999999999999876544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=383.71 Aligned_cols=290 Identities=39% Similarity=0.723 Sum_probs=232.5
Q ss_pred eeecHHHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEE
Q 002255 578 MVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657 (947)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 657 (947)
..+++.++..+.++|++.+.||+|+||.||+|+.++|+.||||++..... ......+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45778899999999999999999999999999988899999999876532 22234689999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 658 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
.+++..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999976543 2345899999999999999999999833339999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccC--ccchhhHHHHHHH
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQ--SEDSVHLVTWFRR 815 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~--~~~~~~l~~~~~~ 815 (947)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........|+..
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987754332 23445669999999999988899999999999999999999999996332 1222233444433
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
... ........+.... ..........+.+++.+|++.||++|||+.||++.|+..
T Consensus 255 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLK-EKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTS-SCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred Hhh-chhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 222 1122222222222 233456667899999999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=384.30 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=216.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|++.+.||+|+||.||+|++. ++..||||+++... .....+++.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467899999999999999999763 35679999997652 455677899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
++..++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 99999999999999999999764321 12347899999999999999999997 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987655433333344567889999999999999999999999999999999 99999765432211
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..+..... ...+......+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 316 -----------------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 -----------------KLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -----------------HHHHTTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------HHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 111122335688999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=379.57 Aligned_cols=272 Identities=24% Similarity=0.372 Sum_probs=212.9
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----eeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 665 (947)
++|++.++||+|+||.||+|++. ++.||||++... ......+..|+.++++++|||||++++++.+.. ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 67899999999999999999886 899999998654 333455677999999999999999999998744 4699
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC----------CeeecCCCCCcEEEcCCCcE
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ----------SFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivHrDlkp~Nill~~~~~~ 735 (947)
||||+++|+|.+++... .+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 99999999999999552 38999999999999999999996 5 99999999999999999999
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~ 810 (947)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999987765433333344679999999999876 35677899999999999999999999876543322222
Q ss_pred HHHHHhhcChhhHHHHh-hccCCC--Ch--hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 811 TWFRRMHINKDTFRKAI-DRTIDL--DE--ETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 811 ~~~~~~~~~~~~~~~~~-~~~~~~--~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
........ .....+.+ ...... .. ........+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCC-HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCc-hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 11122222 111111 11 1223456688999999999999999999999999998754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=372.92 Aligned_cols=293 Identities=27% Similarity=0.477 Sum_probs=223.9
Q ss_pred CCChHHHHHHHHHHHHcCCCCC-CCCC-CCCCCC--CceeEeCCC---CcEEEEEecCCcccc--cCcccccCCCCCCEE
Q 002255 24 SQSSSDAAAMQALKTSLGNPAS-LGWT-DPDPCK--WKHIQCSPS---NRVTRIQIGGQNIEG--TLPKELNSLSSLTVL 94 (947)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~-~~w~-~~d~C~--w~gv~C~~~---~~v~~l~L~~~~l~g--~~p~~l~~l~~L~~L 94 (947)
.|.+.|++||++||+++.++.. .+|. +.|||. |.||+|+.. ++|+.|+|+++++.| .+|+.|+++++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 4778999999999999987652 3785 468998 999999864 799999999999999 999999999999999
Q ss_pred Eccc-CcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCce
Q 002255 95 EVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172 (947)
Q Consensus 95 ~L~~-N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 172 (947)
+|++ |.+.+.+| .|.++++|++|+|++|++++..|..|..+++|++|+|++|.+.+ .+|..+..+++|++|++++|.
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC-cCChHHhcCCCCCeEECcCCc
Confidence 9995 99998887 68888888888888888877666667777777777777777754 456666666666666666666
Q ss_pred eeeccCcccCCCCCC-CccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcC
Q 002255 173 ITGTIPDFLGGDTIP-GLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251 (947)
Q Consensus 173 l~~~~p~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 251 (947)
+++.+|..++ .++ +|++|+|++|++++.+|..+
T Consensus 161 l~~~~p~~l~--~l~~~L~~L~L~~N~l~~~~~~~~-------------------------------------------- 194 (313)
T 1ogq_A 161 ISGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTF-------------------------------------------- 194 (313)
T ss_dssp CEEECCGGGG--CCCTTCCEEECCSSEEEEECCGGG--------------------------------------------
T ss_pred ccCcCCHHHh--hhhhcCcEEECcCCeeeccCChHH--------------------------------------------
Confidence 6655555554 343 55555555555554444433
Q ss_pred CCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCcc
Q 002255 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRV 331 (947)
Q Consensus 252 ~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (947)
..+. |++|++++|++++.+|..+..+++|+.|+|++|++++.+|..
T Consensus 195 -----~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------------- 240 (313)
T 1ogq_A 195 -----ANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV---------------------------- 240 (313)
T ss_dssp -----GGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC----------------------------
T ss_pred -----hCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcc----------------------------
Confidence 3333 666777777777677777777777777777777777655431
Q ss_pred ceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCC
Q 002255 332 NVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411 (947)
Q Consensus 332 ~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 411 (947)
...++|+.|+|++|+++|.+|..++++++|+.|+|++|+|+|.+|
T Consensus 241 -----------------------------------~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 241 -----------------------------------GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp -----------------------------------CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred -----------------------------------cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 112367888888888888889999999999999999999999999
Q ss_pred CcCCCCCCCCcccccccc-cccc
Q 002255 412 KELTTLPSLEMLDVSNNH-LFGK 433 (947)
Q Consensus 412 ~~l~~l~~L~~L~ls~N~-l~g~ 433 (947)
.. ..+++|+.|++++|+ ++|.
T Consensus 286 ~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 286 QG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CS-TTGGGSCGGGTCSSSEEEST
T ss_pred CC-ccccccChHHhcCCCCccCC
Confidence 87 889999999999998 6764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=365.41 Aligned_cols=285 Identities=37% Similarity=0.651 Sum_probs=233.3
Q ss_pred eeecHHHHHHHhcCCCcC------ceecccCceEEEEEEEcCCcEEEEEEecccc--cChHHHHHHHHHHHHHHcCCCCC
Q 002255 578 MVISIQVLRNVTNNFSEE------NVLGRGGFGTVYKGELHDGTKIAVKRMESAV--VSEKGFAEFKSEIAVLTKVRHRH 649 (947)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~n 649 (947)
..+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 467889999999999887 9999999999999986 58999999987542 23345678999999999999999
Q ss_pred cceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 650 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
|+++++++.+++..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999865432 2458999999999999999999997 899999999999999
Q ss_pred cCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhH
Q 002255 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l 809 (947)
+.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.||..........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL- 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-
Confidence 9999999999999987655443333445679999999998764 68999999999999999999999998655433221
Q ss_pred HHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.+..........+...+++.+. .........+.+++.+|++.||.+||++.++++.|+++.
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 -DIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp -HHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred -HHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1222222223344555555443 234455677889999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.99 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=210.9
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 57999999999877666777788999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999998654 238899999999999999999997 899999999999999999999999999998665
Q ss_pred CCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... .....+||+.|+|||++.+..++ .++||||+||++|||++|+.||.+....+ ....+
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------------~~~~i 226 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----------------LRERV 226 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHH
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHH
Confidence 432 23456899999999999887765 79999999999999999999997654221 11222
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......+.. ....+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 227 LRGKYRIPFY---MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHCCCCCCTT---SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2232322221 2345789999999999999999999976
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=366.83 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=207.2
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
..++|+..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 347899999999999999999986 4689999999875532 2346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999998642 37889999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------------~~ 228 (297)
T 3fxz_A 167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY----------------LI 228 (297)
T ss_dssp CSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----------------HH
T ss_pred CCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HH
Confidence 54332 2334679999999999999999999999999999999999999997654322111 11
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.................+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 229 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11111001111223456789999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=367.38 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=214.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|.+.++||+|+||.||+|... +++.||+|++... +....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 57889999999999999999875 6899999988653 56667889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999996532 348999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcce------------eecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 749 NGKHSI------------ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 749 ~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
...... .....||+.|+|||++.+..++.++||||||+++|||++|..|+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------- 232 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------- 232 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------
Confidence 322110 114579999999999999999999999999999999999999987654332110
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
........+.... ......+.+++.+|++.||++||++.++++.|+.+.....
T Consensus 233 ---~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 ---GLNVRGFLDRYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ---SBCHHHHHHHTCC-----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---hhhhhccccccCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0011111111111 0112347899999999999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=371.41 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=211.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|++.++||+|+||.||+|.+. .+..||||+++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 367889999999999999999874 35569999997543 4556678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999985432 348999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---------------- 263 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---------------- 263 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----------------
Confidence 77553222 12233456889999999998899999999999999999999 9999976543211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...+..... ..........+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 264 -~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 264 -ISSVEEGYR-LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHcCCC-CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 111111111 111122345688999999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=383.03 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=212.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|.+.+.||+|+||.||+|.++ +++.||||+++.. ......+++.+|++++++++|||||++++++..++..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 357888999999999999999986 7899999998754 24455667899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999996543 248899999999999999999997 899999999999999999999999999998754
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
............+++.|+|||++....++.++|||||||++|||++ |+.||......+ ..+.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----------------~~~~ 327 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----------------TREF 327 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----------------HHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHH
Confidence 4211111112235778999999998899999999999999999998 999997654321 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
+..... .+.+...+..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus 328 ~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 328 VEKGGR-LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 221111 011112335688999999999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=368.35 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=204.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 478999999999999999999876 789999999865432 223467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999988542 348899999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
............||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .+...
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---------------~~~~~ 221 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------------EYSDW 221 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---------------HHHHH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---------------HHHHH
Confidence 4333333445689999999999987765 7799999999999999999999976543221 11111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... ..........+.+|+.+||+.||++||++.|+++
T Consensus 222 ~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 222 KEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hccccc-CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111 1111223356789999999999999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.76 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=212.0
Q ss_pred eecHHHHHHHhcC----------CCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC
Q 002255 579 VISIQVLRNVTNN----------FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647 (947)
Q Consensus 579 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 647 (947)
.+++++++.+++. |...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence 3566777776654 677789999999999999886 79999999987553 3345678999999999999
Q ss_pred CCcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcE
Q 002255 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727 (947)
Q Consensus 648 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni 727 (947)
|||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 9999999999999999999999999999998853 248999999999999999999997 8999999999999
Q ss_pred EEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchh
Q 002255 728 LLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV 807 (947)
Q Consensus 728 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 807 (947)
+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~- 249 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA- 249 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-
T ss_pred EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 999999999999999987654322 22346799999999999998999999999999999999999999976542211
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. .+.................+.+++.+||+.||++||++.|+++
T Consensus 250 --~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 --MK-------------RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --HH-------------HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HH-------------HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111111101111123356789999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.77 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=209.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+.++|++.+.||+|+||.||+|..+ +|+.||+|+++...... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 5678999999999999999999876 68999999997654322 135688999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC----cEEEe
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~ 738 (947)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 99999999999999998542 348999999999999999999997 8999999999999998877 79999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....+
T Consensus 162 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------------- 225 (361)
T 2yab_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------------- 225 (361)
T ss_dssp CCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------------
T ss_pred ecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------------
Confidence 9999987755322 234579999999999998899999999999999999999999997654221
Q ss_pred ChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+..+......++... ......+.+|+.+||..||++||++.|+++
T Consensus 226 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 226 ---TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1222222233322221 122345789999999999999999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.77 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=211.8
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 578889999999999999999988999999999865433 35789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999986533 358899999999999999999997 89999999999999999999999999999866442
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
. ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----------------~~~~~~ 222 (269)
T 4hcu_A 160 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDIST 222 (269)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHT
T ss_pred c-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----------------HHHHhc
Confidence 1 122233467888999999998899999999999999999999 9999976543211 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
. .. ...+......+.+++.+|++.||++||+++++++.|+++.+
T Consensus 223 ~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 G-FR-LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp T-CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-cc-CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1 11 01111223568899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=376.25 Aligned_cols=267 Identities=29% Similarity=0.435 Sum_probs=218.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|.+.++||+|+||.||+|+.. .+..||||+++.. ......+++.+|+++++++ +|||||++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 468899999999999999999863 2457999999765 3556678899999999999 99999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
++..++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999765421 12358999999999999999999997 79999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987655433333444568899999999999999999999999999999999 999997654221
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
+.+.+..... ..........+.+++.+||+.||++||++.||++.|+++.....
T Consensus 302 ---------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 ---------------LFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp ---------------HHHHHHTTCC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ---------------HHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111111111 01111233568899999999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.84 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=212.8
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|+.+++..||||+++..... .+++.+|++++++++||||+++++++.++...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4678999999999999999999998889999999765333 3578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999996643 348899999999999999999997 8999999999999999999999999999987755
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .....
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~~~ 219 (268)
T 3sxs_A 157 DQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV----------------VLKVS 219 (268)
T ss_dssp TCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------------HHHHH
T ss_pred hhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH----------------HHHHH
Confidence 332 22334557788999999998899999999999999999999 9999976543211 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..... ..+......+.+++.+|++.||++||++.|+++.|+.+.+
T Consensus 220 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 220 QGHRL--YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTCCC--CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred cCCCC--CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11111 0111123468899999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.83 Aligned_cols=275 Identities=16% Similarity=0.206 Sum_probs=218.9
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46799999999999999999986 4789999999875421 24578999999999 999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc-----EEEeecC
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFG 741 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfG 741 (947)
|||+ +++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 999999986532 358999999999999999999997 79999999999999998887 9999999
Q ss_pred cceecCCCCCcc-----eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 742 LVRLAPDNGKHS-----IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 742 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 998764432211 123568999999999999999999999999999999999999999876544332222222111
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCcc
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDIY 887 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~ 887 (947)
.. ........... +.+.+++.+|++.||.+||++.+|.+.|+++.+..........+|.
T Consensus 236 ~~-----------~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 236 KR-----------ATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HH-----------HSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred hc-----------cCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 00 00000000011 2688999999999999999999999999998877655555455554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=376.68 Aligned_cols=260 Identities=26% Similarity=0.482 Sum_probs=201.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|++.+.||+|+||.||+|+++ ++..||||+++... .....+++.+|+.++++++||||+++++++.+++..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357999999999999999999865 57789999997643 4556678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999996532 358999999999999999999997 799999999999999999999999999998
Q ss_pred ecCCCCCcc-eeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKHS-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------- 258 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------- 258 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----------------
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 765432211 1222345788999999999999999999999999999998 999997654221
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+.+...... +........+.+++.+|++.||++||++.+|++.|+.+..
T Consensus 259 ~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 259 VIKAVDEGYRL-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHHHHHTTEEC-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC-CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 11111111110 1111234568899999999999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.37 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=209.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999876 5889999998743 34456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC--CCcEEEeecCcce
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 744 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~ 744 (947)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 99999999999985432 358899999999999999999997 89999999999999987 7899999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.
T Consensus 153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~ 213 (321)
T 1tki_A 153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------IIE 213 (321)
T ss_dssp ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHH
T ss_pred ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----------------HHH
Confidence 875532 2334579999999999998889999999999999999999999997654221 122
Q ss_pred HHhhccCCCChhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETL-ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+............ ....++.+++.+||+.||++|||+.|+++
T Consensus 214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23333333222221 23356789999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=372.74 Aligned_cols=270 Identities=29% Similarity=0.440 Sum_probs=216.0
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 659 (947)
....++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|++++++++||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 345688999999999999999999875 34889999997653 45556789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccC-------------------CCcccHHHHHHHHHHHHHHHHHHhhccCCCeeec
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEG-------------------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr 720 (947)
++..++||||+++|+|.+++....... ...+++.+++.++.||++||+|||+ ++|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 999999999999999999997643211 1468999999999999999999997 899999
Q ss_pred CCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCC
Q 002255 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALD 799 (947)
Q Consensus 721 Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~ 799 (947)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986644322223344578999999999998899999999999999999999 999997
Q ss_pred ccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 800 ETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 800 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
.....+. ...+.+.... ..+......+.+++.+||+.||++||++.++++.|+++.+.+.
T Consensus 279 ~~~~~~~----------------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEV----------------IYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHH----------------HHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHH----------------HHHHhCCCcC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 6542211 1111111111 1111233568899999999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.68 Aligned_cols=265 Identities=27% Similarity=0.406 Sum_probs=217.0
Q ss_pred hcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 46788999999999999999976 245789999997543 45567889999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccccc-------------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEE-------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 723 (947)
.++||||+++|+|.+++...... ....+++.+++.++.||++||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999764321 12348899999999999999999997 899999999
Q ss_pred CCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccC
Q 002255 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQ 802 (947)
Q Consensus 724 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~ 802 (947)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755443333344567889999999998899999999999999999999 999997654
Q ss_pred ccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 803 SEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 803 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..... ..+..... ..........+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 258 ~~~~~-----------------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLF-----------------NLLKTGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHH-----------------HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHH-----------------HHhhcCCc-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 33211 11111111 111122335688999999999999999999999999988653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=377.37 Aligned_cols=273 Identities=25% Similarity=0.392 Sum_probs=218.5
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEE
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLL 654 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 654 (947)
....+...++|++.+.||+|+||.||+|++. +++.||||+++... .....+.+.+|++++.++ +|||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444556789999999999999999999742 46789999997642 445567899999999999 799999999
Q ss_pred EEEEeCCe-eEEEEEecCCCchhhhhhcccccC-----------------------------------------------
Q 002255 655 GYCLDGNE-RLLVYEYMPQGTLSRHLFNRKEEG----------------------------------------------- 686 (947)
Q Consensus 655 ~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~----------------------------------------------- 686 (947)
+++.+.+. .++||||+++|+|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987554 899999999999999997643210
Q ss_pred --------------CCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 687 --------------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 687 --------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1228899999999999999999997 79999999999999999999999999999876554444
Q ss_pred ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 753 SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 753 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ...+....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~~~~~~~ 313 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----------------CRRLKEGT 313 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----------------HHHHHHTC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----------------HHHHHcCC
Confidence 44455678999999999999999999999999999999998 99999765432211 11111111
Q ss_pred CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 832 DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 832 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
. ...+......+.+++.+|++.||++||++.|+++.|+++.+.
T Consensus 314 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 R-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1 011112234688999999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=378.79 Aligned_cols=255 Identities=21% Similarity=0.322 Sum_probs=210.8
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.+.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++|||||++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999765 78999999998766556667789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc---CCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfGl 742 (947)
||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999988653 348899999999999999999997 8999999999999998 568899999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+ .
T Consensus 160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----------------~ 221 (444)
T 3soa_A 160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----------------L 221 (444)
T ss_dssp CBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------H
T ss_pred eEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----------------H
Confidence 987654322 2234679999999999998899999999999999999999999997644221 1
Q ss_pred HHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+........... ......+.+|+.+||+.||++||++.|+++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222222222222111 123456889999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=377.03 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=213.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|++.+.||+|+||.||+|++. +++.||||+++.. .......++.+|+.++++++|||||++++++.++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467889999999999999999853 4678999998754 345566789999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccccc--CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC---cEEE
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 737 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl 737 (947)
.++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999764321 22358999999999999999999997 8999999999999999555 5999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---------- 295 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---------- 295 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------
Confidence 99999975433222223334568999999999999999999999999999999998 9999976542211
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
.+.+..... ..........+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus 296 -------~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 296 -------LEFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -------HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------HHHHHcCCC-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111111111 011112334688999999999999999999999999988753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=370.78 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=211.8
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.+.++|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|++++++++|||||++++++.+++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999875 68999999998776666777889999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC---CcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfGl 742 (947)
||||+++|+|.+++..+ ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999988543 348899999999999999999997 799999999999999865 4599999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~ 238 (362)
T 2bdw_A 178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----------------L 238 (362)
T ss_dssp CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------H
T ss_pred ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----------------H
Confidence 987654322 234679999999999998899999999999999999999999997644211 1
Q ss_pred HHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 823 FRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+..+........... ......+.+++.+||+.||++||++.|+++.
T Consensus 239 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112222222222111 1234567899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.64 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=208.2
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc---ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
+.++|++.+.||+|+||.||+|..+ +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999875 689999999864321 112357789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc---EEEeec
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADF 740 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~Df 740 (947)
++||||+++|+|.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999888654332 2357899999999999999999997 89999999999999987654 999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------- 238 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------------- 238 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----------------
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----------------
Confidence 99987755322 23345799999999999988999999999999999999999999976321
Q ss_pred hhHHHHhhccCCCChhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETL-ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..+...........+ .....+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111222222222222111 22356789999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=364.40 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=206.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||+|++++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67899999999999999999876 689999999976421 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999988653 247899999999999999999997 899999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~ 218 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELIL 218 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 3222 2334689999999999999999999999999999999999999997644221 112222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
......+. ....++.+++.+||+.||++|| ++.|+++
T Consensus 219 ~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 219 MEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCCCCCC---CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 22232222 2235678999999999999999 8888876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.92 Aligned_cols=275 Identities=16% Similarity=0.234 Sum_probs=220.0
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +|+|++++++++.++...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46799999999999999999986 478999999986542 224578899999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc-----EEEeecC
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFG 741 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfG 741 (947)
|||+ +++|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+||+++.++. +||+|||
T Consensus 85 ~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 999999996532 348999999999999999999996 89999999999999987776 9999999
Q ss_pred cceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 742 LVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 742 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 99876543221 1234567999999999999989999999999999999999999999876544333222222111
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCc
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDI 886 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~ 886 (947)
.. ...... ........+.+++.+|++.||++||++.+|++.|+++.+..........||
T Consensus 237 ~~-~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 237 KQ-STPLRE----------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp HH-HSCHHH----------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred cc-CccHHH----------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 10 000000 011223568899999999999999999999999999988766655555554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=357.18 Aligned_cols=263 Identities=21% Similarity=0.375 Sum_probs=207.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 478999999999999999999865 68999999986543 2445567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999998653 248899999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..............
T Consensus 162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQDSVPNVTTD 235 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSSCCCCHHHH
T ss_pred ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhccCCCcchh
Confidence 44221 2233457999999999999989999999999999999999999999765432110 00000000001000
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRP-DMGHVVNVLSSLAE 874 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~~ 874 (947)
+ ....+..+.+++.+|++.||++|| +++++.+.|+.+..
T Consensus 236 ~---------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 236 V---------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp S---------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred c---------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1 112235688999999999999999 89999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.60 Aligned_cols=266 Identities=27% Similarity=0.446 Sum_probs=198.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEcC-C---cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHD-G---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
..++|++.+.||+|+||.||+|.... + ..||||+++.........+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999997653 3 2799999987655566678899999999999999999999999877655
Q ss_pred ------EEEEEecCCCchhhhhhccccc-CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEE
Q 002255 664 ------LLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 664 ------~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 736 (947)
++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999998654322 12258999999999999999999997 7999999999999999999999
Q ss_pred EeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~ 815 (947)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------- 248 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--------- 248 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---------
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---------
Confidence 999999987655433333344567889999999999999999999999999999999 8999976543321
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+...... .........+.+++.+||+.||++||++.++++.|+++..
T Consensus 249 -------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 -------YNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp -------HHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHhcCCCC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111110 1111233568899999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.80 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=203.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|+..++||+|+||.||+|++. +++ +||+|.+.... .....+++.+|+.++++++||||+++++++.++. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 67889999999999999999864 344 46888876432 3345678999999999999999999999998755 78
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 9999999999999996643 348999999999999999999997 799999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~ 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------H
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------H
Confidence 7755444333444567889999999999999999999999999999999 999997654322 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+..... ..........+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 229 SSILEKGER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHTTCC-CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122222111 11112234568899999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.78 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=209.0
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|.+.++..||+|+++..... .+++.+|++++++++||||+++++++.+++..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4678899999999999999999998889999999865433 3578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999996533 248899999999999999999997 8999999999999999999999999999986644
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+.
T Consensus 173 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~----------------~~~~~ 235 (283)
T 3gen_A 173 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET----------------AEHIA 235 (283)
T ss_dssp HH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------------HHHHH
T ss_pred cc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH----------------HHHHh
Confidence 21 112233457788999999998899999999999999999998 9999976543211 11111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.. .. ..........+.+++.+||+.||++||++.++++.|+++.+
T Consensus 236 ~~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 236 QG-LR-LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TT-CC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-cC-CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11 11 01111223467899999999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=359.37 Aligned_cols=270 Identities=25% Similarity=0.355 Sum_probs=205.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+.++|++.++||+|+||.||+|+..+|+.||+|++..........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999999766544555678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||++ |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9997 58888775432 348899999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh-----h
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK-----D 821 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-----~ 821 (947)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.......... .
T Consensus 171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred CCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 4322 2234578999999999876 568999999999999999999999998765544322211111000000 0
Q ss_pred hHHHHhhccCCC-Chhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 TFRKAIDRTIDL-DEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 ~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......+..... .... .....++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000001111000 0000 112246789999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=362.53 Aligned_cols=266 Identities=26% Similarity=0.430 Sum_probs=217.2
Q ss_pred hcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|++.+.||+|+||.||+|++ .+++.||||+++... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999985 246789999997553 344567899999999999 9999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc-------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE-------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
..++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 999999999999999999764321 12358999999999999999999997 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999987765444333445568889999999998999999999999999999999 9999976543221
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
....+..... ..........+.+++.+|++.||++||++.|+++.|+++...
T Consensus 257 ---------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 ---------------FYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---------------HHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------HHHHhccCCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111111 011112335688999999999999999999999999988753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=363.44 Aligned_cols=273 Identities=24% Similarity=0.432 Sum_probs=209.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 661 (947)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 467899999999999999999852 5889999999754 45666789999999999999999999999865 35
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 6899999999999999996643 248899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++........ .......|+..|+|||++.+..++.++||||||+++|||++|..|+...... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~ 235 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ 235 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccc
Confidence 99876543221 2233446788899999999999999999999999999999999998653211 000000000000
Q ss_pred ---hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 821 ---DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 821 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
....+.+..... .+........+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 011112221111 111223345688999999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=369.66 Aligned_cols=284 Identities=16% Similarity=0.219 Sum_probs=215.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChH---------HHHHHHHHHHHHHcCCCCCcce
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEK---------GFAEFKSEIAVLTKVRHRHLVG 652 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~ 652 (947)
..++|++.+.||+|+||.||+|.++. ++.||||++........ ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998764 47899999875421100 0123445666777888999999
Q ss_pred EEEEEEeC----CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 653 LLGYCLDG----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 653 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
+++++... ...++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence 99998764 4579999999 999999986532 358999999999999999999997 79999999999999
Q ss_pred Ec--CCCcEEEeecCcceecCCCCCcc-----eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCcc
Q 002255 729 LG--DDMRAKVADFGLVRLAPDNGKHS-----IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDET 801 (947)
Q Consensus 729 l~--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~ 801 (947)
++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 88999999999998765432211 113346999999999999989999999999999999999999999864
Q ss_pred CccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCC
Q 002255 802 QSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEP 881 (947)
Q Consensus 802 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~ 881 (947)
...... ........ ...+...++..+... ..+..+.+++.+|++.+|++||++.+|++.|+.+.+.......
T Consensus 265 ~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 265 LKDPKY--VRDSKIRY--RENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp TTCHHH--HHHHHHHH--HHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCHHH--HHHHHHHh--hhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 433221 11111110 122334444333211 1234688999999999999999999999999999887776666
Q ss_pred CCCCcc
Q 002255 882 DSDDIY 887 (947)
Q Consensus 882 ~~~~~~ 887 (947)
...+|.
T Consensus 337 ~~~dw~ 342 (364)
T 3op5_A 337 GKLDLS 342 (364)
T ss_dssp CCCCC-
T ss_pred CccceE
Confidence 666653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=363.10 Aligned_cols=267 Identities=27% Similarity=0.449 Sum_probs=216.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|++.+.||+|+||.||+|... ++..||||++.... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 468899999999999999999863 46789999997543 455677899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccC-----------CCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
++..++||||+++|+|.+++......+ ...+++.+++.++.||+.||+|||+ .+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 999999999999999999997643211 1348899999999999999999997 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999987765443333344567889999999988899999999999999999999 9999976542211
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
. ..+..... ..........+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 269 --~--------------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 --F--------------KLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp --H--------------HHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --H--------------HHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1 11111100 01111233568899999999999999999999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=368.64 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=201.2
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC--CCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+.++++++| +||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35689999999999999999998889999999998766667777889999999999976 9999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|| +.+++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 5688999999653 348899999999999999999997 7999999999999997 678999999999877
Q ss_pred CCCCCcceeecccccccccCcccccc-----------CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~ 815 (947)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------- 226 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------- 226 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----------
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----------
Confidence 55433333445689999999999864 67899999999999999999999999754321
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
...+...++...... .+......+.+++.+||+.||++||++.|+++.
T Consensus 227 ----~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ----ISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----HHHHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHhcCCcccC-CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011222232222111 111112457899999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.26 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=203.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
.++|++.++||+|+||.||+|+.+ +|+.||||+++.... .....+.+.+|+++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999876 589999999976432 233456788999999998 69999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999998653 248899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..
T Consensus 174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~ 235 (353)
T 3txo_A 174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----------------DLFEA 235 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHH
T ss_pred cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 43322 2234468999999999999889999999999999999999999999765432 12233
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM------GHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 867 (947)
+.......+.. ....+.+++.+||+.||++||++ .|+++
T Consensus 236 i~~~~~~~p~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDEVVYPTW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCCCCCCTT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCCCCCCCC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 33333332222 23457899999999999999998 66654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=357.28 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=203.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHc--CCCCCcceEEEEEEeC----C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK--VRHRHLVGLLGYCLDG----N 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~ 661 (947)
+.++|++.+.||+|+||.||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999988 5899999998643 23456667777776 7999999999997642 4
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----CCCeeecCCCCCcEEEcCCCcEE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~k 736 (947)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.. +++|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 57999999999999999943 34899999999999999999999211 28999999999999999999999
Q ss_pred EeecCcceecCCCCCcc--eeecccccccccCccccccC------CcCcccccccHHHHHHHHHhC----------CCCC
Q 002255 737 VADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITG----------RKAL 798 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~p~ 798 (947)
|+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998665433221 12234799999999999776 556799999999999999999 7888
Q ss_pred CccCccchhhHHHHHHHhhcChhhHHHHhhc---cCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 799 DETQSEDSVHLVTWFRRMHINKDTFRKAIDR---TIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 799 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
......+... ......+.. ..... .........+.+++.+||+.||++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSF------------EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcch------------hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6544322110 111111111 11111 12234556789999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=382.33 Aligned_cols=258 Identities=27% Similarity=0.470 Sum_probs=210.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..++|++.+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++|||||++++++. ++..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 356788999999999999999999888999999997643 23578999999999999999999999986 66789999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999975432 237888999999999999999997 799999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... ........+|..|+|||++....++.++|||||||++|||++ |+.||.+....+.. ..
T Consensus 336 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~~ 397 (454)
T 1qcf_A 336 DNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-----------------RA 397 (454)
T ss_dssp CHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----------------HH
T ss_pred CCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HH
Confidence 321 111233456789999999998899999999999999999999 99999765432211 11
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+...... +.+...+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 398 i~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 398 LERGYRM-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHcCCCC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1111111 1112234568899999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.28 Aligned_cols=263 Identities=29% Similarity=0.524 Sum_probs=200.3
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.++||+|+||.||+|+.. ..||||+++.........+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999764 4699999987766677778899999999999999999999965 5567899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999985432 458999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...........||+.|+|||++. ...++.++||||||+++|||++|+.||......+. ....+.....
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~------- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSL------- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSC-------
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccccc-------
Confidence 32223334467999999999986 56788899999999999999999999976543221 1111111000
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.. ............+.+++.+||+.||++||++.++++.|+++.+
T Consensus 244 --~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 --SP--DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --CC--CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --Cc--chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 0011112234568899999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.62 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=207.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+.++|.+.+.||+|+||.||+|..+ +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.++..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4567999999999999999999876 68999999997653221 135788999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC----cEEEe
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~ 738 (947)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999998542 348999999999999999999997 8999999999999999887 89999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------ 225 (326)
T 2y0a_A 161 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------------ 225 (326)
T ss_dssp CCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------------
T ss_pred ECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------------
Confidence 9999987754322 2345799999999999988999999999999999999999999976542211
Q ss_pred ChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+........... ......+.+++.+||+.||++|||+.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 226 ----LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111111111 122345789999999999999999999976
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=357.84 Aligned_cols=248 Identities=26% Similarity=0.306 Sum_probs=198.7
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
..++|++.++||+|+||+||+|... +|+.||||++...........++..|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999886 799999999876655555566667777766666 89999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+ +++|.+++.... ..++|..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 135 v~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 99999 779988886543 358999999999999999999997 7999999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~ 263 (311)
T 3p1a_A 207 LGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQ 263 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHH
T ss_pred cccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHH
Confidence 65432 2334579999999998875 799999999999999999999776643211 111
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+...... ..........+.+++.+||+.||++||++.|+++
T Consensus 264 ~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 264 LRQGYLP-PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTTTCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhccCCC-cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111110 1111122356889999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=367.79 Aligned_cols=266 Identities=26% Similarity=0.443 Sum_probs=212.3
Q ss_pred HhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 660 (947)
..++|++.+.||+|+||.||+|... ++..||||++.... .....+.+.+|+.+++++ +||||+++++++..+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3478899999999999999999862 45689999997542 334457899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccccc------------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCC
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEE------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 722 (947)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 9999999999999999999764321 11347899999999999999999997 89999999
Q ss_pred CCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCcc
Q 002255 723 KPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDET 801 (947)
Q Consensus 723 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~ 801 (947)
||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987655443334445568899999999988899999999999999999998 99999765
Q ss_pred CccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 802 QSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 802 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..... +...+...... .........+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 279 ~~~~~----------------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 279 PVDAN----------------FYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSHH----------------HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcHHH----------------HHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 43221 11222221111 1111234568899999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.99 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=202.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-----
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 661 (947)
..++|++.+.||+|+||.||+|+.+ +|+.||||++.... .....+.+.+|++++++++|||||++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4567999999999999999999886 79999999997553 3445678999999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEEecCCCchhhhhhcccccCCCc
Q 002255 662 ----------------------------------------------------ERLLVYEYMPQGTLSRHLFNRKEEGLKP 689 (947)
Q Consensus 662 ----------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~ 689 (947)
..++||||+++|+|.+++...... ..
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--ED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cc
Confidence 379999999999999999764432 34
Q ss_pred ccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc----------ceeeccc
Q 002255 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH----------SIETRLA 759 (947)
Q Consensus 690 ~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~ 759 (947)
..+..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........ .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 6777889999999999999997 89999999999999999999999999999877553211 1223457
Q ss_pred ccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHH
Q 002255 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLA 839 (947)
Q Consensus 760 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (947)
||+.|+|||++.+..++.++|||||||++|||++|..|+.... . ....... .........
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~-------------~~~~~~~--~~~~~~~~~ 297 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----R-------------IITDVRN--LKFPLLFTQ 297 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----H-------------HHHHHHT--TCCCHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----H-------------HHHHhhc--cCCCccccc
Confidence 9999999999999899999999999999999999877643210 0 0111111 122233334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 840 SISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 840 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+.+++.+||+.||++||++.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 4466789999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=353.84 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=199.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4688999999999999999998743 4579999987542 4555678999999999999999999999984 56789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999996532 348899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
....... .......+|+.|+|||++....++.++||||||+++|||++ |+.||......+..
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---------------- 227 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---------------- 227 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------
T ss_pred ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH----------------
Confidence 7654322 12233457889999999988899999999999999999997 99999765433211
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..+..... ..........+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus 228 ~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 228 GRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111110 011112335688999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=352.08 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=209.1
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--CeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+++ ++.||||++..........+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67899999999999999999986 89999999987766677778899999999999999999999999877 7889999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC--eeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+ |+||||||+||+++.++.++++|||++..
T Consensus 89 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999965332 358999999999999999999996 67 99999999999999999999999988654
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCc---ccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTT---KVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||......+.
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------- 219 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------------- 219 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----------------
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----------------
Confidence 322 2246899999999998765544 79999999999999999999976543211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.......... ..........+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 220 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 GMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111111 11112233568899999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=378.99 Aligned_cols=258 Identities=31% Similarity=0.510 Sum_probs=205.5
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|.++.+..||||+++.... ..++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 467888999999999999999998888899999986532 24678999999999999999999999876 67899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999965322 348899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ........++..|+|||++....++.++|||||||++|||++ |+.||.+....+. .+.+
T Consensus 333 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-----------------~~~i 394 (452)
T 1fmk_A 333 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------------LDQV 394 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHH
T ss_pred Cc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHH
Confidence 22 122233457889999999998999999999999999999999 9999976543211 1111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...... +.+......+.+++.+||+.||++||++.++++.|+.+...
T Consensus 395 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 395 ERGYRM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 111110 11122345688999999999999999999999999987644
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=355.67 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=196.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh------------------------HHHHHHHHHHHHHHc
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE------------------------KGFAEFKSEIAVLTK 644 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~ 644 (947)
++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 68999999999999999999875 68899999997543211 123568999999999
Q ss_pred CCCCCcceEEEEEEe--CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCC
Q 002255 645 VRHRHLVGLLGYCLD--GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722 (947)
Q Consensus 645 l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 722 (947)
++||||+++++++.+ ++..++||||+++++|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 999999999999986 5688999999999999876532 358999999999999999999997 79999999
Q ss_pred CCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCC---cCcccccccHHHHHHHHHhCCCCCC
Q 002255 723 KPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 723 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~p~~ 799 (947)
||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654322 234467999999999987654 4788999999999999999999997
Q ss_pred ccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 800 ETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 800 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... .. ..+........ ........+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~---~~-------------~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMC---LH-------------SKIKSQALEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHH---HH-------------HHHHHCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHH---HH-------------HHHhcccCCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 643211 11 11111111111 11122356889999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=370.05 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=201.9
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC--CCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+.++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468999999999999999999888999999999876656677788999999999996 599999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
| +.+++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 56899999986532 47888999999999999999996 8999999999999995 5899999999998765
Q ss_pred CCCCcceeecccccccccCcccccc-----------CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------ 273 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------ 273 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------------
Confidence 4333323345679999999999865 36889999999999999999999999754321
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
...+..+++....... +......+.+|+.+||+.||++||++.|+++.
T Consensus 274 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ---ISKLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HHHHHHHHCTTSCCCC-CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHhCccccCCC-CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1112233333222111 11113457899999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=354.18 Aligned_cols=275 Identities=20% Similarity=0.282 Sum_probs=211.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC--eeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--ERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 665 (947)
.++|.+.++||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 367899999999999999999876 589999999975432 233567889999999999999999999998765 7799
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----cCCCcEEEeecC
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG 741 (947)
||||+++++|.+++...... ..+++.+++.++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999764332 338999999999999999999997 899999999999999 788889999999
Q ss_pred cceecCCCCCcceeecccccccccCccccc--------cCCcCcccccccHHHHHHHHHhCCCCCCccCccch-hhHHHH
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAV--------TGRVTTKVDVFSFGVILMELITGRKALDETQSEDS-VHLVTW 812 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~l~~~ 812 (947)
+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ......
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 9987755332 23457999999999886 46789999999999999999999999975443221 111111
Q ss_pred HHHhhcChhhHH---H----Hh--hccCC-CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 813 FRRMHINKDTFR---K----AI--DRTID-LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 813 ~~~~~~~~~~~~---~----~~--~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+..... ..... . .+ ...+. ...........+.+++.+||+.||++||++.|+++...+-.
T Consensus 239 ~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111000 00000 0 00 00001 01223455567889999999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=383.93 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=212.4
Q ss_pred hcCCCcCceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.++||+|+||.||+|.++. +..||||+++... ...++|.+|++++++++|||||+++++|.+++..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4578889999999999999999874 8899999997653 23578999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999965332 458899999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... ........++..|+|||++....++.++|||||||++|||++ |+.||......+. .+.
T Consensus 370 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----------------~~~ 431 (495)
T 1opk_A 370 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YEL 431 (495)
T ss_dssp TCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------------HHH
T ss_pred CCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHH
Confidence 422 222233456789999999998899999999999999999999 9999976543221 111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
+...... ..+......+.+|+.+||+.||++||++.+|++.|+.+.
T Consensus 432 ~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 432 LEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHcCCCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 2222111 111223356889999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.80 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=202.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
.++|++.++||+|+||.||+|+.+ +++.||||++++.... ....+.+.+|..++.++ +|||||++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367899999999999999999876 5789999999865433 23345688899999887 89999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999988653 248899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .........
T Consensus 203 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~~~~ 273 (396)
T 4dc2_A 203 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQV 273 (396)
T ss_dssp CCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHHHH
T ss_pred cccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHHHHH
Confidence 433222 23456899999999999999999999999999999999999999975432211000 000111223
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
+....+..+.. ....+.+|+.+||+.||++||++
T Consensus 274 i~~~~~~~p~~---~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 274 ILEKQIRIPRS---LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHCCCCCCTT---SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HhccccCCCCc---CCHHHHHHHHHHhcCCHhHcCCC
Confidence 33333333222 33467899999999999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.09 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=206.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67899999999999999999876 689999999976432 1234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999653 247889999999999999999996 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..++
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~ 216 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKIL 216 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHH
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Confidence 32 23457999999999999999999999999999999999999999764421 1223333
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
......+. ....++.+++.+|++.||++|| ++.|+++
T Consensus 217 ~~~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 217 NAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HCCCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hCCCCCCC---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 33333222 1234678999999999999999 7888765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=351.36 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=195.3
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccC--hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|+..+.||+|+||.||+|.+. |+.||||+++..... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367889999999999999999876 899999998754322 23357889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC--------CCcEEEe
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--------DMRAKVA 738 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--------~~~~kl~ 738 (947)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999998843 34889999999999999999999832223999999999999986 7789999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------ 222 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------------ 222 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------------
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------
Confidence 999998654432 2235799999999999988999999999999999999999999976542211
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
.......... ..........+.+++.+|++.||++||++.|+++.|+++
T Consensus 223 ----~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ----AYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHhhhcCCCC-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111111 111122335688999999999999999999999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.82 Aligned_cols=267 Identities=28% Similarity=0.438 Sum_probs=204.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC--
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-- 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 661 (947)
..++|.+.+.||+|+||.||+|... ++..||||+++.........+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567889999999999999999764 3458999999876666677788999999999999999999999998755
Q ss_pred ---eeEEEEEecCCCchhhhhhcccc-cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 662 ---ERLLVYEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 662 ---~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
..++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 34999999999999999854321 233568999999999999999999996 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---------- 258 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---------- 258 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----------
Confidence 99999987654332223344567889999999999899999999999999999999 8899976543221
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...+..... ..........+.+++.+||+.||++||++.++++.|+++.+.
T Consensus 259 ------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 ------YDYLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ------HHHHHTTCC--CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 111122335688999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=361.14 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.++||+|+||.||+|.+. +++ +||+|.+.... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 67999999999999999999864 444 35777775432 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999996643 348899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------- 228 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------- 228 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----------------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----------------
Confidence 7655433333344567889999999999999999999999999999999 9999976543321
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+..... ..........+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 229 SSILEKGER-LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHTTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 112221111 11112233468899999999999999999999999998863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.31 Aligned_cols=258 Identities=32% Similarity=0.531 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 57888999999999999999886 789999998643 34578999999999999999999999876 457999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc-EEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-~kl~DfGla~~~~~ 748 (947)
+++|+|.+++..... ...+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999965432 134788899999999999999999754478999999999999998886 79999999876533
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. .+. ...
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~~------------~~~ 219 (307)
T 2eva_A 159 H-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RI-MWA------------VHN 219 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HH-HHH------------HHT
T ss_pred c-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HH-HHH------------Hhc
Confidence 2 1234699999999999988999999999999999999999999975432211 00 000 000
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
... ..........+.+++.+|++.||++||++.|+++.|+.+.+.+.
T Consensus 220 ~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 220 GTR--PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp TCC--CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCC--CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 11111233567899999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.52 Aligned_cols=252 Identities=31% Similarity=0.490 Sum_probs=207.7
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-eeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-ERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++|||||++++++.+.+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467888999999999999999886 7899999997542 3467899999999999999999999987765 789999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999976432 347889999999999999999997 899999999999999999999999999998653
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..
T Consensus 341 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~~ 398 (450)
T 1k9a_A 341 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----------------PR 398 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-----------------HH
T ss_pred ccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HH
Confidence 321 12357889999999999999999999999999999998 99999765433221 11
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+..... ...+......+.+++.+||+.||++||++.++++.|+.+..
T Consensus 399 i~~~~~-~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 399 VEKGYK-MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111111 01112234568899999999999999999999999998875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=376.16 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=209.8
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 659 (947)
+.+++...++|++.++||+|+||.||+|+.+ +++.||||++.+... .....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999886 478999999975321 11222348899999999999999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
++..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999996532 348999999999999999999997 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+.
T Consensus 219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------- 289 (437)
T 4aw2_A 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------- 289 (437)
T ss_dssp CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------
T ss_pred hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--------
Confidence 999987655332 2234468999999999987 56789999999999999999999999986543221
Q ss_pred HhhcChhhHHHHhhc--cCCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002255 815 RMHINKDTFRKAIDR--TIDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVN 867 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 867 (947)
+..++.. .+..+.........+.+|+.+||..+|++ ||++.|+++
T Consensus 290 --------~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 290 --------YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --------HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --------HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111111 11112111123356789999999888888 999999876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.87 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=206.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||.||+|..+ +|+.||+|++... .......+.+|++++++++||||+++++++.++...++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999875 6899999998754 334456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC--CCcEEEeecCcce
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 744 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~ 744 (947)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 99999999999885432 348999999999999999999997 89999999999999974 5789999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. .
T Consensus 200 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~-------------~ 260 (387)
T 1kob_A 200 KLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL-------------Q 260 (387)
T ss_dssp ECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH-------------H
T ss_pred ecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HH-------------H
Confidence 7755322 233579999999999998899999999999999999999999997654221 11 1
Q ss_pred HHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.......... .......+.+++.+||+.||++||++.|+++
T Consensus 261 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111111111111 1123356789999999999999999999976
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=356.50 Aligned_cols=266 Identities=24% Similarity=0.364 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|+..+|+.||+|++..........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999988899999999976543444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 974 8988885532 348889999999999999999997 89999999999999999999999999999866432
Q ss_pred CCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh-hhHHHH-
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK-DTFRKA- 826 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~- 826 (947)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... .......... ..+...
T Consensus 154 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGG
T ss_pred cc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHCCCChhhchhhh
Confidence 21 1234578999999999875 458999999999999999999999997654332211 1111110000 000000
Q ss_pred ----hhccCCC------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 ----IDRTIDL------DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ----~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.++.... ..........+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000112356789999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.24 Aligned_cols=254 Identities=31% Similarity=0.558 Sum_probs=203.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHH-----HHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKG-----FAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
++|++.+.||+|+||.||+|+.. +++.||+|++......... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67889999999999999999874 7899999998654322211 167899999999999999999999986654
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC--eeecCCCCCcEEEcCCCc-----EE
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMR-----AK 736 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~-----~k 736 (947)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999886533 358999999999999999999996 67 999999999999988776 99
Q ss_pred EeecCcceecCCCCCcceeecccccccccCcccc--ccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA--VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
|+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||......... ..
T Consensus 170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~---- 239 (287)
T 4f0f_A 170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FI---- 239 (287)
T ss_dssp ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HH----
T ss_pred eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HH----
Confidence 999999975433 23346799999999998 3456789999999999999999999999765433211 11
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
......... ..........+.+++.+||+.||++||++.|+++.|+++
T Consensus 240 ---------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 ---------NMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------HHHhccCCC-CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 111122345688999999999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=350.17 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=210.9
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 578889999999999999999988899999999865433 36789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999996532 347899999999999999999997 89999999999999999999999999999865432
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
. ........|++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..
T Consensus 158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~i~~ 220 (267)
T 3t9t_A 158 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDIST 220 (267)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHT
T ss_pred c-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----------------HHHHhc
Confidence 1 112233467889999999988899999999999999999999 8999976442211 111111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
. .. ...+......+.+++.+|++.||++||++.++++.|+++.+
T Consensus 221 ~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 221 G-FR-LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp T-CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-Cc-CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 10 00111223567899999999999999999999999998865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=367.25 Aligned_cols=270 Identities=17% Similarity=0.273 Sum_probs=207.6
Q ss_pred cCCCcCceeccc--CceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRG--GFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
++|++.++||+| +||.||+|+.+ +|+.||||++..........+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 678999999999 99999999886 699999999987766677778899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+...
T Consensus 105 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999866432 348899999999999999999997 89999999999999999999999999998654
Q ss_pred CCCCCc-----ceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh--
Q 002255 747 PDNGKH-----SIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH-- 817 (947)
Q Consensus 747 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~-- 817 (947)
...+.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH--C-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HhcCCCCc
Confidence 322111 11223478999999999987 5799999999999999999999999976544322110 000000
Q ss_pred ------cChhh-------------HHHHhh--------ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 ------INKDT-------------FRKAID--------RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ------~~~~~-------------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ....+. ...............+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000 000000 000000111223356889999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.91 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=203.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||.||+|... +|+.||||++............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999875 68999999998765556666888999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++ ++.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 6666554322 348999999999999999999997 7999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh-hhHHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK-DTFRKA 826 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~ 826 (947)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .+........... ..+...
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 154 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTG
T ss_pred ccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhh
Confidence 322 233457899999999987765 79999999999999999999888644332111 1111111111000 000000
Q ss_pred hh---c--------cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 ID---R--------TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~---~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. . ..............+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0 00000011123356789999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.57 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=204.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcE----EEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.++||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57889999999999999999865 3443 7888775432 2223456788999999999999999999886 56689
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 9999999999999986542 347888999999999999999997 799999999999999999999999999999
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............||..|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---------------- 227 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---------------- 227 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH----------------
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH----------------
Confidence 8765544444455678889999999998999999999999999999999 99999865433211
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+..... ..........+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 228 -~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 228 -DLLEKGER-LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -HHHHTTCB-CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -HHHHcCCC-CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111100 00011122347799999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=363.85 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=204.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999876 58899999987543 12234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+.+|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999998643 348899999999999999999997 899999999999999999999999999998775
Q ss_pred CCCCcceeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.............
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~------------- 230 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH------------- 230 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH-------------
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH-------------
Confidence 432 2345689999999999864 458999999999999999999999997654333222211
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD-MGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 867 (947)
.+.......+. .....+.+|+.+||+.||++||+ +.++.+
T Consensus 231 ~~~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 TFETTVVTYPS---AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHCCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHhhcccCCCC---cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11111122111 22356789999999999999998 666654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.85 Aligned_cols=277 Identities=19% Similarity=0.280 Sum_probs=212.6
Q ss_pred HHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEE-EeCCeeE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC-LDGNERL 664 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~ 664 (947)
.+.++|++.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+++++.++|++++..+.++ ..++..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4568899999999999999999986 578999999876442 224578899999999988877766665 6678889
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecC
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 741 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG 741 (947)
+||||+ +++|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 999999986432 348999999999999999999997 899999999999999 788999999999
Q ss_pred cceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 742 LVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 742 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 99876543321 1223467999999999999999999999999999999999999999876544332222211111
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCc
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDI 886 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~ 886 (947)
.. .. ............+.+++.+|++.||++||++.++++.|+++.+..........||
T Consensus 234 ~~---------~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 234 KM---------ST--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp HH---------HS--CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred cc---------cc--hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 00 00 0000001123568899999999999999999999999999988766555444444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=361.60 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=204.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 664 (947)
..++|.+.++||+|+||.||+|+.+ +|+.||||+++.... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999886 689999999976421 123456778899999887 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 95 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999998653 248899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~ 228 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----------------LFH 228 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHH
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----------------HHH
Confidence 6433221 2345689999999999999999999999999999999999999997654321 111
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG-HVV 866 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 866 (947)
.+.......+. .....+.+++.+||+.||++||++. +++
T Consensus 229 ~i~~~~~~~p~---~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 229 SIRMDNPFYPR---WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHCCCCCCT---TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHhCCCCCCc---ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 22222222221 1235678999999999999999997 554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=348.09 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=210.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999875 589999999987766777778899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc---EEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfGla 743 (947)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999888653 348899999999999999999997 89999999999999986655 999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------------~ 216 (284)
T 3kk8_A 156 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----------------Y 216 (284)
T ss_dssp EECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------H
T ss_pred EEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH----------------H
Confidence 87654322 2345799999999999999999999999999999999999999976542211 1
Q ss_pred HHHhhccCCCCh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDE-ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+......... ........+.+++.+|++.||++||++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 217 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111111111111 11123356789999999999999999999977
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.74 Aligned_cols=246 Identities=25% Similarity=0.345 Sum_probs=206.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999876 689999999975432 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999653 238899999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+.
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~ 251 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIV 251 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----------------HHHHHH
Confidence 42 234579999999999999999999999999999999999999997654221 122333
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
......+. .....+.+++.+||+.||++||+ +.||++
T Consensus 252 ~~~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 252 SGKVRFPS---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HCCCCCCT---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCCCCCC---CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 33333222 22356789999999999999998 777755
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=371.40 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=207.8
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 659 (947)
+++.+...++|++.++||+|+||.||+|+.+ +|+.||||++.+... .....+.+.+|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444555789999999999999999999885 699999999975321 22234558899999999999999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
++..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999996532 248899999999999999999997 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccc-------cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-------TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+.
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------ 278 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------ 278 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------
Confidence 999987755332 1223468999999999987 35789999999999999999999999976543221
Q ss_pred HHHhhcChhhHHHHhh--ccCCCChhcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 002255 813 FRRMHINKDTFRKAID--RTIDLDEETLASISTVADLAGHCCAREPYQR---PDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 867 (947)
+.+++. ..+..+........++.+|+.+||. +|++| |++.|+++
T Consensus 279 ----------~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 ----------YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ----------HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ----------HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111 1111111112233567899999999 99998 58888755
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=358.96 Aligned_cols=275 Identities=25% Similarity=0.393 Sum_probs=219.1
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEE
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLL 654 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 654 (947)
........++|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+++++++ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 344445568999999999999999999975 246889999997653 445567899999999999 799999999
Q ss_pred EEEEeCC-eeEEEEEecCCCchhhhhhcccccC-----------CCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCC
Q 002255 655 GYCLDGN-ERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722 (947)
Q Consensus 655 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 722 (947)
+++...+ ..++||||+++|+|.+++....... ...+++..++.++.|++.||+|||+ .+|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9988754 5899999999999999997643210 1238899999999999999999997 89999999
Q ss_pred CCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCcc
Q 002255 723 KPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDET 801 (947)
Q Consensus 723 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~ 801 (947)
||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987655443333445678899999999999999999999999999999998 99999765
Q ss_pred CccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 802 QSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 802 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
...+. +...+..... ..........+.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus 255 ~~~~~----------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 255 KIDEE----------------FCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCSHH----------------HHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chhHH----------------HHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 43221 1111111110 00111123468899999999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.46 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=207.1
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
+.++...++|++.++||+|+||.||+|+.+ +++.||+|++.+... .....+.+.+|+.+++.++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455688999999999999999999876 588999999875321 112234578999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999988542 37888999999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCC----cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR----VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
|+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+.
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---------- 281 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---------- 281 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH----------
Confidence 99987755322 2233568999999999997655 88999999999999999999999976543221
Q ss_pred hcChhhHHHHhhcc--CCCChhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002255 817 HINKDTFRKAIDRT--IDLDEETLASISTVADLAGHCCAREPYQ--RPDMGHVVN 867 (947)
Q Consensus 817 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 867 (947)
+..++... +..+. .......+.+|+.+||+.+|++ ||++.||++
T Consensus 282 ------~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 282 ------YSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ------HHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ------HHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11222111 11111 0112345789999999999988 999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=366.73 Aligned_cols=270 Identities=26% Similarity=0.404 Sum_probs=197.7
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCC--
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN-- 661 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-- 661 (947)
+.+.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 456789999999999999999999875 6899999999766556677788899999999997 999999999997544
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999996 689888854 247888999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCC-------------------CcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCcc
Q 002255 742 LVRLAPDNG-------------------KHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDET 801 (947)
Q Consensus 742 la~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~ 801 (947)
+++...... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998764311 1112334689999999999876 67899999999999999999999999876
Q ss_pred CccchhhHHHHHHHhhcChhh------------HHHHhhccC-----CCC-hhc------------HHHHHHHHHHHHHh
Q 002255 802 QSEDSVHLVTWFRRMHINKDT------------FRKAIDRTI-----DLD-EET------------LASISTVADLAGHC 851 (947)
Q Consensus 802 ~~~~~~~l~~~~~~~~~~~~~------------~~~~~~~~~-----~~~-~~~------------~~~~~~l~~li~~c 851 (947)
...+....+ +......... +.+.+.... ... ... ......+.+|+.+|
T Consensus 235 ~~~~~~~~i--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 235 STMNQLERI--IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp SHHHHHHHH--HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CHHHHHHHH--HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 543332221 1111110000 000000000 000 000 01234678999999
Q ss_pred cccCCCCCCCHHHHHH
Q 002255 852 CAREPYQRPDMGHVVN 867 (947)
Q Consensus 852 l~~dP~~RPs~~evl~ 867 (947)
|+.||++|||+.|+++
T Consensus 313 L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 313 LQFNPNKRISANDALK 328 (388)
T ss_dssp CCSSGGGSCCHHHHTT
T ss_pred hccCcccCCCHHHHhC
Confidence 9999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.14 Aligned_cols=259 Identities=27% Similarity=0.451 Sum_probs=214.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
..++|++.+.||+|+||.||+|.++ ++..||+|++... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3467889999999999999999886 4889999998754 33457889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999965332 458999999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ .+
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-----------------~~ 223 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YE 223 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------------HH
T ss_pred cCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HH
Confidence 5432 223344567889999999998899999999999999999999 9999976543221 11
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+..... ..........+.+++.+|++.||.+||++.++++.|+.+.+
T Consensus 224 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 224 LLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCC-CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11112233568899999999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.75 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=210.2
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|..++++.||||++..... ..+.+.+|++++++++||||+++++++. ++..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 467889999999999999999998888999999976532 3467899999999999999999999986 456899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999865322 248899999999999999999997 8999999999999999999999999999987754
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. . ..+
T Consensus 162 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~--------------~~~ 223 (279)
T 1qpc_A 162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I--------------QNL 223 (279)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------------HHH
T ss_pred cc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---H--------------HHH
Confidence 32 222234457889999999988899999999999999999999 8999976542211 1 111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..... ..........+.+++.+|++.||++||++.++++.|+.+...
T Consensus 224 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 224 ERGYR-MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcccC-CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11111 011112335688999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.41 Aligned_cols=275 Identities=26% Similarity=0.421 Sum_probs=214.2
Q ss_pred cCC-CcCceecccCceEEEEEEEc-----CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CC
Q 002255 590 NNF-SEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GN 661 (947)
Q Consensus 590 ~~~-~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 661 (947)
++| ++.+.||+|+||.||++.++ +|+.||||+++.. ......+.+.+|++++++++||||+++++++.+ ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 344 88999999999999998753 5889999999765 345567789999999999999999999999987 46
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++|+|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred eEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcc
Confidence 789999999999999998542 38899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....+.... ...
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~-~~~ 257 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQ-MTV 257 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHH-HHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccc-hhH
Confidence 99987654322 223345688899999999988999999999999999999999999975421100 000000000 001
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
..+.+.+..... ..........+.+++.+||+.||++||++.|+++.|+.+.+.+.
T Consensus 258 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 258 LRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 112222222222 11122334568899999999999999999999999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=370.95 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=201.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 660 (947)
+.++|++.++||+|+||.||+|... +|+.||||++..........+++.+|+.+++.++|||||++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999765 689999999987655666778899999999999999999999999654
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
.+.|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEE
Confidence 467999999965 46666532 27889999999999999999997 79999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN- 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~- 819 (947)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+ +......
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i--~~~lg~p~ 283 (464)
T 3ttj_A 209 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPC 283 (464)
T ss_dssp CCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCSCC
T ss_pred EeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCC
Confidence 9998764422 234468999999999999999999999999999999999999999876543322111 1111000
Q ss_pred -------hhhHHHHhhccCCCC-----------------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 -------KDTFRKAIDRTIDLD-----------------EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 -------~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+..+....... .........+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111122222111100 111122456889999999999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=356.25 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=203.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 666 (947)
++|++.+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999876 588999999986543 345567788999999998 899999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998653 248899999999999999999997 89999999999999999999999999999864
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .........+
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~~~~~i 231 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVI 231 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHH
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHHHHHHHH
Confidence 33221 23456899999999999999999999999999999999999999975332111000 0001112223
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
.......+. .....+.+++.+||+.||++||++
T Consensus 232 ~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 232 LEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HcCCCCCCC---CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 333333222 233567899999999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.50 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=205.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 664 (947)
..++|++.++||+|+||.||+|+.+ +|+.||||+++.... .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3478999999999999999999886 478999999976432 223456788999999988 7999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999998653 248899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~ 231 (353)
T 2i0e_A 170 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQ 231 (353)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHH
T ss_pred ccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----------------HHHH
Confidence 6433221 234568999999999999999999999999999999999999999765422 1222
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM-----GHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 867 (947)
.+......++. ....++.+++.+||+.||++||++ .++++
T Consensus 232 ~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 232 SIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHCCCCCCT---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHhCCCCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 33333333222 233567899999999999999964 55544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=352.38 Aligned_cols=270 Identities=23% Similarity=0.354 Sum_probs=204.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+++.+|+.++++++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999874 78999999997532 3455677899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999998653322 2458899999999999999999997 89999999999999999999999999998866
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..+.. .+
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-------------~~ 250 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK-------------KI 250 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH-------------HH
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH-------------Hh
Confidence 44221 2234578999999999998899999999999999999999999997543211 11111 11
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPA 879 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 879 (947)
...... ..........+.+++.+||+.||++||++.+|++.|+++...+..+
T Consensus 251 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 251 EQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred hcccCC-CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 111111 0001122346889999999999999999999999999998766544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.67 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=198.1
Q ss_pred CceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.++||+|+||.||+|... +|+.||+|+++.. .....+++.+|++++++++||||+++++++.+++..++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 578999999999999875 6899999999765 3345678999999999999999999999999999999999999999
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE--cCCCcEEEeecCcceecCCCCC
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPDNGK 751 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill--~~~~~~kl~DfGla~~~~~~~~ 751 (947)
+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 172 ELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 9999886533 348899999999999999999997 899999999999999 5678999999999997755332
Q ss_pred cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccC
Q 002255 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTI 831 (947)
Q Consensus 752 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 831 (947)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..++....
T Consensus 245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~~~~ 305 (373)
T 2x4f_A 245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE----------------TLNNILACRW 305 (373)
T ss_dssp ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHTCC
T ss_pred ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhccC
Confidence 233479999999999988899999999999999999999999997654321 1222222222
Q ss_pred CCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 832 DLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 832 ~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... .......+.+|+.+||+.||.+||++.|+++
T Consensus 306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21111 1223456889999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.20 Aligned_cols=266 Identities=26% Similarity=0.443 Sum_probs=214.0
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
...++|++.+.||+|+||.||+|... +++.||||++.... ......++.+|++++++++||||+++++++.++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34578999999999999999999764 36789999987542 445567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccc-----cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKE-----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 735 (947)
+..++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 999999999999999999865331 112346899999999999999999997 799999999999999999999
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~ 814 (947)
||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------- 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------- 249 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--------
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--------
Confidence 9999999986544322222333467889999999998899999999999999999999 8899976542211
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+...... .........+.+++.+|++.||++||++.|+++.|+++..
T Consensus 250 --------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 --------LRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------HHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------HHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111111 1112233568899999999999999999999999988754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=348.48 Aligned_cols=276 Identities=20% Similarity=0.287 Sum_probs=215.6
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEE-EeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC-LDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 665 (947)
+.++|++.+.||+|+||.||+|+. .+|+.||||++..... .+++.+|+.+++.++|++++..+.++ ..++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999987 5799999999875432 24688999999999998877666655 56778899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGl 742 (947)
||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 999999986432 348999999999999999999997 899999999999999 4889999999999
Q ss_pred ceecCCCCCcc-----eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 743 VRLAPDNGKHS-----IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 743 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 98765533211 1234679999999999999899999999999999999999999998755433322222111110
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCc
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDI 886 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~ 886 (947)
. .... ..+ .......+.+++.+||+.||++||++.++++.|+.+............+|
T Consensus 235 ~-~~~~-~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 235 M-STPI-EVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp H-HSCH-HHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred c-CCch-HHH---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 0 0000 000 01123568899999999999999999999999999987766555544444
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.76 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=206.6
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc---ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
+..+.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3567789999999999999999999875 688999999875421 344567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccC-----------------------------------CCcccHHHHHHHHHHHHHH
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEG-----------------------------------LKPLEWTRRLTIALDVARG 705 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~~~~~~~~~i~~~i~~~ 705 (947)
+..++||||+++|+|.+++....... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985321110 1234677788999999999
Q ss_pred HHHHhhccCCCeeecCCCCCcEEEcCCC--cEEEeecCcceecCCCCC--cceeecccccccccCcccccc--CCcCccc
Q 002255 706 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPDNGK--HSIETRLAGTFGYLAPEYAVT--GRVTTKV 779 (947)
Q Consensus 706 L~~LH~~~~~~ivHrDlkp~Nill~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 779 (947)
|+|||+ .+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999997 7999999999999998776 899999999986533221 112345679999999999865 6789999
Q ss_pred ccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCCh-hcHHHHHHHHHHHHHhcccCCCC
Q 002255 780 DVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDE-ETLASISTVADLAGHCCAREPYQ 858 (947)
Q Consensus 780 DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~ 858 (947)
|||||||++|||++|+.||......+ ....++........ ........+.+++.+||+.||++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD----------------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999997654322 12223333322211 11123456889999999999999
Q ss_pred CCCHHHHHH
Q 002255 859 RPDMGHVVN 867 (947)
Q Consensus 859 RPs~~evl~ 867 (947)
||++.|+++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999977
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=348.02 Aligned_cols=261 Identities=23% Similarity=0.387 Sum_probs=210.9
Q ss_pred cCCCcCc-eecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEEN-VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|.+.+ .||+|+||.||+|.+. ++..||||+++... .....+++.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4555665 9999999999999764 57889999997652 455678899999999999999999999999 5567899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999985432 348999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 746 APDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 746 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~------------ 224 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA------------ 224 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH------------
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HH------------
Confidence 7543322 11233457899999999988889999999999999999999 9999976543211 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
.+..... ...+......+.+++.+|++.||++||++.++++.|+.+.....
T Consensus 225 --~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 225 --FIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --HHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --HHhcCCc-CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111100 11112234568899999999999999999999999999876544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.46 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=206.4
Q ss_pred hcCCCcCc-eecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEEN-VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999653 468899999986654455578899999999999999999999999 667789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999653 348899999999999999999997 799999999999999999999999999998
Q ss_pred ecCCCCCcc-eeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKHS-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---------------- 229 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---------------- 229 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----------------
Confidence 775543321 1223456789999999988889999999999999999999 9999976543211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+..... ..........+.+++.+||+.||++||++.++++.|+++..
T Consensus 230 -~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 230 -TAMLEKGER-MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp -HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111100 11112234568899999999999999999999999998864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.14 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=195.2
Q ss_pred hcCCCcCceecccCceEEEEEEE----cCCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++.... .......+.+|++++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999987 4789999999976532 22345668899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999998653 247888999999999999999997 7999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 168 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~ 229 (327)
T 3a62_A 168 CKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----------------T 229 (327)
T ss_dssp C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------H
T ss_pred ccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----------------H
Confidence 876433221 2334679999999999998899999999999999999999999997654221 1
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
+..+.......+. .....+.+++.+||+.||++|| ++.|+++
T Consensus 230 ~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 IDKILKCKLNLPP---YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHTCCCCCT---TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhCCCCCCC---CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 2222332222222 1235678999999999999999 6666655
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.23 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=194.4
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.+.++|++.+.||+|+||.||+|+.+ +++.||||+++... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 35678999999999999999999886 57899999997542 34578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGl 742 (947)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+
T Consensus 126 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999999998543 348899999999999999999997 79999999999999975 89999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~ 259 (349)
T 2w4o_A 198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---------------M 259 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---------------H
T ss_pred ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---------------H
Confidence 98664321 22345799999999999988999999999999999999999999976443211 1
Q ss_pred HHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002255 823 FRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPA 879 (947)
Q Consensus 823 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 879 (947)
+..+........ +........+.+++.+||+.||++||++.|+++ ++|...
T Consensus 260 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~ 311 (349)
T 2w4o_A 260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ------HPWVTG 311 (349)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTTS
T ss_pred HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc------CcccCC
Confidence 122222222111 111223456789999999999999999999976 566543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=361.64 Aligned_cols=266 Identities=26% Similarity=0.421 Sum_probs=214.7
Q ss_pred hcCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|++.+.||+|+||.||+|.... +..||+|.+.... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4788999999999999999998752 2479999987653 445567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc---------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE---------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999998754321 12357899999999999999999997 799999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVT 811 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~ 811 (947)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence 9999999999986654433333444567889999999998899999999999999999999 9999976543221
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
+...+...... ..+......+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 276 -----------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 -----------FYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -----------HHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------HHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11122211110 11111235688999999999999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.69 Aligned_cols=280 Identities=25% Similarity=0.388 Sum_probs=202.1
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHH--HHcCCCCCcceEEEEEEe-----CC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAV--LTKVRHRHLVGLLGYCLD-----GN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~ 661 (947)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 36889999999999999999977 48999999986431 2334444444 445899999999986643 23
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc------CCCeeecCCCCCcEEEcCCCcE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA------HQSFIHRDLKPSNILLGDDMRA 735 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------~~~ivHrDlkp~Nill~~~~~~ 735 (947)
..++||||+++|+|.+++... ..++..++.++.||+.||+|||+.. +.+|+||||||+|||++.++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred eEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 568999999999999999553 2588899999999999999999721 1199999999999999999999
Q ss_pred EEeecCcceecCCCCC------cceeecccccccccCcccccc-------CCcCcccccccHHHHHHHHHhCCCCCCccC
Q 002255 736 KVADFGLVRLAPDNGK------HSIETRLAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELITGRKALDETQ 802 (947)
Q Consensus 736 kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~p~~~~~ 802 (947)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987654221 112234579999999999876 456789999999999999999987775443
Q ss_pred ccchhh-HHHHHHHhhcChhhHHHHhhccC---CCCh---hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 803 SEDSVH-LVTWFRRMHINKDTFRKAIDRTI---DLDE---ETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 803 ~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...... ..................+.... .... ........+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 222111 00000000001111112221111 1111 1123455789999999999999999999999999999988
Q ss_pred hCCCC
Q 002255 876 WKPAE 880 (947)
Q Consensus 876 ~~~~~ 880 (947)
|....
T Consensus 320 ~~~~~ 324 (336)
T 3g2f_A 320 WERNK 324 (336)
T ss_dssp CCC--
T ss_pred HHhcc
Confidence 87654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.80 Aligned_cols=269 Identities=24% Similarity=0.381 Sum_probs=205.7
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC--CCCCcceEEEEEEeC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV--RHRHLVGLLGYCLDG 660 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~ 660 (947)
...+.+.++|++.+.||+|+||.||+|+.. |+.||||++... ....+..|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 344566789999999999999999999886 899999998643 223455566666655 899999999999887
Q ss_pred ----CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----CCCeeecCCCCCcEEEcC
Q 002255 661 ----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 661 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~ 731 (947)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. +.+|+||||||+||+++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 7889999999999999999542 4889999999999999999999620 129999999999999999
Q ss_pred CCcEEEeecCcceecCCCCCcc--eeecccccccccCccccccCCcCcc------cccccHHHHHHHHHhC---------
Q 002255 732 DMRAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAVTGRVTTK------VDVFSFGVILMELITG--------- 794 (947)
Q Consensus 732 ~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg--------- 794 (947)
++.+||+|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998765432221 1224579999999999987766655 9999999999999999
Q ss_pred -CCCCCccCccchhhHHHHHHHhhcChhhHHHHhh-ccCC--CC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 795 -RKALDETQSEDSVHLVTWFRRMHINKDTFRKAID-RTID--LD--EETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 795 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~--~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+.||......... .......+. .... .. .........+.+++.+||+.||++||++.||++.
T Consensus 258 ~~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 258 YQLPYHDLVPSDPS------------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCTTTTTSCSSCC------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccHhhhcCCCCc------------hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 5666543322211 011111111 1111 11 1122556678999999999999999999999999
Q ss_pred HHhhhhh
Q 002255 869 LSSLAEL 875 (947)
Q Consensus 869 L~~l~~~ 875 (947)
|+.+.+.
T Consensus 326 L~~l~~~ 332 (337)
T 3mdy_A 326 LAKMSES 332 (337)
T ss_dssp HHHHHHT
T ss_pred HHHHHhh
Confidence 9998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=362.23 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=194.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 368999999999999999999876 789999999976432 2356789999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc--EEEeecCccee
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 745 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfGla~~ 745 (947)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999986532 48899999999999999999997 89999999999999987765 99999999875
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcc-cccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
..... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... .....
T Consensus 168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------~~~~~ 232 (361)
T 3uc3_A 168 SVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY------------RKTIQ 232 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH------------HHHHH
T ss_pred ccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH------------HHHHH
Confidence 43221 2234579999999999988887665 89999999999999999999765432221 11112
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
.+.......... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 233 RILSVKYSIPDD-IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHTTCCCCCTT-SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhcCCCCCCCc-CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 222222221111 1123567899999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.97 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=203.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999876 5899999999776555566778899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999998887542 348899999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.......... .........
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (311)
T 4agu_A 154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG--DLIPRHQQV 229 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--SCCHHHHHH
T ss_pred Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhc--ccccccccc
Confidence 4322 2234578999999999876 5689999999999999999999999987654433222111100 000000111
Q ss_pred hhc-------cCCCC----h---hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDR-------TIDLD----E---ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~-------~~~~~----~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ..... . ........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 100 00000 0 00122345789999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.29 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=200.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 4578999999999999999999875 68899999987653 233457889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla 743 (947)
|||+++|+|.+++....... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 99 METCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999886543222 458999999999999999999997 899999999999999 45688999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
+...... ......||+.|+|||++. +.++.++||||||+++|||++|+.||......+..
T Consensus 175 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---------------- 234 (285)
T 3is5_A 175 ELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---------------- 234 (285)
T ss_dssp CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------
T ss_pred eecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence 8664432 223457999999999875 57899999999999999999999999765422111
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....................+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 235 QKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111111111112356789999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=354.68 Aligned_cols=259 Identities=26% Similarity=0.475 Sum_probs=203.7
Q ss_pred cCCCcCceecccCceEEEEEEEcC-----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|+..+.||+|+||.||+|.... +..||||+++... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 567788999999999999997653 2459999997543 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999986532 348899999999999999999997 799999999999999999999999999998
Q ss_pred ecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---------------- 259 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------- 259 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH----------------
Confidence 76543221 11223456889999999998899999999999999999999 9999976542211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+.+. .. .+........+.+++.+||+.||++||++.++++.|+.+..
T Consensus 260 ~~~~~~~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 260 MKAINDG-FR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHHHHTT-CC-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHCC-Cc-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 11 01112234568899999999999999999999999998875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.13 Aligned_cols=261 Identities=22% Similarity=0.364 Sum_probs=198.5
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe---
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE--- 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 662 (947)
+.++|++.+.||+|+||.||+|+. .+++.||||+++.... .......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 347899999999999999999987 4789999999976533 34456789999999999999999999999876543
Q ss_pred -eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 663 -RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 663 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
.++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 49999999999999998653 248899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------------- 227 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------------- 227 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------------
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------------
Confidence 99866543221 222345799999999999998999999999999999999999999976543211
Q ss_pred hhHHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-HHHhh
Q 002255 821 DTFRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN-VLSSL 872 (947)
Q Consensus 821 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~l 872 (947)
....+....... .........+.+++.+||+.||++||++.++++ .+..+
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 228 --AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --HHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --HHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 011111111100 001113356889999999999999997766554 44433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=359.91 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=202.5
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccCh-HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... .....+.+|+++++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999987 478999999987542211 2235788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+ +|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 78999988653 248899999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
.... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .
T Consensus 159 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~ 219 (336)
T 3h4j_B 159 TDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------K 219 (336)
T ss_dssp TTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------C
T ss_pred cCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------H
Confidence 5432 2234579999999999988776 689999999999999999999997654322110 0
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.......+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 220 i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 220 VNSCVYVMP---DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCSSCCCCC---TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHcCCCCCc---ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 001111111 112345789999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=361.40 Aligned_cols=256 Identities=18% Similarity=0.200 Sum_probs=208.9
Q ss_pred hcCCCcCceecccCceEEEEEE------EcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC---CCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGE------LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 659 (947)
.++|.+.++||+|+||.||+|. ..+++.||||++... ...++..|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4678899999999999999993 456899999998754 2356788888888887 9999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC--------
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 731 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-------- 731 (947)
++..++||||+++|+|.+++..........+++..++.++.||+.||+|||+ ++||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999976544444669999999999999999999996 89999999999999998
Q ss_pred ---CCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhh
Q 002255 732 ---DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH 808 (947)
Q Consensus 732 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 808 (947)
++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999998654333333445678999999999999999999999999999999999999999654321100
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhh
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQR-PDMGHVVNVLSSLAEL 875 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~l~~~ 875 (947)
+...+... .....+.+++..|++.+|.+| |+++++.+.|+++.+.
T Consensus 295 ------------------~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 ------------------PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------------------ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------------echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111100 123456789999999999998 5788889888887654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=354.94 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=192.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 367999999999999999999865 68999999997553 2233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccccc-CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 668 EYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
||++ |+|.+++...... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 6999988654321 22348899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh----
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD---- 821 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---- 821 (947)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ .........
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI--FDIMGTPNESLWP 234 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCSCCTTTCG
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCChhHhh
Confidence 53221 2234578999999999876 46899999999999999999999999876543322111 111100000
Q ss_pred ------------------hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 ------------------TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 ------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.+.+.+... ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTK-----EPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCS-----SCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhccccc-----ccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00111111000 012346889999999999999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=343.54 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=206.8
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4578999999999999999999876 68999999987543 233457889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999988542 348899999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
.............||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~--------------~~ 220 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY--------------SD 220 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH--------------HH
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH--------------HH
Confidence 44332223345679999999999987665 7899999999999999999999976543221 11 11
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....... ..........+.+++.+||+.||++||++.|+++
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 221 WKEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccc-cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1111111 0111122346789999999999999999999876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.20 Aligned_cols=270 Identities=23% Similarity=0.408 Sum_probs=208.5
Q ss_pred cCCCcCceecccCceEEEEEEE-----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC--Ce
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NE 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 662 (947)
++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 5688899999999999999984 368999999997553 334457889999999999999999999999876 66
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999985533 348899999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC--
Q 002255 743 VRLAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-- 819 (947)
Q Consensus 743 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-- 819 (947)
++........ .......||..|+|||++.+..++.++||||||+++|||++|+.|+...... ... .......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~ 247 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLK-MIGPTHGQM 247 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHH-HHCSCCGGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----Hhh-ccCCccccc
Confidence 9877654322 2234457888999999999999999999999999999999999987532110 000 0000000
Q ss_pred -hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 820 -KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 820 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.......+..... ..........+.+++.+||+.||.+||++.++++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0111112221111 1111223456889999999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.39 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=206.0
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.+.++|++.+.||+|+||.||+|..+ ++..||+|++..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 35678999999999999999999876 477899999876532 335688999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGl 742 (947)
||||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 99999999999988653 348899999999999999999997 899999999999999 7889999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+ .
T Consensus 156 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~ 215 (277)
T 3f3z_A 156 AARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----------------V 215 (277)
T ss_dssp CEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------H
T ss_pred ceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH----------------H
Confidence 98765432 2234579999999998765 59999999999999999999999997654221 1
Q ss_pred HHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+........... ......+.+++.+|++.||++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112222222222111 123356889999999999999999999976
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.12 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=207.8
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+.++|++.+.||+|+||.||+|..+ +|+.||||++....... ...+++.+|+.++++++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567999999999999999999876 68999999997653222 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC----cEEEe
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~ 738 (947)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999998643 348999999999999999999997 8999999999999999888 79999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------ 226 (321)
T 2a2a_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------------ 226 (321)
T ss_dssp CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------------
T ss_pred cCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------------
Confidence 9999987755322 2345799999999999988999999999999999999999999976542211
Q ss_pred ChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+.......+... ......+.+++.+||+.||++||++.|+++
T Consensus 227 ----~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 227 ----LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111111111111 122345789999999999999999999977
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=367.93 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=206.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|.+.+.||+|+||.||+|+.. +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67899999999999999999876 7999999999754321 123567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999998542 348999999999999999999996 899999999999999999999999999998775
Q ss_pred CCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.... ..+..+
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i 228 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----------------TLFKKI 228 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----------------HHHHHH
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHH
Confidence 432 2234579999999999987765 68999999999999999999999765422 112223
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.....+. .....+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 229 CDGIFYTPQ---YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTTCCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCCcCCCc---cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 333222221 12345789999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=361.18 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=196.4
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHH-HHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAV-LTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
++|++.++||+|+||.||+|+.+ +++.||||++++.... ......+.+|..+ ++.++|||||++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 67899999999999999999876 5889999999766432 3344567777776 5778999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999998653 247888899999999999999997 89999999999999999999999999999864
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i 251 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNI 251 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----------------HHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Confidence 33221 234568999999999999999999999999999999999999999764422 122333
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+...+..... ....+.+++.+||+.||++||++.+.++.
T Consensus 252 ~~~~~~~~~~---~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 252 LNKPLQLKPN---ITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp HHSCCCCCSS---SCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred HhcccCCCCC---CCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 3333332221 23457899999999999999998654443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=346.44 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=205.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|.+.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4678899999999999999998643 3469999987653 44556889999999999999999999999865 4568
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 9999999999999996532 348899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~----------- 226 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GV----------- 226 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HH-----------
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HH-----------
Confidence 6654322 12234567889999999988899999999999999999998 99999765433211 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+..... ..........+.+++.+|++.||++||++.|+++.|+.+.+
T Consensus 227 ---~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 227 ---LEKGDR-LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---HHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HhcCCC-CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111000 00111223558899999999999999999999999998864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.75 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=202.1
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.+.|+..+.||+|+||.||+|+. .+|+.||||++..... .....+++.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688999999999999999986 4789999999976532 234457899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+. |+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99996 68888775432 358999999999999999999997 79999999999999999999999999999865
Q ss_pred CCCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||......+. +
T Consensus 205 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------------~ 262 (348)
T 1u5q_A 205 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------L 262 (348)
T ss_dssp SSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------H
T ss_pred CCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----------------H
Confidence 432 2357999999999884 56789999999999999999999999976542211 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+...... ..........+.+++.+||+.||++||++.++++.
T Consensus 263 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 263 YHIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111110 00111223457899999999999999999999774
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=361.07 Aligned_cols=261 Identities=29% Similarity=0.439 Sum_probs=198.1
Q ss_pred CCCcCceecccCceEEEEEEEc--CC--cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CCeeEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH--DG--TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERLL 665 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 665 (947)
.|+..++||+|+||.||+|.+. ++ ..||||.++.. ......+++.+|+.++++++||||+++++++.+ ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4667789999999999999764 22 36899988653 244567889999999999999999999998764 457899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 999999999999996532 347899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCc--ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 746 APDNGKH--SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 746 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-------------- 307 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------- 307 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH--------------
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH--------------
Confidence 6443211 12234567889999999999999999999999999999999 677776554332111
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
.+...... ..+......+.+++.+||+.||++||++.|+++.|+.+...+.
T Consensus 308 --~~~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 308 --YLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --HHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --HHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111110 0111223568899999999999999999999999999886554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=381.74 Aligned_cols=257 Identities=31% Similarity=0.515 Sum_probs=209.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.++||+|+||.||+|.++++..||||+++.... ..++|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 467888999999999999999998888999999986532 24678999999999999999999999876 67899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999965322 347899999999999999999997 8999999999999999999999999999986643
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ........++..|+|||++....++.++|||||||++|||++ |+.||.+....+. .+.+
T Consensus 416 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-----------------~~~i 477 (535)
T 2h8h_A 416 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------------LDQV 477 (535)
T ss_dssp HH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-----------------HHHH
T ss_pred Cc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHH
Confidence 21 112223457789999999998999999999999999999999 9999976542211 1111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...... .........+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 478 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 478 ERGYRM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111111 1111234568899999999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=361.59 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=193.5
Q ss_pred hcCCCcC-ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHc-CCCCCcceEEEEEEe----CC
Q 002255 589 TNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK-VRHRHLVGLLGYCLD----GN 661 (947)
Q Consensus 589 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~ 661 (947)
.++|.+. ++||+|+||.||+|..+ +|+.||||++... ..+.+|+.++.+ .+||||+++++++.. +.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3566665 78999999999999875 6899999998642 356778888744 589999999999875 56
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEe
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 738 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~ 738 (947)
..|+||||+++|+|.+++..+.. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 78999999999999999965432 358999999999999999999997 89999999999999997 7899999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------- 272 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------- 272 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-----------
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-----------
Confidence 999998764422 223467999999999999999999999999999999999999999765432211
Q ss_pred ChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
......+....+...... .....++.+|+.+||+.||++||++.|+++.
T Consensus 273 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 273 -PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011112222222211111 1233568899999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.02 Aligned_cols=273 Identities=26% Similarity=0.377 Sum_probs=212.6
Q ss_pred cCCCcCceecccCceEEEEEEE-----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEE--eCCe
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL--DGNE 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 662 (947)
++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 6788999999999999999985 36889999999765 4555678999999999999999999999987 4567
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 899999999999999996543 248999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcc-eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 743 VRLAPDNGKHS-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 743 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..+... .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~-~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERD-VPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC-----CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccc-cccHH
Confidence 98775543322 2234568889999999998899999999999999999999999986543211000 000000 00001
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+.+..... ..........+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 252 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 252 RLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12222222221 11122334568899999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=354.28 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=209.0
Q ss_pred HHHHHHHhcCCCcC-ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEE
Q 002255 582 IQVLRNVTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCL 658 (947)
Q Consensus 582 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 658 (947)
++..+.+.++|.+. +.||+|+||.||+|... +|+.||+|++............+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34456677888887 89999999999999876 6899999999876555555678999999999994 699999999999
Q ss_pred eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcE
Q 002255 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRA 735 (947)
Q Consensus 659 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~ 735 (947)
+++..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999885432 2458999999999999999999997 89999999999999998 7899
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~ 815 (947)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------- 241 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--------- 241 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---------
Confidence 9999999987654322 2345799999999999989999999999999999999999999976543211
Q ss_pred hhcChhhHHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 816 MHINKDTFRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+........ .........+.+++.+||+.||++||++.|+++
T Consensus 242 -------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 242 -------YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -------HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------HHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111111111 111223356789999999999999999999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=348.70 Aligned_cols=262 Identities=29% Similarity=0.435 Sum_probs=205.6
Q ss_pred cCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEE-eCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL-DGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 664 (947)
.+|++.++||+|+||.||+|...+ +..||+|.+... ......+.+.+|+.++++++||||+++++++. .++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 467888999999999999998642 235899998753 24556678999999999999999999999865 456789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence 9999999999999996532 347899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc--ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 745 LAPDNGKH--SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 745 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
........ .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-------------- 242 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------------- 242 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH--------------
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH--------------
Confidence 66443211 12334567889999999998899999999999999999999 55566544322211
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
.......... ........+.+++.+|++.||++||++.|+++.|+++...+.
T Consensus 243 --~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 243 --VYLLQGRRLL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --HHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --HHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111110 111123468899999999999999999999999999876443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=381.68 Aligned_cols=261 Identities=22% Similarity=0.367 Sum_probs=204.7
Q ss_pred CCcCc-eecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 592 FSEEN-VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 592 ~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+.+.+ .||+|+||.||+|.++ ++..||||+++... .....+++.+|++++++++|||||++++++.. +..++||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 33334 7999999999999774 46679999997652 33456789999999999999999999999976 5689999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 415 E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp ECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999986532 458999999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 748 DNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 748 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. .+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----------------~~ 550 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----------------MA 550 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-----------------HH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----------------HH
Confidence 43221 11222346789999999998999999999999999999998 9999986543221 11
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPA 879 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 879 (947)
.+..... ...+......+.+++.+||+.||++||++.+|++.|+.+.......
T Consensus 551 ~i~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 551 FIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHHcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 1111111 1111223456889999999999999999999999999987655443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=361.21 Aligned_cols=276 Identities=14% Similarity=0.205 Sum_probs=212.7
Q ss_pred hcCCCcCceecccCceEEEEEEEcC---------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcce-------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD---------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG------- 652 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 652 (947)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3678999999999999999998763 789999998754 36788999999999999987
Q ss_pred --------EEEEEEe-CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCC
Q 002255 653 --------LLGYCLD-GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (947)
Q Consensus 653 --------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 723 (947)
+++++.. +...++||||+ +++|.+++..... ..+++.+++.++.||+.||+|||+ .+|+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777776 77889999999 9999999976422 348999999999999999999997 799999999
Q ss_pred CCcEEEcCCC--cEEEeecCcceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCC
Q 002255 724 PSNILLGDDM--RAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 796 (947)
Q Consensus 724 p~Nill~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 796 (947)
|+||+++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 9999999999866432211 11234579999999999999899999999999999999999999
Q ss_pred CCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 002255 797 ALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876 (947)
Q Consensus 797 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 876 (947)
||........ ......... ....................+.+++.+||+.||++||++.++++.|+.+.+..
T Consensus 267 pf~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 267 PWTNCLPNTE-DIMKQKQKF-------VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTGGGTTCHH-HHHHHHHHH-------HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCCcCHH-HHHHHHHhc-------cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 9987542221 111111100 00000000000000012356889999999999999999999999999998877
Q ss_pred CCCCCCCCCc
Q 002255 877 KPAEPDSDDI 886 (947)
Q Consensus 877 ~~~~~~~~~~ 886 (947)
........+|
T Consensus 339 ~~~~~~~~dw 348 (352)
T 2jii_A 339 RVSPYDPIGL 348 (352)
T ss_dssp TCCTTSCCCC
T ss_pred CCCcCccccC
Confidence 6555555444
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=357.94 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=207.5
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-----CCCcceEEEEEE
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----HRHLVGLLGYCL 658 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~ 658 (947)
...+.++|++.++||+|+||.||+|+.. +++.||||+++.. ......+..|+.+++.++ ||||+++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 3345689999999999999999999874 6899999998742 445567888999999996 999999999999
Q ss_pred eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-------
Q 002255 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 731 (947)
Q Consensus 659 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~------- 731 (947)
..+..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccc
Confidence 999999999999 9999999965432 348899999999999999999997 89999999999999975
Q ss_pred ------------------CCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh
Q 002255 732 ------------------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 793 (947)
Q Consensus 732 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 793 (947)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999875442 234579999999999999999999999999999999999
Q ss_pred CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc-------------C---------------CCChhcHHHHHHHH
Q 002255 794 GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT-------------I---------------DLDEETLASISTVA 845 (947)
Q Consensus 794 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-------------~---------------~~~~~~~~~~~~l~ 845 (947)
|+.||......+....+..... .............. . ............+.
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQ-PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTC-CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcC-CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 9999987554332222211100 00011111111000 0 00000111124577
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 002255 846 DLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 846 ~li~~cl~~dP~~RPs~~evl~ 867 (947)
+|+.+||+.||++|||++|+++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCChhhCCCHHHHhc
Confidence 9999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=353.68 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=184.7
Q ss_pred CceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
.+.||+|+||.||+|..+ +|+.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999875 6899999998643 3457788999999997 99999999999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC---cEEEeecCcceecCCC
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPDN 749 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~~~~~ 749 (947)
|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKKK-----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999653 348999999999999999999997 8999999999999998765 8999999999876543
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .+....+...
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---------~~~~~~i~~~ 231 (325)
T 3kn6_A 163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA---------VEIMKKIKKG 231 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH---------HHHHHHHTTT
T ss_pred CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH---------HHHHHHHHcC
Confidence 22 223457899999999999999999999999999999999999999765432110000 1112222333
Q ss_pred cCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002255 830 TIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPA 879 (947)
Q Consensus 830 ~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 879 (947)
........ .....++.+|+.+||+.||++||++.|+++ +.|...
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~------h~w~~~ 276 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY------NEWLQD 276 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT------CGGGCT
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc------Chhhcc
Confidence 33322222 223456889999999999999999999864 566543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.98 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=201.7
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCeeEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLL 665 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 665 (947)
.|.+.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.. +...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999875 68899999998776677778899999999999999999999999875 456899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC--eeecCCCCCcEEEc-CCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~-~~~~~kl~DfGl 742 (947)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++ .++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999653 347899999999999999999997 56 99999999999998 789999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
+...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||........
T Consensus 179 ~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------- 237 (290)
T 1t4h_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------- 237 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----------------
T ss_pred ccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----------------
Confidence 9755432 223457999999999876 5699999999999999999999999976443211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+................+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 238 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111111111112222356889999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=355.34 Aligned_cols=267 Identities=17% Similarity=0.207 Sum_probs=199.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc----CCcEEEEEEecccccCh---------HHHHHHHHHHHHHHcCCCCCcceEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSE---------KGFAEFKSEIAVLTKVRHRHLVGLLG 655 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~ 655 (947)
.++|.+.+.||+|+||.||+|... ++..||||++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367899999999999999999875 57889999987542111 01134678899999999999999999
Q ss_pred EEEe----CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC
Q 002255 656 YCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (947)
Q Consensus 656 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 731 (947)
++.. +...++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9988 77889999999 999999986533 58999999999999999999997 79999999999999998
Q ss_pred CC--cEEEeecCcceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCcc
Q 002255 732 DM--RAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804 (947)
Q Consensus 732 ~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 804 (947)
++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 9999999999876432211 1113457999999999999889999999999999999999999999653322
Q ss_pred chhhHHHHHHHh-hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 805 DSVHLVTWFRRM-HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 805 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
..... ...... ............. ......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 267 ~~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PVAVQ-TAKTNLLDELPQSVLKWAPS--------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHH-HHHHHHHHTTTHHHHHHSCT--------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cHHHH-HHHHhhcccccHHHHhhccc--------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 21111 111000 0001111111000 012346889999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=354.65 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=207.4
Q ss_pred hcCCCcCceecccCceEEEEEEE------cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|++.+.||+|+||.||+|++ .+++.||||++... .......++.+|+.++++++||||+++++++.+++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46899999999999999999973 35778999999644 245566789999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccccc--CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEE
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl 737 (947)
.++||||+++++|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999764321 12348899999999999999999997 89999999999999984 456999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~------ 255 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL------ 255 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HH------
Confidence 99999875543332223334568999999999988899999999999999999998 999997643221 11
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+.+..... ..........+.+++.+||+.||++||++.++++.|+.+..
T Consensus 256 --------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 --------EFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp --------HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHhcCCC-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111100 01111223568899999999999999999999999998865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.35 Aligned_cols=270 Identities=22% Similarity=0.371 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHc--CCCCCcceEEEEEEe
Q 002255 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK--VRHRHLVGLLGYCLD 659 (947)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 659 (947)
+...+.+.++|++.+.||+|+||.||+|+.. |+.||||++... ....+.+|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3445667789999999999999999999885 899999998643 34567889999888 789999999999988
Q ss_pred CC----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----CCCeeecCCCCCcEEEc
Q 002255 660 GN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLG 730 (947)
Q Consensus 660 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~ 730 (947)
.. ..++||||+++|+|.+++... .+++.+++.++.|++.||+|||+.. ..+|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 789999999999999999542 3889999999999999999999210 27999999999999999
Q ss_pred CCCcEEEeecCcceecCCCCCcc--eeecccccccccCccccccC------CcCcccccccHHHHHHHHHhC--------
Q 002255 731 DDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITG-------- 794 (947)
Q Consensus 731 ~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg-------- 794 (947)
.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999998765433221 22345799999999998765 344789999999999999999
Q ss_pred --CCCCCccCccchhhHHHHHHHhhcChhhHHH-HhhccCCC--Ch--hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 795 --RKALDETQSEDSVHLVTWFRRMHINKDTFRK-AIDRTIDL--DE--ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 795 --~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~--~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.||......+.. . ..+.+ ........ .. ........+.+++.+||+.||++||++.||++
T Consensus 262 ~~~~p~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPS-V-----------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CCCCTTTTTSCSSCC-H-----------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCccccCcCccc-H-----------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 6777654332111 0 11111 11221111 11 12345567889999999999999999999999
Q ss_pred HHHhhhhh
Q 002255 868 VLSSLAEL 875 (947)
Q Consensus 868 ~L~~l~~~ 875 (947)
.|+.+.+.
T Consensus 330 ~L~~i~~~ 337 (342)
T 1b6c_B 330 TLSQLSQQ 337 (342)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=381.90 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=202.6
Q ss_pred ceecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.||+|+||.||+|.+. .++.||||+++.........+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 46789999998765566667889999999999999999999999964 568899999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999643 348899999999999999999997 89999999999999999999999999999876543321
Q ss_pred -ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 753 -SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 753 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~ 588 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKG 588 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTT
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 22333457889999999999999999999999999999998 999997654322 11112111
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.. ...+......+.+++.+||+.||++||++.+|++.|+++..
T Consensus 589 ~~-~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 589 ER-MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 11112234568899999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.78 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=201.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999875 688999999976532 33445789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999998653 348899999999999999999997 7999999999999999999999999999876
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ...
T Consensus 184 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~--------------~~~ 245 (309)
T 2h34_A 184 TTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---V--------------MGA 245 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---H--------------HHH
T ss_pred cccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---H--------------HHH
Confidence 644321 1223457999999999999889999999999999999999999999754321 0 111
Q ss_pred HhhccCCC-ChhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 002255 826 AIDRTIDL-DEETLASISTVADLAGHCCAREPYQRP-DMGHVVNVLSSLAE 874 (947)
Q Consensus 826 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~~ 874 (947)
.+...... ..........+.+++.+||+.||++|| ++.++++.|+.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 246 HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 11111110 011112234578999999999999999 99999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=371.00 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=197.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.++||+|+||.||+|... +|+.||||++..... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 689999999976432 334456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999988653 348899999999999999999995 278999999999999999999999999999864
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+
T Consensus 300 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i 361 (446)
T 4ejn_A 300 IKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELI 361 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHH
T ss_pred cCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----------------HHHHH
Confidence 33221 2344689999999999999999999999999999999999999997654321 11222
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
......++. .....+.+|+.+||+.||++|| ++.|+++
T Consensus 362 ~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 LMEEIRFPR---TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhCCCCCCc---cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 222222221 1235678999999999999999 9998866
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=372.46 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=207.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|+..++||+|+||.||+|+.+ +|+.||||++..... .......+.+|++++++++|||||++++++.+++..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 699999999975432 223346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999865432 348999999999999999999997 79999999999999999999999999999877
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~------------i~~~i 401 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE------------VERLV 401 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH------------HHHHH
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH------------HHHHh
Confidence 54322 2345899999999999998999999999999999999999999986543221110 01111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
........ ......+.+|+.+||+.||++|| ++.||++
T Consensus 402 ~~~~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 402 KEVPEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hcccccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11111111 12235678999999999999999 6788875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.78 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=202.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CC-------cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DG-------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 660 (947)
.++|.+.+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 467889999999999999999765 23 47999998654 344567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc------
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR------ 734 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~------ 734 (947)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 99999999999999999996543 238899999999999999999997 89999999999999998887
Q ss_pred --EEEeecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHH
Q 002255 735 --AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVT 811 (947)
Q Consensus 735 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~ 811 (947)
+||+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus 158 ~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----- 226 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----- 226 (289)
T ss_dssp CEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----
T ss_pred ceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----
Confidence 999999998654331 23468899999999987 6789999999999999999996554433221110
Q ss_pred HHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
............. .....+.+++.+||+.||++||++.|+++.|+++..
T Consensus 227 -----------~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 227 -----------KLQFYEDRHQLPA---PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -----------HHHHHHTTCCCCC---CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -----------HHHHhhccCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0011111111111 112347899999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.55 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=206.2
Q ss_pred CCCcCceecccCceEEEEEEEc-CC---cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee-EE
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER-LL 665 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 665 (947)
.|...++||+|+||.||+|.+. ++ ..||+|++... ......+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4556789999999999999764 22 37999998753 2445668899999999999999999999999876655 99
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+.+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999996532 457899999999999999999997 7999999999999999999999999999986
Q ss_pred cCCCCC--cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCC-CccCccchhhHHHHHHHhhcChhh
Q 002255 746 APDNGK--HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL-DETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 746 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~-~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+ ......+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------- 236 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------- 236 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----------------
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----------------
Confidence 544221 11223456889999999999999999999999999999999965554 4332221
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
....+..... ..........+.+++.+|++.||.+||++.++++.|+++.....
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 237 LTHFLAQGRR-LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHhhcCCC-CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111111111 11111223468899999999999999999999999999987544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=353.67 Aligned_cols=268 Identities=22% Similarity=0.313 Sum_probs=194.5
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
...++|++.++||+|+||.||+|... +|+.||||+++.........+.+.+|++++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999865 78999999997665445556778899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-----CCCcEEEeec
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-----DDMRAKVADF 740 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-----~~~~~kl~Df 740 (947)
||||++ |+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999997 5999988653 238899999999999999999997 7999999999999994 5556999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... .........
T Consensus 182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~ 257 (329)
T 3gbz_A 182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGLP 257 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCC
T ss_pred CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCCC
Confidence 99986643221 22345789999999998774 48999999999999999999999997654332211 111111100
Q ss_pred hhh-HHHHh------hccCCCChhc------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDT-FRKAI------DRTIDLDEET------LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~-~~~~~------~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... +.... .......... .....++.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 00000 0000000000 012256789999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=364.18 Aligned_cols=267 Identities=19% Similarity=0.295 Sum_probs=211.8
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC-CCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 665 (947)
+.++|++.++||+|+||.||+|.. .+++.||||++..... ..++..|+++++.++| ++++.+..++.+.+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 357899999999999999999987 4689999998865432 2357889999999987 556666667778889999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGl 742 (947)
||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+ ++||||||||+|||+ +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 999999986432 348999999999999999999997 899999999999999 6889999999999
Q ss_pred ceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 9876553321 11235679999999999999999999999999999999999999998766544333322222111
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
. ......+ ......++.+++.+||+.+|++||++.+|++.|+.+.....
T Consensus 233 ~-~~~~~~l----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 233 V-ATSIEAL----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp H-HSCHHHH----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred c-cccHHHH----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 1 0000110 01123568899999999999999999999999999876443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=351.81 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=210.4
Q ss_pred cHHHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc--C----hHHHHHHHHHHHHHHcC-CCCCcce
Q 002255 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV--S----EKGFAEFKSEIAVLTKV-RHRHLVG 652 (947)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~h~niv~ 652 (947)
.......+.++|++.+.||+|+||.||+|..+ +|+.||||++..... . ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34556677789999999999999999999886 799999999875431 1 12245788999999999 7999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC
Q 002255 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (947)
Q Consensus 653 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 732 (947)
+++++......++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999998653 348899999999999999999997 799999999999999999
Q ss_pred CcEEEeecCcceecCCCCCcceeecccccccccCcccccc------CCcCcccccccHHHHHHHHHhCCCCCCccCccch
Q 002255 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 806 (947)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 312 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL- 312 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-
Confidence 9999999999987754322 234679999999998863 358899999999999999999999997643211
Q ss_pred hhHHHHHHHhhcChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 807 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+..+........... ......+.+++.+||+.||++||++.|+++
T Consensus 313 ---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 ---------------MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---------------HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---------------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111222222211111 122345889999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=354.82 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=202.3
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 664 (947)
.+.++|++.+.||+|+||.||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+++..+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 35678999999999999999999876 688999999976532 234688888888 7999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC----CcEEEeec
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADF 740 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~Df 740 (947)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||++..+ +.+||+||
T Consensus 93 lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 999999999999988653 348899999999999999999997 899999999999998543 35999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.
T Consensus 165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---------- 232 (342)
T 2qr7_A 165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---------- 232 (342)
T ss_dssp TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----------
T ss_pred CCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----------
Confidence 99987654322 223457999999999998888999999999999999999999999764332222111
Q ss_pred hhHHHHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+....+..... .......+.+|+.+||+.||++||++.|+++
T Consensus 233 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 233 ---ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222222222111 1123356789999999999999999999877
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.32 Aligned_cols=261 Identities=33% Similarity=0.523 Sum_probs=206.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcE--EEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.+.||+|+||.||+|+.. +|.. ||+|+++... .....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 67889999999999999999765 5664 4999887532 344556789999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhhcccc-----------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 666 VYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999976431 112458999999999999999999997 89999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------- 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------- 249 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------
Confidence 999999998743321 11223457889999999988889999999999999999998 999997654221
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..+.+..... ..........+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 250 ---------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 250 ---------LYEKLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---------HHHHGGGTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHhhcCCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111 011112335688999999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=345.87 Aligned_cols=257 Identities=21% Similarity=0.359 Sum_probs=207.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCeeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 665 (947)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367899999999999999999876 68999999998766666777889999999999999999999998854 578899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC-----eeecCCCCCcEEEcCCCcEEEeec
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
||||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999764332 2458999999999999999999997 45 999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
|+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---------- 225 (279)
T 2w5a_A 161 GLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---------- 225 (279)
T ss_dssp CHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----------
T ss_pred chheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HH----------
Confidence 99986644221 1233568999999999998899999999999999999999999997654221 11
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
..+...... .........+.+++.+||+.||++||++.|+++.+
T Consensus 226 ---~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 226 ---GKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---HHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---HHHhhcccc--cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 111111111 11112335688999999999999999999998843
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=349.55 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=199.3
Q ss_pred HHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccC---hHHHHHHHHHHHHHHcCC---CCCcceEEEEEEe
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLD 659 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 659 (947)
.+.++|++.+.||+|+||.||+|+. .+|+.||||++...... ......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999986 46899999998754211 111245667777777764 9999999999987
Q ss_pred CC-----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 660 GN-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 660 ~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
.. ..++||||+. ++|.+++..... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 65 5799999996 699999865432 348999999999999999999997 78999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..
T Consensus 159 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i--~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI--FD 233 (308)
T ss_dssp EEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH--HH
T ss_pred EEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH
Confidence 9999999998664432 224467999999999999999999999999999999999999999775543222111 11
Q ss_pred HhhcCh-hhHHH-------HhhccCCCC--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 815 RMHINK-DTFRK-------AIDRTIDLD--EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 815 ~~~~~~-~~~~~-------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... ..+.. .+....... .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 110000 00000 000000000 000112346789999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.75 Aligned_cols=276 Identities=20% Similarity=0.281 Sum_probs=212.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC--eeEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--ERLL 665 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 665 (947)
.++|.+.++||+|+||.||+|+.. +|+.||||++..... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 367899999999999999999876 589999999975432 233567889999999999999999999998755 7799
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----cCCCcEEEeecC
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG 741 (947)
||||+++|+|.+++...... ..+++..++.++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999764332 338999999999999999999997 899999999999999 778889999999
Q ss_pred cceecCCCCCcceeecccccccccCcccccc--------CCcCcccccccHHHHHHHHHhCCCCCCccCccch-hhHHHH
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVT--------GRVTTKVDVFSFGVILMELITGRKALDETQSEDS-VHLVTW 812 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~l~~~ 812 (947)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 162 AARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 998765432 2234579999999998864 5678899999999999999999999975443221 111111
Q ss_pred HHHhhcChhhH---HHH----h--hccCC-CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 813 FRRMHINKDTF---RKA----I--DRTID-LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 813 ~~~~~~~~~~~---~~~----~--~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+..... .... ... + ...+. ...........+.+++.+||+.||++||++.++++.++++.+
T Consensus 239 ~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HhcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111000 0000 000 0 00000 011224555678899999999999999999999999998865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=354.95 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=200.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-----
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 661 (947)
+.++|+..+.||+|+||.||+|... +|+.||||++..........+++.+|++++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999874 6999999999766555666788999999999999999999999997653
Q ss_pred -eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 662 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEee
Confidence 469999999 8899998854 237889999999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+ +......
T Consensus 173 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i--~~~~g~~ 245 (367)
T 1cm8_A 173 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI--MKVTGTP 245 (367)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCC
T ss_pred ecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCC
Confidence 999876432 234578999999999877 67999999999999999999999999876543322111 1111111
Q ss_pred hh---------hHHHHhhccCCC-----ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KD---------TFRKAIDRTIDL-----DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~---------~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. .....+...... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11 111111111000 0011122356789999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=370.94 Aligned_cols=196 Identities=27% Similarity=0.416 Sum_probs=157.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----Ce
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 662 (947)
.++|++.++||+|+||.||+|... +|+.||||++..........+++.+|++++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999765 689999999977655666778899999999999999999999998543 57
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 67999888542 348999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCc-------------------------ceeecccccccccCcccc-ccCCcCcccccccHHHHHHHHHh
Q 002255 743 VRLAPDNGKH-------------------------SIETRLAGTFGYLAPEYA-VTGRVTTKVDVFSFGVILMELIT 793 (947)
Q Consensus 743 a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt 793 (947)
++........ ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9876432211 122346789999999976 45679999999999999999999
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.65 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=199.7
Q ss_pred hcCCCcC-ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 589 TNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 589 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
.++|++. ++||+|+||.||+|... +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4678774 78999999999999864 68999999997652 33456889999999995 79999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc---EEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfGl 742 (947)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999999653 247899999999999999999997 79999999999999998776 99999999
Q ss_pred ceecCCCCCc-----ceeecccccccccCcccccc-----CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
++........ .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 8765432111 11223469999999999865 5689999999999999999999999976543221000000
Q ss_pred HHHhhcChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... .........+........... ......+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACP-ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCH-HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cch-hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000 000011222223333322211 122356889999999999999999999977
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.68 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=203.4
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh------HHHHHHHHHHHHHHcCCCCCcceEEEEEEe
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 659 (947)
...++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678999999999999999999864 68899999997654222 133467789999999999999999999999
Q ss_pred CCeeEEEEEecCCC-chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEe
Q 002255 660 GNERLLVYEYMPQG-TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (947)
Q Consensus 660 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 738 (947)
++..++||||+.+| +|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 999988543 348999999999999999999997 799999999999999999999999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------- 236 (335)
T 3dls_A 173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------- 236 (335)
T ss_dssp CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------
T ss_pred ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------
Confidence 9999987755332 234579999999999988776 78999999999999999999999753211
Q ss_pred cChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ ......+.+++.+||+.||++||++.|+++
T Consensus 237 ---------~~~~~~~~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ---------VEAAIHPP---YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ---------TTTCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------HhhccCCC---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111101 112345789999999999999999999977
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.29 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=207.0
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.+.++|++.++||+|+||.||+|..+ +|+.||||++............+.+|++++++++|||||++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35678999999999999999999876 78999999997554334456788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc---CCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfGl 742 (947)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 99 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 99999999999988654 248899999999999999999997 8999999999999995 566899999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+ .
T Consensus 171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~ 230 (486)
T 3mwu_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----------------I 230 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------H
T ss_pred CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 98664432 2234579999999998865 69999999999999999999999997654321 1
Q ss_pred HHHHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 823 FRKAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 823 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+..+.......... .......+.+++.+||+.||++|||+.++++.
T Consensus 231 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12222222222211 12234567899999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=345.57 Aligned_cols=253 Identities=30% Similarity=0.475 Sum_probs=200.4
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-CeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-NERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|+.+ |+.||||+++.. ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 367899999999999999999876 899999998754 2456789999999999999999999997654 4789999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999965432 237888999999999999999997 899999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----------------~~~ 226 (278)
T 1byg_A 169 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------VPR 226 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----------------HHH
T ss_pred ccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHH
Confidence 321 22357889999999988899999999999999999998 9999976543221 111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
+..... ..........+.+++.+|++.||++||++.|+++.|+.+...
T Consensus 227 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 227 VEKGYK-MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCC-CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111111 011122345688999999999999999999999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=368.01 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=205.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|...++||+|+||.||+|+.+ +|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67889999999999999999885 6999999999754322 233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++...... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998654321 2458999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+.
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~------------~~~~~~i~ 406 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRVL 406 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH------------HHHHHHHH
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH------------HHHHHHHh
Confidence 4322 223458999999999999999999999999999999999999999765432111 11112223
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
......+. .....+.+++.+||+.||++||++
T Consensus 407 ~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 407 EQAVTYPD---KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HCCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred hcccCCCc---ccCHHHHHHHHHhccCCHhHCCCC
Confidence 33222221 223567899999999999999976
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.35 Aligned_cols=249 Identities=29% Similarity=0.491 Sum_probs=201.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999876 5779999998654322 22346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998653 248899999999999999999996 89999999999999999999999999998654
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~ 219 (279)
T 3fdn_A 160 PSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----------------YKRI 219 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHH
T ss_pred Ccc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH----------------HHHH
Confidence 332 12345799999999999988999999999999999999999999976542211 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
......... .....+.+++.+||+.||++||++.|+++.
T Consensus 220 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 220 SRVEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHTCCCCCT---TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HhCCCCCCC---cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111112111 123457899999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=370.02 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=202.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||.||+|+.+ +++.||+|++............+.+|+.++++++|||||++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999876 688999999987654444567889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGla 743 (947)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988654 248899999999999999999997 89999999999999976 455999999999
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
+...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||......+ .+
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~ 246 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----------------IL 246 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HH
T ss_pred eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HH
Confidence 8765432 223457999999999875 579999999999999999999999998654321 11
Q ss_pred HHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+........... ......+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 22222222222211 123456789999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=352.14 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=205.8
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCee
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNER 663 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 663 (947)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36799999999999999999987 57899999998654 45567789999999999999999999999873 3477
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
++||||+++|+|.+++...... ...+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 9999999999999998764322 2458999999999999999999997 79999999999999999999999999998
Q ss_pred eecCCCCCcc-------eeecccccccccCccccccCC---cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 744 RLAPDNGKHS-------IETRLAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 744 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
+......... ......||+.|+|||++.... ++.++||||||+++|||++|+.||........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------- 254 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------- 254 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-------
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-------
Confidence 7653211100 012245799999999987543 68999999999999999999999964321110
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.....+....... ........+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 255 --------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 --------SVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --------CHHHHHHCC--CC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --------hhhHHhhccCCCC-ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1111111111111 111223568899999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.64 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=203.6
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 664 (947)
...++|++.+.||+|+||.||+|... +++.||+|++...........++.+|+..+.++ +||||+++++++.+++..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35578999999999999999999886 799999999987655556678889999999999 9999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC------------
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------ 732 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~------------ 732 (947)
+||||+++++|.+++...... ...+++.++..++.||+.||+|||+ ++|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------
T ss_pred EEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999764322 1348899999999999999999997 899999999999999844
Q ss_pred -------CcEEEeecCcceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCcc
Q 002255 733 -------MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSE 804 (947)
Q Consensus 733 -------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 804 (947)
..+||+|||.++...... ...||+.|+|||++.+. .++.++|||||||++|||++|.+++.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 489999999998765432 23599999999998765 567899999999999999999887643211
Q ss_pred chhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 805 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+...... ..+......+.+++.+||+.||++||++.|+++
T Consensus 237 ------------------~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ------------------WHEIRQGRLP--RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------------------HHHHHTTCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------------HHHHHcCCCC--CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111111 111122356889999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=359.62 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=194.5
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC------hHHHHHHHHHHHHHHcCCCCCcceEEEEEE
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 658 (947)
..+.++|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++|||||++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 356789999999999999999999875 6899999999764321 122335889999999999999999999975
Q ss_pred eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC---CcE
Q 002255 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRA 735 (947)
Q Consensus 659 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~ 735 (947)
.+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCE
T ss_pred -cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceE
Confidence 45689999999999999988543 348999999999999999999997 799999999999999754 459
Q ss_pred EEeecCcceecCCCCCcceeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 736 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.
T Consensus 282 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~-- 354 (419)
T 3i6u_A 282 KITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK-- 354 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH--
T ss_pred EEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH--
Confidence 99999999876442 22334679999999999853 5688899999999999999999999976543211 11
Q ss_pred HHHhhcChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+........... ......+.+++.+||+.||++||++.|+++
T Consensus 355 -----------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 -----------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -----------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----------HHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111111111111 122356789999999999999999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=360.54 Aligned_cols=203 Identities=27% Similarity=0.392 Sum_probs=170.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 661 (947)
+.++|++.++||+|+||.||+|... +|+.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999875 688999999987655666678899999999999999999999999766 5
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 7899999985 6999988542 348999999999999999999997 799999999999999999999999999
Q ss_pred cceecCCCCCc--------------------ceeecccccccccCcccc-ccCCcCcccccccHHHHHHHHHhCCCCCC
Q 002255 742 LVRLAPDNGKH--------------------SIETRLAGTFGYLAPEYA-VTGRVTTKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 742 la~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~p~~ 799 (947)
+++........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 99876543211 112456899999999986 55679999999999999999998655543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.48 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=184.6
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 47899999998654221 12346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++.... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999986532 458999999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. +...
T Consensus 163 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~ 224 (278)
T 3cok_A 163 KMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKV 224 (278)
T ss_dssp C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------C
T ss_pred cCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHH
Confidence 53222 12235789999999999888899999999999999999999999976543221 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......+. .....+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 225 VLADYEMPS---FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CSSCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccCCcc---ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111111111 12346789999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.99 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=203.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 663 (947)
.++|++.+.||+|+||.||+|... +|+.||+|+++...... ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999886 68999999987653322 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC----cEEEee
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVAD 739 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~D 739 (947)
++||||+++++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999998653 348899999999999999999997 8999999999999999877 899999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------- 219 (283)
T 3bhy_A 156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------------- 219 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------
T ss_pred cccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------------
Confidence 999987654322 2345699999999999988999999999999999999999999976542211
Q ss_pred hhhHHHHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFRKAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+.......... .......+.+++.+|++.||++||++.|+++
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 220 ---LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ---HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11111111111111 1122345789999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=366.69 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=203.9
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh-----------HHHHHHHHHHHHHHcCCCCCcceEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-----------KGFAEFKSEIAVLTKVRHRHLVGLLG 655 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 655 (947)
+.++|.+.++||+|+||.||+|..+ +++.||||++....... ...+.+.+|+.++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5688999999999999999999876 58899999997653221 33567899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC--
Q 002255 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 733 (947)
Q Consensus 656 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-- 733 (947)
++.++...++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999988653 248999999999999999999997 8999999999999998776
Q ss_pred -cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 734 -RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.+....+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------- 254 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------- 254 (504)
T ss_dssp SSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred ccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence 69999999998775532 223457999999999876 579999999999999999999999998654321
Q ss_pred HHHhhcChhhHHHHhhccCCCChhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEETL-ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+..+....+......+ .....+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ---------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 ---------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ---------HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 12222222222222211 22356889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.20 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=190.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999874 7899999999765434444455566666688889999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC-CeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
||++ |+|.+++...... ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9996 5888877553222 2458999999999999999999997 5 9999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCcccc----ccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYA----VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ..
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~ 222 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---------------QQ 222 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---------------HH
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---------------HH
Confidence 44322 2334799999999996 55678999999999999999999999997543211 11
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+...+..... ..........+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEEPSP-QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHSCCC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhccCCC-CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1122222111 1111122356889999999999999999999977
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.25 Aligned_cols=267 Identities=23% Similarity=0.379 Sum_probs=203.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999876 5899999999776556666778899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999998876432 348899999999999999999997 899999999999999999999999999998664
Q ss_pred CCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.... ...............
T Consensus 176 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH--IMMCLGNLIPRHQEL 251 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCSCCHHHHHH
T ss_pred CCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--HHHHhCCCChhhhhH
Confidence 4322 22345799999999998765 689999999999999999999999977654322211 111111101111111
Q ss_pred hhcc----------CCC-Ch---hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRT----------IDL-DE---ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~----------~~~-~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+... ... .. ........+.+|+.+||+.||++||++.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1100 000 00 00122456889999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.03 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=206.3
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe------
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------ 659 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 659 (947)
...++|++.+.||+|+||.||+|... +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 45578999999999999999999886 79999999987542 356789999999999999999998864
Q ss_pred ----------CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 660 ----------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 660 ----------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
....++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 3457999999999999999975432 358899999999999999999997 799999999999999
Q ss_pred cCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhH
Q 002255 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l 809 (947)
+.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..|+....
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------- 225 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------- 225 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------
Confidence 9999999999999987755322 234579999999999998899999999999999999999998874321
Q ss_pred HHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..........+. . .....+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 226 -----------~~~~~~~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 -----------KFFTDLRDGIIS-D----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -----------HHHHHHHTTCCC-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -----------HHHHHhhccccc-c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 001111111111 1 1224578999999999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.56 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=207.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999876 588999999876542 345567889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988543 348899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~ 227 (294)
T 2rku_A 166 EYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRI 227 (294)
T ss_dssp CSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHH
T ss_pred ccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHH
Confidence 54322 22345799999999999888899999999999999999999999976542211 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
......... .....+.+++.+|++.||++||++.|+++.
T Consensus 228 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 KKNEYSIPK---HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HTTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccCCCcc---ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 122222111 223457899999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.48 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=199.1
Q ss_pred cCCCcCceecccCceEEEEEEEc--CCc--EEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH--DGT--KIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.+.||+|+||.||+|++. +++ .||||+++.... .....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57899999999999999999864 233 689999876532 3345678999999999999999999999998765 88
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999986543 348899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcc-eeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKHS-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---------------- 233 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---------------- 233 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH----------------
Confidence 775543322 2234567889999999988889999999999999999999 9999976543211
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+...... ..........+.+++.+|++.||++||++.++++.|+++..
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 234 LHKIDKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHccCCC-CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111111 11112234568899999999999999999999999988753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=351.51 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=196.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 661 (947)
.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999865 6899999999876555666788999999999999999999999997654
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||++ |+|.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999996 578777732 37889999999999999999997 799999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc---
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI--- 818 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~--- 818 (947)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.... .+.....
T Consensus 173 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--i~~~~~~~~~ 247 (371)
T 2xrw_A 173 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK--VIEQLGTPCP 247 (371)
T ss_dssp C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHC-CCCCCH
T ss_pred ccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCCH
Confidence 998664321 22345799999999999998999999999999999999999999987543221110 0000000
Q ss_pred -----ChhhHHHHhhccCCC-----------------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 -----NKDTFRKAIDRTIDL-----------------DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 -----~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........+...... ..........+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 001111111111100 0111223567889999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.89 Aligned_cols=266 Identities=21% Similarity=0.336 Sum_probs=206.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 367999999999999999999876 68999999987653 4556678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... .+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999996532 47899999999999999999997 2489999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH--------------
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF-------------- 813 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~-------------- 813 (947)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 21 123457999999999999999999999999999999999999999765432211110000
Q ss_pred --------HHhhcC----hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 814 --------RRMHIN----KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 814 --------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... ............. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000 0011111111111 1111112346889999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=348.36 Aligned_cols=273 Identities=24% Similarity=0.437 Sum_probs=211.8
Q ss_pred hcCCCcCceecccCceEEEEEEE-----cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC--
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-- 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 661 (947)
.++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35688999999999999999985 36889999998764 4556678999999999999999999999987644
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 6899999999999999996543 348899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcc-eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-
Q 002255 742 LVRLAPDNGKHS-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN- 819 (947)
Q Consensus 742 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~- 819 (947)
+++......... ......++..|+|||++.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~ 266 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ 266 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchh
Confidence 998775543221 123345788899999998888999999999999999999999998643110 00000000000
Q ss_pred --hhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 820 --KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 820 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...+.+.+...... +........+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00112222221111 11122345688999999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=351.94 Aligned_cols=269 Identities=22% Similarity=0.333 Sum_probs=203.1
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--------C
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--------G 660 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 660 (947)
++|++.+.||+|+||.||+|+. .+|+.||||++............+.+|++++++++||||+++++++.. +
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999987 478999999987665444445678899999999999999999999987 4
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
+..++||||++ |+|.+.+.... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 56899999996 47777775432 348999999999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCc--ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 741 GLVRLAPDNGKH--SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 741 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
|+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876532211 22344678999999998876 458999999999999999999999998765433222221111110
Q ss_pred cChhhHHHHhh----ccCCC----ChhcH------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 INKDTFRKAID----RTIDL----DEETL------ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ~~~~~~~~~~~----~~~~~----~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ...+...-. ..+.. ..... .....+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 T-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp C-TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 000000000 00000 00000 11245789999999999999999999977
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=351.72 Aligned_cols=265 Identities=26% Similarity=0.402 Sum_probs=190.2
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 660 (947)
+.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999864 689999999976655566678899999999999999999999999754
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
...++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999999 7899888853 348899999999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh---
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM--- 816 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~--- 816 (947)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+......
T Consensus 177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999865432 234579999999999876 67899999999999999999999999876543322221111000
Q ss_pred ----hcChhhHHHHhhccCCCChhcH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 817 ----HINKDTFRKAIDRTIDLDEETL-----ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 817 ----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......+..+........... .....+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0001112222221111111111 12346789999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.44 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=207.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999999999999876 57899999987653 2345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999988553 348899999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. +..+
T Consensus 192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~ 253 (335)
T 2owb_A 192 EYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRI 253 (335)
T ss_dssp CSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHH
T ss_pred ccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHH
Confidence 54322 22345799999999999988899999999999999999999999976442211 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......... .....+.+++.+||+.||++||++.|+++
T Consensus 254 ~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 254 KKNEYSIPK---HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hcCCCCCCc---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122222111 12245789999999999999999999977
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.60 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=201.8
Q ss_pred cCCCcCceecccCceEEEEEEE----cCCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCe
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 662 (947)
++|++.++||+|+||.||+|+. .+|+.||||+++.... .....+.+.+|+++++++ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6799999999999999999987 3689999999875421 112335677899999999 69999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999653 248899999999999999999997 7999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~----------- 273 (355)
T 1vzo_A 206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE----------- 273 (355)
T ss_dssp EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-----------
T ss_pred CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH-----------
Confidence 987644222 22334679999999999875 3478999999999999999999999975543222110
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVNV 868 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 868 (947)
............. ......+.+|+.+||+.||++|| ++.|+++.
T Consensus 274 -~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 274 -ISRRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -HHHHHhccCCCCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1111122111111 12234578999999999999999 88888763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=368.30 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=208.0
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
+.++|++.++||+|+||.||+|..+ +|+.||||++...... ....+.+.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999876 7899999999765322 3446789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGl 742 (947)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999988653 348999999999999999999997 899999999999999 5678999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ .
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~ 235 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD----------------I 235 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------H
T ss_pred eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----------------H
Confidence 987654322 234579999999998865 79999999999999999999999998654321 1
Q ss_pred HHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+....+...... ......+.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 236 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 122222222222111 223456789999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=342.76 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=203.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|.+.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 5578999999999999999999875 68999999997542 23346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE---cCCCcEEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla 743 (947)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999988653 247899999999999999999997 799999999999999 78899999999998
Q ss_pred eecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 744 RLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..
T Consensus 157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~~ 216 (304)
T 2jam_A 157 KMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----------------LF 216 (304)
T ss_dssp CCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HH
T ss_pred eecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----------------HH
Confidence 765332 1223468999999999998899999999999999999999999997644221 11
Q ss_pred HHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+........ .........+.+++.+|++.||++||++.|+++
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 217 EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11222211111 111123356889999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.71 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=196.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57899999999999999999876 78999999987542 11222245679999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|++ |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 996 68988886543 348899999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh-------
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK------- 820 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------- 820 (947)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..........
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 153 PTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 221 2234578999999999876 568999999999999999999999998765433222221111100000
Q ss_pred -hhHHHHhhccCCCC---hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 -DTFRKAIDRTIDLD---EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 -~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+.....+..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000 000112346789999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.40 Aligned_cols=257 Identities=25% Similarity=0.329 Sum_probs=189.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEE--------e
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCL--------D 659 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~ 659 (947)
.+|++.++||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 57889999999999999999875 6899999998654 4555678899999999996 999999999995 3
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCC--eeecCCCCCcEEEcCCCcEEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl 737 (947)
....++||||+. |+|.+++...... ..+++.+++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 345799999995 7999988653322 458999999999999999999996 66 999999999999999999999
Q ss_pred eecCcceecCCCCCcc----------eeecccccccccCcccc---ccCCcCcccccccHHHHHHHHHhCCCCCCccCcc
Q 002255 738 ADFGLVRLAPDNGKHS----------IETRLAGTFGYLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 804 (947)
+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432211 11134689999999998 5667899999999999999999999999654321
Q ss_pred chhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 805 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
. .+........ .......+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 260 ~--------------------~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 R--------------------IVNGKYSIPP-HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------------------------CCCCT-TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--------------------hhcCcccCCc-ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1111111010 011123467999999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.35 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=206.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+.|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999865 68999999997653 2344678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999998853 348899999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+ .
T Consensus 171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~-------------~ 232 (303)
T 3a7i_A 171 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLI-------------P 232 (303)
T ss_dssp TTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH-------------H
T ss_pred cccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHh-------------h
Confidence 4321 223457999999999999989999999999999999999999999765432111 111 0
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 869 (947)
.... ..........+.+++.+||+.||++||++.|+++..
T Consensus 233 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 233 KNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HSCC--CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cCCC--CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1000 011112234578999999999999999999998853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=337.39 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=205.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367899999999999999999876 5788999998654221 12246789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999998653 247899999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+
T Consensus 165 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~~~~~ 224 (284)
T 2vgo_A 165 PSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----------------THRRI 224 (284)
T ss_dssp SSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHH
T ss_pred cccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----------------HHHHH
Confidence 4422 234579999999999998899999999999999999999999997644221 11122
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......... .....+.+++.+|++.||.+||++.++++
T Consensus 225 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 225 VNVDLKFPP---FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HTTCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccCCCC---cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 222222221 12346789999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=363.89 Aligned_cols=246 Identities=15% Similarity=0.162 Sum_probs=193.1
Q ss_pred hcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccc-cChHHHHHHHHHH---HHHHcCCCCCcceEE-------EE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEI---AVLTKVRHRHLVGLL-------GY 656 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 656 (947)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 569999999997542 2344567899999 555556899999998 77
Q ss_pred EEeCCe-----------------eEEEEEecCCCchhhhhhcccccC--CCcccHHHHHHHHHHHHHHHHHHhhccCCCe
Q 002255 657 CLDGNE-----------------RLLVYEYMPQGTLSRHLFNRKEEG--LKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717 (947)
Q Consensus 657 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 717 (947)
+.+++. .++||||+ +|+|.+++....... ...+++..++.++.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 665532 78999999 689999997643221 1345678889999999999999997 799
Q ss_pred eecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccC-----------CcCcccccccHHH
Q 002255 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-----------RVTTKVDVFSFGV 786 (947)
Q Consensus 718 vHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv 786 (947)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002255 787 ILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVV 866 (947)
Q Consensus 787 il~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 866 (947)
++|||++|+.||.......... .+..... .....+.+++.+||+.||++||++.|++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~----------------~~~~~~~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE----------------WIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHHSSCCC------CCSG----------------GGGSSCC-------CCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHHCCCCCcccccccchh----------------hhhhhcc-------CCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999997654322110 0111100 1124578999999999999999999998
Q ss_pred H
Q 002255 867 N 867 (947)
Q Consensus 867 ~ 867 (947)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.50 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=175.0
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC------CCCCcceEEEEEEeC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV------RHRHLVGLLGYCLDG 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~ 660 (947)
+..+|++.++||+|+||.||+|... +++.||||++... ......+.+|+++++.+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3468999999999999999999775 5899999999753 34456778888888887 567999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc--EEEe
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVA 738 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~ 738 (947)
...++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence 99999999995 689998865432 348999999999999999999997 79999999999999999987 9999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCcc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 804 (947)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999865432 22357999999999999999999999999999999999999999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=349.44 Aligned_cols=269 Identities=25% Similarity=0.325 Sum_probs=196.4
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh---HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE---KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
...++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999875 58999999987543221 112467899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999975 8888875432 347888899999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh-
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK- 820 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~- 820 (947)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.. ...+.......
T Consensus 159 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~i~~~~~~~~~ 234 (346)
T 1ua2_A 159 AKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRIFETLGTPTE 234 (346)
T ss_dssp GSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCT
T ss_pred ceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHcCCCCh
Confidence 987644322 23345799999999998654 5899999999999999999999999765432221 11111110000
Q ss_pred hhHHHHhh--ccCC---CChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DTFRKAID--RTID---LDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~--~~~~---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+..... .... ..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000000 0000 00000 122356889999999999999999999977
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.91 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=200.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcCCCCCcceEEEEEE--eCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL--DGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 662 (947)
..++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999874 688999999975432 1234578999999999999999999999984 4567
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||++++ |.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 7676654332 458899999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCC--cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
++...............||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------- 220 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------------- 220 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---------------
Confidence 98765433333344567999999999987643 4789999999999999999999997643211
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
....+......... .....+.+++.+|++.||++||++.|+++.
T Consensus 221 -~~~~i~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 221 -LFENIGKGSYAIPG---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHHHHHCCCCCCS---SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHHHHhcCCCCCCC---ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111122222111 123457899999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=344.18 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=200.1
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC--CCCcceEEEEEEeCCeeEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 665 (947)
..++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ |+||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34678999999999999999999888999999999876656677788999999999997 5999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||| +.+++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++ +.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 5689999998653 247889999999999999999997 79999999999999964 8999999999987
Q ss_pred cCCCCCcceeecccccccccCcccccc-----------CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~ 814 (947)
..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------- 246 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------- 246 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---------
Confidence 654333223344579999999999865 468889999999999999999999997543211
Q ss_pred HhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
..+...++...... ........+.+++.+||+.||++||++.|+++.
T Consensus 247 ------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 ------SKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ------HHHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHHHhcccccC-CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11222222221111 111113467899999999999999999999873
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=376.78 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=205.3
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 664 (947)
..++|++.++||+|+||.||+|+.+ +++.||||+++.... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3478999999999999999999876 588999999976421 223456788899999988 7999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999654 248899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +.+.
T Consensus 491 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------------~~~~ 552 (674)
T 3pfq_A 491 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQ 552 (674)
T ss_dssp ECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHH
T ss_pred ccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------------HHHH
Confidence 6543322 234568999999999999999999999999999999999999999865422 1233
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 862 (947)
.++...+.++. ....++.+|+.+||+.||++||++
T Consensus 553 ~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 553 SIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHSSCCCCCT---TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HHHhCCCCCCc---cCCHHHHHHHHHHccCCHHHCCCC
Confidence 34444433332 234567899999999999999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.63 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=199.8
Q ss_pred HHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
....++|++.+.||+|+||.||+|... +|+.||||++.... ..+++.+|+.++++++||||+++++++..++..+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345678999999999999999999876 58999999987542 2457889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 101 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 9999999999999986422 358899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 174 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~---------- 238 (314)
T 3com_A 174 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIP---------- 238 (314)
T ss_dssp ECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH----------
T ss_pred hhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHh----------
Confidence 7644321 2234579999999999998899999999999999999999999997654221110 000
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ ........+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 239 TNPPPTFR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HSCCCCCS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCcccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000111 11122356889999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=352.34 Aligned_cols=261 Identities=22% Similarity=0.387 Sum_probs=201.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
..++|++.+.||+|+||.||+|..+. .||+|+++.........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34789999999999999999998763 5999998765444444567788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999996532 358889999999999999999997 7999999999999998 6899999999987543
Q ss_pred CCC---CcceeecccccccccCcccccc---------CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002255 748 DNG---KHSIETRLAGTFGYLAPEYAVT---------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815 (947)
Q Consensus 748 ~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~ 815 (947)
... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||.........
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------- 252 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------- 252 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH--------
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------
Confidence 211 1112233569999999998864 35788999999999999999999999765432110
Q ss_pred hhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
...... .............+.+++.+|++.||++||++.++++.|+.+...
T Consensus 253 --------~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 253 --------WQMGTG-MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp --------HHHHTT-CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred --------HHhccC-CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 011111 000111111224578999999999999999999999999988754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.28 Aligned_cols=256 Identities=19% Similarity=0.313 Sum_probs=199.8
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEe--CCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD--GNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 665 (947)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6799999999999999999986 47899999998743 2367889999999997 9999999999987 667899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCcce
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 744 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~ 744 (947)
||||+++++|.+++. .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999998873 27888899999999999999997 8999999999999999777 89999999998
Q ss_pred ecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+....... . ....
T Consensus 180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~-~-~~~~ 253 (330)
T 3nsz_A 180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVL-G-TEDL 253 (330)
T ss_dssp ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHH-C-HHHH
T ss_pred EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhc-C-Cchh
Confidence 7655332 234578999999999877 678999999999999999999999996543221 1111111111 0 1111
Q ss_pred HHHhhc-cCCCC---------------------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 RKAIDR-TIDLD---------------------EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ~~~~~~-~~~~~---------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.++. ....+ .........+.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111 00000 011113456889999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.10 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=198.1
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
+|....+||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 4555679999999999999874 6889999998765 334457889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEeecCcceecCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPD 748 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~ 748 (947)
+++++|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999865422 2346788899999999999999997 89999999999999987 89999999999987654
Q ss_pred CCCcceeecccccccccCccccccCC--cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... .. .. ..
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~-~~-----------~~ 240 (295)
T 2clq_A 176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MF-KV-----------GM 240 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HH-HH-----------HH
T ss_pred CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HH-hh-----------cc
Confidence 221 223457999999999987643 789999999999999999999999754322110 00 00 00
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... ........+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 241 FKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HCCCCC---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccc---ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011111 11122356789999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.49 Aligned_cols=274 Identities=20% Similarity=0.320 Sum_probs=203.5
Q ss_pred cHHHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEeccccc---------ChHHHHHHHHHHHHHHcCCCCCcc
Q 002255 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV---------SEKGFAEFKSEIAVLTKVRHRHLV 651 (947)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv 651 (947)
..+++..+.++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45778889999999999999999999999988899999999865422 223347899999999999999999
Q ss_pred eEEEEEEe-----CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 002255 652 GLLGYCLD-----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726 (947)
Q Consensus 652 ~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 726 (947)
++++++.. ....++||||+. |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 99999854 336799999997 68888886432 358999999999999999999997 799999999999
Q ss_pred EEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccc
Q 002255 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSED 805 (947)
Q Consensus 727 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~ 805 (947)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999997544322 2234578999999998876 678999999999999999999999998755332
Q ss_pred hhhHHHHHHHhhc---------ChhhHHHHhhccCC-CChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 806 SVHLVTWFRRMHI---------NKDTFRKAIDRTID-LDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 806 ~~~l~~~~~~~~~---------~~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+ +..... ........+..... ..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~i--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKI--VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHH--HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH--HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 22111 110000 01111122211111 01001 112345789999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.06 Aligned_cols=249 Identities=30% Similarity=0.447 Sum_probs=196.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999886 799999999875421 123356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999998653 247899999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... . ...
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-------------~~~ 222 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---L-------------FKK 222 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-------------HHH
T ss_pred CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---H-------------HHH
Confidence 4432 1234578999999999987665 689999999999999999999997643211 1 111
Q ss_pred HhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.......+. .....+.+++.+|++.||++||++.|+++
T Consensus 223 ~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 223 IRGGVFYIPE---YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCcccCch---hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111111111 12345789999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.10 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=198.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc------ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 659 (947)
.+.++|.+.+.||+|+||.||+|... +++.||||++..... .......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45678999999999999999999875 588999999875432 11223468899999999999999999999876
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc---EE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AK 736 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~k 736 (947)
++ .++||||+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 55 89999999999999988542 348899999999999999999997 89999999999999987654 99
Q ss_pred EeecCcceecCCCCCcceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
|+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +...+
T Consensus 158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~ 232 (322)
T 2ycf_A 158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI 232 (322)
T ss_dssp ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH
T ss_pred EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH
Confidence 99999998765421 223457999999999874 46789999999999999999999999976543221 11111
Q ss_pred HHhhcChhhHHHHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........+. .......+.+++.+||+.||++||++.|+++
T Consensus 233 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -------------HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------------HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111111111 1122356789999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.92 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=198.8
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
..++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4578999999999999999999886 5899999998754 334467889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999886532 348899999999999999999997 79999999999999999999999999987533
Q ss_pred CCCCCcceeecccccccccCcccc-----ccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYA-----VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
... ........||+.|+|||++ ....++.++||||||+++|||++|+.||......+.
T Consensus 168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------- 230 (302)
T 2j7t_A 168 LKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--------------- 230 (302)
T ss_dssp HHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------------
T ss_pred ccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---------------
Confidence 211 0112235789999999988 356789999999999999999999999976543211
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....................+.+++.+|++.||++||++.++++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 231 -LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -HHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111111111111111222356889999999999999999999866
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.94 Aligned_cols=266 Identities=23% Similarity=0.363 Sum_probs=203.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----Ce
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 662 (947)
.++|++.++||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999875 68899999987532 445567899999999999999999999999754 46
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+. |+|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999996 699988854 238899999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcc-eeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 743 VRLAPDNGKHS-IETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 743 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+... .....
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~ 252 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI--LGSPS 252 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH--HCSCC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH--hCCCC
Confidence 98765432211 1234579999999998654 45899999999999999999999999876554432221111 00000
Q ss_pred -hh--------HHHHhhccCCCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 -DT--------FRKAIDRTIDLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 -~~--------~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+. ............... ......+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 011111100000000 112356789999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=350.14 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=198.0
Q ss_pred HHHhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC----
Q 002255 586 RNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG---- 660 (947)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 660 (947)
+...++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34567899999999999999999986 4799999999865421 224699999999999999999998543
Q ss_pred ----------------------------------CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHH
Q 002255 661 ----------------------------------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706 (947)
Q Consensus 661 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L 706 (947)
...++||||++ |+|.+.+...... ...+++..+..++.||++||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHH
Confidence 34789999997 6888877653322 24589999999999999999
Q ss_pred HHHhhccCCCeeecCCCCCcEEEc-CCCcEEEeecCcceecCCCCCcceeecccccccccCccccccC-CcCcccccccH
Q 002255 707 EYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSF 784 (947)
Q Consensus 707 ~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSl 784 (947)
+|||+ .+|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+
T Consensus 155 ~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 99996 8999999999999998 689999999999987654322 2345789999999988764 48999999999
Q ss_pred HHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCC---CC---h------hcHHHHHHHHHHHHHhc
Q 002255 785 GVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTID---LD---E------ETLASISTVADLAGHCC 852 (947)
Q Consensus 785 Gvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~---~~---~------~~~~~~~~l~~li~~cl 852 (947)
||++|||++|+.||.+....+.. ...+..............++... +. . ........+.+|+.+||
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999875543322 22222111111111111111100 00 0 00112345789999999
Q ss_pred ccCCCCCCCHHHHHH
Q 002255 853 AREPYQRPDMGHVVN 867 (947)
Q Consensus 853 ~~dP~~RPs~~evl~ 867 (947)
+.||++|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.97 Aligned_cols=256 Identities=27% Similarity=0.364 Sum_probs=208.5
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
......++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34567789999999999999999999876 68999999997665555566789999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC---CcEEEee
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVAD 739 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~D 739 (947)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+|
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred EEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEec
Confidence 99999999999999988653 248899999999999999999997 799999999999999754 4799999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
||+++....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+.
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------- 230 (287)
T 2wei_A 168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------------- 230 (287)
T ss_dssp TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------
T ss_pred cCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------------
Confidence 999886644321 223468999999998765 589999999999999999999999976542211
Q ss_pred hhhHHHHhhccCCCCh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFRKAIDRTIDLDE-ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+......... ........+.+++.+|++.||++||++.|+++
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 231 ---LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1111122221111 11123456889999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.51 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=204.6
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChH---------------HHHHHHHHHHHHHcCCCCCcceE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK---------------GFAEFKSEIAVLTKVRHRHLVGL 653 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l 653 (947)
.++|++.+.||+|+||.||+|.. +|+.||||++........ ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 899999999875432211 12789999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCchhhh------hhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcE
Q 002255 654 LGYCLDGNERLLVYEYMPQGTLSRH------LFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727 (947)
Q Consensus 654 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni 727 (947)
++++.+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ ..+|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 9999999999999999999999998 4321 12568999999999999999999995 37999999999999
Q ss_pred EEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccC-CcCc-ccccccHHHHHHHHHhCCCCCCccCccc
Q 002255 728 LLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTT-KVDVFSFGVILMELITGRKALDETQSED 805 (947)
Q Consensus 728 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~~p~~~~~~~~ 805 (947)
+++.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999876442 23446799999999999877 6666 9999999999999999999998654321
Q ss_pred hhhHHHHHHHhhcChhhHHHHhhccCCCCh----------------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 806 SVHLVTWFRRMHINKDTFRKAIDRTIDLDE----------------ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 806 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... .+......... ........+.+++.+||+.||++||++.|+++
T Consensus 260 --~~~~-------------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 --ELFN-------------NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHH-------------HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHH-------------HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 11111111110 00223356889999999999999999999977
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.66 Aligned_cols=254 Identities=26% Similarity=0.327 Sum_probs=205.6
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc---C----hHHHHHHHHHHHHHHcCC-CCCcceEEEEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---S----EKGFAEFKSEIAVLTKVR-HRHLVGLLGYC 657 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 657 (947)
...++|++.+.||+|+||.||+|..+ +|+.||||++..... . ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999875 689999999975421 1 223467889999999996 99999999999
Q ss_pred EeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 658 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
..++..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999998653 348899999999999999999997 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccc------cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHH
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV------TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVT 811 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~ 811 (947)
+|||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------ 236 (298)
T 1phk_A 166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------ 236 (298)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred ecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------
Confidence 99999987654322 23457999999999885 4568899999999999999999999997643211
Q ss_pred HHHHhhcChhhHHHHhhccCCCCh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 812 WFRRMHINKDTFRKAIDRTIDLDE-ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+......... ........+.+++.+||+.||++||++.|+++
T Consensus 237 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 ----------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----------HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11122222222111 11223456889999999999999999999876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.88 Aligned_cols=279 Identities=25% Similarity=0.357 Sum_probs=188.3
Q ss_pred HhcCCCc-CceecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CC
Q 002255 588 VTNNFSE-ENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GN 661 (947)
Q Consensus 588 ~~~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 661 (947)
+.+.|++ .++||+|+||.||+|+++ +++.||||++...... ..+.+|+.++++++|||||++++++.. +.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3455666 568999999999999876 5788999999755322 467889999999999999999999964 67
Q ss_pred eeEEEEEecCCCchhhhhhccccc----CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----cCCC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDM 733 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~ 733 (947)
..++||||+. |+|.+++...... ....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCC
Confidence 8999999995 5888877543211 12348899999999999999999997 899999999999999 6789
Q ss_pred cEEEeecCcceecCCCCCc-ceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccc------
Q 002255 734 RAKVADFGLVRLAPDNGKH-SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSED------ 805 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~------ 805 (947)
.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999876542211 223346799999999998774 58999999999999999999999997554321
Q ss_pred -hhhHHHHHHHhhcChh-------------hHHHHhh-ccCCCChhc-------HHHHHHHHHHHHHhcccCCCCCCCHH
Q 002255 806 -SVHLVTWFRRMHINKD-------------TFRKAID-RTIDLDEET-------LASISTVADLAGHCCAREPYQRPDMG 863 (947)
Q Consensus 806 -~~~l~~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ 863 (947)
...+...+........ .+...+. ......... ......+.+|+.+||+.||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 1111111111110000 0000000 000000000 00024577999999999999999999
Q ss_pred HHHHHHHhhhhhhCCCC
Q 002255 864 HVVNVLSSLAELWKPAE 880 (947)
Q Consensus 864 evl~~L~~l~~~~~~~~ 880 (947)
|+++ ++|....
T Consensus 330 e~L~------hp~f~~~ 340 (405)
T 3rgf_A 330 QAMQ------DPYFLED 340 (405)
T ss_dssp HHHT------SGGGTSS
T ss_pred HHhc------ChhhccC
Confidence 9976 5665443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=343.96 Aligned_cols=266 Identities=23% Similarity=0.381 Sum_probs=186.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+++.+|+.++++++||||+++++++..++..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3578999999999999999999754 68999999986543 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccc---cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKE---EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 743 (947)
|||+++++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998864221 122458999999999999999999997 79999999999999999999999999998
Q ss_pred eecCCCCCc---ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 744 RLAPDNGKH---SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 744 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .. ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~---~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML--TL---QND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--HH---TSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH--Hh---ccC
Confidence 765443211 12234579999999998865 5689999999999999999999999976553322110 00 000
Q ss_pred hhhHH-HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KDTFR-KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..... ...+.. ........+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKE-----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----C-----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccch-----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 000000 00112245789999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=345.35 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=201.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCee---
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER--- 663 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 663 (947)
+.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999875 689999999987655666678899999999999999999999999877654
Q ss_pred ---EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 664 ---LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 664 ---~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999996 68887772 238899999999999999999997 79999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.... ........
T Consensus 189 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--i~~~~~~~ 261 (371)
T 4exu_A 189 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--ILKVTGVP 261 (371)
T ss_dssp TCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCC
T ss_pred CcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCC
Confidence 999865432 234578999999999877 6789999999999999999999999986553322211 11111110
Q ss_pred h---------hhHHHHhhccCCCChh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 K---------DTFRKAIDRTIDLDEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~---------~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
. ......+......... .......+.+|+.+||+.||++||++.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0111111111110000 0112356889999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=340.70 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=204.5
Q ss_pred hcCCCcCceecccCceEEEEEEE-c-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCC------CcceEEEEEEeC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGEL-H-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR------HLVGLLGYCLDG 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~ 660 (947)
.++|++.+.||+|+||.||+|.. + +|+.||||+++.. ....+.+.+|+++++.++|+ +++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999987 3 6889999998743 44567788999999999765 499999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---------
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--------- 731 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--------- 731 (947)
+..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+ ++|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 8999999865432 358899999999999999999997 89999999999999987
Q ss_pred ----------CCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCcc
Q 002255 732 ----------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDET 801 (947)
Q Consensus 732 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~ 801 (947)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999875432 23457999999999999989999999999999999999999999865
Q ss_pred CccchhhHHHHHHHhhcChhhHH--------------------------HHhhccCCCChhcHHHHHHHHHHHHHhcccC
Q 002255 802 QSEDSVHLVTWFRRMHINKDTFR--------------------------KAIDRTIDLDEETLASISTVADLAGHCCARE 855 (947)
Q Consensus 802 ~~~~~~~l~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 855 (947)
...+........... ....... ....+..............+.+++.+||+.|
T Consensus 238 ~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 238 DSKEHLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp CHHHHHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred ChHHHHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 543322221111100 0000000 0000000001112234567889999999999
Q ss_pred CCCCCCHHHHHH
Q 002255 856 PYQRPDMGHVVN 867 (947)
Q Consensus 856 P~~RPs~~evl~ 867 (947)
|++|||+.|+++
T Consensus 317 P~~Rpt~~ell~ 328 (339)
T 1z57_A 317 PAKRITLREALK 328 (339)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccccCHHHHhc
Confidence 999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=370.80 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=206.0
Q ss_pred hcCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|++.+.||+|+||.||+|.+.. +..||||+++.. ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4678999999999999999998742 567999998754 24555678999999999999999999999985 56689
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 467 lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999996532 348899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+. ..
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~------------ 603 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG------------ 603 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH------------
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HH------------
Confidence 7654322 22234467889999999998899999999999999999997 9999976543221 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+..... ...+......+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 604 -~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 604 -RIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -HHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHcCCC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111110 01111233568899999999999999999999999998864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=352.14 Aligned_cols=261 Identities=23% Similarity=0.271 Sum_probs=201.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC--------CCCcceEEEEEE-
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR--------HRHLVGLLGYCL- 658 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 658 (947)
.++|++.++||+|+||.||+|... +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 478999999999999999999865 6889999999743 445678899999999995 788999999987
Q ss_pred ---eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC-CeeecCCCCCcEEEcCCC-
Q 002255 659 ---DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDM- 733 (947)
Q Consensus 659 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~Nill~~~~- 733 (947)
.+...++||||+ ++++.+++..... ..+++..+..++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccch
Confidence 456789999999 6666666654322 358999999999999999999997 6 999999999999999775
Q ss_pred ------------------------------------------------cEEEeecCcceecCCCCCcceeeccccccccc
Q 002255 734 ------------------------------------------------RAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765 (947)
Q Consensus 734 ------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 765 (947)
.+||+|||+++..... .....||+.|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~ 260 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCccc
Confidence 8999999999876442 23357999999
Q ss_pred CccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhh---HHHHHHHh-hcChhhH------------------
Q 002255 766 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH---LVTWFRRM-HINKDTF------------------ 823 (947)
Q Consensus 766 aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~---l~~~~~~~-~~~~~~~------------------ 823 (947)
|||++.+..++.++|||||||++|||++|+.||......+... ....+... .......
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999999899999999999999999999999997655432211 11111111 0000000
Q ss_pred ----------HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 824 ----------RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 824 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.+.... .........+.+|+.+||+.||++|||++|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKY---EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTS---CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhc---ccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00111111 112345567889999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.75 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=196.1
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe-----
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD----- 659 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 659 (947)
...++|++.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 45678999999999999999999874 68999999987542 2346788999999999 79999999999987
Q ss_pred -CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEe
Q 002255 660 -GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (947)
Q Consensus 660 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 738 (947)
.+..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence 4678999999999999999976432 347889999999999999999997 799999999999999999999999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||......... .
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~-- 244 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---F-- 244 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H--
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---H--
Confidence 9999886543211 123457999999999986 567899999999999999999999999765432111 0
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+...... ..........+.+++.+||+.||++||++.++++
T Consensus 245 -----------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 -----------LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----------HHHHSCCC-CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----------HhhcCccc-cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01110000 0001112346789999999999999999999977
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.97 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=201.7
Q ss_pred HhcCCCcCceecccCceEEEEEEE--cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC---CCCCcceEEEEEE----
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL--HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCL---- 658 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 658 (947)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 3688999999876543333334566777777766 8999999999987
Q ss_pred -eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 659 -DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 659 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
.....++||||+. |+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 699999865432 348899999999999999999997 89999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .......
T Consensus 162 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~~~~ 236 (326)
T 1blx_A 162 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIG 236 (326)
T ss_dssp CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHC
T ss_pred ecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHcC
Confidence 999999865432 12334578999999999998899999999999999999999999998654322211 1111100
Q ss_pred cC-hhhHHH-------HhhccC--CCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 IN-KDTFRK-------AIDRTI--DLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ~~-~~~~~~-------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. ...+.. .+.... ............+.+++.+||+.||++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000 000000 000011122356789999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=351.53 Aligned_cols=255 Identities=10% Similarity=0.060 Sum_probs=183.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcC--CCCCcceEE-------EEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV--RHRHLVGLL-------GYCL 658 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 658 (947)
.+|...+.||+|+||.||+|.+. +|+.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999875 789999999987643 234456778885544444 699988755 5554
Q ss_pred eC-----------------CeeEEEEEecCCCchhhhhhcccccCCCcccHHHH------HHHHHHHHHHHHHHhhccCC
Q 002255 659 DG-----------------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR------LTIALDVARGVEYLHGLAHQ 715 (947)
Q Consensus 659 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~ 715 (947)
.. ...++||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||+ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33 33799999998 899999976432 2344445 7788999999999997 8
Q ss_pred CeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCcccccc--CCcCcccccccHHHHHHHHHh
Q 002255 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELIT 793 (947)
Q Consensus 716 ~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt 793 (947)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999999876431 123467799999999987 679999999999999999999
Q ss_pred CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 794 GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 794 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
|+.||........... ................ ........+.+|+.+||+.||++||++.|+++
T Consensus 289 g~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCC---------CBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccch---------hhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999987643211100 0000000000111111 11123456889999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=350.28 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=195.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC----C--e
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG----N--E 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~ 662 (947)
.+|+..++||+|+||.||+|++. +|+.||||++.... ..+.+|++++++++|||||++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888999999999999999885 68999999986542 1234699999999999999999998542 2 3
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-CcEEEeecC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 741 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG 741 (947)
.++||||+++ ++.+.+..... ....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5799999965 67666643222 22458999999999999999999996 899999999999999965 678999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...+.......
T Consensus 203 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 203 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPT 277 (420)
T ss_dssp TCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCC
T ss_pred hhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 9987654322 2345789999999998764 78999999999999999999999998754332 2222222221111
Q ss_pred -hhHHHHhhccCC---CC---hhcH------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 -DTFRKAIDRTID---LD---EETL------ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 -~~~~~~~~~~~~---~~---~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.+.+. .+.+. +. ...+ ....++.+|+.+||+.||++||++.|+++
T Consensus 278 ~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 278 REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111111 11110 00 0011 12356889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=347.86 Aligned_cols=263 Identities=21% Similarity=0.326 Sum_probs=195.1
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE------ 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 662 (947)
..+|++.++||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 357899999999999999999998777899998865421 12369999999999999999999965432
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CCCcEEEeecC
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFG 741 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfG 741 (947)
.++||||++++ +.+.+..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 78999999765 4443332211 12458899999999999999999997 8999999999999999 79999999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +...+.......
T Consensus 188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~ 262 (394)
T 4e7w_A 188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPS 262 (394)
T ss_dssp TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC
T ss_pred CcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 9987654322 2345789999999998764 589999999999999999999999987653322 222222211111
Q ss_pred hhHHHHhhccCC---C---Chhc------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DTFRKAIDRTID---L---DEET------LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~~~~~---~---~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........+... + .... .....++.+|+.+||+.||++||++.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 111111111100 0 0000 112356889999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=336.98 Aligned_cols=265 Identities=20% Similarity=0.342 Sum_probs=195.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEE---------
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL--------- 658 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------- 658 (947)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 478999999999999999999886 4899999998754 4566788999999999999999999999874
Q ss_pred -----eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CC
Q 002255 659 -----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DD 732 (947)
Q Consensus 659 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~ 732 (947)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ ++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTED 157 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCC
Confidence 3467899999997 699998843 347889999999999999999997 8999999999999997 56
Q ss_pred CcEEEeecCcceecCCCCC-cceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHH
Q 002255 733 MRAKVADFGLVRLAPDNGK-HSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV 810 (947)
Q Consensus 733 ~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~ 810 (947)
+.+||+|||+++....... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-- 235 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ-- 235 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 7999999999986643211 112234567999999998865 678999999999999999999999998765322211
Q ss_pred HHHHHhhcCh-hhHHHHh-------hccCCCC-----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 811 TWFRRMHINK-DTFRKAI-------DRTIDLD-----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 811 ~~~~~~~~~~-~~~~~~~-------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......... ....+.. ....... .........+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111100 0111110 0000000 001122456889999999999999999999977
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=341.10 Aligned_cols=269 Identities=24% Similarity=0.331 Sum_probs=202.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 661 (947)
+.++|++.+.||+|+||.||+|... +|+.||||++... .......++.+|++++++++||||+++++++..+ .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999876 6899999999643 2445567788999999999999999999998754 6
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
..++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999996 699988854 248899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcc--------eeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 742 LVRLAPDNGKHS--------IETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 742 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998765422111 1223578999999998754 6789999999999999999999999987653322111110
Q ss_pred HHHhhc--------ChhhHHHHhhccCCCChh-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHI--------NKDTFRKAIDRTIDLDEE-----TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~--------~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... ......+.+......... .......+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 001112222111110000 0122356789999999999999999999977
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=348.58 Aligned_cols=250 Identities=19% Similarity=0.241 Sum_probs=201.3
Q ss_pred CCCCCCce--eEeCCC---------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC--CCCCCCCCcEE
Q 002255 51 PDPCKWKH--IQCSPS---------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEV 117 (947)
Q Consensus 51 ~d~C~w~g--v~C~~~---------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L 117 (947)
.+.|.|.+ |.|+.. .+++.|+|++|++++..|..|.++++|++|+|++|.+.+.++ .|.++++|++|
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 34566655 888642 479999999999999889999999999999999999987664 69999999999
Q ss_pred ecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCccc--ccCCCCCCeEeccCceeeeccCcc-cCCCCCCCccEEEc
Q 002255 118 LFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPES--LKDATGLQRFSANGANITGTIPDF-LGGDTIPGLMHLHL 194 (947)
Q Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p~~-~~~~~l~~L~~L~L 194 (947)
+|++|+++++++..|.++++|++|+|++|++.+ .++.. +..+++|++|+|++|++++..|.. +. .+++|++|+|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--~l~~L~~L~L 161 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG-AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL--NMRRFHVLDL 161 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBT-HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG--GCTTCCEEEC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCc-cccCcccccCcccCCEEECCCCccCccCcccccC--CCCcccEEeC
Confidence 999999999999999999999999999999975 34444 999999999999999999888876 55 6899999999
Q ss_pred cCCcccCcCCccccC---CCCceeeeccCCCCCCCCCchh-----hhcCCCCCcEEEccCCcCcCCCCC-----------
Q 002255 195 AFNFLQGPIPLSFGK---SSIQTLWLNGQKGDSKLNGSVA-----VIQNMTSLTQLWLHGNSFTGPLPD----------- 255 (947)
Q Consensus 195 s~N~l~~~~p~~~~~---~~L~~L~l~~n~~~~~~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~----------- 255 (947)
++|++++..|..+.. .+|+.|++++|.+......... .+..+++|+.|+|++|++++..|.
T Consensus 162 ~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L 241 (455)
T 3v47_A 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI 241 (455)
T ss_dssp TTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCE
T ss_pred CCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccce
Confidence 999999988887755 5677888888877665433221 123456777777777777543221
Q ss_pred ---------------------------CC--CCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCC
Q 002255 256 ---------------------------LS--GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (947)
Q Consensus 256 ---------------------------~~--~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (947)
+. ..++|++|++++|++++.+|..+.++++|+.|+|++|++++..|..
T Consensus 242 ~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 318 (455)
T 3v47_A 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318 (455)
T ss_dssp EEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred eeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH
Confidence 11 1257888888888888888888888888888888888888776654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=341.96 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=200.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe-----
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE----- 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 662 (947)
.++|...+.||+|+||.||+|..+ +|+.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999875 68999999998765556667889999999999999999999999987654
Q ss_pred -eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 663 -RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 663 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
.++||||+. ++|.+++.. .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999996 688877632 38899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+ ........
T Consensus 172 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~ 244 (353)
T 3coi_A 172 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPG 244 (353)
T ss_dssp CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH--HHHHCBCC
T ss_pred cccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCC
Confidence 98765332 234578999999999876 67899999999999999999999999875533221111 11111100
Q ss_pred ---------hhHHHHhhcc-----CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 ---------DTFRKAIDRT-----IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ---------~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......+... .............+.+++.+||+.||++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111111110 0011111223456889999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.86 Aligned_cols=204 Identities=24% Similarity=0.310 Sum_probs=174.6
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CC-----CcceEEEEEEeC
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HR-----HLVGLLGYCLDG 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 660 (947)
+.++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+++++.++ |+ +|+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4578999999999999999999876 6889999999743 344567888999999885 55 499999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc--CCCcEEEe
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVA 738 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~ 738 (947)
+..++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+. +.+||||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 599999866432 3488999999999999999999952 37899999999999995 47889999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCcc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 804 (947)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999877442 22457999999999999999999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=342.72 Aligned_cols=274 Identities=23% Similarity=0.295 Sum_probs=192.3
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 661 (947)
.......++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 345667789999999999999999999875 68999999986542 22235567888889999999999999997643
Q ss_pred e-------eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CC
Q 002255 662 E-------RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DM 733 (947)
Q Consensus 662 ~-------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~ 733 (947)
. .++||||+++ +|.+.+..... ....+++..+..++.|++.||.|||.. .++|+||||||+|||++. ++
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence 3 7899999976 55444433211 224578899999999999999999921 289999999999999997 89
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+.. ...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEI 244 (360)
T ss_dssp EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH
T ss_pred cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHH
Confidence 999999999987654322 23457899999999986544 899999999999999999999999875533222 222
Q ss_pred HHHhhcChhhHHHHhhccC-CC--------------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHINKDTFRKAIDRTI-DL--------------DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~-~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..............+.+.. .. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2222111111111111110 00 0001113457889999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.98 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=192.4
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-------
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------- 659 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 659 (947)
..++|++.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4578999999999999999999875 7899999998643 4556789999999999999999999999865
Q ss_pred ------CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC
Q 002255 660 ------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (947)
Q Consensus 660 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 733 (947)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 356799999999999999996532 347888999999999999999997 7999999999999999999
Q ss_pred cEEEeecCcceecCCCCC------------cceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCc
Q 002255 734 RAKVADFGLVRLAPDNGK------------HSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDE 800 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~ 800 (947)
.+||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 999999999886543210 1122345689999999998754 68999999999999999998 4432
Q ss_pred cCccchhhHHHHHHHhhcChhhHHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 801 TQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 801 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. +.... ...+.......+ .........+.+++.+||+.||++||++.++++
T Consensus 231 ~~--~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 GM--ERVNI-------------LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH--HHHHH-------------HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch--hHHHH-------------HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11111 111111111111 111223345789999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=335.98 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=182.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367889999999999999999885 6899999999765433344445556666788889999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+ ++.+..+..... ..+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555554443221 348899999999999999999996 2389999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~ 238 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---------------EV 238 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------------HH
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---------------HH
Confidence 422 223457999999999984 4568899999999999999999999997543211 11
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+...........+........+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111222111111111122356889999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=339.75 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=180.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHH-HHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|+..+.||+|+||.||+|..+ +|+.||||++.... ......++..|+. +++.++||||+++++++.+++..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 67889999999999999999875 68999999997653 3344455666666 777789999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC-CeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
||++ |+|.+++..........+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 488777754322223568999999999999999999997 5 9999999999999999999999999999866
Q ss_pred CCCCCcceeecccccccccCcccc----ccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYA----VTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........ .
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~ 238 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------------Q 238 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------------H
Confidence 4432 12334799999999998 456789999999999999999999999975432100 0
Q ss_pred HHHHhhccC-CC-ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002255 823 FRKAIDRTI-DL-DEETLASISTVADLAGHCCAREPYQRPDMGHVVNV 868 (947)
Q Consensus 823 ~~~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 868 (947)
+...+.... .. ..........+.+++.+||+.||++||++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000111100 00 00011233568899999999999999999999773
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.03 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=201.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CC-cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC------cceEEEEEEeC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DG-TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH------LVGLLGYCLDG 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 660 (947)
.++|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999875 34 68999998743 445577889999999997765 89999999999
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE-----------
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----------- 729 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----------- 729 (947)
+..++||||+ ++++.+++.... ...+++.++..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 667777775432 2358999999999999999999996 899999999999999
Q ss_pred --------cCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCcc
Q 002255 730 --------GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDET 801 (947)
Q Consensus 730 --------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~ 801 (947)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56889999999999875442 23457999999999999999999999999999999999999999865
Q ss_pred CccchhhHHHHHHHhhcChhhHHH----------------------HhhccC----CCChhcHHHHHHHHHHHHHhcccC
Q 002255 802 QSEDSVHLVTWFRRMHINKDTFRK----------------------AIDRTI----DLDEETLASISTVADLAGHCCARE 855 (947)
Q Consensus 802 ~~~~~~~l~~~~~~~~~~~~~~~~----------------------~~~~~~----~~~~~~~~~~~~l~~li~~cl~~d 855 (947)
...+........... ........ .+.... ............+.+|+.+||+.|
T Consensus 243 ~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 243 ENREHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SHHHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CHHHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 543322221111100 00000000 000000 000111223456889999999999
Q ss_pred CCCCCCHHHHHH
Q 002255 856 PYQRPDMGHVVN 867 (947)
Q Consensus 856 P~~RPs~~evl~ 867 (947)
|++|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.21 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=173.4
Q ss_pred HhcCCCcC-ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CC
Q 002255 588 VTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GN 661 (947)
Q Consensus 588 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 661 (947)
+.++|.+. ++||+|+||.||+|..+ +|+.||||++... .. ...+....++.++||||+++++++.. +.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 45788885 46999999999999876 6899999998653 22 12223334667799999999999876 44
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEe
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 738 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~ 738 (947)
..++||||+++|+|.+++..+.. ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 58999999999999999975432 458999999999999999999997 79999999999999986 4569999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------- 239 (336)
T 3fhr_A 174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---------- 239 (336)
T ss_dssp CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------
Confidence 999998664422 233578999999999988889999999999999999999999997654322100
Q ss_pred ChhhHHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.....+........ .........+.+++.+||+.||++||++.|+++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 240 --GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00001111111111 111123456889999999999999999999987
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=370.82 Aligned_cols=396 Identities=19% Similarity=0.221 Sum_probs=248.4
Q ss_pred CCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcC-C-CCCCCCCCcEEecCCCcCCCCCccc
Q 002255 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-P-SLSGLSSLQEVLFDDNNFTSVPSDF 131 (947)
Q Consensus 54 C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~-p-~~~~l~~L~~L~L~~n~l~~~~~~~ 131 (947)
|.|..|.+ -..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+++++.|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 56777777 5678999999999999988999999999999999999776666 4 6999999999999999999999999
Q ss_pred ccCCCCCcEEeccCCCCCCCCCccc--ccCCCCCCeEeccCceeeeccC-cccCCCCCCCccEEEccCCcccCcCCcccc
Q 002255 132 FKGLTSLQTISLDYNSFDSWVIPES--LKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIPLSFG 208 (947)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (947)
|.++++|++|+|++|.+.+ .+|.. +.++++|++|+|++|.+++..+ ..|+ .+++|++|+|++|.+++..+..+.
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~-~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~L~~L~~L~Ls~N~i~~~~~~~l~ 169 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSD-AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG--KLNSLKSIDFSSNQIFLVCEHELE 169 (844)
T ss_dssp SCSCSSCCCEECTTCCCSS-CCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG--TCSSCCEEEEESSCCCCCCSGGGH
T ss_pred ccCCcccCEeeCcCCCCCc-ccccCccccccCCCCEEECCCCcccccccchhHh--hCCCCCEEECCCCcCCeeCHHHcc
Confidence 9999999999999999976 44544 8899999999999999987765 4566 688999999999998877665543
Q ss_pred C---CC------------------------------CceeeeccCCCCCCCCCchh------------------------
Q 002255 209 K---SS------------------------------IQTLWLNGQKGDSKLNGSVA------------------------ 231 (947)
Q Consensus 209 ~---~~------------------------------L~~L~l~~n~~~~~~~~~~~------------------------ 231 (947)
. .+ |+.|++++|.+.........
T Consensus 170 ~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~ 249 (844)
T 3j0a_A 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249 (844)
T ss_dssp HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence 2 22 56666666643322111100
Q ss_pred ---------hhcC--CCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccccc
Q 002255 232 ---------VIQN--MTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 232 ---------~~~~--l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
.+.+ .++|+.|+|++|.+++..+. +..+++|+.|+|++|++++..|..|..+++|++|+|++|++++.
T Consensus 250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 329 (844)
T 3j0a_A 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329 (844)
T ss_dssp SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCC
T ss_pred cccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCcc
Confidence 0111 13455555555555544432 44455555555555555544454555555555555555555444
Q ss_pred CCCCCCCcc-cc----------------cccCCCCcccCcCCCcCCC------------ccceeeeccc-----------
Q 002255 300 TPKFNSPVR-FD----------------MAKGSNSFCLDDAGVACDG------------RVNVLLSIVK----------- 339 (947)
Q Consensus 300 ~p~~~~~~~-~~----------------~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~----------- 339 (947)
.|..+..+. +. +....++..++...+.+.. ..+.+...+.
T Consensus 330 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls 409 (844)
T 3j0a_A 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLS 409 (844)
T ss_dssp CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECC
T ss_pred CHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecc
Confidence 443322111 00 0001111222222221111 0000000000
Q ss_pred -----ccC------ChhhhhccCC-------------------------CCCCCCCCCC-C---cccCCCCceeEEEecC
Q 002255 340 -----SVG------YPAVLAESWK-------------------------GNNPCNSDWK-G---VSCDAGGNITVVNLKN 379 (947)
Q Consensus 340 -----~l~------~~~~l~~~~~-------------------------~~~~~~~~~~-~---~~~~~~~~L~~L~Ls~ 379 (947)
.+. ....+..... ..+.....+. + ..+..+++|+.|+|++
T Consensus 410 ~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~ 489 (844)
T 3j0a_A 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489 (844)
T ss_dssp SCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCH
T ss_pred cCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCC
Confidence 000 0000000000 0000000000 0 0123356788888888
Q ss_pred CCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccce-eeecCCCCCCCCCC
Q 002255 380 LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV-IVKTDGNPDIGKDS 455 (947)
Q Consensus 380 n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~-~~~~~~n~~~~~~~ 455 (947)
|++++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|+|.+|..+... .+.+.+||+.|.+.
T Consensus 490 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 490 NYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp HHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred CcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 888888888888888899999999988865555555 788899999999999888765544 56789999999765
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=348.98 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=187.5
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 668 (947)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 455667899999999998877778999999998643 235678899999986 89999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCC--CcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC-------------C
Q 002255 669 YMPQGTLSRHLFNRKEEGL--KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-------------M 733 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-------------~ 733 (947)
|+. |+|.+++........ ....+..++.++.||+.||+|||+ .+|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 799999976432211 111333457899999999999997 899999999999999754 4
Q ss_pred cEEEeecCcceecCCCCCcc--eeecccccccccCcccccc-------CCcCcccccccHHHHHHHHHh-CCCCCCccCc
Q 002255 734 RAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELIT-GRKALDETQS 803 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~ 803 (947)
.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999999775532211 1234579999999999865 578999999999999999999 9999975432
Q ss_pred cchhhHHHHHHHhhcChhhHHHHhhccCCC----ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDL----DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 804 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. ..++...... .........++.+++.+||+.||++||++.||++
T Consensus 246 ~~------------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RE------------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH------------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH------------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 0111111111 1112344567889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.95 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-----------CCCcceEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----------HRHLVGLLGYC 657 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 657 (947)
++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 6899999999999999999987 46899999998743 344567889999999886 89999999998
Q ss_pred EeCC----eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCC-CeeecCCCCCcEEEc--
Q 002255 658 LDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLG-- 730 (947)
Q Consensus 658 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~Nill~-- 730 (947)
...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEecc
Confidence 8654 789999999 9999999865432 348899999999999999999997 5 999999999999994
Q ss_pred ----CCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccc-
Q 002255 731 ----DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSED- 805 (947)
Q Consensus 731 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~- 805 (947)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4458999999999876442 223479999999999999899999999999999999999999997654221
Q ss_pred ---hhhHHHHHHHhhcChhh----------------------------HHHHhhccCCCChhcHHHHHHHHHHHHHhccc
Q 002255 806 ---SVHLVTWFRRMHINKDT----------------------------FRKAIDRTIDLDEETLASISTVADLAGHCCAR 854 (947)
Q Consensus 806 ---~~~l~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 854 (947)
...+...+......... ....+..... ........+.+|+.+||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK---FSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC---CCHHHHHHHHHHHGGGGCS
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc---CCcchHHHHHHHHHHHhcc
Confidence 11111111111100000 0111111111 1234556788999999999
Q ss_pred CCCCCCCHHHHHH
Q 002255 855 EPYQRPDMGHVVN 867 (947)
Q Consensus 855 dP~~RPs~~evl~ 867 (947)
||++|||++|+++
T Consensus 321 dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 321 DPRKRADAGGLVN 333 (373)
T ss_dssp STTTCBCHHHHHT
T ss_pred CccccCCHHHHhh
Confidence 9999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=336.17 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=200.0
Q ss_pred HHHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCC--CCCcceEEEE
Q 002255 584 VLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVR--HRHLVGLLGY 656 (947)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~ 656 (947)
......++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33456688999999999999999999864 68999999997653322 12245678999999996 5999999999
Q ss_pred EEeCCeeEEEEEecCC-CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CCCc
Q 002255 657 CLDGNERLLVYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMR 734 (947)
Q Consensus 657 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~ 734 (947)
+..++..++|||++.+ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999976 8999998653 348899999999999999999997 8999999999999999 7899
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 189 ~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred EEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 9999999998765432 234579999999999877665 6889999999999999999999964310
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.......... .....+.+++.+||+.||++||++.|+++
T Consensus 255 ------------~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ------------IIRGQVFFRQ---RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------------HHHCCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------hhcccccccc---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111111 12345789999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=331.72 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=191.4
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcC----CCCCcceEEE
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKV----RHRHLVGLLG 655 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~ 655 (947)
.+...++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4456789999999999999999999764 68899999997653222 1234466799999999 8999999999
Q ss_pred EEEeCCeeEEEEEe-cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CCC
Q 002255 656 YCLDGNERLLVYEY-MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 733 (947)
Q Consensus 656 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~ 733 (947)
++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 7899999999653 248899999999999999999997 7999999999999999 889
Q ss_pred cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcC-cccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 734 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
.+||+|||+++...... .....||+.|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------
Confidence 99999999998765432 2345799999999998776664 58999999999999999999996421
Q ss_pred HHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.......... .....+.+++.+||+.||++||++.|+++
T Consensus 244 ------------~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 ------------EILEAELHFPA---HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------------HHHHTCCCCCT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------HHhhhccCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111111 12345789999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=342.92 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=185.6
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.++...++|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 46888899999999997766667799999999865422 2356799999999 79999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-----CCcEEEeecCcc
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGLV 743 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~kl~DfGla 743 (947)
|+. |+|.+++..... ...+.++..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||++
T Consensus 99 ~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 995 699999865432 23344567899999999999997 79999999999999953 346889999999
Q ss_pred eecCCCCCc-ceeecccccccccCccccc---cCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhc
Q 002255 744 RLAPDNGKH-SIETRLAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 744 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
+........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------------- 237 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------------- 237 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------------
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------------
Confidence 876543211 2234467999999999987 4567889999999999999999 899996543211
Q ss_pred ChhhHHHHhhc-cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDR-TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....... ..............+.+|+.+||+.||++||++.||++
T Consensus 238 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 ----ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----HHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111111 11111111223345779999999999999999999985
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=364.36 Aligned_cols=355 Identities=26% Similarity=0.389 Sum_probs=256.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-C-CCCCCCCcEEecCCCcCCCCCcccccCCC-CCcEE
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-S-LSGLSSLQEVLFDDNNFTSVPSDFFKGLT-SLQTI 141 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L 141 (947)
..++.|+|++|.+++.+|..|+++++|++|+|++|.++|.+| . +.++++|++|+|++|++++..|..+..++ +|++|
T Consensus 294 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L 373 (768)
T 3rgz_A 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373 (768)
T ss_dssp TTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEE
T ss_pred CcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEE
Confidence 578899999999999999999999999999999999988887 3 88888888888888888866665555544 45555
Q ss_pred e--------------------------ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEcc
Q 002255 142 S--------------------------LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195 (947)
Q Consensus 142 ~--------------------------Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls 195 (947)
+ |++|++.+ .+|..+.++++|++|++++|++++.+|..++ .+++|++|+|+
T Consensus 374 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~--~l~~L~~L~L~ 450 (768)
T 3rgz_A 374 DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG-KIPPTLSNCSELVSLHLSFNYLSGTIPSSLG--SLSKLRDLKLW 450 (768)
T ss_dssp ECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEE-ECCGGGGGCTTCCEEECCSSEEESCCCGGGG--GCTTCCEEECC
T ss_pred EccCCCcCCCcChhhhhcccCCccEEECCCCcccc-ccCHHHhcCCCCCEEECcCCcccCcccHHHh--cCCCCCEEECC
Confidence 4 44554443 4666777777777777777777777777776 57778888888
Q ss_pred CCcccCcCCccccC-CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccc
Q 002255 196 FNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLT 273 (947)
Q Consensus 196 ~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 273 (947)
+|++++.+|..+.. .+|+.|+|++|.+..... ..+.++++|+.|+|++|++++.+|. +..+++|++|+|++|+++
T Consensus 451 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 527 (768)
T 3rgz_A 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIP---SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC---GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred CCcccCcCCHHHcCCCCceEEEecCCcccCcCC---HHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCccc
Confidence 88887777777755 678888888887765543 3467788999999999999988885 788899999999999999
Q ss_pred cCCCccccCCCCCCeEeccCCcccccCCCCCCCccc----cc--------------------------------------
Q 002255 274 GIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRF----DM-------------------------------------- 311 (947)
Q Consensus 274 g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~----~~-------------------------------------- 311 (947)
|.+|..+.++++|+.|+|++|+++|.+|..+..... ..
T Consensus 528 ~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (768)
T 3rgz_A 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607 (768)
T ss_dssp EECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGG
T ss_pred CcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcc
Confidence 999999999999999999999999998864322110 00
Q ss_pred ---------------------ccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCC
Q 002255 312 ---------------------AKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370 (947)
Q Consensus 312 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 370 (947)
....+...++...+.+.+..+ ..++....+.......+...... ...+..+.
T Consensus 608 ~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip------~~l~~l~~L~~L~Ls~N~l~g~i-p~~l~~L~ 680 (768)
T 3rgz_A 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP------KEIGSMPYLFILNLGHNDISGSI-PDEVGDLR 680 (768)
T ss_dssp GGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC------GGGGGCTTCCEEECCSSCCCSCC-CGGGGGCT
T ss_pred ccccccccccceecccCchhhhccccccEEECcCCcccccCC------HHHhccccCCEEeCcCCccCCCC-ChHHhCCC
Confidence 000111222333333332222 22222222222222222211111 11344567
Q ss_pred ceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccccc-cccc
Q 002255 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH-LFGK 433 (947)
Q Consensus 371 ~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~-l~g~ 433 (947)
+|+.|+|++|+++|.||..++++++|++|||++|+|+|.||.. +.+..+..+.+.+|. |+|.
T Consensus 681 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp TCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 8999999999999999999999999999999999999999965 556677777888885 7775
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=348.32 Aligned_cols=374 Identities=17% Similarity=0.154 Sum_probs=264.4
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++.+| .|.++++|++|+|++|++++++|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 478999999999998888889999999999999999998877 6899999999999999999998888999999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeee-ccCcccCCCCCCCccEEEccCCcccCcCCccccC-------------
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK------------- 209 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------- 209 (947)
++|++.. ..+..++++++|++|++++|.+++ .+|..++ .+++|++|+|++|++++..|..++.
T Consensus 112 ~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l 188 (606)
T 3vq2_A 112 VETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFS--NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188 (606)
T ss_dssp TTSCCCC-SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG--TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEEC
T ss_pred cCCcccc-ccccccCCCCCCCEEeCCCCcccceechHhHh--hcCCCCEEEccCCcceecChhhhhhhhccccccceeec
Confidence 9999876 455778999999999999999886 6788887 6889999999988888766554322
Q ss_pred ---------------CCCceeeeccCCCC---------------------------------------------------
Q 002255 210 ---------------SSIQTLWLNGQKGD--------------------------------------------------- 223 (947)
Q Consensus 210 ---------------~~L~~L~l~~n~~~--------------------------------------------------- 223 (947)
.+|+.|++++|.+.
T Consensus 189 ~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred cCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 13444444444321
Q ss_pred ----------------------------------------------------CCC----------------CCchhhhcC
Q 002255 224 ----------------------------------------------------SKL----------------NGSVAVIQN 235 (947)
Q Consensus 224 ----------------------------------------------------~~~----------------~~~~~~~~~ 235 (947)
... ......+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 000 000001234
Q ss_pred CCCCcEEEccCCcCcCCC--C-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCC-CCCCCccccc
Q 002255 236 MTSLTQLWLHGNSFTGPL--P-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP-KFNSPVRFDM 311 (947)
Q Consensus 236 l~~L~~L~L~~N~l~~~~--~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~~ 311 (947)
+++|+.|+|++|.+++.. + .+..+++|++|++++|.+++ +|..+..+++|+.|++++|++++.+| ..+...
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l---- 423 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL---- 423 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC----
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcc----
Confidence 456666666666666542 2 35667888888888888884 66788888888888888888888766 332211
Q ss_pred ccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeecccccc
Q 002255 312 AKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFS 391 (947)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~ 391 (947)
.+...++...+.+..... ..+.....+.......+..........+..+.+|+.|+|++|++++.+|..|+
T Consensus 424 ---~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 494 (606)
T 3vq2_A 424 ---EKLLYLDISYTNTKIDFD------GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494 (606)
T ss_dssp ---TTCCEEECTTSCCEECCT------TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred ---ccCCEEECcCCCCCccch------hhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhc
Confidence 122222222222221111 11111111222221111110000011234567899999999999999999999
Q ss_pred CCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCcc-----ceeeecCCCCCCCCCCC
Q 002255 392 RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ-----NVIVKTDGNPDIGKDSS 456 (947)
Q Consensus 392 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~-----~~~~~~~~n~~~~~~~~ 456 (947)
++++|+.|+|++|++++.+|..+..+++|+.|||++|+|+ .+|.... ...+.+.+|++.|..+.
T Consensus 495 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999999999999999988999999999999999999998 5665322 23467899999997653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.76 Aligned_cols=233 Identities=12% Similarity=0.078 Sum_probs=185.7
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 468999999999999999999876 489999999986543 345568899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++... ....++.+++.|++.||+|||+ ++|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999998431 2344678899999999999997 899999999999999999999998443
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
|++ .++.++|||||||++|||++|+.||.+....+..... . ..
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------~----~~ 217 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------E----RD 217 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------C----BC
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------H----HH
Confidence 333 3688999999999999999999999876543211000 0 00
Q ss_pred hhccCCC-ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 827 IDRTIDL-DEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 827 ~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+...... ..........+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000000 00011223468899999999999999 99999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=337.15 Aligned_cols=335 Identities=16% Similarity=0.171 Sum_probs=270.9
Q ss_pred CCceeEeCCC----------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc
Q 002255 55 KWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN 123 (947)
Q Consensus 55 ~w~gv~C~~~----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~ 123 (947)
.|..|.|... .+++.|+|++|++++..+..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4778888632 368899999999998888889999999999999999998877 78999999999999999
Q ss_pred CCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcC
Q 002255 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (947)
Q Consensus 124 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (947)
++.+++..|.++++|++|+|++|++.. ..+..+.++++|++|++++|.+++..|..|. .+++|++|+|++|++++..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFS--GLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSST--TCTTCCEEEEESCCCSSCC
T ss_pred CCccCcccccCCCCCCEEECCCCcccc-CChhHccccccCCEEECCCCccceeChhhcc--CCCCCCEEECCCCcCcccC
Confidence 999999889999999999999999976 6678889999999999999999988888887 6889999999999998665
Q ss_pred CccccC-CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCcccc
Q 002255 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLV 281 (947)
Q Consensus 204 p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~ 281 (947)
+..+.. .+|+.|+|++|.+...... .+.++++|+.|+|++|.+.+.++ ......+|+.|+|++|++++..+..+.
T Consensus 169 ~~~l~~l~~L~~L~l~~n~i~~~~~~---~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 245 (477)
T 2id5_A 169 TEALSHLHGLIVLRLRHLNINAIRDY---SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245 (477)
T ss_dssp HHHHTTCTTCCEEEEESCCCCEECTT---CSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHT
T ss_pred hhHhcccCCCcEEeCCCCcCcEeChh---hcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhc
Confidence 555654 6799999999888765443 36678899999999988777665 355566899999999999855446788
Q ss_pred CCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCC
Q 002255 282 NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDW 361 (947)
Q Consensus 282 ~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~ 361 (947)
++++|+.|+|++|++++..+..+
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~--------------------------------------------------------- 268 (477)
T 2id5_A 246 HLVYLRFLNLSYNPISTIEGSML--------------------------------------------------------- 268 (477)
T ss_dssp TCTTCCEEECCSSCCCEECTTSC---------------------------------------------------------
T ss_pred CccccCeeECCCCcCCccChhhc---------------------------------------------------------
Confidence 89999999999999886655321
Q ss_pred CCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCcc--
Q 002255 362 KGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ-- 439 (947)
Q Consensus 362 ~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~-- 439 (947)
....+|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.+..+..+.
T Consensus 269 -----~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~ 343 (477)
T 2id5_A 269 -----HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFR 343 (477)
T ss_dssp -----TTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHT
T ss_pred -----cccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHh
Confidence 2234789999999999999999999999999999999999966566788999999999999999887653211
Q ss_pred -ceeeecCCCCCCCCCCCC
Q 002255 440 -NVIVKTDGNPDIGKDSSS 457 (947)
Q Consensus 440 -~~~~~~~~n~~~~~~~~~ 457 (947)
.....+.++...|..|..
T Consensus 344 ~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 344 RRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp TTTSSCCTTCCCBEEESGG
T ss_pred hhhccccCccCceeCCchH
Confidence 111334556666655433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=354.46 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=195.8
Q ss_pred hcCCCcCceecccCceEEEEEEEc--CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe----
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE---- 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 662 (947)
.++|++.++||+|+||.||+|.+. +|+.||||++.... .......+.+|++++++++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999885 58999999986542 44556788999999999999999999999987655
Q ss_pred -eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 663 -RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 663 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
.|+||||+++++|.+++.. .+++.+++.++.||+.||+|||+ ++||||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999887632 48999999999999999999997 899999999999999986 99999999
Q ss_pred cceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 742 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|..||........
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------- 284 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------- 284 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------
T ss_pred cchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------
Confidence 99876543 335799999999988765 48999999999999999999988865321110
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD-MGHVVNVLSSLA 873 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~l~ 873 (947)
............+.+++.+||+.||++||+ +.++.+.|..+.
T Consensus 285 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 001111222356789999999999999995 666767666553
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=339.39 Aligned_cols=378 Identities=17% Similarity=0.165 Sum_probs=250.8
Q ss_pred CCCCceeEeCCC------------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEec
Q 002255 53 PCKWKHIQCSPS------------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLF 119 (947)
Q Consensus 53 ~C~w~gv~C~~~------------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L 119 (947)
.|.|.|+ |+.. .+++.|+|++|++++..|..|.++++|++|+|++|++++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4899888 8632 379999999999999889999999999999999999999887 7999999999999
Q ss_pred CCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccC-cccCCCCCCCccEEEccCCc
Q 002255 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNF 198 (947)
Q Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~ 198 (947)
++|+++++++..|+.+++|++|+|++|++....+|..++++++|++|++++|.+.+.+| ..+. .+++|++|+|++|+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~--~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA--GLTSLNELEIKALS 159 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--TCCEEEEEEEEETT
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhh--cccccCeeeccCCc
Confidence 99999999999999999999999999999865567889999999999999999655665 5676 68999999999999
Q ss_pred ccCcCCccccC-------------------------CCCceeeeccCCCCCCCCCch-----------------------
Q 002255 199 LQGPIPLSFGK-------------------------SSIQTLWLNGQKGDSKLNGSV----------------------- 230 (947)
Q Consensus 199 l~~~~p~~~~~-------------------------~~L~~L~l~~n~~~~~~~~~~----------------------- 230 (947)
+++.+|..++. .+|+.|++++|.+........
T Consensus 160 l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred ccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 99888877643 356667777766654210000
Q ss_pred -----hhhcC-----------------------------------------------------------CCCCcEEEccC
Q 002255 231 -----AVIQN-----------------------------------------------------------MTSLTQLWLHG 246 (947)
Q Consensus 231 -----~~~~~-----------------------------------------------------------l~~L~~L~L~~ 246 (947)
..+.. ..+|+.|++++
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 00000 12233333333
Q ss_pred CcCcCCCCCC-CCCCCCCEEEccCCccccCCCc---cccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCc
Q 002255 247 NSFTGPLPDL-SGLSSLQDFSVRDNQLTGIVPS---SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDD 322 (947)
Q Consensus 247 N~l~~~~~~~-~~l~~L~~L~l~~N~l~g~~p~---~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~ 322 (947)
|.++..+..+ ..+++|++|++++|++++.+|. .++.+++|++|+|++|++++..+.. ..+....+...++.
T Consensus 320 n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-----~~~~~l~~L~~L~L 394 (549)
T 2z81_A 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG-----EILLTLKNLTSLDI 394 (549)
T ss_dssp SCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHH-----HHGGGCTTCCEEEC
T ss_pred CccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccch-----hhhhcCCCCCEEEC
Confidence 3333211122 2456666666666666665532 2556666666666666665432100 00111122222222
Q ss_pred CCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEecc
Q 002255 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLS 402 (947)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls 402 (947)
..+.+. ..+..+..+..+.......+. +..+......+|+.|+|++|++++.+ +.+++|++|+|+
T Consensus 395 s~N~l~-------~lp~~~~~~~~L~~L~Ls~N~----l~~l~~~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 395 SRNTFH-------PMPDSCQWPEKMRFLNLSSTG----IRVVKTCIPQTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp TTCCCC-------CCCSCCCCCTTCCEEECTTSC----CSCCCTTSCTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred CCCCCc-------cCChhhcccccccEEECCCCC----cccccchhcCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 222222 111111111111111111111 11111112357888888888888743 467888888888
Q ss_pred CCcccccCCCcCCCCCCCCccccccccccccCCCCccc----eeeecCCCCCCCCCC
Q 002255 403 GNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN----VIVKTDGNPDIGKDS 455 (947)
Q Consensus 403 ~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~----~~~~~~~n~~~~~~~ 455 (947)
+|+|+ .||. ...+++|++|||++|+|++.+|..+.. ..+.+.+|++.|..+
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 88888 7886 467888888888888888888864432 246778888877653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=348.17 Aligned_cols=271 Identities=24% Similarity=0.352 Sum_probs=202.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe------CC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------GN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 661 (947)
.++|++.++||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++.. ++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 478999999999999999999764 6899999998764 355667889999999999999999999998765 66
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc---EEEe
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVA 738 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~ 738 (947)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 78999999999999999976432 2357888999999999999999997 89999999999999997765 9999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .|......
T Consensus 167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~ 238 (676)
T 3qa8_A 167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVRE 238 (676)
T ss_dssp SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-
T ss_pred cccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhc
Confidence 999998765432 2234679999999999999999999999999999999999999997542110 00000000
Q ss_pred Chh---hHHHHhhccCCC-------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhh
Q 002255 819 NKD---TFRKAIDRTIDL-------DEETLASISTVADLAGHCCAREPYQRPDMGH-----VVNVLSSLA 873 (947)
Q Consensus 819 ~~~---~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~l~ 873 (947)
... ............ ..........+.+++.+||+.||++||++.+ ..+.+..+.
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000 000000011100 1112234567889999999999999999988 445555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.65 Aligned_cols=245 Identities=17% Similarity=0.151 Sum_probs=182.0
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccc-cChHHHHHHHHHHHHHHcCCC-CCcc---------e-----
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRH-RHLV---------G----- 652 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv---------~----- 652 (947)
..|...++||+|+||.||+|.+. +|+.||||++.... ......+.+.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45677889999999999999864 79999999987432 223345789999999999987 3211 1
Q ss_pred -------EEEEEEe-----CCeeEEEEEecCCCchhhhhhccc--ccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCee
Q 002255 653 -------LLGYCLD-----GNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFI 718 (947)
Q Consensus 653 -------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv 718 (947)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.||++||+|||+ ++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 1111111 22456777765 789998884221 1122458899999999999999999997 8999
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCcccc----------ccCCcCcccccccHHHHH
Q 002255 719 HRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA----------VTGRVTTKVDVFSFGVIL 788 (947)
Q Consensus 719 HrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil 788 (947)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999875432 334577 999999998 555688999999999999
Q ss_pred HHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 789 MELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 789 ~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
|||++|+.||......+.. ...+..... .+..+.+|+.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~----------------~~~~~~~~~-------~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS----------------EWIFRSCKN-------IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS----------------GGGGSSCCC-------CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhH----------------HHHHhhccc-------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999765432211 111111111 1255889999999999999999988865
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=335.65 Aligned_cols=244 Identities=15% Similarity=0.156 Sum_probs=184.3
Q ss_pred CceeEeCC----------CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcC
Q 002255 56 WKHIQCSP----------SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNF 124 (947)
Q Consensus 56 w~gv~C~~----------~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l 124 (947)
+..|.|.. ...++.|+|++|++++..|..|+++++|++|+|++|++++..| .|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 45677853 2478999999999998888999999999999999999999887 799999999999999999
Q ss_pred CCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCC
Q 002255 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (947)
Q Consensus 125 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (947)
+++++..|+++++|++|+|++|++.+ ..+..++++++|++|++++|.+++..+..+. .+++|++|+|++|++++..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGF--PTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTC--CCTTCCEEECCSSCCCEECH
T ss_pred cccChhhhcccccccEeeccccCccc-CCcchhccCCcccEEECCCCcccccCccccc--CCcccCEEEcccCcccccCh
Confidence 99999999999999999999999976 4467889999999999999999874433333 37888888888888887666
Q ss_pred ccccC-CCCc--eeeeccCCCCCCCCCch---------------------------------------------------
Q 002255 205 LSFGK-SSIQ--TLWLNGQKGDSKLNGSV--------------------------------------------------- 230 (947)
Q Consensus 205 ~~~~~-~~L~--~L~l~~n~~~~~~~~~~--------------------------------------------------- 230 (947)
..++. .+|+ .|++++|.+........
T Consensus 171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 66644 4566 66777776554332211
Q ss_pred ---------------------hhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeE
Q 002255 231 ---------------------AVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (947)
Q Consensus 231 ---------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L 289 (947)
..+.++++|+.|+|++|+++..++.+..+++|++|++++|++++..|..+.++++|++|
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 12445666666666666666544456666666666666666666656666666666666
Q ss_pred eccCCcccccCCC
Q 002255 290 NLTNNLFQGQTPK 302 (947)
Q Consensus 290 ~Ls~N~l~g~~p~ 302 (947)
++++|.+.+.+|.
T Consensus 331 ~l~~n~~~~~~~~ 343 (606)
T 3t6q_A 331 SIKGNTKRLELGT 343 (606)
T ss_dssp ECCSCSSCCBCCS
T ss_pred ECCCCCcccccch
Confidence 6666666655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.04 Aligned_cols=231 Identities=20% Similarity=0.312 Sum_probs=178.6
Q ss_pred HhcCCCcC-ceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHH-HcCCCCCcceEEEEEEe----C
Q 002255 588 VTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVL-TKVRHRHLVGLLGYCLD----G 660 (947)
Q Consensus 588 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~ 660 (947)
+.++|.+. ++||+|+||.||+|... +++.||+|++... ..+.+|+.++ +..+||||+++++++.. +
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 34667776 78999999999999874 6899999998643 3567888888 55699999999999987 6
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl 737 (947)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred ceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEE
Confidence 778999999999999999976432 358999999999999999999997 89999999999999998 789999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
+|||+++... +..++.++|||||||++|||++|+.||.........
T Consensus 162 ~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------- 207 (299)
T 3m2w_A 162 TDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------- 207 (299)
T ss_dssp CCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------
T ss_pred eccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------
Confidence 9999986542 235678999999999999999999999754322100
Q ss_pred cChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.................. ......+.+++.+||+.||++||++.|+++
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 208 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000111111100 123456889999999999999999999987
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=329.23 Aligned_cols=137 Identities=18% Similarity=0.197 Sum_probs=117.1
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEe
Q 002255 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 64 ~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (947)
..+++.|+|++|++++..|..|.++++|++|+|++|++++..| .|.++++|++|+|++|+++.++.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEE
Confidence 3689999999999998888899999999999999999999877 699999999999999999988876 799999999
Q ss_pred ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCc--cEEEccCCcc--cCcCCcccc
Q 002255 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL--MHLHLAFNFL--QGPIPLSFG 208 (947)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~ 208 (947)
|++|++....+|..++++++|++|++++|.+++.. +. .+++| ++|+|++|++ ++..|..+.
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~---~~--~l~~L~L~~L~L~~n~l~~~~~~~~~l~ 192 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD---LL--PVAHLHLSCILLDLVSYHIKGGETESLQ 192 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT---TG--GGTTSCEEEEEEEESSCCCCSSSCCEEE
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccCc---hh--hhhhceeeEEEeecccccccccCccccc
Confidence 99999987556789999999999999999998632 22 34455 8888888888 666665553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=325.25 Aligned_cols=325 Identities=17% Similarity=0.178 Sum_probs=280.4
Q ss_pred eeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCC
Q 002255 58 HIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136 (947)
Q Consensus 58 gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 136 (947)
+..|... ...+++.+++++ .+|..+. ++|+.|+|++|++++..+ .|.++++|++|+|++|.++++.+..|.+++
T Consensus 6 ~C~C~~~--~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 80 (477)
T 2id5_A 6 RCECSAQ--DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80 (477)
T ss_dssp TCEEETT--TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CCeECCC--CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCc
Confidence 4457543 246889999988 7787664 689999999999999887 799999999999999999999999999999
Q ss_pred CCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCcee
Q 002255 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTL 215 (947)
Q Consensus 137 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L 215 (947)
+|++|+|++|++.. ..+..|.++++|++|+|++|.+++..|..|. .+++|++|+|++|++++..+..|.. .+|+.|
T Consensus 81 ~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 157 (477)
T 2id5_A 81 NLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQ--DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQL 157 (477)
T ss_dssp TCCEEECCSSCCCS-CCTTSSTTCTTCCEEECTTSCCCEECTTTTT--TCTTCCEEEECCTTCCEECTTSSTTCTTCCEE
T ss_pred cCCEEECCCCcCCc-cCcccccCCCCCCEEECCCCccccCChhHcc--ccccCCEEECCCCccceeChhhccCCCCCCEE
Confidence 99999999999976 4445689999999999999999999998887 7999999999999999888888865 789999
Q ss_pred eeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCC
Q 002255 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294 (947)
Q Consensus 216 ~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N 294 (947)
+|++|.+.... ...+.++++|+.|+|++|.+++..+ .+..+++|+.|++++|.+.+.+|..+....+|+.|+|++|
T Consensus 158 ~l~~n~l~~~~---~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n 234 (477)
T 2id5_A 158 TLEKCNLTSIP---TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234 (477)
T ss_dssp EEESCCCSSCC---HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESS
T ss_pred ECCCCcCcccC---hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCC
Confidence 99999877543 3457789999999999999998777 4888999999999999988888888888889999999999
Q ss_pred cccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeE
Q 002255 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITV 374 (947)
Q Consensus 295 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~ 374 (947)
++++..+. .+..+.+|+.
T Consensus 235 ~l~~~~~~--------------------------------------------------------------~~~~l~~L~~ 252 (477)
T 2id5_A 235 NLTAVPYL--------------------------------------------------------------AVRHLVYLRF 252 (477)
T ss_dssp CCCSCCHH--------------------------------------------------------------HHTTCTTCCE
T ss_pred cccccCHH--------------------------------------------------------------HhcCccccCe
Confidence 98743221 1123457999
Q ss_pred EEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccc----eeeecCCCCC
Q 002255 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN----VIVKTDGNPD 450 (947)
Q Consensus 375 L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~----~~~~~~~n~~ 450 (947)
|+|++|.+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+.. ..+.+.+|++
T Consensus 253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 332 (477)
T 2id5_A 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332 (477)
T ss_dssp EECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCE
T ss_pred eECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCc
Confidence 999999999988899999999999999999999999999999999999999999999877754332 3577899999
Q ss_pred CCCCC
Q 002255 451 IGKDS 455 (947)
Q Consensus 451 ~~~~~ 455 (947)
.|...
T Consensus 333 ~c~c~ 337 (477)
T 2id5_A 333 ACDCR 337 (477)
T ss_dssp ECSGG
T ss_pred cCccc
Confidence 98754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=338.55 Aligned_cols=375 Identities=18% Similarity=0.132 Sum_probs=268.3
Q ss_pred CCCceeEeCC----------CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCC
Q 002255 54 CKWKHIQCSP----------SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122 (947)
Q Consensus 54 C~w~gv~C~~----------~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n 122 (947)
|.+..|.|+. ..+++.|+|++|++++..+..|.++++|++|+|++|.+++.+| .|.++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4455566642 2479999999999998777889999999999999999999888 6899999999999999
Q ss_pred cCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCc
Q 002255 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202 (947)
Q Consensus 123 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~ 202 (947)
+++++++..|.++++|++|+|++|++.+ ..|..++++++|++|++++|.+++..|..++ .+++|++|+|++|++++.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQV--QLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSS--CCTTCCEEECCSSCCCCB
T ss_pred ccCccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEEECCCCcccccCchhhc--ccccCCEEEccCCccccc
Confidence 9999999999999999999999999975 5568899999999999999999999888887 799999999999999987
Q ss_pred CCcccc---CCCCceeeeccCCCCCCCCCchhhhcC------------------------CCCCcEEEccCCcCcCCCCC
Q 002255 203 IPLSFG---KSSIQTLWLNGQKGDSKLNGSVAVIQN------------------------MTSLTQLWLHGNSFTGPLPD 255 (947)
Q Consensus 203 ~p~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~------------------------l~~L~~L~L~~N~l~~~~~~ 255 (947)
.+..+. ..+|+.|++++|.+..........+.+ .++|+.|+|++|.+++..|.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 776553 368999999999888766554433222 26788889999999887774
Q ss_pred -CCCCC--CCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcc-cccccC-----------------
Q 002255 256 -LSGLS--SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR-FDMAKG----------------- 314 (947)
Q Consensus 256 -~~~l~--~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~-~~~~~~----------------- 314 (947)
+.+++ +|+.|++++|++++..|..|.++++|++|+|++|++++.+|..+.... +.....
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 66664 499999999999988888899999999999999999988876544322 110000
Q ss_pred --------CCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCC-CCCCCCccc--CCCCceeEEEecCCCce
Q 002255 315 --------SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC-NSDWKGVSC--DAGGNITVVNLKNLGLS 383 (947)
Q Consensus 315 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~-~~~~~~~~~--~~~~~L~~L~Ls~n~l~ 383 (947)
.+...++...+.+..... ..+.....+.......+.. ........+ -...+|+.|+|++|+++
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~ 394 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKS------NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS 394 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCT------TTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCC
T ss_pred ChhhcccCCCCCEEECCCCccCCCCh------hHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCC
Confidence 111111111111111000 0000001111111100000 000000000 01136777777777777
Q ss_pred eeccccccCCccCCeEeccCCcccccCC-CcCCCCCCCCccccccccccccCCCC
Q 002255 384 GTISSNFSRLTSLRQLMLSGNELTGTIP-KELTTLPSLEMLDVSNNHLFGKVPNF 437 (947)
Q Consensus 384 g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~ls~N~l~g~iP~~ 437 (947)
+..|..|..+++|+.|+|++|++++.+| ..+..+++|++|++++|++++..|..
T Consensus 395 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 449 (680)
T 1ziw_A 395 KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449 (680)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTT
T ss_pred eEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhh
Confidence 7777777777788888888888777676 56777777777888877777665543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=330.93 Aligned_cols=348 Identities=17% Similarity=0.175 Sum_probs=220.2
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
+++.|+|++|++++..+..|.++++|++|+|++|++++..+ .|.++++|++|+|++|+++++++..|..+++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 56677777777776666667777777777777777766655 56677777777777777777766667777777777777
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeee-ccCcccCCCCCCCccEEEccCCcccCcCCcccc---------------
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG--------------- 208 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--------------- 208 (947)
+|++.. ..+..++++++|++|++++|.+++ .+|..++ .+++|++|++++|++++..|..++
T Consensus 109 ~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 109 ETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp TSCCCC-STTCSCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred cccccc-CCCccccccccccEEecCCCccceecChhhhc--ccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 776654 222346666666666666666665 3566665 466666666666666544333222
Q ss_pred -------------CCCCcee------------------------------------------------------------
Q 002255 209 -------------KSSIQTL------------------------------------------------------------ 215 (947)
Q Consensus 209 -------------~~~L~~L------------------------------------------------------------ 215 (947)
..+|+.|
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 1122222
Q ss_pred ----------------------eeccCCCCCCCCC----------------------chh----------------hhcC
Q 002255 216 ----------------------WLNGQKGDSKLNG----------------------SVA----------------VIQN 235 (947)
Q Consensus 216 ----------------------~l~~n~~~~~~~~----------------------~~~----------------~~~~ 235 (947)
++++|.+...... ... ....
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 2222222111000 000 0023
Q ss_pred CCCCcEEEccCCcCcCCC--C-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC-CCCCccccc
Q 002255 236 MTSLTQLWLHGNSFTGPL--P-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK-FNSPVRFDM 311 (947)
Q Consensus 236 l~~L~~L~L~~N~l~~~~--~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~~ 311 (947)
+++|+.|+|++|++++.. + .+.++++|++|++++|++++. |..+..+++|+.|++++|.+++.+|. .+..
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~----- 419 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS----- 419 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTT-----
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhc-----
Confidence 455666666666666542 2 356788999999999999965 44599999999999999999987663 2211
Q ss_pred ccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCce-eeccccc
Q 002255 312 AKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS-GTISSNF 390 (947)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~-g~ip~~~ 390 (947)
..+...++...+.+.... ...+..+++|+.|+|++|.++ +.+|..+
T Consensus 420 --l~~L~~L~l~~n~l~~~~-------------------------------~~~~~~l~~L~~L~l~~n~l~~~~~p~~~ 466 (570)
T 2z63_A 420 --LRNLIYLDISHTHTRVAF-------------------------------NGIFNGLSSLEVLKMAGNSFQENFLPDIF 466 (570)
T ss_dssp --CTTCCEEECTTSCCEECC-------------------------------TTTTTTCTTCCEEECTTCEEGGGEECSCC
T ss_pred --CCCCCEEeCcCCcccccc-------------------------------hhhhhcCCcCcEEECcCCcCccccchhhh
Confidence 112222222222111000 011233567888888888887 6788888
Q ss_pred cCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccc----eeeecCCCCCCCCCC
Q 002255 391 SRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN----VIVKTDGNPDIGKDS 455 (947)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~----~~~~~~~n~~~~~~~ 455 (947)
+.+++|+.|+|++|++++..|..+..+++|++|+|++|++++.+|..+.. ..+.+.+|++.|..+
T Consensus 467 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 88888888888888888777888888888888888888888877754432 245677888877654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=327.63 Aligned_cols=127 Identities=17% Similarity=0.224 Sum_probs=102.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|++++..|..|.++++|++|+|++|++++..| .|.++++|++|+|++|+++.++.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 578899999999987777889999999999999999988877 788899999999999999987765 7889999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCc--cEEEccCCcc
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL--MHLHLAFNFL 199 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~Ls~N~l 199 (947)
++|++.+..+|..++++++|++|++++|.+++. .+. .+++| ++|+|++|++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~~~--~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---SVL--PIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---GGG--GGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh---hcc--ccccceeeEEEeecccc
Confidence 999987656788899999999999988888652 222 24444 5666666555
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=324.08 Aligned_cols=309 Identities=19% Similarity=0.233 Sum_probs=250.0
Q ss_pred CcEEEEEecCCcccccCc-ccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCc--ccccCCCCCcE
Q 002255 65 NRVTRIQIGGQNIEGTLP-KELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPS--DFFKGLTSLQT 140 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p-~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~ 140 (947)
.+++.|+|++|.+.+.++ ..|.++++|++|+|++|++++.+| .|.++++|++|+|++|++++..+ ..|..+++|++
T Consensus 54 ~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~ 133 (455)
T 3v47_A 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133 (455)
T ss_dssp TTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCE
T ss_pred ccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCE
Confidence 479999999999987774 569999999999999999999877 79999999999999999998443 44899999999
Q ss_pred EeccCCCCCCCCCccc-ccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCcccc---------CC
Q 002255 141 ISLDYNSFDSWVIPES-LKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG---------KS 210 (947)
Q Consensus 141 L~Ls~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---------~~ 210 (947)
|+|++|++.+ ..|.. +.++++|++|++++|.+++..|..+......+|+.|++++|.+.+..+..++ ..
T Consensus 134 L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 134 LVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EECCSSBCCS-CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EECCCCccCc-cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 9999999976 45655 8999999999999999999888877632224566666666666544333221 13
Q ss_pred CCceeeeccCCCCCCCCCch----------------------------------hhhc--CCCCCcEEEccCCcCcCCCC
Q 002255 211 SIQTLWLNGQKGDSKLNGSV----------------------------------AVIQ--NMTSLTQLWLHGNSFTGPLP 254 (947)
Q Consensus 211 ~L~~L~l~~n~~~~~~~~~~----------------------------------~~~~--~l~~L~~L~L~~N~l~~~~~ 254 (947)
+|+.|++++|.+........ ..+. ..++|+.|+|++|.+++.+|
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 292 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK 292 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECT
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccch
Confidence 45555665555432111000 0111 23689999999999999888
Q ss_pred C-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccce
Q 002255 255 D-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNV 333 (947)
Q Consensus 255 ~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (947)
. +..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+
T Consensus 293 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----------------------------- 343 (455)
T 3v47_A 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF----------------------------- 343 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGG-----------------------------
T ss_pred hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHh-----------------------------
Confidence 5 8889999999999999999889999999999999999999987655421
Q ss_pred eeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCc
Q 002255 334 LLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE 413 (947)
Q Consensus 334 ~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~ 413 (947)
..+.+|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..
T Consensus 344 ---------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 390 (455)
T 3v47_A 344 ---------------------------------ENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGI 390 (455)
T ss_dssp ---------------------------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ---------------------------------cCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhH
Confidence 22357999999999999999999999999999999999999655567
Q ss_pred CCCCCCCCccccccccccccCCC
Q 002255 414 LTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 414 l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
+..+++|+.|+|++|+++|.+|.
T Consensus 391 ~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 391 FDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTT
T ss_pred hccCCcccEEEccCCCcccCCCc
Confidence 89999999999999999999995
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=330.19 Aligned_cols=302 Identities=19% Similarity=0.204 Sum_probs=195.4
Q ss_pred CCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEE
Q 002255 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL 192 (947)
Q Consensus 113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 192 (947)
+|++|++++|.++++++..|..+++|++|+|++|++. .+|..+..+++|++|++++|.+++..|..+. .+++|++|
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L 330 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS--ELPSGLVGLSTLKKLVLSANKFENLCQISAS--NFPSLTHL 330 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS--CCCSSCCSCTTCCEEECTTCCCSBGGGGCGG--GCTTCSEE
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC--CCChhhcccccCCEEECccCCcCcCchhhhh--ccCcCCEE
Confidence 4555555555666666666666666666666666665 3566666666666666666666665565555 46666666
Q ss_pred EccCCcccCcCCcc-ccC-CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccC
Q 002255 193 HLAFNFLQGPIPLS-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRD 269 (947)
Q Consensus 193 ~Ls~N~l~~~~p~~-~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~ 269 (947)
+|++|.+.+.+|.. +.. .+|+.|++++|.+..... ....+.++++|+.|+|++|.+++..|. +..+++|++|++++
T Consensus 331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 409 (606)
T 3t6q_A 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC-CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409 (606)
T ss_dssp ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEE-STTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred ECCCCCcccccchhhhhccCcCCEEECCCCccccccC-cchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence 66666666555543 333 556666666666544320 012345566666666666666665553 55666666666666
Q ss_pred CccccCCCcc-ccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhh
Q 002255 270 NQLTGIVPSS-LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348 (947)
Q Consensus 270 N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~ 348 (947)
|++++..|.. +.++++|+.|+|++|.+++.+|..+.... +...++...+.+.+..
T Consensus 410 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-------~L~~L~L~~n~l~~~~----------------- 465 (606)
T 3t6q_A 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP-------ALQHLNLQGNHFPKGN----------------- 465 (606)
T ss_dssp CCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCT-------TCCEEECTTCBCGGGE-----------------
T ss_pred CcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCC-------CCCEEECCCCCCCccc-----------------
Confidence 6666554433 66666666666666666665555432211 1112222211111000
Q ss_pred ccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
......+..+++|+.|+|++|.+++..|..|+++++|+.|+|++|++++.+|..+..+++| .|+|++|
T Consensus 466 -----------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N 533 (606)
T 3t6q_A 466 -----------IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533 (606)
T ss_dssp -----------ECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSS
T ss_pred -----------cccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCC
Confidence 0000123345789999999999999999999999999999999999999999999999999 9999999
Q ss_pred cccccCCCCccc----eeeecCCCCCCCCCC
Q 002255 429 HLFGKVPNFRQN----VIVKTDGNPDIGKDS 455 (947)
Q Consensus 429 ~l~g~iP~~~~~----~~~~~~~n~~~~~~~ 455 (947)
++++.+|..+.. ..+.+.+||+.|..+
T Consensus 534 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 534 HISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 999998875432 367889999998653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=322.21 Aligned_cols=240 Identities=16% Similarity=0.198 Sum_probs=185.8
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEeccccc------ChHHHHHHHHHHHHHHcCC---------CCCcceE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVR---------HRHLVGL 653 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~l 653 (947)
.++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999988 589999999976532 2233477889999999886 8888888
Q ss_pred EEEEE------------------------------eCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHH
Q 002255 654 LGYCL------------------------------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703 (947)
Q Consensus 654 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~ 703 (947)
.+++. .++..++||||+++|++.+.+.. ..+++.++..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 87653 26789999999999987776633 3478999999999999
Q ss_pred HHHHHHh-hccCCCeeecCCCCCcEEEcCCC--------------------cEEEeecCcceecCCCCCcceeecccccc
Q 002255 704 RGVEYLH-GLAHQSFIHRDLKPSNILLGDDM--------------------RAKVADFGLVRLAPDNGKHSIETRLAGTF 762 (947)
Q Consensus 704 ~~L~~LH-~~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 762 (947)
.||+||| + ++|+||||||+|||++.++ .+||+|||+|+..... ...||+
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 7 7999999999999999887 9999999999876432 237999
Q ss_pred cccCccccccCCcCcccccccHHHH-HHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh----ccCCCChhc
Q 002255 763 GYLAPEYAVTGRVTTKVDVFSFGVI-LMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID----RTIDLDEET 837 (947)
Q Consensus 763 ~y~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 837 (947)
.|+|||++.+.. +.++||||+|++ .+++++|..||.... |... ....++. .........
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~------~~~~~~~~~~~~~~~~~~~~ 305 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHY------LTDKMLKQMTFKTKCNTPAM 305 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHH------HHHHHHHTCCCSSCCCSHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhH------HHHhhhhhhccCcccchhhh
Confidence 999999998655 899999998777 778888999884311 1000 0111111 111112223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002255 838 LASISTVADLAGHCCAREPYQRPDMGHVV 866 (947)
Q Consensus 838 ~~~~~~l~~li~~cl~~dP~~RPs~~evl 866 (947)
.....++.+|+.+||+.| |+.|++
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 345667889999999976 888887
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-32 Score=329.12 Aligned_cols=351 Identities=19% Similarity=0.175 Sum_probs=266.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
..++.|||++|+|++..+.+|.++++|++|+|++|+|++.+| .|.+|++|++|+|++|+|+++++..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 368999999999997777889999999999999999999888 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeee-ccCcccCCCCCCCccEEEccCCcccCcCCccccC-------------
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK------------- 209 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------- 209 (947)
++|++.+ ..+..|+++++|++|+|++|.+++ .+|..++ .+++|++|+|++|++++..|..+..
T Consensus 132 s~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l 208 (635)
T 4g8a_A 132 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 208 (635)
T ss_dssp TTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred CCCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhc--cchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence 9999976 455679999999999999999976 4677776 6899999999999998765544321
Q ss_pred ---------------CC---------------------------------------------------------------
Q 002255 210 ---------------SS--------------------------------------------------------------- 211 (947)
Q Consensus 210 ---------------~~--------------------------------------------------------------- 211 (947)
..
T Consensus 209 s~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~ 288 (635)
T 4g8a_A 209 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 288 (635)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred ccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence 00
Q ss_pred -----------------------------------------CceeeeccCCCCCCCCCc----------------hhhhc
Q 002255 212 -----------------------------------------IQTLWLNGQKGDSKLNGS----------------VAVIQ 234 (947)
Q Consensus 212 -----------------------------------------L~~L~l~~n~~~~~~~~~----------------~~~~~ 234 (947)
++.|++.+|.+....... .....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~ 368 (635)
T 4g8a_A 289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 368 (635)
T ss_dssp ECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCC
T ss_pred hhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccc
Confidence 111111111111000000 00112
Q ss_pred CCCCCcEEEccCCcCcC--------------------------CCCCCCCCCCCCEEEccCCccccCCC-ccccCCCCCC
Q 002255 235 NMTSLTQLWLHGNSFTG--------------------------PLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLA 287 (947)
Q Consensus 235 ~l~~L~~L~L~~N~l~~--------------------------~~~~~~~l~~L~~L~l~~N~l~g~~p-~~l~~l~~L~ 287 (947)
++++|+.|++++|.+.. ..+.+..+++|+.+++..|++....+ ..+..+++|+
T Consensus 369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~ 448 (635)
T 4g8a_A 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 448 (635)
T ss_dssp BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred cccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccc
Confidence 35677888888877643 22346678899999999998876554 5578899999
Q ss_pred eEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccC
Q 002255 288 VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367 (947)
Q Consensus 288 ~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 367 (947)
.+++++|.+++..|..+.... ....++...+... .. +..-.+.
T Consensus 449 ~l~ls~n~l~~~~~~~~~~~~-------~L~~L~Ls~N~~~-------~~-----------------------~~~~~~~ 491 (635)
T 4g8a_A 449 YLDISHTHTRVAFNGIFNGLS-------SLEVLKMAGNSFQ-------EN-----------------------FLPDIFT 491 (635)
T ss_dssp EEECTTSCCEECCTTTTTTCT-------TCCEEECTTCEEG-------GG-----------------------EECSCCT
T ss_pred cccccccccccccccccccch-------hhhhhhhhhcccc-------cc-----------------------cCchhhh
Confidence 999999999988776543222 1111111111000 00 0001123
Q ss_pred CCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCccce-----e
Q 002255 368 AGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV-----I 442 (947)
Q Consensus 368 ~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~-----~ 442 (947)
...+|++|+|++|+|++.+|..|+++++|++|+|++|+|++..|..|..+++|++|||++|+|++.+|..+... .
T Consensus 492 ~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~ 571 (635)
T 4g8a_A 492 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 571 (635)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCE
T ss_pred hccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCE
Confidence 45689999999999999999999999999999999999998888899999999999999999999999765432 4
Q ss_pred eecCCCCCCCCCC
Q 002255 443 VKTDGNPDIGKDS 455 (947)
Q Consensus 443 ~~~~~n~~~~~~~ 455 (947)
+.+.+||+.|.+.
T Consensus 572 L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 572 LNLTQNDFACTCE 584 (635)
T ss_dssp EECTTCCBCCSGG
T ss_pred EEeeCCCCcccCC
Confidence 6789999999764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=330.48 Aligned_cols=220 Identities=15% Similarity=0.138 Sum_probs=179.7
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
+++.++++++.+....+..|..+++|++|+|++|.+++.+| .|.++++|++|+|++|.++++++..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 56889999999886555568899999999999999999888 89999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|.|.. ..+..|+++++|++|+|++|.+++..|..|. .+++|++|+|++|.+++..+..+ .+|+.|++++|.+..
T Consensus 132 ~n~l~~-l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l--~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 132 RNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLLST 206 (597)
T ss_dssp SSCCCC-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECTTSCCSBCCGGGC--TTCSEEECCSSCCSE
T ss_pred CCCCCC-CCHHHhccCCCCCEEEeeCCcCCCCChhhhh--cCCcCcEEECcCCCCCCcChhhh--hhhhhhhcccCcccc
Confidence 999975 3445579999999999999999999898887 78999999999999997543332 568888888887654
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
. ...++|+.|+|++|.++...+.+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|.
T Consensus 207 l--------~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~ 272 (597)
T 3oja_B 207 L--------AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 272 (597)
T ss_dssp E--------ECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESG
T ss_pred c--------cCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHH
Confidence 2 33567777888888777655433 2567777777777775 36677777777777777777766554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=332.88 Aligned_cols=344 Identities=17% Similarity=0.237 Sum_probs=269.6
Q ss_pred CcEEEEEecCCccccc-----------------Cccccc--CCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc-
Q 002255 65 NRVTRIQIGGQNIEGT-----------------LPKELN--SLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN- 123 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~-----------------~p~~l~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~- 123 (947)
.+++.|+|++|.++|. +|+.++ ++++|++|+|++|.+.+.+| .|.++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5799999999999996 999999 99999999999999999998 79999999999999998
Q ss_pred CCC-CCcccccCC------CCCcEEeccCCCCCCCCCcc--cccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEc
Q 002255 124 FTS-VPSDFFKGL------TSLQTISLDYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194 (947)
Q Consensus 124 l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 194 (947)
+++ ..|..+..+ ++|++|+|++|++. .+|. .++++++|++|++++|+++|.+| .++ .+++|++|+|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~--~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~--~l~~L~~L~L 360 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK--TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG--SEIKLASLNL 360 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS--SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE--EEEEESEEEC
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC--ccCchhhhccCCCCCEEeCcCCcCccchh-hhC--CCCCCCEEEC
Confidence 998 666667666 99999999999997 5888 99999999999999999999999 776 7899999999
Q ss_pred cCCcccCcCCccccC-CC-CceeeeccCCCCCCCCCchhhhcCC--CCCcEEEccCCcCcCCCCC-CC-------CCCCC
Q 002255 195 AFNFLQGPIPLSFGK-SS-IQTLWLNGQKGDSKLNGSVAVIQNM--TSLTQLWLHGNSFTGPLPD-LS-------GLSSL 262 (947)
Q Consensus 195 s~N~l~~~~p~~~~~-~~-L~~L~l~~n~~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~-~~-------~l~~L 262 (947)
++|+++ .+|..+.. .+ |+.|++++|.+... .. .+..+ ++|+.|+|++|.+++.+|. +. .+.+|
T Consensus 361 ~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~l-p~---~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L 435 (636)
T 4eco_A 361 AYNQIT-EIPANFCGFTEQVENLSFAHNKLKYI-PN---IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435 (636)
T ss_dssp CSSEEE-ECCTTSEEECTTCCEEECCSSCCSSC-CS---CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE
T ss_pred CCCccc-cccHhhhhhcccCcEEEccCCcCccc-ch---hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC
Confidence 999999 88888766 66 99999999998843 22 23343 4899999999999998874 66 77899
Q ss_pred CEEEccCCccccCCCcc-ccCCCCCCeEeccCCcccccCCCCC-CCcccccccCCCCcccCcCCCcCCCccceeeecccc
Q 002255 263 QDFSVRDNQLTGIVPSS-LVNLHSLAVVNLTNNLFQGQTPKFN-SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKS 340 (947)
Q Consensus 263 ~~L~l~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (947)
++|+|++|+++ .+|.. +..+++|++|+|++|+++ .+|... ...........+...++...+.+. .++..
T Consensus 436 ~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-------~lp~~ 506 (636)
T 4eco_A 436 SSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-------KLSDD 506 (636)
T ss_dssp EEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-------BCCGG
T ss_pred CEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-------ccChh
Confidence 99999999999 55555 556999999999999999 555432 211000001113333444443333 12222
Q ss_pred cC--ChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEe------cCCCceeeccccccCCccCCeEeccCCcccccCCC
Q 002255 341 VG--YPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNL------KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPK 412 (947)
Q Consensus 341 l~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~L------s~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~ 412 (947)
+. .+..+.......+.... +. .....+.+|+.|+| ++|.+.+.+|..++++++|+.|+|++|+| +.||.
T Consensus 507 ~~~~~l~~L~~L~Ls~N~l~~-ip-~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~ 583 (636)
T 4eco_A 507 FRATTLPYLVGIDLSYNSFSK-FP-TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNE 583 (636)
T ss_dssp GSTTTCTTCCEEECCSSCCSS-CC-CGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCS
T ss_pred hhhccCCCcCEEECCCCCCCC-cC-hhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCH
Confidence 21 22223333333332222 11 12335788999999 56889999999999999999999999999 69999
Q ss_pred cCCCCCCCCccccccccccc
Q 002255 413 ELTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 413 ~l~~l~~L~~L~ls~N~l~g 432 (947)
.+. ++|+.|||++|++..
T Consensus 584 ~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 584 KIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CCC--TTCCEEECCSCTTCE
T ss_pred hHh--CcCCEEECcCCCCcc
Confidence 877 799999999997753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-32 Score=306.90 Aligned_cols=220 Identities=16% Similarity=0.163 Sum_probs=174.6
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.++++++.+...-+..+..+++|++|+|++|.+++..+ .|.++++|++|+|++|+++++++..|..+++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 467889999999885444457899999999999999998887 8999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcc-cccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCC
Q 002255 144 DYNSFDSWVIPE-SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKG 222 (947)
Q Consensus 144 s~N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~ 222 (947)
++|++.. +|. .+.++++|++|++++|.+++..|..+. .+++|++|+|++|++++.....+ .+|+.|++++|.+
T Consensus 125 ~~n~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~l--~~L~~L~l~~n~l 198 (390)
T 3o6n_A 125 ERNDLSS--LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLL 198 (390)
T ss_dssp CSSCCCC--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTS--SCTTCCEEECCSSCCSBCCGGGC--TTCSEEECCSSCC
T ss_pred CCCccCc--CCHHHhcCCCCCcEEECCCCccCccChhhcc--CCCCCCEEECCCCcCCccccccc--cccceeecccccc
Confidence 9999975 554 468999999999999999988888887 68999999999999986532222 5688888888766
Q ss_pred CCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 223 DSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
... ...++|+.|++++|.++...... .++|+.|++++|++++. ..+.++++|++|+|++|.+++.+|.
T Consensus 199 ~~~--------~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~ 266 (390)
T 3o6n_A 199 STL--------AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266 (390)
T ss_dssp SEE--------ECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred ccc--------CCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence 542 23456777777777776653322 35677777777777643 4567777777777777777665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=333.39 Aligned_cols=345 Identities=18% Similarity=0.207 Sum_probs=272.5
Q ss_pred CcEEEEEecCCcccc-----------------cCccccc--CCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc-
Q 002255 65 NRVTRIQIGGQNIEG-----------------TLPKELN--SLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN- 123 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g-----------------~~p~~l~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~- 123 (947)
.+++.|+|++|.++| .+|+.++ ++++|++|+|++|.+.+.+| .|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 579999999999999 4999988 99999999999999999998 79999999999999998
Q ss_pred CCC-CCcccccC-------CCCCcEEeccCCCCCCCCCcc--cccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEE
Q 002255 124 FTS-VPSDFFKG-------LTSLQTISLDYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLH 193 (947)
Q Consensus 124 l~~-~~~~~~~~-------l~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 193 (947)
+++ ..|..+.. +++|++|+|++|++. .+|. .++++++|+.|+|++|+++ .+| .++ .+++|++|+
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~--~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~--~L~~L~~L~ 601 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE--EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFG--TNVKLTDLK 601 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC--BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCC--TTSEESEEE
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC--ccCChhhhhcCCCCCEEECCCCCcc-cch-hhc--CCCcceEEE
Confidence 997 55554444 459999999999997 5888 9999999999999999999 888 776 799999999
Q ss_pred ccCCcccCcCCccccC-CC-CceeeeccCCCCCCCCCchhhhcCCC--CCcEEEccCCcCcCCCCCCC------CCCCCC
Q 002255 194 LAFNFLQGPIPLSFGK-SS-IQTLWLNGQKGDSKLNGSVAVIQNMT--SLTQLWLHGNSFTGPLPDLS------GLSSLQ 263 (947)
Q Consensus 194 Ls~N~l~~~~p~~~~~-~~-L~~L~l~~n~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~------~l~~L~ 263 (947)
|++|+++ .+|..+.. .+ |+.|+|++|.+... + ..+..++ +|+.|+|++|++++.+|.+. .+.+|+
T Consensus 602 Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~l-p---~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~ 676 (876)
T 4ecn_A 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYI-P---NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676 (876)
T ss_dssp CCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSC-C---SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEE
T ss_pred CcCCccc-cchHHHhhccccCCEEECcCCCCCcC-c---hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcC
Confidence 9999999 88888766 56 99999999998843 2 2344444 49999999999999887644 456899
Q ss_pred EEEccCCccccCCCcccc-CCCCCCeEeccCCcccccCCCCCCC-cccccccCCCCcccCcCCCcCCCccceeeeccccc
Q 002255 264 DFSVRDNQLTGIVPSSLV-NLHSLAVVNLTNNLFQGQTPKFNSP-VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341 (947)
Q Consensus 264 ~L~l~~N~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 341 (947)
.|+|++|+|+ .+|..+. .+++|+.|+|++|+++ .+|..... ....+....++..++...+.+. .++
T Consensus 677 ~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-------~lp--- 744 (876)
T 4ecn_A 677 TVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-------SLS--- 744 (876)
T ss_dssp EEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-------CCC---
T ss_pred EEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-------cch---
Confidence 9999999999 6777654 8999999999999999 55543211 1000000012222222222111 000
Q ss_pred CChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccC------CcccccCCCcCC
Q 002255 342 GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG------NELTGTIPKELT 415 (947)
Q Consensus 342 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~------N~l~g~iP~~l~ 415 (947)
..+....+++|+.|+|++|.+++ +|..++++++|+.|+|++ |++.+.+|..|.
T Consensus 745 --------------------~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~ 803 (876)
T 4ecn_A 745 --------------------DDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803 (876)
T ss_dssp --------------------GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGG
T ss_pred --------------------HHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHh
Confidence 00111245789999999999998 899999999999999976 889999999999
Q ss_pred CCCCCCccccccccccccCCCCccc--eeeecCCCCCCCCC
Q 002255 416 TLPSLEMLDVSNNHLFGKVPNFRQN--VIVKTDGNPDIGKD 454 (947)
Q Consensus 416 ~l~~L~~L~ls~N~l~g~iP~~~~~--~~~~~~~n~~~~~~ 454 (947)
.+++|+.|+|++|+| +.||..... ..+.+.+|+...-.
T Consensus 804 ~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~i~ 843 (876)
T 4ecn_A 804 TCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNISID 843 (876)
T ss_dssp GCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCEEE
T ss_pred cCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCccC
Confidence 999999999999999 899975432 24567788765433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.88 Aligned_cols=272 Identities=16% Similarity=0.256 Sum_probs=158.1
Q ss_pred CChHHHHHHHHHHHHcC-CCCCC--CCC-----CCCCCCCceeEeCC---------CCcEEEEEecCCcccccCcccccC
Q 002255 25 QSSSDAAAMQALKTSLG-NPASL--GWT-----DPDPCKWKHIQCSP---------SNRVTRIQIGGQNIEGTLPKELNS 87 (947)
Q Consensus 25 ~~~~~~~~l~~~k~~~~-~~~~~--~w~-----~~d~C~w~gv~C~~---------~~~v~~l~L~~~~l~g~~p~~l~~ 87 (947)
+...|++||++||+++. ++..| +|. ..++|.|.|+.|.. ..+|+.|+|++|++. .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 33579999999999984 44343 573 46899999999952 356777777777766 66666666
Q ss_pred CCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeE
Q 002255 88 LSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (947)
Q Consensus 88 l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (947)
+++|++|+|++|.++ .+| .+.++++|++|+|++|+++.++ ..+..+++|++|+|++|++.+ .+|..+...
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp-~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~~------ 173 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALP-ASIASLNRLRELSIRACPELT-ELPEPLAST------ 173 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCC-GGGGGCTTCCEEEEEEETTCC-CCCSCSEEE------
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCc-HHHhcCcCCCEEECCCCCCcc-ccChhHhhc------
Confidence 677777777766666 333 4555555555555555555332 234445555555555544432 233222110
Q ss_pred eccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC
Q 002255 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (947)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (947)
.++..+. .+++|++|+|++|+++ .+|.
T Consensus 174 ---------~~~~~~~--~l~~L~~L~L~~n~l~-~lp~----------------------------------------- 200 (328)
T 4fcg_A 174 ---------DASGEHQ--GLVNLQSLRLEWTGIR-SLPA----------------------------------------- 200 (328)
T ss_dssp ---------C-CCCEE--ESTTCCEEEEEEECCC-CCCG-----------------------------------------
T ss_pred ---------cchhhhc--cCCCCCEEECcCCCcC-cchH-----------------------------------------
Confidence 0001111 2444444444444444 3333
Q ss_pred CcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCc
Q 002255 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (947)
Q Consensus 247 N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (947)
.+..+++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..+.
T Consensus 201 --------~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~--------------------- 250 (328)
T 4fcg_A 201 --------SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG--------------------- 250 (328)
T ss_dssp --------GGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT---------------------
T ss_pred --------hhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc---------------------
Confidence 34444444444444444442 344444555555555555555444443211
Q ss_pred CCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcc
Q 002255 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNEL 406 (947)
Q Consensus 327 ~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l 406 (947)
.+.+|+.|+|++|.+.+.+|..++++++|+.|+|++|++
T Consensus 251 -----------------------------------------~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 251 -----------------------------------------GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp -----------------------------------------CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred -----------------------------------------CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 112455555555555556677778888888888888888
Q ss_pred cccCCCcCCCCCCCCccccccccc
Q 002255 407 TGTIPKELTTLPSLEMLDVSNNHL 430 (947)
Q Consensus 407 ~g~iP~~l~~l~~L~~L~ls~N~l 430 (947)
.|.+|.+++.+++|+.++++.|.+
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGS
T ss_pred hhhccHHHhhccCceEEeCCHHHH
Confidence 888888888888888888887665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-32 Score=321.75 Aligned_cols=334 Identities=19% Similarity=0.181 Sum_probs=255.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|++++..+..|.++++|++|+|++|++++.+| .|.++++|++|++++|+++++++..|+++++|++|+|
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 478999999999998778889999999999999999988877 7899999999999999999988877899999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCC----------------------------------------
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG---------------------------------------- 183 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---------------------------------------- 183 (947)
++|.+....+|..++++++|++|++++|.+++..|..+..
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~ 211 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEeccccc
Confidence 9999876557889999999999999988876654432210
Q ss_pred -------------------------------------------------------------------CCCCCccEEEccC
Q 002255 184 -------------------------------------------------------------------DTIPGLMHLHLAF 196 (947)
Q Consensus 184 -------------------------------------------------------------------~~l~~L~~L~Ls~ 196 (947)
..+++|++|++++
T Consensus 212 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~ 291 (570)
T 2z63_A 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291 (570)
T ss_dssp SCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEES
T ss_pred ccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecC
Confidence 0134555666666
Q ss_pred CcccCcCCccccC-------------------------------------------CCCceeeeccCCCCCCCCCchhhh
Q 002255 197 NFLQGPIPLSFGK-------------------------------------------SSIQTLWLNGQKGDSKLNGSVAVI 233 (947)
Q Consensus 197 N~l~~~~p~~~~~-------------------------------------------~~L~~L~l~~n~~~~~~~~~~~~~ 233 (947)
|.++ .+|..+.. .+|+.|++++|.+.... .....+
T Consensus 292 ~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~ 369 (570)
T 2z63_A 292 VTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG-CCSQSD 369 (570)
T ss_dssp CEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEE-EEEHHH
T ss_pred ccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccc-cccccc
Confidence 6555 34433321 23444444444433211 013457
Q ss_pred cCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCC-ccccCCCCCCeEeccCCcccccCCCCCCCcccccc
Q 002255 234 QNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMA 312 (947)
Q Consensus 234 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~ 312 (947)
.++++|+.|+|++|.+++.++.+..+++|++|++++|++++..| ..+.++++|++|+|++|.+++.+|..+....
T Consensus 370 ~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~---- 445 (570)
T 2z63_A 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS---- 445 (570)
T ss_dssp HTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT----
T ss_pred cccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC----
Confidence 78999999999999999887778889999999999999998766 5788999999999999999998886543322
Q ss_pred cCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccC
Q 002255 313 KGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR 392 (947)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~ 392 (947)
+...++...+.+... ..+ ..+..+++|+.|+|++|++++..|..|++
T Consensus 446 ---~L~~L~l~~n~l~~~-----~~p-------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 492 (570)
T 2z63_A 446 ---SLEVLKMAGNSFQEN-----FLP-------------------------DIFTELRNLTFLDLSQCQLEQLSPTAFNS 492 (570)
T ss_dssp ---TCCEEECTTCEEGGG-----EEC-------------------------SCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ---cCcEEECcCCcCccc-----cch-------------------------hhhhcccCCCEEECCCCccccCChhhhhc
Confidence 222222222211100 000 11234568999999999999999999999
Q ss_pred CccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCC
Q 002255 393 LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437 (947)
Q Consensus 393 l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~ 437 (947)
+++|+.|+|++|++++..|..+..+++|+.|++++|+++|.+|..
T Consensus 493 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 999999999999999888888999999999999999999999964
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-31 Score=322.18 Aligned_cols=225 Identities=22% Similarity=0.238 Sum_probs=169.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|.+++..|..|+++++|++|+|++|.+++.++ .|.++++|++|+|++|+++++++..|.++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 478999999999998888899999999999999999998777 6999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC--------------
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-------------- 209 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------------- 209 (947)
++|.+.+ ..|..++++++|++|++++|.+++..+..+....+++|++|+|++|++++..|..+..
T Consensus 129 s~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l 207 (680)
T 1ziw_A 129 SHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207 (680)
T ss_dssp CSSCCSC-CCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred CCCcccc-cCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence 9999976 6778889999999999999999887777654224578899999999888777765532
Q ss_pred --------------CCCceeeeccCCCCCCCCCchhhhcCC--CCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCcc
Q 002255 210 --------------SSIQTLWLNGQKGDSKLNGSVAVIQNM--TSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQL 272 (947)
Q Consensus 210 --------------~~L~~L~l~~n~~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l 272 (947)
.+|+.|++++|.+....... +.++ ++|+.|+|++|++++.++. +..+++|++|++++|++
T Consensus 208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~---~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 284 (680)
T 1ziw_A 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT---FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284 (680)
T ss_dssp HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT---TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCB
T ss_pred ChhhHHHHHHHhhhccccEEEccCCcccccChhH---hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCcc
Confidence 34566666666655443332 2233 2366666666666665553 56666666666666666
Q ss_pred ccCCCccccCCCCCCeEeccC
Q 002255 273 TGIVPSSLVNLHSLAVVNLTN 293 (947)
Q Consensus 273 ~g~~p~~l~~l~~L~~L~Ls~ 293 (947)
++..|..+..+++|+.|+|++
T Consensus 285 ~~~~~~~~~~l~~L~~L~L~~ 305 (680)
T 1ziw_A 285 QHLFSHSLHGLFNVRYLNLKR 305 (680)
T ss_dssp SEECTTTTTTCTTCCEEECTT
T ss_pred CccChhhhcCCCCccEEeccc
Confidence 655555444444444444433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=298.15 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=183.5
Q ss_pred CcEEecCCCcCCC--CCcccccCCCCCcEEeccC-CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCcc
Q 002255 114 LQEVLFDDNNFTS--VPSDFFKGLTSLQTISLDY-NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190 (947)
Q Consensus 114 L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 190 (947)
+++|+|++|.+++ ..|..|.++++|++|+|++ |.+.+ .+|..++++++|++|+|++|++++.+|..+. .+++|+
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~-~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~--~l~~L~ 128 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--QIKTLV 128 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEES-CCCGGGGGCTTCSEEEEEEECCEEECCGGGG--GCTTCC
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccc-cCChhHhcCCCCCEEECcCCeeCCcCCHHHh--CCCCCC
Confidence 3344444444443 3333444555555555552 54443 4555555555555555556666666666665 566677
Q ss_pred EEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCC-CCCEEEcc
Q 002255 191 HLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLS-SLQDFSVR 268 (947)
Q Consensus 191 ~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~-~L~~L~l~ 268 (947)
+|+|++|++++.+|..+. ++++|++|+|++|++++.+| .+..++ +|++|+++
T Consensus 129 ~L~Ls~N~l~~~~p~~~~--------------------------~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~ 182 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSIS--------------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182 (313)
T ss_dssp EEECCSSEEESCCCGGGG--------------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECC
T ss_pred EEeCCCCccCCcCChHHh--------------------------cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECc
Confidence 777777776666665543 36777777777777776655 366666 89999999
Q ss_pred CCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhh
Q 002255 269 DNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348 (947)
Q Consensus 269 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~ 348 (947)
+|++++.+|..+..++ |+.|+|++|++++.+|..+
T Consensus 183 ~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~-------------------------------------------- 217 (313)
T 1ogq_A 183 RNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLF-------------------------------------------- 217 (313)
T ss_dssp SSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGC--------------------------------------------
T ss_pred CCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHH--------------------------------------------
Confidence 9999999999999998 9999999999998776532
Q ss_pred ccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
...++|+.|+|++|.+++.+|. +..+++|++|+|++|+|+|.+|..+..+++|++|+|++|
T Consensus 218 ------------------~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 218 ------------------GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp ------------------CTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ------------------hcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 2234799999999999988877 899999999999999999999999999999999999999
Q ss_pred cccccCCCCccc---eeeecCCCCCCCCCCC
Q 002255 429 HLFGKVPNFRQN---VIVKTDGNPDIGKDSS 456 (947)
Q Consensus 429 ~l~g~iP~~~~~---~~~~~~~n~~~~~~~~ 456 (947)
+|+|.+|...+. ..+.+.+|+++|+.|.
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred cccccCCCCccccccChHHhcCCCCccCCCC
Confidence 999999986322 2456889999998643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=316.47 Aligned_cols=159 Identities=20% Similarity=0.265 Sum_probs=141.9
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 147 (947)
.+++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++++++..|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5788888888 7887765 899999999999999888 89999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccC-cCCccccC-CCCceeeeccCCCCCC
Q 002255 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSK 225 (947)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~-~~L~~L~l~~n~~~~~ 225 (947)
+.+ ..|..|+++++|++|++++|.+++..+..++ .+++|++|+|++|++++ .+|..++. .+|+.|++++|.+...
T Consensus 92 l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~ 168 (606)
T 3vq2_A 92 IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIG--QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168 (606)
T ss_dssp CCC-CCTTSSTTCTTCCEEECTTSCCCCSSSSCCT--TCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred ccc-cChhhcCCcccCCEEEccCCccccccccccC--CCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence 976 6689999999999999999999988878887 79999999999999986 67888876 7899999999998876
Q ss_pred CCCchhhh
Q 002255 226 LNGSVAVI 233 (947)
Q Consensus 226 ~~~~~~~~ 233 (947)
....+..+
T Consensus 169 ~~~~~~~l 176 (606)
T 3vq2_A 169 TVNDLQFL 176 (606)
T ss_dssp CTTTTHHH
T ss_pred Chhhhhhh
Confidence 55544333
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=297.43 Aligned_cols=337 Identities=16% Similarity=0.119 Sum_probs=237.4
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+|++|++++. | .++.+++|++|+|++|++++. | +..+++|++|+|++|++++++ ++.+++|++|+|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCD 114 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCceee---cCCCCcCCEEECC
Confidence 4789999999999964 5 799999999999999999985 4 899999999999999999984 8899999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|++.+ +| ++.+++|++|++++|++++. + ++ .+++|++|++++|+..+.++ .....+|+.|++++|++..
T Consensus 115 ~N~l~~--l~--~~~l~~L~~L~l~~N~l~~l-~--l~--~l~~L~~L~l~~n~~~~~~~-~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 115 TNKLTK--LD--VSQNPLLTYLNCARNTLTEI-D--VS--HNTQLTELDCHLNKKITKLD-VTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp SSCCSC--CC--CTTCTTCCEEECTTSCCSCC-C--CT--TCTTCCEEECTTCSCCCCCC-CTTCTTCCEEECCSSCCCC
T ss_pred CCcCCe--ec--CCCCCcCCEEECCCCcccee-c--cc--cCCcCCEEECCCCCcccccc-cccCCcCCEEECCCCccce
Confidence 999976 44 89999999999999999974 3 54 68999999999997776663 2233789999999999887
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
.. +..+++|+.|+|++|++++. ++..+++|++|++++|++++ +| +..+++|+.|++++|++++..+..+
T Consensus 185 l~------l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l 253 (457)
T 3bz5_A 185 LD------VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL 253 (457)
T ss_dssp CC------CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred ec------cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence 42 56789999999999999986 58889999999999999997 66 8899999999999999998766544
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCC-CCCCCcccCCCCceeEEEecCCCce
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCN-SDWKGVSCDAGGNITVVNLKNLGLS 383 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (947)
..+..-.....+...++...+...+.++ ......+..+..-.....+..++. ..+..+.....++|+.|+|++|+++
T Consensus 254 ~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~ 331 (457)
T 3bz5_A 254 SKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT 331 (457)
T ss_dssp TTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCS
T ss_pred CCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccc
Confidence 4333111111122223333222222111 011111111111000001111110 1122233445567788888888887
Q ss_pred eeccccccCCccCCeEeccCCcccccCCCcCCC-------------CCCCCccccccccccccCCC
Q 002255 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTT-------------LPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 384 g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~-------------l~~L~~L~ls~N~l~g~iP~ 436 (947)
| ++ ++++++|+.|+|++|+|+| +| .+.. +..|..+++++|+|+|.||.
T Consensus 332 ~-l~--l~~l~~L~~L~l~~N~l~~-l~-~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 332 E-LD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp C-CC--CTTCTTCSEEECCSSCCCB-CT-TGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCT
T ss_pred c-cc--cccCCcCcEEECCCCCCCC-cc-ccccccccCCcEEecceeeecCccccccCcEEEEcCh
Confidence 7 33 7778888888888888875 32 1111 12345556666666666664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=316.62 Aligned_cols=287 Identities=20% Similarity=0.254 Sum_probs=252.6
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|.+++..|..|+.+++|++|+|++|.+++.+| .|.++++|++|+|++|.++++++..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 368999999999998888899999999999999999999888 6899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCC
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~ 223 (947)
++|.+.+ ..|..++++++|++|+|++|.+++..+ . .+++|++|++++|.+++... ..+|+.|++++|.+.
T Consensus 155 s~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~---~--~l~~L~~L~l~~n~l~~l~~----~~~L~~L~ls~n~l~ 224 (597)
T 3oja_B 155 SNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDL---S--LIPSLFHANVSYNLLSTLAI----PIAVEELDASHNSIN 224 (597)
T ss_dssp CSSCCCB-CCTTTTTTCTTCCEEECTTSCCSBCCG---G--GCTTCSEEECCSSCCSEEEC----CTTCSEEECCSSCCC
T ss_pred eCCcCCC-CChhhhhcCCcCcEEECcCCCCCCcCh---h--hhhhhhhhhcccCccccccC----CchhheeeccCCccc
Confidence 9999976 677889999999999999999997532 2 57899999999999986321 246999999999987
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCC
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (947)
...... .++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|.+++..+.
T Consensus 225 ~~~~~~------~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~- 296 (597)
T 3oja_B 225 VVRGPV------NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLY- 296 (597)
T ss_dssp EEECSC------CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECS-
T ss_pred cccccc------CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcc-
Confidence 654432 46899999999999974 6688899999999999999999999999999999999999999874221
Q ss_pred CCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCce
Q 002255 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (947)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (947)
...+++|+.|+|++|.++
T Consensus 297 --------------------------------------------------------------~~~l~~L~~L~Ls~N~l~ 314 (597)
T 3oja_B 297 --------------------------------------------------------------GQPIPTLKVLDLSHNHLL 314 (597)
T ss_dssp --------------------------------------------------------------SSCCTTCCEEECCSSCCC
T ss_pred --------------------------------------------------------------cccCCCCcEEECCCCCCC
Confidence 012347999999999999
Q ss_pred eeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCC
Q 002255 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 384 g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP 435 (947)
.+|..++.+++|+.|+|++|+|+ .+| +..+++|+.|+|++|+|+|..+
T Consensus 315 -~i~~~~~~l~~L~~L~L~~N~l~-~~~--~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 315 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp -CCGGGHHHHTTCSEEECCSSCCC-CCC--CCTTCCCSEEECCSSCEEHHHH
T ss_pred -ccCcccccCCCCCEEECCCCCCC-CcC--hhhcCCCCEEEeeCCCCCChhH
Confidence 68889999999999999999999 454 7788999999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=316.83 Aligned_cols=144 Identities=17% Similarity=0.229 Sum_probs=128.3
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
+.|++++|+++ .+|..+. ++|++|+|++|.+++.+| .|.++++|++|+|++|++++++|..|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999999 7888777 899999999999999887 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeee-ccCcccCCCCCCCccEEEccCCcccCcCCccccCCCC--ceeeeccCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI--QTLWLNGQKG 222 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L--~~L~l~~n~~ 222 (947)
++.. +|.. .+++|++|+|++|.+++ .+|..++ .+++|++|+|++|++++.....+ .+| +.|++++|.+
T Consensus 80 ~l~~--lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~l--~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 80 KLVK--ISCH--PTVNLKHLDLSFNAFDALPICKEFG--NMSQLKFLGLSTTHLEKSSVLPI--AHLNISKVLLVLGET 150 (520)
T ss_dssp CCCE--EECC--CCCCCSEEECCSSCCSSCCCCGGGG--GCTTCCEEEEEESSCCGGGGGGG--TTSCEEEEEEEECTT
T ss_pred ceee--cCcc--ccCCccEEeccCCccccccchhhhc--cCCcceEEEecCcccchhhcccc--ccceeeEEEeecccc
Confidence 9974 6766 89999999999999997 5788888 79999999999999987332222 456 9999999988
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=310.86 Aligned_cols=317 Identities=19% Similarity=0.194 Sum_probs=229.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCC-cccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVP-SDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|.+++..|..|.++++|++|+|++|+++. +|.. .+++|++|+|++|++++++ |..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L 153 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC-PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC-CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc-ccccCCEEECCCCCccccCchHhhcccCcccEEec
Confidence 579999999999999889999999999999999999995 5533 8999999999999999976 578999999999999
Q ss_pred cCCCCCCCCCcccccCCCCC--CeEeccCcee--eeccCcccCCCC------------------------C---------
Q 002255 144 DYNSFDSWVIPESLKDATGL--QRFSANGANI--TGTIPDFLGGDT------------------------I--------- 186 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L--~~L~l~~n~l--~~~~p~~~~~~~------------------------l--------- 186 (947)
++|++.. ..+..+++| ++|++++|.+ ++..|..+.... +
T Consensus 154 ~~n~l~~----~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 229 (562)
T 3a79_B 154 SAAKFRQ----LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229 (562)
T ss_dssp ECSBCCT----TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEE
T ss_pred CCCcccc----CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccc
Confidence 9999965 234444555 9999999988 666666554211 1
Q ss_pred ----------------------------------------------CCccEEEccCCcccCcCCcccc------------
Q 002255 187 ----------------------------------------------PGLMHLHLAFNFLQGPIPLSFG------------ 208 (947)
Q Consensus 187 ----------------------------------------------~~L~~L~Ls~N~l~~~~p~~~~------------ 208 (947)
++|++|++++|+++|.+|..+.
T Consensus 230 ~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~ 309 (562)
T 3a79_B 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309 (562)
T ss_dssp CCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEE
T ss_pred ccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheeh
Confidence 2677777777888877777651
Q ss_pred --------------------CCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEc
Q 002255 209 --------------------KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSV 267 (947)
Q Consensus 209 --------------------~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l 267 (947)
..+|+.|++++|.+..... ...+++|++|+|++|++++.+| .+.++++|++|+|
T Consensus 310 ~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~-----~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 384 (562)
T 3a79_B 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC-----PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384 (562)
T ss_dssp EEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCC-----CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEEC
T ss_pred hhcccceeecChhhhhhhhccCcceEEEccCCCcccccC-----ccCCCCceEEECCCCccccchhhhhcccCCCCEEEC
Confidence 1235666666665543221 1568999999999999999766 5889999999999
Q ss_pred cCCcccc--CCCccccCCCCCCeEeccCCcccccCCCC-CCCcccccccCCCCcccCcCCCcCCCccceeeecccccCCh
Q 002255 268 RDNQLTG--IVPSSLVNLHSLAVVNLTNNLFQGQTPKF-NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYP 344 (947)
Q Consensus 268 ~~N~l~g--~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 344 (947)
++|++++ .+|..+.++++|++|+|++|++++.+|.. +... .+...++...+.+.
T Consensus 385 ~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l-------~~L~~L~l~~n~l~---------------- 441 (562)
T 3a79_B 385 QRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA-------ESILVLNLSSNMLT---------------- 441 (562)
T ss_dssp CSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC-------TTCCEEECCSSCCC----------------
T ss_pred CCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCc-------ccCCEEECCCCCCC----------------
Confidence 9999996 34577999999999999999999866642 1110 11111111111111
Q ss_pred hhhhccCCCCCCCCCCCCCcccCCC-CceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCc-CCCCCCCCc
Q 002255 345 AVLAESWKGNNPCNSDWKGVSCDAG-GNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEM 422 (947)
Q Consensus 345 ~~l~~~~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~ 422 (947)
+..+... .+|+.|+|++|+++ .+|..+.++++|+.|+|++|+|+ .+|.. +..+++|+.
T Consensus 442 ------------------~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~ 501 (562)
T 3a79_B 442 ------------------GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501 (562)
T ss_dssp ------------------GGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCC
T ss_pred ------------------cchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCE
Confidence 0111111 35667777777666 56666666677777777777776 56655 666677777
Q ss_pred cccccccccccCC
Q 002255 423 LDVSNNHLFGKVP 435 (947)
Q Consensus 423 L~ls~N~l~g~iP 435 (947)
|+|++|+++|.+|
T Consensus 502 L~l~~N~~~c~c~ 514 (562)
T 3a79_B 502 IWLHDNPWDCTCP 514 (562)
T ss_dssp EECCSCCBCCCHH
T ss_pred EEecCCCcCCCcc
Confidence 7777777766665
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=315.49 Aligned_cols=344 Identities=19% Similarity=0.163 Sum_probs=255.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCC-CcccccCCCCCcEEe
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSV-PSDFFKGLTSLQTIS 142 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ 142 (947)
.+++.|+|++|++++..|..|+++++|++|+|++|++++.+| .|.++++|++|+|++|+++++ .+..|.++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 579999999999998888899999999999999999999888 499999999999999999975 356789999999999
Q ss_pred ccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCC----------------------CCCCccEEEccCCccc
Q 002255 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD----------------------TIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~----------------------~l~~L~~L~Ls~N~l~ 200 (947)
|++|++.+...+..+.++++|++|++++|.+++.+|..++.. .+++|++|+|++|+++
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~ 209 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCT
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccc
Confidence 999985443344689999999999999999999888877521 2578888888888888
Q ss_pred CcC--Ccccc--CC------------------------------------------------------------------
Q 002255 201 GPI--PLSFG--KS------------------------------------------------------------------ 210 (947)
Q Consensus 201 ~~~--p~~~~--~~------------------------------------------------------------------ 210 (947)
+.. |..+. ..
T Consensus 210 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~ 289 (549)
T 2z81_A 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289 (549)
T ss_dssp TCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEE
T ss_pred cccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccccc
Confidence 632 11110 01
Q ss_pred ---------------------CCceeeeccCCCCCCCCCchhh-hcCCCCCcEEEccCCcCcCCCC----CCCCCCCCCE
Q 002255 211 ---------------------SIQTLWLNGQKGDSKLNGSVAV-IQNMTSLTQLWLHGNSFTGPLP----DLSGLSSLQD 264 (947)
Q Consensus 211 ---------------------~L~~L~l~~n~~~~~~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~ 264 (947)
+|+.|++++|.+.. .+.. +.++++|+.|+|++|++++.+| .+..+++|++
T Consensus 290 ~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~----ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~ 365 (549)
T 2z81_A 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL----VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365 (549)
T ss_dssp SCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC----CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCE
T ss_pred ccccchhhhcccchhhhhhcccceEEEeccCcccc----CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcE
Confidence 23334444443321 1222 3568999999999999998653 3678999999
Q ss_pred EEccCCccccCCC--ccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccC
Q 002255 265 FSVRDNQLTGIVP--SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVG 342 (947)
Q Consensus 265 L~l~~N~l~g~~p--~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 342 (947)
|+|++|++++..+ ..+..+++|++|+|++|++++ +|..+.. ..+...++...+.+.. ....+
T Consensus 366 L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~-------~~~L~~L~Ls~N~l~~-------l~~~~- 429 (549)
T 2z81_A 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQW-------PEKMRFLNLSSTGIRV-------VKTCI- 429 (549)
T ss_dssp EECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCC-------CTTCCEEECTTSCCSC-------CCTTS-
T ss_pred EEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcc-------cccccEEECCCCCccc-------ccchh-
Confidence 9999999986432 568899999999999999984 5543321 1222333333332221 00000
Q ss_pred ChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCc
Q 002255 343 YPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422 (947)
Q Consensus 343 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 422 (947)
+..+.......+. +.+. ....++|+.|+|++|+|+ .||. .+.+++|+.|+|++|+|++.+|..+..+++|+.
T Consensus 430 -~~~L~~L~Ls~N~----l~~~-~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 501 (549)
T 2z81_A 430 -PQTLEVLDVSNNN----LDSF-SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501 (549)
T ss_dssp -CTTCSEEECCSSC----CSCC-CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCE
T ss_pred -cCCceEEECCCCC----hhhh-cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCE
Confidence 0111112222221 1221 135678999999999999 7887 578999999999999999888888999999999
Q ss_pred cccccccccccCCC
Q 002255 423 LDVSNNHLFGKVPN 436 (947)
Q Consensus 423 L~ls~N~l~g~iP~ 436 (947)
|+|++|+++|.+|.
T Consensus 502 L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 502 IWLHTNPWDCSCPR 515 (549)
T ss_dssp EECCSSCBCCCHHH
T ss_pred EEecCCCccCCCcc
Confidence 99999999999983
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=283.81 Aligned_cols=285 Identities=19% Similarity=0.250 Sum_probs=217.2
Q ss_pred EEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 67 v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
++.++++++++. .+|..+. ++|++|+|++|.+++.+| .|.++++|++|+|++|+++++++..|..+++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 345666667776 6777664 689999999999988877 789999999999999999999888899999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCccc--CcCCccccCCCCceeeeccCCCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ--GPIPLSFGKSSIQTLWLNGQKGD 223 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~~~L~~L~l~~n~~~ 223 (947)
|++.. +|..+. ++|++|++++|.+++..+..+. .+++|++|+|++|+++ +..|..+...+|+.|++++|.+.
T Consensus 112 n~l~~--l~~~~~--~~L~~L~l~~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 112 NHLVE--IPPNLP--SSLVELRIHDNRIRKVPKGVFS--GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp SCCCS--CCSSCC--TTCCEEECCSSCCCCCCSGGGS--SCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred CcCCc--cCcccc--ccCCEEECCCCccCccCHhHhC--CCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 99874 666655 7899999999999876666676 6889999999999986 36677776667888888888776
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
...... .++|+.|+|++|.+++..+ .+..+++|++|+|++|++++..+..+..+++|+.|+|++|+++ .+|.
T Consensus 186 ~l~~~~------~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 186 GIPKDL------PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp SCCSSS------CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred ccCccc------cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 643322 2678888888888887765 4777888888888888888777777888888888888888877 3443
Q ss_pred CCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCc
Q 002255 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (947)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (947)
.+ ...++|+.|+|++|.+
T Consensus 259 ~l--------------------------------------------------------------~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 259 GL--------------------------------------------------------------PDLKLLQVVYLHTNNI 276 (332)
T ss_dssp TG--------------------------------------------------------------GGCTTCCEEECCSSCC
T ss_pred hh--------------------------------------------------------------hcCccCCEEECCCCCC
Confidence 11 1223678888888888
Q ss_pred eeeccccccCC------ccCCeEeccCCccc--ccCCCcCCCCCCCCcccccccc
Q 002255 383 SGTISSNFSRL------TSLRQLMLSGNELT--GTIPKELTTLPSLEMLDVSNNH 429 (947)
Q Consensus 383 ~g~ip~~~~~l------~~L~~L~Ls~N~l~--g~iP~~l~~l~~L~~L~ls~N~ 429 (947)
++..+..|..+ .+|+.|+|++|.+. +..|..|..+++|+.|+|++|+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 277 TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 87666666543 56888888888887 5666778888888888888774
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=294.94 Aligned_cols=285 Identities=17% Similarity=0.247 Sum_probs=234.3
Q ss_pred CCCCCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCC
Q 002255 50 DPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP 128 (947)
Q Consensus 50 ~~d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~ 128 (947)
...+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|++++++
T Consensus 26 ~~~~C~~~~~-c~---------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 26 ASLSCDRNGI-CK---------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp -CCEECTTSE-EE---------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred cCCCCCCCeE-ee---------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 3567999887 64 4566777 7787765 599999999999998877 7999999999999999999999
Q ss_pred cccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccC-cccCCCCCCCccEEEccCCc-ccCcCCcc
Q 002255 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNF-LQGPIPLS 206 (947)
Q Consensus 129 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~ 206 (947)
+..|.++++|++|+|++|++.. ..+..+.++++|++|++++|++++..+ ..+. .+++|++|+|++|+ +++..+..
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~--~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS--HLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCT--TCTTCCEEEEEESSSCCEECTTT
T ss_pred HhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcccCchhhhc--cCCCCcEEECCCCccccccCHHH
Confidence 9999999999999999999975 344458999999999999999985433 3565 68999999999995 65444444
Q ss_pred ccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCC
Q 002255 207 FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHS 285 (947)
Q Consensus 207 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~ 285 (947)
+ .++++|+.|+|++|.+++..| .+..+++|++|++++|+++...+..+..+++
T Consensus 170 ~--------------------------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 223 (353)
T 2z80_A 170 F--------------------------AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223 (353)
T ss_dssp T--------------------------TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTT
T ss_pred c--------------------------cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhccc
Confidence 4 358999999999999999866 5888999999999999997443344556999
Q ss_pred CCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcc
Q 002255 286 LAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365 (947)
Q Consensus 286 L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 365 (947)
|+.|+|++|++++..+..+..
T Consensus 224 L~~L~L~~n~l~~~~~~~l~~----------------------------------------------------------- 244 (353)
T 2z80_A 224 VECLELRDTDLDTFHFSELST----------------------------------------------------------- 244 (353)
T ss_dssp EEEEEEESCBCTTCCCC---------------------------------------------------------------
T ss_pred ccEEECCCCcccccccccccc-----------------------------------------------------------
Confidence 999999999999765432110
Q ss_pred cCCCCceeEEEecCCCcee----eccccccCCccCCeEeccCCcccccCCCc-CCCCCCCCccccccccccccCCC
Q 002255 366 CDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 366 ~~~~~~L~~L~Ls~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
......++.++|++|.+++ .+|..+.++++|+.|+|++|+|+ .+|.. |..+++|++|+|++|+++|.+|.
T Consensus 245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 0112357788888888887 58899999999999999999999 78887 48999999999999999999883
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-30 Score=315.93 Aligned_cols=207 Identities=16% Similarity=0.163 Sum_probs=172.1
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc-CCCCCcccccCCCCCcEEeccC
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
..+++++++++ .+|. ..++|++|||++|.+++..| .|.++++|++|+|++|. +..+++..|.++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 35678888988 6776 45899999999999999877 89999999999999995 4567788999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcc--cCCCCCCCccEEEccCCcccCcCC-ccccC-CCCceeeeccCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDF--LGGDTIPGLMHLHLAFNFLQGPIP-LSFGK-SSIQTLWLNGQK 221 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~--~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~-~~L~~L~l~~n~ 221 (947)
|++.. ..|..|+++++|++|+|++|.+++.+|.. +. .+++|++|+|++|.+++..+ ..|+. .+|+.|+|++|.
T Consensus 83 N~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~--~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~ 159 (844)
T 3j0a_A 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR--NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159 (844)
T ss_dssp CCCCE-ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCS--SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC
T ss_pred CcCcc-cCHhHccCCcccCEeeCcCCCCCcccccCcccc--ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc
Confidence 99976 67999999999999999999999877765 66 79999999999999998765 45654 789999999998
Q ss_pred CCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCC------CCEEEccCCccccCCCccccC
Q 002255 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSS------LQDFSVRDNQLTGIVPSSLVN 282 (947)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~------L~~L~l~~N~l~g~~p~~l~~ 282 (947)
+..........+.+ ++|+.|+|++|.+++..+. +..+.+ |+.|++++|++++.+|..+..
T Consensus 160 i~~~~~~~l~~l~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~ 226 (844)
T 3j0a_A 160 IFLVCEHELEPLQG-KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226 (844)
T ss_dssp CCCCCSGGGHHHHH-CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGG
T ss_pred CCeeCHHHcccccC-CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHh
Confidence 88776655444332 7889999999999887663 444444 899999999888777766654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-29 Score=277.28 Aligned_cols=214 Identities=22% Similarity=0.334 Sum_probs=127.3
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 147 (947)
.+++++++++ .+|..+. +.|++|+|++|++++.++ .|.++++|++|+|++|+++++.+..|..+++|++|+|++|+
T Consensus 35 ~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 4445555555 5565554 578888888888887776 67888888888888888888877778888888888888888
Q ss_pred CCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccC--cCCccccC-CCCceeeeccCCCCC
Q 002255 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG--PIPLSFGK-SSIQTLWLNGQKGDS 224 (947)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~-~~L~~L~l~~n~~~~ 224 (947)
+.. +|..+. ++|++|++++|.+++..+..+. .+++|++|+|++|+++. ..+..+.. .+|+.|++++|.+..
T Consensus 112 l~~--l~~~~~--~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 112 LKE--LPEKMP--KTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp CSB--CCSSCC--TTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCc--cChhhc--ccccEEECCCCcccccCHhHhc--CCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 764 565554 6788888888888876666666 57788888888888753 44444432 233333333333332
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
..... .++|+.|+|++|.+++..+ .+..+++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 186 l~~~~------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 186 IPQGL------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp CCSSC------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred CCccc------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 21111 1334444444444444333 2334444444444444444333334444444444444444443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=289.18 Aligned_cols=310 Identities=13% Similarity=0.111 Sum_probs=231.5
Q ss_pred cCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCC
Q 002255 86 NSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (947)
..+++|+.|++++|.++..++ .|.++++|++|+|++|.++++++..|..+++|++|+|++|++.. ..|..++++++|+
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 120 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLT 120 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCC
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCC
Confidence 346899999999999988776 47889999999999999999999999999999999999999976 5677899999999
Q ss_pred eEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEE
Q 002255 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243 (947)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~ 243 (947)
+|++++|.++...+..+. .+++|++|+|++|++++..|..+.. .+|+.|++++|.+.... +..+++|+.|+
T Consensus 121 ~L~L~~n~l~~l~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------~~~l~~L~~L~ 192 (390)
T 3o6n_A 121 VLVLERNDLSSLPRGIFH--NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD------LSLIPSLFHAN 192 (390)
T ss_dssp EEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC------GGGCTTCSEEE
T ss_pred EEECCCCccCcCCHHHhc--CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc------cccccccceee
Confidence 999999999955444455 6899999999999999888887865 78999999999987652 45689999999
Q ss_pred ccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcC
Q 002255 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323 (947)
Q Consensus 244 L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 323 (947)
+++|.+++. ....+|+.|++++|+++.. |.. ..++|+.|+|++|.+++. +. +....+...++..
T Consensus 193 l~~n~l~~~----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~-~~--------l~~l~~L~~L~Ls 256 (390)
T 3o6n_A 193 VSYNLLSTL----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT-AW--------LLNYPGLVEVDLS 256 (390)
T ss_dssp CCSSCCSEE----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC-GG--------GGGCTTCSEEECC
T ss_pred ccccccccc----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc-HH--------HcCCCCccEEECC
Confidence 999998863 3346899999999999854 443 357999999999999864 11 1122223333333
Q ss_pred CCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccC
Q 002255 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG 403 (947)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~ 403 (947)
.+.+.... ...+...++|+.|+|++|++++ +|..+..+++|+.|+|++
T Consensus 257 ~n~l~~~~-------------------------------~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~ 304 (390)
T 3o6n_A 257 YNELEKIM-------------------------------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 304 (390)
T ss_dssp SSCCCEEE-------------------------------SGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCS
T ss_pred CCcCCCcC-------------------------------hhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCC
Confidence 22221100 0012234567777777777764 455666677777777777
Q ss_pred CcccccCCCcCCCCCCCCccccccccccccCCCCccc-eeeecCCCCCCCC
Q 002255 404 NELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN-VIVKTDGNPDIGK 453 (947)
Q Consensus 404 N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~-~~~~~~~n~~~~~ 453 (947)
|+++ .+|..+..+++|+.|+|++|+++......... ..+.+.+|++.|.
T Consensus 305 n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 305 NHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp SCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHH
T ss_pred Ccce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccch
Confidence 7777 66666777777777777777776543322222 2455677776664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-29 Score=278.61 Aligned_cols=214 Identities=20% Similarity=0.341 Sum_probs=164.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+++++++. .++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|.++.++ .+..+++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 46788888888887 444 47888888888888888886555 888888888888888888863 47888888888888
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|++.. ++. +..+++|++|++++|.....++. +. .+++|++|++++|.+.+..+ .-...+|+.|++++|.+..
T Consensus 119 ~n~i~~--~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~--~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 119 EDNISD--ISP-LANLTKMYSLNLGANHNLSDLSP-LS--NMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp TSCCCC--CGG-GTTCTTCCEEECTTCTTCCCCGG-GT--TCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCC
T ss_pred CCcccC--chh-hccCCceeEEECCCCCCcccccc-hh--hCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCcccc
Confidence 888865 444 88888888888888866655554 44 67888888888888875444 2233678888888887765
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccc
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g 298 (947)
... +..+++|+.|++++|.+++..+ +..+++|++|++++|++++. +. +..+++|++|++++|.+++
T Consensus 192 ~~~-----~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~ 257 (347)
T 4fmz_A 192 ISP-----LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD 257 (347)
T ss_dssp CGG-----GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC
T ss_pred ccc-----ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC
Confidence 432 5678888888888888887655 77788888888888888854 33 8888888888888888774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-29 Score=278.45 Aligned_cols=281 Identities=24% Similarity=0.354 Sum_probs=237.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+|++|.+++ +++ +..+++|++|+|++|.++. ++.+.++++|++|+|++|.++++++ +..+++|++|+++
T Consensus 66 ~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~ 140 (347)
T 4fmz_A 66 TNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLG 140 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECT
T ss_pred CCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-chHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECC
Confidence 579999999999984 555 9999999999999999986 4689999999999999999999876 8899999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|.... .+..+..+++|++|++++|.+.+..+ +. .+++|++|++++|++++..+ .-...+|+.|++++|.+..
T Consensus 141 ~n~~~~--~~~~~~~l~~L~~L~l~~~~~~~~~~--~~--~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 213 (347)
T 4fmz_A 141 ANHNLS--DLSPLSNMTGLNYLTVTESKVKDVTP--IA--NLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD 213 (347)
T ss_dssp TCTTCC--CCGGGTTCTTCCEEECCSSCCCCCGG--GG--GCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred CCCCcc--cccchhhCCCCcEEEecCCCcCCchh--hc--cCCCCCEEEccCCccccccc-ccCCCccceeecccCCCCC
Confidence 997644 34559999999999999999986554 54 68999999999999985443 2234789999999998876
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
... +..+++|+.|+|++|.+++..+ +..+++|++|++++|++++. ..+..+++|++|++++|++++. |.
T Consensus 214 ~~~-----~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-- 282 (347)
T 4fmz_A 214 ITP-----VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SV-- 282 (347)
T ss_dssp CGG-----GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GG--
T ss_pred Cch-----hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hh--
Confidence 533 6678999999999999998766 88899999999999999853 5689999999999999998753 11
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
+..+++|+.|+|++|.+++
T Consensus 283 -------------------------------------------------------------~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 283 -------------------------------------------------------------LNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp -------------------------------------------------------------GGGCTTCSEEECCSSCCCG
T ss_pred -------------------------------------------------------------hcCCCCCCEEECcCCcCCC
Confidence 1123479999999999999
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccccccc
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~ 431 (947)
..|..++.+++|+.|+|++|++++..| +..+++|+.|++++|+|+
T Consensus 302 ~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999999999996666 889999999999999985
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-29 Score=290.50 Aligned_cols=303 Identities=22% Similarity=0.336 Sum_probs=203.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+|++|.+++. ++ +.++++|++|+|++|.+++..+ +.++++|++|+|++|+++++++ +..+++|++|+|+
T Consensus 68 ~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELS 142 (466)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEE
T ss_pred cCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECC
Confidence 3677777777777744 33 7777777777777777776665 7777777777777777777654 6777777777777
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|.+.. ++ .+..+++|++|+++ |.+.+..+ +. .+++|++|+|++|++++. +......+|+.|++++|.+..
T Consensus 143 ~n~l~~--~~-~~~~l~~L~~L~l~-~~~~~~~~--~~--~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~ 213 (466)
T 1o6v_A 143 SNTISD--IS-ALSGLTSLQQLSFG-NQVTDLKP--LA--NLTTLERLDISSNKVSDI-SVLAKLTNLESLIATNNQISD 213 (466)
T ss_dssp EEEECC--CG-GGTTCTTCSEEEEE-ESCCCCGG--GT--TCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC
T ss_pred CCccCC--Ch-hhccCCcccEeecC-CcccCchh--hc--cCCCCCEEECcCCcCCCC-hhhccCCCCCEEEecCCcccc
Confidence 777754 33 36666666666664 34443322 44 578888888888888753 332233678888888887765
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
... +..+++|+.|+|++|.+++. +.+..+++|+.|++++|++++..| +..+++|+.|+|++|++++..+ .
T Consensus 214 ~~~-----~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~- 283 (466)
T 1o6v_A 214 ITP-----LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-L- 283 (466)
T ss_dssp CGG-----GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-G-
T ss_pred ccc-----ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-c-
Confidence 432 55678888888888888764 567778888888888888886544 7888888888888888876543 1
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
....+...++...+.+.... ....+++|+.|+|++|.+++
T Consensus 284 -------~~l~~L~~L~L~~n~l~~~~---------------------------------~~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 284 -------AGLTALTNLELNENQLEDIS---------------------------------PISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp -------TTCTTCSEEECCSSCCSCCG---------------------------------GGGGCTTCSEEECCSSCCSC
T ss_pred -------cCCCccCeEEcCCCcccCch---------------------------------hhcCCCCCCEEECcCCcCCC
Confidence 11112222222222111100 02234567777777777776
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCC
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP 435 (947)
..| ++.+++|+.|+|++|++++. ..+..+++|+.|++++|++++.+|
T Consensus 324 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 324 ISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred chh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 655 66777777777777777753 467777777777777777777776
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=275.25 Aligned_cols=283 Identities=21% Similarity=0.274 Sum_probs=239.4
Q ss_pred CCCceeEeCCC----------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCC
Q 002255 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122 (947)
Q Consensus 54 C~w~gv~C~~~----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n 122 (947)
|.|+.+.|+.. .+++.|+|++|++.+..|..|.++++|++|+|++|++++..| .|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 78999999642 378999999999998888899999999999999999999877 7999999999999999
Q ss_pred cCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceee--eccCcccCCCCCCCccEEEccCCccc
Q 002255 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT--GTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 123 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~--~~~p~~~~~~~l~~L~~L~Ls~N~l~ 200 (947)
+++.+++..+ ++|++|+|++|++.. ..+..+.++++|++|++++|.++ +..|..+. .+ +|++|++++|+++
T Consensus 113 ~l~~l~~~~~---~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLVEIPPNLP---SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD--GL-KLNYLRISEAKLT 185 (332)
T ss_dssp CCCSCCSSCC---TTCCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC--SC-CCSCCBCCSSBCS
T ss_pred cCCccCcccc---ccCCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCccccc--CC-ccCEEECcCCCCC
Confidence 9999888755 899999999999976 45567999999999999999996 46777776 45 9999999999999
Q ss_pred CcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCcc
Q 002255 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSS 279 (947)
Q Consensus 201 ~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~ 279 (947)
+ +|..+. .+|+.|++++|.+...... .+.++++|+.|+|++|++++..+ .+..+++|++|+|++|+++ .+|..
T Consensus 186 ~-l~~~~~-~~L~~L~l~~n~i~~~~~~---~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 186 G-IPKDLP-ETLNELHLDHNKIQAIELE---DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp S-CCSSSC-SSCSCCBCCSSCCCCCCTT---SSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred c-cCcccc-CCCCEEECCCCcCCccCHH---HhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 5 666655 6899999999998876533 46678999999999999999887 4888999999999999999 89999
Q ss_pred ccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCC
Q 002255 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (947)
Q Consensus 280 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~ 359 (947)
+..+++|+.|+|++|++++..+..+.....
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-------------------------------------------------- 289 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGF-------------------------------------------------- 289 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSC--------------------------------------------------
T ss_pred hhcCccCCEEECCCCCCCccChhHcccccc--------------------------------------------------
Confidence 999999999999999999766543221110
Q ss_pred CCCCcccCCCCceeEEEecCCCce--eeccccccCCccCCeEeccCCc
Q 002255 360 DWKGVSCDAGGNITVVNLKNLGLS--GTISSNFSRLTSLRQLMLSGNE 405 (947)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~--g~ip~~~~~l~~L~~L~Ls~N~ 405 (947)
......|+.|++++|.+. +..|..|..+++|+.|+|++|+
T Consensus 290 ------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 290 ------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp ------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ------ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 011246889999999988 6778899999999999999985
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=288.78 Aligned_cols=322 Identities=21% Similarity=0.251 Sum_probs=170.1
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCC--------------------------------
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLS-------------------------------- 112 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~-------------------------------- 112 (947)
++++|++++|++ |.+|++|++|++|++|++++|.+.|.+| .+++++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~~ 90 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELP 90 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSCC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCCc
Confidence 556666666666 5666666666666666666666666555 455544
Q ss_pred -CCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccE
Q 002255 113 -SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191 (947)
Q Consensus 113 -~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 191 (947)
+|++|++++|++++++. .+++|++|++++|++.+ +|.. .++|++|++++|++++ +| .++ .+++|++
T Consensus 91 ~~L~~L~l~~n~l~~lp~----~~~~L~~L~l~~n~l~~--l~~~---~~~L~~L~L~~n~l~~-lp-~~~--~l~~L~~ 157 (454)
T 1jl5_A 91 PHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKA--LSDL---PPLLEYLGVSNNQLEK-LP-ELQ--NSSFLKI 157 (454)
T ss_dssp TTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC--CCSC---CTTCCEEECCSSCCSS-CC-CCT--TCTTCCE
T ss_pred CCCCEEEccCCcCCcccc----ccCCCcEEECCCCccCc--ccCC---CCCCCEEECcCCCCCC-Cc-ccC--CCCCCCE
Confidence 44455555555544332 12455555555555543 2221 1578888888888875 66 355 6788888
Q ss_pred EEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCc
Q 002255 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQ 271 (947)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~ 271 (947)
|++++|++++ +|..+ .+|++|++++|.+.... .+.++++|+.|++++|++++. |.+ .++|++|++++|+
T Consensus 158 L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~l~-----~~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~n~ 226 (454)
T 1jl5_A 158 IDVDNNSLKK-LPDLP--PSLEFIAAGNNQLEELP-----ELQNLPFLTAIYADNNSLKKL-PDL--PLSLESIVAGNNI 226 (454)
T ss_dssp EECCSSCCSC-CCCCC--TTCCEEECCSSCCSSCC-----CCTTCTTCCEEECCSSCCSSC-CCC--CTTCCEEECCSSC
T ss_pred EECCCCcCcc-cCCCc--ccccEEECcCCcCCcCc-----cccCCCCCCEEECCCCcCCcC-CCC--cCcccEEECcCCc
Confidence 8888888875 55544 37888888888776632 366788888888888888863 332 2478888888888
Q ss_pred cccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCC-----------cccCcCCCcCCCccceeeecccc
Q 002255 272 LTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNS-----------FCLDDAGVACDGRVNVLLSIVKS 340 (947)
Q Consensus 272 l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 340 (947)
++ .+|. +..+++|++|++++|++++ +|.....+.. +....|. ..++...+.+.+ +...+
T Consensus 227 l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~-L~l~~N~l~~l~~~~~~L~~L~ls~N~l~~----l~~~~-- 296 (454)
T 1jl5_A 227 LE-ELPE-LQNLPFLTTIYADNNLLKT-LPDLPPSLEA-LNVRDNYLTDLPELPQSLTFLDVSENIFSG----LSELP-- 296 (454)
T ss_dssp CS-SCCC-CTTCTTCCEEECCSSCCSS-CCSCCTTCCE-EECCSSCCSCCCCCCTTCCEEECCSSCCSE----ESCCC--
T ss_pred CC-cccc-cCCCCCCCEEECCCCcCCc-ccccccccCE-EECCCCcccccCcccCcCCEEECcCCccCc----ccCcC--
Confidence 87 6674 7788888888888888876 3332211110 0011111 111111111111 00000
Q ss_pred cCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCC
Q 002255 341 VGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420 (947)
Q Consensus 341 l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 420 (947)
..+.......+. +.++ +....+|+.|++++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|
T Consensus 297 ----~~L~~L~l~~N~----l~~i-~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L 359 (454)
T 1jl5_A 297 ----PNLYYLNASSNE----IRSL-CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNL 359 (454)
T ss_dssp ----TTCCEEECCSSC----CSEE-CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTC
T ss_pred ----CcCCEEECcCCc----CCcc-cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhc
Confidence 111111111111 1111 1122467777777777775 5553 466777777777777 5665 35667
Q ss_pred Cccccccccccc--cCCCCcc
Q 002255 421 EMLDVSNNHLFG--KVPNFRQ 439 (947)
Q Consensus 421 ~~L~ls~N~l~g--~iP~~~~ 439 (947)
++|+|++|+++| .+|....
T Consensus 360 ~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 360 KQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp CEEECCSSCCSSCCCCCTTCC
T ss_pred cEEECCCCCCCcCCCChHHHH
Confidence 777777777777 6665443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=272.40 Aligned_cols=268 Identities=17% Similarity=0.199 Sum_probs=215.0
Q ss_pred CCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc
Q 002255 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (947)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (947)
+|+.++++++.++..+..+. +.|++|+|++|+++++++..|.++++|++|+|++|++.+ ..|..+.++++|++|+++
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCe-eCHHHhcCCCCCCEEECC
Confidence 68899999999986554554 689999999999999999999999999999999999976 568999999999999999
Q ss_pred CceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCc
Q 002255 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (947)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (947)
+|.++ .+|..+. ++|++|++++|++++..+..+.. .+|+.|++++|.+.... .....+.++++|+.|+|++|.
T Consensus 109 ~n~l~-~l~~~~~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 109 KNQLK-ELPEKMP----KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG-IENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp SSCCS-BCCSSCC----TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG-BCTTGGGGCTTCCEEECCSSC
T ss_pred CCcCC-ccChhhc----ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC-cChhhccCCCCcCEEECCCCc
Confidence 99998 5676653 79999999999999776666654 67888888888775421 122446678888889999888
Q ss_pred CcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCC
Q 002255 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (947)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (947)
++..+..+. ++|++|++++|++++..|..+..+++|+.|+|++|++++..+..+
T Consensus 183 l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~------------------------ 236 (330)
T 1xku_A 183 ITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL------------------------ 236 (330)
T ss_dssp CCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG------------------------
T ss_pred cccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhc------------------------
Confidence 887554443 788888999888888778888888888889988888887655321
Q ss_pred CccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccc
Q 002255 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (947)
Q Consensus 329 ~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 408 (947)
...++|+.|+|++|.++ .+|..+..+++|++|+|++|+|++
T Consensus 237 --------------------------------------~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 237 --------------------------------------ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp --------------------------------------GGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred --------------------------------------cCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence 11236888888888888 788888888888888888888885
Q ss_pred cCCCcCCC------CCCCCcccccccccc
Q 002255 409 TIPKELTT------LPSLEMLDVSNNHLF 431 (947)
Q Consensus 409 ~iP~~l~~------l~~L~~L~ls~N~l~ 431 (947)
..+..|+. .+.|+.|++++|++.
T Consensus 278 ~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cChhhcCCcccccccccccceEeecCccc
Confidence 55555654 367788888888875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=287.44 Aligned_cols=301 Identities=24% Similarity=0.348 Sum_probs=239.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+|++|.+.+..+ ++++++|++|+|++|.+++..+ +.++++|++|++++|.+++++ .+..+++|++|+++
T Consensus 90 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~ 164 (466)
T 1o6v_A 90 TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG 164 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE
T ss_pred ccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC
Confidence 579999999999996544 9999999999999999998655 999999999999999999875 38889999999996
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
|.+.. ++ .+.++++|++|++++|.+++. + .+. .+++|++|++++|++++..| .-...+|+.|++++|.+..
T Consensus 165 -~~~~~--~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~--~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 235 (466)
T 1o6v_A 165 -NQVTD--LK-PLANLTTLERLDISSNKVSDI-S-VLA--KLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD 235 (466)
T ss_dssp -ESCCC--CG-GGTTCTTCCEEECCSSCCCCC-G-GGG--GCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred -CcccC--ch-hhccCCCCCEEECcCCcCCCC-h-hhc--cCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCccc
Confidence 55543 23 388999999999999998754 3 344 68899999999999987665 2223679999999998776
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
. ..+..+++|+.|+|++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..|
T Consensus 236 ~-----~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--- 304 (466)
T 1o6v_A 236 I-----GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--- 304 (466)
T ss_dssp C-----GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG---
T ss_pred c-----hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh---
Confidence 4 346778999999999999988766 8888999999999999986544 8889999999999999887544
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
+....+...++...+.+.+.. ....+++|+.|++++|.+++
T Consensus 305 ------~~~l~~L~~L~L~~n~l~~~~---------------------------------~~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 305 ------ISNLKNLTYLTLYFNNISDIS---------------------------------PVSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp ------GGGCTTCSEEECCSSCCSCCG---------------------------------GGGGCTTCCEEECCSSCCCC
T ss_pred ------hcCCCCCCEEECcCCcCCCch---------------------------------hhccCccCCEeECCCCccCC
Confidence 112222333333322221110 12245689999999999998
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccccccccc
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGK 433 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~ 433 (947)
. ..+.++++|+.|+|++|++++.+| +..+++|+.|++++|++++.
T Consensus 346 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 346 V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred c--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 5 579999999999999999998887 89999999999999999984
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=295.98 Aligned_cols=333 Identities=19% Similarity=0.200 Sum_probs=232.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|+|++..|.+|.+|++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 378999999999998778889999999999999999998887 6999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCC----------------------------------------
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG---------------------------------------- 183 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---------------------------------------- 183 (947)
++|.+....+|..++.+++|++|++++|++++..|..+..
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccc
Confidence 9999987678899999999999999999987665443210
Q ss_pred --------------------------------------------------------------------------------
Q 002255 184 -------------------------------------------------------------------------------- 183 (947)
Q Consensus 184 -------------------------------------------------------------------------------- 183 (947)
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence
Q ss_pred ---------CCCCCccEEEccCCcccCcCCccc--------------------cCCCCceeeeccCCCCC----------
Q 002255 184 ---------DTIPGLMHLHLAFNFLQGPIPLSF--------------------GKSSIQTLWLNGQKGDS---------- 224 (947)
Q Consensus 184 ---------~~l~~L~~L~Ls~N~l~~~~p~~~--------------------~~~~L~~L~l~~n~~~~---------- 224 (947)
.....|+.|++.+|++.+..+..+ ...+|+.|+++.|.+..
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhh
Confidence 001123444555554433221111 12456777777665421
Q ss_pred ------------CCCCchhhhcCCCCCcEEEccCCcCcCCCC--CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEe
Q 002255 225 ------------KLNGSVAVIQNMTSLTQLWLHGNSFTGPLP--DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290 (947)
Q Consensus 225 ------------~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~ 290 (947)
........+..+++|+.++++.|++....+ .+..+.+++.++++.|.+.+..|..+..+++|+.|+
T Consensus 396 ~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~ 475 (635)
T 4g8a_A 396 TISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 475 (635)
T ss_dssp CSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred hhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 011111224455666666666666555443 245566666666666666655566666666666666
Q ss_pred ccCCccc-ccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCC
Q 002255 291 LTNNLFQ-GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAG 369 (947)
Q Consensus 291 Ls~N~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 369 (947)
|++|++. +.+|..+..+. +...++...+.+.. . ....+..+
T Consensus 476 Ls~N~~~~~~~~~~~~~l~-------~L~~L~Ls~N~L~~-------l------------------------~~~~f~~l 517 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELR-------NLTFLDLSQCQLEQ-------L------------------------SPTAFNSL 517 (635)
T ss_dssp CTTCEEGGGEECSCCTTCT-------TCCEEECTTSCCCE-------E------------------------CTTTTTTC
T ss_pred hhhcccccccCchhhhhcc-------ccCEEECCCCccCC-------c------------------------ChHHHcCC
Confidence 6666533 23333222111 11111111111110 0 00012345
Q ss_pred CceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCC-CCCCccccccccccccCC
Q 002255 370 GNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL-PSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 370 ~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l-~~L~~L~ls~N~l~g~iP 435 (947)
++|+.|+|++|+|++..|..|.++++|++|||++|+|++..|..+..+ ++|++|+|++|+|++...
T Consensus 518 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 518 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 689999999999999999999999999999999999999999999998 689999999999998765
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=291.63 Aligned_cols=285 Identities=21% Similarity=0.270 Sum_probs=237.0
Q ss_pred CCC-CCCCCCCceeEeC------C-CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEe
Q 002255 47 GWT-DPDPCKWKHIQCS------P-SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVL 118 (947)
Q Consensus 47 ~w~-~~d~C~w~gv~C~------~-~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ 118 (947)
.|. +.+||.|+|..|. + ...++.|++++++++ .+|..+. ++|++|+|++|.|+..++ .+++|++|+
T Consensus 14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~ 87 (622)
T 3g06_A 14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLE 87 (622)
T ss_dssp HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEE
T ss_pred HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEE
Confidence 464 4678999764321 1 235899999999999 8888776 899999999999996444 679999999
Q ss_pred cCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCc
Q 002255 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198 (947)
Q Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~ 198 (947)
|++|+|++++. .+++|++|+|++|++.. +|. .+++|+.|++++|++++ +|.. +++|++|+|++|+
T Consensus 88 Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~--l~~---~l~~L~~L~L~~N~l~~-lp~~-----l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 88 VSGNQLTSLPV----LPPGLLELSIFSNPLTH--LPA---LPSGLCKLWIFGNQLTS-LPVL-----PPGLQELSVSDNQ 152 (622)
T ss_dssp ECSCCCSCCCC----CCTTCCEEEECSCCCCC--CCC---CCTTCCEEECCSSCCSC-CCCC-----CTTCCEEECCSSC
T ss_pred cCCCcCCcCCC----CCCCCCEEECcCCcCCC--CCC---CCCCcCEEECCCCCCCc-CCCC-----CCCCCEEECcCCc
Confidence 99999999886 68999999999999976 555 67899999999999985 5653 4799999999999
Q ss_pred ccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCc
Q 002255 199 LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS 278 (947)
Q Consensus 199 l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~ 278 (947)
+++ +|..+ .+|+.|++++|.+.... ..+++|+.|+|++|+|++.++. +++|+.|++++|.++ .+|.
T Consensus 153 l~~-l~~~~--~~L~~L~L~~N~l~~l~-------~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~ 218 (622)
T 3g06_A 153 LAS-LPALP--SELCKLWAYNNQLTSLP-------MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPA 218 (622)
T ss_dssp CSC-CCCCC--TTCCEEECCSSCCSCCC-------CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCC-cCCcc--CCCCEEECCCCCCCCCc-------ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCC
Confidence 995 45433 57999999999988754 2478999999999999975442 478999999999999 5665
Q ss_pred cccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCC
Q 002255 279 SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCN 358 (947)
Q Consensus 279 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~ 358 (947)
. +++|+.|+|++|+|++ +|.
T Consensus 219 ~---~~~L~~L~Ls~N~L~~-lp~-------------------------------------------------------- 238 (622)
T 3g06_A 219 L---PSGLKELIVSGNRLTS-LPV-------------------------------------------------------- 238 (622)
T ss_dssp C---CTTCCEEECCSSCCSC-CCC--------------------------------------------------------
T ss_pred C---CCCCCEEEccCCccCc-CCC--------------------------------------------------------
Confidence 3 4889999999999986 331
Q ss_pred CCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCc
Q 002255 359 SDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR 438 (947)
Q Consensus 359 ~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~ 438 (947)
.+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .||..+..+++|+.|+|++|+|+|.+|..+
T Consensus 239 ---------~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 239 ---------LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp ---------CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred ---------CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 1236899999999999 5776 6789999999999999 999999999999999999999999998755
Q ss_pred cc
Q 002255 439 QN 440 (947)
Q Consensus 439 ~~ 440 (947)
..
T Consensus 305 ~~ 306 (622)
T 3g06_A 305 RE 306 (622)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=271.72 Aligned_cols=201 Identities=24% Similarity=0.357 Sum_probs=136.9
Q ss_pred CCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCC--cc
Q 002255 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP--SD 130 (947)
Q Consensus 54 C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~--~~ 130 (947)
|.|.+|.|+. ++++ .+|..+. ++|++|+|++|+++..++ .|.++++|++|+|++|+++.+. +.
T Consensus 7 C~~~~l~c~~-----------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 72 (306)
T 2z66_A 7 CSGTEIRCNS-----------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72 (306)
T ss_dssp EETTEEECCS-----------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred eCCCEEEcCC-----------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence 6788777753 3444 5666543 688999999998886655 4788888888888888887542 44
Q ss_pred cccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccC-cccCCCCCCCccEEEccCCcccCcCCccccC
Q 002255 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209 (947)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 209 (947)
.+..+++|++|+|++|.+.. +|..+..+++|++|++++|.+++..+ ..+. .+++|++|+|++|++++..+..+.
T Consensus 73 ~~~~~~~L~~L~Ls~n~i~~--l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~- 147 (306)
T 2z66_A 73 SDFGTTSLKYLDLSFNGVIT--MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL--SLRNLIYLDISHTHTRVAFNGIFN- 147 (306)
T ss_dssp HHHSCSCCCEEECCSCSEEE--EEEEEETCTTCCEEECTTSEEESSTTTTTTT--TCTTCCEEECTTSCCEECSTTTTT-
T ss_pred ccccccccCEEECCCCcccc--ChhhcCCCCCCCEEECCCCcccccccchhhh--hccCCCEEECCCCcCCccchhhcc-
Confidence 45668888888888888764 66677777777777777777775544 3444 566777777777777655554432
Q ss_pred CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcC-CCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCC
Q 002255 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287 (947)
Q Consensus 210 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~ 287 (947)
++++|+.|+|++|.+++ .+| .+..+++|++|+|++|++++..|..+..+++|+
T Consensus 148 -------------------------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 148 -------------------------GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp -------------------------TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred -------------------------cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 35666667777766665 233 356666666666666666665566666666666
Q ss_pred eEeccCCcccc
Q 002255 288 VVNLTNNLFQG 298 (947)
Q Consensus 288 ~L~Ls~N~l~g 298 (947)
.|+|++|++++
T Consensus 203 ~L~L~~N~l~~ 213 (306)
T 2z66_A 203 VLNMSHNNFFS 213 (306)
T ss_dssp EEECTTSCCSB
T ss_pred EEECCCCccCc
Confidence 66666666654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-28 Score=277.65 Aligned_cols=295 Identities=18% Similarity=0.175 Sum_probs=222.4
Q ss_pred cccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcc
Q 002255 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155 (947)
Q Consensus 76 ~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~ 155 (947)
+..+..+..++++++|++|+|++|.+++. |.+..+++|++|+|++|++++++ ++.+++|++|+|++|++.+ ++
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~--~~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTN--LD- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC--CC-
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCce--ee-
Confidence 34455566788999999999999999986 68999999999999999999985 8899999999999999976 43
Q ss_pred cccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCcccc-CCCCceeeeccCCCCCCCCCchhhhc
Q 002255 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG-KSSIQTLWLNGQKGDSKLNGSVAVIQ 234 (947)
Q Consensus 156 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~~ 234 (947)
++++++|++|++++|++++ +| ++ .+++|++|+|++|++++. + ++ ..+|+.|++++|...... .+.
T Consensus 102 -~~~l~~L~~L~L~~N~l~~-l~--~~--~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-----~~~ 167 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTK-LD--VS--QNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-----DVT 167 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSC-CC--CT--TCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-----CCT
T ss_pred -cCCCCcCCEEECCCCcCCe-ec--CC--CCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-----ccc
Confidence 8999999999999999997 44 55 789999999999999974 3 43 378999999999544333 256
Q ss_pred CCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccC
Q 002255 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKG 314 (947)
Q Consensus 235 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~ 314 (947)
.+++|+.|+|++|++++. | +..+++|+.|++++|++++. .++.+++|+.|+|++|++++ +| +. ..
T Consensus 168 ~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~-------~l 232 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VT-------PL 232 (457)
T ss_dssp TCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CT-------TC
T ss_pred cCCcCCEEECCCCcccee-c-cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--cc-------cc
Confidence 789999999999999985 3 88899999999999999975 48999999999999999998 44 11 11
Q ss_pred CCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCc
Q 002255 315 SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLT 394 (947)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~ 394 (947)
.+...++...+.+.+.. +..+. . +..+.+ ...+|+.|++++|.+.|.+| ++.++
T Consensus 233 ~~L~~L~l~~N~l~~~~------~~~l~---~--------------L~~L~l-~~n~L~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 233 TQLTYFDCSVNPLTELD------VSTLS---K--------------LTTLHC-IQTDLLEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp TTCSEEECCSSCCSCCC------CTTCT---T--------------CCEEEC-TTCCCSCCCCTTCTTCCEEE--CTTCT
T ss_pred CCCCEEEeeCCcCCCcC------HHHCC---C--------------CCEEec-cCCCCCEEECCCCccCCccc--ccccc
Confidence 22222222222222110 00000 0 000000 01246677777777777777 46778
Q ss_pred cCCeEeccCCcccccCCCc--------CCCCCCCCccccccccccc
Q 002255 395 SLRQLMLSGNELTGTIPKE--------LTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 395 ~L~~L~Ls~N~l~g~iP~~--------l~~l~~L~~L~ls~N~l~g 432 (947)
+|+.|+|++|++.|.+|.. +..+++|+.|++++|+|+|
T Consensus 287 ~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~ 332 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE 332 (457)
T ss_dssp TCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC
T ss_pred cCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccc
Confidence 8888888888877777653 4445677777888888877
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-28 Score=277.33 Aligned_cols=249 Identities=21% Similarity=0.247 Sum_probs=194.1
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 147 (947)
.+++.+.+++ .+|..+. ++|++|+|++|++++..| .|.++++|++|+|++|+++++++..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4555666676 6777665 689999999999999877 79999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCC
Q 002255 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLN 227 (947)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~ 227 (947)
+.. ..+..+..+++|++|+|++|.++...+..|. .+++|++|+|++|+..+.++...
T Consensus 135 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~~-------------------- 191 (452)
T 3zyi_A 135 LTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFN--RVPSLMRLDLGELKKLEYISEGA-------------------- 191 (452)
T ss_dssp CSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTTT--------------------
T ss_pred CCc-cChhhhcccCCCCEEECCCCCcceeCHhHHh--cCCcccEEeCCCCCCccccChhh--------------------
Confidence 975 4556688899999999999999876666776 68899999998855444554321
Q ss_pred CchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCc
Q 002255 228 GSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV 307 (947)
Q Consensus 228 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~ 307 (947)
+.++++|+.|+|++|++++. |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..
T Consensus 192 -----~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------- 258 (452)
T 3zyi_A 192 -----FEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE------- 258 (452)
T ss_dssp -----TTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC-------
T ss_pred -----ccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC-------
Confidence 33578888888888888864 66778888888888888888877888888888888888877776443
Q ss_pred ccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeecc
Q 002255 308 RFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTIS 387 (947)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip 387 (947)
|
T Consensus 259 -------------------------------------------------------------------------------~ 259 (452)
T 3zyi_A 259 -------------------------------------------------------------------------------R 259 (452)
T ss_dssp -------------------------------------------------------------------------------T
T ss_pred -------------------------------------------------------------------------------H
Confidence 3
Q ss_pred ccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCC
Q 002255 388 SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP 435 (947)
..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+...
T Consensus 260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 445566777777777777775555556677777777777777765543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=275.02 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=189.8
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
..+++.+.+++ .+|..+. ++|+.|+|++|++++..+ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 45666777777 7887765 789999999999998887 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
++.. ..+..+..+++|++|+|++|.++...+..|. .+++|++|+|++|+..+.++...
T Consensus 123 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~~------------------- 180 (440)
T 3zyj_A 123 RLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFN--RIPSLRRLDLGELKRLSYISEGA------------------- 180 (440)
T ss_dssp CCSS-CCTTTSCSCSSCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTTT-------------------
T ss_pred cCCe-eCHhHhhccccCceeeCCCCcccccCHHHhh--hCcccCEeCCCCCCCcceeCcch-------------------
Confidence 9975 4455788888999999999888876666676 67888888888855444444321
Q ss_pred CCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCC
Q 002255 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306 (947)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 306 (947)
+.++++|+.|+|++|+++. +|.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++
T Consensus 181 ------~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------- 245 (440)
T 3zyj_A 181 ------FEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-------- 245 (440)
T ss_dssp ------TTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE--------
T ss_pred ------hhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE--------
Confidence 3357778888888888873 4567777777777777777777667777777777777777776654
Q ss_pred cccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeec
Q 002255 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTI 386 (947)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~i 386 (947)
..
T Consensus 246 ------------------------------------------------------------------------------~~ 247 (440)
T 3zyj_A 246 ------------------------------------------------------------------------------IE 247 (440)
T ss_dssp ------------------------------------------------------------------------------EC
T ss_pred ------------------------------------------------------------------------------EC
Confidence 33
Q ss_pred cccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccC
Q 002255 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434 (947)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~i 434 (947)
|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred hhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 445666677777777777777555555677777777777777776543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=259.50 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=217.7
Q ss_pred CEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC-CCCcccccCCCCCCeEeccC
Q 002255 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS-WVIPESLKDATGLQRFSANG 170 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~p~~~~~l~~L~~L~l~~ 170 (947)
+.++++++.++..+..+. ++|++|+|++|+++.+++..|..+++|++|+|++|++.. +..+..+..+++|++|++++
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 578999999886655443 689999999999999999999999999999999999964 12367788899999999999
Q ss_pred ceeeeccCcccCCCCCCCccEEEccCCcccCcCC-ccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcC
Q 002255 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP-LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (947)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (947)
|.++. +|..+. .+++|++|+|++|++++..+ .. +.++++|+.|+|++|.+
T Consensus 88 n~i~~-l~~~~~--~l~~L~~L~l~~n~l~~~~~~~~--------------------------~~~l~~L~~L~l~~n~l 138 (306)
T 2z66_A 88 NGVIT-MSSNFL--GLEQLEHLDFQHSNLKQMSEFSV--------------------------FLSLRNLIYLDISHTHT 138 (306)
T ss_dssp CSEEE-EEEEEE--TCTTCCEEECTTSEEESSTTTTT--------------------------TTTCTTCCEEECTTSCC
T ss_pred Ccccc-ChhhcC--CCCCCCEEECCCCcccccccchh--------------------------hhhccCCCEEECCCCcC
Confidence 99984 666676 68999999999999986544 22 34589999999999999
Q ss_pred cCCCCC-CCCCCCCCEEEccCCcccc-CCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcC
Q 002255 250 TGPLPD-LSGLSSLQDFSVRDNQLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVAC 327 (947)
Q Consensus 250 ~~~~~~-~~~l~~L~~L~l~~N~l~g-~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (947)
++.++. +.++++|++|++++|.+++ .+|..+..+++|++|+|++|++++..|..+.
T Consensus 139 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~---------------------- 196 (306)
T 2z66_A 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN---------------------- 196 (306)
T ss_dssp EECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT----------------------
T ss_pred CccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhc----------------------
Confidence 988875 7889999999999999997 6899999999999999999999987665321
Q ss_pred CCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCccc
Q 002255 328 DGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT 407 (947)
Q Consensus 328 ~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 407 (947)
..++|+.|+|++|.+++..+..+..+++|+.|+|++|+++
T Consensus 197 ----------------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 197 ----------------------------------------SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp ----------------------------------------TCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred ----------------------------------------CCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 2347999999999999888888999999999999999999
Q ss_pred ccCCCcCCCCC-CCCccccccccccccCC
Q 002255 408 GTIPKELTTLP-SLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 408 g~iP~~l~~l~-~L~~L~ls~N~l~g~iP 435 (947)
+.+|..+..++ +|++|+|++|+|++..+
T Consensus 237 ~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 237 TSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp BCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred ccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 99999999995 99999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-29 Score=291.58 Aligned_cols=188 Identities=20% Similarity=0.170 Sum_probs=131.9
Q ss_pred eecccCceEEEEEE-EcCCcEEEEEEeccccc--------ChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEEE
Q 002255 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVV--------SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 597 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 666 (947)
..+.|++|.+..++ .-.|+.||||++..... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777766653 34589999999976421 123456799999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||++|++|.+++.... +++.. +|+.||+.||+|+|+ +|||||||||+|||++++|.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999996532 34443 589999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCC
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKAL 798 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~ 798 (947)
..... .....+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 390 ~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 54322 2344689999999998864 5778899999999988887665443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-30 Score=297.10 Aligned_cols=224 Identities=18% Similarity=0.225 Sum_probs=166.6
Q ss_pred CCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCc
Q 002255 110 GLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL 189 (947)
Q Consensus 110 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 189 (947)
.+++|++|+|++|.++++++..|..+++|++|+|++|.+.+ ..| +..+++|++|+|++|.|++..+ .++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~l~~-------~~~L 101 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLD--LESLSTLRTLDLNNNYVQELLV-------GPSI 101 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE-EEE--CTTCTTCCEEECCSSEEEEEEE-------CTTC
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC-Ccc--cccCCCCCEEEecCCcCCCCCC-------CCCc
Confidence 34467777777777777766667777777777777777754 222 6777777777777777765432 3678
Q ss_pred cEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEcc
Q 002255 190 MHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVR 268 (947)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~ 268 (947)
++|+|++|.+++..+. .+++|+.|+|++|.+++.+| .+..+++|++|+|+
T Consensus 102 ~~L~L~~N~l~~~~~~-----------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 102 ETLHAANNNISRVSCS-----------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp CEEECCSSCCCCEEEC-----------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred CEEECcCCcCCCCCcc-----------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 8888888888754432 24678888888888888766 47778888888888
Q ss_pred CCccccCCCcccc-CCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhh
Q 002255 269 DNQLTGIVPSSLV-NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347 (947)
Q Consensus 269 ~N~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 347 (947)
+|.|++.+|..+. .+++|+.|+|++|.+++..+..
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------------------------- 188 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-------------------------------------------- 188 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC--------------------------------------------
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccccccc--------------------------------------------
Confidence 8888888888776 7888999999998888653210
Q ss_pred hccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccc
Q 002255 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427 (947)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~ 427 (947)
.+++|+.|+|++|.|++. |+.++.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 189 --------------------~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~ 246 (487)
T 3oja_A 189 --------------------VFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246 (487)
T ss_dssp --------------------CCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTT
T ss_pred --------------------cCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCC
Confidence 134688899999999874 445888999999999999999 4888899999999999999
Q ss_pred cccc-ccCCCCc
Q 002255 428 NHLF-GKVPNFR 438 (947)
Q Consensus 428 N~l~-g~iP~~~ 438 (947)
|++. +.+|.+.
T Consensus 247 N~l~c~~~~~~~ 258 (487)
T 3oja_A 247 NGFHCGTLRDFF 258 (487)
T ss_dssp CCBCHHHHHHHH
T ss_pred CCCcCcchHHHH
Confidence 9987 6666543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=255.09 Aligned_cols=208 Identities=20% Similarity=0.305 Sum_probs=157.4
Q ss_pred eeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCC
Q 002255 58 HIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136 (947)
Q Consensus 58 gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 136 (947)
+..|... ..+.+++++++++ .+|..+ .++|++|+|++|.+++.++ .|.++++|++|+|++|.++++.+..|..++
T Consensus 5 ~C~C~~~-~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 80 (285)
T 1ozn_A 5 ACVCYNE-PKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (285)
T ss_dssp TCEEECS-SSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CceECCC-CCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence 3456433 2367888888888 667654 4799999999999998877 689999999999999999999888899999
Q ss_pred CCcEEeccCCC-CCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCcee
Q 002255 137 SLQTISLDYNS-FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215 (947)
Q Consensus 137 ~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L 215 (947)
+|++|+|++|+ +.. ..|..+..+++|++|++++|.+++..|..+. .+++|++|+|++|++++..+..+.
T Consensus 81 ~L~~L~l~~n~~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~------- 150 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTFR------- 150 (285)
T ss_dssp TCCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT-------
T ss_pred CCCEEeCCCCCCccc-cCHHHhcCCcCCCEEECCCCcCCEECHhHhh--CCcCCCEEECCCCcccccCHhHhc-------
Confidence 99999999997 654 4577888888888888888888877777776 678888888888888755544443
Q ss_pred eeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCC
Q 002255 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294 (947)
Q Consensus 216 ~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N 294 (947)
++++|+.|+|++|++++.++. +..+++|++|+|++|++++..|..+.++++|+.|+|++|
T Consensus 151 -------------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 151 -------------------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp -------------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred -------------------cCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 356667777777766665553 566666666777666666666666666666666666666
Q ss_pred cccc
Q 002255 295 LFQG 298 (947)
Q Consensus 295 ~l~g 298 (947)
++++
T Consensus 212 ~l~~ 215 (285)
T 1ozn_A 212 NLSA 215 (285)
T ss_dssp CCSC
T ss_pred cCCc
Confidence 6654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-29 Score=274.04 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=170.2
Q ss_pred ccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCC-CCccccc-------CCCCCcEEeccCCCCCCCCCcc
Q 002255 85 LNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS-VPSDFFK-------GLTSLQTISLDYNSFDSWVIPE 155 (947)
Q Consensus 85 l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~-~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~p~ 155 (947)
++.+++|+.|++++|.+ .+| .+... |++|+|++|.++. ..+..+. ++++|++|+|++|++.+ .+|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG-TAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBS-CCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccc-hhHH
Confidence 44556677777777776 444 33332 6666666666642 2222232 46667777777776654 4555
Q ss_pred cc--cCCCCCCeEeccCceeeeccCcccCCCCC-----CCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCC
Q 002255 156 SL--KDATGLQRFSANGANITGTIPDFLGGDTI-----PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNG 228 (947)
Q Consensus 156 ~~--~~l~~L~~L~l~~n~l~~~~p~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~ 228 (947)
.+ ..+++|++|+|++|.+++. |..++ .+ ++|++|+|++|++++..|..++
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~--~l~~~~~~~L~~L~L~~N~l~~~~~~~~~-------------------- 170 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLA--ELQQWLKPGLKVLSIAQAHSLNFSCEQVR-------------------- 170 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHH--HHHTTCCTTCCEEEEESCSCCCCCTTTCC--------------------
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHH--HHHHhhcCCCcEEEeeCCCCccchHHHhc--------------------
Confidence 54 6666677777777666655 55444 33 6777777777777665555543
Q ss_pred chhhhcCCCCCcEEEccCCcCcCC---CCCC--CCCCCCCEEEccCCcccc--CCC-ccccCCCCCCeEeccCCcccccC
Q 002255 229 SVAVIQNMTSLTQLWLHGNSFTGP---LPDL--SGLSSLQDFSVRDNQLTG--IVP-SSLVNLHSLAVVNLTNNLFQGQT 300 (947)
Q Consensus 229 ~~~~~~~l~~L~~L~L~~N~l~~~---~~~~--~~l~~L~~L~l~~N~l~g--~~p-~~l~~l~~L~~L~Ls~N~l~g~~ 300 (947)
++++|++|+|++|++.+. ++.+ ..+++|++|+|++|+|++ .++ ..+.++++|++|+|++|++++.+
T Consensus 171 ------~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 171 ------VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp ------CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred ------cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 478888888888887764 2233 678888888888888883 223 33467888999999999888766
Q ss_pred CCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCC
Q 002255 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL 380 (947)
Q Consensus 301 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 380 (947)
|.. .+....+|+.|+|++|
T Consensus 245 ~~~-------------------------------------------------------------~~~~l~~L~~L~Ls~N 263 (312)
T 1wwl_A 245 GAP-------------------------------------------------------------SCDWPSQLNSLNLSFT 263 (312)
T ss_dssp CCS-------------------------------------------------------------CCCCCTTCCEEECTTS
T ss_pred chh-------------------------------------------------------------hhhhcCCCCEEECCCC
Confidence 421 0112346888999999
Q ss_pred CceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccccccccc
Q 002255 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGK 433 (947)
Q Consensus 381 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~ 433 (947)
+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|++|+|++|+|++.
T Consensus 264 ~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 264 GLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 988 7888777 8899999999999954 76 88999999999999998764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-26 Score=262.68 Aligned_cols=312 Identities=22% Similarity=0.279 Sum_probs=197.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|++++|.+++ +|.. +++|++|++++|++++.. .+ .++|++|++++|++++++ .|.++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~-~~--~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALS-DL--PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCC-SC--CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCccc-CC--CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 467788888888876 6643 367888888888877632 22 167888888888888865 37888888888888
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|++.+ +|..+ .+|++|++++|++++ +| .++ .+++|++|++++|++++ +|... .+|+.|++++|.+..
T Consensus 162 ~N~l~~--lp~~~---~~L~~L~L~~n~l~~-l~-~~~--~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~~ 229 (454)
T 1jl5_A 162 NNSLKK--LPDLP---PSLEFIAAGNNQLEE-LP-ELQ--NLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILEE 229 (454)
T ss_dssp SSCCSC--CCCCC---TTCCEEECCSSCCSS-CC-CCT--TCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCSS
T ss_pred CCcCcc--cCCCc---ccccEEECcCCcCCc-Cc-ccc--CCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCCc
Confidence 888864 55443 478888888888886 56 455 68888888888888885 44433 478888888887773
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccc--cCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG--QTPK 302 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~~p~ 302 (947)
.. .+.++++|+.|++++|++++.++ .+++|++|++++|++++ +|.. +++|+.|++++|++++ .+|.
T Consensus 230 lp-----~~~~l~~L~~L~l~~N~l~~l~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~ 297 (454)
T 1jl5_A 230 LP-----ELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPP 297 (454)
T ss_dssp CC-----CCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCT
T ss_pred cc-----ccCCCCCCCEEECCCCcCCcccc---cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCC
Confidence 32 25678888888888888886433 24788888888888885 5654 3778888888888887 2332
Q ss_pred CCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCc
Q 002255 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (947)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (947)
. ...++...+.+.+ +...+. .+.......+. +.++ ...+.+|+.|++++|++
T Consensus 298 ~-------------L~~L~l~~N~l~~----i~~~~~------~L~~L~Ls~N~----l~~l-p~~~~~L~~L~L~~N~l 349 (454)
T 1jl5_A 298 N-------------LYYLNASSNEIRS----LCDLPP------SLEELNVSNNK----LIEL-PALPPRLERLIASFNHL 349 (454)
T ss_dssp T-------------CCEEECCSSCCSE----ECCCCT------TCCEEECCSSC----CSCC-CCCCTTCCEEECCSSCC
T ss_pred c-------------CCEEECcCCcCCc----ccCCcC------cCCEEECCCCc----cccc-cccCCcCCEEECCCCcc
Confidence 1 1112222222111 000111 11112221211 1121 12257899999999999
Q ss_pred eeeccccccCCccCCeEeccCCcccc--cCCCcCCCC-------------CCCCccccccccccc--cCCCCccce
Q 002255 383 SGTISSNFSRLTSLRQLMLSGNELTG--TIPKELTTL-------------PSLEMLDVSNNHLFG--KVPNFRQNV 441 (947)
Q Consensus 383 ~g~ip~~~~~l~~L~~L~Ls~N~l~g--~iP~~l~~l-------------~~L~~L~ls~N~l~g--~iP~~~~~~ 441 (947)
+ .+|. .+++|+.|+|++|+++| .+|.++..+ ++|+.||+++|+++| .||......
T Consensus 350 ~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~L 421 (454)
T 1jl5_A 350 A-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDL 421 (454)
T ss_dssp S-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------------
T ss_pred c-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhhHhhe
Confidence 9 5777 47999999999999999 899999988 899999999999998 899876554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=246.06 Aligned_cols=219 Identities=21% Similarity=0.347 Sum_probs=194.7
Q ss_pred CCCCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCc
Q 002255 51 PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPS 129 (947)
Q Consensus 51 ~d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~ 129 (947)
.|+|.|.|+.|...+.++.+++++++++ .+|..+. ++|+.|+|++|++++..+ .|.++++|++|+|++|+++.+++
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 4899999999987777889999999999 6787665 689999999999998887 79999999999999999999999
Q ss_pred ccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC
Q 002255 130 DFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209 (947)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 209 (947)
..|..+++|++|+|++|++.. ..+..+..+++|++|++++|.+++..+..|. .+++|++|+|++|++++..+..|
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~l~~~~~~~~-- 153 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--SLTKLTYLSLGYNELQSLPKGVF-- 153 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTT--
T ss_pred hhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEECCCCccCeeCHHHhC--cCcCCCEEECCCCcCCccCHhHc--
Confidence 999999999999999999976 4556789999999999999999988888777 78999999999999996554444
Q ss_pred CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCe
Q 002255 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288 (947)
Q Consensus 210 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~ 288 (947)
..+++|+.|+|++|.+++..+. +..+++|++|+|++|+|++..+..+..+++|+.
T Consensus 154 ------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 209 (270)
T 2o6q_A 154 ------------------------DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209 (270)
T ss_dssp ------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred ------------------------cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCE
Confidence 3589999999999999998775 888999999999999999777777999999999
Q ss_pred EeccCCcccccCC
Q 002255 289 VNLTNNLFQGQTP 301 (947)
Q Consensus 289 L~Ls~N~l~g~~p 301 (947)
|+|++|++....+
T Consensus 210 L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 210 LQLQENPWDCTCN 222 (270)
T ss_dssp EECCSSCBCCSSS
T ss_pred EEecCCCeeCCCc
Confidence 9999999976543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=254.10 Aligned_cols=201 Identities=19% Similarity=0.315 Sum_probs=160.8
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccC---------C
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG---------L 135 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~---------l 135 (947)
.+++.|+|++|+++ .+|..++++++|++|+|++|.++..++.+.++++|++|+|++|++.+..|..+.. +
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 47999999999999 9999999999999999999999944338999999999999998887776665543 8
Q ss_pred CCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCcee
Q 002255 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215 (947)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L 215 (947)
++|++|+|++|++. .+|..++++++|++|+|++|.+++ +|..+. .+++|++|+|++|++.+.+|..++
T Consensus 183 ~~L~~L~L~~n~l~--~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~--~l~~L~~L~Ls~n~~~~~~p~~~~------- 250 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPLSA-LGPAIH--HLPKLEELDLRGCTALRNYPPIFG------- 250 (328)
T ss_dssp TTCCEEEEEEECCC--CCCGGGGGCTTCCEEEEESSCCCC-CCGGGG--GCTTCCEEECTTCTTCCBCCCCTT-------
T ss_pred CCCCEEECcCCCcC--cchHhhcCCCCCCEEEccCCCCCc-Cchhhc--cCCCCCEEECcCCcchhhhHHHhc-------
Confidence 88888888888886 477778888888888888888874 555565 577888888888887777776554
Q ss_pred eeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCC
Q 002255 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294 (947)
Q Consensus 216 ~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N 294 (947)
++++|+.|+|++|++.+.+| .+..+++|++|+|++|++.+.+|..++++++|+.+++..|
T Consensus 251 -------------------~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 251 -------------------GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp -------------------CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred -------------------CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 36778888888877777776 4677778888888888777788888888888888877766
Q ss_pred ccc
Q 002255 295 LFQ 297 (947)
Q Consensus 295 ~l~ 297 (947)
.+.
T Consensus 312 ~~~ 314 (328)
T 4fcg_A 312 LQA 314 (328)
T ss_dssp GSC
T ss_pred HHH
Confidence 654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=261.87 Aligned_cols=267 Identities=18% Similarity=0.215 Sum_probs=212.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+....+++.+++...+...+..+++|++|+|++|++++.+| .|.++++|++|+|++|+++++++ |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 356666777777775555666778899999999999998887 79999999999999999998776 889999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCC
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~ 223 (947)
++|++.+ ++ .+++|++|++++|++++..+.. +++|++|+|++|++++..+..++
T Consensus 88 s~n~l~~--l~----~~~~L~~L~l~~n~l~~~~~~~-----~~~L~~L~l~~N~l~~~~~~~~~--------------- 141 (317)
T 3o53_A 88 NNNYVQE--LL----VGPSIETLHAANNNISRVSCSR-----GQGKKNIYLANNKITMLRDLDEG--------------- 141 (317)
T ss_dssp CSSEEEE--EE----ECTTCCEEECCSSCCSEEEECC-----CSSCEEEECCSSCCCSGGGBCTG---------------
T ss_pred cCCcccc--cc----CCCCcCEEECCCCccCCcCccc-----cCCCCEEECCCCCCCCccchhhh---------------
Confidence 9999865 33 3489999999999999776553 57899999999999976665554
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-C-CCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCC
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-L-SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (947)
.+++|+.|+|++|.+++..+. + ..+++|++|+|++|+|++. |. ...+++|++|+|++|++++.++
T Consensus 142 -----------~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 142 -----------CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp -----------GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG
T ss_pred -----------ccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchh
Confidence 367788888888888876553 4 3578888888888888754 32 3347888888888888875433
Q ss_pred CCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCC
Q 002255 302 KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG 381 (947)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~ 381 (947)
.+ ....+|+.|+|++|.
T Consensus 209 ~~---------------------------------------------------------------~~l~~L~~L~L~~N~ 225 (317)
T 3o53_A 209 EF---------------------------------------------------------------QSAAGVTWISLRNNK 225 (317)
T ss_dssp GG---------------------------------------------------------------GGGTTCSEEECTTSC
T ss_pred hh---------------------------------------------------------------cccCcccEEECcCCc
Confidence 21 112367888888888
Q ss_pred ceeeccccccCCccCCeEeccCCccc-ccCCCcCCCCCCCCccccc-cccccccCCC
Q 002255 382 LSGTISSNFSRLTSLRQLMLSGNELT-GTIPKELTTLPSLEMLDVS-NNHLFGKVPN 436 (947)
Q Consensus 382 l~g~ip~~~~~l~~L~~L~Ls~N~l~-g~iP~~l~~l~~L~~L~ls-~N~l~g~iP~ 436 (947)
++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++|..|.
T Consensus 226 l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 88 57888899999999999999999 8889999999999999999 5678887764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=258.86 Aligned_cols=276 Identities=21% Similarity=0.234 Sum_probs=197.0
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEe
Q 002255 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 64 ~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (947)
..+++.|+|++|++++..+..|.++++|++|+|++|++++..| .|.++++|++|+|++|+++++++..|..+++|++|+
T Consensus 51 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence 3589999999999997767789999999999999999999887 699999999999999999999999899999999999
Q ss_pred ccCCCCCCCCCcc--cccCCCCCCeEeccCce-eeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeecc
Q 002255 143 LDYNSFDSWVIPE--SLKDATGLQRFSANGAN-ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNG 219 (947)
Q Consensus 143 Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~-l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~ 219 (947)
|++|++.. +|. .+.++++|++|++++|+ +.+..+..+. .+++|++|+|++|++++..|..+..
T Consensus 131 L~~n~l~~--l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~l~~---------- 196 (353)
T 2z80_A 131 LLGNPYKT--LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA--GLTFLEELEIDASDLQSYEPKSLKS---------- 196 (353)
T ss_dssp CTTCCCSS--SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--TCCEEEEEEEEETTCCEECTTTTTT----------
T ss_pred CCCCCCcc--cCchhhhccCCCCcEEECCCCccccccCHHHcc--CCCCCCEEECCCCCcCccCHHHHhc----------
Confidence 99999975 554 89999999999999995 6766677787 6899999999999999888877754
Q ss_pred CCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCcccc---CCCCCCeEeccCCc
Q 002255 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLV---NLHSLAVVNLTNNL 295 (947)
Q Consensus 220 n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~---~l~~L~~L~Ls~N~ 295 (947)
+++|++|+|++|.++..++. +..+++|+.|++++|++++..+..+. ..+.++.++|++|.
T Consensus 197 ----------------l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~ 260 (353)
T 2z80_A 197 ----------------IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260 (353)
T ss_dssp ----------------CSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCB
T ss_pred ----------------cccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccc
Confidence 44455555555554332222 22244555555555555543333222 23445555555555
Q ss_pred ccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEE
Q 002255 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375 (947)
Q Consensus 296 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L 375 (947)
+++..- ...+. .+...++|+.|
T Consensus 261 l~~~~l---------------------------------~~l~~-------------------------~l~~l~~L~~L 282 (353)
T 2z80_A 261 ITDESL---------------------------------FQVMK-------------------------LLNQISGLLEL 282 (353)
T ss_dssp CCHHHH---------------------------------HHHHH-------------------------HHHTCTTCCEE
T ss_pred ccCcch---------------------------------hhhHH-------------------------HHhcccCCCEE
Confidence 543100 00000 00112345666
Q ss_pred EecCCCceeecccc-ccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCC
Q 002255 376 NLKNLGLSGTISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 376 ~Ls~n~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP 435 (947)
+|++|+++ .+|.. |+++++|++|+|++|.+++..| .+++|...-+...+.+|
T Consensus 283 ~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~-------~l~~l~~~~~~~~~~~~ 335 (353)
T 2z80_A 283 EFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP-------RIDYLSRWLNKNSQKEQ 335 (353)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH-------HHHHHHHHHHHTTTTEE
T ss_pred ECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC-------CcHHHHHHHHhccccCC
Confidence 66666666 45555 5889999999999999985443 56677666677666664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=246.01 Aligned_cols=179 Identities=19% Similarity=0.264 Sum_probs=104.3
Q ss_pred CEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCc
Q 002255 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (947)
+.++.+++.++..+..+ .++|++|+|++|+++++++..|..+++|++|+|++|.+.+ ..|..+..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccce-eCHhhcCCccCCCEEeCCCC
Confidence 56777777776543333 3567777777777777776667777777777777777654 34556666666666666666
Q ss_pred e-eeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCc
Q 002255 172 N-ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250 (947)
Q Consensus 172 ~-l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 250 (947)
. +....|..+. .+++|++|+|++|++++..|..+. ++++|++|+|++|.++
T Consensus 91 ~~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~l~~L~~L~l~~n~l~ 142 (285)
T 1ozn_A 91 AQLRSVDPATFH--GLGRLHTLHLDRCGLQELGPGLFR--------------------------GLAALQYLYLQDNALQ 142 (285)
T ss_dssp TTCCCCCTTTTT--TCTTCCEEECTTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCC
T ss_pred CCccccCHHHhc--CCcCCCEEECCCCcCCEECHhHhh--------------------------CCcCCCEEECCCCccc
Confidence 5 4444455554 455666666666665544443332 3555666666666655
Q ss_pred CCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCC
Q 002255 251 GPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (947)
Q Consensus 251 ~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (947)
+.++. +..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 143 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 194 (285)
T 1ozn_A 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (285)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCH
Confidence 54443 4555555555555555554444445555555555555555554433
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-27 Score=271.21 Aligned_cols=235 Identities=18% Similarity=0.212 Sum_probs=182.1
Q ss_pred CCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeE
Q 002255 88 LSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (947)
Q Consensus 88 l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (947)
+++|++|+|++|.+++.+| .|.++++|++|+|++|.++++++ |..+++|++|+|++|.|.+ +| ..++|++|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~--l~----~~~~L~~L 104 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE--LL----VGPSIETL 104 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE--EE----ECTTCCEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC--CC----CCCCcCEE
Confidence 3478888888888888776 68888888888888888887766 7888888888888888864 33 23788888
Q ss_pred eccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC
Q 002255 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (947)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (947)
++++|.+++..+.. +++|++|+|++|++++..|..++ ++++|+.|+|++
T Consensus 105 ~L~~N~l~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~--------------------------~l~~L~~L~Ls~ 153 (487)
T 3oja_A 105 HAANNNISRVSCSR-----GQGKKNIYLANNKITMLRDLDEG--------------------------CRSRVQYLDLKL 153 (487)
T ss_dssp ECCSSCCCCEEECC-----CSSCEEEECCSSCCCSGGGBCGG--------------------------GGSSEEEEECTT
T ss_pred ECcCCcCCCCCccc-----cCCCCEEECCCCCCCCCCchhhc--------------------------CCCCCCEEECCC
Confidence 88888888766543 56788899999988877776554 367788888888
Q ss_pred CcCcCCCCC-CC-CCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCC
Q 002255 247 NSFTGPLPD-LS-GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324 (947)
Q Consensus 247 N~l~~~~~~-~~-~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 324 (947)
|.|++.+|. +. .+++|++|+|++|.|++. | .+..+++|+.|+|++|++++.+|.+
T Consensus 154 N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~--------------------- 210 (487)
T 3oja_A 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEF--------------------- 210 (487)
T ss_dssp SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGG---------------------
T ss_pred CCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhH---------------------
Confidence 888876553 44 578888888888888755 2 2345788888888888887654431
Q ss_pred CcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCC
Q 002255 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN 404 (947)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N 404 (947)
..+++|+.|+|++|.|++ +|..++.+++|+.|+|++|
T Consensus 211 ------------------------------------------~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N 247 (487)
T 3oja_A 211 ------------------------------------------QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247 (487)
T ss_dssp ------------------------------------------GGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTC
T ss_pred ------------------------------------------cCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCC
Confidence 112357888888888885 7888999999999999999
Q ss_pred ccc-ccCCCcCCCCCCCCcccccc
Q 002255 405 ELT-GTIPKELTTLPSLEMLDVSN 427 (947)
Q Consensus 405 ~l~-g~iP~~l~~l~~L~~L~ls~ 427 (947)
.+. +.+|..+..++.|+.|+++.
T Consensus 248 ~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 248 GFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp CBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred CCcCcchHHHHHhCCCCcEEeccc
Confidence 998 88899999999999999873
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-28 Score=262.36 Aligned_cols=263 Identities=18% Similarity=0.189 Sum_probs=208.6
Q ss_pred CCCC-CCCCCCceeEeCC-CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCccc-CcCC-CCC-------CCCCCc
Q 002255 47 GWTD-PDPCKWKHIQCSP-SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT-GQIP-SLS-------GLSSLQ 115 (947)
Q Consensus 47 ~w~~-~d~C~w~gv~C~~-~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~-~~~p-~~~-------~l~~L~ 115 (947)
.|.. ..|+.+..+.... ..+++.|++++|.+ .+|..+... |+.|+|++|.++ +.+| .+. ++++|+
T Consensus 23 ~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~ 98 (312)
T 1wwl_A 23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98 (312)
T ss_dssp CGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCC
T ss_pred chHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCcc
Confidence 4643 3555565544321 24678888999999 788877755 999999999994 4566 343 799999
Q ss_pred EEecCCCcCCCCCcccc--cCCCCCcEEeccCCCCCCCCCcccccCC-----CCCCeEeccCceeeeccCcccCCCCCCC
Q 002255 116 EVLFDDNNFTSVPSDFF--KGLTSLQTISLDYNSFDSWVIPESLKDA-----TGLQRFSANGANITGTIPDFLGGDTIPG 188 (947)
Q Consensus 116 ~L~L~~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 188 (947)
+|+|++|++++..|..+ ..+++|++|+|++|++.+ +|..++.+ ++|++|+|++|++++..|..++ .+++
T Consensus 99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~--~l~~ 174 (312)
T 1wwl_A 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT--RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR--VFPA 174 (312)
T ss_dssp EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSS--SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC--CCSS
T ss_pred EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcc--hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc--cCCC
Confidence 99999999997666655 899999999999999986 38888877 9999999999999998889988 7999
Q ss_pred ccEEEccCCcccCcC--CccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCC--C-C-CCCCCCC
Q 002255 189 LMHLHLAFNFLQGPI--PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL--P-D-LSGLSSL 262 (947)
Q Consensus 189 L~~L~Ls~N~l~~~~--p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~-~-~~~l~~L 262 (947)
|++|+|++|++.+.+ |..+. +.++++|++|+|++|+|++.. + . +..+++|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L 230 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALC------------------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSC------------------------TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCC
T ss_pred CCEEECCCCCcCcchHHHHHHH------------------------hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCC
Confidence 999999999988653 22221 245788999999999988432 1 2 3567899
Q ss_pred CEEEccCCccccCCC-ccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeeccccc
Q 002255 263 QDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341 (947)
Q Consensus 263 ~~L~l~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 341 (947)
++|+|++|++++.+| ..+..+++|++|+|++|+++ .+|..+
T Consensus 231 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~------------------------------------- 272 (312)
T 1wwl_A 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL------------------------------------- 272 (312)
T ss_dssp SEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC-------------------------------------
T ss_pred CEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc-------------------------------------
Confidence 999999999998775 55667899999999999998 455321
Q ss_pred CChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccc
Q 002255 342 GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (947)
Q Consensus 342 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 408 (947)
..+|+.|+|++|+|++. |. +..+++|++|+|++|+|++
T Consensus 273 ---------------------------~~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 ---------------------------PAKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp ---------------------------CSEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred ---------------------------cCCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 03689999999999976 66 9999999999999999985
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-25 Score=253.59 Aligned_cols=237 Identities=21% Similarity=0.312 Sum_probs=206.9
Q ss_pred CCceeEeCC----------CCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc
Q 002255 55 KWKHIQCSP----------SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN 123 (947)
Q Consensus 55 ~w~gv~C~~----------~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~ 123 (947)
.|..|.|.. ...++.|+|++|++.+..+..|.++++|++|+|++|.+++..+ .|.++++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 367888864 2468999999999998888999999999999999999998876 79999999999999999
Q ss_pred CCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCc-ccCCCCCCCccEEEccCCcccCc
Q 002255 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMHLHLAFNFLQGP 202 (947)
Q Consensus 124 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~~~l~~L~~L~Ls~N~l~~~ 202 (947)
++.+++..|..+++|++|+|++|++.. ..+..|.++++|++|+|++|+..+.++. .|. .+++|++|+|++|+++ .
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~--~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFE--GLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTT--TCSSCCEEECTTSCCS-S
T ss_pred CCeeCHhHhhccccCceeeCCCCcccc-cCHHHhhhCcccCEeCCCCCCCcceeCcchhh--cccccCeecCCCCcCc-c
Confidence 999999999999999999999999976 5566899999999999999665555555 565 6899999999999999 5
Q ss_pred CCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCcccc
Q 002255 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLV 281 (947)
Q Consensus 203 ~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~ 281 (947)
+|......+|+.|+|++|.+...... .|.++++|+.|+|++|++++..+. +.++++|+.|+|++|+|++..+..+.
T Consensus 200 ~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 276 (440)
T 3zyj_A 200 IPNLTPLIKLDELDLSGNHLSAIRPG---SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276 (440)
T ss_dssp CCCCTTCSSCCEEECTTSCCCEECTT---TTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred ccccCCCcccCEEECCCCccCccChh---hhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence 67544557899999999988766443 467789999999999999998774 88899999999999999988788889
Q ss_pred CCCCCCeEeccCCcccc
Q 002255 282 NLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 282 ~l~~L~~L~Ls~N~l~g 298 (947)
.+++|+.|+|++|++..
T Consensus 277 ~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 277 PLHHLERIHLHHNPWNC 293 (440)
T ss_dssp SCTTCCEEECCSSCEEC
T ss_pred cccCCCEEEcCCCCccC
Confidence 99999999999999873
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=255.21 Aligned_cols=236 Identities=19% Similarity=0.300 Sum_probs=206.9
Q ss_pred CceeEeCCC----------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcC
Q 002255 56 WKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNF 124 (947)
Q Consensus 56 w~gv~C~~~----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l 124 (947)
|..|.|... .+++.|+|++|++++..|..|.++++|++|+|++|++++..+ .|.++++|++|+|++|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 567888642 379999999999999989999999999999999999999887 799999999999999999
Q ss_pred CCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCc-ccCCCCCCCccEEEccCCcccCcC
Q 002255 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMHLHLAFNFLQGPI 203 (947)
Q Consensus 125 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (947)
+.+++..|..+++|++|+|++|++.. ..+..+.++++|++|++++|+..+.++. .|. .+++|++|+|++|++++ +
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~--~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFE--GLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTT--TCTTCCEEECTTSCCSS-C
T ss_pred CccChhhhcccCCCCEEECCCCCcce-eCHhHHhcCCcccEEeCCCCCCccccChhhcc--CCCCCCEEECCCCcccc-c
Confidence 99999999999999999999999975 4566899999999999999655555655 465 68999999999999995 5
Q ss_pred CccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccC
Q 002255 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVN 282 (947)
Q Consensus 204 p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~ 282 (947)
|......+|+.|+|++|.+..... ..|.++++|+.|+|++|++++..+. +.++++|+.|+|++|+|++..+..+..
T Consensus 212 ~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 212 PNLTPLVGLEELEMSGNHFPEIRP---GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp CCCTTCTTCCEEECTTSCCSEECG---GGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred ccccccccccEEECcCCcCcccCc---ccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 654445789999999998876544 3477899999999999999998774 888999999999999999877788899
Q ss_pred CCCCCeEeccCCcccc
Q 002255 283 LHSLAVVNLTNNLFQG 298 (947)
Q Consensus 283 l~~L~~L~Ls~N~l~g 298 (947)
+++|+.|+|++|++..
T Consensus 289 l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTCCEEECCSSCEEC
T ss_pred ccCCCEEEccCCCcCC
Confidence 9999999999999874
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=253.56 Aligned_cols=245 Identities=18% Similarity=0.214 Sum_probs=207.9
Q ss_pred CCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEec
Q 002255 90 SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (947)
Q Consensus 90 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (947)
.++.++++.+.+...+. .+..+++|++|+|++|+++++++..|..+++|++|+|++|++.+ ++. +..+++|++|++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~--~~~-~~~l~~L~~L~L 87 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLD-LESLSTLRTLDL 87 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE--EEE-ETTCTTCCEEEC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc--chh-hhhcCCCCEEEC
Confidence 45566777887766555 46678899999999999999999999999999999999999975 333 999999999999
Q ss_pred cCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCc
Q 002255 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (947)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (947)
++|.+++..+ .++|++|++++|++++..+. .+++|+.|+|++|+
T Consensus 88 s~n~l~~l~~-------~~~L~~L~l~~n~l~~~~~~-----------------------------~~~~L~~L~l~~N~ 131 (317)
T 3o53_A 88 NNNYVQELLV-------GPSIETLHAANNNISRVSCS-----------------------------RGQGKKNIYLANNK 131 (317)
T ss_dssp CSSEEEEEEE-------CTTCCEEECCSSCCSEEEEC-----------------------------CCSSCEEEECCSSC
T ss_pred cCCccccccC-------CCCcCEEECCCCccCCcCcc-----------------------------ccCCCCEEECCCCC
Confidence 9999986432 47999999999999865432 25789999999999
Q ss_pred CcCCCC-CCCCCCCCCEEEccCCccccCCCcccc-CCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCc
Q 002255 249 FTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLV-NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (947)
Q Consensus 249 l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (947)
+++..+ .+..+++|++|+|++|++++..|..+. .+++|++|+|++|++++..+.
T Consensus 132 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------------------------ 187 (317)
T 3o53_A 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ------------------------ 187 (317)
T ss_dssp CCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC------------------------
T ss_pred CCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccc------------------------
Confidence 999877 588899999999999999988787774 799999999999999864211
Q ss_pred CCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcc
Q 002255 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNEL 406 (947)
Q Consensus 327 ~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l 406 (947)
....+|+.|+|++|++++ +|..+..+++|+.|+|++|+|
T Consensus 188 ----------------------------------------~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l 226 (317)
T 3o53_A 188 ----------------------------------------VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226 (317)
T ss_dssp ----------------------------------------CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCC
T ss_pred ----------------------------------------cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcc
Confidence 013479999999999996 555699999999999999999
Q ss_pred cccCCCcCCCCCCCCcccccccccc-ccCCCCcc
Q 002255 407 TGTIPKELTTLPSLEMLDVSNNHLF-GKVPNFRQ 439 (947)
Q Consensus 407 ~g~iP~~l~~l~~L~~L~ls~N~l~-g~iP~~~~ 439 (947)
+ .+|..+..+++|+.|+|++|+++ +.+|.+..
T Consensus 227 ~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp C-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred c-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 9 79999999999999999999998 77775543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-26 Score=265.34 Aligned_cols=188 Identities=16% Similarity=0.189 Sum_probs=147.8
Q ss_pred CcCceecccCceEEEEEEEcCCcEEEEEEecccccCh------HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
...++||+|+||.||+|.. .++.+|+|+........ ...+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 47889999875443221 1235689999999999999999777777788888999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999843 45789999999999997 89999999999999999 9999999999987
Q ss_pred CCCCCcc-----eeecccccccccCcccccc--CCcCcccccccHHHHHHHHHhCCCCCC
Q 002255 747 PDNGKHS-----IETRLAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 747 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~p~~ 799 (947)
....... ......||+.|||||++.. ..|+.++|+|+..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5532211 1235689999999999976 568889999999999888888777663
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=254.86 Aligned_cols=248 Identities=24% Similarity=0.293 Sum_probs=210.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+|++|+++ .+|. .+++|++|+|++|+|++.++ .+++|++|+|++|++++++. .+++|++|+|+
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~ 129 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIF 129 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECC
Confidence 47999999999999 6776 57999999999999986544 78999999999999999886 57899999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|++.. +|.. +++|++|+|++|++++ +|.. +++|+.|+|++|++++ +|.. ..+|+.|++++|.+..
T Consensus 130 ~N~l~~--lp~~---l~~L~~L~Ls~N~l~~-l~~~-----~~~L~~L~L~~N~l~~-l~~~--~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 130 GNQLTS--LPVL---PPGLQELSVSDNQLAS-LPAL-----PSELCKLWAYNNQLTS-LPML--PSGLQELSVSDNQLAS 195 (622)
T ss_dssp SSCCSC--CCCC---CTTCCEEECCSSCCSC-CCCC-----CTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSC
T ss_pred CCCCCc--CCCC---CCCCCEEECcCCcCCC-cCCc-----cCCCCEEECCCCCCCC-Cccc--CCCCcEEECCCCCCCC
Confidence 999975 6664 4899999999999985 4542 4689999999999995 6632 3679999999999886
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
... .+++|+.|++++|.++..+. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++ +|.
T Consensus 196 l~~-------~~~~L~~L~L~~N~l~~l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~-- 258 (622)
T 3g06_A 196 LPT-------LPSELYKLWAYNNRLTSLPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM-- 258 (622)
T ss_dssp CCC-------CCTTCCEEECCSSCCSSCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC--
T ss_pred CCC-------ccchhhEEECcCCcccccCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc--
Confidence 433 25889999999999996543 25889999999999995 67 566899999999999984 332
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
.+++|+.|+|++|+|+
T Consensus 259 ---------------------------------------------------------------~~~~L~~L~Ls~N~L~- 274 (622)
T 3g06_A 259 ---------------------------------------------------------------LPSGLLSLSVYRNQLT- 274 (622)
T ss_dssp ---------------------------------------------------------------CCTTCCEEECCSSCCC-
T ss_pred ---------------------------------------------------------------ccccCcEEeCCCCCCC-
Confidence 1236899999999999
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCCC
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP 418 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 418 (947)
.+|..|+++++|+.|+|++|.|+|.+|..+..++
T Consensus 275 ~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 8899999999999999999999999998777655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-24 Score=230.75 Aligned_cols=218 Identities=22% Similarity=0.264 Sum_probs=155.2
Q ss_pred cCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCccccc
Q 002255 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLK 158 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 158 (947)
.+|..+. ++|++|+|++|++++..+ .|.++++|++|+|++|+++++++..|..+++|++|+|++|++.+ ..+..+.
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~ 97 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFS 97 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc-cChhhhc
Confidence 4554443 456677777777666655 56666777777777777776666666667777777777776654 3445666
Q ss_pred CCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCc-CCccccC-CCCceeeeccCCCCCCCCCchhhhcCC
Q 002255 159 DATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP-IPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNM 236 (947)
Q Consensus 159 ~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l 236 (947)
++++|++|++++|++++..+..+. .+++|++|+|++|++++. +|..+.. .+|+.|+|++|.+..........+.++
T Consensus 98 ~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 175 (276)
T 2z62_A 98 GLSSLQKLVAVETNLASLENFPIG--HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175 (276)
T ss_dssp TCTTCCEEECTTSCCCCSTTCCCT--TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTC
T ss_pred CCccccEEECCCCCccccCchhcc--cCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhc
Confidence 677777777777776665554555 566777777777776652 4655544 567777777776666555455555566
Q ss_pred CCCc-EEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 237 TSLT-QLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 237 ~~L~-~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
+.|. .|+|++|.+++..+......+|+.|+|++|++++..+..+.++++|+.|+|++|++++..|.
T Consensus 176 ~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp TTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred cccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 6666 89999999999888766667999999999999977777789999999999999999987764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=227.79 Aligned_cols=212 Identities=17% Similarity=0.173 Sum_probs=127.4
Q ss_pred CCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccE
Q 002255 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191 (947)
Q Consensus 112 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 191 (947)
++|++|+|++|+++++++..|..+++|++|+|++|++.. ..+..+.++++|++|++++|.+++..+..+. .
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~------ 98 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFS--G------ 98 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTT--T------
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhc--C------
Confidence 457777777777777666666667777777777776643 2333444444444444444444444333333 2
Q ss_pred EEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCC
Q 002255 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDN 270 (947)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N 270 (947)
+++|+.|+|++|.+++..+ .+..+++|++|++++|
T Consensus 99 --------------------------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 134 (276)
T 2z62_A 99 --------------------------------------------LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134 (276)
T ss_dssp --------------------------------------------CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSS
T ss_pred --------------------------------------------CccccEEECCCCCccccCchhcccCCCCCEEECcCC
Confidence 4555555555555555444 3555666666666666
Q ss_pred cccc-CCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhc
Q 002255 271 QLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349 (947)
Q Consensus 271 ~l~g-~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~ 349 (947)
++++ .+|..+.++++|++|+|++|++++..+..+..+
T Consensus 135 ~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------------------------------------------ 172 (276)
T 2z62_A 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL------------------------------------------ 172 (276)
T ss_dssp CCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH------------------------------------------
T ss_pred ccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhh------------------------------------------
Confidence 6654 246666667777777777776665433210000
Q ss_pred cCCCCCCCCCCCCCcccCCCCcee-EEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 350 SWKGNNPCNSDWKGVSCDAGGNIT-VVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~-~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
.....|. .|++++|.+++..+..+. ..+|+.|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 173 -----------------~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 234 (276)
T 2z62_A 173 -----------------HQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234 (276)
T ss_dssp -----------------HTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred -----------------hhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence 0001122 577777777754444443 347888888888888554555788888999999999
Q ss_pred cccccCCC
Q 002255 429 HLFGKVPN 436 (947)
Q Consensus 429 ~l~g~iP~ 436 (947)
++++..|.
T Consensus 235 ~~~c~c~~ 242 (276)
T 2z62_A 235 PWDCSCPR 242 (276)
T ss_dssp CBCCCTTT
T ss_pred cccccCCc
Confidence 98888874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-27 Score=273.19 Aligned_cols=231 Identities=18% Similarity=0.196 Sum_probs=149.7
Q ss_pred cEEEEEecCCcccc----cCcccccCCCCCCEEEcccCcccCcCC-C-CCCCC----CCcEEecCCCcCCC----CCccc
Q 002255 66 RVTRIQIGGQNIEG----TLPKELNSLSSLTVLEVMKNKLTGQIP-S-LSGLS----SLQEVLFDDNNFTS----VPSDF 131 (947)
Q Consensus 66 ~v~~l~L~~~~l~g----~~p~~l~~l~~L~~L~L~~N~l~~~~p-~-~~~l~----~L~~L~L~~n~l~~----~~~~~ 131 (947)
+++.|+|++|++++ .++..+..+++|++|+|++|.++...+ . +..++ +|++|+|++|+++. ..+..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 56777777777764 345667777777778877777765332 2 22233 57778887777773 34566
Q ss_pred ccCCCCCcEEeccCCCCCCCCCccc-----ccCCCCCCeEeccCceeeecc----CcccCCCCCCCccEEEccCCcccCc
Q 002255 132 FKGLTSLQTISLDYNSFDSWVIPES-----LKDATGLQRFSANGANITGTI----PDFLGGDTIPGLMHLHLAFNFLQGP 202 (947)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~~~~~p~~-----~~~l~~L~~L~l~~n~l~~~~----p~~~~~~~l~~L~~L~Ls~N~l~~~ 202 (947)
+..+++|++|+|++|.+.. ..+.. ....++|++|++++|++++.. +..+. .+++|++|+|++|.+++.
T Consensus 109 l~~~~~L~~L~Ls~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGD-AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR--AKPDFKELTVSNNDINEA 185 (461)
T ss_dssp TTSCTTCCEEECCSSBCHH-HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHH--HCTTCCEEECCSSBCHHH
T ss_pred HccCCceeEEECCCCcCch-HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHh--hCCCCCEEECcCCCcchH
Confidence 7777778888887777643 11221 223556777888877777533 44444 457788888888877654
Q ss_pred CCcccc------CCCCceeeeccCCCCCCCCC-chhhhcCCCCCcEEEccCCcCcCCC-----CC-CCCCCCCCEEEccC
Q 002255 203 IPLSFG------KSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGPL-----PD-LSGLSSLQDFSVRD 269 (947)
Q Consensus 203 ~p~~~~------~~~L~~L~l~~n~~~~~~~~-~~~~~~~l~~L~~L~L~~N~l~~~~-----~~-~~~l~~L~~L~l~~ 269 (947)
.+..+. .++|+.|+|++|.+...... ....+..+++|++|+|++|.+++.. +. +..+++|++|++++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 444332 24778888887766543211 2344566788888888888876532 22 23577888888888
Q ss_pred CccccC----CCccccCCCCCCeEeccCCccccc
Q 002255 270 NQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 270 N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
|+++.. ++..+.++++|++|+|++|.+++.
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence 888753 567777788888888888877643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=226.77 Aligned_cols=42 Identities=14% Similarity=0.141 Sum_probs=28.9
Q ss_pred ceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCC
Q 002255 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPS 419 (947)
Q Consensus 371 ~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~ 419 (947)
+|+.|+|++|.+.+. +++|+.|+++.|+++|.+|.+++.+..
T Consensus 206 ~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 206 SLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 445555555544432 446788888889999999988887664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=227.15 Aligned_cols=225 Identities=22% Similarity=0.281 Sum_probs=135.4
Q ss_pred CCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc
Q 002255 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (947)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (947)
++..+++..+.+...+ .+..+++|+.|++++|.++.++. +..+++|++|+|++|++.+ + ..+..+++|++|+++
T Consensus 20 ~l~~l~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--l~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD--I-SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE-CHHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECTTSCCCC--C-GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc-ccccccceeeeeeCCCCcccccc--cccCCCCcEEECCCCCCCC--c-hhhcCCCCCCEEECC
Confidence 4445556665555432 34456667777777776665442 5566666666666666643 1 244444455555555
Q ss_pred CceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcC
Q 002255 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (947)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (947)
+|.+++..+..+. . +++|++|+|++|++
T Consensus 94 ~n~l~~~~~~~~~--~--------------------------------------------------l~~L~~L~L~~n~l 121 (272)
T 3rfs_A 94 GNQLQSLPNGVFD--K--------------------------------------------------LTNLKELVLVENQL 121 (272)
T ss_dssp TSCCCCCCTTTTT--T--------------------------------------------------CTTCCEEECTTSCC
T ss_pred CCccCccChhHhc--C--------------------------------------------------CcCCCEEECCCCcC
Confidence 4444443333333 3 44555555555555
Q ss_pred cCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCC
Q 002255 250 TGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (947)
Q Consensus 250 ~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (947)
++.++. +..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..+
T Consensus 122 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------------ 177 (272)
T 3rfs_A 122 QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVF------------------------ 177 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT------------------------
T ss_pred CccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHh------------------------
Confidence 544443 4455555555555555554444445555555666666555554333211
Q ss_pred CccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccc
Q 002255 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (947)
Q Consensus 329 ~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 408 (947)
..+.+|+.|+|++|.+++..|..++++++|+.|+|++|.+.|
T Consensus 178 --------------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 178 --------------------------------------DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp --------------------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred --------------------------------------cCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 112245566666666666666678899999999999999986
Q ss_pred cCCCcCCCCCCCCccccccccccccCCCCccce
Q 002255 409 TIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV 441 (947)
Q Consensus 409 ~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~ 441 (947)
. +++|++|+++.|+++|.+|.+....
T Consensus 220 ~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 220 T-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp C-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred c-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 5 4579999999999999999876543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-27 Score=269.88 Aligned_cols=311 Identities=18% Similarity=0.201 Sum_probs=200.8
Q ss_pred CcEEEEEecCCcccccCccccc-CCC----CCCEEEcccCcccC----cCC-CCCCCCCCcEEecCCCcCCCCCccc---
Q 002255 65 NRVTRIQIGGQNIEGTLPKELN-SLS----SLTVLEVMKNKLTG----QIP-SLSGLSSLQEVLFDDNNFTSVPSDF--- 131 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~-~l~----~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~L~~n~l~~~~~~~--- 131 (947)
.+++.|+|++|.+.+..+..+. .++ +|++|+|++|+++. .++ .+.++++|++|+|++|.++...+..
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 4678888888887765444432 344 68888888888874 334 6778888888888888877433322
Q ss_pred --ccCCCCCcEEeccCCCCCCCC---CcccccCCCCCCeEeccCceeeeccCcccCC---CCCCCccEEEccCCcccCc-
Q 002255 132 --FKGLTSLQTISLDYNSFDSWV---IPESLKDATGLQRFSANGANITGTIPDFLGG---DTIPGLMHLHLAFNFLQGP- 202 (947)
Q Consensus 132 --~~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---~~l~~L~~L~Ls~N~l~~~- 202 (947)
+..+++|++|+|++|++.... ++..+..+++|++|++++|.++...+..+.. ...++|++|+|++|.+++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 233567888888888875411 3556667788888888888877554444321 0145788888888888753
Q ss_pred ---CCccccC-CCCceeeeccCCCCCCCCCc--hhhhcCCCCCcEEEccCCcCcCC----CC-CCCCCCCCCEEEccCCc
Q 002255 203 ---IPLSFGK-SSIQTLWLNGQKGDSKLNGS--VAVIQNMTSLTQLWLHGNSFTGP----LP-DLSGLSSLQDFSVRDNQ 271 (947)
Q Consensus 203 ---~p~~~~~-~~L~~L~l~~n~~~~~~~~~--~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~l~~N~ 271 (947)
++..+.. .+|+.|++++|.+....... ...+..+++|+.|+|++|.++.. ++ .+..+++|++|++++|.
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 3444432 67888888888665421111 11223477888888888888763 22 35567788888888888
Q ss_pred cccCCCccccC-----CCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhh
Q 002255 272 LTGIVPSSLVN-----LHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV 346 (947)
Q Consensus 272 l~g~~p~~l~~-----l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 346 (947)
+++..+..+.. .++|+.|+|++|.+++..... . +.
T Consensus 296 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~---------------------------------l------~~- 335 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH---------------------------------F------SS- 335 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH---------------------------------H------HH-
T ss_pred CchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHH---------------------------------H------HH-
Confidence 87554444443 267888888888876431100 0 00
Q ss_pred hhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccC-----CccCCeEeccCCcccc----cCCCcCCCC
Q 002255 347 LAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR-----LTSLRQLMLSGNELTG----TIPKELTTL 417 (947)
Q Consensus 347 l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~-----l~~L~~L~Ls~N~l~g----~iP~~l~~l 417 (947)
.....++|+.|+|++|.+++..+..+.. .++|+.|+|++|++++ .+|..+..+
T Consensus 336 ------------------~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 397 (461)
T 1z7x_W 336 ------------------VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397 (461)
T ss_dssp ------------------HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred ------------------HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence 0011235777888888777655544443 5678888888888875 677777777
Q ss_pred CCCCcccccccccccc
Q 002255 418 PSLEMLDVSNNHLFGK 433 (947)
Q Consensus 418 ~~L~~L~ls~N~l~g~ 433 (947)
++|++|+|++|++++.
T Consensus 398 ~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 398 HSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCCCEEECCSSSCCHH
T ss_pred CCccEEECCCCCCCHH
Confidence 7888888888877654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=215.53 Aligned_cols=190 Identities=20% Similarity=0.320 Sum_probs=129.6
Q ss_pred CCCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcc
Q 002255 52 DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSD 130 (947)
Q Consensus 52 d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~ 130 (947)
+||.|.|++|.. ..+.+++++++++ .+|..+. ++|+.|+|++|++++..+ .|.++++|++|+|++|+++++++.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 688999999953 3457899999888 7777665 688999999999888777 688888888888888888888888
Q ss_pred cccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCC
Q 002255 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (947)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 210 (947)
.|..+++|++|+|++|++.. ..+..+..+++|++|+|++|++++..+..+.
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------- 128 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD---------------------------- 128 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT----------------------------
T ss_pred HhccCCcCCEEECCCCcccc-cChhHhcccCCCCEEEcCCCcCCCcChhHhc----------------------------
Confidence 88888888888888888764 3334444444444444444444433333232
Q ss_pred CCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeE
Q 002255 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (947)
Q Consensus 211 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L 289 (947)
++++|+.|+|++|+|++.++ .+..+++|++|+|++|+|++..+..+..+++|+.|
T Consensus 129 ------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 129 ------------------------RLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp ------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ------------------------cCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 24555555666665555555 25556666666666666665555566666666666
Q ss_pred eccCCccccc
Q 002255 290 NLTNNLFQGQ 299 (947)
Q Consensus 290 ~Ls~N~l~g~ 299 (947)
+|++|++++.
T Consensus 185 ~l~~N~~~c~ 194 (251)
T 3m19_A 185 TLFGNQFDCS 194 (251)
T ss_dssp ECCSCCBCTT
T ss_pred EeeCCceeCC
Confidence 6666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-22 Score=217.19 Aligned_cols=206 Identities=29% Similarity=0.333 Sum_probs=127.6
Q ss_pred CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCC
Q 002255 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186 (947)
Q Consensus 107 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 186 (947)
.+.++++|+++++++|.++.+|+... ++|++|+|++|++.. ..+..+.++++|++|+|++|.+++..+. + .+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~--~l 76 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKLQVD--G--TL 76 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEEECC--S--CC
T ss_pred cccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcccCC--C--CC
Confidence 35667777788888877777776533 567777777777754 3455666666666666666666543322 2 35
Q ss_pred CCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEE
Q 002255 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDF 265 (947)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L 265 (947)
++|++|+|++|+++ .+|..+ .++++|+.|+|++|+|++.++. +.++++|++|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~--------------------------~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLG--------------------------QTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCT--------------------------TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred CcCCEEECCCCcCC-cCchhh--------------------------ccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 55566666655555 333322 1245555555555555554442 4445555555
Q ss_pred EccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChh
Q 002255 266 SVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345 (947)
Q Consensus 266 ~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 345 (947)
+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------------------------------------------- 159 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNN-------------------------------------------------- 159 (290)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSC--------------------------------------------------
T ss_pred ECCCCCCCccChhhcccccCCCEEECCCCc--------------------------------------------------
Confidence 555555554444444445555555555554
Q ss_pred hhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccc
Q 002255 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425 (947)
Q Consensus 346 ~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 425 (947)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|
T Consensus 160 ------------------------------------l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L 202 (290)
T 1p9a_G 160 ------------------------------------LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202 (290)
T ss_dssp ------------------------------------CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEEC
T ss_pred ------------------------------------CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEe
Confidence 44333345677888999999999998 88888888888999999
Q ss_pred ccccccccC
Q 002255 426 SNNHLFGKV 434 (947)
Q Consensus 426 s~N~l~g~i 434 (947)
++|++.+..
T Consensus 203 ~~Np~~C~c 211 (290)
T 1p9a_G 203 HGNPWLCNC 211 (290)
T ss_dssp CSCCBCCSG
T ss_pred CCCCccCcC
Confidence 988886643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-22 Score=217.02 Aligned_cols=202 Identities=23% Similarity=0.255 Sum_probs=168.1
Q ss_pred eCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCc
Q 002255 61 CSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139 (947)
Q Consensus 61 C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 139 (947)
|..-..++++++++++++ .+|..+. ++|+.|+|++|.+++..+ .|.++++|++|+|++|.++++++. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 333456788888888888 6776664 688899999998888776 688889999999999998887664 6788899
Q ss_pred EEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeecc
Q 002255 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNG 219 (947)
Q Consensus 140 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~ 219 (947)
+|+|++|++.. +|..+..+++|++|+|++|++++..|..|. .+++|++|+|++|++++..+..|
T Consensus 81 ~L~Ls~N~l~~--l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~------------ 144 (290)
T 1p9a_G 81 TLDLSHNQLQS--LPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLL------------ 144 (290)
T ss_dssp EEECCSSCCSS--CCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTT------------
T ss_pred EEECCCCcCCc--CchhhccCCCCCEEECCCCcCcccCHHHHc--CCCCCCEEECCCCCCCccChhhc------------
Confidence 99999998864 788888888889999999888877777776 68888888888888886554443
Q ss_pred CCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccc
Q 002255 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 220 n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g 298 (947)
..+++|+.|+|++|+|+..++. +..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 145 --------------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 145 --------------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp --------------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred --------------ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 3589999999999999987775 678999999999999999 789999999999999999999863
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-22 Score=210.76 Aligned_cols=205 Identities=21% Similarity=0.274 Sum_probs=120.3
Q ss_pred CCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEE
Q 002255 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL 192 (947)
Q Consensus 113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 192 (947)
+++++++++++++.+|.... ++|++|+|++|++.. ..+..+.++++|++|++++|.++...+..|. .+++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~--~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP---ADTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK--ELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTS--SCTTCCEE
T ss_pred CCCEEEccCCCCCccCCCCC---CCCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhc--CCCCCCEE
Confidence 46677777777777665422 467777777777754 3334555566666666665555533333333 34555555
Q ss_pred EccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCc
Q 002255 193 HLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQ 271 (947)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~ 271 (947)
+|++|++++..+..+ .++++|+.|+|++|++++..+. +..+++|++|+|++|+
T Consensus 91 ~l~~n~l~~~~~~~~--------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALPIGVF--------------------------DQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCCTTTT--------------------------TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCCHhHc--------------------------ccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 555555553222222 1244455555555555544442 3444445555555554
Q ss_pred cccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccC
Q 002255 272 LTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW 351 (947)
Q Consensus 272 l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~ 351 (947)
|++..+..|..+++
T Consensus 145 l~~~~~~~~~~l~~------------------------------------------------------------------ 158 (270)
T 2o6q_A 145 LQSLPKGVFDKLTS------------------------------------------------------------------ 158 (270)
T ss_dssp CCCCCTTTTTTCTT------------------------------------------------------------------
T ss_pred CCccCHhHccCCcc------------------------------------------------------------------
Confidence 44333333444444
Q ss_pred CCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccccccc
Q 002255 352 KGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431 (947)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~ 431 (947)
|+.|+|++|.+++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++.
T Consensus 159 --------------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 159 --------------------LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp --------------------CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred --------------------cceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 445555555555444556777888999999999998555556888899999999999987
Q ss_pred ccCC
Q 002255 432 GKVP 435 (947)
Q Consensus 432 g~iP 435 (947)
+..+
T Consensus 219 c~c~ 222 (270)
T 2o6q_A 219 CTCN 222 (270)
T ss_dssp CSSS
T ss_pred CCCc
Confidence 7665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-23 Score=228.04 Aligned_cols=203 Identities=18% Similarity=0.211 Sum_probs=136.0
Q ss_pred CCCcEEeccCCCCCCCCCcccc--cCCCCCCeEeccCceeeeccC----cccCCCCCCCccEEEccCCcccCcCCccccC
Q 002255 136 TSLQTISLDYNSFDSWVIPESL--KDATGLQRFSANGANITGTIP----DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209 (947)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 209 (947)
++|++|+|++|++.+ ..|..+ ..+++|++|+|++|.+++..+ ..+. .+++|++|+|++|++++..+..++
T Consensus 91 ~~L~~L~l~~n~l~~-~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~--~~~~L~~L~Ls~n~l~~~~~~~~~- 166 (310)
T 4glp_A 91 SRLKELTLEDLKITG-TMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW--LKPGLKVLSIAQAHSPAFSCEQVR- 166 (310)
T ss_dssp SCCCEEEEESCCCBS-CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT--BCSCCCEEEEECCSSCCCCTTSCC-
T ss_pred CceeEEEeeCCEecc-chhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh--hccCCCEEEeeCCCcchhhHHHhc-
Confidence 345555555555543 344444 555555555555555554433 1222 467777788888777766555543
Q ss_pred CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcC---CCCC--CCCCCCCCEEEccCCccccCCCc----cc
Q 002255 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG---PLPD--LSGLSSLQDFSVRDNQLTGIVPS----SL 280 (947)
Q Consensus 210 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~--~~~l~~L~~L~l~~N~l~g~~p~----~l 280 (947)
++++|++|+|++|++.+ ..+. +..+++|++|+|++|+++ .++. .+
T Consensus 167 -------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~ 220 (310)
T 4glp_A 167 -------------------------AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALA 220 (310)
T ss_dssp -------------------------CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHH
T ss_pred -------------------------cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHH
Confidence 36777778888887765 2222 356788888888888886 3333 25
Q ss_pred cCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCC
Q 002255 281 VNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD 360 (947)
Q Consensus 281 ~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~ 360 (947)
.++++|++|+|++|++++.+|..+..
T Consensus 221 ~~l~~L~~L~Ls~N~l~~~~p~~~~~------------------------------------------------------ 246 (310)
T 4glp_A 221 AAGVQPHSLDLSHNSLRATVNPSAPR------------------------------------------------------ 246 (310)
T ss_dssp HHTCCCSSEECTTSCCCCCCCSCCSS------------------------------------------------------
T ss_pred hcCCCCCEEECCCCCCCccchhhHHh------------------------------------------------------
Confidence 67788888888888888776643211
Q ss_pred CCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccc
Q 002255 361 WKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 361 ~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g 432 (947)
+...++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+.
T Consensus 247 -----~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 247 -----CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp -----CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred -----ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence 111246888888888888 6787775 799999999999995 454 6788999999999999864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=217.51 Aligned_cols=59 Identities=29% Similarity=0.467 Sum_probs=27.6
Q ss_pred CCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 236 MTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 236 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
+++|+.|+|++|.+++..+ +..+++|++|+|++|++++.. .+..+++|+.|+|++|+++
T Consensus 172 l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 172 LSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred CCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 4445555555555543322 444445555555555554322 1444455555555555444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-24 Score=239.97 Aligned_cols=211 Identities=15% Similarity=0.245 Sum_probs=151.5
Q ss_pred CCCCCceeEeCCCCcEEEEEecCCcccccCcccccCC--CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCC-C
Q 002255 52 DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSL--SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV-P 128 (947)
Q Consensus 52 d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~-~ 128 (947)
-|.+|.++.|+ ...++.++++++++. +..+..+ ++++.|++++|.+.+.++.+.++++|++|+|++|.+++. .
T Consensus 35 vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHH
Confidence 45579999886 346889999998877 5567777 899999999999999888888889999999999988764 6
Q ss_pred cccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCc-eeeec-cCcccCCCCCCCccEEEccCC-cccCc-CC
Q 002255 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA-NITGT-IPDFLGGDTIPGLMHLHLAFN-FLQGP-IP 204 (947)
Q Consensus 129 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~~~l~~L~~L~Ls~N-~l~~~-~p 204 (947)
+..+..+++|++|+|++|++.. ..+..++.+++|++|++++| .+++. ++..+. .+++|++|+|++| .+++. ++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~-~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~--~~~~L~~L~l~~~~~l~~~~~~ 187 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--SCSRLDELNLSWCFDFTEKHVQ 187 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH--HCTTCCEEECCCCTTCCHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCH-HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh--cCCCCCEEcCCCCCCcChHHHH
Confidence 6667888888888888888754 46677777888888888887 56653 555554 5677777777777 66642 22
Q ss_pred ccccCCCCceeeeccCCCCCCCCCchhhhcCCC-CCcEEEccCC--cCc-CCCC-CCCCCCCCCEEEccCCc-cccCCCc
Q 002255 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT-SLTQLWLHGN--SFT-GPLP-DLSGLSSLQDFSVRDNQ-LTGIVPS 278 (947)
Q Consensus 205 ~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~-~L~~L~L~~N--~l~-~~~~-~~~~l~~L~~L~l~~N~-l~g~~p~ 278 (947)
.. +.+++ +|++|+|++| .++ +.++ .+..+++|+.|++++|. +++..+.
T Consensus 188 ~~--------------------------~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 241 (336)
T 2ast_B 188 VA--------------------------VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 241 (336)
T ss_dssp HH--------------------------HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred HH--------------------------HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH
Confidence 22 33466 7777777777 343 2222 24456677777777776 5556666
Q ss_pred cccCCCCCCeEeccCCc
Q 002255 279 SLVNLHSLAVVNLTNNL 295 (947)
Q Consensus 279 ~l~~l~~L~~L~Ls~N~ 295 (947)
.+.++++|+.|+|++|.
T Consensus 242 ~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 242 EFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp GGGGCTTCCEEECTTCT
T ss_pred HHhCCCCCCEeeCCCCC
Confidence 66667777777776664
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=209.55 Aligned_cols=185 Identities=17% Similarity=0.239 Sum_probs=133.9
Q ss_pred cCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc-CCCCCcccccCCCCCcEEeccC-CCCCCCCCccc
Q 002255 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISLDY-NSFDSWVIPES 156 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~p~~ 156 (947)
.+|. +. ++|++|+|++|++++.++ .|.++++|++|+|++|+ ++.+++..|..+++|++|+|++ |++.. ..+..
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~-i~~~~ 100 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY-IDPDA 100 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE-ECTTS
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE-cCHHH
Confidence 6666 43 489999999999988777 78889999999999996 8888888888999999999998 88865 44567
Q ss_pred ccCCCCCCeEeccCceeeeccCcccCCCCCCCcc---EEEccCC-cccCcCCccccCCCCceeeeccCCCCCCCCCchhh
Q 002255 157 LKDATGLQRFSANGANITGTIPDFLGGDTIPGLM---HLHLAFN-FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232 (947)
Q Consensus 157 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~ 232 (947)
|.++++|++|++++|.+++ +|. +. .+++|+ +|+|++| ++++..+..|.
T Consensus 101 f~~l~~L~~L~l~~n~l~~-lp~-~~--~l~~L~~L~~L~l~~N~~l~~i~~~~~~------------------------ 152 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKM-FPD-LT--KVYSTDIFFILEITDNPYMTSIPVNAFQ------------------------ 152 (239)
T ss_dssp EECCTTCCEEEEEEECCCS-CCC-CT--TCCBCCSEEEEEEESCTTCCEECTTTTT------------------------
T ss_pred hCCCCCCCEEeCCCCCCcc-ccc-cc--cccccccccEEECCCCcchhhcCccccc------------------------
Confidence 7888888888888888875 565 44 466666 8888888 77754443333
Q ss_pred hcCCCCCc-EEEccCCcCcCCCCCCCCCCCCCEEEccCCc-cccCCCccccCC-CCCCeEeccCCcccc
Q 002255 233 IQNMTSLT-QLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQ-LTGIVPSSLVNL-HSLAVVNLTNNLFQG 298 (947)
Q Consensus 233 ~~~l~~L~-~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~-l~g~~p~~l~~l-~~L~~L~Ls~N~l~g 298 (947)
++++|+ .|+|++|+++..++.....++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|++++
T Consensus 153 --~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 153 --GLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp --TTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred --chhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 366677 7777777776444433333667777777773 665555566666 677777777776653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.2e-24 Score=237.78 Aligned_cols=80 Identities=13% Similarity=0.118 Sum_probs=40.2
Q ss_pred EEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-----CCCCCC-CCcEEecCCCcCCCCCcccccCC-----CCC
Q 002255 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLS-SLQEVLFDDNNFTSVPSDFFKGL-----TSL 138 (947)
Q Consensus 70 l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-----~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L 138 (947)
.+|+.++++|.+|..+...++|++|+|++|.+++..+ .|.+++ +|++|+|++|+++...+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 3455555555555544444445555555555554432 244444 45555555555555444444333 455
Q ss_pred cEEeccCCCCC
Q 002255 139 QTISLDYNSFD 149 (947)
Q Consensus 139 ~~L~Ls~N~l~ 149 (947)
++|+|++|++.
T Consensus 83 ~~L~Ls~n~l~ 93 (362)
T 3goz_A 83 TSLNLSGNFLS 93 (362)
T ss_dssp CEEECCSSCGG
T ss_pred cEEECcCCcCC
Confidence 55555555543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=219.29 Aligned_cols=227 Identities=17% Similarity=0.146 Sum_probs=134.6
Q ss_pred cEEEEEecCCcccccCcc---cccCCCCCCEEEcccCcccCcCC-CC--CCCCCCcEEecCCCcCCCCCc----ccccCC
Q 002255 66 RVTRIQIGGQNIEGTLPK---ELNSLSSLTVLEVMKNKLTGQIP-SL--SGLSSLQEVLFDDNNFTSVPS----DFFKGL 135 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~---~l~~l~~L~~L~L~~N~l~~~~p-~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l 135 (947)
++..+.+.++.++...-. .+..+++|++|+|++|.+++.+| .+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 355555555554321100 12223456666666666666555 34 556666666666666665333 223356
Q ss_pred CCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeec--cCcccCCCCCCCccEEEccCCcccCcCCc---c-cc-
Q 002255 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT--IPDFLGGDTIPGLMHLHLAFNFLQGPIPL---S-FG- 208 (947)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~--~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~-~~- 208 (947)
++|++|+|++|++.. ..+..++.+++|++|+|++|++.+. ++.......+++|++|+|++|+++. ++. . +.
T Consensus 145 ~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 145 PGLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp SCCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred cCCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 666666666666643 4445666666666666666665442 2111110145666666666666652 221 1 11
Q ss_pred CCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCe
Q 002255 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288 (947)
Q Consensus 209 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~ 288 (947)
..+|+.|+|++|.+..........+..+++|++|+|++|+|+..+..+. ++|++|+|++|+|++. |. +..+++|+.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 1456666666666555433332223335799999999999995544553 7999999999999964 44 678899999
Q ss_pred EeccCCcccc
Q 002255 289 VNLTNNLFQG 298 (947)
Q Consensus 289 L~Ls~N~l~g 298 (947)
|+|++|+|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=205.35 Aligned_cols=195 Identities=17% Similarity=0.185 Sum_probs=169.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCc-ccCcCC-CCCCCCCCcEEecCC-CcCCCCCcccccCCCCCcEE
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK-LTGQIP-SLSGLSSLQEVLFDD-NNFTSVPSDFFKGLTSLQTI 141 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L 141 (947)
..++.|+|++|++++..+..|.++++|++|+|++|+ ++...+ .|.++++|++|+|++ |+++++++..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998777789999999999999997 887777 799999999999999 99999999999999999999
Q ss_pred eccCCCCCCCCCcccccCCCCCC---eEeccCc-eeeeccCcccCCCCCCCcc-EEEccCCcccCcCCccccCCCCceee
Q 002255 142 SLDYNSFDSWVIPESLKDATGLQ---RFSANGA-NITGTIPDFLGGDTIPGLM-HLHLAFNFLQGPIPLSFGKSSIQTLW 216 (947)
Q Consensus 142 ~Ls~N~l~~~~~p~~~~~l~~L~---~L~l~~n-~l~~~~p~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~~~L~~L~ 216 (947)
+|++|++.+ +|. +..+++|+ +|++++| ++++..+..|. .+++|+ +|+|++|+++ .+|....
T Consensus 111 ~l~~n~l~~--lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~--~l~~L~~~L~l~~n~l~-~i~~~~~-------- 176 (239)
T 2xwt_C 111 GIFNTGLKM--FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ--GLCNETLTLKLYNNGFT-SVQGYAF-------- 176 (239)
T ss_dssp EEEEECCCS--CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT--TTBSSEEEEECCSCCCC-EECTTTT--------
T ss_pred eCCCCCCcc--ccc-cccccccccccEEECCCCcchhhcCccccc--chhcceeEEEcCCCCCc-ccCHhhc--------
Confidence 999999976 676 88888888 9999999 99977777787 689999 9999999998 5654321
Q ss_pred eccCCCCCCCCCchhhhcCCCCCcEEEccCCc-CcCCCCC-CCCC-CCCCEEEccCCccccCCCccccCCCCCCeEeccC
Q 002255 217 LNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS-FTGPLPD-LSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293 (947)
Q Consensus 217 l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~-~~~l-~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~ 293 (947)
. .++|+.|+|++|+ +++..+. +.++ ++|+.|++++|+|+ .+|.. .+++|+.|++++
T Consensus 177 -----------------~-~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~ 235 (239)
T 2xwt_C 177 -----------------N-GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARN 235 (239)
T ss_dssp -----------------T-TCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTT
T ss_pred -----------------C-CCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccC
Confidence 1 3789999999995 9877664 7788 99999999999998 45554 688999999987
Q ss_pred C
Q 002255 294 N 294 (947)
Q Consensus 294 N 294 (947)
+
T Consensus 236 ~ 236 (239)
T 2xwt_C 236 T 236 (239)
T ss_dssp C
T ss_pred c
Confidence 6
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-24 Score=245.31 Aligned_cols=196 Identities=17% Similarity=0.174 Sum_probs=124.6
Q ss_pred cCcccccCCCCCCEEEcccCcccCcCC-----CCCCCCCCcEEecCCCcCC---CCCcccc-------cCCCCCcEEecc
Q 002255 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLSSLQEVLFDDNNFT---SVPSDFF-------KGLTSLQTISLD 144 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~n~l~---~~~~~~~-------~~l~~L~~L~Ls 144 (947)
.++..+..+++|+.|+|++|.++...+ .+..+++|++|+|++|.+. +..|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 566677788888888888888876532 3677888888888886544 3333323 567778888888
Q ss_pred CCCCCCC---CCcccccCCCCCCeEeccCceeeeccCcccCCC--CC---------CCccEEEccCCccc-CcCCccccC
Q 002255 145 YNSFDSW---VIPESLKDATGLQRFSANGANITGTIPDFLGGD--TI---------PGLMHLHLAFNFLQ-GPIPLSFGK 209 (947)
Q Consensus 145 ~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~--~l---------~~L~~L~Ls~N~l~-~~~p~~~~~ 209 (947)
+|.+... .+|..+.++++|++|+|++|.+++..+..+... .+ ++|++|+|++|+++ +.++.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~---- 178 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE---- 178 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH----
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH----
Confidence 8877531 245566777777777777777754433333200 11 56666666666665 22221
Q ss_pred CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCc--C---CCC-CCCCCCCCCEEEccCCccc----cCCCcc
Q 002255 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT--G---PLP-DLSGLSSLQDFSVRDNQLT----GIVPSS 279 (947)
Q Consensus 210 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~--~---~~~-~~~~l~~L~~L~l~~N~l~----g~~p~~ 279 (947)
....+..+++|+.|+|++|.++ | ..+ .+..+++|++|+|++|.|+ +.+|..
T Consensus 179 -------------------l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 179 -------------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp -------------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred -------------------HHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 0122445677777777777776 2 334 5666777777777777775 456667
Q ss_pred ccCCCCCCeEeccCCcccc
Q 002255 280 LVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 280 l~~l~~L~~L~Ls~N~l~g 298 (947)
+..+++|++|+|++|++++
T Consensus 240 l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp GGGCTTCCEEECTTCCCCH
T ss_pred HccCCCcCEEECCCCCCch
Confidence 7777777777777777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-22 Score=214.69 Aligned_cols=154 Identities=14% Similarity=0.053 Sum_probs=121.3
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccCh----------------HHHHHHHHHHHHHHcCC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE----------------KGFAEFKSEIAVLTKVR 646 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~ 646 (947)
..+..-...|.+.+.||+|+||.||+|...+|+.||||+++...... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 34444456677889999999999999988779999999986432111 23567899999999999
Q ss_pred CCCcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 002255 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726 (947)
Q Consensus 647 h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 726 (947)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+ .+|+||||||+|
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 4 666665543 55699999999999988 421 1234699999999999997 899999999999
Q ss_pred EEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccc
Q 002255 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771 (947)
Q Consensus 727 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 771 (947)
||++ ++.+||+|||+++.. ..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 9999 999999999998643 3468888774
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-20 Score=199.30 Aligned_cols=160 Identities=21% Similarity=0.274 Sum_probs=111.1
Q ss_pred CcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEE
Q 002255 114 LQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLH 193 (947)
Q Consensus 114 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 193 (947)
.++++++++.++.+|.... ++|++|+|++|++.+ ..+..+.++++|++|+|++|.+++..|..+. .+++|++|+
T Consensus 16 ~~~l~~~~~~l~~~p~~~~---~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~ 89 (251)
T 3m19_A 16 KKEVDCQGKSLDSVPSGIP---ADTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFD--DLTELGTLG 89 (251)
T ss_dssp GTEEECTTCCCSSCCSCCC---TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEE
T ss_pred CeEEecCCCCccccCCCCC---CCCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhc--cCCcCCEEE
Confidence 3344444444444443321 344555555555543 3334455555555555555555555555565 577888888
Q ss_pred ccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCcc
Q 002255 194 LAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQL 272 (947)
Q Consensus 194 Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l 272 (947)
|++|++++..+..|. ++++|+.|+|++|+|++.++. +..+++|++|+|++|+|
T Consensus 90 L~~n~l~~~~~~~~~--------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 90 LANNQLASLPLGVFD--------------------------HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp CTTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcccccChhHhc--------------------------ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcC
Confidence 888888855554443 478999999999999987776 68899999999999999
Q ss_pred ccCCCccccCCCCCCeEeccCCcccccCCCCCC
Q 002255 273 TGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305 (947)
Q Consensus 273 ~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 305 (947)
++..+..|..+++|++|+|++|++++..+..+.
T Consensus 144 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 176 (251)
T 3m19_A 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD 176 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred CccCHHHcCcCcCCCEEECCCCcCCccCHHHHh
Confidence 987777899999999999999999988776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=228.26 Aligned_cols=197 Identities=24% Similarity=0.358 Sum_probs=163.3
Q ss_pred CCCCC-----CCcee-EeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCc
Q 002255 50 DPDPC-----KWKHI-QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123 (947)
Q Consensus 50 ~~d~C-----~w~gv-~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~ 123 (947)
+.++| .|.|+ .|.. ++++.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip--~~l~~L~~L~Ls~N~ 111 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP--ELPASLEYLDACDNR 111 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC--CCCTTCCEEECCSSC
T ss_pred cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc--cccCCCCEEEccCCC
Confidence 45678 79999 7863 589999999999996 888774 89999999999999 455 568999999999999
Q ss_pred CCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcC
Q 002255 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (947)
Q Consensus 124 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (947)
|++++. +.. +|++|+|++|+|++ +|. .+++|++|+|++|.|++ +|. .+++|++|+|++|+|++ +
T Consensus 112 l~~ip~--l~~--~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~l~~-lp~-----~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 112 LSTLPE--LPA--SLKHLDVDNNQLTM--LPE---LPALLEYINADNNQLTM-LPE-----LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp CSCCCC--CCT--TCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSC-CCC-----CCTTCCEEECCSSCCSC-C
T ss_pred CCCcch--hhc--CCCEEECCCCcCCC--CCC---cCccccEEeCCCCccCc-CCC-----cCCCcCEEECCCCCCCC-c
Confidence 999776 554 99999999999976 666 68999999999999986 665 26789999999999986 6
Q ss_pred CccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCC-------CEEEccCCccccCC
Q 002255 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL-------QDFSVRDNQLTGIV 276 (947)
Q Consensus 204 p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L-------~~L~l~~N~l~g~~ 276 (947)
|. +. ++|+.|+|++|+|+..++ +.. +| +.|+|++|+|+ .+
T Consensus 176 p~-l~----------------------------~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~l 222 (571)
T 3cvr_A 176 PE-LP----------------------------ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HI 222 (571)
T ss_dssp CC-CC----------------------------TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CC
T ss_pred ch-hh----------------------------CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ec
Confidence 64 42 678888888888885444 544 66 99999999999 68
Q ss_pred CccccCCCCCCeEeccCCcccccCCC
Q 002255 277 PSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 277 p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
|..+.++++|+.|+|++|+|++.+|.
T Consensus 223 p~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 223 PENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred CHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 99999999999999999999988775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-23 Score=233.52 Aligned_cols=263 Identities=16% Similarity=0.212 Sum_probs=198.6
Q ss_pred EEEcccCcccCcCCCCCCC-CCCcEEecCCCcCCCCCc----ccccCCC-CCcEEeccCCCCCCCCCcccccCC-----C
Q 002255 93 VLEVMKNKLTGQIPSLSGL-SSLQEVLFDDNNFTSVPS----DFFKGLT-SLQTISLDYNSFDSWVIPESLKDA-----T 161 (947)
Q Consensus 93 ~L~L~~N~l~~~~p~~~~l-~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l-----~ 161 (947)
.++|+.|.++|.+|.+... ++|++|+|++|.++...+ ..|..++ +|++|+|++|++.. ..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~-~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF-KNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGG-SCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCH-HHHHHHHHHHhccCC
Confidence 4688999999999965554 449999999999999988 7788898 89999999999976 456666664 9
Q ss_pred CCCeEeccCceeeeccCcccCCC--CC-CCccEEEccCCcccCcCCccccC------CCCceeeeccCCCCCCCCCc-hh
Q 002255 162 GLQRFSANGANITGTIPDFLGGD--TI-PGLMHLHLAFNFLQGPIPLSFGK------SSIQTLWLNGQKGDSKLNGS-VA 231 (947)
Q Consensus 162 ~L~~L~l~~n~l~~~~p~~~~~~--~l-~~L~~L~Ls~N~l~~~~p~~~~~------~~L~~L~l~~n~~~~~~~~~-~~ 231 (947)
+|++|+|++|.+++..+..++.. .+ ++|++|+|++|++++..+..+.. .+|++|+|++|.+....... ..
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 99999999999998777654410 23 79999999999998776655432 48999999999887544322 24
Q ss_pred hhcCCC-CCcEEEccCCcCcCCCCC-----CCCC-CCCCEEEccCCccccC----CCccccCC-CCCCeEeccCCccccc
Q 002255 232 VIQNMT-SLTQLWLHGNSFTGPLPD-----LSGL-SSLQDFSVRDNQLTGI----VPSSLVNL-HSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 232 ~~~~l~-~L~~L~L~~N~l~~~~~~-----~~~l-~~L~~L~l~~N~l~g~----~p~~l~~l-~~L~~L~Ls~N~l~g~ 299 (947)
.+..++ +|++|+|++|++++..+. +..+ ++|++|+|++|+|++. ++..+..+ ++|++|+|++|++++.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 455565 999999999999987662 4445 5999999999999863 56666664 5999999999999854
Q ss_pred CCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecC
Q 002255 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKN 379 (947)
Q Consensus 300 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 379 (947)
.+..+ . ..+....+|+.|+|++
T Consensus 241 ~~~~l-------------------------------------------~---------------~~~~~l~~L~~L~L~~ 262 (362)
T 3goz_A 241 SLENL-------------------------------------------K---------------LLKDSLKHLQTVYLDY 262 (362)
T ss_dssp CHHHH-------------------------------------------H---------------HTTTTTTTCSEEEEEH
T ss_pred HHHHH-------------------------------------------H---------------HHHhcCCCccEEEecc
Confidence 33100 0 0112334688999999
Q ss_pred CCcee-------eccccccCCccCCeEeccCCcccccCCCcC
Q 002255 380 LGLSG-------TISSNFSRLTSLRQLMLSGNELTGTIPKEL 414 (947)
Q Consensus 380 n~l~g-------~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l 414 (947)
|.+.+ .++..+.++++|+.|||++|++.+..|..+
T Consensus 263 n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred CCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 98443 345577888889999999999887655443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-21 Score=208.78 Aligned_cols=194 Identities=22% Similarity=0.328 Sum_probs=160.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+++++++.. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++++ .+..+++|++|+|+
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECC
Confidence 478899999998884 55 68889999999999999988766 889999999999999999874 48889999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~ 223 (947)
+|++.. ++. +..+++|++|++++|.+++..+ +. .+++|++|+|++|++++..+ +.. .+|+.|++++|.+.
T Consensus 116 ~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~--l~--~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 116 STQITD--VTP-LAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp TSCCCC--CGG-GTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred CCCCCC--chh-hcCCCCCCEEECCCCccCcCcc--cc--CCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 999975 443 8899999999999999986554 55 68899999999999986444 433 78999999999887
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCcc
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSS 279 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~ 279 (947)
.... +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++ .|..
T Consensus 187 ~~~~-----l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~-~~~~ 235 (308)
T 1h6u_A 187 DISP-----LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITN-QPVF 235 (308)
T ss_dssp CCGG-----GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEEC-CCEE
T ss_pred cChh-----hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeec-CCee
Confidence 6532 6778999999999999987764 8889999999999999984 4433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-21 Score=196.12 Aligned_cols=183 Identities=23% Similarity=0.357 Sum_probs=140.2
Q ss_pred CCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccc
Q 002255 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFF 132 (947)
Q Consensus 54 C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~ 132 (947)
|.|.+|.|+.. +++ .+|..+ .++|++|+|++|++++.++ .|.++++|++|+|++|+++++++..|
T Consensus 7 C~~~~v~c~~~-----------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 7 CSGTTVECYSQ-----------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EETTEEECCSS-----------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred ECCCEEEecCC-----------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 68999999643 333 455444 3689999999999998777 57899999999999999999999889
Q ss_pred cCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCC
Q 002255 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212 (947)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L 212 (947)
..+++|++|+|++|++.. ..+..+.++++|++|++++|++++..+..+. .+++|++|+|++|++++..+..+.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~---- 145 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFD--KLTQLKDLRLYQNQLKSVPDGVFD---- 145 (208)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTTT----
T ss_pred CCCCCcCEEECCCCcCCc-cCHhHhcCccCCCEEEcCCCcCcccCHhHhc--cCCcCCEEECCCCccceeCHHHhc----
Confidence 999999999999999975 4445578888888888888888866666565 577888888888888754443332
Q ss_pred ceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCC
Q 002255 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHS 285 (947)
Q Consensus 213 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~ 285 (947)
++++|+.|+|++|.+.+. +++|++|+++.|+++|.+|..++.++.
T Consensus 146 ----------------------~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 146 ----------------------RLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----------------------TCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----------------------cCCCccEEEecCCCeecC------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 467778888888866643 346777777777787777777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-21 Score=211.02 Aligned_cols=197 Identities=16% Similarity=0.189 Sum_probs=147.2
Q ss_pred EEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCC-CCcccccCCCCCcE-EeccCC
Q 002255 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS-VPSDFFKGLTSLQT-ISLDYN 146 (947)
Q Consensus 70 l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~-L~Ls~N 146 (947)
++.++++++ .+|..+. ++|++|+|++|+|+..++ .|.++++|++|+|++|++.+ +++.+|.++++|++ +.++.|
T Consensus 14 v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N 90 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90 (350)
T ss_dssp EEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred EEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence 445566777 7787663 689999999999997776 68999999999999999855 66778899988775 666778
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccC-CcccCcCCccccCCCCceeeeccCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF-NFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~L~~L~l~~n~~~~~ 225 (947)
++.. ..|..|..+++|++|++++|.+++..+..+. ...++..|++.+ |++....+..|..
T Consensus 91 ~l~~-l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~--~~~~l~~l~l~~~~~i~~l~~~~f~~---------------- 151 (350)
T 4ay9_X 91 NLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKI--HSLQKVLLDIQDNINIHTIERNSFVG---------------- 151 (350)
T ss_dssp TCCE-ECTTSBCCCTTCCEEEEEEECCSSCCCCTTC--CBSSCEEEEEESCTTCCEECTTSSTT----------------
T ss_pred cccc-cCchhhhhccccccccccccccccCCchhhc--ccchhhhhhhccccccccccccchhh----------------
Confidence 8876 5577888899999999999988866555554 456777888865 4555333333321
Q ss_pred CCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccC-CccccCCC-ccccCCCCCCeEeccCCcccc
Q 002255 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD-NQLTGIVP-SSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~-N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g 298 (947)
....++.|+|++|+|+...+......+|+.|++++ |.++ .+| ..|..+++|+.|+|++|+|+.
T Consensus 152 ---------~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 152 ---------LSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp ---------SBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCC
T ss_pred ---------cchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCc
Confidence 12457888888888887777666677888888875 5555 555 467888888888888888874
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=219.46 Aligned_cols=134 Identities=27% Similarity=0.410 Sum_probs=83.6
Q ss_pred CCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEE
Q 002255 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL 192 (947)
Q Consensus 113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 192 (947)
+|+.|+|++|+|+++|+.. +++|++|+|++|+|.. +| ..+++|++|+|++|+|++ +|. +. . +|++|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l---~~~L~~L~Ls~N~l~~--ip---~~l~~L~~L~Ls~N~l~~-ip~-l~--~--~L~~L 125 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNL---PPQITVLEITQNALIS--LP---ELPASLEYLDACDNRLST-LPE-LP--A--SLKHL 125 (571)
T ss_dssp TCSEEECCSSCCSCCCSCC---CTTCSEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSC-CCC-CC--T--TCCEE
T ss_pred CccEEEeCCCCCCccCHhH---cCCCCEEECcCCCCcc--cc---cccCCCCEEEccCCCCCC-cch-hh--c--CCCEE
Confidence 5555555555555544432 2456666666666642 44 334556666666666655 555 43 1 67777
Q ss_pred EccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCcc
Q 002255 193 HLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQL 272 (947)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l 272 (947)
+|++|+|++ +|. .+++|+.|+|++|+|++. |. .+++|++|+|++|+|
T Consensus 126 ~Ls~N~l~~-lp~-----------------------------~l~~L~~L~Ls~N~l~~l-p~--~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 126 DVDNNQLTM-LPE-----------------------------LPALLEYINADNNQLTML-PE--LPTSLEVLSVRNNQL 172 (571)
T ss_dssp ECCSSCCSC-CCC-----------------------------CCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCC
T ss_pred ECCCCcCCC-CCC-----------------------------cCccccEEeCCCCccCcC-CC--cCCCcCEEECCCCCC
Confidence 777777765 443 156677777777777763 33 467777888888887
Q ss_pred ccCCCccccCCCCCCeEeccCCccc
Q 002255 273 TGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 273 ~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
++ +|. |. ++|+.|+|++|+|+
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLE 193 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCS
T ss_pred CC-cch-hh--CCCCEEECcCCCCC
Confidence 75 666 55 77888888888777
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.2e-22 Score=224.58 Aligned_cols=206 Identities=20% Similarity=0.278 Sum_probs=160.8
Q ss_pred CcEEEEEecCCcccccCc----ccccCCCCCCEEEcccC---cccCcCC-C-------CCCCCCCcEEecCCCcCCC---
Q 002255 65 NRVTRIQIGGQNIEGTLP----KELNSLSSLTVLEVMKN---KLTGQIP-S-------LSGLSSLQEVLFDDNNFTS--- 126 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p----~~l~~l~~L~~L~L~~N---~l~~~~p-~-------~~~l~~L~~L~L~~n~l~~--- 126 (947)
.+++.|+|++|++.+..+ ..|..+++|++|+|++| ++++.+| . +..+++|++|+|++|+++.
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 469999999999987644 45779999999999995 5556665 3 3789999999999999998
Q ss_pred -CCcccccCCCCCcEEeccCCCCCCC---CCcccccCC---------CCCCeEeccCceee-eccC---cccCCCCCCCc
Q 002255 127 -VPSDFFKGLTSLQTISLDYNSFDSW---VIPESLKDA---------TGLQRFSANGANIT-GTIP---DFLGGDTIPGL 189 (947)
Q Consensus 127 -~~~~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l---------~~L~~L~l~~n~l~-~~~p---~~~~~~~l~~L 189 (947)
..+..+..+++|++|+|++|.+... .++..+..+ ++|++|+|++|+++ +.+| ..+. .+++|
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~L 189 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SHRLL 189 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH--HCTTC
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH--hCCCc
Confidence 4566788999999999999998531 123344444 89999999999998 4455 3454 57899
Q ss_pred cEEEccCCcccC-----cCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCc----CCCC-CCCCC
Q 002255 190 MHLHLAFNFLQG-----PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT----GPLP-DLSGL 259 (947)
Q Consensus 190 ~~L~Ls~N~l~~-----~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~----~~~~-~~~~l 259 (947)
++|+|++|+++. .+|. .+.++++|+.|+|++|.++ +.+| .+..+
T Consensus 190 ~~L~L~~n~l~~~g~~~l~~~--------------------------~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 190 HTVKMVQNGIRPEGIEHLLLE--------------------------GLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp CEEECCSSCCCHHHHHHHHHT--------------------------TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred CEEECcCCCCCHhHHHHHHHH--------------------------HhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 999999999872 1221 2446899999999999996 4444 47789
Q ss_pred CCCCEEEccCCccccC----CCccccC--CCCCCeEeccCCcccc
Q 002255 260 SSLQDFSVRDNQLTGI----VPSSLVN--LHSLAVVNLTNNLFQG 298 (947)
Q Consensus 260 ~~L~~L~l~~N~l~g~----~p~~l~~--l~~L~~L~Ls~N~l~g 298 (947)
++|++|+|++|+|++. +|..+.. +++|+.|+|++|.+++
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 9999999999999876 5666633 7778888877777763
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-20 Score=187.48 Aligned_cols=151 Identities=25% Similarity=0.305 Sum_probs=76.0
Q ss_pred CEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCc
Q 002255 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (947)
+.++++++.++..+..+ .++|++|+|++|+++++++..|..+++|++|+|++|++..
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--------------------- 66 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS--------------------- 66 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC---------------------
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc---------------------
Confidence 34555555555443332 2355666666666665555555555555555555555543
Q ss_pred eeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcC
Q 002255 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251 (947)
Q Consensus 172 ~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 251 (947)
..+..+. .+++|++|+|++|++++..+..+ .++++|+.|+|++|++++
T Consensus 67 ----~~~~~~~--~l~~L~~L~Ls~n~l~~~~~~~~--------------------------~~l~~L~~L~L~~N~l~~ 114 (208)
T 2o6s_A 67 ----LPNGVFN--KLTSLTYLNLSTNQLQSLPNGVF--------------------------DKLTQLKELALNTNQLQS 114 (208)
T ss_dssp ----CCTTTTT--TCTTCCEEECCSSCCCCCCTTTT--------------------------TTCTTCCEEECCSSCCCC
T ss_pred ----cChhhcC--CCCCcCEEECCCCcCCccCHhHh--------------------------cCccCCCEEEcCCCcCcc
Confidence 2222222 34445555555555543222222 124555555555555554
Q ss_pred CCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 252 PLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 252 ~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
.++. +..+++|++|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 115 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 115 LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 4443 445555555555555555444444555555555555555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.3e-20 Score=204.91 Aligned_cols=251 Identities=15% Similarity=0.136 Sum_probs=182.4
Q ss_pred CEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCe-EeccC
Q 002255 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR-FSANG 170 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~-L~l~~ 170 (947)
++++.++|+|+..+..+ .++|++|+|++|+|+.+++.+|.++++|++|+|++|++.+...+..|.++++|.+ +.+..
T Consensus 12 ~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 57889999999655455 3689999999999999999999999999999999999866333457888988776 56667
Q ss_pred ceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC-CcC
Q 002255 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG-NSF 249 (947)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l 249 (947)
|+++...|..|. .+++|++|++++|++++..+..+. ....+..|++.+ |++
T Consensus 90 N~l~~l~~~~f~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~~~~l~~l~l~~~~~i 141 (350)
T 4ay9_X 90 NNLLYINPEAFQ--NLPNLQYLLISNTGIKHLPDVHKI--------------------------HSLQKVLLDIQDNINI 141 (350)
T ss_dssp TTCCEECTTSBC--CCTTCCEEEEEEECCSSCCCCTTC--------------------------CBSSCEEEEEESCTTC
T ss_pred CcccccCchhhh--hccccccccccccccccCCchhhc--------------------------ccchhhhhhhcccccc
Confidence 899988888887 689999999999999865544332 245677788765 566
Q ss_pred cCCCC-CCCCC-CCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcC
Q 002255 250 TGPLP-DLSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVAC 327 (947)
Q Consensus 250 ~~~~~-~~~~l-~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (947)
+...+ .+..+ ..++.|+|++|+|+ .+|.......+|+.|++++|+.-+.+|..
T Consensus 142 ~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~------------------------ 196 (350)
T 4ay9_X 142 HTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPND------------------------ 196 (350)
T ss_dssp CEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTT------------------------
T ss_pred ccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHH------------------------
Confidence 65554 35555 46889999999998 56666667788999999864433344431
Q ss_pred CCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCccc
Q 002255 328 DGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT 407 (947)
Q Consensus 328 ~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 407 (947)
.+....+|+.|+|++|+|+..-+..+. +|+.|.+.++.--
T Consensus 197 -------------------------------------~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l 236 (350)
T 4ay9_X 197 -------------------------------------VFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNL 236 (350)
T ss_dssp -------------------------------------TTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTC
T ss_pred -------------------------------------HhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCc
Confidence 011234688999999999843333444 4555554444333
Q ss_pred ccCCCcCCCCCCCCccccccccccccCCCCc
Q 002255 408 GTIPKELTTLPSLEMLDVSNNHLFGKVPNFR 438 (947)
Q Consensus 408 g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~ 438 (947)
..+| .+..+++|+.++++++.-+.....|.
T Consensus 237 ~~lP-~l~~l~~L~~l~l~~~~~c~~~~~~~ 266 (350)
T 4ay9_X 237 KKLP-TLEKLVALMEASLTYPSHCCAFANWR 266 (350)
T ss_dssp CCCC-CTTTCCSCCEEECSCHHHHHHHHHSC
T ss_pred CcCC-CchhCcChhhCcCCCCccccchhhhh
Confidence 4788 58889999999998877665544443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-21 Score=213.89 Aligned_cols=201 Identities=13% Similarity=0.164 Sum_probs=165.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCc-CC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEe
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQ-IP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (947)
.+++.++++++.+.+..+. +..+++|++|+|++|.+++. ++ .+.++++|++|+|++|.+++..+..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5799999999999977665 67899999999999999875 56 688999999999999999987788899999999999
Q ss_pred ccCC-CCCCCCCcccccCCCCCCeEeccCc-eeeec-cCcccCCCCCC-CccEEEccCCc--cc-CcCCccccCCCCcee
Q 002255 143 LDYN-SFDSWVIPESLKDATGLQRFSANGA-NITGT-IPDFLGGDTIP-GLMHLHLAFNF--LQ-GPIPLSFGKSSIQTL 215 (947)
Q Consensus 143 Ls~N-~l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~~~l~-~L~~L~Ls~N~--l~-~~~p~~~~~~~L~~L 215 (947)
|++| .+....++..+.++++|++|++++| .+++. ++..+. .++ +|++|+|++|. ++ +.+|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~--~l~~~L~~L~l~~~~~~~~~~~l~~---------- 216 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA--HVSETITQLNLSGYRKNLQKSDLST---------- 216 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH--HSCTTCCEEECCSCGGGSCHHHHHH----------
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHH--hcccCCCEEEeCCCcccCCHHHHHH----------
Confidence 9999 6764336777899999999999999 99865 566666 688 99999999994 44 23332
Q ss_pred eeccCCCCCCCCCchhhhcCCCCCcEEEccCCc-CcCC-CCCCCCCCCCCEEEccCCc-cccCCCccccCCCCCCeEecc
Q 002255 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS-FTGP-LPDLSGLSSLQDFSVRDNQ-LTGIVPSSLVNLHSLAVVNLT 292 (947)
Q Consensus 216 ~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~-~~~~~~l~~L~~L~l~~N~-l~g~~p~~l~~l~~L~~L~Ls 292 (947)
.+.++++|+.|+|++|. +++. ++.+..+++|++|++++|. +.......+.++++|+.|+|+
T Consensus 217 ----------------~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~ 280 (336)
T 2ast_B 217 ----------------LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 280 (336)
T ss_dssp ----------------HHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred ----------------HHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEecc
Confidence 24458999999999999 6654 4468889999999999995 332222367888999999998
Q ss_pred CC
Q 002255 293 NN 294 (947)
Q Consensus 293 ~N 294 (947)
+|
T Consensus 281 ~~ 282 (336)
T 2ast_B 281 GI 282 (336)
T ss_dssp TS
T ss_pred Cc
Confidence 87
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.7e-21 Score=230.21 Aligned_cols=223 Identities=17% Similarity=0.147 Sum_probs=107.7
Q ss_pred hHHHHHHHHHHHHcCCC---CCCCCCC--CCCCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcc
Q 002255 27 SSDAAAMQALKTSLGNP---ASLGWTD--PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKL 101 (947)
Q Consensus 27 ~~~~~~l~~~k~~~~~~---~~~~w~~--~d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l 101 (947)
..++++|.++..+.... ....|.. ...+.|.++.++. .+++.|+|.++++.. ++. ..|+.++|+.|.|
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i 203 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSI 203 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCccCcccc
Confidence 45778888887665321 2225643 3457899998875 689999999998885 333 3456666777665
Q ss_pred cCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCccc
Q 002255 102 TGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFL 181 (947)
Q Consensus 102 ~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 181 (947)
.+ ++++.|.+. +++..|..+++|++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|
T Consensus 204 ~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~--~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 266 (727)
T 4b8c_D 204 DE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF--NISANIFKYDFLTRLYLNGNSLT-ELPAEI 266 (727)
T ss_dssp --------------------------------CCCCCCEEECTTSCCS--CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG
T ss_pred cC-------------cccccccee-cChhhhccCCCCcEEECCCCCCC--CCChhhcCCCCCCEEEeeCCcCc-ccChhh
Confidence 53 244455555 55666777778888888888775 36666667777777777777777 677777
Q ss_pred CCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCC
Q 002255 182 GGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSS 261 (947)
Q Consensus 182 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 261 (947)
+ .+++|++|+|++|+|+ .+|..|+ ++++|+.|+|++|.|+..+..|..+++
T Consensus 267 ~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~L~~N~l~~lp~~~~~l~~ 317 (727)
T 4b8c_D 267 K--NLSNLRVLDLSHNRLT-SLPAELG--------------------------SCFQLKYFYFFDNMVTTLPWEFGNLCN 317 (727)
T ss_dssp G--GGTTCCEEECTTSCCS-SCCSSGG--------------------------GGTTCSEEECCSSCCCCCCSSTTSCTT
T ss_pred h--CCCCCCEEeCcCCcCC-ccChhhc--------------------------CCCCCCEEECCCCCCCccChhhhcCCC
Confidence 6 5777888888888877 6666553 367777777777777755445777777
Q ss_pred CCEEEccCCccccCCCccccCCCC-CCeEeccCCcccccCCC
Q 002255 262 LQDFSVRDNQLTGIVPSSLVNLHS-LAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 262 L~~L~l~~N~l~g~~p~~l~~l~~-L~~L~Ls~N~l~g~~p~ 302 (947)
|++|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.
T Consensus 318 L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 318 LQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred ccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 777777777777777777655422 22356777777766664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.4e-19 Score=183.21 Aligned_cols=163 Identities=21% Similarity=0.359 Sum_probs=134.0
Q ss_pred CCCCCCCCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCC
Q 002255 47 GWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT 125 (947)
Q Consensus 47 ~w~~~d~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~ 125 (947)
.|.+.+.|.|++|.|+.. ++. .+|..+. ++|++|+|++|++++.+| .|.++++|++|+|++|+|+
T Consensus 12 ~~~~~~~Cs~~~v~c~~~-----------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 77 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSK-----------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG 77 (229)
T ss_dssp CCCTTCEEETTEEECTTS-----------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCCCCEEeCCEeEccCC-----------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC
Confidence 455678899999999642 333 6666554 899999999999999877 6899999999999999999
Q ss_pred CCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCc
Q 002255 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205 (947)
Q Consensus 126 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 205 (947)
.+++..|..+++|++|+|++|+|.. ..+..+..+++|++|+|++|+|+ .+|..+. .+++|++|+|++|+|++..+.
T Consensus 78 ~i~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~--~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 78 ALPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIE--RLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC-SCCTTGG--GCTTCSEEECCSSCCCCCCTT
T ss_pred CcChhhcccCCCcCEEECCCCcCCc-cChhHhCcchhhCeEeccCCccc-ccCcccc--cCCCCCEEECCCCcCCccCHH
Confidence 9999999999999999999999975 45566789999999999999998 7788776 689999999999999865554
Q ss_pred cccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCC
Q 002255 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL 253 (947)
Q Consensus 206 ~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 253 (947)
.+. .+++|+.|+|++|.+....
T Consensus 154 ~~~--------------------------~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 154 AFD--------------------------RLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TTT--------------------------TCTTCCEEECTTSCBCTTB
T ss_pred HHh--------------------------CCCCCCEEEeeCCCccCCc
Confidence 443 4777888888888777543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-19 Score=209.84 Aligned_cols=176 Identities=24% Similarity=0.360 Sum_probs=143.8
Q ss_pred ccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCC
Q 002255 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (947)
Q Consensus 85 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (947)
+..|++|+.|+|++|.+... +.+..|++|+.|+|++|+|+++++ +..+++|++|+|++|.|.. + ..+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~--l-~~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD--L-SSLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC--C-TTSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC--C-hhhccCCCCC
Confidence 45678888888888888754 568888888888888888888876 7888888888888888865 3 3688888888
Q ss_pred eEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEc
Q 002255 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (947)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (947)
.|+|++|.+++ ++ .+. .+++|+.|+|++|++++. .. +..+++|+.|+|
T Consensus 113 ~L~Ls~N~l~~-l~-~l~--~l~~L~~L~Ls~N~l~~l--~~--------------------------l~~l~~L~~L~L 160 (605)
T 1m9s_A 113 SLSLEHNGISD-IN-GLV--HLPQLESLYLGNNKITDI--TV--------------------------LSRLTKLDTLSL 160 (605)
T ss_dssp EEECTTSCCCC-CG-GGG--GCTTCSEEECCSSCCCCC--GG--------------------------GGSCTTCSEEEC
T ss_pred EEEecCCCCCC-Cc-ccc--CCCccCEEECCCCccCCc--hh--------------------------hcccCCCCEEEC
Confidence 88888888875 33 344 578888888888888753 22 446899999999
Q ss_pred cCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCC
Q 002255 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (947)
Q Consensus 245 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (947)
++|.|++.+| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++...
T Consensus 161 s~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 161 EDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp CSSCCCCCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred cCCcCCCchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence 9999998877 88999999999999999964 469999999999999999987543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-19 Score=189.38 Aligned_cols=174 Identities=24% Similarity=0.351 Sum_probs=134.3
Q ss_pred ccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCC
Q 002255 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (947)
Q Consensus 85 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (947)
+..+++|+.|++++|.++.. +.+..+++|++|+|++|+++++++ +..+++|++|+|++|++.. +..+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~---~~~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD---LSSLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---GGGGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC---ChhhccCCCCC
Confidence 34567788888888877654 567778888888888888887766 7778888888888888754 33477788888
Q ss_pred eEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEc
Q 002255 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (947)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (947)
+|++++|++++. ..+. .+++|++|+|++|++++. .. +..+++|+.|+|
T Consensus 116 ~L~L~~n~i~~~--~~l~--~l~~L~~L~l~~n~l~~~--~~--------------------------l~~l~~L~~L~L 163 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLV--HLPQLESLYLGNNKITDI--TV--------------------------LSRLTKLDTLSL 163 (291)
T ss_dssp EEECTTSCCCCC--GGGG--GCTTCCEEECCSSCCCCC--GG--------------------------GGGCTTCSEEEC
T ss_pred EEECCCCcCCCC--hhhc--CCCCCCEEEccCCcCCcc--hh--------------------------hccCCCCCEEEc
Confidence 888888887753 3344 578888888888888743 12 345888999999
Q ss_pred cCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccccc
Q 002255 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 245 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
++|++++..+ +..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+++..
T Consensus 164 ~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 164 EDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred cCCccccchh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 9999988766 8889999999999999985 45 488999999999999998864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.4e-19 Score=211.58 Aligned_cols=169 Identities=23% Similarity=0.332 Sum_probs=128.9
Q ss_pred CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEec
Q 002255 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (947)
..+..+.|..+.+...+ .+..|++|+.|+|++|.+..++ .+..+++|++|+|++|+|.+ ++. +..+++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~-~~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~--~~~-l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD--IKP-LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEE-CHHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCC--CGG-GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCccccc-chhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCC--Chh-hccCCCCCEEEC
Confidence 34555667777766544 3567788888888888888875 37788888888888888865 343 788888888888
Q ss_pred cCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCc
Q 002255 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (947)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (947)
++|.+++ +| .+. .+++|++|+|++|++++. + . +.++++|+.|+|++|.
T Consensus 95 s~N~l~~-l~-~l~--~l~~L~~L~Ls~N~l~~l-~-~--------------------------l~~l~~L~~L~Ls~N~ 142 (605)
T 1m9s_A 95 DENKIKD-LS-SLK--DLKKLKSLSLEHNGISDI-N-G--------------------------LVHLPQLESLYLGNNK 142 (605)
T ss_dssp CSSCCCC-CT-TST--TCTTCCEEECTTSCCCCC-G-G--------------------------GGGCTTCSEEECCSSC
T ss_pred cCCCCCC-Ch-hhc--cCCCCCEEEecCCCCCCC-c-c--------------------------ccCCCccCEEECCCCc
Confidence 8888875 33 454 578888888888887742 2 1 3457888888888888
Q ss_pred CcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccc
Q 002255 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g 298 (947)
|++. +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++
T Consensus 143 l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 143 ITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred cCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 8876 668888888888888888887655 8888888888888888875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.5e-21 Score=228.55 Aligned_cols=332 Identities=16% Similarity=0.106 Sum_probs=225.9
Q ss_pred CcEEEEEecCCccccc----CcccccCCCCCCEEEcccCcccCc----CC-CCCCCCCCcEEecCCCcCCCCCcccccCC
Q 002255 65 NRVTRIQIGGQNIEGT----LPKELNSLSSLTVLEVMKNKLTGQ----IP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~----~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 135 (947)
.+++.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++ .+.++++|++|+|++|.+.+++ ..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 4789999999998766 555667889999999999999743 23 3567999999999999999865 668899
Q ss_pred CCCcEEeccCCCCC--CCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCcc-cc-CCC
Q 002255 136 TSLQTISLDYNSFD--SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS-FG-KSS 211 (947)
Q Consensus 136 ~~L~~L~Ls~N~l~--~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~-~~~ 211 (947)
++|++|+++.+... ....+..+..+++|+.|++.++. .+.+|..+. .+++|++|+|++|.+++..... +. ..+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~--~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFP--FAAQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGG--GGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHh--hcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 99999999854322 12345678888999999998853 346677665 6889999999999987544422 22 268
Q ss_pred CceeeeccCCCCCCCCCchhhhcCCCCCcEEEcc-----------CCcCcCC-CCC-CCCCCCCCEEEccCCccccCCCc
Q 002255 212 IQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH-----------GNSFTGP-LPD-LSGLSSLQDFSVRDNQLTGIVPS 278 (947)
Q Consensus 212 L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~~~-~~~l~~L~~L~l~~N~l~g~~p~ 278 (947)
|+.|+++++ +.. .+......++++|++|+|+ .|.+++. ++. ..++++|++|+++.|++++..+.
T Consensus 320 L~~L~L~~~-~~~--~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~ 396 (592)
T 3ogk_B 320 LEVLETRNV-IGD--RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396 (592)
T ss_dssp CCEEEEEGG-GHH--HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHH
T ss_pred CCEEeccCc-cCH--HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHH
Confidence 999999833 211 1122334568889999999 3566543 122 34578999999999999888777
Q ss_pred cccC-CCCCCeEecc----CCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCC
Q 002255 279 SLVN-LHSLAVVNLT----NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKG 353 (947)
Q Consensus 279 ~l~~-l~~L~~L~Ls----~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~ 353 (947)
.+.. +++|+.|+|+ .|.+++.+.+. .....+....++..++... +.+ .+... .+.
T Consensus 397 ~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~--~~~~~~~~~~~L~~L~L~~--~~~----------~l~~~-~~~----- 456 (592)
T 3ogk_B 397 SIGTYLKNLCDFRLVLLDREERITDLPLDN--GVRSLLIGCKKLRRFAFYL--RQG----------GLTDL-GLS----- 456 (592)
T ss_dssp HHHHHCCSCCEEEEEECSCCSCCSSCCCHH--HHHHHHHHCTTCCEEEEEC--CGG----------GCCHH-HHH-----
T ss_pred HHHhhCCCCcEEEEeecCCCccccCchHHH--HHHHHHHhCCCCCEEEEec--CCC----------CccHH-HHH-----
Confidence 7776 8999999996 67777532110 0000000011111111100 000 00000 000
Q ss_pred CCCCCCCCCCcccCCCCceeEEEecCCCcee-eccccccCCccCCeEeccCCccccc-CCCcCCCCCCCCcccccccccc
Q 002255 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGT-IPKELTTLPSLEMLDVSNNHLF 431 (947)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~-iP~~l~~l~~L~~L~ls~N~l~ 431 (947)
......++|+.|+|++|++++ .++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|+++
T Consensus 457 ----------~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 457 ----------YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp ----------HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred ----------HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 001124579999999999987 4566678899999999999998865 4444567899999999999987
Q ss_pred cc
Q 002255 432 GK 433 (947)
Q Consensus 432 g~ 433 (947)
+.
T Consensus 527 ~~ 528 (592)
T 3ogk_B 527 MT 528 (592)
T ss_dssp TT
T ss_pred HH
Confidence 65
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=178.35 Aligned_cols=155 Identities=21% Similarity=0.256 Sum_probs=130.3
Q ss_pred cEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC--CCCCCCCCEEEc
Q 002255 190 MHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV 267 (947)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~l 267 (947)
+.+++++|.++ .+|..+ ...++.|+|++|+|++.++. +..+++|++|+|
T Consensus 14 ~~l~~s~n~l~-~iP~~~----------------------------~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 64 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHI----------------------------PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINF 64 (220)
T ss_dssp TEEECCSSCCS-SCCSCC----------------------------CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEEC
T ss_pred CEeEeCCCCcc-cCccCC----------------------------CCCCCEEEcCCCcCCccCchhhhccCCCCCEEEC
Confidence 57888888887 466544 24567899999999887653 778899999999
Q ss_pred cCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhh
Q 002255 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347 (947)
Q Consensus 268 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 347 (947)
++|+|++..+..|.++++|++|+|++|++++..|..
T Consensus 65 ~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------------------------- 100 (220)
T 2v70_A 65 SNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKM-------------------------------------------- 100 (220)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGG--------------------------------------------
T ss_pred CCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhH--------------------------------------------
Confidence 999999877778999999999999999988665532
Q ss_pred hccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccc
Q 002255 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427 (947)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~ 427 (947)
+..+.+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 101 ------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 162 (220)
T 2v70_A 101 ------------------FKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162 (220)
T ss_dssp ------------------GTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ------------------hcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecC
Confidence 12234788999999999988899999999999999999999988899999999999999999
Q ss_pred ccccccCC
Q 002255 428 NHLFGKVP 435 (947)
Q Consensus 428 N~l~g~iP 435 (947)
|+|++..+
T Consensus 163 N~l~c~c~ 170 (220)
T 2v70_A 163 NPFNCNCY 170 (220)
T ss_dssp CCEECSGG
T ss_pred cCCcCCCc
Confidence 99998877
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=182.46 Aligned_cols=138 Identities=22% Similarity=0.224 Sum_probs=106.3
Q ss_pred CCcCceecccCceEEEEEEE-cCCcE--EEEEEecccccCh----------------------HHHHHHHHHHHHHHcCC
Q 002255 592 FSEENVLGRGGFGTVYKGEL-HDGTK--IAVKRMESAVVSE----------------------KGFAEFKSEIAVLTKVR 646 (947)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 646 (947)
|.+.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999987 67999 9999875432110 11246889999999998
Q ss_pred CCCc--ceEEEEEEeCCeeEEEEEecCC-C----chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHh-hccCCCee
Q 002255 647 HRHL--VGLLGYCLDGNERLLVYEYMPQ-G----TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH-GLAHQSFI 718 (947)
Q Consensus 647 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~iv 718 (947)
|+++ ..++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||+||| + .+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 8764 344432 356899999942 4 56554422 223456789999999999999 6 8999
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 719 HRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 719 HrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=7.9e-18 Score=173.16 Aligned_cols=150 Identities=21% Similarity=0.300 Sum_probs=127.0
Q ss_pred EEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002255 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (947)
Q Consensus 70 l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (947)
+++++++++ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|+++++.+..|..+++|++|+|++|+|
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 455566666 6777665 689999999999998887 799999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCC
Q 002255 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNG 228 (947)
Q Consensus 149 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~ 228 (947)
.. ..+..|..+++|++|+|++|.|++..|..|. .+++|++|+|++|++++..+..|.
T Consensus 93 ~~-l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~-------------------- 149 (220)
T 2v9t_B 93 TE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQ--DLHNLNLLSLYDNKLQTIAKGTFS-------------------- 149 (220)
T ss_dssp CC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTTT--------------------
T ss_pred Cc-cCHhHccCCCCCCEEECCCCCCCEeCHHHcC--CCCCCCEEECCCCcCCEECHHHHh--------------------
Confidence 75 4445578899999999999999988888887 689999999999999976665543
Q ss_pred chhhhcCCCCCcEEEccCCcCcC
Q 002255 229 SVAVIQNMTSLTQLWLHGNSFTG 251 (947)
Q Consensus 229 ~~~~~~~l~~L~~L~L~~N~l~~ 251 (947)
.+++|+.|+|++|.+..
T Consensus 150 ------~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 150 ------PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp ------TCTTCCEEECCSSCEEC
T ss_pred ------CCCCCCEEEeCCCCcCC
Confidence 47788888888887763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=190.34 Aligned_cols=174 Identities=18% Similarity=0.232 Sum_probs=119.9
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCC-CCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLS-GLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
.+++++++|+ .+|..+. +.|+.|+|++|+|++..+ .|. ++++|++|+|++|+|+++++..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 5677788887 5777664 458889999999988777 466 8888888888888888888888888888888888888
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
+|.. ..+..|.++++|++|+|++|+|++..|..|. .+++|++|+|++|+|+
T Consensus 99 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~-------------------------- 149 (361)
T 2xot_A 99 HLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFE--DMAQLQKLYLSQNQIS-------------------------- 149 (361)
T ss_dssp CCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTT--TCTTCCEEECCSSCCC--------------------------
T ss_pred cCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhC--CcccCCEEECCCCcCC--------------------------
Confidence 8864 3344555566666666665555555455444 3445555555555544
Q ss_pred CCchhhhcCCCCCcEEEccCCcCcCCCCC-C---CCCCCCCEEEccCCccccCCCccccCCCC--CCeEeccCCcccc
Q 002255 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPD-L---SGLSSLQDFSVRDNQLTGIVPSSLVNLHS--LAVVNLTNNLFQG 298 (947)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~---~~l~~L~~L~l~~N~l~g~~p~~l~~l~~--L~~L~Ls~N~l~g 298 (947)
+.++. + ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++..
T Consensus 150 ------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 150 ------------------------RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp ------------------------SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ------------------------eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 43332 1 45677777777777777555566777776 4788999998873
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-17 Score=172.24 Aligned_cols=135 Identities=27% Similarity=0.332 Sum_probs=87.1
Q ss_pred cEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeec
Q 002255 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN 218 (947)
Q Consensus 139 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~ 218 (947)
++|+|++|+|.....+..|..+++|++|+|++|.|++..+..|. .+++|++|+|++|++++..+..|.
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~---------- 102 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE--GASGVNEILLTSNRLENVQHKMFK---------- 102 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTT--TCTTCCEEECCSSCCCCCCGGGGT----------
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhC--CCCCCCEEECCCCccCccCHhHhc----------
Confidence 44444444443311122344455555555555555555555555 466777777777777655444332
Q ss_pred cCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 219 GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 219 ~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
++++|++|+|++|+|++..|. +.++++|++|+|++|+|++..|..|..+++|+.|+|++|+++
T Consensus 103 ----------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 103 ----------------GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ----------------TCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ----------------CCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 467777777777777777653 777888888888888888777888888888888888888887
Q ss_pred ccCC
Q 002255 298 GQTP 301 (947)
Q Consensus 298 g~~p 301 (947)
+..+
T Consensus 167 c~c~ 170 (220)
T 2v70_A 167 CNCY 170 (220)
T ss_dssp CSGG
T ss_pred CCCc
Confidence 6543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-20 Score=221.88 Aligned_cols=332 Identities=12% Similarity=0.065 Sum_probs=226.9
Q ss_pred cEEEEEecCCc-ccc-cCcccccCCCCCCEEEcccCcccCc----CC-CCCCCCCCcEEecCCCcCCCCCc----ccccC
Q 002255 66 RVTRIQIGGQN-IEG-TLPKELNSLSSLTVLEVMKNKLTGQ----IP-SLSGLSSLQEVLFDDNNFTSVPS----DFFKG 134 (947)
Q Consensus 66 ~v~~l~L~~~~-l~g-~~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~n~l~~~~~----~~~~~ 134 (947)
+++.|+|+++. ++. .++..+..+++|++|+|++|.+++. ++ .+.++++|++|+|++|.++++.. ..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999886 221 2333345889999999999998765 33 34578999999999999985443 44567
Q ss_pred CCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceee---eccCcccCCCCCCCccEEEccCCcccCcCCccccC-C
Q 002255 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT---GTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-S 210 (947)
Q Consensus 135 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~---~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~ 210 (947)
+++|++|+|++|.+.+ +|..+.++++|++|+++.+... +..+..+. .+++|+.|+++++... .+|..+.. .
T Consensus 219 ~~~L~~L~L~~~~~~~--l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~--~~~~L~~L~l~~~~~~-~l~~~~~~~~ 293 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE--LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV--FPRKLCRLGLSYMGPN-EMPILFPFAA 293 (592)
T ss_dssp CTTCCEEECSSCBGGG--GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC--CCTTCCEEEETTCCTT-TGGGGGGGGG
T ss_pred CCCCcEEeccCccHHH--HHHHHhhhhHHHhhcccccccccchHHHHHHhh--ccccccccCccccchh-HHHHHHhhcC
Confidence 8999999999999875 7899999999999999864433 23334454 6789999999986443 56666644 6
Q ss_pred CCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcC-CCCC-CCCCCCCCEEEcc-----------CCccccC-C
Q 002255 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPD-LSGLSSLQDFSVR-----------DNQLTGI-V 276 (947)
Q Consensus 211 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~-~~~l~~L~~L~l~-----------~N~l~g~-~ 276 (947)
+|++|+|++|.+... .....+.++++|+.|+|+ |.++. .++. ...+++|++|+++ .|.+++. +
T Consensus 294 ~L~~L~Ls~~~l~~~--~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~ 370 (592)
T 3ogk_B 294 QIRKLDLLYALLETE--DHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370 (592)
T ss_dssp GCCEEEETTCCCCHH--HHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH
T ss_pred CCcEEecCCCcCCHH--HHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH
Confidence 899999999874322 122346789999999999 44443 3333 3558899999999 4677654 3
Q ss_pred CccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCC
Q 002255 277 PSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356 (947)
Q Consensus 277 p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~ 356 (947)
+.....+++|++|+++.|.+++..+..+.. ...+...+...... .-+.+...+ ....+.
T Consensus 371 ~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~------~~~~L~~L~l~~~~---~~n~l~~~p----~~~~~~-------- 429 (592)
T 3ogk_B 371 IALAQGCQELEYMAVYVSDITNESLESIGT------YLKNLCDFRLVLLD---REERITDLP----LDNGVR-------- 429 (592)
T ss_dssp HHHHHHCTTCSEEEEEESCCCHHHHHHHHH------HCCSCCEEEEEECS---CCSCCSSCC----CHHHHH--------
T ss_pred HHHHhhCccCeEEEeecCCccHHHHHHHHh------hCCCCcEEEEeecC---CCccccCch----HHHHHH--------
Confidence 333556999999999999998754321100 01111111110000 000000000 000000
Q ss_pred CCCCCCCcccCCCCceeEEEecCC--CceeeccccccC-CccCCeEeccCCcccc-cCCCcCCCCCCCCccccccccccc
Q 002255 357 CNSDWKGVSCDAGGNITVVNLKNL--GLSGTISSNFSR-LTSLRQLMLSGNELTG-TIPKELTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 357 ~~~~~~~~~~~~~~~L~~L~Ls~n--~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L~ls~N~l~g 432 (947)
.....+++|+.|+|++| .+++..+..++. +++|+.|+|++|++++ .++..+..+++|+.|+|++|++++
T Consensus 430 -------~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 430 -------SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp -------HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred -------HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 00122467999999854 477776666654 8999999999999987 456667889999999999999876
Q ss_pred c
Q 002255 433 K 433 (947)
Q Consensus 433 ~ 433 (947)
.
T Consensus 503 ~ 503 (592)
T 3ogk_B 503 R 503 (592)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.8e-18 Score=173.19 Aligned_cols=145 Identities=21% Similarity=0.402 Sum_probs=133.9
Q ss_pred CCCceeEeCCC----------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCC
Q 002255 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122 (947)
Q Consensus 54 C~w~gv~C~~~----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n 122 (947)
|.|..|.|... ..++.|+|++|++++..+..|..+++|++|+|++|++++..| .|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 78999999642 368999999999998777789999999999999999999877 7999999999999999
Q ss_pred cCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccC
Q 002255 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (947)
Q Consensus 123 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~ 201 (947)
+|+.+++..|..+++|++|+|++|+|.. ..|..|..+++|++|+|++|+|++..+..+. .+++|++|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS--PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCE-eCHHHcCCCCCCCEEECCCCcCCEECHHHHh--CCCCCCEEEeCCCCcCC
Confidence 9999999999999999999999999976 6688999999999999999999988888787 68999999999999974
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.5e-18 Score=183.15 Aligned_cols=169 Identities=25% Similarity=0.385 Sum_probs=147.8
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|++++|++.. ++ .+..+++|++|+|++|++++..+ +.++++|++|+|++|++++++. +..+++|++|+|+
T Consensus 46 ~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred CcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh--hccCCCCCEEECC
Confidence 478999999999984 44 58999999999999999998776 9999999999999999999654 8999999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|++.. + ..+..+++|++|++++|++++. ..+. .+++|++|+|++|++++..| +
T Consensus 121 ~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~--~~l~--~l~~L~~L~L~~N~l~~~~~--l----------------- 174 (291)
T 1h6t_A 121 HNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP--L----------------- 174 (291)
T ss_dssp TSCCCC--C-GGGGGCTTCCEEECCSSCCCCC--GGGG--GCTTCSEEECCSSCCCCCGG--G-----------------
T ss_pred CCcCCC--C-hhhcCCCCCCEEEccCCcCCcc--hhhc--cCCCCCEEEccCCccccchh--h-----------------
Confidence 999976 3 5789999999999999999975 4555 68999999999999986544 3
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCcccc
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTG 274 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g 274 (947)
..+++|+.|+|++|.+++. +.+..+++|+.|++++|+++.
T Consensus 175 ---------~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 175 ---------AGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ---------TTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred ---------cCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 3488999999999999875 568889999999999999985
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-18 Score=188.82 Aligned_cols=147 Identities=19% Similarity=0.271 Sum_probs=125.4
Q ss_pred CCCceeEeCCC----------CcEEEEEecCCcccccCccccc-CCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCC
Q 002255 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELN-SLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDD 121 (947)
Q Consensus 54 C~w~gv~C~~~----------~~v~~l~L~~~~l~g~~p~~l~-~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~ 121 (947)
|.|..|.|... ..++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+ .|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 67888999642 3588999999999987777787 99999999999999999887 699999999999999
Q ss_pred CcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCC-CCCCCccEEEccCCccc
Q 002255 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG-DTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 122 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-~~l~~L~~L~Ls~N~l~ 200 (947)
|+|+.+++..|..+++|++|+|++|+|.. ..|..|..+++|+.|+|++|+|++..+..+.+ ..+++|++|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999999999999999999999999976 56889999999999999999999654444421 14677777777777777
Q ss_pred C
Q 002255 201 G 201 (947)
Q Consensus 201 ~ 201 (947)
+
T Consensus 177 ~ 177 (361)
T 2xot_A 177 K 177 (361)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-20 Score=218.31 Aligned_cols=189 Identities=17% Similarity=0.139 Sum_probs=117.3
Q ss_pred cCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCc-------------CCCCCcccccCCCCCcEEe-ccCCCCCCC
Q 002255 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN-------------FTSVPSDFFKGLTSLQTIS-LDYNSFDSW 151 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~~ 151 (947)
..+++|+.|+|++|+|+..++.+++|++|++|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence 56788889999999887554478888899999987775 5566677777788888887 6666542
Q ss_pred CCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCCCCCCch
Q 002255 152 VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV 230 (947)
Q Consensus 152 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~~ 230 (947)
.|..+.+.+|.++...+ ..|+.|+|++|+|++ +|. ++. .+|+.|+|++|.+... +
T Consensus 424 ----------~L~~l~l~~n~i~~l~~--------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~l----p 479 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY--------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRAL----P 479 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH--------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCC----C
T ss_pred ----------hhhhhhhhcccccccCc--------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccccc----c
Confidence 12333333333332111 134555555555553 333 322 2333333333333211 1
Q ss_pred hhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCC-CccccCCCCCCeEeccCCcccccCC
Q 002255 231 AVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIV-PSSLVNLHSLAVVNLTNNLFQGQTP 301 (947)
Q Consensus 231 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~-p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (947)
..++++++|+.|+|++|+|++ +|.+..+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|
T Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 480 PALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp GGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred hhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 123457777777777777776 346777777777777777777665 7777777777777777777776554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.3e-17 Score=168.13 Aligned_cols=154 Identities=20% Similarity=0.265 Sum_probs=86.8
Q ss_pred CCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccC
Q 002255 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (947)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (947)
.+.++.+++.++..+..+. ++|++|+|++|+++++++..|..+++|++|+|++|+|.. ..+..|..+
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l---------- 87 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSL---------- 87 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTC----------
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-cChhhcccC----------
Confidence 4556676666665443333 666666666666666666666666666666666666643 222334444
Q ss_pred ceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCc
Q 002255 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250 (947)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 250 (947)
++|++|+|++|+|++..+..|. .+++|+.|+|++|+|+
T Consensus 88 ----------------~~L~~L~Ls~N~l~~l~~~~~~--------------------------~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 88 ----------------TQLTVLDLGTNQLTVLPSAVFD--------------------------RLVHLKELFMCCNKLT 125 (229)
T ss_dssp ----------------TTCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCC
T ss_pred ----------------CCcCEEECCCCcCCccChhHhC--------------------------cchhhCeEeccCCccc
Confidence 4555555555555433332221 2455555555555555
Q ss_pred CCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccccc
Q 002255 251 GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 251 ~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
..+..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|++.+.
T Consensus 126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 4433455556666666666666654445566666666666666666544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-20 Score=217.83 Aligned_cols=203 Identities=17% Similarity=0.159 Sum_probs=137.2
Q ss_pred cCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCce-------------eeeccCcccCCCCCCCccEEE-ccCCc
Q 002255 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN-------------ITGTIPDFLGGDTIPGLMHLH-LAFNF 198 (947)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~-------------l~~~~p~~~~~~~l~~L~~L~-Ls~N~ 198 (947)
..+++|+.|+|++|++. .+|..++++++|+.|++++|. +.+.+|..++ .+++|+.|+ ++.|.
T Consensus 346 ~~~~~L~~L~Ls~n~L~--~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~--~l~~L~~L~~l~~n~ 421 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST--VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ--YFSTLKAVDPMRAAY 421 (567)
T ss_dssp STTTTSSSCCCCHHHHH--HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHH--HHHHHHHHCGGGHHH
T ss_pred ccCccceeccCChhhHH--hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHH--HHHhcccCcchhhcc
Confidence 56778888888888875 378888888888888876664 4556666665 566777777 56665
Q ss_pred ccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCc
Q 002255 199 LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS 278 (947)
Q Consensus 199 l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~ 278 (947)
+. .|..+++++|.+... . ...|+.|+|++|+|++. |.+..+++|+.|+|++|+|+ .+|.
T Consensus 422 ~~----------~L~~l~l~~n~i~~l--------~-~~~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~ 480 (567)
T 1dce_A 422 LD----------DLRSKFLLENSVLKM--------E-YADVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPP 480 (567)
T ss_dssp HH----------HHHHHHHHHHHHHHH--------H-HTTCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCG
T ss_pred cc----------hhhhhhhhccccccc--------C-ccCceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccch
Confidence 43 123333333322211 0 13588888888888874 45888888888888888888 7888
Q ss_pred cccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCC
Q 002255 279 SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCN 358 (947)
Q Consensus 279 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~ 358 (947)
.++++++|+.|+|++|+|++ +|.
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~-lp~-------------------------------------------------------- 503 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALEN-VDG-------------------------------------------------------- 503 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CGG--------------------------------------------------------
T ss_pred hhhcCCCCCEEECCCCCCCC-Ccc--------------------------------------------------------
Confidence 88888888888888888875 331
Q ss_pred CCCCCcccCCCCceeEEEecCCCceeec-cccccCCccCCeEeccCCcccccCCCcCC----CCCCCCcccc
Q 002255 359 SDWKGVSCDAGGNITVVNLKNLGLSGTI-SSNFSRLTSLRQLMLSGNELTGTIPKELT----TLPSLEMLDV 425 (947)
Q Consensus 359 ~~~~~~~~~~~~~L~~L~Ls~n~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~----~l~~L~~L~l 425 (947)
+..+++|+.|+|++|+|++.+ |..|+.|++|+.|+|++|+|++..| .+. .+++|+.||+
T Consensus 504 -------l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 504 -------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG-IQERLAEMLPSVSSILT 567 (567)
T ss_dssp -------GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS-CTTHHHHHCTTCSEEEC
T ss_pred -------cCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc-HHHHHHHHCcccCccCC
Confidence 112335777777777777665 7777777777777777777774433 322 2666766653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.4e-18 Score=179.52 Aligned_cols=172 Identities=23% Similarity=0.289 Sum_probs=126.1
Q ss_pred CCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeE
Q 002255 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (947)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (947)
++.++..+++++|.++... .+..+++|++|++++|.++.++ .+..+++|++|+|++|++.+ ++. +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~--~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD--LSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC--CGG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC--Chh-hccCCCCCEE
Confidence 3556667777777776544 5667777778888877777765 46777788888888887764 444 7777777777
Q ss_pred eccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC
Q 002255 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (947)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (947)
+|++|++++ +|.. . . ++|++|+|++|++++. + . +.++++|+.|+|++
T Consensus 91 ~L~~N~l~~-l~~~-~--~-~~L~~L~L~~N~l~~~-~-~--------------------------l~~l~~L~~L~Ls~ 137 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-P--S-ACLSRLFLDNNELRDT-D-S--------------------------LIHLKNLEILSIRN 137 (263)
T ss_dssp ECCSSCCSC-CTTC-C--C-SSCCEEECCSSCCSBS-G-G--------------------------GTTCTTCCEEECTT
T ss_pred ECCCCccCC-cCcc-c--c-CcccEEEccCCccCCC-h-h--------------------------hcCcccccEEECCC
Confidence 777777765 3332 2 2 6777888888877742 2 1 34578888888888
Q ss_pred CcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccC
Q 002255 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (947)
Q Consensus 247 N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (947)
|++++. +.+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++..
T Consensus 138 N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 138 NKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp SCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 888875 4677888899999999998865 67888889999999999988663
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=168.03 Aligned_cols=155 Identities=12% Similarity=0.173 Sum_probs=99.3
Q ss_pred CCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCC
Q 002255 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188 (947)
Q Consensus 109 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 188 (947)
..+++|++|++++|.++.++ .+..+++|++|++++|.+. .+..+..+++|++|++++|.+++..|..+. .+++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~---~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~--~l~~ 113 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHAT---NYNPISGLSNLERLRIMGKDVTSDKIPNLS--GLTS 113 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCS---CCGGGTTCTTCCEEEEECTTCBGGGSCCCT--TCTT
T ss_pred hhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCC---cchhhhcCCCCCEEEeECCccCcccChhhc--CCCC
Confidence 44555555555555555444 2555666666666666553 234566666666666766666666666666 5777
Q ss_pred ccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEcc
Q 002255 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVR 268 (947)
Q Consensus 189 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~ 268 (947)
|++|+|++|++++..|..+ ..+++|+.|+|++|.+.+.++.+..+++|++|+++
T Consensus 114 L~~L~Ls~n~i~~~~~~~l--------------------------~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKI--------------------------NTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167 (197)
T ss_dssp CCEEECCSSBCBGGGHHHH--------------------------TTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECT
T ss_pred CCEEEecCCccCcHhHHHH--------------------------hhCCCCCEEEccCCCCccccHhhcCCCCCCEEECC
Confidence 7777777777775554433 34677777777777733344567777788888888
Q ss_pred CCccccCCCccccCCCCCCeEeccCCcccc
Q 002255 269 DNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 269 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g 298 (947)
+|++++ ++ .+..+++|+.|++++|++.+
T Consensus 168 ~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 168 FDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888874 44 67778888888888888753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.71 E-value=7.2e-20 Score=218.95 Aligned_cols=131 Identities=13% Similarity=0.183 Sum_probs=87.9
Q ss_pred CcEEEEEecCCcccccCccccc-CCCCCCEEEcccC-cccCc-CCC-CCCCCCCcEEecCCCcCCCCCccccc----CCC
Q 002255 65 NRVTRIQIGGQNIEGTLPKELN-SLSSLTVLEVMKN-KLTGQ-IPS-LSGLSSLQEVLFDDNNFTSVPSDFFK----GLT 136 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~-~l~~L~~L~L~~N-~l~~~-~p~-~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~ 136 (947)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++. +.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688888888888877666665 6788888888888 45442 333 34688888888888887765544333 566
Q ss_pred CCcEEeccCCC--CCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCC
Q 002255 137 SLQTISLDYNS--FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197 (947)
Q Consensus 137 ~L~~L~Ls~N~--l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N 197 (947)
+|++|+|++|. +....++..+.++++|++|++++|...+.+|..+. .+++|++|+++.+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~--~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQ--RAPQLEELGTGGY 245 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHH--HCTTCSEEECSBC
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHh--cCCcceEcccccc
Confidence 88888888886 22111223334568888888888833223666555 5677777775544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-18 Score=210.36 Aligned_cols=162 Identities=21% Similarity=0.150 Sum_probs=94.7
Q ss_pred CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEec
Q 002255 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (947)
+.++.|+|.+|.+..... ..|+.++|+.|.|.+ ++++.|.+. ..+..+..++.|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~~~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~--~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQ-----ALLQHKKLSQYSIDE--------------DDDIENRMV--MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcchh-----hHhhcCccCcccccC--------------cccccccee--cChhhhccCCCCcEEEC
Confidence 456677777776665322 224445555554433 345556653 35778888888899999
Q ss_pred cCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCc
Q 002255 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (947)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (947)
++|.+. .+|..++ .+++|++|+|++|+|+ .+|..|+ ++++|+.|+|++|.
T Consensus 232 s~n~l~-~l~~~~~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 232 SNLQIF-NISANIF--KYDFLTRLYLNGNSLT-ELPAEIK--------------------------NLSNLRVLDLSHNR 281 (727)
T ss_dssp TTSCCS-CCCGGGG--GCCSCSCCBCTTSCCS-CCCGGGG--------------------------GGTTCCEEECTTSC
T ss_pred CCCCCC-CCChhhc--CCCCCCEEEeeCCcCc-ccChhhh--------------------------CCCCCCEEeCcCCc
Confidence 888887 6776666 6888888888888888 7776554 48899999999999
Q ss_pred CcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCC
Q 002255 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (947)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (947)
|+..+..+..+++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|+|.+|.
T Consensus 282 l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 282 LTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK 334 (727)
T ss_dssp CSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred CCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence 9955446888999999999999997 7888899999999999999999887765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=165.54 Aligned_cols=153 Identities=14% Similarity=0.219 Sum_probs=90.3
Q ss_pred cCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCe
Q 002255 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (947)
..+++|+.|++++|.++ .+|.+..+++|++|++++|.++.++ .+..+++|++|+|++|++.. ..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTS-DKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCTTGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBG-GGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChHHHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCc-ccChhhcCCCCCCE
Confidence 34455666666666665 2335555666666666666554432 35566666666666666643 34555666666666
Q ss_pred EeccCceeeeccCcccCCCCCCCccEEEccCCc-ccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEc
Q 002255 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNF-LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (947)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (947)
|++++|.+++..|..+. .+++|++|+|++|+ ++ .+| . +.++++|+.|+|
T Consensus 117 L~Ls~n~i~~~~~~~l~--~l~~L~~L~L~~n~~i~-~~~-~--------------------------l~~l~~L~~L~l 166 (197)
T 4ezg_A 117 LDISHSAHDDSILTKIN--TLPKVNSIDLSYNGAIT-DIM-P--------------------------LKTLPELKSLNI 166 (197)
T ss_dssp EECCSSBCBGGGHHHHT--TCSSCCEEECCSCTBCC-CCG-G--------------------------GGGCSSCCEEEC
T ss_pred EEecCCccCcHhHHHHh--hCCCCCEEEccCCCCcc-ccH-h--------------------------hcCCCCCCEEEC
Confidence 66666666666666665 56677777777776 33 333 1 234666777777
Q ss_pred cCCcCcCCCCCCCCCCCCCEEEccCCccc
Q 002255 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLT 273 (947)
Q Consensus 245 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 273 (947)
++|.+++.. .+..+++|++|++++|+|.
T Consensus 167 ~~n~i~~~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 167 QFDGVHDYR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TTBCCCCCT-TGGGCSSCCEEEECBC---
T ss_pred CCCCCcChH-HhccCCCCCEEEeeCcccC
Confidence 777766533 5666677777777777765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.2e-17 Score=174.87 Aligned_cols=167 Identities=18% Similarity=0.258 Sum_probs=138.8
Q ss_pred EEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 67 v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
++.++++++.+++. + .+..+++|+.|++++|.++. ++.+..+++|++|+|++|+++++++ +..+++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-chHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 44556677777643 3 57889999999999999985 4588899999999999999999887 889999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
++.+ +|.... ++|++|+|++|++++. + .+. .+++|++|+|++|++++. + .
T Consensus 96 ~l~~--l~~~~~--~~L~~L~L~~N~l~~~-~-~l~--~l~~L~~L~Ls~N~i~~~-~-~-------------------- 145 (263)
T 1xeu_A 96 RLKN--LNGIPS--ACLSRLFLDNNELRDT-D-SLI--HLKNLEILSIRNNKLKSI-V-M-------------------- 145 (263)
T ss_dssp CCSC--CTTCCC--SSCCEEECCSSCCSBS-G-GGT--TCTTCCEEECTTSCCCBC-G-G--------------------
T ss_pred ccCC--cCcccc--CcccEEEccCCccCCC-h-hhc--CcccccEEECCCCcCCCC-h-H--------------------
Confidence 9976 454333 8999999999999864 4 455 689999999999999854 2 2
Q ss_pred CCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccC
Q 002255 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275 (947)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~ 275 (947)
+..+++|+.|+|++|++++. +.+..+++|+.|++++|.+++.
T Consensus 146 ------l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 ------LGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ------GGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred ------HccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 34589999999999999987 7788999999999999999865
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.4e-19 Score=210.18 Aligned_cols=328 Identities=13% Similarity=0.109 Sum_probs=207.4
Q ss_pred CcEEEEEecCC-ccccc-CcccccCCCCCCEEEcccCcccCcCC----C-CCCCCCCcEEecCCCcCCCCCccc----cc
Q 002255 65 NRVTRIQIGGQ-NIEGT-LPKELNSLSSLTVLEVMKNKLTGQIP----S-LSGLSSLQEVLFDDNNFTSVPSDF----FK 133 (947)
Q Consensus 65 ~~v~~l~L~~~-~l~g~-~p~~l~~l~~L~~L~L~~N~l~~~~p----~-~~~l~~L~~L~L~~n~l~~~~~~~----~~ 133 (947)
.+++.|+|.+| .+... ++..+.++++|++|+|++|.+++..+ . ...+++|++|+|++|. ..+.... +.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 47999999998 55543 44555689999999999999877543 2 3368899999999997 3333332 34
Q ss_pred CCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCce--------------------------ee----eccCcccCC
Q 002255 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN--------------------------IT----GTIPDFLGG 183 (947)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~--------------------------l~----~~~p~~~~~ 183 (947)
.+++|++|+|++|.... .++..+.++++|++|++..+. +. +.++..+.
T Consensus 209 ~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~- 286 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS- 286 (594)
T ss_dssp HCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH-
T ss_pred hCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH-
Confidence 56999999999984322 267777788888888765442 11 12333222
Q ss_pred CCCCCccEEEccCCcccCcCCcc-c-cCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC---------CcCcCC
Q 002255 184 DTIPGLMHLHLAFNFLQGPIPLS-F-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG---------NSFTGP 252 (947)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~~~p~~-~-~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~---------N~l~~~ 252 (947)
.+++|++|+|++|.+++..... + ...+|+.|++++| +.. .+.......+++|+.|+|++ |.+++.
T Consensus 287 -~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~--~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 287 -VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED--AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp -HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH--HHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred -hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH--HHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 4689999999999987544332 2 2268999999987 221 11122233589999999944 444432
Q ss_pred CC-CC-CCCCCCCEEEccCCccccCCCcccc-CCCCCCeEecc--C----CcccccCCCCCCCcccccccCCCCcccCcC
Q 002255 253 LP-DL-SGLSSLQDFSVRDNQLTGIVPSSLV-NLHSLAVVNLT--N----NLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323 (947)
Q Consensus 253 ~~-~~-~~l~~L~~L~l~~N~l~g~~p~~l~-~l~~L~~L~Ls--~----N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 323 (947)
.. .+ .++++|+.|++..|++++..+..+. .+++|+.|+|+ + |.+++...+. ....-+....++..++..
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~--~~~~l~~~~~~L~~L~L~ 440 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI--GFGAIVEHCKDLRRLSLS 440 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH--HHHHHHHHCTTCCEEECC
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh--HHHHHHhhCCCccEEeec
Confidence 11 22 2478999999999999877666665 58999999999 3 4444211100 000000000111111110
Q ss_pred CCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccc-cCCccCCeEecc
Q 002255 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNF-SRLTSLRQLMLS 402 (947)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~-~~l~~L~~L~Ls 402 (947)
. .+... .+. . .....++|+.|+|++|.+++..+..+ ..+++|+.|+|+
T Consensus 441 ~-~l~~~------~~~------~------------------l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~ 489 (594)
T 2p1m_B 441 G-LLTDK------VFE------Y------------------IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489 (594)
T ss_dssp S-SCCHH------HHH------H------------------HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEE
T ss_pred C-cccHH------HHH------H------------------HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECc
Confidence 0 00000 000 0 00114578899999999887665555 678899999999
Q ss_pred CCcccccCCCc-CCCCCCCCccccccccccc
Q 002255 403 GNELTGTIPKE-LTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 403 ~N~l~g~iP~~-l~~l~~L~~L~ls~N~l~g 432 (947)
+|.+++..+.. +..+++|+.|+|++|+++.
T Consensus 490 ~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 490 DCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp SCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred CCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 99987655543 3458899999999998853
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=5.4e-16 Score=155.74 Aligned_cols=133 Identities=20% Similarity=0.254 Sum_probs=109.0
Q ss_pred cEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCc-cccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCc
Q 002255 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSF 318 (947)
Q Consensus 240 ~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~ 318 (947)
+.|++++|.++..+..+.. +|++|+|++|+|++..+. .+.++++|++|+|++|++++.+|..+.
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------- 75 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE------------- 75 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTT-------------
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcC-------------
Confidence 6788888888765554543 888899999988866554 488888999999999988877665322
Q ss_pred ccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCe
Q 002255 319 CLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398 (947)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~ 398 (947)
...+|+.|+|++|+|++..|..|.++++|++
T Consensus 76 -------------------------------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 106 (192)
T 1w8a_A 76 -------------------------------------------------GASHIQELQLGENKIKEISNKMFLGLHQLKT 106 (192)
T ss_dssp -------------------------------------------------TCTTCCEEECCSCCCCEECSSSSTTCTTCCE
T ss_pred -------------------------------------------------CcccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 2346888999999999888888999999999
Q ss_pred EeccCCcccccCCCcCCCCCCCCccccccccccccCCC
Q 002255 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 399 L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
|+|++|+|++.+|..|..+++|++|+|++|+|+|..|.
T Consensus 107 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 107 LNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp EECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred EECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 99999999998899999999999999999999998874
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=5e-16 Score=156.02 Aligned_cols=131 Identities=18% Similarity=0.300 Sum_probs=117.5
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCC--CCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
+.|+++++++. .+|..+.. +|++|+|++|++++.++. |.++++|++|+|++|+|+++++..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 35677777885 78877754 999999999999998874 89999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (947)
|+|.+ ..+..+.++++|++|+|++|++++.+|..+. .+++|++|+|++|.+++..+
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSGG
T ss_pred CcCCc-cCHHHhcCCCCCCEEECCCCcCCeeCHHHhh--cCCCCCEEEeCCCCccCcCc
Confidence 99976 5677799999999999999999999999988 78999999999999997654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.9e-16 Score=169.02 Aligned_cols=140 Identities=13% Similarity=0.100 Sum_probs=101.9
Q ss_pred CCCcCceecccCceEEEEEEEcCCcEEEEEEecccccC------------hHH--------HHHHHHHHHHHHcCCCCCc
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS------------EKG--------FAEFKSEIAVLTKVRHRHL 650 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------~~~--------~~~~~~E~~~l~~l~h~ni 650 (947)
-|++.+.||+|+||.||+|...+|+.||||+++....+ ... .....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38999999999999999999889999999987643211 000 0112457777777765544
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc
Q 002255 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (947)
Q Consensus 651 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 730 (947)
....-+... ..+|||||++|++|.++... .....++.|++.+|.|||. .+||||||||.|||++
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEe
Confidence 322222222 23799999999888655311 1234678999999999996 8999999999999998
Q ss_pred CCC----------cEEEeecCcceec
Q 002255 731 DDM----------RAKVADFGLVRLA 746 (947)
Q Consensus 731 ~~~----------~~kl~DfGla~~~ 746 (947)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999976543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-15 Score=148.29 Aligned_cols=134 Identities=22% Similarity=0.369 Sum_probs=112.6
Q ss_pred CCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccc
Q 002255 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFF 132 (947)
Q Consensus 54 C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~ 132 (947)
|.|.+|.|+ +++++ .+|..+. ++|+.|+|++|++++.++ .|.++++|++|+|++|+++++++..|
T Consensus 7 C~~~~l~~~-----------~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (177)
T 2o6r_A 7 CSGTEIRCN-----------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF 72 (177)
T ss_dssp EETTEEECC-----------SSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred eCCCEEEec-----------CCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence 567777775 34454 5565443 799999999999998777 57899999999999999999999999
Q ss_pred cCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCC
Q 002255 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (947)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (947)
..+++|++|+|++|++.+ ..+..+..+++|++|++++|++++..+..+. .+++|++|+|++|.+++..|
T Consensus 73 ~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFD--RLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCEEECCCCCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhc--CCcccCEEEecCCCeeccCc
Confidence 999999999999999976 5556688999999999999999966665565 68999999999999997665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=8.2e-16 Score=150.95 Aligned_cols=137 Identities=17% Similarity=0.168 Sum_probs=117.8
Q ss_pred CcEEEEEecCCccc-ccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~-g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.+++. +.+..+++|++|+|++|++++.++..+..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 57899999999998 88898899999999999999999887 88999999999999999999988888888999999999
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccC---cccCCCCCCCccEEEccCCcccCcCCc
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIP---DFLGGDTIPGLMHLHLAFNFLQGPIPL 205 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 205 (947)
++|++.+...+..+..+++|++|++++|.+++..+ ..+. .+++|++|++++|.+. .+|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFK--LLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHT--TCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHH--hCccCcEecCCCCChh-hccc
Confidence 99999762233788999999999999999986655 3665 6889999999999887 4443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-15 Score=145.65 Aligned_cols=128 Identities=18% Similarity=0.230 Sum_probs=90.8
Q ss_pred CcEEEEEecCCccc-ccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~-g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.+++. +.+.++++|++|+|++|++++.+|..+..+++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 35777777777777 67777777777777777777777766 66777777777777777777766666666777777777
Q ss_pred cCCCCCCCCCcccccCCCCCCeEeccCceeeeccC---cccCCCCCCCccEEEcc
Q 002255 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIP---DFLGGDTIPGLMHLHLA 195 (947)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~Ls 195 (947)
++|++.+...+..+..+++|++|++++|.+++..+ ..+. .+++|++|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFK--LLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHH--HCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHH--HCCCcccccCC
Confidence 77777652233667777777777777777775544 3444 56677777665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=146.23 Aligned_cols=127 Identities=22% Similarity=0.338 Sum_probs=111.5
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (947)
.+++++++++ .+|..+. ++|++|+|++|+|+..+..|.++++|++|+|++|+|+++++..|.++++|++|+|++|+|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 4677778887 7777664 689999999999985555899999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccC
Q 002255 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (947)
Q Consensus 149 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~ 201 (947)
.. ..|..|..+++|++|+|++|.|++..+..|. .+++|++|+|++|.+..
T Consensus 91 ~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 91 RC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFN--DLSALSHLAIGANPLYC 140 (193)
T ss_dssp CB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECCSSCEEC
T ss_pred CE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhh--cCccccEEEeCCCCeec
Confidence 76 5667899999999999999999976666676 68999999999999974
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.56 E-value=6.5e-15 Score=144.49 Aligned_cols=133 Identities=20% Similarity=0.209 Sum_probs=84.0
Q ss_pred CCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCcee
Q 002255 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215 (947)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L 215 (947)
++|++|+|++|++..+.+|..+..+++|++|++++|.+++. ..+. .+++|++|+|++|++++.+|..+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~--~l~~L~~L~Ls~N~l~~~~~~~~-------- 91 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLP--KLPKLKKLELSENRIFGGLDMLA-------- 91 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCC--CCSSCCEEEEESCCCCSCCCHHH--------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhc--cCCCCCEEECcCCcCchHHHHHH--------
Confidence 44555555555554223444445555555555555555543 3444 46677777777777775555433
Q ss_pred eeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCC--CCCCCCCCCCEEEccCCccccCCC---ccccCCCCCCeEe
Q 002255 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL--PDLSGLSSLQDFSVRDNQLTGIVP---SSLVNLHSLAVVN 290 (947)
Q Consensus 216 ~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~g~~p---~~l~~l~~L~~L~ 290 (947)
.++++|+.|+|++|.+++.. +.+..+++|++|++++|.+++..+ ..+..+++|++|+
T Consensus 92 ------------------~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 153 (168)
T 2ell_A 92 ------------------EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153 (168)
T ss_dssp ------------------HHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred ------------------hhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence 23677777777777777654 457777888888888888885544 4778888888888
Q ss_pred ccCCcccc
Q 002255 291 LTNNLFQG 298 (947)
Q Consensus 291 Ls~N~l~g 298 (947)
+++|.+..
T Consensus 154 l~~n~~~~ 161 (168)
T 2ell_A 154 GYDREDQE 161 (168)
T ss_dssp TEETTSCB
T ss_pred CCCCChhh
Confidence 88887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.2e-15 Score=141.94 Aligned_cols=106 Identities=23% Similarity=0.279 Sum_probs=70.1
Q ss_pred CCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCC
Q 002255 236 MTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315 (947)
Q Consensus 236 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~ 315 (947)
+++|+.|+|++|.+++. +.+..+++|++|++++|++++.+|..+..+++|++|+|++|++++.
T Consensus 41 l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~---------------- 103 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL---------------- 103 (149)
T ss_dssp CTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSH----------------
T ss_pred cCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCCh----------------
Confidence 56666666666666655 5556666666666666666655666665666666666666665421
Q ss_pred CCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCcc
Q 002255 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS 395 (947)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~ 395 (947)
..|..++.+++
T Consensus 104 ---------------------------------------------------------------------~~~~~~~~l~~ 114 (149)
T 2je0_A 104 ---------------------------------------------------------------------STIEPLKKLEN 114 (149)
T ss_dssp ---------------------------------------------------------------------HHHGGGGGCTT
T ss_pred ---------------------------------------------------------------------HHHHHHhhCCC
Confidence 13356777888
Q ss_pred CCeEeccCCcccccCC---CcCCCCCCCCcccccc
Q 002255 396 LRQLMLSGNELTGTIP---KELTTLPSLEMLDVSN 427 (947)
Q Consensus 396 L~~L~Ls~N~l~g~iP---~~l~~l~~L~~L~ls~ 427 (947)
|+.|+|++|++++..+ ..+..+++|+.||+++
T Consensus 115 L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 115 LKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888888888885444 3678888888888864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=142.79 Aligned_cols=134 Identities=21% Similarity=0.241 Sum_probs=105.5
Q ss_pred CcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCc
Q 002255 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSF 318 (947)
Q Consensus 239 L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~ 318 (947)
.+.+++++|+++..+..+ .++|+.|++++|++++..+..+.++++|++|+|++|++++..+..+
T Consensus 9 ~~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------- 72 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF-------------- 72 (177)
T ss_dssp TTEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT--------------
T ss_pred CCEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc--------------
Confidence 467788888887665443 3678888888888887666677888888888888888876544321
Q ss_pred ccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCe
Q 002255 319 CLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398 (947)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~ 398 (947)
....+|+.|+|++|++++..+..+.++++|+.
T Consensus 73 ------------------------------------------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 104 (177)
T 2o6r_A 73 ------------------------------------------------DKLTKLTILYLHENKLQSLPNGVFDKLTQLKE 104 (177)
T ss_dssp ------------------------------------------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ------------------------------------------------cCCCccCEEECCCCCccccCHHHhhCCcccCE
Confidence 12346888888888888777777899999999
Q ss_pred EeccCCcccccCCCcCCCCCCCCccccccccccccCCC
Q 002255 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 399 L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
|+|++|+|++..+..+..+++|+.|+|++|+++|.+|.
T Consensus 105 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 105 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred EECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 99999999954445578899999999999999998883
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.3e-14 Score=143.74 Aligned_cols=131 Identities=21% Similarity=0.287 Sum_probs=111.0
Q ss_pred cEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcc
Q 002255 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFC 319 (947)
Q Consensus 240 ~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~ 319 (947)
+.+++++|.++..+..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|++++..+..+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f--------------- 74 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF--------------- 74 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTT---------------
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHc---------------
Confidence 578999999986655543 68999999999998 788999999999999999999987665422
Q ss_pred cCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeE
Q 002255 320 LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQL 399 (947)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L 399 (947)
..+.+|+.|+|++|.|++..|..|..+++|+.|
T Consensus 75 -----------------------------------------------~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 107 (193)
T 2wfh_A 75 -----------------------------------------------SNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLL 107 (193)
T ss_dssp -----------------------------------------------TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred -----------------------------------------------cCCCCCCEEECCCCccCEeCHHHhCCCCCCCEE
Confidence 223478999999999998888899999999999
Q ss_pred eccCCcccccCCCcCCCCCCCCccccccccccccCC
Q 002255 400 MLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (947)
Q Consensus 400 ~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP 435 (947)
+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 108 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 108 SLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 999999995555579999999999999999987654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.4e-15 Score=163.01 Aligned_cols=285 Identities=12% Similarity=0.160 Sum_probs=143.5
Q ss_pred cEEEEEecCCcccccCcccccC-CCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccC--------CC
Q 002255 66 RVTRIQIGGQNIEGTLPKELNS-LSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG--------LT 136 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~-l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------l~ 136 (947)
++++|.++++ +.+.--..+.. +++|+.|||++|++.........++.++.+.+..| .++..+|.+ ++
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~---~I~~~aF~~~~~~~~~g~~ 101 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMAN---FVPAYAFSNVVNGVTKGKQ 101 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTT---EECTTTTEEEETTEEEECT
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccccccccccccc---ccCHHHhcccccccccccC
Confidence 4666666542 11111112323 66777777777777611101111122344444444 455556666 77
Q ss_pred CCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcc----cCcCCccccC-CC
Q 002255 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL----QGPIPLSFGK-SS 211 (947)
Q Consensus 137 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l----~~~~p~~~~~-~~ 211 (947)
+|+.|+|.+ ++.. .-+..|.++++|+.|++.+|.+....+..|. .+.++..+.+..+.. .......|.. .+
T Consensus 102 ~L~~l~L~~-~i~~-I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~--~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 102 TLEKVILSE-KIKN-IEDAAFKGCDNLKICQIRKKTAPNLLPEALA--DSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp TCCC-CBCT-TCCE-ECTTTTTTCTTCCEEEBCCSSCCEECTTSSC--TTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred CCcEEECCc-cccc-hhHHHhhcCcccceEEcCCCCccccchhhhc--CCCceEEecCcchhhhhccccccccccccccc
Confidence 777777776 5544 3345566777777777777776655555554 344555555444221 1111111111 11
Q ss_pred Cc-eeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCC-CCCCCCEEEccCCccccCCCccccCCCCCCeE
Q 002255 212 IQ-TLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLS-GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (947)
Q Consensus 212 L~-~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L 289 (947)
|+ .+.+.... .........-....++..+.+.++-.......+. .+++|+.|+|++|+++...+..|.++++|+.|
T Consensus 178 L~~~i~~~~~~--~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l 255 (329)
T 3sb4_A 178 LETTIQVGAMG--KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKI 255 (329)
T ss_dssp CEEEEEECTTC--CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEE
T ss_pred cceeEEecCCC--cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEE
Confidence 21 11111100 0000000000012334444444331111111111 25677777777777775555567777777777
Q ss_pred eccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCC
Q 002255 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAG 369 (947)
Q Consensus 290 ~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 369 (947)
+|.+| ++...+. .+..+
T Consensus 256 ~l~~n-i~~I~~~--------------------------------------------------------------aF~~~ 272 (329)
T 3sb4_A 256 KLPHN-LKTIGQR--------------------------------------------------------------VFSNC 272 (329)
T ss_dssp ECCTT-CCEECTT--------------------------------------------------------------TTTTC
T ss_pred ECCcc-cceehHH--------------------------------------------------------------HhhCC
Confidence 77766 4322111 11223
Q ss_pred Ccee-EEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccc
Q 002255 370 GNIT-VVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424 (947)
Q Consensus 370 ~~L~-~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 424 (947)
.+|+ .+++.+ +++..-+.+|.+|++|+.|+|++|+++..-+..|.++++|+.++
T Consensus 273 ~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 273 GRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred hhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 4566 777766 56655567888888888888888888844445788888888775
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-14 Score=154.60 Aligned_cols=257 Identities=14% Similarity=0.110 Sum_probs=176.0
Q ss_pred CCcEEEEEecCCccc--ccCcccccCCCCCCEEEcccCcccCcCC-CCCC--------CCCCcEEecCCCcCCCCCcccc
Q 002255 64 SNRVTRIQIGGQNIE--GTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSG--------LSSLQEVLFDDNNFTSVPSDFF 132 (947)
Q Consensus 64 ~~~v~~l~L~~~~l~--g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~--------l~~L~~L~L~~n~l~~~~~~~~ 132 (947)
..+++.|||++|++. ...+. .++.+..+.+..|.+ .+ .|.+ +++|+.|+|.+ .++.+...+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 357999999999988 22222 223355666666632 12 5777 99999999998 8999999999
Q ss_pred cCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCcee----eeccCcccCCCCCCCcc-EEEccCCcccCcCCccc
Q 002255 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANI----TGTIPDFLGGDTIPGLM-HLHLAFNFLQGPIPLSF 207 (947)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l----~~~~p~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~ 207 (947)
.++++|++|+|++|.+.. ..+..|..+.++..+.+..+.. ...-...|. .+..|+ .+.+.... .++..+
T Consensus 121 ~~~~~L~~l~l~~n~i~~-i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~--~~~~L~~~i~~~~~~---~l~~~~ 194 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPN-LLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFI--EGEPLETTIQVGAMG---KLEDEI 194 (329)
T ss_dssp TTCTTCCEEEBCCSSCCE-ECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEE--ESCCCEEEEEECTTC---CHHHHH
T ss_pred hcCcccceEEcCCCCccc-cchhhhcCCCceEEecCcchhhhhccccccccccc--cccccceeEEecCCC---cHHHHH
Confidence 999999999999998865 5567788887787777766332 111122222 234454 34443321 122211
Q ss_pred -----cCCCCceeeeccCCCCCCCCCchhhh-cCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccc
Q 002255 208 -----GKSSIQTLWLNGQKGDSKLNGSVAVI-QNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSL 280 (947)
Q Consensus 208 -----~~~~L~~L~l~~n~~~~~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l 280 (947)
...++..+.+.++-.. .....+ ..+++|+.|+|++|+++...+ .|.++.+|+.|+|.+| ++..-+..|
T Consensus 195 ~~~~~~~~~~~~l~~~~~l~~----~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF 269 (329)
T 3sb4_A 195 MKAGLQPRDINFLTIEGKLDN----ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVF 269 (329)
T ss_dssp HHTTCCGGGCSEEEEEECCCH----HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred hhcccCccccceEEEeeeecH----HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHh
Confidence 1234556665544111 111111 237899999999999997766 4899999999999998 876777889
Q ss_pred cCCCCCC-eEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCC
Q 002255 281 VNLHSLA-VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (947)
Q Consensus 281 ~~l~~L~-~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~ 359 (947)
.++++|+ .|+|.+ .++...+.
T Consensus 270 ~~~~~L~~~l~l~~-~l~~I~~~--------------------------------------------------------- 291 (329)
T 3sb4_A 270 SNCGRLAGTLELPA-SVTAIEFG--------------------------------------------------------- 291 (329)
T ss_dssp TTCTTCCEEEEECT-TCCEECTT---------------------------------------------------------
T ss_pred hCChhccEEEEEcc-cceEEchh---------------------------------------------------------
Confidence 9999999 999988 55432222
Q ss_pred CCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEec
Q 002255 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML 401 (947)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~L 401 (947)
.+..+.+|+.|+++.|+++..-+..|.++++|+.|+.
T Consensus 292 -----aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 292 -----AFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp -----TTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred -----hhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 1234568999999999999877889999999999974
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=5.8e-14 Score=138.78 Aligned_cols=43 Identities=23% Similarity=0.304 Sum_probs=36.0
Q ss_pred cccCCccCCeEeccCCcccccCCCc----CCCCCCCCccccccccccc
Q 002255 389 NFSRLTSLRQLMLSGNELTGTIPKE----LTTLPSLEMLDVSNNHLFG 432 (947)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~g~iP~~----l~~l~~L~~L~ls~N~l~g 432 (947)
.+..+++|+.|+|++|.++ .+|.. +..+++|++||+++|.+..
T Consensus 108 ~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 108 PLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp GGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred hhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 5777888999999999998 67775 8889999999999988754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=5.3e-14 Score=139.05 Aligned_cols=128 Identities=16% Similarity=0.252 Sum_probs=103.2
Q ss_pred CcEEEEEecCCcccccCcccccCCC-CCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEec
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLS-SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (947)
..++.|+|++|+++ .+|. +..+. +|++|+|++|.+++. +.|.++++|++|+|++|+++++++..|..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 36788999999888 4544 55554 899999999998876 78888899999999999999888887788899999999
Q ss_pred cCCCCCCCCCcc--cccCCCCCCeEeccCceeeeccCcc----cCCCCCCCccEEEccCCccc
Q 002255 144 DYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIPDF----LGGDTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 144 s~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~----~~~~~l~~L~~L~Ls~N~l~ 200 (947)
++|+|.. +|. .+..+++|+.|++++|.++ .+|.. +. .+++|++||+++|.+.
T Consensus 96 ~~N~i~~--~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~--~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLVE--LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIY--KVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCCC--GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHH--HCTTCSEETTEECCHH
T ss_pred CCCcCCc--chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHH--HCCccceeCCCcCCHH
Confidence 9998854 565 7888888999999988887 45553 55 6788888888888875
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=129.05 Aligned_cols=104 Identities=20% Similarity=0.338 Sum_probs=84.9
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
+.++++++++. .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++++..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57889999886 7887775 889999999999998877 6889999999999999999999888888999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeee
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITG 175 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~ 175 (947)
+|.. ..+..+..+++|++|+|++|.+..
T Consensus 92 ~l~~-l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKS-IPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCC-CCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccce-eCHHHhccccCCCEEEeCCCCccc
Confidence 8875 333446677777777777776653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-15 Score=154.35 Aligned_cols=160 Identities=21% Similarity=0.301 Sum_probs=95.7
Q ss_pred ccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCC
Q 002255 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (947)
Q Consensus 85 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (947)
+.....++.++++.|.++|.+|.+.. ++ ..|..+++|++|+|++|++.. +| .+.++++|+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~----------------l~-~~~~~l~~L~~L~ls~n~l~~--l~-~~~~l~~L~ 73 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEK----------------MD-ATLSTLKACKHLALSTNNIEK--IS-SLSGMENLR 73 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCC----------------CH-HHHHHTTTCSEEECSEEEESC--CC-CHHHHTTCC
T ss_pred HHhcccccCcchheeEeccccCcHhh----------------hh-HHHhcCCCCCEEECCCCCCcc--cc-ccccCCCCC
Confidence 45556777777777777776653211 11 134455555555555555543 33 455555555
Q ss_pred eEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEc
Q 002255 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (947)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (947)
+|++++|.++ .+|..+. .+++|++|+|++|++++ +| . +.++++|+.|+|
T Consensus 74 ~L~l~~n~l~-~l~~~~~--~~~~L~~L~L~~N~l~~-l~-~--------------------------~~~l~~L~~L~l 122 (198)
T 1ds9_A 74 ILSLGRNLIK-KIENLDA--VADTLEELWISYNQIAS-LS-G--------------------------IEKLVNLRVLYM 122 (198)
T ss_dssp EEEEEEEEEC-SCSSHHH--HHHHCSEEEEEEEECCC-HH-H--------------------------HHHHHHSSEEEE
T ss_pred EEECCCCCcc-cccchhh--cCCcCCEEECcCCcCCc-CC-c--------------------------cccCCCCCEEEC
Confidence 5555555555 3454443 34566666666666663 22 1 234566777777
Q ss_pred cCCcCcCCCC--CCCCCCCCCEEEccCCccccCCCcc----------ccCCCCCCeEeccCCccc
Q 002255 245 HGNSFTGPLP--DLSGLSSLQDFSVRDNQLTGIVPSS----------LVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 245 ~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~g~~p~~----------l~~l~~L~~L~Ls~N~l~ 297 (947)
++|++++..+ .+..+++|++|++++|.+++.+|.. +..+++|+.|| +|.++
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 7777765433 4667777888888888877665543 78888888887 66665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=9.8e-13 Score=128.91 Aligned_cols=105 Identities=22% Similarity=0.379 Sum_probs=82.9
Q ss_pred EEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 68 ~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
+.|++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++++..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 35677777887 5777664 789999999999998877 6888999999999999999988888888889999999988
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeec
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGT 176 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 176 (947)
+|.+ ..+..|.++++|++|+|++|.++..
T Consensus 89 ~l~~-~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKS-IPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCE-eCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 8865 3444577777777777777766643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.39 E-value=1e-15 Score=154.68 Aligned_cols=133 Identities=22% Similarity=0.286 Sum_probs=101.2
Q ss_pred CcEEEEEecCCcccccCcc------cccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCC
Q 002255 65 NRVTRIQIGGQNIEGTLPK------ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 138 (947)
.+|+.++++++.+.|.+|. .+..+++|++|+|++|.+++ +|.+.++++|++|+|++|+++.++. .+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~~l~~-~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIKKIEN-LDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEECSCSS-HHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcccccc-hhhcCCcC
Confidence 4677888888888888876 89999999999999999987 5588888889999998888887654 46667888
Q ss_pred cEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccC-cccCCCCCCCccEEEccCCcccCcCC
Q 002255 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIP 204 (947)
Q Consensus 139 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (947)
++|+|++|++.+ +| .+..+++|++|++++|++++..+ ..+. .+++|++|+|++|.+++.+|
T Consensus 96 ~~L~L~~N~l~~--l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~--~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 96 EELWISYNQIAS--LS-GIEKLVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEEEEEECCC--HH-HHHHHHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSCHHHHHHH
T ss_pred CEEECcCCcCCc--CC-ccccCCCCCEEECCCCcCCchhHHHHHh--cCCCCCEEEecCCccccccc
Confidence 888888888865 44 57777777777777777764322 3444 56777777777777765544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.8e-11 Score=137.20 Aligned_cols=261 Identities=12% Similarity=0.158 Sum_probs=160.8
Q ss_pred CCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEe
Q 002255 89 SSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 167 (947)
..++.+.+.+ .++.... .|.++ +|+.+.|.+| ++.+...+|.+. +|+.+.|.. .+.. .-+..|.++.+|+.++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~-I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ-LKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE-ECSSTTTTCTTCCEEE
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE-ehHHHhhCcccCCeee
Confidence 5556666554 2443333 46554 5666666655 666666666663 566666664 4433 3345666666777777
Q ss_pred ccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC
Q 002255 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (947)
Q Consensus 168 l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (947)
+.+|+++......|. ..+|+.+.|..+ ++..-...|.. .+|+.+.+..+ +..... .+|.+ .+|+.+.|.
T Consensus 187 l~~n~l~~I~~~aF~---~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~---~aF~~-~~L~~i~lp- 256 (401)
T 4fdw_A 187 LSKTKITKLPASTFV---YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQ---EAFRE-SGITTVKLP- 256 (401)
T ss_dssp CTTSCCSEECTTTTT---TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECT---TTTTT-CCCSEEEEE-
T ss_pred cCCCcceEechhhEe---ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccc---ccccc-CCccEEEeC-
Confidence 766666644444443 356666766633 55344444544 35666666543 222211 22444 678888884
Q ss_pred CcCcCCCC-CCCCCCCCCEEEccCCccc-----cCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCccc
Q 002255 247 NSFTGPLP-DLSGLSSLQDFSVRDNQLT-----GIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCL 320 (947)
Q Consensus 247 N~l~~~~~-~~~~l~~L~~L~l~~N~l~-----g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~ 320 (947)
|.++.... .|.++++|+.+++.+|.+. ...+..|.++++|+.++|.++ ++.....
T Consensus 257 ~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~-i~~I~~~------------------ 317 (401)
T 4fdw_A 257 NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPES-IRILGQG------------------ 317 (401)
T ss_dssp TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTT-CCEECTT------------------
T ss_pred CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCc-eEEEhhh------------------
Confidence 45554444 4788888888888887765 345677888888998888743 4421111
Q ss_pred CcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEe
Q 002255 321 DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLM 400 (947)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~ 400 (947)
.+..+.+|+.+.|..| ++..-+.+|.++ +|+.|+
T Consensus 318 --------------------------------------------aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~ 351 (401)
T 4fdw_A 318 --------------------------------------------LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVK 351 (401)
T ss_dssp --------------------------------------------TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEE
T ss_pred --------------------------------------------hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEE
Confidence 1123346788888554 665556788999 999999
Q ss_pred ccCCcccccCCCcCCCCC-CCCccccccccc
Q 002255 401 LSGNELTGTIPKELTTLP-SLEMLDVSNNHL 430 (947)
Q Consensus 401 Ls~N~l~g~iP~~l~~l~-~L~~L~ls~N~l 430 (947)
|++|.+.-..+..|..++ ++..|++..|.+
T Consensus 352 l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 352 VEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp ECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred EcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 999998854456677774 678888877765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=2.1e-12 Score=126.58 Aligned_cols=109 Identities=20% Similarity=0.256 Sum_probs=95.9
Q ss_pred CCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc
Q 002255 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (947)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (947)
..+.|++++|+|+..+..+. ++|++|+|++|+|+++++..|..+++|++|+|++|+|.. ..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECC
Confidence 35789999999997655553 889999999999999999999999999999999999986 555668999999999999
Q ss_pred CceeeeccCcccCCCCCCCccEEEccCCcccCcC
Q 002255 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (947)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (947)
+|+|++..+..|. .+++|++|+|++|.++...
T Consensus 87 ~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFD--NLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTT--TCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhc--CCCCCCEEEeCCCCCCCCc
Confidence 9999987777777 6899999999999998554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.6e-12 Score=124.51 Aligned_cols=107 Identities=16% Similarity=0.253 Sum_probs=93.0
Q ss_pred CCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccC
Q 002255 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (947)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (947)
-+.+++++|+++..++.+. ++|++|+|++|+|+++++..|..+++|++|+|++|+|.+ ..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCC
Confidence 3789999999976555554 899999999999999999999999999999999999976 3445578999999999999
Q ss_pred ceeeeccCcccCCCCCCCccEEEccCCcccCc
Q 002255 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202 (947)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~ 202 (947)
|+|++..+..|. .+++|++|+|++|.+...
T Consensus 91 N~l~~l~~~~~~--~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFD--NLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTT--TCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhc--cccCCCEEEeCCCCcccc
Confidence 999976666676 689999999999999843
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=137.06 Aligned_cols=106 Identities=20% Similarity=0.328 Sum_probs=79.4
Q ss_pred CCCceeEeCCCCcEEEEEecCC-cccccCcccccCCCCCCEEEccc-CcccCcCC-CCCCCCCCcEEecCCCcCCCCCcc
Q 002255 54 CKWKHIQCSPSNRVTRIQIGGQ-NIEGTLPKELNSLSSLTVLEVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSD 130 (947)
Q Consensus 54 C~w~gv~C~~~~~v~~l~L~~~-~l~g~~p~~l~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~ 130 (947)
|.|.+|.|+ ++ +|+ .+|. |..+++|+.|+|++ |+|++.++ .|.+|++|++|+|++|+|+++++.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 777666664 44 566 5888 99999999999996 99998887 688999999999999999999988
Q ss_pred cccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceee
Q 002255 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT 174 (947)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (947)
.|.+|++|++|+|++|+|.+ ..+..+..+. |+.|+|.+|.+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALES-LSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSC-CCSTTTCSCC-CCEEECCSSCCC
T ss_pred HhcCCcCCCEEeCCCCccce-eCHHHcccCC-ceEEEeeCCCcc
Confidence 88889999999999998864 2222333332 555555555443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.6e-11 Score=128.23 Aligned_cols=147 Identities=16% Similarity=0.090 Sum_probs=114.6
Q ss_pred HHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCee
Q 002255 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNER 663 (947)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 663 (947)
+....+.|+....++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++...+..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3455577988889999999999999755 78999999865321 11235888999999995 67788999999999999
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc------------------------------
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA------------------------------ 713 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------ 713 (947)
|+||||++|.+|.+.+.. ......++.+++++++.||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 999999999999775311 1123467889999999999721
Q ss_pred --------------------------CCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 714 --------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 714 --------------------------~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667799998654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.20 E-value=8.8e-10 Score=123.38 Aligned_cols=247 Identities=12% Similarity=0.113 Sum_probs=184.7
Q ss_pred CCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCc
Q 002255 110 GLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL 189 (947)
Q Consensus 110 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 189 (947)
.+..++.+.+.+ .++.+...+|.+. +|+.++|..| +.. .-...|.+ .+|+.+.+.+ .++..-+..|. .+++|
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~-I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~--~c~~L 182 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKS-IGDMAFFN-STVQEIVFPS-TLEQLKEDIFY--YCYNL 182 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCE-ECTTTTTT-CCCCEEECCT-TCCEECSSTTT--TCTTC
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccE-ECHHhcCC-CCceEEEeCC-CccEehHHHhh--CcccC
Confidence 357788888874 6888999999985 8999999877 544 34456666 4799999986 66655666776 68999
Q ss_pred cEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEcc
Q 002255 190 MHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVR 268 (947)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~ 268 (947)
+.++|++|+++......|..++|+.+.|..+ +..... ..|.++++|+.++|..| ++.... .|.+ .+|+.+.+
T Consensus 183 ~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~---~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l- 255 (401)
T 4fdw_A 183 KKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGS---QAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL- 255 (401)
T ss_dssp CEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECT---TTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-
T ss_pred CeeecCCCcceEechhhEeecccCEEEeCCc-hheehh---hHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-
Confidence 9999999999966666777788999999744 333322 35778999999999975 554444 3666 78999999
Q ss_pred CCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhh
Q 002255 269 DNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348 (947)
Q Consensus 269 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~ 348 (947)
.|.++..-...|.++++|+.+++.+|.+.......
T Consensus 256 p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~--------------------------------------------- 290 (401)
T 4fdw_A 256 PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAM--------------------------------------------- 290 (401)
T ss_dssp ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCE---------------------------------------------
T ss_pred CCCccEEChhHhhCCCCCCEEEeCCccccCCcccE---------------------------------------------
Confidence 56677566888999999999999998775110000
Q ss_pred ccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
...-.+..+.+|+.+.|. +.++-.-...|.+|++|+.|+|..| ++..-+.+|..+ +|+.+++++|
T Consensus 291 ------------I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n 355 (401)
T 4fdw_A 291 ------------IHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGT 355 (401)
T ss_dssp ------------ECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCS
T ss_pred ------------ECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCC
Confidence 000122345578999998 4577566678999999999999665 773445789999 9999999999
Q ss_pred ccc
Q 002255 429 HLF 431 (947)
Q Consensus 429 ~l~ 431 (947)
.+.
T Consensus 356 ~~~ 358 (401)
T 4fdw_A 356 TPP 358 (401)
T ss_dssp SCC
T ss_pred CCc
Confidence 764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=129.24 Aligned_cols=105 Identities=17% Similarity=0.240 Sum_probs=89.2
Q ss_pred CEEEcccC-cccCcCCCCCCCCCCcEEecCC-CcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc
Q 002255 92 TVLEVMKN-KLTGQIPSLSGLSSLQEVLFDD-NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (947)
Q Consensus 92 ~~L~L~~N-~l~~~~p~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (947)
..++++++ +|++.++ +..+++|++|+|++ |+|+++++..|.+|++|++|+|++|+|.+ ..|..|.+|++|++|+|+
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eCHHHhcCCcCCCEEeCC
Confidence 35688887 8987666 99999999999996 99999999999999999999999999976 677788999999999999
Q ss_pred CceeeeccCcccCCCCCCCccEEEccCCcccC
Q 002255 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (947)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~ 201 (947)
+|+|++..+..+. .++ |+.|+|.+|.|..
T Consensus 89 ~N~l~~~~~~~~~--~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQ--GLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTC--SCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcc--cCC-ceEEEeeCCCccC
Confidence 9999876666654 344 9999999998873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.9e-13 Score=146.28 Aligned_cols=66 Identities=21% Similarity=0.177 Sum_probs=44.3
Q ss_pred hcCCCCCcEEEccCCcCcCCC----C-CCCCCCCCCEEEccCCccccC----CCccccCCCCCCeEeccCCcccc
Q 002255 233 IQNMTSLTQLWLHGNSFTGPL----P-DLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g 298 (947)
+..+++|++|+|++|.|+... . .+...++|+.|+|++|.|+.. ++..+...++|++|+|++|.|+.
T Consensus 179 L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 344667777777777776432 1 245566788888888887642 44555667888888888888764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=9.1e-11 Score=123.86 Aligned_cols=136 Identities=17% Similarity=0.135 Sum_probs=100.1
Q ss_pred CCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC--cceEEEEEEeCCeeEEEEE
Q 002255 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e 668 (947)
.|.+..+.+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34443333456669999998777888999987543 1245778999999996545 4568888888888999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----------------------------------
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA----------------------------------- 713 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 713 (947)
|++|.++. ... .. ...++.++++.|+.||+..
T Consensus 96 ~i~G~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 96 EVPGQDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp CCSSEETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred ecCCcccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99998884 211 11 1256778888888888632
Q ss_pred --------------------CCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 714 --------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 714 --------------------~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.1e-12 Score=143.30 Aligned_cols=185 Identities=15% Similarity=0.168 Sum_probs=94.8
Q ss_pred cEEEEEecCCcccccCcccccCC-----CCCCEEEcccCcccCcCC-C-CCCCCCCcEEecCCCcCCCCCcccc-----c
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSL-----SSLTVLEVMKNKLTGQIP-S-LSGLSSLQEVLFDDNNFTSVPSDFF-----K 133 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l-----~~L~~L~L~~N~l~~~~p-~-~~~l~~L~~L~L~~n~l~~~~~~~~-----~ 133 (947)
.++.|+|++|.++..-...|..+ ++|+.|+|++|.++.... . ...+++|++|+|++|.|+......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 46666666666654333332222 566666666666654221 2 2234566666666666654333322 2
Q ss_pred CCCCCcEEeccCCCCCCC---CCcccccCCCCCCeEeccCceeeec----cCcccCCCCCCCccEEEccCCcccCcCCcc
Q 002255 134 GLTSLQTISLDYNSFDSW---VIPESLKDATGLQRFSANGANITGT----IPDFLGGDTIPGLMHLHLAFNFLQGPIPLS 206 (947)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 206 (947)
..++|++|+|++|.|... .++..+..+++|++|+|++|.|+.. ++..+. ..++|++|+|++|.|+......
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~--~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLD--RNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGG--GCSCCCEEECCSSCCCHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHh--cCCCcCeEECCCCCCCHHHHHH
Confidence 345666666666665320 1233445556666666666665532 123333 3345666666666655322111
Q ss_pred ccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC----CCCCCC--CCCEEE--ccCCcccc
Q 002255 207 FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP----DLSGLS--SLQDFS--VRDNQLTG 274 (947)
Q Consensus 207 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~--~L~~L~--l~~N~l~g 274 (947)
+ ...+...++|++|+|++|.|+.... .+.... .|+.+. +..|.+..
T Consensus 231 l----------------------~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~ 284 (372)
T 3un9_A 231 L----------------------ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE 284 (372)
T ss_dssp H----------------------HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CHH
T ss_pred H----------------------HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCH
Confidence 1 1234457889999999999876433 122222 277777 77777753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.7e-09 Score=118.26 Aligned_cols=144 Identities=15% Similarity=0.227 Sum_probs=107.3
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEec--ccccChHHHHHHHHHHHHHHcCC--CCCcceEEEEEEeC---CeeEEE
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRME--SAVVSEKGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDG---NERLLV 666 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV 666 (947)
..+.++.|.++.||+.... +..+++|+.. .... ......+.+|+.+++.+. +..+.++++++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4578999999999999876 4688888765 3221 122357788999999997 45678899888776 458999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc---------------------------------
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--------------------------------- 713 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------- 713 (947)
|||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999988774421 123567778889999999999999731
Q ss_pred ----------------------CCCeeecCCCCCcEEEcCCCc--EEEeecCcceec
Q 002255 714 ----------------------HQSFIHRDLKPSNILLGDDMR--AKVADFGLVRLA 746 (947)
Q Consensus 714 ----------------------~~~ivHrDlkp~Nill~~~~~--~kl~DfGla~~~ 746 (947)
...++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999988753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.94 E-value=3.8e-08 Score=110.46 Aligned_cols=289 Identities=15% Similarity=0.103 Sum_probs=157.1
Q ss_pred ccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCC------------C
Q 002255 83 KELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF------------D 149 (947)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l------------~ 149 (947)
.+|.++++|+.+.|..+ ++.... +|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+-- .
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCS
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeeccccc
Confidence 34666666666666533 443333 5666666666666543 5555555666666665555433210 0
Q ss_pred C--------CCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccC
Q 002255 150 S--------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQ 220 (947)
Q Consensus 150 ~--------~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n 220 (947)
. ..-...|.++++|+.+.+.++-.+ .-...|. .+.+|+.+++..| ++......|.. ..|+.+.+..+
T Consensus 143 ~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~--~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 143 EITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFS--GCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTT--TCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred ccccCccccccchhhhcccCCCcEEecCCccce-ecccccc--CCCCceEEEcCCC-ceEeCchhhccccccceeecCCC
Confidence 0 012346778888888888765432 3334444 5678888888766 44233334433 45666655443
Q ss_pred CCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCC-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccccc
Q 002255 221 KGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
...- -.......+|+.+.+..+. +.... .+.++..|+.+.+..+... .....+..+..|+.+.+..+.+...
T Consensus 219 ~~~i-----~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~ 291 (394)
T 4fs7_A 219 LYYL-----GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEK 291 (394)
T ss_dssp CCEE-----CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTT
T ss_pred ceEe-----ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccc
Confidence 2110 0112234567777775432 22222 3666777888887776554 5556677777777777665543211
Q ss_pred CCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecC
Q 002255 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKN 379 (947)
Q Consensus 300 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 379 (947)
. +. ...++..+ ..+..+. ....-.+..+.+|+.++|.+
T Consensus 292 ~---F~-------~~~~L~~i---------------~l~~~i~-----------------~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 292 T---FY-------GCSSLTEV---------------KLLDSVK-----------------FIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp T---TT-------TCTTCCEE---------------EECTTCC-----------------EECTTTTTTCTTCCEECCCT
T ss_pred c---cc-------cccccccc---------------ccccccc-----------------eechhhhcCCCCCCEEEeCC
Confidence 0 00 00000000 0000000 00001223345788888865
Q ss_pred CCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 380 LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 380 n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
+ ++..-..+|.++++|+.++|..| ++-.-..+|.++.+|+.++|..|
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 4 65444678889999999999877 66233467888999999988654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.1e-09 Score=116.05 Aligned_cols=188 Identities=16% Similarity=0.205 Sum_probs=122.3
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCC--cceEEEEEEeCC---eeEEEEE
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRH--LVGLLGYCLDGN---ERLLVYE 668 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e 668 (947)
.+.++.|.+..||+.. +.+++|+-.. ......+.+|+++++.+. +.. +.+++.....++ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4678999999999863 5688987542 234567899999999884 333 334554443333 3489999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----------------------------------
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA----------------------------------- 713 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 713 (947)
+++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865332 12556667778888888888888511
Q ss_pred --------------------CCCeeecCCCCCcEEEcC--CCcEEEeecCcceecCCCCCcceeec------------cc
Q 002255 714 --------------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLAPDNGKHSIETR------------LA 759 (947)
Q Consensus 714 --------------------~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~ 759 (947)
...++|+|++|.||++++ ...+.|+||+.+.............. +.
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 135899999999999998 45688999998875433111000000 00
Q ss_pred ccccccC-ccccccCCcCcccccccHHHHHHHHHhCCCCCC
Q 002255 760 GTFGYLA-PEYAVTGRVTTKVDVFSFGVILMELITGRKALD 799 (947)
Q Consensus 760 gt~~y~a-PE~~~~~~~~~~~DvwSlGvil~elltg~~p~~ 799 (947)
...++.. |+... ......+.|+++.++|++.+|+.+|.
T Consensus 250 ~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0001111 22211 11223689999999999999987763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=4.3e-10 Score=123.48 Aligned_cols=82 Identities=13% Similarity=0.158 Sum_probs=43.5
Q ss_pred CCcEEEEEecCCcccc-cC-------cccccCCCCCCEEEcccCcccC---------cCC-CCCCCCCCcEEecCCCcCC
Q 002255 64 SNRVTRIQIGGQNIEG-TL-------PKELNSLSSLTVLEVMKNKLTG---------QIP-SLSGLSSLQEVLFDDNNFT 125 (947)
Q Consensus 64 ~~~v~~l~L~~~~l~g-~~-------p~~l~~l~~L~~L~L~~N~l~~---------~~p-~~~~l~~L~~L~L~~n~l~ 125 (947)
..+|+.|.+...+..| .. ..++..+++|+.|.+.++.... .+. .+..+++|+.|.|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3478888888666553 22 3345567888888887653311 111 2344556666666555211
Q ss_pred CCCcccccCCCCCcEEeccCCCC
Q 002255 126 SVPSDFFKGLTSLQTISLDYNSF 148 (947)
Q Consensus 126 ~~~~~~~~~l~~L~~L~Ls~N~l 148 (947)
.+++ +. +++|++|+|..|.+
T Consensus 186 ~l~~--~~-~~~L~~L~L~~~~l 205 (362)
T 2ra8_A 186 SIGK--KP-RPNLKSLEIISGGL 205 (362)
T ss_dssp BCCS--CB-CTTCSEEEEECSBC
T ss_pred eecc--cc-CCCCcEEEEecCCC
Confidence 2221 22 55556665555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.73 E-value=3.9e-07 Score=102.10 Aligned_cols=271 Identities=12% Similarity=0.022 Sum_probs=172.5
Q ss_pred ccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCcee------
Q 002255 101 LTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANI------ 173 (947)
Q Consensus 101 l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l------ 173 (947)
++.... +|.++++|+.+.|.. .++.+...+|.++++|+.++|..+ +.. .-...|.++.+|+.+.+..+-.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~-I~~~aF~~c~~L~~i~~p~~l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM-IGRCTFSGCYALKSILLPLMLKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCCCCCCTTCCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE-ccchhhcccccchhhcccCceeeeccee
Confidence 443333 799999999999975 599999999999999999999865 433 3345677788888776654311
Q ss_pred ---------------eeccCcccCCCCCCCccEEEccCCcccCcCCccccC-CCCceeeeccCCCCCCCCCchhhhcCCC
Q 002255 174 ---------------TGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMT 237 (947)
Q Consensus 174 ---------------~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~~l~ 237 (947)
...-...|. .+++|+.+.|.++..+ .....|.. .+|+.+.+..+ +.... ...+.++.
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~--~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~---~~~F~~~~ 208 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFA--TCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIR---DYCFAECI 208 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTT--TCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEEC---TTTTTTCT
T ss_pred eecccccccccCccccccchhhhc--ccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeC---chhhcccc
Confidence 001122333 5788999999866432 33445544 67888888755 22211 23466788
Q ss_pred CCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCC
Q 002255 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNS 317 (947)
Q Consensus 238 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~ 317 (947)
.|+.+.+..+... .........+|+.+.+..+. +..-...+..+..|+.+.+..|..+= ....+... ...
T Consensus 209 ~L~~i~~~~~~~~-i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~i-~~~~F~~~-------~~l 278 (394)
T 4fs7_A 209 LLENMEFPNSLYY-LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLRI-GGSLFYNC-------SGL 278 (394)
T ss_dssp TCCBCCCCTTCCE-ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCEE-CSCTTTTC-------TTC
T ss_pred ccceeecCCCceE-eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCccee-eccccccc-------ccc
Confidence 8888888776543 22234446789999887553 33455678889999999998775431 11110000 000
Q ss_pred cccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCC
Q 002255 318 FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLR 397 (947)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~ 397 (947)
.... .... ......+....+|+.+.+..+ ++..-..+|.++++|+
T Consensus 279 ~~~~----------------~~~~------------------~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~ 323 (394)
T 4fs7_A 279 KKVI----------------YGSV------------------IVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLV 323 (394)
T ss_dssp CEEE----------------ECSS------------------EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ceec----------------cCce------------------eeccccccccccccccccccc-cceechhhhcCCCCCC
Confidence 0000 0000 000112334567888888765 6645567899999999
Q ss_pred eEeccCCcccccC-CCcCCCCCCCCccccccc
Q 002255 398 QLMLSGNELTGTI-PKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 398 ~L~Ls~N~l~g~i-P~~l~~l~~L~~L~ls~N 428 (947)
.++|..+ ++ .| ..+|.++.+|+.+++..|
T Consensus 324 ~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 324 SIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp EECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred EEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence 9999754 77 55 567999999999998765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.1e-06 Score=98.50 Aligned_cols=36 Identities=14% Similarity=0.277 Sum_probs=23.8
Q ss_pred CCCCCCCCEEEccCCccccCCCccccCCCCCCeEecc
Q 002255 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292 (947)
Q Consensus 256 ~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls 292 (947)
|.++..|+.+.+.++..+ .....|.++++|+.+.+.
T Consensus 261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~ 296 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS 296 (394)
T ss_dssp TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC
T ss_pred eeecccccEEecccccce-ecCcccccccccccccCC
Confidence 566677777777655443 445566777777777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.68 E-value=4.9e-09 Score=115.10 Aligned_cols=185 Identities=14% Similarity=0.173 Sum_probs=114.7
Q ss_pred CCCCCEEEcccCcccC-c--------CCCCCCCCCCcEEecCCCcCC---------CCCcccccCCCCCcEEeccCCCCC
Q 002255 88 LSSLTVLEVMKNKLTG-Q--------IPSLSGLSSLQEVLFDDNNFT---------SVPSDFFKGLTSLQTISLDYNSFD 149 (947)
Q Consensus 88 l~~L~~L~L~~N~l~~-~--------~p~~~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~Ls~N~l~ 149 (947)
++.++.|.+......| . ..+...+++|+.|.+..+... +.....+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3467888888665543 1 123456788999988765432 123344566788888888777311
Q ss_pred CCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccC--CcccCcC-CccccCCCCceeeeccCCCCCCC
Q 002255 150 SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF--NFLQGPI-PLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 150 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~--N~l~~~~-p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
.++. +. +++|+.|+|..|.+.......++...+|+|++|+|+. |...+.. ...+.
T Consensus 186 --~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~------------------ 243 (362)
T 2ra8_A 186 --SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR------------------ 243 (362)
T ss_dssp --BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG------------------
T ss_pred --eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH------------------
Confidence 2333 32 6778888887777654443333322467777777753 2211110 00000
Q ss_pred CCchhhh--cCCCCCcEEEccCCcCcCCCC----CCCCCCCCCEEEccCCccccC----CCccccCCCCCCeEeccCCcc
Q 002255 227 NGSVAVI--QNMTSLTQLWLHGNSFTGPLP----DLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLF 296 (947)
Q Consensus 227 ~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~l~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l 296 (947)
..+ ..+++|+.|+|.+|.+++..+ ....+++|++|+|+.|.|++. ++..+.++++|+.|+|++|.+
T Consensus 244 ----~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 244 ----PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp ----GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred ----HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 001 247899999999999875332 123578999999999999864 445556779999999999988
Q ss_pred cc
Q 002255 297 QG 298 (947)
Q Consensus 297 ~g 298 (947)
+.
T Consensus 320 ~d 321 (362)
T 2ra8_A 320 SD 321 (362)
T ss_dssp CH
T ss_pred CH
Confidence 74
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1e-09 Score=114.12 Aligned_cols=146 Identities=15% Similarity=0.110 Sum_probs=64.7
Q ss_pred CCCCceeEeCCCC-cEEEEEecC---CcccccCcc-cccCCCCCCEEEcccCcccCcCC--CCCCCCCCcE--EecCCCc
Q 002255 53 PCKWKHIQCSPSN-RVTRIQIGG---QNIEGTLPK-ELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQE--VLFDDNN 123 (947)
Q Consensus 53 ~C~w~gv~C~~~~-~v~~l~L~~---~~l~g~~p~-~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~--L~L~~n~ 123 (947)
.|+|.|+.|+..+ +|+.+...+ ..+.+.+++ .+..++. .|...+|..++.++ .|...+.|+. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 4899999998754 676666654 344455542 2222222 22222333333222 1333333333 3444442
Q ss_pred CC---CCCcccccCCCCCcEEeccCCCCCCC-CCcccccCCCCCCeEeccCceeeeccCcccCCCCCC--CccEEEccCC
Q 002255 124 FT---SVPSDFFKGLTSLQTISLDYNSFDSW-VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIP--GLMHLHLAFN 197 (947)
Q Consensus 124 l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~--~L~~L~Ls~N 197 (947)
.. ++......++++|++|+|++|+|.+. .+|..+..+++|+.|+|++|+|++. ..+. .+. +|++|+|++|
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~--~l~~l~L~~L~L~~N 230 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELD--KIKGLKLEELWLDGN 230 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGG--GGTTSCCSEEECTTS
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhh--hcccCCcceEEccCC
Confidence 22 11111223344555555555555431 1223344455555555555555433 1111 122 5555555555
Q ss_pred cccCcCC
Q 002255 198 FLQGPIP 204 (947)
Q Consensus 198 ~l~~~~p 204 (947)
.+.+.+|
T Consensus 231 pl~~~~~ 237 (267)
T 3rw6_A 231 SLCDTFR 237 (267)
T ss_dssp TTGGGCS
T ss_pred cCccccC
Confidence 5554443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.55 E-value=5.1e-06 Score=92.98 Aligned_cols=292 Identities=11% Similarity=0.149 Sum_probs=166.2
Q ss_pred ccccCCC-CCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCc---CCCCCcccccCCCCCcEEeccCCCCCCCCCcccc
Q 002255 83 KELNSLS-SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN---FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESL 157 (947)
Q Consensus 83 ~~l~~l~-~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~ 157 (947)
.+|.+.. .|+.+.+-.+ ++..-. +|.++++|+.+.+..|. ++.+...+|..+.+|+.+.+..+ +.. .....|
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~-I~~~aF 133 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE-IDSEAF 133 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE-ECTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce-ehhhhh
Confidence 3466663 5888888654 554444 68888888888887764 67777788888888888877655 322 234567
Q ss_pred cCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCC
Q 002255 158 KDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237 (947)
Q Consensus 158 ~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~ 237 (947)
..+.+|+.+.+..+- .......|. .+..|+.+.+..+ ++..-...|..+.|+.+.+..+-. ......+.++.
T Consensus 134 ~~c~~L~~i~lp~~~-~~I~~~~F~--~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~----~i~~~af~~c~ 205 (394)
T 4gt6_A 134 HHCEELDTVTIPEGV-TSVADGMFS--YCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVT----RIGTNAFSECF 205 (394)
T ss_dssp TTCTTCCEEECCTTC-CEECTTTTT--TCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCC----EECTTTTTTCT
T ss_pred hhhccccccccccee-eeeccccee--cccccccccccce-eeEeccccccccceeEEEECCccc----ccccchhhhcc
Confidence 778888888886543 323333443 4677888887655 443444456556777777654311 11123355667
Q ss_pred CCcEEEccCCcCcCCCCC--------------CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCC
Q 002255 238 SLTQLWLHGNSFTGPLPD--------------LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (947)
Q Consensus 238 ~L~~L~L~~N~l~~~~~~--------------~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (947)
+|.......+........ +.....+..+.+. +.++..-...|.++.+|+.+.+.++..+ +...
T Consensus 206 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~--I~~~ 282 (394)
T 4gt6_A 206 ALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS--IGTG 282 (394)
T ss_dssp TCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE--ECTT
T ss_pred ccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce--ecCc
Confidence 777766665544322111 1122334444443 2333344566788888888888665432 1110
Q ss_pred -CCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCc
Q 002255 304 -NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (947)
Q Consensus 304 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (947)
+. ...++. .+..+..+. ....-.+..+.+|+.+.|..+ +
T Consensus 283 aF~-------~c~~L~---------------------~i~l~~~i~-----------~I~~~aF~~c~~L~~i~lp~~-v 322 (394)
T 4gt6_A 283 AFM-------NCPALQ---------------------DIEFSSRIT-----------ELPESVFAGCISLKSIDIPEG-I 322 (394)
T ss_dssp TTT-------TCTTCC---------------------EEECCTTCC-----------EECTTTTTTCTTCCEEECCTT-C
T ss_pred ccc-------cccccc---------------------cccCCCccc-----------ccCceeecCCCCcCEEEeCCc-c
Confidence 00 000000 000000000 000112334457788888654 5
Q ss_pred eeeccccccCCccCCeEeccCCcccccCC-CcCCCCCCCCccccccccc
Q 002255 383 SGTISSNFSRLTSLRQLMLSGNELTGTIP-KELTTLPSLEMLDVSNNHL 430 (947)
Q Consensus 383 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~ls~N~l 430 (947)
+..-..+|.+|.+|+.+.|..+ ++ .|+ .+|.++.+|+.+++.+|..
T Consensus 323 ~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 323 TQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred cEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 5444567888888888888654 66 554 5688888888888887654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.7e-06 Score=90.37 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=93.4
Q ss_pred CceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCC---CcceEEEEEE-eCCeeEEEEEec
Q 002255 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR---HLVGLLGYCL-DGNERLLVYEYM 670 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~ 670 (947)
.+.++.|....||+. |+.+++|+-. .......+.+|+++++.+.+. .+.+.+.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888888899997 5778888742 233456889999999999753 3556676664 445678999999
Q ss_pred CCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 002255 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL-------------------------------------- 712 (947)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------- 712 (947)
+|..+.+.... .++..++..++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 99888653211 123333444445555555555432
Q ss_pred -------------------cCCCeeecCCCCCcEEEcC---CCc-EEEeecCccee
Q 002255 713 -------------------AHQSFIHRDLKPSNILLGD---DMR-AKVADFGLVRL 745 (947)
Q Consensus 713 -------------------~~~~ivHrDlkp~Nill~~---~~~-~kl~DfGla~~ 745 (947)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1345799999999999997 455 48999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.5e-06 Score=88.11 Aligned_cols=135 Identities=16% Similarity=0.159 Sum_probs=97.6
Q ss_pred ceecccCce-EEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFG-TVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.+..|..| .||+.... ++..+++|+-... ...++.+|+..++.+. +--+.++++++.+++..++|||+++|
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 345556555 69988665 4667899976532 3457888999999884 33466889999999999999999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL---------------------------------------- 712 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------------------- 712 (947)
.++.+...... .....++.++++.|+.||+.
T Consensus 105 ~~~~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 105 KTAFQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp EEHHHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 88876543211 12234666777777777741
Q ss_pred ---------------cCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 713 ---------------AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 713 ---------------~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237899999999999988777899998765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.24 E-value=8.1e-05 Score=82.62 Aligned_cols=60 Identities=18% Similarity=0.220 Sum_probs=46.9
Q ss_pred CCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCC-CcCCCCCCCCccccccc
Q 002255 367 DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP-KELTTLPSLEMLDVSNN 428 (947)
Q Consensus 367 ~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~ls~N 428 (947)
..+.+|+.+.+.++.++..-...|.++.+|+.++|..+ ++ .|+ .+|.++.+|+.+.+..|
T Consensus 283 ~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 283 SGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEECCc
Confidence 34567889999888888666678999999999999755 66 554 57888999999887543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.17 E-value=1.2e-07 Score=93.66 Aligned_cols=121 Identities=13% Similarity=0.179 Sum_probs=81.8
Q ss_pred cccCcccccCCCCCCEEEcccC-cccCcC-----CCCCCCCCCcEEecCCCcCCC----CCcccccCCCCCcEEeccCCC
Q 002255 78 EGTLPKELNSLSSLTVLEVMKN-KLTGQI-----PSLSGLSSLQEVLFDDNNFTS----VPSDFFKGLTSLQTISLDYNS 147 (947)
Q Consensus 78 ~g~~p~~l~~l~~L~~L~L~~N-~l~~~~-----p~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~ 147 (947)
...+...+...+.|++|+|++| .++..- ..+...++|++|+|++|.|+. .....+...++|++|+|++|.
T Consensus 25 ~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~ 104 (185)
T 1io0_A 25 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 104 (185)
T ss_dssp HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence 3344556777888888999888 776421 146667888888888888873 223345556788888888888
Q ss_pred CCCC---CCcccccCCCCCCeEec--cCceeeecc----CcccCCCCCCCccEEEccCCccc
Q 002255 148 FDSW---VIPESLKDATGLQRFSA--NGANITGTI----PDFLGGDTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 148 l~~~---~~p~~~~~l~~L~~L~l--~~n~l~~~~----p~~~~~~~l~~L~~L~Ls~N~l~ 200 (947)
|... .+...+...+.|++|+| ++|.|...- ...+. ..++|++|+|++|.+.
T Consensus 105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~--~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLE--KNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHH--HCSSCCEEECCCSSHH
T ss_pred CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHH--hCCCcCEEeccCCCCC
Confidence 8541 13456677778888888 778776442 23332 3467888888888775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.14 E-value=1.4e-07 Score=97.89 Aligned_cols=79 Identities=25% Similarity=0.359 Sum_probs=53.0
Q ss_pred CCCCccEEEccCCcccC--cCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCC--CCCCCCCC
Q 002255 185 TIPGLMHLHLAFNFLQG--PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP--LPDLSGLS 260 (947)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~--~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~l~ 260 (947)
.+++|+.|+|++|+|++ .+|.. +..+++|+.|+|++|+|++. +..+..+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~--------------------------~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l- 220 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSI--------------------------VQKAPNLKILNLSGNELKSERELDKIKGL- 220 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTH--------------------------HHHSTTCCEEECTTSCCCSGGGGGGGTTS-
T ss_pred hCCCCCEEECCCCCCCCCccchhH--------------------------HhhCCCCCEEECCCCccCCchhhhhcccC-
Confidence 35677777777777775 22222 23477788888888887764 1223344
Q ss_pred CCCEEEccCCccccCCC-------ccccCCCCCCeEe
Q 002255 261 SLQDFSVRDNQLTGIVP-------SSLVNLHSLAVVN 290 (947)
Q Consensus 261 ~L~~L~l~~N~l~g~~p-------~~l~~l~~L~~L~ 290 (947)
+|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 221 ~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 221 KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 78888888888887666 2467788888886
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.13 E-value=2.6e-07 Score=91.40 Aligned_cols=119 Identities=17% Similarity=0.197 Sum_probs=71.3
Q ss_pred CCCCCCCcEEecCCC-cCCC----CCcccccCCCCCcEEeccCCCCCCC---CCcccccCCCCCCeEeccCceeeec---
Q 002255 108 LSGLSSLQEVLFDDN-NFTS----VPSDFFKGLTSLQTISLDYNSFDSW---VIPESLKDATGLQRFSANGANITGT--- 176 (947)
Q Consensus 108 ~~~l~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~--- 176 (947)
+...+.|++|+|++| .++. .....+...++|++|+|++|+|... .+...+...++|++|+|++|.|...
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 556778888888888 7763 2234456677888888888887431 1234455556777777777777643
Q ss_pred -cCcccCCCCCCCccEEEc--cCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCc
Q 002255 177 -IPDFLGGDTIPGLMHLHL--AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250 (947)
Q Consensus 177 -~p~~~~~~~l~~L~~L~L--s~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 250 (947)
+...+. ..++|++|+| ++|.+.......+ ...+...++|++|+|++|.+.
T Consensus 112 ~l~~~L~--~n~~L~~L~L~~~~N~i~~~g~~~l----------------------~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQ--SNTSLIELRIDNQSQPLGNNVEMEI----------------------ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGG--GCSSCCEEECCCCSSCCCHHHHHHH----------------------HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHH--hCCCceEEEecCCCCCCCHHHHHHH----------------------HHHHHhCCCcCEEeccCCCCC
Confidence 233333 3456777777 6666653222111 123344566777777777664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=6.5e-06 Score=90.73 Aligned_cols=83 Identities=10% Similarity=-0.007 Sum_probs=56.3
Q ss_pred Ccee-cccCceEEEEEEEc-------CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCC-C--CCcceEEEEEEeC--
Q 002255 595 ENVL-GRGGFGTVYKGELH-------DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVR-H--RHLVGLLGYCLDG-- 660 (947)
Q Consensus 595 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 660 (947)
.+.| +.|....+|+.... +++.+++|+-..... .......+.+|+.+++.+. + -.+.++++++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 267889997654310 0001135678888888884 3 3566788877655
Q ss_pred -CeeEEEEEecCCCchhh
Q 002255 661 -NERLLVYEYMPQGTLSR 677 (947)
Q Consensus 661 -~~~~lV~e~~~~gsL~~ 677 (947)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=8.1e-05 Score=81.29 Aligned_cols=142 Identities=20% Similarity=0.306 Sum_probs=81.1
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC--CCcceEEE------EEEeCCeeEEEE
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLG------YCLDGNERLLVY 667 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~ 667 (947)
+.|+.|..+.||+....+| .+++|+.... . .++..|+.+++.+.. -.+.+++. +...++..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566677899999987654 5899988642 2 233445555655531 12333332 123467789999
Q ss_pred EecCCCchh--------------hhhhccccc-----C----CCcccHHHHH----------------------------
Q 002255 668 EYMPQGTLS--------------RHLFNRKEE-----G----LKPLEWTRRL---------------------------- 696 (947)
Q Consensus 668 e~~~~gsL~--------------~~l~~~~~~-----~----~~~~~~~~~~---------------------------- 696 (947)
||++|..+. ..+|..... . .....|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 112211110 0 0112332211
Q ss_pred ---HHHHHHHHHHHHHhh----------ccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 697 ---TIALDVARGVEYLHG----------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 697 ---~i~~~i~~~L~~LH~----------~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
.+..++..++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 125789999999999999888899999999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.0014 Score=72.43 Aligned_cols=58 Identities=9% Similarity=0.126 Sum_probs=44.2
Q ss_pred CceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 370 GNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 370 ~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
.+|+.+.+..+ +...-...|.++++|+.++|.+|.++-.-...|.++.+|+.++|.++
T Consensus 263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 45677777543 44344567899999999999999998333567999999999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0001 Score=82.38 Aligned_cols=77 Identities=17% Similarity=0.169 Sum_probs=50.0
Q ss_pred CceecccCceEEEEEEEc-CCcEEEEEEeccccc--Ch---HHHHHHHHHHHHHHcCCC--CCcc-eEEEEEEeCCeeEE
Q 002255 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV--SE---KGFAEFKSEIAVLTKVRH--RHLV-GLLGYCLDGNERLL 665 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 665 (947)
.+.||.|.++.||++... +++.|+||....... .+ ....++..|+++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999654 468899998653211 00 122456779999988742 3444 55543 3455689
Q ss_pred EEEecCCC
Q 002255 666 VYEYMPQG 673 (947)
Q Consensus 666 V~e~~~~g 673 (947)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00027 Score=75.45 Aligned_cols=141 Identities=17% Similarity=0.167 Sum_probs=93.6
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC---CCCcceEEEEEEeCCeeEEEEEec
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDGNERLLVYEYM 670 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~ 670 (947)
..+.|+.|.+..+|+.... +..+++|+.... ....+..|++.|+.+. ...+.++++++...+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3467899999999998764 678899986532 2467889999999884 356788999888888899999999
Q ss_pred CCCchhh-----------hhhcccc---cCC--------------CcccHHHHH---HHHH----------------HHH
Q 002255 671 PQGTLSR-----------HLFNRKE---EGL--------------KPLEWTRRL---TIAL----------------DVA 703 (947)
Q Consensus 671 ~~gsL~~-----------~l~~~~~---~~~--------------~~~~~~~~~---~i~~----------------~i~ 703 (947)
++..+.. .+|.... .+. -.-+|.+.. ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9876421 2222211 000 012465432 1111 111
Q ss_pred HH-HHHHhh-ccCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 002255 704 RG-VEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (947)
Q Consensus 704 ~~-L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 741 (947)
+. ...|.. .....+||+|+.+.|++++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 223321 1247899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00012 Score=77.79 Aligned_cols=80 Identities=20% Similarity=0.230 Sum_probs=57.2
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCC---CcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR---HLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV 666 (947)
......+.+|.|..+.||+.+..+|+.|.||+-.... ......|.+|++.|+.+.-. -+.+++++. ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3455667899999999999999999999999865432 11224578899999988422 344555442 24799
Q ss_pred EEecCCCch
Q 002255 667 YEYMPQGTL 675 (947)
Q Consensus 667 ~e~~~~gsL 675 (947)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0011 Score=71.58 Aligned_cols=160 Identities=13% Similarity=0.137 Sum_probs=90.4
Q ss_pred ecHHHHHHHhcCCCcC-----ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC--cce
Q 002255 580 ISIQVLRNVTNNFSEE-----NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVG 652 (947)
Q Consensus 580 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 652 (947)
++.+++..+..+|... +.|+.|....+|+....+| .+++|+..... ..+++..|+.+++.+...+ +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3456666666667652 4566788889999987755 68899876521 1234566778777774222 223
Q ss_pred EEEE------EEeCCeeEEEEEecCCCchhh--------------hhhccc-c---cC---CCcccHHHHHH--------
Q 002255 653 LLGY------CLDGNERLLVYEYMPQGTLSR--------------HLFNRK-E---EG---LKPLEWTRRLT-------- 697 (947)
Q Consensus 653 l~~~------~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~-~---~~---~~~~~~~~~~~-------- 697 (947)
++.. ....+..++||+|++|..+.. .+|... . .. .....|...+.
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 123456789999998865321 112110 0 00 01123433111
Q ss_pred ----HHHHHHHHHHHHhhc----cCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 698 ----IALDVARGVEYLHGL----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 698 ----i~~~i~~~L~~LH~~----~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+...+.+.+++++.. ....++|+|+++.||+++.+..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 13579999999999999987666899998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00087 Score=75.32 Aligned_cols=79 Identities=18% Similarity=0.124 Sum_probs=47.5
Q ss_pred CCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccC---CcCcccccccHHHHHHH
Q 002255 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILME 790 (947)
Q Consensus 714 ~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~e 790 (947)
...++|+|+++.||+++.++ ++++||+.+..-.........- ..-...|++|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 57899999999999998876 9999999887543211100000 0001345666544311 11223455577777777
Q ss_pred HHhC
Q 002255 791 LITG 794 (947)
Q Consensus 791 lltg 794 (947)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0031 Score=68.11 Aligned_cols=144 Identities=11% Similarity=0.051 Sum_probs=82.4
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC--cceEEEE-----EEeCCeeEEEEE
Q 002255 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVGLLGY-----CLDGNERLLVYE 668 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e 668 (947)
..++ |....||+....+|+.+++|+......+ ...+..|..+++.+.... +++++.. ...++..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 8888999987777878999998643222 245667888888774222 3444432 223456689999
Q ss_pred ecCCCchhh-----------h---hhcccc----cCCCcccHHHH----HHH---------------HHHHHHHHHHHhh
Q 002255 669 YMPQGTLSR-----------H---LFNRKE----EGLKPLEWTRR----LTI---------------ALDVARGVEYLHG 711 (947)
Q Consensus 669 ~~~~gsL~~-----------~---l~~~~~----~~~~~~~~~~~----~~i---------------~~~i~~~L~~LH~ 711 (947)
|++|..+.. . +|.... ......++... ..+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754421 0 111100 00011222111 000 0111112233321
Q ss_pred c----cCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 712 L----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 712 ~----~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 245689999999999999 4 899999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0012 Score=71.65 Aligned_cols=144 Identities=15% Similarity=0.113 Sum_probs=73.9
Q ss_pred ceecccCceE-EEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC--CCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGT-VYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
+.|+.|+... +|+....+|+.+++|...... ..++..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4566665554 667765446778887654321 0234557777777742 23456676643333 789999977
Q ss_pred Cchhhhhhccc---------------------ccCCCcccHHHHH-------H-------------HHHHHHHHHHHHh-
Q 002255 673 GTLSRHLFNRK---------------------EEGLKPLEWTRRL-------T-------------IALDVARGVEYLH- 710 (947)
Q Consensus 673 gsL~~~l~~~~---------------------~~~~~~~~~~~~~-------~-------------i~~~i~~~L~~LH- 710 (947)
..+.+.+.... ......++..... . ....+...++.+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654332110 0001111111000 0 0001111222221
Q ss_pred --hccCCCeeecCCCCCcEEEcCC----CcEEEeecCcceec
Q 002255 711 --GLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLA 746 (947)
Q Consensus 711 --~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfGla~~~ 746 (947)
......++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124679999999999999875 68999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=69.82 Aligned_cols=72 Identities=13% Similarity=0.136 Sum_probs=45.9
Q ss_pred cCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc-ceEEEEEEeCCeeEEEEEec-C
Q 002255 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLLVYEYM-P 671 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~ 671 (947)
-.+.|+.|....+|+. +.+++|+..... . ......+|+.+++.+...++ .+++++ +.+.-++|+||+ +
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~--~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGT--E-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCc--c-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 3678999999999998 568888775431 1 11123568888887753333 355544 344457899999 6
Q ss_pred CCch
Q 002255 672 QGTL 675 (947)
Q Consensus 672 ~gsL 675 (947)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0013 Score=73.89 Aligned_cols=73 Identities=19% Similarity=0.250 Sum_probs=50.1
Q ss_pred CceecccCceEEEEEEEcC--------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc-ceEEEEEEeCCeeEE
Q 002255 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLL 665 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 665 (947)
.+.|+.|....+|++...+ ++.+++|+..... . .+.+.+|+.+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4578888889999998763 5789999874321 1 1345579999988854344 566765532 38
Q ss_pred EEEecCCCch
Q 002255 666 VYEYMPQGTL 675 (947)
Q Consensus 666 V~e~~~~gsL 675 (947)
||||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00013 Score=69.95 Aligned_cols=33 Identities=6% Similarity=0.228 Sum_probs=13.1
Q ss_pred CCCEEEcccCcccCc-CCCCCCCCCCcEEecCCC
Q 002255 90 SLTVLEVMKNKLTGQ-IPSLSGLSSLQEVLFDDN 122 (947)
Q Consensus 90 ~L~~L~L~~N~l~~~-~p~~~~l~~L~~L~L~~n 122 (947)
+|+.|||+++.++.. +..+.++++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 344444444443321 112334444444444444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0028 Score=69.51 Aligned_cols=143 Identities=15% Similarity=0.167 Sum_probs=82.9
Q ss_pred CceecccCceEEEEEEEc--------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCC-cceEEEEEEeCCeeEE
Q 002255 595 ENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH-LVGLLGYCLDGNERLL 665 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 665 (947)
.+.+..|-...+|+.... +++.|++|+.... ......+.+|.++++.+...+ ..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888899999864 2478999985321 123456678999999885333 3566666543 39
Q ss_pred EEEecCCCchhhh-----------------hhcccccCCCcc--cHHHHHHHHHHHHH-------------------HHH
Q 002255 666 VYEYMPQGTLSRH-----------------LFNRKEEGLKPL--EWTRRLTIALDVAR-------------------GVE 707 (947)
Q Consensus 666 V~e~~~~gsL~~~-----------------l~~~~~~~~~~~--~~~~~~~i~~~i~~-------------------~L~ 707 (947)
||||++|..+... +|.....-.+.. -|.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665321 111111001112 24444444443321 223
Q ss_pred HHh----h-ccCCCeeecCCCCCcEEEcCC----CcEEEeecCcce
Q 002255 708 YLH----G-LAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVR 744 (947)
Q Consensus 708 ~LH----~-~~~~~ivHrDlkp~Nill~~~----~~~kl~DfGla~ 744 (947)
.|. . .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 1 123568999999999999876 789999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0016 Score=59.58 Aligned_cols=37 Identities=27% Similarity=0.525 Sum_probs=28.3
Q ss_pred CCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCC
Q 002255 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD 149 (947)
Q Consensus 113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 149 (947)
+|++|+|++|+|+.+++..|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4677777777777777777778888888888888764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00032 Score=67.33 Aligned_cols=85 Identities=18% Similarity=0.094 Sum_probs=60.8
Q ss_pred CCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCC-CCCCCCcccccCC----CCCCeEeccCce-eeeccCcccCCC
Q 002255 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS-FDSWVIPESLKDA----TGLQRFSANGAN-ITGTIPDFLGGD 184 (947)
Q Consensus 111 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l----~~L~~L~l~~n~-l~~~~p~~~~~~ 184 (947)
--+|++|||+++.++..--..+..+++|++|+|+++. |+. .--..++.+ ++|++|+|++|. ++..--..+.
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD-~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~-- 136 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED-GCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALH-- 136 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH-HHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGG--
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH-HHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHh--
Confidence 3579999999999886555567889999999999986 533 112334443 368888888874 7655444555
Q ss_pred CCCCccEEEccCCc
Q 002255 185 TIPGLMHLHLAFNF 198 (947)
Q Consensus 185 ~l~~L~~L~Ls~N~ 198 (947)
.+++|++|+|+++.
T Consensus 137 ~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 137 HFRNLKYLFLSDLP 150 (176)
T ss_dssp GCTTCCEEEEESCT
T ss_pred cCCCCCEEECCCCC
Confidence 57888888888875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0027 Score=69.90 Aligned_cols=74 Identities=15% Similarity=0.147 Sum_probs=45.1
Q ss_pred CceecccCceEEEEEEEcC---------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc-ceEEEEEEeCCeeE
Q 002255 595 ENVLGRGGFGTVYKGELHD---------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERL 664 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~ 664 (947)
.+.++.|....+|+....+ ++.+++|+..... ....+...|.++++.+...++ .++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3567788888999998764 2688888765421 111224678888888853343 4666544 2 37
Q ss_pred EEEEecCCCch
Q 002255 665 LVYEYMPQGTL 675 (947)
Q Consensus 665 lV~e~~~~gsL 675 (947)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.01 Score=66.91 Aligned_cols=74 Identities=11% Similarity=0.093 Sum_probs=48.4
Q ss_pred CceecccCceEEEEEEEcC-CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc-ceEEEEEEeCCeeEEEEEecCC
Q 002255 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 672 (947)
.+.|+.|-...+|+....+ +..+++|+..... . ...+..+|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4578888889999998875 4788898864321 1 11112578999999975555 46676662 2 359999987
Q ss_pred Cch
Q 002255 673 GTL 675 (947)
Q Consensus 673 gsL 675 (947)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0091 Score=64.70 Aligned_cols=33 Identities=24% Similarity=0.438 Sum_probs=28.5
Q ss_pred CCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 714 ~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
...++|+|+.+.||++++++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998889999999876543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.00034 Score=68.45 Aligned_cols=118 Identities=16% Similarity=0.153 Sum_probs=73.7
Q ss_pred cccCCCCCCeEeccCc-eeeec----cCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCch
Q 002255 156 SLKDATGLQRFSANGA-NITGT----IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230 (947)
Q Consensus 156 ~~~~l~~L~~L~l~~n-~l~~~----~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~ 230 (947)
.+.+-+.|++|+|++| +|... +...+. .-+.|+.|+|++|++...--..+ .
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~--~N~~L~~L~L~~n~igd~ga~al----------------------A 91 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAAC--NSKHIEKFSLANTAISDSEARGL----------------------I 91 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHT--TCSCCCEEECTTSCCBHHHHTTH----------------------H
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHh--hCCCcCEEEccCCCCChHHHHHH----------------------H
Confidence 3445567777777764 55422 233333 23567777777777653322222 1
Q ss_pred hhhcCCCCCcEEEccCCcCcCCCC-----CCCCCCCCCEEEccCC---cccc----CCCccccCCCCCCeEeccCCccc
Q 002255 231 AVIQNMTSLTQLWLHGNSFTGPLP-----DLSGLSSLQDFSVRDN---QLTG----IVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 231 ~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~l~~N---~l~g----~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
..+..-++|+.|+|++|.|+...- .+..-+.|+.|+|++| .+.. .+...+..-++|+.|+|+.|.+.
T Consensus 92 ~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 92 ELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 334456789999999999875322 2556677999999865 3332 24556777788999999888754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.00062 Score=66.63 Aligned_cols=68 Identities=6% Similarity=0.172 Sum_probs=37.5
Q ss_pred CcccccCCCCCCEEEcccC-cccCc----C-CCCCCCCCCcEEecCCCcCCC----CCcccccCCCCCcEEeccCCCC
Q 002255 81 LPKELNSLSSLTVLEVMKN-KLTGQ----I-PSLSGLSSLQEVLFDDNNFTS----VPSDFFKGLTSLQTISLDYNSF 148 (947)
Q Consensus 81 ~p~~l~~l~~L~~L~L~~N-~l~~~----~-p~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l 148 (947)
+...+.+-+.|+.|+|++| .|... + ..+..-+.|+.|+|++|+|+. -+...+..-+.|++|+|+.|.|
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~I 110 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFL 110 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBC
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcC
Confidence 3344556677888888875 66431 1 134445566666666666662 2223333445566666666655
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0069 Score=55.23 Aligned_cols=56 Identities=20% Similarity=0.225 Sum_probs=46.0
Q ss_pred cEEEccCCcCc--CCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 240 TQLWLHGNSFT--GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 240 ~~L~L~~N~l~--~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
..++.+++.|+ ..+..+. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47888999998 5444433 56999999999999766777899999999999999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.86 E-value=0.037 Score=54.34 Aligned_cols=102 Identities=15% Similarity=0.106 Sum_probs=65.9
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcc
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 753 (947)
+|.+.|..+. .++++.++|.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 7888887654 56999999999999999987762111 11 1233457999999999998864 1110
Q ss_pred eeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCC
Q 002255 754 IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 797 (947)
Q Consensus 754 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p 797 (947)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888653 3456778899999999999874433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.55 E-value=0.14 Score=56.81 Aligned_cols=142 Identities=13% Similarity=0.187 Sum_probs=84.2
Q ss_pred CceecccCceEEEEEEEcC--------CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc-ceEEEEEEeCCeeEE
Q 002255 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLL 665 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 665 (947)
.+.+..|-...+|+....+ ++.+++|+.... . ....+..+|..+++.+...++ .++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--V-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--c-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 4567778888999998763 578999986432 1 111233578888888853333 4555533 2 278
Q ss_pred EEEecCCCchhhh-----------------hhcccc-----c---CCCcccHHHHHHHHHHH------------------
Q 002255 666 VYEYMPQGTLSRH-----------------LFNRKE-----E---GLKPLEWTRRLTIALDV------------------ 702 (947)
Q Consensus 666 V~e~~~~gsL~~~-----------------l~~~~~-----~---~~~~~~~~~~~~i~~~i------------------ 702 (947)
||||++|..|... +|.... . ...+.-|.++.++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 9999998764210 111111 0 11122344443333222
Q ss_pred -HHHHHHHhh---------------------ccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 703 -ARGVEYLHG---------------------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 703 -~~~L~~LH~---------------------~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
...+.+|.. .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 222333321 11346899999999999 888899999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.15 E-value=0.85 Score=50.27 Aligned_cols=30 Identities=30% Similarity=0.501 Sum_probs=24.8
Q ss_pred CeeecCCCCCcEEE------cCCCcEEEeecCccee
Q 002255 716 SFIHRDLKPSNILL------GDDMRAKVADFGLVRL 745 (947)
Q Consensus 716 ~ivHrDlkp~Nill------~~~~~~kl~DfGla~~ 745 (947)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999987653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.19 E-value=0.11 Score=58.69 Aligned_cols=62 Identities=10% Similarity=0.082 Sum_probs=17.9
Q ss_pred cCceecccCceEEEEEEEcC-CcEEEE------EEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEE
Q 002255 594 EENVLGRGGFGTVYKGELHD-GTKIAV------KRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~-g~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 658 (947)
..+.|| ||.||+|.+.. ..+||| |..+....+.+....+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 346666 99999998863 367888 776655445555667899999999999999999988765
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.14 E-value=0.045 Score=38.09 Aligned_cols=31 Identities=23% Similarity=0.547 Sum_probs=17.2
Q ss_pred cceEEEeehhHHHHHHHHHhheeEEEEeeccC
Q 002255 490 TGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRS 521 (947)
Q Consensus 490 ~~~i~~~v~gvv~~~~i~~l~~~~~~r~r~~~ 521 (947)
...++++++|++ .++++++.+++|.|+|+.+
T Consensus 11 ~~~Ia~~vVGvl-l~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 11 LTSIISAVVGIL-LVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHH-HHHHHHHHHHHHHHHHCSC
T ss_pred ccchHHHHHHHH-HHHHHHHHHHhheehhhhh
Confidence 345677777744 4455555555555554443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.02 E-value=3.4 Score=40.58 Aligned_cols=82 Identities=10% Similarity=0.042 Sum_probs=59.3
Q ss_pred CCCCcceEEEEEEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHH-HHhhccCCCeeecCCCC
Q 002255 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE-YLHGLAHQSFIHRDLKP 724 (947)
Q Consensus 646 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~ivHrDlkp 724 (947)
.||++ -..+-.+++...+.|+.-+++.=...+. ..+..++++++.+|+.... ++++ -+|--++|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 57877 4445567778777777653432222331 2667888999999888776 5553 57788999
Q ss_pred CcEEEcCCCcEEEeecCc
Q 002255 725 SNILLGDDMRAKVADFGL 742 (947)
Q Consensus 725 ~Nill~~~~~~kl~DfGl 742 (947)
+||+++.++.+++.-.|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp GGEEECTTCCEEESCCEE
T ss_pred ceEEEeCCCcEEEEEcCC
Confidence 999999999999987775
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.02 E-value=0.075 Score=36.02 Aligned_cols=24 Identities=25% Similarity=0.362 Sum_probs=15.3
Q ss_pred CcceEEEeehhHHHHHHHHHhhee
Q 002255 489 NTGKIVGSVVGVVCGAFIVGLGFC 512 (947)
Q Consensus 489 ~~~~i~~~v~gvv~~~~i~~l~~~ 512 (947)
+.+.+.++++|+++++.++....+
T Consensus 9 s~GaIAGiVvG~v~gv~li~~l~~ 32 (38)
T 2k1k_A 9 TGGEIVAVIFGLLLGAALLLGILV 32 (38)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCceeeeehHHHHHHHHHHHHHH
Confidence 456778888888777655444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 947 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-76 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-13 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-10 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-10 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-08 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (633), Expect = 6e-76
Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 26/288 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ +G G FGTVYKG+ H +AVK + + + FK+E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ +GY + +V ++ +L HL + E + + IA A+G++YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H +S IHRDLK +NI L +D+ K+ DFGL + +L+G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 770 AVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826
+ + DV++FG++L EL+TG+ + D + + + + R
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+ + L C ++ +RP ++ + LA
Sbjct: 238 CPK-------------AMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 5e-68
Identities = 82/285 (28%), Positives = 127/285 (44%), Gaps = 28/285 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ + +G G FG V+ G + K+A+K + +SE+ +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L G CL+ LV+E+M G LS +L ++ L + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYL 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
IHRDL N L+G++ KV+DFG+ R D+ S + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEV 173
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829
R ++K DV+SFGV++ E+ + K E +S V + I
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----------------EDIST 217
Query: 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
L + LAS + V + HC P RP ++ L+ +AE
Sbjct: 218 GFRLYKPRLAS-THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 1e-67
Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V+ G + TK+AVK ++ +S F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L ++ EYM G+L L L + L +A +A G+ ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFI 125
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+++IHRDL+ +NIL+ D + K+ADFGL RL DN + + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEA 181
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV-HLVTWFRRMHINKDTFRKAID 828
G T K DV+SFG++L E++T + + V + RM
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD-------- 233
Query: 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+ EE + L C P RP ++ +VL
Sbjct: 234 ---NCPEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 4e-65
Identities = 69/280 (24%), Positives = 115/280 (41%), Gaps = 28/280 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ + LG G FG V G+ +A+K ++ +SE EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L G C ++ EYM G L +L + + + L + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+ F+HRDL N L+ D KV+DFGL R D+ S + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEV 172
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829
+ + ++K D+++FGV++ E+ + K E + + I +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQ 216
Query: 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+ L LAS V + C + +RP +++ +
Sbjct: 217 GLRLYRPHLAS-EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (557), Expect = 6e-65
Identities = 79/310 (25%), Positives = 129/310 (41%), Gaps = 46/310 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
NN +G G FG V++ T +AVK ++ S A+F+ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------------------ 685
+ + ++V LLG C G L++EYM G L+ L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 686 -GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G PL +L IA VA G+ YL + F+HRDL N L+G++M K+ADFGL R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804
+ + A ++ PE R TT+ DV+++GV+L E+ + +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGH 864
+ V ++ +D A L+ + +L C ++ P RP
Sbjct: 249 EEV--------IYYVRDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCS 291
Query: 865 VVNVLSSLAE 874
+ +L + E
Sbjct: 292 IHRILQRMCE 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 7e-65
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 34/284 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G+G FG V G+ + G K+AVK +++ ++ F +E +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
LV LLG ++ L +V EYM +G+L +L +R G L L +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L +F+HRDL N+L+ +D AKV+DFGL + A S + + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPE 170
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
+ +TK DV+SFG++L E+ + + V + + ++
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKMDAP 222
Query: 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
V ++ +C + RP + L +
Sbjct: 223 DGCPPA---------VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-64
Identities = 86/296 (29%), Positives = 133/296 (44%), Gaps = 34/296 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ E LG+G FG V+ G + T++A+K ++ +S + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L +V EYM +G+L L K L + + +A +A G+ Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYV 129
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+++HRDL+ +NIL+G+++ KVADFGL RL DN + + APE
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEA 185
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV-HLVTWFRRMHINKDTFRKAID 828
A+ GR T K DV+SFG++L EL T + V V RM
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP-------- 237
Query: 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL----SSLAELWKPAE 880
+ E + DL C +EP +RP ++ L +S ++P E
Sbjct: 238 ---ECPES-------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 8e-64
Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 38/300 (12%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
++F + + LG G G V+K G +A K + + + E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++VG G E + E+M G+L + L + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLT 118
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YL +HRD+KPSNIL+ K+ DFG+ D+ +S GT Y++P
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSP 172
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV----------TWFRRMH 817
E + + D++S G+ L+E+ GR + +++ + T R
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 818 INKDTFRKAIDRTIDLDEETLASIST---------------VADLAGHCCAREPYQRPDM 862
+ +D + L D C + P +R D+
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 9e-64
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 594 EENVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E+ LG G FGTV KG +AVK +++ E +E V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V ++G C + +LV E G L+++L + ++ + + V+ G++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE 124
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPEY 769
+F+HRDL N+LL AK++DFGL + L D + +T + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 770 AVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
+ ++K DV+SFGV++ E + G+K + + ++ RM
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-------- 233
Query: 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
E + DL C + RP V L +
Sbjct: 234 ---GCPRE-------MYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-63
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 45/307 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
N VLG G FG V + ++AVK ++ SE+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMT 95
Query: 644 KV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK------------------E 684
++ H ++V LLG C L++EY G L +L +++ E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 685 EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
E L L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSE 804
+ + + ++APE G T K DV+S+G++L E+ +
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 805 DSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGH 864
D F K I +D+ A+ + + C A + +RP +
Sbjct: 273 D---------------ANFYKLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPN 316
Query: 865 VVNVLSS 871
+ + L
Sbjct: 317 LTSFLGC 323
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (544), Expect = 3e-63
Identities = 68/311 (21%), Positives = 129/311 (41%), Gaps = 43/311 (13%)
Query: 581 SIQVLRNVTNNFSEE---------NVLGRGGFGTVYKGELHDGTK----IAVKRMESAVV 627
+ + F++E V+G G FG V G L K +A+K ++S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY- 66
Query: 628 SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL 687
+EK +F SE +++ + H +++ L G +++ E+M G+L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---- 122
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
+ + + +A G++YL +++HRDL NIL+ ++ KV+DFGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 748 DNGKHSIETR---LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQS 803
D+ T + APE + T+ DV+S+G+++ E+++ G + + +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 804 EDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG 863
+D ++ + R+ D + L C ++ RP G
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSA------------------LHQLMLDCWQKDRNHRPKFG 281
Query: 864 HVVNVLSSLAE 874
+VN L +
Sbjct: 282 QIVNTLDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-62
Identities = 62/290 (21%), Positives = 125/290 (43%), Gaps = 33/290 (11%)
Query: 589 TNNFSEENV-LGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+N ++ LG G FG+V +G +A+K ++ + E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ 65
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ + ++V L+G C +LV E G L + L ++ + + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSM 120
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFG 763
G++YL ++F+HRDL N+LL + AK++DFGL + L D+ ++ +
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822
+ APE + +++ DV+S+GV + E ++ G+K + + + + + +RM
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-- 235
Query: 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872
+ E + L C + RPD V + +
Sbjct: 236 ---------ECPPE-------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-62
Identities = 55/282 (19%), Positives = 106/282 (37%), Gaps = 26/282 (9%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
++ +G G +G K DG + K ++ ++E SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 650 LVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V +D L V EY G L+ + +E + L+ L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 708 YLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
H + +HRDLKP+N+ L K+ DFGL R+ + + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYM 181
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825
+PE K D++S G +L EL ++ + + I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY----- 236
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
+E + ++ + Y RP + ++
Sbjct: 237 ------RYSDE-------LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-62
Identities = 62/279 (22%), Positives = 114/279 (40%), Gaps = 33/279 (11%)
Query: 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+ +GRG F TVYKG + ++A ++ +++ FK E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 654 LGYCLDGNER----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ +LV E M GTL +L K ++ + + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 710 HGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H IHRDLK NI + G K+ D GL L S + GT ++APE
Sbjct: 129 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 183
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
+ VDV++FG+ ++E+ T E Q+ ++ + + D
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------RRVTSGVKPASFD 235
Query: 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
+ + V ++ C + +R + ++N
Sbjct: 236 KVAIPE---------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 2e-62
Identities = 59/300 (19%), Positives = 110/300 (36%), Gaps = 30/300 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+ +G+G FG V++G+ G ++AVK S E+ ++EI +RH +++G +
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 63
Query: 655 GYCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
N + LV +Y G+L +L + + +AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH 117
Query: 711 -----GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFG 763
+ HRDLK NIL+ + +AD GL GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 764 YLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR-- 815
Y+APE + D+++ G++ E+ + +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 816 -MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+ K + + I ++ ++ +A + C R + LS L++
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-62
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 40/303 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
N S LG G FG V + + +AVK ++ + SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLS 81
Query: 644 KV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-------------EEGLKP 689
+ H ++V LLG C G L++ EY G L L ++ E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L+ L+ + VA+G+ +L ++ IHRDL NILL K+ DFGL R ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809
+ ++ ++APE T + DV+S+G+ L EL + + DS
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257
Query: 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+ K+ FR + + D+ C +P +RP +V ++
Sbjct: 258 ------YKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 870 SSL 872
Sbjct: 303 EKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 8e-62
Identities = 72/300 (24%), Positives = 130/300 (43%), Gaps = 36/300 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGT-----KIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ + + V+G G FG VYKG L + +A+K +++ +EK +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQ 65
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +++ L G +++ EYM G L + L + + + + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAA 121
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFG 763
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ D+ + + +
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823
+ APE + T+ DV+SFG+++ E++T + S V M D F
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--------MKAINDGF 230
Query: 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDS 883
R + L C +E +RP +V++L L PDS
Sbjct: 231 RLPTPMDCPSA---------IYQLMMQCWQQERARRPKFADIVSILDKLIRA-----PDS 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (532), Expect = 2e-61
Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 36/286 (12%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTK 644
+ FS+ +G G FG VY + + +A+K+M S S + + + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+RH + + G L + LV EY ++ KPL+ + +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQ 126
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH + IHRD+K NILL + K+ DFG + GT +
Sbjct: 127 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYW 177
Query: 765 LAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821
+APE + G+ KVDV+S G+ +EL + L + +++ HI ++
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------HIAQN 229
Query: 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
+ C + P RP ++
Sbjct: 230 ESPALQSGHWSEY---------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-61
Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 33/280 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
+F LG+G FG VY +A+K + A + + G + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ L GY D L+ EY P GT+ R L + R T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H + IHRD+KP N+LLG K+ADFG AP + + ++ GT YL P
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPP 173
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827
E KVD++S GV+ E + G+ + ++ ++R+ + TF +
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFTFPDFV 227
Query: 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
DL P QRP + V+
Sbjct: 228 T-------------EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 5e-61
Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + ++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+LV LLG C ++ E+M G L +L + + L +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEY 130
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L ++FIHRDL N L+G++ KVADFGL RL + + + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE 186
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVH-LVTWFRRMHINKDTFRKAI 827
+ + K DV++FGV+L E+ T + V+ L+ RM + K
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+L C P RP + ++ +
Sbjct: 247 ------------------ELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-60
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 35/302 (11%)
Query: 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFK 636
+++L+ F + VLG G FGTVYKG +A+K + A S K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEIL 59
Query: 637 SEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
E V+ V + H+ LLG CL +L + + MP G L ++ K + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK----DNIGSQYLL 114
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756
+ +A+G+ YL + +HRDL N+L+ K+ DFGL +L K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 757 RLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRR 815
++A E + T + DV+S+GV + EL+T G K D + + ++ R
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231
Query: 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875
+ + V + C + RP ++ S +A
Sbjct: 232 LPQPP-----------ICTID-------VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
Query: 876 WK 877
+
Sbjct: 274 PQ 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 7e-60
Identities = 85/309 (27%), Positives = 131/309 (42%), Gaps = 39/309 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKV- 645
N+ ++V+G G FG V K + A+KRM S+ +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 68
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----------FNRKEEGLKPLEWTR 694
H +++ LLG C L EY P G L L F L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
L A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL R K
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 755 ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFR 814
T ++A E TT DV+S+GV+L E+++ + +
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 237
Query: 815 RMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
++ +++ ++ D+E V DL C +PY+RP ++ L+ + E
Sbjct: 238 KLPQGYR-----LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 875 LWKPAEPDS 883
K +
Sbjct: 286 ERKTYVNTT 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 60/280 (21%), Positives = 99/280 (35%), Gaps = 27/280 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
++ LG G +G V +AVK ++ + K EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V G+ +GN + L EY G L + + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH HRD+KP N+LL + K++DFGL + N + + ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 769 YAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827
VDV+S G++L ++ G D+ + +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------SDWKEKKTYLNP 228
Query: 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
+ ID S L P R + +
Sbjct: 229 WKKID---------SAPLALLHKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-59
Identities = 60/282 (21%), Positives = 98/282 (34%), Gaps = 33/282 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
N + + LG G FG VYK + + A K +++ SE+ ++ EI +L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASC 66
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H ++V LL N ++ E+ G + + + +PL ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDA 122
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ YLH IHRDLK NIL D K+ADFG+ + GT ++
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWM 177
Query: 766 APEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820
APE + K DV+S G+ L+E+ E +
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-------LKIAKS 230
Query: 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
+ A + D C + R
Sbjct: 231 EPPTLAQPSRWSSN---------FKDFLKKCLEKNVDARWTT 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-59
Identities = 78/297 (26%), Positives = 124/297 (41%), Gaps = 34/297 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVL 642
++ +F+E V+GRG FG VY G L D AVK + + + ++F +E ++
Sbjct: 26 SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIM 82
Query: 643 TKVRHRHLVGLLGYCLDG-NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
H +++ LLG CL L+V YM G L + N + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQ 138
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE--TRLA 759
VA+G+++L + F+HRDL N +L + KVADFGL R D S+ T
Sbjct: 139 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819
++A E T + TTK DV+SFGV+L EL+T +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---------------T 240
Query: 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876
D + L E + ++ C + RP +V+ +S++ +
Sbjct: 241 FDITVYLLQGRRLLQPEYCP--DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-59
Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 32/298 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+ LG+G FG VY+G T++A+K + A S + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-----EEGLKPLEWTRRLTI 698
+ H+V LLG G L++ E M +G L +L + + L P ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
A ++A G+ YL+ F+HRDL N ++ +D K+ DFG+ R + + +
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 759 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818
+++PE G TT DV+SFGV+L E+ T + + S + V +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------LRFV 248
Query: 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876
+ D D+ + +L C P RP +++ + E
Sbjct: 249 MEGGLLDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 7e-58
Identities = 73/286 (25%), Positives = 113/286 (39%), Gaps = 30/286 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTK 644
+ LG G FG V +GE +AVK ++ V+S+ + F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ HR+L+ L G L ++ V E P G+L L + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAE 122
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFG 763
G+ YL + FIHRDL N+LL K+ DFGL+R P N H + + F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823
+ APE T + D + FGV L E+ T + + + I+K+
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKIDKEGE 232
Query: 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
R D + ++ C A +P RP + + L
Sbjct: 233 RLPRPEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-57
Identities = 68/321 (21%), Positives = 128/321 (39%), Gaps = 41/321 (12%)
Query: 568 SDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV 626
SD ++E ++S+ + ++ +G+G GTVY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ- 56
Query: 627 VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG 686
+ +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 -QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDS 806
+ + GT ++APE KVD++S G++ +E+I G +
Sbjct: 167 TPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 807 VHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVV 866
++L+ T + D C + +R ++
Sbjct: 225 LYLI-------ATNGTPELQNPEKLSAI---------FRDFLNRCLDMDVEKRGSAKELL 268
Query: 867 N--------VLSSLAELWKPA 879
LSSL L A
Sbjct: 269 QHQFLKIAKPLSSLTPLIAAA 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-56
Identities = 80/306 (26%), Positives = 130/306 (42%), Gaps = 41/306 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAV 641
+ LG G FG V E + TK+AVK ++S +EK ++ SE+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEM 71
Query: 642 LTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KP 689
+ + +H++++ LLG C ++ EY +G L +L R+ GL +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L ++ A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL 809
+ T ++APE T + DV+SFGV+L E+ T + + +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 246
Query: 810 VTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVL 869
+ K+ R +D+ + E + + C P QRP +V L
Sbjct: 247 ------FKLLKEGHR--MDKPSNCTNE-------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 870 SSLAEL 875
+ L
Sbjct: 292 DRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 66/289 (22%), Positives = 107/289 (37%), Gaps = 31/289 (10%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHR 648
+F +LG G F TV EL + A+K +E ++ E E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
V L D + Y G L +++ + T ++ +EY
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEY 123
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + IHRDLKP NILL +DM ++ DFG ++ K + GT Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828
D+++ G I+ +L+ G FR + F+K I
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGL---------------PPFRAGN-EYLIFQKIIK 224
Query: 829 RTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMGHVVNVLSSLAELW 876
D E+ A DL + +R + A +
Sbjct: 225 LEYDFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 4e-56
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+G G FG V++G +A+K ++ S+ +F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF 65
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H H+V L+G + ++ E G L L RK L+ + A ++
Sbjct: 66 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTA 120
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ YL + F+HRD+ N+L+ + K+ DFGL R D+ + ++ ++
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWM 176
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFR 824
APE R T+ DV+ FGV + E++ G K ++ D + + R+ +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---- 232
Query: 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877
+ + L C A +P +RP + LS++ E K
Sbjct: 233 -------NCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 193 bits (492), Expect = 2e-55
Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 32/280 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+V +++ LG G FG V++ E G A K + + S+K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
RH LV L D NE +++YE+M G L + + + + V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKG 136
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
+ ++H +++H DLKP NI+ K+ DFGL + T GT
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAE 190
Query: 764 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823
+ APE A V D++S GV+ L++G + +T
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----------------DDETL 234
Query: 824 RKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
R ++D+ + IS D +P R +
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 1e-53
Identities = 68/303 (22%), Positives = 116/303 (38%), Gaps = 37/303 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+ LGRG FG V + + +AVK ++ + A ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 644 KVRHRHLVGLLGYCL-DGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLE 691
H ++V LLG C G +++ E+ G LS +L +++ E + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
+ + VA+G+E+L + IHRDL NILL + K+ DFGL R +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 752 HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVT 811
+ + ++APE T + DV+SFGV+L E+ + + D
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------ 243
Query: 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871
+ F + + + + + C EP QRP +V L +
Sbjct: 244 ---------EEFCRRLKEGTRMRAPDYTT-PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 872 LAE 874
L +
Sbjct: 294 LLQ 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 185 bits (471), Expect = 1e-52
Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 32/281 (11%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+V + + LG G FG V++ E G K + + +K K+EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ H L+ L D E +L+ E++ G L + + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACE 138
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
G++++H S +H D+KP NI+ K+ DFGL + + T T
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATA 192
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822
+ APE V D+++ GV+ L++G + +T
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----------------DLET 236
Query: 823 FRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
+ + DE+ +S+S A D + +EP +R +
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 178 bits (453), Expect = 6e-51
Identities = 66/288 (22%), Positives = 100/288 (34%), Gaps = 43/288 (14%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-------SAVVSEKGFAEFKSEIAVL 642
N+ + +LGRG V + + AVK ++ SA ++ E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 643 TKVR-HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
KV H +++ L LV++ M +G L +L + L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ + LH + +HRDLKP NILL DDM K+ DFG K + GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGT 172
Query: 762 FGYLAPEYAVTGRV------TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815
YLAPE +VD++S GVI+ L+ G +
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------------- 219
Query: 816 MHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
R + S DL +P +R
Sbjct: 220 ---QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 177 bits (449), Expect = 2e-50
Identities = 61/282 (21%), Positives = 106/282 (37%), Gaps = 32/282 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTK 644
++++ + +LG GG V+ L +AVK + + + + F F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 645 VRHRHLVGLLGYCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
+ H +V + G +V EY+ TL + P+ R + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 118
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET-RLA 759
D + + + H IHRD+KP+NI++ KV DFG+ R D+G +T +
Sbjct: 119 DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819
GT YL+PE A V + DV+S G +L E++TG
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----------------P 219
Query: 820 KDTFRKAIDRTIDLDEETLASIST-VADLAGHCCAREPYQRP 860
+ + +S + + A+ P R
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (451), Expect = 2e-50
Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ + + +VLG G F V E +A+K + + K ++EIAVL K+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKI 64
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+H ++V L G L+ + + G L + + + V
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDA 119
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
V+YLH +HRDLKP N+L +D + ++DFGL ++ S+ + GT
Sbjct: 120 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTP 173
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822
GY+APE + VD +S GVI L+ G + +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----------------DAKL 217
Query: 823 FRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
F + + + D IS A D H ++P +R
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (451), Expect = 1e-49
Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 34/277 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKG----FAEFKSEIAVLTK 644
N+FS ++GRGGFG VY D G A+K ++ + K + +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+V + ++ + + M G L HL A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIIL 118
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+E++H ++ ++RDLKP+NILL + +++D GL H+ GT GY
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 171
Query: 765 LAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823
+APE G + D FS G +L +L+ G + +++D + R
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVEL 228
Query: 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRP 860
+ + L R+ +R
Sbjct: 229 PDSFS-------------PELRSLLEGLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 4e-49
Identities = 55/312 (17%), Positives = 104/312 (33%), Gaps = 40/312 (12%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V N + +G G FG +Y G + G ++A+K + + E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQ 60
Query: 647 HRHLVGLLGYCL-DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+ + +C +G+ ++V E + F + L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISR 115
Query: 706 VEYLHGLAHQSFIHRDLKPSNIL---LGDDMRAKVADFGLVRLAPDNGKHSIE-----TR 757
+EY+H ++FIHRD+KP N L + DFGL + D H
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV--TWFRR 815
L GT Y + + + + D+ S G +LM G ++ ++
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 816 MHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875
M + K A C + +PD ++ + L
Sbjct: 233 MSTPIEVLCKGYPSEF-------------ATYLNFCRSLRFDDKPDYSYLRQLFR---NL 276
Query: 876 WKPAEPDSDDIY 887
+ D ++
Sbjct: 277 FHRQGFSYDYVF 288
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-48
Identities = 60/291 (20%), Positives = 113/291 (38%), Gaps = 21/291 (7%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+V ++ + +G G +G V + + ++A+K++ S + EI +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
RH +++G+ + Y+ + L+ + L + RG
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PDNGKHSIETRLAGTFGY 764
++Y+H + +HRDLKPSN+LL K+ DFGL R+A PD+ T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 765 LAPEYAVTGRVTT-KVDVFSFGVILMELITGR------------KALDETQSEDSVHLVT 811
APE + + T +D++S G IL E+++ R + S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 812 WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
+ + + + S DL P++R ++
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-48
Identities = 54/281 (19%), Positives = 97/281 (34%), Gaps = 33/281 (11%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ + + LGRG FG V++ E K ++ + K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
RHR+++ L E ++++E++ + + L ++ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCE 113
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+++LH + H D++P NI+ K+ +FG R L
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAP 167
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822
Y APE V+T D++S G ++ L++G N+
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA----------------ETNQQI 211
Query: 823 FRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
++ DEE IS A D +E R
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (434), Expect = 3e-48
Identities = 47/300 (15%), Positives = 97/300 (32%), Gaps = 37/300 (12%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V ++ +G G FG +++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLA 58
Query: 647 HR-HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+ + + +G +LV + + + A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLAR 113
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFGLVRLAPDNGKHSIE----- 755
V+ +H +S ++RD+KP N L+G V DFG+V+ D
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 756 TRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRR 815
L+GT Y++ + + + D+ + G + M + G Q + + R
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS---LPWQGLKAATNKQKYER 227
Query: 816 MHINKDTFRKAIDRTIDLDEETLASIST-VADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874
+ K + E A + PD ++ + S + E
Sbjct: 228 IGEKKQSTP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (432), Expect = 4e-48
Identities = 56/283 (19%), Positives = 104/283 (36%), Gaps = 19/283 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ +G G +G VYK + + G A+K++ E + EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L +LV+E++ Q LE + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H + +HRDLKP N+L+ + K+ADFGL R + + +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVL 172
Query: 770 AVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV----------TWFRRMHIN 819
+ + +T +D++S G I E++ G D + + W +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 820 KDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
K + + + + DL +P QR
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-48
Identities = 63/291 (21%), Positives = 106/291 (36%), Gaps = 26/291 (8%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE--LHDGTKIAVKRMESAVVSEKGFAEFKSEIAV---LT 643
+ +G G +G V+K + G +A+KR+ E E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSR-HLFNRKEEGLKPLEWTRRLTIALDV 702
H ++V L C + + + + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
RG+++LH +HRDLKP NIL+ + K+ADFGL R+ T + T
Sbjct: 126 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTL 179
Query: 763 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV----------TW 812
Y APE + T VD++S G I E+ + + D + + W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 813 FRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
R + + + F + I E+ + I + DL C P +R
Sbjct: 240 PRDVALPRQAFHSKSAQPI---EKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (429), Expect = 2e-47
Identities = 67/274 (24%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
+F LG G FG V+ H+G A+K ++ +V E E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++ + G D + ++ +Y+ G L L + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALE 118
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH + I+RDLKP NILL + K+ DFG + PD L GT Y+AP
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAP 170
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827
E T +D +SFG+++ E++ G ++ T+ K +
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----------------TMKTYEKIL 214
Query: 828 DRTIDLDEETLASIST-VADLAGHCCAREPYQRP 860
+ + + V DL R+ QR
Sbjct: 215 NAELRFPPF----FNEDVKDLLSRLITRDLSQRL 244
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 9e-47
Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 32/276 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKV-R 646
+F +LG+G FG V+ E A+K ++ V+ + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H L + V EY+ G L H+ + + +R A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
++LH + ++RDLK NILL D K+ADFG+ + GT Y+A
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIA 171
Query: 767 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826
PE + + VD +SFGV+L E++ G+ +D L R +
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNPF------- 221
Query: 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
R ++ + DL REP +R +
Sbjct: 222 YPRWLEKE---------AKDLLVKLFVREPEKRLGV 248
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-47
Identities = 61/286 (21%), Positives = 109/286 (38%), Gaps = 37/286 (12%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEK----GFAEFKSEIAV 641
NV + + LG G F V K E G + A K ++ + + E+++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
L +++H +++ L + + +L+ E + G L L + + L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQ 121
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLAPDNGKHSIETR 757
+ GV YLH H DLKP NI+L D R K+ DFGL +
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817
+ GT ++APE + + D++S GVI L++G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA----------------SPFLGD 219
Query: 818 INKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
++T + ++E ++ S +A D ++P +R +
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 62/284 (21%), Positives = 105/284 (36%), Gaps = 21/284 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
NF + +G G +G VYK G +A+K++ +E + EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V LL N+ LV+E++ Q + + + + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFC 118
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE- 768
H +HRDLKP N+L+ + K+ADFGL R + T T Y APE
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEI 173
Query: 769 YAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV----------TWFRRMHI 818
+T VD++S G I E++T R D + + W +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
D + L +P +R
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-45
Identities = 58/295 (19%), Positives = 106/295 (35%), Gaps = 31/295 (10%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
R ++++ V+G G FG VY+ +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69
Query: 645 VRHRHLVGLLGYCLDGNER------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTI 698
+ H ++V L + E+ LV +Y+P+ + + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLY 127
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETR 757
+ R + Y+H HRD+KP N+LL D K+ DFG + + +
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSY 182
Query: 758 LAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV------- 810
+ + T+ +DV+S G +L EL+ G+ D + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 811 --TWFRRMHINKDTFRKAIDRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDM 862
R M+ N F+ + + A L P R
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 24/281 (8%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKG---FAEFKSEIAVLTKVRHRHLV 651
+ LG G F TVYK + +A+K+++ SE EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
GLL + LV+++M N L + L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH- 117
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAV 771
+HRDLKP+N+LL ++ K+ADFGL + + T T Y APE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLF 173
Query: 772 TGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVT---------WFRRMHINKD 821
R+ VD+++ G IL EL+ L D + + + M D
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
I L A+ + DL P R
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-45
Identities = 54/277 (19%), Positives = 98/277 (35%), Gaps = 36/277 (12%)
Query: 595 ENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652
VLG G G V + K A+K ++ + + E+ + + + H+V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVR 69
Query: 653 LLGYCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++ + L+V E + G L + ++ G + I + ++Y
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 709 LHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
LH + HRD+KP N+L + K+ DFG + + T T Y+
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYV 180
Query: 766 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825
APE + D++S GVI+ L+ G + R+ + + F
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQYEFPN 238
Query: 826 AIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
+ + V L + EP QR +
Sbjct: 239 PEWSEVSEE---------VKMLIRNLLKTEPTQRMTI 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-44
Identities = 62/287 (21%), Positives = 107/287 (37%), Gaps = 45/287 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE----FKSEIAVLTK 644
+ + +LG GGFG+VY G + D +A+K +E +S+ G E+ +L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 645 VRHRH--LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
V ++ LL + + +L+ E + L+ + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQV 119
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
V + H + +HRD+K NIL+ + K+ DFG L D ++ T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGT 172
Query: 762 FGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820
Y PE+ R + V+S G++L +++ G + + + +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ 220
Query: 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867
FR+ + S L C A P RP + N
Sbjct: 221 VFFRQRVS-------------SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-43
Identities = 60/298 (20%), Positives = 107/298 (35%), Gaps = 33/298 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + + +G+G FG V+K G K+A+K++ E EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 649 HLVGLLGYCLDGNER--------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
++V L+ C LV+++ + L +R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRL 758
+ L+ + +HRD+K +N+L+ D K+ADFGL R N + + T
Sbjct: 127 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 759 AGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVT------ 811
T Y PE + R +D++ G I+ E+ T + + + L++
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 812 -------WFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
K K R + + DL +P QR D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 57/286 (19%), Positives = 105/286 (36%), Gaps = 23/286 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + +G G +GTV+K + +A+KR+ E + EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V L + LV+E+ Q + + + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGF 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H ++ +HRDLKP N+L+ + K+A+FGL R + + T Y P+
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171
Query: 769 YAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSV-----------HLVTWFRRM 816
++ +T +D++S G I EL + L D W
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDM 862
+ T L +T DL + P QR
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-42
Identities = 81/333 (24%), Positives = 132/333 (39%), Gaps = 37/333 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
V + + +G G +G V + G K+A+K++ SE E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 646 RHRHLVGLLGYCLDGN------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
RH +++GLL + LV +M GT L + L R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGEDRIQFLV 127
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A + TR
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-- 182
Query: 760 GTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM-- 816
Y APE + R T VD++S G I+ E+ITG+ + D + +
Sbjct: 183 ---WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 817 -----HINKDTFRKAIDRTIDLDEETLASISTVA-----DLAGHCCAREPYQRPDMGHVV 866
+ D + + +L+++ ASI T A +L + QR G +
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 867 N--VLSSLAELWKPAEPDSDDIYGIDLDMTLPQ 897
SL + + D D+D TL +
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDE 332
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-42
Identities = 67/277 (24%), Positives = 103/277 (37%), Gaps = 33/277 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
N+F +LG+G FG V G A+K + ++++ A +E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L L + V EY G L HL + R ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH + ++RD+K N++L D K+ DFGL + +G GT YLAP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAP 174
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827
E VD + GV++ E++ GR F ++ F +
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR---------------LPFYNQD-HERLFELIL 218
Query: 828 DRTIDLDEETLASISTVA-DLAGHCCAREPYQRPDMG 863
I ++S A L ++P QR G
Sbjct: 219 MEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGG 251
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-40
Identities = 64/306 (20%), Positives = 106/306 (34%), Gaps = 44/306 (14%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
V + +G G G V + +A+K++ ++ E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 646 RHRHLVGLLGYCL------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
H++++ LL + + LV E M E R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLL 125
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ G+++LH IHRDLKPSNI++ D K+ DFGL R A + T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYV 179
Query: 760 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR----------------KALDETQS 803
T Y APE + VD++S G I+ E++ + + L
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 804 EDSVHLVTWFRRMHINKDTFRKAI------DRTIDLDEETLASISTVA-DLAGHCCAREP 856
E L R N+ + D D E ++ A DL +P
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 857 YQRPDM 862
+R +
Sbjct: 300 AKRISV 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (369), Expect = 5e-39
Identities = 56/208 (26%), Positives = 80/208 (38%), Gaps = 15/208 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+ F LG G FG V + G A+K ++ VV K +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
LV L D + +V EY+ G + HL A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH I+RDLKP N+L+ +V DFG + L GT LAP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAP 207
Query: 768 EYAVTGRVTTKVDVFSFGVILMELITGR 795
E ++ VD ++ GV++ E+ G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-36
Identities = 63/295 (21%), Positives = 116/295 (39%), Gaps = 33/295 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
V + + +G G +G+V G ++AVK++ S E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 646 RHRHLVGLLGYCLDGN-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
+H +++GLL + + ++ L+ + +K L +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIY 128
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ RG++Y+H IHRDLKPSN+ + +D K+ DFGL R D + TR
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 761 TFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLV--------- 810
Y APE + VD++S G I+ EL+TGR T D + L+
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240
Query: 811 -TWFRRMHINKDTFRKAIDRTIDLD-EETLASISTVA-DLAGHCCAREPYQRPDM 862
+ + + +++ + ++ + +A DL + +R
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (345), Expect = 5e-36
Identities = 48/301 (15%), Positives = 102/301 (33%), Gaps = 44/301 (14%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+++ LGRG + V++ + + K+ VK + + K EI +L +
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENL 86
Query: 646 R-HRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
R +++ L D R LV+E++ + + L ++
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFYMYEI 138
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ ++Y H +HRD+KP N+++ + + ++ D+GL ++ +
Sbjct: 139 LKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
Query: 762 FGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSV-----------HL 809
+ PE V + +D++S G +L +I ++ L
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 810 VTWFRRMHINKDTFRKAI-------DRTIDLDEETLASISTVA-DLAGHCCAREPYQRPD 861
+ + +I D I + E +S A D + R
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 862 M 862
Sbjct: 313 A 313
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 65/284 (22%), Positives = 108/284 (38%), Gaps = 33/284 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVLT 643
NF VLG G +G V+ G A+K + + V K ++E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 644 KVRHR-HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+R LV L + L+ +Y+ G L HL R+ ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+E+LH I+RD+K NILL + + DFGL + + + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTI 194
Query: 763 GYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820
Y+AP+ G VD +S GV++ EL+TG ++S + RR+ ++
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE 252
Query: 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGH 864
+ + + + DL ++P +R G
Sbjct: 253 PPYPQEMS-------------ALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (320), Expect = 2e-32
Identities = 44/214 (20%), Positives = 80/214 (37%), Gaps = 18/214 (8%)
Query: 595 ENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH------ 647
LG G F TV+ + + + T +A+K + V + + EI +L +V
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKE 74
Query: 648 -----RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
H++ LL + + + + L K+ + + I+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
G++Y+H IH D+KP N+L+ D + + L T T
Sbjct: 135 LLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 762 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 795
Y +PE + D++S ++ ELITG
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.9 bits (248), Expect = 1e-24
Identities = 26/161 (16%), Positives = 45/161 (27%), Gaps = 28/161 (17%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK--------GFAEFKSEIAVLTKVRH 647
++G G V+ + VK + S K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 648 RHLVGLLGYC----LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
R L L G ++ E + L R +E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------------VLDMIL 113
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
V + H+ +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.5 bits (228), Expect = 6e-21
Identities = 61/306 (19%), Positives = 108/306 (35%), Gaps = 16/306 (5%)
Query: 26 SSSDAAAMQALKTSLGNPASL-GW---TDPDPCKWKHIQCSPSN---RVTRIQIGGQNIE 78
+ D A+ +K LGNP +L W TD W + C RV + + G N+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 79 G--TLPKELNSLSSLTV--LEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
+P L +L L + + N + P+++ L+ L + N + DF
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+ +L T+ YN+ +P S+ L + +G I+G IPD G +
Sbjct: 124 IKTLVTLDFSYNALS-GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP 254
P + +
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 255 DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKG 314
+L +R+N++ G +P L L L +N++ N G+ P+ + RFD++
Sbjct: 243 S----KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 315 SNSFCL 320
+N+ CL
Sbjct: 299 ANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 4e-14
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 7/110 (6%)
Query: 327 CDGR-VNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGN---ITVVNLKNLGL 382
C+ + LL I K +G P L+ + CN W GV CD + ++L L L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 383 SG--TISSNFSRLTSLRQLMLSGNE-LTGTIPKELTTLPSLEMLDVSNNH 429
I S+ + L L L + G L G IP + L L L +++ +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 1e-12
Identities = 48/260 (18%), Positives = 88/260 (33%), Gaps = 16/260 (6%)
Query: 189 LMHLHLAFNFLQG--PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
+ +L L+ L PIP S + L++ G I +T L L++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA--IAKLTQLHYLYIT 109
Query: 246 GNSFTGPLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ---TP 301
+ +G +PD L N L+G +P S+ +L +L + N G +
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 302 KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW------KGNN 355
S + M N + + + + A +
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELT 415
+ + N+ ++L+N + GT+ ++L L L +S N L G IP +
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288
Query: 416 TLPSLEMLDVSNNHLFGKVP 435
L ++ +NN P
Sbjct: 289 NLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.5 bits (218), Expect = 3e-19
Identities = 63/379 (16%), Positives = 118/379 (31%), Gaps = 44/379 (11%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+ +G N+ T+ + L +T L+ + + I + L++L ++ F +N T
Sbjct: 24 KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD 80
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT L I ++ N +L + TGL F+ +I
Sbjct: 81 ITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN--------GQKGDSKLNGSVAVIQNMTS 238
+ + T S ++V+ +T+
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198
Query: 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N + P ++L + S+ NQL I +L +L +L ++L NN
Sbjct: 199 LESLIATNNQISDITPLGIL-TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 255
Query: 299 QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV--LAESWKGNNP 356
P + L + + L
Sbjct: 256 LAPLSG----------------------LTKLTELKLGANQISNISPLAGLTALTNLELN 293
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
N N+T + L +S S LT L++L + N+++ L
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 417 LPSLEMLDVSNNHLFGKVP 435
L ++ L +N + P
Sbjct: 350 LTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.0 bits (214), Expect = 1e-18
Identities = 42/247 (17%), Positives = 83/247 (33%), Gaps = 43/247 (17%)
Query: 48 WTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS 107
+ + + I P + + +L L + N+L I +
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGT 236
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167
L+ L++L ++ +N +++ GLT L + L N + L T L+
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294
Query: 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLN 227
+ D + L +L L FN + P+S
Sbjct: 295 NQ-------LEDISPISNLKNLTYLTLYFNNISDISPVS--------------------- 326
Query: 228 GSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287
++T L +L+ N + L+ L+++ S NQ++ + P L NL +
Sbjct: 327 -------SLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376
Query: 288 VVNLTNN 294
+ L +
Sbjct: 377 QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.2 bits (212), Expect = 2e-18
Identities = 68/426 (15%), Positives = 140/426 (32%), Gaps = 55/426 (12%)
Query: 15 LLSATLSVNSQSSS---DAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQ 71
L SAT++ ++ + D A + +KT LG TD + + ++VT +Q
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKT---NVTDT-------VSQTDLDQVTTLQ 50
Query: 72 IGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDF 131
I+ + L++LT + N+LT I L L+ L ++L ++N +
Sbjct: 51 ADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLA 107
Query: 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191
+ T+ + + + + + L + + + + +
Sbjct: 108 NLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD 167
Query: 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGS------VAVIQNMTSLTQLWLH 245
L N L L + + + +T+L +L L+
Sbjct: 168 LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLN 227
Query: 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305
GN L+ L++L D + +NQ++ + P L L L + L N +P
Sbjct: 228 GNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGL 284
Query: 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365
++ N + L V
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV------------------- 325
Query: 366 CDAGGNITVVNLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
++T L+ L + + S+ + LT++ L N+++ P L L +
Sbjct: 326 ----SSLT--KLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 377
Query: 423 LDVSNN 428
L +++
Sbjct: 378 LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 3e-09
Identities = 44/284 (15%), Positives = 90/284 (31%), Gaps = 36/284 (12%)
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
I D + M L + + + + TL + G ++G
Sbjct: 12 INQIFTD----TALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADR-LGIKSIDG---- 61
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSL------ 286
++ + +LTQ+ N T + L L+ L D + +NQ+ I P + + +
Sbjct: 62 VEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120
Query: 287 ---------------AVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRV 331
+ +N + + ++ + A + R+
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180
Query: 332 NVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFS 391
++ + V + A L N N+ ++L L +
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLA 238
Query: 392 RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
LT+L L L+ N+++ P L+ L L L + N + P
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 53/283 (18%), Positives = 90/283 (31%), Gaps = 46/283 (16%)
Query: 54 CKWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG 103
C + +QCS P + + + I + +L +L L ++ NK++
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 104 QIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF-------------- 148
P + + L L+ + N +P K L L+ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 149 --------DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200
S + + + L NIT TIP L P L LHL N +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL----PPSLTELHLDGNKIT 184
Query: 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLS 260
S + L G +S + N L +L L+ N L+
Sbjct: 185 KVDAASL--KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 261 SLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTNNLFQ 297
+Q + +N ++ I P S + V+L +N Q
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.7 bits (182), Expect = 5e-15
Identities = 45/301 (14%), Positives = 78/301 (25%), Gaps = 32/301 (10%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
L+ V D VP D + L N + + K+ L
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNK 66
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
I+ P + L L+L+ N L+ +P ++Q L ++ +
Sbjct: 67 ISKISPGAFAP--LVKLERLYLSKNQLKE-LPEKM-PKTLQELRVHENEITKVRKSVFNG 122
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ M + S G+ L + D +T I +L L +L
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLD 179
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
N + G + + L
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL---------------REL 224
Query: 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNF------SRLTSLRQLMLSGNEL 406
N I VV L N +S S++F ++ S + L N +
Sbjct: 225 HLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
Query: 407 T 407
Sbjct: 285 Q 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.7 bits (151), Expect = 4e-11
Identities = 34/207 (16%), Positives = 66/207 (31%), Gaps = 23/207 (11%)
Query: 237 TSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L L N T D L +L + +N+++ I P + L L + L+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
+ K ++ + + + ++ V+
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--------------------E 130
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR--LTSLRQLMLSGNELTGTIPKE 413
+ K + G + L + ++ T + + SL +L L GN++T
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAAS 190
Query: 414 LTTLPSLEMLDVSNNHLFGKVPNFRQN 440
L L +L L +S N + N
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLAN 217
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.8 bits (133), Expect = 8e-09
Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 10/85 (11%)
Query: 356 PCNSDWKGVSCDAGG----------NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNE 405
C + V C G + +++L+N ++ +F L +L L+L N+
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
++ P L LE L +S N L
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQL 91
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 67.0 bits (162), Expect = 6e-13
Identities = 34/216 (15%), Positives = 76/216 (35%), Gaps = 15/216 (6%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
+L++ + K+ +T + + + L + + T++ + L +L + L N
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDN 73
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT---------IPGLMHLHLAFN 197
++L T L+ N++ + L L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 198 FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLS 257
++ L + + + N++ LT L N + + L+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
L +L + +++NQ++ + P L N +L +V LTN
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 2e-11
Identities = 31/206 (15%), Positives = 75/206 (36%), Gaps = 6/206 (2%)
Query: 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLV 281
G S + +V ++ +T L G T + + L++L ++DNQ+T + P +
Sbjct: 27 GKSNVTDTVT-QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLKNL 84
Query: 282 NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341
+ ++ S D+ + AG++ + + L+ + ++
Sbjct: 85 TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI 144
Query: 342 GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML 401
A L + +T + + +S + L +L ++ L
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHL 202
Query: 402 SGNELTGTIPKELTTLPSLEMLDVSN 427
N+++ P L +L ++ ++N
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 9e-10
Identities = 29/201 (14%), Positives = 65/201 (32%), Gaps = 5/201 (2%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + ++ ++ T + + L + S +T I + L++L + L +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
P N ++ N A + L+ + + S
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414
+ + G + L + + + L+ L L N+++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 415 TTLPSLEMLDVSNNHLFGKVP 435
+LP+L + + NN + P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 18/59 (30%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
L +LS LT L+ NK++ I L+ L +L EV +N + V ++L ++L
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 2e-12
Identities = 46/323 (14%), Positives = 89/323 (27%), Gaps = 52/323 (16%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
+VP + Q I L N S V S + L +
Sbjct: 11 EPKVTTSCPQQGLQAVPVGIP---AASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSN 66
Query: 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV 230
+ G + + L L+ P +F + TL L+ G
Sbjct: 67 VLARIDAAAFTGLALLEQLDLS-DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG-- 123
Query: 231 AVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
+ + + +L L+L N+ D L +L + N+++ + + LHSL +
Sbjct: 124 -LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
L N P ++F + N
Sbjct: 183 LLHQNRVAHVHP--------------HAFRDLGRLMTLYLFAN----------------- 211
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
S + + + L + L++ S +E+ +
Sbjct: 212 -------NLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCS 263
Query: 410 IPKELTTLPSLEMLDVSNNHLFG 432
+P+ L ++ ++ N L G
Sbjct: 264 LPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 49/274 (17%), Positives = 83/274 (30%), Gaps = 37/274 (13%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP---- 106
C + +Q P RI + G I + +LT+L + N L
Sbjct: 18 CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 107 ----------------------SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+ GL L + D + F+GL +LQ + L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N+ + ++ +D L +G I+ G + L L L N + P
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG--LHSLDRLLLHQNRVAHVHP 194
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
+F S L + + +L L L+ N + + LQ
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALP--TEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
F +++ +P L + L N QG
Sbjct: 253 FRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 24/178 (13%), Positives = 53/178 (29%), Gaps = 13/178 (7%)
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFC 319
++ Q + N+++ + +S +L ++ L +N+ + + +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 320 LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKN 379
+ L L G + + L++
Sbjct: 92 QLRSVDPATFHGLGRLH---------TLHLDRCGLQELGPGLFRGLA----ALQYLYLQD 138
Query: 380 LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
L F L +L L L GN ++ + L SL+ L + N + P+
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (87), Expect = 0.003
Identities = 10/67 (14%), Positives = 21/67 (31%), Gaps = 7/67 (10%)
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELT 415
PC C +T + GL + + +++ L GN ++
Sbjct: 1 PCPG---ACVCYNEPKVTT-SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFR 53
Query: 416 TLPSLEM 422
+L +
Sbjct: 54 ACRNLTI 60
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 33/203 (16%), Positives = 56/203 (27%), Gaps = 10/203 (4%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ + S ++ + T PDL + +N L ++L+ L +NL
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 293 NNLFQGQTPKFNSPV-------RFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345
PV + A D N L S+
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNE 405
+ + ++L N L+ + + L +L L+L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 406 LTGTIPKELTTLPSLEMLDVSNN 428
L TIPK L + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 35/215 (16%), Positives = 63/215 (29%), Gaps = 12/215 (5%)
Query: 84 ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
E++ ++S + K LT +P + +N + T L ++L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
D + +L L + + + L L
Sbjct: 63 DRAELTKLQVDGTLPV---LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSL 262
G+ L N K ++ L +L L N+ T L+GL +L
Sbjct: 120 LRGLGELQELYLKGNELKTLPP-----GLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+++N L +P H L L N +
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 8e-05
Identities = 11/65 (16%), Positives = 17/65 (26%), Gaps = 3/65 (4%)
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+ VN L+ + + L LS N L L L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 425 VSNNH 429
+
Sbjct: 62 LDRAE 66
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 4e-10
Identities = 26/198 (13%), Positives = 64/198 (32%), Gaps = 15/198 (7%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ L S T + + L+S+ ++ + + + L ++ + L N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 295 LFQGQT-----PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
+ S D + + +S + + + L
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
+ GNN +++ + + + + LT L+ L LS N ++
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKLQNLYLSKNHISD- 192
Query: 410 IPKELTTLPSLEMLDVSN 427
+ L L +L++L++ +
Sbjct: 193 -LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 1e-08
Identities = 29/229 (12%), Positives = 77/229 (33%), Gaps = 27/229 (11%)
Query: 71 QIGGQNIEGTLPKELNSLSSLTVLE------VMKNKLTGQIPSLSGLSSLQEVLFDDNNF 124
+G + I T+P + + S + K +T + + + L+S+ +++ ++++
Sbjct: 2 PLGSETI--TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDI 58
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD 184
SV + L ++ + L+ N +LK+ L +++
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+ L + + + +
Sbjct: 117 LSLEHNGISDINGL--------------VHLPQLESLYLGNNKITDITVLSRLTKLDTLS 162
Query: 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
++ + L+GL+ LQ+ + N ++ + +L L +L V+ L +
Sbjct: 163 LEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 44/277 (15%), Positives = 92/277 (33%), Gaps = 19/277 (6%)
Query: 191 HLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L L L + + S ++ +A + + + L +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPR----SFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 251 --GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR 308
LS S LQ+ S+ +L+ + ++L +L +NL+ ++
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF-----SEFALQ 114
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368
++ S L+ + +V +++ L S N SD +
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174
Query: 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSN 427
+ + ++ L F +L L+ L LS ++ EL +P+L+ L V
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234
Query: 428 NHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPP 464
G + ++ + P + + S FT + P
Sbjct: 235 IVPDGTLQLLKEAL-------PHLQINCSHFTTIARP 264
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 30/189 (15%), Positives = 60/189 (31%), Gaps = 5/189 (2%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + L + T + + L + + I + L++L +N +NN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
TP N D+ +N + L + + +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414
+S+ G ++ L T + LT+L +L +S N+++ L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 415 TTLPSLEML 423
L +LE L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 7e-07
Identities = 37/200 (18%), Positives = 67/200 (33%), Gaps = 18/200 (9%)
Query: 88 LSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147
L+ + K +T S + L + + D S+ + L +L I+ N
Sbjct: 17 LAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQ 73
Query: 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207
N + + + I L +L ++
Sbjct: 74 LTDI-------------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 120
Query: 208 GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSV 267
LN + S ++ + +TSL QL N T L L+ L++L+ +
Sbjct: 121 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDI 179
Query: 268 RDNQLTGI-VPSSLVNLHSL 286
N+++ I V + L NL SL
Sbjct: 180 SSNKVSDISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 52.1 bits (123), Expect = 4e-08
Identities = 31/185 (16%), Positives = 56/185 (30%), Gaps = 12/185 (6%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
V +P D + L+ N L +
Sbjct: 9 EGTTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVA 231
+TG P+ G + + L N ++ F ++TL L + + GS
Sbjct: 66 LTGIEPNAFEGASHIQELQLG--ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS-- 121
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNL 291
+++ SLT L L N F L+ S+ PS + ++ +L
Sbjct: 122 -FEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DL 177
Query: 292 TNNLF 296
++ F
Sbjct: 178 PHSEF 182
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (122), Expect = 9e-08
Identities = 34/242 (14%), Positives = 66/242 (27%), Gaps = 15/242 (6%)
Query: 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLS 112
C + C ++VT I P +L + L + KL + SG
Sbjct: 8 CSNRVFLCQ-ESKVTEI-----------PSDL--PRNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
L+++ N+ V + + I ++
Sbjct: 54 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
+PD ++ ++ + SF S +++ L K + + A
Sbjct: 114 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
L + N P G S + ++ + L NL L +
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
Query: 293 NN 294
N
Sbjct: 234 NL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 7/39 (17%), Positives = 10/39 (25%)
Query: 390 FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
F + L +S + L L L N
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 12/84 (14%), Positives = 30/84 (35%), Gaps = 4/84 (4%)
Query: 48 WTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP 106
W + + + H ++ + + N LP + + S +L++ + ++
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 107 S-LSGLSSLQEVLFDDNNFTSVPS 129
L L L+ N +P+
Sbjct: 219 YGLENLKKLR--ARSTYNLKKLPT 240
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 7e-07
Identities = 22/113 (19%), Positives = 41/113 (36%), Gaps = 8/113 (7%)
Query: 48 WTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS 107
S + + + + SL L V NKL ++P+
Sbjct: 243 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 301
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW-VIPESLKD 159
L L+ ++ N+ VP +L+ + ++YN + IPES++D
Sbjct: 302 L--PPRLERLIASFNHLAEVPEL----PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 14/56 (25%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L+ L +S + + L +L+ S N L +P+ +L+ L V N L
Sbjct: 285 SLEELNVSNNKLIELPALPPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 12/77 (15%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
S++ L ++ N + + L +L N +P+L +L+ V
Sbjct: 284 PSLEELNVSN-------NKLIELPALPPRLERLIASFNHLAE-VPEL--PQNLKQLHVEY 333
Query: 270 NQLTGI--VPSSLVNLH 284
N L +P S+ +L
Sbjct: 334 NPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 23/87 (26%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE 413
+ D + S I S SL +L +S N+L +P
Sbjct: 244 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 302
Query: 414 LTTLPSLEMLDVSNNHLFGKVPNFRQN 440
P LE L S NHL +VP QN
Sbjct: 303 P---PRLERLIASFNHL-AEVPELPQN 325
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 7/72 (9%)
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSL 286
N ++ SL +L + N LP L L+ N L + P NL L
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLAEV-PELPQNLKQL 329
Query: 287 AVVNLTNNLFQG 298
++ N +
Sbjct: 330 ---HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 11/48 (22%), Positives = 19/48 (39%), Gaps = 2/48 (4%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
L+ L S ++ +L+QL + N L P ++ L M
Sbjct: 305 RLERLIASFNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 12/79 (15%)
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
P L L+++ N L +P ++ L + N V + +L QL +
Sbjct: 283 PPSLEELNVSNNKLIE-LPALPP--RLERLIASF-------NHLAEVPELPQNLKQLHVE 332
Query: 246 GNSFTGPLPDL-SGLSSLQ 263
N PD+ + L+
Sbjct: 333 YNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 8/62 (12%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ L NLGLS ++ L L+ S N LT +P+ SL+ L V NN+L
Sbjct: 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNL 90
Query: 431 FG 432
Sbjct: 91 KA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 7/69 (10%)
Query: 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148
LE+ L+ +P L L+ ++ N+ T +P SL+++ +D N+
Sbjct: 38 RQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNL 90
Query: 149 DSWVIPESL 157
+ L
Sbjct: 91 KALSDLPPL 99
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (112), Expect = 9e-07
Identities = 10/45 (22%), Positives = 21/45 (46%), Gaps = 1/45 (2%)
Query: 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
++ ++ R+L L G ++ I TL + +D S+N +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 4e-06
Identities = 18/142 (12%), Positives = 33/142 (23%), Gaps = 4/142 (2%)
Query: 101 LTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
L Q + +E+ + + L I N L
Sbjct: 7 LIEQAAQYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKLDGFPLL--- 62
Query: 161 TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQ 220
L+ N I + L G + S+ L +
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 221 KGDSKLNGSVAVIQNMTSLTQL 242
+K + + VI + + L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 12/66 (18%), Positives = 25/66 (37%), Gaps = 10/66 (15%)
Query: 375 VNLKNLGLSGT------ISSNFSRLTSLRQLMLSGNELTG----TIPKELTTLPSLEMLD 424
+++++L + + L + + L LT I L P+L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 425 VSNNHL 430
+ +N L
Sbjct: 62 LRSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 15/83 (18%), Positives = 26/83 (31%), Gaps = 10/83 (12%)
Query: 231 AVIQNMTSLTQLWLHGNSFTG----PLPD-LSGLSSLQDFSVRDNQLTGIVPSSLV---- 281
+ Q + L LWL + L L SL++ + +N L LV
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 282 -NLHSLAVVNLTNNLFQGQTPKF 303
L + L + + +
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 20/112 (17%), Positives = 36/112 (32%), Gaps = 17/112 (15%)
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT---------ISSNFSRLTSLRQLMLSGN 404
+N D G L+ L L+ +++ SLR+L LS N
Sbjct: 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 407
Query: 405 ELTGTIPKELTT-----LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDI 451
L +L LE L + + + ++ + Q + P +
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD---KPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 9/68 (13%)
Query: 371 NITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKEL-----TTLPSLE 421
VV L + GL+ ISS +L +L L NEL + T ++
Sbjct: 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
Query: 422 MLDVSNNH 429
L + N
Sbjct: 88 KLSLQNCC 95
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 5/115 (4%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
T+ L L +T L++ N+L P+L+ L L+ + DN +V LQ
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL--PRLQ 68
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG--DTIPGLMHL 192
+ L N + L L + G ++ + +P + +
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 22/162 (13%), Positives = 39/162 (24%), Gaps = 47/162 (29%)
Query: 266 SVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGV 325
+ LT + L L + ++L++N + P +
Sbjct: 4 HLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAA-------------------- 41
Query: 326 ACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385
L N+ + + L N L +
Sbjct: 42 ---------------------LRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQS 80
Query: 386 IS-SNFSRLTSLRQLMLSGNELT---GTIPKELTTLPSLEML 423
+ L L L GN L G + LPS+ +
Sbjct: 81 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 17/89 (19%), Positives = 29/89 (32%), Gaps = 23/89 (25%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSL----------------------QDFSVRDN 270
++ + +T L L N P L+ L L Q+ + +N
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNN 75
Query: 271 QLTGI-VPSSLVNLHSLAVVNLTNNLFQG 298
+L LV+ L ++NL N
Sbjct: 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 8e-04
Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 15/119 (12%)
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN 235
T+ L + + HL L+ N L+ P + + ++G + N
Sbjct: 11 TVLCHLEQ--LLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG----VAN 63
Query: 236 MTSLTQLWLHGNSFTG--PLPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSL 286
+ L +L L N + L L +++ N L + L ++ S+
Sbjct: 64 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 13/41 (31%), Positives = 19/41 (46%), Gaps = 2/41 (4%)
Query: 397 RQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
R L L+ +LT + L L + LD+S+N L P
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL 39
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 36/333 (10%), Positives = 80/333 (24%), Gaps = 17/333 (5%)
Query: 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW---VIPESLKDATGL 163
S+ G S L+ + SV + + S++ I L N+ + + E++ L
Sbjct: 4 SIEGKS-LKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 164 QRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223
+ + + + L +FG ++ + L K
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNL 283
+ + L+ N+L
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 284 HSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGY 343
+ T + Q ++ ++
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 344 PAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT----------ISSNFSRL 393
L E + ++ DA + + L+ L L + ++
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 394 TSLRQLMLSGNELT--GTIPKELTTLPSLEMLD 424
L L L+GN + + E+ + S
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 34/313 (10%), Positives = 81/313 (25%), Gaps = 21/313 (6%)
Query: 137 SLQTISLDYNSF---DSWVIPESLKDATGLQRFSANGANITG----TIPDFLGGDTIPGL 189
S++ SL ++ D + L + ++ +G I + + + + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIA--SKKDL 61
Query: 190 MHLHLAFNFL-QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL--WLHG 246
+ F + + + L K + A H
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
L + R Q + + +++ N L G ++
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
+ + + + + L ++ + ++ +
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 367 DAGGNITVVNLKNLGLSGTIS----SNFSRLTSLRQLMLSGNELTGTIPKELTT-----L 417
+N L G + + L+ L L NE+ + L T +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 418 PSLEMLDVSNNHL 430
P L L+++ N
Sbjct: 302 PDLLFLELNGNRF 314
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.7 bits (91), Expect = 6e-04
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 9/76 (11%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIP-------SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+ S+ E K +L G IP +LS L + + + NN + S G+
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS--LSGM 69
Query: 136 TSLQTISLDYNSFDSW 151
+L+ +SL N
Sbjct: 70 ENLRILSLGRNLIKKI 85
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 947 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.7 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.39 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.35 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.21 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.14 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.13 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.13 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.16 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.21 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.43 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=427.06 Aligned_cols=260 Identities=28% Similarity=0.503 Sum_probs=208.1
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||+||+|+++ ..||||+++....+....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999865 469999998776667778899999999999999999999998754 56899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||++|+|.+++.... ..+++.++..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999996533 348999999999999999999997 7999999999999999999999999999987655
Q ss_pred CCCcceeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
...........||+.|||||++.+ ..++.++|||||||++|||+||+.||.+....... ..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~----------------~~ 220 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI----------------IF 220 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----------------HH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH----------------HH
Confidence 433334455789999999999864 35899999999999999999999999865432211 11
Q ss_pred HhhccCC---CChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 826 AIDRTID---LDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 826 ~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+..... ........+..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 221 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 011112234568899999999999999999999999998875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=421.98 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=205.2
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 357999999999999999999875 689999999976532 233467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999998542 358999999999999999999997 899999999999999999999999999999775
Q ss_pred CCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
...........+||+.|||||++.+..+ +.++||||+||++|||++|+.||......... +...
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------~~~~ 219 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDW 219 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---------------HHHH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH---------------HHHH
Confidence 5443334456789999999999988776 57899999999999999999999765432211 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...... .........++.+|+.+||+.||++|||++|+++
T Consensus 220 ~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 220 KEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCC-CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 1111122356789999999999999999999854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=420.79 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=200.4
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|+..+.||+|+||.||+|++++++.||||+++..... .++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 468888999999999999999998999999999765333 36799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++|+|.+++.... ..++|..+..++.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 99999999986533 458899999999999999999997 89999999999999999999999999999876553
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhC-CCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...... .+...+ .
T Consensus 155 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i--------------~ 216 (263)
T d1sm2a_ 155 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDI--------------S 216 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHH--------------H
T ss_pred Cc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHH--------------H
Confidence 32 223345799999999999999999999999999999999995 4455433211 111111 1
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.... ...+.....++.+++.+||+.||++||+|+||++.|+++.+
T Consensus 217 ~~~~-~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 217 TGFR-LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCC-CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1111 01111223568899999999999999999999999998865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=417.85 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=206.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|+..+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 57999999999999999999864 699999999976532 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
||++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999988754 238899999999999999999997 8999999999999999999999999999997754
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .....
T Consensus 169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~~~~~ 230 (293)
T d1yhwa1 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----------------YLIAT 230 (293)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHH
T ss_pred ccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH----------------HHHHh
Confidence 332 234568999999999999999999999999999999999999999765432211 11111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...............+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111101111223456889999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-49 Score=422.14 Aligned_cols=259 Identities=26% Similarity=0.475 Sum_probs=201.2
Q ss_pred cCCCcCceecccCceEEEEEEEcC-C---cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD-G---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.++||+|+||+||+|.++. | ..||||.+.... .....++|.+|++++++++|||||+++|++.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 457778999999999999998752 3 358999886543 55566789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
|||||++|+|.+++.... ..++|.++..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 999999999999886532 358999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCcce---eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 746 APDNGKHSI---ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 746 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
......... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+. .
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~----------- 243 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---I----------- 243 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-----------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---H-----------
Confidence 654322211 223468999999999999999999999999999999998 8999976543221 1
Q ss_pred hHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 822 TFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+..... .+.+...+..+.+|+.+||+.||++||++.||++.|+++.+
T Consensus 244 ---~~i~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 244 ---NAIEQDYR-LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HHHHcCCC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111111 11122334568899999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=412.51 Aligned_cols=247 Identities=29% Similarity=0.503 Sum_probs=207.7
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||+|++...... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999885 6899999998754322 233567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||++|+|.+++... ..+++.++..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999998653 348999999999999999999997 899999999999999999999999999998665
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ .+..+.
T Consensus 158 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i~ 217 (263)
T d2j4za1 158 SSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------TYKRIS 217 (263)
T ss_dssp CCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHH
T ss_pred CCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 432 234679999999999999999999999999999999999999997654321 112222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
......+. ....++.+|+.+||+.||++|||++|+++
T Consensus 218 ~~~~~~p~---~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 218 RVEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 22222222 12356789999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=417.16 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=208.3
Q ss_pred hcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
.++|++.+.||+|+||.||+|.+++++.||||+++.... ..++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 367888999999999999999999889999999976432 34679999999999999999999998754 56799999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..... ..++|.++++++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999998765433 348999999999999999999997 8999999999999999999999999999998755
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. ........||+.|+|||++.++.++.++|||||||++|||+||..|+....... ... .. +.
T Consensus 162 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~-------------~~-i~ 224 (272)
T d1qpca_ 162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI-------------QN-LE 224 (272)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH-------------HH-HH
T ss_pred Cc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHH-------------HH-HH
Confidence 32 223345679999999999999999999999999999999999766554332211 111 11 11
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.... ...+.....++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 225 ~~~~-~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 225 RGYR-MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCC-CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1111 0111123356889999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=418.13 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=199.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--CCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 666 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||++.....++...+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999875 68999999998876677777889999999999999999999999865 4567999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc--CCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
||||++|+|.+++...... ...+++.+++.++.||+.||+|||+.+ ..+||||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998654322 245899999999999999999999732 2359999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
....... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+....+ + ..
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~-------------~~ 224 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L-------------AG 224 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H-------------HH
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---H-------------HH
Confidence 7654322 2345689999999999999999999999999999999999999997654321 1 11
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+...... ..+.....++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 KIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12222211 111123356889999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-49 Score=420.96 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=212.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||+||+|.++ +|+.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 357888999999999999999886 58899999987643 23467999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++..... ..+++..+..++.||++||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999865432 458999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ........||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+.+
T Consensus 167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----------------~~~~~i 229 (287)
T d1opja_ 167 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELL 229 (287)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHHHHH
T ss_pred CCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH----------------HHHHHH
Confidence 532 223344568999999999999999999999999999999999777664432211 112222
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
..... .+.+......+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 230 ~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 230 EKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hcCCC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22221 1111223456889999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=407.83 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=212.0
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|+..++||+|+||+||+|++++++.||||+++..... .++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 578999999999999999999998889999999865433 36799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++|+|.+++.... ..+++..+++++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999876543 347899999999999999999997 89999999999999999999999999999876553
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+..
T Consensus 154 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----------------~~i~~ 216 (258)
T d1k2pa_ 154 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQ 216 (258)
T ss_dssp SC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----------------HHHHT
T ss_pred Cc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH----------------HHHHh
Confidence 32 23344679999999999999999999999999999999998 89999766532211 11111
Q ss_pred ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002255 829 RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSS 871 (947)
Q Consensus 829 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 871 (947)
... ...+.....++.+|+.+||+.||++|||++||++.|.+
T Consensus 217 -~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 217 -GLR-LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -TCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CCC-CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111 11112233568899999999999999999999998865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=417.78 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=211.6
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... .+...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 689999999975432 2334577999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999988654 348899999999999999999997 899999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
...........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..+.
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~i~ 223 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------------IFQKII 223 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----------------HHHHHH
Confidence 5444334455689999999999999999999999999999999999999998654221 122233
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
...+.++. ....++.+|+.+||+.||++|||++|+++.-.-..++|.
T Consensus 224 ~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff 270 (288)
T d1uu3a_ 224 KLEYDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270 (288)
T ss_dssp TTCCCCCT---TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred cCCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCcc
Confidence 33333222 223567899999999999999999998765433345554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=416.77 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=207.0
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.+.|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 357899999999999999999875 6899999999765 3445678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||++|+|.+++.... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 89 Ey~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred ecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence 9999999999876532 348999999999999999999997 899999999999999999999999999997653
Q ss_pred CCCCcceeecccccccccCccccc-----cCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
... .......||+.|+|||++. ...|+.++|||||||++|||++|+.||.+....+.
T Consensus 162 ~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---------------- 223 (288)
T d2jfla1 162 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---------------- 223 (288)
T ss_dssp HHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----------------
T ss_pred CCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH----------------
Confidence 311 1223467999999999884 45689999999999999999999999987654322
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+................++.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122222221111112233456889999999999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=411.90 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=209.3
Q ss_pred cCCCcCce-ecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENV-LGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
++|.+.+. ||+|+||.||+|.++ ++..||||+++... .....++|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666664 999999999999764 35579999997553 55667889999999999999999999999865 56899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCccee
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 745 (947)
||||+++|+|.+++.... ..+++.++..++.||++||+|||+ ++||||||||+||+++.++.+||+|||+++.
T Consensus 86 vmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999875433 358999999999999999999997 8999999999999999999999999999998
Q ss_pred cCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 746 APDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 746 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
....... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+. ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~------------ 223 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA------------ 223 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH------------
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH------------
Confidence 7654322 22334578999999999999999999999999999999998 8999986543221 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+..... .+.+...+.++.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 224 --~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 224 --FIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --HHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHcCCC-CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 11112234568899999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=407.58 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=199.8
Q ss_pred CcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe----CCeeEEEE
Q 002255 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVY 667 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 667 (947)
+..++||+|+||+||+|..+ +++.||+|++..........+.+.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999875 68899999998776677777889999999999999999999999865 34679999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc-CCCcEEEeecCcceec
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLA 746 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~ 746 (947)
||+++|+|.+++... ..+++.++..++.||++||+|||+. ..+|+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999653 3488999999999999999999972 12399999999999996 5799999999999865
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+...... +.+.
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~----------------~~~~ 224 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYRR 224 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----------------HHHH
T ss_pred cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH----------------HHHH
Confidence 432 2234689999999998865 699999999999999999999999975442211 1111
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..............+++.+|+.+||+.||++|||+.|+++
T Consensus 225 i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111111111223356889999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=409.95 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=201.0
Q ss_pred ceecccCceEEEEEEEc---CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEecCC
Q 002255 596 NVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 672 (947)
++||+|+||.||+|.++ .++.||||+++....+....++|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999865 35689999997665555566889999999999999999999999865 567899999999
Q ss_pred CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCCCCc
Q 002255 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (947)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 752 (947)
|+|.+++... ..++|..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998653 348999999999999999999997 89999999999999999999999999999977554332
Q ss_pred c-eeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhcc
Q 002255 753 S-IETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRT 830 (947)
Q Consensus 753 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 830 (947)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ...+...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-----------------~~~i~~~ 226 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKG 226 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTT
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-----------------HHHHHcC
Confidence 2 2334579999999999999999999999999999999998 8999986543211 1111111
Q ss_pred CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 831 IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 831 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
.. .+.+...+.++.+|+.+||+.||++||++++|++.|+...
T Consensus 227 ~~-~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 227 ER-MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC-CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11 1111223456889999999999999999999999887653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=411.45 Aligned_cols=260 Identities=26% Similarity=0.452 Sum_probs=203.4
Q ss_pred cCCCcCceecccCceEEEEEEEcCC-----cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|+..++||+|+||.||+|.++.. ..||||+++... .+....+|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4678889999999999999987642 369999997543 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+.+|++.+++.... ..++|.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999998875533 458999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKH-SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
........ .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... .+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----------------~~ 222 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EV 222 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HH
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH----------------HH
Confidence 76543222 22334578999999999999999999999999999999999766654332211 11
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+.+..... .+.+...+..+.+|+.+||+.||++||+|.||++.|+.+.+
T Consensus 223 ~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 223 MKAINDGFR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHTTCC-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCC-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111222111 11122234568899999999999999999999999998865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=422.60 Aligned_cols=261 Identities=27% Similarity=0.460 Sum_probs=210.0
Q ss_pred hcCCCcCceecccCceEEEEEEEcC------CcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|++.++||+|+||+||+|++.. ...||||++.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3678899999999999999998753 2369999986543 334456789999999998 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccccc------------------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCC
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEE------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 723 (947)
..++|||||++|+|.+++..+... ....++|..++.++.||++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 999999999999999999764321 12358999999999999999999997 899999999
Q ss_pred CCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccC
Q 002255 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQ 802 (947)
Q Consensus 724 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~ 802 (947)
|+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655444444455678999999999999999999999999999999998 899997654
Q ss_pred ccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002255 803 SEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLS 870 (947)
Q Consensus 803 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 870 (947)
... .+.+++...... +.+.....++.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~~----------------~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA----------------NFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH----------------HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH----------------HHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 322 122223222221 111223456889999999999999999999999885
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=421.91 Aligned_cols=266 Identities=21% Similarity=0.341 Sum_probs=206.5
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.++||+|+||+||+|+.. +|+.||+|+++... .....+++.+|++++++++|||||+++++|.++++.++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 578999999999999999999875 68999999997653 3444578999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+ +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999653 248899999999999999999996 2489999999999999999999999999998653
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhH-HHHHHHhhc--------
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHL-VTWFRRMHI-------- 818 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l-~~~~~~~~~-------- 818 (947)
+. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.... .........
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 32 22346899999999999999999999999999999999999999976543221100 000000000
Q ss_pred -------------Ch----hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 -------------NK----DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 -------------~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. +........... .........++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000001110000 0000112346789999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-46 Score=411.26 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=210.5
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3568999999999999999999875 6999999999765 345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC--CCcEEEeecCcce
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 744 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~ 744 (947)
||||++|+|.+++.... ..+++.++..++.||+.||+|||+ ++||||||||+|||++. ++.+||+|||+|+
T Consensus 102 mE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp ECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 99999999999985432 348999999999999999999997 89999999999999964 6889999999999
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
...... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ .+.
T Consensus 175 ~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~ 235 (350)
T d1koaa2 175 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------------TLR 235 (350)
T ss_dssp ECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHH
T ss_pred eccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 875532 2334689999999999999999999999999999999999999997654321 122
Q ss_pred HHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.......... ......++.+|+.+||+.||++|||++|+++
T Consensus 236 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222222222221 1223456889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=406.47 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=202.8
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.+.||+|+||.||+|++++++.||||+++.... ..++|.+|+.++++++|||||++++++. ++..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 57899999999999999999999888999999976533 3467999999999999999999999985 4568999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+++|+|..++..... ..++|.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999988866433 348999999999999999999997 79999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhhc
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAIDR 829 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 829 (947)
.. .......||+.|+|||++..+.++.++|||||||++|||++|..|+....... ..... +..
T Consensus 167 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~--------------i~~ 229 (285)
T d1fmka3 167 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQ--------------VER 229 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH--------------HHT
T ss_pred Cc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH--------------HHh
Confidence 22 23344679999999999999999999999999999999999766665433211 11111 111
Q ss_pred cCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 830 TIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 830 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
... .+.......++.+++.+||+.||++||++++|++.|+....
T Consensus 230 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 230 GYR-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cCC-CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 111 11112233568899999999999999999999999887553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-47 Score=410.53 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=203.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-hHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
+.|+..+.||+|+||.||+|+.. +|+.||||++...... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999865 6889999999765433 344577999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||.+|+|..++..+ ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999997665432 348999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCcceeecccccccccCcccccc---CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
.. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+....+. +.
T Consensus 167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----------------~~ 224 (309)
T d1u5ra_ 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LY 224 (309)
T ss_dssp SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HH
T ss_pred CC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH----------------HH
Confidence 32 23579999999999864 4689999999999999999999999976543211 11
Q ss_pred HHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+...... ..........+.+|+.+||+.||++|||++|+++
T Consensus 225 ~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 225 HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHSCCC-CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhCCCC-CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 22222111 1111122356889999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=411.24 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=193.3
Q ss_pred HHhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEE
Q 002255 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 665 (947)
.+.+.|++.+.||+|+||+||+|+.+ +|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35678999999999999999999875 6899999999765432 234678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc---CCCcEEEeecCc
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 742 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfGl 742 (947)
|||||++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+||++. +++.+||+|||+
T Consensus 85 vmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccce
Confidence 99999999999999653 348999999999999999999997 8999999999999995 578999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
|+...... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ .
T Consensus 157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~ 217 (307)
T d1a06a_ 157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----------------L 217 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------H
T ss_pred eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 98664432 2234679999999999999999999999999999999999999997654321 1
Q ss_pred HHHHhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 823 FRKAIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 823 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+.......... ......++.+|+.+||+.||++|||++|+++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 12222222222211 1223456889999999999999999999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=412.75 Aligned_cols=269 Identities=29% Similarity=0.441 Sum_probs=216.9
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEE
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 656 (947)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++... .....++|.+|++++++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 345556788999999999999999999875 35789999987543 45567789999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCchhhhhhcccc-------------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCe
Q 002255 657 CLDGNERLLVYEYMPQGTLSRHLFNRKE-------------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717 (947)
Q Consensus 657 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 717 (947)
|.+++..++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+ ++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence 9999999999999999999999865321 112348899999999999999999997 899
Q ss_pred eecCCCCCcEEEcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCC-C
Q 002255 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR-K 796 (947)
Q Consensus 718 vHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~ 796 (947)
|||||||+|||++.++.+||+|||+|+...........+...||+.|+|||++.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998765544444445567999999999999999999999999999999999986 5
Q ss_pred CCCccCccchhhHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 002255 797 ALDETQSEDSVHLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLA 873 (947)
Q Consensus 797 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~ 873 (947)
||......+. ...+.+.... +.+...+.++.+|+.+||+.+|++||||.||++.|+++.
T Consensus 242 p~~~~~~~e~----------------~~~v~~~~~~--~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEV----------------IYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHH----------------HHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHH----------------HHHHHcCCCC--CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6765443221 1111111111 111223356889999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=401.95 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=209.3
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
+.++|++.+.||+|+||+||+|+.+ +|+.||||++....... ...+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999875 79999999997653322 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC----cEEEe
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~ 738 (947)
.|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+ .+||||||||+||+++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999998653 248999999999999999999997 8999999999999998776 59999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.
T Consensus 160 DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------------ 224 (293)
T d1jksa_ 160 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------------ 224 (293)
T ss_dssp CCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------
T ss_pred chhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------------
Confidence 9999987754322 2345799999999999998999999999999999999999999986543221
Q ss_pred ChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+..+........... ......+.+|+.+||+.||++|||++|+++
T Consensus 225 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 225 ----LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112222222222111 122356789999999999999999999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-46 Score=410.35 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=209.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999875 7999999999765 3444567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEc--CCCcEEEeecCccee
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 745 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~DfGla~~ 745 (947)
|||++|+|.+++.... ..+++.++..++.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 9999999998875432 358999999999999999999997 8999999999999998 678999999999998
Q ss_pred cCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHH
Q 002255 746 APDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRK 825 (947)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 825 (947)
..... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ .+..
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~~~~ 239 (352)
T d1koba_ 179 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------------TLQN 239 (352)
T ss_dssp CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHHH
T ss_pred cCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHH
Confidence 76532 2344579999999999999999999999999999999999999997654322 1122
Q ss_pred HhhccCCCChh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AIDRTIDLDEE-TLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
+.......... ......++.+|+.+||+.||++|||+.|+++
T Consensus 240 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 240 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222222211 1223456789999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=398.27 Aligned_cols=251 Identities=30% Similarity=0.495 Sum_probs=199.4
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 668 (947)
++|+..++||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 56788899999999999999986 789999999754 234679999999999999999999999865 456899999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+++|+|.+++..+.. ..++|..+++++.||+.||+|||+ .+||||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999976432 348999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
. .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......+ ...+ +
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~--------------i 213 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR--------------V 213 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH--------------H
T ss_pred C-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH--------------H
Confidence 2 223468899999999999999999999999999999998 677776544322 1111 1
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..... .+......+++.+|+.+||+.||++|||+.|+++.|+.++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 214 EKGYK-MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC-CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11111 11112233568899999999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=398.26 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=200.5
Q ss_pred hcCCCcCceecccCceEEEEEEEcC----CcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
.++|++.+.||+|+||.||+|++.. +..||||.++.. ..+...+.|.+|++++++++|||||++++++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4678999999999999999998752 456899988654 24555678999999999999999999999985 56789
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++.... ..+++..++.++.||++||+|||+ ++||||||||+||+++.++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999875533 358999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||......+..
T Consensus 157 ~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---------------- 219 (273)
T d1mp8a_ 157 YMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---------------- 219 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------
T ss_pred eccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH----------------
Confidence 765432 223345678999999999999999999999999999999998 89999766543221
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
..+..... .+.+...+..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 220 ~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 220 GRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111 011122345688999999999999999999999999988653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=407.32 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=203.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc----EEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.++||+|+||+||+|.+. +|+ +||+|+++... +....++|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46899999999999999999875 343 68999886542 344567899999999999999999999999865 567
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+.+|+|.+++.... ..+++..+++++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 8899999999999886543 458999999999999999999997 799999999999999999999999999999
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~----------------- 222 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------- 222 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----------------
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-----------------
Confidence 8765444434445679999999999999999999999999999999999 7888876543321
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
...+..... .+.+......+.+|+.+||+.||++|||+.||++.|..+.+
T Consensus 223 ~~~i~~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 223 SSILEKGER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCC-CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 01112233568899999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=402.04 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=208.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||||++++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999874 799999999976532 2334577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++++|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999986542 47888899999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+..+.
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----------------~~~~i~ 218 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELIL 218 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----------------HHHHHh
Confidence 4322 2345689999999999999999999999999999999999999998754321 122233
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
...+.++. ....++.+||.+||+.||++||+ +.|+++
T Consensus 219 ~~~~~~p~---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 MEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCCCCCc---cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 33333222 23356789999999999999995 677765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=402.22 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=203.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeC-
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG- 660 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 660 (947)
.++|++.++||+|+||.||+|++. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++.++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 478999999999999999999864 24689999987543 445567788888888887 689999999998764
Q ss_pred CeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 729 (947)
...++|||||++|+|.+++..+... ....+++.++..++.||++||+|||+ ++||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 4689999999999999999764321 12348899999999999999999997 899999999999999
Q ss_pred cCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCC-CCCCccCccchhh
Q 002255 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR-KALDETQSEDSVH 808 (947)
Q Consensus 730 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~ 808 (947)
++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||......+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998765544444445568999999999999999999999999999999999975 57765433211
Q ss_pred HHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 809 LVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 809 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
+...+...... ..+....+++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 246 --------------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 --------------FCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp --------------HHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------HHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11112111111 1111233568899999999999999999999999998865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.4e-46 Score=395.33 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=204.9
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----e
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----E 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 662 (947)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... +....+.+.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999874 799999999986543 3455678999999999999999999999997654 3
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.|+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.++++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 78999999999999888553 348999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCC-cceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChh
Q 002255 743 VRLAPDNGK-HSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKD 821 (947)
Q Consensus 743 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 821 (947)
++....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------------- 222 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------------- 222 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---------------
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH---------------
Confidence 876543322 2233456899999999999998999999999999999999999999976543211
Q ss_pred hHHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 002255 822 TFRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRP-DMGHVVNVLSSLA 873 (947)
Q Consensus 822 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~ 873 (947)
+...+....... .........+.+++.+||+.||++|| +++++++.|.++.
T Consensus 223 -~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 223 -AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111122111111 11112235688999999999999999 8999999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=400.17 Aligned_cols=264 Identities=29% Similarity=0.440 Sum_probs=211.3
Q ss_pred hcCCCcCceecccCceEEEEEEEcC--------CcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 659 (947)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3678889999999999999997532 3479999997653 455668899999999998 89999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhccccc-----------CCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
++..++||||+++|+|.+++..+... ....+++.++++++.||+.||+|||+ ++||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 99999999999999999999765421 12458999999999999999999997 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 807 (947)
++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |++||.+....+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-- 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--
Confidence 99999999999999987755444444455679999999999999999999999999999999998 688886544321
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
..+.+..... .+.+......+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 246 ---------------~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ---------------LFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---------------HHHHHHTTCC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHHHHcCCC-CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111111 11112234568899999999999999999999999998853
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=394.13 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=198.9
Q ss_pred cCCCcCceecccCceEEEEEEEcC--C--cEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHD--G--TKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.+.||+|+||.||+|+++. + ..||||+++.... .+...++|.+|++++++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 2 3789999876543 33456789999999999999999999999965 4678
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|++.+++..+. ..+++..+..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999998886543 348999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCcce-eecccccccccCccccccCCcCcccccccHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhcChhh
Q 002255 745 LAPDNGKHSI-ETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDETQSEDSVHLVTWFRRMHINKDT 822 (947)
Q Consensus 745 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 822 (947)
.......... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---------------- 223 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---------------- 223 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------------
Confidence 8765443322 334568889999999999999999999999999999998 8999976543221
Q ss_pred HHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002255 823 FRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSL 872 (947)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l 872 (947)
...+...... .+.....+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 224 ~~~i~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 LHKIDKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122222211 111122345688999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=400.58 Aligned_cols=265 Identities=26% Similarity=0.429 Sum_probs=216.6
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 661 (947)
.++|++.++||+|+||.||+|++. +++.||||+++... ......+|.+|+.+++++ +|||||+++++|.+++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 367888999999999999999863 46789999997653 455567899999999999 6999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcccc-------------cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEE
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKE-------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 728 (947)
..++|||||++|+|.++++.... .....+++..+..++.||++||+|||+ ++||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 99999999999999999976432 122358999999999999999999997 89999999999999
Q ss_pred EcCCCcEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhC-CCCCCccCccchh
Q 002255 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDETQSEDSV 807 (947)
Q Consensus 729 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~ 807 (947)
++.++.+|++|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+||......+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-- 255 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999987665555555667899999999999999999999999999999999995 55554433221
Q ss_pred hHHHHHHHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 808 HLVTWFRRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 808 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+.++++..... ..+......+.+|+.+||+.||++|||+.+|+++|++...
T Consensus 256 --------------~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 --------------KFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp --------------HHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------HHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 122233322221 1112234568899999999999999999999999987653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-45 Score=398.18 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=206.3
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999875 699999999975432 2234578899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
|||++|+|..++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999998886533 36788888999999999999996 899999999999999999999999999999875
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. ....+||+.|||||++.+..++.++||||+||++|||++|+.||.+....+ ....+.
T Consensus 156 ~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~ 214 (316)
T d1fota_ 156 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKIL 214 (316)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHH
T ss_pred cc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----------------HHHHHH
Confidence 43 234689999999999999999999999999999999999999997654321 122333
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
......+. ....++.+++.+||+.||.+|| +++|+++
T Consensus 215 ~~~~~~p~---~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 215 NAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HCCCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCCCCCC---CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 33333222 1234578999999999999996 8888865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-45 Score=387.35 Aligned_cols=252 Identities=26% Similarity=0.319 Sum_probs=207.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccC-------hHHHHHHHHHHHHHHcCC-CCCcceEEEEEEe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-------EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 659 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... +...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999874 7899999999765322 123356889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEee
Q 002255 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (947)
Q Consensus 660 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 739 (947)
++..|+|||||++|+|.+++..+ ..+++.++..++.||++||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999653 348999999999999999999997 8999999999999999999999999
Q ss_pred cCcceecCCCCCcceeecccccccccCcccccc------CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWF 813 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~ 813 (947)
||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+
T Consensus 154 FG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------- 222 (277)
T d1phka_ 154 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------- 222 (277)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------
T ss_pred chheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------
Confidence 99999875532 2344689999999998853 347889999999999999999999998654321
Q ss_pred HHhhcChhhHHHHhhccCCCC-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 814 RRMHINKDTFRKAIDRTIDLD-EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+........ +......+++.+|+.+||+.||++||++.||++
T Consensus 223 --------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 --------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122222222211 112234467889999999999999999999855
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=395.41 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=209.7
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEE
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 666 (947)
+.++|++.+.||+|+||+||+|..+ +|+.||||+++.. ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 6889999999765 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCC--CcEEEeecCcce
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVR 744 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfGla~ 744 (947)
||||++|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 99999999999986532 348999999999999999999997 899999999999999854 589999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFR 824 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 824 (947)
...... ......||+.|+|||...+..++.++||||+||++|||++|+.||......+ .+.
T Consensus 153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----------------~~~ 213 (321)
T d1tkia_ 153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------IIE 213 (321)
T ss_dssp ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHH
T ss_pred ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 775432 2334579999999999999999999999999999999999999997654321 223
Q ss_pred HHhhccCCCChhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 825 KAIDRTIDLDEETL-ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 825 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.+.......+.... ....++.+|+.+||+.||++|||+.|+++
T Consensus 214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333333333222 22356789999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=393.21 Aligned_cols=259 Identities=28% Similarity=0.420 Sum_probs=206.5
Q ss_pred CceecccCceEEEEEEEcCC----cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe-CCeeEEEEEe
Q 002255 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERLLVYEY 669 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~ 669 (947)
.++||+|+||+||+|++.++ ..||||+++.. .+....++|.+|++++++++|||||+++|++.+ +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 47899999999999987532 35899998753 356667899999999999999999999999876 5688999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
|++|+|.+++.... ...++..+++++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999886543 347888999999999999999997 89999999999999999999999999999876543
Q ss_pred CCc--ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 750 GKH--SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 750 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... .......||+.|+|||++.+..++.++||||||+++|||+||+.||....... +... .+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~-------------~i~ 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV-------------YLL 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH-------------HHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH-------------HHH
Confidence 222 12334578999999999999999999999999999999999888876533211 1111 111
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCC
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKP 878 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 878 (947)
..... ..+......+.+|+.+||+.||++||+|.||++.|+++.+.+..
T Consensus 249 ~g~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 249 QGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cCCCC--CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 11110 11112235688999999999999999999999999999876543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=397.13 Aligned_cols=261 Identities=33% Similarity=0.512 Sum_probs=206.1
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCc--EEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEeCCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 665 (947)
++|++.++||+|+||.||+|+++ +|. .||||+++... .....++|.+|+++++++ +|||||+++++|.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 67888999999999999999876 444 47788876432 344567899999999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhhccc-----------ccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCc
Q 002255 666 VYEYMPQGTLSRHLFNRK-----------EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 734 (947)
||||+++|+|.++++... ......++|..+.+++.||++||.|||+ ++||||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999996542 1223568999999999999999999997 89999999999999999999
Q ss_pred EEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCC-CCCccCccchhhHHHHH
Q 002255 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK-ALDETQSEDSVHLVTWF 813 (947)
Q Consensus 735 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~l~~~~ 813 (947)
+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.+....+
T Consensus 166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------- 234 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------- 234 (309)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------
T ss_pred eEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------
Confidence 99999999986543221 223468999999999999999999999999999999999765 665443211
Q ss_pred HHhhcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 814 RRMHINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
+.+.+..... .+.+.....++.+|+.+||+.||++||+|+||++.|+++.+.
T Consensus 235 ---------~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 235 ---------LYEKLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ---------HHHHGGGTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHHHhcCC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111111 111122345688999999999999999999999999998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=392.58 Aligned_cols=274 Identities=21% Similarity=0.307 Sum_probs=202.9
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----eeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 665 (947)
.+|...+.||+|+||.||+|+++ |+.||||+++.. ......+..|+..+.+++|||||++++++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 56778899999999999999875 899999998643 222222334555566789999999999998654 5799
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhcc-----CCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
|||||++|+|.+++.+. .++|..+++++.|+|.||+|+|+.. .++||||||||+||||+.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999652 3899999999999999999999632 369999999999999999999999999
Q ss_pred CcceecCCCCCcc--eeecccccccccCccccccC------CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002255 741 GLVRLAPDNGKHS--IETRLAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTW 812 (947)
Q Consensus 741 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~ 812 (947)
|+++......... ......||+.|+|||++... .++.++|||||||++|||+||..||........... ..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hc
Confidence 9998775533221 23356899999999998654 367799999999999999999988854432211000 00
Q ss_pred HHHhhcChhhHH-HHhhccCC--C--ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 002255 813 FRRMHINKDTFR-KAIDRTID--L--DEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAEL 875 (947)
Q Consensus 813 ~~~~~~~~~~~~-~~~~~~~~--~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~ 875 (947)
. .......... ...+.... . ..........+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 232 V-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp S-CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0 0000011111 12222221 1 111234456688999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=396.25 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=215.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc------CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCe
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 662 (947)
.++|+..+.||+|+||.||+|.++ +++.||||+++... .......|.+|++++++++|||||++++++..++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 367888999999999999999764 35789999997543 55566789999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccc-----cCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEE
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKE-----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 737 (947)
.++||||+++|+|.+++..... .....+++..+.+++.|+++||.|||+ ++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 9999999999999998865321 222447899999999999999999997 79999999999999999999999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCC-CCCCccCccchhhHHHHHHHh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR-KALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||.+....+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----------- 243 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----------- 243 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----------
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 9999998765544433445567999999999999999999999999999999999985 6665543221
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAE 874 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~ 874 (947)
.+..+.+.... +.+......+.+++.+||+.+|++|||+.+|++.|++..+
T Consensus 244 -----~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 -----VLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----HHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----HHHHHHhCCCC--CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 12222222211 1111233568899999999999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-45 Score=398.22 Aligned_cols=246 Identities=25% Similarity=0.345 Sum_probs=206.8
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 667 (947)
++|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+.+|++++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 799999999875432 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecC
Q 002255 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (947)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 747 (947)
||+.+|+|.+++.... .+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999999986542 48899999999999999999997 899999999999999999999999999999775
Q ss_pred CCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 748 DNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||.+..... .+..+.
T Consensus 193 ~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~ 251 (350)
T d1rdqe_ 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIV 251 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----------------HHHHHh
Confidence 42 224579999999999999999999999999999999999999997654221 122223
Q ss_pred hccCCCChhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002255 828 DRTIDLDEETLASISTVADLAGHCCAREPYQRP-----DMGHVVN 867 (947)
Q Consensus 828 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 867 (947)
........ ....++.+++.+||+.||.+|+ +++|+++
T Consensus 252 ~~~~~~p~---~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 252 SGKVRFPS---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HCCCCCCT---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCCCCCc---cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 33322222 2335688999999999999994 8888865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=394.17 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=200.0
Q ss_pred HhcCCCcCc-eecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcC-CCCCcceEEEEEEe----C
Q 002255 588 VTNNFSEEN-VLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD----G 660 (947)
Q Consensus 588 ~~~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~ 660 (947)
+.++|.+.. +||+|+||.||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||++++++.+ +
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 346888764 699999999999987 47899999998643 4567899987655 89999999999875 4
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEE
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl 737 (947)
...|+|||||+||+|.+++..+. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccc
Confidence 56899999999999999996532 2459999999999999999999997 89999999999999985 567999
Q ss_pred eecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 738 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.........
T Consensus 156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-------- 224 (335)
T d2ozaa1 156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------- 224 (335)
T ss_dssp CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------
T ss_pred cccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--------
Confidence 99999987755332 2346899999999999999999999999999999999999999976543221100
Q ss_pred cChhhHHHHhhccCCCChhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 INKDTFRKAIDRTIDLDEET-LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
....+......++... .....++.+|+.+||+.||++|||+.|+++
T Consensus 225 ----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 225 ----MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111122222211 233457889999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-44 Score=395.77 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=199.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh-HHHHHH---HHHHHHHHcCCCCCcceEEEEEEeCCeeE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEF---KSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 664 (947)
++|++.++||+|+||.||+|+.. +|+.||||++....... .....+ ..|+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 69999999986542211 112233 34577777888999999999999999999
Q ss_pred EEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 665 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999653 347889999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTF 823 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 823 (947)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+...+ .
T Consensus 156 ~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-------------~ 218 (364)
T d1omwa3 156 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------D 218 (364)
T ss_dssp ECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-------------H
T ss_pred ecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------H
Confidence 775532 234579999999999875 4689999999999999999999999987554332111 1
Q ss_pred HHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 824 RKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
+........... ....++.+||.+||+.||++||+ ++|+++
T Consensus 219 ~~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCCCCCCS---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCCCCCCC---CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111111111 22356789999999999999999 577765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=392.09 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=203.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEeccccc-ChHHHHHHHHHHHHHH-cCCCCCcceEEEEEEeCCeeEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLT-KVRHRHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 666 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 699999999975421 2233456677777665 68999999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceec
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 746 (947)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999996543 37888999999999999999997 79999999999999999999999999999866
Q ss_pred CCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHH
Q 002255 747 PDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKA 826 (947)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 826 (947)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +..+
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------------~~~i 215 (320)
T d1xjda_ 154 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----------------FHSI 215 (320)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHH
T ss_pred ccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH----------------HHHH
Confidence 44322 23446899999999999999999999999999999999999999986543221 1112
Q ss_pred hhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 002255 827 IDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMG-HVVN 867 (947)
Q Consensus 827 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 867 (947)
.......+. ....++.+|+.+||+.||++||++. |+++
T Consensus 216 ~~~~~~~p~---~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 RMDNPFYPR---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHCCCCCCT---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HcCCCCCCc---cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 222222221 2235688999999999999999995 6643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=384.31 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=199.8
Q ss_pred cCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||+||+|.. .+|+.||||+++.....+...+++.+|++++++++|||||++++++.++++.|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 479999999997654444456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
|+.++ +.+++.... ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~-~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEE-HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCc-hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99654 444443322 2458999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHh
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAI 827 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 827 (947)
... ......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+... ..........+.....+
T Consensus 155 ~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 155 PVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp CSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTG
T ss_pred Ccc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhcccc
Confidence 322 233457999999999877655 5789999999999999999999997654322211 11111111010000000
Q ss_pred hcc---------CCCCh---hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 828 DRT---------IDLDE---ETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 828 ~~~---------~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ..... .......++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 00000 00112246789999999999999999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=385.50 Aligned_cols=263 Identities=25% Similarity=0.287 Sum_probs=194.0
Q ss_pred cCceecccCceEEEEEEEc-CCcEEEEEEecccccChH---HHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 594 EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK---GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
..++||+|+||+||+|+.+ +|+.||||+++....... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999875 689999999975532221 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+.++++..+.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9888776655322 347788899999999999999997 89999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. .....+||+.|+|||++... .++.++|||||||++|||++|+.||.+....+....+........ ...+.....
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~-~~~~~~~~~ 230 (299)
T d1ua2a_ 154 NR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCS 230 (299)
T ss_dssp CC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TTTSSSTTS
T ss_pred cc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC-hhhccchhc
Confidence 22 22345799999999988654 579999999999999999999999976554332211111000000 000000000
Q ss_pred ----ccC-CCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 ----RTI-DLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 ----~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
... ...... ....+.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 000000 112356889999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=380.61 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=197.1
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccCh----HHHHHHHHHHHHHHcCC--CCCcceEEEEEEeCC
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDGN 661 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 661 (947)
.++|++.++||+|+||.||+|+.. +|+.||||++....... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999875 78999999997653322 11234678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-CCcEEEee
Q 002255 662 ERLLVYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVAD 739 (947)
Q Consensus 662 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~D 739 (947)
..++||||+.+ +++.+++... ..+++.++..++.||++||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 5777777543 348899999999999999999997 89999999999999985 47999999
Q ss_pred cCcceecCCCCCcceeecccccccccCccccccCCc-CcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 740 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
||+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 155 FG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------------- 214 (273)
T d1xwsa_ 155 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------- 214 (273)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------
T ss_pred cccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------------
Confidence 9999876442 2334689999999999987765 577999999999999999999996531
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
++......... ....++.+|+.+||+.||++|||++|+++
T Consensus 215 ------~i~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ------EIIRGQVFFRQ---RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------HHHHCCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHhhcccCCCC---CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111111111 12356789999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.1e-44 Score=381.75 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=202.6
Q ss_pred cCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEEe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 669 (947)
++|++.++||+|+||+||+|++++|+.||||+++.....+...+++.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999976644444567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCCC
Q 002255 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (947)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 749 (947)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9877766665332 458999999999999999999997 89999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcChhhHHHHhh
Q 002255 750 GKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINKDTFRKAID 828 (947)
Q Consensus 750 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 828 (947)
.. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+....+........ ...+.....
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 230 (286)
T d1ob3a_ 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN-SKNWPNVTE 230 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGG
T ss_pred cc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC-hhhccchhh
Confidence 22 22334689999999998654 568999999999999999999999976543322211111100000 000000000
Q ss_pred -----ccCC----C--ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 829 -----RTID----L--DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 829 -----~~~~----~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.... . ..........+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 0001122346789999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-42 Score=372.02 Aligned_cols=275 Identities=16% Similarity=0.234 Sum_probs=216.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC-CCcceEEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV 666 (947)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.++...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999875 68999999886542 12356789999999965 8999999999999999999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC-----CCcEEEeecC
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFG 741 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~kl~DfG 741 (947)
|||+ +++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9998 789988885533 348899999999999999999996 89999999999999974 5789999999
Q ss_pred cceecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002255 742 LVRLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRM 816 (947)
Q Consensus 742 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 816 (947)
+|+........ .......||+.|||||++.+..++.++|||||||++|||++|+.||.+............+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99976543221 1233467999999999999999999999999999999999999999876544433222221111
Q ss_pred hcChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCc
Q 002255 817 HINKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSDDI 886 (947)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~ 886 (947)
.. .....+.. ...++++.+++..|++.+|++||+++.+.+.|+++.+..........||
T Consensus 232 ~~-~~~~~~l~----------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 232 KQ-STPLRELC----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HH-HSCHHHHT----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred cC-CCChHHhc----------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 10 00011110 1123568899999999999999999999999999887666555444444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=383.08 Aligned_cols=268 Identities=23% Similarity=0.310 Sum_probs=199.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-C-CcEEEEEEecccccChHHHHHHHHHHHHHHcC---CCCCcceEEEEEEe----
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-D-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLD---- 659 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 659 (947)
.++|++.+.||+|+||+||+|+.. + ++.||||+++.....+.....+.+|+.+++.+ +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 4 66799999976544443344566788877766 79999999999863
Q ss_pred -CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEe
Q 002255 660 -GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (947)
Q Consensus 660 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 738 (947)
....+++|||+.++.+....... ...+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 34679999999888775444322 2448899999999999999999997 899999999999999999999999
Q ss_pred ecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 739 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
|||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+....+........
T Consensus 159 dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 159 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred chhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 99998765432 233456899999999999999999999999999999999999999987654332222111110000
Q ss_pred ChhhHH-------HHhhccCCC--ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 NKDTFR-------KAIDRTIDL--DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 ~~~~~~-------~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
...+. ......... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 -EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp -GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000000000 0011122345779999999999999999999866
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=374.78 Aligned_cols=281 Identities=20% Similarity=0.284 Sum_probs=203.9
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe--------C
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--------G 660 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 660 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++......+...+++.+|++++++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999874 79999999987665555556788999999999999999999999865 3
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
.+.++||||+.++.+....... ..++...+..++.|+++||.|||+ ++||||||||+|||++.++.+|++||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 4679999999877765544221 347888899999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCc--ceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002255 741 GLVRLAPDNGKH--SIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH 817 (947)
Q Consensus 741 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~ 817 (947)
|+++........ ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876543222 122335799999999998764 68999999999999999999999997655433222222111110
Q ss_pred cCh-------hhHHHHhhccCCCChhc------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhCCCCCCCC
Q 002255 818 INK-------DTFRKAIDRTIDLDEET------LASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWKPAEPDSD 884 (947)
Q Consensus 818 ~~~-------~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~ 884 (947)
... ......+.......... ......+.+|+.+||+.||++|||++|+++ ++|....+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~------Hpff~~~p~p~ 315 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFWSDPMPS 315 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGSSSSCCC
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc------ChhhccCCCCC
Confidence 000 00000011000000000 111235679999999999999999999976 67765544433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=373.07 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=201.4
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcce-EEEEEEeCCeeEEE
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG-LLGYCLDGNERLLV 666 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV 666 (947)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ..+++..|+++++.++|+|++. +.+++.+++..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 367999999999999999999874 68999999887542 1245788999999998776554 55556778889999
Q ss_pred EEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcC---CCcEEEeecCcc
Q 002255 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (947)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGla 743 (947)
|||+ ++++.+.+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++. +..+|++|||+|
T Consensus 82 me~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEc-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999 566666654322 458999999999999999999997 89999999999999864 567999999999
Q ss_pred eecCCCCCc-----ceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc
Q 002255 744 RLAPDNGKH-----SIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI 818 (947)
Q Consensus 744 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 818 (947)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 977543321 123446799999999999999999999999999999999999999987654433222111111000
Q ss_pred ChhhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhC
Q 002255 819 NKDTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVNVLSSLAELWK 877 (947)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 877 (947)
..... ......+.++.+++.+|++.+|++||+++++.+.|+.+.....
T Consensus 234 -~~~~~----------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 234 -STPIE----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp -HSCHH----------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -CCChh----------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 00000 0011223568899999999999999999999999998765433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.1e-41 Score=370.98 Aligned_cols=294 Identities=27% Similarity=0.491 Sum_probs=228.8
Q ss_pred CChHHHHHHHHHHHHcCCCCC-CCCC-CCCCCC--CceeEeCCC---CcEEEEEecCCcccc--cCcccccCCCCCCEEE
Q 002255 25 QSSSDAAAMQALKTSLGNPAS-LGWT-DPDPCK--WKHIQCSPS---NRVTRIQIGGQNIEG--TLPKELNSLSSLTVLE 95 (947)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~-~~w~-~~d~C~--w~gv~C~~~---~~v~~l~L~~~~l~g--~~p~~l~~l~~L~~L~ 95 (947)
|.+.|++||++||+++.++.. .+|. +.|||. |.||+|+.. +||++|+|+++++.| .+|++|++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 778999999999999998754 3685 679994 999999864 389999999999998 5899999999999999
Q ss_pred ccc-CcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCcee
Q 002255 96 VMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANI 173 (947)
Q Consensus 96 L~~-N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l 173 (947)
|++ |+++|.+| .|.+|++|++|+|++|++.++++..+..+.+|+++++++|.+.. .+|..+++++.|+.+++++|.+
T Consensus 83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~-~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccc-cCchhhccCcccceeecccccc
Confidence 997 89999888 78888888888888888888888878888888888888887754 5666666666666666666666
Q ss_pred eeccCcccCCCCCCCc-cEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCC
Q 002255 174 TGTIPDFLGGDTIPGL-MHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP 252 (947)
Q Consensus 174 ~~~~p~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 252 (947)
++.+|..+. .+..+ +.+++++|++++..|..+
T Consensus 162 ~~~ip~~~~--~l~~l~~~l~~~~n~l~~~~~~~~--------------------------------------------- 194 (313)
T d1ogqa_ 162 SGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTF--------------------------------------------- 194 (313)
T ss_dssp EEECCGGGG--CCCTTCCEEECCSSEEEEECCGGG---------------------------------------------
T ss_pred ccccccccc--cccccccccccccccccccccccc---------------------------------------------
Confidence 666665554 23332 445555555554444332
Q ss_pred CCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccc
Q 002255 253 LPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVN 332 (947)
Q Consensus 253 ~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (947)
..+ .+..+++++|.+.|.+|..+..+++|+.+++++|.+++.+|..
T Consensus 195 ----~~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~----------------------------- 240 (313)
T d1ogqa_ 195 ----ANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV----------------------------- 240 (313)
T ss_dssp ----GGC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC-----------------------------
T ss_pred ----ccc-ccccccccccccccccccccccccccccccccccccccccccc-----------------------------
Confidence 222 3346777777777777887888888888888888887765531
Q ss_pred eeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCC
Q 002255 333 VLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPK 412 (947)
Q Consensus 333 ~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~ 412 (947)
....+|+.|+|++|+++|.+|.+|++|++|++|||++|+|+|.||
T Consensus 241 ----------------------------------~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP- 285 (313)
T d1ogqa_ 241 ----------------------------------GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285 (313)
T ss_dssp ----------------------------------CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-
T ss_pred ----------------------------------ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-
Confidence 112367888888888889999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccc-cccc-CC
Q 002255 413 ELTTLPSLEMLDVSNNH-LFGK-VP 435 (947)
Q Consensus 413 ~l~~l~~L~~L~ls~N~-l~g~-iP 435 (947)
+++.+.+|+.+++++|+ ++|. +|
T Consensus 286 ~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 286 QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CcccCCCCCHHHhCCCccccCCCCC
Confidence 56889999999999997 6765 44
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=375.26 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=199.3
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC-----
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 661 (947)
+.++|++.++||+|+||+||+|..+ +|+.||||+++.....+...+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999875 6999999999876666677788999999999999999999999997654
Q ss_pred -eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 662 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
+.++||||+ +.+|..+... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 569999999 6677776643 348999999999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN 819 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 819 (947)
|+|+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+........ ....
T Consensus 166 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~--~~~~ 238 (346)
T d1cm8a_ 166 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV--TGTP 238 (346)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH--HCCC
T ss_pred cceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc--cCCC
Confidence 999876442 2345799999999998764 5689999999999999999999999876543322211111 1100
Q ss_pred hh---------hHHHHhhccCCCC-----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 820 KD---------TFRKAIDRTIDLD-----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 820 ~~---------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. ............. .........+.+|+.+||..||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000111000000 001122345779999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=371.55 Aligned_cols=270 Identities=22% Similarity=0.328 Sum_probs=199.6
Q ss_pred HhcCCCcCceecccCceEEEEEEE-cCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCC----e
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----E 662 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 662 (947)
+.++|++.++||+|+||+||+|.. .+|+.||||++.... .....+++.+|+++|++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 346899999999999999999976 479999999997543 4455678999999999999999999999997643 2
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.+++++|+.+|+|.+++..+ .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 35555667799999998542 48999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCc-ceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhc--
Q 002255 743 VRLAPDNGKH-SIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHI-- 818 (947)
Q Consensus 743 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~-- 818 (947)
++........ ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.............
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 9876443221 12344679999999999854 4678999999999999999999999976654332221111110000
Q ss_pred -----ChhhHHHHhhccCCCChhcH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 819 -----NKDTFRKAIDRTIDLDEETL-----ASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 819 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.................... ....++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111111101011111 11245789999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=362.12 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=206.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeCCeeEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 668 (947)
++|++.+.||+|+||+||+|+.. +|+.||||+++.....+....++.+|+.++++++|||||++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999875 78999999997765556667899999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCcceecCC
Q 002255 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (947)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 748 (947)
++.++++..++... ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+|++|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999988777543 347888999999999999999997 8999999999999999999999999999987755
Q ss_pred CCCcceeecccccccccCccccccCC-cCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC--hhhHHH
Q 002255 749 NGKHSIETRLAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN--KDTFRK 825 (947)
Q Consensus 749 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~ 825 (947)
... ......+++.|+|||++.... ++.++||||+||++|||++|+.||.......+ ....+...... ......
T Consensus 154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 154 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTT
T ss_pred CCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhh
Confidence 332 223446788999999887655 68999999999999999999999754432211 11111111110 000000
Q ss_pred Hh---h--------ccCCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 826 AI---D--------RTIDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 826 ~~---~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.. + .............+.+.+|+.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 000000111122346789999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=371.40 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=193.5
Q ss_pred CCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC------Cee
Q 002255 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------NER 663 (947)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 663 (947)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++|||||++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5778899999999999999875 699999999976531 234799999999999999999998643 347
Q ss_pred EEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCc
Q 002255 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGL 742 (947)
Q Consensus 664 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGl 742 (947)
++||||++++.+. .+..... ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~~-~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVYR-VARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHHH-HHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCccHH-HHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999766443 3332211 22458999999999999999999996 8999999999999999775 899999999
Q ss_pred ceecCCCCCcceeecccccccccCcccccc-CCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcC-h
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHIN-K 820 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~ 820 (947)
++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+... ..+...... .
T Consensus 170 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~--~i~~~~g~~~~ 244 (350)
T d1q5ka_ 170 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV--EIIKVLGTPTR 244 (350)
T ss_dssp CEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH--HHHHHHCCCCH
T ss_pred hhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH--HHHHHhCCChH
Confidence 987754322 234579999999998765 568999999999999999999999997655433221 111111111 1
Q ss_pred hhHHHHhhc----cCC---CC----hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 821 DTFRKAIDR----TID---LD----EETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~~----~~~---~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
..+...... .+. .. .......+++.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111110 000 00 001122346789999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=369.10 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=197.0
Q ss_pred HhcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEe------C
Q 002255 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------G 660 (947)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~ 660 (947)
+.++|++.++||+|+||+||+|.+. +|+.||||++.....+....+++.+|+.++++++|||||++++++.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3468999999999999999999876 69999999998776667777889999999999999999999999964 3
Q ss_pred CeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeec
Q 002255 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (947)
Q Consensus 661 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 740 (947)
.+.|+||||+.++.+ +.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++||
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ceeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeech
Confidence 688999999966544 4442 237889999999999999999997 89999999999999999999999999
Q ss_pred CcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh---
Q 002255 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH--- 817 (947)
Q Consensus 741 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~--- 817 (947)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+ .....
T Consensus 164 ~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i--~~~~~~~~ 238 (355)
T d2b1pa1 164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPC 238 (355)
T ss_dssp CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCC
T ss_pred hhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH--HHhccCCC
Confidence 9988664432 234567999999999999999999999999999999999999999765432221111 11000
Q ss_pred -----cChhhHHHHhhccCCC-----------------ChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 -----INKDTFRKAIDRTIDL-----------------DEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 -----~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
................ ..........+.+|+.+||+.||++|||++||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0011122222221110 1122334567889999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=366.31 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=201.4
Q ss_pred cCCCcCceecccCceEEEEEEEc----CCcEEEEEEeccccc--ChHHHHHHHHHHHHHHcCCC-CCcceEEEEEEeCCe
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNE 662 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 662 (947)
++|++.+.||+|+||+||+|... +|+.||||+++.... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 488999999875432 22234568899999999976 899999999999999
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||||+.+|+|.+++.... .+.......++.||+.||+|||+ .+||||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999986543 35677888999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccC--CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhcCh
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMHINK 820 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 820 (947)
++.+..... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+
T Consensus 176 a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---------- 244 (322)
T d1vzoa_ 176 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------- 244 (322)
T ss_dssp EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH----------
T ss_pred hhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------
Confidence 987654322 223446799999999998654 4688999999999999999999999876544322111
Q ss_pred hhHHHHhhccCCCChhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002255 821 DTFRKAIDRTIDLDEETLASISTVADLAGHCCAREPYQRPD-----MGHVVN 867 (947)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 867 (947)
............ .....++.+|+.+||+.||++||+ ++|+++
T Consensus 245 --~~~~~~~~~~~~---~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 --SRRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --HHhcccCCCCCc---ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111112222211 123456889999999999999995 677754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-40 Score=360.45 Aligned_cols=259 Identities=17% Similarity=0.296 Sum_probs=196.2
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEe--CCeeEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD--GNERLL 665 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 665 (947)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999874 7899999998753 2457889999999995 9999999999975 356899
Q ss_pred EEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC-cEEEeecCcce
Q 002255 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 744 (947)
Q Consensus 666 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~ 744 (947)
||||+.+++|..+. +.+++.++..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999997654 348889999999999999999997 8999999999999998765 69999999998
Q ss_pred ecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchh-hHH----------HH
Q 002255 745 LAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSV-HLV----------TW 812 (947)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~-~l~----------~~ 812 (947)
....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+ .+
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 7755322 2345799999999998765 4799999999999999999999999765432211 000 00
Q ss_pred HHHhhcCh-hhHHHHhhcc-------CCCChhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 813 FRRMHINK-DTFRKAIDRT-------IDLDEETLASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 813 ~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
........ ..+....... ............++.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 0000000000 0000111122346789999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-40 Score=361.08 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=200.3
Q ss_pred hcCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCcceEEEEEEeC-----Ce
Q 002255 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NE 662 (947)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 662 (947)
.++|++.++||+|+||+||+|+.. +|+.||||++.....+....+++.+|++++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999864 799999999987766666778899999999999999999999998643 34
Q ss_pred eEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEEEeecCc
Q 002255 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (947)
Q Consensus 663 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 742 (947)
.++||+|+.+|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccch
Confidence 4677788889999998854 248999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccccccccCccccccC-CcCcccccccHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh----
Q 002255 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDETQSEDSVHLVTWFRRMH---- 817 (947)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~---- 817 (947)
+...... .....||+.|+|||...+. .++.++||||+||++|||++|+.||.+.........+.......
T Consensus 168 a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 8755332 2345799999999987665 46889999999999999999999997665332222111110000
Q ss_pred ---cChhhHHHHhhccCCCChhc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002255 818 ---INKDTFRKAIDRTIDLDEET-----LASISTVADLAGHCCAREPYQRPDMGHVVN 867 (947)
Q Consensus 818 ---~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 867 (947)
.................... ......+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00011111111111111111 112346789999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-35 Score=325.06 Aligned_cols=271 Identities=21% Similarity=0.287 Sum_probs=193.5
Q ss_pred cCCCcCceecccCceEEEEEEEc-CCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-----------CCCcceEEEEE
Q 002255 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----------HRHLVGLLGYC 657 (947)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 657 (947)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 46999999999999999999874 7999999999754 334467788999998885 47899999887
Q ss_pred Ee--CCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCC--
Q 002255 658 LD--GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 733 (947)
Q Consensus 658 ~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-- 733 (947)
.. ....++||+++..+.......... ....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 64 456677777776654433332222 22457888999999999999999997 47899999999999998665
Q ss_pred ----cEEEeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHHHHHHhCCCCCCccCccchh--
Q 002255 734 ----RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQSEDSV-- 807 (947)
Q Consensus 734 ----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~-- 807 (947)
.++++|||.++..... ....+||+.|+|||++....++.++||||+||+++||++|+.||.........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 4999999999865432 23457999999999999999999999999999999999999999754322111
Q ss_pred --hHHHHHHHhhcCh-hhH------HHHhhc-----cCC-------------CChhcHHHHHHHHHHHHHhcccCCCCCC
Q 002255 808 --HLVTWFRRMHINK-DTF------RKAIDR-----TID-------------LDEETLASISTVADLAGHCCAREPYQRP 860 (947)
Q Consensus 808 --~l~~~~~~~~~~~-~~~------~~~~~~-----~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RP 860 (947)
.+...+....... ... ....+. ... ...........+.+|+.+||+.||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 1111111111100 000 001100 000 0011234556788999999999999999
Q ss_pred CHHHHHHHHHhhhhhhCC
Q 002255 861 DMGHVVNVLSSLAELWKP 878 (947)
Q Consensus 861 s~~evl~~L~~l~~~~~~ 878 (947)
|++|+++ ++|..
T Consensus 321 ta~e~L~------Hp~f~ 332 (362)
T d1q8ya_ 321 DAGGLVN------HPWLK 332 (362)
T ss_dssp CHHHHHT------CGGGT
T ss_pred CHHHHhc------CcccC
Confidence 9999864 56654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.6e-29 Score=274.21 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=178.8
Q ss_pred CCCCEEEcccCcccCc--CC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCe
Q 002255 89 SSLTVLEVMKNKLTGQ--IP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~--~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (947)
.+++.|+|++|.++|. +| .+.+|++|++|+|++ .|++.+ .+|..+++|++|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~-----------------------~N~l~g-~iP~~i~~L~~L~~ 105 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGG-----------------------INNLVG-PIPPAIAKLTQLHY 105 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEE-----------------------ETTEES-CCCGGGGGCTTCSE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCcccccccccc-----------------------cccccc-ccccccccccccch
Confidence 3566777777776663 33 444444444444443 144433 34555555555555
Q ss_pred EeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEcc
Q 002255 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (947)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (947)
|+|++|++.+..+..+. .+..|+++++++|++.+.+|..++ +++.|+.++++
T Consensus 106 L~Ls~N~l~~~~~~~~~--~~~~L~~l~l~~N~~~~~~p~~l~--------------------------~l~~L~~l~l~ 157 (313)
T d1ogqa_ 106 LYITHTNVSGAIPDFLS--QIKTLVTLDFSYNALSGTLPPSIS--------------------------SLPNLVGITFD 157 (313)
T ss_dssp EEEEEECCEEECCGGGG--GCTTCCEEECCSSEEESCCCGGGG--------------------------GCTTCCEEECC
T ss_pred hhhcccccccccccccc--chhhhcccccccccccccCchhhc--------------------------cCcccceeecc
Confidence 55555555555555554 455666666666666666665443 36666677777
Q ss_pred CCcCcCCCCC-CCCCCC-CCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcC
Q 002255 246 GNSFTGPLPD-LSGLSS-LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323 (947)
Q Consensus 246 ~N~l~~~~~~-~~~l~~-L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 323 (947)
+|.+++.+|. +..+.. ++.+++++|+++|..|..+.++..+ .+++++|.+.|.+|....
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~------------------ 218 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFG------------------ 218 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCC------------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc------------------
Confidence 7777666653 445544 4889999999999999999888654 799999999988875321
Q ss_pred CCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccC
Q 002255 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG 403 (947)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~ 403 (947)
...+++.+++++|.+++.+| .++.+++|+.|+|++
T Consensus 219 --------------------------------------------~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~ 253 (313)
T d1ogqa_ 219 --------------------------------------------SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN 253 (313)
T ss_dssp --------------------------------------------TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCS
T ss_pred --------------------------------------------cccccccccccccccccccc-ccccccccccccCcc
Confidence 23468899999999998776 589999999999999
Q ss_pred CcccccCCCcCCCCCCCCccccccccccccCCCCcc--ce-eeecCCCCCCCCCC
Q 002255 404 NELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ--NV-IVKTDGNPDIGKDS 455 (947)
Q Consensus 404 N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~--~~-~~~~~~n~~~~~~~ 455 (947)
|+|+|.+|.+|+.+++|++|||++|+|+|.||.+.. ++ .+.+.+|+.+|+.|
T Consensus 254 N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999999999999999999999999999999998643 22 35678999999864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=7.7e-25 Score=235.95 Aligned_cols=273 Identities=20% Similarity=0.302 Sum_probs=212.3
Q ss_pred CCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccc
Q 002255 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFF 132 (947)
Q Consensus 54 C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~ 132 (947)
|.|.+|.|+ +++++ .+|..+. +.|++|+|++|+|+..++ .|.++++|++|++++|.++.+++..|
T Consensus 10 c~~~~~~C~-----------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCS-----------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECT-----------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ecCCEEEec-----------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh
Confidence 567777775 34566 7787764 689999999999998887 69999999999999999999999999
Q ss_pred cCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCC
Q 002255 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212 (947)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L 212 (947)
.++++|++|++++|+++. +|..+ ...|..|++.+|.+.+..+..+. ....+..+++..|.......
T Consensus 76 ~~l~~L~~L~l~~n~l~~--l~~~~--~~~l~~L~~~~n~l~~l~~~~~~--~~~~~~~l~~~~n~~~~~~~-------- 141 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLKE--LPEKM--PKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGI-------- 141 (305)
T ss_dssp TTCTTCCEEECCSSCCSB--CCSSC--CTTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGB--------
T ss_pred hCCCccCEecccCCccCc--Cccch--hhhhhhhhccccchhhhhhhhhh--ccccccccccccccccccCC--------
Confidence 999999999999999875 55433 34677778888777765554444 35566667776665432111
Q ss_pred ceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEecc
Q 002255 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292 (947)
Q Consensus 213 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls 292 (947)
....+..+++|+.+++++|.++.....+ +++|+.|++++|.+++..+..+.+++.++.|+++
T Consensus 142 ----------------~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s 203 (305)
T d1xkua_ 142 ----------------ENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203 (305)
T ss_dssp ----------------CTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred ----------------CccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence 1123456889999999999988654333 6889999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCce
Q 002255 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNI 372 (947)
Q Consensus 293 ~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L 372 (947)
+|.+++..+.++ ...++|
T Consensus 204 ~n~l~~~~~~~~--------------------------------------------------------------~~l~~L 221 (305)
T d1xkua_ 204 FNSISAVDNGSL--------------------------------------------------------------ANTPHL 221 (305)
T ss_dssp SSCCCEECTTTG--------------------------------------------------------------GGSTTC
T ss_pred cccccccccccc--------------------------------------------------------------cccccc
Confidence 999987665421 123478
Q ss_pred eEEEecCCCceeeccccccCCccCCeEeccCCcccccCCC-------cCCCCCCCCcccccccccc-ccCCC
Q 002255 373 TVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPK-------ELTTLPSLEMLDVSNNHLF-GKVPN 436 (947)
Q Consensus 373 ~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-------~l~~l~~L~~L~ls~N~l~-g~iP~ 436 (947)
+.|+|++|+|+ .+|.+|.++++|++|+|++|+|+ .|+. .+..+.+|+.|+|++|+++ +++|.
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence 99999999998 67889999999999999999999 6653 2345788999999999984 55553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=8.2e-25 Score=244.05 Aligned_cols=215 Identities=26% Similarity=0.398 Sum_probs=165.8
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
..+++|++++++++. + +.+..|++|++|+|++|+|++.. .+.++++|++|++++|+++++++ +..+++|+.|+++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc-cccCCcccccccccccccccccc--ccccccccccccc
Confidence 479999999999984 4 46889999999999999999765 59999999999999999998865 7899999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeec-----------------------------------------cCcccCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGT-----------------------------------------IPDFLGG 183 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-----------------------------------------~p~~~~~ 183 (947)
+|.+.. + ........+..+....|.+... ....+.
T Consensus 119 ~~~~~~--~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 194 (384)
T d2omza2 119 NNQITD--I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA- 194 (384)
T ss_dssp SSCCCC--C-GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG-
T ss_pred cccccc--c-ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc-
Confidence 999865 2 2233444555555544443211 111122
Q ss_pred CCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCC
Q 002255 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ 263 (947)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~ 263 (947)
.++++..|++++|.+++..|.. ...+|+.|++++|.+... ..+..+++|+.|++++|.+++.. .+..+++|+
T Consensus 195 -~l~~~~~l~l~~n~i~~~~~~~-~~~~L~~L~l~~n~l~~~-----~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~ 266 (384)
T d2omza2 195 -KLTNLESLIATNNQISDITPLG-ILTNLDELSLNGNQLKDI-----GTLASLTNLTDLDLANNQISNLA-PLSGLTKLT 266 (384)
T ss_dssp -GCTTCSEEECCSSCCCCCGGGG-GCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCS
T ss_pred -cccccceeeccCCccCCCCccc-ccCCCCEEECCCCCCCCc-----chhhcccccchhccccCccCCCC-cccccccCC
Confidence 4678899999999998765532 336799999999887653 34667889999999999998754 477888999
Q ss_pred EEEccCCccccCCCccccCCCCCCeEeccCCcccc
Q 002255 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 264 ~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g 298 (947)
.|++++|++++.. .+..++.++.+++++|++++
T Consensus 267 ~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~ 299 (384)
T d2omza2 267 ELKLGANQISNIS--PLAGLTALTNLELNENQLED 299 (384)
T ss_dssp EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC
T ss_pred EeeccCcccCCCC--cccccccccccccccccccc
Confidence 9999999998543 37788889999999998875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5e-25 Score=234.63 Aligned_cols=214 Identities=20% Similarity=0.319 Sum_probs=158.8
Q ss_pred CCCCceeEeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCccc
Q 002255 53 PCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDF 131 (947)
Q Consensus 53 ~C~w~gv~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~ 131 (947)
||. .+..|..... ..+++++++++ .+|..+. +.+++|+|++|+|+..++ .|.++++|++|++++|++..+++..
T Consensus 1 ~cp-~~C~C~~~~~-~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~ 75 (284)
T d1ozna_ 1 PCP-GACVCYNEPK-VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75 (284)
T ss_dssp CCC-TTCEEECSSS-CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred CcC-CCCEEcCCCC-eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccc
Confidence 454 2566743322 44577888888 7787664 678999999999998777 6999999999999999999999999
Q ss_pred ccCCCCCcEEeccC-CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCC
Q 002255 132 FKGLTSLQTISLDY-NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (947)
Q Consensus 132 ~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 210 (947)
+..+..++.++... |.+.. ..+..+.++++|++|++++|.+....+..+. ..++|+.+++++|++++..+..|..
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~-l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~~~~L~~l~l~~N~l~~i~~~~f~~- 151 (284)
T d1ozna_ 76 FTGLALLEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTFRD- 151 (284)
T ss_dssp TTTCTTCCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTTT-
T ss_pred cccccccccccccccccccc-ccchhhcccccCCEEecCCcccccccccccc--hhcccchhhhccccccccChhHhcc-
Confidence 99999999998764 45544 5678899999999999999998876666665 5788999999999998665555543
Q ss_pred CCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeE
Q 002255 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (947)
Q Consensus 211 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L 289 (947)
+++|+.|+|++|+|++..+. +.++++|+++++++|++++..|..|.++++|++|
T Consensus 152 -------------------------~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 152 -------------------------LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp -------------------------CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred -------------------------ccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 55666666666666655543 5556666666666666666666666666666666
Q ss_pred eccCCcccccC
Q 002255 290 NLTNNLFQGQT 300 (947)
Q Consensus 290 ~Ls~N~l~g~~ 300 (947)
++++|++++..
T Consensus 207 ~l~~N~i~~~~ 217 (284)
T d1ozna_ 207 YLFANNLSALP 217 (284)
T ss_dssp ECCSSCCSCCC
T ss_pred ccccccccccc
Confidence 66666665433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=8.8e-24 Score=235.59 Aligned_cols=297 Identities=22% Similarity=0.317 Sum_probs=214.3
Q ss_pred ecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCC
Q 002255 72 IGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW 151 (947)
Q Consensus 72 L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 151 (947)
+...++++.+. ...+.+|++|++++|.++. +..+..|++|++|+|++|+|+++++ ++++++|++|+|++|++..
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~- 102 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD- 102 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCCCCCCCccC--HHHhCCCCEEECCCCCCCC-ccccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc-
Confidence 33344444443 2456789999999999985 4678899999999999999999875 8999999999999999975
Q ss_pred CCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCc-----------------------------
Q 002255 152 VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP----------------------------- 202 (947)
Q Consensus 152 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~----------------------------- 202 (947)
++ .++++++|+.|++++|.+++..+... ...+..+....|.+...
T Consensus 103 -i~-~l~~l~~L~~L~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (384)
T d2omza2 103 -IT-PLANLTNLTGLTLFNNQITDIDPLKN----LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT 176 (384)
T ss_dssp -CG-GGTTCTTCCEEECCSSCCCCCGGGTT----CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTT
T ss_pred -cc-cccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 33 48999999999999999986554332 23444444444332211
Q ss_pred ------------CCccc-cCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccC
Q 002255 203 ------------IPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269 (947)
Q Consensus 203 ------------~p~~~-~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~ 269 (947)
....+ ...+++.+++++|.+..... +...++|+.|++++|.++. ++.+..+++|+.|++++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-----~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~ 250 (384)
T d2omza2 177 LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-----LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLAN 250 (384)
T ss_dssp CCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-----GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCS
T ss_pred cccccccccccccccccccccccceeeccCCccCCCCc-----ccccCCCCEEECCCCCCCC-cchhhcccccchhcccc
Confidence 01111 12678899999998776532 3457899999999999986 45688899999999999
Q ss_pred CccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhc
Q 002255 270 NQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349 (947)
Q Consensus 270 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~ 349 (947)
|++++..+ +..+++|+.|++++|++++..+-. . ......+....+.+
T Consensus 251 n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~-~--------~~~l~~l~~~~n~l---------------------- 297 (384)
T d2omza2 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLA-G--------LTALTNLELNENQL---------------------- 297 (384)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGT-T--------CTTCSEEECCSSCC----------------------
T ss_pred CccCCCCc--ccccccCCEeeccCcccCCCCccc-c--------cccccccccccccc----------------------
Confidence 99996543 888999999999999998654311 0 00001111111100
Q ss_pred cCCCCCCCCCCCCCc-ccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccc
Q 002255 350 SWKGNNPCNSDWKGV-SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (947)
Q Consensus 350 ~~~~~~~~~~~~~~~-~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N 428 (947)
.++ ......+++.|++++|++++..| +..+++|+.|+|++|+|+ .+| .+..+++|++|+|++|
T Consensus 298 ------------~~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 298 ------------EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHN 361 (384)
T ss_dssp ------------SCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSS
T ss_pred ------------ccccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCC
Confidence 011 12334578888999998887533 788889999999999888 455 6888889999999999
Q ss_pred cccccCC
Q 002255 429 HLFGKVP 435 (947)
Q Consensus 429 ~l~g~iP 435 (947)
+|++.+|
T Consensus 362 ~l~~l~~ 368 (384)
T d2omza2 362 QISDLTP 368 (384)
T ss_dssp CCCBCGG
T ss_pred cCCCChh
Confidence 9887765
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=5.8e-23 Score=221.05 Aligned_cols=263 Identities=19% Similarity=0.226 Sum_probs=210.5
Q ss_pred CCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc
Q 002255 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (947)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (947)
+++.+|-++++|+..++.+. +.|++|+|++|+|+.+++..|.++++|++|++++|.+.. ..|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-cchhhhhCCCccCEeccc
Confidence 67788999999997665664 689999999999999999999999999999999999976 567889999999999999
Q ss_pred CceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcC
Q 002255 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (947)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (947)
+|+++ .+|..+ .+.|..|++++|.+.+..+..+ .....+..++...|..
T Consensus 88 ~n~l~-~l~~~~----~~~l~~L~~~~n~l~~l~~~~~--------------------------~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 88 KNQLK-ELPEKM----PKTLQELRVHENEITKVRKSVF--------------------------NGLNQMIVVELGTNPL 136 (305)
T ss_dssp SSCCS-BCCSSC----CTTCCEEECCSSCCCBBCHHHH--------------------------TTCTTCCEEECCSSCC
T ss_pred CCccC-cCccch----hhhhhhhhccccchhhhhhhhh--------------------------hccccccccccccccc
Confidence 99998 456554 4678999999999885443333 2356677788888765
Q ss_pred cCCC--C-CCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCc
Q 002255 250 TGPL--P-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (947)
Q Consensus 250 ~~~~--~-~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (947)
.... + .+..+++|+++++++|+++ .+|..+ +++|+.|++++|.+++.++..
T Consensus 137 ~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~----------------------- 190 (305)
T d1xkua_ 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS----------------------- 190 (305)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGG-----------------------
T ss_pred cccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhH-----------------------
Confidence 4432 2 3777899999999999998 566654 689999999999988765532
Q ss_pred CCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcc
Q 002255 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNEL 406 (947)
Q Consensus 327 ~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l 406 (947)
+.....+++|++++|.+++..+..+.++++|++|+|++|+|
T Consensus 191 ---------------------------------------~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L 231 (305)
T d1xkua_ 191 ---------------------------------------LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231 (305)
T ss_dssp ---------------------------------------GTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred ---------------------------------------hhccccccccccccccccccccccccccccceeeecccccc
Confidence 12234688999999999999999999999999999999999
Q ss_pred cccCCCcCCCCCCCCccccccccccccCCCCc----------cceeeecCCCCCCC
Q 002255 407 TGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR----------QNVIVKTDGNPDIG 452 (947)
Q Consensus 407 ~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~----------~~~~~~~~~n~~~~ 452 (947)
+ .||.+|..+++|++|+|++|+|+.--...+ ....+.+.+|++.+
T Consensus 232 ~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 232 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred c-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9 899999999999999999999985322211 11245677887654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1e-22 Score=214.14 Aligned_cols=203 Identities=22% Similarity=0.241 Sum_probs=176.7
Q ss_pred EeCCCCcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCC
Q 002255 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138 (947)
Q Consensus 60 ~C~~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 138 (947)
.|+......++++++++|+ .+|+.|. ++|++|+|++|+|++..+ .|.++++|++|+|++|+|+.+++ ++.+++|
T Consensus 5 ~~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (266)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred EEcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--ccccccc
Confidence 3555556677899999999 6888775 689999999999998776 79999999999999999998764 5789999
Q ss_pred cEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeec
Q 002255 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN 218 (947)
Q Consensus 139 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~ 218 (947)
++|+|++|++.. ++..+.++++|+.|++++|.+.+..+..+. .+.++++|++++|.++...+..+
T Consensus 80 ~~L~Ls~N~l~~--~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~--~l~~l~~L~l~~n~l~~l~~~~~----------- 144 (266)
T d1p9ag_ 80 GTLDLSHNQLQS--LPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLL----------- 144 (266)
T ss_dssp CEEECCSSCCSS--CCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTT-----------
T ss_pred cccccccccccc--cccccccccccccccccccccceeeccccc--cccccccccccccccceeccccc-----------
Confidence 999999999975 688899999999999999999877777766 68899999999999985554443
Q ss_pred cCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccc
Q 002255 219 GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 219 ~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
..+++|+.|++++|+|++.+++ +..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 145 ---------------~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 145 ---------------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ---------------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------------cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 3488999999999999998875 788999999999999999 89999999999999999999986
Q ss_pred c
Q 002255 298 G 298 (947)
Q Consensus 298 g 298 (947)
.
T Consensus 209 C 209 (266)
T d1p9ag_ 209 C 209 (266)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=6.3e-23 Score=218.23 Aligned_cols=177 Identities=19% Similarity=0.266 Sum_probs=92.5
Q ss_pred EEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc-Cc
Q 002255 93 VLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN-GA 171 (947)
Q Consensus 93 ~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~-~n 171 (947)
.++.++++++..+..+. +.+++|+|++|+|+++++..|.++++|++|++++|++.. ..+..+.++..+..+... .|
T Consensus 15 ~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~-i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccc-ccccccccccccccccccccc
Confidence 45666666664332332 456777777777777777777777777777777777654 344445555555555443 33
Q ss_pred eeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcC
Q 002255 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251 (947)
Q Consensus 172 ~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 251 (947)
.++...|..+. .+++|++|+|++|.+....+..+. ...+|+.+++++|+|++
T Consensus 92 ~~~~l~~~~~~--~l~~L~~L~l~~n~~~~~~~~~~~--------------------------~~~~L~~l~l~~N~l~~ 143 (284)
T d1ozna_ 92 QLRSVDPATFH--GLGRLHTLHLDRCGLQELGPGLFR--------------------------GLAALQYLYLQDNALQA 143 (284)
T ss_dssp TCCCCCTTTTT--TCTTCCEEECTTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCCC
T ss_pred ccccccchhhc--ccccCCEEecCCcccccccccccc--------------------------hhcccchhhhccccccc
Confidence 33333344443 345555555555554433222221 24445555555555554
Q ss_pred CCCC-CCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccC
Q 002255 252 PLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (947)
Q Consensus 252 ~~~~-~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (947)
.++. +..+++|+.|++++|+|++..+..|.++++|+.+++++|++++..
T Consensus 144 i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 4432 444455555555555555444444555555555555555544433
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=9.9e-22 Score=206.49 Aligned_cols=205 Identities=24% Similarity=0.234 Sum_probs=126.9
Q ss_pred CCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCC
Q 002255 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIP 187 (947)
Q Consensus 108 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~ 187 (947)
..+.+.+.+++.+++.|+.+|+... ++|++|+|++|+|.. ..+..|.++++|++|+|++|+|+. +|. ++ .
T Consensus 6 ~~~~~~~~~v~C~~~~L~~iP~~lp---~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~~-l~~-~~--~-- 75 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTK-LQV-DG--T-- 75 (266)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCE-EEC-CS--C--
T ss_pred EcccCCCeEEEccCCCCCeeCcCcC---cCCCEEECcCCcCCC-cCHHHhhccccccccccccccccc-ccc-cc--c--
Confidence 3455566667777777777665422 456777777777654 222445555555555555555542 221 11 2
Q ss_pred CccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEc
Q 002255 188 GLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSV 267 (947)
Q Consensus 188 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l 267 (947)
+++|+.|+|++|++++..+.+.++++|++|++
T Consensus 76 ------------------------------------------------l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 76 ------------------------------------------------LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107 (266)
T ss_dssp ------------------------------------------------CTTCCEEECCSSCCSSCCCCTTTCTTCCEEEC
T ss_pred ------------------------------------------------cccccccccccccccccccccccccccccccc
Confidence 44455555555555544444555555555555
Q ss_pred cCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhh
Q 002255 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347 (947)
Q Consensus 268 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 347 (947)
++|.+....+..+..+.+++.|++++|.+++..+..+
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~------------------------------------------- 144 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL------------------------------------------- 144 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT-------------------------------------------
T ss_pred cccccceeeccccccccccccccccccccceeccccc-------------------------------------------
Confidence 5555555555555556666666666666554333211
Q ss_pred hccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccccCCCcCCCCCCCCcccccc
Q 002255 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427 (947)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~ 427 (947)
....+|+.|++++|++++..+..|+.+++|++|+|++|+|+ .||.++..+++|+.|+|++
T Consensus 145 -------------------~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~ 204 (266)
T d1p9ag_ 145 -------------------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204 (266)
T ss_dssp -------------------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred -------------------cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecC
Confidence 11224566666666666666677888999999999999999 8999999999999999999
Q ss_pred cccccc
Q 002255 428 NHLFGK 433 (947)
Q Consensus 428 N~l~g~ 433 (947)
|++.+.
T Consensus 205 Np~~Cd 210 (266)
T d1p9ag_ 205 NPWLCN 210 (266)
T ss_dssp CCBCCS
T ss_pred CCCCCC
Confidence 988654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=5.8e-23 Score=204.18 Aligned_cols=171 Identities=16% Similarity=0.134 Sum_probs=121.7
Q ss_pred CcCceecccCceEEEEEEEcCCcEEEEEEecccccC----------------hHHHHHHHHHHHHHHcCCCCCcceEEEE
Q 002255 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS----------------EKGFAEFKSEIAVLTKVRHRHLVGLLGY 656 (947)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 656 (947)
.+.++||+|+||.||+|...+|+.||||+++....+ .........|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999889999999987642111 1112345678999999999999998866
Q ss_pred EEeCCeeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEcCCCcEE
Q 002255 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (947)
Q Consensus 657 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 736 (947)
. ..++||||+++..+.++ +......++.|++++++|||+ ++|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 3 23799999987655332 223345789999999999997 899999999999999965 589
Q ss_pred EeecCcceecCCCCCcceeecccccccccCccccccCCcCcccccccHHHHH
Q 002255 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 788 (947)
Q Consensus 737 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil 788 (947)
++|||+|+............+.+. . -.|. ..+.|+.++||||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHHH
Confidence 999999987643321110000000 0 0111 236788999999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.79 E-value=3.2e-17 Score=179.23 Aligned_cols=304 Identities=20% Similarity=0.284 Sum_probs=194.6
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
++++|||++++++ .+|+. +++|++|+|++|+|+.. |.. +.+|+.|++++|+++.+.. -.+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~--~~~L~~L~l~~n~l~~l~~----lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL--PQSLKSLLVDNNNLKALSD----LPPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC--CTTCCEEECCSSCCSCCCS----CCTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc--hhhhhhhhhhhcccchhhh----hccccccccccc
Confidence 5788999999998 68864 47899999999999844 532 4589999999999987653 124799999999
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCcccc-CCCCceeeeccCCCCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG-KSSIQTLWLNGQKGDS 224 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~l~~n~~~~ 224 (947)
|.+.. +|. ++++++|+.|++++|.+....+ . ...+..|.+..+..... ..+. ...++.|++.+|.+..
T Consensus 108 n~l~~--lp~-~~~l~~L~~L~l~~~~~~~~~~-~-----~~~l~~l~~~~~~~~~~--~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 108 NQLEK--LPE-LQNSSFLKIIDVDNNSLKKLPD-L-----PPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp SCCSS--CCC-CTTCTTCCEEECCSSCCSCCCC-C-----CTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSS
T ss_pred ccccc--ccc-hhhhccceeecccccccccccc-c-----cccccchhhcccccccc--ccccccccceecccccccccc
Confidence 99975 564 6889999999999998874332 2 34677788777766532 2222 2567777777776554
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCC
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (947)
.... ......+.+.++.+. .++.+..++.|+.+++++|... .+|.. ..++..+.+.+|.+...... .
T Consensus 177 ~~~~-------~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~~~~-~ 243 (353)
T d1jl5a_ 177 LPDL-------PLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLPEL-P 243 (353)
T ss_dssp CCCC-------CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCCCCC-C
T ss_pred cccc-------ccccccccccccccc-cccccccccccccccccccccc-ccccc---cccccccccccccccccccc-c
Confidence 3221 233455555555544 4556677888888888888776 34433 45677777888777643321 1
Q ss_pred CCcccccccCCCCcccCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee
Q 002255 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (947)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (947)
..+... ...... ...+......... .+.....+.+ ....+++|+.|+|++|+|+
T Consensus 244 ~~l~~~----------~~~~~~----~~~l~~l~~~~~~----------~~~~~~~~~~-~~~~~~~L~~L~Ls~N~l~- 297 (353)
T d1jl5a_ 244 QSLTFL----------DVSENI----FSGLSELPPNLYY----------LNASSNEIRS-LCDLPPSLEELNVSNNKLI- 297 (353)
T ss_dssp TTCCEE----------ECCSSC----CSEESCCCTTCCE----------EECCSSCCSE-ECCCCTTCCEEECCSSCCS-
T ss_pred cccccc----------cccccc----ccccccccchhcc----------cccccCcccc-ccccCCCCCEEECCCCccC-
Confidence 111100 000000 0000000000000 0000000111 1234568999999999998
Q ss_pred eccccccCCccCCeEeccCCcccccCCCcCCCCCCCCccccccccccccCCCCc
Q 002255 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR 438 (947)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~ 438 (947)
.+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|...
T Consensus 298 ~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~ 343 (353)
T d1jl5a_ 298 ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP 343 (353)
T ss_dssp CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC
T ss_pred ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc
Confidence 67764 578999999999999 78864 468999999999997 566543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.9e-18 Score=176.47 Aligned_cols=99 Identities=14% Similarity=0.234 Sum_probs=50.3
Q ss_pred CEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCc
Q 002255 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (947)
..++++.+++++.+ .+..+.+|++|++.+|.|+.+. .+..+++|++|+|++|++.. + ..+..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~-~~~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~--~-~~l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITD--L-APLKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC--C-GGGTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC-CHHHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeec--c-ccccccccccccccccc
Confidence 33455555555432 3444556666666666666542 25566666666666666543 1 12455555555555555
Q ss_pred eeeeccCcccCCCCCCCccEEEccCCccc
Q 002255 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 172 ~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~ 200 (947)
.++ .++ .+. .+++|++|++++|...
T Consensus 96 ~~~-~i~-~l~--~l~~L~~l~l~~~~~~ 120 (227)
T d1h6ua2 96 PLK-NVS-AIA--GLQSIKTLDLTSTQIT 120 (227)
T ss_dssp CCS-CCG-GGT--TCTTCCEEECTTSCCC
T ss_pred ccc-ccc-ccc--cccccccccccccccc
Confidence 444 222 122 3455555555555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=4.4e-18 Score=173.71 Aligned_cols=189 Identities=23% Similarity=0.372 Sum_probs=119.2
Q ss_pred cCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCe
Q 002255 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (947)
..|.+|+.|++.+|.++.. +.+.++++|++|++++|+++++.+ +..+++|++|++++|.++. + ..+.++++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~--i-~~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--V-SAIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC--C-GGGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc--c-ccccccccccc
Confidence 4445566666666655543 445556666666666666655543 5556666666666665542 2 24555666666
Q ss_pred EeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEcc
Q 002255 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (947)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (947)
+++++|...+..+ +. ..+.+..+.++.+.+....+ .....+|+.|++++|.+... ..+.++++|+.|+|+
T Consensus 112 l~l~~~~~~~~~~--~~--~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~-----~~l~~l~~L~~L~Ls 181 (227)
T d1h6ua2 112 LDLTSTQITDVTP--LA--GLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDL-----TPLANLSKLTTLKAD 181 (227)
T ss_dssp EECTTSCCCCCGG--GT--TCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-----GGGTTCTTCCEEECC
T ss_pred cccccccccccch--hc--cccchhhhhchhhhhchhhh-hccccccccccccccccccc-----hhhcccccceecccC
Confidence 6666665553322 11 34556666666666553322 22234566666666554432 225678999999999
Q ss_pred CCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccC
Q 002255 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293 (947)
Q Consensus 246 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~ 293 (947)
+|++++ ++.+.++++|++|+|++|+|++ ++ .++++++|+.|+|++
T Consensus 182 ~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 182 DNKISD-ISPLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLTN 226 (227)
T ss_dssp SSCCCC-CGGGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEEE
T ss_pred CCccCC-ChhhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEeeC
Confidence 999986 4568889999999999999995 44 388999999999974
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=7e-18 Score=167.13 Aligned_cols=171 Identities=17% Similarity=0.252 Sum_probs=136.5
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC--CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 146 (947)
.+++++++++ .+|..+. +++++|+|++|+|++.++ .|.++++|++|+|++|++..+++..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4666777888 7888764 789999999999988664 6899999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCC
Q 002255 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (947)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~ 226 (947)
+|.. ..+..|.++++|++|+|++|+|++..|..|. .+++|++|+|++|.+.......+-
T Consensus 89 ~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~--~l~~L~~l~L~~N~~~~~~~~~~~------------------ 147 (192)
T d1w8aa_ 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNCHLAWF------------------ 147 (192)
T ss_dssp CCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSGGGHHH------------------
T ss_pred cccc-cCHHHHhCCCcccccccCCccccccCHHHhc--CCcccccccccccccccccchHHH------------------
Confidence 9986 5677899999999999999999988888887 689999999999999754332211
Q ss_pred CCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccCCcccc
Q 002255 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTG 274 (947)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g 274 (947)
...++.+.+..|.++...|. .+..++.++|+.|.|.-
T Consensus 148 ---------~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 148 ---------AEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp ---------HHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCC
T ss_pred ---------hhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcC
Confidence 11234445556666654442 34556677788887764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2e-17 Score=166.29 Aligned_cols=166 Identities=25% Similarity=0.361 Sum_probs=123.2
Q ss_pred CCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeE
Q 002255 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (947)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (947)
.|.+|+.|++++|.++.. +.+..+++|++|+|++|+++++++ ++.+++|++|++++|+++. +| .+.++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~--l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD--LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc--cc-ccccccccccc
Confidence 356777788888777653 346777788888888888877664 5677888888888887754 33 57777778888
Q ss_pred eccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccC
Q 002255 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (947)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (947)
++++|.+.. ++ .+. .++.|+.+++++|.+++.. .+..+++|+.+++++
T Consensus 118 ~l~~~~~~~-~~-~l~--~l~~l~~l~~~~n~l~~~~----------------------------~~~~l~~L~~l~l~~ 165 (210)
T d1h6ta2 118 SLEHNGISD-IN-GLV--HLPQLESLYLGNNKITDIT----------------------------VLSRLTKLDTLSLED 165 (210)
T ss_dssp ECTTSCCCC-CG-GGG--GCTTCCEEECCSSCCCCCG----------------------------GGGGCTTCSEEECCS
T ss_pred ccccccccc-cc-ccc--ccccccccccccccccccc----------------------------ccccccccccccccc
Confidence 887777653 23 333 4677888888888776322 133578899999999
Q ss_pred CcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccC
Q 002255 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293 (947)
Q Consensus 247 N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~ 293 (947)
|++++. +.+.++++|+.|+|++|+|+ .+| .+.++++|++|+|++
T Consensus 166 n~l~~i-~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 166 NQISDI-VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp SCCCCC-GGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred cccccc-ccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 999864 45888999999999999998 455 589999999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=3.1e-17 Score=169.24 Aligned_cols=101 Identities=20% Similarity=0.351 Sum_probs=60.4
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCC-CCcccccCCCCCcEEeccC-
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS-VPSDFFKGLTSLQTISLDY- 145 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~- 145 (947)
.+++++.+++ .+|+.+. +++++|+|++|+|+..++ .|.++++|++|+|++|.+.. +++..|.+++++++|++..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4666677777 7777653 467888888888876555 57777777777777776654 4455666666666666543
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCcee
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANI 173 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l 173 (947)
|++.. ..+..|.++++|++|++.+|.+
T Consensus 89 n~l~~-~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 89 NNLLY-INPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp TTCCE-ECTTSEECCTTCCEEEEESCCC
T ss_pred ccccc-cccccccccccccccccchhhh
Confidence 34432 2233344444444444444333
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=3.1e-17 Score=169.26 Aligned_cols=212 Identities=17% Similarity=0.197 Sum_probs=162.4
Q ss_pred CCCceeEeCCC----------CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCC--CCCCCCCCcEEecC-
Q 002255 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFD- 120 (947)
Q Consensus 54 C~w~gv~C~~~----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~- 120 (947)
|.+..|.|... ..+++|+|++|.++..-+..|.++++|++|+|++|.+...++ .|.+++++++|.+.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888999631 369999999999985555679999999999999999987665 68999999999976
Q ss_pred CCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCccc
Q 002255 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~ 200 (947)
.|++..+++..|..+++|++|++++|++........+..+..+..+...++.+....+..+.+ ....++.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~-~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG-LSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTT-SBSSCEEEECCSSCCC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccc-ccccceeeeccccccc
Confidence 478999999999999999999999999976333345566777777778888887665666552 2247888999999998
Q ss_pred CcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEE-EccCCcCcCCCCC-CCCCCCCCEEEccCCccccCCCc
Q 002255 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL-WLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPS 278 (947)
Q Consensus 201 ~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~ 278 (947)
...+..+. .+++..+ ++++|+++...+. |.++++|++|+|++|+|+...+.
T Consensus 167 ~i~~~~~~---------------------------~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 219 (242)
T d1xwdc1 167 EIHNCAFN---------------------------GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 219 (242)
T ss_dssp EECTTTTT---------------------------TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSS
T ss_pred cccccccc---------------------------chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHH
Confidence 54443332 3444444 5677888866554 78889999999999999855455
Q ss_pred cccCCCCCCeEeccC
Q 002255 279 SLVNLHSLAVVNLTN 293 (947)
Q Consensus 279 ~l~~l~~L~~L~Ls~ 293 (947)
.|.++++|+.+++.+
T Consensus 220 ~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 220 GLENLKKLRARSTYN 234 (242)
T ss_dssp SCTTCCEEESSSEES
T ss_pred HHcCCcccccCcCCC
Confidence 677777777766654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.70 E-value=3.7e-15 Score=162.54 Aligned_cols=298 Identities=23% Similarity=0.283 Sum_probs=194.5
Q ss_pred CCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEec
Q 002255 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (947)
.+|++|||++|.++. +|.+ +++|++|+|++|+|+.+|.. +.+|+.|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~--l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKA--LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSC--CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccch--hhhh---ccccccccc
Confidence 479999999999986 4542 57899999999999988643 5689999999999975 4432 246999999
Q ss_pred cCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCc
Q 002255 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (947)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (947)
++|.+. .+|. ++ .+++|++|++++|.+..... .. ..+..+.+..+..... ..+..++.++.|++++|.
T Consensus 106 ~~n~l~-~lp~-~~--~l~~L~~L~l~~~~~~~~~~-~~--~~l~~l~~~~~~~~~~-----~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQ--NSSFLKIIDVDNNSLKKLPD-LP--PSLEFIAAGNNQLEEL-----PELQNLPFLTAIYADNNS 173 (353)
T ss_dssp CSSCCS-SCCC-CT--TCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSSC-----CCCTTCTTCCEEECCSSC
T ss_pred cccccc-cccc-hh--hhccceeecccccccccccc-cc--ccccchhhcccccccc-----ccccccccceeccccccc
Confidence 999998 5665 34 68999999999999984433 22 3466666665544332 224568899999999999
Q ss_pred CcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCcccccCCCCCCCcccccccCCCCcccCcCCCcCC
Q 002255 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (947)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (947)
+...... ....+.+.+.++.+. .+| .+..++.|+.+++++|.... +|.....+.. .....+.+.
T Consensus 174 ~~~~~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~----------~~~~~~~~~ 237 (353)
T d1jl5a_ 174 LKKLPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEA----------LNVRDNYLT 237 (353)
T ss_dssp CSSCCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCCTTCCE----------EECCSSCCS
T ss_pred ccccccc---ccccccccccccccc-ccc-cccccccccccccccccccc-cccccccccc----------ccccccccc
Confidence 8764432 233567777777776 444 46789999999999998765 3332221110 000000000
Q ss_pred CccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCceeeccccccCCccCCeEeccCCcccc
Q 002255 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (947)
Q Consensus 329 ~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 408 (947)
. ....+..+...... .+ ...++ ..........++..+.+.+. ...+++|++|+|++|+|+
T Consensus 238 ~----~~~~~~~l~~~~~~------~~----~~~~l-~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~- 297 (353)
T d1jl5a_ 238 D----LPELPQSLTFLDVS------EN----IFSGL-SELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI- 297 (353)
T ss_dssp C----CCCCCTTCCEEECC------SS----CCSEE-SCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-
T ss_pred c----cccccccccccccc------cc----ccccc-ccccchhcccccccCccccc----cccCCCCCEEECCCCccC-
Confidence 0 00000000000000 00 00000 11123456677777777643 234689999999999999
Q ss_pred cCCCcCCCCCCCCccccccccccccCCCCccce-eeecCCCCC
Q 002255 409 TIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNV-IVKTDGNPD 450 (947)
Q Consensus 409 ~iP~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~-~~~~~~n~~ 450 (947)
.+|.. +++|+.|+|++|+|+ .+|....++ .+.+.+|+.
T Consensus 298 ~lp~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 298 ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPL 336 (353)
T ss_dssp CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred ccccc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcC
Confidence 89964 578999999999998 678765544 456777763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=8.1e-17 Score=160.33 Aligned_cols=163 Identities=25% Similarity=0.386 Sum_probs=116.8
Q ss_pred cCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCe
Q 002255 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (947)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (947)
..+.+|+.|++++|.++. ++.+..+++|++|+|++|+++++++ +.++++|++|++++|.+.. ++ .+.+++.|+.
T Consensus 37 ~~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~--~~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--IT-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--CG-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc--cc-cccccccccc
Confidence 345677778887777764 3456777788888888888777664 6778888888888887753 33 4777777888
Q ss_pred EeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEcc
Q 002255 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (947)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (947)
|++++|.+.... .+. .+++|+.|++++|++.. ++ . +..+++|+.|+++
T Consensus 111 L~l~~~~~~~~~--~~~--~l~~L~~L~l~~n~l~~-~~-~--------------------------l~~~~~L~~L~l~ 158 (199)
T d2omxa2 111 LTLFNNQITDID--PLK--NLTNLNRLELSSNTISD-IS-A--------------------------LSGLTSLQQLNFS 158 (199)
T ss_dssp EECCSSCCCCCG--GGT--TCTTCSEEECCSSCCCC-CG-G--------------------------GTTCTTCSEEECC
T ss_pred cccccccccccc--ccc--hhhhhHHhhhhhhhhcc-cc-c--------------------------ccccccccccccc
Confidence 888777776432 233 57788888888887763 22 1 3347888888888
Q ss_pred CCcCcCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeE
Q 002255 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (947)
Q Consensus 246 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L 289 (947)
+|++++. +.+.++++|++|++++|+++. ++ .++++++|+.|
T Consensus 159 ~n~l~~l-~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 159 SNQVTDL-KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp SSCCCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccCC-ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 8888764 457788888888888888884 44 57888888775
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.67 E-value=3.9e-17 Score=161.68 Aligned_cols=175 Identities=20% Similarity=0.234 Sum_probs=133.7
Q ss_pred CCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCC-CCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEecc
Q 002255 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS-VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (947)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (947)
.++++.++|+|+..++.+. +++++|+|++|+|+. +.+..|.++++|++|+|++|++.. ..+..+..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc-ccccccccccccceeeec
Confidence 3578999999986554553 678999999999975 667788899999999999999876 677888889999999999
Q ss_pred CceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcC
Q 002255 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (947)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (947)
+|+|+...|..|. .+++|++|+|++|+|++..|..|. ++++|++|+|++|.+
T Consensus 87 ~N~l~~l~~~~F~--~l~~L~~L~L~~N~l~~i~~~~f~--------------------------~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 87 ENKIKEISNKMFL--GLHQLKTLNLYDNQISCVMPGSFE--------------------------HLNSLTSLNLASNPF 138 (192)
T ss_dssp SCCCCEECSSSST--TCTTCCEEECCSSCCCEECTTSST--------------------------TCTTCCEEECTTCCB
T ss_pred cccccccCHHHHh--CCCcccccccCCccccccCHHHhc--------------------------CCccccccccccccc
Confidence 9999887777777 688999999999999866665553 478888999999888
Q ss_pred cCCCCCCCCCCCCCEEEccCCccccCCCccccCCCCCCeEeccCCccccc
Q 002255 250 TGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (947)
Q Consensus 250 ~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (947)
........-...++.+.+..|.++...|..+ ..++.++|+.|.|.-.
T Consensus 139 ~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 139 NCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred ccccchHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCC
Confidence 7654321112345666777788877777554 4566778888887643
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=3.1e-16 Score=157.38 Aligned_cols=163 Identities=25% Similarity=0.366 Sum_probs=137.4
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
.++.|+++++++.. ++ .+..+++|++|+|++|++++.. .+..+++|++|++++|+++.++ .+..+++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--ccccccccccccccc
Confidence 68899999999984 33 4888999999999999999754 5788999999999999999876 388999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCC
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~ 225 (947)
|.+.. ...+.+++.|+.+++++|.+++.. .+. .+++|+++++++|++++..+
T Consensus 122 ~~~~~---~~~l~~l~~l~~l~~~~n~l~~~~--~~~--~l~~L~~l~l~~n~l~~i~~--------------------- 173 (210)
T d1h6ta2 122 NGISD---INGLVHLPQLESLYLGNNKITDIT--VLS--RLTKLDTLSLEDNQISDIVP--------------------- 173 (210)
T ss_dssp SCCCC---CGGGGGCTTCCEEECCSSCCCCCG--GGG--GCTTCSEEECCSSCCCCCGG---------------------
T ss_pred ccccc---cccccccccccccccccccccccc--ccc--cccccccccccccccccccc---------------------
Confidence 99854 457899999999999999998533 333 68999999999999985322
Q ss_pred CCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEEEccC
Q 002255 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269 (947)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~ 269 (947)
+.++++|+.|+|++|+++. ++.+.++++|++|+|++
T Consensus 174 -------l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 -------LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp -------GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred -------ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 3458899999999999985 46788899999999864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=1.2e-15 Score=151.63 Aligned_cols=160 Identities=26% Similarity=0.437 Sum_probs=134.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEecc
Q 002255 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 144 (947)
.+++.|+++++++. .++ .+..+++|++|+|++|++++..| +.++++|++|++++|.+..+++ +.++++|++|+++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 47889999999998 443 58889999999999999997654 9999999999999999998764 8899999999999
Q ss_pred CCCCCCCCCcccccCCCCCCeEeccCceeeeccCcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCC
Q 002255 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (947)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~ 224 (947)
+|.+.. ...+..+++|+.|++++|++.. ++ .+. .+++|++|++++|++++..+
T Consensus 115 ~~~~~~---~~~~~~l~~L~~L~l~~n~l~~-~~-~l~--~~~~L~~L~l~~n~l~~l~~-------------------- 167 (199)
T d2omxa2 115 NNQITD---IDPLKNLTNLNRLELSSNTISD-IS-ALS--GLTSLQQLNFSSNQVTDLKP-------------------- 167 (199)
T ss_dssp SSCCCC---CGGGTTCTTCSEEECCSSCCCC-CG-GGT--TCTTCSEEECCSSCCCCCGG--------------------
T ss_pred cccccc---ccccchhhhhHHhhhhhhhhcc-cc-ccc--ccccccccccccccccCCcc--------------------
Confidence 999854 3568899999999999999974 44 354 68999999999999985322
Q ss_pred CCCCchhhhcCCCCCcEEEccCCcCcCCCCCCCCCCCCCEE
Q 002255 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDF 265 (947)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 265 (947)
+.++++|+.|+|++|++++ ++.+.++++|+.|
T Consensus 168 --------l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~~L 199 (199)
T d2omxa2 168 --------LANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199 (199)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-CccccCCCCCCcC
Confidence 3458899999999999986 4567788888875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=6.9e-17 Score=183.33 Aligned_cols=109 Identities=17% Similarity=0.208 Sum_probs=64.5
Q ss_pred cEEEEEecCCcccccC-cccccCCCCCCEEEcccCcccC----cCC-CCCCCCCCcEEecCCCcCCCCC----ccccc-C
Q 002255 66 RVTRIQIGGQNIEGTL-PKELNSLSSLTVLEVMKNKLTG----QIP-SLSGLSSLQEVLFDDNNFTSVP----SDFFK-G 134 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~-p~~l~~l~~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~L~~n~l~~~~----~~~~~-~ 134 (947)
++++||++++++++.- ..-+..+++|++|+|++|.++. .+. .+..+++|++|+|++|+|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4677777777776532 2334556777777777776652 112 3556777777777777765211 11121 2
Q ss_pred CCCCcEEeccCCCCCCC---CCcccccCCCCCCeEeccCceee
Q 002255 135 LTSLQTISLDYNSFDSW---VIPESLKDATGLQRFSANGANIT 174 (947)
Q Consensus 135 l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~ 174 (947)
..+|++|+|++|+++.. .++..+..+++|++|++++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 34677777777776431 13445666777777777777654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1e-14 Score=153.53 Aligned_cols=197 Identities=15% Similarity=0.225 Sum_probs=116.3
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCC-CcccccCCCCCcEEeccCCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV-PSDFFKGLTSLQTISLDYNS 147 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~ 147 (947)
.|||+++.+.......+.. ..+..+.++...+...+.......+|++|+|++|.++.. ....+..+++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 6788887775443333322 245566666666554444555667888888888887642 34457778888888888888
Q ss_pred CCCCCCcccccCCCCCCeEeccCc-eeeecc-CcccCCCCCCCccEEEccCC-cccCc-CCccccCCCCceeeeccCCCC
Q 002255 148 FDSWVIPESLKDATGLQRFSANGA-NITGTI-PDFLGGDTIPGLMHLHLAFN-FLQGP-IPLSFGKSSIQTLWLNGQKGD 223 (947)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~-p~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~L~~L~l~~n~~~ 223 (947)
+.. ..+..++.+++|++|++++| .++... ..... .+++|++|+|+++ .++.. +...+.
T Consensus 83 l~~-~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~--~~~~L~~L~ls~c~~~~~~~~~~~~~--------------- 144 (284)
T d2astb2 83 LSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--SCSRLDELNLSWCFDFTEKHVQVAVA--------------- 144 (284)
T ss_dssp CCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH--HCTTCCEEECCCCTTCCHHHHHHHHH---------------
T ss_pred CCc-HHHHHHhcCCCCcCccccccccccccccchhhH--HHHhccccccccccccccccchhhhc---------------
Confidence 754 45667777888888888885 454221 11122 4678888888875 34321 111111
Q ss_pred CCCCCchhhhcCCCCCcEEEccCCc--CcCC-CCC-CCCCCCCCEEEccCC-ccccCCCccccCCCCCCeEeccCC
Q 002255 224 SKLNGSVAVIQNMTSLTQLWLHGNS--FTGP-LPD-LSGLSSLQDFSVRDN-QLTGIVPSSLVNLHSLAVVNLTNN 294 (947)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~--l~~~-~~~-~~~l~~L~~L~l~~N-~l~g~~p~~l~~l~~L~~L~Ls~N 294 (947)
...++|+.|+++++. ++.. +.. ...+++|++|++++| .+++.....+.++++|++|+|+++
T Consensus 145 ----------~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 145 ----------HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp ----------HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred ----------ccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 123456666666432 2221 111 233566677777664 455555666666777777777663
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=4.9e-14 Score=134.18 Aligned_cols=123 Identities=15% Similarity=0.224 Sum_probs=80.5
Q ss_pred cEEEEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002255 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (947)
Q Consensus 66 ~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 145 (947)
++.+|+|++|+|+ .++..+..+++|+.|+|++|+|+.. +.|..+++|++|++++|+++.+++..+..+++|++|+|++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 4667777777776 4455556677777777777777643 5677777777777777777777776666777777777777
Q ss_pred CCCCCCCCcccccCCCCCCeEeccCceeeeccCc----ccCCCCCCCccEEE
Q 002255 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPD----FLGGDTIPGLMHLH 193 (947)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~----~~~~~~l~~L~~L~ 193 (947)
|+|........+..+++|++|++++|.++.. |. .+. .+|+|++||
T Consensus 97 N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~-~~~r~~~i~--~lp~L~~LD 145 (162)
T d1a9na_ 97 NSLVELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIY--KVPQVRVLD 145 (162)
T ss_dssp CCCCCGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHH--HCTTCSEET
T ss_pred ccccccccccccccccccchhhcCCCccccc-cchHHHHHH--HCCCcCeeC
Confidence 7775422224566677777777777766532 22 233 456666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=1.2e-13 Score=124.72 Aligned_cols=102 Identities=22% Similarity=0.294 Sum_probs=56.6
Q ss_pred EEEecCCcccccCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002255 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (947)
Q Consensus 69 ~l~L~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (947)
.|+|++|+++ .++ .+..+++|++|++++|+|+..++.+..+++|++|++++|+|+.++ .+..+++|++|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC--ccccccccCeEECCCCcc
Confidence 3556666665 333 355666666666666666544335555666666666666666553 255566666666666666
Q ss_pred CCCCCcccccCCCCCCeEeccCceee
Q 002255 149 DSWVIPESLKDATGLQRFSANGANIT 174 (947)
Q Consensus 149 ~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (947)
........+..+++|++|++++|.++
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCC
Confidence 54222234555555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=3.8e-13 Score=121.45 Aligned_cols=103 Identities=19% Similarity=0.270 Sum_probs=87.5
Q ss_pred CEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCc
Q 002255 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (947)
++|+|++|+++. ++.+.++++|++|++++|+|+.+++. |..+++|++|++++|.|.. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~~l~~l~~L~~L~ls~N~l~~lp~~-~~~l~~L~~L~l~~N~i~~--l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN--VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCCCCCGG-GGGCTTCCEEECCSSCCCC--CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-CcccccCCCCCEEECCCCccCcchhh-hhhhhcccccccccccccc--cC-ccccccccCeEECCCC
Confidence 579999999984 46789999999999999999998764 7889999999999999975 44 5899999999999999
Q ss_pred eeeeccC-cccCCCCCCCccEEEccCCcccC
Q 002255 172 NITGTIP-DFLGGDTIPGLMHLHLAFNFLQG 201 (947)
Q Consensus 172 ~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~ 201 (947)
+++.... ..+. .+++|++|+|++|+++.
T Consensus 76 ~i~~~~~~~~l~--~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLV--SCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGG--GCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhc--CCCCCCEEECCCCcCCc
Confidence 9985432 4455 68899999999999974
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=2.1e-14 Score=151.09 Aligned_cols=251 Identities=13% Similarity=0.162 Sum_probs=159.4
Q ss_pred CEEEcccCcccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccC
Q 002255 92 TVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (947)
Q Consensus 92 ~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (947)
+.|||+++.+..... .+.. ..+..+.++.+.+...... .....+|++|||+++.+....+...+.++++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 478999887754322 1111 2355677777666654444 334568999999988876544556678888899999999
Q ss_pred ceeeeccCcccCCCCCCCccEEEccCC-cccCcCCccccCCCCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCC-c
Q 002255 171 ANITGTIPDFLGGDTIPGLMHLHLAFN-FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN-S 248 (947)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N-~ 248 (947)
|.+++..+..++ .+++|++|+|+++ .++... ......++++|++|+|+++ .
T Consensus 81 ~~l~~~~~~~l~--~~~~L~~L~Ls~c~~itd~~-------------------------l~~l~~~~~~L~~L~ls~c~~ 133 (284)
T d2astb2 81 LRLSDPIVNTLA--KNSNLVRLNLSGCSGFSEFA-------------------------LQTLLSSCSRLDELNLSWCFD 133 (284)
T ss_dssp CBCCHHHHHHHT--TCTTCSEEECTTCBSCCHHH-------------------------HHHHHHHCTTCCEEECCCCTT
T ss_pred cCCCcHHHHHHh--cCCCCcCccccccccccccc-------------------------cchhhHHHHhccccccccccc
Confidence 888877777776 6788888888885 444210 0111345789999999986 4
Q ss_pred CcCC-CC-CCC-CCCCCCEEEccCC--cccc-CCCccccCCCCCCeEeccCCc-ccccCCCCCCCcccccccCCCCcccC
Q 002255 249 FTGP-LP-DLS-GLSSLQDFSVRDN--QLTG-IVPSSLVNLHSLAVVNLTNNL-FQGQTPKFNSPVRFDMAKGSNSFCLD 321 (947)
Q Consensus 249 l~~~-~~-~~~-~l~~L~~L~l~~N--~l~g-~~p~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~~~~~~~~~~~~~~~ 321 (947)
++.. +. .+. ..++|+.|+++++ .++. .+...+.++++|++|+|++|. +++....
T Consensus 134 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~------------------- 194 (284)
T d2astb2 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ------------------- 194 (284)
T ss_dssp CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG-------------------
T ss_pred cccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhh-------------------
Confidence 5432 11 122 2478999999975 3443 244445678999999999864 5432211
Q ss_pred cCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCC-CceeeccccccCCccCCeEe
Q 002255 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL-GLSGTISSNFSRLTSLRQLM 400 (947)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n-~l~g~ip~~~~~l~~L~~L~ 400 (947)
.....++|++|+|+++ .+++.....++++++|+.|+
T Consensus 195 -------------------------------------------~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~ 231 (284)
T d2astb2 195 -------------------------------------------EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231 (284)
T ss_dssp -------------------------------------------GGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred -------------------------------------------hhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEe
Confidence 0112346888888884 67776667788888888888
Q ss_pred ccCCcccccCCCcCCCCCCCCccccccccccccCCC
Q 002255 401 LSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (947)
Q Consensus 401 Ls~N~l~g~iP~~l~~l~~L~~L~ls~N~l~g~iP~ 436 (947)
++++--.+.++.-...+++ |.+..++++...+.
T Consensus 232 l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~ 264 (284)
T d2astb2 232 VFGIVPDGTLQLLKEALPH---LQINCSHFTTIARP 264 (284)
T ss_dssp CTTSSCTTCHHHHHHHSTT---SEESCCCSCCTTCS
T ss_pred eeCCCCHHHHHHHHHhCcc---ccccCccCCCCCCC
Confidence 8877222222221223343 44566777665443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=4.3e-16 Score=176.66 Aligned_cols=313 Identities=19% Similarity=0.208 Sum_probs=191.6
Q ss_pred CCCCEEEcccCcccCcC--CCCCCCCCCcEEecCCCcCCC----CCcccccCCCCCcEEeccCCCCCCCC---Cccccc-
Q 002255 89 SSLTVLEVMKNKLTGQI--PSLSGLSSLQEVLFDDNNFTS----VPSDFFKGLTSLQTISLDYNSFDSWV---IPESLK- 158 (947)
Q Consensus 89 ~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~---~p~~~~- 158 (947)
.+|+.||++.|++++.. .-+..+++|++|+|++|.++. .....+..+++|++|||++|+|.... +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998743 236668999999999999883 33445678999999999999985311 223333
Q ss_pred CCCCCCeEeccCceeeec----cCcccCCCCCCCccEEEccCCcccCcCCcccc--------------------------
Q 002255 159 DATGLQRFSANGANITGT----IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG-------------------------- 208 (947)
Q Consensus 159 ~l~~L~~L~l~~n~l~~~----~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-------------------------- 208 (947)
...+|++|+|++|+++.. ++..+. .+++|++|+|++|.++......+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~--~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 159 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLR--TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 159 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTT--SCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred CCCCCCEEECCCCCccccccccccchhh--ccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc
Confidence 245899999999999754 445555 678999999999987532100000
Q ss_pred --------CCCCceeeeccCCCCCC--------------------------CC----CchhhhcCCCCCcEEEccCCcCc
Q 002255 209 --------KSSIQTLWLNGQKGDSK--------------------------LN----GSVAVIQNMTSLTQLWLHGNSFT 250 (947)
Q Consensus 209 --------~~~L~~L~l~~n~~~~~--------------------------~~----~~~~~~~~l~~L~~L~L~~N~l~ 250 (947)
...++.++++++..... .. .....+.....++.+++++|.+.
T Consensus 160 ~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~ 239 (460)
T d1z7xw1 160 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 239 (460)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccc
Confidence 02344444443322100 00 01122445677888888888775
Q ss_pred CCC-----C-CCCCCCCCCEEEccCCccccC----CCccccCCCCCCeEeccCCcccccCCCCCCCcccccc-cCCCCcc
Q 002255 251 GPL-----P-DLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMA-KGSNSFC 319 (947)
Q Consensus 251 ~~~-----~-~~~~l~~L~~L~l~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~-~~~~~~~ 319 (947)
... . .......|+.|++++|.+... ....+...+.++.+++++|.++......+.. .+. .......
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~---~l~~~~~~L~~ 316 (460)
T d1z7xw1 240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE---TLLEPGCQLES 316 (460)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH---HHTSTTCCCCE
T ss_pred ccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc---ccccccccccc
Confidence 421 1 144567899999999988743 3345667889999999999987421110000 000 0000001
Q ss_pred cCcCCCcCCCccceeeecccccCChhhhhccCCCCCCCCCCCCCcccCCCCceeEEEecCCCcee----ecccccc-CCc
Q 002255 320 LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFS-RLT 394 (947)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g----~ip~~~~-~l~ 394 (947)
+......+.... ... +.. .+....+|+.|+|++|+++. .++..+. ..+
T Consensus 317 l~l~~~~l~~~~------~~~------l~~---------------~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~ 369 (460)
T d1z7xw1 317 LWVKSCSFTAAC------CSH------FSS---------------VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 369 (460)
T ss_dssp EECTTSCCBGGG------HHH------HHH---------------HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred ccccccchhhhh------hhh------ccc---------------ccccccchhhhheeeecccCcccchhhhhhhcccC
Confidence 111111110000 000 000 00112368899999998875 3444454 456
Q ss_pred cCCeEeccCCcccc----cCCCcCCCCCCCCcccccccccccc
Q 002255 395 SLRQLMLSGNELTG----TIPKELTTLPSLEMLDVSNNHLFGK 433 (947)
Q Consensus 395 ~L~~L~Ls~N~l~g----~iP~~l~~l~~L~~L~ls~N~l~g~ 433 (947)
.|++|+|++|+|+. .++..+..+++|++|||++|+|+..
T Consensus 370 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 79999999999974 3555666778899999999998643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=1.8e-14 Score=156.54 Aligned_cols=196 Identities=16% Similarity=0.153 Sum_probs=109.8
Q ss_pred cCcccccCCCCCCEEEcccCcccCcC-----CCCCCCCCCcEEecCCCcCCCCCc----------ccccCCCCCcEEecc
Q 002255 80 TLPKELNSLSSLTVLEVMKNKLTGQI-----PSLSGLSSLQEVLFDDNNFTSVPS----------DFFKGLTSLQTISLD 144 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~L~~n~l~~~~~----------~~~~~l~~L~~L~Ls 144 (947)
.+...+.+.+.|+.|+|++|.++..- ..+...++|+.|+++++.+..... ..+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 34455777788888998888875421 146677888888888776543321 224456677777777
Q ss_pred CCCCCCCC---CcccccCCCCCCeEeccCceeeeccCcccCC-----------CCCCCccEEEccCCcccCcCCccccCC
Q 002255 145 YNSFDSWV---IPESLKDATGLQRFSANGANITGTIPDFLGG-----------DTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (947)
Q Consensus 145 ~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-----------~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 210 (947)
+|.+.... +...+...++|++|++++|.+...-...++. ...+.|+.|++++|+++...-..
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~---- 177 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE---- 177 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH----
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccc----
Confidence 77764311 2233445566666666666553211111100 01234445555555443111111
Q ss_pred CCceeeeccCCCCCCCCCchhhhcCCCCCcEEEccCCcCcCC-----C-CCCCCCCCCCEEEccCCccccC----CCccc
Q 002255 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP-----L-PDLSGLSSLQDFSVRDNQLTGI----VPSSL 280 (947)
Q Consensus 211 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~-~~~~~l~~L~~L~l~~N~l~g~----~p~~l 280 (947)
....+...+.|+.|+|++|.++.. + ..+..+++|+.|+|++|.++.. +...+
T Consensus 178 ------------------l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l 239 (344)
T d2ca6a1 178 ------------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239 (344)
T ss_dssp ------------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred ------------------ccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence 112244456777777777776542 1 2245566777777777776532 34455
Q ss_pred cCCCCCCeEeccCCccc
Q 002255 281 VNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 281 ~~l~~L~~L~Ls~N~l~ 297 (947)
..+++|++|+|++|.++
T Consensus 240 ~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 240 KSWPNLRELGLNDCLLS 256 (344)
T ss_dssp GGCTTCCEEECTTCCCC
T ss_pred cccccchhhhhhcCccC
Confidence 66777777777777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=5.2e-13 Score=126.89 Aligned_cols=66 Identities=11% Similarity=0.154 Sum_probs=42.9
Q ss_pred CCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeEeccCceee
Q 002255 105 IPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT 174 (947)
Q Consensus 105 ~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (947)
.|.+.++.+|++|+|++|+|+.++ ..+..+++|++|+|++|+|.. + +.+..+++|++|++++|+++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~~i~-~~~~~l~~L~~L~Ls~N~i~~--l-~~~~~l~~L~~L~ls~N~i~ 76 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRK--L-DGFPLLRRLKTLLVNNNRIC 76 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCCE--E-CCCCCCSSCCEEECCSSCCC
T ss_pred hHhccCcCcCcEEECCCCCCCccC-ccccccccCCEEECCCCCCCc--c-CCcccCcchhhhhccccccc
Confidence 356677778888888888888775 446677788888888887754 2 23444444444444444444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.21 E-value=8.4e-13 Score=143.14 Aligned_cols=232 Identities=17% Similarity=0.188 Sum_probs=163.4
Q ss_pred CcEEEEEecCCcccc----cCcccccCCCCCCEEEcccCcccCcC---C--------CCCCCCCCcEEecCCCcCCCCC-
Q 002255 65 NRVTRIQIGGQNIEG----TLPKELNSLSSLTVLEVMKNKLTGQI---P--------SLSGLSSLQEVLFDDNNFTSVP- 128 (947)
Q Consensus 65 ~~v~~l~L~~~~l~g----~~p~~l~~l~~L~~L~L~~N~l~~~~---p--------~~~~l~~L~~L~L~~n~l~~~~- 128 (947)
..+++|+|++|.+.. .+...+...++|+.|+++++.+.... + .+..+++|++|+|++|.++...
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence 468899999988754 24455778899999999987654321 1 2566889999999999988643
Q ss_pred ---cccccCCCCCcEEeccCCCCCCCC------------CcccccCCCCCCeEeccCceeeec----cCcccCCCCCCCc
Q 002255 129 ---SDFFKGLTSLQTISLDYNSFDSWV------------IPESLKDATGLQRFSANGANITGT----IPDFLGGDTIPGL 189 (947)
Q Consensus 129 ---~~~~~~l~~L~~L~Ls~N~l~~~~------------~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~~~l~~L 189 (947)
...+...++|++|++++|.+.... ........+.|+.|++++|+++.. +...+. ..+.|
T Consensus 111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~--~~~~L 188 (344)
T d2ca6a1 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SHRLL 188 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH--HCTTC
T ss_pred cchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh--hhhhh
Confidence 234556789999999999873200 011224577899999999988633 222233 46789
Q ss_pred cEEEccCCcccCc-----CCccccC-CCCceeeeccCCCCCCCCC-chhhhcCCCCCcEEEccCCcCcCCCC-----CCC
Q 002255 190 MHLHLAFNFLQGP-----IPLSFGK-SSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGPLP-----DLS 257 (947)
Q Consensus 190 ~~L~Ls~N~l~~~-----~p~~~~~-~~L~~L~l~~n~~~~~~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~ 257 (947)
+.|+|++|+++.. +...+.. .+|+.|+|++|.+...... ....+..+++|++|+|++|.|++... .+.
T Consensus 189 ~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~ 268 (344)
T d2ca6a1 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268 (344)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhh
Confidence 9999999998642 2222322 5799999999876543222 22457788999999999999976422 122
Q ss_pred --CCCCCCEEEccCCccccC----CCcccc-CCCCCCeEeccCCcccc
Q 002255 258 --GLSSLQDFSVRDNQLTGI----VPSSLV-NLHSLAVVNLTNNLFQG 298 (947)
Q Consensus 258 --~l~~L~~L~l~~N~l~g~----~p~~l~-~l~~L~~L~Ls~N~l~g 298 (947)
....|+.|++++|+|+.. +...+. ++++|++|+|++|++..
T Consensus 269 ~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 269 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 346799999999999743 344453 67899999999999964
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=3.1e-11 Score=113.56 Aligned_cols=98 Identities=19% Similarity=0.244 Sum_probs=69.0
Q ss_pred cCCcccccCcccccCCCCCCEEEcccC-cccCcCC-CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002255 73 GGQNIEGTLPKELNSLSSLTVLEVMKN-KLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150 (947)
Q Consensus 73 ~~~~l~g~~p~~l~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 150 (947)
.++++. .+|..+..+++|++|+|++| .|+...+ .|.++++|+.|+|++|+|+.+++.+|..+++|++|+|++|+|..
T Consensus 16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 94 (156)
T d2ifga3 16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES 94 (156)
T ss_dssp CSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred cCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc
Confidence 334444 55677778888888888765 4776555 68888888888888888888888888888888888888888864
Q ss_pred CCCcccccCCCCCCeEeccCcee
Q 002255 151 WVIPESLKDATGLQRFSANGANI 173 (947)
Q Consensus 151 ~~~p~~~~~l~~L~~L~l~~n~l 173 (947)
+|.......+|+.|+|++|.+
T Consensus 95 --l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 95 --LSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp --CCSTTTCSCCCCEEECCSSCC
T ss_pred --cChhhhccccccccccCCCcc
Confidence 443333333455555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=8.3e-11 Score=110.56 Aligned_cols=109 Identities=16% Similarity=0.196 Sum_probs=90.2
Q ss_pred CCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCC-cCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccCCCCCCeE
Q 002255 88 LSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN-NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (947)
Q Consensus 88 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (947)
....+.++.+++.+...+..+.++++|++|++++| .|+.+++..|.++++|+.|+|++|+|+. ..+..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC-cccccccccccccce
Confidence 34456788999888876668899999999999766 5999999999999999999999999976 557789999999999
Q ss_pred eccCceeeeccCcccCCCCCCCccEEEccCCccc
Q 002255 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (947)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~ 200 (947)
+|++|+|+...+..+. ...|++|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~---~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQ---GLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTC---SCCCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhc---cccccccccCCCccc
Confidence 9999999854444443 447889999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.13 E-value=3.4e-13 Score=132.97 Aligned_cols=56 Identities=21% Similarity=0.286 Sum_probs=32.4
Q ss_pred CCCCCcEEEccCCcCcCCC--CCCCCCCCCCEEEccCCccccCCCc----------cccCCCCCCeEe
Q 002255 235 NMTSLTQLWLHGNSFTGPL--PDLSGLSSLQDFSVRDNQLTGIVPS----------SLVNLHSLAVVN 290 (947)
Q Consensus 235 ~l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~g~~p~----------~l~~l~~L~~L~ 290 (947)
++++|+.|+|++|+++... ..+..+++|++|+|++|.+....+. .+..+++|+.||
T Consensus 113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 3455666666666655432 2355566666666666666533322 256788888876
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.13 E-value=3.7e-13 Score=132.74 Aligned_cols=118 Identities=22% Similarity=0.270 Sum_probs=98.3
Q ss_pred cCcccccCCCCCCEEEcccCcccCcCCCCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCCcccccC
Q 002255 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKD 159 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~ 159 (947)
.++..|..|++|++|+|++|+|+. ++.+.++++|++|+|++|+|+.+++ .+..+++|++|++++|+++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~~--l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIAS--L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECCC--H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cccccCCccccChhhcccccccccc-cccccccccccccccccccc--c-ccccc
Confidence 566789999999999999999985 4678999999999999999998764 35556789999999999975 3 45888
Q ss_pred CCCCCeEeccCceeeeccC-cccCCCCCCCccEEEccCCcccCcCC
Q 002255 160 ATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIP 204 (947)
Q Consensus 160 l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (947)
+++|+.|++++|+++.... ..+. .+++|++|+|++|.+....+
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~--~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccccchhcccccccccc--CCCccceeecCCCccccCcc
Confidence 9999999999999985422 3455 68999999999999875544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=2.1e-07 Score=95.39 Aligned_cols=149 Identities=15% Similarity=0.099 Sum_probs=103.4
Q ss_pred HHHHHHhcCCCcCceecccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCC-CCCcceEEEEEEeCC
Q 002255 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (947)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 661 (947)
.+++...+.|+..+..+.++.+.||+.... ++.+++|+..... ......+.+|+.+++.+. +--+.+++++...++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 456666678877776555556789998654 6678888876442 112335678888888774 333567888888889
Q ss_pred eeEEEEEecCCCchhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhhc-----------------------------
Q 002255 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL----------------------------- 712 (947)
Q Consensus 662 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~----------------------------- 712 (947)
..++||++++|.++.+..... .. ...++.++++.++.||+.
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 999999999998886544211 11 223456666666667641
Q ss_pred ---------------------------cCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 713 ---------------------------AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 713 ---------------------------~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987777899998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=5e-08 Score=91.80 Aligned_cols=64 Identities=14% Similarity=0.249 Sum_probs=31.7
Q ss_pred CCCCCcEEecCCCcCCCCCc--ccccCCCCCcEEeccCCCCCCCCCcc-cccCCCCCCeEeccCceeee
Q 002255 110 GLSSLQEVLFDDNNFTSVPS--DFFKGLTSLQTISLDYNSFDSWVIPE-SLKDATGLQRFSANGANITG 175 (947)
Q Consensus 110 ~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~ 175 (947)
.+++|++|+|++|+|+.+.+ ..+..+++|++|+|++|+|.. +++ .+....+|+.|++++|.+..
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~--l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS--ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC--GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc--chhhhhhhccccceeecCCCCcCc
Confidence 45555555555555554432 334455566666666666543 221 12223345555555555543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.1e-05 Score=81.49 Aligned_cols=130 Identities=18% Similarity=0.144 Sum_probs=86.6
Q ss_pred eecccCc-eEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCC--CCcceEEEEEEeCCeeEEEEEecCCC
Q 002255 597 VLGRGGF-GTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLVYEYMPQG 673 (947)
Q Consensus 597 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 673 (947)
.+..|.. +.||+...+++..+++|.-.... ...+..|+..++.+.. -.+.+++++..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 68999988888889999765442 2346778888887743 33567888888888899999999887
Q ss_pred chhhhhhcccccCCCcccHHHHHHHHHHHHHHHHHHhh------------------------------------------
Q 002255 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG------------------------------------------ 711 (947)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------ 711 (947)
++.+.. .. ...++.++++.|+-||+
T Consensus 92 ~~~~~~----------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 92 DLLSSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp ETTTSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccc----------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 664311 00 01112233333333332
Q ss_pred ---------c----cCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 712 ---------L----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 712 ---------~----~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
. ....++|+|+.|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12237999999999999987777899998654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=5.9e-07 Score=84.23 Aligned_cols=71 Identities=20% Similarity=0.098 Sum_probs=58.3
Q ss_pred cCcccccCCCCCCEEEcccCcccCcCC---CCCCCCCCcEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002255 80 TLPKELNSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150 (947)
Q Consensus 80 ~~p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 150 (947)
.++.....+++|++|+|++|+|+...+ .+..+++|+.|+|++|.|+.+..-.+....+|+.|+|++|.+..
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 444445678999999999999987543 36779999999999999999887555556689999999999965
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00041 Score=74.41 Aligned_cols=78 Identities=13% Similarity=0.127 Sum_probs=48.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeccccc-C----hHHHHHHHHHHHHHHcCC-C-C-CcceEEEEEEeCCeeEEE
Q 002255 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-S----EKGFAEFKSEIAVLTKVR-H-R-HLVGLLGYCLDGNERLLV 666 (947)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~----~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lV 666 (947)
+.||.|....||++... +++.|+||.-..... . .....+...|++.++.+. + | .+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 56899999999999765 467899996432210 0 112234566888887763 3 3 34455544 45566899
Q ss_pred EEecCCCch
Q 002255 667 YEYMPQGTL 675 (947)
Q Consensus 667 ~e~~~~gsL 675 (947)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999977543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.16 E-value=4.9e-05 Score=71.00 Aligned_cols=62 Identities=18% Similarity=0.110 Sum_probs=36.8
Q ss_pred CCCCCcEEEccCCcCcCCCC-----CCCCCCCCCEEEccCCcccc-------CCCccccCCCCCCeEeccCCcc
Q 002255 235 NMTSLTQLWLHGNSFTGPLP-----DLSGLSSLQDFSVRDNQLTG-------IVPSSLVNLHSLAVVNLTNNLF 296 (947)
Q Consensus 235 ~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~g-------~~p~~l~~l~~L~~L~Ls~N~l 296 (947)
..++|+.|+|++|.++...- .+...++|++|+|++|.+.. .+...+...++|+.|+++.+..
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 34566666666666654211 24555667777777665442 1445556677888888876654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.11 E-value=4.8e-05 Score=71.07 Aligned_cols=86 Identities=8% Similarity=0.152 Sum_probs=41.0
Q ss_pred CCCCCCEEEcccC-cccCcC-----CCCCCCCCCcEEecCCCcCCC----CCcccccCCCCCcEEeccCCCCCCCC---C
Q 002255 87 SLSSLTVLEVMKN-KLTGQI-----PSLSGLSSLQEVLFDDNNFTS----VPSDFFKGLTSLQTISLDYNSFDSWV---I 153 (947)
Q Consensus 87 ~l~~L~~L~L~~N-~l~~~~-----p~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~---~ 153 (947)
+.++|+.|+|+++ .++... ..+...+.|++|+|++|.++. .....+...+.|++|+|++|.|.... +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456666666653 343210 134445556666666665551 22223344455666666666653211 1
Q ss_pred cccccCCCCCCeEeccCce
Q 002255 154 PESLKDATGLQRFSANGAN 172 (947)
Q Consensus 154 p~~~~~l~~L~~L~l~~n~ 172 (947)
-..+...+.|++|++++|.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp HHHTTTTCCCSEEECCCCS
T ss_pred HHHHHhCCcCCEEECCCCc
Confidence 1234444455555555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.88 E-value=0.0018 Score=67.25 Aligned_cols=68 Identities=10% Similarity=0.046 Sum_probs=46.5
Q ss_pred eEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc--ceEE-----EEEEeCCeeEEEEEecCCCc
Q 002255 604 GTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL--VGLL-----GYCLDGNERLLVYEYMPQGT 674 (947)
Q Consensus 604 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~gs 674 (947)
-.||+++.++|+.|++|+.+....+ .+++..|...+..|....+ +..+ ..+..++..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 5899999999999999998765333 3567778888888743222 1111 12234667789999997653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.32 E-value=0.01 Score=61.05 Aligned_cols=160 Identities=11% Similarity=0.021 Sum_probs=85.6
Q ss_pred ecHHHHHHHhcCCCcCceec-----ccCceEEEEEEEcCCcEEEEEEecccccChHHHHHHHHHHHHHHcCCCC-----C
Q 002255 580 ISIQVLRNVTNNFSEENVLG-----RGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR-----H 649 (947)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-----n 649 (947)
.+.++++.+..+|.++++.. .|---+.|+.+..+| .+++|++.... ..+++..|++++..+... .
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccc
Confidence 35578888889998765544 455577899988765 58999876431 123455677777777432 2
Q ss_pred cceEE---EEEEeCCeeEEEEEecCCCchhhh--------------hhcc------cccCCCcccHH-------------
Q 002255 650 LVGLL---GYCLDGNERLLVYEYMPQGTLSRH--------------LFNR------KEEGLKPLEWT------------- 693 (947)
Q Consensus 650 iv~l~---~~~~~~~~~~lV~e~~~~gsL~~~--------------l~~~------~~~~~~~~~~~------------- 693 (947)
.+... .+.........++.++.+...... ++.. .........|.
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22111 012234556677777766433110 0000 00000000000
Q ss_pred ---HHHHHHHHHHHHHHHHhh-ccCCCeeecCCCCCcEEEcCCCcEEEeecCcce
Q 002255 694 ---RRLTIALDVARGVEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (947)
Q Consensus 694 ---~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 744 (947)
.....+..+...+...+. ....++||+|+.+.||+++.+...-|+||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222222222221 125689999999999999998888899999754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.26 E-value=0.00015 Score=67.49 Aligned_cols=114 Identities=12% Similarity=0.149 Sum_probs=63.2
Q ss_pred cccCCCCCCEEEccc-CcccCcC--C---CCCCCCCCcEEecCCCcCCCC----CcccccCCCCCcEEeccCCCCCCCC-
Q 002255 84 ELNSLSSLTVLEVMK-NKLTGQI--P---SLSGLSSLQEVLFDDNNFTSV----PSDFFKGLTSLQTISLDYNSFDSWV- 152 (947)
Q Consensus 84 ~l~~l~~L~~L~L~~-N~l~~~~--p---~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~- 152 (947)
...+.+.|++|+|++ +.++... . .+...++|++|+|++|.++.. ....+...++|+.|++++|.+....
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 344567777777776 4454321 1 355667777777777776632 2233455677777777777764311
Q ss_pred --CcccccCCCCCCeEec--cCceeee----ccCcccCCCCCCCccEEEccCCcc
Q 002255 153 --IPESLKDATGLQRFSA--NGANITG----TIPDFLGGDTIPGLMHLHLAFNFL 199 (947)
Q Consensus 153 --~p~~~~~l~~L~~L~l--~~n~l~~----~~p~~~~~~~l~~L~~L~Ls~N~l 199 (947)
+-..+...++|+.++| ++|.+.. .+...+. ..++|+.|+++.+..
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~--~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLE--KNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHH--HCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHH--hCCCcCEEeCcCCCC
Confidence 2244555666665444 3445532 2333333 355677777665544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.21 E-value=0.0077 Score=64.18 Aligned_cols=73 Identities=21% Similarity=0.241 Sum_probs=49.0
Q ss_pred CceecccCceEEEEEEEcCC--------cEEEEEEecccccChHHHHHHHHHHHHHHcCCCCCc-ceEEEEEEeCCeeEE
Q 002255 595 ENVLGRGGFGTVYKGELHDG--------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLL 665 (947)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 665 (947)
.+.|+.|-.=.+|++..+++ +.|.+++.. .. . ......+|..+++.+.-.++ .++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 35788888889999987643 456666554 21 1 12345689999998853344 467776642 68
Q ss_pred EEEecCCCch
Q 002255 666 VYEYMPQGTL 675 (947)
Q Consensus 666 V~e~~~~gsL 675 (947)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.43 E-value=0.00062 Score=63.15 Aligned_cols=118 Identities=14% Similarity=0.164 Sum_probs=75.5
Q ss_pred cccCCCCCCeEeccC-ceeeecc----CcccCCCCCCCccEEEccCCcccCcCCccccCCCCceeeeccCCCCCCCCCch
Q 002255 156 SLKDATGLQRFSANG-ANITGTI----PDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230 (947)
Q Consensus 156 ~~~~l~~L~~L~l~~-n~l~~~~----p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~~~~~ 230 (947)
...+.+.|++|+|++ +.++... -..+. ..++|++|+|++|.++...-..++
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~--~n~~L~~L~Ls~n~l~~~~~~~L~---------------------- 67 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALK--TNTYVKKFSIVGTRSNDPVAFALA---------------------- 67 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHT--TCCSCCEEECTTSCCCHHHHHHHH----------------------
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHh--cCCccCeeeccCCcccHHHHHHHH----------------------
Confidence 344567888888887 4454322 22222 456788888888877643222221
Q ss_pred hhhcCCCCCcEEEccCCcCcCCC-----CCCCCCCCCCEEEc--cCCcccc----CCCccccCCCCCCeEeccCCccc
Q 002255 231 AVIQNMTSLTQLWLHGNSFTGPL-----PDLSGLSSLQDFSV--RDNQLTG----IVPSSLVNLHSLAVVNLTNNLFQ 297 (947)
Q Consensus 231 ~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l--~~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~ 297 (947)
..+...++|+.|++++|.++... ..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|...
T Consensus 68 ~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 68 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 23455688889999988886532 23666788887555 5677753 35566778899999999877653
|